Citrus Sinensis ID: 009594

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-
Protein Sequence
MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccccccccEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHHcccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccHHHHHHHHHHHcccccccEEHHHHHHHHccHHHHccHHHHHHHHHHHcccccccccHHHHHHHHccccccccHHHHHHHHHHHcccccccccHHHHHHHHHcccccccHHHHHHHHccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHEEccHHccccccEEEEEEEccccccEEEEHHHHHHHcccHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccccccEEEcccEEEEEccccEEEcccccHHHHcHHHHHHHEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccHHHHccccHHHHHHHHccccccHHHcccHHHHHHcHHHHccHHHccccccccHHHHHHHHHHHccHHHHHHHHHcccccHHHHHHHHHHHHHHccccccEEcHHHHHHHHHcccccccHHHHHHHHHHHcccccccEEHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccEcHHHHHHHHHcccccccHHHHHHHHHHHcccccccEcHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
mgnccarpdsssgkrakgkkekpnpfygdeyvvangsTVVHRLCVlkepsgqdisidydlgrelgrgefgvtylctdvnngekfACKSIskkklrtavdiEDVRREVQIMkhlpkhpnivslkdtyeddsAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHeqgvmhrdlkpenflfankkessplkaidfglsvffrpgeqfneivgspyymapevlkrnygpevdvwSAGVILYILLCgvppfwaetEQGVAQAIIRSVIdfkrdpwpkvsENAKDLVKKmlnpdpkqrltaeevlehpwlqnakkapnvslgETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLlkggqnipeaDLQILMEAadvdgdgslnygEFVAVSVHLKKMANDEHLHKAFSFfdrnrsgfiEIEELRNALndevdtsgEDVINAIMhdvdtdkdgriSYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN
Flexible Loop (DISEMBL)
mgnccarpdsssgkrakgkkekpnpfyGDEYVVANGSTVVHRLCVlkepsgqdisiDYDLGRELGRGEFGVTYLCTDVNNGEkfacksiskkklrtavdieDVRREVQimkhlpkhpnivslKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVidfkrdpwpkVSENAKDLVKKMLNPDPKQRLTAEEvlehpwlqnakkapnvslgETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAimhdvdtdkdgRISYEEFAVMMKAgtdwrkasrqysRERFnsislklmreeglqlan
Low Complexity Region (SEG)
MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINleelrlgllkggQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN
Disordered region (IsUnstruct)
*************************FYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP*****************************HPWLQ*******VSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWR****************************
Disordered Region (DISOPRED)
*G**********************************************PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK******L**TVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV**SGEDVINAIMHDVDTDKDGRISYEEFAVMM***********************************
Disordered Region (DISEMBL)
*********************KPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN
Disordered Region (DISPRO)
**********************************************KEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA**********YS***F*S*S*KLMREEG*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	531	2.2.26 [Sep-21-2011]
Q42438	533	Calcium-dependent protein	yes	no	0.994	0.990	0.826	0.0
Q38873	535	Calcium-dependent protein	no	no	0.996	0.988	0.819	0.0
Q6NLQ6	538	Calcium-dependent protein	no	no	0.992	0.979	0.738	0.0
P93759	530	Calcium-dependent protein	no	no	0.981	0.983	0.704	0.0
Q8W4I7	528	Calcium-dependent protein	no	no	0.992	0.998	0.657	0.0
Q9SSF8	541	Calcium-dependent protein	no	no	0.994	0.975	0.661	0.0
Q9M9V8	545	Calcium-dependent protein	no	no	0.992	0.966	0.654	0.0
Q9SIQ7	582	Calcium-dependent protein	no	no	0.988	0.902	0.591	0.0
Q9FMP5	528	Calcium-dependent protein	no	no	0.854	0.859	0.598	1e-165
Q3E9C0	523	Calcium-dependent protein	no	no	0.928	0.942	0.544	1e-163

>sp|Q42438|CDPK8_ARATH Calcium-dependent protein kinase 8 OS=Arabidopsis thaliana GN=CPK8 PE=1 SV=1

 Score =  920 bits (2379), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/530 (82%), Positives = 480/530 (90%), Gaps = 2/530 (0%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
           MGNCCA P S +G +    K K NPFY + Y   NGS    +L VLK+P+G DIS+ YDL
Sbjct: 1   MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTT-NGSGTGFKLSVLKDPTGHDISLMYDL 59

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
           GRE+GRGEFG+TYLCTD+  GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+P+HPNIV
Sbjct: 60  GREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIV 119

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           SLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI+EVVQ+CH+ GVMH
Sbjct: 120 SLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMH 179

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
           RDLKPENFLFANKKE+S LKAIDFGLSVFF+PGE FNEIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 180 RDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVD 239

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VSE AKDLV+KML PD
Sbjct: 240 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPD 299

Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
           PK+RL+A +VLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 300 PKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 359

Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAADVDGDGSLNYGE 419
           VAG+KEAFEMMD+ K GKINLEEL+ GL K G Q IP+ DLQILMEAADVDGDG+LNYGE
Sbjct: 360 VAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAADVDGDGTLNYGE 419

Query: 420 FVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDV 479
           FVAVSVHLKKMANDEHLHKAFSFFD+N+S +IEIEELR ALNDEVDT+ E+V+ AIM DV
Sbjct: 420 FVAVSVHLKKMANDEHLHKAFSFFDQNQSDYIEIEELREALNDEVDTNSEEVVAAIMQDV 479

Query: 480 DTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
           DTDKDGRISYEEFA MMKAGTDWRKASRQYSRERFNS+SLKLMRE  LQL
Sbjct: 480 DTDKDGRISYEEFAAMMKAGTDWRKASRQYSRERFNSLSLKLMREGSLQL 529

May play a role in signal transduction pathways that involve calcium as a second messenger.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q38873|CDPK7_ARATH Calcium-dependent protein kinase 7 OS=Arabidopsis thaliana GN=CPK7 PE=1 SV=1

 Score =  919 bits (2375), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/531 (81%), Positives = 481/531 (90%), Gaps = 2/531 (0%)

Query: 1   MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
           MGNCC  P S++ +  +GK K K NPFY +EY   + S    +L VLK+P+G DIS+ YD
Sbjct: 1   MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           LGRE+GRGEFG+TYLCTD   GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPN+
Sbjct: 61  LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
           VSLKD++EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ+CH+QGVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
           HRDLKPENFLFANKKE+S LKAIDFGLSVFF+PGEQFNEIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240

Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
           DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS++AKDLV+KML P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300

Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
           DPK+RLTA +VLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360

Query: 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGE 419
           E AG+KEAFEMMD NKRGKINLEEL+ GL K GQ I + DLQILMEA DVDGDG+LNY E
Sbjct: 361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEATDVDGDGTLNYSE 420

Query: 420 FVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-TSGEDVINAIMHD 478
           FVAVSVHLKKMANDEHLHKAF+FFD+N+SG+IEI+ELR ALNDE+D TS E+VI AIM D
Sbjct: 421 FVAVSVHLKKMANDEHLHKAFNFFDQNQSGYIEIDELREALNDELDNTSSEEVIAAIMQD 480

Query: 479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
           VDTDKDGRISYEEF  MMKAGTDWRKASRQYSRERFNS+SLKLMR+  LQL
Sbjct: 481 VDTDKDGRISYEEFVAMMKAGTDWRKASRQYSRERFNSLSLKLMRDGSLQL 531

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6NLQ6|CDPKW_ARATH Calcium-dependent protein kinase 32 OS=Arabidopsis thaliana GN=CPK32 PE=1 SV=1

 Score =  823 bits (2126), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/535 (73%), Positives = 463/535 (86%), Gaps = 8/535 (1%)

Query: 1   MGNCCARPDS---SSGKRAKGKKEKPNPFYGDEYVVANGSTVVHR---LCVLKEPSGQDI 54
           MGNCC    S   +  K  KG+K K NPF  D  +   G     R   L VL +P+G++I
Sbjct: 1   MGNCCGTAGSLAQNDNKPKKGRK-KQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREI 59

Query: 55  SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
              Y LGRELGRGEFGVTYLCTD    + FACKSI KKKLRTAVDIEDVRREV+IM+H+P
Sbjct: 60  ESKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMP 119

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+V+LK+TYED+ AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQVCH
Sbjct: 120 EHPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCH 179

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
           + GVMHRDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRN
Sbjct: 180 KHGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRN 239

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YGPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDL++
Sbjct: 240 YGPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIR 299

Query: 295 KMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAE 354
           KML+PD K+RLTA++VL+HPWLQNAK APNVSLGETV+ARLKQF+VMNKLKKRAL+V+AE
Sbjct: 300 KMLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIAE 359

Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGS 414
            LS EE +G++E F++MDT++RGKIN++EL++GL K G  IP+ DLQILM+A D+D DG 
Sbjct: 360 HLSDEEASGIREGFQIMDTSQRGKINIDELKIGLQKLGHAIPQDDLQILMDAGDIDRDGY 419

Query: 415 LNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           L+  EF+A+SVHL+KM NDEHL KAF+FFD+N +G+IEIEELR AL+DE+ TS E+V++A
Sbjct: 420 LDCDEFIAISVHLRKMGNDEHLKKAFAFFDQNNNGYIEIEELREALSDELGTS-EEVVDA 478

Query: 475 IMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
           I+ DVDTDKDGRISYEEF  MMK GTDWRKASRQYSRERFNSISLKLM++  LQ+
Sbjct: 479 IIRDVDTDKDGRISYEEFVTMMKTGTDWRKASRQYSRERFNSISLKLMQDASLQV 533

May play a role in signal transduction pathways that involve calcium as a second messenger. Functions as regulator of the calcium-mediated abscisic acid (ABA) signaling pathway. Phosphorylates ABA-responsive transcription factor ABF4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P93759|CDPKE_ARATH Calcium-dependent protein kinase 14 OS=Arabidopsis thaliana GN=CPK14 PE=2 SV=1

 Score =  797 bits (2059), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/531 (70%), Positives = 456/531 (85%), Gaps = 10/531 (1%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPF---YGDEYVVANGSTVVHRLCVLKEPSGQDISID 57
           MGNCC    S    + K   + PNPF   YG+ +   +G     +L VLKEP+G +I   
Sbjct: 1   MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHH---DGL----KLIVLKEPTGHEIKQK 53

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LGRELGRGEFGVTYLCT++  GE FACKSI KKKL+T++DIEDV+REV+IM+ +P+HP
Sbjct: 54  YKLGRELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHP 113

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV+LK+TYEDD AVH+VMELCEGGELFDRIVARGHYTERAAA+V+KTI+EVVQ+CH+ G
Sbjct: 114 NIVTLKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHG 173

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           VMHRDLKPENFLFANKKE++ LKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVL+R+YG 
Sbjct: 174 VMHRDLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQ 233

Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           E+D+WSAGVILYILLCGVPPFWAETE GVA+AI++SVIDFKRDPWPKVS+NAKDL+KKML
Sbjct: 234 EIDIWSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKML 293

Query: 298 NPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLS 357
           +PDP++RLTA++VL+HPW+QN K A NVSLGETV+ARLKQFSVMNKLKKRAL+V+AE LS
Sbjct: 294 HPDPRRRLTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLS 353

Query: 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNY 417
           VEE + +KE F++MDT+ RGKI + EL +GL K G  +P+ D+QILM+A DVD DG L+ 
Sbjct: 354 VEETSCIKERFQVMDTSNRGKITITELGIGLQKLGIVVPQDDIQILMDAGDVDKDGYLDV 413

Query: 418 GEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH 477
            EFVA+SVH++K+ NDEHL KAF+FFD+N+SG+IEIEELR+AL D+VDT+ E+V+ AI+ 
Sbjct: 414 NEFVAISVHIRKLGNDEHLKKAFTFFDKNKSGYIEIEELRDALADDVDTTSEEVVEAIIL 473

Query: 478 DVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQ 528
           DVDT+KDG+ISY+EFA MMK GTDWRKASRQYSR+ F  +SLKLM++  LQ
Sbjct: 474 DVDTNKDGKISYDEFATMMKTGTDWRKASRQYSRDLFKCLSLKLMQDGSLQ 524

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8W4I7|CDPKD_ARATH Calcium-dependent protein kinase 13 OS=Arabidopsis thaliana GN=CPK13 PE=1 SV=2

 Score =  724 bits (1870), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/531 (65%), Positives = 427/531 (80%), Gaps = 4/531 (0%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
           MGNCC  P + + +  K      +    D    A G      + VL +   ++I   Y L
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSGHDHARKD----AAGGKKSAPIRVLSDVPKENIEDRYLL 56

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
            RELGRGEFGVTYLC + ++ +  ACKSISK+KLRTAVDIEDV+REV IMKHLPK  +IV
Sbjct: 57  DRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIV 116

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           +LK+  EDD+AVH+VMELCEGGELFDRIVARGHYTERAAA V KTIVEVVQ+CH+ GV+H
Sbjct: 117 TLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIH 176

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
           RDLKPENFLFANKKE+SPLKAIDFGLS+FF+PGE+F+EIVGSPYYMAPEVLKRNYGPE+D
Sbjct: 177 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEID 236

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WSAGVILYILLCGVPPFWAE+EQGVAQAI+R VIDFKR+PWP +SE AK+LV++ML PD
Sbjct: 237 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPD 296

Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
           PK+RLTA++VLEHPW+QNAKKAPNV LG+ VK+RLKQFSVMN+ K++AL+V+AEFLS EE
Sbjct: 297 PKRRLTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLSTEE 356

Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEF 420
           V  +K  F  MDT+  G +++EEL+ GL      + E+++Q+L+EA D  G G+L+YGEF
Sbjct: 357 VEDIKVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEAVDTKGKGTLDYGEF 416

Query: 421 VAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVD 480
           VAVS+HL+K+ANDEHL KAFS+FD++ +G+I  +EL +AL ++      DV N I  +VD
Sbjct: 417 VAVSLHLQKVANDEHLRKAFSYFDKDGNGYILPQELCDALKEDGGDDCVDVANDIFQEVD 476

Query: 481 TDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN 531
           TDKDGRISYEEFA MMK GTDWRKASR YSR RFNS+S+KLM++  L L N
Sbjct: 477 TDKDGRISYEEFAAMMKTGTDWRKASRHYSRGRFNSLSIKLMKDGSLNLGN 527

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SSF8|CDPKU_ARATH Calcium-dependent protein kinase 30 OS=Arabidopsis thaliana GN=CPK30 PE=1 SV=1

 Score =  721 bits (1860), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/531 (66%), Positives = 419/531 (78%), Gaps = 3/531 (0%)

Query: 1   MGNC--CARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDY 58
           MGNC  C + D  + K    KK+ P     + Y   +G      L V+       IS  Y
Sbjct: 1   MGNCIACVKFDPDNSK-PNQKKKPPRGRQRNPYDDPDGLRTHAPLRVIPMSHQSQISDKY 59

Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
            LGRELGRGEFG+TYLCTD    E  ACKSISK+KLRTAVD+EDVRREV IM  LP+HPN
Sbjct: 60  ILGRELGRGEFGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPEHPN 119

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           +V LK TYED+  VH+VMELCEGGELFDRIVARGHYTERAAA V +TI EVV++CH  GV
Sbjct: 120 VVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHVNGV 179

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPE 238
           MHRDLKPENFLFANKKE+S LKAIDFGLSV F+PGE+F EIVGSPYYMAPEVLKRNYGPE
Sbjct: 180 MHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNYGPE 239

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
           VDVWSAGVILYILLCGVPPFWAETEQGVA AI+R V+DFKRDPW ++SE+AK LVK+ML 
Sbjct: 240 VDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQMLE 299

Query: 299 PDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSV 358
           PD  +RLTA++VL+HPW+QNAKKAPNV LG+ V++RLKQFS+MN+LKK+AL+V+AE LS+
Sbjct: 300 PDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRLKKKALRVIAEHLSI 359

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
           +EV  ++  F +MD +  GKI+  ELR GL K G  + E ++++LME ADV+G+G L+YG
Sbjct: 360 QEVEVIRNMFTLMDDDNDGKISYLELRAGLRKVGSQLGEPEIKLLMEVADVNGNGCLDYG 419

Query: 419 EFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD 478
           EFVAV +HL+KM NDEH  +AF FFD++ SG+IE EELR AL DE+      VI  IM +
Sbjct: 420 EFVAVIIHLQKMENDEHFRQAFMFFDKDGSGYIESEELREALTDELGEPDNSVIIDIMRE 479

Query: 479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
           VDTDKDG+I+Y+EF VMMKAGTDWRKASRQYSRERF S+SL LM++  + L
Sbjct: 480 VDTDKDGKINYDEFVVMMKAGTDWRKASRQYSRERFKSLSLNLMKDGSMHL 530

May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Acts as a calcium sensor involved in the hormone-signaling pathways.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M9V8|CDPKA_ARATH Calcium-dependent protein kinase 10 OS=Arabidopsis thaliana GN=CPK10 PE=1 SV=1

 Score =  709 bits (1831), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/536 (65%), Positives = 423/536 (78%), Gaps = 9/536 (1%)

Query: 1   MGNC--CARPDSSSGKRAK-----GKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQD 53
           MGNC  C RPDS   K +       +  K NPF GD +  +     V +  V+   +   
Sbjct: 1   MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGD-FTRSPAPIRVLK-DVIPMSNQTQ 58

Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           IS  Y LGRELGRGEFG+TYLCTD    E  ACKSISK+KLRTAVDIEDVRREV IM  L
Sbjct: 59  ISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIMSTL 118

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
           P+HPN+V LK +YED+  VH+VMELCEGGELFDRIVARGHYTERAAAAV +TI EVV +C
Sbjct: 119 PEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVVMMC 178

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H  GVMHRDLKPENFLFANKKE+SPLKAIDFGLSVFF+PG++F EIVGSPYYMAPEVLKR
Sbjct: 179 HSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLKR 238

Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
           +YGP VDVWSAGVI+YILLCGVPPFWAETEQGVA AI+R V+DFKRDPWP++SE+AK LV
Sbjct: 239 DYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAKSLV 298

Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVA 353
           K+ML+PDP +RLTA++VL HPW+QNAKKAPNV LG+ V++RLKQFS+MN+ KK+ L+V+A
Sbjct: 299 KQMLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLRVIA 358

Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDG 413
           E LS++EV  +K  F +MD +K GKI   EL+ GL K G  + E ++++LME ADVDG+G
Sbjct: 359 EHLSIQEVEVIKNMFSLMDDDKDGKITYPELKAGLQKVGSQLGEPEIKMLMEVADVDGNG 418

Query: 414 SLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVIN 473
            L+YGEFVAV +HL+K+ NDE    AF FFD++ S +IE++ELR AL DE+      V++
Sbjct: 419 FLDYGEFVAVIIHLQKIENDELFKLAFMFFDKDGSTYIELDELREALADELGEPDASVLS 478

Query: 474 AIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
            IM +VDTDKDGRI+Y+EF  MMKAGTDWRKASRQYSRERF S+S+ LM++  L L
Sbjct: 479 DIMREVDTDKDGRINYDEFVTMMKAGTDWRKASRQYSRERFKSLSINLMKDGSLHL 534

May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SIQ7|CDPKO_ARATH Calcium-dependent protein kinase 24 OS=Arabidopsis thaliana GN=CPK24 PE=2 SV=1

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/536 (59%), Positives = 416/536 (77%), Gaps = 11/536 (2%)

Query: 1   MGNCCARP--DSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLC------VLKEPSGQ 52
           MG+C + P   S  GKR   ++   N          + + +  RL       VL EP G 
Sbjct: 1   MGSCVSSPLKGSPFGKRPVRRRHSSNSRTSSVPRFDSSTNLSRRLIFQPPSRVLPEPIGD 60

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
            I + YDLG+ELGRGEFGVT+ C +++  E+FACK ISK+KLRT +D+EDVRREV+IM+ 
Sbjct: 61  GIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRC 120

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           LPKHPNIVS K+ +ED  AV++VME+CEGGELFDRIV+RGHYTERAAA+V KTI+EVV+V
Sbjct: 121 LPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKV 180

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
           CHE GV+HRDLKPENFLF+N  E++ LKAIDFGLS+FF+P ++FNEIVGSPYYMAPEVL+
Sbjct: 181 CHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLR 240

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           RNYGPE+DVWSAGVILYILLCGVPPFWAETE+G+A AI+R  IDF+RDPWPKVS  AK+L
Sbjct: 241 RNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKEL 300

Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
           VK ML+ +P  RLT +EVLEHPW++NA++APNV+LG+ V+ +++QF +MN+ KK+ L++V
Sbjct: 301 VKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRIV 360

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           A+ L  EE+A + + F+ MDT+K G +  EELR GL K GQ +P+ D+++LM+AAD DG+
Sbjct: 361 ADNLPNEEIAAIVQMFQTMDTDKNGHLTFEELRDGLKKIGQVVPDGDVKMLMDAADTDGN 420

Query: 413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV--DTSGED 470
           G L+  EFV +S+HLK+M  DEHL +AF +FD+N +GFIE++EL+ AL D+     +G D
Sbjct: 421 GMLSCDEFVTLSIHLKRMGCDEHLQEAFKYFDKNGNGFIELDELKVALCDDKLGHANGND 480

Query: 471 V-INAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREE 525
             I  I  DVD +KDGRIS++EF  MMK+GTDW+ ASRQYSR   N++S+K+ +E+
Sbjct: 481 QWIKDIFFDVDLNKDGRISFDEFKAMMKSGTDWKMASRQYSRALLNALSIKMFKED 536

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1

 Score =  582 bits (1500), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 273/456 (59%), Positives = 342/456 (75%), Gaps = 2/456 (0%)

Query: 45  VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
           VL  P  +D+   Y LG+ELGRG+FGVT+LCT    G +FACK+I+K+KL    DIEDVR
Sbjct: 61  VLGRPM-EDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVR 119

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
           REVQIM HL   PNIV LK  YED  +VH+VMELC GGELFDRI+A+GHY+ERAAA++++
Sbjct: 120 REVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLR 179

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
           TIV++V  CH  GV+HRDLKPENFL  NK E+SPLKA DFGLSVF++PGE F +IVGS Y
Sbjct: 180 TIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAY 239

Query: 225 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           Y+APEVLKR YGPE D+WS GV+LYILLCGVPPFWAE+E G+  AI+R  +DF  DPWP 
Sbjct: 240 YIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPS 299

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 344
           +S  AKDLVKKMLN DPKQRLTA +VL HPW++   +AP+V L   V +RLKQF  MN  
Sbjct: 300 ISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNF 359

Query: 345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILM 404
           KK AL+V+A  LS EE+ GLKE F+ MDT+  G I LEELR GL K G  + E ++Q LM
Sbjct: 360 KKVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLSEYEVQQLM 419

Query: 405 EAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
           EAAD DG+G+++YGEF+A ++H+ ++  +EHL+ AF  FD++ SG+I +EEL  AL +  
Sbjct: 420 EAADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSGYITMEELEQALREFG 479

Query: 465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT 500
              G D I  I+ +VD D DGRI+Y+EF  MM+ G 
Sbjct: 480 MNDGRD-IKEIISEVDGDNDGRINYDEFVAMMRKGN 514

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1

 Score =  574 bits (1480), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 281/516 (54%), Positives = 359/516 (69%), Gaps = 23/516 (4%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPNP-------------FYGDEYVVANGSTVVHRLC--- 44
           MGNCC     S G+ +   KE+P P                 ++  A+      +     
Sbjct: 1   MGNCC-----SHGRDSDDNKEEPRPENGGGGVGAAEASVRASKHPPASPPPATKQGPIGP 55

Query: 45  VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
           VL  P  +D+   Y LG+ELGRG+FGVT+LCT    G +FACK+I+K+KL    DIEDVR
Sbjct: 56  VLGRPM-EDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVR 114

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
           REVQIM HL   PNIV LK  YED  +VH+VMELC GGELFDRI+A+GHY+ERAAA++++
Sbjct: 115 REVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLR 174

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
           TIV+++  CH  GV+HRDLKPENFL  +K E+SPLKA DFGLSVF++PGE F +IVGS Y
Sbjct: 175 TIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAY 234

Query: 225 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           Y+APEVL+R YGPE D+WS GV+LYILLCGVPPFWAE+E G+  AI+   +DF  DPWP 
Sbjct: 235 YIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPV 294

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 344
           +S  AKDLV+KMLN DPKQRLTA +VL HPW++   +AP+V L   V +RLKQF  MN  
Sbjct: 295 ISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNF 354

Query: 345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILM 404
           KK AL+V+A  LS EE+ GLKE F+ MDT+  G I LEELR GL K G  + E ++Q LM
Sbjct: 355 KKVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLSEYEVQQLM 414

Query: 405 EAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
           EAAD DG+G+++YGEF+A ++H+ ++  +EHL+ AF  FD++ SG+I  EEL  AL +  
Sbjct: 415 EAADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSGYITTEELEQALREFG 474

Query: 465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT 500
              G D I  I+ +VD D DGRI+YEEF  MM+ G 
Sbjct: 475 MNDGRD-IKEIISEVDGDNDGRINYEEFVAMMRKGN 509

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	531
449442535	531	PREDICTED: calcium-dependent protein kin	0.994	0.994	0.845	0.0
255544870	536	calcium-dependent protein kinase, putati	1.0	0.990	0.847	0.0
449476073	530	PREDICTED: LOW QUALITY PROTEIN: calcium-	0.992	0.994	0.845	0.0
297812129	533	calcium-dependent protein kinase 19 [Ara	0.994	0.990	0.828	0.0
224104161	533	predicted protein [Populus trichocarpa]	1.0	0.996	0.833	0.0
297811393	535	calmodulin-domain protein kinase 7 [Arab	0.996	0.988	0.822	0.0
15239742	533	calcium-dependent protein kinase 19 [Ara	0.994	0.990	0.826	0.0
18416872	535	calmodulin-domain protein kinase 7 [Arab	0.996	0.988	0.819	0.0
224059554	534	calcium dependent protein kinase 14 [Pop	1.0	0.994	0.822	0.0
373089193	532	calcium-dependent protein kinase [Morus	0.996	0.994	0.828	0.0

>gi|449442535|ref|XP_004139037.1| PREDICTED: calcium-dependent protein kinase 8-like [Cucumis sativus]

 Score =  934 bits (2413), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 449/531 (84%), Positives = 492/531 (92%), Gaps = 3/531 (0%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
           MGNCCA P + SGK+ KGK +K NPF  D YVV+NG+   +   VLK+P+G+DIS  YDL
Sbjct: 1   MGNCCATPATPSGKQHKGKNKKQNPFAAD-YVVSNGNGGGN--WVLKDPTGRDISALYDL 57

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
           G ELGRGEFGVTYLCTD N GEK ACKSISKKKLRTAVDI+DVRREV+IMK+LPKHPNIV
Sbjct: 58  GSELGRGEFGVTYLCTDRNTGEKLACKSISKKKLRTAVDIDDVRREVEIMKNLPKHPNIV 117

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           SL+DTYED+ AVHIVMELCEGGELFDRIVARGHYTERAAA VM+TIVEVVQ+CH+ GVMH
Sbjct: 118 SLRDTYEDEQAVHIVMELCEGGELFDRIVARGHYTERAAAVVMRTIVEVVQMCHKNGVMH 177

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
           RDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 178 RDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 237

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP VS+NAKDLVKKML+PD
Sbjct: 238 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPIVSDNAKDLVKKMLDPD 297

Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
           PK+RLTA+EVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 298 PKKRLTAQEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 357

Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEF 420
           VAG+KEAFEMMDT KRGKINL+ELR+GL K GQ IP+ DLQIL+EAAD+DGDG+LNY EF
Sbjct: 358 VAGIKEAFEMMDTGKRGKINLDELRVGLQKLGQQIPDPDLQILVEAADLDGDGTLNYSEF 417

Query: 421 VAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVD 480
           VAVSVHLKKMANDEHLHKAFSFFD+N+SG+IEIEELRNALND+ +T+GEDV+NAIMHDVD
Sbjct: 418 VAVSVHLKKMANDEHLHKAFSFFDKNQSGYIEIEELRNALNDDDETNGEDVVNAIMHDVD 477

Query: 481 TDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN 531
           TDKDGRISYEEFA MMKAGTDWRKASRQYSRERFNS+SLKLMR+  L L N
Sbjct: 478 TDKDGRISYEEFAAMMKAGTDWRKASRQYSRERFNSLSLKLMRDGSLHLTN 528

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255544870|ref|XP_002513496.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223547404|gb|EEF48899.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  933 bits (2411), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 454/536 (84%), Positives = 491/536 (91%), Gaps = 5/536 (0%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPN----PFYGDEYVVANGSTVV-HRLCVLKEPSGQDIS 55
           MGNCC  P SSS    K  K        PF+G++YVV +GS  + H+L VLKEP+G+DIS
Sbjct: 1   MGNCCTIPSSSSSSEKKKAKGNNKNKQNPFFGNDYVVNSGSGYIDHKLVVLKEPTGRDIS 60

Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             YDLGRELGRGEFG+TYLCTDVN  EK ACKSISKKKLRTAVDIEDVRREV+IMKHLP 
Sbjct: 61  AHYDLGRELGRGEFGITYLCTDVNTDEKLACKSISKKKLRTAVDIEDVRREVEIMKHLPH 120

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           HPNIVSL+ TYEDD+AVHIVMELCEGGELFDRIVARGHYTERAAAAVM+TIVEVVQ+CH+
Sbjct: 121 HPNIVSLRATYEDDNAVHIVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQMCHK 180

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNY 235
            GVMHRDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS+NAKDLVKK
Sbjct: 241 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVKK 300

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEF 355
           MLNPDPK RLTA++VL HPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+VVAE 
Sbjct: 301 MLNPDPKLRLTAQQVLGHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVVAEH 360

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           LSVEEVAG+KEAF+MMDT +RGKINLEELR+GL K GQ IP+ADLQILMEAADVDGDGSL
Sbjct: 361 LSVEEVAGIKEAFDMMDTTRRGKINLEELRIGLQKIGQQIPDADLQILMEAADVDGDGSL 420

Query: 416 NYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAI 475
           NYGEFVAVSVHLKKM NDEH+HKAF+FFD+N+SG+IEIEELR ALNDEVDT  EDVINAI
Sbjct: 421 NYGEFVAVSVHLKKMGNDEHIHKAFAFFDQNQSGYIEIEELREALNDEVDTCSEDVINAI 480

Query: 476 MHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN 531
           MHDVDTDKDGRISYEEFA MMKAGTDWRKASRQYSRERFNS+SLKLMR+  LQ+A+
Sbjct: 481 MHDVDTDKDGRISYEEFATMMKAGTDWRKASRQYSRERFNSLSLKLMRDGSLQVAS 536

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449476073|ref|XP_004154632.1| PREDICTED: LOW QUALITY PROTEIN: calcium-dependent protein kinase 8-like [Cucumis sativus]

 Score =  928 bits (2398), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 449/531 (84%), Positives = 491/531 (92%), Gaps = 4/531 (0%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
           MGNCCA P + SGK+ KG K K NPF  D YVV+NG+   +   VLK+P+G+DIS  YDL
Sbjct: 1   MGNCCATPATPSGKQHKGNK-KQNPFAAD-YVVSNGNGGGN--WVLKDPTGRDISALYDL 56

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
           G ELGRGEFGVTYLCTD N GEK ACKSISKKKLRTAVDI+DVRREV+IMK+LPKHPNIV
Sbjct: 57  GSELGRGEFGVTYLCTDRNTGEKLACKSISKKKLRTAVDIDDVRREVEIMKNLPKHPNIV 116

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           SL+DTYED+ AVHIVMELCEGGELFDRIVARGHYTERAAA VM+TIVEVVQ+CH+ GVMH
Sbjct: 117 SLRDTYEDEQAVHIVMELCEGGELFDRIVARGHYTERAAAVVMRTIVEVVQMCHKNGVMH 176

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
           RDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 177 RDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 236

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP VS+NAKDLVKKML+PD
Sbjct: 237 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPIVSDNAKDLVKKMLDPD 296

Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
           PK+RLTA+EVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 297 PKKRLTAQEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 356

Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEF 420
           VAG+KEAFEMMDT KRGKINL+ELR+GL K GQ IP+ DLQIL+EAAD+DGDG+LNY EF
Sbjct: 357 VAGIKEAFEMMDTGKRGKINLDELRVGLQKLGQQIPDPDLQILVEAADLDGDGTLNYSEF 416

Query: 421 VAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVD 480
           VAVSVHLKKMANDEHLHKAFSFFD+N+SG+IEIEELRNALND+ +T+GEDV+NAIMHDVD
Sbjct: 417 VAVSVHLKKMANDEHLHKAFSFFDKNQSGYIEIEELRNALNDDDETNGEDVVNAIMHDVD 476

Query: 481 TDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN 531
           TDKDGRISYEEFA MMKAGTDWRKASRQYSRERFNS+SLKLMR+  L L N
Sbjct: 477 TDKDGRISYEEFAAMMKAGTDWRKASRQYSRERFNSLSLKLMRDGSLHLTN 527

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297812129|ref|XP_002873948.1| calcium-dependent protein kinase 19 [Arabidopsis lyrata subsp. lyrata] gi|297319785|gb|EFH50207.1| calcium-dependent protein kinase 19 [Arabidopsis lyrata subsp. lyrata]

 Score =  923 bits (2386), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/530 (82%), Positives = 481/530 (90%), Gaps = 2/530 (0%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
           MGNCCA P S +G +    K K NPFY + Y   NGS    +L VLK+P+G DIS+ YDL
Sbjct: 1   MGNCCASPGSETGSKNGKPKIKSNPFYSEAYTT-NGSGTGFKLSVLKDPTGHDISLMYDL 59

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
           GRE+GRGEFG+TYLCTD+N G+K+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPNIV
Sbjct: 60  GREVGRGEFGITYLCTDINTGDKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNIV 119

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           SLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI+EVVQ+CH+ GVMH
Sbjct: 120 SLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMH 179

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
           RDLKPENFLFANKKE+S LKAIDFGLSVFF+PGE FNEIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 180 RDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVD 239

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VSE AKDLV+KML PD
Sbjct: 240 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPD 299

Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
           PK+RL+A +VLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 300 PKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 359

Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAADVDGDGSLNYGE 419
           VAG+KEAFEMMD+ K GKINLEEL+ GL K G Q IP+ DLQILMEAADVDGDG+LNYGE
Sbjct: 360 VAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAADVDGDGTLNYGE 419

Query: 420 FVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDV 479
           FVAVSVHLKKMANDEHLHKAFSFFD+N+S +IEIEELR ALNDE+DTS E+V+ AIM DV
Sbjct: 420 FVAVSVHLKKMANDEHLHKAFSFFDQNQSNYIEIEELREALNDEIDTSSEEVVAAIMQDV 479

Query: 480 DTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
           DTDKDGRISYEEFA MMKAGTDWRKASRQYSRERFNS+SLKLMRE  LQL
Sbjct: 480 DTDKDGRISYEEFAAMMKAGTDWRKASRQYSRERFNSLSLKLMREGSLQL 529

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224104161|ref|XP_002313342.1| predicted protein [Populus trichocarpa] gi|222849750|gb|EEE87297.1| predicted protein [Populus trichocarpa]

 Score =  922 bits (2384), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 444/533 (83%), Positives = 492/533 (92%), Gaps = 2/533 (0%)

Query: 1   MGNCCARPD--SSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDY 58
           MGNCC  P   SSS K+ KGKK+K NPF+GD Y V NGS  V +L VLKEP+G+DI   Y
Sbjct: 1   MGNCCFTPSGASSSEKKVKGKKKKQNPFFGDSYAVTNGSGDVDKLWVLKEPTGRDILAHY 60

Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           DLGRELGRGEFG+TYLCTDVN+G+KFACKSISKKKLRTAVDI+DVRREV+IMKHLP HPN
Sbjct: 61  DLGRELGRGEFGITYLCTDVNSGDKFACKSISKKKLRTAVDIDDVRREVEIMKHLPAHPN 120

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           IV+LK +YEDD+AVHIVMELCEGGELFDRIVARGHYTERAAAAVM+TIVEVVQ+CH+ GV
Sbjct: 121 IVTLKASYEDDTAVHIVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQMCHKHGV 180

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPE 238
           MHRDLKPENFLFANKKE++ LKAIDFGLSVFF+PGE+FNEIVGSPYYMAPE+LKRNYGPE
Sbjct: 181 MHRDLKPENFLFANKKETAVLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEILKRNYGPE 240

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
           VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS IDFKRDPWP+VS+NAKDLVKKMLN
Sbjct: 241 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSFIDFKRDPWPRVSDNAKDLVKKMLN 300

Query: 299 PDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSV 358
           PDPK RLTA++VLEHPW+QNAKKAPNV LGETV+ARLKQFSVMNKLKKRAL+V+AE LSV
Sbjct: 301 PDPKLRLTAQQVLEHPWIQNAKKAPNVPLGETVRARLKQFSVMNKLKKRALRVIAEHLSV 360

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
           EEVAG+KEAF+MMDT KRG INLEELR+GL K GQNI +ADL+ILMEAADVDGDG+LNYG
Sbjct: 361 EEVAGIKEAFDMMDTGKRGSINLEELRVGLQKLGQNIADADLRILMEAADVDGDGALNYG 420

Query: 419 EFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD 478
           EFVA+SVH+KKM NDEHLHKAF+FFDRN+SG+IEIEELR +LND+VDT+ EDVINAIMHD
Sbjct: 421 EFVAISVHIKKMGNDEHLHKAFAFFDRNQSGYIEIEELRESLNDDVDTNNEDVINAIMHD 480

Query: 479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN 531
           VDTDKDGRISYEEFA MMKAGTDWRKASRQYSRERFN++S+ L R+  LQ A 
Sbjct: 481 VDTDKDGRISYEEFATMMKAGTDWRKASRQYSRERFNNLSITLRRDGSLQAAT 533

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297811393|ref|XP_002873580.1| calmodulin-domain protein kinase 7 [Arabidopsis lyrata subsp. lyrata] gi|297319417|gb|EFH49839.1| calmodulin-domain protein kinase 7 [Arabidopsis lyrata subsp. lyrata]

 Score =  922 bits (2384), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 437/531 (82%), Positives = 482/531 (90%), Gaps = 2/531 (0%)

Query: 1   MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
           MGNCC  P S++ +  +GK + K NPFY +EY   + S    +L VLK+P+G DIS+ YD
Sbjct: 1   MGNCCGSPGSATNESKQGKPRNKNNPFYSNEYTATDRSGAGFKLSVLKDPTGHDISLQYD 60

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           LGRE+GRGEFG+TYLCTD   GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPN+
Sbjct: 61  LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
           VSLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ+CH+QGVM
Sbjct: 121 VSLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
           HRDLKPENFLFANKKE+SPLKAIDFGLSVFF+PGEQFNEIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSPLKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240

Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
           DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS++AKDLV+KML P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300

Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
           DPK+RLTA +VLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360

Query: 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGE 419
           E AG+KEAFEMMD NKRGKINLEEL+ GL K GQ I +ADLQILMEA DVDGDG+LNY E
Sbjct: 361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADADLQILMEATDVDGDGTLNYSE 420

Query: 420 FVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-TSGEDVINAIMHD 478
           FVAVSVHLKKMANDEHLHKAF+FFD+N+SG+IEIEELR ALNDE+D TS E+VI AIM D
Sbjct: 421 FVAVSVHLKKMANDEHLHKAFNFFDQNQSGYIEIEELREALNDELDNTSSEEVIAAIMQD 480

Query: 479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
           VDTDKDGRISYEEF  MMKAGTDWRKASRQYSRERFNS+SLKLMR+  LQL
Sbjct: 481 VDTDKDGRISYEEFVAMMKAGTDWRKASRQYSRERFNSLSLKLMRDGSLQL 531

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15239742|ref|NP_197446.1| calcium-dependent protein kinase 19 [Arabidopsis thaliana] gi|30687323|ref|NP_850853.1| calcium-dependent protein kinase 19 [Arabidopsis thaliana] gi|75319668|sp|Q42438.1|CDPK8_ARATH RecName: Full=Calcium-dependent protein kinase 8; AltName: Full=Calcium-dependent protein kinase isoform CDPK19; Short=AtCDPK19 gi|836942|gb|AAA67655.1| calcium-dependent protein kinase [Arabidopsis thaliana] gi|836948|gb|AAA67658.1| calcium-dependent protein kinase [Arabidopsis thaliana] gi|332005325|gb|AED92708.1| calcium-dependent protein kinase 19 [Arabidopsis thaliana] gi|332005326|gb|AED92709.1| calcium-dependent protein kinase 19 [Arabidopsis thaliana]

 Score =  920 bits (2379), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/530 (82%), Positives = 480/530 (90%), Gaps = 2/530 (0%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
           MGNCCA P S +G +    K K NPFY + Y   NGS    +L VLK+P+G DIS+ YDL
Sbjct: 1   MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTT-NGSGTGFKLSVLKDPTGHDISLMYDL 59

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
           GRE+GRGEFG+TYLCTD+  GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+P+HPNIV
Sbjct: 60  GREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIV 119

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           SLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI+EVVQ+CH+ GVMH
Sbjct: 120 SLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMH 179

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
           RDLKPENFLFANKKE+S LKAIDFGLSVFF+PGE FNEIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 180 RDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVD 239

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VSE AKDLV+KML PD
Sbjct: 240 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPD 299

Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
           PK+RL+A +VLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 300 PKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 359

Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAADVDGDGSLNYGE 419
           VAG+KEAFEMMD+ K GKINLEEL+ GL K G Q IP+ DLQILMEAADVDGDG+LNYGE
Sbjct: 360 VAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAADVDGDGTLNYGE 419

Query: 420 FVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDV 479
           FVAVSVHLKKMANDEHLHKAFSFFD+N+S +IEIEELR ALNDEVDT+ E+V+ AIM DV
Sbjct: 420 FVAVSVHLKKMANDEHLHKAFSFFDQNQSDYIEIEELREALNDEVDTNSEEVVAAIMQDV 479

Query: 480 DTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
           DTDKDGRISYEEFA MMKAGTDWRKASRQYSRERFNS+SLKLMRE  LQL
Sbjct: 480 DTDKDGRISYEEFAAMMKAGTDWRKASRQYSRERFNSLSLKLMREGSLQL 529

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18416872|ref|NP_568281.1| calmodulin-domain protein kinase 7 [Arabidopsis thaliana] gi|75319419|sp|Q38873.1|CDPK7_ARATH RecName: Full=Calcium-dependent protein kinase 7; AltName: Full=Calmodulin-domain protein kinase CDPK isoform 7 gi|13605617|gb|AAK32802.1|AF361634_1 AT5g19450/F7K24_200 [Arabidopsis thaliana] gi|1399277|gb|AAB03247.1| calmodulin-domain protein kinase CDPK isoform 7 [Arabidopsis thaliana] gi|14586378|emb|CAC42909.1| calcium-dependent protein kinase-like protein [Arabidopsis thaliana] gi|332004432|gb|AED91815.1| calmodulin-domain protein kinase 7 [Arabidopsis thaliana]

 Score =  919 bits (2375), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/531 (81%), Positives = 481/531 (90%), Gaps = 2/531 (0%)

Query: 1   MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
           MGNCC  P S++ +  +GK K K NPFY +EY   + S    +L VLK+P+G DIS+ YD
Sbjct: 1   MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           LGRE+GRGEFG+TYLCTD   GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPN+
Sbjct: 61  LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
           VSLKD++EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ+CH+QGVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
           HRDLKPENFLFANKKE+S LKAIDFGLSVFF+PGEQFNEIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240

Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
           DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS++AKDLV+KML P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300

Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
           DPK+RLTA +VLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360

Query: 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGE 419
           E AG+KEAFEMMD NKRGKINLEEL+ GL K GQ I + DLQILMEA DVDGDG+LNY E
Sbjct: 361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEATDVDGDGTLNYSE 420

Query: 420 FVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-TSGEDVINAIMHD 478
           FVAVSVHLKKMANDEHLHKAF+FFD+N+SG+IEI+ELR ALNDE+D TS E+VI AIM D
Sbjct: 421 FVAVSVHLKKMANDEHLHKAFNFFDQNQSGYIEIDELREALNDELDNTSSEEVIAAIMQD 480

Query: 479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
           VDTDKDGRISYEEF  MMKAGTDWRKASRQYSRERFNS+SLKLMR+  LQL
Sbjct: 481 VDTDKDGRISYEEFVAMMKAGTDWRKASRQYSRERFNSLSLKLMRDGSLQL 531

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224059554|ref|XP_002299904.1| calcium dependent protein kinase 14 [Populus trichocarpa] gi|222847162|gb|EEE84709.1| calcium dependent protein kinase 14 [Populus trichocarpa]

 Score =  913 bits (2359), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/534 (82%), Positives = 484/534 (90%), Gaps = 3/534 (0%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKP---NPFYGDEYVVANGSTVVHRLCVLKEPSGQDISID 57
           MGNCC  P  +S    K K +K    NPF+GD Y V N S  V +L VLKEP+G+DI   
Sbjct: 1   MGNCCVTPTGASSSEKKVKGKKKEKKNPFFGDNYAVINESGNVDKLGVLKEPTGRDILAH 60

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           YDLGRELGRGEFGVTYLCTD+N GEKFACKSISKKKLRTAVDIEDVRREV+IMKHLP HP
Sbjct: 61  YDLGRELGRGEFGVTYLCTDINTGEKFACKSISKKKLRTAVDIEDVRREVEIMKHLPAHP 120

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIVSLK +YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM+TIVEVVQ+CH+ G
Sbjct: 121 NIVSLKASYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQMCHKHG 180

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           V+HRDLKPENFLFANKKE+S LK IDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRNYGP
Sbjct: 181 VIHRDLKPENFLFANKKETSALKTIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGP 240

Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS+NAK LV KML
Sbjct: 241 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDNAKGLVMKML 300

Query: 298 NPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLS 357
           NPDPK RLTA++VLEHPW+QNAKKAPNV LGETVKARLKQFSVMNKLKKRAL+V+AE LS
Sbjct: 301 NPDPKLRLTAQQVLEHPWIQNAKKAPNVPLGETVKARLKQFSVMNKLKKRALRVIAEHLS 360

Query: 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNY 417
           VEEVAG+K+AF+ MDT K+G INLEELR+GL K GQ+I +ADLQILMEAAD+DGDG+LNY
Sbjct: 361 VEEVAGIKDAFDSMDTGKKGSINLEELRVGLQKLGQHIADADLQILMEAADIDGDGALNY 420

Query: 418 GEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH 477
           GEFVA+SVH+KKM NDEHLHKAF+FFDRN+SG+IEIEELR +LND++DTS EDVINAIMH
Sbjct: 421 GEFVAISVHIKKMGNDEHLHKAFAFFDRNQSGYIEIEELRESLNDDIDTSSEDVINAIMH 480

Query: 478 DVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN 531
           DVDTDKDGRISYEEFA MMKAGTDWRKASRQYSRERFNS+S+ L R+  LQ+A+
Sbjct: 481 DVDTDKDGRISYEEFATMMKAGTDWRKASRQYSRERFNSLSITLRRDGSLQVAS 534

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|373089193|gb|AEY55359.1| calcium-dependent protein kinase [Morus alba var. multicaulis]

 Score =  906 bits (2342), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 440/531 (82%), Positives = 491/531 (92%), Gaps = 2/531 (0%)

Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
           MGNCCA P S+  +  +  K+KPNPF GD Y V N +   ++L VLK+P+G+DI   YDL
Sbjct: 1   MGNCCASP-STPSRNNRKNKKKPNPFAGD-YGVGNENGSGNKLWVLKDPTGRDILERYDL 58

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
           GRELGRGEFG+TYLC DV+ GEKFACKSISKKKLRT+VD++DVRREV+IMKHL  H NIV
Sbjct: 59  GRELGRGEFGITYLCIDVSTGEKFACKSISKKKLRTSVDVDDVRREVEIMKHLRNHQNIV 118

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           SLKDT+ED+SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ CHE GVMH
Sbjct: 119 SLKDTFEDESAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQNCHEHGVMH 178

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
           RDLKPENFLFANKKE+SPLKAIDFGLSVFF+PGEQFNEIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 179 RDLKPENFLFANKKENSPLKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 238

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           VWSAGV+LYILLCGVPPFWAETEQGVAQAIIRSV+DFKRDPWP+VS+NAKDLVKKML+PD
Sbjct: 239 VWSAGVVLYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPRVSDNAKDLVKKMLDPD 298

Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
           PK+RLTA++VLEHPWLQNAKKAPNVSLGETV+ARLKQFSVMNKLKKRAL V+AE LSVEE
Sbjct: 299 PKRRLTAQKVLEHPWLQNAKKAPNVSLGETVRARLKQFSVMNKLKKRALGVIAEHLSVEE 358

Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEF 420
           VAG+KEAF+ +D  K+GK+NLEELR+GLLK GQ IP+ DLQILM++ADVDGDG+LNYGEF
Sbjct: 359 VAGIKEAFDTIDIAKKGKVNLEELRIGLLKLGQQIPDPDLQILMDSADVDGDGALNYGEF 418

Query: 421 VAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVD 480
           VAVSVHL++MANDEHLHKAF++FD+NRSG+IEIEELRNALNDEVDTS E+V++AIMHDVD
Sbjct: 419 VAVSVHLRRMANDEHLHKAFAYFDQNRSGYIEIEELRNALNDEVDTSSEEVVSAIMHDVD 478

Query: 481 TDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN 531
           TDKDGRISYEEFA MMKAGTDWRKASRQYSRERFNS+SLKLMR+  LQL N
Sbjct: 479 TDKDGRISYEEFAAMMKAGTDWRKASRQYSRERFNSLSLKLMRDGSLQLTN 529

Source: Morus alba var. multicaulis

Species: Morus alba

Genus: Morus

Family: Moraceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	531
TAIR|locus:2150230	533	CDPK19 "calcium-dependent prot	0.992	0.988	0.815	6.4e-234
TAIR|locus:505006616	535	CPK7 "calmodulin-domain protei	0.996	0.988	0.804	2.8e-233
TAIR|locus:2103498	538	CPK32 "calcium-dependent prote	0.992	0.979	0.727	6.3e-211
TAIR|locus:2054386	530	CPK14 "calcium-dependent prote	0.984	0.986	0.701	2.7e-203
TAIR|locus:2074338	528	CPK13 "calcium-dependent prote	0.988	0.994	0.645	1.5e-184
TAIR|locus:2011201	545	CDPK1 "calcium-dependent prote	0.990	0.965	0.649	3.2e-184
TAIR|locus:2027227	541	CPK30 "calcium-dependent prote	0.994	0.975	0.647	1.8e-183
TAIR|locus:2061290	582	CPK24 "AT2G31500" [Arabidopsis	0.988	0.902	0.576	2.8e-169
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.853	0.857	0.580	1.1e-144
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.928	0.942	0.536	2.6e-143

TAIR|locus:2150230 CDPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 2256 (799.2 bits), Expect = 6.4e-234, P = 6.4e-234
 Identities = 433/531 (81%), Positives = 474/531 (89%)

Query:     1 MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
             MGNCCA P S +G + KGK K K NPFY + Y   NGS    +L VLK+P+G DIS+ YD
Sbjct:     1 MGNCCASPGSETGSK-KGKPKIKSNPFYSEAYTT-NGSGTGFKLSVLKDPTGHDISLMYD 58

Query:    60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
             LGRE+GRGEFG+TYLCTD+  GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+P+HPNI
Sbjct:    59 LGREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNI 118

Query:   120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
             VSLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI+EVVQ+CH+ GVM
Sbjct:   119 VSLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVM 178

Query:   180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
             HRDLKPENFLFANKKE+S LKAIDFGLSVFF+PGE FNEIVGSPYYMAPEVL+RNYGPEV
Sbjct:   179 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEV 238

Query:   240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
             D+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VSE AKDLV+KML P
Sbjct:   239 DIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEP 298

Query:   300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
             DPK+RL+A +VLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct:   299 DPKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 358

Query:   360 EVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQN-IPEADLQILMEAADVDGDGSLNYG 418
             EVAG+KEAFEMMD+ K GKIN            Q  IP+ DLQILMEAADVDGDG+LNYG
Sbjct:   359 EVAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAADVDGDGTLNYG 418

Query:   419 EFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD 478
             EFVAVSVHLKKMANDEHLHKAFSFFD+N+S +IEIEELR ALNDEVDT+ E+V+ AIM D
Sbjct:   419 EFVAVSVHLKKMANDEHLHKAFSFFDQNQSDYIEIEELREALNDEVDTNSEEVVAAIMQD 478

Query:   479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
             VDTDKDGRISYEEFA MMKAGTDWRKASRQYSRERFNS+SLKLMRE  LQL
Sbjct:   479 VDTDKDGRISYEEFAAMMKAGTDWRKASRQYSRERFNSLSLKLMREGSLQL 529

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:505006616 CPK7 "calmodulin-domain protein kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 2250 (797.1 bits), Expect = 2.8e-233, P = 2.8e-233
 Identities = 427/531 (80%), Positives = 472/531 (88%)

Query:     1 MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
             MGNCC  P S++ +  +GK K K NPFY +EY   + S    +L VLK+P+G DIS+ YD
Sbjct:     1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60

Query:    60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
             LGRE+GRGEFG+TYLCTD   GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPN+
Sbjct:    61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120

Query:   120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
             VSLKD++EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ+CH+QGVM
Sbjct:   121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180

Query:   180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
             HRDLKPENFLFANKKE+S LKAIDFGLSVFF+PGEQFNEIVGSPYYMAPEVL+RNYGPE+
Sbjct:   181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240

Query:   240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
             DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS++AKDLV+KML P
Sbjct:   241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300

Query:   300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
             DPK+RLTA +VLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct:   301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360

Query:   360 EVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSLNYGE 419
             E AG+KEAFEMMD NKRGKIN            Q I + DLQILMEA DVDGDG+LNY E
Sbjct:   361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEATDVDGDGTLNYSE 420

Query:   420 FVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-TSGEDVINAIMHD 478
             FVAVSVHLKKMANDEHLHKAF+FFD+N+SG+IEI+ELR ALNDE+D TS E+VI AIM D
Sbjct:   421 FVAVSVHLKKMANDEHLHKAFNFFDQNQSGYIEIDELREALNDELDNTSSEEVIAAIMQD 480

Query:   479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
             VDTDKDGRISYEEF  MMKAGTDWRKASRQYSRERFNS+SLKLMR+  LQL
Sbjct:   481 VDTDKDGRISYEEFVAMMKAGTDWRKASRQYSRERFNSLSLKLMRDGSLQL 531

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2103498 CPK32 "calcium-dependent protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 2039 (722.8 bits), Expect = 6.3e-211, P = 6.3e-211
 Identities = 389/535 (72%), Positives = 455/535 (85%)

Query:     1 MGNCCARPDS---SSGKRAKGKKEKPNPF---YGDEYVVANGSTVVHRLCVLKEPSGQDI 54
             MGNCC    S   +  K  KG+K K NPF   YG  +   +G     +L VL +P+G++I
Sbjct:     1 MGNCCGTAGSLAQNDNKPKKGRK-KQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREI 59

Query:    55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
                Y LGRELGRGEFGVTYLCTD    + FACKSI KKKLRTAVDIEDVRREV+IM+H+P
Sbjct:    60 ESKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMP 119

Query:   115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
             +HPN+V+LK+TYED+ AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQVCH
Sbjct:   120 EHPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCH 179

Query:   175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
             + GVMHRDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRN
Sbjct:   180 KHGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRN 239

Query:   235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
             YGPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDL++
Sbjct:   240 YGPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIR 299

Query:   295 KMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAE 354
             KML+PD K+RLTA++VL+HPWLQNAK APNVSLGETV+ARLKQF+VMNKLKKRAL+V+AE
Sbjct:   300 KMLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIAE 359

Query:   355 FLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGS 414
              LS EE +G++E F++MDT++RGKIN              IP+ DLQILM+A D+D DG 
Sbjct:   360 HLSDEEASGIREGFQIMDTSQRGKINIDELKIGLQKLGHAIPQDDLQILMDAGDIDRDGY 419

Query:   415 LNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
             L+  EF+A+SVHL+KM NDEHL KAF+FFD+N +G+IEIEELR AL+DE+ TS E+V++A
Sbjct:   420 LDCDEFIAISVHLRKMGNDEHLKKAFAFFDQNNNGYIEIEELREALSDELGTS-EEVVDA 478

Query:   475 IMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
             I+ DVDTDKDGRISYEEF  MMK GTDWRKASRQYSRERFNSISLKLM++  LQ+
Sbjct:   479 IIRDVDTDKDGRISYEEFVTMMKTGTDWRKASRQYSRERFNSISLKLMQDASLQV 533

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004698 "calcium-dependent protein kinase C activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009651 "response to salt stress" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2054386 CPK14 "calcium-dependent protein kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 1967 (697.5 bits), Expect = 2.7e-203, P = 2.7e-203
 Identities = 371/529 (70%), Positives = 449/529 (84%)

Query:     1 MGNCCARPDSS-SGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
             MGNCC    S    K+ KG K  PNPF  +EY   N    + +L VLKEP+G +I   Y 
Sbjct:     1 MGNCCGTAGSLIQDKQKKGFK-LPNPF-SNEY--GNHHDGL-KLIVLKEPTGHEIKQKYK 55

Query:    60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
             LGRELGRGEFGVTYLCT++  GE FACKSI KKKL+T++DIEDV+REV+IM+ +P+HPNI
Sbjct:    56 LGRELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNI 115

Query:   120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
             V+LK+TYEDD AVH+VMELCEGGELFDRIVARGHYTERAAA+V+KTI+EVVQ+CH+ GVM
Sbjct:   116 VTLKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVM 175

Query:   180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
             HRDLKPENFLFANKKE++ LKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVL+R+YG E+
Sbjct:   176 HRDLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEI 235

Query:   240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
             D+WSAGVILYILLCGVPPFWAETE GVA+AI++SVIDFKRDPWPKVS+NAKDL+KKML+P
Sbjct:   236 DIWSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHP 295

Query:   300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
             DP++RLTA++VL+HPW+QN K A NVSLGETV+ARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct:   296 DPRRRLTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLSVE 355

Query:   360 EVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSLNYGE 419
             E + +KE F++MDT+ RGKI               +P+ D+QILM+A DVD DG L+  E
Sbjct:   356 ETSCIKERFQVMDTSNRGKITITELGIGLQKLGIVVPQDDIQILMDAGDVDKDGYLDVNE 415

Query:   420 FVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDV 479
             FVA+SVH++K+ NDEHL KAF+FFD+N+SG+IEIEELR+AL D+VDT+ E+V+ AI+ DV
Sbjct:   416 FVAISVHIRKLGNDEHLKKAFTFFDKNKSGYIEIEELRDALADDVDTTSEEVVEAIILDV 475

Query:   480 DTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQ 528
             DT+KDG+ISY+EFA MMK GTDWRKASRQYSR+ F  +SLKLM++  LQ
Sbjct:   476 DTNKDGKISYDEFATMMKTGTDWRKASRQYSRDLFKCLSLKLMQDGSLQ 524

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2074338 CPK13 "calcium-dependent protein kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1790 (635.2 bits), Expect = 1.5e-184, P = 1.5e-184
 Identities = 344/533 (64%), Positives = 423/533 (79%)

Query:     1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVV--ANGSTVVHRLCVLKEPSGQDISIDY 58
             MGNCC  P       A  +++  + + G ++    A G      + VL +   ++I   Y
Sbjct:     1 MGNCCRSP------AAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRY 54

Query:    59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
              L RELGRGEFGVTYLC + ++ +  ACKSISK+KLRTAVDIEDV+REV IMKHLPK  +
Sbjct:    55 LLDRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSS 114

Query:   119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
             IV+LK+  EDD+AVH+VMELCEGGELFDRIVARGHYTERAAA V KTIVEVVQ+CH+ GV
Sbjct:   115 IVTLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGV 174

Query:   179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPE 238
             +HRDLKPENFLFANKKE+SPLKAIDFGLS+FF+PGE+F+EIVGSPYYMAPEVLKRNYGPE
Sbjct:   175 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 234

Query:   239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
             +D+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R VIDFKR+PWP +SE AK+LV++ML 
Sbjct:   235 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLE 294

Query:   299 PDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSV 358
             PDPK+RLTA++VLEHPW+QNAKKAPNV LG+ VK+RLKQFSVMN+ K++AL+V+AEFLS 
Sbjct:   295 PDPKRRLTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLST 354

Query:   359 EEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSLNYG 418
             EEV  +K  F  MDT+  G ++              + E+++Q+L+EA D  G G+L+YG
Sbjct:   355 EEVEDIKVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEAVDTKGKGTLDYG 414

Query:   419 EFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD 478
             EFVAVS+HL+K+ANDEHL KAFS+FD++ +G+I  +EL +AL ++      DV N I  +
Sbjct:   415 EFVAVSLHLQKVANDEHLRKAFSYFDKDGNGYILPQELCDALKEDGGDDCVDVANDIFQE 474

Query:   479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLAN 531
             VDTDKDGRISYEEFA MMK GTDWRKASR YSR RFNS+S+KLM++  L L N
Sbjct:   475 VDTDKDGRISYEEFAAMMKTGTDWRKASRHYSRGRFNSLSIKLMKDGSLNLGN 527

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2011201 CDPK1 "calcium-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1787 (634.1 bits), Expect = 3.2e-184, P = 3.2e-184
 Identities = 349/537 (64%), Positives = 416/537 (77%)

Query:     1 MGNC--CARPDSSSGK-RAKGKK----EKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQ- 52
             MGNC  C RPDS   K  +K KK     K NPF GD          +  L  +   S Q 
Sbjct:     1 MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGD---FTRSPAPIRVLKDVIPMSNQT 57

Query:    53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
              IS  Y LGRELGRGEFG+TYLCTD    E  ACKSISK+KLRTAVDIEDVRREV IM  
Sbjct:    58 QISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIMST 117

Query:   113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
             LP+HPN+V LK +YED+  VH+VMELCEGGELFDRIVARGHYTERAAAAV +TI EVV +
Sbjct:   118 LPEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVVMM 177

Query:   173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
             CH  GVMHRDLKPENFLFANKKE+SPLKAIDFGLSVFF+PG++F EIVGSPYYMAPEVLK
Sbjct:   178 CHSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLK 237

Query:   233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             R+YGP VDVWSAGVI+YILLCGVPPFWAETEQGVA AI+R V+DFKRDPWP++SE+AK L
Sbjct:   238 RDYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAKSL 297

Query:   293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
             VK+ML+PDP +RLTA++VL HPW+QNAKKAPNV LG+ V++RLKQFS+MN+ KK+ L+V+
Sbjct:   298 VKQMLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLRVI 357

Query:   353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
             AE LS++EV  +K  F +MD +K GKI               + E ++++LME ADVDG+
Sbjct:   358 AEHLSIQEVEVIKNMFSLMDDDKDGKITYPELKAGLQKVGSQLGEPEIKMLMEVADVDGN 417

Query:   413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVI 472
             G L+YGEFVAV +HL+K+ NDE    AF FFD++ S +IE++ELR AL DE+      V+
Sbjct:   418 GFLDYGEFVAVIIHLQKIENDELFKLAFMFFDKDGSTYIELDELREALADELGEPDASVL 477

Query:   473 NAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
             + IM +VDTDKDGRI+Y+EF  MMKAGTDWRKASRQYSRERF S+S+ LM++  L L
Sbjct:   478 SDIMREVDTDKDGRINYDEFVTMMKAGTDWRKASRQYSRERFKSLSINLMKDGSLHL 534

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;TAS

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2027227 CPK30 "calcium-dependent protein kinase 30" [Arabidopsis thaliana (taxid:3702)]

 Score = 1780 (631.7 bits), Expect = 1.8e-183, P = 1.8e-183
 Identities = 344/531 (64%), Positives = 413/531 (77%)

Query:     1 MGNC--CARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDY 58
             MGNC  C + D  + K  + KK+ P     + Y   +G      L V+       IS  Y
Sbjct:     1 MGNCIACVKFDPDNSKPNQ-KKKPPRGRQRNPYDDPDGLRTHAPLRVIPMSHQSQISDKY 59

Query:    59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
              LGRELGRGEFG+TYLCTD    E  ACKSISK+KLRTAVD+EDVRREV IM  LP+HPN
Sbjct:    60 ILGRELGRGEFGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPEHPN 119

Query:   119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
             +V LK TYED+  VH+VMELCEGGELFDRIVARGHYTERAAA V +TI EVV++CH  GV
Sbjct:   120 VVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHVNGV 179

Query:   179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPE 238
             MHRDLKPENFLFANKKE+S LKAIDFGLSV F+PGE+F EIVGSPYYMAPEVLKRNYGPE
Sbjct:   180 MHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNYGPE 239

Query:   239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
             VDVWSAGVILYILLCGVPPFWAETEQGVA AI+R V+DFKRDPW ++SE+AK LVK+ML 
Sbjct:   240 VDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQMLE 299

Query:   299 PDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSV 358
             PD  +RLTA++VL+HPW+QNAKKAPNV LG+ V++RLKQFS+MN+LKK+AL+V+AE LS+
Sbjct:   300 PDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRLKKKALRVIAEHLSI 359

Query:   359 EEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSLNYG 418
             +EV  ++  F +MD +  GKI+              + E ++++LME ADV+G+G L+YG
Sbjct:   360 QEVEVIRNMFTLMDDDNDGKISYLELRAGLRKVGSQLGEPEIKLLMEVADVNGNGCLDYG 419

Query:   419 EFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD 478
             EFVAV +HL+KM NDEH  +AF FFD++ SG+IE EELR AL DE+      VI  IM +
Sbjct:   420 EFVAVIIHLQKMENDEHFRQAFMFFDKDGSGYIESEELREALTDELGEPDNSVIIDIMRE 479

Query:   479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQL 529
             VDTDKDG+I+Y+EF VMMKAGTDWRKASRQYSRERF S+SL LM++  + L
Sbjct:   480 VDTDKDGKINYDEFVVMMKAGTDWRKASRQYSRERFKSLSLNLMKDGSMHL 530

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

TAIR|locus:2061290 CPK24 "AT2G31500" [Arabidopsis thaliana (taxid:3702)]

 Score = 1646 (584.5 bits), Expect = 2.8e-169, P = 2.8e-169
 Identities = 309/536 (57%), Positives = 408/536 (76%)

Query:     1 MGNCCARPDSSS--GKRAKGKKEKPNPFYGDEYVVANGSTVVHRLC------VLKEPSGQ 52
             MG+C + P   S  GKR   ++   N          + + +  RL       VL EP G 
Sbjct:     1 MGSCVSSPLKGSPFGKRPVRRRHSSNSRTSSVPRFDSSTNLSRRLIFQPPSRVLPEPIGD 60

Query:    53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
              I + YDLG+ELGRGEFGVT+ C +++  E+FACK ISK+KLRT +D+EDVRREV+IM+ 
Sbjct:    61 GIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRC 120

Query:   113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
             LPKHPNIVS K+ +ED  AV++VME+CEGGELFDRIV+RGHYTERAAA+V KTI+EVV+V
Sbjct:   121 LPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKV 180

Query:   173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
             CHE GV+HRDLKPENFLF+N  E++ LKAIDFGLS+FF+P ++FNEIVGSPYYMAPEVL+
Sbjct:   181 CHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLR 240

Query:   233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             RNYGPE+DVWSAGVILYILLCGVPPFWAETE+G+A AI+R  IDF+RDPWPKVS  AK+L
Sbjct:   241 RNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKEL 300

Query:   293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
             VK ML+ +P  RLT +EVLEHPW++NA++APNV+LG+ V+ +++QF +MN+ KK+ L++V
Sbjct:   301 VKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRIV 360

Query:   353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
             A+ L  EE+A + + F+ MDT+K G +             Q +P+ D+++LM+AAD DG+
Sbjct:   361 ADNLPNEEIAAIVQMFQTMDTDKNGHLTFEELRDGLKKIGQVVPDGDVKMLMDAADTDGN 420

Query:   413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV--DTSGED 470
             G L+  EFV +S+HLK+M  DEHL +AF +FD+N +GFIE++EL+ AL D+     +G D
Sbjct:   421 GMLSCDEFVTLSIHLKRMGCDEHLQEAFKYFDKNGNGFIELDELKVALCDDKLGHANGND 480

Query:   471 V-INAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREE 525
               I  I  DVD +KDGRIS++EF  MMK+GTDW+ ASRQYSR   N++S+K+ +E+
Sbjct:   481 QWIKDIFFDVDLNKDGRISFDEFKAMMKSGTDWKMASRQYSRALLNALSIKMFKED 536

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:1901979 "regulation of inward rectifier potassium channel activity" evidence=IDA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1414 (502.8 bits), Expect = 1.1e-144, P = 1.1e-144
 Identities = 264/455 (58%), Positives = 333/455 (73%)

Query:    45 VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
             VL  P  +D+   Y LG+ELGRG+FGVT+LCT    G +FACK+I+K+KL    DIEDVR
Sbjct:    61 VLGRPM-EDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVR 119

Query:   105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
             REVQIM HL   PNIV LK  YED  +VH+VMELC GGELFDRI+A+GHY+ERAAA++++
Sbjct:   120 REVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLR 179

Query:   165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
             TIV++V  CH  GV+HRDLKPENFL  NK E+SPLKA DFGLSVF++PGE F +IVGS Y
Sbjct:   180 TIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAY 239

Query:   225 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
             Y+APEVLKR YGPE D+WS GV+LYILLCGVPPFWAE+E G+  AI+R  +DF  DPWP 
Sbjct:   240 YIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPS 299

Query:   285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 344
             +S  AKDLVKKMLN DPKQRLTA +VL HPW++   +AP+V L   V +RLKQF  MN  
Sbjct:   300 ISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNF 359

Query:   345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILM 404
             KK AL+V+A  LS EE+ GLKE F+ MDT+  G I               + E ++Q LM
Sbjct:   360 KKVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLSEYEVQQLM 419

Query:   405 EAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
             EAAD DG+G+++YGEF+A ++H+ ++  +EHL+ AF  FD++ SG+I +EEL  AL +  
Sbjct:   420 EAADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSGYITMEELEQALREFG 479

Query:   465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG 499
                G D I  I+ +VD D DGRI+Y+EF  MM+ G
Sbjct:   480 MNDGRD-IKEIISEVDGDNDGRINYDEFVAMMRKG 513

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 1401 (498.2 bits), Expect = 2.6e-143, P = 2.6e-143
 Identities = 276/514 (53%), Positives = 353/514 (68%)

Query:     1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTV---VHRLC----VLKE-PSG- 51
             MGNCC     S G+ +   KE+P P  G   V A  ++V    H         K+ P G 
Sbjct:     1 MGNCC-----SHGRDSDDNKEEPRPENGGGGVGAAEASVRASKHPPASPPPATKQGPIGP 55

Query:    52 ------QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
                   +D+   Y LG+ELGRG+FGVT+LCT    G +FACK+I+K+KL    DIEDVRR
Sbjct:    56 VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRR 115

Query:   106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
             EVQIM HL   PNIV LK  YED  +VH+VMELC GGELFDRI+A+GHY+ERAAA++++T
Sbjct:   116 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 175

Query:   166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
             IV+++  CH  GV+HRDLKPENFL  +K E+SPLKA DFGLSVF++PGE F +IVGS YY
Sbjct:   176 IVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 235

Query:   226 MAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
             +APEVL+R YGPE D+WS GV+LYILLCGVPPFWAE+E G+  AI+   +DF  DPWP +
Sbjct:   236 IAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVI 295

Query:   286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLK 345
             S  AKDLV+KMLN DPKQRLTA +VL HPW++   +AP+V L   V +RLKQF  MN  K
Sbjct:   296 SPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 355

Query:   346 KRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILME 405
             K AL+V+A  LS EE+ GLKE F+ MDT+  G I               + E ++Q LME
Sbjct:   356 KVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLSEYEVQQLME 415

Query:   406 AADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD 465
             AAD DG+G+++YGEF+A ++H+ ++  +EHL+ AF  FD++ SG+I  EEL  AL +   
Sbjct:   416 AADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSGYITTEELEQALREFGM 475

Query:   466 TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG 499
               G D I  I+ +VD D DGRI+YEEF  MM+ G
Sbjct:   476 NDGRD-IKEIISEVDGDNDGRINYEEFVAMMRKG 508

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q6NLQ6	CDPKW_ARATH	2, ., 7, ., 1, 1, ., 1	0.7383	0.9924	0.9795	no	no
A5A7I8	CDPK5_SOLTU	2, ., 7, ., 1, 1, ., 1	0.5494	0.9096	0.9028	N/A	no
A5A7I7	CDPK4_SOLTU	2, ., 7, ., 1, 1, ., 1	0.5199	0.9548	0.9102	N/A	no
P49101	CDPK2_MAIZE	2, ., 7, ., 1, 1, ., 1	0.5733	0.8380	0.8674	N/A	no
Q42438	CDPK8_ARATH	2, ., 7, ., 1, 1, ., 1	0.8264	0.9943	0.9906	yes	no
P28582	CDPK_DAUCA	2, ., 7, ., 1, 1, ., 1	0.5361	0.8474	0.8458	N/A	no
Q38873	CDPK7_ARATH	2, ., 7, ., 1, 1, ., 1	0.8192	0.9962	0.9887	no	no
P93759	CDPKE_ARATH	2, ., 7, ., 1, 1, ., 1	0.7043	0.9811	0.9830	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh2_kg.6__1969__AT5G19450.2 annotation not avaliable (533 aa) (Arabidopsis lyrata)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	531
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-107
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-98
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-70
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-66
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-64
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-62
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-61
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-59
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-55
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-55
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-52
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-51
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-50
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-50
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-49
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-47
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-46
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-46
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-45
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-44
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-43
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-43
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-43
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-43
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-42
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-42
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-40
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-39
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-38
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-38
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-38
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-37
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-37
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-37
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-37
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-37
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-36
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-36
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-36
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-35
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-35
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-35
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-35
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-35
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-34
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-34
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-34
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-33
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-33
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-33
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-33
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-33
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-33
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-33
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-32
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-32
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-32
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-32
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-32
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-32
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-32
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-32
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-31
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-31
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-31
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-31
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-31
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-31
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-31
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-31
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-30
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-30
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-30
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-30
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-30
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-30
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-30
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-30
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-30
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-29
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-29
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-29
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-29
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-29
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-29
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-29
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-28
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-28
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-28
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-28
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-28
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-27
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-27
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-27
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-27
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-27
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-27
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-27
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-26
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-26
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-26
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-26
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-26
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-26
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-26
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-26
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-26
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-26
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-26
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-26
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-25
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-25
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-25
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-25
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-25
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-25
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-25
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-25
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-25
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-25
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-24
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-24
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-24
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-24
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-24
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-24
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-24
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-24
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-24
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-23
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-23
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-23
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-23
COG5126	160	COG5126, FRQ1, Ca2+-binding protein (EF-Hand super	2e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-23
PTZ00184	149	PTZ00184, PTZ00184, calmodulin; Provisional	4e-23
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-23
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-23
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-23
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-22
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-22
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-22
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-22
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-22
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-22
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-22
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-22
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-22
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-21
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-21
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-21
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-21
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-21
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-21
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-21
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-21
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-20
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-20
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-20
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-20
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-19
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-19
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-19
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-19
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-19
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-18
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-18
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-18
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-18
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-17
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-17
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-17
PTZ00183	158	PTZ00183, PTZ00183, centrin; Provisional	2e-16
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-16
cd00051	63	cd00051, EFh, EF-hand, calcium binding motif; A di	2e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-14
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-13
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-12
cd00051	63	cd00051, EFh, EF-hand, calcium binding motif; A di	1e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-11
pfam13499	60	pfam13499, EF_hand_5, EF-hand domain pair	3e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-08
pfam13833	53	pfam13833, EF_hand_6, EF-hand domain pair	3e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-07
pfam13833	53	pfam13833, EF_hand_6, EF-hand domain pair	5e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-06
pfam13499	60	pfam13499, EF_hand_5, EF-hand domain pair	3e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-06
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	5e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-04
smart00054	29	smart00054, EFh, EF-hand, calcium binding motif	1e-04
pfam00036	29	pfam00036, efhand, EF hand	1e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
pfam13405	30	pfam13405, EF_hand_4, EF-hand domain	6e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-04
pfam13405	30	pfam13405, EF_hand_4, EF-hand domain	0.001
cd00052	67	cd00052, EH, Eps15 homology domain; found in prote	0.001
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
pfam00036	29	pfam00036, efhand, EF hand	0.002
cd05030	88	cd05030, calgranulins, Calgranulins: S-100 domain	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
smart00054	29	smart00054, EFh, EF-hand, calcium binding motif	0.003
pfam00036	29	pfam00036, efhand, EF hand	0.003
cd00052	67	cd00052, EH, Eps15 homology domain; found in prote	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  321 bits (824), Expect = e-107
 Identities = 115/260 (44%), Positives = 156/260 (60%), Gaps = 7/260 (2%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++  +LG G FG  YL  D   G+  A K I KKK++   D E + RE++I+K L KHP
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKL-KHP 57

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV L D +ED+  +++VME CEGG+LFD +  RG  +E  A   ++ I+  ++  H +G
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-YG 236
           ++HRDLKPEN L     E   +K  DFGL+    PGE+    VG+P YMAPEVL    YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
             VD+WS GVILY LL G PPF  + +       I         P   +S  AKDL++K+
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 297 LNPDPKQRLTAEEVLEHPWL 316
           L  DP++RLTAEE L+HP+ 
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  297 bits (763), Expect = 3e-98
 Identities = 113/266 (42%), Positives = 151/266 (56%), Gaps = 13/266 (4%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+L R+LG G FG  Y       G+  A K + K+  ++  D    RRE++I++ L  HP
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRL-SHP 58

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV L D +ED   +++VME CEGG+LFD +   G  +E  A  +   I+  ++  H  G
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVLK--RN 234
           ++HRDLKPEN L         +K  DFGL+    +        VG+P+YMAPEVL     
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----DFKRDPWPKVSENAK 290
           YGP+VDVWS GVILY LL G PPF  E        +IR ++    +F    W   SE AK
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAK 234

Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           DL+KK LN DP +R TAEE+L+HPW 
Sbjct: 235 DLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  224 bits (573), Expect = 5e-70
 Identities = 90/257 (35%), Positives = 136/257 (52%), Gaps = 13/257 (5%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG   L    + G+ +A K + KKK+    ++E    E  I+  +  HP IV L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLH 59

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
             ++ +  +++V+E   GGELF  +   G ++E  A      IV  ++  H  G+++RDL
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119

Query: 184 KPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
           KPEN L         +K  DFGL+      G + N   G+P Y+APEVL    YG  VD 
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           WS GV+LY +L G PPF+AE  + + + I++  + F       +S  A+DL+  +L  DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP 232

Query: 302 KQRLT---AEEVLEHPW 315
            +RL    AEE+  HP+
Sbjct: 233 TKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  212 bits (541), Expect = 9e-66
 Identities = 93/255 (36%), Positives = 130/255 (50%), Gaps = 44/255 (17%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG G FG  YL  D   G+K A K I K+   + +  E++ RE++I+K L  HPNIV L 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKL-NHPNIVKLY 57

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +ED++ +++VME CEGG L D +    G  +E     ++  I+E ++  H  G++HRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVLKRN--YGPEV 239
           LKPEN L     ++  +K  DFGLS            IVG+P YMAPEVL     Y  + 
Sbjct: 118 LKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
           D+WS GVILY L                                      KDL++KML  
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200

Query: 300 DPKQRLTAEEVLEHP 314
           DP++R +A+E+LEH 
Sbjct: 201 DPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  210 bits (537), Expect = 2e-64
 Identities = 76/265 (28%), Positives = 135/265 (50%), Gaps = 16/265 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y++ +++G+G FG  YL    ++G+ +  K I    +    + ED   EV+I+K L  H
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKL-NH 58

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQV 172
           PNI+   +++E+   + IVME  +GG+L  +I  +      + E         +   ++ 
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 173 CHEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMAPEV 230
            H + ++HRD+KP+N FL +N      +K  DFG+S            +VG+PYY++PE+
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGL----VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174

Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
            +   Y  + D+WS G +LY L     PF  E    +A  I++    +   P  + S   
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG--QYPPIP-SQYSSEL 231

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHP 314
           ++LV  +L  DP++R +  ++L+ P
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  203 bits (518), Expect = 9e-62
 Identities = 88/267 (32%), Positives = 135/267 (50%), Gaps = 14/267 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           ++  G  LGRG FG  YL  D + GE  A KS+ +    +  ++E + RE++I+  L +H
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSL-QH 58

Query: 117 PNIVSLKDTYEDDSAVH--IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV    +  D+      I +E   GG L   +   G   E       + I+E +   H
Sbjct: 59  PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---RPGEQFNEIVGSPYYMAPEVL 231
             G++HRD+K  N L  +      +K  DFG +        GE    + G+PY+MAPEV+
Sbjct: 119 SNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 232 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
           +   YG   D+WS G  +  +  G PP W+E       A+ +     +    P+ +SE A
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP-WSELGN-PMAALYKIGSSGEPPEIPEHLSEEA 233

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           KD ++K L  DPK+R TA+E+L+HP+L
Sbjct: 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  200 bits (512), Expect = 5e-61
 Identities = 90/263 (34%), Positives = 139/263 (52%), Gaps = 14/263 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            +++  ++G+G FG  Y       G++ A K I   KL +    E +  E+QI+K   KH
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKC-KH 56

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
           PNIV    +Y     + IVME C GG L D + +     TE   A V K +++ ++  H 
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-N 234
            G++HRD+K  N L  +  E   +K IDFGLS      +  N +VG+PY+MAPEV+    
Sbjct: 117 NGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-SVIDFKRDPWP-KVSENAKDL 292
           Y  + D+WS G+    L  G PP+   +E    +A+ + +         P K S+  KD 
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDF 230

Query: 293 VKKMLNPDPKQRLTAEEVLEHPW 315
           +KK L  +P++R TAE++L+HP+
Sbjct: 231 LKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  195 bits (499), Expect = 6e-59
 Identities = 90/268 (33%), Positives = 138/268 (51%), Gaps = 19/268 (7%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           + +G +G  +L    + G+ +A K I K  +     ++ V  E  I+    + P +V L 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLY 59

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            +++    +++VME   GG+L   +   G   E  A   +  IV  ++  H  G++HRDL
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119

Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN---------EIVGSPYYMAPEV-LKR 233
           KP+N L  +   +  LK  DFGLS       Q N          IVG+P Y+APEV L +
Sbjct: 120 KPDNILIDS---NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            +   VD WS G ILY  L G+PPF  ET + + Q I+   I++  D   +VS+ A DL+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234

Query: 294 KKMLNPDPKQRLTA---EEVLEHPWLQN 318
            K+L PDP++RL A   EE+  HP+ + 
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  191 bits (484), Expect = 1e-55
 Identities = 93/294 (31%), Positives = 142/294 (48%), Gaps = 28/294 (9%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y + R+LG G FG  YL  D    +  A K ++KK    + ++E   RE+QI+  L   
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVC 173
           PNIV L D ++D+ ++++VME  +GG L D +   G     +E  A  ++  I+  ++  
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-------FNEIVGSPYYM 226
           H +G++HRD+KPEN L    ++   +K IDFGL+                +  VG+P YM
Sbjct: 118 HSKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 227 APEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-------- 274
           APEVL            D+WS G+ LY LL G+PPF  E         ++ +        
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 275 -IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
                      +S+ A DL+KK+L  DPK RL++   L H  L + K   +   
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  187 bits (478), Expect = 1e-55
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 33/285 (11%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ +G G F    L  +    +++A K + K++L     ++ V+ E +++  L  H
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P I+ L  T++D+  ++ V+E    GEL   I   G   E+        I+  ++  H +
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---------------------RPGEQ 215
           G++HRDLKPEN L         +K  DFG +                        +   +
Sbjct: 122 GIIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 216 FNEIVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
           F   VG+  Y++PE+L     G   D+W+ G I+Y +L G PPF    E    Q I++  
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238

Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTA----EEVLEHPW 315
             F   P P    +AKDL++K+L  DP+ RL      +E+  HP+
Sbjct: 239 YSF---P-PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  178 bits (454), Expect = 2e-52
 Identities = 88/264 (33%), Positives = 142/264 (53%), Gaps = 14/264 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y LG  +GRG FGV Y   ++  G+  A K IS +K++    ++ + +E+ ++K+L KH
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL-KH 58

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV    + E   +++I++E  E G L   I   G + E   A  +  +++ +   HEQ
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSPYYMAPEVLKRNY 235
           GV+HRD+K  N L    K+   +K  DFG++       +    +VG+PY+MAPEV+    
Sbjct: 119 GVIHRDIKAANILTT--KDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMS 174

Query: 236 GPEV--DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDL 292
           G     D+WS G  +  LL G PP++   +     A+ R V D    P P+ +S   KD 
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYY---DLNPMAALFRIVQD-DHPPLPEGISPELKDF 230

Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
           + +    DP  R TA+++L+HPW+
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  174 bits (444), Expect = 7e-51
 Identities = 82/265 (30%), Positives = 137/265 (51%), Gaps = 18/265 (6%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG G FG   L    +    FA K + K+ +      E +  E +I++    HP IV L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            T++D   ++++ME C GGEL+  +  RG + E  A   +  +V   +  H +G+++RDL
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNYGPEVDVW 242
           KPEN L  +      +K +DFG +   + G++     G+P Y+APE+ L + Y   VD W
Sbjct: 120 KPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 243 SAGVILYILLCGVPPFWAETE--QGVAQAIIRSV--IDFKRDPWPKVSENAKDLVKKMLN 298
           S G++LY LL G PPF  + E    +   I++    ++F       + + AKDL+K++L 
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLR 232

Query: 299 PDPKQRL-----TAEEVLEHPWLQN 318
            +P++RL       +++ +H W   
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWFNG 257

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  173 bits (442), Expect = 2e-50
 Identities = 93/281 (33%), Positives = 145/281 (51%), Gaps = 28/281 (9%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACK--SISKKKLRTAVDIEDVRREV 107
           S  D    Y    ++G G  G  Y  TD   G++ A K   + K+     +       E+
Sbjct: 13  SEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII------NEI 66

Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY---TERAAAAVMK 164
            IMK   KHPNIV   D+Y     + +VME  +GG L D  +   ++    E   A V +
Sbjct: 67  LIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCR 123

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSP 223
            +++ ++  H Q V+HRD+K +N L +       +K  DFG +    +   + N +VG+P
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTP 180

Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI--IRS--VIDFK 278
           Y+MAPEV+KR  YGP+VD+WS G++   +  G PP+  E      +A+  I +  +   K
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPPLK 237

Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
            +P  K S   KD + K L  DP++R +AEE+L+HP+L+ A
Sbjct: 238 -NP-EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  172 bits (438), Expect = 9e-50
 Identities = 84/268 (31%), Positives = 141/268 (52%), Gaps = 22/268 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++  + LG G FG   L     +G+ +A K +SK K+     +E V  E +I++ + +H
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RH 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AAVMKTIVEVVQVC 173
           P +V+L  +++DDS +++VME   GGELF  +   G + E  A   AA    +V  ++  
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA---QVVLALEYL 117

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LK 232
           H   +++RDLKPEN L  +      +K  DFG +   +       + G+P Y+APE+ L 
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGY---IKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILS 172

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           + YG  VD W+ G+++Y +L G PPF+ +    + + I+   + F        S +AKDL
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDL 228

Query: 293 VKKMLNPDPKQRL-----TAEEVLEHPW 315
           ++ +L  D  +RL        ++  HPW
Sbjct: 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  170 bits (433), Expect = 4e-49
 Identities = 86/293 (29%), Positives = 131/293 (44%), Gaps = 41/293 (13%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y +   +G G  G+ +   D   GE  A K ++ ++L   +      RE++ ++   +H
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQAC-QH 58

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
           P +V L D +   S   +VME     +L + +        E    + M+ +++ V   H 
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVL-- 231
            G+MHRDLKP N L +       LK  DFGL+  F   E   ++  V + +Y APE+L  
Sbjct: 118 NGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ--AIIRSV--------------- 274
            R Y P VD+W+ G I   LL G P F  E +  + Q   + R++               
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLP 232

Query: 275 ----IDF---KRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
               I F   K  P     P  S  A DL+K +L  DP +RL+A E L HP+ 
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  166 bits (424), Expect = 1e-47
 Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 47/288 (16%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPNI 119
           LG G +GV Y   D   GE  A K     K+R   + E +     RE+ ++K L KHPNI
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL-KHPNI 60

Query: 120 VSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           V L D    +  +++V E C+    +  D+    G  +     ++M  ++  +  CH   
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQF-NEIVGSPYYMAPEVL--KR 233
           ++HRDLKP+N +  N+     LK  DFGL+  F  P   + +E+V + +Y APE+L   +
Sbjct: 119 ILHRDLKPQN-ILINRDGV--LKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSK 174

Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR--------------SVIDFKR 279
           +Y   VD+WS G I   ++ G P F  ++E      I +               + D+K 
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234

Query: 280 DP--WPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
               +P          +     DL+ KML  +P +R++A+E L+HP+ 
Sbjct: 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  162 bits (413), Expect = 3e-46
 Identities = 85/288 (29%), Positives = 126/288 (43%), Gaps = 42/288 (14%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR--REVQIMKHLPKHPNI 119
            ++G G +GV Y   D   GE  A K I   KLR   +       RE++++K L  HPNI
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKEL-NHPNI 60

Query: 120 VSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           + L D +     +++V E  +    +L      +    E    + +  +++ +  CH  G
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
           ++HRDLKPEN L         LK  DFGL+  F  P   +   V + +Y APE+L   + 
Sbjct: 119 ILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETE-------------------QGVAQAIIRSVI 275
           Y   VD+WS G I   LL   P F  ++E                               
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 276 DFK---RDPWPKV----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
            F      P PK+    S  A DL+ +ML+ DP +R+TAE+ L HP+ 
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  164 bits (418), Expect = 4e-46
 Identities = 94/294 (31%), Positives = 143/294 (48%), Gaps = 37/294 (12%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG FG  +L  D + G+ +A K + K  +     I  VR E  I+      
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADS 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV L  +++D+  +++VME   GG+L + ++ +  + E  A   +  +V  +   H+ 
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS--------------------------VFF 210
           G +HRD+KP+N L         +K  DFGL                           V  
Sbjct: 121 GFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 211 RPGEQ----FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG 265
           R  +Q     N  VG+P Y+APEVL+   YG E D WS GVILY +L G PPF+++T Q 
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237

Query: 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT-AEEVLEHPWLQN 318
               II      +  P P VS  A DL+ ++L  DP+ RL   EE+  HP+ + 
Sbjct: 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  159 bits (405), Expect = 2e-45
 Identities = 75/262 (28%), Positives = 128/262 (48%), Gaps = 8/262 (3%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++L R +G+G FG   +    +  + FA K ++K+K      + +V  E +I++ L  HP
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
            +V+L  +++D+  +++V++L  GG+L   +  +  ++E      +  IV  ++  H +G
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYG 236
           ++HRD+KP+N L     E   +   DF ++    P        G+P YMAPEVL R  Y 
Sbjct: 121 IIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177

Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
             VD WS GV  Y  L G  P+   +     Q I               S  A D + K+
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRAKQETADVLYPATWSTEAIDAINKL 236

Query: 297 LNPDPKQRL--TAEEVLEHPWL 316
           L  DP++RL    +++  HP+ 
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  157 bits (398), Expect = 2e-44
 Identities = 81/263 (30%), Positives = 132/263 (50%), Gaps = 10/263 (3%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + + +G FG  YL    + G+ FA K + K  +     + +V+ E  IM    + P +  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L  +++    +++VME   GG+    I   G   E  A   +  +V  V+  H++G++HR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPE-VD 240
           D+KPEN L     ++  LK  DFGLS   R G +  + VG+P Y+APE +      +  D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            WS G +++  L G PPF AET   V   I+   I++  +     S  A DL+ ++L  D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 301 PKQRLTA---EEVLEHPWLQNAK 320
           P +RL A   +E+  HP+ ++  
Sbjct: 236 PAKRLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  157 bits (398), Expect = 1e-43
 Identities = 91/268 (33%), Positives = 133/268 (49%), Gaps = 13/268 (4%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ +  ++G+G +G  +L    + GE  A K + K  L    ++  V  E  I+    K 
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
             +V L   ++DD  +++ ME   GG+    +   G  +E  A   M  + E V   HE 
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
           G +HRDLKPENFL      S  +K  DFGLS         N +VGSP YMAPEVL+ + Y
Sbjct: 121 GYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGY 175

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR----DPWPKVSENAKD 291
              VD WS G +LY  LCG PPF   T     + +       +R    DP   +S+ A D
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235

Query: 292 LVKKMLNPDPKQRLTA-EEVLEHPWLQN 318
           L+ K++N DP +R  + E++  HP+ + 
Sbjct: 236 LITKLIN-DPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  154 bits (392), Expect = 2e-43
 Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 20/269 (7%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
            G ++G G FG  Y   +++ GE  A K I  +       I+++  E+++++ L KHPN+
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELL-KHPNL 61

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
           V           V+I ME C GG L + +       E         ++E +   H  G++
Sbjct: 62  VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFF-----RPGEQFNEIVGSPYYMAPEVLKRN 234
           HRD+KP N        +  +K  DFG +V         GE+   + G+P YMAPEV+   
Sbjct: 122 HRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 235 ----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP---KVSE 287
               +G   D+WS G ++  +  G  P W+E +      I+  V    + P P   ++S 
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP-WSELDN--EFQIMFHVGAGHKPPIPDSLQLSP 235

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
             KD + + L  DPK+R TA E+L+HP++
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  154 bits (392), Expect = 3e-43
 Identities = 91/277 (32%), Positives = 148/277 (53%), Gaps = 23/277 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISK----KKLRTAVDIEDVRREVQI 109
           +++L R LG G +G  +L   V   + G+ +A K + K    +K +TA   E  R E Q+
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTA---EHTRTERQV 57

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           ++ + + P +V+L   ++ D+ +H++++   GGELF  +  R H+TE      +  IV  
Sbjct: 58  LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA 117

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMA 227
           +   H+ G+++RD+K EN L         +   DFGLS  F   E+       G+  YMA
Sbjct: 118 LDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 228 PEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           PEV++     +   VD WS GV+ + LL G  PF  + EQ  +Q+ I   I   + P+PK
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKPPFPK 233

Query: 285 -VSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQ 317
            +S  A+D ++K+L  DPK+RL    A+E+  HP+ Q
Sbjct: 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  153 bits (390), Expect = 8e-43
 Identities = 91/299 (30%), Positives = 141/299 (47%), Gaps = 56/299 (18%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR--REVQIMKHLPK 115
           Y + ++LG G FG  YL  +   GE  A K + KKK  +    E+    REV+ ++ L +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYS---WEECMNLREVKSLRKLNE 56

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVC 173
           HPNIV LK+ + ++  ++ V E  E G L+  +  R    ++E    +++  I++ +   
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H+ G  HRDLKPEN L +       +K  DFGL+   R    + + V + +Y APE+L R
Sbjct: 116 HKHGFFHRDLKPENLLVSG---PEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR 172

Query: 234 --NYGPEVDVWSAGVI---LYIL---------------LCGV-----PPFWAETEQGVAQ 268
             +Y   VD+W+ G I   LY L               +C V        W E  + +A 
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-LAS 231

Query: 269 AI-----------IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
            +           +  +I       P  S  A DL+K ML  DPK+R TA + L+HP+ 
Sbjct: 232 KLGFRFPQFAPTSLHQLI-------PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  153 bits (388), Expect = 2e-42
 Identities = 86/297 (28%), Positives = 141/297 (47%), Gaps = 45/297 (15%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRREVQIMKHLP 114
           Y+ G++LG G + V Y   D   G   A K I    +K+ +  ++     RE+++++ L 
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINF-TALREIKLLQEL- 59

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEG---GELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
           KHPNI+ L D +   S +++V E  E      + D+ +     T     + M   +  ++
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV---LTPADIKSYMLMTLRGLE 116

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEV 230
             H   ++HRDLKP N L A+      LK  DFGL+  F  P  +    V + +Y APE+
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173

Query: 231 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------------QGVAQA 269
           L   R+YG  VD+WS G I   LL  VP    +++                    GV   
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS- 232

Query: 270 IIRSVIDFK-------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
            +   ++FK       +  +P  S++A DL++++L  +P +R+TA + LEHP+  N 
Sbjct: 233 -LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  150 bits (382), Expect = 5e-42
 Identities = 91/273 (33%), Positives = 131/273 (47%), Gaps = 25/273 (9%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++   +G+G FG        ++G+    K I    + T  + + +  EV I++ L KH
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KH 58

Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRI----VARGHYTERAAAAVMKTIVEVV 170
           PNIV   D   D S   ++IVME CEGG+L   I      R +  E     ++  ++  +
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 171 QVCH-----EQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSP 223
             CH        V+HRDLKP N FL AN      +K  DFGL+        F    VG+P
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGHDSSFAKTYVGTP 174

Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
           YYM+PE L    Y  + D+WS G ++Y L    PPF A  +  +A  I       K    
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG----KFRRI 230

Query: 283 PKV-SENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
           P   S    +++K MLN DP +R + EE+L+ P
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  145 bits (369), Expect = 6e-40
 Identities = 88/283 (31%), Positives = 143/283 (50%), Gaps = 33/283 (11%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKH 116
           + L   +G+G FG  Y   D    +  A K I    L  A D IED+++E+Q +    + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQC-RS 58

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P I     ++   S + I+ME C GG   D ++  G   E   A +++ ++  ++  HE+
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE------QFNEIVGSPYYMAPEV 230
           G +HRD+K  N L + + +   +K  DFG+S     G+      + N  VG+P++MAPEV
Sbjct: 118 GKIHRDIKAANILLSEEGD---VKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEV 169

Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV---- 285
           +K++ Y  + D+WS G+    L  G PP        V   I       K +P P +    
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------KNNP-PSLEGNK 222

Query: 286 -SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
            S+  KD V   LN DPK+R +A+E+L+H +++ AKK   ++L
Sbjct: 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  146 bits (369), Expect = 7e-40
 Identities = 80/269 (29%), Positives = 138/269 (51%), Gaps = 20/269 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D +  + +G G FG  +L  D  +   +A K ++  ++      + V  E +++K +  H
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SH 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P I+ L  T  D   ++++ME   GGELF  +   G ++          IV  ++  H +
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-Y 235
            +++RDLKPEN L    KE   +K  DFG +   R  ++   + G+P Y+APEV++   +
Sbjct: 121 EIVYRDLKPENILL--DKEGH-IKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGH 175

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR--DPWPKVSENAKDLV 293
              VD W+ G+++Y +L G PPF+ +   G+ + I+   ++F R  D +      AKDL+
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLY------AKDLI 229

Query: 294 KKMLNPDPKQRL-----TAEEVLEHPWLQ 317
           KK+L  D  +RL      A++V  H W +
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  144 bits (366), Expect = 1e-39
 Identities = 76/275 (27%), Positives = 128/275 (46%), Gaps = 22/275 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK----- 111
           D +  + LG+G  GV Y       G+ +A K I           E+ R+  Q+++     
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRK--QLLRELKTL 53

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
              + P +V     +  +  + IV+E  +GG L D +   G   E   A + + I++ + 
Sbjct: 54  RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD 113

Query: 172 VCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPE 229
             H +  ++HRD+KP N L  +K E   +K  DFG+S V     +Q N  VG+  YM+PE
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170

Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--VS 286
            ++  +Y    D+WS G+ L     G  PF     Q     +++++ D      P    S
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEFS 229

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
              +D +   L  DPK+R +A E+L+HP+++ A  
Sbjct: 230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  141 bits (357), Expect = 3e-38
 Identities = 90/272 (33%), Positives = 135/272 (49%), Gaps = 25/272 (9%)

Query: 58  YDLGR--ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             L    ++G G  G+  + TD + G + A K   K  LR     E +  EV IM+    
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQ- 74

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           HPNIV +  +Y     + +VME  EGG L D IV      E   A V   +++ +   H 
Sbjct: 75  HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHA 133

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-------IVGSPYYMAP 228
           QGV+HRD+K ++ L         +K  DFG         Q ++       +VG+PY+MAP
Sbjct: 134 QGVIHRDIKSDSILL---TSDGRVKLSDFGFCA------QVSKEVPRRKSLVGTPYWMAP 184

Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           EV+ R  YG EVD+WS G+++  ++ G PP++ E      + I  ++    ++   KVS 
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSP 243

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
             +  + +ML  DP QR TA E+L HP+L  A
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  142 bits (360), Expect = 4e-38
 Identities = 93/303 (30%), Positives = 139/303 (45%), Gaps = 54/303 (17%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLP 114
           Y+L + +G G +GV     D   G K A K IS        D+ D +   RE+++++HL 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS----NVFDDLIDAKRILREIKLLRHL- 56

Query: 115 KHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           +H NI+ L D     + ED + V+IV EL E  +L   I +    T+      +  I+  
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG 115

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS----VFFRPGEQFNEIVGSPYY 225
           ++  H   V+HRDLKP N +  N   +  LK  DFGL+              E V + +Y
Sbjct: 116 LKYLHSANVIHRDLKPSN-ILVN--SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172

Query: 226 MAPEVL--KRNYGPEVDVWSAGVIL--------------YI----LLC---GVPPFWAET 262
            APE+L     Y   +D+WS G I               YI    L+    G P    E 
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS--EED 230

Query: 263 EQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
            + +    A+  ++S+    + P     P  S  A DL++KML  DPK+R+TA+E L HP
Sbjct: 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290

Query: 315 WLQ 317
           +L 
Sbjct: 291 YLA 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  139 bits (353), Expect = 8e-38
 Identities = 82/277 (29%), Positives = 126/277 (45%), Gaps = 32/277 (11%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY+L   +G G   V Y    + N EK A K I  +K +T   ++++R+EVQ M     H
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMS-QCNH 58

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD---RIVARGHYTERAAAAVMKTIVEVVQVC 173
           PN+V    ++     + +VM    GG L D       RG   E   A V+K +++ ++  
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-----RPGEQFNEIVGSPYYMAP 228
           H  G +HRD+K  N L     E   +K  DFG+S        R  +     VG+P +MAP
Sbjct: 119 HSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Query: 229 EVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           EV++    Y  + D+WS G+    L  G  P+       V    +++      DP P + 
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN------DP-PSLE 228

Query: 287 ENA---------KDLVKKMLNPDPKQRLTAEEVLEHP 314
             A         + ++   L  DP +R TAEE+L+H 
Sbjct: 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  140 bits (355), Expect = 2e-37
 Identities = 82/269 (30%), Positives = 139/269 (51%), Gaps = 16/269 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++G  LG G FG   +      GE +A K + K+++     ++ V +E  I+  L  H
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SH 77

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV++  +++D++ V+ ++E   GGELF  +   G +    A      +V   +  H +
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            +++RDLKPEN L  NK     +K  DFG +   +  ++   + G+P Y+APEV++ + +
Sbjct: 138 DIIYRDLKPENLLLDNKGH---VKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGH 192

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           G  VD W+ GV+LY  + G PPF+ +T   + + I+   + F    W      A+DLVK 
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKG 248

Query: 296 MLNPDPKQRLTA-----EEVLEHPWLQNA 319
           +L  D  +RL        +V  HP+   A
Sbjct: 249 LLQTDHTKRLGTLKGGVADVKNHPYFHGA 277

Length = 329

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  137 bits (346), Expect = 5e-37
 Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 18/264 (6%)

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACK--SISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           G  LG G FG  Y   ++++G+ FA K  S++         ++ + +E+ ++  L +HPN
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPN 63

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           IV    T  ++  ++I +EL  GG L   +   G + E       + I+  ++  H++  
Sbjct: 64  IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLS---VFFRPGEQFNEIVGSPYYMAPEVLKR-- 233
           +HRD+K  N L         +K  DFG++   V F   + F    GSPY+MAPEV+ +  
Sbjct: 124 VHRDIKGANILVDTNGV---VKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVIAQQG 177

Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDL 292
            YG   D+WS G  +  +  G PP W++ E     A+ +     +  P P  +S+ AKD 
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDF 234

Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
           + K L  DP  R TA E+LEHP++
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 6e-37
 Identities = 87/298 (29%), Positives = 136/298 (45%), Gaps = 52/298 (17%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+   ++G G +G  Y   +   GE  A K I  +  +    I  +R E+++++ L +HP
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKL-RHP 58

Query: 118 NIVSLKD--TYEDDSAVHIVMELCEGGELFD--RIVARG--HYTERAAAAVMKTIVEVVQ 171
           NIV LK+  T +   ++++V E  +     D   ++      +TE      MK ++E +Q
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--RPGEQFNEIVGSPYYMAPE 229
             H  G++HRD+K  N L  N      LK  DFGL+  +  R    +   V + +Y  PE
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Query: 230 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---SVIDFKRDPWPK 284
           +L     YGPEVD+WS G IL  L  G P F   TE    + I     S  D   + WP 
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD---ENWPG 228

Query: 285 V---------------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
           V                             +A DL+ K+L  DPK+R++A++ L+H +
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 6e-37
 Identities = 92/298 (30%), Positives = 135/298 (45%), Gaps = 61/298 (20%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
            +G G +GV   C +   GE  A K     K + + D EDV+    REV++++ L +H N
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQL-RHEN 61

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER-----AAAAVMKTIVEVVQV- 172
           IV+LK+ +     +++V E  E   L           E         AV   I +++Q  
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVERTLL--------ELLEASPGGLPPDAVRSYIWQLLQAI 113

Query: 173 --CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--RPGEQFNEIVGSPYYMAP 228
             CH   ++HRD+KPEN L     ES  LK  DFG +     RP     + V + +Y AP
Sbjct: 114 AYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 229 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE--------QGVAQAIIRSVIDFK 278
           E+L    NYG  VDVW+ G I+  LL G P F  +++        + +          F 
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230

Query: 279 RDP------WP--------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
            +P      +P              KVS  A D +K  L  DPK+RLT +E+L+HP+ 
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  136 bits (345), Expect = 8e-37
 Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 25/269 (9%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            +D+  +LG G +G  Y       G+  A K +  ++     D++++ +E+ I+K     
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DS 57

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
           P IV    +Y  ++ + IVME C  G + D +       TE   AA++   ++ ++  H 
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKR- 233
              +HRD+K  N L   + ++   K  DFG+S        + N ++G+P++MAPEV++  
Sbjct: 118 NKKIHRDIKAGNILLNEEGQA---KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174

Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP------KVSE 287
            Y  + D+WS G+    +  G PP+ ++         +R++      P P      K S 
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPY-SDIHP------MRAIFMIPNKPPPTLSDPEKWSP 227

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
              D VKK L  DP++R +A ++L+HP++
Sbjct: 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  137 bits (345), Expect = 1e-36
 Identities = 87/289 (30%), Positives = 153/289 (52%), Gaps = 26/289 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKH 112
           +++L + LG G +G  +L   V   ++G+ +A K + K  + + A   E  R E Q+++H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           + + P +V+L   ++ D+ +H++++   GGELF  +  R  + E+        IV  ++ 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--RPGEQFNEIVGSPYYMAPEV 230
            H+ G+++RD+K EN L      +  +   DFGLS  F     E+     G+  YMAP++
Sbjct: 121 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 231 LK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VS 286
           ++     +   VD WS GV++Y LL G  PF  + E+     I R ++     P+P+ +S
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMS 236

Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQN-------AKKAP 323
             AKD+++++L  DPK+RL      A+E+ +HP+ Q        AKK P
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  134 bits (338), Expect = 7e-36
 Identities = 85/268 (31%), Positives = 133/268 (49%), Gaps = 17/268 (6%)

Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHL 113
            ++  G+ LG+G FG  YLC DV+ G + A K +        T  ++  +  E+Q++K+L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
            +H  IV       DD  + I ME   GG + D++ A G  TE       + I+E V+  
Sbjct: 62  -QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYL 120

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFG----LSVFFRPGEQFNEIVGSPYYMAPE 229
           H   ++HRD+K  N L   +  +  +K  DFG    L      G     + G+PY+M+PE
Sbjct: 121 HSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--PKVS 286
           V+    YG + DVWS G  +  +L   PP WAE E   A A I  +     +P     VS
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPQLPSHVS 233

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
            +A++ +++    + K+R +AEE+L H 
Sbjct: 234 PDARNFLRRTFVENAKKRPSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 9e-36
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 43/301 (14%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            +   + LG+G+ G  +L      G+ FA K + KK++     ++ V  E +I+  L  H
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DH 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD-RIVARGHY-TERAAAAVMKTIVEVVQVCH 174
           P + +L  +++ ++ + +VM+ C GGELF       G   +E  A      ++  ++  H
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--------------------------- 207
             G+++RDLKPEN L     ES  +   DF LS                           
Sbjct: 121 LLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 208 ---VFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETE 263
                  P  + N  VG+  Y+APEV+  + +G  VD W+ G++LY +L G  PF     
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237

Query: 264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL----TAEEVLEHPWLQNA 319
                 I++  + F     P VS +A+DL++K+L  DP +RL     A E+ +HP+ +  
Sbjct: 238 DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295

Query: 320 K 320
            
Sbjct: 296 N 296

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 2e-35
 Identities = 90/270 (33%), Positives = 131/270 (48%), Gaps = 24/270 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY+L + +G G +G  Y   D+  GE  A K I   KL    D E +++E+ ++K   +H
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKEC-RH 59

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHE 175
           PNIV+   +Y     + IVME C GG L D   V RG  +E   A V +  ++ +   HE
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--- 231
            G +HRD+K  N L     E   +K  DFG+S        +    +G+PY+MAPEV    
Sbjct: 120 TGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE 176

Query: 232 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
            K  Y  + D+W+ G+    L    PP +          I +S       P PK+ +  K
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS----NFPP-PKLKDKEK 231

Query: 291 ------DLVKKMLNPDPKQRLTAEEVLEHP 314
                 D +KK L  DPK+R TA ++L+HP
Sbjct: 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  133 bits (337), Expect = 2e-35
 Identities = 90/259 (34%), Positives = 140/259 (54%), Gaps = 11/259 (4%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  + T  ++G+  A K   K  LR     E +  EV IM+   +H N+V +
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 82

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            ++Y     + +VME  EGG L D IV      E   AAV   +++ + V H QGV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           +K ++ L  +      +K  DFG      +   +   +VG+PY+MAPE++ R  YGPEVD
Sbjct: 142 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G+++  ++ G PP++ E     A  +IR  +  K     KVS + K  + ++L  D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 301 PKQRLTAEEVLEHPWLQNA 319
           P QR TA E+L+HP+L  A
Sbjct: 258 PAQRATAAELLKHPFLAKA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  134 bits (338), Expect = 3e-35
 Identities = 86/269 (31%), Positives = 138/269 (51%), Gaps = 23/269 (8%)

Query: 62  RELGRGEFGVTYLC---TDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHP 117
           + LG+G +G  +     T  + G+ FA K + K  + R   D    + E  I++ + KHP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHP 60

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
            IV L   ++    +++++E   GGELF  +   G + E  A   +  I   ++  H+QG
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGL---SVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
           +++RDLKPEN L   +     +K  DFGL   S+    G   +   G+  YMAPE+L R+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175

Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            +G  VD WS G ++Y +L G PPF AE  +     I++  ++      P ++  A+DL+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231

Query: 294 KKMLNPDPKQRL-----TAEEVLEHPWLQ 317
           KK+L  +P  RL      A EV  HP+ +
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 3e-35
 Identities = 82/274 (29%), Positives = 137/274 (50%), Gaps = 19/274 (6%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKH---PNI 119
           +GRG +G  Y    V  G   A K I+   L T  D + D++REV ++  L +    PNI
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQL-RQSQPPNI 64

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGV 178
                +Y     + I+ME  EGG +  R + + G   E+  + +++ ++  ++  H+ GV
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVGV 122

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLK--RNY 235
           +HRD+K  N L  N   +  +K  DFG++        + +  VG+PY+MAPEV+   + Y
Sbjct: 123 IHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             + D+WS G+ +Y +  G PP+           I +S     R      S+  ++ V  
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAA 237

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE 329
            L+ +PK+RL+AEE+L+  W++   K P   L E
Sbjct: 238 CLDEEPKERLSAEELLKSKWIKAHSKTPVSILKE 271

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  132 bits (333), Expect = 8e-35
 Identities = 82/294 (27%), Positives = 133/294 (45%), Gaps = 49/294 (16%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR--REVQIMKHLPK 115
           Y +  ++G G F           G+ +A K + KK  +    +E V   RE+Q ++ L  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFK---SLEQVNNLREIQALRRLSP 56

Query: 116 HPNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQV 172
           HPNI+ L +   D     + +V EL +   L++ I  R     E+   + M  +++ +  
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFNEIVGSPYYMAPEV 230
            H  G+ HRD+KPEN L   K +   LK  DFG    ++ +P   + E + + +Y APE 
Sbjct: 116 MHRNGIFHRDIKPENILI--KDDI--LKLADFGSCRGIYSKP--PYTEYISTRWYRAPEC 169

Query: 231 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSV-------IDFKRD 280
           L  +  YGP++D+W+ G + + +L   P F    E  + Q A I  V       +  K  
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFR 227

Query: 281 PW-------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
                                P  S    DL+KK+L  DP +R+TA++ L HP+
Sbjct: 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (335), Expect = 1e-34
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 15/264 (5%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV--RREVQIMKHLPKHPNIVS 121
           +G+G FG  Y     +    +A K +SKK++    ++      R + +   L + P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           LK +++ DS +++V +   GGELF  +   G ++E  A   +  +V  ++  H+  +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 182 DLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPE 238
           DLKPEN L      +  +   DFGLS       +  N   G+  Y+APEVL  ++ Y   
Sbjct: 121 DLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
           VD WS GV+++ + CG  PF+AE  Q + + I    + F ++    +S+  +  VK +LN
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKGLLN 234

Query: 299 PDPKQRL----TAEEVLEHPWLQN 318
            +P+ RL     A E+ EHP+  +
Sbjct: 235 RNPQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  132 bits (334), Expect = 1e-34
 Identities = 79/275 (28%), Positives = 144/275 (52%), Gaps = 16/275 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKH 112
           +++L + LG G +G  +L   V   + G+ +A K + K  L + A  +E  R E  +++H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           + + P +V+L   ++ ++ +H++++   GGE+F  +  R +++E         I+  ++ 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--RPGEQFNEIVGSPYYMAPEV 230
            H+ G+++RD+K EN L  ++     +   DFGLS  F     E+     G+  YMAPE+
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGH---VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 231 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
           +  K  +G  VD WS G++++ LL G  PF  E E+     + R ++         +   
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237

Query: 289 AKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
           A+DL+ K+L  DPK+RL      A E+ EHP+ + 
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 2e-34
 Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 28/274 (10%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ELG G FG  Y       G   A K I   ++ +  ++ED   E+ I+    KHPNIV L
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSEC-KHPNIVGL 67

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHR 181
            + Y  ++ + I++E C+GG L   ++      TE     V + ++E +   H   V+HR
Sbjct: 68  YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNEIVGSPYYMAPEVL------KRN 234
           DLK  N L     +   +K  DFG+S   +   Q  +  +G+PY+MAPEV+         
Sbjct: 128 DLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV------SEN 288
           Y  + D+WS G+ L  L    PP   E         +R ++   +   P +      S +
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPH-HELN------PMRVLLKILKSEPPTLDQPSKWSSS 237

Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
             D +K  L  DP  R TA E+L+HP++ +    
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  127 bits (322), Expect = 1e-33
 Identities = 81/267 (30%), Positives = 134/267 (50%), Gaps = 22/267 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE--DVRREVQIMKHLP 114
           D+ + ++LG+G +G  Y    +++ + +A K   +  L +    E  D   E++I+  + 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALK---EVDLGSMSQKEREDAVNEIRILASV- 56

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVV 170
            HPNI+S K+ + D + + IVME    G+L   I  R        E+    +   ++  +
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 171 QVCHEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           Q  HEQ ++HRDLK  N  L AN      +K  D G+S   +      +I G+P+YMAPE
Sbjct: 117 QALHEQKILHRDLKSANILLVANDL----VKIGDLGISKVLKKNMAKTQI-GTPHYMAPE 171

Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV-SE 287
           V K R Y  + D+WS G +LY +    PPF A + Q +   + R     K  P P + S+
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQ 227

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHP 314
           + ++ ++ ML   PK R   +++L  P
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  127 bits (321), Expect = 2e-33
 Identities = 90/261 (34%), Positives = 137/261 (52%), Gaps = 17/261 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y++ R +G G FG   L   VN+ +K+A K I   K  ++  +ED R+E  ++  + KH
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KH 57

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGH-YTERAAAAVMKTIVEVVQVCH 174
           PNIV+ K+++E D  ++IVME C+GG+L  +I + RG  + E         +   VQ  H
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117

Query: 175 EQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK 232
           E+ V+HRD+K +N FL  N K    +K  DFG + +   PG      VG+PYY+ PE+ +
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGK----VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173

Query: 233 R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVSENAK 290
              Y  + D+WS G ILY L     PF A       + +I  V      P P   S   +
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQA----NSWKNLILKVCQGSYKPLPSHYSYELR 229

Query: 291 DLVKKMLNPDPKQRLTAEEVL 311
            L+K+M   +P+ R +A  +L
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  128 bits (322), Expect = 3e-33
 Identities = 85/265 (32%), Positives = 141/265 (53%), Gaps = 11/265 (4%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y    ++G+G  G  +   DV  G++ A K I+ +K       E +  E+ +MK L K+P
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKEL-KNP 76

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV+  D++     + +VME   GG L D +V      E   AAV +  ++ ++  H   
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
           V+HRD+K +N L         +K  DFG      P + + + +VG+PY+MAPEV+ R  Y
Sbjct: 136 VIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GP+VD+WS G++   ++ G PP+  E        I  +     ++P  K+S   +D + +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPIFRDFLNR 251

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAK 320
            L  D ++R +A+E+L+HP+L+ AK
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLKLAK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  126 bits (319), Expect = 3e-33
 Identities = 80/259 (30%), Positives = 125/259 (48%), Gaps = 12/259 (4%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R LG+G FG   L     +      K ++  +L       D   E+ I+  L +HPNI++
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLL-QHPNIIA 63

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVM 179
             + + DD+ + I ME   GG L+D+IV +    + E      +  IV  V   H+ G++
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-IVGSPYYMAPEVLK-RNYGP 237
           HRD+K  N +F  K  +  +K  DFG+S          E +VG+PYYM+PE+ +   Y  
Sbjct: 124 HRDIKTLN-IFLTK--AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180

Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           + D+W+ G +LY LL     F A     +   I++         +   S     LV  +L
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLVHSLL 237

Query: 298 NPDPKQRLTAEEVLEHPWL 316
             DP++R TA+EVL+ P L
Sbjct: 238 QQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  128 bits (322), Expect = 5e-33
 Identities = 85/260 (32%), Positives = 133/260 (51%), Gaps = 17/260 (6%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKHPNIVSL 122
           LG+G FG   L  +   G+ +A K I KK++  A D +     E +++++  +HP + +L
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTAL 60

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
           K +++    +  VME   GGELF  +     ++E  A      IV  +   H   V++RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 183 LKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           LK EN +     +   +K  DFGL       G       G+P Y+APEVL+ N YG  VD
Sbjct: 121 LKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+  +L  D
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKKD 233

Query: 301 PKQRL-----TAEEVLEHPW 315
           PKQRL      A+E++EH +
Sbjct: 234 PKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  126 bits (317), Expect = 6e-33
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)

Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSIS--KKKLRTAVDIEDVRREVQIMKHL 113
           I++  G+ LG+G FG  YLC DV+ G + A K +    +   T+ ++  +  E+Q++K+L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 114 PKHPNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            +H  IV       D  +  + I ME   GG + D++ A G  TE       + I+E + 
Sbjct: 62  -QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS 120

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG----LSVFFRPGEQFNEIVGSPYYMA 227
             H   ++HRD+K  N L   +  +  +K  DFG    L      G     + G+PY+M+
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-V 285
           PEV+    YG + DVWS G  +  +L   PP WAE E     AI +          P  +
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTNPQLPSHI 234

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           SE+A+D +  +   + + R +AEE+L HP+ Q
Sbjct: 235 SEHARDFLGCIF-VEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  127 bits (321), Expect = 7e-33
 Identities = 80/264 (30%), Positives = 131/264 (49%), Gaps = 14/264 (5%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG+G FG   L       E +A K + K  +    D+E    E +++    KHP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L   ++    +  VME   GG+L   I   G + E  A      IV  +Q  HE+G+++R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEV 239
           DLK +N L  ++     +K  DFG+       G   +   G+P Y+APE+L  + YGP V
Sbjct: 121 DLKLDNVLLDSEGH---IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177

Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
           D W+ GV+LY +L G  PF  + E  + Q+I+   + + R  W  +S+ AK ++K  L  
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--W--LSKEAKSILKSFLTK 233

Query: 300 DPKQRLTA-----EEVLEHPWLQN 318
           +P++RL       +++  HP+ + 
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  125 bits (315), Expect = 1e-32
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 10/260 (3%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+  R +GRG FG+ +LC    + +    K I  +++ T  +    + E Q++K L  HP
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLL-SHP 59

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHE 175
           NI+   + + +D A+ IVME   GG L + I  R +    E         I+  +   H 
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           + ++HRDLK +N L    K    +K  DFG+S       +   +VG+P Y++PE+ + + 
Sbjct: 120 KLILHRDLKTQNILLDKHK--MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           Y  + D+W+ G +LY L      F A     +   I+        D   + S + + L+ 
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLIL 234

Query: 295 KMLNPDPKQRLTAEEVLEHP 314
            MLN DP +R    +++  P
Sbjct: 235 SMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  125 bits (314), Expect = 1e-32
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 24/270 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVRREVQIMKHLP 114
           ++ LG+ LG+G FG  YLC D + G + A K +    +   T+ ++  +  E+Q++K+L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL- 61

Query: 115 KHPNIVS----LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
            H  IV     L+D  E    + I ME   GG + D++ + G  TE       + I+E V
Sbjct: 62  LHERIVQYYGCLRDPME--RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV 119

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG----LSVFFRPGEQFNEIVGSPYYM 226
              H   ++HRD+K  N L   +     +K  DFG    L      G     + G+PY+M
Sbjct: 120 SYLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 227 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--P 283
           +PEV+    YG + D+WS G  +  +L   PP WAE E   A A I  +     +P   P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPVLPP 232

Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
            VS++ +D +K++   + K R +A+E+L H
Sbjct: 233 HVSDHCRDFLKRIF-VEAKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 2e-32
 Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 42/294 (14%)

Query: 46  LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
           L +P+G      ++L   +G G +G  Y       G+  A K +   +       E+++ 
Sbjct: 1   LPDPTG-----IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKE 51

Query: 106 EVQIMKHLPKHPNIVS------LKDTYEDDSAVHIVMELCEGG---ELFDRIVARGH-YT 155
           E  I++    HPNI +       K+   +D  + +VMELC GG   +L   +  +G    
Sbjct: 52  EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111

Query: 156 ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGE 214
           E   A +++  +  +   HE  V+HRD+K +N L     E   +K +DFG+S        
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE---VKLVDFGVSAQLDSTLG 168

Query: 215 QFNEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQ 268
           + N  +G+PY+MAPEV+  +  P+       DVWS G+    L  G PP           
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-------CDM 221

Query: 269 AIIRSVIDFKRDPWPKVSENAK------DLVKKMLNPDPKQRLTAEEVLEHPWL 316
             +R++    R+P P +           D + + L  + +QR   EE+LEHP++
Sbjct: 222 HPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  125 bits (316), Expect = 2e-32
 Identities = 84/260 (32%), Positives = 139/260 (53%), Gaps = 11/260 (4%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G+G  G  Y   DV  G++ A K ++   L+     E +  E+ +M+   KHPNIV+ 
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN-KHPNIVNY 81

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            D+Y     + +VME   GG L D +V      E   AAV +  ++ ++  H   V+HRD
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 140

Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K +N L         +K  DFG      P + + + +VG+PY+MAPEV+ R  YGP+VD
Sbjct: 141 IKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G++   ++ G PP+  E        I  +     ++P  K+S   +D + + L  D
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNRCLEMD 256

Query: 301 PKQRLTAEEVLEHPWLQNAK 320
            ++R +A+E+L+HP+L+ AK
Sbjct: 257 VEKRGSAKELLQHPFLKIAK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  125 bits (316), Expect = 2e-32
 Identities = 81/262 (30%), Positives = 144/262 (54%), Gaps = 23/262 (8%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  +  + ++G + A K +    LR     E +  EV IM+   +H N+V +
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDY-QHQNVVEM 83

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y     + ++ME  +GG L D IV++    E   A V +++++ +   H QGV+HRD
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K ++ L         +K  DFG      +   +   +VG+PY+MAPEV+ R  YG EVD
Sbjct: 143 IKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP------KVSENAKDLVK 294
           +WS G+++  ++ G PP+++++     QA+ R     +  P P      K+S   +D ++
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNAHKISPVLRDFLE 252

Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           +ML  +P++R TA+E+L+HP+L
Sbjct: 253 RMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  125 bits (315), Expect = 5e-32
 Identities = 83/272 (30%), Positives = 128/272 (47%), Gaps = 21/272 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D+   +GRG FG   +  +   G+ +A K + K  L     +     E  I+  +   
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNS 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCH 174
           P I  L+  ++D   +++VME   GG+L   ++ R    + E  A   +  +V  +   H
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVH 119

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI--VGSPYYMAPEVL- 231
           + G +HRD+KPEN L      +  +K  DFG +      +  N    VG+P Y+APEVL 
Sbjct: 120 QMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 232 ------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWP 283
                 K  YG E D WS GVI Y ++ G  PF   T       I+  +  + F  D  P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED--P 234

Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
           KVS +  DL++ +L    K+RL  E +  HP+
Sbjct: 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 9e-32
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 48/297 (16%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
           Y+   E+G G +G  Y   D+N G     + ++ KK+R  +  E +     RE+ ++K L
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTG-----RFVALKKVRVPLSEEGIPLSTLREIALLKQL 55

Query: 114 PK--HPNIVSLKD---TYEDDSA--VHIVMELCEG--GELFDRIVARGHYTERAAAAVMK 164
               HPNIV L D       D    + +V E  +        +    G         +M+
Sbjct: 56  ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
            ++  V   H   ++HRDLKP+N L  +  +   +K  DFGL+  +        +V + +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLW 171

Query: 225 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII------------ 271
           Y APEVL ++ Y   VD+WS G I   L    P F   +E      I             
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Query: 272 ------------RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        +   FK    P++ E   DL+KKML  +P +R++A E L+HP+ 
Sbjct: 232 RNVSLPRSSFPSYTPRSFK-SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  123 bits (310), Expect = 9e-32
 Identities = 86/259 (33%), Positives = 136/259 (52%), Gaps = 11/259 (4%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  + T+ + G++ A K   K  LR     E +  EV IM+    H N+V +
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDY-HHENVVDM 84

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            ++Y     + +VME  EGG L D IV      E   A V  +++  +   H QGV+HRD
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           +K ++ L  +      +K  DFG      +   +   +VG+PY+MAPEV+ R  YG EVD
Sbjct: 144 IKSDSILLTSDGR---IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G+++  ++ G PP++ E     A   IR  +  +     KVS   +  +  ML  +
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259

Query: 301 PKQRLTAEEVLEHPWLQNA 319
           P QR TA+E+L+HP+L+ A
Sbjct: 260 PSQRATAQELLQHPFLKLA 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  122 bits (309), Expect = 1e-31
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 22/268 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           ++ + +++G+G+F V Y    + +G   A K +   ++  A   +D  +E+ ++K L  H
Sbjct: 3   NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DH 61

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC-- 173
           PN++    ++ +++ ++IV+EL + G+L   I    H+ ++      +TI +  VQ+C  
Sbjct: 62  PNVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 174 ----HEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMA 227
               H + +MHRD+KP N F+ A       +K  D GL  FF       + +VG+PYYM+
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVIDFKRDPWPK 284
           PE +  N Y  + D+WS G +LY +     PF+ +      + + I +   D+   P   
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLE 312
            SE  +DLV + +NPDP++R     VL+
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  124 bits (312), Expect = 1e-31
 Identities = 82/262 (31%), Positives = 131/262 (50%), Gaps = 15/262 (5%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +HP + +LK
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
             ++    +  VME   GGELF  +     +TE  A      IV  ++  H + V++RD+
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
           K EN +         +K  DFGL       G       G+P Y+APEVL+ N YG  VD 
Sbjct: 122 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+  +L  DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 234

Query: 302 KQRL-----TAEEVLEHPWLQN 318
           KQRL      A+EV+EH +  +
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLS 256

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  123 bits (310), Expect = 2e-31
 Identities = 89/307 (28%), Positives = 130/307 (42%), Gaps = 61/307 (19%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +D+  ++G G +G  Y   D + GE  A K +     +    I  +R E++I++ L  H 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL-NHR 66

Query: 118 NIVSLKDTYEDDSAV------------------HIVMELCEGGELFDRIVARGHYTERAA 159
           NIV+LK+   D                      H +M L E G +        H++E   
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--------HFSEDHI 118

Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FN 217
            + MK ++E +  CH++  +HRD+K  N L  NK +   +K  DFGL+  +   E   + 
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYT 175

Query: 218 EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275
             V + +Y  PE+L  +  YGP +DVWS G IL  L    P F A  E    + I R   
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235

Query: 276 DFKRDPWPKVSE--------------------------NAKDLVKKMLNPDPKQRLTAEE 309
                 WP V +                           A DL+  ML  DP +R TAEE
Sbjct: 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295

Query: 310 VLEHPWL 316
            L  PWL
Sbjct: 296 ALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  122 bits (306), Expect = 3e-31
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 11/265 (4%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y    ++G+G  G  Y   DV  G++ A   I +  L+     E +  E+ +M+   K+P
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 77

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV+  D+Y     + +VME   GG L D +V      E   AAV +  ++ ++  H   
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
           V+HRD+K +N L         +K  DFG      P + + + +VG+PY+MAPEV+ R  Y
Sbjct: 137 VIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GP+VD+WS G++   ++ G PP+  E        I  +     ++P  K+S   +D + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNR 252

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAK 320
            L+ D ++R +A+E+L+H +L+ AK
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAK 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  122 bits (307), Expect = 4e-31
 Identities = 83/286 (29%), Positives = 136/286 (47%), Gaps = 35/286 (12%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++  + +  G +G  YL       ++FA K I+K+ L     I+ V  E  I+    ++
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAEN 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +VS+  ++E    + +VME  EGG+    +   G      A       V  ++  H  
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--------------RPGEQF--NEIV 220
           G++HRDLKP+N L  +      +K  DFGLS                 +   +F   ++ 
Sbjct: 121 GIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 221 GSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVIDFK 278
           G+P Y+APEV L++ YG  VD W+ G+ILY  L G  PF+ +T E+   Q I   +    
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--- 234

Query: 279 RDPWPK----VSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQ 317
              WP+    +  +A+DL+ ++L  +P +RL    A EV +H +  
Sbjct: 235 ---WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  121 bits (305), Expect = 5e-31
 Identities = 88/292 (30%), Positives = 139/292 (47%), Gaps = 33/292 (11%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPNIV 120
             LG G  G    C   N G  FA K+I+        D++  + RE++I K   K P IV
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITT---DPNPDLQKQILRELEINKSC-KSPYIV 62

Query: 121 SLKDTY--EDDSAVHIVMELCEGGEL---FDRIVARGHYT-ERAAAAVMKTIVEVVQVCH 174
                +  E  S++ I ME CEGG L   + ++  RG    E+    + +++++ +   H
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPEV 230
            + ++HRD+KP N L   K +   +K  DFG+S     GE  N +     G+ +YMAPE 
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNSLAGTFTGTSFYMAPER 174

Query: 231 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIR-SVIDFKRDPWP 283
           ++ + Y    DVWS G+ L  +     PF  E E  +        I+     + K +P  
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 284 KV--SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
            +  SE  KD +K+ L  DP +R T  ++LEHPW++   K   V++ + V  
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK-VNMAKFVAQ 285

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  122 bits (307), Expect = 7e-31
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 19/270 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           D++  R LG G FG   L T  N +    A K   K K+     ++ V  E +I+ ++  
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-N 89

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           HP  V+L  +++D+S +++V+E   GGE F  +     +           IV + +    
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRN 234
             +++RDLKPEN L     +   +K  DFG +       +   + G+P Y+APE+L    
Sbjct: 150 LNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVG 204

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDLV 293
           +G   D W+ G+ +Y +L G PPF+A     + Q I+  +I F     PK +  N K L+
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF-----PKFLDNNCKHLM 259

Query: 294 KKMLNPDPKQRL-----TAEEVLEHPWLQN 318
           KK+L+ D  +R       A+ V EHPW  N
Sbjct: 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289

Length = 340

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  121 bits (305), Expect = 9e-31
 Identities = 84/291 (28%), Positives = 129/291 (44%), Gaps = 41/291 (14%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L R +G G +G+ Y   D  +GE  A K +     R  + I  +R E+ ++ +L +HPNI
Sbjct: 12  LNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNL-RHPNI 68

Query: 120 VSLKDTYEDDSA--VHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           V LK+         + +VME CE     L D +     ++E     +M  ++  +Q  HE
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHE 126

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--K 232
             ++HRDLK  N L  +K     LK  DFGL+  +  P +     V + +Y APE+L   
Sbjct: 127 NFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------------S 273
             Y   +D+W+ G IL  LL   P    ++E      II+                    
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243

Query: 274 VIDFKRDPW-------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                + P+       P +SE    L+  +L  DPK+R TAEE LE  + +
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  120 bits (303), Expect = 1e-30
 Identities = 82/289 (28%), Positives = 125/289 (43%), Gaps = 48/289 (16%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-----VRREVQIMKHLPKHP 117
           +LG G +   Y   +   GE  A K I        +D E+       RE+ +MK L KH 
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIH-------LDAEEGTPSTAIREISLMKEL-KHE 58

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV---MKTIVEVVQVCH 174
           NIV L D    ++ + +V E  +  +L   +   G         V      +++ +  CH
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL-- 231
           E  V+HRDLKP+N L   + E   LK  DFGL+  F  P   F+  V + +Y AP+VL  
Sbjct: 118 ENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----------------- 274
            R Y   +D+WS G I+  ++ G P F     +     I R +                 
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 275 -IDFKRDP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
              F R P       +P       DL+ ++L  +P+ R++A + L+HPW
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  120 bits (303), Expect = 1e-30
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 11/265 (4%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y    ++G+G  G  Y   D+  G++ A K ++   L+     E +  E+ +M+   K+P
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE-NKNP 76

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV+  D+Y     + +VME   GG L D +V      E   AAV +  ++ +   H   
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
           V+HRD+K +N L         +K  DFG      P + + + +VG+PY+MAPEV+ R  Y
Sbjct: 136 VIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GP+VD+WS G++   ++ G PP+  E        I  +     ++P  ++S   +D + +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFRDFLNR 251

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAK 320
            L  D  +R +A+E+L+HP+L+ AK
Sbjct: 252 CLEMDVDRRGSAKELLQHPFLKLAK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  118 bits (299), Expect = 2e-30
 Identities = 73/269 (27%), Positives = 118/269 (43%), Gaps = 32/269 (11%)

Query: 60  LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           LG++LG G FG  Y             + A K++  K+  +   IE+  RE +IM+ L  
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKL-D 59

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC- 173
           HPN+V L     ++  ++IVME  EGG+L   +              +  ++   +Q+  
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS------LSDLLSFALQIAR 113

Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG-SPY-YM 226
                  +  +HRDL   N L         +K  DFGLS      + + +  G  P  +M
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLPIRWM 170

Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           APE LK   +  + DVWS GV+L+ I   G  P+   +     + ++  + +  R P P 
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----NEEVLEYLKNGYRLPQPP 226

Query: 285 V-SENAKDLVKKMLNPDPKQRLTAEEVLE 312
                  DL+ +    DP+ R T  E++E
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 3e-30
 Identities = 82/304 (26%), Positives = 141/304 (46%), Gaps = 52/304 (17%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++  + +GRG FG   L    + G  +A K + K ++     +  VR E  I+     +
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADN 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L  +++D++ ++++ME   GG++   ++ +  +TE      +   +  +   H+ 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGL---------SVFFR------PGEQFNEI-- 219
           G +HRD+KP+N L   K     +K  DFGL         + F+R      P    + I  
Sbjct: 121 GYIHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177

Query: 220 ----------------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVP 256
                                 VG+P Y+APEV L+  Y  E D WS GVI+Y +L G P
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237

Query: 257 PFWAETEQGVAQAII--RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVL 311
           PF ++  Q   + II  +  + F  +    +S  AKDL+K++   + ++RL      E+ 
Sbjct: 238 PFCSDNPQETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294

Query: 312 EHPW 315
            HP+
Sbjct: 295 SHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  120 bits (302), Expect = 3e-30
 Identities = 92/298 (30%), Positives = 141/298 (47%), Gaps = 47/298 (15%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           +I+  Y   + +G G FG+     D   G+  A K I K    T V  +   RE++++KH
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKH 65

Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L +H NI+SL D +    ED   ++ V EL   G    R++      ++     +  I+ 
Sbjct: 66  L-RHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILR 119

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMA 227
            ++  H  GV+HRDLKP N L     E+  LK  DFGL+   R  + Q    V + YY A
Sbjct: 120 GLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA---RIQDPQMTGYVSTRYYRA 173

Query: 228 PEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAE---------TE------QGVAQAI 270
           PE++   + Y  EVD+WSAG I   +L G P F  +         T+        V   I
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233

Query: 271 --------IRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                   ++S+   +  P    +     +A DL++KML  DP++R++A E L HP+L
Sbjct: 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  118 bits (297), Expect = 3e-30
 Identities = 80/271 (29%), Positives = 123/271 (45%), Gaps = 25/271 (9%)

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           G  LG+G +G  Y C   N G+  A K +   +   L    + E ++ EV ++K L KH 
Sbjct: 5   GEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHV 62

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV    T  DD+ + I ME   GG +   +   G   E       K I++ V   H   
Sbjct: 63  NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFG-------LSVFFRPGEQFNEIVGSPYYMAPEV 230
           V+HRD+K  N +      +  +K IDFG       + +          + G+PY+MAPEV
Sbjct: 123 VVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV---- 285
           +  + YG + D+WS G  ++ +  G PP  A  ++  A   I +     R   P++    
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMFYIGA----HRGLMPRLPDSF 234

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           S  A D V   L  D  +R +A ++L H +L
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 4e-30
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 56/308 (18%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKK-----LRTAVDIEDVRREV 107
           D+   Y     +G G +G+    T    G K A K IS  +      RT        RE+
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-------REI 54

Query: 108 QIMKHLPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV 162
           +I++   KH NI+ + D     ++E  + V+IV EL E  +L+ +++   H +       
Sbjct: 55  KILRRF-KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYF 111

Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE----QFNE 218
           +  I+  ++  H   V+HRDLKP N L      +  LK  DFGL+    P         E
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTE 168

Query: 219 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF------------------ 258
            V + +Y APE++   + Y   +D+WS G IL  +L   P F                  
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228

Query: 259 -WAETEQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEE 309
              E    +    A+  I+S+    + PW    P     A DL+ KML  +P +R+T EE
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288

Query: 310 VLEHPWLQ 317
            L HP+L+
Sbjct: 289 ALAHPYLE 296

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  118 bits (297), Expect = 4e-30
 Identities = 76/268 (28%), Positives = 143/268 (53%), Gaps = 30/268 (11%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           +++G G FG   L     +G+++  K I+  K+    + E+ R+EV ++ ++ KHPNIV 
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNM-KHPNIVQ 63

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC------H 174
            ++++E++  ++IVM+ CEGG+L+ +I A+     R        I++  VQ+C      H
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQ-----RGVLFPEDQILDWFVQICLALKHVH 118

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK- 232
           ++ ++HRD+K +N +F  K     +K  DFG++ V     E     +G+PYY++PE+ + 
Sbjct: 119 DRKILHRDIKSQN-IFLTK--DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV----SEN 288
           R Y  + D+W+ G +LY +      F A   + +   IIR         +P V    S +
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-------SYPPVSSHYSYD 228

Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
            ++LV ++   +P+ R +   +LE  ++
Sbjct: 229 LRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  118 bits (298), Expect = 4e-30
 Identities = 84/265 (31%), Positives = 129/265 (48%), Gaps = 12/265 (4%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R LG+G FG    C     G+ +ACK + KK+++          E QI++ +     +V+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVN 64

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
           L   YE   A+ +V+ +  GG+L   I   G+  + E  A      I+  ++  H +  +
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
           +RDLKPEN L     +   ++  D GL+V    GE     VG+  YMAPEVL  + Y   
Sbjct: 125 YRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
            D W  G ++Y ++ G  PF    E+   + + R V++ +     K SE AK + K +L 
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 299 PDPKQRL-----TAEEVLEHPWLQN 318
            DPKQRL      A EV  HP+ +N
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFRN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  117 bits (295), Expect = 9e-30
 Identities = 82/259 (31%), Positives = 131/259 (50%), Gaps = 12/259 (4%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG    C     G+ +ACK + KK+L+     +    E +I++ +     IVSL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT--IVEVVQVCHEQGVMHR 181
             +E    + +VM L  GG+L   I   G      A A+     I+  ++  H++ +++R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           DLKPEN L     +   ++  D GL+V  + G++     G+P YMAPEVL+   Y   VD
Sbjct: 120 DLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            ++ G  LY ++ G  PF    E+   + + R  ++   +   K S  AKDL + +L  D
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236

Query: 301 PKQRL-----TAEEVLEHP 314
           P++RL     +A+EV EHP
Sbjct: 237 PEKRLGCRGGSADEVREHP 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  118 bits (298), Expect = 1e-29
 Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 16/258 (6%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +HP + +LK
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-EQGVMHRD 182
            +++    +  VME   GGELF  +     ++E  A      IV  +   H E+ V++RD
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 183 LKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           LK EN +     +   +K  DFGL     + G       G+P Y+APEVL+ N YG  VD
Sbjct: 122 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W  GV++Y ++CG  PF+ +  + + + I+   I F R   P+    AK L+  +L  D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE----AKSLLSGLLKKD 234

Query: 301 PKQRL-----TAEEVLEH 313
           PKQRL      A+E+++H
Sbjct: 235 PKQRLGGGPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  116 bits (293), Expect = 2e-29
 Identities = 81/262 (30%), Positives = 127/262 (48%), Gaps = 21/262 (8%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKF-ACKSIS-------KKKLRTAVDIEDVRREVQI 109
           Y +   LG G FG  Y     NNG+   A K I+       K K      I D+  EV I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG---GELFDRIVARG-HYTERAAAAVMKT 165
           +K   +HPNIV    T+ ++  ++IVM+L EG   GE F+ +  +   +TE     +   
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 166 IVEVVQVCH-EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
           +V  ++  H E+ ++HRDL P N +     E   +   DFGL+   +P  +   +VG+  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 225 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-FKRDPW 282
           Y  PE++K   YG + DVW+ G ILY +    PPF++     +A  I+ +V +      +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238

Query: 283 PKVSENAKDLVKKMLNPDPKQR 304
              SE+  D++   L PD + R
Sbjct: 239 ---SEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  117 bits (295), Expect = 2e-29
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 40/283 (14%)

Query: 67  GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD-- 124
           G +GV Y   D   GE  A K +  +K +    I  +R E+ I+  L +HPNIV++K+  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKL-QHPNIVTVKEVV 73

Query: 125 TYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
              +   +++VME  E  +L   +   +  + +     +M  ++  V   H+  ++HRDL
Sbjct: 74  VGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDL 132

Query: 184 KPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVL--KRNYGPEVD 240
           K  N L  N+     LK  DFGL+  +  P + + ++V + +Y APE+L   + Y   +D
Sbjct: 133 KTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAID 189

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP----------------- 283
           +WS G I   LL   P F  ++E      I + +       WP                 
Sbjct: 190 MWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYP 249

Query: 284 -----------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
                       +S+N  DL+ ++L  DP +R++AE+ L+HP+
Sbjct: 250 YNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  117 bits (295), Expect = 2e-29
 Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 15/264 (5%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R LG+G FG   L     +G  +A K + K  +    D+E    E +I+     HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L   ++    +  VME   GG+L   I     + E  A      I   +   H++G+++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEV 239
           DLK +N L  ++      K  DFG+       G+  +   G+P Y+APE+L+   YGP V
Sbjct: 121 DLKLDNVLLDHEGHC---KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177

Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
           D W+ GV+LY +LCG  PF AE E  + +AI+   + +    W  +S++A D++K  +  
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TW--LSQDAVDILKAFMTK 233

Query: 300 DPKQRLTA------EEVLEHPWLQ 317
           +P  RL +      E +L HP+ +
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  115 bits (290), Expect = 3e-29
 Identities = 73/257 (28%), Positives = 130/257 (50%), Gaps = 16/257 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           ++ + +++GRG+F   Y  T + + +  A K +   ++  A   +D  +E+ ++K L  H
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC-- 173
           PN++   D++ +D+ ++IV+EL + G+L   I    ++ ++      +T+ +  VQ+C  
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIK---YFKKQKRLIPERTVWKYFVQLCSA 118

Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSPYYMAP 228
               H + VMHRD+KP N        +  +K  D GL  FF       + +VG+PYYM+P
Sbjct: 119 VEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           E +  N Y  + D+WS G +LY +     PF+ +     +        D+   P    SE
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235

Query: 288 NAKDLVKKMLNPDPKQR 304
             ++LV   + PDP QR
Sbjct: 236 KLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  117 bits (296), Expect = 4e-29
 Identities = 87/274 (31%), Positives = 137/274 (50%), Gaps = 20/274 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D+ + +GRG FG   L    ++ + +A K +SK ++    D      E  IM H    
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANS 102

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
             IV L   ++DD  +++VME   GG+L + +++     E+ A      +V  +   H  
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSM 161

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKRN 234
           G +HRD+KP+N L     +S  LK  DFG  +          +  VG+P Y++PEVLK  
Sbjct: 162 GFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
                YG E D WS GV LY +L G  PF+A++  G    I+  ++ + F  D   ++S+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEISK 276

Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQN 318
            AKDL+   L  D + RL     +E+  HP+ +N
Sbjct: 277 QAKDLICAFLT-DREVRLGRNGVDEIKSHPFFKN 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  114 bits (289), Expect = 5e-29
 Identities = 77/271 (28%), Positives = 116/271 (42%), Gaps = 35/271 (12%)

Query: 60  LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           LG++LG G FG  Y  T          + A K++  K+  +   IE+  RE +IM+ L  
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRKL-D 59

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC- 173
           HPNIV L     ++  + IVME   GG+L D +              +  ++   +Q+  
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS-----LSDLLSFALQIAR 114

Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG-SPY-YM 226
                  +  +HRDL   N L         +K  DFGLS      + +    G  P  +M
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLPIRWM 171

Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           APE LK   +  + DVWS GV+L+ I   G  P+   +       ++  +    R P P 
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS----NAEVLEYLKKGYRLPKPP 227

Query: 285 VSENAKDLVKKML---NPDPKQRLTAEEVLE 312
                 +L K ML     DP+ R T  E++E
Sbjct: 228 NCP--PELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  115 bits (288), Expect = 6e-29
 Identities = 83/269 (30%), Positives = 132/269 (49%), Gaps = 18/269 (6%)

Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVRREVQIMKHL 113
           +++ LG+ LGRG FG  YLC D + G + A K +        T+ ++  +  E+Q++K+L
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 114 PKHPNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            +H  IV       D  +  + I +E   GG + D++ A G  TE       + I++ V 
Sbjct: 62  -RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS----VFFRPGEQFNEIVGSPYYMA 227
             H   ++HRD+K  N L   +  +  +K  DFG S         G     + G+PY+M+
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-V 285
           PEV+    YG + DVWS    +  +L   PP WAE E     AI +      +   P  V
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTKPMLPDGV 234

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
           S+  +D +K++   + K+R TAE +L HP
Sbjct: 235 SDACRDFLKQIFVEE-KRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  114 bits (288), Expect = 8e-29
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 31/275 (11%)

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSI------SKKKLRTAVDIEDVRREVQIMKHLP 114
           G  +G G FG  YL  + ++GE  A K +      +  K R    ++ + RE+ ++K L 
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL- 63

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +H NIV    +  D   ++I +E   GG +   +   G + E      ++ I++ +   H
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------------RPGEQFNEIVGS 222
            +G++HRD+K  N L  NK     +K  DFG+S               RP  Q     GS
Sbjct: 124 NRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPSLQ-----GS 175

Query: 223 PYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281
            ++MAPEV+K+  Y  + D+WS G ++  +L G  P + +  Q   QAI +   +   + 
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP-FPDCTQ--LQAIFKIGENASPEI 232

Query: 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
              +S  A D ++K    D  +R TA E+L+HP+L
Sbjct: 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  113 bits (285), Expect = 2e-28
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 29/280 (10%)

Query: 54  ISIDYDLGRE-----LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
           +  +Y+         LG+G +G+ Y   D++   + A K I ++  R    ++ +  E+ 
Sbjct: 1   LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIA 57

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG---HYTERAAAAVMKT 165
           +  +L KH NIV    +  ++    I ME   GG L   + ++       E+      K 
Sbjct: 58  LHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116

Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS---VFFRP-GEQFNEIVG 221
           I+E ++  H+  ++HRD+K +N L      S  +K  DFG S       P  E F    G
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINPCTETFT---G 171

Query: 222 SPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
           +  YMAPEV+    R YG   D+WS G  +  +  G PPF    E G  QA +  V  FK
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---IELGEPQAAMFKVGMFK 228

Query: 279 RDPW--PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
             P     +S  AK+ + +   PDP +R +A ++L+ P+L
Sbjct: 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  114 bits (287), Expect = 3e-28
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 15/260 (5%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG   L  +  +G+ +A K + K+ +    ++     E +++K+  +HP + SLK
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            +++    +  VME   GGELF  +     ++E         IV  +   H   +++RDL
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
           K EN +     +   +K  DFGL               G+P Y+APEVL+ N YG  VD 
Sbjct: 122 KLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S +AK L+  +L  DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIKDP 234

Query: 302 KQRL-----TAEEVLEHPWL 316
            +RL      A+E++ H + 
Sbjct: 235 NKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (284), Expect = 3e-28
 Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 33/272 (12%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
            ELG G  GV         G+  A K+I     + ++  +      RE+ I+      P 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-----LRELDILHKC-NSPY 60

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRI--VARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           IV     + ++  + I ME  +GG L D+I    +G   ER    +   +++ +   HE+
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPEVL 231
             ++HRD+KP N L  ++ +   +K  DFG+S     G+  N +    VG+  YMAPE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171

Query: 232 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIRSVIDFKRDPWPKV 285
           + N Y  + D+WS G+ L  L  G  P+  E +         Q I+       R P  K 
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE--PPPRLPSGKF 229

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           S + +D V   L  DP++R + +E+LEHP+++
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  114 bits (288), Expect = 4e-28
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 46/291 (15%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
             +G G +G      D   G K A K +S+   ++A+  +   RE++++KH+  H N++ 
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELRLLKHM-DHENVIG 78

Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L D +      ED   V++V  L  G +L + IV     ++     ++  I+  ++  H 
Sbjct: 79  LLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGLKYIHS 136

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVL--K 232
            G++HRDLKP N +  N  E   LK +DFGL+   R  + +    V + +Y APE++   
Sbjct: 137 AGIIHRDLKPSN-IAVN--EDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNW 190

Query: 233 RNYGPEVDVWSAGVILYILL---------------------CGVPP--FWAETEQGVAQA 269
            +Y   VD+WS G I+  LL                      G P      +     A+ 
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250

Query: 270 IIRSVIDFKR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
            I+S+    +    + +   +  A DL++KML  DP +R+TA E L HP+L
Sbjct: 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  114 bits (287), Expect = 5e-28
 Identities = 95/337 (28%), Positives = 142/337 (42%), Gaps = 73/337 (21%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++ ++LG+G +G+ +   D    E  A K I     R A D +   RE+  ++ L  HP
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQELGDHP 67

Query: 118 NIVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
           NIV L +    E+D  +++V E  E  +L        H      A +   I+E V     
Sbjct: 68  NIVKLLNVIKAENDKDIYLVFEYMET-DL--------H------AVIRANILEDVHKRYI 112

Query: 174 -----------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI--- 219
                      H   V+HRDLKP N L  +      +K  DFGL+      E+  E    
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVL 169

Query: 220 ---VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF---------------- 258
              V + +Y APE+L     Y   VD+WS G IL  +L G P F                
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229

Query: 259 WAETEQGVAQ-------AIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTA 307
              + + +          ++ S+    R P     PK S++A DL+KK+L  +P +RLTA
Sbjct: 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289

Query: 308 EEVLEHPWLQNAKK-APNVSLGETVKARL---KQFSV 340
           EE LEHP++      +    L   +   L    + SV
Sbjct: 290 EEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSV 326

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  113 bits (284), Expect = 5e-28
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 51/290 (17%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED---VR----REVQIMKHLPKH 116
           +G G +GV + C +   G+  A K          V+ ED   ++    RE++++K L KH
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIRMLKQL-KH 59

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
           PN+V+L + +     +H+V E C+   + + +        E     ++   ++ V  CH+
Sbjct: 60  PNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--K 232
              +HRD+KPEN L     +   +K  DFG + +   PG+ + + V + +Y APE+L   
Sbjct: 119 HNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175

Query: 233 RNYGPEVDVWSAGVILYILLCGVP--PFWAETEQ------GVAQAIIRSVIDFK------ 278
             YGP VDVW+ G +   LL G P  P  ++ +Q       +   I R    F       
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235

Query: 279 ---------RDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
                    R+P    +P +S  A   +K  L  DP +RL+ EE+LEHP+
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  112 bits (282), Expect = 7e-28
 Identities = 85/294 (28%), Positives = 134/294 (45%), Gaps = 43/294 (14%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKH 112
           DY    ++G G +GV Y   +   G+  A K     K+R   + E V     RE+ ++K 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKE 55

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMEL--CEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
           L +HPNIV L+D    +S ++++ E    +  +  D +    +       + +  I++ +
Sbjct: 56  L-QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPE 229
             CH + V+HRDLKP+N L  NK     +K  DFGL+  F  P   +   V + +Y APE
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE 171

Query: 230 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS- 286
           VL     Y   VD+WS G I   +    P F  ++E      I R +     D WP V+ 
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231

Query: 287 ------------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                                   E+  DL++KML  DP +R++A++ L HP+ 
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  111 bits (279), Expect = 8e-28
 Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 14/265 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++  ++G+G FGV +      +   +A K I   K+    + E+   E +++  L   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKL-DS 58

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGH-YTERAAAAVMKTIVEVVQVCH 174
             I+   +++ D   ++IVME  E G+L   +   RG    E         I+  +   H
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMAPEVLK- 232
            + ++HRD+K  N LF +  ++  +K  D G++        F N IVG+PYY++PE+ + 
Sbjct: 119 SKKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVSENAKD 291
           + Y  + DVW+ GV+LY    G  PF A   QG   A+I  +I     P     S+    
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANN-QG---ALILKIIRGVFPPVSQMYSQQLAQ 231

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWL 316
           L+ + L  D +QR    ++L +P L
Sbjct: 232 LIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  111 bits (279), Expect = 1e-27
 Identities = 85/270 (31%), Positives = 129/270 (47%), Gaps = 23/270 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++L + +G G +G  Y   +VN GE  A K I   KL    D   V++E+ +MK   KH
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDC-KH 65

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            NIV+   +Y     + I ME C GG L D     G  +E   A V +  ++ +   H +
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIVGSPYYMAPEVL---- 231
           G MHRD+K  N L     ++  +K  DFG+S        +    +G+PY+MAPEV     
Sbjct: 126 GKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK- 290
           K  Y    D+W+ G+    L    PP +          + +S  +F+    PK+ +  K 
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQP---PKLKDKMKW 237

Query: 291 -----DLVKKMLNPDPKQRLTAEEVLEHPW 315
                  VK  L  +PK+R TAE++L+HP+
Sbjct: 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 1e-27
 Identities = 83/266 (31%), Positives = 129/266 (48%), Gaps = 12/266 (4%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R LG+G FG    C     G+ +ACK + KK+++          E QI++ +     +VS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 64

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
           L   YE   A+ +V+ L  GG+L   I   G+  + E  A      I   ++  H + ++
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
           +RDLKPEN L  +      ++  D GL+V    GE     VG+  YMAPEV+K   Y   
Sbjct: 125 YRDLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
            D W  G ++Y ++ G  PF    E+   + + R V + + +   K SE A+ + +++L 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241

Query: 299 PDPKQRL-----TAEEVLEHPWLQNA 319
            DP  RL      AEEV  HP+ + A
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  110 bits (276), Expect = 2e-27
 Identities = 76/267 (28%), Positives = 137/267 (51%), Gaps = 19/267 (7%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED--VRREVQIMKHLPK 115
           Y   R +G+G +G   L     +G+++    I K  LR A   E     +E Q++  L K
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYV---IKKLNLRNASRRERKAAEQEAQLLSQL-K 57

Query: 116 HPNIVSLKDTYE-DDSAVHIVMELCEGGELFDRIV-ARGHY-TERAAAAVMKTIVEVVQV 172
           HPNIV+ ++++E +D  ++IVM  CEGG+L+ ++   +G    E         I   +Q 
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL 231
            HE+ ++HRDLK +N        ++ +K  D G++ V     +  + ++G+PYYM+PE+ 
Sbjct: 118 LHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174

Query: 232 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
             + Y  + DVW+ G  +Y +      F A+       +++  +I+ K  P PK  S   
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYRIIEGKLPPMPKDYSPEL 230

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWL 316
            +L+  ML+  P++R + + +L  P++
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  110 bits (277), Expect = 3e-27
 Identities = 83/261 (31%), Positives = 128/261 (49%), Gaps = 12/261 (4%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R LG+G FG    C     G+ +ACK + KK+++          E QI++ +     +VS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVS 64

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
           L   YE   A+ +V+ L  GG+L   I   G   + E  A      I   ++  H++ ++
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
           +RDLKPEN L     +   ++  D GL+V    G+     VG+  YMAPEV+K   Y   
Sbjct: 125 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
            D W+ G +LY ++ G  PF    ++   + + R V + + +   K S +A+ L K +L 
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241

Query: 299 PDPKQRL-----TAEEVLEHP 314
            DPK+RL      A EV EHP
Sbjct: 242 KDPKERLGCQGGGAREVKEHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  110 bits (276), Expect = 3e-27
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 16/257 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           ++ + +++GRG+F   Y  T + +G   A K +    L  A    D  +E+ ++K L  H
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC-- 173
           PN++    ++ +D+ ++IV+EL + G+L   I    H+ ++      KT+ +  VQ+C  
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNEIVGSPYYMAP 228
               H + VMHRD+KP N        +  +K  D GL  FF       + +VG+PYYM+P
Sbjct: 119 LEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           E +  N Y  + D+WS G +LY +     PF+ +     +        D+   P    SE
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235

Query: 288 NAKDLVKKMLNPDPKQR 304
             + LV   +NPDP++R
Sbjct: 236 ELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  112 bits (281), Expect = 3e-27
 Identities = 86/295 (29%), Positives = 132/295 (44%), Gaps = 53/295 (17%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +GRG +G+     +    EK A K I+       +D +   RE+++++HL  H N++++K
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTLREIKLLRHL-DHENVIAIK 70

Query: 124 D--------TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           D         + D   V+IV EL +  +L   I +    ++      +  ++  ++  H 
Sbjct: 71  DIMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP----GEQFNEIVGSPYYMAPEVL 231
             V+HRDLKP N L      +  LK  DFGL+   R     G+   E V + +Y APE+L
Sbjct: 127 ANVLHRDLKPSNLLL---NANCDLKICDFGLA---RTTSEKGDFMTEYVVTRWYRAPELL 180

Query: 232 --KRNYGPEVDVWSAGVILYILLCGVPPFWA------------------ETEQGV----- 266
                Y   +DVWS G I   LL   P F                    E + G      
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 267 AQAIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           A+  IRS+    R      +P  +  A DL++KML  DP +R+T EE L HP+L 
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  110 bits (276), Expect = 5e-27
 Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 46/293 (15%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
           Y+   ++G G +G  +   +    E  A K     ++R   D E V     RE+ ++K L
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKEL 56

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            KH NIV L D    D  + +V E C+    + FD     G        + M  +++ + 
Sbjct: 57  -KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLA 113

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEV 230
            CH   V+HRDLKP+N L     E   LK  DFGL+  F  P   ++  V + +Y  P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170

Query: 231 L--KRNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           L   + Y   +D+WSAG I   L   G P F         + I R +     + WP VS+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230

Query: 288 -------------------------NAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
                                      +DL++ +L  +P QR++AEE L+HP+
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 5e-27
 Identities = 73/258 (28%), Positives = 127/258 (49%), Gaps = 13/258 (5%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G+G FG        +    +A K+I K  + +  ++     E  ++  +   P IV LK
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            +++    +++V+    GGELF  +   G +    A      ++  ++  H+  V++RDL
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDV 241
           KPEN L         +   DFGL  +  +  ++ N   G+P Y+APE+L    Y   VD 
Sbjct: 120 KPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           W+ GV+LY +L G+PPF+ E    + + I++  + F          +AKDL+  +L+ DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRDP 232

Query: 302 KQRL---TAEEVLEHPWL 316
            +RL    A+E+  HP+ 
Sbjct: 233 TRRLGYNGAQEIKNHPFF 250

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  110 bits (278), Expect = 6e-27
 Identities = 89/302 (29%), Positives = 139/302 (46%), Gaps = 51/302 (16%)

Query: 58  YDLGRELGRGEFGVTYLCTDV--NNGEKFACKSISK---KKLRTAVDIEDVRREVQIMKH 112
           Y+L +ELG+G +G+     +   +  E  A K I+    KK+     +    RE+++++H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLRH 57

Query: 113 LPKHPNIVSLKD----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
              H NI  L D       + + +++  EL E  +L   I +    T+    + +  I+ 
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILC 116

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN-----EIVGSP 223
            ++  H   V+HRDLKP N L     E   LK  DFGL+  F      N     E V + 
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA-------------------ET 262
           +Y APE++   ++Y   +DVWS G IL  LL   P F                     ET
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233

Query: 263 EQGV----AQAIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
              +    AQ  IRS+ +  + P    +P  +  A DL++K+L  DP +R++ EE LEHP
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293

Query: 315 WL 316
           +L
Sbjct: 294 YL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  109 bits (274), Expect = 6e-27
 Identities = 71/265 (26%), Positives = 124/265 (46%), Gaps = 15/265 (5%)

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV----RREVQIMKHLPKH 116
           G++LG G F   Y   DV  G   A K ++  +  T+ + E+V    R+E+++M  L  H
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMARL-NH 62

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P+I+ +     +DS  ++ +E   GG +   +   G + E       + ++  +   HE 
Sbjct: 63  PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-----FFRPGEQFNEIVGSPYYMAPEVL 231
            ++HRD+K  N L  +  +   L+  DFG +          GE   +++G+  +MAPEVL
Sbjct: 123 QIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 232 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
           +   YG   DVWS G ++  +    PP+ AE        I +          P+ +S   
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHP 314
           +D+  + L   P+ R  + E+L+HP
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  109 bits (273), Expect = 2e-26
 Identities = 82/301 (27%), Positives = 136/301 (45%), Gaps = 30/301 (9%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           RE+G G FG  Y   DV   E  A K +S    ++    +D+ +EV+ ++ L +HPN + 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIE 79

Query: 122 LKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
            K  Y  +    +VME C G   ++ +  V +    E   AA+    ++ +   H    +
Sbjct: 80  YKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERI 137

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNY 235
           HRD+K  N L     E   +K  DFG +    P   F   VG+PY+MAPEV+    +  Y
Sbjct: 138 HRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAMDEGQY 191

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA-----K 290
             +VDVWS G+    L    PP +          I ++      D  P +S N      +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------DS-PTLSSNDWSDYFR 244

Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV--SLGETVKARLKQFSVMNKLKKRA 348
           + V   L   P+ R ++EE+L+H ++   ++ P V   L +  K  +++   +   K + 
Sbjct: 245 NFVDSCLQKIPQDRPSSEELLKHRFVLR-ERPPTVIIDLIQRTKDAVRELDNLQYRKMKK 303

Query: 349 L 349
           +
Sbjct: 304 I 304

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  110 bits (276), Expect = 2e-26
 Identities = 81/306 (26%), Positives = 130/306 (42%), Gaps = 57/306 (18%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G FG   L   V+    +A K++ K  +        V+ E  I+     +  +V 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L  +++D   ++ VM+   GG++   ++  G + E  A   +  +   ++  H+ G +HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFR--------------------PGEQFNEI-- 219
           D+KP+N L         +K  DFGL   FR                    P E+++EI  
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 220 ----------------------VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVP 256
                                 VG+P Y+APEVL R  Y    D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 257 PFWAETEQGVAQAII--RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVL 311
           PF A+T       +I   + +        K+S  A DL+ + L    + RL    A+E+ 
Sbjct: 243 PFLADTPAETQLKVINWETTLHIP--SQAKLSREASDLILR-LCCGAEDRLGKNGADEIK 299

Query: 312 EHPWLQ 317
            HP+ +
Sbjct: 300 AHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  107 bits (269), Expect = 2e-26
 Identities = 72/265 (27%), Positives = 132/265 (49%), Gaps = 15/265 (5%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++ +++G G FG  YL    ++ E    K I   K+    + E  ++EV ++  + KHP
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKM-KHP 59

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV---VQVCH 174
           NIV+   +++++  + IVME C+GG+L  RI  R      +   ++   V++   ++  H
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 175 EQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-VGSPYYMAPEVLK 232
           ++ ++HRD+K +N FL  N   +   K  DFG++       +     VG+PYY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVA---KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 233 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
            R Y  + D+WS G +LY L     PF       +   I +          P  S + + 
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF---APISPNFSRDLRS 232

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWL 316
           L+ ++    P+ R +   +L+ P+L
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  107 bits (269), Expect = 3e-26
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 31/276 (11%)

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACK-------SISKKKLRTAVDIEDVRREVQIMKHL 113
           G  +G+G +G  YL  +V  GE  A K          +   R    ++ +R E++ +K L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
             H NIV        +  + I +E   GG +   +   G + E+      + ++E +   
Sbjct: 66  -DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE------QFNEIVGSPYYMA 227
           H +G++HRDLK +N L          K  DFG+S   +  +      Q   + GS ++MA
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGIS---KKSDDIYDNDQNMSMQGSVFWMA 178

Query: 228 PEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP- 283
           PEV+    + Y  +VD+WS G ++  +  G  P W++ E     A+ +        P P 
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEA--IAAMFKLGNKRSAPPIPP 235

Query: 284 ----KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
                +S  A D +      +P  R TA E+L+HP+
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  109 bits (274), Expect = 4e-26
 Identities = 85/274 (31%), Positives = 140/274 (51%), Gaps = 20/274 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DYD+ + +GRG FG   L    ++ + +A K +SK ++    D      E  IM      
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANS 102

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++DD  +++VME   GG+L + +++     E+ A      +V  +   H  
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKRN 234
           G++HRD+KP+N L     +   LK  DFG  +          +  VG+P Y++PEVLK  
Sbjct: 162 GLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
                YG E D WS GV L+ +L G  PF+A++  G    I+  ++ ++F  D   ++S+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEISK 276

Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQN 318
           +AK+L+   L  D + RL     EE+ +HP+ +N
Sbjct: 277 HAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKN 309

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  108 bits (272), Expect = 4e-26
 Identities = 78/271 (28%), Positives = 128/271 (47%), Gaps = 20/271 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++    LG+G FG   L       E +A K + K  +    D+E    E +++    K 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  L   ++    ++ VME   GG+L   I   G + E  A      I   +   H +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGL---SVFFRPGEQFNEIVGSPYYMAPE-VLK 232
           G+++RDLK +N +         +K  DFG+   ++F   G+      G+P Y+APE +  
Sbjct: 121 GIIYRDLKLDNVML---DAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAY 175

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKD 291
           + YG  VD W+ GV+LY +L G PPF  E E  + Q+I+   + +     PK +S+ A  
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----PKSLSKEAVS 230

Query: 292 LVKKMLNPDPKQRL----TAE-EVLEHPWLQ 317
           + K +L   P +RL    T E ++ EH + +
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  107 bits (268), Expect = 5e-26
 Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 12/265 (4%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R LG+G FG    C     G+ +ACK + KK+++          E +I++ +     +VS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
           L   YE   A+ +V+ +  GG+L   I   G+  + E+ A      +   ++    + ++
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
           +RDLKPEN L  ++     ++  D GL+V    GE     VG+  YMAPEV+    Y   
Sbjct: 125 YRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
            D W  G ++Y ++ G  PF    E+   + + R V + + +   K SE+AK + + +L 
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241

Query: 299 PDPKQRL-----TAEEVLEHPWLQN 318
            +PK+RL      A  V +HP  +N
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 5e-26
 Identities = 80/313 (25%), Positives = 137/313 (43%), Gaps = 61/313 (19%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+   + +G+G FG   L    + G+ +A K++ K ++     +  V+ E  ++      
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDS 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +VSL  +++D   ++++ME   GG+L   ++    ++E      M   V  ++  H+ 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------------------------RP 212
           G +HRD+KP+N L         +K  DFGLS  F                        R 
Sbjct: 121 GFIHRDIKPDNILIDRGGH---IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177

Query: 213 GEQFNEI------------------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVI 247
               + I                        VG+P Y+APE+ L++ YG E D WS G I
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237

Query: 248 LYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL 305
           ++  L G PPF +E      + II  R  + F  D    +S  A+DL+++++  + + RL
Sbjct: 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRL 294

Query: 306 ---TAEEVLEHPW 315
               A E+  HP+
Sbjct: 295 GRGGAHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  107 bits (270), Expect = 6e-26
 Identities = 77/264 (29%), Positives = 133/264 (50%), Gaps = 17/264 (6%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK--HPNIVS 121
           LGRG FG   L      GE +A K++ K  +    ++E +  E +I +      HP +V+
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L   ++ +  V  VME   GG+L   I     ++E  A      +V  +Q  HE  +++R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVL-KRNYGPEV 239
           DLK +N L   +     +K  DFGL       G++ +   G+P ++APEVL + +Y   V
Sbjct: 126 DLKLDNLLLDTEGF---VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182

Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
           D W  GV++Y +L G  PF  + E+ V  +I+   + + R     +S  A  +++++L  
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRLLRR 238

Query: 300 DPKQRL-----TAEEVLEHPWLQN 318
           +P++RL      AE+V + P+ ++
Sbjct: 239 NPERRLGSGEKDAEDVKKQPFFRD 262

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  107 bits (269), Expect = 7e-26
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 24/274 (8%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R +GRG +    L         +A K + K+ +    DI+ V+ E  + +    HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L   ++ +S +  V+E   GG+L   +  +    E  A      I   +   HE+G+++R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEV 239
           DLK +N L  ++     +K  D+G+     RPG+  +   G+P Y+APE+L+  +YG  V
Sbjct: 121 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 240 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           D W+ GV+++ ++ G  PF            TE  + Q I+   I   R     +S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233

Query: 291 DLVKKMLNPDPKQRLTA------EEVLEHPWLQN 318
            ++K  LN DPK+RL         ++  HP+ +N
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 7e-26
 Identities = 86/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPNI 119
           +G G +GV Y   D   GE  A K     K+R   + E V     RE+ ++K L  HPNI
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL-NHPNI 60

Query: 120 VSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           V L D    ++ +++V E  +    +  D     G        + +  +++ +  CH   
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHR 119

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
           V+HRDLKP+N L  +++ +  LK  DFGL+  F  P   +   V + +Y APE+L   R 
Sbjct: 120 VLHRDLKPQNLLI-DREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR--------------SVIDFK-- 278
           Y   VD+WS G I   ++   P F  ++E      I R              S+ D+K  
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236

Query: 279 -----RDPWPKV----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                R    KV     E+  DL+ KML  DP +R++A+  L+HP+ 
Sbjct: 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  107 bits (270), Expect = 8e-26
 Identities = 85/302 (28%), Positives = 133/302 (44%), Gaps = 52/302 (17%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
           Y     +G G +GV     D  +G+K A K I       A D+  +     RE++I++H 
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-----AFDVPTLAKRTLRELKILRHF 61

Query: 114 PKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
            KH NI++++D       D   V++VM+L E  +L   I +    TE      +  ++  
Sbjct: 62  -KHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL--SVFFRPGEQ---FNEIVGSPY 224
           ++  H   V+HRDLKP N L     E   L+  DFG+   +   P E      E V + +
Sbjct: 120 LKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 225 YMAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVPP--FW 259
           Y APE+L     Y   +D+WS G I                     L + + G P     
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 260 AETEQGVAQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
                   +  I+++   +  PW    PK S  A DL+ +ML  DP++R+T E+ L+HP+
Sbjct: 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296

Query: 316 LQ 317
           L 
Sbjct: 297 LA 298

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  107 bits (269), Expect = 8e-26
 Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 19/261 (7%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G+G FG   L     +G+ +A K + KK +    + + +  E  ++    KHP +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            +++    ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV----GSPYYMAPEVL-KRNYGPE 238
           KPEN L  ++     +   DFGL    + G + ++      G+P Y+APEVL K+ Y   
Sbjct: 123 KPENILLDSQGH---VVLTDFGLC---KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
           VD W  G +LY +L G+PPF++     +   I+   +  K    P +S +A+ L++ +L 
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ 232

Query: 299 PDPKQRLTA----EEVLEHPW 315
            D  +RL A     E+  H +
Sbjct: 233 KDRTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  107 bits (268), Expect = 1e-25
 Identities = 72/263 (27%), Positives = 121/263 (46%), Gaps = 16/263 (6%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG   L       E +A K + K  +    D++    E +I+    KHP + +L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
             ++    +  VME   GG+L  +I     + E  +      +   +   H  GV++RDL
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDV 241
           K +N L          K  DFG+       G       G+P Y+APE+L+   YGP VD 
Sbjct: 123 KLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           W+ GV++Y ++ G PPF A+ E  + ++I+    D     W  +S+ A  ++K  +  +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFMTKNP 235

Query: 302 KQRL-------TAEEVLEHPWLQ 317
            +RL         + + +HP+ +
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFK 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  105 bits (264), Expect = 2e-25
 Identities = 80/296 (27%), Positives = 135/296 (45%), Gaps = 17/296 (5%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           RE+G G FG  Y   DV N E  A K +S    ++    +D+ +EV+ ++ L +HPN + 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
            +  Y  +    +VME C G       V +    E   AAV    ++ +   H   ++HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNYGP 237
           D+K  N L +   E   +K  DFG +    P   F   VG+PY+MAPEV+    +  Y  
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193

Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-FKRDPWPKVSENAKDLVKKM 296
           +VDVWS G+    L    PP +          I ++     +   W   SE  ++ V   
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250

Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
           L   P+ R T+E +L+H ++   ++ P   + + ++        ++ L+ R ++ +
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVL--RERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  106 bits (265), Expect = 2e-25
 Identities = 82/257 (31%), Positives = 130/257 (50%), Gaps = 10/257 (3%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG   L       E FA K++ K  +    D+E    E +++    +HP +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            T++    +  VME   GG+L   I + G + E  A      I+  +Q  H++G+++RDL
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDV 241
           K +N L     +   +K  DFG+      GE + +   G+P Y+APE+LK + Y   VD 
Sbjct: 123 KLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           WS GV+LY +L G  PF  E E  +  +I+     F R  W  +S+ AKD + K+   DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLFERDP 235

Query: 302 KQRL-TAEEVLEHPWLQ 317
            +RL    ++ +HP+ +
Sbjct: 236 TKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  106 bits (265), Expect = 3e-25
 Identities = 72/253 (28%), Positives = 120/253 (47%), Gaps = 16/253 (6%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R +GRG +    L     N + +A K + K+ +    DI+ V+ E  + +    +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L   ++  S + +V+E   GG+L   +  +    E  A      I   +   HE+G+++R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEV 239
           DLK +N L         +K  D+G+      PG+  +   G+P Y+APE+L+   YG  V
Sbjct: 121 DLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177

Query: 240 DVWSAGVILYILLCGVPPF-------WAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           D W+ GV+++ ++ G  PF          TE  + Q I+   I   R     +S  A  +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233

Query: 293 VKKMLNPDPKQRL 305
           +K  LN DPK+RL
Sbjct: 234 LKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  106 bits (265), Expect = 5e-25
 Identities = 85/274 (31%), Positives = 134/274 (48%), Gaps = 20/274 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ + +GRG FG   L    +  + +A K +SK ++    D      E  IM      
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANS 102

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++DD  +++VME   GG+L + +++     E+ A      +V  +   H  
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKRN 234
           G +HRD+KP+N L     +S  LK  DFG  +          +  VG+P Y++PEVLK  
Sbjct: 162 GFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
                YG E D WS GV LY +L G  PF+A++  G    I+  ++ + F  D    +S+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISK 276

Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQN 318
            AK+L+   L  D + RL     EE+  H + +N
Sbjct: 277 EAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  105 bits (264), Expect = 6e-25
 Identities = 83/311 (26%), Positives = 130/311 (41%), Gaps = 57/311 (18%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACK-------SISKKKLRTAVDIEDVR----REVQ 108
            G  LG G +G      D   G+  A K       S    K R  V +  +     RE++
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           IM  + KH NI+ L D Y +   +++VM++    +L   +  +   TE     ++  I+ 
Sbjct: 73  IMNEI-KHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILN 130

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---------------RPG 213
            + V H+   MHRDL P N +F N K     K  DFGL+  +               +  
Sbjct: 131 GLNVLHKWYFMHRDLSPAN-IFINSK--GICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 214 EQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
           E+    V + +Y APE+L     Y   VD+WS G I   LL G P F  E E      I 
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247

Query: 272 RSVIDFKRDPWPKV------------------------SENAKDLVKKMLNPDPKQRLTA 307
             +     D WP+                         S++A DL++ +L  +P +R++A
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307

Query: 308 EEVLEHPWLQN 318
           +E L+H + ++
Sbjct: 308 KEALKHEYFKS 318

Length = 335

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  105 bits (262), Expect = 6e-25
 Identities = 68/248 (27%), Positives = 118/248 (47%), Gaps = 9/248 (3%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G+G FG   L       + +A K + KK +    + + +  E  ++    KHP +V L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            +++    ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVL-KRNYGPEVDV 241
           KPEN L  ++     +   DFGL           +   G+P Y+APEVL K+ Y   VD 
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           W  G +LY +L G+PPF++     +   I+   +  K    P ++ +A+ L++ +L  D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235

Query: 302 KQRLTAEE 309
            +RL A++
Sbjct: 236 TKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  103 bits (258), Expect = 6e-25
 Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 18/268 (6%)

Query: 58  YDLGRELGRGEFGVTYLCTD--VNNGEKF-ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           Y L + LG+G FG  YL  D      E+    K I   +L     ++   +E Q++  L 
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKL- 59

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER-AAAAVMKTIVEV---V 170
            HP IV    ++ +  A  I+ E CEG +L  ++    H  +  +   V +  +++   V
Sbjct: 60  DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIVGSPYYMAPE 229
              H++ ++HRDLK +N    N    + LK  DFG+S       +      G+PYYM+PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175

Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
            LK + Y  + D+WS G ILY + C    F  +    V   I+        + + +   N
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSR-QLN 234

Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +  +++ MLN DP  R +A E+L +P++
Sbjct: 235 S--IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  104 bits (261), Expect = 9e-25
 Identities = 74/259 (28%), Positives = 129/259 (49%), Gaps = 14/259 (5%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG  +L       + FA K++ K  +    D+E    E +++    +HP +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            T++    +  VME   GG+L   I +   +    A      I+  +Q  H +G+++RDL
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122

Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEV-LKRNYGPEVDV 241
           K +N L         +K  DFG+      G+ +     G+P Y+APE+ L + Y   VD 
Sbjct: 123 KLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP-WPK-VSENAKDLVKKMLNP 299
           WS GV+LY +L G  PF    E+ + Q+I         +P +P+ ++  AKD++ K+   
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------NPCYPRWLTREAKDILVKLFVR 233

Query: 300 DPKQRLTAE-EVLEHPWLQ 317
           +P++RL  + ++ +HP+ +
Sbjct: 234 EPERRLGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  103 bits (259), Expect = 9e-25
 Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 42/286 (14%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 60

Query: 119 IVSLKDTYEDDSAVHIVME-LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           IV L D    ++ +++V E L +  + F               + +  +++ +  CH   
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
           V+HRDLKP+N L         +K  DFGL+  F  P   +   V + +Y APE+L   + 
Sbjct: 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS-------- 286
           Y   VD+WS G I   ++     F  ++E      I R++       WP V+        
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237

Query: 287 -----------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
                            E+ +DL+ +ML+ DP +R++A+  L HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  103 bits (260), Expect = 1e-24
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 56/305 (18%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+   ++G+G FG  +        +  A K +  +  +    I  +R E++I++ L KH 
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLL-KHE 71

Query: 118 NIVSLKD--------TYEDDSAVHIVMELCE---GGELFDRIVARGHYTERAAAAVMKTI 166
           N+V+L +              + ++V E CE    G L ++ V    +T      VMK +
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKVMKML 128

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------RPGEQFNEIV 220
           +  +   H   ++HRD+K  N L     +   LK  DFGL+  F      +P    N +V
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
            + +Y  PE+L  +R+YGP +D+W AG I+  +    P     TEQ     I +      
Sbjct: 186 -TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244

Query: 279 RDPWPKV----------------------------SENAKDLVKKMLNPDPKQRLTAEEV 310
            + WP V                              +A DL+ K+L  DP +R+ A+  
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304

Query: 311 LEHPW 315
           L H +
Sbjct: 305 LNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  104 bits (260), Expect = 1e-24
 Identities = 76/257 (29%), Positives = 118/257 (45%), Gaps = 15/257 (5%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           RE+G G FG  Y   DV   E  A K +S    ++    +D+ +EV+ ++ + KHPN + 
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIE 89

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
            K  Y  +    +VME C G       V +    E   AA+    ++ +   H   ++HR
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNYGP 237
           D+K  N L     E   +K  DFG +    P   F   VG+PY+MAPEV+    +  Y  
Sbjct: 150 DIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYDG 203

Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-VIDFKRDPWPKVSENAKDLVKKM 296
           +VDVWS G+    L    PP +          I ++     + + W   S+  ++ V   
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNFVDSC 260

Query: 297 LNPDPKQRLTAEEVLEH 313
           L   P+ R T+EE+L+H
Sbjct: 261 LQKIPQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  103 bits (258), Expect = 2e-24
 Identities = 86/301 (28%), Positives = 139/301 (46%), Gaps = 45/301 (14%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
           Y+   ++G G +GV Y   D     +   ++I+ KK+R   + E V     RE+ ++K +
Sbjct: 4   YEKVEKIGEGTYGVVYKARD-----RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM 58

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTE--RAAAAVMKTIVEVVQ 171
            +H NIV L+D    +  +++V E  +  +L   + +   + +  R     +  I+  + 
Sbjct: 59  -QHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEV 230
            CH   V+HRDLKP+N L   +  +  LK  DFGL+  F  P   F   V + +Y APE+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNA--LKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI 174

Query: 231 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR--------------SV 274
           L   R+Y   VD+WS G I   ++   P F  ++E      I R              S+
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234

Query: 275 IDFKRDPWPK------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
            D+K   +PK            +     DL+ KML  DP +R+TA   LEH + ++   A
Sbjct: 235 PDYK-SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Query: 323 P 323
           P
Sbjct: 294 P 294

Length = 294

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  102 bits (254), Expect = 3e-24
 Identities = 87/280 (31%), Positives = 128/280 (45%), Gaps = 18/280 (6%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ELG G FG  Y   +   G   A K I  K   +  ++ED   E+ I+     HPNIV L
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKL 67

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMH 180
            D +  ++ + I++E C GG + D ++       TE     V K  +E +   HE  ++H
Sbjct: 68  LDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL------KR 233
           RDLK  N LF    +   +K  DFG+S    R  ++ +  +G+PY+MAPEV+       R
Sbjct: 127 RDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183

Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            Y  + DVWS G+ L  +    PP        V   I +S       P  + S   KD +
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSEFKDFL 242

Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
           KK L  +   R T  ++L+HP++      P   L    KA
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAKA 282

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  102 bits (256), Expect = 3e-24
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 21/292 (7%)

Query: 42  RLCVLKEPSGQDISIDYDLGR------ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR 95
           R  V+K+P   D+    D         E+G G FG  Y  T+ +  E  A K +S    +
Sbjct: 1   RKGVVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ 60

Query: 96  TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYT 155
           T    +D+ +EV+ ++ L KHPN +  K  Y  +    +VME C G       V +    
Sbjct: 61  TNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ 119

Query: 156 ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
           E   AA+    ++ +   H   ++HRD+K  N L     E   +K  DFG +    P   
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPANS 176

Query: 216 FNEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
           F   VG+PY+MAPEV+    +  Y  +VDVWS G+    L    PP +          I 
Sbjct: 177 F---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233

Query: 272 RS-VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
           ++     + + W   +++ +  V   L   P++R  + E+L H +++  + A
Sbjct: 234 QNDSPTLQSNEW---TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  102 bits (257), Expect = 4e-24
 Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 60/312 (19%)

Query: 58  YDLG------RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
           +DLG      R LG G  G+ +   D +  ++ A K I    L     ++   RE++I++
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV---LTDPQSVKHALREIKIIR 57

Query: 112 HLPKHPNIVSLKDTYEDDS--------------AVHIVMELCEGGELFDRIVARGHYTER 157
            L  H NIV + +                    +V+IV E  E       ++ +G  +E 
Sbjct: 58  RL-DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEE 114

Query: 158 AAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-- 215
            A   M  ++  ++  H   V+HRDLKP N +F N  E   LK  DFGL+    P     
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHK 172

Query: 216 --FNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
              +E + + +Y +P +L    NY   +D+W+AG I   +L G P F    E    Q I+
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232

Query: 272 RSV----------------IDFKRDPW----------PKVSENAKDLVKKMLNPDPKQRL 305
            SV                   + D            P V+  A D ++++L  +P  RL
Sbjct: 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292

Query: 306 TAEEVLEHPWLQ 317
           TAEE L HP++ 
Sbjct: 293 TAEEALMHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  103 bits (258), Expect = 5e-24
 Identities = 82/309 (26%), Positives = 131/309 (42%), Gaps = 57/309 (18%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   V+    +A K++ KK +     +  V+ E  I+     +  +V 
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L  +++D   ++ VM+   GG++   ++  G + E  A   +  +   V+  H+ G +HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 182 DLKPENFLFANKKESSPLKAIDFGL---------SVFFRPGEQFNE-------------- 218
           D+KP+N L         +K  DFGL         S +++ G+   +              
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 219 -------------------------IVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL 252
                                    +VG+P Y+APEVL R  Y    D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 253 CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEE 309
            G PPF A+T       +I         P  K+S  A DL+ K+    P+ RL    A+E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADE 301

Query: 310 VLEHPWLQN 318
           +  HP+ + 
Sbjct: 302 IKAHPFFKT 310

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  102 bits (255), Expect = 5e-24
 Identities = 70/261 (26%), Positives = 125/261 (47%), Gaps = 13/261 (4%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G+G FG   L     +G+ +A K + KK +    + + +  E  ++    KHP +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            +++    ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
           KPEN L  ++     +   DFGL        +      G+P Y+APEV+++  Y   VD 
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           W  G +LY +L G+PPF+      +   I+   +  +    P  S  A  +++++L  D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLEKDR 235

Query: 302 KQRLTAE----EVLEHPWLQN 318
           ++RL A+    E+ EHP+ ++
Sbjct: 236 QRRLGAKEDFLEIQEHPFFES 256

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  101 bits (254), Expect = 8e-24
 Identities = 85/313 (27%), Positives = 127/313 (40%), Gaps = 65/313 (20%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++  +LG G FG  Y    +  G   A K I     +    I  +R E++I+K L KH
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL-KH 66

Query: 117 PNIVSLKD-TYE--DDSA-----VHIVM-----ELCEGGELFDRIVARGHYTERAAAAVM 163
           PN+V L D   E  D S      V++V      +L   G L +  V     TE      M
Sbjct: 67  PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIKCYM 121

Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNE---- 218
             ++E +   HE  ++HRD+K  N L  N+     LK  DFGL+  +  P          
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFGLARPYDGPPPNPKGGGGG 178

Query: 219 -------IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 269
                  +V + +Y  PE+L  +R Y   VD+W  G +   +    P    +++      
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238

Query: 270 IIR--------------------SVIDFKRDPWPKVSENAK-------DLVKKMLNPDPK 302
           I +                     V  F   P   + E          DL+ K+L+ DP 
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLSLDPY 297

Query: 303 QRLTAEEVLEHPW 315
           +RLTA + LEHP+
Sbjct: 298 KRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  101 bits (253), Expect = 8e-24
 Identities = 68/246 (27%), Positives = 116/246 (47%), Gaps = 9/246 (3%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G+G FG   L    ++G  +A K + KK +    +   +  E  ++    KHP +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            +++    ++ V++   GGELF  +     + E  A      +   +   H   +++RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
           KPEN L  ++     +   DFGL      P E  +   G+P Y+APEVL++  Y   VD 
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           W  G +LY +L G+PPF++     +   I+   +          +  A DL+  +L+ D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235

Query: 302 KQRLTA 307
           ++RL A
Sbjct: 236 RRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  101 bits (252), Expect = 9e-24
 Identities = 81/293 (27%), Positives = 126/293 (43%), Gaps = 49/293 (16%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPNI 119
           +G G +G  Y   D N G     K ++ KK R  +D E +     RE+ +++ L +   I
Sbjct: 9   IGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 120 VSLKD---TYEDD--SAVHIVMELCEGG-----ELFDRIVARGHYTERAAAAVMKTIVEV 169
           V L D     E +   ++++V E  +       +   R   R     +   + M  +++ 
Sbjct: 64  VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQLLKG 122

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAP 228
           V  CH+ GVMHRDLKP+N L    K+   LK  D GL   F  P + +   + + +Y AP
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180

Query: 229 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV- 285
           EVL    +Y   VD+WS G I   +    P F  ++E      I + +       WP V 
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240

Query: 286 -----------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
                                  S    DL++KML  DP +R++A+  L HP+
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  101 bits (252), Expect = 1e-23
 Identities = 75/257 (29%), Positives = 127/257 (49%), Gaps = 10/257 (3%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG   L      GE FA K++ K  +    D+E    E +++    ++P +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            T++    +  VME   GG+L   I  +G +    A      IV  +Q  H +G+++RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDV 241
           K +N +         +K  DFG+      G+ + +   G+P Y+APE+L+   Y   VD 
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           WS GV+LY +L G  PF  + E  + ++I      + R  W  +++ +KD+++K+   DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLFERDP 235

Query: 302 KQRL-TAEEVLEHPWLQ 317
            +RL     +  HP+ +
Sbjct: 236 TRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  101 bits (252), Expect = 2e-23
 Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 24/274 (8%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R +GRG +    L         +A K I K+ +    DI+ V+ E  + +    HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L   ++ +S +  V+E   GG+L   +  +    E  A      I   +   HE+G+++R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEV 239
           DLK +N L   +     +K  D+G+     RPG+  +   G+P Y+APE+L+  +YG  V
Sbjct: 121 DLKLDNVLLDAEGH---IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 240 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           D W+ GV+++ ++ G  PF            TE  + Q I+   I   R     +S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233

Query: 291 DLVKKMLNPDPKQRLTAE------EVLEHPWLQN 318
            ++K  LN DPK+RL         ++  HP+ +N
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  101 bits (253), Expect = 2e-23
 Identities = 82/305 (26%), Positives = 135/305 (44%), Gaps = 53/305 (17%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++  + +GRG FG   L    + G  +A K + K  +     +  +R E  I+      
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-ADG 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
             +V +  +++D   ++++ME   GG++   ++ +   +E A    +   V  +   H+ 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV---------FFR-----PGEQFN----- 217
           G +HRD+KP+N L   K     +K  DFGL           F+R     P   F+     
Sbjct: 121 GFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 218 -----------------EIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFW 259
                              VG+P Y+APEV ++  Y    D WS GVI+Y +L G PPF 
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 260 AETEQGVAQAIIRSVIDFKRD----PWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLE 312
           +ET     Q   R V+++K      P   +SE AKDL+ +    D + R+     EE+  
Sbjct: 238 SET----PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292

Query: 313 HPWLQ 317
           HP+ +
Sbjct: 293 HPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =   99 bits (249), Expect = 2e-23
 Identities = 88/298 (29%), Positives = 129/298 (43%), Gaps = 43/298 (14%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSI----SKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           ELG+G +G  Y       G   A K I     + K    +       E+ I+ H    P 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII------MELDIL-HKAVSPY 60

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV-----QVC 173
           IV     +  + AV++ ME  + G L D++ A G  TE     V++ I   V      + 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPE 229
            E  ++HRD+KP N L     +   +K  DFG+S     G     +    +G   YMAPE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE 171

Query: 230 VLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV---AQAIIRSVIDFKR 279
            +K         Y  + DVWS G+ +  +  G  P+  ET   +     AI+    D   
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPT 229

Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
            P    S++A+D V K LN  P +R T  ++LEHPWL    K  +V + E V   LK+
Sbjct: 230 LP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV-KYKNADVDMAEWVTGALKR 285

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

 Score = 96.2 bits (240), Expect = 2e-23
 Identities = 51/147 (34%), Positives = 81/147 (55%), Gaps = 2/147 (1%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           L+ E++  LKEAF++ D +  G I+  EL   L   G N  EA++  L E  D  G+ ++
Sbjct: 14  LTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEID-AGNETV 72

Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ V SV LK+   +E L +AF  FD++  G+I I ELR  L    +   ++ +  
Sbjct: 73  DFPEFLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEK 132

Query: 475 IMHDVDTDKDGRISYEEFAVMMKAGTD 501
           ++ + D D DG I YEEF  ++K    
Sbjct: 133 LLKEYDEDGDGEIDYEEFKKLIKDSPT 159

Length = 160

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 98.7 bits (247), Expect = 3e-23
 Identities = 77/280 (27%), Positives = 117/280 (41%), Gaps = 51/280 (18%)

Query: 60  LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           LG++LG G FG  Y  T          K A K++  K+  +  + E+   E  IMK L  
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL-S 59

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVC- 173
           HPNIV L         ++IV E   GG+L D +   G          +K ++++ +Q+  
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE------KLTLKDLLQMALQIAK 113

Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
                  +  +HRDL   N L         +K  DFGLS          +I    YY   
Sbjct: 114 GMEYLESKNFVHRDLAARNCLVTENLV---VKISDFGLS---------RDIYEDDYYRKR 161

Query: 226 ---------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                    MAPE LK   +  + DVWS GV+L+ I   G  P+   + + V + +    
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG- 220

Query: 275 IDFKRDPWPKV-SENAKDLVKKMLNPDPKQRLTAEEVLEH 313
               R P P+   +   +L+ +    DP+ R T  E++E 
Sbjct: 221 ---YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional

 Score = 95.2 bits (237), Expect = 4e-23
 Identities = 50/145 (34%), Positives = 88/145 (60%), Gaps = 1/145 (0%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I  +EL   +   GQN  EA+LQ ++   D DG+
Sbjct: 2   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 61

Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FDR+ +GFI   ELR+ + +  +   ++ 
Sbjct: 62  GTIDFPEFLTLMARKMKDTDSEEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEE 121

Query: 472 INAIMHDVDTDKDGRISYEEFAVMM 496
           ++ ++ + D D DG+I+YEEF  MM
Sbjct: 122 VDEMIREADVDGDGQINYEEFVKMM 146

Length = 149

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 98.6 bits (245), Expect = 5e-23
 Identities = 80/268 (29%), Positives = 129/268 (48%), Gaps = 23/268 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY+L + +G G +G  Y   +++ GE  A K I   KL    D   +++E+ ++K   KH
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKEC-KH 65

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            NIV+   +Y     + I ME C GG L D     G  +E   A V +  ++ +   H +
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIVGSPYYMAPEV--LKR 233
           G MHRD+K  N L  +  +   +K  DFG++        +    +G+PY+MAPEV  +++
Sbjct: 126 GKMHRDIKGANILLTDNGD---VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 234 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK- 290
           N  Y    D+W+ G+    L    PP +      +    + S  +F+    PK+ +  K 
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMF--DLHPMRALFLMSKSNFQP---PKLKDKTKW 237

Query: 291 -----DLVKKMLNPDPKQRLTAEEVLEH 313
                + VK  L  +PK+R TAE +L H
Sbjct: 238 SSTFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 98.2 bits (244), Expect = 6e-23
 Identities = 77/271 (28%), Positives = 134/271 (49%), Gaps = 23/271 (8%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKHPNIVSL 122
           +G+G FG  +   D    +  A K I    L  A D IED+++E+ ++      P +   
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLSQC-DSPYVTKY 67

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y   + + I+ME   GG   D + A G + E   A ++K I++ +   H +  +HRD
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126

Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K  N L +   E   +K  DFG++      + + N  VG+P++MAPEV++++ Y  + D
Sbjct: 127 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV----SENAKDLVKKM 296
           +WS G+    L  G PP             +R +    ++  P +    S+  K+ +   
Sbjct: 184 IWSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236

Query: 297 LNPDPKQRLTAEEVLEHPWL-QNAKKAPNVS 326
           LN DP  R TA+E+L+H ++ +NAKK   ++
Sbjct: 237 LNKDPSFRPTAKELLKHKFIVKNAKKTSYLT 267

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 98.4 bits (245), Expect = 7e-23
 Identities = 73/263 (27%), Positives = 127/263 (48%), Gaps = 17/263 (6%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN-IVSL 122
           LG+G FG    C     G+ +ACK ++KK+L+     E    E +I+  +  H   IVSL
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFIVSL 58

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVVQVCHEQGV 178
              ++  + + +VM +  GG+L   I         + E  A      I+  ++  H++ +
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-IVGSPYYMAPEVLK-RNYG 236
           ++RDLKPEN L  N      ++  D GL+V  + G+   +   G+P +MAPE+L+   Y 
Sbjct: 119 IYRDLKPENVLLDNDGN---VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
             VD ++ GV LY ++    PF A  E+   + + + +++       K S  +K   + +
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 297 LNPDPKQRL-----TAEEVLEHP 314
           L  DP++RL       + +  HP
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHP 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 40/290 (13%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
            +LG G  G       +  G   A K +   +K  +R     + + RE+QIM H  + P 
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR-----KQILRELQIM-HECRSPY 64

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-----HYTERAAAAVMKTIVEVVQVC 173
           IVS    + +++ + + ME  + G L DRI  +G         + A AV++ +  +  V 
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPE 229
               +MHRD+KP N L  ++ +   +K  DFG+S     GE  N I    VG+  YM+PE
Sbjct: 124 R---IMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYMSPE 172

Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR----DPWPK 284
            ++   Y  + DVWS G+ +  L  G  PF         Q     ++D  +    +P P+
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232

Query: 285 V-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE 329
           +      E+ +D V   L  DP +R T +++   P    A +A NV L  
Sbjct: 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQA 282

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 70/251 (27%), Positives = 118/251 (47%), Gaps = 9/251 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++    LG+G FG   L       E +A K + K  +    D+E    E +++    K 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  L   ++    ++ VME   GG+L   I   G + E  A      I   +   H +
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N +  ++     +K  DFG+       G       G+P Y+APE++  + 
Sbjct: 121 GIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W+ GV+LY +L G PPF  E E  + Q+I+   + + +     +S+ A  + K
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK 233

Query: 295 KMLNPDPKQRL 305
            ++   P +RL
Sbjct: 234 GLMTKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 84/279 (30%), Positives = 130/279 (46%), Gaps = 22/279 (7%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ELG G FG  Y   +   G   A K I  K   +  ++ED   E++I+     HP IV L
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-NHPYIVKL 74

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
              +  D  + I++E C GG + D I+    RG  TE     + + ++E +Q  H   ++
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKII 132

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL------K 232
           HRDLK  N L     +   +K  DFG+S    +  ++ +  +G+PY+MAPEV+       
Sbjct: 133 HRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             Y  + D+WS G+ L  +    PP        V   I +S       P  K S   +D 
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP-SKWSMEFRDF 248

Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETV 331
           +K  L+  P+ R +A ++LEHP++  +    N  L E V
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFV--SSVTSNRPLRELV 285

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 81/319 (25%), Positives = 136/319 (42%), Gaps = 66/319 (20%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNN--GEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLP 114
           Y++   +GRG +G  Y     N   G+++A K     K+  T +     R E+ +++ L 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL- 59

Query: 115 KHPNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAA-------AVMKT 165
           KH N+VSL + + + +   V+++ +  E  +L+  I  + H   +  +       +++  
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII--KFHRQAKRVSIPPSMVKSLLWQ 116

Query: 166 IVEVVQVCHEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFR-PGEQF---NEIV 220
           I+  V   H   V+HRDLKP N  +     E   +K  D GL+  F  P +     + +V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA---------QA 269
            + +Y APE+L   R+Y   +D+W+ G I   LL   P F     +            + 
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 270 II---------------------RSVIDFKRDPWP------------KVSENAKDLVKKM 296
           I                        + DFK   +P            K      DL++K+
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 297 LNPDPKQRLTAEEVLEHPW 315
           L  DP +R+TAEE LEHP+
Sbjct: 297 LEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 97.0 bits (241), Expect = 2e-22
 Identities = 83/288 (28%), Positives = 131/288 (45%), Gaps = 40/288 (13%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMK 111
           D S  +++   +G+G +G  +   +  NG K A K      L    DI E++  E  I+K
Sbjct: 15  DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILK 69

Query: 112 HLPKHPNIVSL------KDTYEDDSAVHIVMELCEGGELFDRI---VARG-HYTERAAAA 161
            L  HPN+V        KD    D  + +V+ELC GG + D +   + RG    E   A 
Sbjct: 70  ALSDHPNVVKFYGMYYKKDVKNGDQ-LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128

Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIV 220
           ++   +  +Q  H    +HRD+K  N L   +     +K +DFG+S        + N  V
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSV 185

Query: 221 GSPYYMAPEV------LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
           G+P++MAPEV      L   Y    DVWS G+    L  G PP  A+         +R++
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRAL 238

Query: 275 IDFKRDPWPKV------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
               R+P P +      S    D ++K L  D ++R T  ++L+H ++
Sbjct: 239 FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 96.7 bits (240), Expect = 2e-22
 Identities = 76/266 (28%), Positives = 132/266 (49%), Gaps = 21/266 (7%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G+G FG  +   D    +  A K I  ++     +IED+++E+ ++      P +   
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQC-DSPYVTKY 67

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y  D+ + I+ME   GG   D ++  G   E   A +++ I++ +   H +  +HRD
Sbjct: 68  YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126

Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K  N L +   E   +K  DFG++      + + N  VG+P++MAPEV+K++ Y  + D
Sbjct: 127 IKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN----AKDLVKKM 296
           +WS G+    L  G PP        V   I       K +P P +  N     K+ V+  
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIP------KNNP-PTLEGNYSKPLKEFVEAC 236

Query: 297 LNPDPKQRLTAEEVLEHPW-LQNAKK 321
           LN +P  R TA+E+L+H + ++ AKK
Sbjct: 237 LNKEPSFRPTAKELLKHKFIVRFAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 96.7 bits (240), Expect = 3e-22
 Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 22/265 (8%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKHPNIVSL 122
           +G+G FG  Y   D    E  A K I    L  A D IED+++E+ ++      P I   
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQC-DSPYITRY 67

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y   + + I+ME   GG   D ++  G   E   A +++ I++ +   H +  +HRD
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRD 126

Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K  N L +   E   +K  DFG++      + + N  VG+P++MAPEV+K++ Y  + D
Sbjct: 127 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV----SENAKDLVKKM 296
           +WS G+    L  G PP             +R +    ++  P +    S+  K+ V+  
Sbjct: 184 IWSLGITAIELAKGEPPN-------SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC 236

Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKK 321
           LN DP+ R TA+E+L+H ++    K
Sbjct: 237 LNKDPRFRPTAKELLKHKFITRYTK 261

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 74/286 (25%), Positives = 133/286 (46%), Gaps = 43/286 (15%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPNI 119
           +G G +G+   C     G+  A K     K   + D + V+    RE++++K L +H N+
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQL-RHENL 62

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
           V+L + +     +++V E  +   L D         E      +  I+  ++ CH   ++
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVLKRN--YG 236
           HRD+KPEN L +   +S  +K  DFG +     PGE + + V + +Y APE+L  +  YG
Sbjct: 123 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--------FKRDP------- 281
             VD+W+ G ++  +L G P F  +++      II+ + +        F+++P       
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 282 ------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
                       +PK+S    DL K+ L  DP  R ++ ++L H +
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 95.5 bits (237), Expect = 5e-22
 Identities = 76/291 (26%), Positives = 138/291 (47%), Gaps = 39/291 (13%)

Query: 46  LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
           L++P+G      ++L   +G G +G  Y    V  G+  A K +      T  + E++++
Sbjct: 1   LRDPAGI-----FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQ 51

Query: 106 EVQIMKHLPKHPNIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYT--ER 157
           E+ ++K    H NI +       K+    D  + +VME C  G + D I      T  E 
Sbjct: 52  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111

Query: 158 AAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQF 216
             A + + I+  +   H+  V+HRD+K +N L     E++ +K +DFG+S    R   + 
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168

Query: 217 NEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQAI 270
           N  +G+PY+MAPEV+  +  P+       D+WS G+    +  G PP             
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHP 221

Query: 271 IRSVIDFKRDPWPKV-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +R++    R+P P++     S+  +  ++  L  +  QR T E++++HP++
Sbjct: 222 MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 96.8 bits (241), Expect = 6e-22
 Identities = 89/309 (28%), Positives = 132/309 (42%), Gaps = 51/309 (16%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y +   +G+G +GV     D + GEK A K I         D   + RE+++++ L +HP
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLL-RHP 59

Query: 118 NIVSLKD--------TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           +IV +K          ++D   +++V EL E  +L   I A    T       +  ++  
Sbjct: 60  DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRA 115

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFR--PGEQF-NEIVGSPYY 225
           ++  H   V HRDLKP+N L AN      LK  DFGL+ V F   P   F  + V + +Y
Sbjct: 116 LKYIHTANVFHRDLKPKNIL-ANA--DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 226 MAPEV---LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETE 263
            APE+       Y P +D+WS G I   +L G P F                     ET 
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 264 QGVAQAIIRSVIDF--KRDP------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
             V     R  +    K+ P      +P     A  L++++L  DPK R TAEE L  P+
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 316 LQNAKKAPN 324
            +   K   
Sbjct: 293 FKGLAKVER 301

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 95.4 bits (237), Expect = 7e-22
 Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 38/292 (13%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-- 115
           Y+   E+G G +G  Y   D ++G   A KS+  +     + +  VR EV ++K L    
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFD 60

Query: 116 HPNIVSLKDT-----YEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVE 168
           HPNIV L D       + ++ V +V E  +       D++   G   E     +M+  + 
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD-LMRQFLR 119

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            +   H   ++HRDLKPEN L  +  +   +K  DFGL+  +        +V + +Y AP
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRAP 176

Query: 229 EV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW----- 282
           EV L+  Y   VD+WS G I   +    P F   +E      I   +     D W     
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236

Query: 283 ------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                             P++ E+   L+ +ML  +P +R++A   L+HP+ 
Sbjct: 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 9e-22
 Identities = 77/273 (28%), Positives = 137/273 (50%), Gaps = 20/273 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG FG   +    N G+ +A K ++K ++    +    R E  ++ +  + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHE 175
             I +L   ++D++ +++VM+   GG+L   +        E  A   +  +V  +   H+
Sbjct: 62  W-ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVL-- 231
            G +HRD+KP+N L     ++  ++  DFG  +        Q N  VG+P Y++PE+L  
Sbjct: 121 LGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177

Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKV 285
               K  YGPE D WS GV +Y +L G  PF+AE+       I+  +    F  D    V
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDV 236

Query: 286 SENAKDLVKKMLNPDPKQRL---TAEEVLEHPW 315
           SE AKDL+++++   P+ RL     ++  +HP+
Sbjct: 237 SEEAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 41/294 (13%)

Query: 46  LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
           L +P+       +++   +G+G +G  Y  T+  +G   A K +        VD E++  
Sbjct: 17  LGDPTD-----TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVD-EEIEA 67

Query: 106 EVQIMKHLPKHPNIVSLKDT-YEDDSAVH----IVMELCEGG---ELFDRIVARGHYTER 157
           E  I++ LP HPN+V      Y+ D  V     +V+ELC GG   EL   ++  G   + 
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127

Query: 158 AAAA-VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q 215
           A  + ++   +  +Q  H   ++HRD+K  N L   +     +K +DFG+S        +
Sbjct: 128 AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLR 184

Query: 216 FNEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 269
            N  VG+P++MAPEV+        +Y    DVWS G+    L  G PP +          
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF-------DMH 237

Query: 270 IIRSVIDFKRDPWP------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
            ++++    R+P P      K   +    + + L  D + R +   +LEHP+++
Sbjct: 238 PVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 96.6 bits (240), Expect = 1e-21
 Identities = 76/315 (24%), Positives = 130/315 (41%), Gaps = 55/315 (17%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   V+    +A K++ KK +     +  V+ E  I+     +  +V 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L  +++D   ++ VM+   GG++   ++    + E  A   +  +   ++  H+ G +HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFR--------------------PGEQFNEI-- 219
           D+KP+N L         +K  DFGL   FR                    P + ++++  
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 220 --------------------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILL 252
                                     VG+P Y+APEV L++ Y    D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 253 CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML--NPDPKQRLTAEEV 310
            G PPF A T       +I         P  K+S  A DL+ K+     +   R  A+++
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302

Query: 311 LEHPWLQNAKKAPNV 325
             HP+      + ++
Sbjct: 303 KAHPFFSEVDFSSDI 317

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 96.3 bits (239), Expect = 1e-21
 Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 41/274 (14%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++  + +GRG FG   L    + G  +A K + K  +     +  +R E  I+      
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADS 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
             +V +  +++D   ++++ME   GG++   ++ +   TE      +   V  +   H+ 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV---------FFR------PGE-QFNEI- 219
           G +HRD+KP+N L  +K     +K  DFGL           F+R      P +  F  + 
Sbjct: 121 GFIHRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 220 -------------------VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFW 259
                              VG+P Y+APEV  +  Y    D WS GVI+Y +L G PPF 
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 260 AETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
           +ET Q   + ++         P   +SE AKDL+
Sbjct: 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 98.7 bits (245), Expect = 1e-21
 Identities = 84/295 (28%), Positives = 138/295 (46%), Gaps = 41/295 (13%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y++ +++G G FG  +L       E F  K+IS + L+     + V  EV +M+ L KH
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMREL-KH 71

Query: 117 PNIVSLKDTY--EDDSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVV 170
            NIV   D +  + +  ++I+ME C+ G+L   I       G   E A   + + ++  +
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 171 QVCHE-------QGVMHRDLKPENFLF-------------ANKKESSPLKAI-DFGLSVF 209
             CH        + V+HRDLKP+N                AN     P+  I DFGLS  
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 210 FRPGEQFNEIVGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 266
                  +  VG+PYY +PE+L    ++Y  + D+W+ G I+Y L  G  PF        
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK------ 245

Query: 267 AQAIIRSVIDFKRDPWPKVSENAKD---LVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           A    + + + KR P   +   +K+   L+K +LN   K+R +A + L +  ++N
Sbjct: 246 ANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300

Length = 1021

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 71/266 (26%), Positives = 123/266 (46%), Gaps = 30/266 (11%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG        N G+ +ACK + KK+L+     +    E +I++ +   P IV+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLA 59

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARG----------HYTERAAAAVMKTIVEVVQVC 173
             +E  + + +VM L  GG+L   I   G          HY+ +    ++          
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL-------- 111

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H   +++RD+KPEN L  ++      +  D GL+V  + G+   +  G+  YMAPE+LK 
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNC---RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168

Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID----FKRDPWPKVSEN 288
             Y   VD ++ G  +Y ++ G  PF    E+   + + R  ++    F+       +E 
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEE 225

Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHP 314
           +KD+ +  L   P+ RL + E  + P
Sbjct: 226 SKDICRLFLAKKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 68/281 (24%), Positives = 119/281 (42%), Gaps = 50/281 (17%)

Query: 62  RELGRGEFGVTYLCT---DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           ++LG G FG  Y            + A K++  K+  +  + +D  +E ++MK L  HPN
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKL-GHPN 57

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV----QVC- 173
           +V L     ++  +++V+E  EGG+L D +            + + ++ +++    Q+  
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL-SLKDLLSFAIQIAK 116

Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
                  +  +HRDL   N L         +K  DFGLS          ++    YY   
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSR---------DVYDDDYYRKK 164

Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV-AQAIIRS 273
                    MAPE LK   +  + DVWS GV+L+ I   G  P+      G+  + ++  
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-----GLSNEEVLEY 219

Query: 274 VIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
           +    R P P+   +   +L+      DP+ R T  E++E 
Sbjct: 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 71/254 (27%), Positives = 127/254 (50%), Gaps = 20/254 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG FG   +    N  + FA K ++K ++    +    R E  ++ +   +
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDN 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE 175
             I +L   ++D++ +++VM+   GG+L   +        E  A   +  +V  +   H+
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFNEIVGSPYYMAPEVL-- 231
              +HRD+KP+N L      +  ++  DFG  L +      Q +  VG+P Y++PE+L  
Sbjct: 121 LHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP---- 283
               K  YGPE D WS GV +Y +L G  PF+AE+       I+     F+   +P    
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVT 234

Query: 284 KVSENAKDLVKKML 297
            VSE+AKDL+++++
Sbjct: 235 DVSEDAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 94.7 bits (235), Expect = 3e-21
 Identities = 69/251 (27%), Positives = 118/251 (47%), Gaps = 9/251 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++    LG+G FG   L       E +A K + K  +    D+E    E +++    K 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  L   ++    ++ VME   GG+L  +I   G + E  A      I   +   H +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N +  ++     +K  DFG+       G       G+P Y+APE++  + 
Sbjct: 121 GIIYRDLKLDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W+ GV+LY +L G  PF  E E  + Q+I+   + + +     +S+ A  + K
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK 233

Query: 295 KMLNPDPKQRL 305
            ++   P +RL
Sbjct: 234 GLMTKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 84/305 (27%), Positives = 135/305 (44%), Gaps = 57/305 (18%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D +  R +G G FGV +  TD  +G++ A K +     +  V  + V RE++++    KH
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFF-KH 58

Query: 117 PNIVSLKDT--------YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
            N++S  D         +E+   +++V EL +  +L   IV+    +       +  I+ 
Sbjct: 59  DNVLSALDILQPPHIDPFEE---IYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILR 114

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN---EIVGSPYY 225
            ++  H  G++HRD+KP N L  +   +  LK  DFGL+    P E  +   E+V + YY
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170

Query: 226 MAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVPPFWAET 262
            APE+L   R+Y   VD+WS G I                     L   L G P   A  
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230

Query: 263 E--QGVAQAIIRSVIDFKRDPWPKV--------SENAKDLVKKMLNPDPKQRLTAEEVLE 312
              +G    I+R      + P   V        +  A  L+ +ML  DP +R++A + L 
Sbjct: 231 SACEGARAHILRGP---HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287

Query: 313 HPWLQ 317
           HP+L 
Sbjct: 288 HPYLD 292

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 74/263 (28%), Positives = 128/263 (48%), Gaps = 21/263 (7%)

Query: 64  LGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
           LG+G FG  +L   +   + G+ +A K + K  L+   D    + E  I+  +  HP IV
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEV-NHPFIV 61

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
            L   ++ +  ++++++   GG+LF R+     +TE      +  +   +   H  G+++
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN-EIVGSPYYMAPEVL-KRNYGPE 238
           RDLKPEN L     E   +K  DFGLS      E+      G+  YMAPEV+ +R +   
Sbjct: 122 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDLVKKML 297
            D WS GV+++ +L G  PF  +  +     I+++ +       P+ +S  A+ L++ + 
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM-----PQFLSPEAQSLLRALF 233

Query: 298 NPDPKQRLTA-----EEVLEHPW 315
             +P  RL A     EE+  HP+
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 92.3 bits (229), Expect = 2e-20
 Identities = 85/296 (28%), Positives = 137/296 (46%), Gaps = 49/296 (16%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   GEK A K +S+   ++ +  +   RE+ ++KH+ +H N++ L 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHM-QHENVIGLL 80

Query: 124 DTYEDDSAVH------IVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQ 176
           D +    +        +VM   +     D     GH  +E     ++  ++  ++  H  
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKR-- 233
           G++HRDLKP N L  N  E   LK +DFGL+   R  + +    V + +Y APEV+    
Sbjct: 137 GIIHRDLKPGN-LAVN--EDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNWM 190

Query: 234 NYGPEVDVWSAGVILYILLCGV-----------------------PPFWAETEQGVAQAI 270
           +Y   VD+WS G I+  +L G                        P F  + E   A++ 
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250

Query: 271 IRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
           I+S+  + R      +PK S  A DL++KML  D  +RLTA E LEHP+  + + A
Sbjct: 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 70/262 (26%), Positives = 117/262 (44%), Gaps = 31/262 (11%)

Query: 67  GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPNIVSLKDT 125
           G+FG   +       + F  K I  K       IE  V    Q+MK    +PN + L  +
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVH---QLMKD---NPNFIKLYYS 77

Query: 126 YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP 185
                   ++M+  + G+LFD +   G  +E     +++ +VE +   H+  ++H D+K 
Sbjct: 78  VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137

Query: 186 ENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-------YMAPE-VLKRNYGP 237
           EN L+   K+   +   D+GL           +I+G+P        Y +PE +   NY  
Sbjct: 138 ENVLYDRAKDR--IYLCDYGLC----------KIIGTPSCYDGTLDYFSPEKIKGHNYDV 185

Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
             D W+ GV+ Y LL G  PF  + ++ +    +      K      VS+NA D V+ ML
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSML 245

Query: 298 NPDPKQRLTA-EEVLEHPWLQN 318
             +   RLT   E+++HP+L+ 
Sbjct: 246 KYNINYRLTNYNEIIKHPFLKI 267

Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 77/294 (26%), Positives = 137/294 (46%), Gaps = 39/294 (13%)

Query: 43  LCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED 102
           L  L++P+G      ++L   +G G +G  Y    V  G+  A K +      T  + E+
Sbjct: 8   LSALRDPAGI-----FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEE 58

Query: 103 VRREVQIMKHLPKHPNIVSL------KDTYEDDSAVHIVMELCEGGELFDRIV-ARGH-Y 154
           ++ E+ ++K    H NI +       K     D  + +VME C  G + D +   +G+  
Sbjct: 59  IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118

Query: 155 TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPG 213
            E   A + + I+  +   H   V+HRD+K +N L     E++ +K +DFG+S    R  
Sbjct: 119 KEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTV 175

Query: 214 EQFNEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVA 267
            + N  +G+PY+MAPEV+  +  P+       D+WS G+    +  G PP          
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL-------CD 228

Query: 268 QAIIRSVIDFKRDPWPKV-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
              +R++    R+P PK+     S+   D ++  L  +   R + E++L+HP++
Sbjct: 229 MHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 82/267 (30%)

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIV-----------MELCEGG------ELFDR 147
           RE  ++K L KH NIV+L D       + +V           M+ C GG       LF  
Sbjct: 52  REASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF 110

Query: 148 IVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL- 206
            + RG                 +  CH++ V+HRDLKP+N L + + E   LK  DFGL 
Sbjct: 111 QLLRG-----------------LAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLA 150

Query: 207 ---SVFFRPGEQF-NEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA 260
              SV   P + + NE+V + +Y  P+VL     Y   +D+W  G I Y +  G P F  
Sbjct: 151 RAKSV---PSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206

Query: 261 ET---EQGVAQAIIRSVIDFKRDPWPKVSENAK--------------------------- 290
            T   +Q     I R +     + WP VS N +                           
Sbjct: 207 STDVEDQ--LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHG 264

Query: 291 -DLVKKMLNPDPKQRLTAEEVLEHPWL 316
            +L  K L  +PK+R++A E ++HP+ 
Sbjct: 265 EELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 41/245 (16%)

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV-M 163
           REV ++K+L KH NIV+L D    +  + +V E  +  +L   +   G+        + M
Sbjct: 52  REVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109

Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL----SVFFRPGEQFNEI 219
             ++  +  CH++ ++HRDLKP+N L   K E   LK  DFGL    SV   P + ++  
Sbjct: 110 FQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSV---PTKTYSNE 163

Query: 220 VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF 277
           V + +Y  P+VL     Y   +D+W  G ILY +  G P F   T +     I R +   
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223

Query: 278 KRDPWPKVSENAK--------------------------DLVKKMLNPDPKQRLTAEEVL 311
             + WP ++ N +                          DL+  +L  + K R++AE  L
Sbjct: 224 TEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283

Query: 312 EHPWL 316
            H + 
Sbjct: 284 RHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 92.6 bits (230), Expect = 1e-19
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 20/223 (8%)

Query: 104 RREVQIMKHLPKHPNIVSLKDTYE-DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV 162
           RRE  +   L  HPNIV+L D+ E     +  V E   G  L + + A G         +
Sbjct: 26  RRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84

Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG--------- 213
           M  +++ +   H QG++HRDLKP+N + +        K +DFG+     PG         
Sbjct: 85  MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATL 143

Query: 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
            +  E++G+P Y APE L+     P  D+++ G+I    L G       +   VA+ + +
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS---VAEILYQ 200

Query: 273 --SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQR-LTAEEVLE 312
             S +D    PW         +++K LN DP+QR  +A  + E
Sbjct: 201 QLSPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPALAE 242

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 90.8 bits (225), Expect = 2e-19
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 28/218 (12%)

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVV 170
            H  IV   D ++ D  + ++ME   GG+L  +I  R      + E     +   IV  +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV---------G 221
              H + +MHRDLK  N        +  +K  DFG S      +Q+++ V         G
Sbjct: 183 DEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFS------KQYSDSVSLDVASSFCG 233

Query: 222 SPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
           +PYY+APE+ +R  Y  + D+WS GVILY LL    PF   +++ + Q ++      K D
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG----KYD 289

Query: 281 PWP-KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           P+P  VS   K L+  +L+ +P  R T +++L   +L+
Sbjct: 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 87.3 bits (216), Expect = 4e-19
 Identities = 83/296 (28%), Positives = 119/296 (40%), Gaps = 56/296 (18%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR----TAVDIEDVRREVQIMKHLPKHP 117
            +LG G +   Y      NG+  A K IS K       TA+      RE  ++K L KH 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI------REASLLKGL-KHA 63

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV L D       +  V E          I   G          M  ++  +   H Q 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL--KRN 234
           ++HRDLKP+N L +   E   LK  DFGL+     P + ++  V + +Y  P+VL    +
Sbjct: 124 ILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-----IRSVIDF-KRDPWPKVSE- 287
           Y   +D+W AG I   +L G P F      GV+        I +V+     D WP VS+ 
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAF-----PGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235

Query: 288 ---------------------------NAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                                       A+DL  +ML   PK R++A++ L HP+ 
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 88.2 bits (218), Expect = 5e-19
 Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 44/290 (15%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
             +G G +G      D    +K A K +S+   ++ +      RE++++KH+ KH N++ 
Sbjct: 21  TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHM-KHENVIG 78

Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L D +      E+ + V++V  L   G   + IV     ++     ++  ++  ++  H 
Sbjct: 79  LLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-- 233
            G++HRDLKP N       E   L+ +DFGL+   +  ++    V + +Y APE++    
Sbjct: 137 AGIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIMLNWM 191

Query: 234 NYGPEVDVWSAGVILYILLCG-----------------------VPPFWAETEQGVAQAI 270
           +Y   VD+WS G I+  LL G                        P    +     A+  
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKY 251

Query: 271 IRSVIDFKRDPWPKVSENAK----DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           I+S+    +    K+   A     DL++KML  D  +R++A E L HP+ 
Sbjct: 252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 86.6 bits (214), Expect = 8e-19
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 44/286 (15%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +GV   C      E  A K     +    V  E   RE+++++ L K  NIV LK
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL-KQENIVELK 66

Query: 124 DTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           + +     +++V E  E    EL + +   G   E+  + + + +++ +  CH+  ++HR
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCHKNDIVHR 124

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN--EIVGSPYYMAPE-VLKRNYGPE 238
           D+KPEN L ++   +  LK  DFG +     G   N  E V + +Y +PE +L   YG  
Sbjct: 125 DIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAI-IRSVID---------FKRDP------W 282
           VD+WS G IL  L  G P F  E+E  + Q   I+ V+          F  +P      +
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESE--IDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239

Query: 283 PKVSENAK--------------DLVKKMLNPDPKQRLTAEEVLEHP 314
           P V+                  DL+K +L  +P  R   E+ L HP
Sbjct: 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 87.4 bits (216), Expect = 9e-19
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 82

Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 83  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 141 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 195

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255

Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 256 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 77/314 (24%), Positives = 132/314 (42%), Gaps = 54/314 (17%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ELG G  GV        +G   A K I   +++ A+    + RE++++ H    P IV  
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIR-NQIIRELKVL-HECNSPYIVGF 64

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVE-VVQVCHEQGVMH 180
              +  D  + I ME  +GG L D+++ + G   E     +   ++  +  +  +  +MH
Sbjct: 65  YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVLKRN-Y 235
           RD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L+   Y
Sbjct: 124 RDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHY 175

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVA---------------------------- 267
             + D+WS G+ L  +  G  P      + +                             
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235

Query: 268 -QAIIRSVIDFKRDPWPKV-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
             AI   +     +P PK+     S+  +D V K L  +PK+R   +E+ +HP+++ A +
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA-E 294

Query: 322 APNVSLGETVKARL 335
              V     V + +
Sbjct: 295 LEEVDFAGWVCSTM 308

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 29/273 (10%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKH 112
           + +    +G G  G  Y       G  +A K I           + VR    RE++I++ 
Sbjct: 75  ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRD 128

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           +  HPN+V   D ++ +  + +++E  +GG L    +A     E+  A V + I+  +  
Sbjct: 129 V-NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAY 183

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL 231
            H + ++HRD+KP N L  + K    +K  DFG+S +  +  +  N  VG+  YM+PE +
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERI 240

Query: 232 KRNY------GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-- 283
             +       G   D+WS GV +     G  PF     QG   A +   I   + P    
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQG-DWASLMCAICMSQPPEAPA 298

Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
             S   +  +   L  +P +R +A ++L+HP++
Sbjct: 299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 20/254 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG FG   +    +    +A K ++K ++    +    R E  ++ +    
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GDC 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE 175
             I +L   ++D++ +++VM+   GG+L   +        E  A   +  +V  +   H+
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              +HRD+KP+N L      +  ++  DFG  L +      Q +  VG+P Y++PE+L+ 
Sbjct: 121 LHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 234 ------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
                  YGPE D WS GV +Y +L G  PF+AE+       I+     F+   +P    
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHIT 234

Query: 285 -VSENAKDLVKKML 297
            VSE AKDL+++++
Sbjct: 235 DVSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 35/243 (14%)

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV-M 163
           REV ++K L KH NIV+L D    + ++ +V E  +  +L   +   G+        + +
Sbjct: 53  REVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL 110

Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGS 222
             ++  +  CH + V+HRDLKP+N L   + E   LK  DFGL+     P + ++  V +
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVT 167

Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
            +Y  P++L    +Y  ++D+W  G I Y +  G P F   T +     I R +     +
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE 227

Query: 281 PWPKVSENAK--------------------------DLVKKMLNPDPKQRLTAEEVLEHP 314
            WP +  N +                          +L+ K+L  + ++R++AEE ++HP
Sbjct: 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287

Query: 315 WLQ 317
           +  
Sbjct: 288 YFH 290

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 18/266 (6%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH---PNIV 120
           +GRG FG  Y C   + G+ +A K + KK+++     E +    +IM  L      P IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
            +   +     +  +++L  GG+L   +   G ++E         I+  ++  H + V++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN--YGPE 238
           RDLKP N L     E   ++  D GL+  F   ++ +  VG+  YMAPEVL++   Y   
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 176

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVSENAKDLVKKML 297
            D +S G +L+ LL G  PF     +   +  I  +        P   S   + L++ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF--RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234

Query: 298 NPDPKQRL-----TAEEVLEHPWLQN 318
             D  +RL      A+EV EHP+ ++
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 66/244 (27%), Positives = 112/244 (45%), Gaps = 35/244 (14%)

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV-M 163
           REV ++K L KH NIV+L D    D ++ +V E  +  +L   +   G+        + +
Sbjct: 53  REVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL 110

Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGS 222
             I+  +  CH + V+HRDLKP+N L   + E   LK  DFGL+     P + ++  V +
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVT 167

Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
            +Y  P+VL     Y  ++D+W  G I + +  G P F   T +     I R +     +
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227

Query: 281 PWPKVSENAK--------------------------DLVKKMLNPDPKQRLTAEEVLEHP 314
            WP +S N +                          +L+ K L  + K+R++AEE ++H 
Sbjct: 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287

Query: 315 WLQN 318
           + ++
Sbjct: 288 YFRS 291

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 83.6 bits (207), Expect = 9e-18
 Identities = 75/275 (27%), Positives = 109/275 (39%), Gaps = 39/275 (14%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR--REVQIMKHLPKHPNIV 120
           E+G G  G  Y       G   A K +     RT    E+ R   ++ ++      P IV
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMR----RTGNKEENKRILMDLDVVLKSHDCPYIV 77

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCH---- 174
                +  DS V I MEL       D+++ R  G   E       K  V +V+  H    
Sbjct: 78  KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILG---KMTVAIVKALHYLKE 132

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--- 231
           + GV+HRD+KP N L      S  +K  DFG+S      +      G   YMAPE +   
Sbjct: 133 KHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPP 189

Query: 232 --KRNYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
                Y    DVWS G+ L  L  G  P+   +TE  V   I+       ++  P +  N
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-------QEEPPSLPPN 242

Query: 289 A------KDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                     V   L  D ++R    E+L+HP+++
Sbjct: 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 70/291 (24%), Positives = 134/291 (46%), Gaps = 44/291 (15%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           +++G G +G      D   G K A K + +   ++ +  +   RE++++KH+ KH N++ 
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHM-KHENVIG 78

Query: 122 LKDTYEDDSAV------HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L D +  D ++      ++VM     G    +++     +E     ++  +++ ++  H 
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA 136

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-- 233
            G++HRDLKP N       E   LK +DFGL+   +   +    V + +Y APEV+    
Sbjct: 137 AGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVILNWM 191

Query: 234 NYGPEVDVWSAGVILYILLCGVP-----------------------PFWAETEQGVAQAI 270
           +Y   VD+WS G I+  +L G P                        F  + +   A+  
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251

Query: 271 IRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           ++ +  F++  +    P  +  A ++++KML  D + R+TA E L HP+ +
Sbjct: 252 VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 77/295 (26%), Positives = 131/295 (44%), Gaps = 45/295 (15%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
           Y+   E+G G +G  +   D+ NG +F    ++ K++R     E +     REV +++HL
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 114 P--KHPNIVSLKDT-----YEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMK 164
              +HPN+V L D       + ++ + +V E  +       D++   G  TE     +M 
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMF 117

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
            ++  +   H   V+HRDLKP+N L  +   S  +K  DFGL+  +        +V + +
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLW 174

Query: 225 YMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
           Y APEV L+ +Y   VD+WS G I   +    P F   ++      I+  +     + WP
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234

Query: 284 K-----------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
           +                       + E  KDL+ K L  +P +R++A   L HP+
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 28/208 (13%)

Query: 62  RELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG G FG   LC       N GE+ A KS+            D  RE++I++ L  H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTL-DHE 66

Query: 118 NIVSLKDTYEDD--SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
           NIV  K   E     ++ ++ME    G L  R   + H  +     ++       Q+C  
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLF---SSQICKG 121

Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSP-YY 225
                 Q  +HRDL   N L  ++     +K  DFGL+      + +    E   SP ++
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178

Query: 226 MAPEVLK-RNYGPEVDVWSAGVILYILL 252
            APE L+   +    DVWS GV LY L 
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 73/264 (27%), Positives = 122/264 (46%), Gaps = 16/264 (6%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH---PNIV 120
           +GRG FG  Y C   + G+ +A K + KK+++     E +    +IM  L      P IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
            +   +     +  +++L  GG+L   +   G ++E+        I+  ++  H + V++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN--YGPE 238
           RDLKP N L     E   ++  D GL+  F   ++ +  VG+  YMAPEVL++   Y   
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGTAYDSS 176

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
            D +S G +L+ LL G  PF     +     I R  +    +     S   K L++ +L 
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235

Query: 299 PDPKQRL-----TAEEVLEHPWLQ 317
            D  +RL      A+EV EH + +
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 83.5 bits (206), Expect = 3e-17
 Identities = 96/384 (25%), Positives = 160/384 (41%), Gaps = 80/384 (20%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LG  +G G FGV Y    ++  EK A K + +       D +   RE+ IMK+L  H 
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-------DPQYKNRELLIMKNL-NHI 119

Query: 118 NIVSLKDTY--------EDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTI- 166
           NI+ LKD Y        E +  +++VM      E   + V +   HY     A  +  + 
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVM------EFIPQTVHKYMKHYARNNHALPLFLVK 173

Query: 167 VEVVQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
           +   Q+C      H + + HRDLKP+N L      +  LK  DFG +     G++    +
Sbjct: 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRSVSYI 231

Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------ 272
            S +Y APE++    NY   +D+WS G I+  ++ G P F  ++       II+      
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291

Query: 273 ---------SVIDFK---------RDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
                    +  D K         +  +PK   ++A + + + L  +P +RL   E L  
Sbjct: 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351

Query: 314 PWLQNAKKAPNVSLGETV----------KARLKQFSVMNKLK---KRALQVVAEFLSVEE 360
           P+  + +  P + L + +           A +K+ S   + K   K   +   EFL  +E
Sbjct: 352 PFFDDLRD-PCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCTYEAYKEFLMSDE 410

Query: 361 VAGLKEAFEMMDT--NKRGKINLE 382
                +A  + D      G+ N++
Sbjct: 411 ----NDANIIADKISKDFGESNID 430

Length = 440

>gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional

 Score = 76.7 bits (189), Expect = 2e-16
 Identities = 38/143 (26%), Positives = 81/143 (56%), Gaps = 1/143 (0%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           L+ ++   ++EAF++ DT+  G I+ +EL++ +   G    + +++ ++   D DG G +
Sbjct: 11  LTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKI 70

Query: 416 NYGEFV-AVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+  ++  L +    E + KAF  FD +++G I ++ L+    +  +T  ++ +  
Sbjct: 71  DFEEFLDIMTKKLGERDPREEILKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQE 130

Query: 475 IMHDVDTDKDGRISYEEFAVMMK 497
           ++ + D + DG IS EEF  +MK
Sbjct: 131 MIDEADRNGDGEISEEEFYRIMK 153

Length = 158

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 82.2 bits (203), Expect = 2e-16
 Identities = 43/102 (42%), Positives = 63/102 (61%), Gaps = 12/102 (11%)

Query: 219 IVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF 277
           I+G+P Y+APE+L  + +GP VD W+ GV L+  L G+PPF  ET Q V Q I+      
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL------ 593

Query: 278 KRD-PWP----KVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
            RD PWP    K+S NA++ ++ +L  DP +R   +E+ +HP
Sbjct: 594 NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 65/264 (24%)

Query: 105 REVQIMKHLPKHPNIVSL------KDTYEDDSAVHIVME-----LCEGGELFDRIVARGH 153
           RE+ +MK L  H NI+ L      + + E+   V++VME     LC+       ++    
Sbjct: 64  RELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-------VIQMDL 115

Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
             ER +  + + +  +  + H  G++HRDLKP N +    K    LK +DFGL+      
Sbjct: 116 DHERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 171

Query: 214 EQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVIL---------------------YIL 251
                 V + YY APEV L   Y   VD+WS G I+                      I 
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231

Query: 252 LCGVPP--FWAETEQGVA---------QAIIRSVIDFKRDPWPKVSEN--------AKDL 292
             G P   F +  +  V                 + F    +P  SE+        A+DL
Sbjct: 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL-FPDVLFPPDSESHNKLKASQARDL 290

Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
           + KML  DP++R++ ++ L+HP++
Sbjct: 291 LSKMLVIDPEKRISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

 Score = 73.0 bits (180), Expect = 2e-16
 Identities = 23/63 (36%), Positives = 37/63 (58%)

Query: 435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAV 494
            L +AF  FD++  G I  +EL+ AL    +   E+ I+ ++ +VD D DG+I +EEF  
Sbjct: 1   ELREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREVDKDGDGKIDFEEFLE 60

Query: 495 MMK 497
           +M 
Sbjct: 61  LMA 63

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 81.7 bits (202), Expect = 4e-16
 Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 40/283 (14%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           YD+ R +G+G  G  YL  D     + A K I +      +  +   RE +I   L  HP
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHP 62

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFD--------RIVARGHYTERAAAAVMK---TI 166
            IV +     D   V+  M   EG  L            +++    + +  A +     I
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-------------PG 213
              ++  H +GV+HRDLKP+N L     E   L   D+G ++F +               
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL---DWGAAIFKKLEEEDLLDIDVDERN 179

Query: 214 EQFNE------IVGSPYYMAPEVLKRNYGPE-VDVWSAGVILYILLCGVPPFWAETEQGV 266
             ++       IVG+P YMAPE L      E  D+++ GVILY +L    P+  +  + +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239

Query: 267 AQAIIRSVIDFKRD--PWPKVSENAKDLVKKMLNPDPKQRLTA 307
           +    R VI    +  P+ ++      +  K L  DP +R ++
Sbjct: 240 S---YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS 279

Length = 932

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 15/192 (7%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           E+G G+FG+ +L   +    K A K+I +     A+  ED   E Q+M  L  HP +V L
Sbjct: 11  EIGSGQFGLVWLGYWLEK-RKVAIKTIREG----AMSEEDFIEEAQVMMKL-SHPKLVQL 64

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
                + S + +V E  E G L D + A RG +++     +   + E +       V+HR
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLK-RNYGP 237
           DL   N L     E+  +K  DFG++ F    +Q+    G+ +   + +PEV     Y  
Sbjct: 125 DLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 238 EVDVWSAGVILY 249
           + DVWS GV+++
Sbjct: 181 KSDVWSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 79/304 (25%), Positives = 131/304 (43%), Gaps = 53/304 (17%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y   + +G G  G+     D   G   A K +S+   +     +   RE+ ++K +  H 
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCV-NHK 80

Query: 118 NIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
           NI+SL      + + E+   V++VMEL +      +++      ER +  + + +  +  
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKH 138

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV- 230
           + H  G++HRDLKP N +    K    LK +DFGL+            V + YY APEV 
Sbjct: 139 L-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 231 LKRNYGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIR 272
           L   Y   VD+WS G I+  L+ G   F        W +  + +           Q  +R
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254

Query: 273 SVID-------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLE 312
           + ++             F    +P  SE        A+DL+ KML  DP +R++ +E L 
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314

Query: 313 HPWL 316
           HP++
Sbjct: 315 HPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 82/280 (29%), Positives = 117/280 (41%), Gaps = 42/280 (15%)

Query: 62  RELGRGEFG-VTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           R LG G FG V+  C D  N   GE  A K++  K+     +    ++E+ I+K L  H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEINILKTL-YHE 66

Query: 118 NIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
           NIV  K    +     + ++ME    G L D       Y  +    + + ++   Q+C  
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119

Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSP-YY 225
               H Q  +HRDL   N L  N +    +K  DFGL+     G ++    E   SP ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILL--CG---VPPFWAETEQGVAQAIIRSV--IDF 277
            A E LK N +    DVWS GV LY LL  C     PP   E   G  Q  +  V  I+ 
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236

Query: 278 ----KRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLE 312
                R P PK   +    L+K     + K R T   ++ 
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 76.7 bits (188), Expect = 4e-15
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 80

Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + + E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 137

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 138 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 235 YGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGVAQAIIR 272
           Y   VD+WS G I+                      I   G P P + +  Q   +  + 
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 273 SVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +   +    +PK+                +  A+DL+ KML  DP +R++ +E L+HP++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 58/199 (29%), Positives = 83/199 (41%), Gaps = 21/199 (10%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           +LG G FGV        +G K    A K +   KL   +D  D  +E  IM  L  H N+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSL-DHENL 58

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRI--VARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           + L         + +V EL   G L DR+   A GH+           I   ++    + 
Sbjct: 59  IRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----QFNEIVGSPY-YMAPEVL 231
            +HRDL   N L A+  +   +K  DFGL       E     + +  V  P+ + APE L
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172

Query: 232 K-RNYGPEVDVWSAGVILY 249
           + R +    DVW  GV L+
Sbjct: 173 RTRTFSHASDVWMFGVTLW 191

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 77/277 (27%), Positives = 114/277 (41%), Gaps = 54/277 (19%)

Query: 64  LGRGEFGVTYLCT-----DVNNGE-KFACKSISKKKLRTAVDIEDVR--REVQIMKHLPK 115
           LG G FG  Y  T        +G  + A K++ K     A D E     +E  +M +   
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNF-N 57

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           HPNIV L      +   +I+MEL EGG+L   +  R    ER    ++ T+ E++ +C +
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLL-TLKELLDICLD 114

Query: 176 --QGV--------MHRDLKPENFLFANKKESSP--LKAIDFGLSVFFRPGEQFNEIVGSP 223
             +G         +HRDL   N L + K   +   +K  DFGL+          +I  S 
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSD 165

Query: 224 YY------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
           YY            MAPE L    +  + DVWS GV+++ IL  G  P+ A   Q V Q 
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225

Query: 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT 306
           +       +        +    L+      DP +R T
Sbjct: 226 VTA---GGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 62/261 (23%), Positives = 110/261 (42%), Gaps = 23/261 (8%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-AVDIEDVRREVQIMKHLPKHPN 118
             +ELG G+FGV      V+ G+      ++ K +R  A+  +D   E ++M  L  HPN
Sbjct: 8   FLKELGSGQFGV------VHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPN 60

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM-KTIVEVVQVCHEQG 177
           +V L         + IV E    G L + +  R           M   + E ++     G
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN 234
            +HRDL   N L     E + +K  DFGL+ +    +Q+    G+ +   +  PEV   +
Sbjct: 121 FIHRDLAARNCLVG---EDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYS 176

Query: 235 -YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV-SENAKD 291
            +  + DVWS GV+++ +   G  P+   +   V +++        R   PK+       
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY----RLYRPKLAPTEVYT 232

Query: 292 LVKKMLNPDPKQRLTAEEVLE 312
           ++    +  P+ R   +++L 
Sbjct: 233 IMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 87

Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201

Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261

Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 76.1 bits (187), Expect = 1e-14
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 32/277 (11%)

Query: 58  YDLGRELGRGEFGVTYLCTD-VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH---- 112
           Y + R LG G  G T LC   V++GE FA K +  + + +  D    + EV  + +    
Sbjct: 34  YWISRVLGSGATG-TVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFF 91

Query: 113 --LPKHPNIV-SLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKT 165
             +  H +         E+   + +V++    G+L   I +R      + E  A  +   
Sbjct: 92  SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP------GEQFNEI 219
           ++  V   H + ++HRD+K  N L  +   +  +K  DFG S  +        G  F   
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTF--- 205

Query: 220 VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
            G+PYY+APE+ +R  Y  + D++S GV+LY LL    PF  E  + V    +      +
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG----R 261

Query: 279 RDPWP-KVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
            DP P  +S   +++V  +L+ DPK+R ++ ++L  P
Sbjct: 262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 80/302 (26%), Positives = 126/302 (41%), Gaps = 56/302 (18%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR----TAVDIEDVRREVQIMKHL 113
           Y+   +LG G +   Y      NG+  A K I  ++      TA+      RE  ++K L
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI------REASLLKGL 60

Query: 114 PKHPNIVSLKDTYEDDSAVHIVME-----LCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
            KH NIV L D       + +V E     LC+     D+    G          +  ++ 
Sbjct: 61  -KHANIVLLHDIIHTKETLTLVFEYVHTDLCQ---YMDK--HPGGLHPENVKLFLFQLLR 114

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMA 227
            +   H++ ++HRDLKP+N L ++  E   LK  DFGL+     P   ++  V + +Y  
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRP 171

Query: 228 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAI-------------- 270
           P+VL     Y   +D+W  G I   ++ GV  F    + Q   + I              
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231

Query: 271 IRSVIDFK------------RDPWPKVS--ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           + S+  FK            R  W K+S   +A+DL  K+L   PK RL+A+  L H + 
Sbjct: 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291

Query: 317 QN 318
            +
Sbjct: 292 SD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 73.6 bits (180), Expect = 3e-14
 Identities = 74/323 (22%), Positives = 137/323 (42%), Gaps = 78/323 (24%)

Query: 61  GRELGRGEFGVTYLCT--DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           G ++GRG +G  Y     D  +   +A K I    +  +       RE+ +++ L KHPN
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-----CREIALLREL-KHPN 59

Query: 119 IVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERA-----------AAAVMKT 165
           ++SL+  +    D  V ++ +  E  +L+   + + H   +A             +++  
Sbjct: 60  VISLQKVFLSHADRKVWLLFDYAEH-DLWH--IIKFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGLSVFF----RPGEQFNEIV 220
           I++ +   H   V+HRDLKP N L   +  E   +K  D G +  F    +P    + +V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------- 258
            + +Y APE+L   R+Y   +D+W+ G I   LL   P F                    
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236

Query: 259 ------------WAETEQGVAQAIIRSVIDFKRDPWP-----------KVSENAK--DLV 293
                       W + ++    + +    DF+R+ +            KV  ++K   L+
Sbjct: 237 IFNVMGFPADKDWEDIKKMPEHSTLMK--DFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294

Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
           +K+L  DP +R+T+E+ ++ P+ 
Sbjct: 295 QKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 74.5 bits (183), Expect = 4e-14
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 4/151 (2%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           ++ + + + RG FG  YL    NN + +A K + K  +     +  V+ E   +  L K 
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKS 63

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV L  + +  + V++VME   GG++   +   G++ E  A   +  +   +   H  
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS 207
           G++HRDLKP+N L +N+     +K  DFGLS
Sbjct: 124 GIIHRDLKPDNMLISNEGH---IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 72.6 bits (178), Expect = 4e-14
 Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 39/270 (14%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-----KHPN 118
           LG G  G  Y    +      A K I        +DI  V  + QIM  L        P 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVI-------PLDIT-VELQKQIMSELEILYKCDSPY 60

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           I+     +  ++ + I  E  +GG L  + +I    H   R A AV+K +  +  +    
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPE--HVLGRIAVAVVKGLTYLWSL---- 114

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPE-VL 231
            ++HRD+KP N L   + +   +K  DFG+S      +  N I    VG+  YMAPE + 
Sbjct: 115 KILHRDVKPSNMLVNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERIS 166

Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPF-WAETEQG--VAQAIIRSVIDFK--RDPWPKVS 286
              YG   DVWS G+    L  G  P+   +  QG  +   +++ ++D      P  + S
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           E     + + +   PK+R   E +++HP++
Sbjct: 227 EKFVHFITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 68/225 (30%), Positives = 97/225 (43%), Gaps = 34/225 (15%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           D  LGR +G G+FG  Y    ++   EK A    + K   +    E   +E  IM+    
Sbjct: 7   DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-D 65

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVEVVQVC 173
           HP+IV L     ++  V IVMEL   GEL         Y    + +  +   I+   Q+ 
Sbjct: 66  HPHIVKLIGVITENP-VWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQLS 117

Query: 174 ------HEQGVMHRDLKPENFLFANKKESSP--LKAIDFGLSVFFRPGEQFNEIVGS-PY 224
                   +  +HRD+   N L +     SP  +K  DFGLS +      +    G  P 
Sbjct: 118 TALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172

Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 266
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----QGV 212

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 67/329 (20%), Positives = 126/329 (38%), Gaps = 65/329 (19%)

Query: 55  SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMK 111
            +   +G+                N        ++ K  L +    ED++    E+   +
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNT-----LVAVKKINLDSCSK-EDLKLLQQEIITSR 54

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYT----ERAAAAVMKTIV 167
            L +HPNI+    ++  DS +++V  L   G   D +  + H+     E A A ++K ++
Sbjct: 55  QL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVL 111

Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV---FFRPGEQFNEIVGSP- 223
             +   H +G +HR +K  + L      S   K +  GL       + G++   +   P 
Sbjct: 112 NALDYIHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166

Query: 224 ------YYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF---------------- 258
                  +++PEVL++N   Y  + D++S G+    L  G  PF                
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226

Query: 259 ---------WAETEQGVAQAIIRSVIDFKRDPWP-----KVSENAKDLVKKMLNPDPKQR 304
                    +   E  ++Q+   +     RD          SE+    V+  L  DP+ R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286

Query: 305 LTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
            +A ++L H + +  K+  N SL + +K 
Sbjct: 287 PSASQLLNHSFFKQCKRR-NTSLLDLLKP 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 75/267 (28%), Positives = 115/267 (43%), Gaps = 42/267 (15%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-AVDIEDVRREVQIMKHLPKHPN 118
           L R+LG G+FG      +V  G       ++ K L+   +D +D   E QIMK L +HP 
Sbjct: 10  LLRKLGAGQFG------EVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPK 62

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK--TIVEV-VQVC-- 173
           ++ L      +  ++IV EL + G L +       Y +  A   +K   ++++  QV   
Sbjct: 63  LIQLYAVCTLEEPIYIVTELMKYGSLLE-------YLQGGAGRALKLPQLIDMAAQVASG 115

Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YM 226
                 Q  +HRDL   N L     E++  K  DFGL+   +    +    G+ +   + 
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDI-YEAREGAKFPIKWT 171

Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           APE    N +  + DVWS G++L  I+  G  P+   T   V Q + +      R P P 
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY----RMPCPP 227

Query: 285 VSENAKDLVKKML---NPDPKQRLTAE 308
                K+L   ML     DP  R T E
Sbjct: 228 GCP--KELYDIMLDCWKEDPDDRPTFE 252

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 75/323 (23%), Positives = 136/323 (42%), Gaps = 78/323 (24%)

Query: 61  GRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           G ++GRG +G  Y     D  + +++A K I    +  +       RE+ +++ L KHPN
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-----CREIALLREL-KHPN 59

Query: 119 IVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-----------T 165
           +++L+  +    D  V ++ +  E  +L+   + + H   +A    M+            
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAEH-DLWH--IIKFHRASKANKKPMQLPRSMVKSLLYQ 116

Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGLSVFF----RPGEQFNEIV 220
           I++ +   H   V+HRDLKP N L   +  E   +K  D G +  F    +P    + +V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------- 258
            + +Y APE+L   R+Y   +D+W+ G I   LL   P F                    
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236

Query: 259 ------------WAETEQGVAQAIIRSVIDFKRDPWP-----------KVSENAKD--LV 293
                       W +  +      ++   DF+R  +            KV  ++K   L+
Sbjct: 237 IFSVMGFPADKDWEDIRKMPEYPTLQK--DFRRTTYANSSLIKYMEKHKVKPDSKVFLLL 294

Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
           +K+L  DP +R+T+E+ L+ P+ 
Sbjct: 295 QKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 21/238 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 62

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L
Sbjct: 123 HKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 174

Query: 232 K-RNYGPEVDVWSAGVILYILLCG----VPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           +  +Y  + D+WS G+ L  +  G     PP   E E      +     + +  P P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 45/283 (15%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLPKHPN 118
            ELGRG +GV      V  G   A K     ++R  V+ ++ +R   ++ I       P 
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPY 61

Query: 119 IVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHE 175
            V+       +  V I ME+ +    + + ++  +G    E     +  +IV+ ++  H 
Sbjct: 62  TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 176 Q-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV-----GSPYYMAPE 229
           +  V+HRD+KP N L  N+     +K  DFG+S     G   + +      G   YMAPE
Sbjct: 122 KLSVIHRDVKPSNVL-INRN--GQVKLCDFGIS-----GYLVDSVAKTIDAGCKPYMAPE 173

Query: 230 VL-----KRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVIDFKRDPW 282
            +     ++ Y  + DVWS G+ +  L  G  P+  W    Q + Q +         +P 
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------EEPS 225

Query: 283 PKV-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320
           P++     S   +D V K L  + K+R    E+L+HP+ +   
Sbjct: 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 74/284 (26%), Positives = 116/284 (40%), Gaps = 61/284 (21%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +  LG  +G+GEFG   L      G+K A K +  K   TA        E  +M  L +H
Sbjct: 7   ELKLGATIGKGEFGDVMLGD--YRGQKVAVKCL--KDDSTAAQ--AFLAEASVMTTL-RH 59

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC--- 173
           PN+V L       + ++IV E    G L D + +RG    RA   + + +   + VC   
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQLGFALDVCEGM 115

Query: 174 ---HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-YMAPE 229
               E+  +HRDL   N L +   E    K  DFGL+   +   Q  +    P  + APE
Sbjct: 116 EYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPE 169

Query: 230 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
            L+   +  + DVWS G++L+                        +  F R P+P++   
Sbjct: 170 ALREKKFSTKSDVWSFGILLW-----------------------EIYSFGRVPYPRIP-- 204

Query: 289 AKDLVK------KMLNPD--PKQRLTAEEVLEHPWLQNAKKAPN 324
            KD+V       +M  P+  P +     +V++  W  +  K P 
Sbjct: 205 LKDVVPHVEKGYRMEAPEGCPPE---VYKVMKDCWELDPAKRPT 245

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 31/204 (15%)

Query: 62  RELGRGEFGVT---YLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           +ELG G FG               + A K++ ++ +      ++  RE  +M  L  HP 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQL-DHPC 57

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           IV L    + +  + +VMEL   G L   +  R          +   +   +     +  
Sbjct: 58  IVRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK---RNY 235
           +HRDL   N L  N+ ++   K  DFG+S             GS YY A    +   + Y
Sbjct: 117 VHRDLAARNVLLVNRHQA---KISDFGMSRALGA--------GSDYYRATTAGRWPLKWY 165

Query: 236 GPEV----------DVWSAGVILY 249
            PE           DVWS GV L+
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLW 189

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 32/210 (15%)

Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           R+LG G FG   LC       N GE+ A KS+  K       I D+++E++I+++L  H 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNL-YHE 66

Query: 118 NIVSLKDTYEDD--SAVHIVMELCEGGELFDRIVARGHYTERAAAAV-MKTIVE-VVQVC 173
           NIV  K    +D  + + ++ME    G L +       Y  R    + +K  ++  VQ+C
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQQLKYAVQIC 119

Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI---VGSP- 223
                   +  +HRDL   N L  ++ +   +K  DFGL+      +++  +   + SP 
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEYYTVKDDLDSPV 176

Query: 224 YYMAPEVL-KRNYGPEVDVWSAGVILYILL 252
           ++ APE L +  +    DVWS GV LY LL
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 62/244 (25%), Positives = 102/244 (41%), Gaps = 47/244 (19%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI---EDVRREVQIMKHLPKHPNI 119
           ELG G FG  Y        E+ +  S++ K L+   +    ++ R+E ++M  L +HPNI
Sbjct: 12  ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNI 70

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT-------------- 165
           V L      +    ++ E    G+L + +V    +++  A +  +T              
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 166 --IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
             I   ++       +HRDL   N L         +K  DFGLS          +I  + 
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDFGLS---------RDIYSAD 178

Query: 224 YY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
           YY            M PE +L   +  E D+WS GV+L+ I   G+ P++  + Q V + 
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE- 237

Query: 270 IIRS 273
           +IRS
Sbjct: 238 MIRS 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 48/242 (19%)

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCH 174
           HP+++ +KDT    +   +V+      +L+  +  R        A  + K I+E ++  H
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
            Q ++HRD+K EN +F N  +   +   D G + F      F  + G+    APEVL R+
Sbjct: 175 AQRIIHRDVKTEN-IFINDVDQVCIG--DLGAAQFPVVAPAFLGLAGTVETNAPEVLARD 231

Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-------VI--------DFK 278
            Y  + D+WSAG++L+ +L   P    E      +  ++S       +I        +F 
Sbjct: 232 KYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290

Query: 279 RDP---------------------WPKVS-----ENAKDLVKKMLNPDPKQRLTAEEVLE 312
           RDP                     +P         + + LV KML  D   R +AEE+L 
Sbjct: 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350

Query: 313 HP 314
           +P
Sbjct: 351 YP 352

Length = 357

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 18/218 (8%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-AVDIEDVRREVQIMKHLPKHPNIV 120
           +ELG G+FGV +L      G+  A   ++ K +   A+  ED   E ++M  L  HP +V
Sbjct: 10  KELGSGQFGVVHL------GKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLV 62

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVM 179
            L         ++IV E  E G L + +  R G  ++    ++ + + E ++       +
Sbjct: 63  QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN-Y 235
           HRDL   N L +    +  +K  DFG++ +    +++    G+ +   +  PEV   + Y
Sbjct: 123 HRDLAARNCLVS---STGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKY 178

Query: 236 GPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
             + DVWS GV+++ +   G  PF  ++   V + I R
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 27/228 (11%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           ++ L R+LG G FG  +     N   + A K +    L      +D ++EVQ +K L +H
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQ---QDFQKEVQALKRL-RH 61

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT---------IV 167
            +++SL         V+I+ EL E G L         +       V+           + 
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVASLIDMACQVA 114

Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-YM 226
           E +    EQ  +HRDL   N L     E    K  DFGL+   +     +     PY + 
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT 171

Query: 227 APEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
           APE      +  + DVWS G++LY +   G  P+       V   I  
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

 Score = 59.5 bits (145), Expect = 1e-11
 Identities = 19/59 (32%), Positives = 35/59 (59%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVA 422
           L+EAF + D +  G I+ +EL+  L   G+ + E ++  ++   D DGDG +++ EF+ 
Sbjct: 2   LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREVDKDGDGKIDFEEFLE 60

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 67/237 (28%), Positives = 98/237 (41%), Gaps = 39/237 (16%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQI 109
            ++I+    + +G GEFG          G+K     ++ K L+   +     D   E  I
Sbjct: 5   YVTIE----KVIGGGEFGEVCRGRLKLPGKK--EIDVAIKTLKAGSSDKQRLDFLTEASI 58

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTE-------RAAA 160
           M     HPNI+ L+        V I+ E  E G L  F R    G +T        R  A
Sbjct: 59  MGQF-DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIA 116

Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL--KAIDFGLSVFFRPGEQFNE 218
           + MK + E+  V       HRDL   N L      +S L  K  DFGLS      E    
Sbjct: 117 SGMKYLSEMNYV-------HRDLAARNILV-----NSNLVCKVSDFGLSRRLEDSEATYT 164

Query: 219 IVG--SPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
             G   P  + APE +  R +    DVWS G++++ ++  G  P+W  + Q V +A+
Sbjct: 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV        +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 62

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +       E     V   ++  +    E+
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L
Sbjct: 123 HQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 174

Query: 232 K-RNYGPEVDVWSAGVILYILLCG---VPP 257
           +  +Y  + D+WS G+ L  L  G   +PP
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair

 Score = 58.5 bits (142), Expect = 3e-11
 Identities = 23/58 (39%), Positives = 34/58 (58%), Gaps = 4/58 (6%)

Query: 443 FDRNRSGFIEIEELRNALN----DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            D++  G+I++EELR  L        D   E++I A  +++D D DGRIS+EEF   M
Sbjct: 3   LDKDGDGYIDVEELRKLLKALGLKLTDEEVEELIEADFNEIDKDGDGRISFEEFLEAM 60

Length = 60

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 67/250 (26%), Positives = 106/250 (42%), Gaps = 49/250 (19%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           LG  +G GEFG       V  GE +  + ++ K ++  V  +    E  +M  L  H N+
Sbjct: 10  LGEIIGEGEFG------AVLQGE-YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNL 61

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH----- 174
           V L      +  ++IVMEL   G L + +  RG    RA  +V++ +   + V       
Sbjct: 62  VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYL 116

Query: 175 -EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
             + ++HRDL   N L +   E    K  DFGL+     G   +++     + APE LK 
Sbjct: 117 ESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKL--PVKWTAPEALKH 171

Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN-AKD 291
             +  + DVWS GV+L+                        V  + R P+PK+S    K+
Sbjct: 172 KKFSSKSDVWSYGVLLW-----------------------EVFSYGRAPYPKMSLKEVKE 208

Query: 292 LVKKMLNPDP 301
            V+K    +P
Sbjct: 209 CVEKGYRMEP 218

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 67/278 (24%), Positives = 101/278 (36%), Gaps = 37/278 (13%)

Query: 60  LGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           L R LG G FG  Y         +  +      +  +  +  D  D   E  IM     H
Sbjct: 10  LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NH 68

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV----EVVQV 172
            NIV L     +     I++EL  GG+L   +       ER ++  MK ++    +V + 
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 173 CH---EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY---- 225
           C    E   +HRD+   N L   K      K  DFG++          +I  + YY    
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYRKGG 179

Query: 226 --------MAPEV-LKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVI 275
                   M PE  L   +  + DVWS GV+L+ I   G  P+   T Q V + +     
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG- 238

Query: 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
             + DP          ++       P+ R     +LE 
Sbjct: 239 --RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 73/299 (24%), Positives = 121/299 (40%), Gaps = 67/299 (22%)

Query: 67  GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126
           G  G  + C D    E    K+  +    T         E  I++ +  HP+I+ LK T+
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQRGGTAT---------EAHILRAI-NHPSIIQLKGTF 152

Query: 127 EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPE 186
             +    +++   +  +L+  + A+ +       A+ ++++  +Q  HE  ++HRD+K E
Sbjct: 153 TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAE 211

Query: 187 NFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--------MAPEVLKRN-YGP 237
           N +F N      L   DFG + F  P     +I  + YY         APE+L R+ YGP
Sbjct: 212 N-IFINHPGDVCLG--DFGAACF--P----VDINANKYYGWAGTIATNAPELLARDPYGP 262

Query: 238 EVDVWSAGVILY----------------------------ILLCGVPP--FWAETEQGVA 267
            VD+WSAG++L+                            I   G  P  F  + +  + 
Sbjct: 263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322

Query: 268 QAIIRSVIDFKRDP-----WPKVSENAKD---LVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           +  I       R P     W  + E   D   L+ KML  D   R +AE +L+    Q+
Sbjct: 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381

Length = 391

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 67/215 (31%), Positives = 93/215 (43%), Gaps = 49/215 (22%)

Query: 64  LGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           LG+G FG   LC       N GE  A K   K +  TA  + D  RE++I+K L +H NI
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSL-QHDNI 67

Query: 120 VSLKDT-YEDDSA----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           V  K   Y   SA    + +VME    G L D +       +       K ++   Q+C 
Sbjct: 68  VKYKGVCY---SAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-----KLLLYASQICK 119

Query: 175 ------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS----------VFFRPGEQFNE 218
                  +  +HRDL   N L  ++   + +K  DFGL+              PGE    
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVREPGE---- 172

Query: 219 IVGSP-YYMAPEVLKRN-YGPEVDVWSAGVILYIL 251
              SP ++ APE L  + +    DVWS GV+LY L
Sbjct: 173 ---SPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 8e-11
 Identities = 73/312 (23%), Positives = 137/312 (43%), Gaps = 58/312 (18%)

Query: 54  ISIDYDLGRELGRGEFGVTYLCT--DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
           + + Y++   L  G  G  ++CT       +K   K+++  K           RE+ I+K
Sbjct: 90  VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILK 141

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            +  H  I++L   Y   S V +VM   +  +LF  +   G      A  + + ++E + 
Sbjct: 142 TI-SHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALA 199

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-----IVGSPYYM 226
             H +G++HRD+K EN +F ++ E++ L   DFG +   +     +        G+    
Sbjct: 200 YLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAAC--KLDAHPDTPQCYGWSGTLETN 254

Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ--AIIRSV----IDF- 277
           +PE+L  + Y  + D+WSAG++L+ + +  V  F  + +   +Q  +IIR +    ++F 
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314

Query: 278 -----------------KRDPW--PKV------SENAKDLVKKMLNPDPKQRLTAEEVLE 312
                             R P+  P V        + + L+ KML  D + R +A+++L 
Sbjct: 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374

Query: 313 HPWLQNAKKAPN 324
            P     K+  N
Sbjct: 375 LPLF--TKEPIN 384

Length = 392

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 58/213 (27%), Positives = 85/213 (39%), Gaps = 33/213 (15%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
            ++G+G FG  Y    +    + A K+   +            +E +I+K    HPNIV 
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQY-DHPNIVK 56

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC------HE 175
           L         ++IVMEL  GG L   +       ++    V K +   +           
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFL-----RKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY------YMAPE 229
           +  +HRDL   N L     E++ LK  DFG+S   R  E     V          + APE
Sbjct: 112 KNCIHRDLAARNCLVG---ENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPE 165

Query: 230 VLKRNYG---PEVDVWSAGVILY-ILLCGVPPF 258
            L  NYG    E DVWS G++L+     G  P+
Sbjct: 166 AL--NYGRYTSESDVWSYGILLWETFSLGDTPY 196

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 68/286 (23%), Positives = 118/286 (41%), Gaps = 51/286 (17%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-TAVDI--EDVRREVQIMKHLPKH 116
           L RELG G FG  +L    +   +   + ++ K L+ TA +   +D  RE +++ +  +H
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QH 67

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK------TIVEVV 170
            NIV       +     +V E  E G+L      R H  + A            T+ +++
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNK--FLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 171 QVCHE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
           Q+  +          Q  +HRDL   N L         +K  DFG+S          ++ 
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---------RDVY 173

Query: 221 GSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 266
            + YY            M PE ++ R +  E DVWS GV+L+ I   G  P++  + + V
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233

Query: 267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
            + I +  +  +    P       D++      DP+QR+  +++ E
Sbjct: 234 IECITQGRLLQRPRTCPS---EVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +     +E+  +E  +MK + KH
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEI-KH 61

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV-MKT-IVEVVQVCH 174
           PN+V L      +   +I+ E    G L D +         A   + M T I   ++   
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 122 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 177

Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 77/266 (28%), Positives = 114/266 (42%), Gaps = 29/266 (10%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L R+LG G+FG  ++ T  N   K A K++        +  E   +E QIMK L +H  +
Sbjct: 10  LERKLGAGQFGEVWMGT-WNGTTKVAVKTLKP----GTMSPEAFLQEAQIMKKL-RHDKL 63

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT-IVEVVQVCHEQG 177
           V L     ++  ++IV E    G L D +    G          M   I E +     + 
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN 234
            +HRDL   N L     E+   K  DFGL+      E +    G+ +   + APE    N
Sbjct: 124 YIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA--N 177

Query: 235 YGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
           YG    + DVWS G++L  I+  G  P+   T + V + + R      R P P    E  
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY----RMPRPPNCPEEL 233

Query: 290 KDLVKKMLNPDPKQRLTAE---EVLE 312
            DL+ +  + DP++R T E     LE
Sbjct: 234 YDLMLQCWDKDPEERPTFEYLQSFLE 259

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 70/278 (25%), Positives = 114/278 (41%), Gaps = 33/278 (11%)

Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLPK 115
           DLG E+GRG FG         +G   A K I     R+ VD ++ +R   ++ ++     
Sbjct: 8   DLG-EIGRGAFGTVNKMLHKPSGTIMAVKRI-----RSTVDEKEQKRLLMDLDVVMRSSD 61

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGG-ELFDRIV---ARGHYTERAAAAVMKTIVEVVQ 171
            P IV        +    I MEL +   + F + V    +    E     +    V+ + 
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121

Query: 172 VCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-----VGSPYY 225
              E+  ++HRD+KP N L      +  +K  DFG+S     G+  + I      G   Y
Sbjct: 122 YLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPY 173

Query: 226 MAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVIDFKR 279
           MAPE +  +    Y    DVWS G+ LY +  G  P+  W      + Q +         
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233

Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
               + S +  + +   L  D  +R   +E+LEHP+++
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVM 163
           +E +I+K    HPNIV L         ++IVMEL +GG+    +   G     +    ++
Sbjct: 42  QEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMV 100

Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
           +     ++    +  +HRDL   N L     E + LK  DFG+S      E+ + +  S 
Sbjct: 101 ENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMS-----REEEDGVYAST 152

Query: 224 --------YYMAPEVLKRNYG---PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 271
                    + APE L  NYG    E DVWS G++L+     G  P+   + Q   +AI 
Sbjct: 153 GGMKQIPVKWTAPEAL--NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE 210

Query: 272 RSVIDFKRDPWPKVSENAKDLVKKMLNP----DPKQR 304
           + V    R P P   E   D V +++      DP QR
Sbjct: 211 QGV----RLPCP---ELCPDAVYRLMERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 36/229 (15%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI----------EDVRREVQIMK 111
           + +G GEFG      +V +G     K   K+++  A+             D   E  IM 
Sbjct: 10  KVIGAGEFG------EVCSGR---LKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEV 169
               HPNI+ L+        V IV E  E G L D  + +  G +T      +++ I   
Sbjct: 61  QF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASG 118

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPL--KAIDFGLSVFFR--PGEQFNEIVGS-PY 224
           ++   + G +HRDL   N L      +S L  K  DFGLS      P   +    G  P 
Sbjct: 119 MKYLSDMGYVHRDLAARNILV-----NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173

Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
            + APE +  R +    DVWS G++++ ++  G  P+W  + Q V +AI
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 36/271 (13%)

Query: 58  YDLGRELGRGEFGV---TYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           + LGR LG+GEFG      L ++  + +K A K + K  + ++ DIE+  RE   MK   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF- 58

Query: 115 KHPNI-----VSLKDTYEDDSAVHIV-MELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
            HPN+     VSL+   +    + +V +   + G+L   ++      E      ++T+V 
Sbjct: 59  DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM-SRIGEEPFTLPLQTLVR 117

Query: 169 -VVQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
            ++ +         +  +HRDL   N +     E+  +   DFGLS     G+ + +   
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 222 SPY---YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVI- 275
           S     ++A E L  N Y    DVW+ GV ++ I+  G  P+      GV  + I + + 
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLI 229

Query: 276 --DFKRDPWPKVSENAKDLVKKMLNPDPKQR 304
             +  + P P   E+  +L+ +  +P+PK R
Sbjct: 230 KGNRLKQP-PDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)

Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   +   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 79

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG------HYTERAAAAVMKTI 166
           + KH NI++L      D  +++++E    G L + + AR        Y          + 
Sbjct: 80  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 167 VEVVQVCHE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
            ++V   ++          +  +HRDL   N L     E + +K  DFGL+      + +
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 196

Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 29/225 (12%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACK--SISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +   +   +    K  +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 16  LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E + +K  DFGL+      + + +
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHNIDYYKK 192

Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 26/223 (11%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR----EVQIMKHLPKHPNI 119
           +G GEFG          G++    +I  K L++    E  RR    E  IM     HPNI
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAI--KTLKSGYT-EKQRRDFLSEASIMGQF-DHPNI 67

Query: 120 VSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           + L+        V I+ E  E G L  F R    G +T      +++ I   ++   E  
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 178 VMHRDLKPENFLFANKKESSPL--KAIDFGLSVFFRPGEQ---FNEIVGSPY---YMAPE 229
            +HRDL   N L      +S L  K  DFGLS F         +   +G      + APE
Sbjct: 127 YVHRDLAARNILV-----NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 230 VLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
            +  R +    DVWS G++++ ++  G  P+W  + Q V  AI
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 29/225 (12%)

Query: 60  LGRELGRGEFG--VTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG  V      ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 19  LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYKK 195

Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 65/232 (28%), Positives = 94/232 (40%), Gaps = 45/232 (19%)

Query: 60  LGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           LG+ LG G FG       V   N  E         K   T  D+ D+  E+++MK + KH
Sbjct: 16  LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR---GHYTERAAAAVMK---TIVEVV 170
            NI++L      +  +++V+E    G L D + AR   G Y         +   T  ++V
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 171 QVCHE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
              ++          +  +HRDL   N L     E   +K  DFGL+          +I 
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA---------RDIH 183

Query: 221 GSPYY------------MAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
              YY            MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 72/261 (27%), Positives = 112/261 (42%), Gaps = 47/261 (18%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG  +  T + +    A K+  K+ L   + I+ +  E +I+K    HPNIV L 
Sbjct: 3   LGKGNFGEVFKGT-LKDKTPVAVKT-CKEDLPQELKIKFLS-EARILKQY-DHPNIVKLI 58

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV---VQVCHEQGVMH 180
                   ++IVMEL  GG+    +  R    E     ++K  ++    +     +  +H
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS------VFFRPGEQFNEIVGSPYYMAPEVLKRN 234
           RDL   N L     E++ LK  DFG+S      ++   G +   I     + APE L  N
Sbjct: 117 RDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPI----KWTAPEAL--N 167

Query: 235 YG---PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-------------------II 271
           YG    E DVWS G++L+     GV P+   T Q   +                    ++
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227

Query: 272 RSVIDFKRDPWPKVSENAKDL 292
           +   D+K +  PK SE  K+L
Sbjct: 228 QRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 48/224 (21%)

Query: 62  RELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKHP 117
           R +G+G FG  Y  T + ++G+K  C   + K L    D+E+V    +E  IMK    HP
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHC---AVKSLNRITDLEEVEQFLKEGIIMKDF-SHP 56

Query: 118 NIVSLKD-TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-- 174
           N++SL       + +  +V+   + G+L + I      +E     V   I   +QV    
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGM 111

Query: 175 ----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY----- 225
                +  +HRDL   N +     ES  +K  DFGL+          +I    YY     
Sbjct: 112 EYLASKKFVHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNH 159

Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPF 258
                    MA E L+ + +  + DVWS GV+L+ L+  G PP+
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 81/305 (26%), Positives = 113/305 (37%), Gaps = 63/305 (20%)

Query: 60  LGRELGRGEFGVTYLCTDVN-----------NGEKFACKSISKKKLRTAVDI---EDVRR 105
              +LG G+FG  +LC               N    A   ++ K LR        ED  +
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68

Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV--- 162
           EV+I+  L   PNI  L      D  + ++ME  E G+L   +      T   A      
Sbjct: 69  EVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 163 -------MKT-IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214
                  M T I   ++       +HRDL   N L      +  +K  DFG+S       
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADFGMS------- 177

Query: 215 QFNEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-IL-LCGVPPFW 259
               +  S YY            MA E VL   +  + DVW+ GV L+ IL LC   P+ 
Sbjct: 178 --RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235

Query: 260 AETEQGVAQAIIRSVIDFKRD---PWPKVSENAKDLVKKMLN---PDPKQRLTAEEVLEH 313
             T+Q V +       D  R    P P      KD+ + ML     D + R T  E+  H
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNC--PKDIYELMLECWRRDEEDRPTFREI--H 291

Query: 314 PWLQN 318
            +LQ 
Sbjct: 292 LFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 27/269 (10%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +  L + +G+GEFG      DV  G+ +    ++ K ++     +    E  +M  L +H
Sbjct: 7   ELKLLQTIGKGEFG------DVMLGD-YRGNKVAVKCIKNDATAQAFLAEASVMTQL-RH 58

Query: 117 PNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK---TIVEVVQV 172
            N+V L     E+   ++IV E    G L D + +RG  +      ++K    + E ++ 
Sbjct: 59  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEY 117

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-YMAPEVL 231
                 +HRDL   N L +   E +  K  DFGL+   +      +    P  + APE L
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEAL 171

Query: 232 K-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           + + +  + DVWS G++L+ I   G  P+       +   + R    +K D         
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY---PRIPLKDVVPRVEKGYKMDAPDGCPPVV 228

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
            D++K+  + D   R +  ++ E   L++
Sbjct: 229 YDVMKQCWHLDAATRPSFLQLRE--QLEH 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 65/255 (25%), Positives = 107/255 (41%), Gaps = 42/255 (16%)

Query: 74  LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVSLKDTYEDDSAV 132
           L  D    + F  K      LR + +    R  +     +P   PN+V L      + +V
Sbjct: 11  LVMDTRTQQTFILKG-----LRKSSEYSRERLTI-----IPHCVPNMVCLHKYIVSEDSV 60

Query: 133 HIVMELCEGGELFDRIVARGHYTE---RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL 189
            +V++  EGG+L+  I    +  E   +  AA M   ++ +   H +G++ RDL P N L
Sbjct: 61  FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNIL 117

Query: 190 FANKKESSPLKAIDFGLSVFFRPGEQFNEIVG---SPYYMAPEVLKRNYGPEV-DVWSAG 245
             ++            L+ F R  E  +   G      Y APEV   +   E  D WS G
Sbjct: 118 LDDRGH--------IQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLG 169

Query: 246 VILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL 305
            IL+ LL G          G+      ++ ++       VSE A+ L++++L  +P +RL
Sbjct: 170 AILFELLTGKTLVECHP-SGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPTERL 221

Query: 306 TA-----EEVLEHPW 315
            A     E++  HP+
Sbjct: 222 GAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 35/291 (12%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD--IEDVRREVQIMKHLPKHP 117
           L RELG G FG  +L    N   +     ++ K L+ A D   +D  RE +++ +L +H 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHE 67

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-------------HYTERAAAAVMK 164
           +IV       +   + +V E  + G+L   + A G               T+     + +
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV------FFRPGEQFNE 218
            I   +     Q  +HRDL   N L     E+  +K  DFG+S       ++R G     
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYSTDYYRVG---GH 181

Query: 219 IVGSPYYMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVID 276
            +    +M PE ++ R +  E DVWS GV+L+ I   G  P++  +   V + I +  + 
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241

Query: 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
            +    P   +   DL+      +P  RL  +E+  H  LQN  KA  V L
Sbjct: 242 QRPRTCP---KEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKASPVYL 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 35/220 (15%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI---EDVRREVQIMKHLPKH 116
            G+ LG G FG     T     +  A   ++ K L+        E +  E++IM HL  H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT---------IV 167
            NIV+L         + ++ E C  G+L +       +  R   + +           + 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLN-------FLRRKRESFLTLEDLLSFSYQVA 151

Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL-------SVFFRPGEQFNEIV 220
           + +     +  +HRDL   N L  + K    +K  DFGL       S +   G     + 
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSNYVVKGNARLPV- 207

Query: 221 GSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
               +MAPE +    Y  E DVWS G++L+ I   G  P+
Sbjct: 208 ---KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 57/287 (19%)

Query: 60  LGRELGRGEFGVTY--LCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           L RELG+G FG+ Y  L   V  GE     A K++++    +  +  +   E  +MK   
Sbjct: 10  LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF- 66

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC- 173
              ++V L           +VMEL   G+L   + +R    E        T+ + +Q+  
Sbjct: 67  NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 174 ---------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
                      +  +HRDL   N + A   E   +K  DFG++          +I  + Y
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT---------RDIYETDY 174

Query: 225 Y------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA-QA 269
           Y            MAPE LK   +  + DVWS GV+L+ +      P+     QG++ + 
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-----QGLSNEE 229

Query: 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNP----DPKQRLTAEEVLE 312
           +++ VID      P   EN  D + +++      +PK R T  E++ 
Sbjct: 230 VLKFVIDGGHLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---F 216
            AV + ++  +   H +G++HRD+K EN +  N  E   L   DFG + F R        
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFH 319

Query: 217 NEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY 249
             I G+    APEVL  + Y P VD+WSAG++++
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 62/269 (23%), Positives = 110/269 (40%), Gaps = 32/269 (11%)

Query: 64  LGRGEFGVTYLC----TDVNNGEKF-ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           LGRGEFG  +L      +   GE     K++ K K        + RRE+ + + L  H N
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKL-SHKN 69

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAAAAVMKTIVEVV-QVCH- 174
           +V L     +    ++++E  + G+L  F R         +      K  V +  Q+   
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 175 -----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPYYMA 227
                    +HRDL   N L ++++E   +K     LS  V+     +    +    ++A
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186

Query: 228 PE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
           PE V + ++  + DVWS GV+++ +   G  PF+  +++ V        +   +   P  
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----LQAGKLELPVP 241

Query: 286 SENAKDLVKKMLN---PDPKQRLTAEEVL 311
                 L K M      +PK R +  E++
Sbjct: 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 48/286 (16%)

Query: 57  DYDLGRELGRGEFGVTYL--CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           D  L RELG G FG  +L  C +++  +     ++   K  T    +D +RE +++ +L 
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL- 64

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGEL--FDR--------------IVARGHYTERA 158
           +H +IV       D   + +V E  + G+L  F R                A+G      
Sbjct: 65  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
              +   I   +     Q  +HRDL   N L      +  +K  DFG+S          +
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RD 172

Query: 219 IVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
           +  + YY            M PE ++ R +  E DVWS GVIL+ I   G  P++  +  
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232

Query: 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV 310
            V + I +  +  +    PK      D++      +P+QRL  +E+
Sbjct: 233 EVIECITQGRVLERPRVCPK---EVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 57/293 (19%)

Query: 62  RELGRGEFGVTY--LCTDVNNGE---KFACKSISKK-KLRTAVDIEDVRREVQIMKHLPK 115
           RELG+G FG+ Y     D+  GE   + A K++++   LR  ++  +   E  +MK    
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTC 68

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H ++V L           +VMEL   G+L   + +     E        T+ E++Q+  E
Sbjct: 69  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 176 ----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
                     +  +HRDL   N + A       +K  DFG++          +I  + YY
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT---------RDIYETDYY 175

Query: 226 ------------MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAII 271
                       MAPE LK   +    D+WS GV+L+     +     +  QG++ + ++
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW----EITSLAEQPYQGLSNEQVL 231

Query: 272 RSVIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLE------HPWLQ 317
           + V+D      P    E   DL++     +PK R T  E++       HP   
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair

 Score = 49.4 bits (119), Expect = 3e-08
 Identities = 18/53 (33%), Positives = 29/53 (54%)

Query: 375 KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL 427
           ++G I  EEL+  L   G ++ E ++ IL    D DGDG +++ EF  +   L
Sbjct: 1   EKGLITREELKRALALLGISLSEEEVDILFREFDTDGDGKISFEEFCVLLQRL 53

Length = 53

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 21/220 (9%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           ++LG G+FG  ++    NN  K A K++    +     +E    E  +MK L +H  +V 
Sbjct: 12  KKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTL-QHDKLVR 65

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVM 179
           L      +  ++I+ E    G L D + +   G             I E +     +  +
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRNYG 236
           HRDL+  N L +   ES   K  DFGL+      E +    G+ +   + APE +  N+G
Sbjct: 126 HRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFG 179

Query: 237 P---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
               + DVWS G++LY I+  G  P+   +   V  A+ R
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 29/225 (12%)

Query: 60  LGRELGRGEFG--VTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG  V      ++        +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 16  LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERA 158
           KH NI++L      +  +++++E    G L + + AR                   + + 
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    +  +HRDL   N L     E + +K  DFGL+      + + +
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYYKK 192

Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS G++++ I   G  P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 53/241 (21%), Positives = 96/241 (39%), Gaps = 46/241 (19%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI---EDVRREVQIMKHLPKHPNI 119
           ELG   FG  Y             ++++ K L+   +    E+ + E  +   L +HPNI
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNI 70

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAA---AVMKTIVEVVQVCH-- 174
           V L      +  + ++   C   +L + +V R  +++  +      +K+ +E     H  
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 175 -----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
                         V+H+DL   N L  +K     +K  D GL         F E+  + 
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL---------FREVYAAD 178

Query: 224 YY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
           YY            M+PE ++   +  + D+WS GV+L+ +   G+ P+   + Q V + 
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238

Query: 270 I 270
           I
Sbjct: 239 I 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 17/194 (8%)

Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-VRREVQIMKHLPKHPNIV 120
           +ELG G+FGV      V  G+      ++ K ++     ED    E ++M  L  H  +V
Sbjct: 10  KELGTGQFGV------VKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLV 62

Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM-KTIVEVVQVCHEQGVM 179
            L         ++IV E    G L + +   G   + +    M K + E +     +  +
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKR-NY 235
           HRDL   N L     +   +K  DFGLS +    +++   VGS +   +  PEVL    +
Sbjct: 123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKF 178

Query: 236 GPEVDVWSAGVILY 249
             + DVW+ GV+++
Sbjct: 179 SSKSDVWAFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 20/219 (9%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISK-KKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +G GEFG  +       G K    +I   K   T    +D   E  IM     H NI+ L
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRL 71

Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           +          I+ E  E G L D+ +    G ++      +++ I   ++   +   +H
Sbjct: 72  EGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-------YMAPEVLK- 232
           RDL   N L  +  E    K  DFGLS   R  E   E   +         + APE +  
Sbjct: 131 RDLAARNILVNSNLEC---KVSDFGLS---RVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 233 RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
           R +    DVWS G++++ ++  G  P+W  +   V +AI
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 11/193 (5%)

Query: 63  ELGRGEFG-VTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           ELG G FG V      +   EK     I K         +++ RE  +M+ L  +P IV 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVR 60

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           +    E +S + +VMEL E G L   +    H TE+    ++  +   ++   E   +HR
Sbjct: 61  MIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS---PY-YMAPEVLK-RNYG 236
           DL   N L   +  +   K  DFGLS      E + +       P  + APE +    + 
Sbjct: 120 DLAARNVLLVTQHYA---KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 237 PEVDVWSAGVILY 249
            + DVWS GV+++
Sbjct: 177 SKSDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 72/259 (27%), Positives = 111/259 (42%), Gaps = 27/259 (10%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L ++LG G+FG  ++    N   K A KS+ +  +      E    E  +MK L +HP +
Sbjct: 10  LVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQL-QHPRL 63

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT-IVEVVQVCHEQG 177
           V L      +  ++I+ E  E G L D +    G          M   I E +     + 
Sbjct: 64  VRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN 234
            +HRDL+  N L +   E+   K  DFGL+      E +    G+ +   + APE +  N
Sbjct: 123 YIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--N 176

Query: 235 YGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
           YG    + DVWS G++L  I+  G  P+   T   V Q + R      R P P    E  
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY----RMPRPDNCPEEL 232

Query: 290 KDLVKKMLNPDPKQRLTAE 308
            +L++      P++R T E
Sbjct: 233 YELMRLCWKEKPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 30/216 (13%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G FG         +G K        K+  +  D  D   E++++  L  HPNI++L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 124 DTYEDDSAVHIVMELCEGGELFD-----RIV------ARGHYTERAAAA--VMKTIVEV- 169
              E+   ++I +E    G L D     R++      A+ H T     +  +++   +V 
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 170 --VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGS-PY 224
             +Q   E+  +HRDL   N L      S   K  DFGLS     GE+    + +G  P 
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLAS---KIADFGLS----RGEEVYVKKTMGRLPV 182

Query: 225 -YMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 256
            +MA E L  + Y  + DVWS GV+L+  + L G P
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 71/275 (25%), Positives = 109/275 (39%), Gaps = 52/275 (18%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           + RG+ G +Y    + NG +F  K I+      + +I D+ +         +HPNIV L 
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL--------QHPNIVKLI 749

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH---EQGVMH 180
                +   +++ E  EG  L +  V R    ER    +   I + ++  H      V+ 
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSE--VLRNLSWER-RRKIAIGIAKALRFLHCRCSPAVVV 806

Query: 181 RDLKPENFLFANKKE-----SSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
            +L PE  +   K E     S P L   D    +             S  Y+APE  +  
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFI-------------SSAYVAPETRETK 853

Query: 235 YGPE-VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----SVIDFKRDPW------P 283
              E  D++  G+IL  LL G  P  A+ E GV  +I+        D   D W       
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911

Query: 284 KVSENAKDLVKKM---LN---PDPKQRLTAEEVLE 312
            VS N  ++V+ M   L+    DP  R  A +VL+
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946

Length = 968

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 30/216 (13%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G FG         +G +        K+  +  D  D   E++++  L  HPNI++L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 124 DTYEDDSAVHIVMELCEGGELFD-----RIV------ARGHYT-----ERAAAAVMKTIV 167
              E    +++ +E    G L D     R++      A  + T      +        + 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGS--P 223
             +    ++  +HRDL   N L      +   K  DFGLS     G++    + +G    
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLS----RGQEVYVKKTMGRLPV 175

Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 256
            +MA E L  + Y    DVWS GV+L+  + L G P
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair

 Score = 46.4 bits (111), Expect = 5e-07
 Identities = 19/50 (38%), Positives = 31/50 (62%)

Query: 448 SGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
            G I  EEL+ AL     +  E+ ++ +  + DTD DG+IS+EEF V+++
Sbjct: 2   KGLITREELKRALALLGISLSEEEVDILFREFDTDGDGKISFEEFCVLLQ 51

Length = 53

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 62/258 (24%), Positives = 111/258 (43%), Gaps = 25/258 (9%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L ++LG G+FG  ++ T  N   K A K++    +     +     E  +MK L +H  +
Sbjct: 10  LEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTL-QHDKL 63

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVCHEQG 177
           V L      +  ++I+ E    G L D + +     +     +     I E +    ++ 
Sbjct: 64  VKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN 234
            +HRDL+  N L +    S   K  DFGL+      E +    G+ +   + APE +  N
Sbjct: 123 YIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--N 176

Query: 235 YGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           +G    + DVWS G++L  I+  G  P+   +   V +A+ R     + +  P   E   
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP---EELY 233

Query: 291 DLVKKMLNPDPKQRLTAE 308
           +++ +     P++R T E
Sbjct: 234 NIMMRCWKNRPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 51.3 bits (123), Expect = 9e-07
 Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 40/204 (19%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKK-KLRTAVDI---EDVRREV--QIM 110
           D+ LG++LG G FGV Y  + VN   K   K + KK     AV+I   E VRR       
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCA 192

Query: 111 KHLPKHPNIVSLKD--------TYEDDSAVHIVME------------LCEGGELFDRIVA 150
             +      VS K          YE +S +  +M+            L +  +L      
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDL-----P 247

Query: 151 RGHYTERAAA---AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207
           +G   ER       +M+ I+  +   H  G++HRD+KP+N +F+    S   K ID G +
Sbjct: 248 KG--LERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS--FKIIDLGAA 303

Query: 208 VFFRPGEQF--NEIVGSPYYMAPE 229
              R G  +   E +  P Y APE
Sbjct: 304 ADLRVGINYIPKEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 66/255 (25%), Positives = 112/255 (43%), Gaps = 32/255 (12%)

Query: 43  LCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-- 100
           L +LKE   + I +       LG G FG  Y    +  GEK     ++ K+LR A     
Sbjct: 1   LRILKETEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKI-PVAIKELREATSPKA 52

Query: 101 -EDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA 159
            +++  E  +M  +  +P++  L       S V ++ +L   G L D +  R H     +
Sbjct: 53  NKEILDEAYVMASV-DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGS 108

Query: 160 AAVMKTIVEVVQ---VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
             ++   V++ +      E+ ++HRDL   N L    +    +K  DFGL+      E+ 
Sbjct: 109 QYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKE 165

Query: 217 NEIVGSPY---YMAPE-VLKRNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 271
               G      +MA E +L R Y  + DVWS GV ++ L+  G  P+      G+  + I
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEI 220

Query: 272 RSVIDF-KRDPWPKV 285
            S+++  +R P P +
Sbjct: 221 SSILEKGERLPQPPI 235

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 49/258 (18%)

Query: 63  ELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDI----------EDVRREVQ 108
           +LG G+FG  +LC  VN  +    +F       + L  AV I           D  +EV+
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA--------A 160
           I+  L K PNI+ L     D+  + ++ E  E G+L ++ ++  H  ++          A
Sbjct: 72  ILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129

Query: 161 AVMKTIVE------VVQVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208
             +  I         +Q+            +HRDL   N L     E+  +K  DFG+S 
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTIKIADFGMSR 186

Query: 209 FFRPGEQF---NEIVGSPYYMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAET 262
               G+ +      V    +MA E +L   +    DVW+ GV L+  ++LC   P+   T
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246

Query: 263 EQGVAQAIIRSVIDFKRD 280
           ++ V    I +  +F RD
Sbjct: 247 DEQV----IENAGEFFRD 260

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair

 Score = 44.3 bits (105), Expect = 3e-06
 Identities = 16/58 (27%), Positives = 31/58 (53%), Gaps = 4/58 (6%)

Query: 369 EMMDTNKRGKINLEELRLGLLKGGQNIPEAD----LQILMEAADVDGDGSLNYGEFVA 422
           +++D +  G I++EELR  L   G  + + +    ++      D DGDG +++ EF+ 
Sbjct: 1   KLLDKDGDGYIDVEELRKLLKALGLKLTDEEVEELIEADFNEIDKDGDGRISFEEFLE 58

Length = 60

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 54/243 (22%), Positives = 97/243 (39%), Gaps = 50/243 (20%)

Query: 63  ELGRGEFGVTY----LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           ELG   FG  Y        +++ +  A K++  K +       + ++E  +M  L  HPN
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAEL-HHPN 68

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE---------- 168
           IV L      +  V ++ E    G+L + ++ R  +++   ++     V+          
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 169 -VVQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
             +Q+            +H+DL   N L     E   +K  D GLS          EI  
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLS---------REIYS 176

Query: 222 SPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 267
           + YY            M PE ++   +  + D+WS GV+L+ I   G+ P++  + Q V 
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236

Query: 268 QAI 270
           + +
Sbjct: 237 EMV 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 25/219 (11%)

Query: 60  LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           LG+ LG GEFG      L  D  +  K A K++ K  + T  +IE+   E   MK    H
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDF-DH 60

Query: 117 PNIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVAR------GHYTERAAAAVMK 164
           PN++ L        + +      +++   + G+L   ++             +     M 
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE--IVGS 222
            I   ++    +  +HRDL   N +     E   +   DFGLS     G+ + +  I   
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 223 PY-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
           P  ++A E L    Y  + DVW+ GV ++ I   G  P+
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 64/252 (25%), Positives = 102/252 (40%), Gaps = 40/252 (15%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKS---------ISKKKLRTAVDI---EDVRREV 107
           L  +LG G+FG  +LC      E     +         ++ K LR  V      D  +E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAA------A 161
           +IM  L K+PNI+ L      D  + ++ E  E G+L   +  R   +    A      +
Sbjct: 69  KIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 162 VMKTIVEVVQVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
           +   +   VQ+            +HRDL   N L  N      +K  DFG+S     G+ 
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN---HYTIKIADFGMSRNLYSGDY 184

Query: 216 FNEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQGVAQ 268
           +  I G       +MA E +L   +    DVW+ GV L+    LC   P+   +++ V  
Sbjct: 185 Y-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV-- 241

Query: 269 AIIRSVIDFKRD 280
             I +  +F R+
Sbjct: 242 --IENTGEFFRN 251

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 18/202 (8%)

Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHLPKHP 117
            + LG G FG  Y    +  GEK     ++ K LR        +++  E  +M  +  HP
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEK-VKIPVAIKVLREETSPKANKEILDEAYVMASV-DHP 69

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV---VQVCH 174
           ++V L       S V ++ +L   G L D +  R H     +  ++   V++   +    
Sbjct: 70  HVVRLLGICLS-SQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLE 126

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPE-V 230
           E+ ++HRDL   N L    K    +K  DFGL+      E+     G      +MA E +
Sbjct: 127 EKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 231 LKRNYGPEVDVWSAGVILYILL 252
           L R Y  + DVWS GV ++ L+
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 31/203 (15%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI----------EDVRREVQIMKH 112
           ELG G FG            K     + KK++  A+ +          +++ RE +IM  
Sbjct: 2   ELGSGNFGCV----------KKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ 51

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQ 171
           L  +P IV +    E + A+ +VME+  GG L   +   +   T      +M  +   ++
Sbjct: 52  L-DNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMK 109

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS---PY-YMA 227
               +  +HRDL   N L  N+  +   K  DFGLS      + + +   +   P  + A
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYA---KISDFGLSKALGADDSYYKARSAGKWPLKWYA 166

Query: 228 PE-VLKRNYGPEVDVWSAGVILY 249
           PE +  R +    DVWS G+ ++
Sbjct: 167 PECINFRKFSSRSDVWSYGITMW 189

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 42/234 (17%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
           LG+ LG GEFG     T      +    +++ K L+   ++ ++ D+  E  ++K +  H
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NH 62

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGEL-----FDRIVARGHYTERAA------------ 159
           P+++ L      D  + +++E  + G L       R V   +                  
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 160 AAVMKTIVEVV-QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
           A  M  ++    Q+        E  ++HRDL   N L A  ++   +K  DFGLS   R 
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLS---RD 176

Query: 213 GEQFNEIVGSPY------YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             + +  V          +MA E L  + Y  + DVWS GV+L+ I+  G  P+
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 74/290 (25%), Positives = 123/290 (42%), Gaps = 53/290 (18%)

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKS------------ISKKKLRTAVDI---EDVRREV 107
           +LG G+FG  +LC +    EKF  K             ++ K LR   +     D  +E+
Sbjct: 12  KLGEGQFGEVHLC-EAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT-- 165
           +IM  L K PNI+ L         + ++ E  E G+L ++ ++R    E A  A + T  
Sbjct: 71  KIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTIS 128

Query: 166 ----------IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
                     I   ++       +HRDL   N L     ++  +K  DFG+S     G+ 
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADFGMSRNLYSGDY 185

Query: 216 FNEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQGVAQ 268
           +  I G       +M+ E +L   +    DVW+ GV L+  + LC   P+   +++ V  
Sbjct: 186 Y-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV-- 242

Query: 269 AIIRSVIDFKRDP-----WPKVSENAKDLVKKMLN---PDPKQRLTAEEV 310
             I +  +F RD       PK +     L K ML+    + K+R + +E+
Sbjct: 243 --IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 27/73 (36%), Positives = 39/73 (53%), Gaps = 5/73 (6%)

Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
            VM+ ++  ++  H  G++HRD+KPEN L     +   +K IDFG +V    G  FN + 
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLY 369

Query: 221 G--SPYYMAPEVL 231
           G   P Y  PE L
Sbjct: 370 GMLDPRYSPPEEL 382

Length = 507

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 67/282 (23%), Positives = 115/282 (40%), Gaps = 49/282 (17%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR------------EV 107
           + RELG+G FG+ Y        E  A K + K +  T V I+ V              E 
Sbjct: 10  MSRELGQGSFGMVY--------EGIA-KGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
            +MK    H ++V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 61  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 168 EVVQVCHE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSV------FFR 211
           +++Q+  E             +HRDL   N + A   E   +K  DFG++       ++R
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 176

Query: 212 PGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
            G +    V    +M+PE LK   +    DVWS GV+L+ I      P+   + + V + 
Sbjct: 177 KGGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233

Query: 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVL 311
           ++   +  K D  P +     +L++     +PK R +  E++
Sbjct: 234 VMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 52/244 (21%)

Query: 62  RELGRGEFGVTYLCT--DVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPN 118
           R++G+G FG  +      +   E F   ++   K   + D++ D +RE  +M     HPN
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPN 69

Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT----------IVE 168
           IV L         + ++ E    G+L + +  R    + + +    +          +  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 169 VVQVCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
             Q+C  + V            +HRDL   N L     E+  +K  DFGLS         
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS--------- 177

Query: 217 NEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAET 262
             I  + YY            M PE +    Y  E DVW+ GV+L+ I   G+ P++   
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237

Query: 263 EQGV 266
            + V
Sbjct: 238 HEEV 241

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNE- 218
           A+MK ++  V+  H++ ++HRD+K EN +F N      L   DFG ++ F +  E F+  
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYG 327

Query: 219 IVGSPYYMAPEVLKRN-YGPEVDVWSAGVIL 248
            VG+    +PE+L  + Y    D+WS G+IL
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLIL 358

Length = 501

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 64/298 (21%), Positives = 117/298 (39%), Gaps = 55/298 (18%)

Query: 52  QDISIDYDLGRELGRGEFGVTYL--CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
           +DI + +    ELG G FG  +L  C ++   +     ++   K  +    +D +RE ++
Sbjct: 5   RDIVLKW----ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 60

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG---HYTERAAAAVMK-- 164
           +  L +H +IV       +   + +V E    G+L   + + G                 
Sbjct: 61  LTVL-QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119

Query: 165 TIVEVVQVCHEQG----------VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214
           T+ +++ +  +             +HRDL   N L     +   +K  DFG+S       
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGLVVKIGDFGMS------- 169

Query: 215 QFNEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWA 260
              +I  + YY            M PE +L R +  E D+WS GV+L+ I   G  P W 
Sbjct: 170 --RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-WY 226

Query: 261 ETEQGVAQAIIRSVIDFKRDPWPKVSEN-AKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           +     A   I    + +R   P+        +++     +P+QR+  +++  H  LQ
Sbjct: 227 QLSNTEAIECITQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDI--HSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 21/210 (10%)

Query: 61  GRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            + LG G FG  +    +  G+      A K+I  +  R     +++   +  M  L  H
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQT--FQEITDHMLAMGSL-DH 68

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VC 173
             IV L       +++ +V +L   G L D +  R H        ++   V++ +     
Sbjct: 69  AYIVRLLGICPG-ASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYL 125

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPE- 229
            E  ++HR+L   N L    K  S ++  DFG++    P ++   ++E      +MA E 
Sbjct: 126 EEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 230 VLKRNYGPEVDVWSAGVILYILLC-GVPPF 258
           +L   Y  + DVWS GV ++ ++  G  P+
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 80/349 (22%), Positives = 132/349 (37%), Gaps = 91/349 (26%)

Query: 51  GQDISID---YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           G+DI +    + +   LG G FG      D    E  A K +      T     D + E+
Sbjct: 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT----RDAKIEI 176

Query: 108 QIMKHL------PKHPNIVSLKDTYEDDSA-VHIVMELCEGGELFDRIVARGHYTERAAA 160
           Q M+ +       + P ++ ++  +++++  + IVM    G  L D I+  G ++ R  A
Sbjct: 177 QFMEKVRQADPADRFP-LMKIQRYFQNETGHMCIVMPK-YGPCLLDWIMKHGPFSHRHLA 234

Query: 161 AVMKTIVEVVQVCH-EQGVMHRDLKPENFLF---------ANKKESSP----LKAIDFGL 206
            ++      +   H E  +MH DLKPEN L             +   P    ++  D G 
Sbjct: 235 QIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 207 SVFFRPGEQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYIL-------------- 251
               R       IV + +Y +PEV L   +    D+WS G I+Y L              
Sbjct: 295 CCDERHSR--TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352

Query: 252 --------LCGVPPFWAE---TEQG---------------------VAQAIIRSVIDFKR 279
                   L  +P  WA    TE+                      +A+A  R V +  R
Sbjct: 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARA--RPVREVIR 410

Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN----AKKAPN 324
           D          DL+  +L+ D ++RL A ++  HP++       ++ PN
Sbjct: 411 DDL------LCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPN 453

Length = 467

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 28/169 (16%)

Query: 156 ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
           E    AV    +  ++  H Q      L   + L               G SV F+  EQ
Sbjct: 16  EEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-----------DG-SVAFKTPEQ 63

Query: 216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
                  PY+MAPEV++  +Y  + D++S G+ LY  L    P     E+    AI+  +
Sbjct: 64  SR---PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP---YNEERELSAILEIL 117

Query: 275 IDF-------KRDPWPKVSE--NAKDLVKKMLNPDPKQRLTAEEVLEHP 314
           ++         R     VS   + +D ++   +  P++R  A   L H 
Sbjct: 118 LNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 28/215 (13%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G FG         +G +        K+  +  D  D   E++++  L  HPNI++L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 124 DTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT--IVEVVQVCH------ 174
              E    +++ +E    G L D +  +R   T+ A A    T   +   Q+ H      
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 175 -------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGS-PY- 224
                  ++  +HRDL   N L     E+   K  DFGLS   R  E +  + +G  P  
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMGRLPVR 188

Query: 225 YMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 256
           +MA E L  + Y    DVWS GV+L+  + L G P
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 44.3 bits (104), Expect = 7e-05
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 60  LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           LG+ LG GEFG          ++  K A K++ K  + T  ++ED   E   MK    HP
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEF-DHP 60

Query: 118 NIVSLK----DTYEDDS--AVHIVMELCEGGEL-----FDRIVARGHY-TERAAAAVMKT 165
           N++ L      T E +   +  +++   + G+L     + R+     Y   +     M  
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE--IVGSP 223
           I   ++    +  +HRDL   N +     E+  +   DFGLS     G+ + +  I   P
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 224 Y-YMAPEVL-KRNYGPEVDVWSAGVILY 249
             ++A E L  R Y  + DVWS GV ++
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMW 205

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.8 bits (101), Expect = 8e-05
 Identities = 27/123 (21%), Positives = 46/123 (37%), Gaps = 20/123 (16%)

Query: 92  KKLRTAVDIEDVRREVQIMKHLPKH----PNIVSLKDTYEDDSAVHIVMELCEGGELFDR 147
           K   +     D  REV I++ L +     P ++    + E D   +++ME  EG  L + 
Sbjct: 27  KINPSREKGADREREVAILQLLARKGLPVPKVL---ASGESDGWSYLLMEWIEGETLDEV 83

Query: 148 IVARGHYTERAAAAVMKTIVEVVQVCHEQ---GVMHRDLKPENFLFANKKESSPLKAIDF 204
                       A ++  +       H+     + H DL P N L  + K    L  ID+
Sbjct: 84  SEEEKEDIAEQLAELLAKL-------HQLPLLVLCHGDLHPGNILVDDGKI---LGIIDW 133

Query: 205 GLS 207
             +
Sbjct: 134 EYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 23/169 (13%)

Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYT----ERAAAA 161
           E+ + K L  HPNIV  + T+  D+ + +V      G   D I    H+     E A A 
Sbjct: 49  ELHVSK-LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAY 105

Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFA--NKKESSPLKAIDFGLSVFFRPGEQFNEI 219
           +++ +++ +   H  G +HR +K  + L +   K   S L++    LS+    G++   +
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN---LSM-INHGQRLRVV 161

Query: 220 VGSPYY-------MAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF 258
              P Y       ++PEVL++N   Y  + D++S G+    L  G  PF
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif

 Score = 38.9 bits (92), Expect = 1e-04
 Identities = 10/27 (37%), Positives = 15/27 (55%)

Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           +       D D DG+I +EEF  ++KA
Sbjct: 2   LKEAFRLFDKDGDGKIDFEEFKDLLKA 28

EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29

>gnl|CDD|200946 pfam00036, efhand, EF hand

 Score = 38.6 bits (91), Expect = 1e-04
 Identities = 10/27 (37%), Positives = 16/27 (59%)

Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           +     + D D DG+IS+EEF  ++K 
Sbjct: 2   LKEAFKEFDKDGDGKISFEEFKELLKK 28

The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 16/143 (11%)

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY-YMAPE-VLKRN 234
           +HRDL   N L +   E++ +K  DFGL+  ++  P          P  +MAPE +  R 
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257

Query: 235 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
           Y  + DVWS GV+L+ I   G  P+       + +   R + +  R   P  +    ++ 
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRLKEGTRMRAPDYT--TPEMY 312

Query: 294 KKMLN---PDPKQRLTAEEVLEH 313
           + ML+    +P QR T  E++EH
Sbjct: 313 QTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain

 Score = 36.8 bits (86), Expect = 6e-04
 Identities = 13/27 (48%), Positives = 17/27 (62%)

Query: 436 LHKAFSFFDRNRSGFIEIEELRNALND 462
           L +AF  FD++  G+I  EELR AL  
Sbjct: 2   LREAFKLFDKDGDGYISAEELRKALRS 28

Length = 30

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 3/90 (3%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV---DIEDVRREVQIMKHLPKH 116
           LGR LG G FG     T        +   ++ K L++     + + +  E++IM HL  H
Sbjct: 41  LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH 100

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD 146
            NIV+L         ++I+ E C  G+L D
Sbjct: 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVD 130

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.8 bits (98), Expect = 7e-04
 Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 3/90 (3%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHLPKH 116
            G+ LG G FG     T    G++     ++ K L+ +      E +  E++I+ HL +H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD 146
            NIV+L         V ++ E C  G+L +
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLN 131

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 22/167 (13%)

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVC 173
           H NIV L+      + + IV E    G L D  + +  G         ++  +   ++  
Sbjct: 65  HSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ------FNEIVG-SP-YY 225
            E G +H+ L     L      +S L     G    FR  ++      +  + G SP  +
Sbjct: 124 SEMGYVHKGLAAHKVLV-----NSDLVCKISG----FRRLQEDKSEAIYTTMSGKSPVLW 174

Query: 226 MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
            APE ++  ++    DVWS G++++ ++  G  P+W  + Q V +A+
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain

 Score = 36.4 bits (85), Expect = 0.001
 Identities = 13/29 (44%), Positives = 18/29 (62%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGG 392
           L+EAF++ D +  G I+ EELR  L   G
Sbjct: 2   LREAFKLFDKDGDGYISAEELRKALRSLG 30

Length = 30

>gnl|CDD|238009 cd00052, EH, Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction

 Score = 37.6 bits (88), Expect = 0.001
 Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 3/67 (4%)

Query: 365 KEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVS 424
            + F  +D +  G I+ +E R  L K G  +P + L  + + AD D DG L+  EF  ++
Sbjct: 2   DQIFRSLDPDGDGLISGDEARPFLGKSG--LPRSVLAQIWDLADTDKDGKLDKEEFA-IA 58

Query: 425 VHLKKMA 431
           +HL  +A
Sbjct: 59  MHLIALA 65

The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. Length = 67

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.3 bits (95), Expect = 0.001
 Identities = 36/122 (29%), Positives = 49/122 (40%), Gaps = 24/122 (19%)

Query: 92  KKLRTAVDIEDVRREVQIMKHLPKH----PNIVSLKDTYEDDSAVHIVMELCEGGELFDR 147
           ++ RT       RRE +IM    K     P  V   D         IVME  EG  L D 
Sbjct: 42  RRERT-------RREARIMSRARKAGVNVP-AVYFVDPENFI----IVMEYIEGEPLKDL 89

Query: 148 IVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207
           I + G         + + I  +V   H  G++H DL   N + +  K    +  IDFGL+
Sbjct: 90  INSNG----MEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGK----IYLIDFGLA 141

Query: 208 VF 209
            F
Sbjct: 142 EF 143

Length = 211

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 40.0 bits (94), Expect = 0.001
 Identities = 23/76 (30%), Positives = 35/76 (46%), Gaps = 11/76 (14%)

Query: 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK 193
           IVME  EG  L D         E A   +++ +  +V   H+ G++H DL   N + +  
Sbjct: 76  IVMEYIEGELLKD-------ALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG 128

Query: 194 KESSPLKAIDFGLSVF 209
           +    +  IDFGL  F
Sbjct: 129 R----IYFIDFGLGEF 140

Length = 204

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 66/328 (20%), Positives = 130/328 (39%), Gaps = 65/328 (19%)

Query: 59  DLGRELGRGEFGVT--YLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +L  E+GRG   +T  YL      G     + I+  +  T   ++ ++ EV ++ H  +H
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEV-VLSHFFRH 58

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI----VEVVQV 172
           PNI++    +   S + ++      G      + + ++ E  + A++  I    +  +  
Sbjct: 59  PNIMTSWTVFTTGSWLWVISPFMAYGSA--NSLLKTYFPEGMSEALIGNILFGALRGLNY 116

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
            H+ G +HR++K  + L +     S L  +   L    R G++   +   P +       
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVS-LSGLS-HLYSLVRNGQKAKVVYDFPQFSTSVLPW 174

Query: 226 MAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF------------------------ 258
           ++PE+L+++   Y  + D++S G+    L  G  PF                        
Sbjct: 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234

Query: 259 --------WAETEQGVAQAIIRSVI----------DFKRDPWPKV-SENAKDLVKKMLNP 299
                      ++ GV   I  SV+          +  R P  K  S   ++LV+  L  
Sbjct: 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQ 294

Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           DP++R +A  +L H + +  K+    S+
Sbjct: 295 DPEKRPSASSLLSHAFFKQVKEQTQGSI 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|200946 pfam00036, efhand, EF hand

 Score = 35.1 bits (82), Expect = 0.002
 Identities = 10/27 (37%), Positives = 14/27 (51%)

Query: 436 LHKAFSFFDRNRSGFIEIEELRNALND 462
           L +AF  FD++  G I  EE +  L  
Sbjct: 2   LKEAFKEFDKDGDGKISFEEFKELLKK 28

The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29

>gnl|CDD|240156 cd05030, calgranulins, Calgranulins: S-100 domain found in proteins belonging to the Calgranulin subgroup of the S100 family of EF-hand calcium-modulated proteins, including S100A8, S100A9, and S100A12

 Score = 36.9 bits (86), Expect = 0.002
 Identities = 17/42 (40%), Positives = 28/42 (66%), Gaps = 3/42 (7%)

Query: 455 ELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
           EL N L  E +   +  I+ I  D+DT++DG++S+EEF V++
Sbjct: 39  ELPNFLKKEKN---QKAIDKIFEDLDTNQDGQLSFEEFLVLV 77

Note that the S-100 hierarchy, to which this Calgranulin group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. These proteins are expressed mainly in granulocytes, and are involved in inflammation, allergy, and neuritogenesis, as well as in host-parasite response. Calgranulins are modulated not only by calcium, but also by other metals such as zinc and copper. Structural data suggested that calgranulins may exist in multiple structural forms, homodimers, as well as hetero-oligomers. For example, the S100A8/S100A9 complex called calprotectin plays important roles in the regulation of inflammatory processes, wound repair, and regulating zinc-dependent enzymes as well as microbial growth. Length = 88

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 26/94 (27%)

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------------M 226
           +HRDL   N L +   E++ +K  DFGL+          +I   P Y            M
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGSARLPLKWM 243

Query: 227 APE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 258
           APE +  + Y  + DVWS GV+L+ I   G  P+
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif

 Score = 35.0 bits (82), Expect = 0.003
 Identities = 11/22 (50%), Positives = 15/22 (68%)

Query: 364 LKEAFEMMDTNKRGKINLEELR 385
           LKEAF + D +  GKI+ EE +
Sbjct: 2   LKEAFRLFDKDGDGKIDFEEFK 23

EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29

>gnl|CDD|200946 pfam00036, efhand, EF hand

 Score = 35.1 bits (82), Expect = 0.003
 Identities = 12/25 (48%), Positives = 16/25 (64%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGL 388
           LKEAF+  D +  GKI+ EE +  L
Sbjct: 2   LKEAFKEFDKDGDGKISFEEFKELL 26

The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29

>gnl|CDD|238009 cd00052, EH, Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction

 Score = 36.0 bits (84), Expect = 0.003
 Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 6/62 (9%)

Query: 438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEEFAVM 495
           + F   D +  G I  +E R  L      SG    V+  I    DTDKDG++  EEFA+ 
Sbjct: 3   QIFRSLDPDGDGLISGDEARPFLG----KSGLPRSVLAQIWDLADTDKDGKLDKEEFAIA 58

Query: 496 MK 497
           M 
Sbjct: 59  MH 60

The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. Length = 67

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	531
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG5126	160	FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG0027	151	consensus Calmodulin and related proteins (EF-Hand	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG0028	172	consensus Ca2+-binding protein (centrin/caltractin	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.84
KOG0031	171	consensus Myosin regulatory light chain, EF-Hand p	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0037	221	consensus Ca2+-binding protein, EF-Hand protein su	99.83
PTZ00183	158	centrin; Provisional	99.83
smart00090	237	RIO RIO-like kinase.	99.83
PTZ00184	149	calmodulin; Provisional	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
KOG0030	152	consensus Myosin essential light chain, EF-Hand pr	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
KOG0044	193	consensus Ca2+ sensor (EF-Hand superfamily) [Signa	99.73
KOG0034	187	consensus Ca2+/calmodulin-dependent protein phosph	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
KOG4223	325	consensus Reticulocalbin, calumenin, DNA supercoil	99.7
KOG0027	151	consensus Calmodulin and related proteins (EF-Hand	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG0036	463	consensus Predicted mitochondrial carrier protein	99.62
COG5126	160	FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.6
PTZ00183	158	centrin; Provisional	99.59
KOG0044	193	consensus Ca2+ sensor (EF-Hand superfamily) [Signa	99.54
PTZ00184	149	calmodulin; Provisional	99.54
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.49
KOG0028	172	consensus Ca2+-binding protein (centrin/caltractin	99.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.44
KOG3087	229	consensus Serine/threonine protein kinase [General	99.43
KOG0030	152	consensus Myosin essential light chain, EF-Hand pr	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
KOG0031	171	consensus Myosin regulatory light chain, EF-Hand p	99.38
KOG1243	690	consensus Protein kinase [General function predict	99.35
PLN02964	644	phosphatidylserine decarboxylase	99.35
KOG0037	221	consensus Ca2+-binding protein, EF-Hand protein su	99.32
KOG4223	325	consensus Reticulocalbin, calumenin, DNA supercoil	99.32
KOG4251	362	consensus Calcium binding protein [General functio	99.29
KOG0034	187	consensus Ca2+/calmodulin-dependent protein phosph	99.28
cd05022	89	S-100A13 S-100A13: S-100A13 domain found in protei	99.24
PF13499	66	EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A	99.24
KOG0038	189	consensus Ca2+-binding kinase interacting protein	99.23
KOG0036	463	consensus Predicted mitochondrial carrier protein	99.22
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.21
PLN02964	644	phosphatidylserine decarboxylase	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
cd05027	88	S-100B S-100B: S-100B domain found in proteins sim	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
PF13499	66	EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A	99.07
cd05022	89	S-100A13 S-100A13: S-100A13 domain found in protei	99.06
KOG2643	489	consensus Ca2+ binding protein, contains EF-hand m	99.05
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
cd05029	88	S-100A6 S-100A6: S-100A6 domain found in proteins	99.01
cd05026	93	S-100Z S-100Z: S-100Z domain found in proteins sim	98.99
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.99
cd05025	92	S-100A1 S-100A1: S-100A1 domain found in proteins	98.98
COG4248	637	Uncharacterized protein with protein kinase and he	98.98
cd05031	94	S-100A10_like S-100A10_like: S-100A10 domain found	98.96
cd05027	88	S-100B S-100B: S-100B domain found in proteins sim	98.95
PF13833	54	EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A	98.91
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.88
KOG0377	631	consensus Protein serine/threonine phosphatase RDG	98.88
cd00052	67	EH Eps15 homology domain; found in proteins implic	98.87
cd05023	89	S-100A11 S-100A11: S-100A11 domain found in protei	98.86
smart00027	96	EH Eps15 homology domain. Pair of EF hand motifs t	98.86
smart00027	96	EH Eps15 homology domain. Pair of EF hand motifs t	98.84
cd05029	88	S-100A6 S-100A6: S-100A6 domain found in proteins	98.83
PRK09902	216	hypothetical protein; Provisional	98.82
cd05026	93	S-100Z S-100Z: S-100Z domain found in proteins sim	98.81

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-61  Score=452.27  Aligned_cols=269  Identities=38%  Similarity=0.685  Sum_probs=245.8

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChh----hHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV----DIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ..+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.......    ....+.+|+++|++| +|||||+++++|.
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~  246 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFE  246 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeee
Confidence            34777899999999999999999999999999999999877654321    234467999999999 9999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      ..+..||||||+.||+|.+++..++.+.+.....+++||+.||.|||+.||+||||||+|||+..+..+..+||+|||+|
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999998877888999999999


Q ss_pred             cccCCCCccccccCCcccccchhccc-c---CCCccchhHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhcccCCCCCCC
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKR-N---YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~---~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  282 (531)
                      +....+..+.+.+|||.|.|||++.+ .   +..++|+||+||+||-+++|.+||....... ..+++.++...+....|
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            99887888899999999999999873 2   4458999999999999999999998876655 78899999999999999


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ..++++..+||.+||..||++|||+.++|+||||+.+..
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            999999999999999999999999999999999986654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-58  Score=400.82  Aligned_cols=300  Identities=41%  Similarity=0.762  Sum_probs=273.0

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ...+.+.|++.+.||+|+|+.|+++.+..+|+.+|+|++....+... ..+.+.+|+.|.+.| +||||+++.+.+....
T Consensus         6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen    6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL-QHPNIVRLHDSIQEES   83 (355)
T ss_pred             ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhc-CCCcEeehhhhhcccc
Confidence            35577889999999999999999999999999999999987766544 678999999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ..|||+|++.|++|..-+.++.-+++..+-.+++||+.||.|+|.+||||||+||+|+++.+......+||+|||+|..+
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999999999887777777899999999999999999999999999999999999999888888999999999998


Q ss_pred             CCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ..+......+|||+|||||+++ .+|+..+||||.||+||-|+.|.+||++.+.....+.+..+..+++.+.|+.+++++
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            8777777889999999999998 579999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhhhHHHHHHHhhhhhh
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV  352 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~  352 (531)
                      ++|+++||..||.+|+|+.|+|+|||+.+...-....-.++..+.+++|....+++...+..+
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav  306 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTV  306 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHH
Confidence            999999999999999999999999999875543332233567788888888888888777655

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-56  Score=437.92  Aligned_cols=257  Identities=38%  Similarity=0.637  Sum_probs=239.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.++.+......+.+.+||++.++| +|||||+++++|++.+++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence            4699999999999999999999999999999999998887777889999999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-C
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~  214 (531)
                      .|+|+.++|..+++++..++|.+++.+++||+.||.|||+++|+|||||..|++++   .+.+|||+|||+|..+..+ +
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~---~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN---ENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec---CcCcEEecccceeeeecCccc
Confidence            99999999999999999999999999999999999999999999999999999995   4456999999999988744 6


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ...+.+|||.|.|||++. ..++..+||||+||+||-|++|++||...+-.+++..+......++.    .++.++++||
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI  249 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI  249 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence            778899999999999987 56899999999999999999999999999999999999887666554    6799999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcccccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .++|+++|.+|||+++||.|+||+...
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            999999999999999999999996543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-56  Score=412.52  Aligned_cols=257  Identities=27%  Similarity=0.433  Sum_probs=224.0

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-eEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-AVHI  134 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~~~l  134 (531)
                      .+.+.+..||+|+.|+||+|+|+.++..+|+|++...  .++...+++.+|+++++.. +|||||.+|++|.... ..+|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence            3678889999999999999999999999999999433  2445568899999999999 9999999999999888 5999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+||||..++...+.+++..+..|+.++++||.|||+ ++||||||||+|||+++.++   |||||||.|..+...
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe---VKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE---VKICDFGVSGILVNS  232 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC---EEeccccccHHhhhh
Confidence            99999999999999988899999999999999999999996 89999999999999976554   999999999877654


Q ss_pred             CccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCC-----CHHHHHHHHHhcccCCCCCCCC-CCC
Q 009594          214 EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE-----TEQGVAQAIIRSVIDFKRDPWP-KVS  286 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~-~~~  286 (531)
                       ..++.+||..|||||.+.+ .|+.++||||||++++|+.+|+.||...     ...+....|..+..   ..... .+|
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp---P~lP~~~fS  308 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP---PRLPEGEFS  308 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC---CCCCcccCC
Confidence             5578899999999999985 7999999999999999999999999774     33444445544322   21112 489


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                      +++++||..||++||.+|||+.|+++|||+++....
T Consensus       309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            999999999999999999999999999999976553

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-54  Score=425.76  Aligned_cols=322  Identities=57%  Similarity=0.999  Sum_probs=293.9

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ...+...|++.+.||+|.||.||+|+++.+|+.+|+|++.+...........+.+|+.+|++++.|||||.++++|++..
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            35677789999999999999999999999999999999998877666567889999999999966999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC-CCCeEEEeeccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGLSVF  209 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~-~~~ikl~Dfg~a~~  209 (531)
                      .+++|||+|.||.|++.+... .+++..+..++.|++.|+.|||+.||+||||||+|+|+..... ++.+|++|||+|..
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999999877 5999999999999999999999999999999999999987654 45799999999999


Q ss_pred             cCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ...+......+||+.|+|||++. ..|+..+||||+||++|.|++|.+||++.+......++.+..+.+..++|+.++..
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence            88877778899999999999998 68999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhhhHHHHHHHhhhhhhHhhhhhHHHhhHHHHh
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAF  368 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~i~~~F  368 (531)
                      ++++|..||..||.+|+|+.++|+|||++.....+............+++..++++++...+..++..+   +..++..|
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  345 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLKEMF  345 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHHHHH
Confidence            999999999999999999999999999998766665555566677788888898888887777777666   77888899


Q ss_pred             cccccCCC
Q 009594          369 EMMDTNKR  376 (531)
Q Consensus       369 ~~~D~~~~  376 (531)
                      ..+|.+++
T Consensus       346 ~~~~~~~~  353 (382)
T KOG0032|consen  346 KLMDTDNN  353 (382)
T ss_pred             Hhhccccc
Confidence            99998877

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-55  Score=405.23  Aligned_cols=259  Identities=34%  Similarity=0.652  Sum_probs=235.8

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++++.||+|+||+||+++.+.+++.+|+|++.++......+.....+|..+|.++ +||+||+++-.|++...+|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEE
Confidence            34799999999999999999999999999999999998877777788999999999998 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc-CCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~-~~~  213 (531)
                      |+||+.||.|+-.|.+.+.+++..++-++..|+.||.|||++|||||||||+|||++   ..++|+|+|||+|+.. ..+
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd---~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD---EQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec---CCCcEEEeccccchhcccCC
Confidence            999999999999999999999999999999999999999999999999999999995   4566999999999854 344


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ....+.+||+.|||||++. ..|+..+|+||||+++|+|++|.+||.+.+......++.+.......   .-++.+++++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardl  256 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDL  256 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHH
Confidence            5667789999999999877 67999999999999999999999999999999988888877633222   2378999999


Q ss_pred             HHHccccCcCCCC----CHHHHhcCCcccccc
Q 009594          293 VKKMLNPDPKQRL----TAEEVLEHPWLQNAK  320 (531)
Q Consensus       293 i~~~l~~~p~~Rp----s~~~~l~h~~~~~~~  320 (531)
                      +.++|..+|++|.    ++.++-+||||....
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            9999999999995    799999999998754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-54  Score=403.40  Aligned_cols=264  Identities=39%  Similarity=0.664  Sum_probs=234.5

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ .....+.+..|+.+|+.+ +|||||.+++++...+.+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~   85 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIY   85 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEE
Confidence            34579999999999999999999999999999999988765 344567788999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCC---CCeEEEeecccccc
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES---SPLKAIDFGLSVFF  210 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~---~~ikl~Dfg~a~~~  210 (531)
                      +|||||.||+|..++.+.+.+++..++.++.||+.||++||+++||||||||.|||+......   ..+||+|||+|+.+
T Consensus        86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999999999999999999999999999999999999999999999999999999875233   57999999999999


Q ss_pred             CCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      .++.-..+.+|+|.|||||++. ++|+.|+|+||+|+++|++++|++||...+..+....+.+..-..+.. -..+++..
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~-~~~~s~~~  244 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL-PAELSNPL  244 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch-hhhccCch
Confidence            9888888899999999999985 899999999999999999999999999999888877555443222211 12345567


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .+|+...|..+|.+|.+..+-+.|+++....
T Consensus       245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  245 RELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            7999999999999999999999999997654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-53  Score=411.44  Aligned_cols=259  Identities=33%  Similarity=0.627  Sum_probs=236.7

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      -.+|.+.+.||.|+|++|++|+++.++..||||++.++.+-.......+.+|-.+|.+|.+||.|++|+-.|++...+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            34899999999999999999999999999999999988776666667788899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |+||+++|+|.++|.+.+.+++..++.++.+|+.||+|||++|||||||||+|||++   .++++||+|||.|+.+.+..
T Consensus       152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd---~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD---KDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc---CCCcEEEeeccccccCChhh
Confidence            999999999999999999999999999999999999999999999999999999995   45569999999998775421


Q ss_pred             c------------c--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 009594          215 Q------------F--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR  279 (531)
Q Consensus       215 ~------------~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  279 (531)
                      .            .  .+++||-.|.+||++. +..++.+|||+||||+|+|+.|.+||.+.++--+.++|+.....++ 
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp-  307 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP-  307 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC-
Confidence            1            1  3489999999999998 6788999999999999999999999999999999999998777665 


Q ss_pred             CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       280 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                         +.+++.+.+||.++|..||.+|+|+.+|.+||||....
T Consensus       308 ---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  308 ---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             ---CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence               36789999999999999999999999999999997654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-53  Score=404.57  Aligned_cols=264  Identities=32%  Similarity=0.512  Sum_probs=231.0

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-e
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-A  131 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~  131 (531)
                      .+.++|.++++||.|+||.||+|+.+.+|..||||.++++... . +.-.-++|+..|++|..||||+++.+++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-H-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            4567899999999999999999999999999999999876543 2 23344679999999955999999999998877 9


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      +++|||||+ .+|+++++.++ .+++..++.|++||++||+|+|++|+.|||+||+|||+..   ...|||+|||+|+.+
T Consensus        85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLAREV  160 (538)
T ss_pred             EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEeccccccccc
Confidence            999999995 59999998654 5999999999999999999999999999999999999963   445999999999999


Q ss_pred             CCCCccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC-------
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP-------  281 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  281 (531)
                      .....+..++.|.+|+|||++.  +.|+.+.||||+|||++|+++-++.|.+.++.+++.++..-........       
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            9888999999999999999875  5699999999999999999999999999999988888866443332222       


Q ss_pred             -------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          282 -------------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       282 -------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                                         .+..+.++.++|.+||..||++||||.++|+||||+.....
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                               23467899999999999999999999999999999876543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-53  Score=378.04  Aligned_cols=257  Identities=32%  Similarity=0.613  Sum_probs=237.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      --.+|++++.||.|+||.|.+++++.+|..+|+|++.+...-.....+...+|..+|+.+ .||+++++++.|.+.+.++
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEE
Confidence            345799999999999999999999999999999999988776666778889999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |||||.+||.|+.++.+.+++++..++-++.||+.||+|||+++|++|||||+|||+++   ++.+||+|||+|+.....
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~---~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQ---NGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeecc---CCcEEEEeccceEEecCc
Confidence            99999999999999999999999999999999999999999999999999999999954   556999999999987644


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                        ..+.+|||.|+|||++. .+|+.++|+|||||++|||+.|.+||...+...+.++|......++.    .+++++++|
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdL  271 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDL  271 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHH
Confidence              56789999999999887 68999999999999999999999999999999999999998887764    578999999


Q ss_pred             HHHccccCcCCCC-----CHHHHhcCCcccccc
Q 009594          293 VKKMLNPDPKQRL-----TAEEVLEHPWLQNAK  320 (531)
Q Consensus       293 i~~~l~~~p~~Rp-----s~~~~l~h~~~~~~~  320 (531)
                      |.++|+.|-.+|.     ...+|.+||||+...
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence            9999999999994     678999999998643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.5e-53  Score=380.02  Aligned_cols=256  Identities=28%  Similarity=0.586  Sum_probs=222.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|+.+.++|+|+||+||+|+++.+|+.||||++..+. .++.-.+-.++||++|++| +|||+|.++++|.....+++|+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEEe
Confidence            5888999999999999999999999999999997543 2333456678999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-CCC
Q 009594          137 ELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-~~~  214 (531)
                      |||+- ++.+.|.+.. .++...+.+++.|++.|+.|+|++++|||||||+|||++.   ++.+||||||+|+.+. +++
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~---~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ---NGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec---CCcEEeccchhhHhhcCCcc
Confidence            99975 6666666544 4899999999999999999999999999999999999965   4569999999999887 777


Q ss_pred             ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------------
Q 009594          215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--------------  278 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------------  278 (531)
                      .+..++.|.+|+|||.+-|  +|+..+||||+||++.||++|.+.|.+.++-+++-.|.....+..              
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            8888999999999998875  699999999999999999999999999998887776654332111              


Q ss_pred             -------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          279 -------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       279 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                   ...+++++.-+.+|+.+||+.||++|+|.+|+|.||||..
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence                         1124567778999999999999999999999999999954

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.8e-52  Score=399.84  Aligned_cols=263  Identities=33%  Similarity=0.569  Sum_probs=235.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .-.++|+++..||+|+||+||+|+.+.+|..+|+|++.++........+.++.|-.+|... ++|.||+|+-.|++..++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCee
Confidence            3455899999999999999999999999999999999998887777888999999999996 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||||++||++..+|.+.+.|++..++.++.+++.|++-||+.|+|||||||+|+||+   ..+++||+|||+|.-+..
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD---~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID---AKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec---CCCCEeeccccccchhhh
Confidence            99999999999999999999999999999999999999999999999999999999995   556799999999842110


Q ss_pred             ----------------------C--C-----c-------------------cccccCCcccccchhcc-ccCCCccchhH
Q 009594          213 ----------------------G--E-----Q-------------------FNEIVGSPYYMAPEVLK-RNYGPEVDVWS  243 (531)
Q Consensus       213 ----------------------~--~-----~-------------------~~~~~gt~~y~aPE~~~-~~~~~~~Di~s  243 (531)
                                            .  .     .                   ..+.+|||-|||||++. ..|+..+|+||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                  0  0     0                   01257999999999987 46999999999


Q ss_pred             HHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCC---CHHHHhcCCcccccc
Q 009594          244 AGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNAK  320 (531)
Q Consensus       244 lG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~~~  320 (531)
                      ||||+|||+.|.+||.+.+.+++..++.+.......+.-..+++++.+||.+||. ||++|.   ++.||.+||||+...
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            9999999999999999999999999999877555554445788999999999999 999999   599999999998764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-51  Score=402.69  Aligned_cols=260  Identities=42%  Similarity=0.726  Sum_probs=230.7

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh--hhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA--VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ...+.|.+.+.||+|+||.|+.|.+..++..||+|++.++.....  ...+.+.+|+.+++++..||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            345679999999999999999999999999999998876533211  234567789999999944999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .+++||||+.||+|++++.+.+++++..++.+++|+++|++|||++||+||||||+|||++.+.  +.+||+|||++...
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~--~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE--GNLKLSDFGLSAIS  171 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC--CCEEEecccccccc
Confidence            9999999999999999999988999999999999999999999999999999999999997652  56999999999988


Q ss_pred             -CCCCccccccCCcccccchhccc-c-C-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC-
Q 009594          211 -RPGEQFNEIVGSPYYMAPEVLKR-N-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV-  285 (531)
Q Consensus       211 -~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  285 (531)
                       ..+....+.+||+.|+|||++.+ . | +.++||||+||+||.|++|..||...+.......+.+....++.    .+ 
T Consensus       172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~~~  247 (370)
T KOG0583|consen  172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----YLL  247 (370)
T ss_pred             CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----CcC
Confidence             46677888999999999999985 3 5 47899999999999999999999998888888887776655543    23 


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      +++++.|+.+||..+|.+|+|+.+++.||||+.
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999999997

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.4e-51  Score=361.89  Aligned_cols=259  Identities=32%  Similarity=0.579  Sum_probs=226.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|..++.||+|.||.||+|++..+|+.||||+++..+..+.... ...+||..|+.+ +||||+.++++|...+.+.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~-talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINR-TALREIKLLQEL-KHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccH-HHHHHHHHHHHc-cCcchhhhhhhccCCCceEEE
Confidence            468899999999999999999999999999999998776655544 456799999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      +||++. +|...++.+. .++...+.+++.++++||+|||++.|+||||||.|+|++++   +.+||+|||+|+.+.+..
T Consensus        80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~---g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD---GQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC---CcEEeecccchhccCCCC
Confidence            999975 9999887654 48999999999999999999999999999999999999654   559999999999876544


Q ss_pred             c-cccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCC-------
Q 009594          215 Q-FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-------  284 (531)
Q Consensus       215 ~-~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------  284 (531)
                      . ....+-|.+|+|||.+.|  +|+..+||||.|||+.||+.|.+-|.+.++-++...+.+.........||.       
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            3 333478999999998874  699999999999999999999999999999999988887665555555543       


Q ss_pred             -----------------CCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          285 -----------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       285 -----------------~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                       .++++.+|+.+||.+||.+|+|+.|+|+|+||+...
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                             356789999999999999999999999999999743

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-52  Score=371.39  Aligned_cols=262  Identities=36%  Similarity=0.696  Sum_probs=239.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ..|.-.+.||.|..++|.++.++.+|..+|+|++.......     ..-.+.-.+|+.||+++.+||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            35777789999999999999999999999999997432211     1123456689999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .+++|+|.|+.|.|+++|...-.+++...++|++|++.|+.|||.++||||||||+|||+++   +.++||+|||+|+.+
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd---n~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD---NMNIKISDFGFACQL  173 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc---ccceEEeccceeecc
Confidence            99999999999999999998888999999999999999999999999999999999999964   455999999999999


Q ss_pred             CCCCccccccCCcccccchhccc-------cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      .+++.....+|||+|.|||.+..       .|+..+|+||+|||||.|+.|.+|||.....-.+..+..+...+..+.|.
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa  253 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA  253 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence            99999999999999999998852       47889999999999999999999999998888899999999999999999


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      +++...++||.+||+.||++|.|+.|+|.||||....
T Consensus       254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~  290 (411)
T KOG0599|consen  254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA  290 (411)
T ss_pred             hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence            9999999999999999999999999999999996543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-52  Score=370.67  Aligned_cols=249  Identities=30%  Similarity=0.554  Sum_probs=214.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecce-EEEcCC
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD-TYEDDS  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~-~~~~~~  130 (531)
                      ..-..+|+++++||+|+||+||++.+..+|..+|.|.+.-... +....+.+..|+.+|++| +|||||++++ .|...+
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccc
Confidence            3344579999999999999999999999999999999984433 455678889999999999 9999999998 455444


Q ss_pred             -eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeecCCCCCceEeecCCCCCCeEE
Q 009594          131 -AVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHE--QG--VMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       131 -~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~--~~--iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                       .++||||||.+|+|.+.++.    ...+++..++.++.|++.||.++|+  ..  |+||||||.||+++.   ++.+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~---~gvvKL  169 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA---NGVVKL  169 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC---CCceee
Confidence             49999999999999998853    3459999999999999999999999  45  999999999999964   456999


Q ss_pred             EeeccccccCCCCc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 009594          202 IDFGLSVFFRPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR  279 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  279 (531)
                      +|||+++.+..... ..+.+|||.||+||.+. .+|+.+|||||+||++|||+.-++||++.+-.+...+|.++..+  +
T Consensus       170 GDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~--~  247 (375)
T KOG0591|consen  170 GDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP--P  247 (375)
T ss_pred             ccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC--C
Confidence            99999998876544 45789999999999887 67999999999999999999999999999888888888777432  1


Q ss_pred             CCCCCCCHHHHHHHHHccccCcCCCCCH
Q 009594          280 DPWPKVSENAKDLVKKMLNPDPKQRLTA  307 (531)
Q Consensus       280 ~~~~~~~~~~~~li~~~l~~~p~~Rps~  307 (531)
                      -+-..+|..+..||..|+..||+.||+.
T Consensus       248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  248 LPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            1113578899999999999999999986

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-51  Score=403.32  Aligned_cols=258  Identities=38%  Similarity=0.682  Sum_probs=238.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      -|++++.||.|+-|.|-+|++..||+.+|||++.+...........+.+||.+|+-+ .||||+++|++|+...++|+|.
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEE
Confidence            399999999999999999999999999999999887433344457788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF  216 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~  216 (531)
                      ||++||.|++++.+.+++++.++++++.||+.|+.|+|..+|+||||||+|+|++.+++   |||+|||+|..-.++.-.
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n---IKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN---IKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC---EeeeccceeecccCCccc
Confidence            99999999999999999999999999999999999999999999999999999975543   999999999988888888


Q ss_pred             ccccCCcccccchhccc-cC-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          217 NEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .+.+|+|.|.|||++.| +| +.++||||+|||||.|+||+.||.+.+-...+.++.++.+..+    ..+|+++.+||.
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLLr  244 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLLR  244 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHHH
Confidence            89999999999999986 44 6799999999999999999999999999999999999988776    478999999999


Q ss_pred             HccccCcCCCCCHHHHhcCCcccccccC
Q 009594          295 KMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       295 ~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                      +||..||++|+|..+|++|||+......
T Consensus       245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  245 RMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             HHhccCccccccHHHHhhCchhhcCCCC
Confidence            9999999999999999999999876543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-50  Score=386.28  Aligned_cols=258  Identities=30%  Similarity=0.548  Sum_probs=224.9

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--CeE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAV  132 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~  132 (531)
                      .+.|+.+++||+|+||.||+|++..+|..||+|++......... ..-..+||.||++| +||||++|.+...+.  ..+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~-~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF-PITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc-hHHHHHHHHHHHhc-CCCcccceeeEEEecCCceE
Confidence            34689999999999999999999999999999999876644433 34566799999999 999999999987765  789


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |||+|||+. +|..++... -++++.++..++.||+.||+|+|++||+|||||.+||||+++   +.+||+|||+|+++.
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~---G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN---GVLKIADFGLARFYT  269 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC---CCEEeccccceeecc
Confidence            999999964 888877653 369999999999999999999999999999999999999654   559999999999876


Q ss_pred             CCC--ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC----
Q 009594          212 PGE--QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP----  283 (531)
Q Consensus       212 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----  283 (531)
                      ...  .+...+-|.+|+|||.+.|  .|+.++|+||.||||.||++|+++|++.++.+++..|.+..-......|+    
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            554  4667788999999999875  69999999999999999999999999999999999998766555554454    


Q ss_pred             ---------------------CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          284 ---------------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       284 ---------------------~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                           .++....+|+..||..||.+|.||.++|+|+||..
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                                 24567899999999999999999999999999953

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-50  Score=391.43  Aligned_cols=255  Identities=32%  Similarity=0.596  Sum_probs=227.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. ....++..+.+|+++++.| +||||+.+++.|+...++++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEE
Confidence            46899999999999999999999999999999998654 3455788999999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      +|||.| +|..++...+.++++.++.++.+++.||.|||+++|+|||+||.|||+.   ..+.+|+||||+|+.+..+..
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhhcccCce
Confidence            999977 9999999999999999999999999999999999999999999999994   556799999999998876654


Q ss_pred             -cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          216 -FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       216 -~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                       .....|||.|||||.+. ++|+..+|+|||||++||+++|++||....-......|.....    .+.+..+..+..|+
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v----~~p~~~S~~f~nfl  231 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV----KPPSTASSSFVNFL  231 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC----CCcccccHHHHHHH
Confidence             34567999999999988 6799999999999999999999999988766665555554432    22347899999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcccccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ..+|.+||.+|.|+.+++.|||.+...
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhhh
Confidence            999999999999999999999998643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-49  Score=373.77  Aligned_cols=265  Identities=31%  Similarity=0.512  Sum_probs=227.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..-..+|++...||.|.-++||+|++..+++.||||++...+...  +.+.+++|++.++.+ +||||++++..|..+..
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhc-CCCCcceEEEEEEecce
Confidence            334557999999999999999999999999999999998876544  378999999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          132 VHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +|+||.||.+||+.+.+...-  .+++..++.|++++++||.|||.+|.||||||+.||||++   ++.|||+|||.+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~---dG~VkLadFgvsa~  175 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDS---DGTVKLADFGVSAS  175 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcC---CCcEEEcCceeeee
Confidence            999999999999999987643  3899999999999999999999999999999999999965   45599999998765


Q ss_pred             cCC-CCc----cccccCCcccccchhcc---ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC----
Q 009594          210 FRP-GEQ----FNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF----  277 (531)
Q Consensus       210 ~~~-~~~----~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----  277 (531)
                      +.. +..    .++.+||+.|||||++.   ..|+.|+||||||++..||.+|..||.......++..-++...+.    
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~  255 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS  255 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence            433 221    25568999999999964   369999999999999999999999998888777665555544321    


Q ss_pred             --CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          278 --KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       278 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                        ..+.....+..+.+++..||.+||.+|||++++|+|+||+..+..
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence              122234567889999999999999999999999999999987643

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-50  Score=379.01  Aligned_cols=258  Identities=34%  Similarity=0.547  Sum_probs=212.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC--eEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS--AVH  133 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~~~  133 (531)
                      .+|...+.||+|+||.||++.+..+|..+|+|.+......   ..+.+.+|+.+|.+| +|||||+++|......  .++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeE
Confidence            3588899999999999999999999999999999766321   167789999999999 6999999999855444  699


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |+|||+++|+|.+++.+.+ .+++..++.++.||+.||.|||++|||||||||+|||++..  ++.+||+|||++.....
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCcccccccc
Confidence            9999999999999999877 79999999999999999999999999999999999999752  34599999999987653


Q ss_pred             ----CCccccccCCcccccchhcccc-C-CCccchhHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhcccCCCCCCCCCC
Q 009594          213 ----GEQFNEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       213 ----~~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                          ........||+.|||||++... . ..++|||||||++.||+||.+||... ......-.+......  +.....+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~--P~ip~~l  248 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL--PEIPDSL  248 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC--CCCCccc
Confidence                1223457899999999998843 2 34999999999999999999999763 222222223222211  1222358


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      |+++++||.+|+..+|++||||.++|+|||.+....
T Consensus       249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            999999999999999999999999999999986443

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-49  Score=369.96  Aligned_cols=261  Identities=36%  Similarity=0.688  Sum_probs=241.0

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..+..+|++.+.||+|+||.|-+|.+...|+.||||.+.+..+.+..++-.+++||+||..| +||||+.+|++|+..+.
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDK  127 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCce
Confidence            45667899999999999999999999999999999999999999999999999999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ..|||||..+|.|++++.+++.+++.+++.+++||.+|+.|+|+++++|||||.+|||++.+   .++||+|||++..+.
T Consensus       128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N---~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN---NNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC---CCeeeeccchhhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999654   459999999999998


Q ss_pred             CCCccccccCCcccccchhcccc-C-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ......+++|+|.|.+||+++|. | ++.+|-|||||+||.|+.|..||.+.+......++.++....     |..|..+
T Consensus       205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE-----P~~PSdA  279 (668)
T KOG0611|consen  205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE-----PETPSDA  279 (668)
T ss_pred             cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC-----CCCCchH
Confidence            88888999999999999999963 4 678999999999999999999999999988888888776543     2446778


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .-||..||..||++|.|+.+|..|-|......
T Consensus       280 ~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~  311 (668)
T KOG0611|consen  280 SGLIRWMLMVNPERRATIEDIASHWWVNWGYN  311 (668)
T ss_pred             HHHHHHHHhcCcccchhHHHHhhhheeecccc
Confidence            89999999999999999999999999975443

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-49  Score=375.01  Aligned_cols=272  Identities=35%  Similarity=0.661  Sum_probs=231.3

Q ss_pred             ccCCCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC-----------hhhHHHHHHHHHHHHhCC
Q 009594           46 LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----------AVDIEDVRREVQIMKHLP  114 (531)
Q Consensus        46 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~  114 (531)
                      ....++...-++|++++.||+|.||.|-+|++..+++.||||++.+.....           ...++.+++||.+|++| 
T Consensus        87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-  165 (576)
T KOG0585|consen   87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-  165 (576)
T ss_pred             ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-
Confidence            344555666778999999999999999999999999999999998654321           12356899999999999 


Q ss_pred             CCCCeeecceEEEc--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeec
Q 009594          115 KHPNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFAN  192 (531)
Q Consensus       115 ~h~niv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~  192 (531)
                      .|||||+|+++..+  .+.+|||+|||..|.+...-.....+++.+++.|+++++.||+|||.+|||||||||+|+|+++
T Consensus       166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence            99999999999876  4679999999999888643322323899999999999999999999999999999999999964


Q ss_pred             CCCCCCeEEEeeccccccCCC------CccccccCCcccccchhccc-c----CCCccchhHHHHHHHHHhhCCCCCCCC
Q 009594          193 KKESSPLKAIDFGLSVFFRPG------EQFNEIVGSPYYMAPEVLKR-N----YGPEVDVWSAGVILYILLCGVPPFWAE  261 (531)
Q Consensus       193 ~~~~~~ikl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~-~----~~~~~Di~slG~il~~l~tg~~pf~~~  261 (531)
                         +++|||+|||.+.....+      ......+|||.|+|||.+.+ .    .+.+.||||+||+||.|+.|+.||.+.
T Consensus       246 ---~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  246 ---DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             ---CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence               466999999999866322      23445789999999998764 2    356899999999999999999999999


Q ss_pred             CHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCC
Q 009594          262 TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP  323 (531)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~  323 (531)
                      ...+...+|+...+.++..  +.+.+.+++||.+||.+||++|++..+|..|||.......+
T Consensus       323 ~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  323 FELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             hHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            9999999999988877765  46789999999999999999999999999999998764433

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-49  Score=384.79  Aligned_cols=258  Identities=33%  Similarity=0.562  Sum_probs=222.9

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ...|....+||+|+.|.||.|....+++.||||.+......   ..+-+.+|+.+|+.+ .|+|||.+++.|...+.+++
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEE
Confidence            34688899999999999999999999999999999876533   246788999999999 99999999999988899999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||||++||+|.+.+... .+++.+++.|+++++.||+|||.+||+|||||.+|||+..+   +.+||+|||++..+....
T Consensus       348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~---g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD---GSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC---CcEEEeeeeeeecccccc
Confidence            99999999999987655 58999999999999999999999999999999999999654   449999999998776554


Q ss_pred             -ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 -QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                       .-.+.+|||.|||||++. ..|++++||||||++++||+-|++||...+.......+. .........+..+|+.+++|
T Consensus       424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-hcCCCCcCCccccCHHHHHH
Confidence             456789999999999987 689999999999999999999999998766544433333 22233333456799999999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +.+||..|+++|+|+.++|+||||+.+..
T Consensus       503 L~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  503 LDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            99999999999999999999999965443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.3e-49  Score=359.68  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=223.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--CCeEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAVH  133 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~  133 (531)
                      ++|+.+..|++|+||.||+|+++.+++.||+|+++...-.....+. .++||.+|.++ +|||||.+-++...  -+.+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIt-sLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPIT-SLREINILLKA-RHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcch-hHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence            3699999999999999999999999999999999877644444444 45699999999 89999999998764  45699


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||||+ .+|..++...+ ++...++..++.|++.||+|||.+.|+||||||+|+|+...   +.+||+|||+|+.+..
T Consensus       154 ~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~---G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  154 IVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK---GILKIADFGLAREYGS  229 (419)
T ss_pred             eeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC---CcEEecccchhhhhcC
Confidence            9999996 59999888765 79999999999999999999999999999999999999654   4599999999998865


Q ss_pred             C-CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCC-----
Q 009594          213 G-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-----  284 (531)
Q Consensus       213 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----  284 (531)
                      . ..+...+-|.+|+|||.+.+  .|+.+.|+||+|||+.||+++++.|.+.+..+++..|.+.........|+.     
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            4 34566778999999999875  599999999999999999999999999999999888876554433333332     


Q ss_pred             -----------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          285 -----------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       285 -----------------------~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                             +++...+|+..+|.+||.+|.|+.++|+|+||....
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                                   346778999999999999999999999999998744

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-50  Score=349.78  Aligned_cols=254  Identities=32%  Similarity=0.619  Sum_probs=232.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|-||.||+|+.+.++..||+|++.++.+.......++.+|++|-..| +||||+++|++|.+....|++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccceeEEE
Confidence            4699999999999999999999999999999999988776666678899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          136 MELCEGGELFDRIV--ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||.+.|+|+..|.  ...++++...+.++.|++.||.|+|.++||||||||+|+|++..+   .+||+|||.+...+ .
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~---~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG---ELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC---CeeccCCCceeecC-C
Confidence            99999999999998  556799999999999999999999999999999999999996554   49999999988755 4


Q ss_pred             CccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ..-.+.+||..|.|||+..+ .++..+|+|++|++.||++.|.+||...+..+..+.+.+....++    ..++..+.++
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl  252 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL  252 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence            44567899999999999984 689999999999999999999999999998888998888776655    4789999999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcccc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      |.+||.++|.+|.+..|++.|||+..
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHh
Confidence            99999999999999999999999874

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=366.47  Aligned_cols=261  Identities=34%  Similarity=0.541  Sum_probs=222.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-----C
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-----D  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-----~  129 (531)
                      ...|..++.||.|+||.|+.|.++.+|+.||||++.. .+......+...+|+.+|+.+ +|+||+.+.+++..     -
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHh-cCCCcceEEeeccccccccc
Confidence            3457778999999999999999999999999999863 234555678889999999999 79999999999854     4


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +.+|+|+|+| +-+|...++.+..+++..+..+++|++.||.|+|+.+|+||||||+|+|++.   +..+||+|||+|+.
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~---~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA---DCDLKICDFGLARY  174 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc---CCCEEeccccceee
Confidence            5799999999 5699999988877999999999999999999999999999999999999964   44589999999998


Q ss_pred             cCC---CCccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC--------
Q 009594          210 FRP---GEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--------  276 (531)
Q Consensus       210 ~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------  276 (531)
                      ..+   ...+..++.|.+|+|||++.  ..|+...||||+|||+.||++|++.|.+.+...++..+......        
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            864   34456788999999999865  57999999999999999999999999998777666655432211        


Q ss_pred             ---------------CCCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          277 ---------------FKRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       277 ---------------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                     .+..    .+++.++.+.+|+.+||..||.+|+|++|+|.||||.....
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence                           1111    24678899999999999999999999999999999986543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-49  Score=389.18  Aligned_cols=260  Identities=30%  Similarity=0.530  Sum_probs=234.9

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .-..+|.+++.||+|+||+|++|..+.+++.+|||++++..+-...+.+....|.+|+....+||.++.++.+|+..+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            33457999999999999999999999999999999999998888888999999999999998899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-  211 (531)
                      |+||||+.||++.. +...+.+++..++-|+..|+.||.|||++||||||||.+|||++.   .+++||+|||+++..- 
T Consensus       445 ~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~---eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT---EGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc---cCcEEecccccccccCC
Confidence            99999999999544 334567999999999999999999999999999999999999964   4569999999998654 


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .+....+++|||.|||||++. +.|+.++|+|||||+||||+.|.+||.+.++.++...|+.....++.    .+|.++.
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~  596 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAI  596 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHH
Confidence            455678899999999999998 57999999999999999999999999999999999999876554432    5799999


Q ss_pred             HHHHHccccCcCCCCC-----HHHHhcCCcccccc
Q 009594          291 DLVKKMLNPDPKQRLT-----AEEVLEHPWLQNAK  320 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps-----~~~~l~h~~~~~~~  320 (531)
                      +++.++|.++|++|..     +.+|..||||+.+.
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            9999999999999994     68999999998765

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-48  Score=364.64  Aligned_cols=260  Identities=32%  Similarity=0.554  Sum_probs=233.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++++.||.|.-|+||+|....++..+|+|++.+..+.....+.....|-+||+.+ +||.++.||..|+.....|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence            4699999999999999999999999999999999998877777788888999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-
Q 009594          136 MELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-  212 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-  212 (531)
                      ||||+||+|..+++++.  .+++..++-++..++.||+|||..|||+|||||+||||.   ++++|.|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr---edGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR---EDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe---cCCcEEeeeccccccCCCC
Confidence            99999999999887654  499999999999999999999999999999999999995   456699999998742210 


Q ss_pred             ----------------------------------C----------------------CccccccCCcccccchhccc-cC
Q 009594          213 ----------------------------------G----------------------EQFNEIVGSPYYMAPEVLKR-NY  235 (531)
Q Consensus       213 ----------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~-~~  235 (531)
                                                        .                      ...++.+||-.|.|||++.| ..
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                              0                      01134679999999999995 58


Q ss_pred             CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCC----HHHHh
Q 009594          236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT----AEEVL  311 (531)
Q Consensus       236 ~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l  311 (531)
                      +.++|+|+|||++|||+.|..||.+.+..++..+++.....++..+  .++..+++||+++|.+||.+|..    +.||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999999999999999999999999999888877663  77899999999999999999998    99999


Q ss_pred             cCCccccccc
Q 009594          312 EHPWLQNAKK  321 (531)
Q Consensus       312 ~h~~~~~~~~  321 (531)
                      +||||+..+.
T Consensus       391 ~HpFF~gVnW  400 (459)
T KOG0610|consen  391 RHPFFEGVNW  400 (459)
T ss_pred             cCccccCCCh
Confidence            9999987653

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-49  Score=353.82  Aligned_cols=269  Identities=42%  Similarity=0.737  Sum_probs=240.3

Q ss_pred             ccccceeec-cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE----
Q 009594           53 DISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE----  127 (531)
Q Consensus        53 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~----  127 (531)
                      .+.++|.+. +.||-|-.|.|..+.++.+|+.+|+|++...        ...++|+++.-..+.|||||.++++|+    
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            356678775 5699999999999999999999999988532        466788888877789999999999975    


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                      ....+.||||.++||.|++.+..++.  +++.++..|+.||+.|+.|||+.+|.||||||+|+|+.....+..+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence            35678899999999999999998776  9999999999999999999999999999999999999998889999999999


Q ss_pred             cccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHhcccCCCCC
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVIDFKRD  280 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~  280 (531)
                      +|+.-.......+.+-||.|.|||++. ..|+..+|+||+||++|-|++|.+||+...    ..+....|..+...|+.+
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            999876666677888999999999997 679999999999999999999999998764    345667788888999999


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCchh
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE  329 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~  329 (531)
                      .|..+|+..+++|+.+|..+|++|.|+.++++|||+.....-|.+.+..
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t  338 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST  338 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence            9999999999999999999999999999999999999887777666543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-48  Score=378.22  Aligned_cols=247  Identities=30%  Similarity=0.462  Sum_probs=211.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcE-EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-eEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEK-FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-AVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~~~l  134 (531)
                      ...+.+.||+|+||+||+|.  ..|+. ||+|++......... ...+.+|+.+|.++ +|||||+++|++.... .++|
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             HhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceEE
Confidence            35566779999999999998  56667 999999876554443 67999999999999 9999999999999887 7999


Q ss_pred             EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          135 VMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQG-VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~-iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ||||+++|+|..++..  ...++...+..++.||+.||.|||+++ ||||||||+|||++.+.  .++||+|||+++...
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREKV  195 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceeec
Confidence            9999999999999987  578999999999999999999999999 99999999999996543  369999999998765


Q ss_pred             CC-CccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC-CCC
Q 009594          212 PG-EQFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVS  286 (531)
Q Consensus       212 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  286 (531)
                      .. .......||+.|||||++.+   .|+.|+||||||+++|||+||..||...........+.....   ++..+ .++
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~---Rp~~p~~~~  272 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL---RPPIPKECP  272 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC---CCCCCccCC
Confidence            44 33344789999999999984   499999999999999999999999999887555555554433   23323 389


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +.+..|+..||..+|+.||++.+++.
T Consensus       273 ~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  273 PHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            99999999999999999999999865

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-48  Score=375.81  Aligned_cols=253  Identities=30%  Similarity=0.549  Sum_probs=222.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+.+++||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEE
Confidence            699999999999999999999999999999999765443333456788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF  216 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~  216 (531)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.   ++.+||+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~---~~~~kl~Dfg~~~~~~~~--~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK---EGHIKLTDFGFAKKLRDR--T  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC---CCCEEEEecCcchhccCC--c
Confidence            99999999999988888999999999999999999999999999999999999964   345999999998865432  2


Q ss_pred             ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK  295 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  295 (531)
                      ....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++    ..+++.+.+||.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~  231 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIKK  231 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHHHH
Confidence            3457899999999887 4588999999999999999999999998887777777766544332    2468899999999


Q ss_pred             ccccCcCCCCC-----HHHHhcCCccccc
Q 009594          296 MLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       296 ~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      ||+.||.+||+     +.++++||||...
T Consensus       232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         232 LLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            99999999995     9999999999754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-47  Score=373.07  Aligned_cols=259  Identities=29%  Similarity=0.490  Sum_probs=218.0

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence            78889999999999999999999999999999765544333345678899999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          138 LCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       138 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |+++|+|..++...  ..+++..+..++.|++.||.|||++||+||||||+|||+++   ++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD---RGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC---CCCEEEeeCCCcEEcCCCCe
Confidence            99999998887543  35899999999999999999999999999999999999964   34599999999987655444


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+..............+++.+.+|+.
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            45567999999999887 57899999999999999999999999876554333333332222222333468999999999


Q ss_pred             HccccCcCCCCC-----HHHHhcCCcccccc
Q 009594          295 KMLNPDPKQRLT-----AEEVLEHPWLQNAK  320 (531)
Q Consensus       295 ~~l~~~p~~Rps-----~~~~l~h~~~~~~~  320 (531)
                      +||+.+|++||+     ++++++||||....
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999997     89999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=375.19  Aligned_cols=272  Identities=28%  Similarity=0.466  Sum_probs=229.7

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|+..+.||+|+||.||+|.+..+++.||+|++.....  ..+++.+.+|+.+|.++ ++|||.++|+.|..+..++++|
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHH
Confidence            58888999999999999999999999999999987653  33578899999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~-  215 (531)
                      |||.||++.+.+.....+.+..+.-++++++.||.|||..+.+|||||+.|||+..+   +.+||+|||.+..+..... 
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~---g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES---GDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc---CcEEEEecceeeeeechhhc
Confidence            999999999999887777999999999999999999999999999999999999765   4599999999987765443 


Q ss_pred             cccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC-CCCCCHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP-WPKVSENAKDLV  293 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li  293 (531)
                      ..+++|||.|||||++.+ .|+.++||||||++.|||.+|.+|+.......+.-.|    .....+. -..+++.+++||
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----pk~~PP~L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----PKSAPPRLDGDFSPPFKEFV  243 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----cCCCCCccccccCHHHHHHH
Confidence            367899999999999985 7999999999999999999999999776653222211    1111111 125789999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhhhHH
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM  341 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (531)
                      ..||.+||+.||||.++|+|+|++++.+   .+...++.++.++++..
T Consensus       244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~k---~s~L~~~i~r~~~~~~~  288 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLKHKFIKRAKK---TSELKELIDRYKRWRVK  288 (467)
T ss_pred             HHHhhcCcccCcCHHHHhhhHHHHhcCC---chHHHHHHHHHHHHhhc
Confidence            9999999999999999999999998433   33345556666655544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-47  Score=380.67  Aligned_cols=254  Identities=32%  Similarity=0.615  Sum_probs=222.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++++ +||||+++++++...+..++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEE
Confidence            5799999999999999999999999999999999765443334456788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++......  
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK---GHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC---CCEEEeeccCceEcCCC--
Confidence            9999999999999888889999999999999999999999999999999999999654   45999999999866432  


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......++    ..+++.+.+||.
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  247 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLVK  247 (329)
T ss_pred             cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHHHH
Confidence            23457999999999887 4688999999999999999999999988877766666665543322    237889999999


Q ss_pred             HccccCcCCCCC-----HHHHhcCCccccc
Q 009594          295 KMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       295 ~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      +||+.||.+||+     +.++++||||+..
T Consensus       248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            999999999997     7999999999863

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-47  Score=379.95  Aligned_cols=257  Identities=33%  Similarity=0.552  Sum_probs=222.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..|+||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEEE
Confidence            699999999999999999999999999999999866444344456788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF  216 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~  216 (531)
                      ||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++.....  ..
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA---SGHIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC---CCCEEEEeCcCCccccc--cc
Confidence            99999999999988888999999999999999999999999999999999999964   44599999999876543  33


Q ss_pred             ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC----CCCCHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW----PKVSENAKD  291 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  291 (531)
                      ....||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+.........+.+    ..+++++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            4567999999999887 56899999999999999999999999888777766666543322222222    256899999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ||.+||..+|.+|||+.++++||||...
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            9999999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-47  Score=378.33  Aligned_cols=250  Identities=32%  Similarity=0.581  Sum_probs=217.1

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999999999999999999865444444556778899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~  220 (531)
                      ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+   +.+||+|||++..... ........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---CCEEEeeCCCCcccccCCCccccee
Confidence            9999999888889999999999999999999999999999999999999654   4599999999875322 23334567


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......++    ..+++.+.+||.+||..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            999999999987 5689999999999999999999999988777666666554433322    35789999999999999


Q ss_pred             CcCCCC-----CHHHHhcCCccccc
Q 009594          300 DPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      ||++||     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.4e-47  Score=382.35  Aligned_cols=260  Identities=27%  Similarity=0.477  Sum_probs=219.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++.++ +||||+++++.+.+...+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence            3699999999999999999999999999999999765443344456788899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      |||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.   ++.+||+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~---~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS---KGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC---CCCEEEeeccCccccccccc
Confidence            999999999999988888999999999999999999999999999999999999964   4469999999987543211 


Q ss_pred             -----------------------------------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCC
Q 009594          215 -----------------------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF  258 (531)
Q Consensus       215 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf  258 (531)
                                                         .....+||+.|+|||++. ..++.++|||||||++|+|++|.+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                               012357999999999986 56899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc--CcCCCCCHHHHhcCCccccc
Q 009594          259 WAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP--DPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+.+.......+.........+....+++.++++|.+|+..  ++..||++.++++||||+..
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence            98887777777765433322233345789999999997652  23346899999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-47  Score=382.73  Aligned_cols=259  Identities=29%  Similarity=0.546  Sum_probs=221.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence            3699999999999999999999999999999999765443344456778899999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++........
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~---~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA---KGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC---CCCEEEeecccceecccccc
Confidence            999999999999988888999999999999999999999999999999999999964   44599999999865432110


Q ss_pred             ---------------------------------------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCC
Q 009594          216 ---------------------------------------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV  255 (531)
Q Consensus       216 ---------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~  255 (531)
                                                             ....+||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                   01246899999999876 56899999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCC---HHHHhcCCccccc
Q 009594          256 PPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNA  319 (531)
Q Consensus       256 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~h~~~~~~  319 (531)
                      +||...+.......+.........+....+++.+.+||.+||. +|.+|++   +.++++||||+..
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999888777666665543333333334578999999999997 8999998   9999999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-47  Score=356.14  Aligned_cols=261  Identities=31%  Similarity=0.523  Sum_probs=222.4

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC-
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-  129 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  129 (531)
                      +......|.-.+.+|+|+||.||+|....+++.||||++....-       --.+|+++|+.+ +|||||++.-+|... 
T Consensus        19 ~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l-~HpNIV~L~~~f~~~~   90 (364)
T KOG0658|consen   19 GKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKL-DHPNIVRLLYFFSSST   90 (364)
T ss_pred             CcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhc-CCcCeeeEEEEEEecC
Confidence            44566679999999999999999999999999999998865432       123599999998 999999999888532 


Q ss_pred             -C---eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEE
Q 009594          130 -S---AVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       130 -~---~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                       .   ...+||||++. +|.+.+..    +..++...++-++.||++||.|||+.||+||||||.|+|++.+  .+.+||
T Consensus        91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~--tg~LKi  167 (364)
T KOG0658|consen   91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD--TGVLKI  167 (364)
T ss_pred             CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC--CCeEEe
Confidence             2   45689999975 99888874    5678999999999999999999999999999999999999854  567999


Q ss_pred             EeeccccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--
Q 009594          202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--  277 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--  277 (531)
                      ||||.|+.+..++...++..|..|+|||.+.|  .|+.+.||||.||++.||+-|++.|.+.+..+++..+.+....+  
T Consensus       168 cDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             ccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence            99999999998888888889999999998874  69999999999999999999999999999888887776533111  


Q ss_pred             ------------------CCCCC-----CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          278 ------------------KRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       278 ------------------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                                        ....|     ...++++.+|+.++|.++|.+|.++.|++.||||......
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                              11122     3478999999999999999999999999999999876654

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-47  Score=377.00  Aligned_cols=255  Identities=31%  Similarity=0.553  Sum_probs=221.7

Q ss_pred             ccceeeccccCccCceEEEEEEEccCC-cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNG-EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++.............+.+|+.+++.+ +||||+++++++...+.++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEE
Confidence            346999999999999999999876554 68999999765443444456788999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++......
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~---~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK---DGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC---CCCEEEecCCCCeecCCC
Confidence            99999999999999988888999999999999999999999999999999999999954   456999999999865432


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                        .....||+.|+|||++. ..++.++|||||||++|+|++|.+||...+.......+......++    +.+++.+.++
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  258 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHL  258 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHH
Confidence              23567999999999987 4588999999999999999999999998887777777766544332    3578899999


Q ss_pred             HHHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          293 VKKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       293 i~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      |.+||+.+|++|+     |+.++++||||.+.
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999995     89999999999864

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-46  Score=381.10  Aligned_cols=259  Identities=29%  Similarity=0.493  Sum_probs=218.6

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|++++.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+.+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence            589999999999999999999999999999999876554444567788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC--
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~--  214 (531)
                      ||++||+|.+++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.   .+.+||+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~---~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL---DGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC---CCCEEEeeCcCCccccccccc
Confidence            99999999999988888999999999999999999999999999999999999964   4469999999875321000  


Q ss_pred             ----------------------------------------------ccccccCCcccccchhcc-ccCCCccchhHHHHH
Q 009594          215 ----------------------------------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI  247 (531)
Q Consensus       215 ----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~i  247 (531)
                                                                    .....+||+.|+|||++. ..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                          012357999999999886 568999999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcc--ccCcCCCCCHHHHhcCCccccc
Q 009594          248 LYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML--NPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       248 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l--~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +|+|+||.+||...+.......+.........+.+..+++++.+||.+|+  ..+|..||++.++++||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99999999999887766655555543333333444568999999999955  4555569999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-46  Score=370.38  Aligned_cols=248  Identities=29%  Similarity=0.559  Sum_probs=215.3

Q ss_pred             cCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCc
Q 009594           64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE  143 (531)
Q Consensus        64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  143 (531)
                      ||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++...+..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            79999999999999999999999999765444444567788899999999 99999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-CccccccCC
Q 009594          144 LFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIVGS  222 (531)
Q Consensus       144 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt  222 (531)
                      |.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++...... .......||
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ---GHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC---CcEEEEECcccccCccCCCccccccCC
Confidence            99999888889999999999999999999999999999999999999644   45999999998754322 223456799


Q ss_pred             cccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCc
Q 009594          223 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP  301 (531)
Q Consensus       223 ~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  301 (531)
                      +.|+|||++. ..++.++|||||||++|+|++|..||...........+......+    ...+++.+.++|.+||..+|
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF----PDGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC----CCcCCHHHHHHHHHHcCCCH
Confidence            9999999887 468999999999999999999999998887777666665543332    24578999999999999999


Q ss_pred             CCCC---CHHHHhcCCccccc
Q 009594          302 KQRL---TAEEVLEHPWLQNA  319 (531)
Q Consensus       302 ~~Rp---s~~~~l~h~~~~~~  319 (531)
                      .+||   ++.++++||||...
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCC
Confidence            9997   58999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-47  Score=379.31  Aligned_cols=259  Identities=35%  Similarity=0.628  Sum_probs=224.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence            3699999999999999999999999999999999865544434566788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++....... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD---GHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEeecCCCCccCcccCc
Confidence            9999999999999888889999999999999999999999999999999999999654   459999999987654332 


Q ss_pred             -----------------------------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH
Q 009594          215 -----------------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ  264 (531)
Q Consensus       215 -----------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~  264 (531)
                                                   ......||+.|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                         223456899999999887 56899999999999999999999999888877


Q ss_pred             HHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCC-HHHHhcCCccccc
Q 009594          265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT-AEEVLEHPWLQNA  319 (531)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~~l~h~~~~~~  319 (531)
                      .....+.........+....+++.+.+||.+||. +|.+||+ +.++++||||+..
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            7666666533333333334579999999999997 9999999 9999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-46  Score=381.46  Aligned_cols=258  Identities=31%  Similarity=0.536  Sum_probs=220.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++++ +||||+++++++.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence            589999999999999999999999999999999765443344566788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC---
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG---  213 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~---  213 (531)
                      ||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~---~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEEeECCCCccccccccc
Confidence            99999999999988888999999999999999999999999999999999999964   446999999997532100   


Q ss_pred             ---------------------------------------------CccccccCCcccccchhcc-ccCCCccchhHHHHH
Q 009594          214 ---------------------------------------------EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI  247 (531)
Q Consensus       214 ---------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~i  247 (531)
                                                                   ......+||+.|+|||++. ..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         0012346899999999886 568999999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCC---HHHHhcCCccccc
Q 009594          248 LYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNA  319 (531)
Q Consensus       248 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~h~~~~~~  319 (531)
                      +|+|++|.+||...+.......+.........+....+++++.++|.+|+ .+|.+|++   +.++++||||+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999999988777666666554444444445678999999999986 59999997   9999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-46  Score=380.72  Aligned_cols=258  Identities=28%  Similarity=0.529  Sum_probs=217.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++ +||||+++++++.+...+|+||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEE
Confidence            699999999999999999999999999999999765443344566788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~-  215 (531)
                      ||++||+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.   ++.+||+|||+++....... 
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~---~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR---GGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC---CCCEEEeeccccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999964   44599999999863211000 


Q ss_pred             -----------------------------------------------cccccCCcccccchhcc-ccCCCccchhHHHHH
Q 009594          216 -----------------------------------------------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI  247 (531)
Q Consensus       216 -----------------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~i  247 (531)
                                                                     ....+||+.|+|||++. ..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                           01246899999999886 568999999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCC---CCHHHHhcCCccccc
Q 009594          248 LYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQR---LTAEEVLEHPWLQNA  319 (531)
Q Consensus       248 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~~~l~h~~~~~~  319 (531)
                      +|+|+||.+||...........+.........+....++..+.+||.+||. +|.+|   +|+.+++.||||+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999998877766666665433222222234578999999999998 66665   599999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.8e-46  Score=377.36  Aligned_cols=261  Identities=32%  Similarity=0.509  Sum_probs=222.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      -..+|++.+.||+|+||.||+|++..++..||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEE
Confidence            345799999999999999999999999999999999765433333445677899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~---~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC---CCCEEEEeccceeeccCC
Confidence            999999999999988654 6899999999999999999999999999999999999964   455999999998765433


Q ss_pred             C--ccccccCCcccccchhccc-----cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          214 E--QFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       214 ~--~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .  ......||+.|+|||++.+     .++.++|||||||++|+|++|.+||...+.......+.........+....++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence            2  2234679999999998753     37889999999999999999999999888777777776544333333344689


Q ss_pred             HHHHHHHHHccccCcCC--CCCHHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~--Rps~~~~l~h~~~~~~  319 (531)
                      ..+.+||.+||..+|.+  |+|+.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            99999999999999988  9999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.9e-47  Score=381.48  Aligned_cols=258  Identities=29%  Similarity=0.507  Sum_probs=218.8

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++++ +||||+++++.+.+.+.+|+||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEE
Confidence            699999999999999999999999999999999765433333456788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC---
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG---  213 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~---  213 (531)
                      ||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|......   
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~---~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC---CCCEEEEeCCCCccccccccc
Confidence            99999999999988888999999999999999999999999999999999999964   445999999997532100   


Q ss_pred             -----------------------------------------CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHH
Q 009594          214 -----------------------------------------EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYIL  251 (531)
Q Consensus       214 -----------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l  251 (531)
                                                               ......+||+.|+|||++. ..++.++|||||||++|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                     0011346999999999987 5689999999999999999


Q ss_pred             hhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCC---CHHHHhcCCccccc
Q 009594          252 LCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNA  319 (531)
Q Consensus       252 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~~  319 (531)
                      ++|..||......+....+.........+.+..+++.+.++|.+|+ .+|.+|+   |+.++++||||+..
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            9999999888776665555544333333444568999999999977 5999999   99999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-46  Score=370.69  Aligned_cols=250  Identities=32%  Similarity=0.586  Sum_probs=216.3

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|++..+|..||+|++.............+.+|+.+++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            3689999999999999999999999999865443444556778899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~  220 (531)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..... ........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC---CCEEecccHHhccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999654   4599999999875322 22334567


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. +.++.++|||||||++|+|++|..||...+.......+......++    ..+++.+.++|.+||..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            999999999886 5689999999999999999999999988777666666554433322    35789999999999999


Q ss_pred             CcCCCC-----CHHHHhcCCccccc
Q 009594          300 DPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +|.+||     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            999998     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.1e-46  Score=371.11  Aligned_cols=250  Identities=30%  Similarity=0.567  Sum_probs=215.8

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999999999999999999865444444567788899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~  220 (531)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..... ........
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD---GHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC---CcEEEecCcCCccCCCccccccccc
Confidence            9999999888889999999999999999999999999999999999999644   4599999999875432 22334467


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......++    ..+++.+.+||.+||.+
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence            999999999987 5689999999999999999999999988777666555544333222    35789999999999999


Q ss_pred             CcCCCC-----CHHHHhcCCccccc
Q 009594          300 DPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +|++||     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999997     89999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-46  Score=369.94  Aligned_cols=251  Identities=31%  Similarity=0.560  Sum_probs=216.5

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999999999999999997654333344567778999998876899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~  220 (531)
                      |+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..... ........
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---CcEEEeeCCCCeecCcCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999654   4599999999875432 22334567


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+.......+    ..+++++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence            999999999887 5688999999999999999999999998888777776665433222    34789999999999999


Q ss_pred             CcCCCCCH------HHHhcCCccccc
Q 009594          300 DPKQRLTA------EEVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rps~------~~~l~h~~~~~~  319 (531)
                      ||++||++      .++++||||+..
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            99999998      999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-46  Score=347.49  Aligned_cols=260  Identities=30%  Similarity=0.512  Sum_probs=221.5

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCC-eeecceEEEcCC----
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN-IVSLKDTYEDDS----  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~----  130 (531)
                      ..|..+++||+|+||+||+|+++.+|+.||+|++....-... .-....+|+.+++.| +|+| |+.+++++...+    
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence            458888999999999999999999999999999976543211 224557899999999 9999 999999998766    


Q ss_pred             --eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          131 --AVHIVMELCEGGELFDRIVARG----HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       131 --~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                        .+++|+||++ -+|..++...+    .++...+..++.||+.||+|||+++|+||||||.|||+++   .+.+||+||
T Consensus        89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~---~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS---SGVLKLADF  164 (323)
T ss_pred             cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC---CCcEeeecc
Confidence              8999999996 59999987755    4788999999999999999999999999999999999975   456999999


Q ss_pred             ccccccC-CCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 009594          205 GLSVFFR-PGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       205 g~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  281 (531)
                      |+|+... +...+...++|.+|+|||++.+  .|+...||||+|||++||+++++.|.+.++.++...+.+..-......
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9999776 4445667789999999999875  599999999999999999999999999999888887776554443333


Q ss_pred             CCC--------------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          282 WPK--------------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       282 ~~~--------------------------~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ||.                          ..+...+++.+||+++|.+|.|+..+|.||||.....
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            332                          2347899999999999999999999999999987643

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.8e-46  Score=363.86  Aligned_cols=254  Identities=27%  Similarity=0.439  Sum_probs=210.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||.|+||.||+|.+..++..||+|++......  .....+.+|+.+++++ +||||+++++++...+..++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEE
Confidence            3599999999999999999999999999999998654321  1234667899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.......
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK---GELKLADFGLARAKSVPT  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEECcCcceeeccCCC
Confidence            999975 8988886654 47899999999999999999999999999999999999654   459999999987643322


Q ss_pred             -ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC-----------
Q 009594          215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD-----------  280 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  280 (531)
                       ......+++.|+|||++.+  .++.++|||||||++|+|+||.+||.+.+..+....+.+........           
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence             2334568999999998753  58899999999999999999999998877666555544322111110           


Q ss_pred             ---------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          281 ---------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       281 ---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                     ..+.+++++.+||.+||..||.+|||+.|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                           113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.9e-46  Score=375.34  Aligned_cols=261  Identities=31%  Similarity=0.503  Sum_probs=220.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|++.+.||+|+||.||+|.+..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++++.+...+|
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEE
Confidence            446799999999999999999999999999999999764443334456678899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~---~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH---GHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC---CCEEEEecccceecccC
Confidence            999999999999988654 68999999999999999999999999999999999999644   45999999999876433


Q ss_pred             Cc--cccccCCcccccchhccc-----cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          214 EQ--FNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       214 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ..  .....||+.|+|||++.+     .++.++|||||||++|+|++|.+||...+.......+.........+....++
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  275 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS  275 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence            22  235679999999998863     27889999999999999999999999888777777766544333333334578


Q ss_pred             HHHHHHHHHccccCcCC--CCCHHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~--Rps~~~~l~h~~~~~~  319 (531)
                      +.+++++..||..+|.+  |+|+.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99999999999866554  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-47  Score=344.28  Aligned_cols=266  Identities=36%  Similarity=0.639  Sum_probs=234.0

Q ss_pred             cccceee-ccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           54 ISIDYDL-GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        54 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      +.+-|++ .+.||+|+|+.|-.+....+|..||||++.+..   ......+.+|++++.+.++|+||++++++|+++..+
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            4444665 466999999999999999999999999998763   334578899999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |+|||.+.||+|...|.++..+++.++..+..+|+.||.+||.+||.||||||+|||..+.+.-..||||||.+..-+..
T Consensus       152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999998777767799999998654322


Q ss_pred             C--------CccccccCCcccccchhcc---c---cCCCccchhHHHHHHHHHhhCCCCCCCCC---------------H
Q 009594          213 G--------EQFNEIVGSPYYMAPEVLK---R---NYGPEVDVWSAGVILYILLCGVPPFWAET---------------E  263 (531)
Q Consensus       213 ~--------~~~~~~~gt~~y~aPE~~~---~---~~~~~~Di~slG~il~~l~tg~~pf~~~~---------------~  263 (531)
                      .        ....+.+|+-.|||||++.   +   -|+.++|.||||||+|-|++|.+||.+.-               .
T Consensus       232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ  311 (463)
T KOG0607|consen  232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ  311 (463)
T ss_pred             CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence            1        2234567888999999763   2   38899999999999999999999996642               4


Q ss_pred             HHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                      +...+.|..+..+++...|..+|.+.++++..+|..++.+|.++.++++|||++.....
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            45667788889999999999999999999999999999999999999999999976654

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.6e-46  Score=367.82  Aligned_cols=256  Identities=29%  Similarity=0.506  Sum_probs=220.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..+..|++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999986544344456678889999999955567899999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-CCCc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-~~~~  215 (531)
                      ||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE---GHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC---CCEEEeecCcceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999654   459999999986432 2223


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....||+.|+|||++. ..++.++|||||||++|+|+||..||.+.........+......++    ..+++.+.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            34567999999999887 4689999999999999999999999998887777776665433322    357899999999


Q ss_pred             HccccCcCCCCCH-----HHHhcCCccccc
Q 009594          295 KMLNPDPKQRLTA-----EEVLEHPWLQNA  319 (531)
Q Consensus       295 ~~l~~~p~~Rps~-----~~~l~h~~~~~~  319 (531)
                      +||.++|.+|+++     .++++||||+..
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999976     899999999764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.4e-46  Score=361.94  Aligned_cols=256  Identities=28%  Similarity=0.452  Sum_probs=210.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.+ +||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEE
Confidence            3699999999999999999999999999999999754322 22346778899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      |||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN---DVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CcEEEeeccCccccccccc
Confidence            9999987776555445579999999999999999999999999999999999999644   459999999998764332 


Q ss_pred             -ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---------------
Q 009594          215 -QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF---------------  277 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------  277 (531)
                       ......||+.|+|||++. ..++.++|||||||++|+|++|++||.+.+..+....+.......               
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence             223457899999999886 568999999999999999999999998876555443332211100               


Q ss_pred             ----CC---------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          278 ----KR---------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       278 ----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                          +.         .....+++.+.+||.+||++||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                00         0012367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=364.72  Aligned_cols=243  Identities=29%  Similarity=0.403  Sum_probs=207.7

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .+++++.||+|.||+||.|.. .....||+|.++.....    .+.+.+|+++|++| +|++||++++++.....+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMS----PEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccC----hhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEEE
Confidence            366789999999999999993 33449999999765433    36788999999999 9999999999999988999999


Q ss_pred             eccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||++.|+|.++|..  ...+...+.+.++.|||+||+||+++++|||||.++|||++   .+..+||+|||+|+...++.
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccCCCc
Confidence            99999999999986  45689999999999999999999999999999999999995   45579999999999544333


Q ss_pred             cccccc--CCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          215 QFNEIV--GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       215 ~~~~~~--gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ......  -...|.|||++. +.++.+||||||||+||||+| |+.||.+.+..++++.+.++.. .  +....+|+++.
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR-l--p~P~~CP~~vY  434 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR-L--PRPEGCPDEVY  434 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc-C--CCCCCCCHHHH
Confidence            222211  245699999987 789999999999999999999 9999999999999888877642 2  22257999999


Q ss_pred             HHHHHccccCcCCCCCHHHHh
Q 009594          291 DLVKKMLNPDPKQRLTAEEVL  311 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l  311 (531)
                      ++|..||+.+|++|||+..+.
T Consensus       435 ~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  435 ELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHhhCCcccCCCHHHHH
Confidence            999999999999999998653

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-45  Score=359.32  Aligned_cols=259  Identities=32%  Similarity=0.505  Sum_probs=217.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++++ +||||+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence            388999999999999999999999999999999765443333345677899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++++   ++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD---YGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC---CCCEEEeeCCCceecCCCC
Confidence            999999999887653  35899999999999999999999999999999999999964   4559999999998765444


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ......|++.|+|||++. ..++.++||||+||++|+|++|..||.+.........+..............+++.+.+|+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            444567899999999886 5688999999999999999999999987665444333333322222223346889999999


Q ss_pred             HHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          294 KKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       294 ~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      .+||..||++||     ++.++++||||...
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            999999999999     99999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.6e-46  Score=366.00  Aligned_cols=256  Identities=28%  Similarity=0.485  Sum_probs=221.5

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..++..||+|++.+..............|..++..+..||+|+++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58899999999999999999999999999999986544334445567778889988877999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~  215 (531)
                      ||+++|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC---CcEEEccCCCceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999654   4599999999875432 223


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....||+.|+|||++. +.++.++|||||||++|+|+||..||.+.........+......++    ..+++++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence            34567999999999887 5689999999999999999999999998888777777766543332    357899999999


Q ss_pred             HccccCcCCCCC-----HHHHhcCCccccc
Q 009594          295 KMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       295 ~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      +||+++|++|++     ..++++||||+..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999998     4899999999754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.4e-46  Score=373.98  Aligned_cols=259  Identities=29%  Similarity=0.523  Sum_probs=219.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +||||+++++.+.+.+.+|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            3689999999999999999999999999999999765443344456788899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      |||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.   ++.+||+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~---~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA---KGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC---CCCEEEeeccCCcccccccc
Confidence            999999999999988888999999999999999999999999999999999999964   4569999999986442110 


Q ss_pred             -----------------------------------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCC
Q 009594          215 -----------------------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF  258 (531)
Q Consensus       215 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf  258 (531)
                                                         .....+||+.|+|||++. ..++.++|||||||++|+|+||.+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                               011347999999999887 56899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCC---CHHHHhcCCccccc
Q 009594          259 WAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNA  319 (531)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~~  319 (531)
                      ...+.......+.........+....+++.+++||.+|+. +|.+|+   ++.++++||||+..
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            9888777766665433222222223478999999999874 999998   58999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.2e-46  Score=365.81  Aligned_cols=251  Identities=27%  Similarity=0.513  Sum_probs=216.9

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+++.||+|++.............+..|..++..+.+||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999999999999999998654434444566778999998877899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Ccccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~  220 (531)
                      ++|...+.....+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++...... .......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---GHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEeecccceecccCCccccccc
Confidence            9999999888889999999999999999999999999999999999999654   45999999998754322 2234457


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+.......+    ..+++++.++|.+||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence            899999999887 4689999999999999999999999999888777777765443222    24789999999999999


Q ss_pred             CcCCCC-------CHHHHhcCCccccc
Q 009594          300 DPKQRL-------TAEEVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rp-------s~~~~l~h~~~~~~  319 (531)
                      +|++||       ++.++++||||...
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            999999       99999999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.9e-46  Score=367.30  Aligned_cols=250  Identities=30%  Similarity=0.538  Sum_probs=210.4

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|..+++.+.+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999999999999999998765444445667888999999997899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc-CCCCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~-~~~~~~~~~~  220 (531)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++... ..........
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---GHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEECcCccccccccCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999654   45999999998753 2233344567


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC---------HHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|+||..||....         .....+.+.......    ...++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI----PRSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC----CCCCCHHHH
Confidence            999999999887 568999999999999999999999995321         111222233322221    135788999


Q ss_pred             HHHHHccccCcCCCCC------HHHHhcCCcccc
Q 009594          291 DLVKKMLNPDPKQRLT------AEEVLEHPWLQN  318 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps------~~~~l~h~~~~~  318 (531)
                      ++|.+||+.+|.+|||      +.++++||||..
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999999999997      789999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.5e-46  Score=370.46  Aligned_cols=259  Identities=31%  Similarity=0.496  Sum_probs=220.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence            3699999999999999999999999999999999865543334456788899999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++++|.+++.+. ..+++..+..++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR---TGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC---CCCEEeccCCCCeECCCCC
Confidence            9999999999999876 67999999999999999999999999999999999999964   4459999999998765433


Q ss_pred             cc--ccccCCcccccchhcc-------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          215 QF--NEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       215 ~~--~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ..  ....||+.|+|||++.       ..++.++|||||||++|+|++|..||...........+.........+..+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            22  2346899999999875       34778999999999999999999999887776666666544322222233468


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ++.+.+||.+||. +|.+|||+.++++||||...
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999999999998 99999999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.5e-46  Score=371.59  Aligned_cols=260  Identities=32%  Similarity=0.464  Sum_probs=219.3

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-----CCeeecceEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-----PNIVSLKDTY  126 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----~niv~l~~~~  126 (531)
                      +.+..+|.+.+.||+|+||.|.+|.+..+++.||||+++...    ....+...|+.+|..|.+|     -|+|+++++|
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            445568999999999999999999999999999999997653    2345667799999999534     3899999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          127 EDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       127 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      ...++.|||+|.+ +.+|+++++.+.  .++...++.++.||+.||..||+.||||+||||+||||.+.+.. .|||+||
T Consensus       258 ~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVIDF  335 (586)
T KOG0667|consen  258 YFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVIDF  335 (586)
T ss_pred             ccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEEec
Confidence            9999999999999 569999998764  48999999999999999999999999999999999999876644 7999999


Q ss_pred             ccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-----
Q 009594          205 GLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-----  278 (531)
Q Consensus       205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-----  278 (531)
                      |+|+......  .+++.+..|+|||++. .+|+.+.||||||||++||++|.+.|.+.++.+++..|..-.-.++     
T Consensus       336 GSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  336 GSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9998765433  3778899999999887 5899999999999999999999999999999888877754221000     


Q ss_pred             ---------CC---------------------------------CCC------------CCCHHHHHHHHHccccCcCCC
Q 009594          279 ---------RD---------------------------------PWP------------KVSENAKDLVKKMLNPDPKQR  304 (531)
Q Consensus       279 ---------~~---------------------------------~~~------------~~~~~~~~li~~~l~~~p~~R  304 (531)
                               ..                                 ..|            .-...+.+||.+||..||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                     00                                 001            011357899999999999999


Q ss_pred             CCHHHHhcCCccccc
Q 009594          305 LTAEEVLEHPWLQNA  319 (531)
Q Consensus       305 ps~~~~l~h~~~~~~  319 (531)
                      +|+.++|+||||...
T Consensus       494 ~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGT  508 (586)
T ss_pred             CCHHHHhcCcccccc
Confidence            999999999999853

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-45  Score=362.50  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=206.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.......  ....+.+|+.+++.+ +||||+++++++......++|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEE
Confidence            57999999999999999999999999999999986543211  234567899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      |||++ ++|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.   ++.+||+|||++...... 
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD---TGELKLADFGLARAKSVPS  157 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEECCCCcceeccCCC
Confidence            99996 5787777654 56899999999999999999999999999999999999964   445999999998754322 


Q ss_pred             CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCCCCC---------
Q 009594          214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKRDP---------  281 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~---------  281 (531)
                      .......+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+.... .....+...........         
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            22344578999999998763  4788999999999999999999999875432 22222221110000000         


Q ss_pred             -----------------CC--CCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          282 -----------------WP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       282 -----------------~~--~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                                       |.  ..++.+.+|+.+||+.||.+|||+.++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence                             01  235678999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.2e-46  Score=368.24  Aligned_cols=250  Identities=31%  Similarity=0.582  Sum_probs=215.2

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+|..||+|++.............+.+|+.+++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999999999999999999865544444556778899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-CCCccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEI  219 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-~~~~~~~~  219 (531)
                      ++|..++.....+++..+..++.||+.||.|||+ +||+||||||+|||++.+   +.+||+|||++.... ........
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC---CCEEEecCCCCeecCCCCcccccc
Confidence            9999999888889999999999999999999997 799999999999999644   459999999987533 22333456


Q ss_pred             cCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccc
Q 009594          220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN  298 (531)
Q Consensus       220 ~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (531)
                      .||+.|+|||++. +.++.++|||||||++|+|+||..||...+.......+......++    ..+++.+.+||.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            7999999999886 5689999999999999999999999988777666555544433322    3578999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCCccccc
Q 009594          299 PDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       299 ~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      .+|++|+     ++.++++||||...
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            9999997     99999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-45  Score=378.46  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=208.7

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.+ +||||+++++++...    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhc-CCCCCcceeeeEeeccccc
Confidence            4457999999999999999999999999999999885432       2334699999999 999999999886431    


Q ss_pred             ----CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEE
Q 009594          130 ----SAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       130 ----~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                          ..+++||||+++ +|.+++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++  ..+||
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~--~~vkL  212 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT--HTLKL  212 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC--Cceee
Confidence                247799999975 6766654    345689999999999999999999999999999999999996432  35999


Q ss_pred             EeeccccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--
Q 009594          202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--  277 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--  277 (531)
                      +|||+|+............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+.+.....  
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999987765555556788999999998763  58999999999999999999999998887766555554321110  


Q ss_pred             ---------------CCC-------CC-CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          278 ---------------KRD-------PW-PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       278 ---------------~~~-------~~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                     +..       .+ ...++++.+||.+||.++|.+|||+.++|+||||....
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                           000       01 13578999999999999999999999999999998654

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-45  Score=363.29  Aligned_cols=251  Identities=31%  Similarity=0.527  Sum_probs=213.0

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+++.||+|++................|..++..+.+||||+++++++...+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999999999999999998654333334556667888887766999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Ccccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~  220 (531)
                      |+|..++.....+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++...... .......
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---GHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC---CCEEEccCcCCeECCCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999644   45999999998754332 2334567


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+.......    ...++..+.++|.+||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF----PRWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHccC
Confidence            999999999887 468999999999999999999999999888777666655432221    134788999999999999


Q ss_pred             CcCCCCCH-HHHhcCCccccc
Q 009594          300 DPKQRLTA-EEVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rps~-~~~l~h~~~~~~  319 (531)
                      +|++||++ .++++||||+..
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CHHHcCCChHHHHcCcccCCC
Confidence            99999986 588899999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-45  Score=363.86  Aligned_cols=251  Identities=31%  Similarity=0.559  Sum_probs=216.3

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+.+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999999999999999998654444445567788999999887899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~  220 (531)
                      ++|..++.+...+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++..... ........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---GHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC---CcEEecccCCCeecCcCCCccccee
Confidence            9999999888889999999999999999999999999999999999999654   4599999999865322 22234457


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.......+    ..+++.+.+||.+||..
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence            899999999987 5689999999999999999999999988877666666554433222    35789999999999999


Q ss_pred             CcCCCCCH-----HHHhcCCccccc
Q 009594          300 DPKQRLTA-----EEVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rps~-----~~~l~h~~~~~~  319 (531)
                      +|++|||+     .++++||||+..
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999     999999999764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-45  Score=362.71  Aligned_cols=251  Identities=29%  Similarity=0.498  Sum_probs=212.9

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+|..||+|++................|..++..+.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46899999999999999999999999997654322334556777888888766999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~  220 (531)
                      ++|..++.....+++..+..++.|++.||+|||++||+||||||+||+++.+   +.+||+|||++..... ........
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---GHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEeCccCCCeecccCCCceeccC
Confidence            9999999888889999999999999999999999999999999999999654   4599999999875322 22334567


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+.......+    ..++.++.++|.+||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence            999999999987 5689999999999999999999999988877766665544332221    24788999999999999


Q ss_pred             CcCCCCCH-HHHhcCCccccc
Q 009594          300 DPKQRLTA-EEVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rps~-~~~l~h~~~~~~  319 (531)
                      ||++||++ .++++||||+..
T Consensus       234 dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCCC
Confidence            99999997 589999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-45  Score=365.27  Aligned_cols=251  Identities=29%  Similarity=0.521  Sum_probs=210.0

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46899999999999999999999999998765544455667888999998887899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-CCCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~  220 (531)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.... .........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---CCEEEeeCCccccccCCCCcccccc
Confidence            9999998888889999999999999999999999999999999999999654   459999999987532 233334567


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC---------HHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||....         .......+......    ....++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----~p~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----IPRSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----CCCCCCHHHH
Confidence            999999999887 568899999999999999999999995311         11122222222222    1235788999


Q ss_pred             HHHHHccccCcCCCCC------HHHHhcCCccccc
Q 009594          291 DLVKKMLNPDPKQRLT------AEEVLEHPWLQNA  319 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps------~~~~l~h~~~~~~  319 (531)
                      ++|.+||..+|++|||      +.++++||||+..
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999998      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9.7e-46  Score=367.63  Aligned_cols=260  Identities=30%  Similarity=0.581  Sum_probs=213.0

Q ss_pred             ceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      +|++.+.||+|+||.||+|++.   .++..||+|++.+.... .....+.+.+|+.+++.+.+||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4899999999999999998864   47899999999754322 2223456788999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~---~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE---GHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC---CCEEEeeCcCCccccc
Confidence            9999999999999999888889999999999999999999999999999999999999654   4599999999876533


Q ss_pred             CC--ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          213 GE--QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       213 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|+|+||..||...........+..............+++.
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE  237 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence            22  2234579999999999874  4788999999999999999999999653322111222222222222223467899


Q ss_pred             HHHHHHHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          289 AKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +.+++.+||..+|++||     ++.++++||||+..
T Consensus       238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999999     88999999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=356.29  Aligned_cols=265  Identities=40%  Similarity=0.686  Sum_probs=238.1

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+.+=|.+.+.||+|.|++|-+|++.-+|..||||++.+.++... ....+.+|++.|+.. +|||||++|++......+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHh-cCcCeeeeeehhcccceE
Confidence            355569999999999999999999999999999999998877544 346778899999998 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |+|+|+=++|+|+++|.+. ..+.+..+.+++.||+.|+.|+|+..+|||||||+||.+...  -+.|||+|||++-.+.
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK--lGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK--LGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee--cCceEeeeccccccCC
Confidence            9999999999999999764 459999999999999999999999999999999999999743  4679999999999999


Q ss_pred             CCCccccccCCcccccchhcccc-CC-CccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLKRN-YG-PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~-~~-~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ++....+.+|+..|.|||++.|. |+ +++||||||||||.|++|++||+..++.+.+..|+......+    ..++.++
T Consensus       171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS~eC  246 (864)
T KOG4717|consen  171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVSKEC  246 (864)
T ss_pred             CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhhHHH
Confidence            99999999999999999998864 64 579999999999999999999999999998888877655443    3578999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccccCCCC
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV  325 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~  325 (531)
                      ++||..||..+|.+|.|.++|..|+|++.....+.+
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT  282 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST  282 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence            999999999999999999999999999987665544

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-45  Score=366.29  Aligned_cols=259  Identities=30%  Similarity=0.486  Sum_probs=210.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC-----Ce
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-----SA  131 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-----~~  131 (531)
                      +|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.+ +||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCce
Confidence            58999999999999999999999999999999864321 222345678999999999 999999999987533     35


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++....
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~---~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCcEEEccCccccccc
Confidence            899999995 689999988888999999999999999999999999999999999999964   4459999999987543


Q ss_pred             CCC----ccccccCCcccccchhcc---ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhc-----------
Q 009594          212 PGE----QFNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-----------  273 (531)
Q Consensus       212 ~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~-----------  273 (531)
                      ...    ......||+.|+|||++.   ..++.++|||||||++|+|+||++||.+.+.......+...           
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221    123457899999999875   46889999999999999999999999776543332221110           


Q ss_pred             ------------cc----CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          274 ------------VI----DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       274 ------------~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                  ..    ......++.+++.+.+++.+||..+|++|||+.++++||||+....
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                        00    0001123467888999999999999999999999999999987554

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-45  Score=370.10  Aligned_cols=261  Identities=31%  Similarity=0.492  Sum_probs=220.3

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|++.+.||+|+||.||+|.+..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++++...+.++
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEE
Confidence            346899999999999999999999999999999999764433334455678899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~---~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC---CCCEEEEeCCceeEcCcC
Confidence            999999999999988654 5899999999999999999999999999999999999964   445999999999866433


Q ss_pred             C--ccccccCCcccccchhccc-----cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          214 E--QFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       214 ~--~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .  ......||+.|+|||++.+     .++.++|||||||++|+|++|.+||...+.......+.........+....++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence            2  2235679999999998863     27889999999999999999999999888777777776544333333345689


Q ss_pred             HHHHHHHHHccccCcCC--CCCHHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~--Rps~~~~l~h~~~~~~  319 (531)
                      +.+.++|.+||...+.+  |+++.++++||||++.
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            99999999999854443  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.1e-45  Score=363.75  Aligned_cols=253  Identities=30%  Similarity=0.532  Sum_probs=215.0

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHH---hCCCCCCeeecceEEEcCCeEEE
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK---HLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      |++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++.   .+ +||||+++++++...+..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence            678899999999999999999999999999998654433344566777776664   45 79999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-C
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-G  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~  213 (531)
                      ||||++|++|...+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++..... .
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE---GFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC---CcEEeCcccCCccCCCCC
Confidence            9999999999887754 469999999999999999999999999999999999999654   4599999999875432 2


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      .......|++.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+.......+    ..+++.+.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  231 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISI  231 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            2234567999999999887 4688999999999999999999999998887777666665433322    3578999999


Q ss_pred             HHHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          293 VKKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       293 i~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      |.+||..+|.+||     ++.++++||||+..
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            9999999999999     79999999999764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-46  Score=362.94  Aligned_cols=256  Identities=34%  Similarity=0.565  Sum_probs=230.6

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe-EEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA-VHI  134 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-~~l  134 (531)
                      ++|..++++|+|+||.+++++++..+..+|+|.+.......+. .....+|+.+++++ .|||||.+.+.|..++. +||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEE
Confidence            4699999999999999999999999999999999877665543 34778899999998 99999999999998888 999


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||+||+||+|.+.+.+..  .++++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.   |||+|||+|+.+.+
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~---VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK---VKLGDFGLAKILNP  158 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc---eeecchhhhhhcCC
Confidence            999999999999997654  5899999999999999999999999999999999999976544   89999999999987


Q ss_pred             CC-ccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          213 GE-QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       213 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .. ...+.+|||.||+||++.+ +|+.|+|||||||++|||++-+++|.+.+......++.+.......   ...+.++.
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~  235 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR  235 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence            76 5567899999999999984 7999999999999999999999999999999999888887743322   35789999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+|..||..+|..||++.++|.+|.+...
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            99999999999999999999999988743

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.9e-45  Score=361.54  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=215.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .++|++++.||+|+||.||+|++..++..+|+|++....  .......+.+|+.+++.+ +||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence            467999999999999999999999999999999987542  233356788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||+++.+   +.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC---CcEEEccCccccccccc
Confidence            999999999999998888899999999999999999999986 69999999999999654   45999999998765432


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc-----------------
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI-----------------  275 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-----------------  275 (531)
                       ......||+.|+|||++. ..++.++|||||||++|+|+||+.||......+....+.....                 
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             234457899999999887 4689999999999999999999999976654443222211100                 


Q ss_pred             -------------------------CCCCC--CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          276 -------------------------DFKRD--PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       276 -------------------------~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                               ....+  ....+++++.+||.+||..||++|||+.++++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                     00001  1123678999999999999999999999999999998644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-45  Score=354.89  Aligned_cols=252  Identities=29%  Similarity=0.503  Sum_probs=209.1

Q ss_pred             cCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCc
Q 009594           64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE  143 (531)
Q Consensus        64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  143 (531)
                      ||+|+||+||+|.+..+++.||+|++.............+..|+.+++.+ +||||+++.+++......++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            79999999999999999999999999765444443456778899999999 99999999999999999999999999999


Q ss_pred             hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-ccc
Q 009594          144 LFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNE  218 (531)
Q Consensus       144 L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~-~~~  218 (531)
                      |...+..    ...+++..+..++.||+.||.|||++||+||||||+||+++.   ++.++|+|||++........ ...
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN---DGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEeeCccceecCCCCccccc
Confidence            9887743    345899999999999999999999999999999999999964   44599999999876544332 334


Q ss_pred             ccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcc
Q 009594          219 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML  297 (531)
Q Consensus       219 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  297 (531)
                      ..||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+..............+++.+.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            57899999999887 56889999999999999999999999765433222223322222222223468999999999999


Q ss_pred             ccCcCCCC-----CHHHHhcCCccccc
Q 009594          298 NPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       298 ~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +.+|++||     ++.++++||||+..
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            99999999     88999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.6e-45  Score=355.33  Aligned_cols=255  Identities=27%  Similarity=0.447  Sum_probs=207.5

Q ss_pred             ceeeccccCccCceEEEEEEEcc-CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCCeeecceEEE-----c
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYE-----D  128 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~-----~  128 (531)
                      +|++.+.||+|+||.||+|.+.. +++.||+|++........ ....+.+|+.+++.+.  +||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            69999999999999999999854 578899999875433221 2234566887777663  6999999999875     3


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      ...+++||||++ ++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~---~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC---CCEEEccccc
Confidence            456899999996 5898888653  348999999999999999999999999999999999999654   4599999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC-----
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD-----  280 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-----  280 (531)
                      +.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+....+....+..........     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            98765544445567899999999876 578999999999999999999999999888777666665432111110     


Q ss_pred             ------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          281 ------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       281 ------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                        ..+.+++.+.+|+.+||+.+|++|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.8e-45  Score=360.16  Aligned_cols=251  Identities=28%  Similarity=0.479  Sum_probs=212.4

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||+||+|.+..+++.||+|++................|..++..+.+||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999999999999999998654322233456677888888766999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~  220 (531)
                      |+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---GHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---CCEEEccCCcceECCCCCCceeeec
Confidence            9999999887789999999999999999999999999999999999999654   4599999999875322 22334567


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+.......+    ..++..+.++|.+||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence            899999999887 4689999999999999999999999988877666665544322211    24788999999999999


Q ss_pred             CcCCCCCHH-HHhcCCccccc
Q 009594          300 DPKQRLTAE-EVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rps~~-~~l~h~~~~~~  319 (531)
                      +|++||++. ++++||||+..
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCC
Confidence            999999996 99999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.3e-45  Score=360.47  Aligned_cols=256  Identities=28%  Similarity=0.500  Sum_probs=219.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+..|+.+++.+..||+|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47888999999999999999999999999999986544333445667789999998866788999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Cc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~~  215 (531)
                      ||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~---~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE---GHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEeccccccccCCCCcc
Confidence            999999999999888889999999999999999999999999999999999999654   45999999998754322 22


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....||+.|+|||++. +.++.++|||||||++|+|++|.+||.+.........+.......+    ..+++.+.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  233 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence            34456899999999887 5689999999999999999999999998887777777665443322    357899999999


Q ss_pred             HccccCcCCCCC-----HHHHhcCCccccc
Q 009594          295 KMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       295 ~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      +||.++|.+|++     ..++++||||+..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            999999999997     5799999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.1e-45  Score=362.36  Aligned_cols=250  Identities=28%  Similarity=0.533  Sum_probs=211.6

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHH-HHhCCCCCCeeecceEEEcCCeEEEEEeccC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI-MKHLPKHPNIVSLKDTYEDDSAVHIVMELCE  140 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  140 (531)
                      +.||+|+||+||+|.+..+|+.||+|++.............+..|... ++.+ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            368999999999999999999999999976544333334455566554 5667 99999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCccccc
Q 009594          141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEI  219 (531)
Q Consensus       141 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~  219 (531)
                      +++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..... .......
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---CcEEEeccCCCcccccCCCccccc
Confidence            99999999888889999999999999999999999999999999999999654   4599999999875432 2233446


Q ss_pred             cCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccc
Q 009594          220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN  298 (531)
Q Consensus       220 ~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (531)
                      .||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......    ..+.+++.+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR----LKPNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHHHHHHhh
Confidence            7999999999887 56899999999999999999999999988777766666554332    234679999999999999


Q ss_pred             cCcCCCCCH----HHHhcCCccccc
Q 009594          299 PDPKQRLTA----EEVLEHPWLQNA  319 (531)
Q Consensus       299 ~~p~~Rps~----~~~l~h~~~~~~  319 (531)
                      .+|.+||++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            999999987    699999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-45  Score=360.09  Aligned_cols=250  Identities=33%  Similarity=0.588  Sum_probs=213.3

Q ss_pred             cccCccCceEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           62 RELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      +.||+|+||.||+|++.   .+++.||+|++...... .......+.+|+.+++.+ +||||+++++++...+.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence            57999999999999864   46889999999764321 222345677899999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Ccc
Q 009594          138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQF  216 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~~~  216 (531)
                      |+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++...... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ---GHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEeeCcCCeecccCCCcc
Confidence            99999999999888889999999999999999999999999999999999999644   45999999998754322 223


Q ss_pred             ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK  295 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  295 (531)
                      ....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.......    .+.+++.+.++|.+
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~  233 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL----PPYLTPEARDLLKK  233 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHH
Confidence            3457999999999887 468899999999999999999999998888777666666554332    24578999999999


Q ss_pred             ccccCcCCCC-----CHHHHhcCCccccc
Q 009594          296 MLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       296 ~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      ||.++|++||     ++.++++||||+..
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999     89999999999763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.1e-45  Score=360.66  Aligned_cols=251  Identities=28%  Similarity=0.499  Sum_probs=210.6

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999999999999999998765444445667889999999997899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-CCCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~  220 (531)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.... .........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---GHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC---CCEEEeccccceeccCCCCceeccc
Confidence            9999999888889999999999999999999999999999999999999654   459999999987532 233344567


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC------H-HHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET------E-QGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||....      . ......+......    ....++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----IPRFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----CCCCCCHHHHHH
Confidence            999999999886 568999999999999999999999995421      1 1222222222111    123578999999


Q ss_pred             HHHccccCcCCCCC------HHHHhcCCccccc
Q 009594          293 VKKMLNPDPKQRLT------AEEVLEHPWLQNA  319 (531)
Q Consensus       293 i~~~l~~~p~~Rps------~~~~l~h~~~~~~  319 (531)
                      +.+||..+|.+|++      +.++++||||+..
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99999999999997      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-44  Score=358.64  Aligned_cols=260  Identities=28%  Similarity=0.518  Sum_probs=215.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++...+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence            3699999999999999999999999999999999764433444456788899999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||++|++|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK---NGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC---CCCEEEEECCceeecCCCC
Confidence            999999999999976 456899999999999999999999999999999999999954   4459999999987654332


Q ss_pred             c--cccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-CCCCCCC
Q 009594          215 Q--FNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-RDPWPKV  285 (531)
Q Consensus       215 ~--~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  285 (531)
                      .  .....||+.|+|||++.      +.++.++|||||||++|+|++|..||......+....+........ ....+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence            2  12346899999999885      3478899999999999999999999988776666655554322111 1223457


Q ss_pred             CHHHHHHHHHccccCcCC--CCCHHHHhcCCccccc
Q 009594          286 SENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA  319 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~--Rps~~~~l~h~~~~~~  319 (531)
                      ++.+.++|.+||...+++  |+++.++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            999999999988764444  8899999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-44  Score=351.96  Aligned_cols=255  Identities=32%  Similarity=0.531  Sum_probs=213.1

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++++ +|++|+.+++.+...+..++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEE
Confidence            77888999999999999999999999999998765444333345677899999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          138 LCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |++|++|.+++...+  .+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC---CCEEEeeccceeecCCCcc
Confidence            999999998886433  58999999999999999999999999999999999999654   4599999999876654444


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH---HHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG---VAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      .....|++.|+|||++. ..++.++|||||||++|+|++|..||.......   ........   ........+++.+.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  234 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSPDARS  234 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCHHHHH
Confidence            44567899999999886 568999999999999999999999997654321   11222111   111223457889999


Q ss_pred             HHHHccccCcCCCCC-----HHHHhcCCccccc
Q 009594          292 LVKKMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       292 li~~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      |+.+||+.+|++|||     +.++++||||+..
T Consensus       235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999999999     9999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.1e-44  Score=348.92  Aligned_cols=258  Identities=32%  Similarity=0.518  Sum_probs=219.2

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |+..+.||+|+||+||+|.+..+++.+|+|.+.............+.+|+.+++.+ +|+||+++++++...+..++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEE
Confidence            77888999999999999999999999999999765444333445677899999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          138 LCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       138 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |+++++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++++   ..++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY---GHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC---CCEEEecCCcceecCCCCc
Confidence            99999999888653  358999999999999999999999999999999999999644   4599999999876654444


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....|++.|+|||++. ..++.++|+|||||++|+|++|..||...........+............+.+++.+.+|+.
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            44567899999999886 56899999999999999999999999887665544444443333333334568899999999


Q ss_pred             HccccCcCCCCC-----HHHHhcCCccccc
Q 009594          295 KMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       295 ~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      +||..+|++||+     +.+++.|+||+..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            999999999999     8999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-45  Score=362.26  Aligned_cols=250  Identities=32%  Similarity=0.565  Sum_probs=212.0

Q ss_pred             cCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      ||+|+||+||+|++..+++.||+|++................|..++..+.  +||||+++++++...+.+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997654433334455666777777664  799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~  220 (531)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---GHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEecCCcCcCCCCCCCCccCcc
Confidence            9999999888889999999999999999999999999999999999999654   4599999999875432 22334567


Q ss_pred             CCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccc
Q 009594          221 GSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN  298 (531)
Q Consensus       221 gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (531)
                      ||+.|+|||++.+  .++.++|||||||++|+|+||..||...........+......++.   ..+++.+.++|.+||.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence            9999999998863  4789999999999999999999999888777666666554433322   2478999999999999


Q ss_pred             cCcCCCC----CHHHHhcCCccccc
Q 009594          299 PDPKQRL----TAEEVLEHPWLQNA  319 (531)
Q Consensus       299 ~~p~~Rp----s~~~~l~h~~~~~~  319 (531)
                      .+|.+||    ++.++++||||+..
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccCC
Confidence            9999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-44  Score=364.01  Aligned_cols=252  Identities=24%  Similarity=0.419  Sum_probs=205.3

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++++.||+|+||.||+|.+..+++.||+|....         ..+.+|+.+++++ +||||+++++++......++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEE
Confidence            4579999999999999999999999999999996532         3457899999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      |+|++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|...... 
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~---~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP---GDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC---CCEEEEeCCccccccccc
Confidence            999995 6899988887889999999999999999999999999999999999999644   45999999998754322 


Q ss_pred             -CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHhccc---------
Q 009594          214 -EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVI---------  275 (531)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~-------~~~~~~~~~~~~~---------  275 (531)
                       .......||+.|+|||++. ..++.++|||||||++|+|+||..||....       .......+.....         
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence             2233467999999999886 568999999999999999999998875432       1111111111100         


Q ss_pred             -------------------CCCCCCC---CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          276 -------------------DFKRDPW---PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       276 -------------------~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                         ....+.|   ..++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                               0001111   13467899999999999999999999999999998753

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.6e-44  Score=357.74  Aligned_cols=257  Identities=25%  Similarity=0.431  Sum_probs=208.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.+ +|+||+++++++...+.+++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEE
Confidence            357899999999999999999999999999999986442  223356788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||||+++++|...    ...++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.......
T Consensus       150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA---KNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---CCEEEcccccceeccccc
Confidence            9999999998643    245788889999999999999999999999999999999644   459999999998664332


Q ss_pred             -ccccccCCcccccchhccc------cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          215 -QFNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                       ......||..|+|||++..      ..+.++|||||||++|+|++|+.||...........+..............++.
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence             2345679999999998742      134689999999999999999999974333222222211111122222346789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++.+||.+||..+|++|||+.|+++||||.....
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            9999999999999999999999999999987644

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-44  Score=358.44  Aligned_cols=250  Identities=28%  Similarity=0.535  Sum_probs=211.4

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHH-HHhCCCCCCeeecceEEEcCCeEEEEEeccC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI-MKHLPKHPNIVSLKDTYEDDSAVHIVMELCE  140 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  140 (531)
                      +.||+|+||+||+|.+..+|+.+|+|++.............+..|..+ ++.+ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence            368999999999999999999999999976544333344556666654 5566 99999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCccccc
Q 009594          141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEI  219 (531)
Q Consensus       141 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~  219 (531)
                      +++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---GHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEEeecCCcccCCCCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999654   4599999999875432 2233456


Q ss_pred             cCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccc
Q 009594          220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN  298 (531)
Q Consensus       220 ~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (531)
                      .||+.|+|||++. ..++.++|||||||++|+|++|.+||...+.......+.......    .+..+..+.++|.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----RPGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----CCCCCHHHHHHHHHHhc
Confidence            7999999999887 568999999999999999999999999887777666665543322    24678999999999999


Q ss_pred             cCcCCCCCH----HHHhcCCccccc
Q 009594          299 PDPKQRLTA----EEVLEHPWLQNA  319 (531)
Q Consensus       299 ~~p~~Rps~----~~~l~h~~~~~~  319 (531)
                      .+|.+||++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            999999976    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.3e-44  Score=347.21  Aligned_cols=252  Identities=27%  Similarity=0.470  Sum_probs=206.4

Q ss_pred             cCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCc
Q 009594           64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE  143 (531)
Q Consensus        64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  143 (531)
                      ||+|+||.||++.+..+|+.||+|++.............+..|+++++++ +||||+++++++......++||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            79999999999999999999999999765443333344566799999999 99999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccC
Q 009594          144 LFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG  221 (531)
Q Consensus       144 L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g  221 (531)
                      |..++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.   ++.++|+|||++.............|
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD---QGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC---CCCEEEeeceeeeecCCCceeeccCC
Confidence            998876543  4889999999999999999999999999999999999964   44599999999887655444445678


Q ss_pred             Ccccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC-CCCCCCCCCCHHHHHHHHHcccc
Q 009594          222 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-FKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       222 t~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ++.|+|||++. ..++.++|||||||++|+|++|..||...........+.+.... ........+++++.+|+.+||++
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            99999999886 56899999999999999999999999765432222222222111 11112245789999999999999


Q ss_pred             CcCCCCCH----HHHhcCCccccc
Q 009594          300 DPKQRLTA----EEVLEHPWLQNA  319 (531)
Q Consensus       300 ~p~~Rps~----~~~l~h~~~~~~  319 (531)
                      +|++||++    .+++.||||+..
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    778899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4e-44  Score=355.55  Aligned_cols=260  Identities=25%  Similarity=0.398  Sum_probs=213.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ..++|++.+.||.|+||.||+|.+..++..+|+|++....  .......+.+|+++++.+ +||||+++++++...+.++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEE
Confidence            3467999999999999999999999999999999886542  223346788999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++++   +.+||+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID  156 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC---CCEEEeeCCcchhhhh
Confidence            9999999999999998888899999999999999999999985 79999999999999654   4599999999875532


Q ss_pred             CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHH--------------------
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--------------------  271 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~--------------------  271 (531)
                      . ......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+.                    
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence            2 223457899999999887 468899999999999999999999997654433221110                    


Q ss_pred             --------------------hcccCCCCCCC--CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          272 --------------------RSVIDFKRDPW--PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       272 --------------------~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                          ........+..  ...++++.+||.+||++||++|||+.+++.||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                00000001111  12567899999999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3e-44  Score=349.83  Aligned_cols=255  Identities=28%  Similarity=0.464  Sum_probs=206.2

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCCeeecceEEEc-----C
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYED-----D  129 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~-----~  129 (531)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+........ ......+|+.+++.+.  +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            48999999999999999999999999999999875432221 1234556777777653  69999999998764     3


Q ss_pred             CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          130 SAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      ...++|+||+++ +|.+++...  ..+++..++.++.|++.||.|||+.||+||||||+||+++++   +.+||+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~---~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECccCcc
Confidence            458999999975 888888664  348999999999999999999999999999999999999654   45999999999


Q ss_pred             cccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--------  278 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------  278 (531)
                      .............||+.|+|||++. ..++.++|||||||++|+|++|.+||...........+........        
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            8765444444567899999999876 5689999999999999999999999988776665555443211000        


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          279 ---------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       279 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                     ....+.+++.+.+++.+||++||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                           01123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.4e-44  Score=356.18  Aligned_cols=260  Identities=27%  Similarity=0.492  Sum_probs=216.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||++++..+++.+|+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence            3699999999999999999999999999999999754433333445678899999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~---~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC---CCCEEEeecchheecccCC
Confidence            999999999999976 456899999999999999999999999999999999999964   4459999999987553322


Q ss_pred             c--cccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-CCCCCC
Q 009594          215 Q--FNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-DPWPKV  285 (531)
Q Consensus       215 ~--~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  285 (531)
                      .  .....||+.|+|||++.      +.++.++|||||||++|+|++|+.||...........+......... .....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence            2  22357999999999875      35788999999999999999999999988777777666554322221 123467


Q ss_pred             CHHHHHHHHHccccCcCC--CCCHHHHhcCCccccc
Q 009594          286 SENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA  319 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~--Rps~~~~l~h~~~~~~  319 (531)
                      ++.+.+|+.+||..+|.+  |+++.++++||||...
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            999999999999765554  7899999999999764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.8e-44  Score=356.51  Aligned_cols=260  Identities=26%  Similarity=0.477  Sum_probs=217.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++...+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            3699999999999999999999999999999999764433333455678899999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||++||+|.+++.+ ...+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC---CCEEEEeccceeeccCCC
Confidence            999999999999977 4578999999999999999999999999999999999999644   459999999987654432


Q ss_pred             cc--ccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-CCCCCCC
Q 009594          215 QF--NEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-RDPWPKV  285 (531)
Q Consensus       215 ~~--~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  285 (531)
                      ..  ....||+.|+|||++.      +.++.++|||||||++|+|++|+.||...........+........ ...+..+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            22  2356999999999876      3578899999999999999999999988777666666654332221 1223457


Q ss_pred             CHHHHHHHHHccccCcCC--CCCHHHHhcCCccccc
Q 009594          286 SENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA  319 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~--Rps~~~~l~h~~~~~~  319 (531)
                      ++.+.+++.+||...+.+  |+++.++++||||+..
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            899999999999876654  5699999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-44  Score=356.66  Aligned_cols=250  Identities=28%  Similarity=0.520  Sum_probs=210.2

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCCeeecceEEEcCCeEEEEEeccC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ-IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE  140 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  140 (531)
                      +.||+|+||.||+|++..+++.||+|++.............+..|.. +++.+ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            36899999999999999999999999997654332223344455554 45667 99999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCccccc
Q 009594          141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEI  219 (531)
Q Consensus       141 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~  219 (531)
                      +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..... .......
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEEccCCCCcccccCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999644   4599999999875432 2233456


Q ss_pred             cCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccc
Q 009594          220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN  298 (531)
Q Consensus       220 ~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (531)
                      .||+.|+|||++. ..++.++|||||||++|+|++|.+||...+.......+......    ..+.+++.+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~  232 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----LKPNITNSARHLLEGLLQ  232 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC----CCCCCCHHHHHHHHHHcc
Confidence            7999999999887 46889999999999999999999999988877766666554322    235689999999999999


Q ss_pred             cCcCCCCCHH----HHhcCCccccc
Q 009594          299 PDPKQRLTAE----EVLEHPWLQNA  319 (531)
Q Consensus       299 ~~p~~Rps~~----~~l~h~~~~~~  319 (531)
                      ++|.+||++.    ++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCCC
Confidence            9999999875    89999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-44  Score=357.77  Aligned_cols=249  Identities=28%  Similarity=0.544  Sum_probs=213.2

Q ss_pred             cccCccCceEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEec
Q 009594           62 RELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL  138 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  138 (531)
                      +.||+|+||.||++++.   .+|+.+|+|++...... ......+.+|+.+++++ +||||+++++++...+..|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcC
Confidence            57999999999999863   57899999999765432 22345667899999999 999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Cccc
Q 009594          139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFN  217 (531)
Q Consensus       139 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~~~~  217 (531)
                      +++++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++...... ....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC---CcEEEeeccCCcccCCCCCcee
Confidence            9999999999888889999999999999999999999999999999999999644   45999999998765433 2334


Q ss_pred             cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHc
Q 009594          218 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM  296 (531)
Q Consensus       218 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  296 (531)
                      ...||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.+.....+    ..+++.+.++|.+|
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~  232 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL  232 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence            567899999999887 4688999999999999999999999988877776666655443322    35789999999999


Q ss_pred             cccCcCCCCC-----HHHHhcCCccccc
Q 009594          297 LNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       297 l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      |+.+|++|||     +.+++.||||+..
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999999     7889999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-46  Score=362.56  Aligned_cols=260  Identities=28%  Similarity=0.465  Sum_probs=223.5

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ..+.|.|+..||.|+||.||+|..+.++-..|.|+|..+   ...+++.+.-||.||..+ +||+||+|++.|...+.++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceE
Confidence            345699999999999999999999988888999998654   455678899999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |+.|||.||-....+..- ..+++.++..+++|++.||+|||+++|||||||..|||++.+|+   |+|+|||.+-....
T Consensus       106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn~~  182 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKNKS  182 (1187)
T ss_pred             EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---Eeeecccccccchh
Confidence            999999999998877664 45999999999999999999999999999999999999976655   99999998754332


Q ss_pred             -CCccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          213 -GEQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       213 -~~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                       .....+++|||+|||||++.      .+|+.++||||||++|.+|..+.+|-...+...++-++.+...+.... ....
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS~W  261 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PSHW  261 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cchh
Confidence             23345689999999999864      469999999999999999999999998888877777776654332222 2356


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +..+.+|+.+||.+||..||++.++|+|||+++...
T Consensus       262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             hhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            889999999999999999999999999999986543

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.5e-44  Score=354.67  Aligned_cols=250  Identities=28%  Similarity=0.510  Sum_probs=209.4

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCCeeecceEEEcCCeEEEEEeccC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ-IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE  140 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  140 (531)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|.. +++.+ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36899999999999999999999999997654333333445556655 56777 99999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCccccc
Q 009594          141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEI  219 (531)
Q Consensus       141 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~~~~~~  219 (531)
                      +++|...+.....+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEccCCCCccCCCCCCccccc
Confidence            99999998888889999999999999999999999999999999999999654   4599999999875322 2223446


Q ss_pred             cCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccc
Q 009594          220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN  298 (531)
Q Consensus       220 ~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (531)
                      .||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+.......    .+..+..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~  232 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQL----PGGKTVAACDLLVGLLH  232 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHcc
Confidence            7899999999887 568999999999999999999999998887766666655443222    23568899999999999


Q ss_pred             cCcCCCCCH----HHHhcCCccccc
Q 009594          299 PDPKQRLTA----EEVLEHPWLQNA  319 (531)
Q Consensus       299 ~~p~~Rps~----~~~l~h~~~~~~  319 (531)
                      .+|.+||++    .++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            999999975    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.9e-44  Score=351.79  Aligned_cols=259  Identities=26%  Similarity=0.441  Sum_probs=212.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+.......  ....+.+|+.+++++ +||||+++++++...+..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEE
Confidence            46999999999999999999999999999999987543221  234567899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.......
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECccccceecCCCc
Confidence            999975 8888776544 47999999999999999999999999999999999999654   459999999987543322


Q ss_pred             -ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--------------
Q 009594          215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--------------  277 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------------  277 (531)
                       ......+|+.|+|||++.+  .++.++|||||||++|+|+||.+||.+.+..+....+.+.....              
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             2234567899999998753  57889999999999999999999998877655554443321110              


Q ss_pred             -----CC-------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          278 -----KR-------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       278 -----~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                           +.       ...+.+++++.+||.+||..||.+|||+.++++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence                 00       012356889999999999999999999999999999987543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=347.65  Aligned_cols=260  Identities=32%  Similarity=0.531  Sum_probs=231.8

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|+.-+.||+|+||+||-++.+.+|..+|+|.+.++.+.........++|-.+|.++ +.|.||.+--.|+..+.+|+|+
T Consensus       186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEE
Confidence            478888999999999999999999999999999888777766677888999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ..|+||+|.-+|.+-+  .+++..++-++.+|+.||.+||+.+||+|||||+|||+++   .++|+|+|+|+|..+..+.
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd---~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDD---HGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeecc---CCCeEeeccceEEecCCCC
Confidence            9999999988887655  6999999999999999999999999999999999999964   5569999999999999988


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      .....+||.+|||||+++ +.|+.+.|+|||||++|+|+.|+.||.......-.+.+.+.....+.....+.|+++++|.
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc  421 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLC  421 (591)
T ss_pred             ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHH
Confidence            888889999999999987 5699999999999999999999999987765544445555555444444467899999999


Q ss_pred             HHccccCcCCCC-----CHHHHhcCCcccccc
Q 009594          294 KKMLNPDPKQRL-----TAEEVLEHPWLQNAK  320 (531)
Q Consensus       294 ~~~l~~~p~~Rp-----s~~~~l~h~~~~~~~  320 (531)
                      ..+|.+||++|.     .+.++-+||||+...
T Consensus       422 ~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln  453 (591)
T KOG0986|consen  422 EGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN  453 (591)
T ss_pred             HHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence            999999999998     678999999998754

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-43  Score=367.87  Aligned_cols=259  Identities=23%  Similarity=0.348  Sum_probs=204.3

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----CCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-----KHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~~~~~~~  129 (531)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++....    ........|+.+++.+.     .|++++++++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            468999999999999999999999999999999986421    11234556777777661     345688899988754


Q ss_pred             -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCC------------
Q 009594          130 -SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKE------------  195 (531)
Q Consensus       130 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~------------  195 (531)
                       .++|+|||++ |++|.+++.+.+.+++..+..|+.||+.||.|||+ .|||||||||+|||++..+.            
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5799999998 77999999888889999999999999999999998 59999999999999976442            


Q ss_pred             -CCCeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 009594          196 -SSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS  273 (531)
Q Consensus       196 -~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~  273 (531)
                       ...+||+|||.+....  ......+||+.|+|||++. ..++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus       283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~  360 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT  360 (467)
T ss_pred             CCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence             1259999999876432  2234568999999999887 46999999999999999999999999887765544443322


Q ss_pred             ccCCCC----------------------C--------------CCC--CCCHHHHHHHHHccccCcCCCCCHHHHhcCCc
Q 009594          274 VIDFKR----------------------D--------------PWP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW  315 (531)
Q Consensus       274 ~~~~~~----------------------~--------------~~~--~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~  315 (531)
                      ...++.                      .              .+.  ...+.+.+||.+||.+||++|||+.|+|+|||
T Consensus       361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            111100                      0              000  01356789999999999999999999999999


Q ss_pred             ccccc
Q 009594          316 LQNAK  320 (531)
Q Consensus       316 ~~~~~  320 (531)
                      |....
T Consensus       441 ~~~~~  445 (467)
T PTZ00284        441 VLKYY  445 (467)
T ss_pred             ccccC
Confidence            98744

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-44  Score=346.72  Aligned_cols=254  Identities=41%  Similarity=0.723  Sum_probs=211.3

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |++++.||+|+||+||+|.+..+++.+|+|++........ ......+|+.+++++ +||||+++++++......++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence            7899999999999999999999999999999987643222 122345699999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc-CCCCcc
Q 009594          138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQF  216 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~-~~~~~~  216 (531)
                      |+++++|.+++...+.+++..+..++.||+.||.+||++||+|+||||+||+++.+   +.++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~---~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN---GEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT---SEEEESSGTTTEESTSTTSEB
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence            99999999999877889999999999999999999999999999999999999744   44899999998763 233444


Q ss_pred             ccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHH---HHhcccCCCCCCCCCCCHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA---IIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      ....+++.|+|||++.  ..++.++||||||+++|+|++|..||...........   ................++.+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            5667899999999987  5688999999999999999999999988733333222   2222221111111223489999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCcc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +|.+||+.+|++|||+.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-45  Score=351.88  Aligned_cols=255  Identities=30%  Similarity=0.495  Sum_probs=220.9

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ...|.-++.||.|+||.||-|++..+.+.||||++.-+.-......+.+..|+..|+++ .|||++.+-++|......++
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaWL  103 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAWL  103 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHHH
Confidence            34588889999999999999999999999999999766555555678899999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          135 VMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |||||- ||-.+++. ...++.+..++.|+.+.+.||.|||+.+.||||||..|||+.   +.+.|||+|||.|.+..+ 
T Consensus       104 VMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  104 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc-
Confidence            999995 47777664 245789999999999999999999999999999999999995   455699999999987654 


Q ss_pred             CccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                        .++++|||.|||||++.    |+|+-++||||||++..||...++|+...+....+--|.+...+...  -+..+..+
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eWS~~F  254 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDYF  254 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--CchhHHHH
Confidence              45789999999999763    78999999999999999999999999988877666656554332211  23568899


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +.|+..||++-|.+|||..++|.|+|....
T Consensus       255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  255 RNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             HHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence            999999999999999999999999999753

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.4e-44  Score=379.71  Aligned_cols=266  Identities=29%  Similarity=0.510  Sum_probs=219.8

Q ss_pred             CCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-
Q 009594           50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-  128 (531)
Q Consensus        50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  128 (531)
                      .+.....+|++++.||+|+||+||+|.+..++..+|+|++...... ......+..|+.+++.| +||||++++++|.. 
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMREL-KHKNIVRYIDRFLNK   84 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEec
Confidence            4556667899999999999999999999999999999998765432 33456788999999999 99999999998854 


Q ss_pred             -CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeecCCCCCceEeecC---
Q 009594          129 -DSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQ-------GVMHRDLKPENFLFANK---  193 (531)
Q Consensus       129 -~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-------~iiH~Dlkp~NIll~~~---  193 (531)
                       ...+||||||+++++|.++|..    ...+++..++.|+.||+.||.|||+.       +||||||||+|||++..   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             4679999999999999998865    25699999999999999999999984       49999999999999642   


Q ss_pred             -----------CCCCCeEEEeeccccccCCCCccccccCCcccccchhcc---ccCCCccchhHHHHHHHHHhhCCCCCC
Q 009594          194 -----------KESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFW  259 (531)
Q Consensus       194 -----------~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~il~~l~tg~~pf~  259 (531)
                                 +....+||+|||++.............||+.|+|||++.   ..++.++|||||||++|+|+||..||.
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                       123458999999998765444445567999999999875   348899999999999999999999997


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          260 AETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ...............   +..+....+..+.+||..||..+|.+|||+.++|.|||++...
T Consensus       245 ~~~~~~qli~~lk~~---p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        245 KANNFSQLISELKRG---PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             cCCcHHHHHHHHhcC---CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            765544333333322   2223345789999999999999999999999999999998543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.4e-44  Score=358.86  Aligned_cols=258  Identities=27%  Similarity=0.434  Sum_probs=207.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC---
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  129 (531)
                      .+..+|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.+ +||||+++++++...   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCc
Confidence            355689999999999999999999999999999999865432 233356778899999999 999999999998643   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       130 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                         ..+|+||||+++ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~---~~~kl~Dfg~  169 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGL  169 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEecCCC
Confidence               357999999975 6666553  348899999999999999999999999999999999999654   4599999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc----------
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----------  275 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----------  275 (531)
                      +.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+.....          
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            97655444445567899999999887 4689999999999999999999999987665433322221110          


Q ss_pred             ------------CCCC----------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          276 ------------DFKR----------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       276 ------------~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                  ....                ......++.+.+||.+||..||++|||+.|+|+||||..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                        0000                000123577899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=331.61  Aligned_cols=258  Identities=31%  Similarity=0.605  Sum_probs=235.7

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      -++|..++.||+|.||.|.+++.+.+++.+|+|++++.-+-...+...-+.|-++|+.. +||.+..+--.|+..+++|+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEE
Confidence            35799999999999999999999999999999999988776666777888899999998 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc-cCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF-FRPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~-~~~~  213 (531)
                      ||||+.||.|+-+|.+...+++..++-+...|+.||.|||+++||+||||.+|.|++   .+++|||+|||+++. +..+
T Consensus       246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD---kDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD---KDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec---cCCceEeeecccchhccccc
Confidence            999999999999999888899999999999999999999999999999999999995   455699999999874 3445


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ....+++|||.|.|||++. ..|+.++|+|.+||++|||++|+.||+..........|.-..+.+++    .++++++.|
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktL  398 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTL  398 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHH
Confidence            6678899999999999997 78999999999999999999999999999988888888887777764    689999999


Q ss_pred             HHHccccCcCCCC-----CHHHHhcCCcccccc
Q 009594          293 VKKMLNPDPKQRL-----TAEEVLEHPWLQNAK  320 (531)
Q Consensus       293 i~~~l~~~p~~Rp-----s~~~~l~h~~~~~~~  320 (531)
                      +..+|.++|.+|.     .+.+|..|+||....
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            9999999999998     689999999998654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=352.03  Aligned_cols=263  Identities=32%  Similarity=0.619  Sum_probs=234.5

Q ss_pred             ccceee--ccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           55 SIDYDL--GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        55 ~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ..-|+|  .+.||+|.||+||-|+++.+|+.||||++.+..+.... ...+++|+.||+.+ .||.||.+--.|+..+.+
T Consensus       561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l-~HPGiV~le~M~ET~erv  638 (888)
T KOG4236|consen  561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNL-HHPGIVNLECMFETPERV  638 (888)
T ss_pred             HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhc-CCCCeeEEEEeecCCceE
Confidence            334665  47899999999999999999999999999988776544 47899999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          133 HIVMELCEGGELFDRIV--ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ++|||.+.| +..+.|.  +.+.+++.....++.||+.||.|||-+||+|+||||+|||+.+.....++||||||+|+++
T Consensus       639 FVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  639 FVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             EEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence            999999976 5555443  4577999999999999999999999999999999999999998877778999999999999


Q ss_pred             CCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      .......+.+|||.|.|||+++ +.|+..-|+||+|||+|--++|..||...  .++..+|.+..+-++..+|..+++.+
T Consensus       718 gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~A  795 (888)
T KOG4236|consen  718 GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEA  795 (888)
T ss_pred             chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHH
Confidence            8777777899999999999997 67999999999999999999999999553  35566777788888999999999999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                      .+||..+|+..-.+|.|.++.|.|||++....+
T Consensus       796 idlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w  828 (888)
T KOG4236|consen  796 IDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTW  828 (888)
T ss_pred             HHHHHHHHHHHHHHhcchHhhccchhhhcchHH
Confidence            999999999999999999999999999876543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-43  Score=367.35  Aligned_cols=259  Identities=26%  Similarity=0.477  Sum_probs=218.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  130 (531)
                      .....+|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++..+ +|+||+++++.+.... 
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccc
Confidence            3445689999999999999999999999999999999976543 334456788899999999 9999999988765322 


Q ss_pred             -------eEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCe
Q 009594          131 -------AVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL  199 (531)
Q Consensus       131 -------~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~i  199 (531)
                             .+++||||+++|+|.+++...    ..+++..++.++.|++.||.|||+++|+||||||+|||++.+   +.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~---~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN---GLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC---CCE
Confidence                   378999999999999988643    458999999999999999999999999999999999999654   459


Q ss_pred             EEEeeccccccCCC---CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc
Q 009594          200 KAIDFGLSVFFRPG---EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI  275 (531)
Q Consensus       200 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  275 (531)
                      ||+|||+++.....   .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~  262 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY  262 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            99999998765432   1223467999999999987 5689999999999999999999999988877766666554433


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      ..   ..+.+++.+.+++.+||+.+|.+|||+.++++|||++.
T Consensus       263 ~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        263 DP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            21   22467899999999999999999999999999999875

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-43  Score=357.75  Aligned_cols=258  Identities=29%  Similarity=0.477  Sum_probs=212.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-----e
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-----A  131 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----~  131 (531)
                      +|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++++++...+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccce
Confidence            4788999999999999999999999999999986432 2233456788999999999 9999999999998766     7


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .|+|+||+. ++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~---~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEE  154 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC---CCCEEeccccceeecc
Confidence            999999996 588888877778999999999999999999999999999999999999964   4469999999998654


Q ss_pred             CCC--ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc------------
Q 009594          212 PGE--QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI------------  275 (531)
Q Consensus       212 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~------------  275 (531)
                      ...  ......+|+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+.......+.....            
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  2234567899999998864  478999999999999999999999988776655444432110            


Q ss_pred             -----------CCCC-----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          276 -----------DFKR-----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       276 -----------~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                 ..+.     ......++++.+||.+||+.||++|||+.++|+||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                       0000     01134578899999999999999999999999999998743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=353.45  Aligned_cols=236  Identities=26%  Similarity=0.430  Sum_probs=207.3

Q ss_pred             eccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      .++-||+|+.|.||+|+  -.++.||||++...          -..+|.-|++| +||||+.+.|+|.....+|||||||
T Consensus       128 ELeWlGSGaQGAVF~Gr--l~netVAVKKV~el----------kETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGR--LHNETVAVKKVREL----------KETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             hhhhhccCcccceeeee--ccCceehhHHHhhh----------hhhhHHHHHhc-cCcceeeEeeeecCCceeEEeeecc
Confidence            35679999999999999  46789999987422          12478899999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccc
Q 009594          140 EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI  219 (531)
Q Consensus       140 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~  219 (531)
                      ..|.|+..|+....++......|..+||.|+.|||.+.|||||||.-||||..++   .|||+|||-++..........+
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d---~VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD---VVKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc---eEEeccccchHhhhhhhhhhhh
Confidence            9999999999999999999999999999999999999999999999999997655   4999999999887766666788


Q ss_pred             cCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccc
Q 009594          220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN  298 (531)
Q Consensus       220 ~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (531)
                      .||..|||||+++ .+++.|+|||||||+||||+||..||.......++..+-...+..+.+  ..+|+.++-||.+||+
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP--stcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP--STCPDGFKLLLKQCWN  349 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc--ccCchHHHHHHHHHHh
Confidence            9999999999998 579999999999999999999999998776665554444444433332  4689999999999999


Q ss_pred             cCcCCCCCHHHHhcC
Q 009594          299 PDPKQRLTAEEVLEH  313 (531)
Q Consensus       299 ~~p~~Rps~~~~l~h  313 (531)
                      ..|-.|||+.++|.|
T Consensus       350 sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  350 SKPRNRPSFRQILLH  364 (904)
T ss_pred             cCCCCCccHHHHHHH
Confidence            999999999999998

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-43  Score=365.41  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=215.8

Q ss_pred             ccceeeccccCccCceEEEEEEEccC-CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...|.+.+.||+|++|.||+|.+..+ +..||+|.+...   .......+.+|+.+++.+ +||||+++++++...+.+|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEE
Confidence            34599999999999999999998777 788999976433   233445678899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          134 IVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      |||||++||+|.+++..    ..++++..+..++.|++.||.|||+++|+||||||+|||++.+   +.+||+|||++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~---~~~kL~DFgla~~  218 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT---GIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC---CcEEEEeCcCcee
Confidence            99999999999987753    3468999999999999999999999999999999999999654   4599999999987


Q ss_pred             cCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          210 FRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       210 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ......   ....+||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+.......   ....+
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~  295 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPV  295 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccC
Confidence            643322   23457999999999887 568999999999999999999999998887777666665543321   12357


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      ++.+.++|.+||..+|++|||+.+++.|+|++.
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            899999999999999999999999999999964

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-43  Score=336.54  Aligned_cols=254  Identities=30%  Similarity=0.515  Sum_probs=213.5

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT--AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      +|++.+.||+|++|.||.|.+..+++.+|+|.+.......  ......+.+|+.+++++ +||||+++++++......++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEEE
Confidence            5899999999999999999998899999999987543221  22346788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |+||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.+   +.++|+|||++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~---~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceeccccc
Confidence            99999999999999888889999999999999999999999999999999999999644   459999999987654322


Q ss_pred             cc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          215 QF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       215 ~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ..    ....+++.|+|||.+. ..++.++||||||+++|+|++|+.||..................  ......+++.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  236 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSHVSPDA  236 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCccCCHHH
Confidence            11    2346788999999887 45889999999999999999999999776554444333322211  11223578999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .++|.+||..+|++|||+.++++||||
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.9e-43  Score=345.06  Aligned_cols=258  Identities=26%  Similarity=0.441  Sum_probs=211.3

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+.......  ....+.+|+.+++.+ +||||+++++++...+..++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEE
Confidence            46999999999999999999999999999999986543221  234567899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++++   +.++|+|||++.......
T Consensus        83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPT  158 (301)
T ss_pred             Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC---CcEEECcCcchhccCCCC
Confidence            99997 5898887654 458999999999999999999999999999999999999654   459999999987543222


Q ss_pred             -ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC------------
Q 009594          215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR------------  279 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------  279 (531)
                       ......+++.|+|||++.+  .++.++|||||||++|+|+||.+||...+..+....+.+.......            
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence             2234467889999998763  4788999999999999999999999887765554444332111100            


Q ss_pred             --------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          280 --------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       280 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                    ...+.+++.+.+||.+||+.+|.+|||+.++++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                          01134688899999999999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.1e-43  Score=353.18  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=208.9

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      +..+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhc-CCCCccccceeeccccccc
Confidence            45689999999999999999999999999999999865432 223346678899999999 999999999987543    


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       130 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                        ..+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a  173 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLA  173 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC---CcEEEEeCCCc
Confidence              458999999965 77776643  47899999999999999999999999999999999999644   45999999999


Q ss_pred             cccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--------  278 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------  278 (531)
                      .............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+........        
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            8765444444567899999999887 4689999999999999999999999988776655554433211100        


Q ss_pred             --------------C----------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          279 --------------R----------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       279 --------------~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                    .                ......+..+.+||.+||..||.+|||+.++|+||||..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                          0                000113467899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-43  Score=337.78  Aligned_cols=270  Identities=31%  Similarity=0.501  Sum_probs=222.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|++....  .......+.+|+.+++.+ +||||+++++++......++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEE
Confidence            36899999999999999999999999999999987543  223346788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-C
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~  214 (531)
                      +||+++++|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||+++++   +.++|+|||++...... .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE---GDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEcccccceeeccccc
Confidence            9999999999998765 78999999999999999999999999999999999999654   45999999999876543 2


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ......+++.|+|||.+. ..++.++||||||+++|+|+||..||...........+......  ......+++.+.+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC--CCcccccCHHHHHHH
Confidence            233456888999999876 46899999999999999999999999776655444443333211  111122788999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhh
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ  337 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~  337 (531)
                      .+||..+|++|||+.++++||||++....   ++...+...+++
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~---~~~~~~~~~~~~  272 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKKT---SYLTLLIERIKK  272 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCcc---cHHHHHHHHHHh
Confidence            99999999999999999999999875543   333444444444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.7e-43  Score=340.13  Aligned_cols=254  Identities=32%  Similarity=0.638  Sum_probs=219.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..+++.+|+|++.............+.+|+++++++ +||||+++++++...+.+++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEEE
Confidence            699999999999999999999989999999999765544444567788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF  216 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~  216 (531)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.+   +.+||+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~---~~~kl~dfg~~~~~~~~--~  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD---GYIKITDFGFAKRVKGR--T  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC---CCEEEeeCCCccccCCC--C
Confidence            999999999999888889999999999999999999999999999999999999654   45999999998876543  2


Q ss_pred             ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK  295 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  295 (531)
                      ....+++.|+|||.+. ..++.++||||||+++|+|++|..||...........+.......+    ...++.+.++|.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~  231 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIRN  231 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHHH
Confidence            3456889999999876 5678899999999999999999999987775555555554332222    3468999999999


Q ss_pred             ccccCcCCCC-----CHHHHhcCCcccccc
Q 009594          296 MLNPDPKQRL-----TAEEVLEHPWLQNAK  320 (531)
Q Consensus       296 ~l~~~p~~Rp-----s~~~~l~h~~~~~~~  320 (531)
                      ||..+|.+|+     ++.++++||||+...
T Consensus       232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            9999999999     999999999997643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-43  Score=352.59  Aligned_cols=259  Identities=26%  Similarity=0.412  Sum_probs=208.0

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC---
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  129 (531)
                      .+..+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccc
Confidence            355689999999999999999999999999999999865432 233346777899999999 999999999988643   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       130 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                         ...++||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~---~~~~kl~Dfg~  165 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL  165 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC---CCCEEEeeCcc
Confidence               357999999975 67666643  4889999999999999999999999999999999999964   44599999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC---------
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------  276 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------  276 (531)
                      +.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......         
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            98765444445567899999999887 46899999999999999999999999877654433322221100         


Q ss_pred             -------------CC---------C-------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          277 -------------FK---------R-------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       277 -------------~~---------~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                                   ..         .       ......+..+.+||.+||..||++|||+.|+|+||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                         00         0       0011235678999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.6e-43  Score=345.66  Aligned_cols=249  Identities=27%  Similarity=0.497  Sum_probs=192.8

Q ss_pred             ccccCccCceEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--CCeEEEEE
Q 009594           61 GRELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAVHIVM  136 (531)
Q Consensus        61 ~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~  136 (531)
                      ..+||+|+||+||+|.+.  .+++.+|+|.+.....     ...+.+|+.+++++ +||||+++++++..  ...+++|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEE
Confidence            358999999999999965  4678999999865432     24567899999999 99999999998854  46789999


Q ss_pred             eccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC-CCCCCeEEEeecc
Q 009594          137 ELCEGGELFDRIVAR---------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGL  206 (531)
Q Consensus       137 e~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~-~~~~~ikl~Dfg~  206 (531)
                      ||+. ++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+... ...+.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            9995 5888776532         248999999999999999999999999999999999999643 2345799999999


Q ss_pred             ccccCCCC----ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHH---------HHHHHHH
Q 009594          207 SVFFRPGE----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAII  271 (531)
Q Consensus       207 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------~~~~~~~  271 (531)
                      |.......    ......||+.|+|||++.+  .++.++||||+||++|+|++|.+||......         .....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            98654322    2234678999999998864  4889999999999999999999999654321         1111111


Q ss_pred             hcccCCC---------------------C-------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          272 RSVIDFK---------------------R-------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       272 ~~~~~~~---------------------~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .......                     .             ......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1100000                     0             0001234678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.7e-43  Score=349.36  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=199.9

Q ss_pred             ccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.+.+||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            457999999999999999999752     345789999986432  2234567889999999998899999999988754


Q ss_pred             -CeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 009594          130 -SAVHIVMELCEGGELFDRIVAR---------------------------------------------------------  151 (531)
Q Consensus       130 -~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  151 (531)
                       ..+++||||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999988642                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---cccccCCc
Q 009594          152 -----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSP  223 (531)
Q Consensus       152 -----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~  223 (531)
                           ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++........   .....+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC---CcEEEeecccccccccCcchhcccCCCCCc
Confidence                 236778889999999999999999999999999999999643   4599999999986543322   12334567


Q ss_pred             ccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCc
Q 009594          224 YYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP  301 (531)
Q Consensus       224 ~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  301 (531)
                      .|+|||++. ..++.++|||||||++|+|++ |..||...................  .....+++.+.+++.+||+.+|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp  318 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDP  318 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccCCh
Confidence            899999876 568999999999999999997 999998755433332222221111  1124578899999999999999


Q ss_pred             CCCCCHHHHhc
Q 009594          302 KQRLTAEEVLE  312 (531)
Q Consensus       302 ~~Rps~~~~l~  312 (531)
                      ++|||+.++++
T Consensus       319 ~~RPs~~el~~  329 (338)
T cd05102         319 KERPTFSALVE  329 (338)
T ss_pred             hhCcCHHHHHH
Confidence            99999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-43  Score=350.93  Aligned_cols=259  Identities=26%  Similarity=0.458  Sum_probs=209.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      +.++|++++.||.|+||.||+|.+..++..||+|++..... .......+.+|+.+++++ +||||+++++++...    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccc
Confidence            45679999999999999999999999999999999865432 222345677899999999 999999999987532    


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       130 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                        ...|++++++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~---~~~kl~Dfg~~  165 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED---CELRILDFGLA  165 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC---CCEEEcCCccc
Confidence              4578999998 778987764 4579999999999999999999999999999999999999654   45999999999


Q ss_pred             cccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC---------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------  276 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------  276 (531)
                      .....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.........+......         
T Consensus       166 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         166 RQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             eecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            86543  2344578999999998864  5889999999999999999999999876654444333221100         


Q ss_pred             --------------CCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          277 --------------FKR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       277 --------------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                    .+.    ..+...++.+.+||.+||..||++|||+.++|+||||.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                          000    012245677899999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.2e-43  Score=335.40  Aligned_cols=253  Identities=28%  Similarity=0.504  Sum_probs=217.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|+||.||+|.+..++..||+|++.............+.+|+++++++ +||||+++++++......++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence            489999999999999999999889999999999876554445567889999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF  216 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~  216 (531)
                      ||++|++|..++.....+++..+..++.|++.||.|||++|++|+||+|+||+++++   +.++|+|||++.........
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ---GHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC---CCEEEeecccccccCCCccc
Confidence            999999999999877789999999999999999999999999999999999999654   45999999998876554444


Q ss_pred             ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ....|+..|+|||.+. ..++.++|+||||+++|+|++|..||.....  ..........   ......+..+..+.++|
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i  233 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADVLYPATWSTEAIDAI  233 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccccCcccCcHHHHHHH
Confidence            5567888999999886 4578999999999999999999999987664  2222222221   11222245789999999


Q ss_pred             HHccccCcCCCCCH--HHHhcCCcc
Q 009594          294 KKMLNPDPKQRLTA--EEVLEHPWL  316 (531)
Q Consensus       294 ~~~l~~~p~~Rps~--~~~l~h~~~  316 (531)
                      .+||..+|.+||++  .++++||||
T Consensus       234 ~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHccCChhHcCCccHHHHhcCCCC
Confidence            99999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-42  Score=337.30  Aligned_cols=256  Identities=30%  Similarity=0.577  Sum_probs=212.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++++ +||||+++++++.....+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEE
Confidence            3699999999999999999999889999999998754321 12235677899999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      |||+++++|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++++   +.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ---GQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC---CcEEECccccceecCCCcc
Confidence            9999998888877766679999999999999999999999999999999999999654   459999999998765433 


Q ss_pred             ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC----------------
Q 009594          215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID----------------  276 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------------  276 (531)
                      ......++..|+|||++.+  .++.++||||||+++|+|++|.+||.+....+....+......                
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            2334567889999998763  4788999999999999999999999887665544433221100                


Q ss_pred             ---CCC--------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          277 ---FKR--------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       277 ---~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                         .+.        ..++.++..+.+|+.+||..+|++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence               000        0123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-42  Score=340.64  Aligned_cols=256  Identities=27%  Similarity=0.427  Sum_probs=211.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+....  .......+.+|+++++++ +||||+++++++...+.+++||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEe
Confidence            6999999999999999999999999999999886432  233345688899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.+   +.+||+|||++...... .
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~-~  154 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS-M  154 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC---CcEEEccCCCccccccc-c
Confidence            999999999999888889999999999999999999997 599999999999999654   45999999998755322 2


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-----------------
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-----------------  277 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-----------------  277 (531)
                      .....|++.|+|||.+. ..++.++||||||+++|+|++|..||...+.......+.......                 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            24457889999999886 458889999999999999999999997655333222221110000                 


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          278 -----------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       278 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                                       +..+...++.++.+|+.+||..+|++|||+.++++||||.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                             000112367789999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-42  Score=334.85  Aligned_cols=254  Identities=31%  Similarity=0.502  Sum_probs=211.0

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.+ +||||+++++++...+.+++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEE
Confidence            347999999999999999999999999999999986543   22345677899999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |+||+++++|.+++...+.+++..++.++.|++.||.|||+.||+|+||||+||+++.+   +.++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN---GHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECcceeeeEccCcc
Confidence            99999999999999888889999999999999999999999999999999999999644   459999999987554322


Q ss_pred             -ccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-CCCCCCCHH
Q 009594          215 -QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-DPWPKVSEN  288 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  288 (531)
                       ......|++.|+|||++.    +.++.++|||||||++|+|++|..||..................... .....++..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS  240 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence             223457899999999863    45888999999999999999999999765543333322222211111 111246788


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPW  315 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~  315 (531)
                      +.+++.+||..+|++|||+.++++|||
T Consensus       241 ~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         241 FHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.2e-42  Score=329.41  Aligned_cols=252  Identities=27%  Similarity=0.477  Sum_probs=215.7

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|.+.+.||+|++|.||+|.+..++..|++|.+...... ......+.+|+.+++.+ +||||+++++++...+..++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEE
Confidence            488889999999999999999999999999998765433 34567788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+   +.++|+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~---~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC---CCEEEcccccceeccCcc
Confidence            999999999998764  468999999999999999999999999999999999999654   459999999988665433


Q ss_pred             c-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 Q-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      . .....|++.|+|||++. +.++.++|+||||+++|+|++|..||...+.......+.+.......   ..+++.+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL  232 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence            2 23456889999999876 56889999999999999999999999887766655555543322111   2578899999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +.+||+.+|++||++.+++.|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=341.81  Aligned_cols=258  Identities=31%  Similarity=0.554  Sum_probs=218.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|++|.||+|.+..++..+|+|.+.............+.+|+++++.+ +||||+++++++......++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEE
Confidence            699999999999999999999889999999999876554434567788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+.|++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.+   +.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES---GHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC---CCEEEeecchhhcccccc
Confidence            999999999988754  468999999999999999999999999999999999999654   459999999886543211


Q ss_pred             ------------------------------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH
Q 009594          215 ------------------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE  263 (531)
Q Consensus       215 ------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~  263 (531)
                                                    ......||..|+|||++. ..++.++||||||+++|+|++|..||.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          112346788999999886 4688899999999999999999999988877


Q ss_pred             HHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCC----HHHHhcCCcccccc
Q 009594          264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT----AEEVLEHPWLQNAK  320 (531)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~h~~~~~~~  320 (531)
                      ......+.......+.  ....++.+.++|.+||..+|++|||    +.++++||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         238 DETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            6666555543332222  1236899999999999999999999    99999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=371.72  Aligned_cols=260  Identities=30%  Similarity=0.504  Sum_probs=229.8

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      -..+|.+++.||+|+||.|.+++++.+++.||.|++.+.......+..-|..|-.+|..- +.+=|+.++-.|++..++|
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceE
Confidence            345899999999999999999999999999999999875554455566778888888776 8899999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +|||||+||+|..++.+..++|+..++.++..|+-||.-||+.|+|||||||+|||++   ..|+|||+|||.+..+..+
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld---~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD---KSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec---ccCcEeeccchhHHhcCCC
Confidence            9999999999999999888899999999999999999999999999999999999995   5567999999998877643


Q ss_pred             C--ccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCC
Q 009594          214 E--QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS--VIDFKRDPWP  283 (531)
Q Consensus       214 ~--~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~  283 (531)
                      .  .....+|||-|.|||++.      +.|++.+|+||+||++|||+.|..||+..+-.+++.+|...  .+.+|  .-.
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~  306 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DET  306 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--ccc
Confidence            3  345678999999999985      34899999999999999999999999999999999999876  45555  334


Q ss_pred             CCCHHHHHHHHHccccCcCCCCC---HHHHhcCCcccccc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNAK  320 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps---~~~~l~h~~~~~~~  320 (531)
                      .+|+++++||.+++.. |+.|..   +.++-+||||.+..
T Consensus       307 ~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  307 DVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             ccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCC
Confidence            6999999999999987 888988   99999999998754

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=330.36  Aligned_cols=253  Identities=27%  Similarity=0.473  Sum_probs=216.5

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .-|.++++||+|+||.||+|.++.+|+.+|||.+...     .+++++..|+.+++++ +.|+||++|+.|-....++||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEee
Confidence            3489999999999999999999999999999988643     3578899999999999 999999999999988999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||||..|++.+.+.. +.++++.++..+++..+.||+|||...-||||||..|||++.   .++.||+|||.|..+.+..
T Consensus       107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT---~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT---DGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc---cchhhhhhccccchhhhhH
Confidence            999999999998864 557999999999999999999999999999999999999954   4568999999998765443


Q ss_pred             -ccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC---CCCHHH
Q 009594          215 -QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP---KVSENA  289 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  289 (531)
                       ..+++.|||.|||||++.. .|+.++||||||++..||..|++||........   + -.+...+.+.+.   ..+.++
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---I-FMIPT~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---I-FMIPTKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---e-EeccCCCCCCCCChHhhhhHH
Confidence             3467899999999999984 799999999999999999999999966543211   1 011122222222   257889


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .+|+.+||.++|++|.|+.++++|||.+++..
T Consensus       260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            99999999999999999999999999998754

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.1e-42  Score=338.34  Aligned_cols=258  Identities=30%  Similarity=0.531  Sum_probs=218.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.+ +||||+++++.+...+.+++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEE
Confidence            689999999999999999999999999999998765433333456788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC--
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~--  214 (531)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.   .+.++|+|||++.......  
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~---~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC---CCCEEEeeCCCccccCcCccc
Confidence            99999999999988888999999999999999999999999999999999999964   4459999999886421110  


Q ss_pred             --------------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 009594          215 --------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR  279 (531)
Q Consensus       215 --------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  279 (531)
                                    ......++..|+|||.+. ..++.++|||||||++|+|++|..||.+....+............+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                          001235788899999876 56899999999999999999999999887777666666554433333


Q ss_pred             CCCCCCCHHHHHHHHHccccCcCCCCC---HHHHhcCCccccc
Q 009594          280 DPWPKVSENAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNA  319 (531)
Q Consensus       280 ~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~h~~~~~~  319 (531)
                      .. ..++..+.++|.+||+.+|++||+   +.++|+||||...
T Consensus       238 ~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         238 GD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             cc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            22 257899999999999999999997   7999999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.8e-42  Score=335.73  Aligned_cols=241  Identities=18%  Similarity=0.215  Sum_probs=204.4

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc----CCeEEEEEe
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----DSAVHIVME  137 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e  137 (531)
                      ..||+|++|.||+|..  +|+.||+|.+...........+.+.+|+.+++++ +||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5689999999999985  7899999999765443333356788999999999 99999999999876    457899999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 009594          138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF  216 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~  216 (531)
                      |+++|+|.+++.+...+++.....++.|++.||.|||+. +++||||||+||+++.+   +.+||+|||++.......  
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~---~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN---YKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC---CcEEEcccchHhhhcccc--
Confidence            999999999998888899999999999999999999985 99999999999999654   459999999988654322  


Q ss_pred             ccccCCcccccchhcc---ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ....|++.|+|||++.   +.++.++|||||||++|+|++|..||...+..+....+.........+  ..+++.+.+++
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li  255 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV  255 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence            2346889999999886   468999999999999999999999999888777766665443332211  26789999999


Q ss_pred             HHccccCcCCCCCHHHHhc
Q 009594          294 KKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+||+.+|++|||+.++++
T Consensus       256 ~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHhcCCcccCcCHHHHHH
Confidence            9999999999999999985

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-42  Score=333.95  Aligned_cols=254  Identities=27%  Similarity=0.466  Sum_probs=209.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-----  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-----  128 (531)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++++.+||||+++++++..     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            3456999999999999999999999999999999986542    1235678899999998789999999999864     


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          129 -DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       129 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                       ....++||||+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.+   +.++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~---~~~~l~Dfg  156 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFG  156 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC---CCEEEccCC
Confidence             24689999999999999998763  358999999999999999999999999999999999999654   459999999


Q ss_pred             cccccCCCC-ccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC
Q 009594          206 LSVFFRPGE-QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK  278 (531)
Q Consensus       206 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  278 (531)
                      ++....... ......|++.|+|||++.      ..++.++|||||||++|+|++|..||................  ..
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~  234 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--AP  234 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CC
Confidence            987654322 233457899999999874      247889999999999999999999997665544333332211  12


Q ss_pred             CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       279 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ......++..+.+|+.+||..+|++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            22234578999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-42  Score=335.55  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=207.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++++ +||||+++++++...+..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEE
Confidence            5888999999999999999999999999999986542  223346788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF  216 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~  216 (531)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+   +.++|+|||++...... ..
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~---~~~~l~dfg~~~~~~~~-~~  150 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR---GQVKLCDFGVSTQLVNS-IA  150 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC---CCEEEeeCCcceecccc-cc
Confidence            99999998654    357899999999999999999999999999999999999654   45999999998765432 22


Q ss_pred             ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHhcccCCCCCCCCCCCHH
Q 009594          217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ....||+.|+|||++. ..++.++||||||+++|+|++|..||......       .....+....  .........++.
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  228 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSEK  228 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCHH
Confidence            3457899999999886 56889999999999999999999999653221       1111111111  111122457889


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +.+++.+||+.+|++||++.++++||||+....
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            999999999999999999999999999987644

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.1e-42  Score=333.71  Aligned_cols=257  Identities=31%  Similarity=0.489  Sum_probs=214.6

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      -|++.+.||.|+||.||+|.+..++..+++|.+...   .......+.+|+.+++.+ +||||+++++++...+..++|+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEE
Confidence            378999999999999999999999999999998643   233456788899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      ||+++++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++....... 
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC---CCEEEcccccccccccccc
Confidence            99999999888765 4568999999999999999999999999999999999999654   459999999987543322 


Q ss_pred             ccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          215 QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ......+++.|+|||++.      ..++.++|||||||++|+|++|.+||...+.......+....... ......++..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSE  237 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCHH
Confidence            233456899999999873      246789999999999999999999998877665555554432211 1112357889


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +.++|.+||..+|++|||+.++++||||+....
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            999999999999999999999999999986543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=330.98  Aligned_cols=253  Identities=31%  Similarity=0.520  Sum_probs=210.6

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||.|+||.||+|.+..+++.||+|++.............+..|..++....+||||+++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999998899999999987544322223334555666555545899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccC
Q 009594          142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG  221 (531)
Q Consensus       142 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g  221 (531)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+++||||+|+||+++.+   ..++|+|||++.....   .....+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---GHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CcEEEeecccceeccc---cccCCC
Confidence            9999999888889999999999999999999999999999999999999654   4599999998875432   233467


Q ss_pred             Ccccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccC
Q 009594          222 SPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD  300 (531)
Q Consensus       222 t~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  300 (531)
                      ++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+..............+++.+.+++.+||..+
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            889999998764 5789999999999999999999999887776666666554444444444468999999999999999


Q ss_pred             cCCCC---CHHHHhcCCcccccc
Q 009594          301 PKQRL---TAEEVLEHPWLQNAK  320 (531)
Q Consensus       301 p~~Rp---s~~~~l~h~~~~~~~  320 (531)
                      |++||   ++.|+++||||++..
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcCC
Confidence            99999   557999999997643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-42  Score=335.46  Aligned_cols=253  Identities=32%  Similarity=0.548  Sum_probs=210.2

Q ss_pred             cCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCc
Q 009594           64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE  143 (531)
Q Consensus        64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  143 (531)
                      ||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++...+..|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            69999999999999999999999999765443333455667899999999 89999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccC
Q 009594          144 LFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG  221 (531)
Q Consensus       144 L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g  221 (531)
                      |.+++....  .+++..+..++.|++.||.|||++|++||||+|+||+++++   +.++|+|||.+.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH---GNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEccCcchhhhccCCccccccC
Confidence            999987765  68999999999999999999999999999999999999654   4599999999876654434444567


Q ss_pred             Ccccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccC
Q 009594          222 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD  300 (531)
Q Consensus       222 t~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  300 (531)
                      +..|+|||++. +.++.++||||||+++|+|++|..||...........+............+.+++.+.++|.+||+.+
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            88999999876 46888999999999999999999999765442222233333322233333457899999999999999


Q ss_pred             cCCCC-----CHHHHhcCCcccccc
Q 009594          301 PKQRL-----TAEEVLEHPWLQNAK  320 (531)
Q Consensus       301 p~~Rp-----s~~~~l~h~~~~~~~  320 (531)
                      |++||     ++.++++||||+...
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCC
Confidence            99999     899999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.4e-42  Score=335.86  Aligned_cols=254  Identities=31%  Similarity=0.497  Sum_probs=206.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|++|.||+|.+..++..||+|++...... ......+.+|+.+++++ +||||+++++++...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEE
Confidence            488999999999999999999989999999998654322 22345678899999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          137 ELCEGGELFDRIVAR---GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       137 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||++ ++|.+++...   ..+++..++.++.||+.||.|||+.||+||||+|+||+++++   +.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC---CcEEECcccceeecCCC
Confidence            9997 5888877542   458999999999999999999999999999999999999654   45999999998754332


Q ss_pred             C-ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC------------
Q 009594          214 E-QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK------------  278 (531)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------------  278 (531)
                      . ......+++.|+|||++.+  .++.++|||||||++|+|+||.+||.+.........+.+......            
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            2 2233457889999998763  478899999999999999999999987665444333322111000            


Q ss_pred             -------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          279 -------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       279 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                   ......+++++.++|.+||..||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                         01123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-43  Score=338.88  Aligned_cols=252  Identities=28%  Similarity=0.479  Sum_probs=203.4

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|+++++||+||.+.||++.. .+.+.+|+|++.... .+...+..+.+|+.+|.+|.+|.+||+|++|-..++.+||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            599999999999999999984 455677777665433 345567899999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          137 ELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      ||= ..+|..+|.+... .+.-.++.+..||+.|+.++|..||||.||||.|+|+..    +.+||+|||.|..+.++..
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk----G~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK----GRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe----eeEEeeeechhcccCcccc
Confidence            986 4699999987655 343588899999999999999999999999999999963    4599999999998876543


Q ss_pred             ---cccccCCcccccchhccc------------cCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCCC
Q 009594          216 ---FNEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKR  279 (531)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~  279 (531)
                         ..+.+||+.|||||.+..            ..+.+|||||||||||+|+.|++||...... .-...+.....   .
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~---~  591 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH---E  591 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc---c
Confidence               346799999999998741            1567899999999999999999999554321 11122222111   1


Q ss_pred             CCCCCCC--HHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          280 DPWPKVS--ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       280 ~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      -.++.+|  .++.+++..||..||.+|||+.++|+|||++.
T Consensus       592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            1233332  34999999999999999999999999999975

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.1e-42  Score=335.18  Aligned_cols=259  Identities=30%  Similarity=0.520  Sum_probs=215.5

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|++.+.||+|+||.||+|.+..++..+|+|.+......   ....+.+|+.+++.+ +||||+++++.+......+
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEE
Confidence            345799999999999999999999899999999998764432   246788899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+||+++.+   +.++|+|||++......
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~---~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC---CCEEECccccchhcccc
Confidence            99999999999998854 468999999999999999999999999999999999999643   45999999998765433


Q ss_pred             Cc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 EQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      .. .....+++.|+|||.+. ..++.++|||||||++|+|++|..||................. ........+++.+.+
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~  248 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRD  248 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccCHHHHH
Confidence            22 23356889999999876 4578999999999999999999999987665443333222211 111122457889999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++.+||.++|++|||+.++++||||.....
T Consensus       249 li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            999999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=347.19  Aligned_cols=260  Identities=35%  Similarity=0.620  Sum_probs=232.9

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..-...|.+...||+|.|+.|.+|++..++..||||++++...... ..+.+.+|+++|+.| +|||||+++.+......
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSL-NHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhc-CCcceeeeeeeeeecce
Confidence            3344579999999999999999999999999999999998776544 345588999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +|+||||+.+|.+++++.+.+...+..++.++.|+++|++|||+++|+|||||++|||++.   +.++||+|||++..+.
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~---~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE---NMNIKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc---ccceeeeccccceeec
Confidence            9999999999999999999999999999999999999999999999999999999999954   4459999999999999


Q ss_pred             CCCccccccCCcccccchhcccc--CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      .+....+++|++.|.|||++.+.  -++.+|+||+|+++|-|+.|.+||.+.+-.+.....+.+....+.    .++.++
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dc  282 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDC  282 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechh
Confidence            88888999999999999999853  578999999999999999999999998877766666665544332    467889


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .++|.++|..+|.+|++.+++..|.|.....
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence            9999999999999999999999999997543

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-42  Score=334.49  Aligned_cols=259  Identities=28%  Similarity=0.415  Sum_probs=213.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++++.||+|+||.||+|.+..++..+|+|.+....  .......+.+|+.+++++ +||||+++++++...+..++||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEE
Confidence            6899999999999999999998899999999886432  233456788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          137 ELCEGGELFDRIVAR---GHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       137 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||+++++|..++...   ..+++..+..++.|++.||.|||+ .+|+||||||+||++++   ++.++|+|||.+.....
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC---CCCEEEeecCCcccccC
Confidence            999999998888663   368999999999999999999997 59999999999999965   44599999999876532


Q ss_pred             CCccccccCCcccccchhccc-------cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          213 GEQFNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      . ......+++.|+|||.+.+       .++.++|||||||++|+|++|..||...........+............+.+
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence            2 2233467889999998752       2578999999999999999999999765544433332222111222223458


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                      ++++.++|.+||..+|++||++.++++||||......
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            8999999999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-42  Score=333.26  Aligned_cols=254  Identities=30%  Similarity=0.456  Sum_probs=209.3

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.+++++ +||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEE
Confidence            3579999999999999999999999999999999865422   2345678899999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.+   +.++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~---~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN---GDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---CCEEECcCccceeecccc
Confidence            99999999999999888889999999999999999999999999999999999999644   459999999987654322


Q ss_pred             -ccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC-CCCCCCHH
Q 009594          215 -QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD-PWPKVSEN  288 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  288 (531)
                       ......|++.|+|||.+.    ..++.++|||||||++|+|++|..||...........+.......+.. ....++..
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence             223456889999999873    347889999999999999999999996554333222222211111111 11246889


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPW  315 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~  315 (531)
                      +.++|.+||..+|++|||+.++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.1e-42  Score=329.96  Aligned_cols=250  Identities=32%  Similarity=0.595  Sum_probs=212.8

Q ss_pred             cCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCc
Q 009594           64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE  143 (531)
Q Consensus        64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  143 (531)
                      ||.|++|.||+|.+..++..+|+|++...........+.+.+|+.+++.+ +||||+++++++.+....++|+||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            69999999999999888999999999866544444557889999999999 99999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccCCc
Q 009594          144 LFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP  223 (531)
Q Consensus       144 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~  223 (531)
                      |.+++.+...+++..+..++.|++.||.|||+.+++|+||+|+||+++++   +.++|+|||++.............+++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC---CCEEEeeCCcccccCcccccccccCCc
Confidence            99999887789999999999999999999999999999999999999654   459999999998765543334457889


Q ss_pred             ccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC--HHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccC
Q 009594          224 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD  300 (531)
Q Consensus       224 ~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  300 (531)
                      .|+|||.+. ..++.++|+||||+++|+|++|..||....  .......+.........+  ...++.+.++|.+||..+
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence            999999876 568899999999999999999999997766  444444444212111111  234889999999999999


Q ss_pred             cCCCCC-----HHHHhcCCccccc
Q 009594          301 PKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       301 p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      |++||+     +.|+++||||+..
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCC
Confidence            999999     9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=334.37  Aligned_cols=257  Identities=32%  Similarity=0.502  Sum_probs=215.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .++|++.+.||.|+||.||+|.+..++..+|+|.+...   .......+.+|+.+++++ +||||+++++++......++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEE
Confidence            35699999999999999999999889999999998643   334456788999999999 79999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          135 VMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.+   +.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~---~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD---GDVKLADFGVSAKNKST  156 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC---CCEEEccCccchhhccc
Confidence            99999999999988764 468999999999999999999999999999999999999644   45999999988655332


Q ss_pred             C-ccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          214 E-QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      . ......+++.|+|||.+.      ..++.++||||||+++|+|++|.+||...........+....... ......++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  235 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT-LDQPSKWS  235 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC-cCCcccCC
Confidence            2 223456899999999874      236779999999999999999999998876655554444332211 11123578


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ..+.++|.+||..+|.+|||+.++++||||...
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            899999999999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-42  Score=348.20  Aligned_cols=249  Identities=25%  Similarity=0.397  Sum_probs=197.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++++.||+|+||.||+|.+..++..||+|+....         ....|+.+++++ +||||+++++++......++|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEE
Confidence            3699999999999999999999999999999975332         224599999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      +||+. ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++..   +.+||+|||++.......
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV---DQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEecCccccccccCc
Confidence            99995 588888765 4568999999999999999999999999999999999999654   459999999987544333


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCC-CCCCHH---------HHHHHHHhccc----CCC-
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF-WAETEQ---------GVAQAIIRSVI----DFK-  278 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf-~~~~~~---------~~~~~~~~~~~----~~~-  278 (531)
                      ......||+.|+|||++. ..++.++|||||||++|+|+++..|+ ......         .....+.....    .++ 
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            444567999999999886 56899999999999999999855444 321110         11111111100    000 


Q ss_pred             -----------------CCC--------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          279 -----------------RDP--------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       279 -----------------~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                       ..+        ...++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                             000        1135667888999999999999999999999999975

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4e-42  Score=330.86  Aligned_cols=255  Identities=31%  Similarity=0.514  Sum_probs=214.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||.|+||+||+|....++..+|+|++.......  ....+.+|+.+++.+ +||||+++++.+...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEE
Confidence            36999999999999999999988899999999986544322  567889999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          136 MELCEGGELFDRIVAR---GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +|++++++|.+++...   ..+++..+..++.|++.||.|||+.||+||||+|+||+++++   +.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~---~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED---GSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEcccchHHHhcc
Confidence            9999999999998764   458999999999999999999999999999999999999654   4599999999876654


Q ss_pred             CCcc-----ccccCCcccccchhcc-c-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC--CCC
Q 009594          213 GEQF-----NEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD--PWP  283 (531)
Q Consensus       213 ~~~~-----~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  283 (531)
                      ....     ....|+..|+|||++. . .++.++|+|||||++|+|++|..||...+..................  .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            3222     2346889999999876 3 58899999999999999999999998776655554444432221111  123


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .+++.+.+++.+||..+|++|||+.++++||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            678999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-42  Score=342.56  Aligned_cols=257  Identities=20%  Similarity=0.309  Sum_probs=203.8

Q ss_pred             eccccCcc--CceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           60 LGRELGRG--EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        60 ~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      ++++||+|  +||+||++.+..+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence            56789999  7899999999999999999998755332 22345677899999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-C
Q 009594          138 LCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E  214 (531)
Q Consensus       138 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~  214 (531)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||+++|+||||||+||+++.++   .++++||+.+...... .
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~---~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG---KVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC---cEEEcccchhhccccccc
Confidence            99999999998653  4589999999999999999999999999999999999996543   5999999865432211 1


Q ss_pred             -------ccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC------
Q 009594          215 -------QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK------  278 (531)
Q Consensus       215 -------~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------  278 (531)
                             ......++..|+|||++.+   .++.++|||||||++|+|++|..||....................      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   0112346778999998863   488999999999999999999999976554443332222111000      


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          279 ------------------------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       279 ------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                                          .+....+++.+.+|+.+||+.||++|||+.++++||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~  315 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  315 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence                                                0001124678999999999999999999999999999987543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=349.56  Aligned_cols=269  Identities=29%  Similarity=0.496  Sum_probs=222.7

Q ss_pred             CCCCCccccceeecc-----ccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeec
Q 009594           48 EPSGQDISIDYDLGR-----ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL  122 (531)
Q Consensus        48 ~~~~~~~~~~y~~~~-----~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l  122 (531)
                      .+.++.+..+|+..+     .||+|.||+||.|+|..+...+|||.+..+..   ...+-+..||.+.++| +|.|||++
T Consensus       562 d~ane~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~L-rHkNIVrY  637 (1226)
T KOG4279|consen  562 DPANEKIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTL-RHKNIVRY  637 (1226)
T ss_pred             CCcccceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHH-hhHhHHHH
Confidence            344555666676543     49999999999999999999999999976543   2356677899999999 99999999


Q ss_pred             ceEEEcCCeEEEEEeccCCCchHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCe
Q 009594          123 KDTYEDDSAVHIVMELCEGGELFDRIVA-RGHY--TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL  199 (531)
Q Consensus       123 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l--~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~i  199 (531)
                      +|.+..++.+-|.||..+||||.+++.. .+++  .+.++..+.+||++||.|||.+.|||||||-+|||++.  -.+.+
T Consensus       638 LGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT--ySGvl  715 (1226)
T KOG4279|consen  638 LGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT--YSGVL  715 (1226)
T ss_pred             hhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee--ccceE
Confidence            9999999999999999999999998864 4666  78889999999999999999999999999999999974  35679


Q ss_pred             EEEeeccccccCCC-CccccccCCcccccchhcc-c--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc
Q 009594          200 KAIDFGLSVFFRPG-EQFNEIVGSPYYMAPEVLK-R--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI  275 (531)
Q Consensus       200 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  275 (531)
                      ||+|||-++.+..- ....++.||..|||||++. |  .|+.++|||||||++.||.||++||......... ...-+..
T Consensus       716 KISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-MFkVGmy  794 (1226)
T KOG4279|consen  716 KISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-MFKVGMY  794 (1226)
T ss_pred             EecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-hhhhcce
Confidence            99999998866533 3345788999999999987 3  5999999999999999999999999776544322 2222333


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCC
Q 009594          276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP  323 (531)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~  323 (531)
                      +..++....++.+++.||.+|+.++|.+|||+.++|..||++...+.+
T Consensus       795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~  842 (1226)
T KOG4279|consen  795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKP  842 (1226)
T ss_pred             ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCC
Confidence            333333345788899999999999999999999999999998765443

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.9e-42  Score=333.84  Aligned_cols=261  Identities=29%  Similarity=0.469  Sum_probs=215.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ..+.|++++.||.|+||.||+|.+..++..+|+|.+...   .......+.+|+.+++.+ +||||+++++++...+..+
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEE
Confidence            445799999999999999999999999999999998654   334467788899999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +||||+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.   ++.++|+|||++.....
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL---DGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC---CCCEEEccCccceeccc
Confidence            99999999999887754 456899999999999999999999999999999999999964   34599999998865432


Q ss_pred             C-CccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          213 G-EQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       213 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      . .......+++.|+|||.+.      ..++.++|||||||++|+|++|.+||...+.......+...... .......+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  241 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKW  241 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCccc
Confidence            2 2223456889999999874      24678999999999999999999999776655444444332211 11112356


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                      +..+.++|.+||..+|++||++.++++||||......
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            7899999999999999999999999999999765443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4e-42  Score=332.86  Aligned_cols=271  Identities=27%  Similarity=0.450  Sum_probs=222.0

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ..|+.++.||.|+||.||+|.+..++..||+|++....  .......+.+|+.+++++ +||||+++++++.+....++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEE
Confidence            45888999999999999999998899999999987543  233457788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |||++|++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.+   +.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC---CCEEEcccccceeccCCcc
Confidence            999999999998864 568999999999999999999999999999999999999654   4599999999876544332


Q ss_pred             -cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          216 -FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       216 -~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                       .....++..|+|||.+. ..++.++|+|||||++|+|+||.+||...........+....   .......++..+.+++
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li  233 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFI  233 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHHH
Confidence             23346788999999876 468899999999999999999999998766554443332211   1122235678899999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhh
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQF  338 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~  338 (531)
                      .+||..+|++||++.++++||||.+....  .+....++++++++
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~--~~~~~~~~~~~~~~  276 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIVKNAKK--TSYLTELIDRFKRW  276 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhhhcchh--hhHHHHHHHHHHhc
Confidence            99999999999999999999999765443  33445556565544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-42  Score=350.93  Aligned_cols=255  Identities=24%  Similarity=0.438  Sum_probs=205.7

Q ss_pred             CCccccceeeccccCccCceEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      +..+..+|++++.||.|+||.||+|...  .++..||+|.+...        ....+|+.+++.+ +||||+++++++..
T Consensus        87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l-~h~~iv~~~~~~~~  157 (392)
T PHA03207         87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTI-SHRAIINLIHAYRW  157 (392)
T ss_pred             chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhc-CCCCccceeeeEee
Confidence            3455668999999999999999999753  35678999987543        2345799999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ....|+|||++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.++|+|||++.
T Consensus       158 ~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~---~~~~l~DfG~a~  233 (392)
T PHA03207        158 KSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP---ENAVLGDFGAAC  233 (392)
T ss_pred             CCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC---CCEEEccCcccc
Confidence            999999999995 6898888777789999999999999999999999999999999999999654   459999999987


Q ss_pred             ccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHhccc----CC
Q 009594          209 FFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVI----DF  277 (531)
Q Consensus       209 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---~~~~~~~~~~~----~~  277 (531)
                      .......   .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+....   .....+.+...    .+
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            6543322   23467999999999987 56899999999999999999999999765421   12222221110    00


Q ss_pred             C------------------CCCC--------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          278 K------------------RDPW--------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       278 ~------------------~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      +                  ..++        ..++.++.++|.+||..+|++|||+.++|.||||+.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence            0                  0000        124667899999999999999999999999999975

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6e-42  Score=329.75  Aligned_cols=253  Identities=29%  Similarity=0.500  Sum_probs=211.6

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh------hhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA------VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      +|.+...||.|++|.||+|.+..++..+|+|.+........      ...+.+.+|+.+++++ +||||+++++++....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Confidence            47788899999999999999988999999998865433221      1235678899999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ..++|+||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++++   +..++|+|||.+...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~---~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN---KGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC---CCCEEecccCCCccc
Confidence            99999999999999999988888999999999999999999999999999999999999964   445999999998766


Q ss_pred             CCCC-------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          211 RPGE-------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       211 ~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      ....       ......|++.|+|||.+. +.++.++|||||||++|+|++|..||...........+....   .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~  233 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SPEIP  233 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CCcCC
Confidence            4221       112345788999999886 568889999999999999999999998766544443333321   11222


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ..++..+.++|.+||+.+|.+||++.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            3578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.9e-42  Score=330.85  Aligned_cols=249  Identities=26%  Similarity=0.466  Sum_probs=202.8

Q ss_pred             cceeecccc--CccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           56 IDYDLGREL--GRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        56 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ++|.+.+.+  |+|+||.||++.+..++..+|+|++.......        .|+.....+.+||||+++++.+...+..+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            456777776  99999999999999999999999987653221        13333333447999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++++|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++  ..++|+|||++......
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC--CeEEEecCccceecCCC
Confidence            9999999999999998877899999999999999999999999999999999999997544  25999999998765422


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                         ....+++.|+|||++. ..++.++||||||+++|+|++|..||......... ....... ......++.+++.+.+
T Consensus       164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  239 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAND  239 (267)
T ss_pred             ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHH
Confidence               2346889999999887 56889999999999999999999999765443321 1122211 2222334468999999


Q ss_pred             HHHHccccCcCCCCC-HHHHhcCCcccc
Q 009594          292 LVKKMLNPDPKQRLT-AEEVLEHPWLQN  318 (531)
Q Consensus       292 li~~~l~~~p~~Rps-~~~~l~h~~~~~  318 (531)
                      +|.+||+.+|.+||+ ++++|+||||++
T Consensus       240 li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        240 FVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHhccChhhCCchHHHHhcCCcccC
Confidence            999999999999996 699999999974

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.8e-42  Score=334.18  Aligned_cols=257  Identities=32%  Similarity=0.546  Sum_probs=216.6

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||.|++|.||+|.+..+++.||+|.+.....   .....+.+|+.+++.+ +||||+++++++...+.+++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEE
Confidence            569999999999999999999999999999999875432   2346778899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      +||+++++|..++... .+++.++..++.|++.||.|||+.|++||||+|+||+++.   ++.+||+|||++........
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~---~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEccCccchhcccccc
Confidence            9999999999988654 6899999999999999999999999999999999999964   34599999999876544332


Q ss_pred             -cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          216 -FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       216 -~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                       .....+++.|+|||.+. +.++.++|||||||++|+|++|..||...........+..... ........+++.+.++|
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  249 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPIFRDFL  249 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHHHHHHH
Confidence             23456889999999886 5588999999999999999999999988766544443332221 11122346789999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCccccccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .+||..+|++|||+.++++||||+....
T Consensus       250 ~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         250 NRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            9999999999999999999999987554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.8e-42  Score=330.59  Aligned_cols=258  Identities=26%  Similarity=0.478  Sum_probs=211.6

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      +|+..+.||+|+||.||+|.+..+++.+|+|++.......   ......+.+|+.+++++ +||||+++++++.+.+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence            4788899999999999999999999999999987543221   22356788999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +|+||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++  ..++|+|||.+......
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~--~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG--QRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEcccccccccccc
Confidence            9999999999999998888899999999999999999999999999999999999996433  34899999998765432


Q ss_pred             Cc-----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC-CCCCCCCCCC
Q 009594          214 EQ-----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-FKRDPWPKVS  286 (531)
Q Consensus       214 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  286 (531)
                      ..     .....++..|+|||.+. ..++.++||||||+++|+|++|..||...........+.+.... ........++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            11     12346788999999876 56889999999999999999999999654432222222221111 1111223578


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      +.+.+++.+||..+|++|||+.++++||||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            8999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8e-42  Score=326.70  Aligned_cols=253  Identities=28%  Similarity=0.487  Sum_probs=216.5

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++++ +||||+++++.+...+..++|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEE
Confidence            4889999999999999999999999999999997654432 3457888999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||+|+||+++.+  ...+||+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~--~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEEccCCCceecCCCc
Confidence            999999999999764  348999999999999999999999999999999999999643  2358999999998765544


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ......+++.|+|||.+. ..++.++||||||+++|+|++|..||...+.......+......   .....+++.+.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHHHHH
Confidence            444567889999999887 45788999999999999999999999887766555555443221   11235789999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .+||..+|++|||+.++++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.7e-42  Score=335.58  Aligned_cols=262  Identities=30%  Similarity=0.521  Sum_probs=216.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+......   ..+.+.+|+.+++.+ +||||+++++++......+
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEE
Confidence            446899999999999999999999899999999998754322   346678899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+||+++.   ++.++|+|||++......
T Consensus        93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~---~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEECcCccceEccCC
Confidence            99999999999998865 46899999999999999999999999999999999999964   345999999998765443


Q ss_pred             Cc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 EQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      .. .....+++.|+|||.+. ..++.++|+|||||++|++++|..||...........+.... .........+++.+.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  247 (297)
T cd06656         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRD  247 (297)
T ss_pred             ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHHH
Confidence            32 23456889999999876 568899999999999999999999997765433222111111 1111122357888999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCcccccccCCC
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN  324 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~  324 (531)
                      ++.+||..+|++|||+.++++||||+.....+.
T Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             HHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence            999999999999999999999999997766554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2e-42  Score=336.24  Aligned_cols=254  Identities=30%  Similarity=0.515  Sum_probs=204.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..+|..+|+|.+....... .....+.+|+.+++++ +||||+++++++.+....++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEE
Confidence            4889999999999999999999999999999997543222 1234567899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      ||++ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++....... 
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC---CcEEECccchhhccCCCCC
Confidence            9997 478777754 5568999999999999999999999999999999999999654   459999999987654332 


Q ss_pred             ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHhccc--------------CC
Q 009594          215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVI--------------DF  277 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~-~~~~~~~~~~~~~~~--------------~~  277 (531)
                      ......+++.|+|||++.+  .++.++|||||||++|+|+||..||.. .+.......+.+...              ..
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            2234567889999998764  368899999999999999999888543 333333333222110              00


Q ss_pred             C-----------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          278 K-----------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       278 ~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .           ....+.+++.+.++|.+||..+|.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0           01123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.4e-41  Score=325.15  Aligned_cols=252  Identities=26%  Similarity=0.532  Sum_probs=211.4

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-CCeEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DSAVHIV  135 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~~~lv  135 (531)
                      .|++.+.||.|++|.||++.+..+++.+|+|.+..... .......+.+|+.+++++ +|||++++++.+.. ...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEE
Confidence            48999999999999999999998999999999875433 223456788899999999 99999999998764 4568999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          136 MELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||+++++|.+++...  ..+++.++..++.+++.||.+||++||+||||+|+||+++.   ++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~---~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR---TNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec---CCcEEEecccceEEeccc
Confidence            9999999999988763  35899999999999999999999999999999999999964   445999999998766432


Q ss_pred             C-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 E-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      . ......+++.|+|||++. +.++.++||||||+++|+|++|+.||...+.......+......   ......++.+.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHHH
Confidence            2 223456889999999876 56888999999999999999999999877665555555443321   122457899999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCcc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ++.+||..+|++|||+.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.5e-42  Score=335.59  Aligned_cols=260  Identities=31%  Similarity=0.521  Sum_probs=213.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+......  .......+.+|+.+++++ +||||+++++++...+..++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence            488899999999999999999889999999999765433  111234567899999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          135 VMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||+|+||+++.+   +.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~---~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD---GVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC---CCEEEccceeeeeccCC
Confidence            99999 889999997765 79999999999999999999999999999999999999754   45999999999866543


Q ss_pred             C-ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-----------
Q 009594          214 E-QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-----------  279 (531)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-----------  279 (531)
                      . ......+++.|+|||.+.  ..++.++|||||||++|+|++|.+||......+....+.+.......           
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            2 233345678899999875  35788999999999999999998888776655544444332111000           


Q ss_pred             -------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          280 -------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       280 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                   ..+...+..+.++|.+||.++|++|||+.+++.||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence                         012345788999999999999999999999999999997554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4e-42  Score=334.44  Aligned_cols=255  Identities=26%  Similarity=0.495  Sum_probs=210.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.+ +||||+++++++...+..++|+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEE
Confidence            6999999999999999999998889999999986543322 2345677899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Cc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~~  215 (531)
                      ||+++++|..+......+++..+..++.|++.||.|||+.||+||||+|+||+++++   +.++|+|||++...... ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~---~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---CcEEEEeeeeeeeccCCccc
Confidence            999999998877666679999999999999999999999999999999999999654   45999999998765433 22


Q ss_pred             cccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC----------------
Q 009594          216 FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF----------------  277 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------------  277 (531)
                      .....++..|+|||++.+  .++.++||||||+++|+|++|.+||......+....+.......                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            334568899999998763  47789999999999999999999997766544333332211100                


Q ss_pred             ---C--------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          278 ---K--------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       278 ---~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                         +        ...++.++..+.+|+.+||..+|++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence               0        01134678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-41  Score=327.80  Aligned_cols=254  Identities=31%  Similarity=0.542  Sum_probs=207.6

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--CCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~  131 (531)
                      .+|++.+.||+|+||.||+|.+..++..||+|++......  .......+.+|+.+++++ +||||+++++++..  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence            3689999999999999999999999999999998654322  223346788899999999 89999999998865  467


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .++++||+++++|.+++.....+++..++.++.|++.||.|||+.+|+||||+|+||+++.+   ..++|+|||++....
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~---~~~~l~dfg~~~~~~  157 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEccCCCccccc
Confidence            89999999999999999887789999999999999999999999999999999999999643   459999999987553


Q ss_pred             CC----CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC-CCC
Q 009594          212 PG----EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW-PKV  285 (531)
Q Consensus       212 ~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~  285 (531)
                      ..    .......++..|+|||.+. ..++.++|||||||++|+|++|..||................   ..+.. ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~  234 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP---TNPQLPSHI  234 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC---CCCCCchhc
Confidence            21    1122345788999999887 458899999999999999999999997765444333322211   11111 246


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      ++.+.+++ +||..+|++|||+.++++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            78888888 67788999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-43  Score=310.37  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=217.4

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +.+++..||+|+-|.||++..+.+|...|||.+.+..  +..+...+++.+.++..--++|+||+.+|+|..+..++|.|
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            4567788999999999999999999999999997654  45567788888888877657999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |.|. --+..++.+ .+++|+..+-++..-++.||.||..+ +|+|||+||+|||++   ..++|||||||.|-.+.+..
T Consensus       171 elMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD---e~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  171 ELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc---cCCCEEeecccccceeeccc
Confidence            9984 244444443 45699999999999999999999865 899999999999995   45569999999998887777


Q ss_pred             ccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ......|-+.|||||.+.    ..|+.++||||||++++||.||..||.+. .+.++...+.+...+. .+.-.++++.+
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~-L~~~~gFSp~F  325 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL-LPGHMGFSPDF  325 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC-CCcccCcCHHH
Confidence            777778999999999885    35889999999999999999999999874 4556666676644322 22223489999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccccCC
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP  323 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~  323 (531)
                      .+|+..||.+|+.+||...++|+|||++......
T Consensus       326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             HHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence            9999999999999999999999999998766543

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=326.96  Aligned_cols=253  Identities=32%  Similarity=0.525  Sum_probs=213.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||.|+||.||+|.+..++..+|+|++......   ....+.+|+.+++++ +||||+++++++.....++++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEE
Confidence            5799999999999999999999889999999999755322   457888999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.+   +.+||+|||.+.......
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED---GDVKLADFGVSAQLTATI  155 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC---CCEEECccccchhhhhhh
Confidence            9999999999988775 679999999999999999999999999999999999999754   459999999987654322


Q ss_pred             -ccccccCCcccccchhcc-c---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-CCCCCCCHH
Q 009594          215 -QFNEIVGSPYYMAPEVLK-R---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-DPWPKVSEN  288 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~-~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  288 (531)
                       ......++..|+|||.+. .   .++.++||||||+++|+|+||.+||...........+......... ......+..
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV  235 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence             223456888999999875 3   5888999999999999999999999887655544444333221111 112345788


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPW  315 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~  315 (531)
                      +.+++.+||..+|.+|||+.+++.|+|
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         236 FHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2e-41  Score=324.06  Aligned_cols=252  Identities=31%  Similarity=0.519  Sum_probs=216.6

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|+||.||.+++..++..+++|.+....... .....+.+|+.+++++ +||||+++++++...+..+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence            5899999999999999999999999999999987654332 3456788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+   +.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~---~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA---GLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC---CCEEECcCcceEEccccc
Confidence            999999999999765  458999999999999999999999999999999999999654   459999999988664433


Q ss_pred             -ccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 -QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                       ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+.......   ....++..+.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---VVSVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence             2344578999999998764 57889999999999999999999998877766666655433222   124578999999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +.+||..+|++|||+.++++|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.5e-42  Score=332.14  Aligned_cols=255  Identities=31%  Similarity=0.550  Sum_probs=212.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++++ +||||+++++++......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEe
Confidence            5899999999999999999998899999999997654322 2346788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      ||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.   .+.++|+|||++....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~---~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA---DGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC---CCcEEEeeeeecccccCCCC
Confidence            999 9999998865 346899999999999999999999999999999999999965   3459999999988665433 


Q ss_pred             -ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC------------
Q 009594          215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR------------  279 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------  279 (531)
                       ......++..|+|||.+.+  .++.++||||+|+++|+|+||.+||.+.........+.........            
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             2334568999999998753  4688999999999999999999888777665544444332111100            


Q ss_pred             --------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          280 --------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       280 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                                    ..++..+..+.++|.+||.++|++|||+.++++||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                          11235678899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-41  Score=327.47  Aligned_cols=254  Identities=29%  Similarity=0.458  Sum_probs=210.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC---ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      +|++.+.||+|+||+||+|.+ .+++.+|+|.+......   .......+.+|+.+++++ +||||+++++++.+.+..+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEE
Confidence            488889999999999999986 57899999988754321   122345688999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +|+||+++++|.+++.+..++++..+..++.|++.||.|||+.+|+|+||+|+||+++++   +.++|+|||++......
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN---GIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC---CeEEeccchhhHhhhhc
Confidence            999999999999999887789999999999999999999999999999999999999644   45999999998754211


Q ss_pred             -------CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          214 -------EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       214 -------~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                             .......|+..|+|||.+. ..++.++||||||+++|+|++|..||...........+...... .......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-MPRLPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-CCCCCCCC
Confidence                   1123456889999999887 45789999999999999999999999776554433333322111 11122457


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +..+.++|.+||..+|++||++.++++||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.6e-42  Score=330.64  Aligned_cols=253  Identities=27%  Similarity=0.458  Sum_probs=201.6

Q ss_pred             ccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhC--CCCCCeeecceEEEcCCeEEEEEeccC
Q 009594           63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL--PKHPNIVSLKDTYEDDSAVHIVMELCE  140 (531)
Q Consensus        63 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~e~~~  140 (531)
                      .||+|+||.||+|.+..+++.+|+|.+...............+|..+++.+  .+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999999765443332223344454444332  279999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccc
Q 009594          141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV  220 (531)
Q Consensus       141 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~  220 (531)
                      +++|..++...+.+++..+..++.|++.||.|||+++|+||||||+||+++.+   +.++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~---~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---CCEEEccCCcceeccccC-ccCcC
Confidence            99999999888889999999999999999999999999999999999999644   459999999987543322 23346


Q ss_pred             CCcccccchhcc-c-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccc
Q 009594          221 GSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN  298 (531)
Q Consensus       221 gt~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (531)
                      |++.|+|||.+. + .++.++||||+||++|+|++|..||........ ..+..............+++.+.++|.+||.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            899999999875 3 478899999999999999999999975432211 1121111222222334678999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCCcccccc
Q 009594          299 PDPKQRL-----TAEEVLEHPWLQNAK  320 (531)
Q Consensus       299 ~~p~~Rp-----s~~~~l~h~~~~~~~  320 (531)
                      .+|++||     |+.++++||||+...
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            9999999     699999999998744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.8e-42  Score=331.32  Aligned_cols=252  Identities=29%  Similarity=0.531  Sum_probs=206.0

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--CeEEEE
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVHIV  135 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~lv  135 (531)
                      |++.+.||+|+||.||+|.+..++..+|+|++..... .. ......+|+.+++++.+||||+++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6788999999999999999999999999999865432 11 2234457999999996799999999999877  889999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      +||+++ +|.+.+... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.    +.+||+|||++.......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----CCeEEEecccccccccCC
Confidence            999974 888877653 46899999999999999999999999999999999999975    569999999998765444


Q ss_pred             ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC----------------
Q 009594          215 QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID----------------  276 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------------  276 (531)
                      ......+++.|+|||.+.  +.++.++|||||||++|+|++|.+||.+.+..+....+......                
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            444556889999999764  34788999999999999999999999887665544433321110                


Q ss_pred             --CCCC-------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          277 --FKRD-------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       277 --~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                        ++..       ..+.++..+.++|.+||.++|++|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence              0000       012467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-41  Score=326.00  Aligned_cols=251  Identities=28%  Similarity=0.490  Sum_probs=210.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||.|+||.||+|....++..+|+|.+....     ..+.+.+|+.+++++ +||||+++++++......|++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEE
Confidence            57999999999999999999988889999999986432     157889999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++++   +.++|+|||++.......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~---~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE---GQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC---CcEEEcccccchhcccCc
Confidence            999999999999865 4468999999999999999999999999999999999999654   459999999988765433


Q ss_pred             -ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 -QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                       ......++..|+|||++. ..++.++||||||+++|+|++|..||...........+...... .......++..+.++
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  232 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF  232 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence             223455788999999887 46888999999999999999999999776554433322221111 111113467899999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +.+||+.+|++|||+.+++.||||
T Consensus       233 i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.9e-42  Score=343.89  Aligned_cols=252  Identities=21%  Similarity=0.335  Sum_probs=202.7

Q ss_pred             ccceeeccccCccCceEEEEEEE-----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTD-----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      ..+|++.+.||+|+||.||+|..     ..++..||+|++....  .....+.+.+|+.+++.+.+||||+++++++...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            44799999999999999999974     3456789999986443  2233467889999999998899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC---------------------------------------------------------
Q 009594          130 SAVHIVMELCEGGELFDRIVARG---------------------------------------------------------  152 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  152 (531)
                      +..++||||+++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999886431                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          153 ------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       153 ------------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                                        .+++..+..++.||+.||.|||++||+||||||+|||++.   ...+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~---~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH---GRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC---CCcEEEecCccceeccCcc
Confidence                              3678889999999999999999999999999999999964   3459999999998654332


Q ss_pred             cc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          215 QF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       215 ~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ..   ....++..|+|||++. ..++.++|||||||++|+|++ |..||....................  .....+.++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  346 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEM  346 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHH
Confidence            21   1233456799999886 578999999999999999998 8999977654433333333222111  123467899


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcC
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+|+.+||..+|++|||+.++++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.5e-43  Score=355.98  Aligned_cols=245  Identities=26%  Similarity=0.443  Sum_probs=213.3

Q ss_pred             ceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      +.+..+.||+|+||+||+|+...     ....||||.++...  .....++|++|++++..| +|||||+|+|++..++.
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDP  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCe
Confidence            56778999999999999998543     34679999987553  444578999999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCC
Q 009594          132 VHIVMELCEGGELFDRIVARG--------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~  197 (531)
                      +|+|+|||..|+|.++|....              +++..+.+.|+.|||.||.||-++.+|||||..+|+||   +...
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccce
Confidence            999999999999999996431              27889999999999999999999999999999999999   5667


Q ss_pred             CeEEEeeccccccCCCCccccc---cCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHh
Q 009594          198 PLKAIDFGLSVFFRPGEQFNEI---VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR  272 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~  272 (531)
                      .|||+|||+++.+...+.+...   .-..+|||||.+. ++||.+|||||+||+|||+++ |+.||.+.+.+++++.+..
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            7999999999987765544322   2356899999765 899999999999999999999 9999999999999998887


Q ss_pred             cccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q 009594          273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV  310 (531)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  310 (531)
                      +.. ...+  ..+|.++.+||..||+.+|.+|||++||
T Consensus       721 g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  721 GQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             CCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            655 3222  4799999999999999999999999998

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.3e-41  Score=325.04  Aligned_cols=255  Identities=28%  Similarity=0.495  Sum_probs=213.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++++ +||||+++++++...+.+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEE
Confidence            588999999999999999999889999999999765433 34567889999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~-  215 (531)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||++++   .+.+||+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH---NGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEcccccccccCCCCCc
Confidence            99999999999988777899999999999999999999999999999999999965   44599999999887654322 


Q ss_pred             ----cccccCCcccccchhccc-c---CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          216 ----FNEIVGSPYYMAPEVLKR-N---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       216 ----~~~~~gt~~y~aPE~~~~-~---~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                          .....+++.|+|||++.+ .   ++.++||||||+++|++++|..||.....................+.+..+++
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP  235 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence                123467889999998863 3   78899999999999999999999976533222222222222222233345689


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .+.+++.+||+.+|++|||+.+++.|||+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2e-41  Score=330.40  Aligned_cols=256  Identities=26%  Similarity=0.446  Sum_probs=209.5

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++++.+||||+++++++...    
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            4578999999999999999999999999999999986432    12356778999999997899999999998643    


Q ss_pred             -CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          130 -SAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       130 -~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                       ...++|+||+++++|.+++..    ...+++..++.++.|++.||.|||+.+|+||||||+||+++.+   +.+||+||
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~---~~~kl~df  172 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDF  172 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEeec
Confidence             468999999999999988753    3568999999999999999999999999999999999999654   45999999


Q ss_pred             ccccccCCCC-ccccccCCcccccchhccc------cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC
Q 009594          205 GLSVFFRPGE-QFNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF  277 (531)
Q Consensus       205 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  277 (531)
                      |++....... ......|+..|+|||++..      .++.++|||||||++|+|++|.+||...........+.+.....
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  252 (291)
T cd06639         173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT  252 (291)
T ss_pred             ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence            9987654332 2234568899999998752      26789999999999999999999998776555444443332211


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       278 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      . ......+..+.++|.+||..+|++|||+.++++||||+
T Consensus       253 ~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 L-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             C-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            1 11134677899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-41  Score=331.90  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=208.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe----
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA----  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  131 (531)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+.+||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            3699999999999999999999999999999988654322 22235678899999999778999999999876555    


Q ss_pred             -EEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          132 -VHIVMELCEGGELFDRIVAR-----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       132 -~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                       .++||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||+|+||+++.+  ++.+||+|||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~--~~~~kl~dfg  156 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ--KGLLKIADLG  156 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC--CCeEEEeecc
Confidence             8999999986 888877642     347999999999999999999999999999999999999752  3469999999


Q ss_pred             cccccCCC-CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC---
Q 009594          206 LSVFFRPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR---  279 (531)
Q Consensus       206 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~---  279 (531)
                      ++...... .......+++.|+|||++.+  .++.++||||||+++|+|++|.+||.+.+.......+.........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98755322 22233456889999998753  4788999999999999999999999887766555544432211110   


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          280 ---------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       280 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                                           ...+.+++.+.++|.+||.++|.+|||+.+++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                 01135788899999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=325.56  Aligned_cols=265  Identities=29%  Similarity=0.470  Sum_probs=214.8

Q ss_pred             CCCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-C----Ceeec
Q 009594           48 EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-P----NIVSL  122 (531)
Q Consensus        48 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~----niv~l  122 (531)
                      ...|+.+..+|.+...+|+|+||.|..+.|..++..||+|+++.-    ....+..+-|+++|+++..+ |    -++.+
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            345677889999999999999999999999999999999998642    12235566699999999332 2    37788


Q ss_pred             ceEEEcCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC------
Q 009594          123 KDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK------  194 (531)
Q Consensus       123 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~------  194 (531)
                      .++|...++.|||+|.+ |.|+++++.+++  +++...++.++.|++.++++||+.+++|.||||+|||+.+..      
T Consensus       157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence            88999999999999999 779999998765  489999999999999999999999999999999999986521      


Q ss_pred             -----------CCCCeEEEeeccccccCCCCccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCC
Q 009594          195 -----------ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET  262 (531)
Q Consensus       195 -----------~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~  262 (531)
                                 .+..|+|+|||.|+....  .....+.|..|+|||++.+ .++.++||||+||||+|++||...|++..
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                       134599999999987543  3367789999999999875 89999999999999999999999999888


Q ss_pred             HHHHHHHHHhcccCCC----------------CCCCCCC--------------------------CHHHHHHHHHccccC
Q 009594          263 EQGVAQAIIRSVIDFK----------------RDPWPKV--------------------------SENAKDLVKKMLNPD  300 (531)
Q Consensus       263 ~~~~~~~~~~~~~~~~----------------~~~~~~~--------------------------~~~~~~li~~~l~~~  300 (531)
                      +.+.+..+.+...+++                .-.|+..                          -..+.+||.+||.+|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            6664433322111111                0012110                          124789999999999


Q ss_pred             cCCCCCHHHHhcCCccccc
Q 009594          301 PKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       301 p~~Rps~~~~l~h~~~~~~  319 (531)
                      |.+|+|+.|+|.||||...
T Consensus       394 P~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  394 PARRITLREALSHPFFARL  412 (415)
T ss_pred             ccccccHHHHhcCHHhhcC
Confidence            9999999999999999864

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.7e-42  Score=349.10  Aligned_cols=251  Identities=24%  Similarity=0.433  Sum_probs=201.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ....|.+.+.||+|+||.||+|.+..+++.||+|....         ..+.+|+.+++++ +||||+++++++...+..+
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRL-SHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEE
Confidence            34579999999999999999999999999999996421         2356799999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +|||++. ++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+   ..+||+|||+++....
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~---~~vkL~DFGla~~~~~  312 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP---EDICLGDFGAACFARG  312 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC---CCEEEcccCCceeccc
Confidence            9999995 6888887654 469999999999999999999999999999999999999644   4599999999986543


Q ss_pred             CCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhccc---CC
Q 009594          213 GEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--------EQGVAQAIIRSVI---DF  277 (531)
Q Consensus       213 ~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~--------~~~~~~~~~~~~~---~~  277 (531)
                      ...   .....||+.|+|||++. ..++.++|||||||++|||++|..|+....        .......+.....   .+
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            221   12356999999999887 468999999999999999999876553321        1222222221110   00


Q ss_pred             ------------------------CCCCCC---CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          278 ------------------------KRDPWP---KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       278 ------------------------~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                              ....|.   .++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                    111122   35668999999999999999999999999999974

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.3e-41  Score=323.63  Aligned_cols=252  Identities=27%  Similarity=0.574  Sum_probs=214.7

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.+++++ +||||+++++++...+..++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEE
Confidence            589999999999999999999999999999998754432 23456788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+++++|+||+|+||+++.+   ..++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~---~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---GTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEEeeccceeecCcch
Confidence            9999999999887643  47899999999999999999999999999999999999654   459999999987654332


Q ss_pred             c-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 Q-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      . .....|++.|+|||++. +.++.++|+|||||++|+|++|..||......+....+.......   ....++.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHH
Confidence            2 22346788999999876 567889999999999999999999998877666665555443221   123578899999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      |.+||+.+|++||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-43  Score=344.43  Aligned_cols=254  Identities=24%  Similarity=0.462  Sum_probs=217.3

Q ss_pred             eeccccCccCceEEEEEEEccCCcEEEEEEeecccc-CChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC--eEEEE
Q 009594           59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS--AVHIV  135 (531)
Q Consensus        59 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~~~lv  135 (531)
                      +....||+|+|-+||+|.|..+|..||.=.++...+ ..+...+.+..|+.+|+.| +||||+++|++|.+..  ...+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeee
Confidence            455789999999999999999999998655544333 3555678999999999999 9999999999998654  48889


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ--GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +|++..|+|..|+.+.+.+....+..|++||+.||.|||++  .|||||||-+||+|+  +..+.|||+|+|+|......
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence            99999999999999999999999999999999999999998  599999999999997  56678999999999987654


Q ss_pred             CccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      .. ...+|||.|||||++...|+..+||||||++|.||.|+.+||..... ..++.++..++.+-.-.  .--.+++++|
T Consensus       200 ~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~--kV~dPevr~f  276 (632)
T KOG0584|consen  200 HA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS--KVKDPEVREF  276 (632)
T ss_pred             cc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--ccCCHHHHHH
Confidence            33 34899999999999999999999999999999999999999976554 45556666555332211  1126889999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCccccc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      |.+||.. .+.|||+.|+|+||||..-
T Consensus       277 IekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999999 9999999999999999864

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5e-43  Score=307.08  Aligned_cols=250  Identities=28%  Similarity=0.431  Sum_probs=202.8

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-----C
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-----D  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-----~  129 (531)
                      +.+|++.+.||.|||+.||+++...++..||+|++....   ..+.+..++|+...+++ +||||++++++...     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCc
Confidence            357999999999999999999999999999999997664   34578889999999999 99999999987643     3


Q ss_pred             CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCceEeecCCCCCCeEEEe
Q 009594          130 SAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                      ...||+++|+..|+|.+.+..    ...+++.+++.|+.++++||.+||+..  +.||||||.|||+..   .+.++|.|
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~---~~~~vl~D  172 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD---SGLPVLMD  172 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC---CCceEEEe
Confidence            459999999999999998864    236999999999999999999999998  999999999999964   45599999


Q ss_pred             eccccccCCCCc----------cccccCCcccccchhccc----cCCCccchhHHHHHHHHHhhCCCCCCCCCHHH--HH
Q 009594          204 FGLSVFFRPGEQ----------FNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQG--VA  267 (531)
Q Consensus       204 fg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~--~~  267 (531)
                      ||.++..+-...          ......|..|+|||.+.-    ..+.++|||||||++|.|+.|..||...-.++  ..
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            999876542111          112346889999998862    36889999999999999999999994422211  11


Q ss_pred             HHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      -.+......++..  ..+|+.+.++|..||+.||.+||++.+++.+
T Consensus       253 LAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 LAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1222323333333  3489999999999999999999999999864

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-41  Score=335.88  Aligned_cols=248  Identities=26%  Similarity=0.480  Sum_probs=190.6

Q ss_pred             cccCccCceEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE--cCCeEEEEEe
Q 009594           62 RELGRGEFGVTYLCTDVN--NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--DDSAVHIVME  137 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~~~~~lv~e  137 (531)
                      .+||+|+||.||+|.+..  ++..||+|.+.....     ...+.+|+.+++.+ +||||+++++++.  .....++|+|
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEe
Confidence            579999999999999653  568999998865432     24567899999999 9999999999885  4567899999


Q ss_pred             ccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC-CCCCCeEEEeeccc
Q 009594          138 LCEGGELFDRIVAR---------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGLS  207 (531)
Q Consensus       138 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~-~~~~~ikl~Dfg~a  207 (531)
                      |+.+ +|.+++...         ..+++..+..++.||+.||.|||+.||+||||||+||++..+ ...+.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9964 777776421         247899999999999999999999999999999999999643 23457999999999


Q ss_pred             cccCCCC----ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHH---------HHHHHHHh
Q 009594          208 VFFRPGE----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAIIR  272 (531)
Q Consensus       208 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------~~~~~~~~  272 (531)
                      .......    ......||+.|+|||++.+  .++.++|||||||++|+|+||.+||......         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            8654322    1234568999999998864  4789999999999999999999999653321         11111111


Q ss_pred             cccCCCC----------------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          273 SVIDFKR----------------------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       273 ~~~~~~~----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .......                                  ......+..+.+|+.+||..||.+|||+.|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000000                                  0001234568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=341.48  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=212.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNG----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ..+-.+.++||+|+||+||+|..+..+    ..||+|....+.......+..+.+|+++++.+ +|||||++||+.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEE  234 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCC
Confidence            334556689999999999999875542    23899988764444566788999999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      .++||||+|+||+|.++|.+.+. ++..+...++.+.+.||+|||++++|||||..+|+|+..+   ..+||+|||+|+.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~---~~vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK---GVVKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC---CeEEeCccccccC
Confidence            99999999999999999998874 9999999999999999999999999999999999999643   3489999999886


Q ss_pred             cCCCCccc-cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          210 FRPGEQFN-EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       210 ~~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ...-.... ...-...|+|||.+. +-|+.++|||||||++||+++ |..||.+....++...+.......+.+  ...|
T Consensus       312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p  389 (474)
T KOG0194|consen  312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTP  389 (474)
T ss_pred             CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCH
Confidence            54111111 112346899999987 679999999999999999999 889999999998888886654443333  3678


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ..+..++.+||..+|++|||+.++.+
T Consensus       390 ~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  390 KELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHHhccCChhhccCHHHHHH
Confidence            89999999999999999999999964

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-41  Score=332.49  Aligned_cols=255  Identities=30%  Similarity=0.504  Sum_probs=209.0

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--CeEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVH  133 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  133 (531)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++++ +||||+++++++...  ...|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence            36999999999999999999998899999999997554322 2234567899999999 899999999998876  8999


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +|+||+++ +|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.+   +.++|+|||++.....
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR---GILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---CcEEEeecCceeeccC
Confidence            99999975 8988887644 48999999999999999999999999999999999999654   4599999999886654


Q ss_pred             C-CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC------------
Q 009594          213 G-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF------------  277 (531)
Q Consensus       213 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~------------  277 (531)
                      . .......+++.|+|||.+.+  .++.++||||||+++|+|++|.+||...........+.......            
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 23334567889999998763  36889999999999999999999998877665554443321100            


Q ss_pred             --------------CCCCCCC--CCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          278 --------------KRDPWPK--VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       278 --------------~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                    ....++.  +++.+.++|.+||+.+|++|||+.|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                          0111222  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=339.48  Aligned_cols=250  Identities=22%  Similarity=0.399  Sum_probs=207.8

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      .-.+..+...||+|.||+||+|..  .| .||||++...... ....+.|.+|+.++++- +|-||+-+.|++...+. .
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~w--hG-dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRW--HG-DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL-A  463 (678)
T ss_pred             CHHHhhccceeccccccceeeccc--cc-ceEEEEEecCCCC-HHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce-e
Confidence            334567889999999999999984  33 6899999876654 44789999999999998 99999999999988877 9


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-
Q 009594          134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-  211 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-  211 (531)
                      ||+.+|+|.+|+.+++- ..++.....+.|++||++|+.|||.++|||||||..||++.++   +.|||+|||++.... 
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~---~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED---LKVKIGDFGLATVKTR  540 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC---CcEEEecccceeeeee
Confidence            99999999999999874 3468889999999999999999999999999999999999643   569999999986432 


Q ss_pred             --CCCccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-CCCCCC
Q 009594          212 --PGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-RDPWPK  284 (531)
Q Consensus       212 --~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~  284 (531)
                        ...+.....|...|||||+++    .+|++.|||||||+++|||+||..||.......++-.+-++..... .....+
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence              233445567888999999886    3699999999999999999999999986555554444444432221 122356


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +++++++|+..||.+++++||.+.+||.
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            7889999999999999999999999987

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-41  Score=327.49  Aligned_cols=254  Identities=29%  Similarity=0.457  Sum_probs=210.5

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+.....  ......+.+|+.+++++ +||||+++++++...+..++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEE
Confidence            58889999999999999999999999999999876532  23456788999999999 7999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.   ++.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~---~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS---RGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC---CCCEEEeecccchhhHHHH
Confidence            999999999999775 678999999999999999999999 99999999999999965   3459999999987654322


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      . ....++..|+|||.+. ..++.++||||||+++|+|++|..||....     .......+.....  +..+...+++.
T Consensus       156 ~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  232 (265)
T cd06605         156 A-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGKFSPD  232 (265)
T ss_pred             h-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--CCCChhhcCHH
Confidence            2 1267888999999876 468899999999999999999999996542     1222222222111  11111127889


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +.++|.+||..+|++|||+.+++.||||+..
T Consensus       233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.4e-41  Score=328.26  Aligned_cols=253  Identities=26%  Similarity=0.454  Sum_probs=207.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE------c
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE------D  128 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~------~  128 (531)
                      .+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++++.+||||+++++++.      .
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            357999999999999999999999999999999986532    234567889999999978999999999884      3


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      ....+++|||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+||||+|+||+++.+   +.++|+|||+
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~---~~~~l~dfg~  167 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN---AEVKLVDFGV  167 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCcc
Confidence            46789999999999999988653  348889999999999999999999999999999999999644   4599999999


Q ss_pred             ccccCCC-CccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 009594          207 SVFFRPG-EQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR  279 (531)
Q Consensus       207 a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  279 (531)
                      +...... .......|++.|+|||.+.      ..++.++|||||||++|+|++|..||...........+.+..  ...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~  245 (282)
T cd06636         168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PPK  245 (282)
T ss_pred             hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CCC
Confidence            8755322 2233456899999999874      347889999999999999999999997765544333332221  111


Q ss_pred             CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       280 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .....++..+.+||.+||..+|.+|||+.++++||||
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            1223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=353.94  Aligned_cols=247  Identities=32%  Similarity=0.517  Sum_probs=205.3

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceE-EE---c---
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT-YE---D---  128 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~-~~---~---  128 (531)
                      .+++|.+.|.+|||+.||+|++...|..||+|++...   +...++.+.+||.+|+.|++|+|||.+++. ..   .   
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3688999999999999999999888899999998654   556688999999999999999999999993 22   1   


Q ss_pred             CCeEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCceEeecCCCCCCeEEEee
Q 009594          129 DSAVHIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      .-.++|.||||.||+|-+++..  ...|++.++++|+.++++||.+||...  |||||||-+||||..++   ++|||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g---~~KLCDF  190 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG---NYKLCDF  190 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC---CEEeCcc
Confidence            1358899999999999999974  345999999999999999999999986  99999999999996554   5999999


Q ss_pred             ccccccCCCC-ccc---------cccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHH
Q 009594          205 GLSVFFRPGE-QFN---------EIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI  270 (531)
Q Consensus       205 g~a~~~~~~~-~~~---------~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~  270 (531)
                      |.|...-... ...         ...-|+.|+|||++.    ...+.|+|||||||+||-|+....||......    .|
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aI  266 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AI  266 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eE
Confidence            9987432221 111         134689999999875    36899999999999999999999999765432    34


Q ss_pred             HhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCC
Q 009594          271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP  314 (531)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~  314 (531)
                      +.....+  +++++++..+++||..||+.||++||++.|++.+-
T Consensus       267 lng~Y~~--P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  267 LNGNYSF--PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             EeccccC--CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            4444444  34478999999999999999999999999998763

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.4e-41  Score=328.51  Aligned_cols=258  Identities=26%  Similarity=0.353  Sum_probs=205.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||+|.+..+|..||+|++......  .....+..|+.++.+..+||||+++++++...+..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            3699999999999999999999999999999998754322  12345666777644444999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          136 MELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      |||++ ++|.+++..    ...+++..++.++.|++.||.|||++ +++||||||+||+++.   ++.+||+|||++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~---~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR---NGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC---CCCEEEeeccccccc
Confidence            99996 588777654    34589999999999999999999997 9999999999999965   445999999998865


Q ss_pred             CCCCccccccCCcccccchhccc-----cCCCccchhHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHhcccCCCCCCCCC
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      ..........++..|+|||.+.+     .++.++|+|||||++|+|++|..||.... ..+..........  ...+...
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  232 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEK  232 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCccc
Confidence            43333333568889999998752     46889999999999999999999996532 2222222222211  1111235


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +|+.+.++|.+||..+|++|||+.++++||||+....
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            7899999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-41  Score=329.65  Aligned_cols=256  Identities=28%  Similarity=0.453  Sum_probs=206.6

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE-----
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-----  127 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-----  127 (531)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|++.....    ....+.+|+.+++.+.+||||+++++++.     
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            355689999999999999999999999999999998754321    13567789999999977999999999873     


Q ss_pred             cCCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEe
Q 009594          128 DDSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                      ..+..++||||++|++|.+++..    ...+++..+..++.|++.||.|||+.+|+||||||+||+++.+   +.++|+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC---CCEEEcc
Confidence            45679999999999999988753    3458899999999999999999999999999999999999654   4499999


Q ss_pred             eccccccCCCC-ccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 009594          204 FGLSVFFRPGE-QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       204 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      ||++....... ......|++.|+|||++.      ..++.++|||||||++|+|++|..||................. 
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-  246 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP-  246 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC-
Confidence            99987654322 223456899999999874      3478899999999999999999999977655433332222111 


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ........++..+.+++.+||+.+|++|||+.++++|+||
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            1111112357889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.4e-41  Score=342.24  Aligned_cols=251  Identities=21%  Similarity=0.332  Sum_probs=202.3

Q ss_pred             ccceeeccccCccCceEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .++|++.+.||+|+||.||+|.+...     +..||+|++.....  ......+.+|+.+++.+.+||||+++++++...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            45799999999999999999986443     35799999975432  223567889999999997899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------------------------------------------------------
Q 009594          130 SAVHIVMELCEGGELFDRIVAR----------------------------------------------------------  151 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------  151 (531)
                      +.+++||||+++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999988542                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc---
Q 009594          152 ------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---  216 (531)
Q Consensus       152 ------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~---  216 (531)
                                  ..+++..++.++.||+.||.|||++||+||||||+|||++.   +..+||+|||++.........   
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~---~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD---GRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC---CCeEEEeeceeeeeccCCcceeec
Confidence                        13678889999999999999999999999999999999964   445999999998765433221   


Q ss_pred             ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      ....+++.|+|||++. +.++.++|||||||++|+|++ |..||.....................+  ...++++.+++.
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  349 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMK  349 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHH
Confidence            1223456799999876 678999999999999999997 999997765444333333332222111  246899999999


Q ss_pred             HccccCcCCCCCHHHHhc
Q 009594          295 KMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       295 ~~l~~~p~~Rps~~~~l~  312 (531)
                      +||+.+|++|||+.++++
T Consensus       350 ~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         350 MCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.6e-41  Score=325.26  Aligned_cols=256  Identities=27%  Similarity=0.447  Sum_probs=210.2

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC-------hhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-------AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+.......       ....+.+.+|+.+++.+ +||||+++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence            5888999999999999999998899999999886422111       11235678899999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +..++|+||+++++|.+++.+.+.+++..+..++.|++.||.|||+++++||||+|+||+++.   ++.++|+|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~---~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC---CCeEEEeecccccc
Confidence            999999999999999999988888999999999999999999999999999999999999964   44599999999876


Q ss_pred             cCCCC---ccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcc--cCCCCCC
Q 009594          210 FRPGE---QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV--IDFKRDP  281 (531)
Q Consensus       210 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~  281 (531)
                      .....   ......++..|+|||.+..   .++.++|+||||+++|++++|..||...........+....  ...+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            43221   1233467889999998763   37889999999999999999999996655443333222211  1122223


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .+.++..+.+++.+||.++|++|||+.++|+||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            34678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.4e-41  Score=323.36  Aligned_cols=255  Identities=29%  Similarity=0.531  Sum_probs=208.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeecccc--CChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--CCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~  131 (531)
                      .+|++.+.||+|+||.||.|.+..++..||+|.+.....  ........+.+|+.+++++ .||||+++++++.+  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence            369999999999999999999999999999998864321  1223456788899999999 99999999999876  356


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +++||||+++++|.+++.+...+++..+..++.|++.||.|||+.+|+|+||+|+||+++.+   +.++|+|||.+....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~~l~Dfg~~~~~~  157 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV---GNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC---CCEEECcCccccccc
Confidence            88999999999999999887788999999999999999999999999999999999999643   459999999987543


Q ss_pred             CC----CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          212 PG----EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       212 ~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ..    .......++..|+|||.+. ..++.++|||||||++|+|++|+.||.................  .....+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPHVS  235 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchhhC
Confidence            21    1123356888999999876 4688999999999999999999999977654444333322111  111123567


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      ..+.+++.+||. +|++||++.++++|||+.
T Consensus       236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            889999999995 899999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.6e-41  Score=330.33  Aligned_cols=259  Identities=29%  Similarity=0.483  Sum_probs=213.6

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ......|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+.
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~   89 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHT   89 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCe
Confidence            44556799999999999999999999889999999998755444444456788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++|+||++ |+|.+.+.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.+   +.++|+|||++...
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~---~~~kL~dfg~~~~~  165 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP---GTVKLADFGSASLV  165 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC---CCEEEeecCcceec
Confidence            999999997 477666653 4568999999999999999999999999999999999999644   45999999998765


Q ss_pred             CCCCccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ...   ....+++.|+|||++.    +.++.++||||||+++|+|+||.+||...........+.....  +......++
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  240 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWS  240 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhC
Confidence            432   2456788999999863    4588899999999999999999999987765554433332211  111123467


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ..+.++|.+||..+|++||++.+++.||||....
T Consensus       241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            8999999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.8e-41  Score=332.29  Aligned_cols=258  Identities=31%  Similarity=0.495  Sum_probs=209.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--CeEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVH  133 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  133 (531)
                      .+|++.+.||.|+||.||+|.+..+|+.||+|++........ ......+|+.+++++ +||||+++++++...  +..+
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEE
Confidence            469999999999999999999999999999999875432221 123456799999999 999999999998754  5689


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.+   +.+||+|||++.....
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECccceeeecCC
Confidence            99999964 88887765 3568999999999999999999999999999999999999644   4599999999987654


Q ss_pred             CC-ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC----------
Q 009594          213 GE-QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR----------  279 (531)
Q Consensus       213 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~----------  279 (531)
                      .. ......+++.|+|||.+.+  .++.++|||||||++|+|++|.+||...+..+....+.........          
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            32 2223345788999998753  4788999999999999999999999988877766665542211100          


Q ss_pred             ---------CC-------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          280 ---------DP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       280 ---------~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                               ..       ....++.+.++|.+||..||++|||+.+++.||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                     00       12257889999999999999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.1e-42  Score=331.11  Aligned_cols=255  Identities=28%  Similarity=0.453  Sum_probs=211.3

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ..|+..+.||.|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++++ +||||+++++++...+..++|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEE
Confidence            458888999999999999999988999999999864432  22456788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      +||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+   +.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC---CCEEEccccccccccCcch
Confidence            999999999988754 468999999999999999999999999999999999999654   4599999999876543322


Q ss_pred             -cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          216 -FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       216 -~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                       .....++..|+|||.+. ..++.++|||||||++|+|++|..||...........+.....   ......++..+.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li  233 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---PTLEGQYSKPFKEFV  233 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC---CCCCcccCHHHHHHH
Confidence             22346788999999887 4688899999999999999999999976554443333222211   111124678899999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcccccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .+||..+|++|||+.++++||||....
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         234 EACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            999999999999999999999997543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.6e-41  Score=325.12  Aligned_cols=248  Identities=17%  Similarity=0.256  Sum_probs=205.4

Q ss_pred             cceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+|++.+.||+|+||.||+|...   ..+..||+|.+....  .......+.+|+.+++.+ +||||+++++++...+..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCc
Confidence            46999999999999999999764   356789999987542  223346788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.   +..++++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~---~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC---CCcEEECCCccccccc
Confidence            9999999999999998764 46899999999999999999999999999999999999964   4469999999876543


Q ss_pred             CCCccc--cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQFN--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ......  ...++..|+|||.+. +.++.++|||||||++|++++ |..||+.....+....+.....   .+....++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  235 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR---LPAPRNCPN  235 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---CCCCCCCCH
Confidence            222111  223467899999876 678999999999999999775 9999998887776666544321   122346889


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.+++.+||+.+|++|||+.++++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.6e-41  Score=321.80  Aligned_cols=254  Identities=30%  Similarity=0.506  Sum_probs=213.6

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      +|+..+.||+|++|.||+|.+..++..|++|.+......  .......+.+|+.+++.+ +||||+++++++.....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence            477888999999999999998889999999998654321  223456788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |+||+++++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++.+   +.+||+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~---~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN---GVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEccCccceeccccc
Confidence            99999999999999887779999999999999999999999999999999999999644   459999999987655444


Q ss_pred             ccccccCCcccccchhcc-cc-CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ......+++.|+|||.+. .. ++.++|+||||+++|+|++|..||...........+.... . .......+++.+.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-E-LPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-c-CCCcCCCcCHHHHHH
Confidence            344567889999999876 34 7899999999999999999999997766444443333211 1 111224578999999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +.+||..+|++|||+.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.7e-41  Score=330.57  Aligned_cols=251  Identities=23%  Similarity=0.308  Sum_probs=201.2

Q ss_pred             ccceeeccccCccCceEEEEEEEcc----------------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVN----------------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN  118 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n  118 (531)
                      ..+|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.+++++ +|||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRL-KDPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhc-CCCC
Confidence            3579999999999999999997532                34579999986542  233456788999999999 9999


Q ss_pred             eeecceEEEcCCeEEEEEeccCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 009594          119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-------------------HYTERAAAAVMKTIVEVVQVCHEQGVM  179 (531)
Q Consensus       119 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~qi~~~l~~LH~~~ii  179 (531)
                      |+++++++...+..++||||+++++|.+++....                   .+++..+..++.||+.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886431                   367788999999999999999999999


Q ss_pred             ecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh--
Q 009594          180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--  253 (531)
Q Consensus       180 H~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t--  253 (531)
                      ||||||+|||++.+   +.+||+|||++........   .....++..|+|||++. +.++.++||||||+++|+|++  
T Consensus       161 H~dlkp~Nill~~~---~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLVGEN---LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEEcCC---ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            99999999999644   4599999999986544332   12234578899999876 678999999999999999987  


Q ss_pred             CCCCCCCCCHHHHHHHHHhccc----CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHh
Q 009594          254 GVPPFWAETEQGVAQAIIRSVI----DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVL  311 (531)
Q Consensus       254 g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  311 (531)
                      +..||...+.............    .......+.+++.+.+|+.+||..+|++|||+.+|.
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            6678877766555544332111    111112246789999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-41  Score=327.54  Aligned_cols=258  Identities=26%  Similarity=0.386  Sum_probs=213.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++++.||+|+||+||+|.+..++..||+|++....  .......+.+|+++++.+ +||||+++++++...+.+++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEE
Confidence            57999999999999999999998899999999886542  223356788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      +||+++++|.+++...+.+++..+..++.+++.||.|||+ .+++||||+|+||++++   ++.++|+|||++...... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~---~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS---RGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC---CCcEEEccCCcccchhhh-
Confidence            9999999999999887789999999999999999999997 59999999999999964   445999999998654322 


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH-----------HHHHHHHhcccCCCCCCC
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-----------GVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~  282 (531)
                      ......|+..|+|||++. +.++.++|||||||++|+++||..||......           +....+....  .+....
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  235 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPRLPS  235 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--CCCCCc
Confidence            223457899999999875 67888999999999999999999999765432           1112222111  111111


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                      ..++..+.+|+.+||.++|++|||+.++++|+||......
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~  275 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA  275 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            2378899999999999999999999999999999765443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.4e-41  Score=328.69  Aligned_cols=254  Identities=28%  Similarity=0.478  Sum_probs=207.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++++.||.|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEe
Confidence            488999999999999999999999999999988654322 22235688899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+. ++|..++..  ...+++..++.++.|++.||+|||+.+++||||+|+||+++.+   +.+||+|||++.......
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~---~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPV  154 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEeeccchhhcccCc
Confidence            9996 588888765  3468999999999999999999999999999999999999654   459999999987654322


Q ss_pred             -ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC------------
Q 009594          215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR------------  279 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------  279 (531)
                       ......+++.|+|||.+.+  .++.++||||||+++|+|+||..||...........+.+.......            
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             2233456889999998764  3688999999999999999999999877655444333322111000            


Q ss_pred             -------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          280 -------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       280 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                   ...+.+++.+.++|.+||+.||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                         0123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.2e-41  Score=324.01  Aligned_cols=254  Identities=28%  Similarity=0.463  Sum_probs=215.4

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|++|.||+|.+..++..||+|++......  .....+.+|+..+.++ +||||+++++++...+.+++|+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEE
Confidence            689999999999999999999999999999998765322  3457788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .+++||||+|+||+++.+   +.++|+|||.+........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~---~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK---GEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC---CCEEEccCccceecccCCC
Confidence            999999999999887889999999999999999999999 999999999999999654   4599999999887654333


Q ss_pred             c-ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC---HHHHHHHHHhcccCCCCCCCCC-CCHHH
Q 009594          216 F-NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVIDFKRDPWPK-VSENA  289 (531)
Q Consensus       216 ~-~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~~  289 (531)
                      . ....++..|+|||.+. ..++.++|+||||+++|+|+||..||....   ..+....+.....   ...... ++..+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  232 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---PSLPAEEFSPEF  232 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---CCCCcccCCHHH
Confidence            2 2456788999999876 568889999999999999999999997763   2333333332211   111123 78899


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .++|.+||..+|++|||+.++++|||++..
T Consensus       233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         233 RDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-41  Score=325.25  Aligned_cols=254  Identities=28%  Similarity=0.483  Sum_probs=208.9

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC----
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS----  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  130 (531)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++.....    ....+.+|+.+++++..||||+++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            4679999999999999999999988999999999865432    34678899999999978999999999986544    


Q ss_pred             --eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          131 --AVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       131 --~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                        .+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.+   +.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~---~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN---AEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC---CeEEECCC
Confidence              58999999999999998765    3468999999999999999999999999999999999999654   45999999


Q ss_pred             ccccccCCCC-ccccccCCcccccchhccc------cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC
Q 009594          205 GLSVFFRPGE-QFNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF  277 (531)
Q Consensus       205 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  277 (531)
                      |++....... ......|++.|+|||++..      .++.++||||||+++|+|++|.+||...........+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  237 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT  237 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence            9987654322 2234568899999998742      36788999999999999999999997665544444444332211


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       278 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .. ....+++.+.+||.+||..+|++|||+.++++|||+
T Consensus       238 ~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 LK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            11 112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.1e-41  Score=321.66  Aligned_cols=252  Identities=33%  Similarity=0.568  Sum_probs=212.8

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE--cCCeEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--DDSAVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~~~~~l  134 (531)
                      +|++.+.||.|+||.||+|.+..++..+|+|++..... .....+.+.+|+.+++.+ +||||+++++++.  .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEE
Confidence            48899999999999999999999999999999876543 233456788899999999 9999999999875  3456899


Q ss_pred             EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          135 VMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCH-----EQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH-----~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                      ++||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+|+|+||+|+||+++++   +.+||+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~---~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN---NNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC---CCEEEeccc
Confidence            9999999999998865    356899999999999999999999     8999999999999999653   459999999


Q ss_pred             cccccCCCCc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          206 LSVFFRPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       206 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      ++........ .....+++.|+|||++. ..++.++|+||||+++|+|++|..||...........+......   ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---RIPY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC---CCcc
Confidence            9987654443 34457899999999886 46888999999999999999999999887755555544443221   1123


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ..+..+.+++.+||..+|++|||+.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.7e-41  Score=323.55  Aligned_cols=252  Identities=29%  Similarity=0.540  Sum_probs=207.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.+ +||||+++++++...+..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEE
Confidence            4699999999999999999999999999999988765444444556788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          136 MELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+   +.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~---~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC---CCEEECccccceecc
Confidence            999999999988753    3458999999999999999999999999999999999999654   459999999988664


Q ss_pred             CCCc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      .... .....+++.|+|||.+. ..++.++|+||||+++|+|++|..||.....  ......+...  ..+.......+.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhhcCH
Confidence            3322 23456888999999876 5688899999999999999999999965432  2222222221  122222235778


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+.+++.+||..+|++|||+.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.3e-41  Score=327.92  Aligned_cols=260  Identities=29%  Similarity=0.474  Sum_probs=210.5

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++++ +||||+++++++......++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence            4699999999999999999999889999999998654322 12235677899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          136 MELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |||++ ++|.+++.....  +++..+..++.||+.||.|||+++++||||+|+||+++..+  ..+||+|||++......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~--~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC--CEEEEcccccccccCCC
Confidence            99996 588887765443  57888999999999999999999999999999999997433  35899999998754332


Q ss_pred             -CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC----------
Q 009594          214 -EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD----------  280 (531)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~----------  280 (531)
                       .......+++.|+|||.+.+  .++.++||||||+++|+|+||.+||......+....+..........          
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             22234467889999998763  47889999999999999999999998776655554443221111000          


Q ss_pred             ---------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          281 ---------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       281 ---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                     ..+.+++.+.+++.+||+.+|++||++.++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                           1235688899999999999999999999999999998654

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=328.23  Aligned_cols=255  Identities=32%  Similarity=0.557  Sum_probs=210.5

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++++ +||||+++++++...+..++|+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEE
Confidence            69999999999999999999998999999999865432 222346788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC--
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~--  214 (531)
                      ||++++.+..+..+...+++..+..++.|++.||.|||+.+++||||+|+||+++.   ++.+||+|||++.......  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~---~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE---SGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCCEEEEeeecccccCCCccc
Confidence            99998777766666667999999999999999999999999999999999999965   4559999999988765443  


Q ss_pred             ccccccCCcccccchhcc-c-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------------
Q 009594          215 QFNEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--------------  278 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------------  278 (531)
                      ......++..|+|||++. . .++.++||||||+++|+|++|.+||.+....+....+........              
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            334456789999999876 4 578899999999999999999999987665544433322110000              


Q ss_pred             -----C--------CCCC-CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          279 -----R--------DPWP-KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       279 -----~--------~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                           .        ..++ .+++.+.+||.+||..+|++|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                 0        0011 247889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-41  Score=325.41  Aligned_cols=257  Identities=30%  Similarity=0.555  Sum_probs=212.5

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCCeeecceEEEcCCeEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~l  134 (531)
                      .|++.+.||+|+||.||+|.+..++..+|+|.+....  .......+.+|+.+++.+.  .|||++++++++......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4888899999999999999999999999999986532  2234567888999999994  49999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||||+++++|.+++.. +.+++..++.++.|++.||.|||+.||+|+||+|+||+++.   .+.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~---~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC---CCCEEEccCCceeecCCCc
Confidence            9999999999998855 47899999999999999999999999999999999999965   4459999999988765433


Q ss_pred             c-cccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          215 Q-FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       215 ~-~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      . .....|+..|+|||.+.+  .++.++|+||||+++|+|++|..||...........+...  ..+.......+.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence            2 234568899999998763  4688999999999999999999999776554433222111  1111112237889999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++.+||..+|++||++.+++.||||++...
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence            999999999999999999999999987554

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.9e-41  Score=329.12  Aligned_cols=259  Identities=31%  Similarity=0.525  Sum_probs=214.7

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ....|.....||.|+||.||++.+..++..||||.+....   ......+.+|+.+++.+ +||||+++++.+...+..+
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEE
Confidence            3445666788999999999999998899999999986432   23356788999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.+   +.++|+|||++......
T Consensus        96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---CCEEEccCcchhhcccc
Confidence            99999999999988754 468999999999999999999999999999999999999654   45999999998754332


Q ss_pred             C-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 E-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      . ......|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+..... .........+..+.+
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  250 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLRG  250 (292)
T ss_pred             cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHHH
Confidence            2 223456889999999876 4688999999999999999999999987766555444433221 111222357889999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++.+||..+|++|||+.++++||||+....
T Consensus       251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         251 FLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence            999999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.5e-41  Score=329.20  Aligned_cols=258  Identities=23%  Similarity=0.328  Sum_probs=205.5

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|...+.||+|+||.||++.+..+++.+|+|.+......  .....+.+|+.++.++.+||||+++++++...+..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            577888999999999999999999999999998754322  345678899999999966999999999999889999999


Q ss_pred             eccCCCchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          137 ELCEGGELFDRI---V--ARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       137 e~~~~~~L~~~l---~--~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ||+.+ ++.++.   .  ....+++..+..++.|++.||+|||+. +|+||||||+||+++++   +.++|+|||++...
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN---GNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC---CcEEEeecchhHHh
Confidence            99864 554432   2  235699999999999999999999975 99999999999999654   45999999998765


Q ss_pred             CCCCccccccCCcccccchhccc----cCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcc-cCCCCCCCCC
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-IDFKRDPWPK  284 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~-~~~~~~~~~~  284 (531)
                      ..........|++.|+|||++.+    .++.++|||||||++|+|++|.+||...... .....+.... ..........
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            44333344568899999998863    4888999999999999999999999665421 1111111111 1111122235


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ++..+.+|+.+||..+|++|||+.+++.||||+...
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            789999999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.5e-41  Score=327.33  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=208.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNG-----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      .+|++.+.||+|+||.||+|.+...+     ..+|+|.+....  .......+.+|+.+++++ +||||+++++++....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCC
Confidence            36999999999999999999876554     679999886432  233456788999999999 9999999999999989


Q ss_pred             eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC
Q 009594          131 AVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK  194 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~  194 (531)
                      ..+++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++++ 
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~-  160 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG-  160 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC-
Confidence            999999999999999998764                347889999999999999999999999999999999999654 


Q ss_pred             CCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 009594          195 ESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA  269 (531)
Q Consensus       195 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~  269 (531)
                        +.++|+|||++........   .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....
T Consensus       161 --~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         161 --LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             --CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              4599999999876543321   22345678899999876 678999999999999999998 9999998887776665


Q ss_pred             HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.......   ....+|+++.+|+.+||+.+|.+||++.+++++
T Consensus       239 i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55433221   124689999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-41  Score=335.89  Aligned_cols=262  Identities=30%  Similarity=0.475  Sum_probs=211.8

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      +..+|++.+.||.|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.+ +||||+++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCccchHHheecccccc
Confidence            45679999999999999999999999999999999865422 222345677899999999 999999999987643    


Q ss_pred             -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 -SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                       ...++|+||+. ++|.+++...+++++..+..++.|++.||.|||+++++||||||+||+++.+   +.+||+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~  156 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLAR  156 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECcCcccc
Confidence             35899999995 6899988888889999999999999999999999999999999999999654   459999999998


Q ss_pred             ccCCC-CccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcc-----------
Q 009594          209 FFRPG-EQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-----------  274 (531)
Q Consensus       209 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-----------  274 (531)
                      ..... .......++..|+|||.+.  ..++.++|||||||++|+|++|.+||.+.+.......+....           
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            66443 2233456788999999875  358899999999999999999999997765433222222110           


Q ss_pred             ------------cCCC----CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          275 ------------IDFK----RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       275 ------------~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                  ....    ...++.+++.+.++|.+||+.+|++|||+.++++||||.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                        0000    0113467889999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-41  Score=327.29  Aligned_cols=254  Identities=27%  Similarity=0.474  Sum_probs=202.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+.......  ....+.+|+.+++++ +||||+++++++...+..++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEE
Confidence            46999999999999999999998899999999987543211  123456899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      |||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++++   +.+||+|||++...... 
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER---GELKLADFGLARAKSVPS  157 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC---CCEEECccccccccCCCC
Confidence            999975 899888664 458999999999999999999999999999999999999654   45999999998654322 


Q ss_pred             CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHhcccCCCC-----------
Q 009594          214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVIDFKR-----------  279 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~~~~-----------  279 (531)
                      .......+++.|+|||++.+  .++.++||||+|+++|+|++|..||.... ..+....+.+.......           
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            12223356888999998763  47889999999999999999999997655 22222222111100000           


Q ss_pred             ---------------CCCCCCC--HHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          280 ---------------DPWPKVS--ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       280 ---------------~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                     ..++.++  ..+.+++.+||+.+|++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                           0112334  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-41  Score=334.90  Aligned_cols=260  Identities=30%  Similarity=0.494  Sum_probs=206.8

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++++ +||||+++++++...    
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFES   79 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccc
Confidence            4568999999999999999999999999999999986422  222345677899999999 899999999987543    


Q ss_pred             -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 -SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                       ...++|+||+.+ +|...+. ...+++..+..++.|++.||.|||+.||+||||||+||+++.   .+.+||+|||++.
T Consensus        80 ~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~---~~~~kl~dfg~~~  154 (336)
T cd07849          80 FNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLAR  154 (336)
T ss_pred             cceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC---CCCEEECccccee
Confidence             358999999964 8877764 457999999999999999999999999999999999999964   4459999999987


Q ss_pred             ccCCCCc----cccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC------
Q 009594          209 FFRPGEQ----FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID------  276 (531)
Q Consensus       209 ~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~------  276 (531)
                      .......    .....||+.|+|||.+.  ..++.++|||||||++|+|++|++||.+.........+......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            6543221    12356889999999864  35888999999999999999999999776543332222111000      


Q ss_pred             -----------------CCCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          277 -----------------FKRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       277 -----------------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                       ....    ..+..++.+.++|.+||+.+|++|||+.++++||||+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                             0000    12346788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.7e-41  Score=323.13  Aligned_cols=255  Identities=27%  Similarity=0.466  Sum_probs=212.7

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      -|++.+.||.|+||.||+|.+..++..+|+|++.....  ......+.+|+.+++++ +||||+++++++......++|+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEE
Confidence            47888999999999999999988999999998864432  23346788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-c
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-~  215 (531)
                      ||+++++|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++++   +.++|+|||++....... .
T Consensus        82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~---~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC---CCEEEeecccceecccchhh
Confidence            99999999988754 468999999999999999999999999999999999999644   459999999987654332 1


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....++..|+|||.+. ..++.++|+|||||++|+|++|..||...........+.....   ......++..+.+++.
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~  234 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFVE  234 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHHHH
Confidence            23356788999999876 4678899999999999999999999977665544444322211   1112357889999999


Q ss_pred             HccccCcCCCCCHHHHhcCCccccccc
Q 009594          295 KMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       295 ~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +||..+|++||++.++++||||.+...
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             HHccCChhhCcCHHHHHhCHHHhhhhh
Confidence            999999999999999999999987533

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.4e-41  Score=336.92  Aligned_cols=257  Identities=27%  Similarity=0.430  Sum_probs=207.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      +..+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++...    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCcc
Confidence            45689999999999999999999999999999999864322 223345677899999999 999999999988643    


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       130 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                        ...|+||||+. ++|.+.+...  +++..+..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~---~~~kL~Dfg~~  165 (353)
T cd07850          92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLA  165 (353)
T ss_pred             ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEccCccc
Confidence              35799999996 4888877544  8999999999999999999999999999999999999654   45999999999


Q ss_pred             cccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF---------  277 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------  277 (531)
                      .............+++.|+|||.+. ..++.++|||||||++|+|++|..||...+.......+.......         
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            8765444444456889999999876 568999999999999999999999998766544333332211000         


Q ss_pred             -------------CCC---------C--------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          278 -------------KRD---------P--------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       278 -------------~~~---------~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                   ...         .        ....++.+.++|.+||..||++|||+.++|+||||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                         000         0        1124567899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-40  Score=322.95  Aligned_cols=257  Identities=33%  Similarity=0.551  Sum_probs=214.5

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|...+.||.|++|.||+|.+..+++.+|+|++....   ......+.+|+.+++.+ +||||+++++++...+..++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEE
Confidence            35666779999999999999998899999999885432   22345678899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      +||++|++|.+++.. .++++..+..++.|++.||.|||++||+||||+|+||+++.   ++.++|+|||.+....... 
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC---CCcEEEcccccchhhccCCc
Confidence            999999999998876 57899999999999999999999999999999999999964   3459999999876544322 


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ......|++.|+|||.+. +.++.++||||||+++|+|++|..||...+.......+....... ......++..+.+++
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  249 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK-LKNLHKVSPRLRSFL  249 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC-CcccccCCHHHHHHH
Confidence            223456899999999886 468899999999999999999999998776655555444432211 111234788999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCccccccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .+||..+|++|||+.++++||||++...
T Consensus       250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         250 DRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHcccChhhCcCHHHHccCcccccCCC
Confidence            9999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.5e-41  Score=321.89  Aligned_cols=250  Identities=34%  Similarity=0.604  Sum_probs=212.7

Q ss_pred             cCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCc
Q 009594           64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE  143 (531)
Q Consensus        64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  143 (531)
                      ||.|+||.||+|.+..+|+.+|+|++.............+.+|+.+++++ +||||+++++.+......|+|+||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            68999999999999888999999999765543344567888999999999 89999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC---------
Q 009594          144 LFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE---------  214 (531)
Q Consensus       144 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~---------  214 (531)
                      |.+++.+.+.+++..+..++.||+.||.|||+.+++||||+|+||+++.+   +.++|+|||++.......         
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN---GHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC---CCEEEEecccchhcccCcccccccccc
Confidence            99999887789999999999999999999999999999999999999654   459999999987544321         


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ......++..|+|||.+. ..++.++||||||+++|++++|..||...........+.......+.  ....++.+.+++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i  234 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEVSDEAIDLI  234 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc--cccCCHHHHHHH
Confidence            123346788999999876 45888999999999999999999999888777666666553332221  122489999999


Q ss_pred             HHccccCcCCCCCH---HHHhcCCccccc
Q 009594          294 KKMLNPDPKQRLTA---EEVLEHPWLQNA  319 (531)
Q Consensus       294 ~~~l~~~p~~Rps~---~~~l~h~~~~~~  319 (531)
                      .+||+.+|++|||+   .++|+||||+..
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            99999999999999   999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-40  Score=323.34  Aligned_cols=259  Identities=31%  Similarity=0.473  Sum_probs=207.3

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--CCeEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAVH  133 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~  133 (531)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|+++++++ +||||+++++++..  .+.++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEE
Confidence            368899999999999999999988999999999875432  23356788999999999 89999999998864  45789


Q ss_pred             EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          134 IVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +||||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.+   ..++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK---GQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC---CeEEEeecccccc
Confidence            99999999999887653    3458999999999999999999999999999999999999654   4499999999875


Q ss_pred             cCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHhcccC-CCCCCC
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVID-FKRDPW  282 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~-----~~~~~~~~~~~~~~-~~~~~~  282 (531)
                      ...... ....++..|+|||.+. ..++.++||||||+++|+|++|..||....     ..+....+...... ......
T Consensus       155 ~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         155 LVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             cccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            443221 2345788999999876 568999999999999999999999997652     22333333221111 111111


Q ss_pred             --CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          283 --PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       283 --~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                        ...++.+.+++.+||..+|++|||+.|++.||||++...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence              134678999999999999999999999999999976544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.6e-41  Score=323.19  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=208.3

Q ss_pred             cceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ++|++.+.||+|++|.||+|.+..     ++..||+|.+....  .......+.+|+.+++.+ +||||+++++++....
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   82 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCC
Confidence            569999999999999999999876     67889999875432  233345688899999999 9999999999999888


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEe
Q 009594          131 AVHIVMELCEGGELFDRIVARG-------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                      ..++||||++|++|.+++....       .+++..+..++.||+.||.|||+++++||||||+||+++.++....+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999999987653       488999999999999999999999999999999999998766556799999


Q ss_pred             eccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCC
Q 009594          204 FGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFK  278 (531)
Q Consensus       204 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~  278 (531)
                      ||++........   ......+..|+|||++. +.++.++|||||||++|+|++ |..||...+.......+.... .  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~--  239 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R--  239 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c--
Confidence            999986532221   11223356799999876 569999999999999999997 999998877666555443321 1  


Q ss_pred             CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       279 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ......++..+.+++.+||+.+|++|||+.++++|
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11124578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.1e-41  Score=327.17  Aligned_cols=257  Identities=29%  Similarity=0.529  Sum_probs=214.3

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ..|.....||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.+++.+ +||||+++++++...+..++|
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEE
Confidence            346666789999999999999988999999999865432   2245678899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      +||+++++|..++.. ..+++..++.++.|++.||.|||+.||+||||+|+||+++.+   +.+||+|||++....... 
T Consensus        97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~---~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC---CcEEEeechhHhhcccccc
Confidence            999999999987754 468999999999999999999999999999999999999654   459999999987554322 


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+.... ......+..+++.+.++|
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i  251 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFL  251 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHH
Confidence            223456899999999887 468899999999999999999999998776655554443322 112222346788999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCccccccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .+||+.+|++||++.++++||||.....
T Consensus       252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         252 ERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            9999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.8e-41  Score=356.50  Aligned_cols=253  Identities=27%  Similarity=0.411  Sum_probs=203.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEE
Confidence            4799999999999999999999999999999999754433344456788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          136 MELCEGGELFDRIVAR-----------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      |||++|++|.+++...           ...+...+..++.||+.||+|||++||+||||||+||+++.+   +.++|+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d---g~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF---GEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC---CCEEEEec
Confidence            9999999999988641           234567788999999999999999999999999999999654   45999999


Q ss_pred             ccccccCCCC-------------------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH
Q 009594          205 GLSVFFRPGE-------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ  264 (531)
Q Consensus       205 g~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~  264 (531)
                      |++.......                   .....+||+.|+|||++. ..++.++|||||||++|+|+||..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652110                   011246899999999887 56899999999999999999999999775543


Q ss_pred             HHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ...... .........++..+|+.+.+++.+||..+|++||+..+.+.+
T Consensus       238 ki~~~~-~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRD-VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhh-hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            322211 111111112345688999999999999999999877666644

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.8e-41  Score=325.04  Aligned_cols=253  Identities=29%  Similarity=0.521  Sum_probs=207.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|++|.||+|.+..+|..||+|++......  .....+.+|+.+++++ +||||+++++++...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEE
Confidence            489999999999999999999989999999998754322  2245677899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          137 ELCEGGELFDRIVAR---GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       137 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||+|+||+++++   +.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~---~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR---GELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---CcEEEeecchhhhhcCC
Confidence            99975 888887654   358999999999999999999999999999999999999654   45999999998754332


Q ss_pred             C-ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC----------
Q 009594          214 E-QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD----------  280 (531)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~----------  280 (531)
                      . ......+++.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+.+........          
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            2 2233467889999998764  46889999999999999999999998776655544443221100000          


Q ss_pred             ---------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          281 ---------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       281 ---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                     ..+..++.+.+++.+||+.+|.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                           012457789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.5e-41  Score=328.53  Aligned_cols=249  Identities=22%  Similarity=0.314  Sum_probs=201.4

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcE--EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEK--FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      +|++.+.||+|+||.||+|.+..++..  +|+|.+...  ........+.+|+.++.++.+||||+++++++...+.+++
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            689999999999999999998777764  466665432  2333456788899999999889999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCC
Q 009594          135 VMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                      |+||+++++|.+++....                .+++..++.++.|++.||+|||++||+||||||+|||++.+   ..
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~---~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC---Cc
Confidence            999999999999987542                47899999999999999999999999999999999999644   45


Q ss_pred             eEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccC
Q 009594          199 LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      +||+|||++.............++..|+|||.+. ..++.++|||||||++|+|+| |.+||......+....+....  
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--  240 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--  240 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--
Confidence            9999999986432211112223466799999876 458899999999999999998 999998777665554443221  


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                       .......+++.+.+|+.+||+.+|++|||+.+++.+
T Consensus       241 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 -RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             111223478899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-40  Score=328.30  Aligned_cols=255  Identities=27%  Similarity=0.472  Sum_probs=202.0

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-----
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-----  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  130 (531)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+........ ....+.+|+.+++++ +||||+++++++....     
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLL-KHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence            369999999999999999999999999999999865432221 223456799999999 9999999999876543     


Q ss_pred             ---eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          131 ---AVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       131 ---~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                         ..++||||+. ++|.+.+.... .+++..++.++.|++.||.|||++|++|+||||+||+++.+   +.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD---GILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC---CcEEECcCCC
Confidence               4699999996 48887776543 68999999999999999999999999999999999999644   4599999999


Q ss_pred             ccccCCCCc-----cccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 009594          207 SVFFRPGEQ-----FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR  279 (531)
Q Consensus       207 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  279 (531)
                      +........     .....++..|+|||.+.+  .++.++||||||+++|+|+||.+||.+.........+.......+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            876543221     123457888999998764  3788999999999999999999999877655444433332111111


Q ss_pred             CCC----------------------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          280 DPW----------------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       280 ~~~----------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ..+                            ...++.+.++|.+||..+|++|||+.++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            100                            0135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-41  Score=324.60  Aligned_cols=253  Identities=30%  Similarity=0.489  Sum_probs=207.6

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |++.+.||.|++|.||+|.+..+|..||+|++....... .....+.+|+.+++.+ +||||+++++++...+..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEe
Confidence            677889999999999999999999999999987543222 2235677899999999 89999999999999999999999


Q ss_pred             ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          138 LCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      |++ ++|.+++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.   ++.++|+|||++....... 
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC---CCcEEEeecccccccCCCcc
Confidence            995 68999887765  6899999999999999999999999999999999999965   4459999999987553222 


Q ss_pred             ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC---------------
Q 009594          215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF---------------  277 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------  277 (531)
                      ......+++.|+|||++.+  .++.++||||||+++|+|++|.+||...........+.+.....               
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            2233456889999998763  46889999999999999999999998776654444433321100               


Q ss_pred             ----------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          278 ----------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       278 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                .....+.++..+.++|.+||+.+|++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                      011124567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.5e-42  Score=309.41  Aligned_cols=264  Identities=29%  Similarity=0.514  Sum_probs=208.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-CC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNG----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~  130 (531)
                      ..|+++..||+|+||.||+|....++    ..+|||.++...-.+... ...-+|+.+++.+ +||||+.+..+|.. +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLREL-KHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHh-cCCcchhHHHHHhccCc
Confidence            35999999999999999999755543    378999997654333333 4566799999999 99999999999876 78


Q ss_pred             eEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC-CCCCeEEEee
Q 009594          131 AVHIVMELCEGGELFDRIVA-----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDF  204 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~-~~~~ikl~Df  204 (531)
                      .+++++||++ .+|+..|+-     ...++...+.+|+.||+.|+.|||++.|+||||||.|||+..++ ..+.|||+|+
T Consensus       102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            8999999996 489888853     23589999999999999999999999999999999999997542 2467999999


Q ss_pred             ccccccCCCC----ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCC---------HHHHHHH
Q 009594          205 GLSVFFRPGE----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQA  269 (531)
Q Consensus       205 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~---------~~~~~~~  269 (531)
                      |+++.+...-    ....++-|.+|+|||.+.|  .|+++.||||.|||+.||+|-.+.|.+..         ..++...
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999875432    2344677999999998874  69999999999999999999988885531         1223333


Q ss_pred             HHhcccCCCCCCCCC---------------------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          270 IIRSVIDFKRDPWPK---------------------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~---------------------------------~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      |..-...+....||.                                 -++...+|+.+||.+||-+|.|++++|+|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            333222222222321                                 23457899999999999999999999999999


Q ss_pred             cccccC
Q 009594          317 QNAKKA  322 (531)
Q Consensus       317 ~~~~~~  322 (531)
                      ......
T Consensus       341 ~~d~lp  346 (438)
T KOG0666|consen  341 TEDPLP  346 (438)
T ss_pred             ccCCCC
Confidence            876443

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.6e-41  Score=324.31  Aligned_cols=254  Identities=31%  Similarity=0.617  Sum_probs=216.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++++.+||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36999999999999999999998899999999997655444444577889999999994499999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      |||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.+   +.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~---~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD---MHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEecCCccccccCCccc
Confidence            9999999999999888889999999999999999999999999999999999999644   459999999987554322 


Q ss_pred             --------------------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 009594          215 --------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS  273 (531)
Q Consensus       215 --------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~  273 (531)
                                          ......++..|+|||++. ..++.++||||||+++|++++|..||...........+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                112345788999999876 56888999999999999999999999887765555555433


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCH----HHHhcCCcc
Q 009594          274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTA----EEVLEHPWL  316 (531)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~~l~h~~~  316 (531)
                      ....+    ..+++.+.+++.+||..+|++|||+    .++++||||
T Consensus       238 ~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            22222    3568999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2e-40  Score=320.99  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=200.7

Q ss_pred             ccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHH---HHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ---IMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        63 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~---~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      .||+|+||.||+|.+..+++.||+|++................|..   .++.. .||+|+++++++...+..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence            4899999999999998899999999997654432222222333433   34444 7999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccc
Q 009594          140 EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI  219 (531)
Q Consensus       140 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~  219 (531)
                      +|++|..++...+.+++..++.++.|++.||.|||+.+|+||||||+||+++.+   +.++|+|||++....... ....
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~---~~~kl~dfg~~~~~~~~~-~~~~  155 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK-PHAS  155 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC---CCEEEccCcCccccCccC-CcCc
Confidence            999999999888889999999999999999999999999999999999999644   459999999987554322 2345


Q ss_pred             cCCcccccchhcc-c-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcc
Q 009594          220 VGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML  297 (531)
Q Consensus       220 ~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  297 (531)
                      .|+..|+|||.+. + .++.++||||+|+++|+|++|..||.......... +..............+++.+.+++.+||
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~l  234 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLL  234 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence            7899999999986 3 48899999999999999999999997653221111 1111111111222346899999999999


Q ss_pred             ccCcCCCC-----CHHHHhcCCcccccc
Q 009594          298 NPDPKQRL-----TAEEVLEHPWLQNAK  320 (531)
Q Consensus       298 ~~~p~~Rp-----s~~~~l~h~~~~~~~  320 (531)
                      ..+|.+||     ++.++++||||+...
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            99999999     999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-40  Score=318.21  Aligned_cols=253  Identities=27%  Similarity=0.556  Sum_probs=212.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|.+.+.||+|+||.||+|.+..+|..+|+|.+....... .....+.+|+.+++.+ +||||+++++.+......++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEE
Confidence            4889999999999999999999999999999987653322 2346778999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||++++++  ..+||+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG--MVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC--CeEEecccccchhccCCc
Confidence            9999999999987643  479999999999999999999999999999999999996543  347999999987664432


Q ss_pred             c-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 Q-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      . .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||...+.......+.....   ....+..+..+.++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF---APISPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC---CCCCCCCCHHHHHH
Confidence            2 23346889999999876 5688999999999999999999999987666555544443322   12224578899999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +.+||..+|++|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6e-41  Score=333.43  Aligned_cols=261  Identities=30%  Similarity=0.483  Sum_probs=210.7

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE----cCC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE----DDS  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~----~~~  130 (531)
                      ..+|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+++++ +||||+++++++.    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCc
Confidence            4679999999999999999999999999999999875432 222346677899999999 8999999999875    345


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ..++|+||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++...
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~---~~~~kl~dfg~~~~~  157 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGMARGL  157 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCcEEecccccceee
Confidence            7899999995 589998887778999999999999999999999999999999999999965   445999999998765


Q ss_pred             CCCCc-----cccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcc---------
Q 009594          211 RPGEQ-----FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---------  274 (531)
Q Consensus       211 ~~~~~-----~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~---------  274 (531)
                      .....     .....++..|+|||.+.  ..++.++|||||||++|+|++|++||.+.........+....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     12357889999999875  358899999999999999999999997765443332222110         


Q ss_pred             --------------cCCCCCC----CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          275 --------------IDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       275 --------------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                    .......    ++..++.+.++|.+||+.+|++|||+.+++.||||.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                          0011111    2456889999999999999999999999999999976443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-40  Score=320.26  Aligned_cols=251  Identities=29%  Similarity=0.549  Sum_probs=206.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||.|+||.||+|.+..++..+|+|.+.............+.+|+.+++.+ +||||+++++++...+..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence            3688999999999999999999899999999988765444444557888999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          136 MELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.+   +.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEECcchhhhccc
Confidence            999999999998863    3458999999999999999999999999999999999999644   459999999987654


Q ss_pred             CCCc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH--HHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      .... .....+++.|+|||.+. ..++.++|+||||+++|+|++|..||.+....  .....+...  ..+..+....++
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence            3322 23456889999999886 56888999999999999999999999765432  222222211  122222345788


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.+++.+||..+|++|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.8e-40  Score=317.22  Aligned_cols=248  Identities=31%  Similarity=0.558  Sum_probs=209.7

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|+||.||++.+..++..+|+|.+....  .....+.+.+|+.+++.+ +||||+++++++...+.+++|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEE
Confidence            5889999999999999999999999999999986433  223456788899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||||+||+++++   +.++|+|||.+.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN---GKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC---CcEEEcccCcceeecccc
Confidence            999999999988653  348999999999999999999999999999999999999644   459999999987654322


Q ss_pred             -ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 -QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                       ......|++.|+|||++. ..++.++|+||||+++|+|++|..||...+.......+.......   ....++..+.++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---LPSHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC---CCcccCHHHHHH
Confidence             223456889999999887 468899999999999999999999998877666555554433221   123578899999


Q ss_pred             HHHccccCcCCCCCHHHHhcC
Q 009594          293 VKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.+||..+|++|||+.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.5e-40  Score=322.74  Aligned_cols=261  Identities=29%  Similarity=0.478  Sum_probs=216.0

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      +......|...+.||+|+||.||+|.+..++..+|+|++.............+.+|+.+++.+ +|||++++++++....
T Consensus        20 ~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   98 (317)
T cd06635          20 KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREH   98 (317)
T ss_pred             CCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCC
Confidence            344555689999999999999999999889999999998765443444456788999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          131 AVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      ..++||||++| +|.+.+.. ..++++..+..++.|++.||.|||+.||+||||+|+||+++.+   +.++|+|||++..
T Consensus        99 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~---~~~kl~dfg~~~~  174 (317)
T cd06635          99 TAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASI  174 (317)
T ss_pred             eEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC---CCEEEecCCCccc
Confidence            99999999975 77776654 4568999999999999999999999999999999999999653   4599999998875


Q ss_pred             cCCCCccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ....   ....|++.|+|||.+.    +.++.++|||||||++|+|++|.+||...........+......  ......+
T Consensus       175 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  249 (317)
T cd06635         175 ASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--TLQSNEW  249 (317)
T ss_pred             cCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--CCCCccc
Confidence            4332   3346888999999863    45888999999999999999999999887665555555443221  1122356


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++.+.+++.+||+.+|.+||++.++++|+|+.....
T Consensus       250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             cHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            889999999999999999999999999999976444

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.5e-40  Score=334.27  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=201.2

Q ss_pred             ccceeeccccCccCceEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      ..+|++.+.||+|+||.||+|.+...     +..||+|++....  .....+.+.+|+.+++++..||||+++++++...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            45799999999999999999986433     3479999986542  2333567889999999995599999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------------------------------------------------------
Q 009594          130 SAVHIVMELCEGGELFDRIVAR----------------------------------------------------------  151 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------  151 (531)
                      +..|||||||++|+|.+++..+                                                          
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            9999999999999999887642                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC
Q 009594          152 --------------------------------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK  193 (531)
Q Consensus       152 --------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~  193 (531)
                                                            ..+++..+..++.||+.||.|||+.+|+||||||+|||++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence                                                  136778889999999999999999999999999999999653


Q ss_pred             CCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHH
Q 009594          194 KESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ  268 (531)
Q Consensus       194 ~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~  268 (531)
                         ..+||+|||++........   .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||..........
T Consensus       274 ---~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         274 ---KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             ---CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence               4599999999876543222   12345678899999876 568999999999999999997 999997765433333


Q ss_pred             HHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          269 AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .........  .....++..+.+++.+||..+|++|||+.++.+
T Consensus       351 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSGYRM--AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcCCCC--CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333222211  122467899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2e-40  Score=323.39  Aligned_cols=254  Identities=29%  Similarity=0.452  Sum_probs=201.0

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||+|.+..+|..||+|++.......  ....+.+|+.+++.+ +|+||+++++++......++|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEE
Confidence            56999999999999999999999999999999986543221  223567899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      +||+. ++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.+   +.++|+|||++...... 
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL---GELKLADFGLARAKSIPS  157 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC---CcEEEeccccccccCCCC
Confidence            99996 577766654 3457889999999999999999999999999999999999644   45999999998754322 


Q ss_pred             CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcc--------------cC
Q 009594          214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV--------------ID  276 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~--------------~~  276 (531)
                      .......+++.|+|||.+.+  .++.++||||||+++|+|++|..||...... +....+....              ..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            22234457899999998864  4788999999999999999999999765432 1111111100              00


Q ss_pred             CCCC------------CCC--CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          277 FKRD------------PWP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       277 ~~~~------------~~~--~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ....            .+.  ..+..+.+++.+||..+|++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0000            011  125688999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-40  Score=324.70  Aligned_cols=260  Identities=31%  Similarity=0.539  Sum_probs=214.2

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|.+.+.||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEE
Confidence            357999999999999999999988899999999986432   22346788899999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||+|+||+++.+   +.++|+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~---~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC---CCEEEccCcceecccccc
Confidence            99999999999988654 58899999999999999999999999999999999999643   459999999887554332


Q ss_pred             -ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 -QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                       ......+++.|+|||.+. +.++.++|+||||+++|++++|..||...+.......+.... .........++..+.++
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l  248 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF  248 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHH
Confidence             223456888999999876 568899999999999999999999997765443322222111 11111223467889999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcccccccCC
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP  323 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~  323 (531)
                      +.+||..+|++||++.+++.||||+......
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~  279 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQHPFLKIAKPLS  279 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhcCcccc
Confidence            9999999999999999999999998766443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.2e-40  Score=317.94  Aligned_cols=250  Identities=28%  Similarity=0.490  Sum_probs=202.4

Q ss_pred             eccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      ....||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++++ +||||+++++++...+..++|+||+
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecC
Confidence            3457999999999999998899999999886543   23456788999999999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-c
Q 009594          140 EGGELFDRIVAR-GHY--TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q  215 (531)
Q Consensus       140 ~~~~L~~~l~~~-~~l--~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-~  215 (531)
                      ++++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++..  ...++|+|||.+....... .
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~--~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC--CCeEEEecchhheecccCCCc
Confidence            999999998764 445  888899999999999999999999999999999999642  3459999999987654322 2


Q ss_pred             cccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      .....|++.|+|||.+.+   .++.++||||||+++|+|++|..||............. ............+++.+.++
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhccCCCCCcccCHHHHHH
Confidence            233467899999998753   37889999999999999999999997643322111111 11111111123578899999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +.+||..+|++|||+.+++.||||
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=322.49  Aligned_cols=253  Identities=32%  Similarity=0.546  Sum_probs=208.7

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--CeEEEE
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVHIV  135 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~lv  135 (531)
                      |++.+.||.|+||.||+|.+..+++.+|+|++.... ........+.+|+.+++.+ +|||++++++++...  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEE
Confidence            678899999999999999998899999999998654 2222345677899999999 899999999999887  899999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      +||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||++++   ++.++|+|||++.......
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~---~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN---DGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC---CCCEEEccccceeeccCCC
Confidence            999975 888888665 57899999999999999999999999999999999999965   4459999999988665432


Q ss_pred             --ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC--------
Q 009594          215 --QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--------  282 (531)
Q Consensus       215 --~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  282 (531)
                        ......++..|+|||.+.+  .++.++||||||+++|+|+||..||...+.......+...........|        
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence              2233456888999997653  5788999999999999999999999887766555555432211111111        


Q ss_pred             ------------------CC-CCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          283 ------------------PK-VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       283 ------------------~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                        .. +++.+.+++.+||..+|++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                              12 27889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-40  Score=323.14  Aligned_cols=261  Identities=31%  Similarity=0.586  Sum_probs=211.5

Q ss_pred             ceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      +|++.+.||.|+||.||.|.+.   .+|..||+|++...... .......+.+|+.+++++.+||||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999874   47899999998754322 1223456788999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.   ++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC---CCCEEEeeCccceeccc
Confidence            999999999999999988888999999999999999999999999999999999999964   44699999999876543


Q ss_pred             CC--ccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          213 GE--QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       213 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ..  ......|+..|+|||.+.+   .++.++||||||+++|+|++|..||...........+.........+....+++
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  237 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence            32  2234568899999998753   467899999999999999999999964332222222222221111111235788


Q ss_pred             HHHHHHHHccccCcCCCC-----CHHHHhcCCcccccc
Q 009594          288 NAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNAK  320 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rp-----s~~~~l~h~~~~~~~  320 (531)
                      .+.+++.+||..+|++||     ++.+++.||||+...
T Consensus       238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            999999999999999997     899999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.6e-40  Score=323.35  Aligned_cols=257  Identities=28%  Similarity=0.449  Sum_probs=213.1

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .....|...+.||+|+||.||+|.+..++..+|+|++.............+.+|+.+++.+ +|||++++++++.+....
T Consensus        18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEE
Confidence            3444578888999999999999999899999999999765444444456788899999999 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+. ++|.+++.. ...+++..++.++.|++.||.|||++||+||||+|+||+++.+   +.+||+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~---~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC---CCEEEeecCCCcccC
Confidence            99999996 477777654 4568999999999999999999999999999999999999644   459999999886432


Q ss_pred             CCCccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                         ......|+..|+|||.+.    +.++.++|||||||++|+|++|.+||...........+.....  +......++.
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  247 (313)
T cd06633         173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTD  247 (313)
T ss_pred             ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCH
Confidence               223457889999999873    4588899999999999999999999988766555544443322  1222235678


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+.+|+.+||+++|++||++.+++.||||+..
T Consensus       248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         248 SFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            89999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=333.09  Aligned_cols=250  Identities=36%  Similarity=0.551  Sum_probs=212.4

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..+...|.+...+|.|+||.|-.+.+..+++..++|++.+...       ...+|+.++....+||||+++.+++.+..+
T Consensus       318 ~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~  390 (612)
T KOG0603|consen  318 APFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKE  390 (612)
T ss_pred             CCcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCce
Confidence            4567789999999999999999999999999999999987621       233577777777899999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .|+|||++.|+-+.+.+.....+. ..+..|+.+|+.|+.|||++|+|||||||+|||+.  +..++++|+|||.++..+
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCc
Confidence            999999999999988887765555 78889999999999999999999999999999996  455679999999998776


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ..  ..+.+-|..|.|||++. ..|+.++||||||++||+|++|+.||........+...+.   .....  ..+|..++
T Consensus       468 ~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~---~~~~s--~~vS~~AK  540 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ---MPKFS--ECVSDEAK  540 (612)
T ss_pred             hh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc---CCccc--cccCHHHH
Confidence            54  44456688999999987 5799999999999999999999999988776622222221   11111  46899999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      +||.+||+.+|.+||++.+++.||||-.
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             HHHHHhccCChhhCcChhhhccCcchhc
Confidence            9999999999999999999999999933

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=331.28  Aligned_cols=262  Identities=34%  Similarity=0.525  Sum_probs=218.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-----e
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-----A  131 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----~  131 (531)
                      +|++.+.||.|++|.||+|.+..++..||+|++.... ......+.+.+|+.+++.+ +||||+++++++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccc
Confidence            5899999999999999999998889999999987542 1233456788999999999 8999999999987765     7


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .|+||||++ ++|.+++.+...+++..++.++.||+.||.|||+.||+||||||+||+++.+   +.++|+|||.+....
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~---~~~~L~dfg~~~~~~  154 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN---CDLKICDFGLARGVD  154 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEcccCceEeec
Confidence            899999997 4899988877789999999999999999999999999999999999999654   569999999998765


Q ss_pred             CCC----ccccccCCcccccchhcc-c-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC-----
Q 009594          212 PGE----QFNEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD-----  280 (531)
Q Consensus       212 ~~~----~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-----  280 (531)
                      ...    ......+++.|+|||.+. . .++.++||||||+++|+|++|.+||.+.+..+....+..........     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            443    234456789999999886 3 58889999999999999999999998887666555544422111110     


Q ss_pred             ----------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCC
Q 009594          281 ----------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN  324 (531)
Q Consensus       281 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~  324 (531)
                                            ..+.+++.+.++|.+||+.+|++|||+.+++.||||+.....+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~  300 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED  300 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence                                  12346788999999999999999999999999999997766543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-41  Score=347.54  Aligned_cols=264  Identities=21%  Similarity=0.313  Sum_probs=194.9

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccC-CcEEEEEE--------------eeccccCChhhHHHHHHHHHHHHhCCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNN-GEKFACKS--------------ISKKKLRTAVDIEDVRREVQIMKHLPK  115 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~~  115 (531)
                      +..+..+|++++.||+|+||+||+|..+.. +..++.|.              +.+...........+.+|+.+++++ +
T Consensus       143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~  221 (501)
T PHA03210        143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-N  221 (501)
T ss_pred             chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-C
Confidence            455667899999999999999999875432 22222221              1111111222345678999999999 9


Q ss_pred             CCCeeecceEEEcCCeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEe
Q 009594          116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLF  190 (531)
Q Consensus       116 h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll  190 (531)
                      ||||+++++++...+..|+|++++. ++|..++...     .......++.|+.||+.||.|||++||+||||||+|||+
T Consensus       222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl  300 (501)
T PHA03210        222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL  300 (501)
T ss_pred             CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            9999999999999999999999995 5777776542     123466788999999999999999999999999999999


Q ss_pred             ecCCCCCCeEEEeeccccccCCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC---HH
Q 009594          191 ANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQ  264 (531)
Q Consensus       191 ~~~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~  264 (531)
                      +.+   +.+||+|||++..+.....  .....||+.|+|||++. ..++.++|||||||++|+|++|..|+....   ..
T Consensus       301 ~~~---~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        301 NCD---GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             CCC---CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            644   4599999999987654322  23467999999999987 568999999999999999999876543321   22


Q ss_pred             HHHHHHHhccc----CCCC------------------CC------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          265 GVAQAIIRSVI----DFKR------------------DP------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       265 ~~~~~~~~~~~----~~~~------------------~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .....+.....    .++.                  ..      ...++..+.++|.+||+.||.+|||+.|+|.||||
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            22222222110    0000                  00      01246678889999999999999999999999999


Q ss_pred             ccc
Q 009594          317 QNA  319 (531)
Q Consensus       317 ~~~  319 (531)
                      ...
T Consensus       458 ~~~  460 (501)
T PHA03210        458 SAE  460 (501)
T ss_pred             hcC
Confidence            764

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=328.16  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=198.3

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-eE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-AV  132 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~~  132 (531)
                      ..++|.-...||+|+||.||+|.. .+|..||||++.......   ..+|.+|+.++.++ +|||+|+|+|||.+.+ +.
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~~~  147 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRL-RHPNLVKLLGYCLEGGEHR  147 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcC-CCcCcccEEEEEecCCceE
Confidence            345788889999999999999995 455999999776543221   35599999999999 7999999999999888 59


Q ss_pred             EEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          133 HIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQ---GVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~---~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      +||+||+++|+|.++|....  .++|....+|+.++|.||+|||..   .||||||||+|||++.   +...||+|||+|
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~---~~~aKlsDFGLa  224 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE---DFNAKLSDFGLA  224 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC---CCCEEccCccCc
Confidence            99999999999999998765  789999999999999999999985   3999999999999964   455999999999


Q ss_pred             cccCC-CCccccc-cCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC---HHHHHH---HHHhc--ccC
Q 009594          208 VFFRP-GEQFNEI-VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQ---AIIRS--VID  276 (531)
Q Consensus       208 ~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~---~~~~~--~~~  276 (531)
                      +..+. ....... .||.+|+|||.+. +..+.++|||||||+|.|++||+.|.....   ......   .....  ...
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~e  304 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLRE  304 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhh
Confidence            77655 4333333 8999999999886 789999999999999999999998876432   111111   11111  111


Q ss_pred             CCCCCC--CCCC-----HHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          277 FKRDPW--PKVS-----ENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       277 ~~~~~~--~~~~-----~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ...+..  ...+     ..+..+..+|++.+|..||++.++++
T Consensus       305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111111  1222     23678888999999999999999754

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.6e-40  Score=320.75  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=206.6

Q ss_pred             cceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      .+|.+.+.||+|+||.||+|.+..     ++..||+|++....  .....+.+.+|+++++.+ +||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNF-QHENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCC
Confidence            458999999999999999998643     36789999986542  222356888999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCC
Q 009594          131 AVHIVMELCEGGELFDRIVARG--------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES  196 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~  196 (531)
                      ..++||||+++++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||+++.+   
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~---  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD---  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC---
Confidence            9999999999999999987542              37888999999999999999999999999999999999654   


Q ss_pred             CCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 009594          197 SPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII  271 (531)
Q Consensus       197 ~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~  271 (531)
                      +.+||+|||++........   .....+++.|+|||++. +.++.++|||||||++|+|++ |..||...........+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            5599999999876533221   12334577899999886 578999999999999999998 999998877776666665


Q ss_pred             hcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ......   ....++..+.+++.+||..+|++|||+.++++
T Consensus       239 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            443322   12467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-42  Score=319.54  Aligned_cols=260  Identities=29%  Similarity=0.510  Sum_probs=232.0

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      -..+|.++..||+|+||.|-+|..+.+.+.+|||++++.-+-+..+.+--..|-++|....+-|.+++++.+|+.-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            34479999999999999999999999999999999988766555566666678889988878889999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc-CC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~-~~  212 (531)
                      +||||+.||+|--.+.+-+++.+..+.-++..|+-||-+||++|||+||||..||+++.+   ++|||+|||+++.- ..
T Consensus       427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e---GHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIFD  503 (683)
T ss_pred             eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC---CceEeeecccccccccC
Confidence            999999999999999999999999999999999999999999999999999999999654   56999999998743 34


Q ss_pred             CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      +....+.+|||.|+|||++. ++|+.++|+||+||+||||+.|++||.+.++.+..+.|......++    ..+|.++.+
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----KslSkEAv~  579 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----KSLSKEAVA  579 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----ccccHHHHH
Confidence            45567889999999999887 8899999999999999999999999999999999999988766655    357999999


Q ss_pred             HHHHccccCcCCCCC-----HHHHhcCCcccccc
Q 009594          292 LVKKMLNPDPKQRLT-----AEEVLEHPWLQNAK  320 (531)
Q Consensus       292 li~~~l~~~p~~Rps-----~~~~l~h~~~~~~~  320 (531)
                      ++..+|.+.|.+|..     -.+|-.||||+...
T Consensus       580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             HHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            999999999999984     47899999998764

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.9e-40  Score=319.76  Aligned_cols=260  Identities=35%  Similarity=0.557  Sum_probs=217.9

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .....|++...||+|++|.||+|.+..++..+|+|++.....    ....+.+|+.+++.+ +||||+++++++......
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDC-KHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEE
Confidence            355679999999999999999999988899999999975432    356788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++++   +.++|+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~---~~~~l~d~~~~~~~~  167 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD---GSVKLADFGFAAQLT  167 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC---CCEEECccchhhhhc
Confidence            99999999999999998776 79999999999999999999999999999999999999654   459999999887554


Q ss_pred             CCC-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          212 PGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       212 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ... ......+++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+...... .......++..+
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  246 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEF  246 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHH
Confidence            332 223345788999999876 46889999999999999999999999876655444433332221 111223478999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .++|.+||+.+|.+|||+.++++||||+..-.
T Consensus       247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            99999999999999999999999999987433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.7e-40  Score=329.65  Aligned_cols=258  Identities=31%  Similarity=0.486  Sum_probs=208.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      +..+|++.+.||.|+||.||+|.+..+|..||+|++.....   .....+.+|+.+++.+ +||||+++++++...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence            45689999999999999999999999999999999876543   2346788899999999 999999999876543    


Q ss_pred             ----------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCe
Q 009594          130 ----------SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL  199 (531)
Q Consensus       130 ----------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~i  199 (531)
                                ...++|+||++ ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++..  +..+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~--~~~~  154 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE--DLVL  154 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC--CceE
Confidence                      35799999997 588887754 468999999999999999999999999999999999999643  3458


Q ss_pred             EEEeeccccccCCCCc----cccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 009594          200 KAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS  273 (531)
Q Consensus       200 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~  273 (531)
                      ||+|||.+........    .....++..|+|||.+.  ..++.++|||||||++|+|++|..||...+.......+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999876533211    12235788999999765  35788999999999999999999999877665554444322


Q ss_pred             ccCC----------------------CC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          274 VIDF----------------------KR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       274 ~~~~----------------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ....                      ..    ...+.++.++.+||.+||..+|.+|||+.+++.||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            1100                      00    0123567889999999999999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-40  Score=329.24  Aligned_cols=252  Identities=21%  Similarity=0.344  Sum_probs=200.6

Q ss_pred             ccceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-  128 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  128 (531)
                      .++|++.+.||.|+||.||+|.+..     +++.||+|++....  .......+.+|+.+++++.+||||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            3579999999999999999997433     45789999986432  223356778899999999889999999998764 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR---------------------------------------------------------  151 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  151 (531)
                      ...+++++||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            56789999999999999988542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcc
Q 009594          152 ----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPY  224 (531)
Q Consensus       152 ----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~  224 (531)
                          ..+++..+..++.||+.||.|||++||+||||||+||+++.+   +.++|+|||++..+.....   .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~---~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC---CcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                257889999999999999999999999999999999999743   4599999999986543321   123345678


Q ss_pred             cccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcC
Q 009594          225 YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPK  302 (531)
Q Consensus       225 y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  302 (531)
                      |+|||++. ..++.++|||||||++|+|++ |..||.+....+..............  ....++++.+++.+||+.+|+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChh
Confidence            99999876 579999999999999999998 99999775443333333222211111  135688999999999999999


Q ss_pred             CCCCHHHHhcC
Q 009594          303 QRLTAEEVLEH  313 (531)
Q Consensus       303 ~Rps~~~~l~h  313 (531)
                      +|||+.++++|
T Consensus       319 ~RPs~~ell~~  329 (337)
T cd05054         319 DRPTFSELVEI  329 (337)
T ss_pred             hCcCHHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.5e-40  Score=328.23  Aligned_cols=264  Identities=30%  Similarity=0.460  Sum_probs=212.7

Q ss_pred             ccccceee-ccccCccCceEEEEEEEccCCcEEEEEEeeccccCChh-----------hHHHHHHHHHHHHhCCCCCCee
Q 009594           53 DISIDYDL-GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----------DIEDVRREVQIMKHLPKHPNIV  120 (531)
Q Consensus        53 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~niv  120 (531)
                      .+.++|.. .+.||.|+||+||+|.+..+++.||+|++.........           ....+.+|+.+++++ +||||+
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv   83 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIM   83 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCccee
Confidence            35567765 46799999999999999999999999998654322100           012467899999999 999999


Q ss_pred             ecceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeE
Q 009594          121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK  200 (531)
Q Consensus       121 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ik  200 (531)
                      ++++++...+..++||||+. ++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.+   +.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~---~~~k  159 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK---GICK  159 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC---CCEE
Confidence            99999999999999999996 5999999887789999999999999999999999999999999999999644   4599


Q ss_pred             EEeeccccccCCC---------------CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCH
Q 009594          201 AIDFGLSVFFRPG---------------EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE  263 (531)
Q Consensus       201 l~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~  263 (531)
                      |+|||.+......               .......+++.|+|||.+.+  .++.++|||||||++|+|++|.+||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999998755411               11122346788999998864  468899999999999999999999988877


Q ss_pred             HHHHHHHHhcccCCCCC------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          264 QGVAQAIIRSVIDFKRD------------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       264 ~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+....+..........                        ..+..+..+.++|.+||..+|++|||+.++|.||||+..
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            66555444322111111                        012457889999999999999999999999999999865


Q ss_pred             cc
Q 009594          320 KK  321 (531)
Q Consensus       320 ~~  321 (531)
                      ..
T Consensus       320 ~~  321 (335)
T PTZ00024        320 PL  321 (335)
T ss_pred             CC
Confidence            43

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.6e-40  Score=319.15  Aligned_cols=251  Identities=20%  Similarity=0.315  Sum_probs=204.1

Q ss_pred             cccceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..++|++.+.||+|+||.||+|.+..     .+..||+|++....  .......+.+|+.+++.+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence            45679999999999999999998642     35689999885432  223345688999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCC
Q 009594          129 DSAVHIVMELCEGGELFDRIVARG----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                      ....++||||+++++|.+++....          .++...+..++.|++.||.|||+.|++||||||+||+++.   ++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~---~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE---DFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC---CCC
Confidence            999999999999999999986532          2567889999999999999999999999999999999964   445


Q ss_pred             eEEEeeccccccCCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 009594          199 LKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS  273 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  273 (531)
                      ++|+|||++.........   ....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+.........+...
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998755432221   1234577899999886 568999999999999999999 78999887776655554443


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ...   .....+++.+.+++.+||+.+|++|||+.+++++
T Consensus       238 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            221   1123578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.5e-40  Score=313.56  Aligned_cols=252  Identities=29%  Similarity=0.569  Sum_probs=215.2

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|+||.||++.+..++..+|+|++...... ......+.+|+++++.+ +|||++++++.+......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEE
Confidence            588999999999999999999889999999999765432 23456788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          137 ELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       137 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||+++++|.+++.+.    ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.+   +.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~---~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN---GLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC---CcEEECCccceeeccc
Confidence            999999999998764    669999999999999999999999999999999999999653   4599999999876544


Q ss_pred             CC-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          213 GE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       213 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .. ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||...................   ....++..+.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence            33 223456889999999876 568889999999999999999999998776665555554433221   1135789999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +++.+||..+|++|||+.++|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.6e-40  Score=322.42  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=202.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGE--KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.+...  ......+.+.+|+.+++++.+||||+++++++...+.++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            469999999999999999999877664  4688877532  223345678899999999977999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCC
Q 009594          134 IVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~  197 (531)
                      +|+||+++++|.+++....                .+++..++.++.|++.||+|||++||+||||||+||+++.   +.
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE---NL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC---CC
Confidence            9999999999999986532                4788999999999999999999999999999999999964   44


Q ss_pred             CeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhccc
Q 009594          198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVI  275 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  275 (531)
                      .+||+|||++..............+..|+|||++. ..++.++|||||||++|+|++ |..||...........+.....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            59999999986432211111122355799999876 568999999999999999997 9999988877666665544321


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                         ......++..+.+|+.+||..+|.+|||+.++++.
T Consensus       237 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 ---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               11223578999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=327.71  Aligned_cols=258  Identities=30%  Similarity=0.522  Sum_probs=202.4

Q ss_pred             ceeeccccCccCceEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--CeE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVN--NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAV  132 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~  132 (531)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+.............+.+|+.+++.+ +||||+++++++.+.  ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence            48899999999999999999988  8999999999764322222345677899999999 999999999999887  889


Q ss_pred             EEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC-CCCCeEEEeecc
Q 009594          133 HIVMELCEGGELFDRIVAR-----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGL  206 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~-~~~~ikl~Dfg~  206 (531)
                      ++||||+++ +|.+.+...     ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ ..+.+||+|||+
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999999975 676665421     2689999999999999999999999999999999999997622 256699999999


Q ss_pred             ccccCCCCc----cccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHH---------HHHHHH
Q 009594          207 SVFFRPGEQ----FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQG---------VAQAII  271 (531)
Q Consensus       207 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~---------~~~~~~  271 (531)
                      +........    .....+++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.....         ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            886543221    233467889999998764  47889999999999999999999997654321         111111


Q ss_pred             hccc---------------------CCCCCCCC------------CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          272 RSVI---------------------DFKRDPWP------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       272 ~~~~---------------------~~~~~~~~------------~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ....                     ......++            ..+..+.+++.+||..+|++|||+.++++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            1000                     00011111            456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-40  Score=314.20  Aligned_cols=254  Identities=30%  Similarity=0.517  Sum_probs=209.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeecccc--CChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--Ce
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~  131 (531)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+.....  ........+.+|+.+++++ +||||+++++++.+.  ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence            369999999999999999999999999999998854321  1233456788999999999 999999999998754  56


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +++++||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.+   +.++|+|||++....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~~  157 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECccccccccc
Confidence            88999999999999999887789999999999999999999999999999999999999654   459999999987653


Q ss_pred             CC----CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          212 PG----EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       212 ~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ..    .......++..|+|||.+. ..++.++|+|||||++|+|++|..||...........+....  ........++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~~~  235 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLPDGVS  235 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCCcccC
Confidence            21    1123456889999999887 457889999999999999999999998766555444333221  1122234678


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +.+.+++.+||.. |..||++.+++.|||.
T Consensus       236 ~~~~~~i~~~l~~-~~~r~~~~~~~~~~~~  264 (264)
T cd06653         236 DACRDFLKQIFVE-EKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHHhcC-cccCccHHHHhcCCCC
Confidence            9999999999994 7999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=279.10  Aligned_cols=257  Identities=30%  Similarity=0.543  Sum_probs=217.8

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|.-.++||+|.||+||+|+.+.+++.||+|.+....-.... -....+|+.+++.| +|.|||+++++...++.+-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-pssalreicllkel-khknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-cHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeH
Confidence            467778999999999999999999999999999765543332 35677899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      |||. .+|..+... ++.++.+.+++++.|++.||.++|++++.||||||.|.||+.+   +.+||+|||+|+...-.- 
T Consensus        81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n---gelkladfglarafgipvr  156 (292)
T KOG0662|consen   81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN---GELKLADFGLARAFGIPVR  156 (292)
T ss_pred             HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC---CcEEecccchhhhcCCceE
Confidence            9995 578777654 6679999999999999999999999999999999999999654   459999999998765332 


Q ss_pred             ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC------
Q 009594          215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV------  285 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------  285 (531)
                      .+...+-|.+|++|.++.+  -|+.+.|+||-|||+.|+.. |++.|.+.+-.++...+.+.........||.+      
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            3445567999999999875  48999999999999999887 88889998888888888776655555555432      


Q ss_pred             -------------------CHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          286 -------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       286 -------------------~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                                         +..-.+++.++|.-+|.+|++++++++||||...
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                               2346799999999999999999999999999753

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.5e-40  Score=315.36  Aligned_cols=246  Identities=22%  Similarity=0.356  Sum_probs=206.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|.+.+.||+|+||.||+|.+..++..+|+|++....    .....+.+|+.+++++ +||||+++++++...+.+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEE
Confidence            45899999999999999999998899999999986432    2356788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          136 MELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||++++   ++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~---~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE---NHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC---CCcEEeCCCccccccccc
Confidence            9999999999998754  35899999999999999999999999999999999999964   445999999998866543


Q ss_pred             Ccc--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          214 EQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       214 ~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ...  ....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+....+....+....   .......+|+.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  234 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPPKV  234 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCHHH
Confidence            221  1223456899999876 568899999999999999998 999998877666555554322   112224678999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+++.+||..+|++|||+.++++
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1e-39  Score=311.07  Aligned_cols=251  Identities=34%  Similarity=0.555  Sum_probs=212.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|.+.+.||+|++|.||+|.+..++..+++|++.....   .....+.+|+.+++.+ +||||+++++++......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEE
Confidence            48888999999999999999988999999999975432   2457888999999999 7999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          137 ELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      ||+++++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.+   +.++|+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD---GEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC---CeEEEeecccccccccccc
Confidence            999999999998775 578999999999999999999999999999999999999653   4599999999887665443


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....++..|+|||.+. ..++.++||||||+++|+|++|..||................... ......++..+.+++.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG-LRNPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC-cCcccccCHHHHHHHH
Confidence            34567889999999887 457889999999999999999999998775544444333321111 1111224889999999


Q ss_pred             HccccCcCCCCCHHHHhcCCc
Q 009594          295 KMLNPDPKQRLTAEEVLEHPW  315 (531)
Q Consensus       295 ~~l~~~p~~Rps~~~~l~h~~  315 (531)
                      +||..+|++|||+.++++|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.2e-40  Score=312.66  Aligned_cols=253  Identities=33%  Similarity=0.565  Sum_probs=213.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--CeEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~l  134 (531)
                      +|++.+.||+|++|.||+|.+..++..+++|++...... ....+.+.+|+.+++++ +||||+++++.+...  ..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEE
Confidence            478889999999999999999889999999998755432 34467888999999999 899999999999888  89999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |+||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.   ++.++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~---~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC---CCCEEEcccccEEeccccc
Confidence            9999999999999988778999999999999999999999999999999999999975   3459999999988776554


Q ss_pred             c---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          215 Q---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       215 ~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      .   .....++..|+|||.+. ..++.++||||||+++|+|++|..||...... .....+..  ...........++.+
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  233 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHLSEEA  233 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCcccCHHH
Confidence            3   34467889999999887 45889999999999999999999999776522 11111111  011111223468999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .+++.+||..+|++||++.++++||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.4e-40  Score=319.25  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=204.8

Q ss_pred             cceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      .+|.+.+.||+|+||.||++.+.     .++..+|+|.+...   .......+.+|+.+++++ +||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence            46999999999999999999853     34567899988643   233456788999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCC
Q 009594          131 AVHIVMELCEGGELFDRIVARG-------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~  197 (531)
                      .+++|+||+++++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+||+++.   ++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~---~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE---NL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc---CC
Confidence            9999999999999999987543             3899999999999999999999999999999999999964   44


Q ss_pred             CeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHh
Q 009594          198 PLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR  272 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~  272 (531)
                      .+||+|||++........   .....+++.|+|||.+. ..++.++|||||||++|+|+| |.+||...........+..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            599999999876543321   12234577899999887 568899999999999999998 9999988877766666655


Q ss_pred             cccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .....   ....+++.+.+|+.+||+.+|.+|||+.+++.
T Consensus       238 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            43221   11357889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.1e-40  Score=314.51  Aligned_cols=251  Identities=28%  Similarity=0.548  Sum_probs=207.0

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||.|+||.||+|.+..+|+.||+|.+.............+.+|+.+++++ +|+||+++++++...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence            4699999999999999999999889999999998765444444467888999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          136 MELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |||+++++|..++..    ...+++..+..++.+++.||.|||+.||+||||+|+||+++.+   +.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~---~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT---GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC---CcEEEeccceeeecc
Confidence            999999999998864    3458999999999999999999999999999999999999654   459999999987654


Q ss_pred             CCC-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ... ......+++.|+|||.+. ..++.++|||||||++|+|++|..||.....  ......+....  ....+.+..+.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CCCCChhhcCH
Confidence            332 223456888999999876 4688999999999999999999999965432  12222222221  11122235788


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=311.39  Aligned_cols=252  Identities=32%  Similarity=0.586  Sum_probs=215.8

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+...... ......+.+|+++++++ +|||++++++++...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Confidence            488899999999999999999889999999999765432 23567889999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~-  215 (531)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||+++.   ++.++|+|||.+........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~---~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC---CCCEEEeccccceecCCCccc
Confidence            99999999999988888999999999999999999999999999999999999965   34699999999987654433 


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....++..|+|||.+. ..++.++||||||+++|+|++|..||................   .......+++.+.+++.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD---HPPLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---CCCCCCCCCHHHHHHHH
Confidence            23456788999999876 457889999999999999999999998766544444433221   12223467899999999


Q ss_pred             HccccCcCCCCCHHHHhcCCcc
Q 009594          295 KMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       295 ~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.1e-40  Score=318.53  Aligned_cols=257  Identities=23%  Similarity=0.320  Sum_probs=206.6

Q ss_pred             cccceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++.+ +||||+++++++..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence            34679999999999999999997542     35589999876432  222345678899999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCC
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR----------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                      ....++||||+++|+|.+++...          ..++...+..++.|++.||.|||+++|+||||||+||+++.   +..
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~---~~~  157 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFT  157 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC---CCc
Confidence            99999999999999999999652          23466788999999999999999999999999999999965   445


Q ss_pred             eEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 009594          199 LKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS  273 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  273 (531)
                      ++|+|||+++.......   .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+...
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG  237 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999876543221   11224567899999876 578999999999999999998 78999887766655544432


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc------CCccccc
Q 009594          274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE------HPWLQNA  319 (531)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~------h~~~~~~  319 (531)
                      ...   .....+++.+.+++.+||+.+|++|||+.++++      ||||...
T Consensus       238 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         238 GYL---DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            211   111356889999999999999999999999987      8888753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.6e-40  Score=322.60  Aligned_cols=259  Identities=32%  Similarity=0.536  Sum_probs=209.3

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  130 (531)
                      .....+|++.+.||.|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++++ +||||+++++++.... 
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQL-NHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhC-CCCCeeeeeheecCcch
Confidence            445668999999999999999999999899999999987543222 2234667899999999 9999999999887544 


Q ss_pred             ---------eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeE
Q 009594          131 ---------AVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK  200 (531)
Q Consensus       131 ---------~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ik  200 (531)
                               .+++|+||+++ ++...+... ..+++..++.++.|++.||.|||+.||+||||+|+||++++   .+.+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~---~~~~k  156 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN---KGQIK  156 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCcEE
Confidence                     79999999976 777766543 46899999999999999999999999999999999999964   44599


Q ss_pred             EEeeccccccCCCC--ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 009594          201 AIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       201 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      |+|||++.......  ......++..|+|||.+.+  .++.++|||||||++|+|++|++||...........+.+....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999988664332  1223356788999998753  4788999999999999999999999877666555544442211


Q ss_pred             CCC--------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          277 FKR--------------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       277 ~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ...                          ..+..+|+.+.+++.+||..+|++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            110                          1123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-40  Score=328.97  Aligned_cols=261  Identities=29%  Similarity=0.492  Sum_probs=212.7

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe-
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA-  131 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-  131 (531)
                      .+.++|++...||.|++|.||+|++..++..||+|++..... .......+.+|+.+++.+ +||||+++++++...+. 
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSL   89 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccc
Confidence            456789999999999999999999999999999998865422 222345677899999999 99999999998765544 


Q ss_pred             -----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          132 -----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       132 -----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                           .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++++   +.++|+|||+
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~---~~~kL~dfg~  164 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGL  164 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEccccc
Confidence                 89999999 6699888765 469999999999999999999999999999999999999653   4599999999


Q ss_pred             ccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-------
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-------  277 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------  277 (531)
                      +......  .....+++.|+|||.+.+  .++.++||||||+++|++++|..||...........+.......       
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            8765432  334567889999998753  57889999999999999999999998776655554443321100       


Q ss_pred             ----------------CC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          278 ----------------KR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       278 ----------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                                      ..    ..+...++.+.++|.+||..+|++|||+.++++||||+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                            00    0113468899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.5e-40  Score=314.07  Aligned_cols=245  Identities=26%  Similarity=0.406  Sum_probs=203.6

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||+|... .+..+|+|.+.....    ....+.+|+.+++++ +||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEE
Confidence            35899999999999999999864 556899998764322    235788899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||+|+||+++.   +..+||+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~---~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS---TGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC---CCeEEECCCCCccccCCCc
Confidence            9999999999988753 46899999999999999999999999999999999999964   3459999999987654322


Q ss_pred             cc--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          215 QF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       215 ~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ..  ....++..|+|||.+. ..++.++||||||+++|+|++ |+.||...+..+....+.+......   ....+..+.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~  231 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVY  231 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHH
Confidence            21  1223456899999886 568899999999999999999 9999988877777666655432111   123678899


Q ss_pred             HHHHHccccCcCCCCCHHHHhc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +++.+||..+|++|||+.++++
T Consensus       232 ~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         232 EVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.4e-40  Score=320.03  Aligned_cols=255  Identities=23%  Similarity=0.333  Sum_probs=206.6

Q ss_pred             CCccccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceE
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT  125 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~  125 (531)
                      .....++|.+.+.||+|+||.||+|.+.     .++..+|+|.+....  .....+.+.+|+.+++++.+||||++++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            3455668999999999999999999752     345689999886543  223356788999999999779999999999


Q ss_pred             EEcCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEe
Q 009594          126 YEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       126 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                      +...+..++||||+++++|.+++....  .+++.++..++.|++.||.|||+++|+|+||||+||+++.   +..++|+|
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~~l~d  184 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH---GKIVKICD  184 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC---CCeEEECC
Confidence            999999999999999999999987643  3899999999999999999999999999999999999964   44599999


Q ss_pred             eccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCC
Q 009594          204 FGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFK  278 (531)
Q Consensus       204 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~  278 (531)
                      ||++........   .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||................... 
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-  263 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-  263 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-
Confidence            999876543321   12234567899999876 568999999999999999998 999998766554443433322211 


Q ss_pred             CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       279 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                       ......++.+.+++.+||.++|++|||+.++++
T Consensus       264 -~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 -AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             122356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-40  Score=311.60  Aligned_cols=245  Identities=36%  Similarity=0.653  Sum_probs=210.8

Q ss_pred             cCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCc
Q 009594           64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE  143 (531)
Q Consensus        64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  143 (531)
                      ||.|+||.||++.+..+++.+|+|++.............+..|+.+++.+ +||||+++++.+......++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            69999999999999888999999999876555444567888999999999 89999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-CccccccCC
Q 009594          144 LFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIVGS  222 (531)
Q Consensus       144 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt  222 (531)
                      |.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.+   +.++|+|||.+...... .......++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD---GHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC---CcEEEeecCcceecccCCCcccCCcCC
Confidence            99999888789999999999999999999999999999999999999654   45999999998766443 233455688


Q ss_pred             cccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCc
Q 009594          223 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP  301 (531)
Q Consensus       223 ~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  301 (531)
                      ..|+|||.+. ...+.++|+||||+++|++++|..||...........+......    .....+..+.+++.+||..+|
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR----FPEFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCHHHHHHHHHHhcCCH
Confidence            8999999876 45788999999999999999999999777665545554442221    223458999999999999999


Q ss_pred             CCCCCH---HHHhcCCcc
Q 009594          302 KQRLTA---EEVLEHPWL  316 (531)
Q Consensus       302 ~~Rps~---~~~l~h~~~  316 (531)
                      ++||++   .++++||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-40  Score=328.45  Aligned_cols=256  Identities=17%  Similarity=0.283  Sum_probs=201.4

Q ss_pred             cccCcc--CceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           62 RELGRG--EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        62 ~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      ..||.|  +||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.+ +||||+++++++...+..++|+||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecc
Confidence            456666  9999999999999999999998754332 23457788999999999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-cc
Q 009594          140 EGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QF  216 (531)
Q Consensus       140 ~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-~~  216 (531)
                      .+++|.+++.+..  .+++..+..++.|++.||+|||++||+||||||+||+++++   +.++++||+.+....... ..
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~---~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD---GLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---CcEEEechHHHhhhhccCccc
Confidence            9999999887643  48999999999999999999999999999999999999654   459999998653322111 00


Q ss_pred             -------ccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------
Q 009594          217 -------NEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--------  278 (531)
Q Consensus       217 -------~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------  278 (531)
                             ....++..|+|||++.+   .++.++|||||||++|+|++|.+||...................+        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                   11234567999998864   378899999999999999999999977665444333222110000        


Q ss_pred             -----------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          279 -----------------------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       279 -----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                                                         ......+++.+.+|+.+||+.+|++|||+.++|+||||++..+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                               00012356789999999999999999999999999999876553

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=351.17  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=211.1

Q ss_pred             cceeeccccCccCceEEEEEEEccC-C----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNN-G----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~-~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ..-.+.+.||+|+||+||.|.-... |    ..||+|.+.+  ..+..+...|.+|..+|+.+ +|||||+++|++.+..
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCC
Confidence            3567788999999999999985432 2    3478887754  34666788999999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEe
Q 009594          131 AVHIVMELCEGGELFDRIVAR-------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                      ..+|++|||.||+|..+|.+.       ..++...++.++.+||+|+.||+++++|||||..+|+|++..   ..|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~---r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER---RVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc---CcEEEcc
Confidence            999999999999999999875       248899999999999999999999999999999999999644   6799999


Q ss_pred             eccccccCCCCcccc--c-cCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCC
Q 009594          204 FGLSVFFRPGEQFNE--I-VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFK  278 (531)
Q Consensus       204 fg~a~~~~~~~~~~~--~-~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~  278 (531)
                      ||+|+.+...+.+..  . .-...|||||.+. +.++.|+|||||||++||++| |..||...+..++.....++- .  
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R--  922 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R--  922 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c--
Confidence            999995554333221  1 2245799999987 889999999999999999999 999999999988887666654 2  


Q ss_pred             CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       279 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .++.+.+|..+.++|.+||+.+|++||++..|++
T Consensus       923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            2233579999999999999999999999999987

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-40  Score=317.80  Aligned_cols=245  Identities=27%  Similarity=0.445  Sum_probs=198.9

Q ss_pred             eeccccCccCceEEEEEEEc----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           59 DLGRELGRGEFGVTYLCTDV----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        59 ~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .+.+.||.|+||.||+|...    ..+..|+||.+...  ........+.+|++.++++ +||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence            45678999999999999976    34678999999542  2344468899999999999 99999999999998888999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |+||+++|+|.+++...  ..+++..+..|+.||+.||.|||+++++|+||+|+||+++.++   .+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~---~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG---QVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT---EEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccc
Confidence            99999999999999886  6799999999999999999999999999999999999997544   599999999987632


Q ss_pred             CCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          213 GEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       213 ~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ...   .....+...|+|||.+. ..++.++||||||+++||+++ |..||...+.......+.+.....   ....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence            222   12344677899999987 558999999999999999999 789998888877777764443211   1235799


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.++|.+||..+|++|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=328.98  Aligned_cols=258  Identities=31%  Similarity=0.537  Sum_probs=235.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +++++..||-|+||.|-++........+|+|++++...-.....+.+..|-++|... +.|.||++|..|.+...+|++|
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhhH
Confidence            577888999999999999986665566999999998887777888999999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF  216 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~  216 (531)
                      |-|-||.|+..+..++.+.+..++-++.-++.|++|||++|||+|||||+|.+++.   .+.+||.|||+|+.+..+...
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~---~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN---RGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc---CCceEEeehhhHHHhccCCce
Confidence            99999999999999999999999999999999999999999999999999999954   456999999999999999998


Q ss_pred             ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK  295 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  295 (531)
                      .+++|||.|.|||++. ...+.++|.||||+++|||++|.+||.+.++..++..|++++-...-+  ..++....+||.+
T Consensus       577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~  654 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKK  654 (732)
T ss_pred             eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHH
Confidence            9999999999999764 678999999999999999999999999999999999998876443322  4688899999999


Q ss_pred             ccccCcCCCCC-----HHHHhcCCcccccc
Q 009594          296 MLNPDPKQRLT-----AEEVLEHPWLQNAK  320 (531)
Q Consensus       296 ~l~~~p~~Rps-----~~~~l~h~~~~~~~  320 (531)
                      +...+|.+|..     +.+|-+|.||....
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            99999999995     89999999997643

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-40  Score=318.56  Aligned_cols=253  Identities=33%  Similarity=0.551  Sum_probs=208.1

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |++.+.||.|++|+||+|....+++.||+|.+......  .......+|+..++++.+||||+++++++...+..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67889999999999999999888999999998654321  2233455799999999449999999999999999999999


Q ss_pred             ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          138 LCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |+ +++|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.   .+.++|+|||.+........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~---~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG---PEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC---CCCEEEeecccceeccCCCC
Confidence            99 779999887754  6899999999999999999999999999999999999965   44599999999987655444


Q ss_pred             cccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC--------------
Q 009594          216 FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR--------------  279 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--------------  279 (531)
                      .....++..|+|||++.  ..++.++|+||||+++|+|++|.+||......+....+.........              
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            45567889999999875  35788999999999999999999999877665554443321111100              


Q ss_pred             ------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          280 ------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       280 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                  ...+..+..+.+++.+||+.+|++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                        0112346789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.3e-40  Score=318.07  Aligned_cols=249  Identities=20%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             cceeeccccCccCceEEEEEEEc----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDV----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .+|++.+.||+|+||.||+|...    .++..+|+|.+....  .......+.+|+.+++++ +||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCc
Confidence            35899999999999999999853    356789999886432  233456788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC
Q 009594          132 VHIVMELCEGGELFDRIVAR-----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK  194 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~  194 (531)
                      .|+||||+++++|.+++...                 ..+++..+..++.|++.||.|||++||+||||||+||+++.+ 
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~-  160 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ-  160 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC-
Confidence            99999999999999988532                 237888999999999999999999999999999999999654 


Q ss_pred             CCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 009594          195 ESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA  269 (531)
Q Consensus       195 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~  269 (531)
                        ..+||+|||++........   .....++..|+|||.+. +.++.++||||||+++|+|++ |.+||.+.........
T Consensus       161 --~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         161 --LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             --CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              4599999999976543321   22334567899999876 568999999999999999998 9999988776555554


Q ss_pred             HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.....   ......+++.+.+++.+||+.+|++||++.+++++
T Consensus       239 ~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            443221   12234578999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-40  Score=318.36  Aligned_cols=254  Identities=30%  Similarity=0.490  Sum_probs=206.7

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCCeeecceEEEcCCe----
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYEDDSA----  131 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~----  131 (531)
                      |++.+.||.|+||.||+|.+..++..+|+|++........ ....+.+|+.+++++.  .||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            6788999999999999999988899999999975433221 2345667888887763  59999999999987766    


Q ss_pred             -EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          132 -VHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       132 -~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                       .+++|||+++ +|.+++....  .+++..++.++.|++.||.|||+.+++|+||+|+||+++.+   +.+||+|||.+.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~---~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD---GQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC---CCEEEeccCcce
Confidence             9999999975 8988887643  48999999999999999999999999999999999999654   559999999988


Q ss_pred             ccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC---------
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK---------  278 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------  278 (531)
                      ............+++.|+|||++. ..++.++|||||||++|+|++|.+||...+..+....+........         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            765544444456788999999876 5688899999999999999999999988777666655543221100         


Q ss_pred             --------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          279 --------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       279 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                    ....+.+++.+.++|.+||+.+|++||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                          00012346778999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-40  Score=327.50  Aligned_cols=259  Identities=28%  Similarity=0.483  Sum_probs=210.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC---
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS---  130 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  130 (531)
                      +.++|++.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++++ +||||+++++++....   
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcccc
Confidence            5678999999999999999999999999999999986432 2222345678899999999 9999999999986543   


Q ss_pred             ---eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          131 ---AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       131 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                         ..++||||+ |++|..++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++++   +.++|+|||++
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~---~~~kl~dfg~~  165 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED---CELKILDFGLA  165 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccc
Confidence               468999999 7788887754 578999999999999999999999999999999999999644   45999999998


Q ss_pred             cccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC---------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------  276 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------  276 (531)
                      ......  .....+++.|+|||.+.+  .++.++|+||||+++|++++|.+||...........+......         
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            765332  234467889999998763  4788999999999999999999999877655444433321110         


Q ss_pred             --------------CC----CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          277 --------------FK----RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       277 --------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                    ..    ...++.+++.+.++|.+||..+|++|||+.+++.||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                          00    0112457888999999999999999999999999999987544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5e-40  Score=324.27  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=201.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcE----EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEK----FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .+|++.+.||+|+||.||+|.+..++..    ||+|++....  .......+.+|+.+++.+ +||||+++++++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-C
Confidence            4699999999999999999997666554    8999886432  233456788999999999 999999999998764 5


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.+   ..+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~---~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP---QHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC---CcEEEccccccccc
Confidence            67999999999999998764 358899999999999999999999999999999999999644   45999999999876


Q ss_pred             CCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          211 RPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       211 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ......   ....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+........ +.......+.  .+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~~  236 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQ--PPIC  236 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCCC--CCCC
Confidence            543322   1223466899999876 578999999999999999998 999998776555433 3332222222  2457


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +..+.+++.+||..+|++|||+.+++.+
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-39  Score=318.47  Aligned_cols=256  Identities=29%  Similarity=0.476  Sum_probs=211.7

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ....|...+.||.|+||.||+|++..++..+|+|.+.............+.+|+.+++.+ +|||++++++++......+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeE
Confidence            445688899999999999999999989999999998754333334456778899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +|+||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++.   ++.++|+|||++.....
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC---CCcEEECCcccceeecC
Confidence            9999996 577776654 446899999999999999999999999999999999999964   34599999999876543


Q ss_pred             CCccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      .   ....+++.|+|||.+.    +.++.++|||||||++|+|++|..||...........+......  .......+..
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  242 (308)
T cd06634         168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEY  242 (308)
T ss_pred             c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCcccccHH
Confidence            2   2346788999999863    45788999999999999999999999776655444444333221  1112357889


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +.++|.+||..+|++||++.++++|||+...
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            9999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.1e-40  Score=312.13  Aligned_cols=242  Identities=26%  Similarity=0.369  Sum_probs=198.3

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.+..+++.+|+|.+....  .......+.+|+.+++.+ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            46899999999999998899999999876432  223346788999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccc---
Q 009594          142 GELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN---  217 (531)
Q Consensus       142 ~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~---  217 (531)
                      ++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++..........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK---NVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC---CcEEECccccCcccccccccccCC
Confidence            99999987644 58999999999999999999999999999999999999644   459999999987544321111   


Q ss_pred             cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHH
Q 009594          218 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK  295 (531)
Q Consensus       218 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  295 (531)
                      ....+..|+|||.+. +.++.++||||||+++|+|++ |.+||...........+.....   ......++..+.+++.+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~  231 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---LPCPELCPDAVYRLMER  231 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---CCCcccCCHHHHHHHHH
Confidence            112245699999876 568899999999999999998 8999977766555444443221   12223568999999999


Q ss_pred             ccccCcCCCCCHHHHhc
Q 009594          296 MLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       296 ~l~~~p~~Rps~~~~l~  312 (531)
                      ||..+|++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-39  Score=318.69  Aligned_cols=251  Identities=23%  Similarity=0.291  Sum_probs=205.3

Q ss_pred             cceeeccccCccCceEEEEEEEccCC----------------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNG----------------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI  119 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni  119 (531)
                      .+|++.+.||+|+||.||+|.+...+                ..||+|.+....  .....+.+.+|+++++++ +||||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i   81 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRL-SDPNI   81 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhc-CCCCE
Confidence            46999999999999999999876533                568999886543  223456788999999999 99999


Q ss_pred             eecceEEEcCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCce
Q 009594          120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF  188 (531)
Q Consensus       120 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NI  188 (531)
                      +++++++...+..++|+||+++++|.+++.+..           .+++..++.++.|++.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999997765           689999999999999999999999999999999999


Q ss_pred             EeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh--CCCCCCCCC
Q 009594          189 LFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAET  262 (531)
Q Consensus       189 ll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t--g~~pf~~~~  262 (531)
                      +++++   +.++|+|||++........   .....+++.|+|||.+. +.++.++|||||||++|+|++  |..||....
T Consensus       162 li~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         162 LVGKN---YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eecCC---CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99654   5599999999876543321   12345677899999876 578999999999999999998  778987776


Q ss_pred             HHHHHHHHHhccc----CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          263 EQGVAQAIIRSVI----DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       263 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .............    .......+.+|.++.+++.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            6665555543211    1111112356789999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-42  Score=302.44  Aligned_cols=258  Identities=29%  Similarity=0.543  Sum_probs=216.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE--------
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--------  127 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--------  127 (531)
                      ..|.-..+||+|.||+||+|+++.+|+.||+|++-..+-.....+ ...+|+.+|..| +|+|++.+++.+.        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpi-talreikiL~~l-kHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPI-TALREIKILQLL-KHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcH-HHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence            358888999999999999999999999999998765443333333 345699999999 9999999998764        


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      +...+|+|+.+|+ .+|..++.+. -.++...+..++.+++.||.|+|+..|+|||+||+|+||+.   ++.+||+|||+
T Consensus        95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~---dgilklADFGl  170 (376)
T KOG0669|consen   95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK---DGILKLADFGL  170 (376)
T ss_pred             ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC---CceEEeecccc
Confidence            2345999999996 4888888765 56999999999999999999999999999999999999954   45699999999


Q ss_pred             ccccCCCC-----ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 009594          207 SVFFRPGE-----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR  279 (531)
Q Consensus       207 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  279 (531)
                      ++.....+     .+...+-|.+|++||.+.|  .|+++.|||+-||++.+|+|+.+.+++.+++.++..+.....+...
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            97654332     2344566999999998874  6999999999999999999999999999999988888776666666


Q ss_pred             CCCCCC-------------------------------CHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          280 DPWPKV-------------------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       280 ~~~~~~-------------------------------~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +.||++                               .++..+|+.++|..||.+|++++++++|.||+.-
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            666643                               1367899999999999999999999999999853

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-39  Score=311.37  Aligned_cols=251  Identities=30%  Similarity=0.521  Sum_probs=213.6

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|+||.||++.+..++..+|+|.+...... ......+.+|+.+++.+ +||||+++++++......++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEe
Confidence            488999999999999999999889999999998765432 23456778899999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          137 ELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       137 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||+++++|.+++.+    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.   ...+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~---~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA---NDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec---CCcEEEeeccchhhhcc
Confidence            99999999998866    346899999999999999999999999999999999999975   34599999999987654


Q ss_pred             CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      . ......+++.|+|||.+. ..++.++|+||||+++|+|++|..||...+.......+.......   .....+.++.+
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP---IPPIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---CchhhCHHHHH
Confidence            4 333456889999999876 458889999999999999999999998877665555544332221   11357889999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCcc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ++.+||..+|++|||+.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-39  Score=318.75  Aligned_cols=260  Identities=26%  Similarity=0.357  Sum_probs=207.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.....  ......+..|+.++..+.+||||+++++++......++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            3569999999999999999999988899999999975432  22345566788877777579999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||+. ++|.+++.. ...+++..+..++.|++.||.|||+ .||+||||+|+||++++   ++.+||+|||++.....
T Consensus        92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~---~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA---SGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC---CCCEEECccccchhccC
Confidence            999985 477766654 4568999999999999999999997 59999999999999964   44699999999876544


Q ss_pred             CCccccccCCcccccchhccc-----cCCCccchhHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhcccCCCCCCCCCCC
Q 009594          213 GEQFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ........+++.|+|||.+.+     .++.++||||||+++|+|++|+.||..... .+....+....... .+....++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  246 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-LPPNEGFS  246 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-CCCCCCCC
Confidence            333334457889999998863     378899999999999999999999966332 22333333322111 11112478


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .++.+|+.+||..+|++|||+.+++.||||.....
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            89999999999999999999999999999986443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8e-40  Score=322.25  Aligned_cols=256  Identities=29%  Similarity=0.473  Sum_probs=204.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC-----
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-----  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-----  129 (531)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++........ ....+.+|+.+++++ +||||+++++++...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence            5689999999999999999999999999999999875443222 123567899999999 999999999987543     


Q ss_pred             ---CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          130 ---SAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       130 ---~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                         ..+++|+||+.+ +|...+.. ...+++..+..++.|++.||.|||++||+||||||+||+++++   +.++|+|||
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg  160 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ---GILKIADFG  160 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECcCc
Confidence               347999999965 67766654 3469999999999999999999999999999999999999654   459999999


Q ss_pred             cccccCCCCc------------cccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 009594          206 LSVFFRPGEQ------------FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII  271 (531)
Q Consensus       206 ~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~  271 (531)
                      ++........            .....+++.|+|||.+.+  .++.++|||||||++|+|++|.+||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9875543211            122356888999998753  47889999999999999999999998877766555544


Q ss_pred             hcccCCCCC--------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          272 RSVIDFKRD--------------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       272 ~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .........                          .+...++.+.++|.+||..+|++|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            321111000                          112345778999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.6e-40  Score=326.46  Aligned_cols=264  Identities=33%  Similarity=0.519  Sum_probs=212.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--C
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--D  129 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~  129 (531)
                      ..+.++|++.+.||+|+||.||+|.+..+|..+|+|++.... ........+.+|+.+++++.+||||+++++++..  .
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            346678999999999999999999998899999999886432 2222345677899999999889999999998864  3


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      ...++||||++ ++|..++... .+++..+..++.||+.||.|||++||+||||+|+||+++.   ++.+||+|||++..
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~---~~~~kl~d~g~~~~  156 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARS  156 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCcEEEeeccchhc
Confidence            46899999997 5998888665 7889999999999999999999999999999999999964   44699999999876


Q ss_pred             cCCCC------ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC-----
Q 009594          210 FRPGE------QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-----  276 (531)
Q Consensus       210 ~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-----  276 (531)
                      .....      ......|++.|+|||.+.  ..++.++||||||+++|+|+||++||.+.........+......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            54332      223356889999999875  35788999999999999999999999776554443332221100     


Q ss_pred             ----------------------CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          277 ----------------------FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       277 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                            ......+.++..+.++|.+||+.+|++|||+.++++|||++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                                  001122446889999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=312.13  Aligned_cols=243  Identities=25%  Similarity=0.388  Sum_probs=206.6

Q ss_pred             cccCccCceEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEec
Q 009594           62 RELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL  138 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  138 (531)
                      +.||+|+||.||+|.+...   +..+|+|.+.......  ....+.+|+.+++.+ +||||+++++++.....+++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEe
Confidence            4689999999999998765   8999999987654322  467888999999999 799999999999999999999999


Q ss_pred             cCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          139 CEGGELFDRIVAR---------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       139 ~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +++++|.+++...         ..+++..+..++.|++.||.|||++||+||||+|+||+++.+   +.++|+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~---~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED---LVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC---CcEEEcccccccc
Confidence            9999999999875         679999999999999999999999999999999999999654   4599999999987


Q ss_pred             cCCCC---ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          210 FRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       210 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      .....   ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.....   ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPKPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence            65432   123345788999999887 578999999999999999999 6999988877666666654221   112235


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +++.+.+++.+||..+|++|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            68999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-39  Score=312.60  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=204.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.++||+|+||.||+|.. .++..||+|.+....    ...+.+.+|+.+++.+ +||||+++++++...+..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT----MSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc----hhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEE
Confidence            5799999999999999999985 456789999876432    2346788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          136 MELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||+++++|.+++...  ..+++..+..++.|++.||.|||+.+++||||||+||+++.   ++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE---SLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC---CCcEEECCCccceecCCC
Confidence            9999999999998653  45889999999999999999999999999999999999964   445999999999865432


Q ss_pred             Cc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          214 EQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       214 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ..  .....++..|+|||.+. +.++.++|||||||++|+|+| |..||...........+....   ..+....++..+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  233 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---RMPRMENCPDEL  233 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHH
Confidence            21  12234567899999876 568889999999999999998 999998877766665554432   122334678999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+++.+||..+|++|||+.++++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.7e-41  Score=290.97  Aligned_cols=255  Identities=30%  Similarity=0.600  Sum_probs=214.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--CCeE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAV  132 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~  132 (531)
                      .++|++.+++|+|.|++||.|....+++.++||++++      ...+.+.+|+.+|+.|++||||++++++..+  ....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            3579999999999999999999999999999999854      3357889999999999889999999999865  4568


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      .+|+||.+..+...+.   ..++...++.++.+++.||.|+|+.||+|||+||.|++|+...  ..++|+|||+|.++.+
T Consensus       111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~--rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh--ceeeeeecchHhhcCC
Confidence            8999999887766544   4578899999999999999999999999999999999998543  3489999999999999


Q ss_pred             CCccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCC-CCCCHHHHHHHHHhcc-------------c-
Q 009594          213 GEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRSV-------------I-  275 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf-~~~~~~~~~~~~~~~~-------------~-  275 (531)
                      +...+..+.+..|.-||.+-  +.|+.+-|+|||||++..|+..+.|| .+.+..+++.++.+-.             + 
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            99988889999999999875  67999999999999999999988776 4555555554443211             0 


Q ss_pred             ----------CCCCCCCCC---------CCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          276 ----------DFKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       276 ----------~~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                ...+.+|..         .++++.+|+.++|.+|..+|||+.|++.||||....
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence                      112223321         468999999999999999999999999999997544

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-40  Score=317.77  Aligned_cols=253  Identities=32%  Similarity=0.553  Sum_probs=208.8

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++++ +||||+++++++......++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEe
Confidence            56778999999999999999889999999998765432 22346778899999999 89999999999999999999999


Q ss_pred             ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-c
Q 009594          138 LCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q  215 (531)
Q Consensus       138 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-~  215 (531)
                      |+++ +|.+++.. ...+++..+..++.|++.||.|||+.+|+|+||+|+||+++.+   +.++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE---GVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC---CcEEEeeeeeeEecCCCccc
Confidence            9975 88887766 3578999999999999999999999999999999999999643   459999999987765443 2


Q ss_pred             cccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC--------------
Q 009594          216 FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR--------------  279 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--------------  279 (531)
                      .....++..|+|||.+.+  .++.++|+||||+++|+|+||+.||...+..+....+.........              
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            334567889999998763  5788999999999999999999999877665544443322111100              


Q ss_pred             ------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          280 ------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       280 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                                  ..++.++..+.++|.+||.++|.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                        1123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-39  Score=317.06  Aligned_cols=256  Identities=32%  Similarity=0.549  Sum_probs=212.4

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|.....||+|+||.||++....++..||+|++...   .......+.+|+.+++.+ +||||+++++++...+..++||
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEE
Confidence            355557899999999999999899999999987533   223456788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-c
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-~  215 (531)
                      ||+++++|.+++. .+.+++..+..++.|++.||.|||+.|++||||+|+||+++.+   +.++|+|||++....... .
T Consensus        97 e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~---~~~~l~dfg~~~~~~~~~~~  172 (292)
T cd06657          97 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPR  172 (292)
T ss_pred             ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEcccccceeccccccc
Confidence            9999999998764 4468999999999999999999999999999999999999654   459999999887554322 2


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+.........+..... ........+++.+.+++.
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~  251 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLD  251 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHH
Confidence            33456889999999876 5678899999999999999999999987666554444433222 112223457899999999


Q ss_pred             HccccCcCCCCCHHHHhcCCccccccc
Q 009594          295 KMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       295 ~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +||..+|.+||++.+++.||||.....
T Consensus       252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         252 RLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHhCCcccCcCHHHHhcChHHhccCC
Confidence            999999999999999999999987664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-39  Score=311.61  Aligned_cols=246  Identities=22%  Similarity=0.324  Sum_probs=203.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||.|... .+..+|+|.+.....    ....+.+|+.+++++ +||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEE
Confidence            36999999999999999999854 455699998864332    235688999999999 899999999999988899999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.   ++.+||+|||.+.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~---~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD---QGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC---CCCEEECCCccceecCCCc
Confidence            9999999999998764 36899999999999999999999999999999999999964   3459999999987654332


Q ss_pred             cc--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          215 QF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       215 ~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ..  ....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+........   ....+..+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence            21  1223556799999887 568899999999999999998 9999987777666665554432211   124688999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcC
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +++.+||..+|++|||+.+++.+
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=314.73  Aligned_cols=250  Identities=23%  Similarity=0.307  Sum_probs=205.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..++|++.+.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.+++.+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~   80 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVST   80 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC
Confidence            345799999999999999999987643     4789999985432  223345788899999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCC
Q 009594          129 DSAVHIVMELCEGGELFDRIVARG----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                      ....++||||+++++|.+++....          .+++..+..++.|++.||.|||+.+|+||||||+||+++.+   +.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~---~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED---LT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC---CC
Confidence            999999999999999999986532          36788999999999999999999999999999999999654   45


Q ss_pred             eEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 009594          199 LKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS  273 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  273 (531)
                      +||+|||++........   .....++..|+|||.+. +.++.++|||||||++|+++| |..||...+.......+...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG  237 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence            99999999876543321   12334678899999876 578999999999999999998 99999887776665555432


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ..   ......++..+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 GH---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CC---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            21   1112346899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=312.17  Aligned_cols=249  Identities=24%  Similarity=0.357  Sum_probs=205.7

Q ss_pred             cceeeccccCccCceEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ++|++.+.||+|+||.||+|.....   ...||+|.+....  .......+.+|+.+++.+ +||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCce
Confidence            4699999999999999999987543   4589999886443  233356788899999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+++++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+||+++.   +..++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~---~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC---CCCEEECccchhhccc
Confidence            9999999999999998764 46899999999999999999999999999999999999964   4459999999998764


Q ss_pred             CCC-ccc--cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          212 PGE-QFN--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       212 ~~~-~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ... ...  ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.....   .+....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR---LPPPMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence            211 111  223467899999887 568999999999999999998 9999988776665555543321   11224578


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.6e-40  Score=317.23  Aligned_cols=248  Identities=21%  Similarity=0.338  Sum_probs=204.5

Q ss_pred             ceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      +|++.+.||.|+||.||+|.+..     .+..||+|++....  .......+.+|+.++..+ +||||+++++++.....
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCc
Confidence            58899999999999999998754     35789999986432  222345688899999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC
Q 009594          132 VHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE  195 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~  195 (531)
                      .++++||+++++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||+++.+  
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~--  160 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK--  160 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC--
Confidence            99999999999999988532                247888899999999999999999999999999999999643  


Q ss_pred             CCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 009594          196 SSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI  270 (531)
Q Consensus       196 ~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~  270 (531)
                       ..+||+|||++........   .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+
T Consensus       161 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         161 -LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             -CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             4599999999876543322   12344578899999875 678999999999999999998 88999887777666666


Q ss_pred             HhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .......   ....++..+.+++.+||+.+|.+||++.+++..
T Consensus       240 ~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            5543221   124688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.6e-39  Score=322.91  Aligned_cols=259  Identities=30%  Similarity=0.474  Sum_probs=207.2

Q ss_pred             ceeeccccCccCceEEEEEEEccC--CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE----cCC
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNN--GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE----DDS  130 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~----~~~  130 (531)
                      +|++.+.||+|+||.||+|.+..+  +..||+|++.... ........+.+|+.+++++.+||||++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            488999999999999999999877  8999999986432 222234567789999999977999999998743    235


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .+++++||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~---~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC---CCEEeCcCCCceec
Confidence            6889999985 6899998887889999999999999999999999999999999999999654   45999999999765


Q ss_pred             CCCCc-----cccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc--------
Q 009594          211 RPGEQ-----FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI--------  275 (531)
Q Consensus       211 ~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~--------  275 (531)
                      .....     .....||+.|+|||.+.+  .++.++|||||||++|+|++|.+||...........+.....        
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            43221     233568999999998753  578999999999999999999999987654443333222110        


Q ss_pred             ---------------CCC----CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          276 ---------------DFK----RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       276 ---------------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                     ...    ...++..+..+.+++.+||+.+|++|||+.+++.||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence                           000    112345678999999999999999999999999999997544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=316.20  Aligned_cols=253  Identities=32%  Similarity=0.543  Sum_probs=209.3

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |++.+.||+|++|.||+|++..+++.+|+|++..... .......+.+|+.+++++ +||||+++++++......++|+|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEec
Confidence            6677899999999999999998999999999976542 222345677899999999 89999999999999999999999


Q ss_pred             ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-c
Q 009594          138 LCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q  215 (531)
Q Consensus       138 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-~  215 (531)
                      |++ ++|.+++.+. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.   ++.++|+|||.+....... .
T Consensus        79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~---~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR---DGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC---CCCEEEecCCcccccCCCccc
Confidence            997 5999999876 57999999999999999999999999999999999999965   4559999999987654332 2


Q ss_pred             cccccCCcccccchhcc-c-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC----------------
Q 009594          216 FNEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF----------------  277 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------------  277 (531)
                      .....++..|+|||.+. . .++.++||||||+++|++++|.+||......+....+.+.....                
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            33445678899999875 3 68889999999999999999999998876655544443311100                


Q ss_pred             ---------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          278 ---------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       278 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                               ....++..+..+.++|.+||..+|++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                     001223457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-39  Score=325.20  Aligned_cols=259  Identities=29%  Similarity=0.503  Sum_probs=207.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      +..+|.+...||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++...    
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhc-CCCCccchhheecccccCC
Confidence            446899999999999999999999889999999998754322 22235678899999999 999999999998644    


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       130 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                        ..+++|+||+.. +|..++  ...+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++
T Consensus        91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~---~~~kL~dfg~~  164 (342)
T cd07879          91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED---CELKILDFGLA  164 (342)
T ss_pred             CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCCCC
Confidence              356999999964 676654  3468999999999999999999999999999999999999654   45999999998


Q ss_pred             cccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcc-----------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-----------  274 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-----------  274 (531)
                      .....  ......+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.........+....           
T Consensus       165 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         165 RHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             cCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            76432  2234567889999998763  57889999999999999999999998876544443333210           


Q ss_pred             ------------cCCCCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          275 ------------IDFKRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       275 ------------~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                                  ...+..    .++..++.+.+||.+||+.+|++|||+.+++.||||+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                        000111    124567889999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-39  Score=317.24  Aligned_cols=261  Identities=33%  Similarity=0.588  Sum_probs=208.5

Q ss_pred             ceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      +|++.+.||+|++|.||+|.+.   .++..||+|++...... .......+.+|+.++.++.+||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   46789999998754322 1223456778999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++||||+++++|.+++.....+++..++.++.|++.||.|||+.+++||||+|+||+++.   ++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS---EGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC---CCCEEEEECcccccccc
Confidence            999999999999999987778999999999999999999999999999999999999964   34599999999876543


Q ss_pred             CCc--cccccCCcccccchhcccc---CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          213 GEQ--FNEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       213 ~~~--~~~~~gt~~y~aPE~~~~~---~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ...  .....|++.|+|||.+.+.   .+.++||||||+++|+|++|..||...........+.+............++.
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA  237 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence            322  1234688999999987632   68899999999999999999999964332211122222111111222235788


Q ss_pred             HHHHHHHHccccCcCCCCC---HHHHhcCCcccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNAK  320 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps---~~~~l~h~~~~~~~  320 (531)
                      .+.+++.+||+.+|++|||   +.++|+||||+...
T Consensus       238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             HHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            9999999999999999998   56779999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-39  Score=309.89  Aligned_cols=241  Identities=24%  Similarity=0.326  Sum_probs=198.2

Q ss_pred             ccCccCceEEEEEEE--ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccC
Q 009594           63 ELGRGEFGVTYLCTD--VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE  140 (531)
Q Consensus        63 ~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  140 (531)
                      .||+|+||.||+|..  ..++..+|+|++..... .....+.+.+|+.+++.+ +||||+++++++.. ...++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCC
Confidence            689999999999964  45688999999864432 333456788999999999 99999999998754 56789999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc----
Q 009594          141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----  216 (531)
Q Consensus       141 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~----  216 (531)
                      +++|.+++.....+++..+..++.|++.||.|||++||+||||||.||+++.   +..+||+|||++.........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT---QHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC---CCeEEECCCccccccCCCCCeeeec
Confidence            9999999988778999999999999999999999999999999999999964   345999999998765433221    


Q ss_pred             ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      ....+++.|+|||.+. +.++.++|||||||++|+|++ |..||...........+.+...   ......+++.+.++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l~~li~  232 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---MECPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHHH
Confidence            1223457899999876 568889999999999999998 9999988777666665544321   1122458999999999


Q ss_pred             HccccCcCCCCCHHHHhc
Q 009594          295 KMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       295 ~~l~~~p~~Rps~~~~l~  312 (531)
                      +||+.+|++|||+.+|..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.5e-39  Score=317.49  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=207.0

Q ss_pred             ccccceeeccccCccCceEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      .-..+|++.+.||+|+||.||++.....     ...+|+|.+....  .......+.+|+.+++++.+||||+++++++.
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3445799999999999999999987543     3789999886542  23345678899999999978999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEee
Q 009594          128 DDSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFA  191 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~  191 (531)
                      ..+.++++|||+++++|..++...                ..+++..+..++.|++.||.|||+++|+||||||+||+++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            999999999999999999998642                3588999999999999999999999999999999999996


Q ss_pred             cCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHH
Q 009594          192 NKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV  266 (531)
Q Consensus       192 ~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~  266 (531)
                      .   ++.+||+|||++........   .....++..|+|||.+. ..++.++|||||||++|++++ |..||........
T Consensus       167 ~---~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         167 E---DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             C---CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            4   44699999999986654322   11223456799999876 568999999999999999997 9999988776665


Q ss_pred             HHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ...+......   .....++..+.+|+.+||..+|++|||+.+++++
T Consensus       244 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 FKLLKEGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5555443211   1223578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-39  Score=328.04  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=203.6

Q ss_pred             CccccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY  126 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  126 (531)
                      ..-..+|.+.+.||+|+||.||+|++.     ..+..||+|++.....  ....+.+.+|+.++.++..||||+++++++
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            334457999999999999999999853     3456899999975432  223456889999999995599999999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhcC------------------------------------------------------
Q 009594          127 EDDSAVHIVMELCEGGELFDRIVARG------------------------------------------------------  152 (531)
Q Consensus       127 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------  152 (531)
                      ...+..++|+||+++|+|.+++.+.+                                                      
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            99999999999999999999986532                                                      


Q ss_pred             --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCce
Q 009594          153 --------------------------------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF  188 (531)
Q Consensus       153 --------------------------------------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NI  188 (531)
                                                                  .+++..++.++.||+.||.|||+.+|+||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni  270 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV  270 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence                                                        256677889999999999999999999999999999


Q ss_pred             EeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCH
Q 009594          189 LFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETE  263 (531)
Q Consensus       189 ll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~  263 (531)
                      |++.   ...+||+|||++........   .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.....
T Consensus       271 Ll~~---~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         271 LICE---GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             EEeC---CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            9964   34599999999976532221   12345678899999876 568899999999999999998 8999977655


Q ss_pred             HHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+............  .....++..+.+++.+||..+|++||++.++++.
T Consensus       348 ~~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         348 NEQFYNAIKRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             hHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44443333322211  1223578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.6e-39  Score=313.46  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=201.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ..+|++.+.||.|+||+||+|....++.    .||+|++....  .......+.+|+.+++.+ .||||+++++++.. .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-S   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-C
Confidence            3469999999999999999999776665    48999886432  233456788899999999 99999999998865 4


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          131 AVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      ..++++||+++|+|.+++... +.+++..+..++.|++.||.|||+++|+||||||+||+++++   ..+||+|||++..
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~---~~~kL~dfG~~~~  158 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP---NHVKITDFGLARL  158 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC---CcEEECCCCceee
Confidence            577999999999999998764 468999999999999999999999999999999999999643   4599999999987


Q ss_pred             cCCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          210 FRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       210 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      .......   ....+++.|+|||.+. +.++.++|||||||++|+|++ |..||...........+... ...  +..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~--~~~~~  235 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERL--PQPPI  235 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcC--CCCcc
Confidence            6533221   1223467899999876 568999999999999999998 99999776655544433332 111  22346


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ++..+.+++.+||..+|++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.5e-39  Score=318.07  Aligned_cols=253  Identities=24%  Similarity=0.358  Sum_probs=204.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT  125 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~  125 (531)
                      ...++|.+.+.||+|+||.||+|.+..       ++..+|+|.+....  .......+.+|+.+++.+.+||||++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            344679999999999999999998643       23579999987542  233456788899999999789999999999


Q ss_pred             EEcCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceE
Q 009594          126 YEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL  189 (531)
Q Consensus       126 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIl  189 (531)
                      +...+..++||||+++++|.+++....                .+++..++.++.|++.||+|||++|++||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997542                3788999999999999999999999999999999999


Q ss_pred             eecCCCCCCeEEEeeccccccCCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHH
Q 009594          190 FANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ  264 (531)
Q Consensus       190 l~~~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~  264 (531)
                      ++.+   +.+||+|||.+.........   ....+++.|+|||++. +.++.++|||||||++|+|++ |..||......
T Consensus       173 l~~~---~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         173 VTED---NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             EcCC---CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            9643   45999999998765432211   1123456899999876 568999999999999999998 88999877665


Q ss_pred             HHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +....+.....   ......++..+.+++.+||..+|++|||+.+++++
T Consensus       250 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            55544433221   12224578999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-39  Score=341.37  Aligned_cols=257  Identities=28%  Similarity=0.484  Sum_probs=201.6

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC---
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  129 (531)
                      ....+|+.++.||+||||.||+|+.+-+|+.||||+|....  .......+.+|+..|.+| +|||||+++..|...   
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCc
Confidence            35567999999999999999999999999999999998664  334456788999999999 999999865443100   


Q ss_pred             --------------------------------------------------------------------------------
Q 009594          130 --------------------------------------------------------------------------------  129 (531)
Q Consensus       130 --------------------------------------------------------------------------------  129 (531)
                                                                                                      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------------------CeEEEEEeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHH
Q 009594          130 ------------------------------------SAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQV  172 (531)
Q Consensus       130 ------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~qi~~~l~~  172 (531)
                                                          -.+||-||||+.-+|.+++.++... ....++.++++|+.||.|
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence                                                1368899999987777777665443 467889999999999999


Q ss_pred             HHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC----C--------------C-CccccccCCcccccchhcc-
Q 009594          173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR----P--------------G-EQFNEIVGSPYYMAPEVLK-  232 (531)
Q Consensus       173 LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~----~--------------~-~~~~~~~gt~~y~aPE~~~-  232 (531)
                      +|+.|||||||||.||++++++   .|||+|||+|+...    .              + ....+.+||.-|+|||++. 
T Consensus       713 IH~~giIHRDLKP~NIFLd~~~---~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQGIIHRDLKPRNIFLDSRN---SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCceeeccCCcceeEEcCCC---CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            9999999999999999997554   49999999998621    0              0 1234568999999999986 


Q ss_pred             -c--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHH
Q 009594          233 -R--NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAE  308 (531)
Q Consensus       233 -~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  308 (531)
                       .  .|+.|+|+||||++++||+   .||...-+.. ++.++.+..++.+...+..--+.-..+|..||+.||++||||.
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence             2  5999999999999999998   4675544433 3334444444433222333345567899999999999999999


Q ss_pred             HHhcCCcccc
Q 009594          309 EVLEHPWLQN  318 (531)
Q Consensus       309 ~~l~h~~~~~  318 (531)
                      |+|++.||-.
T Consensus       867 eLL~s~llpp  876 (1351)
T KOG1035|consen  867 ELLNSELLPP  876 (1351)
T ss_pred             HHhhccCCCc
Confidence            9999999964

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-42  Score=358.89  Aligned_cols=262  Identities=27%  Similarity=0.481  Sum_probs=222.0

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      +.+.-+|+-...||.|.||.||.|.+..+|+..|+|.+...... ......+.+|..++..+ +|||+|+++|+-.+.+.
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHH
Confidence            34556788899999999999999999999999999999766544 44567788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++|.||||.||+|.+.+...+..++.....+..|++.|+.|||+.|||||||||+||+++.+   +.+|++|||.|..+.
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~---g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN---GLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC---CcEEeecccceeEec
Confidence            99999999999999999888778888899999999999999999999999999999999654   469999999998776


Q ss_pred             CCC-----ccccccCCcccccchhcccc----CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          212 PGE-----QFNEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       212 ~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      .+.     ..+...||+.|||||++.+.    ..-+.|||||||++.||.||+.||...+..-.+...+.....+..+  
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P-- 1463 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP-- 1463 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc--
Confidence            543     23567899999999999742    4568999999999999999999997766554433333322222222  


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .+++++..+||..||..||++|.++.|+++|.|-+...
T Consensus      1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence            24899999999999999999999999999999887543

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-39  Score=311.09  Aligned_cols=243  Identities=22%  Similarity=0.312  Sum_probs=196.0

Q ss_pred             cccCccCceEEEEEEEccCCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           62 RELGRGEFGVTYLCTDVNNGE--KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      +.||+|+||.||+|.+..++.  .+|+|.+....  .......+.+|+.++.++.+||||+++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            368999999999999877775  46778775322  23345678899999999988999999999999999999999999


Q ss_pred             CCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEe
Q 009594          140 EGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       140 ~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                      ++++|.+++....                .+++..+..++.|++.||+|||++|++||||||+||+++.   ++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~---~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE---NYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC---CCeEEECC
Confidence            9999999987542                3788999999999999999999999999999999999964   44599999


Q ss_pred             eccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 009594          204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  281 (531)
                      ||++..............++.|+|||++. ..++.++|||||||++|+|++ |..||...+..+....+....   ....
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---CCCC
Confidence            99986332111111123356799999876 568899999999999999997 999998877666555543321   1112


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ...++..+.+++.+||..+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-39  Score=323.24  Aligned_cols=252  Identities=22%  Similarity=0.346  Sum_probs=198.6

Q ss_pred             ccceeeccccCccCceEEEEEEE-----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTD-----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-  128 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  128 (531)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .......+.+|+.++.++.+||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            35799999999999999999984     3467899999986543  223356788999999999789999999998764 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC--------------------------------------------------------
Q 009594          129 DSAVHIVMELCEGGELFDRIVARG--------------------------------------------------------  152 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------------  152 (531)
                      ....++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            456899999999999999886421                                                        


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---ccc
Q 009594          153 -----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNE  218 (531)
Q Consensus       153 -----------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~  218 (531)
                                 .+++..+..++.|++.||.|||++||+||||||+||+++.   +..+||+|||++........   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE---NNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC---CCcEEEEecccccccccCcchhhcCC
Confidence                       2577888999999999999999999999999999999964   44599999999876533221   112


Q ss_pred             ccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHc
Q 009594          219 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM  296 (531)
Q Consensus       219 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  296 (531)
                      ..+++.|+|||.+. ..++.++||||||+++|+|++ |..||.....................+  ...++.+.+++..|
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~c  318 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDC  318 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHH
Confidence            34567799999876 568999999999999999997 999997654333222222222111111  23678899999999


Q ss_pred             cccCcCCCCCHHHHhcC
Q 009594          297 LNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       297 l~~~p~~Rps~~~~l~h  313 (531)
                      |+.+|++|||+.++++|
T Consensus       319 l~~~p~~Rps~~eil~~  335 (343)
T cd05103         319 WHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.6e-39  Score=346.93  Aligned_cols=149  Identities=30%  Similarity=0.487  Sum_probs=135.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++.....+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEE
Confidence            4699999999999999999999999999999999866554555567788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      |||+.|++|.+++...+.+++..++.|+.||+.||.|||+++|+||||||+|||++.   ++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~---~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN---EGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC---CCCEEEEeCCCCc
Confidence            999999999999988778999999999999999999999999999999999999964   3469999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-39  Score=316.05  Aligned_cols=251  Identities=24%  Similarity=0.316  Sum_probs=201.1

Q ss_pred             cceeeccccCccCceEEEEEEEccC--------------CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeee
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNN--------------GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS  121 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~  121 (531)
                      .+|++.+.||+|+||.||+|.+..+              ...||+|.+....  .......+.+|+++++++ +||||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRL-KNPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCcCe
Confidence            5799999999999999999986543              2358999886532  233356788999999999 9999999


Q ss_pred             cceEEEcCCeEEEEEeccCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceE
Q 009594          122 LKDTYEDDSAVHIVMELCEGGELFDRIVARG------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL  189 (531)
Q Consensus       122 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIl  189 (531)
                      +++++...+..++||||+++++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999886532            3678899999999999999999999999999999999


Q ss_pred             eecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh--CCCCCCCCCH
Q 009594          190 FANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAETE  263 (531)
Q Consensus       190 l~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t--g~~pf~~~~~  263 (531)
                      ++.+   ..+||+|||++........   .....+++.|+|||++. +.++.++|||||||++|+|++  |..||...+.
T Consensus       162 l~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 VGNH---YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EcCC---CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9643   4599999999876543321   12234567899999876 678999999999999999988  6788887766


Q ss_pred             HHHHHHHHhccc----CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          264 QGVAQAIIRSVI----DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       264 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ............    .......+..|+.+.+|+.+||..+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            555544432111    1111122457899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-39  Score=311.69  Aligned_cols=248  Identities=23%  Similarity=0.325  Sum_probs=201.1

Q ss_pred             eeeccccCccCceEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC----
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS----  130 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  130 (531)
                      |++.+.||+|+||.||+|....+   +..||+|.+..... .......+.+|+.+++.+ +||||+++++++....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence            56788999999999999987543   47899999875432 233456788999999999 9999999999876544    


Q ss_pred             --eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEE
Q 009594          131 --AVHIVMELCEGGELFDRIVAR------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       131 --~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                        ..++|+||+++++|..++...      ..+++..++.++.|++.||.|||+.+|+||||||+||+++++   ..+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED---MTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC---CeEEEC
Confidence              389999999999999887542      358999999999999999999999999999999999999643   459999


Q ss_pred             eeccccccCCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCC
Q 009594          203 DFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDF  277 (531)
Q Consensus       203 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  277 (531)
                      |||++.........   ....++..|+|||.+. ..++.++|||||||++|+|++ |.+||.+.........+...... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL-  234 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            99998865433221   1223467899999876 568899999999999999999 99999887776666555443211 


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       278 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                        .....+++.+.+++.+||..+|++|||+.+++++
T Consensus       235 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 --KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             --CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              1224578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.2e-39  Score=314.81  Aligned_cols=247  Identities=26%  Similarity=0.377  Sum_probs=203.4

Q ss_pred             cceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      .+|.+.+.||+|+||.||+|.+..     ++..+++|.+....   ......+.+|+.+++++ +||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNL-QHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCC
Confidence            358999999999999999998532     45668888875432   23346788999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC
Q 009594          131 AVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK  194 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~  194 (531)
                      ..++||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+||+++.+ 
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~-  159 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-  159 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-
Confidence            9999999999999999986542                37899999999999999999999999999999999999644 


Q ss_pred             CCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 009594          195 ESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA  269 (531)
Q Consensus       195 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~  269 (531)
                        +.++|+|||++........   .....+++.|+|||.+. ..++.++||||||+++|+|+| |..||...........
T Consensus       160 --~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         160 --LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             --CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence              4599999999876543321   12345678899999876 568889999999999999999 9999988777666555


Q ss_pred             HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +.......   ....+|..+.+++.+||+++|++|||+.++++
T Consensus       238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            54433221   12356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-39  Score=309.10  Aligned_cols=246  Identities=24%  Similarity=0.319  Sum_probs=203.8

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++.+.||+|++|.||+|.+. .+..||+|.+.....    ....+.+|+.+++++ +||||+++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeee
Confidence            456999999999999999999864 567899999865432    245688899999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.+   +.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN---NICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC---CCEEECCcceEEEccC
Confidence            999999999999987654  68999999999999999999999999999999999999654   4599999999987653


Q ss_pred             CCcc--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          213 GEQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       213 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ....  .....+..|+|||.+. ..++.++||||||+++|+|+| |+.||.+.........+.....   .+....++..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR---MPCPPGCPKE  232 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHH
Confidence            2211  1122345799999876 568899999999999999999 9999988776666555543321   1122457899


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +.+++.+||+.+|++||++.++++
T Consensus       233 ~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.3e-39  Score=316.69  Aligned_cols=251  Identities=23%  Similarity=0.333  Sum_probs=203.9

Q ss_pred             cccceeeccccCccCceEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY  126 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  126 (531)
                      ...+|.+.+.||+|+||.||+|.+..       ....+|+|.+....  .......+.+|+.+++++.+||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34579999999999999999998632       34578999886432  2334567889999999996799999999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEe
Q 009594          127 EDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLF  190 (531)
Q Consensus       127 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll  190 (531)
                      ...+.+++||||+++++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9989999999999999999998653                247889999999999999999999999999999999999


Q ss_pred             ecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHH
Q 009594          191 ANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG  265 (531)
Q Consensus       191 ~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~  265 (531)
                      +.+   +.+||+|||++........   .....+++.|+|||++. +.++.++||||||+++|+|++ |..||......+
T Consensus       168 ~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 TED---NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             cCC---CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            644   4599999999976543221   11223446799999876 568999999999999999999 899998877666


Q ss_pred             HHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ....+.....   ......++..+.+++.+||..+|++|||+.++++
T Consensus       245 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 LFKLLREGHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            5555543321   1122467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-39  Score=322.89  Aligned_cols=260  Identities=27%  Similarity=0.474  Sum_probs=207.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC---
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  129 (531)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence            355789999999999999999999999999999999865322 222345677899999999 999999999987532   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       130 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                         ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++++   +.+||+|||+
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kl~dfg~  166 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGL  166 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC---CCEEEecccc
Confidence               3478888887 7799887754 468999999999999999999999999999999999999654   4599999999


Q ss_pred             ccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc---------
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI---------  275 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~---------  275 (531)
                      +.....  ......+++.|+|||.+.+  .++.++|||||||++|+|++|.+||...........+.+...         
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         167 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             cccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            876432  2334568899999998754  578899999999999999999999977655443333322110         


Q ss_pred             --------------CCCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          276 --------------DFKR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       276 --------------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                    ..+.    ..+...++.+.++|.+||..+|.+|||+.+++.||||+....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                          0001    011245788999999999999999999999999999986443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-39  Score=308.63  Aligned_cols=245  Identities=22%  Similarity=0.372  Sum_probs=202.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||+|+||.||+|.+. ++..+|+|++.....    ....+.+|+.+++.+ +||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEE
Confidence            5889999999999999999875 567899999864332    234677899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          137 ELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++++   +.+||+|||++........
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~---~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED---NVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC---CcEEECCcccceecccccc
Confidence            999999999998764 468999999999999999999999999999999999999654   4599999999876543221


Q ss_pred             c--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          216 F--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       216 ~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      .  ....++..|+|||.+. ..++.++||||||+++|++++ |..||......+....+.... ..  .....+++.+.+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~  232 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RL--YRPKLAPTEVYT  232 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-cC--CCCCCCCHHHHH
Confidence            1  1122345799999876 578999999999999999999 899998777666555554332 11  112357899999


Q ss_pred             HHHHccccCcCCCCCHHHHhcC
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ++.+||..+|++|||+.++++.
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-39  Score=310.90  Aligned_cols=247  Identities=24%  Similarity=0.346  Sum_probs=207.3

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++.+.||.|+||.||+|.+.. +..+|+|++.....   .....+.+|+.+++.+ +||||+++++++......++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEE
Confidence            3569999999999999999999876 89999999875432   2346788899999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||+|+||+++.+   +.+||+|||.+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~---~~~kl~d~g~~~~~~~  156 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED---LVCKVADFGLARLIKE  156 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC---ceEEEccccchhhcCC
Confidence            99999999999999753  358999999999999999999999999999999999999644   4599999999876543


Q ss_pred             CCc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          213 GEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       213 ~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+.....   .+....+++.+
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---MPCPAKCPQEI  233 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---CCCCCCCCHHH
Confidence            322 12234567899999876 568899999999999999998 8999988777666666553321   12224678999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+++.+||..+|++|||+.++++
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         234 YKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.4e-39  Score=315.87  Aligned_cols=254  Identities=23%  Similarity=0.353  Sum_probs=207.0

Q ss_pred             CccccceeeccccCccCceEEEEEEEc-------cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecce
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD  124 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~  124 (531)
                      .....+|.+.+.||+|+||.||+|++.       ..+..+|+|.+....  .......+.+|+.+++.+.+||||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            344567999999999999999999753       234579999886432  23345678899999999978999999999


Q ss_pred             EEEcCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCce
Q 009594          125 TYEDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF  188 (531)
Q Consensus       125 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NI  188 (531)
                      ++......++||||+++++|.+++...                ..++...+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            999999999999999999999998763                2367888999999999999999999999999999999


Q ss_pred             EeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCH
Q 009594          189 LFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETE  263 (531)
Q Consensus       189 ll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~  263 (531)
                      +++.   ++.+||+|||++........   .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+.+.
T Consensus       169 li~~---~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         169 LVTE---NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EEcC---CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9964   34599999999986643221   12234567899999876 568999999999999999998 8899988777


Q ss_pred             HHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+....+..... .  .....++..+.+++.+||..+|++|||+.++++.
T Consensus       246 ~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGHR-M--DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCCc-C--CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            666655543321 1  1124678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-39  Score=307.32  Aligned_cols=241  Identities=22%  Similarity=0.346  Sum_probs=197.8

Q ss_pred             cccCccCceEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEec
Q 009594           62 RELGRGEFGVTYLCTDVNNG---EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL  138 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  138 (531)
                      +.||+|+||.||+|.....+   ..+|+|.+......  .....+.+|+.+++.+ +||||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEe
Confidence            46999999999999865544   78999998755432  3456788999999999 9999999999876 4568999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccc-
Q 009594          139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN-  217 (531)
Q Consensus       139 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~-  217 (531)
                      +++++|.+++.....+++..+..++.|++.||.|||+.+++||||||+||+++.+   +.+||+|||++.......... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~---~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR---HQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC---CcEEeccccccceeecCCcccc
Confidence            9999999999888789999999999999999999999999999999999999654   459999999988664333211 


Q ss_pred             ---cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          218 ---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       218 ---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                         ...++..|+|||.+. ..++.++||||||+++|++++ |.+||...+.......+.... .  ......++..+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~l  230 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-R--LPRPEECPQEIYSI  230 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-c--CCCCCCCCHHHHHH
Confidence               112346799999876 568999999999999999998 999998777665555443322 1  12224578999999


Q ss_pred             HHHccccCcCCCCCHHHHhc
Q 009594          293 VKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~  312 (531)
                      +.+||..+|++|||+.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.4e-39  Score=311.17  Aligned_cols=247  Identities=21%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcE----EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEK----FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .+|++.+.||.|+||+||+|....+++.    +++|.+...  ........+..|+.+++++ +||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-Cc
Confidence            4699999999999999999998777764    666766422  1223346677888899999 99999999998754 45


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++++||+++|+|.+++... +.+++..+..++.||+.||.|||+++++||||||+||+++.   +..+||+|||++...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~---~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS---DSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC---CCcEEEcCCccceec
Confidence            78899999999999999764 46899999999999999999999999999999999999964   445999999999865


Q ss_pred             CCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          211 RPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       211 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      .+...   .....++..|+|||.+. +.++.++||||||+++|++++ |..||.+.........+.... ...  ....+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~  236 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-RLA--QPQIC  236 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCC--CCCCC
Confidence            43322   22345677899999876 678999999999999999998 999998876655443333221 111  12346


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +..+.+++.+||..+|++|||+.++++
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.1e-39  Score=309.05  Aligned_cols=245  Identities=24%  Similarity=0.325  Sum_probs=200.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++.++||+|+||.||+|.+..+ ..||+|++.....    ....+.+|+.+++++ +||||+++++++.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhC-CCCCcceEEEEECC-CCcEE
Confidence            45799999999999999999987554 5699999875332    235688899999999 89999999988754 56899


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+|+||||||+||+++.   ++.++|+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~---~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE---NLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC---CCcEEeccCCceeeccc
Confidence            99999999999999753  34789999999999999999999999999999999999964   44599999999976543


Q ss_pred             CCcc--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          213 GEQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       213 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ....  ....++..|+|||.+. +.++.++||||||+++|+|+| |.+||...........+.....   ......++..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPES  231 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC---CCCccccCHH
Confidence            3321  2234567899999876 578999999999999999999 8899988776665554433221   1112457899


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +.+++.+||+.+|++|||+.++++
T Consensus       232 l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         232 LHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.1e-39  Score=318.94  Aligned_cols=260  Identities=33%  Similarity=0.503  Sum_probs=208.5

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-CCeE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DSAV  132 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~~  132 (531)
                      +.++|++.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.+++.+ +||||+++++++.. ....
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDI   85 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcE
Confidence            56789999999999999999999999999999998865432 222346677899999999 99999999999865 5678


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++|+||+ +++|..++.. ..+++..+..++.|++.||.|||+++|+||||+|+||+++.   ++.++|+|||.+.....
T Consensus        86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~---~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE---NCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC---CCCEEeCccccccccCC
Confidence            9999999 5688887754 46889999999999999999999999999999999999964   44599999999875432


Q ss_pred             CCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcc----------------
Q 009594          213 GEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----------------  274 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~----------------  274 (531)
                        ......+++.|+|||.+.+  .++.++||||||+++|+|+||.+||...........+.+..                
T Consensus       161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence              2234567889999998753  58899999999999999999999997765433222111100                


Q ss_pred             -------cCCCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          275 -------IDFKR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       275 -------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                             .....    ...+.+++.+.++|.+||+.+|++|||+.+++.||||......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                   00000    1123567899999999999999999999999999999865543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.2e-39  Score=318.48  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=198.0

Q ss_pred             eeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEec
Q 009594           59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL  138 (531)
Q Consensus        59 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  138 (531)
                      .+.+.+|.|  |.||.+++..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...+..+++|||
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEec
Confidence            344444444  5566666667999999999976532 334567899999999999 899999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 009594          139 CEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-  215 (531)
Q Consensus       139 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~-  215 (531)
                      +++++|.+++...  ..+++..+..++.|++.||+|||+++|+||||||+||+++.+   +.+||+|||.+........ 
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~---~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD---GKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---CceEEecCccceeecccccc
Confidence            9999999998763  458999999999999999999999999999999999999754   4599999998865432211 


Q ss_pred             -------cccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-------
Q 009594          216 -------FNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-------  278 (531)
Q Consensus       216 -------~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-------  278 (531)
                             .....++..|+|||++.+   .++.++|||||||++|+|++|..||....................       
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                   123456788999998863   478899999999999999999999977654433322221110000       


Q ss_pred             C-----------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          279 R-----------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       279 ~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .                       .....++..+.+|+.+||..+|++|||+.++|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            0                       00011245788999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.1e-39  Score=309.40  Aligned_cols=248  Identities=25%  Similarity=0.374  Sum_probs=204.0

Q ss_pred             cceeeccccCccCceEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNG---EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+|++.+.||+|+||.||+|.+..++   ..+|+|.+....  .......+.+|+.+++++ +||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence            46999999999999999999876544   379999886432  223356788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.   +..++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~---~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC---CCeEEeCCCCcccccc
Confidence            9999999999999998764 45899999999999999999999999999999999999964   4459999999988664


Q ss_pred             CCCcc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          212 PGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       212 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      .....    ....++..|+|||.+. +.++.++|+||||+++|++++ |..||......+....+.... ..  +....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~  234 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RL--PAPMDC  234 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cC--CCCCCC
Confidence            33221    1122356799999887 578999999999999999886 999998877666555554331 11  222457


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ++.+.+++.+||+++|.+|||+.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.9e-39  Score=311.71  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             cceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      .+|.+.++||+|+||.||+|...     .++..+|+|.+...   .......+.+|+++++.+ +||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVL-QHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCC
Confidence            46888999999999999999743     34668899987643   233456889999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC
Q 009594          131 AVHIVMELCEGGELFDRIVARG---------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE  195 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~  195 (531)
                      ..++++||+++++|.+++...+               .+++..+..++.|++.||.|||+.|++||||||+||+++.   
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~---  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ---  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC---
Confidence            9999999999999999987642               4788999999999999999999999999999999999964   


Q ss_pred             CCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 009594          196 SSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI  270 (531)
Q Consensus       196 ~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~  270 (531)
                      +..+||+|||++........   .....+++.|+|||.+. ..++.++|||||||++|+|++ |.+||...........+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            45599999999876543322   12233567899999876 568999999999999999998 99999877766666555


Q ss_pred             HhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ......   .....+++.+.+++.+||+.+|++||++.+++.
T Consensus       238 ~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            443221   112467899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.7e-39  Score=309.98  Aligned_cols=252  Identities=29%  Similarity=0.512  Sum_probs=206.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      +|.+.+.||+|+||.||++.+...+..+++|++......  .......+..|+.+++.+ +||||+++++++......++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEE
Confidence            588999999999999999998887777777776543221  112234566799999999 99999999999999899999


Q ss_pred             EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          135 VMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      |+||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++|+||+|+||++++    ..++|+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeec
Confidence            9999999999988753    346899999999999999999999999999999999999953    34999999998765


Q ss_pred             CCCCc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          211 RPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       211 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ..... .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+......   .....++..
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC---CCcchhcHH
Confidence            43322 23456888999999876 45788999999999999999999999776655554444332211   112357889


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      +.++|.+||..+|++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.6e-39  Score=306.70  Aligned_cols=240  Identities=24%  Similarity=0.335  Sum_probs=194.8

Q ss_pred             ccCccCceEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccC
Q 009594           63 ELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE  140 (531)
Q Consensus        63 ~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  140 (531)
                      .||+|+||.||+|...  ..+..||+|++....  .....+.+.+|+.+++++ +||||+++++++.. ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            4899999999999764  345679999886542  233456788999999999 99999999998754 57899999999


Q ss_pred             CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc---
Q 009594          141 GGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---  216 (531)
Q Consensus       141 ~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~---  216 (531)
                      +++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.   +..+||+|||++.........   
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN---QHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC---CCcEEeccCCccccccCCccceec
Confidence            9999998875 446899999999999999999999999999999999999964   345999999998765433221   


Q ss_pred             -ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          217 -NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       217 -~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                       ....+++.|+|||.+. +.++.++||||||+++|++++ |..||...........+.....   ....+.+++++.+++
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li  231 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR---LDCPAECPPEMYALM  231 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHH
Confidence             1122356899999876 568899999999999999996 9999988777666555544321   111245789999999


Q ss_pred             HHccccCcCCCCCHHHHhc
Q 009594          294 KKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+||..+|++||++.++++
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999965

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.1e-39  Score=309.70  Aligned_cols=247  Identities=22%  Similarity=0.325  Sum_probs=198.6

Q ss_pred             eeccccCccCceEEEEEEEccCCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc------CC
Q 009594           59 DLGRELGRGEFGVTYLCTDVNNGE--KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED------DS  130 (531)
Q Consensus        59 ~~~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~------~~  130 (531)
                      .+.+.||+|+||.||+|....++.  .+|+|.+..... .....+.+.+|+.+++.+ +||||+++++++..      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCC
Confidence            467889999999999999876665  689998865432 334467788999999999 99999999997642      23


Q ss_pred             eEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          131 AVHIVMELCEGGELFDRIVA------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      ..++++||+++|+|.+++..      ...+++..+..++.|++.||.|||+++|+||||||+||+++.   +..+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE---NMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC---CCCEEECCC
Confidence            57899999999999988742      124789999999999999999999999999999999999954   445999999


Q ss_pred             ccccccCCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCC
Q 009594          205 GLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKR  279 (531)
Q Consensus       205 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~  279 (531)
                      |++.........   ....+++.|+|||.+. ..++.++||||||+++|+|++ |.+||...........+.....   .
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~  233 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR---L  233 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---C
Confidence            999876443221   1234567899999886 568999999999999999999 8999988776665555544321   1


Q ss_pred             CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       280 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ...+.++..+.+++.+||..+|++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1224678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=313.61  Aligned_cols=268  Identities=30%  Similarity=0.457  Sum_probs=218.8

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccc-cCC---hhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKK-LRT---AVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ..+.++|-++..||+|+|++||+|.|....+.||||+-.... ...   ....+...+|..|.+.| +||.||++|++|.
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfs  537 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFS  537 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeee
Confidence            456678999999999999999999999999999999865322 111   11234567899999999 9999999999996


Q ss_pred             -cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          128 -DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ--GVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       128 -~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                       +.+.+|-|+|||+|.+|.-+|+....+++.++++|+-||+.||.||...  .|||-||||.|||+.+....+-|||+||
T Consensus       538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence             6678999999999999999999988899999999999999999999976  6999999999999998888888999999


Q ss_pred             ccccccCCCCc--------cccccCCcccccchhcc-c----cCCCccchhHHHHHHHHHhhCCCCCCCCCH-HHHHHHH
Q 009594          205 GLSVFFRPGEQ--------FNEIVGSPYYMAPEVLK-R----NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAI  270 (531)
Q Consensus       205 g~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~  270 (531)
                      |+++++..+..        .....||.+|++||.+- +    ..+.++||||+|||+|.++.|+.||..... +++++.-
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            99998865422        12357999999999764 3    378899999999999999999999955332 2222210


Q ss_pred             -HhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          271 -IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       271 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                       +-...+..-++-|.+++++++||.+||++.-++|....++..||||....
T Consensus       698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence             00111112223356899999999999999999999999999999997643

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-39  Score=306.55  Aligned_cols=242  Identities=26%  Similarity=0.393  Sum_probs=203.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||.|+||.||+|..  .|+.||+|.+.....    ....+.+|+.+++.+ +||||+++++++......++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEE
Confidence            4689999999999999999985  488999999865432    457788999999999 899999999999989999999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          136 MELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.   ++.++|+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~---~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE---DLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC---CCCEEEcccccccccccc
Confidence            99999999999997765  6899999999999999999999999999999999999964   445999999998866332


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      ..  ....+..|+|||.+. +.++.++||||||+++|++++ |..||...........+.....   ......+++.+.+
T Consensus       156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  230 (256)
T cd05039         156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYK  230 (256)
T ss_pred             cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHH
Confidence            22  233456799999876 678889999999999999997 9999988776665554443211   1112357899999


Q ss_pred             HHHHccccCcCCCCCHHHHhc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ++.+||..+|++|||+.++++
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.7e-39  Score=312.41  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=200.7

Q ss_pred             ceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....  .......+.+|+.+++.+ +||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCC
Confidence            47888999999999999998643     23578888876432  233456788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 009594          132 VHIVMELCEGGELFDRIVAR------------------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPEN  187 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~N  187 (531)
                      .++++||+++++|.+++...                        ..+++..++.++.|++.||.|||+.+|+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999987642                        247888999999999999999999999999999999


Q ss_pred             eEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCC
Q 009594          188 FLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET  262 (531)
Q Consensus       188 Ill~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~  262 (531)
                      |+++++   ..+||+|||++........   .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+..
T Consensus       158 ill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVAEG---RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEcCC---CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999643   4599999999876533221   12234567899999876 568899999999999999998 999998877


Q ss_pred             HHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .......+... ...  .....++..+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~-~~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTG-YRM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCC-CCC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            66655444332 221  122457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.4e-39  Score=309.05  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=204.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+|++.+.||+|+||.||+|.+..++.   .||+|.+....  .......+..|+.+++.+ +||||+++++++......
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCce
Confidence            358999999999999999999876654   69999886432  333457889999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.   +..+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~---~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC---CCcEEECCCccccccc
Confidence            9999999999999988753 45899999999999999999999999999999999999954   4469999999987654


Q ss_pred             CCCccc---ccc---CCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          212 PGEQFN---EIV---GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       212 ~~~~~~---~~~---gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      ......   ...   .+..|+|||.+. +.++.++|||||||++|++++ |..||...........+... .  ..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~--~~~~~~  234 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-Y--RLPPPM  234 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-C--cCCCcc
Confidence            332211   111   245799999886 578999999999999999886 99999888776665555332 1  222234


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .++..+.+++.+||..+|++||++.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=298.79  Aligned_cols=259  Identities=21%  Similarity=0.273  Sum_probs=212.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +.+-+..||.|+||+|++..++.+|+..|||.+.....  ..+..+++.|.....+-+++||||++||..-.++..+|.|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            45667889999999999999999999999999986653  4567889999998888889999999999988888999999


Q ss_pred             eccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          137 ELCEGGELFDRIV-----ARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       137 e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      |+|. .||..+.+     ++..+++..+..|..-.+.||+||.. ..|||||+||+|||++..+.   |||||||.+..+
T Consensus       143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~---vKLCDFGIcGqL  218 (361)
T KOG1006|consen  143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD---VKLCDFGICGQL  218 (361)
T ss_pred             HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC---EeeecccchHhH
Confidence            9995 46654432     35679999999999999999999986 48999999999999976554   999999998766


Q ss_pred             CCCCccccccCCcccccchhcc--c-cCCCccchhHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhcccCCCCCCC--CC
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK--R-NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDFKRDPW--PK  284 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~--~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~--~~  284 (531)
                      ...-....-.|-..|||||.+.  . .|+.+|||||||++|||+.||..||...+. .+++..+..+..+......  -.
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence            5443334456778899999886  2 489999999999999999999999977654 2444444444433222211  23


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++..++.+|..||.+|.+.||+..+++++||++....
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            7889999999999999999999999999999986554

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-38  Score=307.45  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=204.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+|+..+.||+|+||.||+|.+..++.   .+|+|.+....  .....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCc
Confidence            468889999999999999999876554   78999886432  233356788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.   +..+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~---~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS---NLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC---CCcEEECCCccceecc
Confidence            9999999999999998764 56899999999999999999999999999999999999964   4459999999987654


Q ss_pred             CCCcc--c--cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          212 PGEQF--N--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       212 ~~~~~--~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      .....  .  ....++.|+|||++. +.++.++|||||||++|++++ |..||...+.......+....   ..+....+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---CCCCCCCC
Confidence            32211  1  112345799999876 568899999999999999997 999998877766665554332   11222357


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +..+.+++.+||..+|++||++.++++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.8e-39  Score=310.86  Aligned_cols=248  Identities=25%  Similarity=0.346  Sum_probs=194.6

Q ss_pred             cce-eeccccCccCceEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--
Q 009594           56 IDY-DLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--  128 (531)
Q Consensus        56 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--  128 (531)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+....  .......+.+|+.+++.+ +||||+++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence            455 999999999999998864    33568899999986542  222346778899999999 99999999998764  


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ....++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++++   ..++|+|||++.
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~  155 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND---RLVKIGDFGLAK  155 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC---CcEEEeeccccc
Confidence            34689999999999999988664 59999999999999999999999999999999999999643   459999999988


Q ss_pred             ccCCCCcc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH--H------------HHH
Q 009594          209 FFRPGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--V------------AQA  269 (531)
Q Consensus       209 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~--~------------~~~  269 (531)
                      ........    ....++..|+|||.+. +.++.++||||||+++|+|+||..||......-  .            ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            66543221    1224566799999876 568999999999999999999999985432210  0            000


Q ss_pred             HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .......  .+....++..+.+++.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         236 LLERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000000  1112346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.4e-39  Score=318.03  Aligned_cols=254  Identities=24%  Similarity=0.359  Sum_probs=206.0

Q ss_pred             CccccceeeccccCccCceEEEEEEEccC-------CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecce
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNN-------GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD  124 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~  124 (531)
                      +....+|++.+.||+|+||.||+|.+...       +..+|+|.+....  .......+.+|+.+++++.+||||+++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            44455799999999999999999986432       2368999876432  23345678899999999978999999999


Q ss_pred             EEEcCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCce
Q 009594          125 TYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF  188 (531)
Q Consensus       125 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NI  188 (531)
                      ++...+..++++||+++++|.+++....                .++...+..++.|++.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  165 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV  165 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            9999999999999999999999987532                367888999999999999999999999999999999


Q ss_pred             EeecCCCCCCeEEEeeccccccCCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCH
Q 009594          189 LFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETE  263 (531)
Q Consensus       189 ll~~~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~  263 (531)
                      +++.+   +.+||+|||+++........   ....++..|+|||++. ..++.++||||||+++|+|++ |..||.+...
T Consensus       166 ll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         166 LVTED---NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEcCC---CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99644   45999999998765432211   1223456799999886 568899999999999999998 8999988777


Q ss_pred             HHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+....+.....   ......++..+.+++.+||..+|++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         243 EELFKLLKEGHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            666655544321   11224578899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.5e-39  Score=311.40  Aligned_cols=249  Identities=21%  Similarity=0.324  Sum_probs=203.9

Q ss_pred             ccceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .++|++.+.||+|+||.||+|.+..     ++..+|+|++....  .......+.+|+.+++++ +||||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC
Confidence            4579999999999999999998743     57899999886432  233346788999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 009594          130 SAVHIVMELCEGGELFDRIVARG----------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPEN  187 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~----------------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~N  187 (531)
                      ...++|+||+++++|.+++....                      .+++..++.++.|++.||.|||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999986432                      36788899999999999999999999999999999


Q ss_pred             eEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCC
Q 009594          188 FLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET  262 (531)
Q Consensus       188 Ill~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~  262 (531)
                      |+++.   ++.++|+|||++........   ......++.|+|||.+. +.++.++|||||||++|+|++ |..||.+..
T Consensus       161 il~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         161 CLVGE---NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             eEecC---CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99964   44599999999876543321   12233466799999876 578999999999999999997 888998877


Q ss_pred             HHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ..+....+......   .....++..+.+|+.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            76666555443221   111357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.7e-39  Score=309.15  Aligned_cols=250  Identities=21%  Similarity=0.351  Sum_probs=205.8

Q ss_pred             cceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      .+|+++..||+|+||.||+|+...     ....+|+|.+....  .......+.+|+.+++++ +||||+++++++.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence            569999999999999999999653     34678999876432  222356788999999999 9999999999999989


Q ss_pred             eEEEEEeccCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEE
Q 009594          131 AVHIVMELCEGGELFDRIVARG---------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                      ..++||||+++++|.+++....         .+++..+..++.|++.||.|||+.+|+||||||+||+++.+   +.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~---~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ---REVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC---CcEEE
Confidence            9999999999999999997665         68999999999999999999999999999999999999654   45999


Q ss_pred             EeeccccccCCCC--ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCC
Q 009594          202 IDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDF  277 (531)
Q Consensus       202 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  277 (531)
                      +|||++.......  ......+++.|+|||.+. +.++.++||||||+++|++++ |..||...........+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999987543222  223345677899999876 567889999999999999998 888997766666555554333322


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       278 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ..  ...++..+.+++.+||+.+|++|||+.+++..
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            21  23578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-38  Score=312.00  Aligned_cols=252  Identities=21%  Similarity=0.292  Sum_probs=199.9

Q ss_pred             ccceeeccccCccCceEEEEEEEcc----------------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVN----------------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN  118 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n  118 (531)
                      ..+|++.+.||+|+||.||+|.+..                ++..+|+|.+....  .......+.+|+.+++.+ +|||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l-~~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRL-KDPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCC
Confidence            3569999999999999999986432                34578999886432  233356788999999999 9999


Q ss_pred             eeecceEEEcCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 009594          119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPEN  187 (531)
Q Consensus       119 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~N  187 (531)
                      |+++++++...+..++||||+++++|.+++....           .+++..+..++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999987642           36678899999999999999999999999999999


Q ss_pred             eEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh--CCCCCCCC
Q 009594          188 FLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAE  261 (531)
Q Consensus       188 Ill~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t--g~~pf~~~  261 (531)
                      |+++.   ++.++|+|||++..+.....   .....+++.|+|||... +.++.++|||||||++|+|++  |..||...
T Consensus       161 ili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLVGK---NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEEcC---CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99964   44599999999876543321   11233467899999765 678999999999999999998  77899776


Q ss_pred             CHHHHHHHHHhcc----cCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          262 TEQGVAQAIIRSV----IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       262 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +............    .....+....+++.+.+|+.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6655444332211    01111112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-38  Score=305.66  Aligned_cols=246  Identities=24%  Similarity=0.323  Sum_probs=201.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+.....    ..+.+.+|+.+++++ +||||+++++++. ....+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcE
Confidence            3457999999999999999999864 667799999875432    235688999999999 9999999999875 45688


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          134 IVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||++++   ++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~---~~~~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD---GLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC---CceEEeCCceeeeecc
Confidence            999999999999998753  34899999999999999999999999999999999999964   4459999999997654


Q ss_pred             CCCcc--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      .....  ....++..|+|||.+. ..++.++||||||+++|+|++ |.+||...+..+....+....   ..+.....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---RMPCPQDCPI  230 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCcCCH
Confidence            33221  1233556799999876 568899999999999999999 899998877666666554332   1122245788


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.+++.+||.++|++|||+.++++
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-38  Score=305.30  Aligned_cols=247  Identities=25%  Similarity=0.339  Sum_probs=203.3

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ...++|+++++||+|+||.||+|.. .++..||+|.+.....    ....+.+|+.+++++ +||||+++++++. .+..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~   75 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPI   75 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCc
Confidence            3456799999999999999999985 4678899999865432    245788999999999 8999999999874 4568


Q ss_pred             EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          133 HIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      +++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++++   +.++|+|||++...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~  152 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET---LCCKIADFGLARLI  152 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC---CCEEEccCcceeec
Confidence            9999999999999988653  358999999999999999999999999999999999999654   45999999998765


Q ss_pred             CCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          211 RPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       211 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .....  .....++..|+|||++. +.++.++||||||+++|++++ |.+||.+.+.......+.....   .+.....+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  229 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNCP  229 (260)
T ss_pred             CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCCC
Confidence            42221  12234567899999886 568899999999999999999 9999988777666555543321   12224578


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .++.+++.+||..+|++|||++++++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         230 EELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHH
Confidence            89999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-38  Score=304.14  Aligned_cols=246  Identities=28%  Similarity=0.413  Sum_probs=206.1

Q ss_pred             eeeccccCccCceEEEEEEEccCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNG----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      +++.+.||.|+||.||+|.+...+    ..+|+|++.....  ......+.+|+.+++.+ +||||+++++++...+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence            356789999999999999987766    8999999865432  22457888999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          134 IVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++|||+++++|.+++.....  +++..+..++.|++.||.|||+.+++||||+|+||++++++   .++|+|||++....
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~---~~~l~dfg~~~~~~  154 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLY  154 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC---eEEEcccCCceecc
Confidence            99999999999999876544  89999999999999999999999999999999999996544   59999999987665


Q ss_pred             CCCccc--cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQFN--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ......  ...+++.|+|||.+. ..++.++||||||+++|+|++ |.+||...+.......+.......   ....++.
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  231 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP---KPENCPP  231 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCH
Confidence            442222  123678999999876 568899999999999999998 889998877766666655443221   1234789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.+++.+||..+|++|||+.++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-38  Score=304.18  Aligned_cols=242  Identities=24%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             cccCccCceEEEEEEEcc-CCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEec
Q 009594           62 RELGRGEFGVTYLCTDVN-NGE--KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL  138 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  138 (531)
                      +.||+|++|.||+|.+.. .+.  .+|+|.+......  ...+.+.+|+.+++++ +||||+++++++.. ...++|+||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEe
Confidence            468999999999998755 333  6899998765433  4467888999999999 99999999999988 889999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 009594          139 CEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-  215 (531)
Q Consensus       139 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~-  215 (531)
                      +++++|.+++.+..  .+++..+..++.|++.||.|||++|++||||+|+||+++.+   +.+||+|||++........ 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD---DKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC---CEEEeccccccccccccccc
Confidence            99999999997764  58999999999999999999999999999999999999754   4599999999887644221 


Q ss_pred             ---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          216 ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                         .....++..|+|||.+. ..++.++|||||||++|+|++ |..||...+..+....+........  .....|..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence               11235678899999887 568999999999999999998 9999987777666555544222111  1134688999


Q ss_pred             HHHHHccccCcCCCCCHHHHhc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +++.+||..+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-38  Score=304.69  Aligned_cols=241  Identities=25%  Similarity=0.375  Sum_probs=199.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE-EcCCeEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY-EDDSAVHI  134 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~-~~~~~~~l  134 (531)
                      .+|++.+.||+|+||.||++..  .|..+|+|.+....     ....+.+|+.+++++ +|||++++++++ ...+..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEE
Confidence            3699999999999999999974  47889999885332     245788999999999 999999999975 45667999


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |+||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC---CcEEecCCccceeccc
Confidence            999999999999987654  37899999999999999999999999999999999999644   4599999999875433


Q ss_pred             CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ..  ....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+....   .....+.+++.+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCCHHHH
Confidence            22  2233456799999877 468899999999999999997 999998776666555554332   1222346789999


Q ss_pred             HHHHHccccCcCCCCCHHHHhc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +++.+||..+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-38  Score=306.82  Aligned_cols=247  Identities=23%  Similarity=0.321  Sum_probs=203.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .+|++.+.||+|+||.||+|.+..+|.    .+|+|.+....  .......+.+|+.+++++ +||||+++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-Cc
Confidence            469999999999999999999776654    58899876443  233456788999999999 99999999999887 78


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++|+||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.+   ..+||+|||.+...
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC---CeEEECCCcccccc
Confidence            99999999999999998764 468999999999999999999999999999999999999644   45999999999876


Q ss_pred             CCCCccc---cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          211 RPGEQFN---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       211 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      .......   ...++..|+|||.+. +.++.++||||||+++|++++ |..||......+....+..... .+.  ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~  236 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQ--PPIC  236 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCC--CCCC
Confidence            5433211   122356799999876 678999999999999999998 9999988877666655543321 111  1346


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +..+.+++.+||..+|+.|||+.++++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-38  Score=303.59  Aligned_cols=245  Identities=25%  Similarity=0.323  Sum_probs=199.9

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++.+.||+|++|.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.+++++ +|||++++++++.. +..++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKL-RHDKLVPLYAVVSE-EPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhC-CCCCeeeEEEEEcC-CCcEE
Confidence            35699999999999999999987544 4699998764322    235678899999999 99999999988754 56889


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||+.||+|+||||+||++++   ++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~---~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD---NLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC---CCeEEECCCccceEccC
Confidence            999999999999987543  4789999999999999999999999999999999999964   44599999999976543


Q ss_pred             CCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          213 GEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       213 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ...  .....++..|+|||.+. +.++.++||||||+++|+|+| |..||.+.........+.....   .......+..
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---MPCPQGCPES  231 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHH
Confidence            321  12234567899999876 568899999999999999999 9999988777666555544321   1222457899


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +.+++.+||.++|++||++.++++
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         232 LHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.3e-39  Score=307.60  Aligned_cols=240  Identities=18%  Similarity=0.257  Sum_probs=191.8

Q ss_pred             cccCccCceEEEEEEEccCCc-------EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           62 RELGRGEFGVTYLCTDVNNGE-------KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~-------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      +.||+|+||.||+|.+...+.       .+|+|.+....   ....+.+.+|+.+++.+ +||||+++++++......++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEE
Confidence            469999999999998765443       38888775432   23346778899999999 99999999999999889999


Q ss_pred             EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCC-----CCeEEEeecccc
Q 009594          135 VMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES-----SPLKAIDFGLSV  208 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~-----~~ikl~Dfg~a~  208 (531)
                      ||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++..     ..++++|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999997654 58999999999999999999999999999999999999765421     247999999987


Q ss_pred             ccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      .....   ....+++.|+|||++.+  .++.++||||||+++|+|++| .+||.......... ........+    ...
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~----~~~  228 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLP----APK  228 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCC----CCC
Confidence            55432   23467889999998874  478899999999999999998 46665554443322 222222211    235


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.++.+++.+||+.+|++|||+.++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            6789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-38  Score=302.76  Aligned_cols=247  Identities=26%  Similarity=0.357  Sum_probs=205.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+.....    ....+.+|+.+++++ +||||+++++++......+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceE
Confidence            4567999999999999999999964 567899999875432    246788999999999 8999999999999888999


Q ss_pred             EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          134 IVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++++   +.++|+|||++....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~---~~~~l~d~g~~~~~~  154 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIE  154 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC---CCEEECccccceecc
Confidence            9999999999999997643  58999999999999999999999999999999999999654   559999999987654


Q ss_pred             CCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ....  .....++..|+|||.+. +.++.++||||||+++|++++ |+.||.+.........+.....   .......+.
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR---MPRPPNCPE  231 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence            3221  11223456899999887 568889999999999999998 9999988777666666554321   112235688


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.+++.+||..+|++||++.++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.6e-38  Score=306.63  Aligned_cols=249  Identities=18%  Similarity=0.262  Sum_probs=203.7

Q ss_pred             ccceeeccccCccCceEEEEEEEcc----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-C
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVN----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-D  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~  129 (531)
                      .++|++.+.||+|+||.||+|.+..    ++..|++|.+...  ........+.+|+.+++.+ +||||+++++++.. .
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence            4579999999999999999999765    3678999987532  2344467788999999999 99999999998765 5


Q ss_pred             CeEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEE
Q 009594          130 SAVHIVMELCEGGELFDRIVAR--------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                      ...++++||+++++|.+++...        ..+++..+..++.|++.||.|||+++++||||||+||+++.+   ..+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE---LQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC---CcEEE
Confidence            7789999999999999998653        358899999999999999999999999999999999999643   56999


Q ss_pred             EeeccccccCCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccC
Q 009594          202 IDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      +|||+++.+.+....   ....++..|+|||++. ..++.++||||||+++|++++ |.+||...+..+....+... ..
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YR  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CC
Confidence            999999865433221   2234567899999876 568999999999999999999 99999887666555444332 11


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .  .....+++.+.+++.+||..+|++|||+.++++
T Consensus       238 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1  122457899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-38  Score=308.61  Aligned_cols=248  Identities=25%  Similarity=0.404  Sum_probs=196.4

Q ss_pred             eeeccccCccCceEEEEEEE----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--Ce
Q 009594           58 YDLGRELGRGEFGVTYLCTD----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SA  131 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~  131 (531)
                      |++++.||+|+||.||+|..    ..++..||+|.+....  .......+.+|+.+++.+ +||||+++++++...  ..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence            78999999999999999974    4578899999986442  233356788999999999 999999999998764  67


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++||||++|++|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.+   +.++|+|||++...
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~---~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC---CCEEECCCcccccc
Confidence            899999999999999986653 58999999999999999999999999999999999999653   45999999998866


Q ss_pred             CCCCcc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH--------------HHHHHHHH
Q 009594          211 RPGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--------------QGVAQAII  271 (531)
Q Consensus       211 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~--------------~~~~~~~~  271 (531)
                      ......    ....++..|+|||++. +.++.++||||||+++|+|+|+..|+.....              ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            443221    2345677899999876 5688999999999999999998766432110              00001111


Q ss_pred             hcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ...  ...+.+..+++.+.+|+.+||+.+|++|||+.+++++
T Consensus       240 ~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         240 EEG--KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HcC--ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            111  1112234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.8e-38  Score=299.50  Aligned_cols=242  Identities=24%  Similarity=0.352  Sum_probs=197.9

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||+|+||.||+|.. .++..+|+|.+....  .......+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence            3689999999999985 468899999886432  222345688899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc--cc
Q 009594          142 GELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NE  218 (531)
Q Consensus       142 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~--~~  218 (531)
                      ++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.   ++.+||+|||++.........  ..
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~---~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE---NNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC---CCeEEECCCccceeccccccccCCC
Confidence            9999988653 45799999999999999999999999999999999999964   445999999998754332211  11


Q ss_pred             ccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHc
Q 009594          219 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM  296 (531)
Q Consensus       219 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  296 (531)
                      ..+++.|+|||++. +.++.++||||||+++|++++ |..||...........+....   .......++..+.+++.+|
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~  230 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---RMSCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHHHHHHHHH
Confidence            23456799999887 568899999999999999998 999998877666555444322   1122245789999999999


Q ss_pred             cccCcCCCCCHHHHhcC
Q 009594          297 LNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       297 l~~~p~~Rps~~~~l~h  313 (531)
                      |..+|++|||+.++++.
T Consensus       231 l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         231 WDYKPENRPKFSELQKE  247 (250)
T ss_pred             cccCcccCCCHHHHHHH
Confidence            99999999999999753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.3e-38  Score=304.07  Aligned_cols=252  Identities=30%  Similarity=0.522  Sum_probs=206.8

Q ss_pred             ceeeccccCccCceEEEEEEEcc-CCcEEEEEEeecccc-------CChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKL-------RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      .|++.+.||+|+||.||+|.+.. .+..+|+|.+.....       ........+.+|+.++.+..+||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999877 688999998864321       1223355677899988764499999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEe
Q 009594          129 DSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                      .+..++||||++|++|.+++..    ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++++   +.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~---~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED---DKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC---CcEEEec
Confidence            9999999999999999887743    3458999999999999999999996 689999999999999654   4599999


Q ss_pred             eccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      ||.+.............|+..|+|||.+. +.++.++||||||+++|+|++|.+||...........+.......  ...
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~  235 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--LPE  235 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--CCc
Confidence            99998765544444567889999999887 568899999999999999999999997776655555554433221  112


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ..+++.+.+++.+||+.||++|||+.++..+
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            2578999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.6e-38  Score=303.99  Aligned_cols=248  Identities=26%  Similarity=0.354  Sum_probs=201.9

Q ss_pred             cceeeccccCccCceEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+|.+.+.||.|+||.||+|.+...   ...+|+|.+....  .....+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCc
Confidence            4688999999999999999987543   3568999875432  233456788999999999 89999999998875 457


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++..   +.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~---~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP---DCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC---CCeEEccCceeeecc
Confidence            89999999999999997644 58999999999999999999999999999999999999654   459999999987654


Q ss_pred             CCCccc--cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQFN--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ......  ...+++.|+|||.+. ..++.++||||||+++|++++ |..||......+....+.....   ....+.++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~  235 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER---LPMPPNCPP  235 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCH
Confidence            432211  223456799999876 568899999999999999886 9999988777665555543321   122356789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+.+++.+||..+|++|||+.+++..
T Consensus       236 ~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         236 TLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.8e-38  Score=302.93  Aligned_cols=244  Identities=21%  Similarity=0.298  Sum_probs=190.9

Q ss_pred             cccCccCceEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           62 RELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      +.||+|+||.||+|...  .++..+|+|.+....  .......+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECC
Confidence            36899999999999753  345689999876543  223345788899999999 9999999999999888999999999


Q ss_pred             CCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          140 EGGELFDRIVARG-----HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       140 ~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ++|+|.+++....     ..++..+..++.|++.||.|||+++++||||||+||+++.   ...+||+|||.+.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~---~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC---CCcEEECCccccccccCcc
Confidence            9999999986432     3567788899999999999999999999999999999964   4569999999987543322


Q ss_pred             c---cccccCCcccccchhccc--------cCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-ccCCCCCC
Q 009594          215 Q---FNEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS-VIDFKRDP  281 (531)
Q Consensus       215 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~  281 (531)
                      .   .....+++.|+|||++.+        .++.++||||||+++|+|++ |..||............... ......+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1   123456788999998753        25789999999999999996 99999776655543332222 12222222


Q ss_pred             C-CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          282 W-PKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       282 ~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      . ...++.+.+++.+|| .+|++|||+.+|+.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            1 246788999999999 58999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-39  Score=317.82  Aligned_cols=259  Identities=29%  Similarity=0.520  Sum_probs=221.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      -|..++.||-|+||+|.++....+...||.|.+.+...-.......+..|-.||... +++-||+||-.|.+.+.+|+||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEE
Confidence            377889999999999999998888899999999888776666677888899999998 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-----
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-----  211 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-----  211 (531)
                      +|++||++-.+|.+.+-|++..++.++..+.+|+++.|+.|+|||||||+||||+.   +++|||+|||+++-..     
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr---dGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc---CCceeeeeccccccceecccc
Confidence            99999999999999999999999999999999999999999999999999999964   5569999999985321     


Q ss_pred             ----CCCc----------------------------------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHh
Q 009594          212 ----PGEQ----------------------------------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILL  252 (531)
Q Consensus       212 ----~~~~----------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~  252 (531)
                          .+..                                  ....+||+.|+|||++. ..|+..+|+||.|||||+|+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                1000                                  01257999999999886 57999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCC---CHHHHhcCCcccccc
Q 009594          253 CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNAK  320 (531)
Q Consensus       253 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~~~  320 (531)
                      .|++||...+..+...++++...........++++++.++|.+++.- ++.|.   .++++..||||+.+.
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~s-ad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCS-ADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcC-hhhhhcccchhhhhcCccccccc
Confidence            99999988887777666665544444445567899999999997765 77787   577899999998753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=295.26  Aligned_cols=258  Identities=29%  Similarity=0.535  Sum_probs=224.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|.++..||+|+|+.|.+++++.+.+.+|+|++++.-.....++.-...|-.+..+.++||.+|-++.+|+....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            47999999999999999999999999999999999888877778888889999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc-cCCCC
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF-FRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~-~~~~~  214 (531)
                      .||.+||+|--.+.++.++|++.++.+...|+.||.|||++|||+||||..|||++..+   ++||+|+|+++. +.+++
T Consensus       330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg---hikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG---HIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC---ceeecccchhhcCCCCCc
Confidence            99999999988888888999999999999999999999999999999999999996554   599999999874 45667


Q ss_pred             ccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCC--------CHHHHHHHHHhcccCCCCCCCCCC
Q 009594          215 QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE--------TEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ..++++|||.|.|||++++ .|..++|+|+|||+++||+.|+.||.-.        ++.-..+-++...+..++    .+
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----sl  482 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SL  482 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----ee
Confidence            7788999999999999996 6999999999999999999999999431        122233444444333332    35


Q ss_pred             CHHHHHHHHHccccCcCCCC------CHHHHhcCCcccccc
Q 009594          286 SENAKDLVKKMLNPDPKQRL------TAEEVLEHPWLQNAK  320 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rp------s~~~~l~h~~~~~~~  320 (531)
                      +-.+..++...|.+||.+|.      .+.++..|+||+...
T Consensus       483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            66677899999999999997      578999999998543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-38  Score=305.65  Aligned_cols=239  Identities=18%  Similarity=0.208  Sum_probs=189.7

Q ss_pred             ccCccCceEEEEEEEcc------------------------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCC
Q 009594           63 ELGRGEFGVTYLCTDVN------------------------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN  118 (531)
Q Consensus        63 ~lg~G~~g~V~~~~~~~------------------------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n  118 (531)
                      .||+|+||.||+|....                        ....||+|++....   ......+.+|+.+++.+ +|||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l-~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQV-SHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcC-CCCC
Confidence            69999999999987422                        12458888875432   22345677899999999 9999


Q ss_pred             eeecceEEEcCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC---
Q 009594          119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK---  194 (531)
Q Consensus       119 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~---  194 (531)
                      |+++++++......++||||+++++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++..+   
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999988865 45689999999999999999999999999999999999997542   


Q ss_pred             -CCCCeEEEeeccccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHH-hhCCCCCCCCCHHHHHHHH
Q 009594          195 -ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYIL-LCGVPPFWAETEQGVAQAI  270 (531)
Q Consensus       195 -~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l-~tg~~pf~~~~~~~~~~~~  270 (531)
                       ....+|++|||.+......   ....+++.|+|||.+.+  .++.++||||||+++|++ ++|..||.......... .
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~  233 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-F  233 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-H
Confidence             2234899999987644322   22357788999998763  578999999999999998 46999998766544332 2


Q ss_pred             HhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .......+    ...++.+.++|.+||..+|++|||+.+++++
T Consensus       234 ~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22211111    2345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.7e-38  Score=302.99  Aligned_cols=244  Identities=22%  Similarity=0.330  Sum_probs=190.7

Q ss_pred             cccCccCceEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           62 RELGRGEFGVTYLCTDVN--NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      +.||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.+ +||||+++++.+.....+++||||+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeC
Confidence            368999999999996432  34578888765432  233346778899999999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          140 EGGELFDRIVARG-----HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       140 ~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ++|+|.+++....     ..++..+..++.||+.||+|||++||+||||||+||+++.+   +.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD---LSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---CcEEEeccccccccccch
Confidence            9999999987643     24677889999999999999999999999999999999654   459999999986543322


Q ss_pred             c---cccccCCcccccchhcc--------ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCC
Q 009594          215 Q---FNEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV-IDFKRDP  281 (531)
Q Consensus       215 ~---~~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~  281 (531)
                      .   .....+++.|+|||++.        ..++.++|||||||++|+|++ |..||......+......... ...+.+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence            1   12234567899999864        246789999999999999999 788998776665555444332 2222222


Q ss_pred             C-CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          282 W-PKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       282 ~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      + ..+++.+.+++..|| .+|++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2 357888999999999 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-38  Score=300.15  Aligned_cols=228  Identities=25%  Similarity=0.372  Sum_probs=187.2

Q ss_pred             cCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCchHH
Q 009594           67 GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFD  146 (531)
Q Consensus        67 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~  146 (531)
                      |.+|.||+|++..+++.+|+|.+....        ...+|...+... .||||+++++++......++||||++|++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999986542        122344445555 79999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccCCcccc
Q 009594          147 RIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM  226 (531)
Q Consensus       147 ~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~  226 (531)
                      ++.+...+++..+..++.|++.||.|||++||+||||||+||+++.+   +.++++|||.+......  .....++..|+
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEecccchhccccc--cccCCcCcccc
Confidence            99887789999999999999999999999999999999999999654   45999999987654332  23345677899


Q ss_pred             cchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCC
Q 009594          227 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL  305 (531)
Q Consensus       227 aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  305 (531)
                      |||.+. +.++.++||||+|+++|+|++|..|+.......      ........  .+.+++.+.++|.+||+.||++||
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNI--PEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCC--cccCCHHHHHHHHHHccCCHHHhc
Confidence            999886 568899999999999999999998875432210      00001111  134788999999999999999999


Q ss_pred             CH-----HHHhcCCcc
Q 009594          306 TA-----EEVLEHPWL  316 (531)
Q Consensus       306 s~-----~~~l~h~~~  316 (531)
                      ++     .++++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            85     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.9e-38  Score=302.22  Aligned_cols=240  Identities=20%  Similarity=0.214  Sum_probs=190.0

Q ss_pred             cccCccCceEEEEEEEcc------------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           62 RELGRGEFGVTYLCTDVN------------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~------------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      +.||+|+||.||+|+...            ....+|+|.+....   ......+..|+.+++.+ +||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQV-SHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence            368999999999997422            23358888875432   22345778899999999 999999999999998


Q ss_pred             CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC----CCCeEEEee
Q 009594          130 SAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE----SSPLKAIDF  204 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~----~~~ikl~Df  204 (531)
                      ...++||||+++++|..++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.    ...++++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            899999999999999888865 356899999999999999999999999999999999999975432    123899999


Q ss_pred             ccccccCCCCccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHh-hCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 009594          205 GLSVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  281 (531)
                      |++......   ....++..|+|||.+.  ..++.++|||||||++|+|+ +|..||......+.. ........    .
T Consensus       157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~----~  228 (262)
T cd05077         157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM----L  228 (262)
T ss_pred             CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc----C
Confidence            998755322   2345788899999875  45889999999999999997 588888765543322 22222111    1


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ....++++.+||.+||+.+|++||++.+|+++
T Consensus       229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            22346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-40  Score=327.33  Aligned_cols=248  Identities=24%  Similarity=0.392  Sum_probs=215.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNG---EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...|.+.||.|.||+||+|+.+..|   ..||||.++...  .......|+.|+.||.++ +||||++|.|+......++
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeE
Confidence            4678899999999999999987655   579999987544  444567899999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||+|||++|+|..+|.+ .+.++..++..+++.|+.|+.||-+.|+|||||..+|||++   .+..+|++|||+++.+.+
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN---snLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec---cceEEEeccccceeeccc
Confidence            99999999999999976 46799999999999999999999999999999999999994   566799999999998765


Q ss_pred             CC-c-cccccC--Ccccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          213 GE-Q-FNEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       213 ~~-~-~~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      +. . ..+..|  ..+|.|||.+. .+++.+|||||+|++|||.++ |..|||..++++++..+..+..   .++...+|
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR---LPpPmDCP  860 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR---LPPPMDCP  860 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC---CCCCCCCc
Confidence            44 2 222233  46899999887 789999999999999998665 9999999999999988877542   33335899


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ..+.+|+..||++|-.+||.+.||+.+
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999999864

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.8e-38  Score=300.06  Aligned_cols=245  Identities=25%  Similarity=0.431  Sum_probs=202.4

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +|++.+.||.|+||.||+|.+. .+..+|+|++.....    ....+.+|+.+++++ +||||+++++++......++|+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEE
Confidence            5889999999999999999864 477899998864432    235688899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          137 ELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       137 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      ||+++++|.+++... +.+++..+..++.|++.||.|||+.+++||||||+||+++.   +..++|+|||.+........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~---~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE---NQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC---CCeEEECCCcceeecccCcc
Confidence            999999999988764 45899999999999999999999999999999999999964   34599999999875533211


Q ss_pred             --cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          216 --FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       216 --~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                        .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+....... .  ....++.+.+
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~  232 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY-K--PRLASQSVYE  232 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC-C--CCCCCHHHHH
Confidence              11223457899999877 578889999999999999998 999998777666665554332111 1  1236889999


Q ss_pred             HHHHccccCcCCCCCHHHHhcC
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      |+.+||..+|++|||+.+++++
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHh
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-38  Score=298.47  Aligned_cols=241  Identities=25%  Similarity=0.334  Sum_probs=198.1

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCC
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG  141 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  141 (531)
                      +.||.|+||.||+|.+.. ++.||+|.+......  .....+.+|+.+++++ +||||+++++++......++|+||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            468999999999999876 999999988654322  3456788999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc---c
Q 009594          142 GELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---N  217 (531)
Q Consensus       142 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~---~  217 (531)
                      ++|.+++... ..++...+..++.+++.||.|||+++++||||+|+||+++.+   +.++|+|||++.........   .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~---~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC---CcEEEeeccccccccCCcceeccc
Confidence            9999998653 458999999999999999999999999999999999999644   45999999998765422211   1


Q ss_pred             cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHH
Q 009594          218 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK  295 (531)
Q Consensus       218 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  295 (531)
                      ...++..|+|||.+. +.++.++||||||+++|+|+| |..||...........+... ..  ......++..+.+++.+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~li~~  230 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YR--MPAPQLCPEEIYRLMLQ  230 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CC--CCCCccCCHHHHHHHHH
Confidence            123356799999876 568999999999999999999 88999777665554444332 11  11223578899999999


Q ss_pred             ccccCcCCCCCHHHHhc
Q 009594          296 MLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       296 ~l~~~p~~Rps~~~~l~  312 (531)
                      ||..+|.+|||+.++++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.6e-38  Score=303.80  Aligned_cols=245  Identities=27%  Similarity=0.368  Sum_probs=198.0

Q ss_pred             cccCccCceEEEEEEEccCC------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           62 RELGRGEFGVTYLCTDVNNG------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      +.||+|+||.||+|++....      ..+|+|.+....  .......+.+|+.+++.+ +||||+++++++......++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEE
Confidence            36899999999999875433      689999875432  123356788899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC--CCCCeEEEeecc
Q 009594          136 MELCEGGELFDRIVAR-------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGL  206 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~--~~~~ikl~Dfg~  206 (531)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++  ....++|+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999998642       2378899999999999999999999999999999999998654  223699999999


Q ss_pred             ccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 009594          207 SVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       207 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  281 (531)
                      +........   .....++..|+|||.+. +.++.++|||||||++|+|+| |..||...........+....   ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---RLQK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---ccCC
Confidence            876543221   12234567899999876 678999999999999999998 999998777665555443321   1112


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ...+|+.+.+++.+||..+|++|||+.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2457899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=314.96  Aligned_cols=244  Identities=27%  Similarity=0.400  Sum_probs=203.8

Q ss_pred             eeeccccCccCceEEEEEEEcc--CC--cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           58 YDLGRELGRGEFGVTYLCTDVN--NG--EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~--~~--~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ..+.+.||.|-||.||+|....  .|  -.||||..+...  ++.+.+.|+.|.-+|+.+ +||||++++|++... ..+
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-cee
Confidence            3456789999999999997532  23  357888876543  444578999999999999 999999999999764 679


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||+++.|.|..+|..+. .++...+..+++||+.||.|||++++|||||..+|||+.+..   -|||+|||+++.+..
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~---CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ---CVKLADFGLSRYLED  543 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc---eeeecccchhhhccc
Confidence            9999999999999998765 489999999999999999999999999999999999997654   399999999998876


Q ss_pred             CCccccccC--Ccccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          213 GEQFNEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       213 ~~~~~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ...+....|  ...|||||.++ ..++.+||||-|||.+||++. |..||.+..+.+++-.+.++..-   +..+++|+.
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl---P~P~nCPp~  620 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL---PCPPNCPPA  620 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC---CCCCCCChH
Confidence            655444344  45699999988 789999999999999999877 99999998877766555544321   223589999


Q ss_pred             HHHHHHHccccCcCCCCCHHHHh
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVL  311 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l  311 (531)
                      +..|+.+||.++|.+||.+.++.
T Consensus       621 LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  621 LYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHHHhccCcccCCcHHHHH
Confidence            99999999999999999887764

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.7e-38  Score=304.03  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=194.7

Q ss_pred             cceeeccccCccCceEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--C
Q 009594           56 IDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--D  129 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~  129 (531)
                      .+|++.+.||+|+||.||+|.    +..++..||+|.+...   .......+.+|+++++.+ +||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCC
Confidence            369999999999999999987    3457889999998643   233456788999999999 99999999998643  4


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 SAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ..+++|+||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~---~~~~l~dfg~~~  156 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTK  156 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC---CeEEECCCcccc
Confidence            5689999999999999998764 458999999999999999999999999999999999999644   459999999998


Q ss_pred             ccCCCCcc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHH---------------HH
Q 009594          209 FFRPGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV---------------AQ  268 (531)
Q Consensus       209 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~---------------~~  268 (531)
                      ........    ....++..|+|||++. +.++.++|||||||++|+|++|..|+......-.               ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            76543221    1112345699999876 5688999999999999999998776533221100               00


Q ss_pred             HHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          269 AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ........  .+....++..+.+|+.+||..+|++|||+.++++
T Consensus       237 ~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         237 ELLKNNGR--LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHhcCCc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11111111  1122457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=308.64  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=208.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      +....+.++||+|-||+|.++. ...+..||+|.++...  .......|..|+++|.+| +||||+.++++|..++.+|+
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEE-ecCceEEEEeecCccc--chhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHH
Confidence            3457789999999999999998 3457999999997654  333457899999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |+||++.|+|.+++.+..  .+......+|+.||+.||+||.+.++|||||.|.|+|++   ...++||+|||+++.+..
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~---~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD---GEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec---CcccEEecCccccccccc
Confidence            999999999999998763  345567788999999999999999999999999999994   556799999999997776


Q ss_pred             CCcccc---ccCCcccccchhc-cccCCCccchhHHHHHHHHHhh--CCCCCCCCCHHHHHHHHHhcccCCCCC----CC
Q 009594          213 GEQFNE---IVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLC--GVPPFWAETEQGVAQAIIRSVIDFKRD----PW  282 (531)
Q Consensus       213 ~~~~~~---~~gt~~y~aPE~~-~~~~~~~~Di~slG~il~~l~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~  282 (531)
                      ++.+..   .+-..+|||||.+ .++++.+||+|+||+++||+++  ...||...++.++.++...-.......    ..
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence            665432   3456789999965 5999999999999999998765  788998888777766554433222221    12


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHh
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVL  311 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l  311 (531)
                      +-+|..+.++|.+||..+.++|||++++.
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            45889999999999999999999999993

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.1e-38  Score=301.55  Aligned_cols=237  Identities=18%  Similarity=0.202  Sum_probs=189.9

Q ss_pred             cccCccCceEEEEEEEccCC----------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           62 RELGRGEFGVTYLCTDVNNG----------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~----------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      +.||+|+||.||+|.+..++          ..+++|++.....    ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQL-SHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcC-CCcchhheeeEEec-CC
Confidence            46899999999999987766          3577887654321    146788899999999 99999999999887 77


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC----CCCCeEEEeecc
Q 009594          132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK----ESSPLKAIDFGL  206 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~----~~~~ikl~Dfg~  206 (531)
                      .++|+||+++++|.+++...+ .++...+..++.||+.||.|||++||+||||||+||+++.++    ....+||+|||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            899999999999999998766 689999999999999999999999999999999999997654    122599999999


Q ss_pred             ccccCCCCccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      +.....   .....++..|+|||++.+   .++.++||||||+++|+|++ |..||...+......... .....+    
T Consensus       155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~----  226 (259)
T cd05037         155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLP----  226 (259)
T ss_pred             cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCC----
Confidence            886543   223456778999998863   58889999999999999999 578886665333222222 111111    


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ......+.+++.+||..+|++|||+.++++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         227 MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            112378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.7e-38  Score=299.76  Aligned_cols=240  Identities=26%  Similarity=0.396  Sum_probs=199.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||++.  .+++.+|+|.+....     ....+.+|+.+++++ +||||+++++++... ..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEE
Confidence            469999999999999999987  578899999885432     235788899999999 999999999998654 47999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          136 MELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||+++.+   +.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~---~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED---GVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC---CcEEECCCccceecccc
Confidence            99999999999987643  47899999999999999999999999999999999999654   45999999998754322


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                        ......+..|+|||.+. +.++.++|+||||+++|+|++ |.+||...........+.+...   ......++..+.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---MEPPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---CCCCCcCCHHHHH
Confidence              12233456799999876 578899999999999999997 9999988777666555544321   1223467899999


Q ss_pred             HHHHccccCcCCCCCHHHHhc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ++.+||+.+|++||++.+++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-37  Score=298.79  Aligned_cols=246  Identities=24%  Similarity=0.363  Sum_probs=201.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|++.+.||+|+||.||+|.+ ..+..+|+|.+....    .....+.+|+.+++.+ +|+||+++++++.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh----hHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeE
Confidence            456799999999999999999985 456679999876432    2346788899999999 89999999999887 7789


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          134 IVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.   .+.+||+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~---~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC---CCcEEECCCcceeecc
Confidence            999999999999998763  34788899999999999999999999999999999999964   4469999999987654


Q ss_pred             CCCcc--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      .....  ....++..|+|||.+. +.++.++|+|||||++|+++| |..||...+.......+....   ..+.....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPENCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---CCCCcccCCH
Confidence            33221  1234567799999886 568889999999999999999 999998877666555544332   1222346789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.+++.+||.++|++||++.++++
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.9e-38  Score=306.69  Aligned_cols=256  Identities=14%  Similarity=0.161  Sum_probs=188.6

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccC---CcEEEEEEeeccccCChhhH--------HHHHHHHHHHHhCCCCCCe
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDI--------EDVRREVQIMKHLPKHPNI  119 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~~h~ni  119 (531)
                      .+....+|++.+.||+|+||.||+|.+..+   +..+|+|+..........+.        .....+...+..+ .|+||
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i   85 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGI   85 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCC
Confidence            345567899999999999999999998776   66777776443221110000        1122334445566 89999


Q ss_pred             eecceEEEcCC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC
Q 009594          120 VSLKDTYEDDS----AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE  195 (531)
Q Consensus       120 v~l~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~  195 (531)
                      ++++++.....    ..+++++++. .++.+.+......++..++.++.|++.||.|||+++|+||||||+|||++.+  
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~--  162 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN--  162 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--
Confidence            99998765432    4577888874 4676766665557889999999999999999999999999999999999643  


Q ss_pred             CCCeEEEeeccccccCCCC--------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH-HH
Q 009594          196 SSPLKAIDFGLSVFFRPGE--------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-QG  265 (531)
Q Consensus       196 ~~~ikl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~  265 (531)
                       ..++|+|||+|+......        ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+... ..
T Consensus       163 -~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        163 -NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             -CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence             459999999997653221        112346999999999887 4689999999999999999999999977632 22


Q ss_pred             HHHHH----HhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          266 VAQAI----IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       266 ~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .....    ..... ......+.+++.+.+++..||..+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        242 LIHAAKCDFIKRLH-EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhHHHHHHHhh-hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            21111    11111 111223567899999999999999999999999875

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.2e-38  Score=307.00  Aligned_cols=248  Identities=22%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             cceeeccccCccCceEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .+|++.+.||+|+||.||+|.+..+|.    .+|+|.+....  .......+.+|+.+++.+ +||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-C
Confidence            468999999999999999999877776    46888775432  222344678899999999 999999999988654 4


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+   ..+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~---~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP---NHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC---CceEEccccccccc
Confidence            679999999999999987644 58999999999999999999999999999999999999643   45999999999865


Q ss_pred             CCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          211 RPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       211 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      .....   .....++..|+|||.+. ..++.++||||||+++|++++ |..||.+.........+ ......  +..+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~--~~~~~~  236 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERL--PQPPIC  236 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCC--CCCCCC
Confidence            43322   12234567899999876 568899999999999999997 99999776655443333 322222  122457


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +..+.+++.+||..+|++||++.++++.
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8899999999999999999999999774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.3e-38  Score=329.24  Aligned_cols=340  Identities=21%  Similarity=0.265  Sum_probs=218.3

Q ss_pred             ccceeeccccCccCceEEEEEEEccC----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceE-----
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNN----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT-----  125 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~-----  125 (531)
                      .++|++.+.||+|+||.||+|.+..+    +..||+|++.....     .+....|  .++.. .+.+++.++..     
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~-~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRA-CPNSCADFVYGFLEPV  202 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhh-chhhHHHHHHhhhccc
Confidence            45799999999999999999999888    89999998753221     1111111  12222 23333333222     


Q ss_pred             -EEcCCeEEEEEeccCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 009594          126 -YEDDSAVHIVMELCEGGELFDRIVARGH--------------------YTERAAAAVMKTIVEVVQVCHEQGVMHRDLK  184 (531)
Q Consensus       126 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlk  184 (531)
                       .......++|+||+++++|.+++.....                    .....+..++.||+.||.|||+++|+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             1355679999999999999998865421                    1234467899999999999999999999999


Q ss_pred             CCceEeecCCCCCCeEEEeeccccccCCCC--ccccccCCcccccchhcc-c----------------------cCCCcc
Q 009594          185 PENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLK-R----------------------NYGPEV  239 (531)
Q Consensus       185 p~NIll~~~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~----------------------~~~~~~  239 (531)
                      |+|||++.+  ...+||+|||+|.......  ......+|+.|+|||.+. .                      .++.++
T Consensus       283 P~NILl~~~--~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFSEG--SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEeCC--CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999743  3459999999998654332  224567899999999653 1                      133456


Q ss_pred             chhHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-hccc----------CCCCCC-------CCCCCHHHHHHHHHccccCc
Q 009594          240 DVWSAGVILYILLCGVPPFWAETEQGVAQAII-RSVI----------DFKRDP-------WPKVSENAKDLVKKMLNPDP  301 (531)
Q Consensus       240 Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~----------~~~~~~-------~~~~~~~~~~li~~~l~~~p  301 (531)
                      |||||||++|+|+++..|+..  ......... ....          ......       +...+....+||.+||++||
T Consensus       361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999999997766432  111111111 1000          000000       00122345689999999999


Q ss_pred             CCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhhhHHHHHHHhhhhhhHhhhhhHHHhhHHHHhcccccCCCCcccH
Q 009594          302 KQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINL  381 (531)
Q Consensus       302 ~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~  381 (531)
                      .+|||+.++|+||||+...... .+..+.+....             .... ...-.+-...+......-+++.+|..+.
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~~~-~~~~~~~~~~~-------------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~e  503 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGLLG-LSVMQNLRLQL-------------FRAT-QQDYGEAAAWVVFLMAKSGTEKEGGFTE  503 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCccc-ccccccccccc-------------chhh-HHHHHHHHHHHHHHHHhcCCCCCCCccH
Confidence            9999999999999998654321 11111110000             0000 0011111223444455567788899999


Q ss_pred             HHHHHHHHhCCCCCCHHHHHH--HHHhcCCCCCCceecchhHhH
Q 009594          382 EELRLGLLKGGQNIPEADLQI--LMEAADVDGDGSLNYGEFVAV  423 (531)
Q Consensus       382 ~el~~~l~~~~~~~~~~~~~~--~f~~~D~~~~g~i~~~ef~~~  423 (531)
                      .++..+...- .. .+.+.++  +-..++.+..|..++++++.-
T Consensus       504 ~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (566)
T PLN03225        504 AQLQELREKE-PK-KKGSAQRNALASALRLQRKGVKTVARTVDE  545 (566)
T ss_pred             HHHHHhhhhc-Cc-chhhhhhhhHHHHHhhhhhhhhhhhhhhhc
Confidence            9996665543 22 2223333  666778888888888888763

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-37  Score=299.09  Aligned_cols=243  Identities=23%  Similarity=0.349  Sum_probs=191.6

Q ss_pred             cccCccCceEEEEEEEcc---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE-cCCeEEEEEe
Q 009594           62 RELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-DDSAVHIVME  137 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-~~~~~~lv~e  137 (531)
                      +.||+|+||.||+|.+..   .+..+|+|.+....  .......+.+|+.+++.+ +||||+++++++. .++..++|+|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence            368999999999998643   34679999875322  333456788899999999 9999999999765 4566899999


Q ss_pred             ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 009594          138 LCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-  215 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~-  215 (531)
                      |+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+++||||||+||++++   ++.+||+|||++........ 
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~---~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE---SFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC---CCcEEECCccccccccCCcce
Confidence            999999999987643 4678888999999999999999999999999999999964   44599999999875533211 


Q ss_pred             ----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          216 ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       216 ----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                          .....+++.|+|||.+. ..++.++|||||||++|+|++ |.+||...........+......   .....+++.+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL---LQPEYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---CCCCcCCHHH
Confidence                12234567899999876 578899999999999999999 56777766665555444332211   1112468899


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcC
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+++.+||..+|++||++.++++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=299.51  Aligned_cols=265  Identities=26%  Similarity=0.475  Sum_probs=202.9

Q ss_pred             CCCccc-cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-------CCeee
Q 009594           50 SGQDIS-IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-------PNIVS  121 (531)
Q Consensus        50 ~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-------~niv~  121 (531)
                      -|+.|. .+|.++++||+|-|++||+|.|.+..+.||+|+.+....    ..+....||.+|++++.+       ..||+
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence            377788 899999999999999999999999999999999976432    345677899999988533       26999


Q ss_pred             cceEEE----cCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCC
Q 009594          122 LKDTYE----DDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKK  194 (531)
Q Consensus       122 l~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~  194 (531)
                      |++.|.    .+.++|||+|++ |.+|..+|....  .++...+++|++||+.||.|||.+ ||||.||||+|||+....
T Consensus       147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence            999996    457899999999 789999887653  499999999999999999999975 999999999999983210


Q ss_pred             --------------------------------------------------------------------------------
Q 009594          195 --------------------------------------------------------------------------------  194 (531)
Q Consensus       195 --------------------------------------------------------------------------------  194 (531)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------------C------------------------------------------------
Q 009594          195 -------------------------------E------------------------------------------------  195 (531)
Q Consensus       195 -------------------------------~------------------------------------------------  195 (531)
                                                     .                                                
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                           0                                                


Q ss_pred             ----CCCeEEEeeccccccCCCCccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCC------HH
Q 009594          196 ----SSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET------EQ  264 (531)
Q Consensus       196 ----~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~------~~  264 (531)
                          +..|||+|||.|+-.  ...+..-+.|..|+|||++.+ .|+..+||||++|++|||.||-+.|....      +.
T Consensus       386 ~~~~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             CCccceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence                002455555555432  223334457889999999874 79999999999999999999999884432      12


Q ss_pred             HHHHHHHhcccCCC-------------------------CCCCC---------CC----CHHHHHHHHHccccCcCCCCC
Q 009594          265 GVAQAIIRSVIDFK-------------------------RDPWP---------KV----SENAKDLVKKMLNPDPKQRLT  306 (531)
Q Consensus       265 ~~~~~~~~~~~~~~-------------------------~~~~~---------~~----~~~~~~li~~~l~~~p~~Rps  306 (531)
                      +.+..++......+                         ..+|+         ..    ..++.+|+.-||+.+|++|||
T Consensus       464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t  543 (590)
T KOG1290|consen  464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT  543 (590)
T ss_pred             HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence            22222322111111                         11222         11    246889999999999999999


Q ss_pred             HHHHhcCCccccccc
Q 009594          307 AEEVLEHPWLQNAKK  321 (531)
Q Consensus       307 ~~~~l~h~~~~~~~~  321 (531)
                      |.++|+|||+.....
T Consensus       544 A~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  544 AAQCLKHPWLNPVAG  558 (590)
T ss_pred             HHHHhcCccccCCCC
Confidence            999999999987654

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=320.28  Aligned_cols=202  Identities=32%  Similarity=0.532  Sum_probs=178.5

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc------CC
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED------DS  130 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~------~~  130 (531)
                      -|...+.||+|+||.||+++++.+|+.||||.+....  .....+...+|+++|++| +|||||+++++-+.      ..
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccc
Confidence            4777789999999999999999999999999997644  334567888999999999 79999999987543      34


Q ss_pred             eEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC-CCCCeEEEeecc
Q 009594          131 AVHIVMELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGL  206 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~-~~~~ikl~Dfg~  206 (531)
                      ...+|||||.||||+..+.+   ...+++.+.+.++..+..||.|||++||+||||||.||++.... +....||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            67899999999999999864   23599999999999999999999999999999999999997543 344579999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCC
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAE  261 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~  261 (531)
                      |+.++++....+.+||+.|.+||++.  +.|+..+|.|||||++|++.||..||...
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99999999899999999999999886  57899999999999999999999999554

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-37  Score=301.12  Aligned_cols=249  Identities=25%  Similarity=0.400  Sum_probs=199.0

Q ss_pred             cceeeccccCccCceEEEEEEEc----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--C
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDV----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--D  129 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~  129 (531)
                      .+|++.+.||+|+||.||+|...    .++..+|+|++......  .....+.+|+.+++.+ .||||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTL-DHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhC-CCCChheEEeeeecCCC
Confidence            35888899999999999999854    34789999998754322  3457889999999999 99999999999876  5


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ...++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+   ..++|+|||.+.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~  157 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE---DLVKISDFGLAK  157 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEccccccc
Confidence            68999999999999999997654 58999999999999999999999999999999999999654   559999999998


Q ss_pred             ccCCCCcc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH--------------HHHH
Q 009594          209 FFRPGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------VAQA  269 (531)
Q Consensus       209 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~--------------~~~~  269 (531)
                      ........    ....++..|+|||.+. ..++.++||||||+++|+|+||..|+.......              ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76533221    1223456799999876 568889999999999999999999986543221              1111


Q ss_pred             HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ........  .....++.++.+++.+||..+|++|||+.++++
T Consensus       238 ~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         238 LLKEGERL--PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHcCCcC--CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11111111  112356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.5e-37  Score=298.66  Aligned_cols=248  Identities=23%  Similarity=0.370  Sum_probs=197.9

Q ss_pred             eeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC----
Q 009594           58 YDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS----  130 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  130 (531)
                      |++.+.||+|+||.||+|...   .++..+|+|++..... .....+.+.+|+.+++.+ +||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCc
Confidence            677889999999999999854   3578999999865432 333467788999999999 9999999999875432    


Q ss_pred             --eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEE
Q 009594          131 --AVHIVMELCEGGELFDRIVAR------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       131 --~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                        ..++++||+++++|..++...      ..+++..+..++.|++.||+|||++||+||||||+||++++   +..+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~---~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE---NMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC---CCCEEEC
Confidence              357899999999998877532      24788999999999999999999999999999999999954   4459999


Q ss_pred             eeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCC
Q 009594          203 DFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDF  277 (531)
Q Consensus       203 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  277 (531)
                      |||++........   .....+++.|++||.+. +.++.++|||||||++|+|++ |.+||......+....+..... .
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~  234 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-L  234 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-C
Confidence            9999886543321   12234567899999876 568889999999999999999 8999987776655554443221 1


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       278 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                        ...+..++.+.+++.+||..+|++|||+.+++.+
T Consensus       235 --~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         235 --KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              1113578899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.8e-37  Score=294.70  Aligned_cols=244  Identities=20%  Similarity=0.307  Sum_probs=189.5

Q ss_pred             cccCccCceEEEEEEEccC--CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           62 RELGRGEFGVTYLCTDVNN--GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      +.||+|+||.||+|.....  ...+++|.+....  .......+.+|+.+++.+ +||||+++++.+......++||||+
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecC
Confidence            3699999999999975332  2345666664432  223456888999999999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          140 EGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       140 ~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      ++++|.+++.+.    ...+...+..++.||+.||.|||+.+++||||||+|||++.   ++.++|+|||++....... 
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~---~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC---CccEEecccccccccCcchh
Confidence            999999998753    23567788899999999999999999999999999999964   4459999999986432221 


Q ss_pred             --ccccccCCcccccchhccc--------cCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcc-cCCCCCCC
Q 009594          215 --QFNEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV-IDFKRDPW  282 (531)
Q Consensus       215 --~~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~  282 (531)
                        ......+++.|+|||++..        .++.++||||||+++|+|++ |..||......+....+.+.. .....+.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL  234 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence              1223567889999998742        35778999999999999997 577887777666665544332 22222222


Q ss_pred             -CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          283 -PKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       283 -~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                       ..+++.+.+++..|| .+|++|||+.++++
T Consensus       235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence             346888999999999 67999999999965

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-38  Score=318.06  Aligned_cols=255  Identities=27%  Similarity=0.480  Sum_probs=213.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE-----cCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-----DDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-----~~~  130 (531)
                      +-|++.+.||.|.+|.||+++++.+++.+|+|+.....-    ..+++..|.++++.++.|||++.++++|.     .++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            359999999999999999999999999999999875432    23567789999999999999999999985     357


Q ss_pred             eEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          131 AVHIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      .++||||||.|||..+++++  ...+.|..++.|++.++.||.+||.+.++|||||-.|||++.++.   |||+|||++.
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~---VKLvDFGvSa  171 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE---VKLVDFGVSA  171 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc---EEEeeeeeee
Confidence            89999999999999998865  346899999999999999999999999999999999999976554   9999999998


Q ss_pred             ccCCCC-ccccccCCcccccchhccc------cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 009594          209 FFRPGE-QFNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       209 ~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  281 (531)
                      .+.... ..++.+|||.|||||++..      .|+..+|+||||++..||--|.+|+......-.+-.+.+. .++....
T Consensus       172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkr  250 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKR  250 (953)
T ss_pred             eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccc
Confidence            776443 3467889999999998852      3777999999999999999999999776654332222221 1111122


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      +.+.++++.++|..||.+|-++||+..++|+|||++.
T Consensus       251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            4567899999999999999999999999999999984

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=306.36  Aligned_cols=265  Identities=23%  Similarity=0.377  Sum_probs=218.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +...-++||-|.||.||.|..+.-.-.||||.++..    .-+.++|+.|+.+|+.+ .|||+|+|+++|.....+|||+
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEE
Confidence            355668899999999999998888889999988643    44578999999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          137 ELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||..|+|.++|.+..  .++.-.++.++.||..|+.||..+++|||||..+|+|+   +.+..||++|||+++++..+.
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCc
Confidence            9999999999998754  37788889999999999999999999999999999999   566779999999999886543


Q ss_pred             ccccccC---Ccccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          215 QFNEIVG---SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       215 ~~~~~~g---t~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      . ....|   ...|.|||.+. +.++.|+|||+|||+|||+.| |..||.+.....++..+.++ ...  .....||+..
T Consensus       420 Y-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM--~~PeGCPpkV  495 (1157)
T KOG4278|consen  420 Y-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRM--DGPEGCPPKV  495 (1157)
T ss_pred             e-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-ccc--cCCCCCCHHH
Confidence            2 22223   45699999887 789999999999999999998 89999998877666655443 222  2235799999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhh
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ  337 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~  337 (531)
                      .+||..||+.+|.+||++.++  |.-|.....  ..++.+.+.+.+.+
T Consensus       496 YeLMraCW~WsPsDRPsFaei--HqafEtmf~--~sSisdEV~keLgk  539 (1157)
T KOG4278|consen  496 YELMRACWNWSPSDRPSFAEI--HQAFETMFS--SSSISDEVQKELGK  539 (1157)
T ss_pred             HHHHHHHhcCCcccCccHHHH--HHHHHHHhc--cccccHHHHHHHhh
Confidence            999999999999999999999  444543332  33455555555544

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=312.86  Aligned_cols=254  Identities=26%  Similarity=0.367  Sum_probs=213.8

Q ss_pred             cceeeccccCccCceEEEEEEEcc-CC--cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVN-NG--EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+.++.++||+|.||+|++|.... +|  ..||||++.......  ....|++|+.+|.+| +|||+++|||+..+ ...
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhc-cCcceeEEeeeecc-chh
Confidence            457888999999999999998543 23  468999997655433  578999999999999 99999999999987 678


Q ss_pred             EEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          133 HIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .+|+|+++.|+|.+.|.+  ...|....+..++.||+.||.||.++++|||||..+|+|+.+.   ..|||+|||+.+.+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp---rtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP---RTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc---ceeeeecccceecc
Confidence            899999999999999987  3457888899999999999999999999999999999999653   45999999999988


Q ss_pred             CCCCcccccc----CCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          211 RPGEQFNEIV----GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       211 ~~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      ..++.+....    -...|.|||.++ ..++.+||||++||++|||+| |+.||.+.....+++++-.+. ..++  -+.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-rLpR--Pk~  339 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-RLPR--PKY  339 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-cCCC--CCC
Confidence            7666544322    245699999998 789999999999999999999 889999999888887776322 2222  246


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +++.+.+++..||..+|++|||+..|.+.-+...+
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence            89999999999999999999999999766555544

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.7e-38  Score=304.48  Aligned_cols=262  Identities=24%  Similarity=0.407  Sum_probs=216.0

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----CCCCeeecc
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-----KHPNIVSLK  123 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~  123 (531)
                      .-|+.+..+|.+....|+|-||+|..|.+..-|+.||||+|......    ...-+.|+++|++|.     +..++++|+
T Consensus       425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            34677888999999999999999999999999999999999765432    345567999999994     234899999


Q ss_pred             eEEEcCCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeE
Q 009594          124 DTYEDDSAVHIVMELCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK  200 (531)
Q Consensus       124 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ik  200 (531)
                      ..|...+++|||+|-+ ..+|.+.|.+-+   .|....++.++.|+.-||..|-..||+|.||||.|||++.  ....+|
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--~k~iLK  577 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--SKNILK  577 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc--Ccceee
Confidence            9999999999999998 469999998755   3788999999999999999999999999999999999964  345699


Q ss_pred             EEeeccccccCCCCccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 009594          201 AIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR  279 (531)
Q Consensus       201 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  279 (531)
                      |||||.|.....++... +.-+..|+|||++.| +|+...|+||+||+||||+||+..|.+.+...++...+.....++.
T Consensus       578 LCDfGSA~~~~eneitP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  578 LCDFGSASFASENEITP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             eccCccccccccccccH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            99999998876554432 333567999998885 7999999999999999999999999999988877665443322221


Q ss_pred             CC-------------------------------------------------CCCCC-------HHHHHHHHHccccCcCC
Q 009594          280 DP-------------------------------------------------WPKVS-------ENAKDLVKKMLNPDPKQ  303 (531)
Q Consensus       280 ~~-------------------------------------------------~~~~~-------~~~~~li~~~l~~~p~~  303 (531)
                      ..                                                 .+.+|       ..+.+|+.+||..||++
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence            00                                                 00011       35889999999999999


Q ss_pred             CCCHHHHhcCCcccc
Q 009594          304 RLTAEEVLEHPWLQN  318 (531)
Q Consensus       304 Rps~~~~l~h~~~~~  318 (531)
                      |.|..++|.||||..
T Consensus       737 Rit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  737 RITVNQALKHPFITE  751 (752)
T ss_pred             cCCHHHHhcCCcccC
Confidence            999999999999964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.2e-36  Score=284.17  Aligned_cols=242  Identities=45%  Similarity=0.755  Sum_probs=204.0

Q ss_pred             CceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCchHHH
Q 009594           68 EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDR  147 (531)
Q Consensus        68 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~  147 (531)
                      +||.||+|.+..+|+.+|+|++........  ...+.+|+..++++ +|+||+++++++......++++||+++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            589999999988899999999976543221  57888999999999 999999999999998999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccCCccccc
Q 009594          148 IVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA  227 (531)
Q Consensus       148 l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~a  227 (531)
                      +.....++...+..++.+++.++.|||+.+++|+||+|+||+++++   +.++|+|||.+.............++..|+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED---GHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC---CcEEEccccceeeeccccccccccCCcCCCC
Confidence            9877668999999999999999999999999999999999999654   4599999999987765544556678899999


Q ss_pred             chhcc-ccCCCccchhHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCC
Q 009594          228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL  305 (531)
Q Consensus       228 PE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  305 (531)
                      ||.+. ..++.++||||||+++|++++|..||.. .........+...... ....+..++..+.+++.+||..+|++||
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-FPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-CccccccCCHHHHHHHHHHccCCchhcc
Confidence            99876 5688899999999999999999999977 3333333333322222 1222222789999999999999999999


Q ss_pred             CHHHHhcCCcc
Q 009594          306 TAEEVLEHPWL  316 (531)
Q Consensus       306 s~~~~l~h~~~  316 (531)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=280.27  Aligned_cols=255  Identities=28%  Similarity=0.472  Sum_probs=207.3

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      +..+|.-+..+|.|+- .|..|.|.-.++.||+|+.... ...........+|+.++..+ .|+||++++.+|.-.    
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHH
Confidence            4457888999999999 8889999999999999998765 33344457788999999999 999999999998532    


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       130 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                        ..+|+||||+. .+|.+.+.  -.++-..+..|+.|++.|+.|||+.||+||||||+||++.   .+..+||.|||+|
T Consensus        92 ~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   92 EFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILDFGLA  165 (369)
T ss_pred             HHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeeccchhh
Confidence              45899999995 58988876  3467889999999999999999999999999999999995   4566999999999


Q ss_pred             cccCCCCccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC----------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID----------  276 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------  276 (531)
                      ....+.-.+..++.|..|+|||++-+ .|...+||||+||++.||++|+..|.+.+.-++..++.+....          
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            87655534556788999999998763 5999999999999999999999999887655544444322111          


Q ss_pred             ---------------------CCCCCCCC-------CCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          277 ---------------------FKRDPWPK-------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       277 ---------------------~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                                           ++...|+.       -+..+.+++.+||..+|++|.|+.++|.|||++
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                 11111211       134578999999999999999999999999997

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=308.11  Aligned_cols=252  Identities=29%  Similarity=0.478  Sum_probs=198.7

Q ss_pred             eeeccccCccCceE-EEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           58 YDLGRELGRGEFGV-TYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        58 y~~~~~lg~G~~g~-V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      |.-.+.+|.|+.|+ ||+|.  -.|+.||||.+....      ..-..+|+..|+.-..|||||++++.-.+....||+.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            34456789999886 68887  578999999885432      3456789999999989999999999989999999999


Q ss_pred             eccCCCchHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC--CCCCeEEEeecccccc
Q 009594          137 ELCEGGELFDRIVARG-H---YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVFF  210 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~-~---l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~--~~~~ikl~Dfg~a~~~  210 (531)
                      |.|. .+|.+++...+ .   ......+.++.|++.||+|||+.+||||||||.||||...+  ....++|+|||+++.+
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9995 69999997641 1   11144678899999999999999999999999999998642  2356899999999988


Q ss_pred             CCCCc----cccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          211 RPGEQ----FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       211 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      ..+..    ..+..||.+|+|||++.. .-+.++||+||||++|+.++| ..||......  ..+|+........-. +.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~-~~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE-PL  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec-cC
Confidence            76654    345679999999999984 456689999999999998885 8999554433  234554443321110 11


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ...++.+||.+|+.++|..||+|.++|.||+|....+
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek  775 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK  775 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence            1128999999999999999999999999999997554

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-36  Score=254.28  Aligned_cols=215  Identities=24%  Similarity=0.345  Sum_probs=178.3

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .-.++..-+..||+|+||.|-+.++..+|...|+|.+...-  .......+++|+.+..+...+|++|++||.+.+...+
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            34455677789999999999999999999999999997553  3445678889999998888999999999999999999


Q ss_pred             EEEEeccCCCchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          133 HIVMELCEGGELFDR----IVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~----l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      +|.||.|. .||..+    +...+.+++..+-+|+..++.||.|||++ .+||||+||+|||++.+   +++|+||||.+
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~---GqVKiCDFGIs  196 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD---GQVKICDFGIS  196 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC---CcEEEcccccc
Confidence            99999995 477554    44567899999999999999999999986 89999999999999654   55999999999


Q ss_pred             cccCCCCccccccCCcccccchhccc-----cCCCccchhHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhc
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRS  273 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~  273 (531)
                      -.+.+.-......|-..|||||.+..     .|+.+|||||||++++||.+++.||... ++.+++.++...
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            87765444343567788999998852     5888999999999999999999999553 445555555543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.3e-35  Score=298.19  Aligned_cols=261  Identities=22%  Similarity=0.315  Sum_probs=185.4

Q ss_pred             cccceeeccccCccCceEEEEEEEc----------------cCCcEEEEEEeeccccCChh-----------hHHHHHHH
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDV----------------NNGEKFACKSISKKKLRTAV-----------DIEDVRRE  106 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~E  106 (531)
                      -.++|++.++||+|+||+||+|...                ..++.||+|.+.........           ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3558999999999999999999742                24568999998643211000           11223457


Q ss_pred             HHHHHhCCCCCC-----eeecceEEEc--------CCeEEEEEeccCCCchHHHHHhcC---------------------
Q 009594          107 VQIMKHLPKHPN-----IVSLKDTYED--------DSAVHIVMELCEGGELFDRIVARG---------------------  152 (531)
Q Consensus       107 ~~~l~~l~~h~n-----iv~l~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~---------------------  152 (531)
                      +.++.++ .|.+     ++++++++..        .+..++|+||+++++|.+++....                     
T Consensus       223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777 4444     3567776642        356899999999999999886421                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccc--ccCCccccc
Q 009594          153 ---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE--IVGSPYYMA  227 (531)
Q Consensus       153 ---~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~--~~gt~~y~a  227 (531)
                         .+++..++.++.|++.||.|||+.+|+||||||+||+++.+   ..+||+|||++...........  ..+|+.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC---CcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence               23566788999999999999999999999999999999654   4599999999976544333222  234789999


Q ss_pred             chhcccc---------------------CC--CccchhHHHHHHHHHhhCCC-CCCCCCHHHHHHH----HH-----hcc
Q 009594          228 PEVLKRN---------------------YG--PEVDVWSAGVILYILLCGVP-PFWAETEQGVAQA----II-----RSV  274 (531)
Q Consensus       228 PE~~~~~---------------------~~--~~~Di~slG~il~~l~tg~~-pf~~~~~~~~~~~----~~-----~~~  274 (531)
                      ||.+...                     ++  .+.||||+||++|+|++|.. ||...........    ..     ...
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            9986421                     11  24799999999999999875 7643221111000    00     001


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHccccCc---CCCCCHHHHhcCCcccc
Q 009594          275 IDFKRDPWPKVSENAKDLVKKMLNPDP---KQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~~l~~~p---~~Rps~~~~l~h~~~~~  318 (531)
                      .......+...++...+|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            112223456788999999999999766   68999999999999964

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=303.95  Aligned_cols=248  Identities=26%  Similarity=0.423  Sum_probs=203.2

Q ss_pred             ceeeccccCccCceEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      +..+.+.||+|+||.||+|....       ....||+|..+.....  .+...+..|+.+|+.+..||||+.+++++...
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            44566799999999999997431       1467999988655432  56788999999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC
Q 009594          130 SAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK  193 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~  193 (531)
                      +.+++|+||+..|+|..++...+                .++...+..++.||+.|++||+++++|||||..+|||+.. 
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~-  453 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK-  453 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC-
Confidence            99999999999999999998765                3888999999999999999999999999999999999954 


Q ss_pred             CCCCCeEEEeeccccccCCCCcccc--ccC--Ccccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCC-HHHH
Q 009594          194 KESSPLKAIDFGLSVFFRPGEQFNE--IVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET-EQGV  266 (531)
Q Consensus       194 ~~~~~ikl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~-~~~~  266 (531)
                        +..+||+|||+|+..........  ..+  ...|||||.+. ..|+.+||||||||+||||+| |..||.+.. ..+.
T Consensus       454 --~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  454 --NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             --CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence              45699999999997655443321  122  34599999988 579999999999999999999 899998855 4455


Q ss_pred             HHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+ .++.......+  ..+++++.+++..||+.+|++||++.++.+
T Consensus       532 ~~-~l~~G~r~~~P--~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  532 LE-FLKEGNRMEQP--EHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HH-HHhcCCCCCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            44 33332222222  357999999999999999999999999964

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=269.51  Aligned_cols=258  Identities=29%  Similarity=0.477  Sum_probs=208.4

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC-----Ce
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-----SA  131 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-----~~  131 (531)
                      +.+-.+.||.|+||.||.+.|..+|+.||+|++..- .......+.+.+|+.+|..+ +|.|++..+++....     ..
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHH
Confidence            455568899999999999999999999999988642 23344457888999999999 999999999887543     35


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +|+++|++. .+|...+..-..++...+.-+++||++||+|||+.+|.||||||.|.|+   +.+..+||||||+++...
T Consensus       132 iYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  132 LYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccc
Confidence            778899985 4888877777789999999999999999999999999999999999999   456779999999999876


Q ss_pred             CCCc--cccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC---------
Q 009594          212 PGEQ--FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK---------  278 (531)
Q Consensus       212 ~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------  278 (531)
                      .++.  +...+-|..|+|||++.|  .|+.+.||||+|||+.|++..+..|+..+.-+.++.+........         
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            5543  333456889999999985  699999999999999999999999988877766665543221110         


Q ss_pred             -----------CC-CCC---------CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          279 -----------RD-PWP---------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       279 -----------~~-~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                 +. ..+         ....+...++.++|..+|.+|.+..+++.|++..+.+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                       00 000         1124578899999999999999999999999997654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=3.5e-35  Score=276.97  Aligned_cols=258  Identities=28%  Similarity=0.486  Sum_probs=203.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEcc---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..+.+.|..+.+||.|.|++||+|.+..   .++.||+|.+.....     ...+.+|+++|..+.++.||+++.+++..
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            4466679999999999999999999877   789999999875432     25688999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ++.+++|+||++-....+++.   .++...+..+++.++.||.++|.+|||||||||+|+|++...+  .-.|+|||+|.
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~--rg~LvDFgLA~  181 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ--RGVLVDFGLAQ  181 (418)
T ss_pred             CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC--CceEEechhHH
Confidence            999999999999888877763   4678999999999999999999999999999999999986554  36789999986


Q ss_pred             cc-----------------CC--CC--------------------------ccccccCCcccccchhcc--ccCCCccch
Q 009594          209 FF-----------------RP--GE--------------------------QFNEIVGSPYYMAPEVLK--RNYGPEVDV  241 (531)
Q Consensus       209 ~~-----------------~~--~~--------------------------~~~~~~gt~~y~aPE~~~--~~~~~~~Di  241 (531)
                      ..                 .+  +.                          ..-...||++|+|||++.  +..+.++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            11                 00  00                          001246999999999986  567889999


Q ss_pred             hHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHh--------------cc---------------------------cC---
Q 009594          242 WSAGVILYILLCGVPPFWAETE-QGVAQAIIR--------------SV---------------------------ID---  276 (531)
Q Consensus       242 ~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~--------------~~---------------------------~~---  276 (531)
                      ||.|||+..++++..||..... .+....+..              +.                           .+   
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            9999999999999999844321 111111100              00                           00   


Q ss_pred             --CCCCCCCC-CCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          277 --FKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       277 --~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                        .....|.. .+..+.+|+.+||..||.+|.|++++|+||||...
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence              00011111 34578999999999999999999999999999854

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=273.20  Aligned_cols=247  Identities=24%  Similarity=0.389  Sum_probs=190.7

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHh-CCCCCCeeecceEEEcC-
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH-LPKHPNIVSLKDTYEDD-  129 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~~h~niv~l~~~~~~~-  129 (531)
                      ..+..+..+.+.||+|.||+||+|.  +.|+.||||++...      +...+.+|.+|.+. +-+|+||+.+++.-..+ 
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecc--ccCCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            3456678999999999999999998  78999999999643      34678888888873 23999999999875432 


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCceEeecCCCCCC
Q 009594          130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ--------GVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       130 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                         .+++||++|-+.|||+++|.+ ..++....++++..++.||+|||..        .|.|||||..|||+.+   +++
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk---n~~  354 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NGT  354 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc---CCc
Confidence               369999999999999999987 4789999999999999999999963        4999999999999964   455


Q ss_pred             eEEEeeccccccCCCC-----ccccccCCcccccchhccccCC-------CccchhHHHHHHHHHhhC----------CC
Q 009594          199 LKAIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVLKRNYG-------PEVDVWSAGVILYILLCG----------VP  256 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~Di~slG~il~~l~tg----------~~  256 (531)
                      +.|+|+|+|.......     ..+..+||.+|||||++....+       ..+||||||.++||+...          .+
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            9999999997665432     2456799999999999975432       258999999999998752          47


Q ss_pred             CCCCCCHHHH----HHHH--HhcccCCCCCCCCCCC--HHHHHHHHHccccCcCCCCCHHHH
Q 009594          257 PFWAETEQGV----AQAI--IRSVIDFKRDPWPKVS--ENAKDLVKKMLNPDPKQRLTAEEV  310 (531)
Q Consensus       257 pf~~~~~~~~----~~~~--~~~~~~~~~~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~~  310 (531)
                      ||+...+.+-    ..++  .+...+..+..|...+  ..+..+|+.||..||.-|.|+--+
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            8865432221    1111  1122222333454433  357789999999999999998665

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=293.57  Aligned_cols=259  Identities=30%  Similarity=0.494  Sum_probs=220.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ..++|.++..+|+|+||.||+|+++.+++..|+|+++...   ..+...+.+|+-+++.. +|||||.+++.|.....++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecC-CCcChHHHHhhhhhhcCcE
Confidence            4567999999999999999999999999999999997653   34567788899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |+||||.||+|++...-.+++++.++...++..++||+|||+.|=+|||||-.||++.+.++   +|+.|||.+-.+...
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---vklaDfgvsaqitat  165 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---VKLADFGVSAQITAT  165 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc---eeecccCchhhhhhh
Confidence            99999999999998888889999999999999999999999999999999999999976654   999999998765433


Q ss_pred             -CccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-CCCCCCCCH
Q 009594          214 -EQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-RDPWPKVSE  287 (531)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  287 (531)
                       ....++.|||.|||||+..    +.|+..+|||++|++..|+-.-++|..........-.+.+..+..+ ...-.+.++
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~  245 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE  245 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence             2345688999999999753    6799999999999999999888888766555444443333333222 122234688


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+-+|++.+|.++|.+|||++.+|.|||....
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            99999999999999999999999999998754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=274.09  Aligned_cols=242  Identities=26%  Similarity=0.398  Sum_probs=187.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCCeeecceEEEcCC----e
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-KHPNIVSLKDTYEDDS----A  131 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~----~  131 (531)
                      ..++.+.||+|.||.||+|+.  +++.||||++...      +.+.+.+|-+|.+... .|+||++++++-....    .
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            467889999999999999994  5699999999543      4577888888877432 8999999999876544    8


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCceEeecCCCCCCeEEE
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ---------GVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                      ++||++|.+.|+|.++|..+ .+++....+++.-|++||+|||+.         .|+|||||..|||+.+   +.++.|+
T Consensus       283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~---DlTccIa  358 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN---DLTCCIA  358 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc---CCcEEee
Confidence            99999999999999999876 589999999999999999999962         5999999999999954   4569999


Q ss_pred             eeccccccCCCCc---cccccCCcccccchhccccCCC-------ccchhHHHHHHHHHhhCCC------------CCCC
Q 009594          203 DFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLKRNYGP-------EVDVWSAGVILYILLCGVP------------PFWA  260 (531)
Q Consensus       203 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-------~~Di~slG~il~~l~tg~~------------pf~~  260 (531)
                      |||+|..+.++..   .-..+||.+|||||++.+..+.       +.||||+|.+||||++...            ||..
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            9999998876543   2347899999999999864332       5899999999999998532            3321


Q ss_pred             -----CCHHHHHHHHHhccc-CCCCCCCCCC--CHHHHHHHHHccccCcCCCCCHHHH
Q 009594          261 -----ETEQGVAQAIIRSVI-DFKRDPWPKV--SENAKDLVKKMLNPDPKQRLTAEEV  310 (531)
Q Consensus       261 -----~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~li~~~l~~~p~~Rps~~~~  310 (531)
                           .+..+....+++... +..+..|.+.  ..-+++.+..||..||+.|.|+.=+
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                 122222233333221 1122223332  3468999999999999999998543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=290.38  Aligned_cols=245  Identities=25%  Similarity=0.367  Sum_probs=202.6

Q ss_pred             eeeccccCccCceEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      .+..++||+|+||+||+|.....|+    +||||++....  ......+++.|+-+|.++ +|||+++|++++.... +.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HH
Confidence            4556789999999999998655444    68888886543  333457889999999999 9999999999997765 88


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||++|+++|+|.+++.. +.++-....+.|..||++||.|||.++++||||..+|||+.+.   .++|+.|||+|+...+
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP---~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP---NHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC---CeEEEEecchhhccCc
Confidence            99999999999999976 4568899999999999999999999999999999999999654   4599999999998876


Q ss_pred             CCc-cccccC--Ccccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          213 GEQ-FNEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       213 ~~~-~~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      +.. +....|  .+.|||-|.+. ..|+.+||||||||++||++| |..||.+....++-..+..+.. ..  ..+.++-
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Ls--qPpiCti  927 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LS--QPPICTI  927 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CC--CCCCccH
Confidence            543 222222  45699999877 789999999999999999998 9999999887766554443322 22  2357889


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ++.-++.+||..|+..||+++++..
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999999999865

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-34  Score=323.75  Aligned_cols=239  Identities=23%  Similarity=0.320  Sum_probs=182.9

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|.....||+|+||.||+|.+..++..||+|.+.....       ....|+.+++++ +|||||++++++...+..++||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEE
Confidence            46667889999999999999988999999998864321       112468889999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH---EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||+++|+|.+++.   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.+..   .++. ||.+......
T Consensus       763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~---~~~~-~~~~~~~~~~  835 (968)
T PLN00113        763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE---PHLR-LSLPGLLCTD  835 (968)
T ss_pred             eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc---eEEE-eccccccccC
Confidence            9999999999985   3789999999999999999999   669999999999999965432   4544 6655433221


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH--HHHHHHHhc--------ccCCC-CCC
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRS--------VIDFK-RDP  281 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~--~~~~~~~~~--------~~~~~-~~~  281 (531)
                         ....+|+.|+|||++. ..++.++|||||||++|||+||+.||......  .........        ..+.. ...
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence               2236789999999887 56999999999999999999999998542110  111110000        00000 000


Q ss_pred             CC---CCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          282 WP---KVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       282 ~~---~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+   ....++.+++.+||+.+|++|||+.++++.
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00   112356789999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=273.76  Aligned_cols=200  Identities=33%  Similarity=0.577  Sum_probs=174.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChh-----hHHHHHHHHHHHHhCC--CCCCeeecceEEEcC
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----DIEDVRREVQIMKHLP--KHPNIVSLKDTYEDD  129 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~  129 (531)
                      +|..++.+|.|+||.|++|.++.+...|+||.+.+.+.-...     .+-.+-.||+||..|.  .|+||++++++|++.
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            589999999999999999999999999999999876543211     2234556999999993  299999999999999


Q ss_pred             CeEEEEEecc-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 SAVHIVMELC-EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 ~~~~lv~e~~-~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      +.+||+||-- +|.+|+++|...+.+++..+..|++|++.|+++||+.||||||||-+||.+++   ++-+||+|||.|.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~---~g~~klidfgsaa  718 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS---NGFVKLIDFGSAA  718 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEec---CCeEEEeeccchh
Confidence            9999999975 57899999999999999999999999999999999999999999999999964   4569999999987


Q ss_pred             ccCCCCccccccCCcccccchhcccc--CCCccchhHHHHHHHHHhhCCCCCCC
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWA  260 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~  260 (531)
                      ....+ ....++||..|.|||++.|.  .+..-|||+||++||.++....||+.
T Consensus       719 ~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            65544 45678999999999999863  46789999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-33  Score=246.44  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=194.3

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceE-EEcCC
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT-YEDDS  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~-~~~~~  130 (531)
                      -.+.+.|.|.+.||.|.||.+-+|.|+.+++.+++|.+....    ..+..|.+|...--.|+.|.||+.-|++ |+..+
T Consensus        20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            456778999999999999999999999999999999987643    2367899999988888899999998875 77888


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .+++++||++.|+|.+-+... .+-+.....++.|+++|+.|+|++++||||||.+||||...+ ...|||||||+++..
T Consensus        96 ~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRKV  173 (378)
T ss_pred             eEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeeccccccc
Confidence            999999999999999877654 478999999999999999999999999999999999997643 447999999998754


Q ss_pred             CCCCccccccCCcccccchhcc----c--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHH-HHHHH---HhcccCCCCC
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK----R--NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAI---IRSVIDFKRD  280 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~----~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~---~~~~~~~~~~  280 (531)
                      ...-  ...-.+..|.+||.+.    +  ...+.+|||.||+++|.++||.+||+.....+ -....   ......-.+.
T Consensus       174 g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  174 GTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             Ccee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence            3221  1122345699999763    2  35788999999999999999999996432111 11111   1111111222


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCC
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRL  305 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rp  305 (531)
                      .+..+++.+..+..+-|..+|++|.
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCcccccc
Confidence            3456788999999999999999993

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.5e-30  Score=237.82  Aligned_cols=211  Identities=44%  Similarity=0.768  Sum_probs=183.8

Q ss_pred             cCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCc
Q 009594           64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE  143 (531)
Q Consensus        64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  143 (531)
                      ||.|++|.||++.+..+++.+++|++.......  ....+.+|+..++.+ .|++|+++++++......++++|+++|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999988789999999997654321  346788999999999 89999999999999899999999999999


Q ss_pred             hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-ccccccC
Q 009594          144 LFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVG  221 (531)
Q Consensus       144 L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~g  221 (531)
                      |.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++..  ...++|+|||.+....... ......+
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence            99998765 468999999999999999999999999999999999999752  3459999999987665432 1233557


Q ss_pred             Ccccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          222 SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       222 t~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ...|++||.+..  .++.++|+||+|++++++                                   ..+.+++.+|+..
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence            888999998874  678899999999999998                                   5688999999999


Q ss_pred             CcCCCCCHHHHhcCC
Q 009594          300 DPKQRLTAEEVLEHP  314 (531)
Q Consensus       300 ~p~~Rps~~~~l~h~  314 (531)
                      +|++||++.++++|+
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-31  Score=243.63  Aligned_cols=248  Identities=18%  Similarity=0.239  Sum_probs=201.3

Q ss_pred             cceeeccccCccCceEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE-cC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-DD  129 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-~~  129 (531)
                      .+++....+.+|.||.||.|..+..     .+.|-+|.++...  .......++.|...+..+ .|||+.++.++.. +.
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcC-cCCCccceeEEEeecc
Confidence            3677888899999999999964432     3345566554332  444567888999999999 7999999999864 56


Q ss_pred             CeEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEE
Q 009594          130 SAVHIVMELCEGGELFDRIVAR--------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                      ...++++.+..-|+|..++...        ..++..++..++.|++.|++|||+.||||.||..+|.+|+   +..++||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId---d~LqVkl  437 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID---DQLQVKL  437 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh---hheeEEe
Confidence            7788999999999999998732        2367788999999999999999999999999999999995   4467999


Q ss_pred             EeeccccccCCCCccc---cccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccC
Q 009594          202 IDFGLSVFFRPGEQFN---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      +|=.+++.+-+.+...   .......|||||.+. ..|+.++|+|||||+||||+| |+.||...++.++...+..+.. 
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR-  516 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR-  516 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce-
Confidence            9999999876655321   122356799999887 679999999999999999998 9999999988888777665432 


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                        .....++|+++..++.-||...|++|||++|+..
T Consensus       517 --laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 --LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             --ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence              1222479999999999999999999999999864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.3e-29  Score=235.22  Aligned_cols=208  Identities=42%  Similarity=0.757  Sum_probs=177.2

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |.+.+.||.|++|.||+|.+..++..+|+|.+......  .....+.+|+..++++ +|+|++++++++......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence            56778999999999999999888999999999765432  2457888999999999 99999999999998899999999


Q ss_pred             ccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC--
Q 009594          138 LCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--  214 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~--  214 (531)
                      |+++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.+   ..++|+|||.+.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~---~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD---GLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeeCceeeEecCcccc
Confidence            9999999999987766 8999999999999999999999999999999999999654   559999999988765443  


Q ss_pred             ccccccCCcccccchhc-c-ccCCCccchhHHHHHHHHHhhCCCCCCC-CCHH-HHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQ-GVAQAII  271 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~-~-~~~~~~~Di~slG~il~~l~tg~~pf~~-~~~~-~~~~~~~  271 (531)
                      ......++..|++||.+ . ..++.++|+||||+++|+|++|+.||.. .... .+.+.+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            33445678899999987 3 4577899999999999999999999977 3443 3333333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=7.2e-31  Score=288.79  Aligned_cols=199  Identities=20%  Similarity=0.271  Sum_probs=147.4

Q ss_pred             CC-CCeeecceEE-------EcCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 009594          115 KH-PNIVSLKDTY-------EDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP  185 (531)
Q Consensus       115 ~h-~niv~l~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp  185 (531)
                      .| +||..++++|       .....++.++|++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP  108 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP  108 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence            45 5777777776       2234577788988 5699999965 34589999999999999999999999999999999


Q ss_pred             CceEeecC----------------CCCCCeEEEeeccccccCCCC-----------------ccccccCCcccccchhcc
Q 009594          186 ENFLFANK----------------KESSPLKAIDFGLSVFFRPGE-----------------QFNEIVGSPYYMAPEVLK  232 (531)
Q Consensus       186 ~NIll~~~----------------~~~~~ikl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~  232 (531)
                      +|||++..                +....+|++|||+++......                 ......||+.|||||++.
T Consensus       109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  188 (793)
T PLN00181        109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN  188 (793)
T ss_pred             hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence            99999542                223457888888876421100                 001245889999999876


Q ss_pred             -ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHh
Q 009594          233 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVL  311 (531)
Q Consensus       233 -~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  311 (531)
                       ..++.++|||||||+||||++|.+|+....  .....+.....   .+......+....++.+||.++|.+|||+.+++
T Consensus       189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil  263 (793)
T PLN00181        189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL---PPQILLNWPKEASFCLWLLHPEPSCRPSMSELL  263 (793)
T ss_pred             cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc---ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence             579999999999999999999998875322  12222222111   111112245677899999999999999999999


Q ss_pred             cCCccccc
Q 009594          312 EHPWLQNA  319 (531)
Q Consensus       312 ~h~~~~~~  319 (531)
                      +||||...
T Consensus       264 ~h~~~~~~  271 (793)
T PLN00181        264 QSEFINEP  271 (793)
T ss_pred             hchhhhhh
Confidence            99999764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.9e-27  Score=212.51  Aligned_cols=162  Identities=25%  Similarity=0.320  Sum_probs=126.0

Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccc
Q 009594          142 GELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV  220 (531)
Q Consensus       142 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~  220 (531)
                      |+|.+++... ..+++..++.|+.|++.||.|||+.+      ||+||+++.   ++.+|+  ||++.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~---~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW---DGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC---ccceee--ccceEeecccc----CC
Confidence            6899999764 45999999999999999999999999      999999954   345888  99987654322    26


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCCC---CCCCCCCH--HHHHHH
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKR---DPWPKVSE--NAKDLV  293 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~--~~~~li  293 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|+||..||...... .....+.........   .....++.  .+.+++
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            889999999887 57899999999999999999999999665432 223333322221111   11112333  699999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      .+||..+|.+|||+.++++|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            9999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-25  Score=221.40  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=194.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCC-cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC---CCCeeecceEE-EcCCe
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNG-EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK---HPNIVSLKDTY-EDDSA  131 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---h~niv~l~~~~-~~~~~  131 (531)
                      +|++.+.||+|+||.||.|.+..++ ..+|+|.-........   ..+..|+.++..+..   .++++.+++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            7999999999999999999987764 6788887765432211   156678999998842   36899999988 57788


Q ss_pred             EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCC--CCeEEEeeccc
Q 009594          132 VHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES--SPLKAIDFGLS  207 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~--~~ikl~Dfg~a  207 (531)
                      .+|||+.+ |.+|.++....  +.++..++..|+.|++.+|.+||+.|++||||||+|+++......  ..+.|.|||+|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999999 78999987554  469999999999999999999999999999999999999754322  46999999999


Q ss_pred             cccC---CCC-------c-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc
Q 009594          208 VFFR---PGE-------Q-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI  275 (531)
Q Consensus       208 ~~~~---~~~-------~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  275 (531)
                      +...   ...       . .....||..|.++.+.. ...+.+.|+||++.++.+++.|..||...........+.+...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8322   111       1 12345999999999877 4689999999999999999999999977654333333333222


Q ss_pred             CCCCC-CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          276 DFKRD-PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       276 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ..... .....+..+..+...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            22221 223456778888888888888899988777554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4e-26  Score=199.95  Aligned_cols=250  Identities=20%  Similarity=0.260  Sum_probs=198.3

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ....+.|+++++||+|+||.+|.|....+|..||||+=.... .    ...+..|..+.+.|+....|+.+..+.....+
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            345567999999999999999999999999999999764332 2    24567799999999888899999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      -.+||++. |-||.++..- ...++..+++.++-|++.-++|+|.+++|||||||+|+|+.-.-....+.|+|||+|+.+
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999999 7788887653 346899999999999999999999999999999999999965555566999999999876


Q ss_pred             CCCCc--------cccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHH---HHHhcccCCC
Q 009594          211 RPGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ---AIIRSVIDFK  278 (531)
Q Consensus       211 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~  278 (531)
                      .+...        -....||.+|.+-....+ ..+...|+-|+|.+|.++.-|..||++.......+   .|.....+.+
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            54321        234679999999776553 45778999999999999999999999876554433   3333332222


Q ss_pred             C-CCCCCCCHHHHHHHHHccccCcCCCCCH
Q 009594          279 R-DPWPKVSENAKDLVKKMLNPDPKQRLTA  307 (531)
Q Consensus       279 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~  307 (531)
                      . ......|.++.-.+..|-..--++-|+.
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            1 2245678888888888877666666654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.5e-26  Score=223.21  Aligned_cols=166  Identities=20%  Similarity=0.248  Sum_probs=129.2

Q ss_pred             CccccceeeccccCccCceEEEEEEEcc-CCcEEEEEEeecccc--CChhhHHHHHHHHHHHHhCCCCCCeee-cceEEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHLPKHPNIVS-LKDTYE  127 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~-l~~~~~  127 (531)
                      ..+..+|.+.+.||+|+||+||+|.+.. +++.+|||++.....  ........+.+|+.+|+++ +|+|+++ +++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~---   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA---   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE---
Confidence            5567789999999999999999999876 678889998753211  1222356788999999999 8999885 443   


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCceEeecCCCCCCeEEEeecc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL-KPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dl-kp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                       .+..++||||++|++|.. +.   ...   ...++.|++.||.|||+.||+|||| ||+|||++.+   +.+||+|||+
T Consensus        90 -~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~---~~ikLiDFGl  158 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD---GEAAVIDFQL  158 (365)
T ss_pred             -cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC---CCEEEEECcc
Confidence             246899999999999963 21   111   2568899999999999999999999 9999999543   4599999999


Q ss_pred             ccccCCCCc---------cccccCCcccccchhcc
Q 009594          207 SVFFRPGEQ---------FNEIVGSPYYMAPEVLK  232 (531)
Q Consensus       207 a~~~~~~~~---------~~~~~gt~~y~aPE~~~  232 (531)
                      |+.......         .....+++.|+|||.+.
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            986653321         13456788899999886

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.2e-27  Score=249.57  Aligned_cols=258  Identities=29%  Similarity=0.497  Sum_probs=198.2

Q ss_pred             eeccccCccCceEEEEEEEccCCcEEEEEEeecc--ccCChhh-HHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKK--KLRTAVD-IEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        59 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .....+|.|++|.|+.+........++.|.+...  ....... ...+..|+.+-..| .|||++..+..+.+.....-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhh
Confidence            4567899999999999887777777777765421  1111111 22256677778888 999999888777666555556


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      ||||++ +|+.++...+.++...+-.++.|++.||+|+|+.||.||||||+|+++...   +.+||+|||.+.....+- 
T Consensus       400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~---g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN---GILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC---CceEEeecCcceeeccCcc
Confidence            999999 999999988889999999999999999999999999999999999999654   469999999987554321 


Q ss_pred             ----ccccccCCcccccchhcc-ccCCC-ccchhHHHHHHHHHhhCCCCCCCCCHHHHH--HHHH---hcccCCCCCCCC
Q 009594          215 ----QFNEIVGSPYYMAPEVLK-RNYGP-EVDVWSAGVILYILLCGVPPFWAETEQGVA--QAII---RSVIDFKRDPWP  283 (531)
Q Consensus       215 ----~~~~~~gt~~y~aPE~~~-~~~~~-~~Di~slG~il~~l~tg~~pf~~~~~~~~~--~~~~---~~~~~~~~~~~~  283 (531)
                          .....+|+..|+|||++. ..|.+ ..||||.|++++.|++|+.||......+..  ....   ......+...+.
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence                234678999999999987 56765 589999999999999999999554333221  1110   111111222344


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .+|...+.+|.+||+.+|.+|.|+.+|++.+||+....
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            57888999999999999999999999999999997654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.5e-24  Score=215.10  Aligned_cols=257  Identities=37%  Similarity=0.609  Sum_probs=206.1

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-CeeecceEEEcCCeEEEEE
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-NIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~  136 (531)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.............+.+|+.+++.+ .|+ +|+++.+++......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCEEEEEE
Confidence            778889999999999999976   78899999876544433467889999999999 666 8999999998877789999


Q ss_pred             eccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          137 ELCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +++.++++.+++....   .++......++.|++.++.|+|+.+++|||+||+||+++..+.  .++++|||.+......
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~  155 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDP  155 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCC
Confidence            9999999997776664   6899999999999999999999999999999999999965431  4899999998755443


Q ss_pred             C-------ccccccCCcccccchhccc----cCCCccchhHHHHHHHHHhhCCCCCCCCCH----HHHHHHHHhcccC-C
Q 009594          214 E-------QFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVID-F  277 (531)
Q Consensus       214 ~-------~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~-~  277 (531)
                      .       ......||..|+|||.+.+    .++...|+||+|++++++++|..||.....    ......+...... .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            2       2356789999999998864    578899999999999999999999877653    3333333333222 1


Q ss_pred             CCCCCCCC----CHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          278 KRDPWPKV----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       278 ~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ........    ...+.+++..++..+|..|.+..+...++|.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence            11111111    25789999999999999999999999987665443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.4e-25  Score=202.81  Aligned_cols=248  Identities=21%  Similarity=0.313  Sum_probs=190.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+...|++.++||.|+||+++.|...-+++.||||.=..+.     +..++..|....+.|...++|+..|-+...+.+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            34457999999999999999999999999999999654332     2357888999999998999999999888888889


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC--CCCCeEEEeeccccc
Q 009594          133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVF  209 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~--~~~~ikl~Dfg~a~~  209 (531)
                      .||+|++ |-||.++..= ...++..+++.++.|++.-++|+|++.+|+|||||+|+||...+  ....|.++|||+|+.
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999999 7788887754 34699999999999999999999999999999999999997533  233589999999998


Q ss_pred             cCCCCc--------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHH---HHHHHhcccCC
Q 009594          210 FRPGEQ--------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV---AQAIIRSVIDF  277 (531)
Q Consensus       210 ~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~  277 (531)
                      +.+...        ..+..||-+||+-.... ..-+...|+=|||-++++.+-|..||++......   .++|-......
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            765432        24567999999977544 3578889999999999999999999988654332   33332211111


Q ss_pred             C-CCCCCCCCHHHHHHHHHccccCcCCCCC
Q 009594          278 K-RDPWPKVSENAKDLVKKMLNPDPKQRLT  306 (531)
Q Consensus       278 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps  306 (531)
                      + ......+|.++..-+...-..+-.+-|+
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD  288 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPD  288 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence            0 1112345666655555554444444454

>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

Probab=99.93  E-value=2.4e-25  Score=187.23  Aligned_cols=146  Identities=32%  Similarity=0.550  Sum_probs=137.5

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-ccC
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-KMA  431 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~~~  431 (531)
                      ..+++++++.+++++|..+|.|++|.|+..||..+++.+|.+++..++..+|..+|. +.+.|+|.+|+.++.... ...
T Consensus        11 ~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~~~~   89 (160)
T COG5126          11 FTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLKRGD   89 (160)
T ss_pred             cccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhccCC
Confidence            467899999999999999999999999999999999999999999999999999999 999999999999876654 556


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .+++++++|+.||.|++|+|+..|++.+++.+|..+++++++.+++.+|.|+||.|+|+||++.+...
T Consensus        90 ~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~~~~~  157 (160)
T COG5126          90 KEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKLIKDS  157 (160)
T ss_pred             cHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCCCCceEeHHHHHHHHhcc
Confidence            68999999999999999999999999999999999999999999999999999999999999987654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-26  Score=230.10  Aligned_cols=242  Identities=26%  Similarity=0.489  Sum_probs=202.7

Q ss_pred             ccCccCceEEEEEEE---ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           63 ELGRGEFGVTYLCTD---VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        63 ~lg~G~~g~V~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      .+|.|+||.|+++..   ...|..+|.|+..+......... ....|-.++.....||.++++...++.+...++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999998753   23577889998876654433322 45568888888867999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccc
Q 009594          140 EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI  219 (531)
Q Consensus       140 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~  219 (531)
                      .||.|...+.....+.+.....+...++-|++++|+.+|+|||+|++||+++.   .+++++.|||+++..-..+..   
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~---~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL---EGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc---cCccccCCchhhhHhHhhhhc---
Confidence            99999999988888999999999999999999999999999999999999964   455999999999876544332   


Q ss_pred             cCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          220 VGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      +||..|||||+++ .....+|.||||+++++|+||..||.+    ++...|.+..+..+.    .++..+.+++..++..
T Consensus       154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR  224 (612)
T ss_pred             ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence            8999999999998 567789999999999999999999977    556666665544443    4567889999999999


Q ss_pred             CcCCCCC-----HHHHhcCCcccccc
Q 009594          300 DPKQRLT-----AEEVLEHPWLQNAK  320 (531)
Q Consensus       300 ~p~~Rps-----~~~~l~h~~~~~~~  320 (531)
                      +|..|.-     +.++++|+||+.+.
T Consensus       225 ~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  225 NPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             CHHHHhccCcchhHHHhccchheeee
Confidence            9999984     58999999998654

>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=99.91  E-value=8.9e-24  Score=183.27  Aligned_cols=142  Identities=36%  Similarity=0.630  Sum_probs=132.1

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccC-----
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMA-----  431 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~-----  431 (531)
                      +..+...++++|+.+|++++|+|+..||..+++.+|..++..++..++..+|.|++|.|+|+||+.++.......     
T Consensus         3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~   82 (151)
T KOG0027|consen    3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEA   82 (151)
T ss_pred             CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccc
Confidence            456788999999999999999999999999999999999999999999999999999999999999877553322     


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..+.++.+|+.||.|++|+||.+||+.+|..+|.+.+.++++.++..+|.|+||.|+|+||++++..
T Consensus        83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~~~m~~  149 (151)
T KOG0027|consen   83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDVDGDGKVNFEEFVKMMSG  149 (151)
T ss_pred             cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHhc
Confidence            2458999999999999999999999999999999999999999999999999999999999999864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=5.9e-24  Score=193.49  Aligned_cols=176  Identities=20%  Similarity=0.221  Sum_probs=135.6

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHH------HHHHHHHHHhCCCCCCeeecceE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED------VRREVQIMKHLPKHPNIVSLKDT  125 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~h~niv~l~~~  125 (531)
                      ..+.++|++++.||.|+||.||++.+  ++..+|+|++.............      +.+|+..+.++ .||+|+.+.++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~  103 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDF  103 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEe
Confidence            45677999999999999999999764  47789999997665444433333      57899999999 99999999988


Q ss_pred             EEcC--------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCC
Q 009594          126 YEDD--------SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       126 ~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~  197 (531)
                      +...        +..+|||||++|.+|.++.    .+++    ....+++.+|..+|+.|++|||+||+||+++.+   +
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~---g  172 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN---G  172 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC---C
Confidence            6533        3588999999999998763    2333    345699999999999999999999999999643   3


Q ss_pred             CeEEEeeccccccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHh
Q 009594          198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILL  252 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~  252 (531)
                       ++|+|||.+...........          =++...|+.++|+||||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence             99999998765432221110          012355778999999999987654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-24  Score=192.95  Aligned_cols=241  Identities=17%  Similarity=0.263  Sum_probs=191.1

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      ..++-+|.....|+.|+|+  +.|..++.|++......... ...|..|...|+-+ .||||+.+++.+....++.++..
T Consensus       192 lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~ri-srdfneefp~lrif-shpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTARI-SRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchhh-cchhhhhCcceeee-cCCchhhhhhhccCCCCceEeee
Confidence            4566788999999999998  67788888988766554332 35678899999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC-C-eecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          138 LCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQG-V-MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~-i-iH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||+.|||+..++....  ++..++.+++.++++|++|||+.. + .---|....|+++.+- ...+-.+|--++...   
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsfqe---  343 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSFQE---  343 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeeeec---
Confidence            9999999999988765  578899999999999999999973 3 3446888999996532 223434454333221   


Q ss_pred             CccccccCCcccccchhcccc----CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                         ......|.|||||.++..    .-.++|+|||++++||+.|...||...+..+.-.++.-..+....+  |.+++.+
T Consensus       344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip--pgis~hm  418 (448)
T KOG0195|consen  344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP--PGISRHM  418 (448)
T ss_pred             ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC--CCccHHH
Confidence               223457899999998742    2347999999999999999999999988887776665554443333  5789999


Q ss_pred             HHHHHHccccCcCCCCCHHHHh
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVL  311 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l  311 (531)
                      ..|+.-|+..||.+||.+..++
T Consensus       419 ~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999988774

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.8e-23  Score=188.60  Aligned_cols=142  Identities=20%  Similarity=0.222  Sum_probs=111.2

Q ss_pred             ccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhh-----------------------HHHHHHHHHHHHhCCCCC
Q 009594           61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-----------------------IEDVRREVQIMKHLPKHP  117 (531)
Q Consensus        61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~~h~  117 (531)
                      ...||+|++|.||+|.+. +|+.||+|++..........                       .....+|+.++.++ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence            468999999999999986 89999999997643211100                       11234599999999 777


Q ss_pred             CeeecceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCceEeecCCCC
Q 009594          118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-HEQGVMHRDLKPENFLFANKKES  196 (531)
Q Consensus       118 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~iiH~Dlkp~NIll~~~~~~  196 (531)
                      ++.....+... . .+|||||++|+++.........++...+..++.|++.+|.++ |+.||+||||||+||++++    
T Consensus        80 ~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~----  153 (190)
T cd05147          80 GIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD----  153 (190)
T ss_pred             CCCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC----
Confidence            77544433222 2 379999999887766555566799999999999999999999 7999999999999999963    


Q ss_pred             CCeEEEeecccccc
Q 009594          197 SPLKAIDFGLSVFF  210 (531)
Q Consensus       197 ~~ikl~Dfg~a~~~  210 (531)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            34999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.90  E-value=2.8e-24  Score=223.72  Aligned_cols=224  Identities=31%  Similarity=0.556  Sum_probs=178.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ....+|..++.|..|+||.||.++|+.+.+.+|.| +.++++        +.+-  ++... ++|.+|            
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a-~npfvv------------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFA-GNPFVV------------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--ccccc-CCccee------------
Confidence            34568999999999999999999999999999994 443321        1111  33333 666666            


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                               |+-...+..-++++...        +.+++|||+.||+|||+||+|.+|+.-   +++|++|||+++..-.
T Consensus       136 ---------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m---GhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 ---------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM---GHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             ---------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeec---ccccccchhhhhhhhh
Confidence                     45555565556666544        778999999999999999999999654   4599999999864321


Q ss_pred             C--------C------c--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc
Q 009594          213 G--------E------Q--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI  275 (531)
Q Consensus       213 ~--------~------~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  275 (531)
                      .        .      .  -...+|||.|+|||++. ..|+..+|+|++|+|+|+.+-|..||.+.+..+....++....
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            1        0      0  12358999999999865 7799999999999999999999999999999999999988888


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCcCCCC---CHHHHhcCCccccccc
Q 009594          276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNAKK  321 (531)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~~~~  321 (531)
                      .++... ...++++++++.++|..+|..|.   .+.++.+|+||+....
T Consensus       276 ~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  276 EWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             cccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence            777764 46789999999999999999997   6889999999986543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=2.6e-23  Score=194.98  Aligned_cols=234  Identities=26%  Similarity=0.418  Sum_probs=152.6

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC---------CCCeeecceEE-
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK---------HPNIVSLKDTY-  126 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~niv~l~~~~-  126 (531)
                      .+...+.||.|+++.||.+.|..+|+.+|+|++...........+.+.+|.-....+..         |-.++..++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            35677889999999999999999999999999987664444467778777766555422         22233333322 


Q ss_pred             --------EcC---C-----eEEEEEeccCCCchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 009594          127 --------EDD---S-----AVHIVMELCEGGELFDRIV---ARGH----YTERAAAAVMKTIVEVVQVCHEQGVMHRDL  183 (531)
Q Consensus       127 --------~~~---~-----~~~lv~e~~~~~~L~~~l~---~~~~----l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dl  183 (531)
                              ...   .     ..+++|+-+. ++|..++.   ....    +.......+..|+++.+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                    111   1     2367888884 58877653   2222    223344567789999999999999999999


Q ss_pred             CCCceEeecCCCCCCeEEEeeccccccCCCCccccccCCcccccchhccc---------cCCCccchhHHHHHHHHHhhC
Q 009594          184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR---------NYGPEVDVWSAGVILYILLCG  254 (531)
Q Consensus       184 kp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~Di~slG~il~~l~tg  254 (531)
                      +|+|++++.+   +.+.|+||+......  ........+..|.+||....         .++.+.|.|+||+++|.|++|
T Consensus       172 ~~~nfll~~~---G~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQD---GGVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TT---S-EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCC---CCEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999654   459999998765432  22222344577999997642         368889999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 009594          255 VPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQR  304 (531)
Q Consensus       255 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  304 (531)
                      ..||...........      .+.  ...++|+.++.||..+|+.+|.+|
T Consensus       247 ~lPf~~~~~~~~~~~------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW------DFS--RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence            999966533211110      122  223789999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-23  Score=218.30  Aligned_cols=239  Identities=23%  Similarity=0.356  Sum_probs=179.8

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeecccc-CChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      +|...+.||++.|=.|.+|++. .|. |++|++-+... -......+-..|++ ...+ ++||++++.-+.......|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence            5788899999999999999974 454 88999977652 22223344444555 3344 899999998887778888999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC--CC
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--PG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~--~~  213 (531)
                      -+|.. .+|++++..++.+...+...|+.|++.||.-+|+.||+|||||.+|||+++-+.   +.|+||..-+...  .+
T Consensus       100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW---~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW---LYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech---hhhhcccccCCccCCCC
Confidence            99994 599999998888999999999999999999999999999999999999998776   7899998655332  11


Q ss_pred             Cc--cc----cccCCcccccchhccc-----------c-CCCccchhHHHHHHHHHhh-CCCCCCCCC-------HHHHH
Q 009594          214 EQ--FN----EIVGSPYYMAPEVLKR-----------N-YGPEVDVWSAGVILYILLC-GVPPFWAET-------EQGVA  267 (531)
Q Consensus       214 ~~--~~----~~~gt~~y~aPE~~~~-----------~-~~~~~Di~slG~il~~l~t-g~~pf~~~~-------~~~~~  267 (531)
                      ..  +.    +......|.|||.+..           . .+++.||||+||+++||++ |.+||.-..       .....
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP  255 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence            11  11    1222346999997631           1 4678999999999999988 788882210       01111


Q ss_pred             HHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.+++.+          -+..++.+|..|++.+|++|.|+++.|+.
T Consensus       256 e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1222211          12358899999999999999999999985

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3e-22  Score=178.13  Aligned_cols=188  Identities=21%  Similarity=0.305  Sum_probs=140.4

Q ss_pred             eccccCccCceEEEEEEEccCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEec
Q 009594           60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL  138 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  138 (531)
                      +...|++|+||+||.+.  ..+.+++.+.+.....- .......+.+|+++|++|.+|++|++++++    +..+++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            45689999999999877  37788887776543321 111122578899999999777899999886    356899999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCceEeecCCCCCCeEEEeeccccccCCCCcc-
Q 009594          139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL-KPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-  216 (531)
Q Consensus       139 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dl-kp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~-  216 (531)
                      +.|.+|...+..       ....++.|++.+|.++|+.||+|||| ||+|||++.+   +.++|+|||+|......... 
T Consensus        80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~---g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED---GSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC---CCEEEEECCCceecCCcchHH
Confidence            999998754321       12457889999999999999999999 7999999643   45999999999865443311 


Q ss_pred             -------------ccccCCcccccchhcc--ccCC-CccchhHHHHHHHHHhhCCCCCCCCCH
Q 009594          217 -------------NEIVGSPYYMAPEVLK--RNYG-PEVDVWSAGVILYILLCGVPPFWAETE  263 (531)
Q Consensus       217 -------------~~~~gt~~y~aPE~~~--~~~~-~~~Di~slG~il~~l~tg~~pf~~~~~  263 (531)
                                   .-...++.|++|+.-.  ...+ ...++++.|+-+|.++|+..|.++.++
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                         0123577888888432  3334 567888999999999999999877653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=4.8e-22  Score=180.17  Aligned_cols=143  Identities=18%  Similarity=0.187  Sum_probs=112.4

Q ss_pred             ccccCccCceEEEEEEEccCCcEEEEEEeeccccCC---------------------hh--hHHHHHHHHHHHHhCCCCC
Q 009594           61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---------------------AV--DIEDVRREVQIMKHLPKHP  117 (531)
Q Consensus        61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---------------------~~--~~~~~~~E~~~l~~l~~h~  117 (531)
                      ...||+|++|.||+|.+. +|+.||+|++.......                     ..  ......+|...+.++ .|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence            568999999999999976 89999999998652110                     00  012345789999999 888


Q ss_pred             CeeecceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCC
Q 009594          118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKES  196 (531)
Q Consensus       118 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~  196 (531)
                      +|.....+....  .+|||||++|+++.........++...+..++.|++.+|.++|+ .||+||||||+||+++    +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----~  153 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----D  153 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----C
Confidence            876554443332  48999999988665443345578889999999999999999999 9999999999999996    2


Q ss_pred             CCeEEEeeccccccC
Q 009594          197 SPLKAIDFGLSVFFR  211 (531)
Q Consensus       197 ~~ikl~Dfg~a~~~~  211 (531)
                      +.++|+|||+|....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            459999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=2e-21  Score=158.59  Aligned_cols=146  Identities=28%  Similarity=0.508  Sum_probs=135.8

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHH-HHhhccCc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVS-VHLKKMAN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~-~~~~~~~~  432 (531)
                      ..+++++..+|+..|..||.+++|+|+..||..+++++|..+...++..+...+|+++.|.|+|++|...+ ..+....+
T Consensus        25 ~~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt  104 (172)
T KOG0028|consen   25 SELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFRRVMTVKLGERDT  104 (172)
T ss_pred             ccccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHHHHHHHHHhccCc
Confidence            34567788899999999999999999999999999999999999999999999999999999999999864 44455568


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .++++.+|+.+|.|++|+|+..+|+.+...+|++++++++.+|+.++|.|+||.|+-+||..+|++.
T Consensus       105 ~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~dgevneeEF~~imk~t  171 (172)
T KOG0028|consen  105 KEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGDGEVNEEEFIRIMKKT  171 (172)
T ss_pred             HHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcccccccccHHHHHHHHhcC
Confidence            8999999999999999999999999999999999999999999999999999999999999998753

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6.1e-21  Score=173.56  Aligned_cols=139  Identities=17%  Similarity=0.220  Sum_probs=109.2

Q ss_pred             eccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC----CCCCeeecceEEEcCC---e-
Q 009594           60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP----KHPNIVSLKDTYEDDS---A-  131 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~---~-  131 (531)
                      -...||+|+||.||.  ++.++.. +||++.....   .....+.+|+.+++.+.    +||||++++++++.+.   . 
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            346899999999995  6667666 6998865432   23467899999999994    4799999999998763   3 


Q ss_pred             EEEEEec--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCCceEeecCC-CCCCeEEEeeccc
Q 009594          132 VHIVMEL--CEGGELFDRIVARGHYTERAAAAVMKTIVEVV-QVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLS  207 (531)
Q Consensus       132 ~~lv~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~iiH~Dlkp~NIll~~~~-~~~~ikl~Dfg~a  207 (531)
                      +.+|+||  +.+++|.+++.+. .+++.  ..++.+++.++ +|||+++|+||||||+|||++..+ ....++|+||+.+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            3378999  5579999999664 56666  46688888887 999999999999999999997644 3447999995433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.2e-20  Score=177.05  Aligned_cols=193  Identities=26%  Similarity=0.418  Sum_probs=140.5

Q ss_pred             CCCCCeeecceEEEc---------------------------CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHH
Q 009594          114 PKHPNIVSLKDTYED---------------------------DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI  166 (531)
Q Consensus       114 ~~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi  166 (531)
                      ..|||||++..+|.+                           ...+|+||-.++ .+|.+++..+ ..+....+-++.|+
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHH
Confidence            479999998877632                           235889998885 5999988765 56788889999999


Q ss_pred             HHHHHHHHHcCCeecCCCCCceEeecCC-CCCCeEEEeeccccccCCC-------CccccccCCcccccchhccc---cC
Q 009594          167 VEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFRPG-------EQFNEIVGSPYYMAPEVLKR---NY  235 (531)
Q Consensus       167 ~~~l~~LH~~~iiH~Dlkp~NIll~~~~-~~~~ikl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~~  235 (531)
                      ++|+.|||++||.|||+|.+|||+.-++ ....+.|+|||.+..-...       .......|.-.-||||+...   +.
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            9999999999999999999999997543 3345789999976532211       01123456777999998763   21


Q ss_pred             ----CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q 009594          236 ----GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV  310 (531)
Q Consensus       236 ----~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  310 (531)
                          -.++|.|+.|.+.||+++...||+.......-..-.++  .........+|+.+.+++..+|+.||++|+|+.-+
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe--~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE--SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh--hhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence                23899999999999999999999884322111111111  00111123588999999999999999999986433

>KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=99.83  E-value=1.2e-19  Score=146.94  Aligned_cols=144  Identities=28%  Similarity=0.474  Sum_probs=132.8

Q ss_pred             hHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHH-Hhhcc
Q 009594          352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSV-HLKKM  430 (531)
Q Consensus       352 ~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~-~~~~~  430 (531)
                      +-..|++.++.++++.|..+|+|+||.|+++||+.++.++|...++++++.++.+.    .|.|+|.-|+.++- ++...
T Consensus        22 vFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea----~gPINft~FLTmfGekL~gt   97 (171)
T KOG0031|consen   22 VFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEA----PGPINFTVFLTMFGEKLNGT   97 (171)
T ss_pred             HHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhC----CCCeeHHHHHHHHHHHhcCC
Confidence            34567889999999999999999999999999999999999999999999999875    68999999999765 44555


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..++.+..+|+.||.+++|.|..+.|+.+|...|..+++++++.+++.+-.|..|.++|.+|..++...
T Consensus        98 dpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~~~ithG  166 (171)
T KOG0031|consen   98 DPEEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFDYKAFTYIITHG  166 (171)
T ss_pred             CHHHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhCCcccCCceeHHHHHHHHHcc
Confidence            678899999999999999999999999999999999999999999999999999999999999999854

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.7e-20  Score=199.78  Aligned_cols=193  Identities=24%  Similarity=0.383  Sum_probs=158.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCCeeecceEEEcCCeEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~l  134 (531)
                      .|.|.+.||.|+||.||+|.+.. |+.||+|+=+....      -++.--.+++.+|.  --+.|..+..++...+.-++
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~------WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP------WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc------eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            69999999999999999999766 99999998654331      11222344555661  12456667777777788899


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC----CCCCCeEEEeecccccc
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK----KESSPLKAIDFGLSVFF  210 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~----~~~~~ikl~Dfg~a~~~  210 (531)
                      |+||.+.|+|.+++...+..++..+..++.|++..|++||..+|||+||||+|+||...    ....-++|+|||.|..+
T Consensus       772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            99999999999999877779999999999999999999999999999999999999642    12345999999998654


Q ss_pred             ---CCCCccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCC
Q 009594          211 ---RPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVP  256 (531)
Q Consensus       211 ---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~  256 (531)
                         .++......++|-.+-.+|+..| ++++..|.|.|+.+++-|+.|++
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence               34556677889999999999885 79999999999999999999865

>KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.83  E-value=5.7e-20  Score=159.01  Aligned_cols=158  Identities=23%  Similarity=0.350  Sum_probs=145.7

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhCC-CCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhh
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGG-QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAF  440 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~-~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  440 (531)
                      ..+..+|...|+|+.|.|+.+||..+|.... ...+.+.++.|+..+|.+.+|+|+|+||..++..+..      ++.+|
T Consensus        57 ~~~~~~f~~vD~d~sg~i~~~eLq~aLsn~~~~~Fs~~TcrlmI~mfd~~~~G~i~f~EF~~Lw~~i~~------Wr~vF  130 (221)
T KOG0037|consen   57 PQLAGWFQSVDRDRSGRILAKELQQALSNGTWSPFSIETCRLMISMFDRDNSGTIGFKEFKALWKYINQ------WRNVF  130 (221)
T ss_pred             HHHHHHHHhhCccccccccHHHHHHHhhcCCCCCCCHHHHHHHHHHhcCCCCCccCHHHHHHHHHHHHH------HHHHH
Confidence            4688999999999999999999999998664 5788899999999999999999999999999976654      89999


Q ss_pred             cccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCCcCC--
Q 009594          441 SFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSIS--  518 (531)
Q Consensus       441 ~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G~i~--  518 (531)
                      +.||.|++|.|+..||+.+|..+|..++++..+.+++.+|.-++|.|.|++|++++.....+-++|+.+|++.+|.|+  
T Consensus       131 ~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L~~lt~~Fr~~D~~q~G~i~~~  210 (221)
T KOG0037|consen  131 RTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVLQRLTEAFRRRDTAQQGSITIS  210 (221)
T ss_pred             HhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHHHHHHHHHHHhccccceeEEEe
Confidence            999999999999999999999999999999999999999988899999999999999999999999999999999875  


Q ss_pred             HHHHHHH
Q 009594          519 LKLMREE  525 (531)
Q Consensus       519 ~~e~~~~  525 (531)
                      .++|.+.
T Consensus       211 y~dfl~~  217 (221)
T KOG0037|consen  211 YDDFLQM  217 (221)
T ss_pred             HHHHHHH
Confidence            4666554

>PTZ00183 centrin; Provisional

Probab=99.83  E-value=9.7e-20  Score=160.34  Aligned_cols=147  Identities=25%  Similarity=0.493  Sum_probs=134.0

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMAN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~  432 (531)
                      ..++++++.+++.+|..+|.+++|.|+.+||..+++.+|..++..++..+|..+|.+++|.|+|.||+..+... .....
T Consensus         9 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~   88 (158)
T PTZ00183          9 PGLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDP   88 (158)
T ss_pred             CCCCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCc
Confidence            45778889999999999999999999999999999999888888999999999999999999999999876543 33445


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      .+.++.+|+.+|.+++|.|+.+||..++..+|..++.++++.+|..+|.|++|.|+++||.+++...+
T Consensus        89 ~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~  156 (158)
T PTZ00183         89 REEILKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDEADRNGDGEISEEEFYRIMKKTN  156 (158)
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhccc
Confidence            67899999999999999999999999999999999999999999999999999999999999987643

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=5.5e-20  Score=171.63  Aligned_cols=146  Identities=18%  Similarity=0.139  Sum_probs=113.6

Q ss_pred             ceeeccccCccCceEEEEEE-EccCCcEEEEEEeeccccCC-------------------hh--hHHHHHHHHHHHHhCC
Q 009594           57 DYDLGRELGRGEFGVTYLCT-DVNNGEKFACKSISKKKLRT-------------------AV--DIEDVRREVQIMKHLP  114 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~~~~~~-------------------~~--~~~~~~~E~~~l~~l~  114 (531)
                      -|.+.+.||.|++|.||+|. +..+|+.||+|++.......                   ..  ....+.+|+.+++++ 
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-  107 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-  107 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            48899999999999999999 67899999999997543210                   00  012356899999999 


Q ss_pred             CCC--CeeecceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCceEee
Q 009594          115 KHP--NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG-VMHRDLKPENFLFA  191 (531)
Q Consensus       115 ~h~--niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-iiH~Dlkp~NIll~  191 (531)
                      .+.  .++++++   .. ..++||||++|.+|.........+....+..++.|++.+|.+||+.| |+||||||+||+++
T Consensus       108 ~~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      108 YEAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             HhcCCCCCeeeE---ec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            542  2334443   22 35899999999888776545556677778899999999999999999 99999999999996


Q ss_pred             cCCCCCCeEEEeeccccccC
Q 009594          192 NKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       192 ~~~~~~~ikl~Dfg~a~~~~  211 (531)
                          .+.++|+|||.|....
T Consensus       184 ----~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 ----DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ----CCCEEEEEChhhhccC
Confidence                2359999999987543

>PTZ00184 calmodulin; Provisional

Probab=99.82  E-value=1.2e-19  Score=158.17  Aligned_cols=145  Identities=34%  Similarity=0.628  Sum_probs=131.7

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccC
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMA  431 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~  431 (531)
                      +..++++++..+++.|..+|.+++|.|+.+||..++..++..++..++..+|..+|.+++|.|+|++|+.++... ....
T Consensus         2 ~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~   81 (149)
T PTZ00184          2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTLMARKMKDTD   81 (149)
T ss_pred             CCccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCc
Confidence            345678888999999999999999999999999999999888888899999999999999999999999877643 2234


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ..+.+..+|+.+|.+++|+|+.+||..++...|..++.++++.++..+|.+++|.|+|+||+.++.
T Consensus        82 ~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~  147 (149)
T PTZ00184         82 SEEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINYEEFVKMMM  147 (149)
T ss_pred             HHHHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHHh
Confidence            456789999999999999999999999999999889999999999999999999999999998875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=1.2e-20  Score=184.40  Aligned_cols=175  Identities=31%  Similarity=0.479  Sum_probs=132.9

Q ss_pred             CeEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      .++||.|++|...+|.++|.++..   .+....+.++.|++.|++|   ++.+|||+||.||+...++   .+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~---q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD---QLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch---hhhhhhhhh
Confidence            468899999999999999975433   5778889999999999999   9999999999999996544   599999999


Q ss_pred             ccccCCCC-------ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCC
Q 009594          207 SVFFRPGE-------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDF  277 (531)
Q Consensus       207 a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  277 (531)
                      ........       .....+||.+||+||.+. .+|+.++||||||++|+|+++ -..++...   .....+....+  
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~i--  477 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGII--  477 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCC--
Confidence            87665444       445678999999999988 579999999999999999997 22222111   11111222211  


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       278 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ++..+.+. +.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus       478 p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  478 PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            11112222 345689999999999999988887777765

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=1.6e-19  Score=180.22  Aligned_cols=224  Identities=21%  Similarity=0.297  Sum_probs=165.4

Q ss_pred             HhCCCCCCeeecceEEEcCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCC-eecCCCCCce
Q 009594          111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGV-MHRDLKPENF  188 (531)
Q Consensus       111 ~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~i-iH~Dlkp~NI  188 (531)
                      +.+ .|.|+.++++.+.++...++|.+||.-|+|.+.+.. ...+++--...++++|+.||.|||+..| .|+.+++.|.
T Consensus         2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            456 899999999999999999999999999999999977 4458888899999999999999998866 9999999999


Q ss_pred             EeecCCCCCCeEEEeeccccccCCC---CccccccCCcccccchhcccc--------CCCccchhHHHHHHHHHhhCCCC
Q 009594          189 LFANKKESSPLKAIDFGLSVFFRPG---EQFNEIVGSPYYMAPEVLKRN--------YGPEVDVWSAGVILYILLCGVPP  257 (531)
Q Consensus       189 ll~~~~~~~~ikl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~Di~slG~il~~l~tg~~p  257 (531)
                      +++   ....+||+|||+.......   .......-...|.|||.+.+.        .+.+.||||+|++++|+++...|
T Consensus        81 lvd---~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LVD---SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             eee---eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            995   4567999999998776421   111112234569999998642        46789999999999999999999


Q ss_pred             CCCCCH----HHHHHHHHhcccCCCCCCCC---CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCC--CCCch
Q 009594          258 FWAETE----QGVAQAIIRSVIDFKRDPWP---KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP--NVSLG  328 (531)
Q Consensus       258 f~~~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~--~~~~~  328 (531)
                      |.....    .++...+.........+...   ..++.+..++..||..+|+.||++.++-..  +.......  .-++.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~--~~~~~~~~~~~~nl~  235 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK--LLTINKGGSSKGNLM  235 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh--hhhhcccccccchhH
Confidence            966322    23444433312222222211   456689999999999999999999998442  22221211  11455


Q ss_pred             hHHHHHHhhhhH
Q 009594          329 ETVKARLKQFSV  340 (531)
Q Consensus       329 ~~~~~~~~~~~~  340 (531)
                      .++...+.+|..
T Consensus       236 D~m~~~le~Y~~  247 (484)
T KOG1023|consen  236 DSLFRMLESYAD  247 (484)
T ss_pred             HHHHHHHHHHHh
Confidence            566666666544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.9e-18  Score=158.64  Aligned_cols=137  Identities=29%  Similarity=0.391  Sum_probs=113.4

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA-----VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      +.||+|++|.||+|..  .|..+++|+.........     .....+.+|+.++..+ .|++|+....++......++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEE
Confidence            5799999999999985  778899998754332211     1234577899999999 8999888777777778889999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      ||++|++|.+.+....   . ....++.+++.+|.++|+.|++|||++|.||+++    ...++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            9999999999886543   2 8889999999999999999999999999999997    34489999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=2.1e-20  Score=195.48  Aligned_cols=260  Identities=31%  Similarity=0.529  Sum_probs=206.6

Q ss_pred             cceeeccccCccCceEEEEEEEcc-CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..|.+.+.||+|+|+.|-.+.... ....+|.|.+.... ........+..|..+-+.+.+|+|++.+++...+....++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            348888999999999999887533 34456666665443 2223345556688888888669999999999999999999


Q ss_pred             EEeccCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          135 VMELCEGGELFDRI-VARG-HYTERAAAAVMKTIVEVVQVCH-EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       135 v~e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~qi~~~l~~LH-~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +++|..|+++...+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+.  .++++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhcccc
Confidence            99999999999988 5554 5788889999999999999999 999999999999999975542  58999999998776


Q ss_pred             C-CC---ccccccC-Ccccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCC
Q 009594          212 P-GE---QFNEIVG-SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFKRDPWP  283 (531)
Q Consensus       212 ~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~  283 (531)
                      . ..   .....+| ++.|+|||...+  ...+..|+||.|+++.-+++|..|+......... .........+...+|.
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            5 22   2334678 999999998775  4577899999999999999999998654433211 1111111223456788


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      .++....+++.+++..+|+.|.+..++..+||+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            89999999999999999999999999999999987

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=7.7e-18  Score=154.29  Aligned_cols=134  Identities=26%  Similarity=0.355  Sum_probs=106.7

Q ss_pred             ccCccCceEEEEEEEccCCcEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        63 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      .||+|+||.||+|.  ..+..+++|+........     ......+.+|+.+++.+ .|+++....-++...+..++|||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEE
Confidence            48999999999998  567899999865433221     11235677899999999 77776655555556667789999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      |++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|.||+++    .+.++++|||++...
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence            9999999988754321       8899999999999999999999999999996    345999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=99.75  E-value=1.2e-17  Score=133.12  Aligned_cols=141  Identities=23%  Similarity=0.359  Sum_probs=126.0

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC--CCCceecchhHhHHHHhhc---c
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD--GDGSLNYGEFVAVSVHLKK---M  430 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~--~~g~i~~~ef~~~~~~~~~---~  430 (531)
                      +++++..+++++|..||..+||.|+..++..+|+.+|.+|++.++.+.....+.+  +--.|+|++|+.+++.+..   .
T Consensus         5 ~~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm~q~vaknk~q   84 (152)
T KOG0030|consen    5 FTPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPKRREMNVKRLDFEEFLPMYQQVAKNKDQ   84 (152)
T ss_pred             cCcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcccchhhhhhhhHHHHHHHHHHHHhcccc
Confidence            4567778999999999999999999999999999999999999999999888776  4468999999998876544   3


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .+.++.-+.++.||++++|.|...||+++|..+|+.+++++++.++.-. .|.+|.|+|++|++.+.
T Consensus        85 ~t~edfvegLrvFDkeg~G~i~~aeLRhvLttlGekl~eeEVe~Llag~-eD~nG~i~YE~fVk~i~  150 (152)
T KOG0030|consen   85 GTYEDFVEGLRVFDKEGNGTIMGAELRHVLTTLGEKLTEEEVEELLAGQ-EDSNGCINYEAFVKHIM  150 (152)
T ss_pred             CcHHHHHHHHHhhcccCCcceeHHHHHHHHHHHHhhccHHHHHHHHccc-cccCCcCcHHHHHHHHh
Confidence            4568888999999999999999999999999999999999999998765 57889999999998654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.1e-17  Score=152.99  Aligned_cols=139  Identities=24%  Similarity=0.298  Sum_probs=106.0

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh-------------------hhHHHHHHHHHHHHhCCCCCC
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA-------------------VDIEDVRREVQIMKHLPKHPN  118 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~~h~n  118 (531)
                      |.+.+.||.|+||.||++.. .+|+.+|+|++........                   ........|+.++..+ .|++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence            78889999999999999986 4799999999764321000                   0112356789999988 6664


Q ss_pred             --eeecceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCC
Q 009594          119 --IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES  196 (531)
Q Consensus       119 --iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~  196 (531)
                        ++..++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||+|+||+++.   +
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~---~  161 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD---D  161 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC---C
Confidence              444433    245589999999999876432      1345688899999999999999999999999999964   4


Q ss_pred             CCeEEEeeccccccC
Q 009594          197 SPLKAIDFGLSVFFR  211 (531)
Q Consensus       197 ~~ikl~Dfg~a~~~~  211 (531)
                      +.++|+|||.+....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            469999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=1.7e-17  Score=174.44  Aligned_cols=140  Identities=23%  Similarity=0.304  Sum_probs=111.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ..|...+.||+|+||.||++...  +..+++|+.......     .......+.+|+.+++.+ +|++++....++....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCC
Confidence            34567889999999999999853  444555543322211     112245688999999999 8999988877777777


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ..++||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+||+++    +..++|+|||+++..
T Consensus       410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCcccccC
Confidence            7899999999999998874        4578899999999999999999999999999993    234999999998764

>KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=99.73  E-value=4.4e-17  Score=142.65  Aligned_cols=156  Identities=22%  Similarity=0.322  Sum_probs=132.8

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCH-HHHHHHHHhcCCCCCCceecchhHhHHHHhhccC
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPE-ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMA  431 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~-~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~  431 (531)
                      .+.+++.++..+++-|..  ...+|.++.++|+.++.+.+..... .-++.+|+.+|.|+||.|+|.||+..++......
T Consensus        20 ~t~f~~~ei~~~Yr~Fk~--~cP~G~~~~~~F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt   97 (193)
T KOG0044|consen   20 QTKFSKKEIQQWYRGFKN--ECPSGRLTLEEFREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGT   97 (193)
T ss_pred             hcCCCHHHHHHHHHHhcc--cCCCCccCHHHHHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCc
Confidence            356778888888888877  5679999999999999999864443 4467799999999999999999999988888888


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhc----CC-------CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDE----VD-------TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~-------~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      .++.++++|+.||.|++|+||.+|+..++..+    +.       ..+++-++.+|+.+|.|+||.||++||+..++..+
T Consensus        98 ~eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~d~  177 (193)
T KOG0044|consen   98 LEEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALPEDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKADP  177 (193)
T ss_pred             HHHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCCcccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhhCH
Confidence            89999999999999999999999999988753    21       12345689999999999999999999999999988


Q ss_pred             hHHHHHhhhC
Q 009594          501 DWRKASRQYS  510 (531)
Q Consensus       501 ~~~~~f~~~D  510 (531)
                      .+..++..+.
T Consensus       178 ~i~~~l~~~~  187 (193)
T KOG0044|consen  178 SILRALEQDP  187 (193)
T ss_pred             HHHHHhhhcc
Confidence            8888776544

>KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms]

Probab=99.73  E-value=3.4e-17  Score=143.46  Aligned_cols=149  Identities=29%  Similarity=0.454  Sum_probs=124.2

Q ss_pred             hhhhhHHHhhHHHHhcccccC-CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCc-eecchhHhHHHHhhccC
Q 009594          354 EFLSVEEVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGS-LNYGEFVAVSVHLKKMA  431 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~-i~~~ef~~~~~~~~~~~  431 (531)
                      +.++..|+..|...|..+|.+ ++|+|+.+||..+. .+..++   -.+++++.++.+++|. |+|++|+..+.......
T Consensus        25 ~~fs~~EI~~L~~rF~kl~~~~~~g~lt~eef~~i~-~~~~Np---~~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~~  100 (187)
T KOG0034|consen   25 TQFSANEIERLYERFKKLDRNNGDGYLTKEEFLSIP-ELALNP---LADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPKA  100 (187)
T ss_pred             cccCHHHHHHHHHHHHHhccccccCccCHHHHHHHH-HHhcCc---HHHHHHHHHhccCCCCccCHHHHHHHHhhhcCCc
Confidence            458899999999999999999 99999999998887 333333   3567888889888888 99999999877665554


Q ss_pred             cH-HHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCC--H----HHHHHHHHhccCCCCcceeHHHHHHHHHhCchHH
Q 009594          432 ND-EHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSG--E----DVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWR  503 (531)
Q Consensus       432 ~~-~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~--~----~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~  503 (531)
                      .. +.++-+|+.||.+++|+|+.+|+..++..+ +...+  +    +.++.+|.++|.|+||+|+++||.+++.+.+.+.
T Consensus       101 ~~~~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~IsfeEf~~~v~~~P~~~  180 (187)
T KOG0034|consen  101 SKREKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLEDIVDKTFEEADTDGDGKISFEEFCKVVEKQPDLL  180 (187)
T ss_pred             cHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcCccHH
Confidence            44 599999999999999999999999999876 33333  3    3377899999999999999999999999887776


Q ss_pred             HHH
Q 009594          504 KAS  506 (531)
Q Consensus       504 ~~f  506 (531)
                      +.+
T Consensus       181 ~~m  183 (187)
T KOG0034|consen  181 EKM  183 (187)
T ss_pred             HHc
Confidence            644

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=4.2e-17  Score=147.81  Aligned_cols=140  Identities=21%  Similarity=0.244  Sum_probs=98.0

Q ss_pred             ccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHH---------------------HHHHHHHHHHhCCCCC--
Q 009594           61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE---------------------DVRREVQIMKHLPKHP--  117 (531)
Q Consensus        61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h~--  117 (531)
                      .+.||+|+||.||+|.+. +|+.||+|++............                     ....|...+.++ .+.  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL-YEAGV   79 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH-HHcCC
Confidence            467999999999999975 8999999998754322111111                     113566666666 333  


Q ss_pred             CeeecceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCC
Q 009594          118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKES  196 (531)
Q Consensus       118 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~  196 (531)
                      .+++++++    ...++||||++|+++........... ..+..++.+++.++.++|. .||+||||||+||+++    +
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~  150 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----D  150 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----C
Confidence            24444433    24589999999854432111111111 6788999999999999999 9999999999999997    3


Q ss_pred             CCeEEEeeccccccC
Q 009594          197 SPLKAIDFGLSVFFR  211 (531)
Q Consensus       197 ~~ikl~Dfg~a~~~~  211 (531)
                      +.++|+|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            459999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.70  E-value=8.3e-17  Score=147.66  Aligned_cols=167  Identities=17%  Similarity=0.227  Sum_probs=135.7

Q ss_pred             HHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc-------cCc
Q 009594          360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK-------MAN  432 (531)
Q Consensus       360 ~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~-------~~~  432 (531)
                      ...++..+|..+|.+++|.|+..|+..++..........+..+-+...|.|.||.|+|+|+...+.....       ...
T Consensus        75 ~~~rl~~l~~~iD~~~Dgfv~~~El~~wi~~s~k~~v~~~~~~~~~~~d~~~Dg~i~~eey~~~~~~~~~~~~~~~d~e~  154 (325)
T KOG4223|consen   75 SQERLGKLVPKIDSDSDGFVTESELKAWIMQSQKKYVVEEAARRWDEYDKNKDGFITWEEYLPQTYGRVDLPDEFPDEED  154 (325)
T ss_pred             hHHHHHHHHhhhcCCCCCceeHHHHHHHHHHHHHHHHHHHHHHHHHHhccCccceeeHHHhhhhhhhcccCccccccchh
Confidence            4458999999999999999999999999887665556667778899999999999999999987654211       111


Q ss_pred             H-------HHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-----
Q 009594          433 D-------EHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-----  499 (531)
Q Consensus       433 ~-------~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----  499 (531)
                      .       ..-+.-|+..|.|+||.+|++||..+|... .+.|..-.+.+.+...|+|+||.|+++||+.=|...     
T Consensus       155 ~~~~~km~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~~~~~  234 (325)
T KOG4223|consen  155 NEEYKKMIARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHEGNEE  234 (325)
T ss_pred             cHHHHHHHHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhccCCCC
Confidence            1       123567999999999999999999999865 456666778999999999999999999999987643     


Q ss_pred             ------chHHHHHhhhCccCCCcCCHHHHHHHH
Q 009594          500 ------TDWRKASRQYSRERFNSISLKLMREEG  526 (531)
Q Consensus       500 ------~~~~~~f~~~D~~~~G~i~~~e~~~~~  526 (531)
                            .+-...|..+|+|+||+++.+|+++-+
T Consensus       235 epeWv~~Ere~F~~~~DknkDG~L~~dEl~~WI  267 (325)
T KOG4223|consen  235 EPEWVLTEREQFFEFRDKNKDGKLDGDELLDWI  267 (325)
T ss_pred             CcccccccHHHHHHHhhcCCCCccCHHHHhccc
Confidence                  224455668899999999999998643

>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=99.69  E-value=1.3e-16  Score=138.36  Aligned_cols=97  Identities=27%  Similarity=0.445  Sum_probs=68.2

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-----------chH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-----------TDW  502 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----------~~~  502 (531)
                      ..++.+|+.||.|++|+|+..||..+++.+|..+++.++..++..+|.|++|.|+++||+.++...           ..+
T Consensus         8 ~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~~~~el   87 (151)
T KOG0027|consen    8 LELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEASSEEL   87 (151)
T ss_pred             HHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccccHHHH
Confidence            446677777777777777777777777777777777777777777777777777777777766621           156


Q ss_pred             HHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          503 RKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       503 ~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      +++|+.||+||+|+||.+||+++|..+|
T Consensus        88 ~eaF~~fD~d~~G~Is~~el~~~l~~lg  115 (151)
T KOG0027|consen   88 KEAFRVFDKDGDGFISASELKKVLTSLG  115 (151)
T ss_pred             HHHHHHHccCCCCcCcHHHHHHHHHHhC
Confidence            7777777777777777777777777665

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=5.5e-16  Score=145.05  Aligned_cols=138  Identities=20%  Similarity=0.292  Sum_probs=103.5

Q ss_pred             cccC-ccCceEEEEEEEccCCcEEEEEEeecccc----------CChhhHHHHHHHHHHHHhCCCCCCe--eecceEEEc
Q 009594           62 RELG-RGEFGVTYLCTDVNNGEKFACKSISKKKL----------RTAVDIEDVRREVQIMKHLPKHPNI--VSLKDTYED  128 (531)
Q Consensus        62 ~~lg-~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~  128 (531)
                      ..|| .|+.|+||.+..  .+..+++|.+.....          ........+.+|+.++.+| .|++|  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence            4577 888899999874  478899998864321          1112345678899999999 88775  666666432


Q ss_pred             C-C---eEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEe
Q 009594          129 D-S---AVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       129 ~-~---~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                      . .   ..++|+|+++| .+|.+++.. ..+++..    +.+++.+|.+||+.||+||||||.|||++.++   .++|+|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---~v~LID  185 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG---KFWLID  185 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC---CEEEEE
Confidence            2 2   23599999997 688887754 3556543    56899999999999999999999999996543   599999


Q ss_pred             ecccccc
Q 009594          204 FGLSVFF  210 (531)
Q Consensus       204 fg~a~~~  210 (531)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9988764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=9.7e-17  Score=160.28  Aligned_cols=259  Identities=20%  Similarity=0.253  Sum_probs=198.3

Q ss_pred             CccccceeeccccCc--cCceEEEEEEE--ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           52 QDISIDYDLGRELGR--GEFGVTYLCTD--VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ..+...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.. ...+..-..=.+|+...+.+..|+|.++.+..+.
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccc
Confidence            334456788899999  99999999998  788999999873321 1222222333457777778888999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCeecCCCCCceEeecCCCCCCeEEE
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVE----VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~----~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                      ..+..++-+|+| +.+|..+...... ++...++.++.+...    ||.++|+.+++|-|+||.||++..+.  ..++++
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~  265 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLT  265 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecC
Confidence            999999999999 5788888876555 889999999999999    99999999999999999999996542  458999


Q ss_pred             eeccccccCCCCcccc------ccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 009594          203 DFGLSVFFRPGEQFNE------IVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       203 Dfg~a~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      |||+...+.++.....      ..|...|++||..++-++..+||||+|.++.+..++..+..........  ..+... 
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~r~~~-  342 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QLRQGY-  342 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--cccccc-
Confidence            9999887766543221      2467789999999999999999999999999988876554332111100  001110 


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      .+.......+..+...+..|+..+|-.|+++..+++|++..
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence            11222234456677799999999999999999999999987

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.7e-15  Score=132.02  Aligned_cols=134  Identities=23%  Similarity=0.283  Sum_probs=110.3

Q ss_pred             eccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-CCeeecceEEEcCCeEEEEEec
Q 009594           60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVSLKDTYEDDSAVHIVMEL  138 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~e~  138 (531)
                      +.+.||.|.++.||++...  +..+++|.......     ...+.+|+.+++.+..+ +++++++.++...+..++++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            3567999999999999963  47899998854432     35688899999999434 6899998888877889999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ---GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       139 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ++|+++..+       +......++.+++.+|.+||..   +++|+|++|+||+++.   ...++++|||.+...
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~---~~~~~l~Df~~~~~~  139 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD---GKILGIIDWEYAGYG  139 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC---CcEEEEEecccccCC
Confidence            998877643       5677788899999999999985   7999999999999975   345999999988643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism]

Probab=99.62  E-value=5e-15  Score=139.53  Aligned_cols=157  Identities=20%  Similarity=0.270  Sum_probs=135.7

Q ss_pred             hHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHH
Q 009594          358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHL  436 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~  436 (531)
                      ++-..+++.+|+.+|.+++|.++..++...+.++... +..+-+..+|..+|.|.||.++|.||...+.     ..+.++
T Consensus        10 ~er~~r~~~lf~~lD~~~~g~~d~~~l~k~~~~l~~~~~~~~~~~~l~~~~d~~~dg~vDy~eF~~Y~~-----~~E~~l   84 (463)
T KOG0036|consen   10 EERDIRIRCLFKELDSKNDGQVDLDQLEKGLEKLDHPKPNYEAAKMLFSAMDANRDGRVDYSEFKRYLD-----NKELEL   84 (463)
T ss_pred             HHHHHHHHHHHHHhccCCCCceeHHHHHHHHHhcCCCCCchHHHHHHHHhcccCcCCcccHHHHHHHHH-----HhHHHH
Confidence            3444489999999999999999999999999999765 6777788999999999999999999999875     356678


Q ss_pred             HHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh--CchHHHH---Hh---h
Q 009594          437 HKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA--GTDWRKA---SR---Q  508 (531)
Q Consensus       437 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~--~~~~~~~---f~---~  508 (531)
                      ..+|+..|.+.||.|+.+|+...|+.+|.++++++++.+|+.+|+++++.|+++||...+.-  .+++.++   ++   .
T Consensus        85 ~~~F~~iD~~hdG~i~~~Ei~~~l~~~gi~l~de~~~k~~e~~d~~g~~~I~~~e~rd~~ll~p~s~i~di~~~W~h~~~  164 (463)
T KOG0036|consen   85 YRIFQSIDLEHDGKIDPNEIWRYLKDLGIQLSDEKAAKFFEHMDKDGKATIDLEEWRDHLLLYPESDLEDIYDFWRHVLL  164 (463)
T ss_pred             HHHHhhhccccCCccCHHHHHHHHHHhCCccCHHHHHHHHHHhccCCCeeeccHHHHhhhhcCChhHHHHHHHhhhhheE
Confidence            99999999999999999999999999999999999999999999999999999999998873  3334333   22   3


Q ss_pred             hCccCCCcCCH
Q 009594          509 YSRERFNSISL  519 (531)
Q Consensus       509 ~D~~~~G~i~~  519 (531)
                      +|-..+..|..
T Consensus       165 idigE~~~iPd  175 (463)
T KOG0036|consen  165 IDIGEDAVLPD  175 (463)
T ss_pred             EEccccccCCc
Confidence            57777777773

>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

Probab=99.62  E-value=7.3e-15  Score=124.03  Aligned_cols=135  Identities=17%  Similarity=0.246  Sum_probs=118.4

Q ss_pred             CCCCHHHH---HHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCC
Q 009594          393 QNIPEADL---QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSG  468 (531)
Q Consensus       393 ~~~~~~~~---~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~  468 (531)
                      ..++.+++   ++.|..+|+|++|.|++.++..++..+...+.+..+..+|..+|. +.|.|+..+|..+|... ....+
T Consensus        12 ~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~~~~~   90 (160)
T COG5126          12 TQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLKRGDK   90 (160)
T ss_pred             ccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhccCCc
Confidence            34555554   456888899999999999999998888888889999999999999 99999999999999765 45566


Q ss_pred             HHHHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          469 EDVINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       469 ~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+++..+|+.+|.|+||.|+..|+..+++..      +.+...++.+|+|+||.|+.+||.+.+..
T Consensus        91 ~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~~~~  156 (160)
T COG5126          91 EEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKLIKD  156 (160)
T ss_pred             HHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCCCCceEeHHHHHHHHhc
Confidence            8899999999999999999999999999954      56999999999999999999999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.60  E-value=2.5e-16  Score=165.05  Aligned_cols=261  Identities=28%  Similarity=0.461  Sum_probs=201.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      +.+.+.+.+.+|+++.++.+.-..+|...++|+......-...+.+..+.+-.++-.- .+|.++...--+......+++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchh
Confidence            4577888999999999999987777877777766543322222233444444443333 566777665556667889999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC---C
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR---P  212 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~---~  212 (531)
                      ++|+.+++|...++..+..++..++..+..+..+++|||+..+.|||++|.|++..   ..++.+++|||......   +
T Consensus       883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccccccccC
Confidence            99999999999999888888889999999999999999999999999999999995   44568999998332110   0


Q ss_pred             ------------------C-----------CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC
Q 009594          213 ------------------G-----------EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET  262 (531)
Q Consensus       213 ------------------~-----------~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~  262 (531)
                                        .           .......||+.|.+||.+. ......+|+|++|+++++.++|.+||....
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                              0           0012246899999999876 467888999999999999999999999999


Q ss_pred             HHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHH---HHhcCCccccccc
Q 009594          263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAE---EVLEHPWLQNAKK  321 (531)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~---~~l~h~~~~~~~~  321 (531)
                      .+.+.+++.......+..+ ...+....+++..++..+|.+|..+.   ++-.|+||+....
T Consensus      1040 pq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred             hhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence            9888888777655444332 24678899999999999999999888   9999999987554

>PTZ00183 centrin; Provisional

Probab=99.59  E-value=1.6e-14  Score=126.99  Aligned_cols=133  Identities=18%  Similarity=0.234  Sum_probs=115.0

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~  476 (531)
                      +++..+|..+|.+++|.|++.||..++...........+..+|+.+|.+++|.|+.+||..++... ......+.++.+|
T Consensus        17 ~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F   96 (158)
T PTZ00183         17 KEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDPREEILKAF   96 (158)
T ss_pred             HHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            456778999999999999999999887655444566789999999999999999999999988654 3455677899999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      +.+|.+++|.|+.+||..++...      ..+..+|..+|.+++|.|+.+||.+.+...+
T Consensus        97 ~~~D~~~~G~i~~~e~~~~l~~~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~  156 (158)
T PTZ00183         97 RLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDEADRNGDGEISEEEFYRIMKKTN  156 (158)
T ss_pred             HHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhccc
Confidence            99999999999999999999842      4589999999999999999999999987643

>KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=99.54  E-value=9.6e-14  Score=121.72  Aligned_cols=150  Identities=19%  Similarity=0.214  Sum_probs=122.3

Q ss_pred             CcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhc-cCcHHHHHHhhcccCCCCCcceeHH
Q 009594          377 GKINLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKK-MANDEHLHKAFSFFDRNRSGFIEIE  454 (531)
Q Consensus       377 g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~~~~G~i~~~  454 (531)
                      ..++.+.+......  ...+..++..+++.+=.+ .+|.++-++|..++..... .........+|+.||.|+||.|+..
T Consensus         7 ~~~~~~~~e~l~~~--t~f~~~ei~~~Yr~Fk~~cP~G~~~~~~F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~   84 (193)
T KOG0044|consen    7 SKLQPESLEQLVQQ--TKFSKKEIQQWYRGFKNECPSGRLTLEEFREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFL   84 (193)
T ss_pred             ccCCcHHHHHHHHh--cCCCHHHHHHHHHHhcccCCCCccCHHHHHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHH
Confidence            34444444333322  567889999999988655 4899999999998765543 4566778899999999999999999


Q ss_pred             HHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-----------------chHHHHHhhhCccCCCcC
Q 009594          455 ELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-----------------TDWRKASRQYSRERFNSI  517 (531)
Q Consensus       455 el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----------------~~~~~~f~~~D~~~~G~i  517 (531)
                      ||...|........++-++-+|+.+|.|+||.||++|+++++...                 .-+..+|+.+|+|+||.|
T Consensus        85 Efi~als~~~rGt~eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~~~~~~~~~~v~~if~k~D~n~Dg~l  164 (193)
T KOG0044|consen   85 EFICALSLTSRGTLEEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALPEDEETPEERVDKIFSKMDKNKDGKL  164 (193)
T ss_pred             HHHHHHHHHcCCcHHHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCCcccccHHHHHHHHHHHcCCCCCCcc
Confidence            999999877666677788899999999999999999999998721                 128899999999999999


Q ss_pred             CHHHHHHHHhh
Q 009594          518 SLKLMREEGLQ  528 (531)
Q Consensus       518 ~~~e~~~~~~~  528 (531)
                      |.+||.+.+..
T Consensus       165 T~eef~~~~~~  175 (193)
T KOG0044|consen  165 TLEEFIEGCKA  175 (193)
T ss_pred             cHHHHHHHhhh
Confidence            99999998764

>PTZ00184 calmodulin; Provisional

Probab=99.54  E-value=7.4e-14  Score=121.42  Aligned_cols=130  Identities=21%  Similarity=0.273  Sum_probs=111.8

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC-CCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~  476 (531)
                      +.+...|..+|.+++|.|+++||..++.........+.+..+|+.+|.+++|.|+.+||..++.... .....+.+..+|
T Consensus        11 ~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~~F   90 (149)
T PTZ00184         11 AEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDSEEEIKEAF   90 (149)
T ss_pred             HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            3466789999999999999999998876555445677899999999999999999999999987643 334556789999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      ..+|.|++|.|+.+||..++...      ..+..+|..+|.+++|.|+.+||...+.
T Consensus        91 ~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~  147 (149)
T PTZ00184         91 KVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINYEEFVKMMM  147 (149)
T ss_pred             HhhCCCCCCeEeHHHHHHHHHHHCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHHh
Confidence            99999999999999999998742      5588999999999999999999998764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.49  E-value=4.5e-13  Score=119.62  Aligned_cols=143  Identities=14%  Similarity=0.126  Sum_probs=103.1

Q ss_pred             ccccCccCceEEEEEEEcc------CCcEEEEEEeecccc--CC-----------------hhhHHHHH----HHHHHHH
Q 009594           61 GRELGRGEFGVTYLCTDVN------NGEKFACKSISKKKL--RT-----------------AVDIEDVR----REVQIMK  111 (531)
Q Consensus        61 ~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~--~~-----------------~~~~~~~~----~E~~~l~  111 (531)
                      ...||.|--+.||.|....      .+..+|+|++.....  ..                 ......+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998543      357999999863211  00                 01122333    7999999


Q ss_pred             hCCCC-CCeeecceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCceE
Q 009594          112 HLPKH-PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-HEQGVMHRDLKPENFL  189 (531)
Q Consensus       112 ~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~iiH~Dlkp~NIl  189 (531)
                      ++... -+++.++++    ..-+|||||+.+..+..-..+...++...+..+..+++.+|..| |+.||||+||+|.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            98432 467777754    45679999997654433222333566677788899999999999 8999999999999999


Q ss_pred             eecCCCCCCeEEEeeccccccC
Q 009594          190 FANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       190 l~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +..    +.+.|+|||.|....
T Consensus       158 ~~~----~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WHD----GKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEC----CcEEEEECCCceeCC
Confidence            963    348999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=3.8e-13  Score=110.43  Aligned_cols=131  Identities=18%  Similarity=0.202  Sum_probs=115.8

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHh-hcCCCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN-DEVDTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~-~~~~~~~~~~~~~~~  476 (531)
                      .+++.-|..+|.+++|.|++.|+...+..+--....+++..+..-+|+++.|.|+.++|+..+. .++..-+.+++..+|
T Consensus        33 q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt~eEi~~af  112 (172)
T KOG0028|consen   33 QEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFRRVMTVKLGERDTKEEIKKAF  112 (172)
T ss_pred             hhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHHHHHHHHHhccCcHHHHHHHH
Confidence            4578889999999999999999966665555556778899999999999999999999999976 457666999999999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +.+|.|++|+||+.+|..++...      +++.++....|+|+||-|..+||.+.|+.
T Consensus       113 rl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~dgevneeEF~~imk~  170 (172)
T KOG0028|consen  113 RLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGDGEVNEEEFIRIMKK  170 (172)
T ss_pred             HcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcccccccccHHHHHHHHhc
Confidence            99999999999999999999853      46999999999999999999999999874

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=9.1e-14  Score=128.24  Aligned_cols=200  Identities=18%  Similarity=0.209  Sum_probs=140.1

Q ss_pred             HHHHhCCCCCCeeecceEEEcC-----CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc--
Q 009594          108 QIMKHLPKHPNIVSLKDTYEDD-----SAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQ--  176 (531)
Q Consensus       108 ~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~--  176 (531)
                      ..|-++ -|.|||+++.||.+.     ....+++||+..|++..+|++.    ..+......+|+.||+.||.|||+.  
T Consensus       119 dnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  119 DNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            344555 799999999998653     4588899999999999999763    3478889999999999999999987  


Q ss_pred             CCeecCCCCCceEeecCCCCCCeEEEeeccccccCC---C--CccccccCCcccccchhcc-ccCCCccchhHHHHHHHH
Q 009594          177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP---G--EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYI  250 (531)
Q Consensus       177 ~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~---~--~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~  250 (531)
                      .|+|+++.-+-|++.   .++.||++----......   .  .......+-++|.|||.=. -+.+-++|||+||....+
T Consensus       198 piihgnlTc~tifiq---~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQ---HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             ccccCCcchhheeec---CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence            599999999999995   344566543221111100   0  0111234568899999643 456678999999999999


Q ss_pred             HhhCCCC-CCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          251 LLCGVPP-FWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       251 l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      |..+..- -.+.+....-..+.+-++...       ...-..++.+|++..|..||++.+++-||.+-+
T Consensus       275 mailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             HHHheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            9887643 222222222222222222111       122356899999999999999999999998754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=6.1e-14  Score=140.40  Aligned_cols=253  Identities=23%  Similarity=0.228  Sum_probs=186.3

Q ss_pred             ccccceeeccccCccCceEEEEEEEc-cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ....+|..+..||.|.|+.|+.+.-. .++..|++|...........++ .-..|+.+...+..|.+++..+..|....+
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            34457889999999999999997644 5788999998865544333333 334577788888789999999998888888


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .||-.|||.++++...+.-...+.+...+.+..|++.++.++|++.++|+|++|+||++.+++  ...+++|||....+.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccc
Confidence            889999999998877664445578889999999999999999999999999999999997654  457899999875321


Q ss_pred             CCCccccccCCcccc-cchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          212 PGEQFNEIVGSPYYM-APEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~-aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                        -......+.-++. .+|++.  ..+..+.|++|||..+.+.++|.+--+....   ...+..+.    .+..+.....
T Consensus       419 --~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~----~p~~~~~~~~  489 (524)
T KOG0601|consen  419 --FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD----TPNLPGLKLQ  489 (524)
T ss_pred             --eecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc----ccCCCchHHh
Confidence              1111222334455 356554  3467799999999999999998653222111   11121111    1122344577


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      +..+...++..++..||++.++..|+=|.
T Consensus       490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  490 LQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhhhhcCCccccchhhhhhcccchhh
Confidence            88899999999999999999998887654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=7.3e-13  Score=134.83  Aligned_cols=143  Identities=20%  Similarity=0.268  Sum_probs=96.1

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChh-----------------------h--------------HHHHH
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----------------------D--------------IEDVR  104 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------------------~--------------~~~~~  104 (531)
                      +.||.|++|.||+|+. .+|+.||||+........-.                       .              .-.+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5699999999999985 57999999998643210000                       0              01244


Q ss_pred             HHHHHHHhCC----CCCCeeecceEEEcCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcCC
Q 009594          105 REVQIMKHLP----KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVE-VVQVCHEQGV  178 (531)
Q Consensus       105 ~E~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~-~l~~LH~~~i  178 (531)
                      +|+..+.++.    ++++|.-..-+.......+|||||++|++|.+..... ...+   ...++..++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            4555555552    3444332222233345578999999999998876432 1222   3455666655 4788999999


Q ss_pred             eecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       179 iH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +|+|++|.||++..+   +.++++|||++..+.
T Consensus       279 ~H~D~hPgNilv~~~---g~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKD---GKIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCC---CcEEEEeCCCeeECC
Confidence            999999999999543   459999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.44  E-value=6.3e-13  Score=136.68  Aligned_cols=147  Identities=21%  Similarity=0.338  Sum_probs=93.6

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC--------------------------Chh-----hHHH---
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--------------------------TAV-----DIED---  102 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------------~~~-----~~~~---  102 (531)
                      +|.. +.||+|++|.||+|+.+.+|+.||||+..+....                          ...     ....   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3555 6899999999999998877999999999754210                          000     0112   


Q ss_pred             ---HHHHHHHHHhCC---CCCCeeecceEE-EcCCeEEEEEeccCCCchHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 009594          103 ---VRREVQIMKHLP---KHPNIVSLKDTY-EDDSAVHIVMELCEGGELFDR--IVARG----HYTERAAAAVMKTIVEV  169 (531)
Q Consensus       103 ---~~~E~~~l~~l~---~h~niv~l~~~~-~~~~~~~lv~e~~~~~~L~~~--l~~~~----~l~~~~~~~i~~qi~~~  169 (531)
                         +.+|+..+.++.   .+.+.+.+-.++ ......+|||||++|+++.+.  +...+    .+.+..+..++.|+   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence               333444444442   122223222323 224557799999999999764  33332    13333344444444   


Q ss_pred             HHHHHHcCCeecCCCCCceEeecCC-CCCCeEEEeeccccccC
Q 009594          170 VQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       170 l~~LH~~~iiH~Dlkp~NIll~~~~-~~~~ikl~Dfg~a~~~~  211 (531)
                          ...|++|+|+||.||+++.++ ..+.++++|||++..++
T Consensus       277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                458999999999999997543 23369999999987654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.43  E-value=3.5e-12  Score=108.94  Aligned_cols=148  Identities=20%  Similarity=0.253  Sum_probs=114.8

Q ss_pred             eccccCccCceEEEEEEEccCCcEEEEEEeeccccCChh-----hHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .+..|-+|+-+.|+++.  ..|+.++||.-..+....+.     ......+|+++|.++ .--.|.-..=++.+...-+|
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeE
Confidence            45678899999999988  67899888866554443322     345667899999988 44455555555777777889


Q ss_pred             EEeccCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          135 VMELCEG-GELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       135 v~e~~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      +|||++| .++.+++....  .........++..|=..+.-||..+|+|+||..+||++.+++....+.++|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999987 46777776532  2344445789999999999999999999999999999999988888899999998754

>KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=99.42  E-value=5.2e-13  Score=106.81  Aligned_cols=100  Identities=20%  Similarity=0.276  Sum_probs=92.0

Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCC--CCcceeHHHHHHHHHhC---------c
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTD--KDGRISYEEFAVMMKAG---------T  500 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~--~dG~i~~~Ef~~~~~~~---------~  500 (531)
                      ..++++.+|..||..+||+|+..+...+|+.+|.++++.++.+.+...+.+  +--+|+|++|+-+++..         +
T Consensus         9 ~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm~q~vaknk~q~t~e   88 (152)
T KOG0030|consen    9 QMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPKRREMNVKRLDFEEFLPMYQQVAKNKDQGTYE   88 (152)
T ss_pred             hHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcccchhhhhhhhHHHHHHHHHHHHhccccCcHH
Confidence            347899999999999999999999999999999999999999999999887  55789999999999832         6


Q ss_pred             hHHHHHhhhCccCCCcCCHHHHHHHHhhcCC
Q 009594          501 DWRKASRQYSRERFNSISLKLMREEGLQLAN  531 (531)
Q Consensus       501 ~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~~  531 (531)
                      ++.+.+++||++|+|.|...|++++|.++|+
T Consensus        89 dfvegLrvFDkeg~G~i~~aeLRhvLttlGe  119 (152)
T KOG0030|consen   89 DFVEGLRVFDKEGNGTIMGAELRHVLTTLGE  119 (152)
T ss_pred             HHHHHHHhhcccCCcceeHHHHHHHHHHHHh
Confidence            6899999999999999999999999999985

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=1.6e-12  Score=115.75  Aligned_cols=129  Identities=19%  Similarity=0.198  Sum_probs=94.1

Q ss_pred             ccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccC
Q 009594           61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE  140 (531)
Q Consensus        61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  140 (531)
                      ++.|+.|.++.||++..  .+..+++|+......    ....+..|+.+++.+.+...+++++.+..  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            35688999999999985  478899998754321    12345679999998833333445554432  34579999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV-----MHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       141 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i-----iH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      |.++...        ......++.+++.+|..||+.++     +|+|++|.||+++ +   ..++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~---~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D---GRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C---CeEEEEecccccC
Confidence            9888643        11123567899999999999985     9999999999997 2   2489999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=9.7e-12  Score=106.92  Aligned_cols=136  Identities=25%  Similarity=0.333  Sum_probs=103.0

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChh-----hHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      ..+++|+-+.+|.+.  .-|..+++|.-.++....+.     ......+|+.++..+ .-..|...+=+..+.....|+|
T Consensus         2 ~~i~~GAEa~i~~~~--~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTD--FLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeee--ccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEE
Confidence            357899999999985  35666778866555444332     234566799999988 5556666655666777888999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ||.+|-.|.+.+...       ...++..+=.-+.-||..||+|+||.++||++.+.+    +.++|||++....
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~----i~~IDfGLg~~s~  142 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEFSD  142 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc----EEEEECCcccccc
Confidence            999998888888655       245666666777889999999999999999996433    8999999987543

>KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=99.38  E-value=3.2e-12  Score=104.18  Aligned_cols=94  Identities=24%  Similarity=0.443  Sum_probs=86.8

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh-------CchHHHHH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA-------GTDWRKAS  506 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~-------~~~~~~~f  506 (531)
                      ++++++|..+|.|+||.|++++|+.++..+|...++++++.|+++    ..|-|+|--|+.++..       .+.+..+|
T Consensus        32 qEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~E----a~gPINft~FLTmfGekL~gtdpe~~I~~AF  107 (171)
T KOG0031|consen   32 QEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKE----APGPINFTVFLTMFGEKLNGTDPEEVILNAF  107 (171)
T ss_pred             HHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHh----CCCCeeHHHHHHHHHHHhcCCCHHHHHHHHH
Confidence            578999999999999999999999999999999999999999988    4689999999999973       25599999


Q ss_pred             hhhCccCCCcCCHHHHHHHHhhcCC
Q 009594          507 RQYSRERFNSISLKLMREEGLQLAN  531 (531)
Q Consensus       507 ~~~D~~~~G~i~~~e~~~~~~~~~~  531 (531)
                      +.||.+++|.|..+.++++|++-|+
T Consensus       108 ~~FD~~~~G~I~~d~lre~Ltt~gD  132 (171)
T KOG0031|consen  108 KTFDDEGSGKIDEDYLRELLTTMGD  132 (171)
T ss_pred             HhcCccCCCccCHHHHHHHHHHhcc
Confidence            9999999999999999999998764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=6.3e-11  Score=120.10  Aligned_cols=168  Identities=18%  Similarity=0.217  Sum_probs=126.8

Q ss_pred             EEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEeccCCCchHHHHHhcCC
Q 009594           74 LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH  153 (531)
Q Consensus        74 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  153 (531)
                      .|..+.++.+|.+..++.+..   .......+-+.-|+.+ +||||+++++.++..++.|||+|.+.  .|..++.+.+ 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-
Confidence            355567889999998876543   2245567788899999 99999999999999999999999984  6777776554 


Q ss_pred             CCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-cccccCCcccccchhc
Q 009594          154 YTERAAAAVMKTIVEVVQVCH-EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNEIVGSPYYMAPEVL  231 (531)
Q Consensus       154 l~~~~~~~i~~qi~~~l~~LH-~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~  231 (531)
                        ...+...+.||+.||.+|| +.+++|++|.-..|+++..+   ..||++|-++........ ......-..|..|+.+
T Consensus       103 --~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G---eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~  177 (690)
T KOG1243|consen  103 --KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG---EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEI  177 (690)
T ss_pred             --HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC---cEEEeeeEEEeccccCCcccccchhhhcccChhhc
Confidence              6777888899999999998 56899999999999996544   499999987754332111 1111122346666654


Q ss_pred             cccCCCccchhHHHHHHHHHhhC
Q 009594          232 KRNYGPEVDVWSAGVILYILLCG  254 (531)
Q Consensus       232 ~~~~~~~~Di~slG~il~~l~tg  254 (531)
                      ... +-..|.|-|||++++++.|
T Consensus       178 ~~s-~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  178 DPS-EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             Ccc-ccchhhhhHHHHHHHHhCc
Confidence            311 1346999999999999998

>PLN02964 phosphatidylserine decarboxylase

Probab=99.35  E-value=4.5e-12  Score=131.19  Aligned_cols=105  Identities=20%  Similarity=0.320  Sum_probs=95.0

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCC-CCCCHHH---HHHHHHhcCCCCCCceecchhHhHHHHhhc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-QNIPEAD---LQILMEAADVDGDGSLNYGEFVAVSVHLKK  429 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~-~~~~~~~---~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~  429 (531)
                      ..|+.+|+.++++.|+.+|.|++|.+    +..+++.+| ..+++.+   ++.+|+.+|.|++|.|+|+||+.++..+..
T Consensus       135 t~f~~kqi~elkeaF~lfD~dgdG~i----Lg~ilrslG~~~pte~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~  210 (644)
T PLN02964        135 FDFVTQEPESACESFDLLDPSSSNKV----VGSIFVSCSIEDPVETERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGN  210 (644)
T ss_pred             hhccHHHHHHHHHHHHHHCCCCCCcC----HHHHHHHhCCCCCCHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcc
Confidence            45677788999999999999999997    888999999 5888887   899999999999999999999998876655


Q ss_pred             cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhh
Q 009594          430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALND  462 (531)
Q Consensus       430 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~  462 (531)
                      ...++++..+|+.||.|++|+|+.+||..+|..
T Consensus       211 ~~seEEL~eaFk~fDkDgdG~Is~dEL~~vL~~  243 (644)
T PLN02964        211 LVAANKKEELFKAADLNGDGVVTIDELAALLAL  243 (644)
T ss_pred             CCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHh
Confidence            567888999999999999999999999999987

>KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.32  E-value=7.7e-12  Score=108.88  Aligned_cols=98  Identities=30%  Similarity=0.429  Sum_probs=90.9

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSR  511 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~  511 (531)
                      ...+...|...|.|++|.|+.+|+..+|... ....+.+-++.|+..+|.+++|+|++.||..+......|+..|+.||+
T Consensus        56 ~~~~~~~f~~vD~d~sg~i~~~eLq~aLsn~~~~~Fs~~TcrlmI~mfd~~~~G~i~f~EF~~Lw~~i~~Wr~vF~~~D~  135 (221)
T KOG0037|consen   56 FPQLAGWFQSVDRDRSGRILAKELQQALSNGTWSPFSIETCRLMISMFDRDNSGTIGFKEFKALWKYINQWRNVFRTYDR  135 (221)
T ss_pred             cHHHHHHHHhhCccccccccHHHHHHHhhcCCCCCCCHHHHHHHHHHhcCCCCCccCHHHHHHHHHHHHHHHHHHHhccc
Confidence            3467889999999999999999999999855 466788899999999999999999999999999999999999999999


Q ss_pred             cCCCcCCHHHHHHHHhhcC
Q 009594          512 ERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       512 ~~~G~i~~~e~~~~~~~~~  530 (531)
                      |++|.|+..||++.+.++|
T Consensus       136 D~SG~I~~sEL~~Al~~~G  154 (221)
T KOG0037|consen  136 DRSGTIDSSELRQALTQLG  154 (221)
T ss_pred             CCCCcccHHHHHHHHHHcC
Confidence            9999999999999999886

>KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.32  E-value=4.3e-12  Score=116.92  Aligned_cols=134  Identities=24%  Similarity=0.347  Sum_probs=107.3

Q ss_pred             HhhHHHHhcccccCCCCcccHHHHHHHHHhCC-CCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc-----CcHH
Q 009594          361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM-----ANDE  434 (531)
Q Consensus       361 ~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~-~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~-----~~~~  434 (531)
                      +.+=++.|+.-|.|++|.++.+||..+|.--. ..+..-.+.+-+..+|+|+||.|+++||+.-+......     +...
T Consensus       162 ~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~~~~~epeWv~~  241 (325)
T KOG4223|consen  162 IARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHEGNEEEPEWVLT  241 (325)
T ss_pred             HHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhccCCCCCcccccc
Confidence            34556789999999999999999988876432 22333446777888999999999999999844332211     1112


Q ss_pred             HHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHH
Q 009594          435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAV  494 (531)
Q Consensus       435 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~  494 (531)
                      +-.+.|...|+|+||+++.+|++.++..-+....+.+++-++.+.|.|+||++|++|.+.
T Consensus       242 Ere~F~~~~DknkDG~L~~dEl~~WI~P~~~d~A~~EA~hL~~eaD~dkD~kLs~eEIl~  301 (325)
T KOG4223|consen  242 EREQFFEFRDKNKDGKLDGDELLDWILPSEQDHAKAEARHLLHEADEDKDGKLSKEEILE  301 (325)
T ss_pred             cHHHHHHHhhcCCCCccCHHHHhcccCCCCccHHHHHHHHHhhhhccCccccccHHHHhh
Confidence            334677788999999999999999998888888899999999999999999999999875

>KOG4251 consensus Calcium binding protein [General function prediction only]

Probab=99.29  E-value=4.4e-12  Score=111.08  Aligned_cols=169  Identities=18%  Similarity=0.180  Sum_probs=119.3

Q ss_pred             HHHhhHHHHhcccccCCCCcccHHHHHHHHHhCC---CCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcH--
Q 009594          359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG---QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND--  433 (531)
Q Consensus       359 ~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~---~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~--  433 (531)
                      .-..+|..+|.+.|.|.||+|+..|+++++..-.   ..-..++-+..|+..|+|+||.|+|+||...+.........  
T Consensus        98 rsrrklmviFsKvDVNtDrkisAkEmqrwImektaEHfqeameeSkthFraVDpdgDGhvsWdEykvkFlaskghsekev  177 (362)
T KOG4251|consen   98 RSRRKLMVIFSKVDVNTDRKISAKEMQRWIMEKTAEHFQEAMEESKTHFRAVDPDGDGHVSWDEYKVKFLASKGHSEKEV  177 (362)
T ss_pred             HHHHHHHHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHHhhhhhheeeeCCCCCCceehhhhhhHHHhhcCcchHHH
Confidence            4456799999999999999999999998876531   11122344557889999999999999998755433222111  


Q ss_pred             ------------HHHHHhhcccCCCCCcc---------eeHHHHHHHHhhc-CCCCCHHHHHHHHHhccCCCCcceeHHH
Q 009594          434 ------------EHLHKAFSFFDRNRSGF---------IEIEELRNALNDE-VDTSGEDVINAIMHDVDTDKDGRISYEE  491 (531)
Q Consensus       434 ------------~~~~~~F~~~D~~~~G~---------i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~dG~i~~~E  491 (531)
                                  ++-.+.|..-++++.|.         +|.+||..+|+.. ...+--..++.++..+|.|||.++|..|
T Consensus       178 adairlneelkVDeEtqevlenlkdRwyqaDsppadlllteeEflsFLHPEhSrgmLrfmVkeivrdlDqdgDkqlSvpe  257 (362)
T KOG4251|consen  178 ADAIRLNEELKVDEETQEVLENLKDRWYQADSPPADLLLTEEEFLSFLHPEHSRGMLRFMVKEIVRDLDQDGDKQLSVPE  257 (362)
T ss_pred             HHHhhccCcccccHHHHHHHHhhhhhhccccCchhhhhhhHHHHHHHcChHhhhhhHHHHHHHHHHHhccCCCeeecchh
Confidence                        11123344444555554         4559999999754 2333456788999999999999999999


Q ss_pred             HHHHHHhC--------------chHHHHHh-hhCccCCCcCCHHHHHHHHh
Q 009594          492 FAVMMKAG--------------TDWRKASR-QYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       492 f~~~~~~~--------------~~~~~~f~-~~D~~~~G~i~~~e~~~~~~  527 (531)
                      |++.....              .+-+..|. .+|.|+||.+|++|+-..+.
T Consensus       258 FislpvGTVenqqgqdiddnwvkdRkkEFeElIDsNhDGivTaeELe~y~d  308 (362)
T KOG4251|consen  258 FISLPVGTVENQQGQDIDDNWVKDRKKEFEELIDSNHDGIVTAEELEDYVD  308 (362)
T ss_pred             hhcCCCcchhhhhccchHHHHHHHHHHHHHHHhhcCCccceeHHHHHhhcC
Confidence            99876421              12334454 77999999999999977643

>KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms]

Probab=99.28  E-value=4.5e-11  Score=105.09  Aligned_cols=131  Identities=18%  Similarity=0.208  Sum_probs=108.0

Q ss_pred             CCHHHHHH---HHHhcCCC-CCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcc-eeHHHHHHHHhhcCCCCCH
Q 009594          395 IPEADLQI---LMEAADVD-GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGF-IEIEELRNALNDEVDTSGE  469 (531)
Q Consensus       395 ~~~~~~~~---~f~~~D~~-~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~-i~~~el~~~l~~~~~~~~~  469 (531)
                      .+..+|..   .|..+|.+ ++|.++.+||..+......    .....+++.||.+++|. |++++|.+.+.......+.
T Consensus        27 fs~~EI~~L~~rF~kl~~~~~~g~lt~eef~~i~~~~~N----p~~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~~~~  102 (187)
T KOG0034|consen   27 FSANEIERLYERFKKLDRNNGDGYLTKEEFLSIPELALN----PLADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPKASK  102 (187)
T ss_pred             cCHHHHHHHHHHHHHhccccccCccCHHHHHHHHHHhcC----cHHHHHHHHHhccCCCCccCHHHHHHHHhhhcCCccH
Confidence            55666555   57788998 9999999999998733222    33567899999998888 9999999999988766555


Q ss_pred             H-HHHHHHHhccCCCCcceeHHHHHHHHHhC-------------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          470 D-VINAIMHDVDTDKDGRISYEEFAVMMKAG-------------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       470 ~-~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-------------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      . -++-+|+.+|.+++|.|+.+|+..++...             ..+...|..+|.|+||.||.+|+.+++..-
T Consensus       103 ~~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~IsfeEf~~~v~~~  176 (187)
T KOG0034|consen  103 REKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLEDIVDKTFEEADTDGDGKISFEEFCKVVEKQ  176 (187)
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcC
Confidence            5 78999999999999999999999888721             227888999999999999999999988654

>cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13

Probab=99.24  E-value=1.2e-11  Score=95.07  Aligned_cols=67  Identities=18%  Similarity=0.272  Sum_probs=61.9

Q ss_pred             HHHHHhhcccCC-CCCcceeHHHHHHHHhh-cCCCCCH-HHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          434 EHLHKAFSFFDR-NRSGFIEIEELRNALND-EVDTSGE-DVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       434 ~~~~~~F~~~D~-~~~G~i~~~el~~~l~~-~~~~~~~-~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      ..+..+|+.||. +++|+|+.+||+.+|.. +|..++. ++++.+|+.+|.|+||+|+|+||+.++....
T Consensus         8 ~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l~   77 (89)
T cd05022           8 ETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGELA   77 (89)
T ss_pred             HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHH
Confidence            457899999999 99999999999999998 8887887 8999999999999999999999999998653

S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu

>PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E

Probab=99.24  E-value=2e-11  Score=89.66  Aligned_cols=62  Identities=42%  Similarity=0.725  Sum_probs=54.6

Q ss_pred             HHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHH----HHHHHHHhccCCCCcceeHHHHHHHH
Q 009594          435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED----VINAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       435 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~----~~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      .++.+|+.+|.|++|+|+.+||..++..++...+++    .++.+|+.+|+|+||.|+++||++++
T Consensus         1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~   66 (66)
T PF13499_consen    1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM   66 (66)
T ss_dssp             HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred             CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence            378899999999999999999999999998766554    45566999999999999999999875

...

>KOG0038 consensus Ca2+-binding kinase interacting protein (KIP) (EF-Hand protein superfamily) [General function prediction only]

Probab=99.23  E-value=4.7e-11  Score=96.06  Aligned_cols=150  Identities=21%  Similarity=0.397  Sum_probs=111.0

Q ss_pred             hhhhhHHHhhHHHHhcccccC-----CCC------cccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHh
Q 009594          354 EFLSVEEVAGLKEAFEMMDTN-----KRG------KINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVA  422 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~-----~~g------~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~  422 (531)
                      ++|+..++-++...|..+-.+     -.|      .+..+.+ .-+-.+..++-.   +++...+..||.|.++|++|+.
T Consensus        20 TFFtrKdIlrl~~Rf~~L~P~lVP~~~~~~~~~~v~vp~e~i-~kMPELkenpfk---~ri~e~FSeDG~GnlsfddFlD   95 (189)
T KOG0038|consen   20 TFFTRKDILRLHKRFYELAPHLVPTDMTGNRPPIVKVPFELI-EKMPELKENPFK---RRICEVFSEDGRGNLSFDDFLD   95 (189)
T ss_pred             ccccHHHHHHHHHHHHHhCcccccccccCCCCCceeecHHHH-hhChhhhcChHH---HHHHHHhccCCCCcccHHHHHH
Confidence            566777787887777765432     111      2333332 222233333333   3466667789999999999999


Q ss_pred             HHHHhhcc-CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC-CCCCHHH----HHHHHHhccCCCCcceeHHHHHHHH
Q 009594          423 VSVHLKKM-ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DTSGEDV----INAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       423 ~~~~~~~~-~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~----~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      +++.+... +..-.+.-+|++||-|+|++|..+++...+..+. ..+++++    ++.++.++|.||||++++.||.+++
T Consensus        96 mfSV~sE~APrdlK~~YAFkIYDfd~D~~i~~~DL~~~l~~lTr~eLs~eEv~~i~ekvieEAD~DgDgkl~~~eFe~~i  175 (189)
T KOG0038|consen   96 MFSVFSEMAPRDLKAKYAFKIYDFDGDEFIGHDDLEKTLTSLTRDELSDEEVELICEKVIEEADLDGDGKLSFAEFEHVI  175 (189)
T ss_pred             HHHHHHhhChHHhhhhheeEEeecCCCCcccHHHHHHHHHHHhhccCCHHHHHHHHHHHHHHhcCCCCCcccHHHHHHHH
Confidence            87765543 3445678899999999999999999999999884 4567766    5678899999999999999999999


Q ss_pred             HhCchHHHHHh
Q 009594          497 KAGTDWRKASR  507 (531)
Q Consensus       497 ~~~~~~~~~f~  507 (531)
                      ..++++...|.
T Consensus       176 ~raPDFlsTFH  186 (189)
T KOG0038|consen  176 LRAPDFLSTFH  186 (189)
T ss_pred             HhCcchHhhhe
Confidence            99999887764

>KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism]

Probab=99.22  E-value=9e-11  Score=111.18  Aligned_cols=125  Identities=22%  Similarity=0.306  Sum_probs=110.6

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhcc-CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM-ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~  476 (531)
                      ..++.+|+.+|.+++|.++..+....+..+... ...+....+|+..|.|.||.++.+||++++..     .+.++-.+|
T Consensus        14 ~r~~~lf~~lD~~~~g~~d~~~l~k~~~~l~~~~~~~~~~~~l~~~~d~~~dg~vDy~eF~~Y~~~-----~E~~l~~~F   88 (463)
T KOG0036|consen   14 IRIRCLFKELDSKNDGQVDLDQLEKGLEKLDHPKPNYEAAKMLFSAMDANRDGRVDYSEFKRYLDN-----KELELYRIF   88 (463)
T ss_pred             HHHHHHHHHhccCCCCceeHHHHHHHHHhcCCCCCchHHHHHHHHhcccCcCCcccHHHHHHHHHH-----hHHHHHHHH
Confidence            347789999999999999999998877666554 66788899999999999999999999999965     356788899


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      ...|.++||.|+.+|.-..++..      +....+|.+.|++|++.|+.+|+++.+.
T Consensus        89 ~~iD~~hdG~i~~~Ei~~~l~~~gi~l~de~~~k~~e~~d~~g~~~I~~~e~rd~~l  145 (463)
T KOG0036|consen   89 QSIDLEHDGKIDPNEIWRYLKDLGIQLSDEKAAKFFEHMDKDGKATIDLEEWRDHLL  145 (463)
T ss_pred             hhhccccCCccCHHHHHHHHHHhCCccCHHHHHHHHHHhccCCCeeeccHHHHhhhh
Confidence            99999999999999999999854      5688899999999999999999998875

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.21  E-value=7e-09  Score=102.26  Aligned_cols=212  Identities=17%  Similarity=0.234  Sum_probs=152.8

Q ss_pred             CceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE----cCCeEEEEEeccCC-C
Q 009594           68 EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE----DDSAVHIVMELCEG-G  142 (531)
Q Consensus        68 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~----~~~~~~lv~e~~~~-~  142 (531)
                      --.+.|++....+|..|++|++.........   ....-+++++++ .|+|||++.++|.    ....+++|++|+++ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            4567899999999999999999543332221   122346788898 9999999999886    35679999999986 6


Q ss_pred             chHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          143 ELFDRIVA---------------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       143 ~L~~~l~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      +|.++...               +...++..+|.++.|+..||.++|+.|+.-+-|.|.+|+++.+   ..++|+..|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~---~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK---MRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc---ceEEEecccce
Confidence            78775432               2347889999999999999999999999999999999999633   35888888876


Q ss_pred             cccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCC-HHHH-HHHHHhcccCCCCCCCCCC
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGV-AQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~-~~~~~~~~~~~~~~~~~~~  285 (531)
                      ..+..+.           .  +.+.+  -.+-|.=.||.+++.|.||..--+..+ .+.. ...+.           +.+
T Consensus       441 Dvl~~d~-----------~--~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~y  494 (655)
T KOG3741|consen  441 DVLQEDP-----------T--EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTY  494 (655)
T ss_pred             eeecCCC-----------C--cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhh
Confidence            6554332           1  11111  124688899999999999965422222 1111 11111           356


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.++.++|..+...++.+ -++.+++.+
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            788999999998888876 677777755

>PLN02964 phosphatidylserine decarboxylase

Probab=99.17  E-value=1e-10  Score=121.32  Aligned_cols=91  Identities=18%  Similarity=0.210  Sum_probs=52.4

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcC-CCCCHHH---HHHHHHhccCCCCcceeHHHHHHHHHhC------chHH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DTSGEDV---INAIMHDVDTDKDGRISYEEFAVMMKAG------TDWR  503 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~---~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~  503 (531)
                      ++++++|..+|+|++|.+    +..+++.+| ..+++++   ++.+|..+|.|++|.|+++||+.++...      +++.
T Consensus       143 ~elkeaF~lfD~dgdG~i----Lg~ilrslG~~~pte~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~~~seEEL~  218 (644)
T PLN02964        143 ESACESFDLLDPSSSNKV----VGSIFVSCSIEDPVETERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGNLVAANKKE  218 (644)
T ss_pred             HHHHHHHHHHCCCCCCcC----HHHHHHHhCCCCCCHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhccCCCHHHHH
Confidence            345555666666666654    555555555 3444444   5566666666666666666666555421      2356


Q ss_pred             HHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          504 KASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       504 ~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      ++|+.+|+|++|.|+.+||+++|..
T Consensus       219 eaFk~fDkDgdG~Is~dEL~~vL~~  243 (644)
T PLN02964        219 ELFKAADLNGDGVVTIDELAALLAL  243 (644)
T ss_pred             HHHHHhCCCCCCcCCHHHHHHHHHh
Confidence            6666666666666666666666554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=3.2e-10  Score=105.56  Aligned_cols=144  Identities=24%  Similarity=0.377  Sum_probs=104.9

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCCeeecceEEEcC---CeEEEEEe
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-HPNIVSLKDTYEDD---SAVHIVME  137 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~---~~~~lv~e  137 (531)
                      +.|+.|..+.||++... +|..+++|........  .....+.+|+.+++.+.. +.++++++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            46899999999999853 3689999987543321  123567889999999943 23467777766543   36789999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 009594          138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE------------------------------------------  175 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~------------------------------------------  175 (531)
                      |++|.++...+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888765432 356777777888888888888874                                          


Q ss_pred             --------------cCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          176 --------------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       176 --------------~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                                    ..++|+|++|.||+++.+ ....+.|+||+.+...
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccccC
Confidence                          135899999999999753 1234789999987643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B

Probab=99.13  E-value=1.4e-10  Score=89.57  Aligned_cols=66  Identities=21%  Similarity=0.438  Sum_probs=60.9

Q ss_pred             HHHHHhhcccC-CCCCc-ceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSFFD-RNRSG-FIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..++.+|+.|| .|++| +|+.+||+.+|+.     +|...++++++.+++.+|.|+||+|+|+||+.++...
T Consensus         8 ~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~   80 (88)
T cd05027           8 VALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMV   80 (88)
T ss_pred             HHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            45889999998 79999 5999999999999     8888899999999999999999999999999988754

S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=3.2e-09  Score=100.54  Aligned_cols=135  Identities=19%  Similarity=0.159  Sum_probs=94.6

Q ss_pred             EEEEEEccCCcEEEEEEeeccccC----C----hhhHHHHHHHHHHHHhCCCCCCee--ecceEEEc-----CCeEEEEE
Q 009594           72 TYLCTDVNNGEKFACKSISKKKLR----T----AVDIEDVRREVQIMKHLPKHPNIV--SLKDTYED-----DSAVHIVM  136 (531)
Q Consensus        72 V~~~~~~~~~~~~aiK~~~~~~~~----~----~~~~~~~~~E~~~l~~l~~h~niv--~l~~~~~~-----~~~~~lv~  136 (531)
                      |+++.  ..|+.+.||........    .    ......+.+|...+.+| ...+|.  .++.+...     ....+||+
T Consensus        38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            55544  46778888876432210    0    01112467888888887 333433  34555542     23578999


Q ss_pred             eccCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC----CCCCCeEEEeeccccc
Q 009594          137 ELCEGG-ELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK----KESSPLKAIDFGLSVF  209 (531)
Q Consensus       137 e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~----~~~~~ikl~Dfg~a~~  209 (531)
                      |++++- +|.+++..  ....+......++.+++..+.-||..||+|+|++|+|||++.+    ++...+.|+||+.+..
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999875 78888754  3345677888999999999999999999999999999999752    2345699999998754

>PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E

Probab=99.07  E-value=2.5e-10  Score=83.82  Aligned_cols=62  Identities=34%  Similarity=0.621  Sum_probs=52.7

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHH----HHHHHHhcCCCCCCceecchhHhHH
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD----LQILMEAADVDGDGSLNYGEFVAVS  424 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~----~~~~f~~~D~~~~g~i~~~ef~~~~  424 (531)
                      +|+++|+.+|+|++|+|+.+||..++..++...+..+    ++.+|+.+|.|+||.|+|+||+.++
T Consensus         1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~   66 (66)
T PF13499_consen    1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM   66 (66)
T ss_dssp             HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred             CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence            5789999999999999999999999999987665544    4445889999999999999998753

...

>cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13

Probab=99.06  E-value=2.9e-10  Score=87.49  Aligned_cols=69  Identities=19%  Similarity=0.262  Sum_probs=62.5

Q ss_pred             HHHhhHHHHhccccc-CCCCcccHHHHHHHHHh-CCCCCCH-HHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          359 EEVAGLKEAFEMMDT-NKRGKINLEELRLGLLK-GGQNIPE-ADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       359 ~~~~~i~~~F~~~D~-~~~g~i~~~el~~~l~~-~~~~~~~-~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      .-+..|.++|+.||. +++|+|+..||+.++++ +|..++. ++++.+++.+|.|+||.|+|+||+.++..+
T Consensus         5 ~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l   76 (89)
T cd05022           5 KAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGEL   76 (89)
T ss_pred             HHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            345678999999999 99999999999999999 8877787 899999999999999999999999987654

S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu

>KOG2643 consensus Ca2+ binding protein, contains EF-hand motifs [Inorganic ion transport and metabolism]

Probab=99.05  E-value=9.9e-10  Score=104.92  Aligned_cols=162  Identities=20%  Similarity=0.239  Sum_probs=118.2

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhC------CC--------CCCHH-HHHH--HHHhcCCCCCCceecchhHhHH
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG------GQ--------NIPEA-DLQI--LMEAADVDGDGSLNYGEFVAVS  424 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~------~~--------~~~~~-~~~~--~f~~~D~~~~g~i~~~ef~~~~  424 (531)
                      ..+.-.|..||.|+||.|+.+||....+-.      |.        ..+-. ++..  +..-+..+++++++++||...+
T Consensus       233 ~~F~IAFKMFD~dgnG~IdkeEF~~v~~li~sQ~~~g~~hrd~~tt~~s~~~~~nsaL~~yFFG~rg~~kLs~deF~~F~  312 (489)
T KOG2643|consen  233 RNFRIAFKMFDLDGNGEIDKEEFETVQQLIRSQTSVGVRHRDHFTTGNSFKVEVNSALLTYFFGKRGNGKLSIDEFLKFQ  312 (489)
T ss_pred             ccceeeeeeeecCCCCcccHHHHHHHHHHHHhccccceecccCccccceehhhhhhhHHHHhhccCCCccccHHHHHHHH
Confidence            467789999999999999999997655221      11        00101 1111  2334688999999999999988


Q ss_pred             HHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCC-CC--CHHHHHHHHHhccCCCCcceeHHHHHHHHH---h
Q 009594          425 VHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-TS--GEDVINAIMHDVDTDKDGRISYEEFAVMMK---A  498 (531)
Q Consensus       425 ~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~--~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~---~  498 (531)
                      ..++    ++-++.-|..+|+..+|.|+..+|..+|-.... +.  .....+..-+.++.++- .||++||..+.+   +
T Consensus       313 e~Lq----~Eil~lEF~~~~~~~~g~Ise~DFA~~lL~~a~~n~~~k~~~lkrvk~kf~~~~~-gISl~Ef~~Ff~Fl~~  387 (489)
T KOG2643|consen  313 ENLQ----EEILELEFERFDKGDSGAISEVDFAELLLAYAGVNSKKKHKYLKRVKEKFKDDGK-GISLQEFKAFFRFLNN  387 (489)
T ss_pred             HHHH----HHHHHHHHHHhCcccccccCHHHHHHHHHHHcccchHhHHHHHHHHHHhccCCCC-CcCHHHHHHHHHHHhh
Confidence            7654    355677899999999999999999998866532 21  12246666677766644 499999988775   1


Q ss_pred             C------------------------------------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          499 G------------------------------------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       499 ~------------------------------------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .                                    .-+.-+|.-||.|+||.||-+||..+|++
T Consensus       388 l~dfd~Al~fy~~Ag~~i~~~~f~raa~~vtGveLSdhVvdvvF~IFD~N~Dg~LS~~EFl~Vmk~  453 (489)
T KOG2643|consen  388 LNDFDIALRFYHMAGASIDEKTFQRAAKVVTGVELSDHVVDVVFTIFDENNDGTLSHKEFLAVMKR  453 (489)
T ss_pred             hhHHHHHHHHHHHcCCCCCHHHHHHHHHHhcCcccccceeeeEEEEEccCCCCcccHHHHHHHHHH
Confidence            1                                    12666799999999999999999999975

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=1.5e-09  Score=96.78  Aligned_cols=129  Identities=24%  Similarity=0.258  Sum_probs=82.5

Q ss_pred             EEEEEEccCCcEEEEEEeeccccC-----------------------ChhhHHHHHHHHHHHHhCCCC-CCeeecceEEE
Q 009594           72 TYLCTDVNNGEKFACKSISKKKLR-----------------------TAVDIEDVRREVQIMKHLPKH-PNIVSLKDTYE  127 (531)
Q Consensus        72 V~~~~~~~~~~~~aiK~~~~~~~~-----------------------~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~  127 (531)
                      ||.|.. ..|..+|+|+.......                       .........+|.+.|.++... -++++++++. 
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            899885 56889999998643111                       001134567899999999433 2577776553 


Q ss_pred             cCCeEEEEEeccC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          128 DDSAVHIVMELCE--GGELFDRIVARGHYTERAAAAVMKTIVEVVQV-CHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       128 ~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                         .-+|||||++  |..+..+.. . .++......++.+++..+.. +|+.||+|+||.+.||++..+    .+.|+||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~-~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD-V-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH-C-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHh-c-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEEec
Confidence               2369999998  666655332 2 22245567778888886555 579999999999999999754    4999999


Q ss_pred             ccccccC
Q 009594          205 GLSVFFR  211 (531)
Q Consensus       205 g~a~~~~  211 (531)
                      |.+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6

Probab=99.01  E-value=9.2e-10  Score=84.97  Aligned_cols=66  Identities=18%  Similarity=0.326  Sum_probs=59.6

Q ss_pred             HHHHHhhcccCC-CC-CcceeHHHHHHHHh---hcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSFFDR-NR-SGFIEIEELRNALN---DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~~D~-~~-~G~i~~~el~~~l~---~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..+-.+|..||. |+ +|+|+.+||+.+|.   .+|.++++++++++++.+|.|++|+|+|+||+.++...
T Consensus        10 ~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l   80 (88)
T cd05029          10 GLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGAL   80 (88)
T ss_pred             HHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence            346789999998 77 89999999999997   47999999999999999999999999999999988754

S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact

>cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z

Probab=98.99  E-value=1.1e-09  Score=85.91  Aligned_cols=67  Identities=25%  Similarity=0.481  Sum_probs=57.7

Q ss_pred             HHHHHhhcccC-CCCCc-ceeHHHHHHHHhhc-----CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          434 EHLHKAFSFFD-RNRSG-FIEIEELRNALNDE-----VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       434 ~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      ..+..+|+.|| .|++| +||.+||+.+|...     +...++.+++.++..+|.|+||.|+|+||+.++....
T Consensus        10 ~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l~   83 (93)
T cd05026          10 DTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAALT   83 (93)
T ss_pred             HHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Confidence            35778899999 78998 59999999999762     3345778999999999999999999999999998653

S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=3.3e-10  Score=115.47  Aligned_cols=151  Identities=21%  Similarity=0.320  Sum_probs=108.3

Q ss_pred             HHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccc----------cccCCcccccchhccc
Q 009594          165 TIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN----------EIVGSPYYMAPEVLKR  233 (531)
Q Consensus       165 qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~----------~~~gt~~y~aPE~~~~  233 (531)
                      +++.|+.|+|.. ++||++|.|++|.++..   +..||+.|+++....++..+.          -..-...|.|||.+.+
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~---~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN---GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccC---cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            344999999975 89999999999999644   448999999876554422111          1123456999998874


Q ss_pred             -cCCCccchhHHHHHHHHHh-hCCCCCCCCCHHHHHHHHHhcccCCCCC-CCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q 009594          234 -NYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFKRD-PWPKVSENAKDLVKKMLNPDPKQRLTAEEV  310 (531)
Q Consensus       234 -~~~~~~Di~slG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  310 (531)
                       ..+.++|+||+|+++|.++ .|+..+......... .......+.... .-.++|+++++=+.+++..++.-||++..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence             5788999999999999998 465555443322221 122211111111 114689999999999999999999999999


Q ss_pred             hcCCccccc
Q 009594          311 LEHPWLQNA  319 (531)
Q Consensus       311 l~h~~~~~~  319 (531)
                      +..|||...
T Consensus       263 ~~~~ff~D~  271 (700)
T KOG2137|consen  263 LSIPFFSDP  271 (700)
T ss_pred             hcccccCCc
Confidence            999999764

>cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1

Probab=98.98  E-value=1.5e-09  Score=85.36  Aligned_cols=74  Identities=24%  Similarity=0.381  Sum_probs=62.8

Q ss_pred             HHHHHHhhcccC-CCCCc-ceeHHHHHHHHhh-cCC----CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHH
Q 009594          433 DEHLHKAFSFFD-RNRSG-FIEIEELRNALND-EVD----TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKA  505 (531)
Q Consensus       433 ~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-~~~----~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~  505 (531)
                      .+.++.+|+.|| .|++| .|+.+||+.+|+. +|.    .+++++++.+|..+|.|++|.|+|+||+.++.......+.
T Consensus         8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~~~~~~~~   87 (92)
T cd05025           8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALTVACNN   87 (92)
T ss_pred             HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHHHHH
Confidence            366899999997 99999 5999999999985 543    4678899999999999999999999999999876554443


Q ss_pred             H
Q 009594          506 S  506 (531)
Q Consensus       506 f  506 (531)
                      |
T Consensus        88 ~   88 (92)
T cd05025          88 F   88 (92)
T ss_pred             H
Confidence            3

S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.98  E-value=1.3e-08  Score=97.79  Aligned_cols=238  Identities=17%  Similarity=0.193  Sum_probs=152.9

Q ss_pred             eccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeee----cceE-E-Ec-CCeE
Q 009594           60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS----LKDT-Y-ED-DSAV  132 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~----l~~~-~-~~-~~~~  132 (531)
                      ..+.||+|+-+.+|-.-   .-...+.|++......      .-.+.+..|.....||-+-.    -... + .+ ....
T Consensus        15 ~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa------~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          15 PGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPA------AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCccccCCccceeeecc---hhhchhheeecCCCch------HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            44689999999999744   2223345888654321      11123344455556764433    1111 1 11 2236


Q ss_pred             EEEEeccCCC-chHHHHH---hc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          133 HIVMELCEGG-ELFDRIV---AR---GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       133 ~lv~e~~~~~-~L~~~l~---~~---~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                      -+.|...+|. .+..++.   ++   ....+..+++.++.++.+.+.||..|.+-+|+.++|+|+.++   +.|.|.|=.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~---~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD---SKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC---ceEEEEccc
Confidence            6788888764 2333332   12   236788899999999999999999999999999999999644   448888755


Q ss_pred             cccccCCCCccccccCCcccccchhcc-c-----cCCCccchhHHHHHHHHHhhC-CCCCCCCCHH----HHHH-HHHhc
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-R-----NYGPEVDVWSAGVILYILLCG-VPPFWAETEQ----GVAQ-AIIRS  273 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~----~~~~-~~~~~  273 (531)
                      .-.....+..+...+|.+.|.+||... +     .-+...|.|.||+++++++.| +.||.+....    .-.+ .|...
T Consensus       163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            433334444555678999999999765 3     246689999999999998886 8999664210    0011 11111


Q ss_pred             c------------cCCCCCCCCCCCHHHHHHHHHcccc--CcCCCCCHHH
Q 009594          274 V------------IDFKRDPWPKVSENAKDLVKKMLNP--DPKQRLTAEE  309 (531)
Q Consensus       274 ~------------~~~~~~~~~~~~~~~~~li~~~l~~--~p~~Rps~~~  309 (531)
                      .            ......+|.-+++.+..|..+|+..  ++.-|||++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            1            1112234556889999999999975  3668998753

>cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10

Probab=98.96  E-value=1.8e-09  Score=85.26  Aligned_cols=69  Identities=20%  Similarity=0.398  Sum_probs=60.9

Q ss_pred             HHHHHHhhcccCC-CC-CcceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCch
Q 009594          433 DEHLHKAFSFFDR-NR-SGFIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD  501 (531)
Q Consensus       433 ~~~~~~~F~~~D~-~~-~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~  501 (531)
                      ...+..+|+.||. |+ +|+|+.+||+.+|..     +|..+++++++.++..+|.|++|.|+|+||+.++....-
T Consensus         7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~~~   82 (94)
T cd05031           7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGLSI   82 (94)
T ss_pred             HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHH
Confidence            3568899999997 97 799999999999986     466788999999999999999999999999999986543

S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions.

>cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B

Probab=98.95  E-value=2e-09  Score=83.07  Aligned_cols=67  Identities=22%  Similarity=0.319  Sum_probs=61.3

Q ss_pred             HHhhHHHHhcccc-cCCCC-cccHHHHHHHHHh-----CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          360 EVAGLKEAFEMMD-TNKRG-KINLEELRLGLLK-----GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       360 ~~~~i~~~F~~~D-~~~~g-~i~~~el~~~l~~-----~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      -+..|.++|+.|| .+++| +|+.+||+.+|+.     +|..+++++++++++.+|.|++|.|+|+||+.++..
T Consensus         6 ~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~   79 (88)
T cd05027           6 AMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAM   79 (88)
T ss_pred             HHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            4567899999998 79999 5999999999999     898899999999999999999999999999987654

S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i

>PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A

Probab=98.91  E-value=4.5e-09  Score=73.54  Aligned_cols=52  Identities=37%  Similarity=0.565  Sum_probs=48.8

Q ss_pred             CCcceeHHHHHHHHhhcCCC-CCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          447 RSGFIEIEELRNALNDEVDT-SGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       447 ~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+|.|+.+||+.+|..+|.. +++++++.+|..+|.|++|.|+|+||+.++..
T Consensus         1 ~~G~i~~~~~~~~l~~~g~~~~s~~e~~~l~~~~D~~~~G~I~~~EF~~~~~~   53 (54)
T PF13833_consen    1 KDGKITREEFRRALSKLGIKDLSEEEVDRLFREFDTDGDGYISFDEFISMMQR   53 (54)
T ss_dssp             SSSEEEHHHHHHHHHHTTSSSSCHHHHHHHHHHHTTSSSSSEEHHHHHHHHHH
T ss_pred             CcCEECHHHHHHHHHHhCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Confidence            47999999999999888988 99999999999999999999999999999863

...

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=2.2e-08  Score=91.81  Aligned_cols=110  Identities=17%  Similarity=0.250  Sum_probs=86.2

Q ss_pred             HHHHHHHHHHHHhCCCCC--CeeecceEEEcC----CeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 009594          100 IEDVRREVQIMKHLPKHP--NIVSLKDTYEDD----SAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV  172 (531)
Q Consensus       100 ~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~----~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~  172 (531)
                      .....+|...+..| ..-  .+++.+.+....    ...++|+|++++ .+|.+++......+......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L-~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRL-REAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHH-HHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence            34677788877777 333  344555555432    246899999987 4799988775557788889999999999999


Q ss_pred             HHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       173 LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ||..||+|+|++|.|||++.++....+.++||+.+...
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999987765567999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0377 consensus Protein serine/threonine phosphatase RDGC/PPEF, contains STphosphatase and EF-hand domains [Signal transduction mechanisms]

Probab=98.88  E-value=3.1e-08  Score=94.60  Aligned_cols=135  Identities=24%  Similarity=0.364  Sum_probs=102.8

Q ss_pred             HhhHHHHhcccccCCCCcccHHHHHHHHHhC-CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh--hc--------
Q 009594          361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG-GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL--KK--------  429 (531)
Q Consensus       361 ~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~-~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~--~~--------  429 (531)
                      ...+...|+.+|.++.|+|+...+..++... |.+++=.-++--.  ...+.||.+.|.+-...+..-  ..        
T Consensus       463 ~sdL~~eF~~~D~~ksG~lsis~Wa~~mE~i~~L~LPWr~L~~kl--a~~s~d~~v~Y~~~~~~l~~e~~~~ea~~slve  540 (631)
T KOG0377|consen  463 RSDLEDEFRKYDPKKSGKLSISHWAKCMENITGLNLPWRLLRPKL--ANGSDDGKVEYKSTLDNLDTEVILEEAGSSLVE  540 (631)
T ss_pred             hhHHHHHHHhcChhhcCeeeHHHHHHHHHHHhcCCCcHHHhhhhc--cCCCcCcceehHhHHHHhhhhhHHHHHHhHHHH
Confidence            3478899999999999999999998888765 5555544333222  234557788888766543211  00        


Q ss_pred             --cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc----CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          430 --MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE----VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       430 --~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                        -.....+..+|+.+|.|++|.||.+||+.+.+-+    ...+++.++.++-+.+|.|+||.|++.||++.++
T Consensus       541 tLYr~ks~LetiF~~iD~D~SG~isldEF~~a~~l~~sh~~~~i~~~~i~~la~~mD~NkDG~IDlNEfLeAFr  614 (631)
T KOG0377|consen  541 TLYRNKSSLETIFNIIDADNSGEISLDEFRTAWKLLSSHMNGAISDDEILELARSMDLNKDGKIDLNEFLEAFR  614 (631)
T ss_pred             HHHhchhhHHHHHHHhccCCCCceeHHHHHHHHHHHHhhcCCCcCHHHHHHHHHhhccCCCCcccHHHHHHHHh
Confidence              0123467889999999999999999999988754    4556788999999999999999999999998876

>cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction

Probab=98.87  E-value=5e-09  Score=77.11  Aligned_cols=60  Identities=33%  Similarity=0.461  Sum_probs=55.2

Q ss_pred             HHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          437 HKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       437 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +.+|+.+|.|++|.|+.+|+..++..+|.  +.++++.++..+|.+++|.|+++||+.++..
T Consensus         2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g~--~~~~~~~i~~~~d~~~~g~i~~~ef~~~~~~   61 (67)
T cd00052           2 DQIFRSLDPDGDGLISGDEARPFLGKSGL--PRSVLAQIWDLADTDKDGKLDKEEFAIAMHL   61 (67)
T ss_pred             hHHHHHhCCCCCCcCcHHHHHHHHHHcCC--CHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence            56899999999999999999999998874  7888999999999999999999999998863

The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs.

>cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11

Probab=98.86  E-value=7.4e-09  Score=80.05  Aligned_cols=66  Identities=20%  Similarity=0.384  Sum_probs=57.4

Q ss_pred             HHHHHhhcc-cCCCCCc-ceeHHHHHHHHhhc-----CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSF-FDRNRSG-FIEIEELRNALNDE-----VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~-~D~~~~G-~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..+..+|+. +|.+++| +|+.+||+.++...     +...++.+++.+++.+|.|+||.|+|+||+.++...
T Consensus         9 ~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~~~l   81 (89)
T cd05023           9 ESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLIGGL   81 (89)
T ss_pred             HHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHH
Confidence            457889999 7788876 99999999999875     345667899999999999999999999999988754

S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S

>smart00027 EH Eps15 homology domain

Probab=98.86  E-value=5.9e-09  Score=82.66  Aligned_cols=70  Identities=30%  Similarity=0.479  Sum_probs=63.5

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      ++.+++..++++|..+|.+++|.|+.+|++.+++.++  ++.++++.+|..+|.+++|.|+|+||+.++...
T Consensus         4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~~   73 (96)
T smart00027        4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADIDNDGELDKDEFALAMHLI   73 (96)
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHH
Confidence            4678899999999999999999999999999999865  678899999999999999999999999876543

Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences.

>smart00027 EH Eps15 homology domain

Probab=98.84  E-value=9e-09  Score=81.59  Aligned_cols=64  Identities=22%  Similarity=0.363  Sum_probs=58.8

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ...++.+|+.+|.|++|.|+.+|++.+|+..+  +++++++.++..+|.+++|.|+|+||+.++..
T Consensus         9 ~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~   72 (96)
T smart00027        9 KAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADIDNDGELDKDEFALAMHL   72 (96)
T ss_pred             HHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHH
Confidence            35688999999999999999999999999875  57889999999999999999999999998874

Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences.

>cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6

Probab=98.83  E-value=9.9e-09  Score=79.24  Aligned_cols=70  Identities=21%  Similarity=0.322  Sum_probs=61.5

Q ss_pred             hHHHhhHHHHhccccc-CC-CCcccHHHHHHHHH---hCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          358 VEEVAGLKEAFEMMDT-NK-RGKINLEELRLGLL---KGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~-~~-~g~i~~~el~~~l~---~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      ++.+..|-++|+.||. ++ +|+|+.+||+.+++   .+|..++.++++++|+.+|.|++|.|+|+||+.++..+
T Consensus         6 e~~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l   80 (88)
T cd05029           6 DQAIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGAL   80 (88)
T ss_pred             HHHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence            3445678899999998 67 89999999999996   36888999999999999999999999999999877554

S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact

>PRK09902 hypothetical protein; Provisional

Probab=98.82  E-value=8e-08  Score=86.11  Aligned_cols=139  Identities=16%  Similarity=0.190  Sum_probs=100.4

Q ss_pred             CccCceEEEEEEEccCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHhCCCCCC--eeecceEEE-c----CCeEEE
Q 009594           65 GRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKHPN--IVSLKDTYE-D----DSAVHI  134 (531)
Q Consensus        65 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~-~----~~~~~l  134 (531)
                      |+||.|.|+....  .|..+-+|.-.......   +.....+.+|+..+.+| ...+  ++++. ++. .    .-..+|
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L-~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKEL-ERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHH-HHcCCCCCccc-eeeeeccCCceEEEE
Confidence            6788889998763  34467778664221111   33567899999999988 3322  44554 332 1    234779


Q ss_pred             EEeccCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          135 VMELCEG-GELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       135 v~e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      |+|-++| .+|.+++.+.  .+.+......++.+++..+.-||+.|+.|+|+.+.||+++.++ ...++++||--++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccc
Confidence            9997754 6888887653  3467888899999999999999999999999999999997544 3459999997654

>cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z

Probab=98.81  E-value=1.1e-08  Score=80.25  Aligned_cols=69  Identities=19%  Similarity=0.248  Sum_probs=58.5

Q ss_pred             HHHhhHHHHhcccc-cCCCC-cccHHHHHHHHHh-C----CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          359 EEVAGLKEAFEMMD-TNKRG-KINLEELRLGLLK-G----GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       359 ~~~~~i~~~F~~~D-~~~~g-~i~~~el~~~l~~-~----~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      .-+..+.++|+.|| .|++| +|+.+||+.++.. +    +...++.+++.+++.+|.|++|.|+|+||+.++..+
T Consensus         7 ~a~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l   82 (93)
T cd05026           7 GAMDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAAL   82 (93)
T ss_pred             HHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            34557889999999 78998 5999999999976 2    344577899999999999999999999999987654

S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	531
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-77
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-75
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-75
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-74
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-74
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-72
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-71
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-71
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-63
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-63
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-62
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-61
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-61
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-61
3soa_A	444	Full-Length Human Camkii Length = 444		2e-60
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-60
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-59
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-59
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-59
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-58
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-58
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-58
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-57
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-57
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-57
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-56
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-56
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-56
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-56
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-56
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-55
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-54
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-53
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-53
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-52
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-52
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-52
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-51
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-50
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-50
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-50
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-50
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-50
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-50
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-50
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-50
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-50
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-50
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-50
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-50
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-50
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-50
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-50
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-50
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-50
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-49
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-49
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-49
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-49
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-46
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-46
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-46
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-46
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-46
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-46
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-46
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-46
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-46
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-46
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-46
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-46
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-46
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-46
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-45
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-45
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-45
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-45
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-45
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-45
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-45
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-45
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-45
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-45
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-45
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-45
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-45
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-43
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-43
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-43
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-43
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-42
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-42
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-42
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-42
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-42
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-42
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-42
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-42
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-42
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-42
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-42
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-42
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-42
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-41
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-41
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-41
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-41
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-41
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-41
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-41
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-41
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-41
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-41
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-40
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-40
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-40
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-40
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-40
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-40
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-40
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-40
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-40
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-40
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-40
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-40
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-40
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-40
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-40
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-40
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-40
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-40
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-40
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-40
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-40
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-40
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-40
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-40
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		9e-40
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-39
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-39
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-39
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-39
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-39
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-38
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-38
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-38
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-38
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-37
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-37
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-37
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-37
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-37
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-34
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-34
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-34
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-34
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-33
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-33
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-33
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-32
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-32
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-32
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-32
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-32
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-32
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-32
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-32
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-32
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-31
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-31
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-31
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-31
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-31
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-31
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-31
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-31
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-31
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-31
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-31
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-31
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-31
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-31
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-31
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-31
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-31
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-31
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-31
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-31
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-31
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-31
2aao_A	166	Regulatory Apparatus Of Calcium Dependent Protein K		1e-30
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-30
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-30
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-30
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-30
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-30
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-30
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-30
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-30
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-30
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-30
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-30
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-30
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-30
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-30
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-29
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-29
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-29
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-29
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-29
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-29
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-28
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-28
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-28
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-28
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-28
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-28
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-28
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-28
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-28
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-28
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-28
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-28
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-28
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-28
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-28
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-28
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-28
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-28
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-28
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-28
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-28
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-28
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-28
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-28
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-28
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-28
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-28
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-28
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-28
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-28
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-28
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-28
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-28
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-28
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-28
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-28
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-28
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-28
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-28
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-28
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-28
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-28
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-28
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-28
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-28
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-28
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-28
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-28
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-28
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-28
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-28
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-28
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-28
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-28
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-28
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-28
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-28
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-28
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-28
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-28
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-28
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-27
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-27
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-27
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-27
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-27
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-27
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-27
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-27
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-27
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-27
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-27
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-27
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-27
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-27
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-27
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-27
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-27
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-27
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-27
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-27
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-27
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-27
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-27
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-27
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-27
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-27
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-26
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-26
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-26
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-26
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-26
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-26
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-26
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-26
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-26
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-26
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-26
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-26
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-26
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-26
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-26
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-26
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-26
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-26
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-26
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-26
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-26
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-26
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-26
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-26
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-26
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-26
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-26
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-26
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-25
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-25
1s6i_A	188	Ca2+-Regulatory Region (Cld) From Soybean Calcium-D		1e-25
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-25
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-25
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-25
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-25
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-25
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-25
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-25
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-25
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-25
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-25
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-25
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-25
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-25
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-25
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-25
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-24
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-24
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-24
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-24
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-24
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-24
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-24
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-24
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-23
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-23
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-23
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-22
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-22
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-22
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-22
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-22
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-22
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-22
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-22
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-22
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-22
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-22
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-22
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-22
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		8e-22
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-21
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-21
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-21
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-21
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-21
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-21
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-21
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-21
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-21
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-21
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-21
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-21
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-21
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-21
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-21
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-21
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-21
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-20
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-20
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-20
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-20
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-20
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-20
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-20
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-20
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-20
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-20
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-20
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-20
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-20
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-20
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-20
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-20
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-20
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-20
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-20
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-20
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-20
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-20
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-20
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-20
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-20
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-20
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-20
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-20
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-20
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-20
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-20
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-20
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-20
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-20
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-20
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-20
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-20
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-20
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-20
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-20
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-20
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-20
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-20
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-20
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-20
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-20
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-20
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-20
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-20
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-19
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-19
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-19
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-19
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-19
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-19
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-19
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-19
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-19
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-19
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-19
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-19
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-19
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-19
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-19
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-19
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-19
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-19
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-19
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-19
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-19
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-19
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-19
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-19
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-19
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-19
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-19
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-19
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-19
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-19
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-19
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-19
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-19
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-19
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-19
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-19
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-19
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-19
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-19
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-19
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-19
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-19
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-19
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-18
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-18
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-18
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-18
3u0k_A	440	Crystal Structure Of The Genetically Encoded Calciu		3e-18
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-18
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-18
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-18
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-18
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-18
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-18
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-18
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-18
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-18
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-18
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-18
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-18
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-18
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-18
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-18
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-18
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-18
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-18
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-18
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-17
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-17
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-17
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-17
3sg5_A	448	Crystal Structure Of Dimeric Gcamp3-D380y, Qp(Linke		2e-17
3sg7_A	448	Crystal Structure Of Gcamp3-Kf(Linker 1) Length = 4		2e-17
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-17
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-17
3sg3_A	449	Crystal Structure Of Gcamp3-D380y Length = 449		2e-17
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-17
3sg4_A	448	Crystal Structure Of Gcamp3-D380y, Lp(Linker 2) Len		2e-17
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-17
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-17
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-17
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-17
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-17
1exr_A	148	The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Ca		4e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-17
2lv6_A	148	The Complex Between Ca-calmodulin And Skeletal Musc		5e-17
3ek8_A	449	Calcium-Saturated Gcamp2 T116vG87R MUTANT MONOMER L		5e-17
3evu_A	449	Crystal Structure Of Calcium Bound Dimeric Gcamp2,		5e-17
3evr_A	411	Crystal Structure Of Calcium Bound Monomeric Gcamp2		5e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-17
3ekh_A	449	Calcium-Saturated Gcamp2 T116vK378W MUTANT MONOMER		6e-17
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-17
3sg6_A	450	Crystal Structure Of Dimeric Gcamp2-Lia(Linker 1) L		6e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-17
3o77_A	415	The Structure Of Ca2+ Sensor (Case-16) Length = 415		6e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-17
3o78_A	415	The Structure Of Ca2+ Sensor (Case-12) Length = 415		6e-17
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-17
2k0j_A	148	Solution Structure Of Cam Complexed To Drp1p Length		6e-17
3sg2_A	449	Crystal Structure Of Gcamp2-T116v,D381y Length = 44		7e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-17
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-17
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-17
2bkh_B	149	Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Struc		9e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-17
1clm_A	148	Structure Of Paramecium Tetraurelia Calmodulin At 1		9e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-16
2f2o_A	179	Structure Of Calmodulin Bound To A Calcineurin Pept		1e-16
1ooj_A	149	Structural Genomics Of Caenorhabditis Elegans : Cal		1e-16
2bbm_A	148	Solution Structure Of A Calmodulin-Target Peptide C		1e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-16
2vb6_B	149	Myosin Vi (Md-Insert2-Cam, Delta Insert1) Post-Rigo		1e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-16
1xfu_O	149	Crystal Structure Of Anthrax Edema Factor (ef) Trun		1e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-16
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-16
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-16
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-16
2wel_D	150	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-16
2be6_A	150	2.0 A Crystal Structure Of The Cav1.2 Iq Domain-CaC		2e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-16
2ygg_B	150	Complex Of Cambr And Cam Length = 150		2e-16
1iq5_A	149	CalmodulinNEMATODE CA2+CALMODULIN DEPENDENT KINASE		2e-16
4djc_A	152	1.35 A Crystal Structure Of The Nav1.5 Diii-Iv-CaCA		2e-16
1prw_A	149	Crystal Structure Of Bovine Brain Ca++ Calmodulin I		2e-16
1up5_B	148	Chicken Calmodulin Length = 148		2e-16
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-16
3ewt_A	154	Crystal Structure Of Calmodulin Complexed With A Pe		2e-16
1cm1_A	148	Motions Of Calmodulin-Single-Conformer Refinement L		2e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-16
1cdl_A	147	Target Enzyme Recognition By Calmodulin: 2.4 Angstr		2e-16
2vay_A	146	Calmodulin Complexed With Cav1.1 Iq Peptide Length		3e-16
1ahr_A	146	Calmodulin Mutant With A Two Residue Deletion In Th		3e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-16
1cdm_A	144	Modulation Of Calmodulin Plasticity In Molecular Re		4e-16
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-16
1qtx_A	148	The 1.65 Angstrom Structure Of Calmodulin Rs20 Pept		6e-16
1vrk_A	148	The 1.9 Angstrom Structure Of E84k-Calmodulin Rs20		6e-16
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-16
1qs7_A	145	The 1.8 Angstrom Structure Of Calmodulin Rs20 Pepti		8e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-16
1dmo_A	148	Calmodulin, Nmr, 30 Structures Length = 148		9e-16
1y0v_H	146	Crystal Structure Of Anthrax Edema Factor (Ef) In C		1e-15
4gow_D	144	Crystal Structure Of Ca2+CAM:KV7.4 (KCNQ4) B HELIX		1e-15
1k93_D	144	Crystal Structure Of The Adenylyl Cyclase Domain Of		1e-15
4aqr_A	149	Crystal Structure Of A Calmodulin In Complex With T		1e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-15
2ix7_A	145	Structure Of Apo-Calmodulin Bound To Unconventional		1e-15
1deg_A	142	The Linker Of Des-Glu84 Calmodulin Is Bent As Seen		1e-15
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-15
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-15
5tnc_A	162	Refined Crystal Structure Of Troponin C From Turkey		2e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
2w49_0	159	Isometrically Contracting Insect Asynchronous Fligh		2e-15
1ytz_C	162	Crystal Structure Of Skeletal Muscle Troponin In Th		2e-15
4tnc_A	162	Refined Structure Of Chicken Skeletal Muscle Tropon		2e-15
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-15
1rfj_A	149	Crystal Structure Of Potato Calmodulin Pcm6 Length		2e-15
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-15
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-15
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-15
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-15
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-15
1tnw_A	162	Nmr Solution Structure Of Calcium Saturated Skeleta		4e-15
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-15
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-15
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-15
1ggz_A	148	Crystal Structure Of The Calmodulin-Like Protein (H		7e-15
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-15
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-14
2l1w_A	149	The Solution Structure Of Soybean Calmodulin Isofor		1e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-14
2lmt_A	148	Nmr Structure Of Androcam Length = 148		2e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-14
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-14
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-14
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-14
1xfx_O	149	Crystal Structure Of Anthrax Edema Factor (Ef) In C		6e-14
1niw_A	148	Crystal Structure Of Endothelial Nitric Oxide Synth		7e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-14
1y6w_A	148	Trapped Intermediate Of Calmodulin Length = 148		9e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-14
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-13
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-13
3ekj_A	449	Calcium-Free Gcamp2 (Calcium Binding Deficient Muta		1e-13
1a2x_A	159	Complex Of Troponin C With A 47 Residue (1-47) Frag		2e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-13
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-13
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
1tcf_A	159	Crystal Structure Of Calcium-Saturated Rabbit Skele		2e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-13
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-13
3pm8_A	197	Cad Domain Of Pff0520w, Calcium Dependent Protein K		8e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-12
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		2e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-12
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		2e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-12
1la0_A	161	Solution Structure Of Calcium Saturated Cardiac Tro		6e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-12
1aj4_A	161	Structure Of Calcium-Saturated Cardiac Troponin C,		9e-12
3k21_A	191	Crystal Structure Of Carboxy-Terminus Of Pfc0420w L		1e-11
1dtl_A	161	Crystal Structure Of Calcium-Saturated (3ca2+) Card		1e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-11
2lhi_A	176	Solution Structure Of Ca2+CNA1 PEPTIDE-Bound Ycam L		1e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-10
2jt0_A	161	Solution Structure Of F104w Cardiac Troponin C Leng		1e-10
2jt3_A	161	Solution Structure Of F153w Cardiac Troponin C Leng		1e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-10
3o4y_A	196	Crystal Structure Of Cad Domain Of The Plasmodium V		1e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-10
1lkj_A	146	Nmr Structure Of Apo Calmodulin From Yeast Saccharo		3e-10
1s6j_A	87	N-Terminal Region Of The Ca2+-Saturated Calcium Reg		3e-10
2jtz_A	161	Solution Structure And Chemical Shift Assignments O		3e-10
2jt8_A	161	Solution Structure Of The F153-To-5-Flurotryptophan		3e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-10
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-10
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-10
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-10
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-10
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-10
4ds7_A	147	Crystal Structure Of Yeast Calmodulin Bound To The		9e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-09
3l19_A	214	Crystal Structure Of Calcium Binding Domain Of Cpcd		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-09
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		2e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-09
3khe_A	191	Crystal Structure Of The Calcium-Loaded Calmodulin-		3e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-08
2lhh_A	128	Solution Structure Of Ca2+-Bound Ycam Length = 128		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-07
2lan_A	167	Nmr Structure Of Ca2+-Bound Cabp1 N-Domain With Rdc		1e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
1tco_B	169	Ternary Complex Of A Calcineurin A Fragment, Calcin		2e-07
1ozs_A	73	C-Domain Of Human Cardiac Troponin C In Complex Wit		2e-07
1mf8_B	170	Crystal Structure Of Human Calcineurin Complexed Wi		2e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-07
1fi5_A	81	Nmr Structure Of The C Terminal Domain Of Cardiac T		3e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-07
3qrx_A	169	Chlamydomonas Reinhardtii Centrin Bound To Melittin		3e-07
3ox5_A	153	Crystal Structure Of The Calcium Sensor Calcium-Bin		3e-07
2p6b_B	156	Crystal Structure Of Human Calcineurin In Complex W		3e-07
3ctn_A	76	Structure Of Calcium-Saturated Cardiac Troponin C,		4e-07
1ih0_A	71	Structure Of The C-Domain Of Human Cardiac Troponin		4e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-07
3ll8_B	155	Crystal Structure Of Calcineurin In Complex With Ak		4e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-07
3ox6_A	153	Crystal Structure Of The Calcium Sensor Calcium-Bin		5e-07

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  284 bits (726), Expect = 9e-77,   Method: Compositional matrix adjust.
 Identities = 160/459 (34%), Positives = 249/459 (54%), Gaps = 21/459 (4%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++   LG+G FG    C D    +++A K I+K   +   D   + REV+++K L  HP
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD-HP 81
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI+ L +  ED S+ +IV EL  GGELFD I+ R  ++E  AA ++K +   +   H+  
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           ++HRDLKPEN L  +K++   +K IDFGLS  F+   +  + +G+ YY+APEVL+  Y  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           + DVWSAGVILYILL G PPF+ + E  + + +      F    W  +S++AKDL++KML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 298 NPDPKQRLTAEEVLEHPWLQN-AKKAPNVS---LGETVKARLKQFSVMNKLKKRALQVVA 353
              P  R+TA + LEHPW+Q  + + P +S     E+    ++QF    KL + AL  +A
Sbjct: 262 TFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMA 321
Query: 354 EFL-SVEEVAGLKEAFEMMDTNKRGKIN-----------XXXXXXXXXXXXQN---IPEA 398
             L +++E   L E F  +DTN  G ++                       QN     E 
Sbjct: 322 SKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIED 381
Query: 399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
            +  LM   D+DG GS+ Y EF+A ++    + + E + +AF  FD++ SG I  +EL  
Sbjct: 382 QIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSRERMERAFKMFDKDGSGKISTKELFK 441
Query: 459 ALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
             +    +   + + +I+  VD +KDG + + EF  M++
Sbjct: 442 LFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQ 480

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  279 bits (713), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 164/512 (32%), Positives = 264/512 (51%), Gaps = 34/512 (6%)
Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
           +G     P      R++G     +   GD      G  V H   +  +         Y  
Sbjct: 8   LGGAAGEP------RSRGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDR--------YKG 53
Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
            R LG+G FG   LC D   G++ A K ISK++++   D E + REVQ++K L  HPNI+
Sbjct: 54  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIM 112
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
            L + +ED    ++V E+  GGELFD I++R  ++E  AA +++ ++  +   H+  ++H
Sbjct: 113 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 172
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
           RDLKPEN L  +K + + ++ IDFGLS  F   ++  + +G+ YY+APEVL   Y  + D
Sbjct: 173 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCD 232
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           VWS GVILYILL G PPF    E  + + + +    F+   W KVSE+AKDL++KML   
Sbjct: 233 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 292
Query: 301 PKQRLTAEEVLEHPWLQNAKK---APNVSLGETVKARLKQFSVMNKLKKRALQVV-AEFL 356
           P  R++A + L+H W+Q   K   + +V   +     ++QF    KL + AL  + ++  
Sbjct: 293 PSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLT 352
Query: 357 SVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQ-----------NIPEADLQILME 405
           S +E   L   F  MD N  G+++            +           +  E ++  +++
Sbjct: 353 SQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLD 412
Query: 406 AADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN-DEV 464
           A D D +G + Y EFV V++  K + + E L +AF  FD + SG I   EL       +V
Sbjct: 413 AVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIFGVSDV 472
Query: 465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
           D+   +   +++ +VD + DG + ++EF  M+
Sbjct: 473 DS---ETWKSVLSEVDKNNDGEVDFDEFQQML 501

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  279 bits (713), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 164/512 (32%), Positives = 264/512 (51%), Gaps = 34/512 (6%)
Query: 1   MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
           +G     P      R++G     +   GD      G  V H   +  +         Y  
Sbjct: 9   LGGAAGEP------RSRGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDR--------YKG 54
Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
            R LG+G FG   LC D   G++ A K ISK++++   D E + REVQ++K L  HPNI+
Sbjct: 55  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIM 113
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
            L + +ED    ++V E+  GGELFD I++R  ++E  AA +++ ++  +   H+  ++H
Sbjct: 114 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 173
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
           RDLKPEN L  +K + + ++ IDFGLS  F   ++  + +G+ YY+APEVL   Y  + D
Sbjct: 174 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCD 233
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           VWS GVILYILL G PPF    E  + + + +    F+   W KVSE+AKDL++KML   
Sbjct: 234 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 293
Query: 301 PKQRLTAEEVLEHPWLQNAKK---APNVSLGETVKARLKQFSVMNKLKKRALQVV-AEFL 356
           P  R++A + L+H W+Q   K   + +V   +     ++QF    KL + AL  + ++  
Sbjct: 294 PSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLT 353
Query: 357 SVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQ-----------NIPEADLQILME 405
           S +E   L   F  MD N  G+++            +           +  E ++  +++
Sbjct: 354 SQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLD 413
Query: 406 AADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN-DEV 464
           A D D +G + Y EFV V++  K + + E L +AF  FD + SG I   EL       +V
Sbjct: 414 AVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIFGVSDV 473
Query: 465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
           D+   +   +++ +VD + DG + ++EF  M+
Sbjct: 474 DS---ETWKSVLSEVDKNNDGEVDFDEFQQML 502

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  277 bits (708), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 155/455 (34%), Positives = 249/455 (54%), Gaps = 20/455 (4%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y   R LG+G FG   LC D   G++ A K ISK++++   D E + REVQ++K L  HP
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 86
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI+ L + +ED    ++V E+  GGELFD I++R  ++E  AA +++ ++  +   H+  
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           ++HRDLKPEN L  +K + + ++ IDFGLS  F   ++  + +G+ YY+APEVL   Y  
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           + DVWS GVILYILL G PPF    E  + + + +    F+   W KVSE+AKDL++KML
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 266
Query: 298 NPDPKQRLTAEEVLEHPWLQNAKK---APNVSLGETVKARLKQFSVMNKLKKRALQVV-A 353
              P  R++A + L+H W+Q   K   + +V   +     ++QF    KL + AL  + +
Sbjct: 267 TYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGS 326
Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQ-----------NIPEADLQI 402
           +  S +E   L   F  MD N  G+++            +           +  E ++  
Sbjct: 327 KLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQ 386
Query: 403 LMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN- 461
           +++A D D +G + Y EFV V++  K + + E L +AF  FD + SG I   EL      
Sbjct: 387 VLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIFGV 446
Query: 462 DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            +VD+   +   +++ +VD + DG + ++EF  M+
Sbjct: 447 SDVDS---ETWKSVLSEVDKNNDGEVDFDEFQQML 478

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  275 bits (703), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 158/465 (33%), Positives = 248/465 (53%), Gaps = 21/465 (4%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           +S  Y   ++LG G +G   LC D   G + A K I K  + T  +   +  EV ++K L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
             HPNI+ L + +ED    ++VME+  GGELFD I+ R  ++E  AA +MK ++      
Sbjct: 62  D-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H+  ++HRDLKPEN L  +K   + +K +DFGLS  F  G +  E +G+ YY+APEVL++
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 180
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            Y  + DVWS GVILYILLCG PPF  +T+Q + + + +    F    W +VS+ AK LV
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 240
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE----TVKARLKQFSVMNKLKKRAL 349
           K ML  +P +R++AEE L HPW+       +  +G+         +K+F    KL + A+
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWIVKFCSQKHTDVGKHALTGALGNMKKFQSSQKLAQAAM 300
Query: 350 QVV-AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQ-----------NIPE 397
             + ++  ++EE   L + F  +D N  G+++            Q           +  E
Sbjct: 301 LFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDSSQIE 360
Query: 398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELR 457
           A++  ++++ D D +G + Y EFV V +  + + + E L  AF  FD + SG I  EEL 
Sbjct: 361 AEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERLLAAFQQFDSDGSGKITNEELG 420
Query: 458 NALN-DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
                 EVD   ++  + ++ + D + DG + +EEF  MM+   D
Sbjct: 421 RLFGVTEVD---DETWHQVLQECDKNNDGEVDFEEFVEMMQKICD 462

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  269 bits (688), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 156/453 (34%), Positives = 253/453 (55%), Gaps = 17/453 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y   ++LG G +G   LC D     + A K I K  + T+ +   +  EV ++K L  HP
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLK-LLDHP 96
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI+ L D +ED    ++VME  +GGELFD I+ R  + E  AA ++K ++  V   H+  
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           ++HRDLKPEN L  +K++ + +K +DFGLS  F   ++  E +G+ YY+APEVL++ Y  
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDE 216
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           + DVWS GVIL+ILL G PPF  +T+Q + + + +    F    W  VSE AKDL+K+ML
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQML 276
Query: 298 NPDPKQRLTAEEVLEHPWLQN--AKKAPNVSLGETVKA--RLKQFSVMNKLKKRALQVVA 353
             D ++R++A++ LEHPW++   +KK   + L     A   +++F    KL + AL  +A
Sbjct: 277 QFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMA 336
Query: 354 EFL-SVEEVAGLKEAFEMMDTNKRGK------INXXXXXXXXXXXXQNIP--EADLQILM 404
             L S EE   L + F  +D N  G+      I+             ++P  E+++  ++
Sbjct: 337 SKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAIL 396
Query: 405 EAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
            AAD D +G ++Y EFV V++  K + + + L  AF  FD++ +G I ++EL +     +
Sbjct: 397 GAADFDRNGYIDYSEFVTVAMDRKSLLSKDKLESAFQKFDQDGNGKISVDELASVFG--L 454
Query: 465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           D         ++  +D++ DG + +EEF  M++
Sbjct: 455 DHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQ 487

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  266 bits (681), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 153/451 (33%), Positives = 243/451 (53%), Gaps = 20/451 (4%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y   R LG+G FG   LC D   G++ A K ISK++++   D E + REVQ++K L  HP
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 86
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI  L + +ED    ++V E+  GGELFD I++R  ++E  AA +++ ++  +   H+  
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           ++HRDLKPEN L  +K + + ++ IDFGLS  F   ++  + +G+ YY+APEVL   Y  
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYDE 206
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           + DVWS GVILYILL G PPF    E  + + + +    F+   W KVSE+AKDL++K L
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXL 266
Query: 298 NPDPKQRLTAEEVLEHPWLQNAKK---APNVSLGETVKARLKQFSVMNKLKKRALQVV-A 353
              P  R++A + L+H W+Q   K   + +V   +     ++QF    KL + AL    +
Sbjct: 267 TYVPSXRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYXGS 326
Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQ-----------NIPEADLQI 402
           +  S +E   L   F   D N  G+++            +           +  E ++  
Sbjct: 327 KLTSQDETKELTAIFHKXDKNGDGQLDRAELIEGYKELXRXKGQDASXLDASAVEHEVDQ 386
Query: 403 LMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN- 461
           +++A D D +G + Y EFV V+   K + + E L +AF  FD + SG I   EL      
Sbjct: 387 VLDAVDFDKNGYIEYSEFVTVAXDRKTLLSRERLERAFRXFDSDNSGKISSTELATIFGV 446
Query: 462 DEVDTSGEDVINAIMHDVDTDKDGRISYEEF 492
            +VD+   +   +++ +VD + DG + ++EF
Sbjct: 447 SDVDS---ETWKSVLSEVDKNNDGEVDFDEF 474

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  265 bits (676), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 156/465 (33%), Positives = 248/465 (53%), Gaps = 27/465 (5%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVD-------IEDVRREVQIMK 111
           R+LG G +G   LC + N   + A K I K +    R + D        E++  E+ ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L  HPNI+ L D +ED    ++V E  EGGELF++I+ R  + E  AA +MK I+  + 
Sbjct: 102 SLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             H+  ++HRD+KPEN L  NK     +K +DFGLS FF    +  + +G+ YY+APEVL
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL 220
Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
           K+ Y  + DVWS GVI+YILLCG PPF  + +Q + + + +    F  + W  +S+ AK+
Sbjct: 221 KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE 280
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETV---KARLKQFSVMNKLKKRA 348
           L+K ML  D  +R TAEE L   W++      N S  +T+    + +++F    KL + A
Sbjct: 281 LIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAA 340
Query: 349 LQVV-AEFLSVEEVAGLKEAFEMMDTNKRGKI---------NXXXXXXXXXXXXQNIPEA 398
           +  + ++  ++EE   L + F+ +D N  G++         N            +N+ E 
Sbjct: 341 ILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEE 400
Query: 399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
              IL E  D D +G + Y EF++V +  + + ++E L +AF+ FD ++SG I  EEL N
Sbjct: 401 VDNILKE-VDFDKNGYIEYSEFISVCMDKQILFSEERLRRAFNLFDTDKSGKITKEELAN 459
Query: 459 ALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWR 503
                + +  E   N ++ + D +KD  I ++EF  MM    D +
Sbjct: 460 LFG--LTSISEKTWNDVLGEADQNKDNMIDFDEFVSMMHKICDHK 502

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  239 bits (609), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 116/265 (43%), Positives = 165/265 (62%), Gaps = 4/265 (1%)
Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           DI+  Y L   +GRG +G   +        + A K I K  +    D++  ++E++IMK 
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKS 79
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           L  HPNI+ L +T+ED++ +++VMELC GGELF+R+V +  + E  AA +MK ++  V  
Sbjct: 80  L-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 138
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
           CH+  V HRDLKPENFLF      SPLK IDFGL+  F+PG+     VG+PYY++P+VL+
Sbjct: 139 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 198
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             YGPE D WSAGV++Y+LLCG PPF A T+  V   I      F    W  VS  A+ L
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 258
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQ 317
           ++++L   PKQR+T+ + LEH W +
Sbjct: 259 IRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  238 bits (608), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 116/265 (43%), Positives = 165/265 (62%), Gaps = 4/265 (1%)
Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           DI+  Y L   +GRG +G   +        + A K I K  +    D++  ++E++IMK 
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKS 62
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           L  HPNI+ L +T+ED++ +++VMELC GGELF+R+V +  + E  AA +MK ++  V  
Sbjct: 63  L-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
           CH+  V HRDLKPENFLF      SPLK IDFGL+  F+PG+     VG+PYY++P+VL+
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 181
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             YGPE D WSAGV++Y+LLCG PPF A T+  V   I      F    W  VS  A+ L
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQ 317
           ++++L   PKQR+T+ + LEH W +
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  234 bits (598), Expect = 7e-62,   Method: Compositional matrix adjust.
 Identities = 127/298 (42%), Positives = 179/298 (60%), Gaps = 10/298 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +++  ELGRG   + Y C      + +A K + K      VD + VR E+ ++  L  HP
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRL-SHP 108
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI+ LK+ +E  + + +V+EL  GGELFDRIV +G+Y+ER AA  +K I+E V   HE G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYG 236
           ++HRDLKPEN L+A     +PLK  DFGLS           + G+P Y APE+L+   YG
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 237 PEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           PEVD+WS G+I YILLCG  PF+ E  +Q + + I+     F    W +VS NAKDLV+K
Sbjct: 229 PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVA 353
           ++  DPK+RLT  + L+HPW+    KA N    +T + +L++F+   KLK     VVA
Sbjct: 289 LIVLDPKKRLTTFQALQHPWVTG--KAANFVHMDTAQKKLQEFNARRKLKAAVKAVVA 344

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  234 bits (596), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 127/299 (42%), Positives = 185/299 (61%), Gaps = 6/299 (2%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L  ELG+G F V   C  +  G+++A K I+ KKL +A D + + RE +I + L KH
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICRLL-KH 62
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L D+  ++   ++V +L  GGELF+ IVAR +Y+E  A+  ++ I+E V  CH  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNEIVGSPYYMAPEVLKRN- 234
           G++HRDLKPEN L A+K + + +K  DFGL++  +  +Q +    G+P Y++PEVL+++ 
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD+W+ GVILYILL G PPFW E +  + Q I     DF    W  V+  AKDL+ 
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 295 KMLNPDPKQRLTAEEVLEHPWL-QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
           KML  +P +R+TA E L+HPW+ Q +  A  +   ETV   LK+F+   KLK   L  +
Sbjct: 243 KMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDC-LKKFNARRKLKGAILTTM 300

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  233 bits (594), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 127/299 (42%), Positives = 185/299 (61%), Gaps = 6/299 (2%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L  ELG+G F V   C  +  G+++A K I+ KKL +A D + + RE +I + L KH
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICR-LLKH 62
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L D+  ++   ++V +L  GGELF+ IVAR +Y+E  A+  ++ I+E V  CH  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNEIVGSPYYMAPEVLKRN- 234
           G++HRDLKPEN L A+K + + +K  DFGL++  +  +Q +    G+P Y++PEVL+++ 
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD+W+ GVILYILL G PPFW E +  + Q I     DF    W  V+  AKDL+ 
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 295 KMLNPDPKQRLTAEEVLEHPWL-QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
           KML  +P +R+TA E L+HPW+ Q +  A  +   ETV   LK+F+   KLK   L  +
Sbjct: 243 KMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDC-LKKFNARRKLKGAILTTM 300

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  231 bits (589), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 128/292 (43%), Positives = 183/292 (62%), Gaps = 8/292 (2%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y L  ELG+G F V   C  V  G+++A K I+ KKL +A D + + RE +I + L KHP
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL-SARDHQKLEREARICR-LLKHP 81
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV L D+  ++   +++ +L  GGELF+ IVAR +Y+E  A+  ++ I+E V  CH+ G
Sbjct: 82  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGSPYYMAPEVLKRN- 234
           V+HRDLKPEN L A+K + + +K  DFGL++    GEQ  +    G+P Y++PEVL+++ 
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD+W+ GVILYILL G PPFW E +  + Q I     DF    W  V+  AKDL+ 
Sbjct: 201 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 260
Query: 295 KMLNPDPKQRLTAEEVLEHPWLQN-AKKAPNVSLGETVKARLKQFSVMNKLK 345
           KML  +P +R+TA E L+HPW+ + +  A  +   ETV   LK+F+   KLK
Sbjct: 261 KMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDC-LKKFNARRKLK 311

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  230 bits (586), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 128/300 (42%), Positives = 186/300 (62%), Gaps = 8/300 (2%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L  ELG+G F V   C  V  G+++A   I+ KKL +A D + + RE +I + L KH
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICR-LLKH 69
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L D+  ++   +++ +L  GGELF+ IVAR +Y+E  A+  ++ I+E V  CH+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGSPYYMAPEVLKRN 234
           GV+HR+LKPEN L A+K + + +K  DFGL++    GEQ  +    G+P Y++PEVL+++
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            YG  VD+W+ GVILYILL G PPFW E +  + Q I     DF    W  V+  AKDL+
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 248
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQN-AKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
            KML  +P +R+TA E L+HPW+ + +  A  +   ETV   LK+F+   KLK   L V+
Sbjct: 249 NKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDC-LKKFNARRKLKGAILTVM 307

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  229 bits (584), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 121/301 (40%), Positives = 183/301 (60%), Gaps = 5/301 (1%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
            S +YD+  ELG+G F V   C     G +FA K I+ KKL +A D + + RE +I + L
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 85
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
            +HPNIV L D+ +++S  ++V +L  GGELF+ IVAR  Y+E  A+  ++ I+E +  C
Sbjct: 86  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H  G++HR+LKPEN L A+K + + +K  DFGL++     E ++   G+P Y++PEVLK+
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           + Y   VD+W+ GVILYILL G PPFW E +  +   I     D+    W  V+  AK L
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVSLGETVKARLKQFSVMNKLKKRALQV 351
           +  ML  +PK+R+TA++ L+ PW+ N ++ A  +   +TV   LK+F+   KLK   L  
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC-LKKFNARRKLKGAILTT 323
Query: 352 V 352
           +
Sbjct: 324 M 324

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  226 bits (577), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 109/264 (41%), Positives = 163/264 (61%), Gaps = 1/264 (0%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y   R LG+G FG   LC D   G++ A K ISK++++   D E + REVQ++K L  HP
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 92
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI+ L + +ED    ++V E+  GGELFD I++R  ++E  AA +++ ++  +   H+  
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           ++HRDLKPEN L  +K + + ++ IDFGLS  F   ++  + +G+ YY+APEVL   Y  
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 212
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           + DVWS GVILYILL G PPF    E  + + + +    F+   W KVSE+AKDL++KML
Sbjct: 213 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 272
Query: 298 NPDPKQRLTAEEVLEHPWLQNAKK 321
              P  R++A + L+H W+Q   K
Sbjct: 273 TYVPSMRISARDALDHEWIQTYTK 296

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 122/292 (41%), Positives = 182/292 (62%), Gaps = 6/292 (2%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L  ++G+G F V   C  +  G ++A K I+ KKL +A D + + RE +I + L KH
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKL-SARDHQKLEREARICR-LLKH 62
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            NIV L D+  ++   ++V +L  GGELF+ IVAR +Y+E  A+  ++ I+E V  CH+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNEIVGSPYYMAPEVLKRN- 234
           GV+HRDLKPEN L A+K + + +K  DFGL++  +  +Q +    G+P Y++PEVL++  
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD+W+ GVILYILL G PPFW E +  + Q I     DF    W  V+  AK+L+ 
Sbjct: 183 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 242
Query: 295 KMLNPDPKQRLTAEEVLEHPWL-QNAKKAPNVSLGETVKARLKQFSVMNKLK 345
           +ML  +P +R+TA E L+HPW+ Q +  A  +   ETV+  LK+F+   KLK
Sbjct: 243 QMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVEC-LKKFNARRKLK 293

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  225 bits (574), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 111/265 (41%), Positives = 160/265 (60%), Gaps = 1/265 (0%)
Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
           Q +S  Y   ++LG G +G   LC D   G + A K I K  + T  +   +  EV ++K
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L  HPNI+ L + +ED    ++VME+  GGELFD I+ R  ++E  AA +MK ++    
Sbjct: 77  QL-DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             H+  ++HRDLKPEN L  +K   + +K +DFGLS  F  G +  E +G+ YY+APEVL
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 195
Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
           ++ Y  + DVWS GVILYILLCG PPF  +T+Q + + + +    F    W +VS+ AK 
Sbjct: 196 RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQ 255
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWL 316
           LVK ML  +P +R++AEE L HPW+
Sbjct: 256 LVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  222 bits (565), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 111/269 (41%), Positives = 168/269 (62%), Gaps = 3/269 (1%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
            S +YD+  ELG+G F V   C     G +FA K I+ KKL +A D + + RE +I + L
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 62
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
            +HPNIV L D+ +++S  ++V +L  GGELF+ IVAR  Y+E  A+  ++ I+E +  C
Sbjct: 63  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H  G++HR+LKPEN L A+K + + +K  DFGL++     E ++   G+P Y++PEVLK+
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           + Y   VD+W+ GVILYILL G PPFW E +  +   I     D+    W  V+  AK L
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           +  ML  +PK+R+TA++ L+ PW+ N ++
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRER 270

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  222 bits (565), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 111/269 (41%), Positives = 168/269 (62%), Gaps = 3/269 (1%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
            S +YD+  ELG+G F V   C     G +FA K I+ KKL +A D + + RE +I + L
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 61
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
            +HPNIV L D+ +++S  ++V +L  GGELF+ IVAR  Y+E  A+  ++ I+E +  C
Sbjct: 62  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H  G++HR+LKPEN L A+K + + +K  DFGL++     E ++   G+P Y++PEVLK+
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 180
Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           + Y   VD+W+ GVILYILL G PPFW E +  +   I     D+    W  V+  AK L
Sbjct: 181 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 240
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           +  ML  +PK+R+TA++ L+ PW+ N ++
Sbjct: 241 IDSMLTVNPKKRITADQALKVPWICNRER 269

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  222 bits (565), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 111/266 (41%), Positives = 166/266 (62%), Gaps = 3/266 (1%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
            S +YD+  ELG+G F V   C     G +FA K I+ KKL +A D + + RE +I + L
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 62
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
            +HPNIV L D+ +++S  ++V +L  GGELF+ IVAR  Y+E  A+  ++ I+E +  C
Sbjct: 63  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H  G++HR+LKPEN L A+K + + +K  DFGL++     E ++   G+P Y++PEVLK+
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           + Y   VD+W+ GVILYILL G PPFW E +  +   I     D+    W  V+  AK L
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQN 318
           +  ML  +PK+R+TA++ L+ PW+ N
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICN 267

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  221 bits (562), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 123/300 (41%), Positives = 184/300 (61%), Gaps = 8/300 (2%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L  ELG+G F V   C      +++A K I+ KKL +A D + + RE +I + L KH
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL-SARDHQKLEREARICR-LLKH 89
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L D+  ++   ++V +L  GGELF+ IVAR +Y+E  A+  +  I+E V   H+ 
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGSPYYMAPEVLKRN 234
            ++HRDLKPEN L A+K + + +K  DFGL++  + GEQ  +    G+P Y++PEVL+++
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-GEQQAWFGFAGTPGYLSPEVLRKD 208
Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            YG  VD+W+ GVILYILL G PPFW E +  + Q I     DF    W  V+  AK+L+
Sbjct: 209 PYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 268
Query: 294 KKMLNPDPKQRLTAEEVLEHPWL-QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
            +ML  +P +R+TA++ L+HPW+ Q +  A  +   ETV+  L++F+   KLK   L  +
Sbjct: 269 NQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVEC-LRKFNARRKLKGAILTTM 327

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  220 bits (561), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 108/260 (41%), Positives = 159/260 (61%), Gaps = 2/260 (0%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++   LG+G FG    C D    +++A K I+K   +   D   + REV+++K L  HP
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD-HP 81
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI+ L +  ED S+ +IV EL  GGELFD I+ R  ++E  AA ++K +   +   H+  
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           ++HRDLKPEN L  +K++   +K IDFGLS  F+   +  + +G+ YY+APEVL+  Y  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           + DVWSAGVILYILL G PPF+ + E  + + +      F    W  +S++AKDL++KML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 298 NPDPKQRLTAEEVLEHPWLQ 317
              P  R+TA + LEHPW+Q
Sbjct: 262 TFHPSLRITATQCLEHPWIQ 281

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  220 bits (560), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 108/260 (41%), Positives = 159/260 (61%), Gaps = 2/260 (0%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++   LG+G FG    C D    +++A K I+K   +   D   + REV+++K L  HP
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD-HP 81
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI+ L +  ED S+ +IV EL  GGELFD I+ R  ++E  AA ++K +   +   H+  
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           ++HRDLKPEN L  +K++   +K IDFGLS  F+   +  + +G+ YY+APEVL+  Y  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           + DVWSAGVILYILL G PPF+ + E  + + +      F    W  +S++AKDL++KML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 298 NPDPKQRLTAEEVLEHPWLQ 317
              P  R+TA + LEHPW+Q
Sbjct: 262 TFHPSLRITATQCLEHPWIQ 281

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  217 bits (553), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 108/288 (37%), Positives = 173/288 (60%), Gaps = 5/288 (1%)
Query: 51  GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
            +DI   ++    LG G F    L  +   G+ FA K I KK L+       +  E+ ++
Sbjct: 17  AEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES--SIENEIAVL 74
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
           + + KH NIV+L+D YE  + +++VM+L  GGELFDRIV +G YTE+ A+ +++ +++ V
Sbjct: 75  RKI-KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAV 133
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
              H  G++HRDLKPEN L+ ++ E S +   DFGLS     G+  +   G+P Y+APEV
Sbjct: 134 YYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEV 193
Query: 231 L-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           L ++ Y   VD WS GVI YILLCG PPF+ E +  + + I+++  +F    W  +S++A
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSA 253
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
           KD ++ ++  DP +R T E+   HPW+     A N ++ E+V A++++
Sbjct: 254 KDFIRNLMEKDPNKRYTCEQAARHPWIA-GDTALNKNIHESVSAQIRK 300

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  216 bits (550), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 113/297 (38%), Positives = 175/297 (58%), Gaps = 5/297 (1%)
Query: 51  GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
            +DI   YD    LG G F    L  D    +  A K I+KK L        +  E+ ++
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVL 70
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
            H  KHPNIV+L D YE    ++++M+L  GGELFDRIV +G YTER A+ ++  +++ V
Sbjct: 71  -HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 129
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
           +  H+ G++HRDLKPEN L+ +  E S +   DFGLS    PG   +   G+P Y+APEV
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 189
Query: 231 L-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           L ++ Y   VD WS GVI YILLCG PPF+ E +  + + I+++  +F    W  +S++A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
           KD ++ ++  DP++R T E+ L+HPW+     A + ++ ++V  ++K+    +K K+
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  215 bits (547), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 112/297 (37%), Positives = 175/297 (58%), Gaps = 5/297 (1%)
Query: 51  GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
            +DI   YD    LG G F    L  D    +  A K I+K+ L        +  E+ ++
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVL 70
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
            H  KHPNIV+L D YE    ++++M+L  GGELFDRIV +G YTER A+ ++  +++ V
Sbjct: 71  -HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 129
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
           +  H+ G++HRDLKPEN L+ +  E S +   DFGLS    PG   +   G+P Y+APEV
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 189
Query: 231 L-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           L ++ Y   VD WS GVI YILLCG PPF+ E +  + + I+++  +F    W  +S++A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
           KD ++ ++  DP++R T E+ L+HPW+     A + ++ ++V  ++K+    +K K+
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  215 bits (547), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 112/297 (37%), Positives = 175/297 (58%), Gaps = 5/297 (1%)
Query: 51  GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
            +DI   YD    LG G F    L  D    +  A K I+K+ L        +  E+ ++
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVL 70
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
            H  KHPNIV+L D YE    ++++M+L  GGELFDRIV +G YTER A+ ++  +++ V
Sbjct: 71  -HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 129
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
           +  H+ G++HRDLKPEN L+ +  E S +   DFGLS    PG   +   G+P Y+APEV
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 189
Query: 231 L-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           L ++ Y   VD WS GVI YILLCG PPF+ E +  + + I+++  +F    W  +S++A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
           KD ++ ++  DP++R T E+ L+HPW+     A + ++ ++V  ++K+    +K K+
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  215 bits (547), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 120/305 (39%), Positives = 183/305 (60%), Gaps = 12/305 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA--VDIEDVRREVQIMKHLPK 115
           Y+L   +G+G F V   C +   G++FA K +   K  ++  +  ED++RE  I  H+ K
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC-HMLK 84
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVVQ 171
           HP+IV L +TY  D  +++V E  +G +L   IV R      Y+E  A+  M+ I+E ++
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEV 230
            CH+  ++HRD+KPEN L A+K+ S+P+K  DFG+++     G      VG+P++MAPEV
Sbjct: 145 YCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +KR  YG  VDVW  GVIL+ILL G  PF+  T++ + + II+         W  +SE+A
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVSLGETVKARLKQFSVMNKLKKRA 348
           KDLV++ML  DP +R+T  E L HPWL+   + A  + L ETV+ +L++F+   KLK   
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE-QLRKFNARRKLKGAV 322
Query: 349 LQVVA 353
           L  V+
Sbjct: 323 LAAVS 327

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  213 bits (543), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 107/267 (40%), Positives = 160/267 (59%), Gaps = 4/267 (1%)
Query: 51  GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
            +DI   YD    LG G F    L  D    +  A K I+K+ L        +  E+ ++
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVL 70
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
            H  KHPNIV+L D YE    ++++M+L  GGELFDRIV +G YTER A+ ++  +++ V
Sbjct: 71  -HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 129
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
           +  H+ G++HRDLKPEN L+ +  E S +   DFGLS    PG   +   G+P Y+APEV
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 189
Query: 231 L-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           L ++ Y   VD WS GVI YILLCG PPF+ E +  + + I+++  +F    W  +S++A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           KD ++ ++  DP++R T E+ L+HPW+
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  209 bits (531), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 108/254 (42%), Positives = 153/254 (60%), Gaps = 6/254 (2%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG G F   +L      G+ FA K I K     A     +  E+ ++K + KH NIV+L+
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKI-KHENIVTLE 72
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
           D YE  +  ++VM+L  GGELFDRI+ RG YTE+ A+ V++ ++  V+  HE G++HRDL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRNYGPEVDVW 242
           KPEN L+   +E+S +   DFGLS   + G   +   G+P Y+APEVL ++ Y   VD W
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 243 SAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPK 302
           S GVI YILLCG PPF+ ETE  + + I     +F+   W  +SE+AKD +  +L  DP 
Sbjct: 192 SIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPN 251
Query: 303 QRLTAEEVLEHPWL 316
           +R T E+ L HPW+
Sbjct: 252 ERYTCEKALSHPWI 265

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  207 bits (526), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 117/305 (38%), Positives = 180/305 (59%), Gaps = 12/305 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA--VDIEDVRREVQIMKHLPK 115
           Y+L   +G+G F V   C +   G++FA K +   K  ++  +  ED++RE  I  H+ K
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC-HMLK 86
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVVQ 171
           HP+IV L +TY  D  +++V E  +G +L   IV R      Y+E  A+  M+ I+E ++
Sbjct: 87  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 146
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEV 230
            CH+  ++HRD+KP   L A+K+ S+P+K   FG+++     G      VG+P++MAPEV
Sbjct: 147 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 206
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +KR  YG  VDVW  GVIL+ILL G  PF+  T++ + + II+         W  +SE+A
Sbjct: 207 VKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESA 265
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVSLGETVKARLKQFSVMNKLKKRA 348
           KDLV++ML  DP +R+T  E L HPWL+   + A  + L ETV+ +L++F+   KLK   
Sbjct: 266 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE-QLRKFNARRKLKGAV 324
Query: 349 LQVVA 353
           L  V+
Sbjct: 325 LAAVS 329

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  207 bits (526), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 117/305 (38%), Positives = 180/305 (59%), Gaps = 12/305 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA--VDIEDVRREVQIMKHLPK 115
           Y+L   +G+G F V   C +   G++FA K +   K  ++  +  ED++RE  I  H+ K
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC-HMLK 84
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVVQ 171
           HP+IV L +TY  D  +++V E  +G +L   IV R      Y+E  A+  M+ I+E ++
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEV 230
            CH+  ++HRD+KP   L A+K+ S+P+K   FG+++     G      VG+P++MAPEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +KR  YG  VDVW  GVIL+ILL G  PF+  T++ + + II+         W  +SE+A
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVSLGETVKARLKQFSVMNKLKKRA 348
           KDLV++ML  DP +R+T  E L HPWL+   + A  + L ETV+ +L++F+   KLK   
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE-QLRKFNARRKLKGAV 322
Query: 349 LQVVA 353
           L  V+
Sbjct: 323 LAAVS 327

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  204 bits (519), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 161/271 (59%), Gaps = 10/271 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVDIEDVRREVQIMKHLP 114
           Y++G ELG G+F +   C     G+++A K I K++L   R  V  E++ REV I++ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI- 65
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPNI++L D +E+ + V +++EL  GGELFD +  +   TE  A   +K I++ V   H
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
            + + H DLKPEN +  +K   +P +K IDFG++     G +F  I G+P ++APE++  
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-- 183
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  ET+Q     I     DF  + +   SE AK
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           D ++++L  DPK+R+T  + LEH W++  ++
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  202 bits (515), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 104/273 (38%), Positives = 161/273 (58%), Gaps = 10/273 (3%)
Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVDIEDVRREVQ 108
           +D+   Y++G ELG G+F +   C     G+++A K I K++L   R  V  E++ REV 
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           I++ + +HPNI++L D +E+ + V +++EL  GGELFD +  +   TE  A   +K I++
Sbjct: 68  ILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 126
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
            V   H + + H DLKPEN +  +K   +P +K IDFG++     G +F  I G+P ++A
Sbjct: 127 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 186
Query: 228 PEVLKRNYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           PE++  NY P   E D+WS GVI YILL G  PF  ET+Q     I     DF  + +  
Sbjct: 187 PEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 244
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
            SE AKD ++++L  DPK+R+   + LEH W++
Sbjct: 245 TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  202 bits (513), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 160/271 (59%), Gaps = 10/271 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVDIEDVRREVQIMKHLP 114
           Y++G ELG G+F +   C     G+++A K I K++L   R  V  E++ REV I++ + 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI- 86
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPNI++L D +E+ + V +++EL  GGELFD +  +   TE  A   +K I++ V   H
Sbjct: 87  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 146
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
            + + H DLKPEN +  +K   +P +K IDFG++     G +F  I G+P ++APE++  
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-- 204
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  ET+Q     I     DF  + +   SE AK
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 264
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           D ++++L  DPK+R+   + LEH W++  ++
Sbjct: 265 DFIRRLLVKDPKRRMXIAQSLEHSWIKAIRR 295

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  198 bits (504), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 159/266 (59%), Gaps = 10/266 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD+G ELG G+F +   C + + G ++A K I K++ R +   V  E++ REV I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            HPNI++L D YE+ + V +++EL  GGELFD +  +   +E  A + +K I++ V   H
Sbjct: 74  -HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
            + + H DLKPEN +  +K    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     I     DF  + + + SE AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           D ++K+L  + ++RLT +E L HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  197 bits (501), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  197 bits (500), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  197 bits (500), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  196 bits (499), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  196 bits (499), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  196 bits (498), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  196 bits (498), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  196 bits (497), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 70
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 188
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  196 bits (497), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 158/266 (59%), Gaps = 10/266 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD+G ELG G+F +   C + + G ++A K I K++ R +   V  E++ REV I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            H N+++L D YE+ + V +++EL  GGELFD +  +   +E  A + +K I++ V   H
Sbjct: 74  HH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
            + + H DLKPEN +  +K    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     I     DF  + + + SE AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           D ++K+L  + ++RLT +E L HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  195 bits (496), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  195 bits (496), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 159/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 70
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 188
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  195 bits (496), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 157/266 (59%), Gaps = 10/266 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD+G ELG G+F +   C + + G ++A K I K++ R +   V  E++ REV I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            H N+++L D YE+ + V +++EL  GGELFD +  +   +E  A + +K I++ V   H
Sbjct: 74  HH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
            + + H DLKPEN +  +K    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     I     DF  + +   SE AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           D ++K+L  + ++RLT +E L HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  195 bits (496), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 158/266 (59%), Gaps = 10/266 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD+G ELG G+F +   C + + G ++A K I K++ R +   V  E++ REV I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            H N+++L D YE+ + V +++EL  GGELFD +  +   +E  A + +K I++ V   H
Sbjct: 74  HH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
            + + H DLKPEN +  +K    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     I     DF  + + + SE AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           D ++K+L  + ++RLT +E L HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  194 bits (494), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 157/266 (59%), Gaps = 10/266 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD+G ELG G+F +   C + + G ++A K I K++ R +   V  E++ REV I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            H N+++L D YE+ + V +++EL  GGELFD +  +   +E  A + +K I++ V   H
Sbjct: 74  HH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
            + + H DLKPEN +  +K    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     I     DF  + +   SE AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           D ++K+L  + ++RLT +E L HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  194 bits (494), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 157/266 (59%), Gaps = 10/266 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD+G ELG G+F +   C + + G ++A K I K++ R +   V  E++ REV I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            H N+++L D YE+ + V +++EL  GGELFD +  +   +E  A + +K I++ V   H
Sbjct: 74  HH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
            + + H DLKPEN +  +K    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     I     DF  + +   SE AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           D ++K+L  + ++RLT +E L HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  194 bits (493), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 158/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  193 bits (491), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 158/267 (59%), Gaps = 10/267 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP 114
           YD G ELG G+F V   C + + G ++A K I K++ +++   V  ED+ REV I+K + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI- 71
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           +HPN+++L + YE+ + V ++ EL  GGELFD +  +   TE  A   +K I+  V   H
Sbjct: 72  QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 175 EQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++APE++  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-- 189
Query: 234 NYGP---EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           NY P   E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S  AK
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           D ++++L  DPK+R+T ++ L+HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  192 bits (487), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 152/272 (55%), Gaps = 15/272 (5%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVR----REVQIMKH 112
           YD    +GRG   V   C     G +FA K +     R + + +E+VR    RE  I++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           +  HP+I++L D+YE  S + +V +L   GELFD +  +   +E+   ++M++++E V  
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
            H   ++HRDLKPEN L  +  +   ++  DFG S    PGE+  E+ G+P Y+APE+LK
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQ---IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 233 RN-------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
            +       YG EVD+W+ GVIL+ LL G PPFW   +  + + I+     F    W   
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           S   KDL+ ++L  DP+ RLTAE+ L+HP+ +
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  191 bits (486), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 104/262 (39%), Positives = 157/262 (59%), Gaps = 8/262 (3%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R+LG G FG  +L  + ++G +   K+I+K   R+ V +E +  E++++K L  HPNI+ 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKD--RSQVPMEQIEAEIEVLKSL-DHPNIIK 84
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIV---ARGH-YTERAAAAVMKTIVEVVQVCHEQG 177
           + + +ED   ++IVME CEGGEL +RIV   ARG   +E   A +MK ++  +   H Q 
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           V+H+DLKPEN LF +    SP+K IDFGL+  F+  E      G+  YMAPEV KR+   
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTF 204
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           + D+WSAGV++Y LL G  PF   + + V Q       ++  +  P ++  A DL+K+ML
Sbjct: 205 KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTPQAVDLLKQML 263
Query: 298 NPDPKQRLTAEEVLEHPWLQNA 319
             DP++R +A +VL H W + A
Sbjct: 264 TKDPERRPSAAQVLHHEWFKQA 285

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  184 bits (467), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/275 (35%), Positives = 153/275 (55%), Gaps = 16/275 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVR----REVQIM 110
           +Y+    LGRG   V   C      +++A K I  +     +A +++++R    +EV I+
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
           + +  HPNI+ LKDTYE ++   +V +L + GELFD +  +   +E+    +M+ ++EV+
Sbjct: 65  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 124
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
              H+  ++HRDLKPEN L  +      +K  DFG S    PGE+  E+ G+P Y+APE+
Sbjct: 125 CALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 231 LKRN-------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
           ++ +       YG EVD+WS GVI+Y LL G PPFW   +  + + I+     F    W 
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 241
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
             S+  KDLV + L   P++R TAEE L HP+ Q 
Sbjct: 242 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  184 bits (467), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/275 (35%), Positives = 153/275 (55%), Gaps = 16/275 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVR----REVQIM 110
           +Y+    LGRG   V   C      +++A K I  +     +A +++++R    +EV I+
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
           + +  HPNI+ LKDTYE ++   +V +L + GELFD +  +   +E+    +M+ ++EV+
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
              H+  ++HRDLKPEN L  +      +K  DFG S    PGE+  E+ G+P Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 231 LKRN-------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
           ++ +       YG EVD+WS GVI+Y LL G PPFW   +  + + I+     F    W 
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
             S+  KDLV + L   P++R TAEE L HP+ Q 
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 108/272 (39%), Positives = 146/272 (53%), Gaps = 12/272 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----RTAVDIEDVRREVQIMK 111
           +Y + + LG G  G   L  +    +K A K ISK+K      R A    +V  E++I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L  HP I+ +K+ + D    +IV+EL EGGELFD++V      E         ++  VQ
Sbjct: 71  KL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             HE G++HRDLKPEN L ++++E   +K  DFG S           + G+P Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVS 286
                  Y   VD WS GVIL+I L G PPF    T+  +   I     +F  + W +VS
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           E A DLVKK+L  DPK R T EE L HPWLQ+
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 108/272 (39%), Positives = 146/272 (53%), Gaps = 12/272 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----RTAVDIEDVRREVQIMK 111
           +Y + + LG G  G   L  +    +K A K ISK+K      R A    +V  E++I+K
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L  HP I+ +K+ + D    +IV+EL EGGELFD++V      E         ++  VQ
Sbjct: 70  KL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             HE G++HRDLKPEN L ++++E   +K  DFG S           + G+P Y+APEVL
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVS 286
                  Y   VD WS GVIL+I L G PPF    T+  +   I     +F  + W +VS
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 247
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           E A DLVKK+L  DPK R T EE L HPWLQ+
Sbjct: 248 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 108/272 (39%), Positives = 146/272 (53%), Gaps = 12/272 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----RTAVDIEDVRREVQIMK 111
           +Y + + LG G  G   L  +    +K A K ISK+K      R A    +V  E++I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L  HP I+ +K+ + D    +IV+EL EGGELFD++V      E         ++  VQ
Sbjct: 71  KL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             HE G++HRDLKPEN L ++++E   +K  DFG S           + G+P Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVS 286
                  Y   VD WS GVIL+I L G PPF    T+  +   I     +F  + W +VS
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           E A DLVKK+L  DPK R T EE L HPWLQ+
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 108/272 (39%), Positives = 146/272 (53%), Gaps = 12/272 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----RTAVDIEDVRREVQIMK 111
           +Y + + LG G  G   L  +    +K A K ISK+K      R A    +V  E++I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L  HP I+ +K+ + D    +IV+EL EGGELFD++V      E         ++  VQ
Sbjct: 71  KL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             HE G++HRDLKPEN L ++++E   +K  DFG S           + G+P Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVS 286
                  Y   VD WS GVIL+I L G PPF    T+  +   I     +F  + W +VS
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           E A DLVKK+L  DPK R T EE L HPWLQ+
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 111/287 (38%), Positives = 151/287 (52%), Gaps = 19/287 (6%)
Query: 49  PSGQDISI-------DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----RT 96
           P G  +S+       +Y + + LG G  G   L  +    +K A K ISK+K      R 
Sbjct: 2   PLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 61
Query: 97  AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTE 156
           A    +V  E++I+K L  HP I+ +K+ + D    +IV+EL EGGELFD++V      E
Sbjct: 62  ADPALNVETEIEILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE 119
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
                    ++  VQ  HE G++HRDLKPEN L ++++E   +K  DFG S         
Sbjct: 120 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 179
Query: 217 NEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAII 271
             + G+P Y+APEVL       Y   VD WS GVIL+I L G PPF    T+  +   I 
Sbjct: 180 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 239
Query: 272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
               +F  + W +VSE A DLVKK+L  DPK R T EE L HPWLQ+
Sbjct: 240 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 105/279 (37%), Positives = 153/279 (54%), Gaps = 19/279 (6%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++  ++G G + V   C       +FA K I K K        D   E++I+    +HP
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHP 76
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI++LKD Y+D   V++V EL +GGEL D+I+ +  ++ER A+AV+ TI + V+  H QG
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 178 VMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY----MAPEVLK 232
           V+HRDLKP N L+ ++      ++  DFG +   R     N ++ +P Y    +APEVL+
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLMTPCYTANFVAPEVLE 193
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
           R  Y    D+WS GV+LY +L G  PF     +T + +   I           W  VS+ 
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           AKDLV KML+ DP QRLTA  VL HPW+ +  + P   L
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQL 292

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  182 bits (462), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 105/279 (37%), Positives = 152/279 (54%), Gaps = 19/279 (6%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y +   +G G +     C       ++A K I K K        D   E++I+    +HP
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRYGQHP 81
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI++LKD Y+D   V++V EL  GGEL D+I+ +  ++ER A+ V+ TI + V+  H QG
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 178 VMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYY----MAPEVLK 232
           V+HRDLKP N L+ ++  +   L+  DFG +   R     N ++ +P Y    +APEVLK
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE---NGLLMTPCYTANFVAPEVLK 198
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFW---AETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
           R  Y    D+WS G++LY +L G  PF    ++T + +   I           W  VSE 
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           AKDLV KML+ DP QRLTA++VL+HPW+    K P   L
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQL 297

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  182 bits (462), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 107/272 (39%), Positives = 146/272 (53%), Gaps = 12/272 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----RTAVDIEDVRREVQIMK 111
           +Y + + LG G  G   L  +    +K A + ISK+K      R A    +V  E++I+K
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L  HP I+ +K+ + D    +IV+EL EGGELFD++V      E         ++  VQ
Sbjct: 210 KL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             HE G++HRDLKPEN L ++++E   +K  DFG S           + G+P Y+APEVL
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVS 286
                  Y   VD WS GVIL+I L G PPF    T+  +   I     +F  + W +VS
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 387
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           E A DLVKK+L  DPK R T EE L HPWLQ+
Sbjct: 388 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  182 bits (462), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 97/275 (35%), Positives = 152/275 (55%), Gaps = 16/275 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVR----REVQIM 110
           +Y+    LGRG   V   C      +++A K I  +     +A +++++R    +EV I+
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
           + +  HPNI+ LKDTYE ++   +V +L + GELFD +  +   +E+    +M+ ++EV+
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
              H+  ++HRDLKPEN L  +      +K  DFG S    PGE+   + G+P Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 231 LKRN-------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
           ++ +       YG EVD+WS GVI+Y LL G PPFW   +  + + I+     F    W 
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
             S+  KDLV + L   P++R TAEE L HP+ Q 
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  182 bits (461), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 105/279 (37%), Positives = 152/279 (54%), Gaps = 19/279 (6%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y +   +G G +     C       ++A K I K K        D   E++I+    +HP
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRYGQHP 81
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI++LKD Y+D   V++V EL  GGEL D+I+ +  ++ER A+ V+ TI + V+  H QG
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 178 VMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYY----MAPEVLK 232
           V+HRDLKP N L+ ++  +   L+  DFG +   R     N ++ +P Y    +APEVLK
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE---NGLLMTPCYTANFVAPEVLK 198
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFW---AETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
           R  Y    D+WS G++LY +L G  PF    ++T + +   I           W  VSE 
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           AKDLV KML+ DP QRLTA++VL+HPW+    K P   L
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQL 297

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  181 bits (460), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 107/272 (39%), Positives = 146/272 (53%), Gaps = 12/272 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----RTAVDIEDVRREVQIMK 111
           +Y + + LG G  G   L  +    +K A + ISK+K      R A    +V  E++I+K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L  HP I+ +K+ + D    +IV+EL EGGELFD++V      E         ++  VQ
Sbjct: 196 KL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             HE G++HRDLKPEN L ++++E   +K  DFG S           + G+P Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVS 286
                  Y   VD WS GVIL+I L G PPF    T+  +   I     +F  + W +VS
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           E A DLVKK+L  DPK R T EE L HPWLQ+
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  181 bits (459), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 108/294 (36%), Positives = 152/294 (51%), Gaps = 25/294 (8%)
Query: 48  EPSGQDISIDYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRRE 106
           EP    ++ DY L ++ LG G  G    C     G+K A        L+   D    R+E
Sbjct: 1   EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCA--------LKLLYDSPKARQE 52
Query: 107 VQIMKHLPKHPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGH--YTERAAA 160
           V         P+IV + D YE+       + I+ME  EGGELF RI  RG   +TER AA
Sbjct: 53  VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 112
Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNE 218
            +M+ I   +Q  H   + HRD+KPEN L+ +K++ + LK  DFG   F +   Q     
Sbjct: 113 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG---FAKETTQNALQT 169
Query: 219 IVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV--- 274
              +PYY+APEVL    Y    D+WS GVI+YILLCG PPF++ T Q ++  + R +   
Sbjct: 170 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 229
Query: 275 -IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
              F    W +VSE+AK L++ +L  DP +RLT  + + HPW+  +   P   L
Sbjct: 230 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 283

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 108/294 (36%), Positives = 152/294 (51%), Gaps = 25/294 (8%)
Query: 48  EPSGQDISIDYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRRE 106
           EP    ++ DY L ++ LG G  G    C     G+K A        L+   D    R+E
Sbjct: 20  EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCA--------LKLLYDSPKARQE 71
Query: 107 VQIMKHLPKHPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGH--YTERAAA 160
           V         P+IV + D YE+       + I+ME  EGGELF RI  RG   +TER AA
Sbjct: 72  VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131
Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNE 218
            +M+ I   +Q  H   + HRD+KPEN L+ +K++ + LK  DFG   F +   Q     
Sbjct: 132 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG---FAKETTQNALQT 188
Query: 219 IVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV--- 274
              +PYY+APEVL    Y    D+WS GVI+YILLCG PPF++ T Q ++  + R +   
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248
Query: 275 -IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
              F    W +VSE+AK L++ +L  DP +RLT  + + HPW+  +   P   L
Sbjct: 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  180 bits (457), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 111/311 (35%), Positives = 163/311 (52%), Gaps = 25/311 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++  ++G G + V   C       +FA K I K K        D   E++I+    +HP
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK-------RDPTEEIEILLRYGQHP 76
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NI++LKD Y+D   V++V EL +GGEL D+I+ +  ++ER A+AV+ TI + V+  H QG
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 178 VMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY----MAPEVLK 232
           V+HRDLKP N L+ ++      ++  DFG +   R     N ++ +P Y    +APEVL+
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLXTPCYTANFVAPEVLE 193
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
           R  Y    D+WS GV+LY  L G  PF     +T + +   I           W  VS+ 
Sbjct: 194 RQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLG-----ETVK-ARLKQFSVMN 342
           AKDLV K L+ DP QRLTA  VL HPW+ +  + P   L        VK A    +S +N
Sbjct: 254 AKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAXAATYSALN 313
Query: 343 KLKKRALQVVA 353
           + +   L+ V 
Sbjct: 314 RNQSPVLEPVG 324

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  180 bits (457), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 106/283 (37%), Positives = 148/283 (52%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 16  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 67
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 68  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +          E   +PYY+APE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE 187
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 188 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 247
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 248 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  179 bits (454), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 68  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 119
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 120 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 179
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 180 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 239
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 240 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 299
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 300 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 342

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  179 bits (454), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 113
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  179 bits (453), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 69
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 190 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 249
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 250 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 69
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 190 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 249
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 250 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 32  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 83
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 84  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 143
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 144 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 203
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 204 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 263
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 264 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 16  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 67
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 68  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 187
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 188 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 247
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 248 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 17  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 68
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 69  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 128
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 129 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 188
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 189 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 248
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 249 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 291

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 24  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 75
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 76  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 135
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 136 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 195
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 196 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 255
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 256 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 298

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  178 bits (451), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 22  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 73
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 74  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 133
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 134 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 193
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 194 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 253
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 254 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 296

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  178 bits (451), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 147/283 (51%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 23  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 74
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 75  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 134
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 135 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 194
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +
Sbjct: 195 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 254
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 255 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 297

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 105/307 (34%), Positives = 159/307 (51%), Gaps = 10/307 (3%)
Query: 13  GKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVT 72
           G + +GK + P     D++        V +   +K+ S  D    YD+  ELG G FGV 
Sbjct: 11  GSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY---YDILEELGSGAFGVV 67
Query: 73  YLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132
           + C +   G  F  K I+       +D   V+ E+ IM  L  HP +++L D +ED   +
Sbjct: 68  HRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEM 123
Query: 133 HIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFA 191
            +++E   GGELFDRI A  +  +E      M+   E ++  HE  ++H D+KPEN +  
Sbjct: 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 183
Query: 192 NKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYI 250
            KK SS +K IDFGL+    P E       +  + APE++ R   G   D+W+ GV+ Y+
Sbjct: 184 TKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242
Query: 251 LLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV 310
           LL G+ PF  E +    Q + R   +F  D +  VS  AKD +K +L  +P++RLT  + 
Sbjct: 243 LLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
Query: 311 LEHPWLQ 317
           LEHPWL+
Sbjct: 303 LEHPWLK 309

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 146/259 (56%), Gaps = 7/259 (2%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG G FG  + C +   G K A K I   K R   D E+V+ E+ +M  L  H N++ L 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKII---KTRGMKDKEEVKNEISVMNQL-DHANLIQLY 152
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
           D +E  + + +VME  +GGELFDRI+   +  TE      MK I E ++  H+  ++H D
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNY-GPEVDV 241
           LKPEN L  N+ ++  +K IDFGL+  ++P E+     G+P ++APEV+  ++     D+
Sbjct: 213 LKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           WS GVI Y+LL G+ PF  + +      I+    D + + +  +SE AK+ + K+L  + 
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 302 KQRLTAEEVLEHPWLQNAK 320
             R++A E L+HPWL + K
Sbjct: 332 SWRISASEALKHPWLSDHK 350

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  172 bits (437), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 152/262 (58%), Gaps = 10/262 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D+GR LG+G+FG  YL  +  N    A K + K +L        +RRE++I  HL +H
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 74
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ + + + D   +++++E    GEL+  +   G + E+ +A  M+ + + +  CHE+
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 134
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L   K E   LK  DFG SV   P  +   + G+  Y+ PE+++ + +
Sbjct: 135 KVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGTLDYLPPEMIEGKTH 190
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+W AGV+ Y  L G+PPF + +     + I+   +D K  P+  +S+ +KDL+ K
Sbjct: 191 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPPF--LSDGSKDLISK 246
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ 317
           +L   P QRL  + V+EHPW++
Sbjct: 247 LLRYHPPQRLPLKGVMEHPWVK 268

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  171 bits (433), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 160/314 (50%), Gaps = 28/314 (8%)
Query: 58  YDLG---RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           YDL    + LG G F +   C    + + FA K ISK+         + ++E+  +K   
Sbjct: 10  YDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCE 63
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            HPNIV L + + D     +VMEL  GGELF+RI  + H++E  A+ +M+ +V  V   H
Sbjct: 64  GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNEIVGSPYYMAPEVLKR 233
           + GV+HRDLKPEN LF ++ ++  +K IDFG +    P  Q       + +Y APE+L +
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAE-------TEQGVAQAIIRSVIDFKRDPWPKV 285
           N Y    D+WS GVILY +L G  PF +        +   + + I +    F+ + W  V
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-------APNV--SLGETVKARLK 336
           S+ AKDL++ +L  DP +RL    +  + WLQ+  +        P++  S G  V   +K
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVK 303
Query: 337 -QFSVMNKLKKRAL 349
             F   NK K+   
Sbjct: 304 ATFHAFNKYKREGF 317

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  170 bits (431), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 95/269 (35%), Positives = 148/269 (55%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D+GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHL-RH 71
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK 131
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  + + + G+  Y+ PE+++ R +
Sbjct: 132 RVIHRDIKPENLLLGSNGE---LKIADFGWSV-HAPSSRRDTLCGTLDYLPPEMIEGRMH 187
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G+PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDLISR 243
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +  QRLT  EVLEHPW++     P+
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 152/262 (58%), Gaps = 11/262 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G++ A + I K +L ++  ++ + REV+IMK L  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVL-NH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  +++VME   GGE+FD +VA G   E+ A A  + IV  VQ CH++
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +E  GSP Y APE+   K+ 
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+  +S + ++L+K
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           K L  +P +R T E++++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 95/269 (35%), Positives = 147/269 (54%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D+GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHL-RH 71
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK 131
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 132 RVIHRDIKPENLLLGSNGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G+PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDLISR 243
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +  QRLT  EVLEHPW++     P+
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 151/262 (57%), Gaps = 11/262 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G++ A K I K +L ++  ++ + REV+IMK L  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  +++VME   GGE+FD +VA G   E+ A A  + IV  VQ CH++
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +   GSP Y APE+   K+ 
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+  +S + ++L+K
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           K L  +P +R T E++++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 103/283 (36%), Positives = 140/283 (49%), Gaps = 20/283 (7%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQ--------DCPKARREVELHWRASQ 113
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IV E  +GGELF RI  RG   +TER A+ + K+I E 
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEA 173
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 230 VL-KRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPK 284
           VL    Y    D WS GVI YILLCG PPF++        G    I     +F    W +
Sbjct: 234 VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSE 293
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           VSE  K L++ +L  +P QR T  E   HPW+  + K P   L
Sbjct: 294 VSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPL 336

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  169 bits (428), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 151/262 (57%), Gaps = 11/262 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G++ A K I K +L ++  ++ + REV+IMK L  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  +++VME   GGE+FD +VA G   E+ A A  + IV  VQ CH++
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +   GSP Y APE+   K+ 
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+  +S + ++L+K
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           K L  +P +R T E++++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 141/261 (54%), Gaps = 7/261 (2%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           YD+  ELG G FGV +  T+   G  FA K +         D E VR+E+Q M  L +HP
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHP 108
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            +V+L D +EDD+ + ++ E   GGELF+++       +E  A   M+ + + +   HE 
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
             +H DLKPEN +F  K+ S+ LK IDFGL+    P +      G+  + APEV + +  
Sbjct: 169 NYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 227
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           G   D+WS GV+ YILL G+ PF  E +    + +     +     +  +SE+ KD ++K
Sbjct: 228 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 287
Query: 296 MLNPDPKQRLTAEEVLEHPWL 316
           +L  DP  R+T  + LEHPWL
Sbjct: 288 LLLADPNTRMTIHQALEHPWL 308

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 151/262 (57%), Gaps = 10/262 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D+ R LG+G+FG  YL  +  N    A K + K +L        +RRE++I  HL +H
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ + + + D   +++++E    GEL+  +   G + E+ +A  M+ + + +  CHE+
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L   K E   LK  DFG SV   P  +   + G+  Y+ PE+++ + +
Sbjct: 134 KVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGTLDYLPPEMIEGKTH 189
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+W AGV+ Y  L G+PPF + +     + I+   +D K  P+  +S+ +KDL+ K
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPPF--LSDGSKDLISK 245
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ 317
           +L   P QRL  + V+EHPW++
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVK 267

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  168 bits (426), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 141/261 (54%), Gaps = 7/261 (2%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           YD+  ELG G FGV +  T+   G  FA K +         D E VR+E+Q M  L +HP
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHP 214
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            +V+L D +EDD+ + ++ E   GGELF+++       +E  A   M+ + + +   HE 
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
             +H DLKPEN +F  K+ S+ LK IDFGL+    P +      G+  + APEV + +  
Sbjct: 275 NYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           G   D+WS GV+ YILL G+ PF  E +    + +     +     +  +SE+ KD ++K
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393
Query: 296 MLNPDPKQRLTAEEVLEHPWL 316
           +L  DP  R+T  + LEHPWL
Sbjct: 394 LLLADPNTRMTIHQALEHPWL 414

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 151/262 (57%), Gaps = 11/262 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G++ A + I K +L ++  ++ + REV+IMK L  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVL-NH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  +++VME   GGE+FD +VA G   E+ A A  + IV  VQ CH++
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +   GSP Y APE+   K+ 
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+  +S + ++L+K
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           K L  +P +R T E++++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 151/262 (57%), Gaps = 11/262 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G++ A K I K +L ++  ++ + REV+IMK L  H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NH 65
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  +++VME   GGE+FD +VA G   E+ A A  + IV  VQ CH++
Sbjct: 66  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +   GSP Y APE+   K+ 
Sbjct: 126 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+  +S + ++L+K
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 238
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           K L  +P +R T E++++  W+
Sbjct: 239 KFLILNPSKRGTLEQIMKDRWM 260

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  168 bits (425), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 151/262 (57%), Gaps = 11/262 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G++ A K I K +L ++  ++ + REV+IMK L  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  +++VME   GGE+FD +VA G   E+ A A  + IV  VQ CH++
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +   G+P Y APE+   K+ 
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+  +S + ++L+K
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           K L  +P +R T E++++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  167 bits (423), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 97/277 (35%), Positives = 149/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    GE++  +     + E+  A  +  +   +  CH +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 133 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 244
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 98/282 (34%), Positives = 152/282 (53%), Gaps = 11/282 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +  ++ G+  Y+ PE+++ R +
Sbjct: 128 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISR 239
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETVKARLK 336
           +L  +P QR    EVLEHPW+  N+ K  N    E+  A L+
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAAAALE 281

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 97/277 (35%), Positives = 149/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    GE++  +     + E+  A  +  +   +  CH +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 133 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLXGTLDYLPPEMIEGRMH 188
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 244
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 145/269 (53%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  + N+    A K + K +L  A     +RREV+I  HL +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 68  PNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 128 KVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEGRMH 183
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDF----VTEGARDLISR 239
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +P QR    EVLEHPW+      P+
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 159/288 (55%), Gaps = 8/288 (2%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y +  +LGRGEFG+ + C + ++ + +  K +  K      D   V++E+ I+ ++ +H 
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISIL-NIARHR 61
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           NI+ L +++E    + ++ E   G ++F+RI  +     ER   + +  + E +Q  H  
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNY- 235
            + H D++PEN ++  ++ SS +K I+FG +   +PG+ F  +  +P Y APEV + +  
Sbjct: 122 NIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
               D+WS G ++Y+LL G+ PF AET Q + + I+ +   F  + + ++S  A D V +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNK 343
           +L  + K R+TA E L+HPWL+   +  +  +  T+K R    +++ K
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 97/277 (35%), Positives = 149/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +  E+ G+  Y+ PE+++ R +
Sbjct: 128 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTELCGTLDYLPPEMIEGRMH 183
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 239
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 276

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  165 bits (418), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 150/277 (54%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 93
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 153
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  + +++ G+  Y+ PE+++ R +
Sbjct: 154 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYLPPEMIEGRMH 209
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 265
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 266 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 302

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  165 bits (417), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 149/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +  ++ G+  Y+ PE+++ R +
Sbjct: 133 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH 188
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 244
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  165 bits (417), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 149/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +  ++ G+  Y+ PE+++ R +
Sbjct: 129 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 240
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  164 bits (416), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 146/269 (54%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  + +++ G+  Y+ PE+++ R +
Sbjct: 131 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISR 242
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +P QR    EVLEHPW+      P+
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  164 bits (416), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 149/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  + + + G+  Y+ PE+++ R +
Sbjct: 129 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDTLCGTLDYLPPEMIEGRMH 184
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 240
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 97/278 (34%), Positives = 149/278 (53%), Gaps = 13/278 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 26  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 84
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 85  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 144
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 145 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDLVK 294
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F     P  V+E A+DL+ 
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-----PDFVTEGARDLIS 255
Query: 295 KMLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           ++L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 256 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 293

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 93
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 153
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 154 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 209
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 265
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 266 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 302

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 133 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 244
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 131 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 242
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 279

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/276 (34%), Positives = 149/276 (53%), Gaps = 11/276 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +  ++ G+  Y+ PE+++ R +
Sbjct: 128 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISR 239
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGET 330
           +L  +P QR    EVLEHPW+  N+ K  N    E+
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 275

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 128 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 183
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 239
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 276

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 147/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE ++ R +
Sbjct: 133 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEXIEGRXH 188
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 244
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 245 LLKHNPSQRPXLREVLEHPWITANSSKPSNCQNKESA 281

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/262 (36%), Positives = 148/262 (56%), Gaps = 11/262 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G + A K I K +L     ++ + REV+IMK L  H
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  ++++ME   GGE+FD +VA G   E+ A +  + IV  VQ CH++
Sbjct: 71  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 130
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +   GSP Y APE+   K+ 
Sbjct: 131 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+  +S + ++L+K
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 243
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           + L  +P +R T E++++  W+
Sbjct: 244 RFLVLNPIKRGTLEQIMKDRWI 265

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 69
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 130 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEGRMH 185
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 241
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 242 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 278

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 144/269 (53%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 13  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 71
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 131
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 132 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 243
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +P QR    EVLEHPW+      P+
Sbjct: 244 LLKHNPSQRPMLREVLEHPWITANSSKPS 272

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 144/269 (53%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 128 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTXLCGTLDYLPPEMIEGRMH 183
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 239
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +P QR    EVLEHPW+      P+
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 144/269 (53%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 8   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 66
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 126
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 127 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 182
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 238
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +P QR    EVLEHPW+      P+
Sbjct: 239 LLKHNPSQRPMLREVLEHPWITANSSKPS 267

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 131 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEGRMH 186
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 242
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 279

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 101/263 (38%), Positives = 138/263 (52%), Gaps = 10/263 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LG  LG G FG   +      G K A K ++++K+R+   +  +RRE+Q +K L +HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHP 76
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           +I+ L       S + +VME   GGELFD I   G   E+ +  + + I+  V  CH   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY- 235
           V+HRDLKPEN L      +   K  DFGLS     GE      GSP Y APEV+  R Y 
Sbjct: 137 VVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GPEVD+WS+GVILY LLCG  PF  +    + + I   +    +   P V      L+K 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS----LLKH 249
Query: 296 MLNPDPKQRLTAEEVLEHPWLQN 318
           ML  DP +R T +++ EH W + 
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQ 272

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 144/269 (53%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 128 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEGRMH 183
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 239
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +P QR    EVLEHPW+      P+
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 144/269 (53%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 128 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEGRMH 183
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 239
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +P QR    EVLEHPW+      P+
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 142/261 (54%), Gaps = 10/261 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 131 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISR 242
Query: 296 MLNPDPKQRLTAEEVLEHPWL 316
           +L  +P QR    EVLEHPW+
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 144/271 (53%), Gaps = 10/271 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG S    P  +   + G+  Y+ PE+++ R +
Sbjct: 129 RVIHRDIKPENLLLGSAGE---LKIADFGWSCH-APSSRRTTLSGTLDYLPPEMIEGRMH 184
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 240
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVS 326
           +L  +P QR    EVLEHPW+      P+ S
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNS 271

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 95/262 (36%), Positives = 148/262 (56%), Gaps = 11/262 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G + A K I K +L     ++ + REV+IMK L  H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  ++++ME   GGE+FD +VA G   E+ A +  + IV  VQ CH++
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +   G+P Y APE+   K+ 
Sbjct: 134 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+  +S + ++L+K
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 246
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           + L  +P +R T E++++  W+
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWI 268

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 148/277 (53%), Gaps = 11/277 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 69
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  +FG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 130 RVIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 185
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 241
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 242 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 278

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  162 bits (410), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 144/269 (53%), Gaps = 10/269 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  +FG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 131 RVIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISR 242
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           +L  +P QR    EVLEHPW+      P+
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 141/261 (54%), Gaps = 10/261 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +       A K + K +L  A     +RREV+I  HL +H
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 64
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 125 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISR 236
Query: 296 MLNPDPKQRLTAEEVLEHPWL 316
           +L  +P QR    EVLEHPW+
Sbjct: 237 LLKHNPSQRPMLREVLEHPWI 257

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  162 bits (409), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 142/261 (54%), Gaps = 10/261 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 131 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEGRMH 186
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISR 242
Query: 296 MLNPDPKQRLTAEEVLEHPWL 316
           +L  +P QR    EVLEHPW+
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  161 bits (407), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 99/282 (35%), Positives = 138/282 (48%), Gaps = 39/282 (13%)
Query: 57  DYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY +  + LG G  G      +    EKFA K +         D    RREV++     +
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQ 69
Query: 116 HPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+  A    + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG                     A E
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKE 169
Query: 230 VLKRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPKV 285
                Y    D+WS GVI+YILLCG PPF++        G+   I     +F    W +V
Sbjct: 170 TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           SE  K L++ +L  +P QR+T  E + HPW+  + K P   L
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 152/309 (49%), Gaps = 52/309 (16%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPK 115
           Y L   +G+G +GV  +  +       A K ++K K+R     D+E ++ EV++MK L  
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-H 86
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI--------------VARGHYT------ 155
           HPNI  L + YED+  + +VMELC GG L D++              V +          
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 156 --------------------ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE 195
                               E+  + +M+ I   +   H QG+ HRD+KPENFLF+  K 
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK- 205
Query: 196 SSPLKAIDFGLSVFF---RPGEQFNEIV--GSPYYMAPEVLK---RNYGPEVDVWSAGVI 247
           S  +K +DFGLS  F     GE +      G+PY++APEVL     +YGP+ D WSAGV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 248 LYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTA 307
           L++LL G  PF    +      ++   + F+   +  +S  A+DL+  +LN +  +R  A
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 308 EEVLEHPWL 316
              L+HPW+
Sbjct: 326 MRALQHPWI 334

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 135/263 (51%), Gaps = 10/263 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LG  LG G FG   +      G K A K ++++K+R+   +  ++RE+Q +K L +HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           +I+ L       +   +VME   GGELFD I   G   E  A  + + I+  V  CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY- 235
           V+HRDLKPEN L      +   K  DFGLS     GE   +  GSP Y APEV+  R Y 
Sbjct: 132 VVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYA 188
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GPEVD+WS GVILY LLCG  PF  E    + + I   V          ++ +   L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLMH 244
Query: 296 MLNPDPKQRLTAEEVLEHPWLQN 318
           ML  DP +R T +++ EH W + 
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQ 267

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 146/261 (55%), Gaps = 11/261 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G++ A K I K +L ++  ++ + REV+I K L  H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIXKVL-NH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  +++V E   GGE+FD +VA G   E+ A A  + IV  VQ CH++
Sbjct: 73  PNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQK 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +   G+P Y APE+   K+ 
Sbjct: 133 FIVHRDLKAENLLL---DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+   S + ++L+K
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YXSTDCENLLK 245
Query: 295 KMLNPDPKQRLTAEEVLEHPW 315
           K L  +P +R T E++ +  W
Sbjct: 246 KFLILNPSKRGTLEQIXKDRW 266

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 134/263 (50%), Gaps = 10/263 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LG  LG G FG   +      G K A K ++++K+R+   +  ++RE+Q +K L +HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           +I+ L       +   +VME   GGELFD I   G   E  A  + + I+  V  CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY- 235
           V+HRDLKPEN L      +   K  DFGLS     GE      GSP Y APEV+  R Y 
Sbjct: 132 VVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GPEVD+WS GVILY LLCG  PF  E    + + I   V          ++ +   L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLMH 244
Query: 296 MLNPDPKQRLTAEEVLEHPWLQN 318
           ML  DP +R T +++ EH W + 
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 149/262 (56%), Gaps = 11/262 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   V  G + A K I K +L     ++ + REV+IMK L  H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-NPTSLQKLFREVRIMKIL-NH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  +++VME   GGE+FD +VA G   E+ A A  + IV  VQ CH++
Sbjct: 74  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 133
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLK EN L         +K  DFG S  F  G + +   GSP Y APE+   K+ 
Sbjct: 134 YIVHRDLKAENLLLDGDMN---IKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R      R P+  +S + ++L+K
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 246
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           K+L  +P +R + E++++  W+
Sbjct: 247 KLLVLNPIKRGSLEQIMKDRWM 268

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 107/326 (32%), Positives = 163/326 (50%), Gaps = 21/326 (6%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y +   LG G FG   L T     +K A K IS++ L+ +     V RE+  +K L +HP
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHP 69
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           +I+ L D     + + +V+E   GGELFD IV +   TE       + I+  ++ CH   
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRNY 235
           ++HRDLKPEN L     ++  +K  DFGLS     G       GSP Y APEV+  K   
Sbjct: 129 IVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI---DFKRDPWPKVSENAKDL 292
           GPEVDVWS G++LY++L G  PF  E    + + +   V    DF       +S  A+ L
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-------LSPGAQSL 238
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR---AL 349
           +++M+  DP QR+T +E+   PW  N      +   E V+       +++KL +    + 
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWF-NVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSE 297
Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNK 375
             + E L  +E   +KEA+ ++  N+
Sbjct: 298 DYIVEALRSDENNEVKEAYNLLHENQ 323

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  155 bits (391), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 138/264 (52%), Gaps = 13/264 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y + + LG G FG   L      G+K A K I+KK L  +     + RE+  ++ L +H
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P+I+ L D  +    + +V+E   G ELFD IV R   +E+ A    + I+  V+ CH  
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLKPEN L     E   +K  DFGLS     G       GSP Y APEV+  K  
Sbjct: 132 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 188
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDLV 293
            GPEVDVWS GVILY++LC   PF  E+   + + I   V        PK +S  A  L+
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-----PKFLSPGAAGLI 243
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQ 317
           K+ML  +P  R++  E+++  W +
Sbjct: 244 KRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  155 bits (391), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 138/264 (52%), Gaps = 13/264 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y + + LG G FG   L      G+K A K I+KK L  +     + RE+  ++ L +H
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P+I+ L D  +    + +V+E   G ELFD IV R   +E+ A    + I+  V+ CH  
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLKPEN L     E   +K  DFGLS     G       GSP Y APEV+  K  
Sbjct: 133 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 189
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDLV 293
            GPEVDVWS GVILY++LC   PF  E+   + + I   V        PK +S  A  L+
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-----PKFLSPGAAGLI 244
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQ 317
           K+ML  +P  R++  E+++  W +
Sbjct: 245 KRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 98/296 (33%), Positives = 147/296 (49%), Gaps = 35/296 (11%)
Query: 58  YDLGREL-GRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           Y L  EL G G +        + NG+++A K I K+   +      V REV+ +     +
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSR---SRVFREVETLYQCQGN 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            NI+ L + +EDD+  ++V E  +GG +   I  + H+ ER A+ V++ +   +   H +
Sbjct: 71  KNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTK 130
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV--------GSPYYMAP 228
           G+ HRDLKPEN L  + ++ SP+K  DF L    +       I         GS  YMAP
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 229 EVLK------RNYGPEVDVWSAGVILYILLCGVPPF---------WAETE------QGVA 267
           EV++        Y    D+WS GV+LYI+L G PPF         W   E        + 
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 250
Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
           ++I     +F    W  +S  AKDL+ K+L  D KQRL+A +VL+HPW+Q   +AP
Sbjct: 251 ESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG--QAP 304

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 138/264 (52%), Gaps = 13/264 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y + + LG G FG   L      G+K A K I+KK L  +     + RE+  ++ L +H
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RH 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P+I+ L D  +    + +V+E   G ELFD IV R   +E+ A    + I+  V+ CH  
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLKPEN L     E   +K  DFGLS     G       GSP Y APEV+  K  
Sbjct: 123 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 179
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDLV 293
            GPEVDVWS GVILY++LC   PF  E+   + + I   V        PK +S  A  L+
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-----PKFLSPGAAGLI 234
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQ 317
           K+ML  +P  R++  E+++  W +
Sbjct: 235 KRMLIVNPLNRISIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 138/264 (52%), Gaps = 13/264 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y + + LG G FG   L      G+K A K I+KK L  +     + RE+  ++ L +H
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P+I+ L D  +    + +V+E   G ELFD IV R   +E+ A    + I+  V+ CH  
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
            ++HRDLKPEN L     E   +K  DFGLS     G       GSP Y APEV+  K  
Sbjct: 127 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 183
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDLV 293
            GPEVDVWS GVILY++LC   PF  E+   + + I   V        PK +S  A  L+
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-----PKFLSPGAAGLI 238
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQ 317
           K+ML  +P  R++  E+++  W +
Sbjct: 239 KRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  152 bits (385), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 144/264 (54%), Gaps = 11/264 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ +G  LG+G F   Y    ++ G + A K I KK +  A  ++ V+ EV+I   L KH
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
           P+I+ L + +ED + V++V+E+C  GE+   +  R   ++E  A   M  I+  +   H 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVLKRN 234
            G++HRDL   N L         +K  DFGL+   + P E+   + G+P Y++PE+  R+
Sbjct: 131 HGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            +G E DVWS G + Y LL G PPF  +T +     ++  + D++   +  +S  AKDL+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSF--LSIEAKDLI 243
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQ 317
            ++L  +P  RL+   VL+HP++ 
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMS 267

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 142/262 (54%), Gaps = 8/262 (3%)
Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
            +ELGRG+F V   C   + G+++A K + KK+ R      ++  E+ +++     P ++
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFL-KKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGV 178
           +L + YE+ S + +++E   GGE+F   +       +E     ++K I+E V   H+  +
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP- 237
           +H DLKP+N L ++      +K +DFG+S       +  EI+G+P Y+APE+L  NY P 
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL--NYDPI 210
Query: 238 --EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
               D+W+ G+I Y+LL    PF  E  Q     I +  +D+  + +  VS+ A D ++ 
Sbjct: 211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQS 270
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ 317
           +L  +P++R TAE  L H WLQ
Sbjct: 271 LLVKNPEKRPTAEICLSHSWLQ 292

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 98/295 (33%), Positives = 145/295 (49%), Gaps = 38/295 (12%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKK--KLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           LG G       C ++   +++A K I K+   +R+ V      REV+++     H N++ 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-----FREVEMLYQCQGHRNVLE 75
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L + +E++   ++V E   GG +   I  R H+ E  A+ V++ +   +   H +G+ HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI--------VGSPYYMAPEVLK- 232
           DLKPEN L  +  + SP+K  DFGL    +     + I         GS  YMAPEV++ 
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 233 -----RNYGPEVDVWSAGVILYILLCGVPPF---------WAETEQGVA------QAIIR 272
                  Y    D+WS GVILYILL G PPF         W   E   A      ++I  
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255
Query: 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
              +F    W  +S  AKDL+ K+L  D KQRL+A +VL+HPW+Q    AP  +L
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC--APENTL 308

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 136/263 (51%), Gaps = 10/263 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+L +++G G FGV  L  D  + E  A K I + +    +D E+V+RE+   + L +HP
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE---KID-ENVKREIINHRSL-RHP 74
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV  K+     + + IVME   GGELF+RI   G ++E  A    + ++  V  CH   
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNY- 235
           V HRDLK EN L  +   +  LK  DFG S       Q    VG+P Y+APEV LK+ Y 
Sbjct: 135 VCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 193
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--FKRDPWPKVSENAKDLV 293
           G   DVWS GV LY++L G  PF    E    +  I  +++  +    +  +S   + L+
Sbjct: 194 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 253
Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
            ++   DP +R++  E+  H W 
Sbjct: 254 SRIFVADPAKRISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  141 bits (356), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 134/263 (50%), Gaps = 10/263 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+L +++G G FGV  L  D  + E  A K I + +   A    +V+RE+   + L +HP
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAA----NVKREIINHRSL-RHP 75
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV  K+     + + IVME   GGELF+RI   G ++E  A    + ++  V  CH   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNY- 235
           V HRDLK EN L  +   +  LK  DFG S       Q    VG+P Y+APEV LK+ Y 
Sbjct: 136 VCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 194
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--FKRDPWPKVSENAKDLV 293
           G   DVWS GV LY++L G  PF    E    +  I  +++  +    +  +S   + L+
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
            ++   DP +R++  E+  H W 
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWF 277

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  141 bits (356), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 10/262 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K ++        +RRE++I  HL  H
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL-HH 82
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L + + D   +++++E    GEL+  +     + E+  A +M+ + + +  CH +
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK 142
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN           LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 143 KVIHRDIKPEN---LLLGLKGELKIADFGWSV-HAPSLRRKTMCGTLDYLPPEMIEGRMH 198
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+W  GV+ Y LL G PPF + +     + I++  + F       V   A+DL+ K
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPAS----VPTGAQDLISK 254
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ 317
           +L  +P +RL   +V  HPW++
Sbjct: 255 LLRHNPSERLPLAQVSAHPWVR 276

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 136/263 (51%), Gaps = 10/263 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+L +++G G FGV  L  D  + E  A K I + +    +D E+V+RE+   + L +HP
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE---KID-ENVKREIINHRSL-RHP 75
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV  K+     + + IVME   GGELF+RI   G ++E  A    + ++  V  CH   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNY- 235
           V HRDLK EN L  +   +  LK   FG S       Q  + VG+P Y+APEV LK+ Y 
Sbjct: 136 VCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYD 194
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--FKRDPWPKVSENAKDLV 293
           G   DVWS GV LY++L G  PF    E    +  I  +++  +    +  +S   + L+
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
            ++   DP +R++  E+  H W 
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWF 277

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 97/295 (32%), Positives = 144/295 (48%), Gaps = 38/295 (12%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKK--KLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           LG G       C ++   +++A K I K+   +R+ V      REV+++     H N++ 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-----FREVEMLYQCQGHRNVLE 75
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L + +E++   ++V E   GG +   I  R H+ E  A+ V++ +   +   H +G+ HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI--------VGSPYYMAPEVLK- 232
           DLKPEN L  +  + SP+K  DF L    +     + I         GS  YMAPEV++ 
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 233 -----RNYGPEVDVWSAGVILYILLCGVPPF---------WAETEQGVA------QAIIR 272
                  Y    D+WS GVILYILL G PPF         W   E   A      ++I  
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255
Query: 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
              +F    W  +S  AKDL+ K+L  D KQRL+A +VL+HPW+Q    AP  +L
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC--APENTL 308

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 135/263 (51%), Gaps = 10/263 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+L +++G G FGV  L  D  + E  A K I + +    +D E+V+RE+   + L +HP
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE---KID-ENVKREIINHRSL-RHP 75
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV  K+     + + IVME   GGELF+RI   G ++E  A    + ++  V  CH   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNY- 235
           V HRDLK EN L  +   +  LK   FG S       Q    VG+P Y+APEV LK+ Y 
Sbjct: 136 VCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 194
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--FKRDPWPKVSENAKDLV 293
           G   DVWS GV LY++L G  PF    E    +  I  +++  +    +  +S   + L+
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
            ++   DP +R++  E+  H W 
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 134/263 (50%), Gaps = 10/263 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+L +++G G FGV  L  D    E  A K I + +    +D E+V+RE+   + L +HP
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE---KID-ENVKREIINHRSL-RHP 75
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV  K+     + + IVME   GGELF+RI   G ++E  A    + ++  V   H   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNY- 235
           V HRDLK EN L  +   +  LK  DFG S       Q    VG+P Y+APEV LK+ Y 
Sbjct: 136 VAHRDLKLENTLL-DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYD 194
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--FKRDPWPKVSENAKDLV 293
           G   DVWS GV LY++L G  PF    E    +  I  +++  +    +  +S   + L+
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
            ++   DP +R++  E+  H W 
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 131/264 (49%), Gaps = 12/264 (4%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           YD  +++G G FGV  L  D    E  A K I +     A+D E+V+RE+   + L +HP
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG---AAID-ENVQREIINHRSL-RHP 76
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV  K+     + + I+ME   GGEL++RI   G ++E  A    + ++  V  CH   
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNY-- 235
           + HRDLK EN L  +   +  LK  DFG S       Q    VG+P Y+APEVL R    
Sbjct: 137 ICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP---KVSENAKDL 292
           G   DVWS GV LY++L G  PF    E    +  I+ ++  K    P   ++S     L
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS-IPDDIRISPECCHL 254
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
           + ++   DP  R++  E+  H W 
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWF 278

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F  T L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 89
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 150 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 262
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 144/267 (53%), Gaps = 13/267 (4%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  + T  ++G+  A K   K  LR     E +  EV IM+   +H N+V +
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 82
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            ++Y     + +VME  EGG L D IV      E   AAV   +++ + V H QGV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           +K ++ L  +      +K  DFG      +   +   +VG+PY+MAPE++ R  YGPEVD
Sbjct: 142 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G+++  ++ G PP++ E     A  +IR  +  +     KVS + K  + ++L  D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 257
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           P QR TA E+L+HP+L  AK  P  S+
Sbjct: 258 PAQRATAAELLKHPFL--AKAGPPASI 282

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 144/267 (53%), Gaps = 13/267 (4%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  + T  ++G+  A K   K  LR     E +  EV IM+   +H N+V +
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 86
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            ++Y     + +VME  EGG L D IV      E   AAV   +++ + V H QGV+HRD
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           +K ++ L  +      +K  DFG      +   +   +VG+PY+MAPE++ R  YGPEVD
Sbjct: 146 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G+++  ++ G PP++ E     A  +IR  +  +     KVS + K  + ++L  D
Sbjct: 203 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 261
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           P QR TA E+L+HP+L  AK  P  S+
Sbjct: 262 PAQRATAAELLKHPFL--AKAGPPASI 286

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 144/267 (53%), Gaps = 13/267 (4%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  + T  ++G+  A K   K  LR     E +  EV IM+   +H N+V +
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 91
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            ++Y     + +VME  EGG L D IV      E   AAV   +++ + V H QGV+HRD
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 150
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           +K ++ L  +      +K  DFG      +   +   +VG+PY+MAPE++ R  YGPEVD
Sbjct: 151 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G+++  ++ G PP++ E     A  +IR  +  +     KVS + K  + ++L  D
Sbjct: 208 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 266
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           P QR TA E+L+HP+L  AK  P  S+
Sbjct: 267 PAQRATAAELLKHPFL--AKAGPPASI 291

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 144/267 (53%), Gaps = 13/267 (4%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  + T  ++G+  A K   K  LR     E +  EV IM+   +H N+V +
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 136
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            ++Y     + +VME  EGG L D IV      E   AAV   +++ + V H QGV+HRD
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 195
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           +K ++ L  +      +K  DFG      +   +   +VG+PY+MAPE++ R  YGPEVD
Sbjct: 196 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G+++  ++ G PP++ E     A  +IR  +  +     KVS + K  + ++L  D
Sbjct: 253 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 311
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           P QR TA E+L+HP+L  AK  P  S+
Sbjct: 312 PAQRATAAELLKHPFL--AKAGPPASI 336

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 144/267 (53%), Gaps = 13/267 (4%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  + T  ++G+  A K   K  LR     E +  EV IM+   +H N+V +
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 93
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            ++Y     + +VME  EGG L D IV      E   AAV   +++ + V H QGV+HRD
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 152
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           +K ++ L  +      +K  DFG      +   +   +VG+PY+MAPE++ R  YGPEVD
Sbjct: 153 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G+++  ++ G PP++ E     A  +IR  +  +     KVS + K  + ++L  D
Sbjct: 210 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 268
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           P QR TA E+L+HP+L  AK  P  S+
Sbjct: 269 PAQRATAAELLKHPFL--AKAGPPASI 293

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 144/267 (53%), Gaps = 13/267 (4%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  + T  ++G+  A K   K  LR     E +  EV IM+   +H N+V +
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 213
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            ++Y     + +VME  EGG L D IV      E   AAV   +++ + V H QGV+HRD
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 272
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           +K ++ L  +      +K  DFG      +   +   +VG+PY+MAPE++ R  YGPEVD
Sbjct: 273 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G+++  ++ G PP++ E     A  +IR  +  +     KVS + K  + ++L  D
Sbjct: 330 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 388
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           P QR TA E+L+HP+L  AK  P  S+
Sbjct: 389 PAQRATAAELLKHPFL--AKAGPPASI 413

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 154/289 (53%), Gaps = 26/289 (8%)
Query: 57  DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKH 112
           +++L + LG G +G  +L   +   + G+ +A K + K  + + A   E  R E Q+++H
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           + + P +V+L   ++ ++ +H++++   GGELF  +  R  +TE      +  IV  ++ 
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 174
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP--GEQFNEIVGSPYYMAPEV 230
            H+ G+++RD+K EN L  +   +  +   DFGLS  F     E+  +  G+  YMAP++
Sbjct: 175 LHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 231 LK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VS 286
           ++     +   VD WS GV++Y LL G  PF  + E+     I R ++     P+P+ +S
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMS 290
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQN-------AKKAP 323
             AKDL++++L  DPK+RL      A+E+ EH + Q        AKK P
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 339

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 130/258 (50%), Gaps = 12/258 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 88
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 149 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 261
Query: 293 VKKMLNPDPKQRLTAEEV 310
           V+K+L  D  +RL  EE+
Sbjct: 262 VEKLLVLDATKRLGCEEM 279

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 92
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 153 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 265
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 91
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 152 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 264
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 130/258 (50%), Gaps = 12/258 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 88
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 149 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 261
Query: 293 VKKMLNPDPKQRLTAEEV 310
           V+K+L  D  +RL  EE+
Sbjct: 262 VEKLLVLDATKRLGCEEM 279

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 89
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 150 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 262
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 89
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 150 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 262
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 89
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 150 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 262
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 92
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 153 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 265
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 66
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 127 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 184 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 239
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQNA 319
           V+K+L  D  +RL  EE      +  HP+ ++ 
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 130/258 (50%), Gaps = 12/258 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 134 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 191 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 246
Query: 293 VKKMLNPDPKQRLTAEEV 310
           V+K+L  D  +RL  EE+
Sbjct: 247 VEKLLVLDATKRLGCEEM 264

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 91
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 152 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 264
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 130/258 (50%), Gaps = 12/258 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 128 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 240
Query: 293 VKKMLNPDPKQRLTAEEV 310
           V+K+L  D  +RL  EE+
Sbjct: 241 VEKLLVLDATKRLGCEEM 258

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 91
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 152 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 264
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 130/258 (50%), Gaps = 12/258 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 129 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 186 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 241
Query: 293 VKKMLNPDPKQRLTAEEV 310
           V+K+L  D  +RL  EE+
Sbjct: 242 VEKLLVLDATKRLGCEEM 259

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 130/258 (50%), Gaps = 12/258 (4%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 69
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 130 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 187 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 242
Query: 293 VKKMLNPDPKQRLTAEEV 310
           V+K+L  D  +RL  EE+
Sbjct: 243 VEKLLVLDATKRLGCEEM 260

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 94
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 155 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPK----ARDL 267
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 268 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 299

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 134/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 91
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 152 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  +   II+   DF    +PK    A+DL
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK----ARDL 264
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 134/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 91
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + G L   I   G + E         IV  ++  H +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 152 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 209 KSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 264
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 134/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 96
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L   ++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 157 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF    +PK    A+DL
Sbjct: 214 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDL 269
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 270 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 301

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 91/256 (35%), Positives = 132/256 (51%), Gaps = 10/256 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y  GR LG+G F   Y  TD++  E FA K + K  L      E +  E+ I K L  +P
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DNP 102
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           ++V     +EDD  V++V+E+C    L +    R   TE  A   M+  ++ VQ  H   
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNY 235
           V+HRDLK  N LF N  +   +K  DFGL+      GE+  ++ G+P Y+APEVL K+ +
Sbjct: 163 VIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             EVD+WS G ILY LL G PPF     +     I ++     R     ++  A  L+++
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRR 275
Query: 296 MLNPDPKQRLTAEEVL 311
           ML+ DP  R +  E+L
Sbjct: 276 MLHADPTLRPSVAELL 291

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 91/256 (35%), Positives = 132/256 (51%), Gaps = 10/256 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y  GR LG+G F   Y  TD++  E FA K + K  L      E +  E+ I K L  +P
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DNP 86
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           ++V     +EDD  V++V+E+C    L +    R   TE  A   M+  ++ VQ  H   
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNY 235
           V+HRDLK  N LF N  +   +K  DFGL+      GE+  ++ G+P Y+APEVL K+ +
Sbjct: 147 VIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             EVD+WS G ILY LL G PPF     +     I ++     R     ++  A  L+++
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRR 259
Query: 296 MLNPDPKQRLTAEEVL 311
           ML+ DP  R +  E+L
Sbjct: 260 MLHADPTLRPSVAELL 275

>pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 71/166 (42%), Positives = 102/166 (61%), Gaps = 4/166 (2%)
Query: 336 KQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNI 395
           KQFS  NK KK AL+V+AE LS EE+AGLKE F  +D +K G+I              N+
Sbjct: 1   KQFSAXNKFKKXALRVIAESLSEEEIAGLKEXFNXIDADKSGQITFEELKAGLKRVGANL 60
Query: 396 PEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEE 455
            E+++  L +AADVD  G+++Y EF+A ++HL K+  ++HL  AF++FD++ SG+I  +E
Sbjct: 61  KESEILDLXQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFAAFTYFDKDGSGYITPDE 120
Query: 456 LRNALNDEVDTSGEDV-INAIMHDVDTDKDGRISYEEFAVMMKAGT 500
           L+ A     +   EDV I  +  DVD D DGRI Y EF    + G+
Sbjct: 121 LQQACE---EFGVEDVRIEELXRDVDQDNDGRIDYNEFVAXXQKGS 163

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 134/272 (49%), Gaps = 18/272 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 91
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-K 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L +
Sbjct: 152 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  +   II+   DF    +PK    A+DL
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK----ARDL 264
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN 318
           V+K+L  D  +RL  EE      +  HP+ ++
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/256 (35%), Positives = 131/256 (51%), Gaps = 10/256 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y  GR LG+G F   Y  TD++  E FA K + K  L      E +  E+ I K L  +P
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DNP 102
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           ++V     +EDD  V++V+E+C    L +    R   TE  A   M+  ++ VQ  H   
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNY 235
           V+HRDLK  N LF N  +   +K  DFGL+      GE+   + G+P Y+APEVL K+ +
Sbjct: 163 VIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             EVD+WS G ILY LL G PPF     +     I ++     R     ++  A  L+++
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRR 275
Query: 296 MLNPDPKQRLTAEEVL 311
           ML+ DP  R +  E+L
Sbjct: 276 MLHADPTLRPSVAELL 291

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/256 (35%), Positives = 131/256 (51%), Gaps = 10/256 (3%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y  GR LG+G F   Y  TD++  E FA K + K  L      E +  E+ I K L  +P
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DNP 102
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           ++V     +EDD  V++V+E+C    L +    R   TE  A   M+  ++ VQ  H   
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNY 235
           V+HRDLK  N LF N  +   +K  DFGL+      GE+   + G+P Y+APEVL K+ +
Sbjct: 163 VIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             EVD+WS G ILY LL G PPF     +     I ++     R     ++  A  L+++
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRR 275
Query: 296 MLNPDPKQRLTAEEVL 311
           ML+ DP  R +  E+L
Sbjct: 276 MLHADPTLRPSVAELL 291

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 135/267 (50%), Gaps = 15/267 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +H
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P + +LK  ++    +  VME   GGELF  +     +TE  A      IV  ++  H +
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN- 234
            V++RD+K EN +     +   +K  DFGL       G       G+P Y+APEVL+ N 
Sbjct: 128 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+ 
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLA 240
Query: 295 KMLNPDPKQRL-----TAEEVLEHPWL 316
            +L  DPKQRL      A+EV+EH + 
Sbjct: 241 GLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +H
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRH 69
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P + +LK  ++    +  VME   GGELF  +     +TE  A      IV  ++  H +
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 129
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN- 234
            V++RD+K EN +     +   +K  DFGL       G       G+P Y+APEVL+ N 
Sbjct: 130 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+ 
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLA 242
Query: 295 KMLNPDPKQRL-----TAEEVLEH 313
            +L  DPKQRL      A+EV+EH
Sbjct: 243 GLLKKDPKQRLGGGPSDAKEVMEH 266

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +H
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRH 64
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P + +LK  ++    +  VME   GGELF  +     +TE  A      IV  ++  H +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN- 234
            V++RD+K EN +     +   +K  DFGL       G       G+P Y+APEVL+ N 
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLA 237
Query: 295 KMLNPDPKQRL-----TAEEVLEH 313
            +L  DPKQRL      A+EV+EH
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEH 261

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +H
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRH 64
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P + +LK  ++    +  VME   GGELF  +     +TE  A      IV  ++  H +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN- 234
            V++RD+K EN +     +   +K  DFGL       G       G+P Y+APEVL+ N 
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLA 237
Query: 295 KMLNPDPKQRL-----TAEEVLEH 313
            +L  DPKQRL      A+EV+EH
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEH 261

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +H
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRH 64
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P + +LK  ++    +  VME   GGELF  +     +TE  A      IV  ++  H +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN- 234
            V++RD+K EN +     +   +K  DFGL       G       G+P Y+APEVL+ N 
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLA 237
Query: 295 KMLNPDPKQRL-----TAEEVLEH 313
            +L  DPKQRL      A+EV+EH
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEH 261

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 135/267 (50%), Gaps = 15/267 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +H
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRH 64
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P + +LK  ++    +  VME   GGELF  +     +TE  A      IV  ++  H +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN- 234
            V++RD+K EN +     +   +K  DFGL       G       G+P Y+APEVL+ N 
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLA 237
Query: 295 KMLNPDPKQRL-----TAEEVLEHPWL 316
            +L  DPKQRL      A+EV+EH + 
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +H
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRH 64
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P + +LK  ++    +  VME   GGELF  +     +TE  A      IV  ++  H +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN- 234
            V++RD+K EN +     +   +K  DFGL       G       G+P Y+APEVL+ N 
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLA 237
Query: 295 KMLNPDPKQRL-----TAEEVLEH 313
            +L  DPKQRL      A+EV+EH
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEH 261

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 140/272 (51%), Gaps = 19/272 (6%)
Query: 58  YDLGRELGRGEFGVTYLC---TDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHL 113
           ++L R LG+G +G  +     T  N G+ FA K + K  + R A D    + E  I++ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
            KHP IV L   ++    +++++E   GGELF ++   G + E  A   +  I   +   
Sbjct: 79  -KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK 232
           H++G+++RDLKPEN +  ++     +K  DFGL       G   +   G+  YMAPE+L 
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
           R+ +   VD WS G ++Y +L G PPF  E  +     I++  ++      P +++ A+D
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARD 250
Query: 292 LVKKMLNPDPKQRLT-----AEEVLEHPWLQN 318
           L+KK+L  +   RL      A EV  HP+ ++
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 140/272 (51%), Gaps = 19/272 (6%)
Query: 58  YDLGRELGRGEFGVTYLC---TDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHL 113
           ++L R LG+G +G  +     T  N G+ FA K + K  + R A D    + E  I++ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
            KHP IV L   ++    +++++E   GGELF ++   G + E  A   +  I   +   
Sbjct: 79  -KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK 232
           H++G+++RDLKPEN +  ++     +K  DFGL       G   +   G+  YMAPE+L 
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
           R+ +   VD WS G ++Y +L G PPF  E  +     I++  ++      P +++ A+D
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARD 250
Query: 292 LVKKMLNPDPKQRLT-----AEEVLEHPWLQN 318
           L+KK+L  +   RL      A EV  HP+ ++
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 134/267 (50%), Gaps = 16/267 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ + R LG G FG  +L    +NG  +A K + K+ +     +E    E ++M  +  H
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE-RLMLSIVTH 65
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P I+ +  T++D   + ++M+  EGGELF  +     +    A      +   ++  H +
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 125
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            +++RDLKPEN L     ++  +K  DFG + +  P   +  + G+P Y+APEV+  + Y
Sbjct: 126 DIIYRDLKPENILL---DKNGHIKITDFGFAKYV-PDVTY-XLCGTPDYIAPEVVSTKPY 180
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
              +D WS G+++Y +L G  PF+        + I+ + + F     P  +E+ KDL+ +
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSR 236
Query: 296 MLNPDPKQRL-----TAEEVLEHPWLQ 317
           ++  D  QRL       E+V  HPW +
Sbjct: 237 LITRDLSQRLGNLQNGTEDVKNHPWFK 263

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 88/273 (32%), Positives = 141/273 (51%), Gaps = 21/273 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++   +G G +G        ++G+    K +    + T  + + +  EV +++ L KH
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KH 64
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVV 170
           PNIV   D   D  ++ ++IVME CEGG+L   I      R +  E     VM  +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 171 QVCHEQG-----VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPY 224
           + CH +      V+HRDLKP N     K+    +K  DFGL+      E F  E VG+PY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDEDFAKEFVGTPY 181
Query: 225 YMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
           YM+PE + R +Y  + D+WS G +LY L   +PPF A +++ +A  I      F+R P+ 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPY- 238
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           + S+   +++ +MLN     R + EE+LE+P +
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 140/289 (48%), Gaps = 37/289 (12%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL----------------------- 94
           Y L  E+G+G +GV  L  + N+   +A K +SKKKL                       
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 95  RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM--ELCEGGELFDRIVARG 152
           +    IE V +E+ I+K L  HPN+V L +  +D +  H+ M  EL   G + + +    
Sbjct: 75  QPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 153 HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
             +E  A    + +++ ++  H Q ++HRD+KP N L     E   +K  DFG+S  F+ 
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKG 189
Query: 213 GEQF-NEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 267
            +   +  VG+P +MAPE L        G  +DVW+ GV LY  + G  PF  E    + 
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
             I    ++F   P   ++E+ KDL+ +ML+ +P+ R+   E+  HPW+
Sbjct: 250 SKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 145/278 (52%), Gaps = 13/278 (4%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y    ++G+G  G  Y   DV  G++ A   I +  L+     E +  E+ +M+   K+P
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV+  D+Y     + +VME   GG L D +V      E   AAV +  ++ ++  H   
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
           V+HRD+K +N L         +K  DFG      P + + +E+VG+PY+MAPEV+ R  Y
Sbjct: 137 VIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAY 193
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GP+VD+WS G++   ++ G PP+  E        I  +     ++P  K+S   +D + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNR 252
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
            L+ D ++R +A+E+L+H +L+ AK  P  SL   + A
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAK--PLSSLTPLIAA 288

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  125 bits (313), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 139/273 (50%), Gaps = 21/273 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++   +G G +G        ++G+    K +    + T  + + +  EV +++ L KH
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KH 64
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVV 170
           PNIV   D   D  ++ ++IVME CEGG+L   I      R +  E     VM  +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 171 QVCHEQG-----VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPY 224
           + CH +      V+HRDLKP N     K+    +K  DFGL+        F    VG+PY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 225 YMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
           YM+PE + R +Y  + D+WS G +LY L   +PPF A +++ +A  I      F+R P+ 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPY- 238
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           + S+   +++ +MLN     R + EE+LE+P +
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 131/261 (50%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+    +IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN +     +   +K  DFGL+   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLMI---DQQGYIKVTDFGLAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 140/273 (51%), Gaps = 21/273 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++   +G G +G        ++G+    K +    + T  + + +  EV +++ L KH
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KH 64
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVV 170
           PNIV   D   D  ++ ++IVME CEGG+L   I      R +  E     VM  +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 171 QVCHEQG-----VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-IVGSPY 224
           + CH +      V+HRDLKP N     K+    +K  DFGL+        F +  VG+PY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPY 181
Query: 225 YMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
           YM+PE + R +Y  + D+WS G +LY L   +PPF A +++ +A  I      F+R P+ 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPY- 238
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           + S+   +++ +MLN     R + EE+LE+P +
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 86/259 (33%), Positives = 135/259 (52%), Gaps = 11/259 (4%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  + T+ + G++ A K   K  LR     E +  EV IM+    H N+V +
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDY-HHDNVVDM 107
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y     + +VME  EGG L D IV      E   A V  +++  +   H QGV+HRD
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           +K ++ L  +      +K  DFG      +   +   +VG+PY+MAPEV+ R  YG EVD
Sbjct: 167 IKSDSILLTSDGR---IKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVD 223
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
           +WS G+++  ++ G PP++ E      + I  S+    +D   KVS   +  +  ML  +
Sbjct: 224 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKD-LHKVSSVLRGFLDLMLVRE 282
Query: 301 PKQRLTAEEVLEHPWLQNA 319
           P QR TA+E+L HP+L+ A
Sbjct: 283 PSQRATAQELLGHPFLKLA 301

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 20  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 79
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 80  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 138
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     E   ++  DFG +   R   +   + G+P Y+A
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLI---DEQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 193
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 249
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 250 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 144/262 (54%), Gaps = 23/262 (8%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G  G+  L  + ++G + A K +  +K +     E +  EV IM+   +H N+V +
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDY-QHFNVVEM 107
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y     + ++ME  +GG L D IV++    E   A V + +++ +   H QGV+HRD
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K ++ L         +K  DFG      +   +   +VG+PY+MAPEV+ R+ Y  EVD
Sbjct: 167 IKSDSILLTLDGR---VKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVD 223
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK------VSENAKDLVK 294
           +WS G+++  ++ G PP+++++     QA+ R     +  P PK      VS   +D ++
Sbjct: 224 IWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNSHKVSPVLRDFLE 276
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
           +ML  DP++R TA+E+L+HP+L
Sbjct: 277 RMLVRDPQERATAQELLDHPFL 298

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLAGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 135/282 (47%), Gaps = 18/282 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 63
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVSLG 328
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+ G
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 34  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 94  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 207
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 263
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 264 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLXGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 135/282 (47%), Gaps = 18/282 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 63
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVSLG 328
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+ G
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 135/282 (47%), Gaps = 18/282 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 63
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVSLG 328
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+ G
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 135/282 (47%), Gaps = 18/282 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 63
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVSLG 328
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+ G
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 135/282 (47%), Gaps = 18/282 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVSLG 328
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+ G
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 280

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 144/278 (51%), Gaps = 13/278 (4%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y    ++G+G  G  Y   DV  G++ A   I +  L+     E +  E+ +M+   K+P
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV+  D+Y     + +VME   GG L D +V      E   AAV +  ++ ++  H   
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
           V+HRD+K +N L         +K  DFG      P + + + +VG+PY+MAPEV+ R  Y
Sbjct: 137 VIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GP+VD+WS G++   ++ G PP+  E        I  +     ++P  K+S   +D + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNR 252
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
            L+ D ++R +A+E+L+H +L+ AK  P  SL   + A
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAK--PLSSLTPLIAA 288

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 131/261 (50%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+    +IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN +     +   ++  DFGL+   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLMI---DQQGYIQVTDFGLAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G + E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 140/276 (50%), Gaps = 16/276 (5%)
Query: 46  LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
           L +P  +    +++  + LG+G FG   L  +   G  +A K + K+ +    ++     
Sbjct: 141 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 200
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
           E +++++  +HP + +LK +++    +  VME   GGELF  +     ++E  A      
Sbjct: 201 ENRVLQN-SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 259
Query: 166 IVEVVQVCH-EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSP 223
           IV  +   H E+ V++RDLK EN +     +   +K  DFGL     + G       G+P
Sbjct: 260 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
            Y+APEVL+ N YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R   
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 376
Query: 283 PKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEH 313
           P+    AK L+  +L  DPKQRL      A+E+++H
Sbjct: 377 PE----AKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 408

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 140/276 (50%), Gaps = 16/276 (5%)
Query: 46  LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
           L +P  +    +++  + LG+G FG   L  +   G  +A K + K+ +    ++     
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
           E +++++  +HP + +LK +++    +  VME   GGELF  +     ++E  A      
Sbjct: 198 ENRVLQN-SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 166 IVEVVQVCH-EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSP 223
           IV  +   H E+ V++RDLK EN +     +   +K  DFGL     + G       G+P
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
            Y+APEVL+ N YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R   
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 373
Query: 283 PKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEH 313
           P+    AK L+  +L  DPKQRL      A+E+++H
Sbjct: 374 PE----AKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 134/280 (47%), Gaps = 18/280 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEIXINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVS 326
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 278

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G + E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 54  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 114 RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R       + G+P Y+A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGATWTLCGTPEYLA 227
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFS 283
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 284 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G + E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 134/280 (47%), Gaps = 18/280 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEIXINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVS 326
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 278

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 54  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G + E  A      IV
Sbjct: 114 RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 172
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 227
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFS 283
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 284 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN +     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLMI---DQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G + E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 28  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 87
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G + E  A      IV
Sbjct: 88  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 146
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 201
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 257
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 258 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 143/278 (51%), Gaps = 13/278 (4%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y    ++G+G  G  Y   DV  G++ A   I +  L+     E +  E+ +M+   K+P
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV+  D+Y     + +VME   GG L D +V      E   AAV +  ++ ++  H   
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
           V+HRD+K +N L         +K  DFG      P + + + +VG+PY+MAPEV+ R  Y
Sbjct: 137 VIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 193
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GP+VD+WS G++   ++ G PP+  E        I  +     ++P  K+S   +D + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNR 252
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
            L  D ++R +A+E+L+H +L+ AK  P  SL   + A
Sbjct: 253 CLEMDVEKRGSAKELLQHQFLKIAK--PLSSLTPLIAA 288

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 133/261 (50%), Gaps = 16/261 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +HP + +LK
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 74
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-EQGVMHRD 182
            +++    +  VME   GGELF  +     ++E  A      IV  +   H E+ V++RD
Sbjct: 75  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 134
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           LK EN +     +   +K  DFGL     + G       G+P Y+APEVL+ N YG  VD
Sbjct: 135 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 191
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W  GV++Y ++CG  PF+ +  + + + I+   I F R   P+    AK L+  +L  D
Sbjct: 192 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE----AKSLLSGLLKKD 247
Query: 301 PKQRL-----TAEEVLEHPWL 316
           PKQRL      A+E+++H + 
Sbjct: 248 PKQRLGGGSEDAKEIMQHRFF 268

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 137/268 (51%), Gaps = 16/268 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +++  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +H
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-E 175
           P + +LK +++    +  VME   GGELF  +     ++E  A      IV  +   H E
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 128
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN 234
           + V++RDLK EN +     +   +K  DFGL     + G       G+P Y+APEVL+ N
Sbjct: 129 KNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R   P+    AK L+
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE----AKSLL 241
Query: 294 KKMLNPDPKQRL-----TAEEVLEHPWL 316
             +L  DPKQRL      A+E+++H + 
Sbjct: 242 SGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  FA K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  FA K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  FA K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWTLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 134/280 (47%), Gaps = 18/280 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVS 326
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 278

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF 297

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 134/280 (47%), Gaps = 18/280 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 61
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 122 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVS 326
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 277

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 133/261 (50%), Gaps = 16/261 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +HP + +LK
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 76
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-EQGVMHRD 182
            +++    +  VME   GGELF  +     ++E  A      IV  +   H E+ V++RD
Sbjct: 77  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 136
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           LK EN +     +   +K  DFGL     + G       G+P Y+APEVL+ N YG  VD
Sbjct: 137 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 193
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W  GV++Y ++CG  PF+ +  + + + I+   I F R   P+    AK L+  +L  D
Sbjct: 194 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE----AKSLLSGLLKKD 249
Query: 301 PKQRL-----TAEEVLEHPWL 316
           PKQRL      A+E+++H + 
Sbjct: 250 PKQRLGGGSEDAKEIMQHRFF 270

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G + E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN +     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLMI---DQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 134/280 (47%), Gaps = 18/280 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVS 326
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 278

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 144/294 (48%), Gaps = 35/294 (11%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G +GV + C + + G+  A K   + +    +  +   RE++++K L KHPN+V+L
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQL-KHPNLVNL 67
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
            + +     +H+V E C+   L +    +    E    ++    ++ V  CH+   +HRD
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRD 127
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL--KRNYGPEV 239
           +KPEN L     + S +K  DFG +     P + +++ V + +Y +PE+L     YGP V
Sbjct: 128 VKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF------------------KRDP 281
           DVW+ G +   LL GVP +  +++      I +++ D                     DP
Sbjct: 185 DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDP 244
Query: 282 ---------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVS 326
                    +P +S  A  L+K  L+ DP +RLT E++L HP+ +N ++  +++
Sbjct: 245 EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLA 298

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 134/280 (47%), Gaps = 18/280 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVS 326
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 278

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 91
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 151
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 152 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWTLCGTPEYLAPEIILSKGYNKAVD 206
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 207 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 262
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 263 LTKRFGNLKDGVNDIKNHKWF 283

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 143/278 (51%), Gaps = 13/278 (4%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y    ++G+G  G  Y   DV  G++ A   I +  L+     E +  E+ +M+   K+P
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 78
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV+  D+Y     + +VME   GG L D +V      E   AAV +  ++ ++  H   
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
           V+HRD+K +N L         +K  DFG      P + + + +VG+PY+MAPEV+ R  Y
Sbjct: 138 VIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 194
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GP+VD+WS G++   ++ G PP+  E        I  +     ++P  K+S   +D + +
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNR 253
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
            L  D ++R +A+E+++H +L+ AK  P  SL   + A
Sbjct: 254 CLEMDVEKRGSAKELIQHQFLKIAK--PLSSLTPLIAA 289

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           P  +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN +     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLMI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN +     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLII---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE ++ + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G + E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +  
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN +     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 12/254 (4%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPD 300
            + KDL++ +L  D
Sbjct: 263 SDLKDLLRNLLQVD 276

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +  
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN +     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G + E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIXNHKWF 298

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G + E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN +     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 127/261 (48%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R LG G FG   L      G  +A K + K+K+     IE    E +I + +   P +V 
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAV-NFPFLVK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++V+E   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLLI---DQQGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 98
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 159 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 213
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 269
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWF 290

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GG++F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEIXINKML-N 63
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
            L+ K+L  +P  R+T  ++ +  W     K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 127/261 (48%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +  
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTK 106
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G + E  A      IV   +  H   +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN +     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF 298

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G FG   L   +  G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GG++F  +   G ++E  A      IV   +  H   +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   +K  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 166 DLKPENLLI---DQQGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV   +  H   +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 187 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 241
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 297
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWF 318

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
            L+ K+L  +P  R+T  ++ +  W     K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
            L+ K+L  +P  R+T  ++ +  W     K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 17/275 (6%)
Query: 49  PSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A      IV
Sbjct: 93  RILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
              +  H   +++RDLKPEN L     +   ++  DFG +   R   +   + G+P  +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEALA 206
Query: 228 PE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE +L + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F        S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFS 262
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWL 316
            + KDL++ +L  D  +R         ++  H W 
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 63
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
            L+ K+L  +P  R+T  ++ +  W     K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 133/280 (47%), Gaps = 18/280 (6%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G  G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW----LQNAKKAPNVS 326
            L+ K+L  +P  R+T  ++ +  W    L+   K P V+
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 278

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 127/261 (48%), Gaps = 16/261 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + LG G FG   L      G  +A K + K+K+     IE    E +I++ +   P +V 
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 98
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L+ +++D+S +++VME   GGE+F  +   G + E  A      IV   +  H   +++R
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE-VLKRNYGPEVD 240
           DLKPEN L     +   ++  DFG +   R   +   + G+P Y+APE +L + Y   VD
Sbjct: 159 DLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 213
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
            W+ GV++Y +  G PPF+A+    + + I+   + F        S + KDL++ +L  D
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 269
Query: 301 PKQRL-----TAEEVLEHPWL 316
             +R         ++  H W 
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWF 290

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
            L+ K+L  +P  R+T  ++ +  W     K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
            L+ K+L  +P  R+T  ++ +  W     K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 128/265 (48%), Gaps = 14/265 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 63
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW 315
            L+ K+L  +P  R+T  ++ +  W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 128/265 (48%), Gaps = 14/265 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I K L  
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML-N 62
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 123 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPW 315
            L+ K+L  +P  R+T  ++ +  W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 143/278 (51%), Gaps = 13/278 (4%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y    ++G+G  G  Y   DV  G++ A   I +  L+     E +  E+ +M+   K+P
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 78
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV+  D+Y     + +VME   GG L D +V      E   AAV +  ++ ++  H   
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
           V+HR++K +N L         +K  DFG      P + + + +VG+PY+MAPEV+ R  Y
Sbjct: 138 VIHRNIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 194
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GP+VD+WS G++   ++ G PP+  E        I  +     ++P  K+S   +D + +
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNR 253
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
            L  D ++R +A+E+++H +L+ AK  P  SL   + A
Sbjct: 254 CLEMDVEKRGSAKELIQHQFLKIAK--PLSSLTPLIAA 289

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 129/253 (50%), Gaps = 16/253 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G F   +  +D +  E FA K + K  L      E +  E+ I + L  H ++V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 87
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
             +ED+  V +V+ELC    L +    R   TE  A   ++ IV   Q  H   V+HRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNYGPEVDV 241
           K  N LF N  E   +K  DFGL+      GE+   + G+P Y+APEVL K+ +  EVDV
Sbjct: 148 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--PK-VSENAKDLVKKMLN 298
           WS G I+Y LL G PPF  ET       +  + +  K++ +  PK ++  A  L++KML 
Sbjct: 205 WSIGCIMYTLLVGKPPF--ET-----SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 257
Query: 299 PDPKQRLTAEEVL 311
            DP  R T  E+L
Sbjct: 258 TDPTARPTINELL 270

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 16/277 (5%)
Query: 50  SGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
           S   + ID ++  R LG+G FG   L      G+ +A K + K  +    D+E    E +
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           I+     HP +  L   ++    +  VME   GG+L   I     + E  A      I+ 
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMA 227
            +   H++G+++RDLK +N L  ++      K  DFG+       G       G+P Y+A
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHC---KLADFGMCKEGICNGVTTATFCGTPDYIA 192
Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE+L+   YGP VD W+ GV+LY +LCG  PF AE E  + +AI+   + +    W  + 
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LH 248
Query: 287 ENAKDLVKKMLNPDPKQRLTA------EEVLEHPWLQ 317
           E+A  ++K  +  +P  RL +        +L HP+ +
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 129/253 (50%), Gaps = 16/253 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G F   +  +D +  E FA K + K  L      E +  E+ I + L  H ++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 83
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
             +ED+  V +V+ELC    L +    R   TE  A   ++ IV   Q  H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNYGPEVDV 241
           K  N LF N  E   +K  DFGL+      GE+   + G+P Y+APEVL K+ +  EVDV
Sbjct: 144 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--PK-VSENAKDLVKKMLN 298
           WS G I+Y LL G PPF  ET       +  + +  K++ +  PK ++  A  L++KML 
Sbjct: 201 WSIGCIMYTLLVGKPPF--ET-----SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 253
Query: 299 PDPKQRLTAEEVL 311
            DP  R T  E+L
Sbjct: 254 TDPTARPTINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 129/253 (50%), Gaps = 16/253 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G F   +  +D +  E FA K + K  L      E +  E+ I + L  H ++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 83
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
             +ED+  V +V+ELC    L +    R   TE  A   ++ IV   Q  H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNYGPEVDV 241
           K  N LF N  E   +K  DFGL+      GE+   + G+P Y+APEVL K+ +  EVDV
Sbjct: 144 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--PK-VSENAKDLVKKMLN 298
           WS G I+Y LL G PPF  ET       +  + +  K++ +  PK ++  A  L++KML 
Sbjct: 201 WSIGCIMYTLLVGKPPF--ET-----SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 253
Query: 299 PDPKQRLTAEEVL 311
            DP  R T  E+L
Sbjct: 254 TDPTARPTINELL 266

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 129/253 (50%), Gaps = 16/253 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G F   +  +D +  E FA K + K  L      E +  E+ I + L  H ++V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 105
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
             +ED+  V +V+ELC    L +    R   TE  A   ++ IV   Q  H   V+HRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNYGPEVDV 241
           K  N LF N  E   +K  DFGL+      GE+   + G+P Y+APEVL K+ +  EVDV
Sbjct: 166 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--PK-VSENAKDLVKKMLN 298
           WS G I+Y LL G PPF  ET       +  + +  K++ +  PK ++  A  L++KML 
Sbjct: 223 WSIGCIMYTLLVGKPPF--ET-----SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 275
Query: 299 PDPKQRLTAEEVL 311
            DP  R T  E+L
Sbjct: 276 TDPTARPTINELL 288

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 129/253 (50%), Gaps = 16/253 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G F   +  +D +  E FA K + K  L      E +  E+ I + L  H ++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 81
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
             +ED+  V +V+ELC    L +    R   TE  A   ++ IV   Q  H   V+HRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNYGPEVDV 241
           K  N LF N  E   +K  DFGL+      GE+   + G+P Y+APEVL K+ +  EVDV
Sbjct: 142 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--PK-VSENAKDLVKKMLN 298
           WS G I+Y LL G PPF  ET       +  + +  K++ +  PK ++  A  L++KML 
Sbjct: 199 WSIGCIMYTLLVGKPPF--ET-----SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 251
Query: 299 PDPKQRLTAEEVL 311
            DP  R T  E+L
Sbjct: 252 TDPTARPTINELL 264

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 128/271 (47%), Gaps = 14/271 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPK 115
           D+DL + LG G +G   L  +    E  A K +  K+   AVD  E++++E+ I   L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINAML-N 63
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           H N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK 232
            G+ HRD+KPEN L     E   LK  DFGL+  FR   +    N++ G+  Y+APE+LK
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 233 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           R   +   VDVWS G++L  +L G  P W +      +           +PW K+     
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
            L+ K+L  +P  R+T  ++ +  W     K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 129/253 (50%), Gaps = 16/253 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G F   +  +D +  E FA K + K  L      E +  E+ I + L  H ++V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 107
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
             +ED+  V +V+ELC    L +    R   TE  A   ++ IV   Q  H   V+HRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL-KRNYGPEVDV 241
           K  N LF N  E   +K  DFGL+      GE+   + G+P Y+APEVL K+ +  EVDV
Sbjct: 168 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--PK-VSENAKDLVKKMLN 298
           WS G I+Y LL G PPF  ET       +  + +  K++ +  PK ++  A  L++KML 
Sbjct: 225 WSIGCIMYTLLVGKPPF--ET-----SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277
Query: 299 PDPKQRLTAEEVL 311
            DP  R T  E+L
Sbjct: 278 TDPTARPTINELL 290

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 132/285 (46%), Gaps = 38/285 (13%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G +GV Y   + N GE FA K I  +K    +    +R E+ I+K L KH NIV L
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKEL-KHSNIVKL 65
Query: 123 KDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
            D       + +V E  +    +L D  V  G      A + +  ++  +  CH++ V+H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRNYGP 237
           RDLKP+N L   + E   LK  DFGL+  F  P  ++   V + +Y AP+VL   + Y  
Sbjct: 124 RDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK------- 290
            +D+WS G I   ++ G P F   +E      I R +       WP V+E  K       
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 291 ------------------DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                             DL+ KML  DP QR+TA++ LEH + +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 132/285 (46%), Gaps = 38/285 (13%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G +GV Y   + N GE FA K I  +K    +    +R E+ I+K L KH NIV L
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKEL-KHSNIVKL 65
Query: 123 KDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
            D       + +V E  +    +L D  V  G      A + +  ++  +  CH++ V+H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRNYGP 237
           RDLKP+N L   + E   LK  DFGL+  F  P  ++   V + +Y AP+VL   + Y  
Sbjct: 124 RDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK------- 290
            +D+WS G I   ++ G P F   +E      I R +       WP V+E  K       
Sbjct: 181 TIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 291 ------------------DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                             DL+ KML  DP QR+TA++ LEH + +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 132/285 (46%), Gaps = 38/285 (13%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G G +GV Y   + N GE FA K I  +K    +    +R E+ I+K L KH NIV L
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKEL-KHSNIVKL 65
Query: 123 KDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
            D       + +V E  +    +L D  V  G      A + +  ++  +  CH++ V+H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRNYGP 237
           RDLKP+N L   + E   LK  DFGL+  F  P  ++   + + +Y AP+VL   + Y  
Sbjct: 124 RDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK------- 290
            +D+WS G I   ++ G P F   +E      I R +       WP V+E  K       
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 291 ------------------DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                             DL+ KML  DP QR+TA++ LEH + +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 24/280 (8%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+DL R +GRG +    L         +A K + K+ +    DI+ V+ E  + +    H
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++ +S +  V+E   GG+L   +  +    E  A      I   +   HE+
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 140
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N L  ++     +K  D+G+     RPG+  +   G+P Y+APE+L+  +
Sbjct: 141 GIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 197
Query: 235 YGPEVDVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVIDFKRDPWPKV 285
           YG  VD W+ GV+++ ++ G  PF            TE  + Q I+   I   R     +
Sbjct: 198 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SM 253
Query: 286 SENAKDLVKKMLNPDPKQRLTA------EEVLEHPWLQNA 319
           S  A  ++K  LN DPK+RL         ++  HP+ +N 
Sbjct: 254 SVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNV 293

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 24/280 (8%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+DL R +GRG +    L         +A K + K+ +    DI+ V+ E  + +    H
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++ +S +  V+E   GG+L   +  +    E  A      I   +   HE+
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 125
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N L  ++     +K  D+G+     RPG+  +   G+P Y+APE+L+  +
Sbjct: 126 GIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 182
Query: 235 YGPEVDVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVIDFKRDPWPKV 285
           YG  VD W+ GV+++ ++ G  PF            TE  + Q I+   I   R     +
Sbjct: 183 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SL 238
Query: 286 SENAKDLVKKMLNPDPKQRLTAE------EVLEHPWLQNA 319
           S  A  ++K  LN DPK+RL         ++  HP+ +N 
Sbjct: 239 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 278

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 24/280 (8%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+DL R +GRG +    L         +A K + K+ +    DI+ V+ E  + +    H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++ +S +  V+E   GG+L   +  +    E  A      I   +   HE+
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N L  ++     +K  D+G+     RPG+  +   G+P Y+APE+L+  +
Sbjct: 130 GIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 186
Query: 235 YGPEVDVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVIDFKRDPWPKV 285
           YG  VD W+ GV+++ ++ G  PF            TE  + Q I+   I   R     +
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SL 242
Query: 286 SENAKDLVKKMLNPDPKQRLTAE------EVLEHPWLQNA 319
           S  A  ++K  LN DPK+RL         ++  HP+ +N 
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 133/280 (47%), Gaps = 24/280 (8%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+DL R +GRG +    L         +A + + K+ +    DI+ V+ E  + +    H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++ +S +  V+E   GG+L   +  +    E  A      I   +   HE+
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N L  ++     +K  D+G+     RPG+  +   G+P Y+APE+L+  +
Sbjct: 173 GIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 229
Query: 235 YGPEVDVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVIDFKRDPWPKV 285
           YG  VD W+ GV+++ ++ G  PF            TE  + Q I+   I   R     +
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SL 285
Query: 286 SENAKDLVKKMLNPDPKQRLTAE------EVLEHPWLQNA 319
           S  A  ++K  LN DPK+RL         ++  HP+ +N 
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 93/314 (29%), Positives = 146/314 (46%), Gaps = 26/314 (8%)
Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-----VRREV 107
           + S  Y     LG G FG  +   D    ++   K I K+K+     IED     V  E+
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGG-ELFDRIVARGHYTERAAAAVMKTI 166
            I+  + +H NI+ + D +E+     +VME    G +LF  I       E  A+ + + +
Sbjct: 81  AILSRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
           V  V     + ++HRD+K EN + A   E   +K IDFG + +   G+ F    G+  Y 
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196
Query: 227 APEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           APEVL  N   GPE+++WS GV LY L+    PF  E E+ V  AI          P   
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF-CELEETVEAAI---------HPPYL 246
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMN-- 342
           VS+    LV  +L P P++R T E+++  PW+       + +  E  +    +  V++  
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAA 306
Query: 343 --KLKKRALQVVAE 354
             ++  R+L  VA+
Sbjct: 307 SLEMGNRSLSDVAQ 320

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 136/293 (46%), Gaps = 42/293 (14%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY+L   +G G   V          EK A K I+ +K +T++D  ++ +E+Q M     H
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD--ELLKEIQAMSQC-HH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD---RIVARGHYT-----ERAAAAVMKTIVE 168
           PNIVS   ++     + +VM+L  GG + D    IVA+G +      E   A +++ ++E
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE------IVGS 222
            ++  H+ G +HRD+K  N L     E   ++  DFG+S F   G            VG+
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 223 PYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
           P +MAPEV++  R Y  + D+WS G+    L  G  P+       V       ++  + D
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQND 243
Query: 281 PWPKVSENAKD-------------LVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320
           P P +    +D             ++   L  DP++R TA E+L H + Q AK
Sbjct: 244 P-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 115 K-HPNIVSLKDTYE-DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E  DS V I+  +    +LFD I  RG   E  A +    ++E V+ 
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 185
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 235
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 236 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 186
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 236
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 228
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 278
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 279 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSXEC 231
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 220
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 270
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 186
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 236
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 200
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 250
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 251 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 186
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 236
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 185
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 235
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 236 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 201
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 251
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 252 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 228
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSXEC 278
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 279 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 213
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 263
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 264 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 136/293 (46%), Gaps = 42/293 (14%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY+L   +G G   V          EK A K I+ +K +T++D  ++ +E+Q M     H
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD--ELLKEIQAMSQC-HH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD---RIVARGHYT-----ERAAAAVMKTIVE 168
           PNIVS   ++     + +VM+L  GG + D    IVA+G +      E   A +++ ++E
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE------IVGS 222
            ++  H+ G +HRD+K  N L     E   ++  DFG+S F   G            VG+
Sbjct: 128 GLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 223 PYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
           P +MAPEV++  R Y  + D+WS G+    L  G  P+       V       ++  + D
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQND 238
Query: 281 PWPKVSENAKD-------------LVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320
           P P +    +D             ++   L  DP++R TA E+L H + Q AK
Sbjct: 239 P-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 233
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSXEC 283
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 284 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 313

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 201
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSXEC 251
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 252 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 200
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSXEC 250
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 251 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  115 bits (287), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 231
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  115 bits (287), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 208
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSXEC 258
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 259 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 288

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  115 bits (287), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 184
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSEC 234
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 235 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 264

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 201
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E      IIR  + F++    +VS   
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSXEC 251
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 252 QHLIRWCLALRPXDRPTFEEIQNHPWMQDV 281

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 138/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +        V    ++RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------PVKKNKIKREIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|1S6I|A Chain A, Ca2+-Regulatory Region (Cld) From Soybean Calcium-Dependent Protein Kinase-Alpha (Cdpk) In The Presence Of Ca2+ And The Junction Domain (Jd) Length = 188

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 62/164 (37%), Positives = 100/164 (60%), Gaps = 4/164 (2%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           AE LS EE+ GLKE F+M+DT+  G I               + E++++ LM+AAD+D  
Sbjct: 1   AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKS 60
Query: 413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV- 471
           G+++YGEF+A +VHL K+  +E+L  AFS+FD++ SG+I ++E++ A     D   +D+ 
Sbjct: 61  GTIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQACK---DFGLDDIH 117
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFN 515
           I+ ++ ++D D DG+I Y EFA MM+         R+  R+  N
Sbjct: 118 IDDMIKEIDQDNDGQIDYGEFAAMMRKRKGNGGIGRRTMRKTLN 161

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 140/260 (53%), Gaps = 14/260 (5%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           +++G G FG   L     +G ++  K I+  ++ ++ + E+ RREV ++ ++ KHPNIV 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-KHPNIVQ 87
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
            ++++E++ +++IVM+ CEGG+LF RI A+    + E         I   ++  H++ ++
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKIL 147
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGP 237
           HRD+K +N +F  K  +  L   DFG++ V     E     +G+PYY++PE+ + + Y  
Sbjct: 148 HRDIKSQN-IFLTKDGTVQLG--DFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVSENAKDLVKKM 296
           + D+W+ G +LY L      F    E G  + ++  +I     P     S + + LV ++
Sbjct: 205 KSDIWALGCVLYELCTLKHAF----EAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 297 LNPDPKQRLTAEEVLEHPWL 316
              +P+ R +   +LE  ++
Sbjct: 261 FKRNPRDRPSVNSILEKGFI 280

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 138/274 (50%), Gaps = 20/274 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DYD+ + +GRG FG   L     + + +A K +SK ++    D      E  IM      
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANS 134
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++DD  +++VME   GG+L + +++     E+ A      +V  +   H  
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKRN 234
           G++HRD+KP+N L     +   LK  DFG  +          +  VG+P Y++PEVLK  
Sbjct: 194 GLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQ 250
Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
                YG E D WS GV L+ +L G  PF+A++  G    I+  ++ + F  D   ++S+
Sbjct: 251 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPED--AEISK 308
Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQN 318
           +AK+L+   L  D + RL     EE+ +HP+ +N
Sbjct: 309 HAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKN 341

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 132/261 (50%), Gaps = 10/261 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++L + LG+G FG  +L       + FA K++ K  +    D+E    E +++    +H
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 78
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  +  T++    +  VME   GG+L   I +   +    A      I+  +Q  H +
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 138
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEV-LKRN 234
           G+++RDLK +N L     +   +K  DFG+      G+ + NE  G+P Y+APE+ L + 
Sbjct: 139 GIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK 195
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           Y   VD WS GV+LY +L G  PF  + E+ +  +I      + R  W  + + AKDL+ 
Sbjct: 196 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--LEKEAKDLLV 251
Query: 295 KMLNPDPKQRLTAE-EVLEHP 314
           K+   +P++RL    ++ +HP
Sbjct: 252 KLFVREPEKRLGVRGDIRQHP 272

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 98/337 (29%), Positives = 148/337 (43%), Gaps = 64/337 (18%)
Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKK-----KLRTAVDIEDVRREV 107
           +IS D+ L   LG G +GV    T    GE  A K I         LRT        RE+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REI 60
Query: 108 QIMKHLPKHPNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV 162
           +I+KH  KH NI+++      D++E+ + V+I+ EL +      R+++    ++      
Sbjct: 61  KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYF 117
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---------RPG 213
           +   +  V+V H   V+HRDLKP N L  +  +   LK  DFGL+              G
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDFGLARIIDESAADNSEPTG 174
Query: 214 EQ--FNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAE-------- 261
           +Q    E V + +Y APEV+     Y   +DVWS G IL  L    P F           
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 262 ----------------TEQGVAQAIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDP 301
                            E   A+  I+S+  +   P    +P+V+    DL+++ML  DP
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 302 KQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQF 338
            +R+TA+E LEHP+LQ      +   GE +     +F
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 98/337 (29%), Positives = 148/337 (43%), Gaps = 64/337 (18%)
Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKK-----KLRTAVDIEDVRREV 107
           +IS D+ L   LG G +GV    T    GE  A K I         LRT        RE+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REI 60
Query: 108 QIMKHLPKHPNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV 162
           +I+KH  KH NI+++      D++E+ + V+I+ EL +      R+++    ++      
Sbjct: 61  KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYF 117
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---------RPG 213
           +   +  V+V H   V+HRDLKP N L  +  +   LK  DFGL+              G
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDFGLARIIDESAADNSEPTG 174
Query: 214 EQ--FNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAE-------- 261
           +Q    E V + +Y APEV+     Y   +DVWS G IL  L    P F           
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 262 ----------------TEQGVAQAIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDP 301
                            E   A+  I+S+  +   P    +P+V+    DL+++ML  DP
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 302 KQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQF 338
            +R+TA+E LEHP+LQ      +   GE +     +F
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 214
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E    Q   R           +VS   
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ----------RVSSEC 264
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 265 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 214
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E    Q   R           +VS   
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ----------RVSSEC 264
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 265 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 213
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E    Q   R           +VS   
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ----------RVSSEC 263
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 264 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E    Q   R           +VS   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ----------RVSSEC 231
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 213
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E    Q   R           +VS   
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ----------RVSSEC 263
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 264 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 213
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E    Q   R           +VS   
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ----------RVSXEC 263
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 264 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 214
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E    Q   R           +VS   
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ----------RVSXEC 264
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 265 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLP 114
           Y +G  LG G FG  Y    V++    A K + K ++    ++ +  R   EV ++K + 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 115 K-HPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
                ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+ 
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 173 CHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
           CH  GV+HRD+K EN L   N+ E   LK IDFG     +    + +  G+  Y  PE +
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 214
Query: 232 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +  R +G    VWS G++LY ++CG  PF  + E    Q   R           +VS   
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ----------RVSXEC 264
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           + L++  L   P  R T EE+  HPW+Q+ 
Sbjct: 265 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 98/337 (29%), Positives = 148/337 (43%), Gaps = 64/337 (18%)
Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKK-----KLRTAVDIEDVRREV 107
           +IS D+ L   LG G +GV    T    GE  A K I         LRT        RE+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REI 60
Query: 108 QIMKHLPKHPNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV 162
           +I+KH  KH NI+++      D++E+ + V+I+ EL +      R+++    ++      
Sbjct: 61  KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYF 117
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---------RPG 213
           +   +  V+V H   V+HRDLKP N L  +  +   LK  DFGL+              G
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDFGLARIIDESAADNSEPTG 174
Query: 214 EQ--FNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAE-------- 261
           +Q    E V + +Y APEV+     Y   +DVWS G IL  L    P F           
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 262 ----------------TEQGVAQAIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDP 301
                            E   A+  I+S+  +   P    +P+V+    DL+++ML  DP
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 302 KQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQF 338
            +R+TA+E LEHP+LQ      +   GE +     +F
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 22/271 (8%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED---VRREVQIMKHL 113
           +Y LG  LG+G FG  +    + +  + A K I + ++     + D      EV ++  +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 114 PK---HPNIVSLKDTYEDDSAVHIVME-LCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
                HP ++ L D +E      +V+E      +LFD I  +G   E  +      +V  
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q CH +GV+HRD+K EN L   ++  +  K IDFG        E + +  G+  Y  PE
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSGALLH-DEPYTDFDGTRVYSPPE 208
Query: 230 VLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
            + R+  +     VWS G++LY ++CG  PF  +      Q I+ + + F       VS 
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPA----HVSP 258
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           +   L+++ L P P  R + EE+L  PW+Q 
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 133/268 (49%), Gaps = 16/268 (5%)
Query: 46  LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
           L+   G +   ++ + +++GRG+F   Y    + +G   A K +    L  A    D  +
Sbjct: 22  LRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK 81
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
           E+ ++K L  HPN++    ++ +D+ ++IV+EL + G+L  R++   H+ ++      +T
Sbjct: 82  EIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDL-SRMIK--HFKKQKRLIPERT 137
Query: 166 IVE-VVQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFN 217
           + +  VQ+C      H + VMHRD+KP N        +  +K  D GL  FF       +
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAH 194
Query: 218 EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276
            +VG+PYYM+PE +  N Y  + D+WS G +LY +     PF+ +     +        D
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254
Query: 277 FKRDPWPKVSENAKDLVKKMLNPDPKQR 304
           +   P    SE  + LV   +NPDP++R
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 138/277 (49%), Gaps = 17/277 (6%)
Query: 51  GQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
            +D++ D +++ R +G+G FG   +    +  + +A K ++K+K     ++ +V +E+QI
Sbjct: 9   NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI 68
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           M+ L +HP +V+L  +++D+  + +V++L  GG+L   +    H+ E      +  +V  
Sbjct: 69  MQGL-EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +     Q ++HRD+KP+N L     E   +   DF ++       Q   + G+  YMAPE
Sbjct: 128 LDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPE 184
Query: 230 VLKRN----YGPEVDVWSAGVILYILLCGVPPFW---AETEQGVAQAIIRSVIDFKRDPW 282
           +        Y   VD WS GV  Y LL G  P+    + + + +      +V+ +    W
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP-SAW 243
Query: 283 PKVSENAKDLVKKMLNPDPKQRLTA-EEVLEHPWLQN 318
              S+    L+KK+L P+P QR +   +V   P++ +
Sbjct: 244 ---SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 130/269 (48%), Gaps = 22/269 (8%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G +G+ Y   D++N  + A K I ++  R +   + +  E+ + KHL KH NIV   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHL-KHKNIVQYL 85
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHY-----TERAAAAVMKTIVEVVQVCHEQGV 178
            ++ ++  + I ME   GG L    + R  +      E+      K I+E ++  H+  +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-IVGSPYYMAPEVL---KRN 234
           +HRD+K +N L      S  LK  DFG S          E   G+  YMAPE++    R 
Sbjct: 144 VHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP-WPK-VSENAKDL 292
           YG   D+WS G  +  +  G PPF+   E G  QA +  V  FK  P  P+ +S  AK  
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFY---ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           + K   PDP +R  A ++L   +L+ + K
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 139/278 (50%), Gaps = 20/278 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ + +GRG FG   L    +  + +A K +SK ++    D      E  IM      
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANS 133
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++DD  +++VME   GG+L + +++     E+ A      +V  +   H  
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGE-QFNEIVGSPYYMAPEVLKRN 234
           G +HRD+KP+N L     +S  LK  DFG  +   + G  + +  VG+P Y++PEVLK  
Sbjct: 193 GFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
                YG E D WS GV LY +L G  PF+A++  G    I+  ++ + F  D    +S+
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISK 307
Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNAKKA 322
            AK+L+   L  D + RL     EE+  H + +N + A
Sbjct: 308 EAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWA 344

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 139/278 (50%), Gaps = 20/278 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ + +GRG FG   L    +  + +A K +SK ++    D      E  IM      
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANS 133
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++DD  +++VME   GG+L + +++     E+ A      +V  +   H  
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGE-QFNEIVGSPYYMAPEVLKRN 234
           G +HRD+KP+N L     +S  LK  DFG  +   + G  + +  VG+P Y++PEVLK  
Sbjct: 193 GFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
                YG E D WS GV LY +L G  PF+A++  G    I+  ++ + F  D    +S+
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISK 307
Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNAKKA 322
            AK+L+   L  D + RL     EE+  H + +N + A
Sbjct: 308 EAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWA 344

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 139/278 (50%), Gaps = 20/278 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ + +GRG FG   L    +  + +A K +SK ++    D      E  IM      
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANS 128
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++DD  +++VME   GG+L + +++     E+ A      +V  +   H  
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGE-QFNEIVGSPYYMAPEVLKRN 234
           G +HRD+KP+N L     +S  LK  DFG  +   + G  + +  VG+P Y++PEVLK  
Sbjct: 188 GFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
                YG E D WS GV LY +L G  PF+A++  G    I+  ++ + F  D    +S+
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISK 302
Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNAKKA 322
            AK+L+   L  D + RL     EE+  H + +N + A
Sbjct: 303 EAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWA 339

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 130/261 (49%), Gaps = 10/261 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ L + LG+G FG  +L       + FA K++ K  +    D+E    E +++    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  +  T++    +  VME   GG+L   I +   +    A      I+  +Q  H +
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEV-LKRN 234
           G+++RDLK +N L     +   +K  DFG+      G+ + N   G+P Y+APE+ L + 
Sbjct: 138 GIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK 194
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           Y   VD WS GV+LY +L G  PF  + E+ +  +I      + R  W  + + AKDL+ 
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--LEKEAKDLLV 250
Query: 295 KMLNPDPKQRLTAE-EVLEHP 314
           K+   +P++RL    ++ +HP
Sbjct: 251 KLFVREPEKRLGVRGDIRQHP 271

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 137/272 (50%), Gaps = 25/272 (9%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +D+  +LG G +G  Y       G+  A K +  +      D++++ +E+ IM+     P
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQC-DSP 84
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQ 176
           ++V    +Y  ++ + IVME C  G + D I  R    TE   A ++++ ++ ++  H  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKR-N 234
             +HRD+K  N L   +  +   K  DFG++        + N ++G+P++MAPEV++   
Sbjct: 145 RKIHRDIKAGNILLNTEGHA---KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV------SEN 288
           Y    D+WS G+    +  G PP+ A+         +R++     +P P        S+N
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPY-ADIHP------MRAIFMIPTNPPPTFRKPELWSDN 254
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320
             D VK+ L   P+QR TA ++L+HP++++AK
Sbjct: 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 128/265 (48%), Gaps = 22/265 (8%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G +G+ Y   D++N  + A K I ++  R +   + +  E+ + KHL KH NIV   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHL-KHKNIVQYL 71
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHY-----TERAAAAVMKTIVEVVQVCHEQGV 178
            ++ ++  + I ME   GG L    + R  +      E+      K I+E ++  H+  +
Sbjct: 72  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-IVGSPYYMAPEVL---KRN 234
           +HRD+K +N L      S  LK  DFG S          E   G+  YMAPE++    R 
Sbjct: 130 VHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP-WPK-VSENAKDL 292
           YG   D+WS G  +  +  G PPF+   E G  QA +  V  FK  P  P+ +S  AK  
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPFY---ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 244
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQ 317
           + K   PDP +R  A ++L   +L+
Sbjct: 245 ILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 121/251 (48%), Gaps = 9/251 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++    LG+G FG   L       E +A K + K  +    D+E    E +++  L K 
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  L   ++    ++ VME   GG+L   I   G + E  A      I   +   H++
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N +  ++     +K  DFG+       G    E  G+P Y+APE++  + 
Sbjct: 140 GIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP 196
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W+ GV+LY +L G PPF  E E  + Q+I+   + + +     +S+ A  + K
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK 252
Query: 295 KMLNPDPKQRL 305
            ++   P +RL
Sbjct: 253 GLMTKHPAKRL 263

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 118/257 (45%), Gaps = 15/257 (5%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           RE+G G FG  Y   DV N E  A K +S    ++    +D+ +EV+ ++ L +HPN + 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
            +  Y  +    +VME C G       V +    E   AAV    ++ +   H   ++HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNYGP 237
           D+K  N L +   E   +K  DFG +    P    N  VG+PY+MAPEV+    +  Y  
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-VIDFKRDPWPKVSENAKDLVKKM 296
           +VDVWS G+    L    PP +          I ++     +   W   SE  ++ V   
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 297 LNPDPKQRLTAEEVLEH 313
           L   P+ R T+E +L+H
Sbjct: 251 LQKIPQDRPTSEVLLKH 267

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 118/257 (45%), Gaps = 15/257 (5%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           RE+G G FG  Y   DV N E  A K +S    ++    +D+ +EV+ ++ L +HPN + 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 118
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
            +  Y  +    +VME C G       V +    E   AAV    ++ +   H   ++HR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNYGP 237
           D+K  N L +   E   +K  DFG +    P    N  VG+PY+MAPEV+    +  Y  
Sbjct: 179 DVKAGNILLS---EPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDG 232
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-VIDFKRDPWPKVSENAKDLVKKM 296
           +VDVWS G+    L    PP +          I ++     +   W   SE  ++ V   
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 289
Query: 297 LNPDPKQRLTAEEVLEH 313
           L   P+ R T+E +L+H
Sbjct: 290 LQKIPQDRPTSEVLLKH 306

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 9/255 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+   + +G+G FG   L         +A K + KK +    + + +  E  ++    KH
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L  +++    ++ V++   GGELF  +     + E  A      I   +   H  
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL-KRN 234
            +++RDLKPEN L  ++     +   DFGL           +   G+P Y+APEVL K+ 
Sbjct: 159 NIVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           Y   VD W  G +LY +L G+PPF++     +   I+   +  K    P ++ +A+ L++
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLE 271
Query: 295 KMLNPDPKQRLTAEE 309
            +L  D  +RL A++
Sbjct: 272 GLLQKDRTKRLGAKD 286

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 133/289 (46%), Gaps = 18/289 (6%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +++  ELG G FG  Y   +       A K I  K   +  ++ED   E+ I+     HP
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHP 94
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHE 175
           NIV L D +  ++ + I++E C GG + D ++       TE     V K  ++ +   H+
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL--- 231
             ++HRDLK  N LF    +   +K  DFG+S    R  ++ +  +G+PY+MAPEV+   
Sbjct: 154 NKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 232 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
               R Y  + DVWS G+ L  +    PP        V   I +S       P  + S N
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSN 269
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
            KD +KK L  +   R T  ++L+HP++      P   L    KA + +
Sbjct: 270 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTE 318

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 133/289 (46%), Gaps = 18/289 (6%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +++  ELG G FG  Y   +       A K I  K   +  ++ED   E+ I+     HP
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHP 94
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHE 175
           NIV L D +  ++ + I++E C GG + D ++       TE     V K  ++ +   H+
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL--- 231
             ++HRDLK  N LF    +   +K  DFG+S    R  ++ +  +G+PY+MAPEV+   
Sbjct: 154 NKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 232 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
               R Y  + DVWS G+ L  +    PP        V   I +S       P  + S N
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSN 269
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
            KD +KK L  +   R T  ++L+HP++      P   L    KA + +
Sbjct: 270 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTE 318

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 133/289 (46%), Gaps = 18/289 (6%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +++  ELG G FG  Y   +       A K I  K   +  ++ED   E+ I+     HP
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHP 94
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHE 175
           NIV L D +  ++ + I++E C GG + D ++       TE     V K  ++ +   H+
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL--- 231
             ++HRDLK  N LF    +   +K  DFG+S    R  ++ +  +G+PY+MAPEV+   
Sbjct: 154 NKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 232 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
               R Y  + DVWS G+ L  +    PP        V   I +S       P  + S N
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSN 269
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
            KD +KK L  +   R T  ++L+HP++      P   L    KA + +
Sbjct: 270 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTE 318

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 96/378 (25%), Positives = 162/378 (42%), Gaps = 90/378 (23%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+L ++LG+G +G+ +   D   GE  A K I     + + D +   RE+ I+  L  H 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHE 69
Query: 118 NIVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAA-VMKTIVEVVQVCH 174
           NIV+L +    ++D  V++V +  E        V R +  E      V+  +++V++  H
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDL---HAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---------------RPGEQFN-- 217
             G++HRD+KP N L         +K  DFGLS  F                  E F+  
Sbjct: 127 SGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 218 -----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 270
                + V + +Y APE+L     Y   +D+WS G IL  +LCG P F   +     + I
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 271 IRSVIDF-------------------------------KRDPWPK-------------VS 286
           I  VIDF                               KRD + K              +
Sbjct: 244 I-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL---QNAKKAPN------VSLGETVKARLKQ 337
           E A DL+ K+L  +P +R++A + L+HP++    N  + PN      + + + VK  +  
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDD 362
Query: 338 FS--VMNKLKKRALQVVA 353
           +   V +++ +R  ++++
Sbjct: 363 YRNLVYSEISRRKRELIS 380

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLXGG 86
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 144 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 201
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276
           ++Y   +D+WS G +   ++    PF+   +       I  V+                 
Sbjct: 202 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 261
Query: 277 ---------FKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 262 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321
Query: 319 AKKAPN 324
            + A N
Sbjct: 322 VRAAEN 327

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLXGG 85
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276
           ++Y   +D+WS G +   ++    PF+   +       I  V+                 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 277 ---------FKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 261 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 319 AKKAPN 324
            + A N
Sbjct: 321 VRAAEN 326

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 144/306 (47%), Gaps = 49/306 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 53  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLXGG 106
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 163
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 164 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 221
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--------------GVAQAIIRSVIDF- 277
           ++Y   +D+WS G +   ++    PF+   +               G+   + +  I+  
Sbjct: 222 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELD 281
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 282 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341
Query: 319 AKKAPN 324
            + A N
Sbjct: 342 VRAAEN 347

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLXGG 85
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276
           ++Y   +D+WS G +   ++    PF+   +       I  V+                 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 277 ---------FKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 261 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 319 AKKAPN 324
            + A N
Sbjct: 321 VRAAEN 326

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLXGG 85
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276
           ++Y   +D+WS G +   ++    PF+   +       I  V+                 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 277 ---------FKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 261 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 319 AKKAPN 324
            + A N
Sbjct: 321 VRAAEN 326

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLCGG 86
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 144 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 201
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276
           ++Y   +D+WS G +   ++    PF+   +       I  V+                 
Sbjct: 202 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 261
Query: 277 ---------FKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 262 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321
Query: 319 AKKAPN 324
            + A N
Sbjct: 322 VRAAEN 327

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 34  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLCGG 87
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 144
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 145 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 202
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276
           ++Y   +D+WS G +   ++    PF+   +       I  V+                 
Sbjct: 203 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 262
Query: 277 ---------FKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 263 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322
Query: 319 AKKAPN 324
            + A N
Sbjct: 323 VRAAEN 328

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLMGG 85
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276
           ++Y   +D+WS G +   ++    PF+   +       I  V+                 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 277 ---------FKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 261 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 319 AKKAPN 324
            + A N
Sbjct: 321 VRAAEN 326

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 119/252 (47%), Gaps = 15/252 (5%)
Query: 51  GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
           G+ I+  Y +  +LG G     YL  D     K A K+I          ++   REV   
Sbjct: 6   GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
             L  H NIVS+ D  E+D   ++VME  EG  L + I + G  +   A      I++ +
Sbjct: 66  SQL-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAP 228
           +  H+  ++HRD+KP+N L  + K    LK  DFG++         Q N ++G+  Y +P
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNK---TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 229 EVLKRNYGPE-VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           E  K     E  D++S G++LY +L G PPF  ET   +A       I   +D  P V+ 
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-------IKHIQDSVPNVTT 234
Query: 288 NA-KDLVKKMLN 298
           +  KD+ + + N
Sbjct: 235 DVRKDIPQSLSN 246

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLCGG 85
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276
           ++Y   +D+WS G +   ++    PF+   +       I  V+                 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 277 ---------FKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 261 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 319 AKKAPN 324
            + A N
Sbjct: 321 VRAAEN 326

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 78  VNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLPK-HPNIVSLKDTYEDDSAVH 133
           V++    A K + K ++    ++ +  R   EV ++K +      ++ L D +E   +  
Sbjct: 73  VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 132
Query: 134 IVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLF-A 191
           +++E  E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   
Sbjct: 133 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 192
Query: 192 NKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILY 249
           N+ E   LK IDFG     +    + +  G+  Y  PE ++  R +G    VWS G++LY
Sbjct: 193 NRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLY 248
Query: 250 ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEE 309
            ++CG  PF  + E      IIR  + F++    +VS   + L++  L   P  R T EE
Sbjct: 249 DMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEE 298
Query: 310 VLEHPWLQNA 319
           +  HPW+Q+ 
Sbjct: 299 IQNHPWMQDV 308

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 138/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK A K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N L  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVLIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 19/271 (7%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEK---FACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           ++L + LG+G FG  +L   ++  +    +A K + K  L+   D    + E  I+  + 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEV- 83
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            HP IV L   ++ +  ++++++   GG+LF R+     +TE      +  +   +   H
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVL-K 232
             G+++RDLKPEN L     E   +K  DFGLS      E +     G+  YMAPEV+ +
Sbjct: 144 SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           R +    D WS GV+++ +L G  PF  +  +     I+++ +   +     +S  A+ L
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LSPEAQSL 256
Query: 293 VKKMLNPDPKQRLTA-----EEVLEHPWLQN 318
           ++ +   +P  RL A     EE+  H +   
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 19/271 (7%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEK---FACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           ++L + LG+G FG  +L   ++  +    +A K + K  L+   D    + E  I+  + 
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEV- 84
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            HP IV L   ++ +  ++++++   GG+LF R+     +TE      +  +   +   H
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 144
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVL-K 232
             G+++RDLKPEN L     E   +K  DFGLS      E +     G+  YMAPEV+ +
Sbjct: 145 SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           R +    D WS GV+++ +L G  PF  +  +     I+++ +   +     +S  A+ L
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LSPEAQSL 257
Query: 293 VKKMLNPDPKQRLTA-----EEVLEHPWLQN 318
           ++ +   +P  RL A     EE+  H +   
Sbjct: 258 LRMLFKRNPANRLGAGPDGVEEIKRHSFFST 288

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 140/304 (46%), Gaps = 49/304 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ R++GRG++   +   +VNN EK  C     K ++       ++RE++I+++L   
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEK--CIIKILKPVKKKK----IKREIKILQNLCGG 85
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIV L D   D  +    ++ E        D  V     T+      +  +++ +  CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            QG+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276
           ++Y   +D+WS G +   ++    PF+   +       I  V+                 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELD 260
Query: 277 ---------FKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R PW K         VS  A D + K+L  D ++RLTA E + HP+ Q 
Sbjct: 261 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320
Query: 319 AKKA 322
            + A
Sbjct: 321 VRAA 324

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 19/271 (7%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEK---FACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           ++L + LG+G FG  +L   ++  +    +A K + K  L+   D    + E  I+  + 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEV- 83
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            HP IV L   ++ +  ++++++   GG+LF R+     +TE      +  +   +   H
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVL-K 232
             G+++RDLKPEN L     E   +K  DFGLS      E +     G+  YMAPEV+ +
Sbjct: 144 SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           R +    D WS GV+++ +L G  PF  +  +     I+++ +   +     +S  A+ L
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LSPEAQSL 256
Query: 293 VKKMLNPDPKQRLTA-----EEVLEHPWLQN 318
           ++ +   +P  RL A     EE+  H +   
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 19/266 (7%)
Query: 58  YDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           ++L + LG+G FG  +L   V   ++G  +A K + K  L+   D    + E  I+  + 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVR-DRVRTKMERDILADV- 87
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            HP +V L   ++ +  ++++++   GG+LF R+     +TE      +  +   +   H
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKR 233
             G+++RDLKPEN L     E   +K  DFGLS      E +     G+  YMAPEV+ R
Sbjct: 148 SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNR 204
Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             +    D WS GV+++ +L G  PF  +  +     I+++ +   +     +S  A+ L
Sbjct: 205 QGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ----FLSTEAQSL 260
Query: 293 VKKMLNPDPKQRL-----TAEEVLEH 313
           ++ +   +P  RL      AEE+  H
Sbjct: 261 LRALFKRNPANRLGSGPDGAEEIKRH 286

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 51/293 (17%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED------VRREVQIMKHLPKH 116
           ++G G +GV Y   D + G   A K       R  +D ED        RE+ ++K L  H
Sbjct: 28  KVGEGTYGVVYKAKD-SQGRIVALK-------RIRLDAEDEGIPSTAIREISLLKEL-HH 78
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIVSL D    +  + +V E  E    ++ D    +    +      +  ++  V  CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL-- 231
           +  ++HRDLKP+N L  +      LK  DFGL+  F  P   +   V + +Y AP+VL  
Sbjct: 137 QHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII-------------------- 271
            + Y   VD+WS G I   ++ G P F   T+      I                     
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 272 --RSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
             R+   F++ PW    P   +   DL+  ML  DP +R++A + + HP+ ++
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 51/293 (17%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED------VRREVQIMKHLPKH 116
           ++G G +GV Y   D + G   A K       R  +D ED        RE+ ++K L  H
Sbjct: 28  KVGEGTYGVVYKAKD-SQGRIVALK-------RIRLDAEDEGIPSTAIREISLLKEL-HH 78
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNIVSL D    +  + +V E  E    ++ D    +    +      +  ++  V  CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL-- 231
           +  ++HRDLKP+N L  +      LK  DFGL+  F  P   +   V + +Y AP+VL  
Sbjct: 137 QHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII-------------------- 271
            + Y   VD+WS G I   ++ G P F   T+      I                     
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 272 --RSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
             R+   F++ PW    P   +   DL+  ML  DP +R++A + + HP+ ++
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 140/296 (47%), Gaps = 39/296 (13%)
Query: 43  LCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED 102
           L  L++P+G      ++L   +G G +G  Y    V  G+  A K +      T  + E+
Sbjct: 16  LSALRDPAGI-----FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEE 66
Query: 103 VRREVQIMKHLPKHPNIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYT- 155
           +++E+ ++K    H NI +       K+    D  + +VME C  G + D I      T 
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 156 -ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPG 213
            E   A + + I+  +   H+  V+HRD+K +N L     E++ +K +DFG+S    R  
Sbjct: 127 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTV 183
Query: 214 EQFNEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVA 267
            + N  +G+PY+MAPEV+  +  P+       D+WS G+    +  G PP          
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CD 236
Query: 268 QAIIRSVIDFKRDPWPKV-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
              +R++    R+P P++     S+  +  ++  L  +  QR   E++++HP++++
Sbjct: 237 MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 134/288 (46%), Gaps = 43/288 (14%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPNI 119
           +G G +G+   C + + G     + ++ KK   + D + V+    RE++++K L +H N+
Sbjct: 33  VGEGSYGMVMKCRNKDTG-----RIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENL 86
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
           V+L +  +     ++V E  +   L D  +       +     +  I+  +  CH   ++
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN--YG 236
           HRD+KPEN L +   +S  +K  DFG +     PGE +++ V + +Y APE+L  +  YG
Sbjct: 147 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETE--------QGVAQAIIRSVIDFKRDP------- 281
             VDVW+ G ++  +  G P F  +++          +   I R    F ++P       
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263
Query: 282 ------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                       +PK+SE   DL KK L+ DP +R    E+L H + Q
Sbjct: 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 131/271 (48%), Gaps = 20/271 (7%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +++  ELG G FG  Y   +   G   A K I  K   +  ++ED   E++I+     HP
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATC-DHP 76
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCH 174
            IV L   Y  D  + I++E C GG + D I+    RG  TE     V + ++E +   H
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLH 134
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL-- 231
            + ++HRDLK  N L   + +   ++  DFG+S    +  ++ +  +G+PY+MAPEV+  
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
                  Y  + D+WS G+ L  +    PP        V   I +S       P  K S 
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP-SKWSV 250
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
             +D +K  L+ +P+ R +A ++LEHP++ +
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 70
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--K 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 129 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 185
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 245
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN-AKKAPNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 246 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 305
Query: 327 L 327
           L
Sbjct: 306 L 306

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--K 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 298
Query: 327 L 327
           L
Sbjct: 299 L 299

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 64
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E         + +     T      +   + +++Q    CH 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 299
Query: 327 L 327
           L
Sbjct: 300 L 300

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 131/271 (48%), Gaps = 20/271 (7%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +++  ELG G FG  Y   +   G   A K I  K   +  ++ED   E++I+     HP
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATC-DHP 68
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCH 174
            IV L   Y  D  + I++E C GG + D I+    RG  TE     V + ++E +   H
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLH 126
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL-- 231
            + ++HRDLK  N L   + +   ++  DFG+S    +  ++ +  +G+PY+MAPEV+  
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
                  Y  + D+WS G+ L  +    PP        V   I +S       P  K S 
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP-SKWSV 242
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
             +D +K  L+ +P+ R +A ++LEHP++ +
Sbjct: 243 EFRDFLKIALDKNPETRPSAAQLLEHPFVSS 273

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 136/301 (45%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +L D + A    T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 298
Query: 327 L 327
           L
Sbjct: 299 L 299

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 64
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 62
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
Query: 327 L 327
           L
Sbjct: 298 L 298

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 65
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 64
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 179
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 299
Query: 327 L 327
           L
Sbjct: 300 L 300

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 138/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++  R   T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--RQTLTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 298
Query: 327 L 327
           L
Sbjct: 299 L 299

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 298
Query: 327 L 327
           L
Sbjct: 299 L 299

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 125/261 (47%), Gaps = 12/261 (4%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R LG+G FG    C     G+ +ACK + KK+++          E QI++ +     +VS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVS 248
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
           L   YE   A+ +V+ L  GG+L   I   G   + E  A      I   ++  H + ++
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
           +RDLKPEN L  +      ++  D GL+V    G+     VG+  YMAPEV+K   Y   
Sbjct: 309 YRDLKPENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
            D W+ G +LY ++ G  PF    ++   + + R V +   +   + S  A+ L  ++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 299 PDPKQRL-----TAEEVLEHP 314
            DP +RL     +A EV EHP
Sbjct: 426 KDPAERLGCRGGSAREVKEHP 446

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 298
Query: 327 L 327
           L
Sbjct: 299 L 299

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 62
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
Query: 327 L 327
           L
Sbjct: 298 L 298

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 67
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 126 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 242
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 243 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 302
Query: 327 L 327
           L
Sbjct: 303 L 303

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 133/309 (43%), Gaps = 39/309 (12%)
Query: 43  LCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED 102
           + V   PS   I   Y    +LG G +G  Y   D    E  A K I  +     V    
Sbjct: 22  MSVSAAPSATSID-RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA 80
Query: 103 VRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV 162
           +R EV ++K L +H NI+ LK     +  +H++ E  E  +L   +      + R   + 
Sbjct: 81  IR-EVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF 137
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLF--ANKKESSPLKAIDFGLS-VFFRPGEQFNEI 219
           +  ++  V  CH +  +HRDLKP+N L   ++  E+  LK  DFGL+  F  P  QF   
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 220 VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-IRSVID 276
           + + +Y  PE+L   R+Y   VD+WS   I   +L   P F  ++E  + Q   I  V+ 
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE--IDQLFKIFEVLG 255
Query: 277 FKRD-PWPKVSE-----------NAKDLVK---------------KMLNPDPKQRLTAEE 309
              D  WP V+              K L +                ML  DP +R++A+ 
Sbjct: 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315
Query: 310 VLEHPWLQN 318
            LEHP+  +
Sbjct: 316 ALEHPYFSH 324

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 70
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 129 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 185
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 245
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN-AKKAPNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 246 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 305
Query: 327 L 327
           L
Sbjct: 306 L 306

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 129/294 (43%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 66
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E         + +     T      +   + +++Q    CH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 64
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 299
Query: 327 L 327
           L
Sbjct: 300 L 300

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 43/299 (14%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 66
Query: 119 IVSLKDTYEDDSAVHIVME-LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           IV L D    ++ +++V E L +  + F    A          + +  +++ +  CH   
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK--RN 234
           V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + 
Sbjct: 127 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS-------- 286
           Y   VD+WS G I   ++     F  ++E      I R++       WP V+        
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 287 -----------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVSL 327
                            E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ L
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL 302

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 125/261 (47%), Gaps = 12/261 (4%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R LG+G FG    C     G+ +ACK + KK+++          E QI++ +     +VS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVS 248
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
           L   YE   A+ +V+ L  GG+L   I   G   + E  A      I   ++  H + ++
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
           +RDLKPEN L  +      ++  D GL+V    G+     VG+  YMAPEV+K   Y   
Sbjct: 309 YRDLKPENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
            D W+ G +LY ++ G  PF    ++   + + R V +   +   + S  A+ L  ++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 299 PDPKQRL-----TAEEVLEHP 314
            DP +RL     +A EV EHP
Sbjct: 426 KDPAERLGCRGGSAREVKEHP 446

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 62
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
Query: 327 L 327
           L
Sbjct: 298 L 298

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 66
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 301
Query: 327 L 327
           L
Sbjct: 302 L 302

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 298
Query: 327 L 327
           L
Sbjct: 299 L 299

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 65
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 300
Query: 327 L 327
           L
Sbjct: 301 L 301

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 67
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 126 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 182
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 242
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 243 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 302
Query: 327 L 327
           L
Sbjct: 303 L 303

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 62
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 133/307 (43%), Gaps = 55/307 (17%)
Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
           +G+   I Y   + +G G FGV +    V + E    K +  K+ +         RE+QI
Sbjct: 34  TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN--------RELQI 85
Query: 110 MKHLPKHPNIVSLKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM 163
           M+ + KHPN+V LK  +      +D+  +++V+E     E   R  A  HY +      M
Sbjct: 86  MR-IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYR--ASRHYAKLKQTMPM 140
Query: 164 KTI-------VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
             I       +  +   H  G+ HRD+KP+N L      S  LK IDFG +     GE  
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPN 198
Query: 217 NEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
              + S YY APE++    NY   +D+WS G ++  L+ G P F  E+       II+ +
Sbjct: 199 VSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258
Query: 275 IDFKRD--------------------PW-----PKVSENAKDLVKKMLNPDPKQRLTAEE 309
               R+                    P+     P+   +A DL+ ++L   P  RLTA E
Sbjct: 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318
Query: 310 VLEHPWL 316
            L HP+ 
Sbjct: 319 ALCHPFF 325

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 26/273 (9%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           +S  Y+LG  LG G     +L  D+ +    A K +     R        RRE Q    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 114 PKHPNIVSLKDTYEDDSAV----HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
             HP IV++ DT E ++      +IVME  +G  L D +   G  T + A  V+    + 
Sbjct: 70  -NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG----EQFNEIVGSPYY 225
           +   H+ G++HRD+KP N L +    ++ +K +DFG++           Q   ++G+  Y
Sbjct: 129 LNFSHQNGIIHRDVKPANILIS---ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           ++PE  + +      DV+S G +LY +L G PPF  ++   VA   +R       DP P 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIPP 239
Query: 285 ------VSENAKDLVKKMLNPDPKQRL-TAEEV 310
                 +S +   +V K L  +P+ R  TA E+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 64
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 65
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 66
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 136/301 (45%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 66
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +L D + A    T      +   + +++Q    CH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 301
Query: 327 L 327
           L
Sbjct: 302 L 302

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 132/294 (44%), Gaps = 46/294 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 65
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +L D + A    T      +   + +++Q    CH 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 135/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 66
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E  +  +   + +     T      +   + +++Q    CH 
Sbjct: 67  IVKLLDVIHTENKLYLVFEHVD--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 301
Query: 327 L 327
           L
Sbjct: 302 L 302

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 43/299 (14%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 62
Query: 119 IVSLKDTYEDDSAVHIVME-LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           IV L D    ++ +++V E + +  + F    A          + +  +++ +  CH   
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK--RN 234
           V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + 
Sbjct: 123 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS-------- 286
           Y   VD+WS G I   ++     F  ++E      I R++       WP V+        
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 287 -----------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVSL 327
                            E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ L
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL 298

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 46/296 (15%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV----RREVQIMKHL 113
           Y+   ++G G +G  +   +    E      ++ K++R   D E V     RE+ ++K L
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            KH NIV L D    D  + +V E C+    + FD     G        + +  +++ + 
Sbjct: 59  -KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLG 115
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEV 230
            CH + V+HRDLKP+N L     E   LK  DFGL+  F  P   ++  V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 231 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIR--------------S 273
           L   + Y   +D+WSAG I   L     P +   +     + I R               
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 274 VIDFKRDPW-----------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           + D+K  P            PK++   +DL++ +L  +P QR++AEE L+HP+  +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 126/273 (46%), Gaps = 26/273 (9%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           +S  Y+LG  LG G     +L  D+ +    A K +     R        RRE Q    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 114 PKHPNIVSLKDTYEDDSAV----HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
             HP IV++ DT E ++      +IVME  +G  L D +   G  T + A  V+    + 
Sbjct: 70  -NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG----EQFNEIVGSPYY 225
           +   H+ G++HRD+KP N + +    ++ +K +DFG++           Q   ++G+  Y
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           ++PE  + +      DV+S G +LY +L G PPF  ++   VA   +R       DP P 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR------EDPIPP 239
Query: 285 ------VSENAKDLVKKMLNPDPKQRL-TAEEV 310
                 +S +   +V K L  +P+ R  TA E+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 96
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 153
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 154 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 271
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 272 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 331
Query: 319 AKK 321
             K
Sbjct: 332 VVK 334

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 319 AKK 321
             K
Sbjct: 327 VVK 329

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 133/296 (44%), Gaps = 46/296 (15%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV----RREVQIMKHL 113
           Y+   ++G G +G  +   +    E      ++ K++R   D E V     RE+ ++K L
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            KH NIV L D    D  + +V E C+    + FD     G        + +  +++ + 
Sbjct: 59  -KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLG 115
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEV 230
            CH + V+HRDLKP+N L     E   LK  +FGL+  F  P   ++  V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 231 L--KRNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIR--------------S 273
           L   + Y   +D+WSAG I   L   G P F         + I R               
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 274 VIDFKRDPW-----------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           + D+K  P            PK++   +DL++ +L  +P QR++AEE L+HP+  +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 90
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325
Query: 319 AKK 321
             K
Sbjct: 326 VVK 328

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 90
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325
Query: 319 AKK 321
             K
Sbjct: 326 VVK 328

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 89
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 147 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
Query: 319 AKK 321
             K
Sbjct: 325 VVK 327

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A K     K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A       K+R   + E V     RE+ ++K L  HPN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALX-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 298
Query: 327 L 327
           L
Sbjct: 299 L 299

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 47/301 (15%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
           ++G G +GV Y   +   GE  A       K+R   + E V     RE+ ++K L  HPN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALX-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 62
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VCHE 175
           IV L D    ++ +++V E     +   + +     T      +   + +++Q    CH 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS------ 286
           + Y   VD+WS G I   ++     F  ++E      I R++       WP V+      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 287 -------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK-APNVS 326
                              E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
Query: 327 L 327
           L
Sbjct: 298 L 298

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 126/273 (46%), Gaps = 26/273 (9%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           +S  Y+LG  LG G     +L  D+ +    A K +     R        RRE Q    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 114 PKHPNIVSLKDTYEDDSAV----HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
             HP IV++ DT E ++      +IVME  +G  L D +   G  T + A  V+    + 
Sbjct: 70  -NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG----EQFNEIVGSPYY 225
           +   H+ G++HRD+KP N + +    ++ +K +DFG++           Q   ++G+  Y
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           ++PE  + +      DV+S G +LY +L G PPF  ++   VA   +R       DP P 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIPP 239
Query: 285 ------VSENAKDLVKKMLNPDPKQRL-TAEEV 310
                 +S +   +V K L  +P+ R  TA E+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 20/254 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG FG   +    N  + FA K ++K ++    +    R E  ++ +    
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDS 133
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE 175
             I +L   ++DD+ +++VM+   GG+L   +        E  A   +  +V  +   H+
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFNEIVGSPYYMAPEVL-- 231
              +HRD+KP+N L      +  ++  DFG  L +      Q +  VG+P Y++PE+L  
Sbjct: 194 LHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
               K  YGPE D WS GV +Y +L G  PF+AE+       I+     F+   +P    
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPTQVT 307
Query: 285 -VSENAKDLVKKML 297
            VSENAKDL+++++
Sbjct: 308 DVSENAKDLIRRLI 321

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 136/298 (45%), Gaps = 49/298 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K +         RE++I+++L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLRGG 91
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D       +V E     + F ++      T+      M  I++ +  CH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDF------------ 277
           + Y   +D+WS G +L  ++    PF+      +Q V  A +    D             
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 278 ----------KRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                      R  W +         VS  A D + K+L  D + RLTA E +EHP+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 39/299 (13%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKF-ACKSISKKKLRTAVDIEDVRREVQIMKHLP-- 114
           Y+   E+G G +G  +   D+ NG +F A K +  +     + +  +R EV +++HL   
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETF 71
Query: 115 KHPNIVSLKDT-----YEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIV 167
           +HPN+V L D       + ++ + +V E  +       D++   G  TE     +M  ++
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQLL 130
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
             +   H   V+HRDLKP+N L  +   S  +K  DFGL+  +        +V + +Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 228 PEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-- 284
           PEVL + +Y   VD+WS G I   +    P F   ++      I+  +     + WP+  
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 285 ---------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
                                + E  KDL+ K L  +P +R++A   L HP+ Q+ ++ 
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 39/299 (13%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKF-ACKSISKKKLRTAVDIEDVRREVQIMKHLP-- 114
           Y+   E+G G +G  +   D+ NG +F A K +  +     + +  +R EV +++HL   
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETF 71
Query: 115 KHPNIVSLKDT-----YEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIV 167
           +HPN+V L D       + ++ + +V E  +       D++   G  TE     +M  ++
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQLL 130
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
             +   H   V+HRDLKP+N L  +   S  +K  DFGL+  +        +V + +Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 228 PEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-- 284
           PEVL + +Y   VD+WS G I   +    P F   ++      I+  +     + WP+  
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 285 ---------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
                                + E  KDL+ K L  +P +R++A   L HP+ Q+ ++ 
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 28/237 (11%)
Query: 100 IEDVRREVQIMKHLPKHPN-IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERA 158
           ++  R E+  +  L +H + I+ L D    D  +++VME C   +L   +  +       
Sbjct: 98  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWE 156
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-- 216
             +  K ++E V   H+ G++H DLKP NFL  +      LK IDFG++   +P      
Sbjct: 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVV 212
Query: 217 -NEIVGSPYYMAPEVLK-----RNYG-------PEVDVWSAGVILYILLCGVPPFWAETE 263
            +  VG+  YM PE +K     R  G       P+ DVWS G ILY +  G  PF    +
Sbjct: 213 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----Q 268
Query: 264 QGVAQ-AIIRSVIDFKRD-PWPKVSE-NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           Q + Q + + ++ID   +  +P + E + +D++K  L  DPKQR++  E+L HP++Q
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 128/297 (43%), Gaps = 54/297 (18%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSIS----KKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           +LG G +   Y   +   G   A K +     +    TA+      RE+ +MK L KH N
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI------REISLMKEL-KHEN 64
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMK----TIVEVVQV 172
           IV L D    ++ + +V E  +  +L   + +R  G+        ++K     +++ +  
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL 231
           CHE  ++HRDLKP+N L   + +   LK  DFGL+  F  P   F+  V + +Y AP+VL
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180
Query: 232 --KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE-- 287
              R Y   +D+WS G IL  ++ G P F    ++   + I   +       WP V++  
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240
Query: 288 ----------------------------NAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                                       N  D +  +L  +P  RL+A++ L HPW 
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 95
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 153
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 154 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 210
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 211 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 270
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 271 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 322

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 87
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 146 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 262
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 28/237 (11%)
Query: 100 IEDVRREVQIMKHLPKHPN-IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERA 158
           ++  R E+  +  L +H + I+ L D    D  +++VME C   +L   +  +       
Sbjct: 98  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWE 156
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-- 216
             +  K ++E V   H+ G++H DLKP NFL  +      LK IDFG++   +P      
Sbjct: 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVV 212
Query: 217 -NEIVGSPYYMAPEVLK-----RNYG-------PEVDVWSAGVILYILLCGVPPFWAETE 263
            +  VG+  YM PE +K     R  G       P+ DVWS G ILY +  G  PF    +
Sbjct: 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----Q 268
Query: 264 QGVAQ-AIIRSVIDFKRD-PWPKVSE-NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           Q + Q + + ++ID   +  +P + E + +D++K  L  DPKQR++  E+L HP++Q
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 89
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 148 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 264
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 265 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 316

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 91
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L     +   LK  DFGL+    P         E V + +Y APE++   
Sbjct: 150 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 28/237 (11%)
Query: 100 IEDVRREVQIMKHLPKHPN-IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERA 158
           ++  R E+  +  L +H + I+ L D    D  +++VME C   +L   +  +       
Sbjct: 51  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWE 109
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-- 216
             +  K ++E V   H+ G++H DLKP NFL  +      LK IDFG++   +P      
Sbjct: 110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVV 165
Query: 217 -NEIVGSPYYMAPEVLK-----RNYG-------PEVDVWSAGVILYILLCGVPPFWAETE 263
            +  VG+  YM PE +K     R  G       P+ DVWS G ILY +  G  PF    +
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----Q 221
Query: 264 QGVAQ-AIIRSVIDFKRD-PWPKVSE-NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           Q + Q + + ++ID   +  +P + E + +D++K  L  DPKQR++  E+L HP++Q
Sbjct: 222 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 9/251 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++    LG+G FG   L       E +A K + K  +    D+E    E +++    K 
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  L   ++    ++ VME   GG+L   I   G + E  A      I   +     +
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N +  ++     +K  DFG+       G       G+P Y+APE++  + 
Sbjct: 141 GIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W+ GV+LY +L G  PF  E E  + Q+I+   + + +     +S+ A  + K
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK 253
Query: 295 KMLNPDPKQRL 305
            ++   P +RL
Sbjct: 254 GLMTKHPGKRL 264

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 87
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L     +   LK  DFGL+    P         E V + +Y APE++   
Sbjct: 146 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 262
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 87
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L     +   LK  DFGL+    P         E V + +Y APE++   
Sbjct: 146 LHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARN 262
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 87
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L     +   LK  DFGL+    P         E V + +Y APE++   
Sbjct: 146 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARN 262
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 9/251 (3%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++    LG+G FG   L       E +A K + K  +    D+E    E +++    K 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  L   ++    ++ VME   GG+L   I   G + E  A      I   +     +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N +  ++     +K  DFG+       G       G+P Y+APE++  + 
Sbjct: 462 GIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W+ GV+LY +L G  PF  E E  + Q+I+   + + +     +S+ A  + K
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICK 574
Query: 295 KMLNPDPKQRL 305
            ++   P +RL
Sbjct: 575 GLMTKHPGKRL 585

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 92
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 151 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 267
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 268 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 93
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 152 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 268
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 269 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 320

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 84
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 143 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 259
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 260 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 311

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 91
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 150 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 128/291 (43%), Gaps = 46/291 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLAF-RHENIIGIN 89
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +S LK  DFGL+    P         E V + +Y APE++   
Sbjct: 148 LHRDLKPSNLLL---NTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 233 RNYGPEVDVWSAGVILYILLCGVP--------------------PFWAETEQGV---AQA 269
           + Y   +D+WS G IL  +L   P                    P   +   G+   A+ 
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARN 264
Query: 270 IIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
            + S+    + PW    P     A DL+ KML  +P +R+  E+ L HP+L
Sbjct: 265 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 28/237 (11%)
Query: 100 IEDVRREVQIMKHLPKHPN-IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERA 158
           ++  R E+  +  L +H + I+ L D    D  +++VME C   +L   +  +       
Sbjct: 98  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWE 156
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-- 216
             +  K ++E V   H+ G++H DLKP NFL  +      LK IDFG++   +P      
Sbjct: 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVV 212
Query: 217 -NEIVGSPYYMAPEVLK-----RNYG-------PEVDVWSAGVILYILLCGVPPFWAETE 263
            +  VG+  YM PE +K     R  G       P+ DVWS G ILY +  G  PF    +
Sbjct: 213 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----Q 268
Query: 264 QGVAQ-AIIRSVIDFKRD-PWPKVSE-NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           Q + Q + + ++ID   +  +P + E + +D++K  L  DPKQR++  E+L HP++Q
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 126/292 (43%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 85
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 144 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPF---------------WAETEQGVAQAIIR----- 272
           + Y   +D+WS G IL  +L   P F                   EQ     II      
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARN 260
Query: 273 ---SVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
              S+    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 261 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 85
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 144 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 260
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 261 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYX--QRTLREIKILLRF-RHENIIGIN 91
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L     +   LK  DFGL+    P         E V + +Y APE++   
Sbjct: 150 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/321 (26%), Positives = 144/321 (44%), Gaps = 55/321 (17%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N E+   K +   K +         REV+I+++L   
Sbjct: 39  DYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIK------REVKILENLRGG 92
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            NI+ L DT +D       +V E     + F ++      T+      M  +++ +  CH
Sbjct: 93  TNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCH 149
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            +G+MHRD+KP N +  ++++   L+ ID+GL+ F+ P +++N  V S Y+  PE+L   
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 207
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----------------- 275
           + Y   +D+WS G +L  ++    PF+   +       I  V+                 
Sbjct: 208 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLD 267
Query: 276 --------DFKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL-- 316
                      R  W           VS  A DL+ K+L  D +QRLTA+E +EHP+   
Sbjct: 268 PHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYP 327
Query: 317 ----QNAKKAPNVSLGETVKA 333
               Q+   A N  L   + A
Sbjct: 328 VVKEQSQPSADNAVLSSGLTA 348

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 107
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 166 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 282
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 283 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 129/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 107
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V++V  L  G +L+ +++   H +       +  I+  ++  H   V
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLM-GADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L     +   LK  DFGL+    P         E V + +Y APE++   
Sbjct: 166 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 282
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 283 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 87
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 146 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 262
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 125/273 (45%), Gaps = 26/273 (9%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           +S  Y+LG  LG G     +L  D+      A K +     R        RRE Q    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 114 PKHPNIVSLKDTYEDDSAV----HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
             HP IV++ DT E ++      +IVME  +G  L D +   G  T + A  V+    + 
Sbjct: 70  -NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG----EQFNEIVGSPYY 225
           +   H+ G++HRD+KP N + +    ++ +K +DFG++           Q   ++G+  Y
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           ++PE  + +      DV+S G +LY +L G PPF  ++   VA   +R       DP P 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIPP 239
Query: 285 ------VSENAKDLVKKMLNPDPKQRL-TAEEV 310
                 +S +   +V K L  +P+ R  TA E+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 28/288 (9%)
Query: 39  VVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV 98
           +V R   +  PS   +S  Y+LG  LG G     +L  D+      A K +     R   
Sbjct: 14  LVPRGSHMTTPS--HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS 71
Query: 99  DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV----HIVMELCEGGELFDRIVARGHY 154
                RRE Q    L  HP IV++ DT E ++      +IVME  +G  L D +   G  
Sbjct: 72  FYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 130
Query: 155 TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213
           T + A  V+    + +   H+ G++HRD+KP N + +    ++ +K +DFG++       
Sbjct: 131 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSG 187
Query: 214 ---EQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 269
               Q   ++G+  Y++PE  + +      DV+S G +LY +L G PPF  ++   VA  
Sbjct: 188 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 247
Query: 270 IIRSVIDFKRDPWPK------VSENAKDLVKKMLNPDPKQRL-TAEEV 310
            +R       DP P       +S +   +V K L  +P+ R  TA E+
Sbjct: 248 HVR------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 289

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 131/294 (44%), Gaps = 39/294 (13%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKF-ACKSISKKKLRTAVDIEDVRREVQIMKHLP-- 114
           Y+   E+G G +G  +   D+ NG +F A K +  +     + +  +R EV +++HL   
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETF 71
Query: 115 KHPNIVSLKDT-----YEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIV 167
           +HPN+V L D       + ++ + +V E  +       D++   G  TE     +M  ++
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQLL 130
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
             +   H   V+HRDLKP+N L  +   S  +K  DFGL+  +        +V + +Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 228 PEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-- 284
           PEVL + +Y   VD+WS G I   +    P F   ++      I+  +     + WP+  
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 285 ---------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                                + E  KDL+ K L  +P +R++A   L HP+ Q
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 91
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 150 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 28/237 (11%)
Query: 100 IEDVRREVQIMKHLPKHPN-IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERA 158
           ++  R E+  +  L +H + I+ L D    D  +++VME C   +L   +  +       
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWE 128
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-- 216
             +  K ++E V   H+ G++H DLKP NFL  +      LK IDFG++   +P      
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDXXXVV 184
Query: 217 -NEIVGSPYYMAPEVLK-----RNYG-------PEVDVWSAGVILYILLCGVPPFWAETE 263
            +  VG+  YM PE +K     R  G       P+ DVWS G ILY +  G  PF    +
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----Q 240
Query: 264 QGVAQ-AIIRSVIDFKRD-PWPKVSE-NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           Q + Q + + ++ID   +  +P + E + +D++K  L  DPKQR++  E+L HP++Q
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 92
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 151 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 267
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 268 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 137/298 (45%), Gaps = 49/298 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N E+   K +   K +         REV+I+++L   
Sbjct: 44  DYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIK------REVKILENLRGG 97
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            NI+ L DT +D       +V E     + F ++      T+      M  +++ +  CH
Sbjct: 98  TNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCH 154
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--K 232
            +G+MHRD+KP N +  ++++   L+ ID+GL+ F+ P +++N  V S Y+  PE+L   
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 212
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----------------- 275
           + Y   +D+WS G +L  ++    PF+   +       I  V+                 
Sbjct: 213 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLD 272
Query: 276 --------DFKRDPWPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                      R  W           VS  A DL+ K+L  D +QRLTA+E +EHP+ 
Sbjct: 273 PHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 28/237 (11%)
Query: 100 IEDVRREVQIMKHLPKHPN-IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERA 158
           ++  R E+  +  L +H + I+ L D    D  +++VME C   +L   +  +       
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWE 128
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-- 216
             +  K ++E V   H+ G++H DLKP NFL  +      LK IDFG++   +P      
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVV 184
Query: 217 -NEIVGSPYYMAPEVLK-----RNYG-------PEVDVWSAGVILYILLCGVPPFWAETE 263
            +  VG+  YM PE +K     R  G       P+ DVWS G ILY +  G  PF    +
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----Q 240
Query: 264 QGVAQ-AIIRSVIDFKRD-PWPKVSE-NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           Q + Q + + ++ID   +  +P + E + +D++K  L  DPKQR++  E+L HP++Q
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 146/292 (50%), Gaps = 35/292 (11%)
Query: 49  PSGQDISID---YDLGRELGRGEFGVTYLCTDVNNGEK-FACKSISKKKLRTAVDIEDVR 104
           P+ + IS+    Y + +++G G  G + +   +N  ++ +A K ++ ++      ++  R
Sbjct: 2   PANECISVKGRIYSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYR 58
Query: 105 REVQIMKHLPKHPN-IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM 163
            E+  +  L +H + I+ L D    D  +++VME C   +L   +  +         +  
Sbjct: 59  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW 117
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIV 220
           K ++E V   H+ G++H DLKP NFL  +      LK IDFG++   +P       +  V
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVVKDSQV 173
Query: 221 GSPYYMAPEVLK-----RNYG-------PEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 268
           G+  YM PE +K     R  G       P+ DVWS G ILY +  G  PF    +Q + Q
Sbjct: 174 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQ 229
Query: 269 -AIIRSVIDFKRD-PWPKVSE-NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
            + + ++ID   +  +P + E + +D++K  L  DPKQR++  E+L HP++Q
Sbjct: 230 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 91
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKCQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 150 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A + IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYC--QRTLREIKILLRF-RHENIIGIN 91
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 150 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L+
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 132/264 (50%), Gaps = 13/264 (4%)
Query: 48  EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           +P G+D  +D+   R LGRG FG  + C     G+ +ACK ++KK+L+     +    E 
Sbjct: 180 QPMGEDWFLDF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVM 163
           +I+  +     IVSL   +E  + + +VM +  GG++   I         + E  A    
Sbjct: 237 KILAKVHSR-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-IVGS 222
             IV  ++  H++ +++RDLKPEN L     +   ++  D GL+V  + G+   +   G+
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 223 PYYMAPE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281
           P +MAPE +L   Y   VD ++ GV LY ++    PF A  E+   + + + V++     
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412
Query: 282 WPKVSENAKDLVKKMLNPDPKQRL 305
             K S  +KD  + +L  DP++RL
Sbjct: 413 PDKFSPASKDFCEALLQKDPEKRL 436

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 99/359 (27%), Positives = 165/359 (45%), Gaps = 35/359 (9%)
Query: 48  EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           +P G+D  +D+   R LGRG FG  + C     G+ +ACK ++KK+L+     +    E 
Sbjct: 180 QPMGEDWFLDF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVM 163
           +I+  +     IVSL   +E  + + +VM +  GG++   I         + E  A    
Sbjct: 237 KILAKVHSR-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGS 222
             IV  ++  H++ +++RDLKPEN L     +   ++  D GL+V  + G+ +     G+
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 223 PYYMAPE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281
           P +MAPE +L   Y   VD ++ GV LY ++    PF A  E+   + + + V++     
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412
Query: 282 WPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHP------WLQ---NAKKAPNVSL 327
             K S  +KD  + +L  DP++RL     + + +  HP      W Q        P V  
Sbjct: 413 PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472
Query: 328 GETVKARLKQ----FSVMN--KLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKIN 380
             TV A+  Q    FS +     +K   +   EF S       +E  EM++T   G +N
Sbjct: 473 SRTVYAKCIQDVGAFSTVKGVAFEKADTEFFQEFASGTCPIPWQE--EMIETGVFGDLN 529

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G+     D  N  + A K IS  + +T    +   RE++I+    +H NI+ + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLAF-RHENIIGIN 89
Query: 124 D-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           D     T E    V+IV +L E  +L+ +++   H +       +  I+  ++  H   V
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVL--K 232
           +HRDLKP N L      +  LK  DFGL+    P         E V + +Y APE++   
Sbjct: 148 LHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGV----AQAIIRSVIDFK--- 278
           + Y   +D+WS G IL  +L   P F  +          G+    +Q  +  +I+ K   
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 264
Query: 279 ---------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                    + PW    P     A DL+ KML  +P +R+  E+ L HP+L
Sbjct: 265 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 132/264 (50%), Gaps = 13/264 (4%)
Query: 48  EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           +P G+D  +D+   R LGRG FG  + C     G+ +ACK ++KK+L+     +    E 
Sbjct: 180 QPMGEDWFLDF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVM 163
           +I+  +     IVSL   +E  + + +VM +  GG++   I         + E  A    
Sbjct: 237 KILAKVHSR-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGS 222
             IV  ++  H++ +++RDLKPEN L     +   ++  D GL+V  + G+ +     G+
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 223 PYYMAPE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281
           P +MAPE +L   Y   VD ++ GV LY ++    PF A  E+   + + + V++     
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412
Query: 282 WPKVSENAKDLVKKMLNPDPKQRL 305
             K S  +KD  + +L  DP++RL
Sbjct: 413 PDKFSPASKDFCEALLQKDPEKRL 436

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 119/237 (50%), Gaps = 28/237 (11%)
Query: 100 IEDVRREVQIMKHLPKHPN-IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERA 158
           ++  R E+  +  L +H + I+ L D    D  +++VME C   +L   +  +       
Sbjct: 50  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWE 108
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-- 216
             +  K ++E V   H+ G++H DLKP NFL  +      LK IDFG++   +P      
Sbjct: 109 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVV 164
Query: 217 -NEIVGSPYYMAPEVLK-----RNYG-------PEVDVWSAGVILYILLCGVPPFWAETE 263
            +  VG+  YM PE +K     R  G       P+ DVWS G ILY +  G  PF    +
Sbjct: 165 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----Q 220
Query: 264 QGVAQ-AIIRSVIDFKRD-PWPKVSE-NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           Q + Q + + ++ID   +  +P + E + +D++K  L  DPKQR++  E+L HP++Q
Sbjct: 221 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 132/264 (50%), Gaps = 13/264 (4%)
Query: 48  EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           +P G+D  +D+   R LGRG FG  + C     G+ +ACK ++KK+L+     +    E 
Sbjct: 180 QPMGEDWFLDF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVM 163
           +I+  +     IVSL   +E  + + +VM +  GG++   I         + E  A    
Sbjct: 237 KILAKVHSR-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGS 222
             IV  ++  H++ +++RDLKPEN L     +   ++  D GL+V  + G+ +     G+
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 223 PYYMAPE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281
           P +MAPE +L   Y   VD ++ GV LY ++    PF A  E+   + + + V++     
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412
Query: 282 WPKVSENAKDLVKKMLNPDPKQRL 305
             K S  +KD  + +L  DP++RL
Sbjct: 413 PDKFSPASKDFCEALLQKDPEKRL 436

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/342 (26%), Positives = 145/342 (42%), Gaps = 50/342 (14%)
Query: 18  GKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQ---DISIDYDLGRELGRGEFGVTYL 74
           G  E P P   +    A  S     L +LK  S     D+  +Y++   +G G +GV   
Sbjct: 14  GSAEPPGPVKAEPAHTA-ASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSS 72
Query: 75  CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT------YED 128
                 G++ A K I         + +   RE++I+KH  KH NI+++KD       Y +
Sbjct: 73  ARRRLTGQQVAIKKIPNA-FDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGE 130
Query: 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188
             +V++V++L E  +L   I +    T       +  ++  ++  H   V+HRDLKP N 
Sbjct: 131 FKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 189
Query: 189 LFANKKESSPLKAIDFGLS--VFFRPGEQ---FNEIVGSPYYMAPEVLK--RNYGPEVDV 241
           L     E+  LK  DFG++  +   P E      E V + +Y APE++     Y   +D+
Sbjct: 190 LV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246
Query: 242 WSAGVI---------------------LYILLCGVPPFWAETEQGV--AQAIIRSVIDFK 278
           WS G I                     L +++ G P        G    +A I+S+   +
Sbjct: 247 WSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQ 306
Query: 279 RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
             PW    P     A  L+ +ML  +P  R++A   L HP+L
Sbjct: 307 PVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 90/342 (26%), Positives = 145/342 (42%), Gaps = 50/342 (14%)
Query: 18  GKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQ---DISIDYDLGRELGRGEFGVTYL 74
           G  E P P   +    A  S     L +LK  S     D+  +Y++   +G G +GV   
Sbjct: 15  GSAEPPGPVKAEPAHTA-ASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSS 73
Query: 75  CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT------YED 128
                 G++ A K I         + +   RE++I+KH  KH NI+++KD       Y +
Sbjct: 74  ARRRLTGQQVAIKKIPNA-FDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGE 131
Query: 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188
             +V++V++L E  +L   I +    T       +  ++  ++  H   V+HRDLKP N 
Sbjct: 132 FKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 190
Query: 189 LFANKKESSPLKAIDFGLS--VFFRPGEQ---FNEIVGSPYYMAPEVLK--RNYGPEVDV 241
           L     E+  LK  DFG++  +   P E      E V + +Y APE++     Y   +D+
Sbjct: 191 LV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 247
Query: 242 WSAGVI---------------------LYILLCGVPPFWAETEQGV--AQAIIRSVIDFK 278
           WS G I                     L +++ G P        G    +A I+S+   +
Sbjct: 248 WSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQ 307
Query: 279 RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
             PW    P     A  L+ +ML  +P  R++A   L HP+L
Sbjct: 308 PVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 349

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 45/289 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D  +GEK A K +S+   ++ +  +   RE+ ++KH+ +H N++ L 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHM-QHENVIGLL 107
Query: 124 DTYEDDSAV------HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +   S++      ++VM   +      +I+    ++E     ++  +++ ++  H  G
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAG 164
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           V+HRDLKP N L  N  E   LK +DFGL+       +    V + +Y APEV+    +Y
Sbjct: 165 VVHRDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMHY 219
Query: 236 GPEVDVWSAGVILYILLCG---------------------VP--PFWAETEQGVAQAIIR 272
              VD+WS G I+  +L G                     VP   F  +     A++ I+
Sbjct: 220 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 279
Query: 273 SVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           S+    R  +    P+ S  A DL++KML  D  +RLTA + L HP+ +
Sbjct: 280 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 48/296 (16%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y     +G G +G      DV +G K A K +S+   ++ +  +   RE++++KH+ KH 
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHE 110
Query: 118 NIVSLKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
           N++ L D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLK 168
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             H   ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++
Sbjct: 169 YIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIM 223
Query: 232 KR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------SVIDFKRDP- 281
               +Y   VD+WS G I+  LL G   F         Q I+R       SVI   R P 
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVI--SRMPS 281
Query: 282 ---------WPKVSEN------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                     P++ +             A DL++KML  D  +R+TA E L HP+ 
Sbjct: 282 HEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 45/289 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D  +GEK A K +S+   ++ +  +   RE+ ++KH+ +H N++ L 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHM-QHENVIGLL 89
Query: 124 DTYEDDSAV------HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +   S++      ++VM   +      +I+    ++E     ++  +++ ++  H  G
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           V+HRDLKP N L  N  E   LK +DFGL+       +    V + +Y APEV+    +Y
Sbjct: 147 VVHRDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMHY 201
Query: 236 GPEVDVWSAGVILYILLCG---------------------VP--PFWAETEQGVAQAIIR 272
              VD+WS G I+  +L G                     VP   F  +     A++ I+
Sbjct: 202 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 261
Query: 273 SVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           S+    R  +    P+ S  A DL++KML  D  +RLTA + L HP+ +
Sbjct: 262 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 46/304 (15%)
Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           D+   Y   + +G G +G+     D     + A K IS  + +T    +   RE+QI+  
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYC--QRTLREIQILLR 97
Query: 113 LPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
             +H N++ ++D     T E    V+IV +L E  +L+ +++     +       +  I+
Sbjct: 98  F-RHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLY-KLLKSQQLSNDHICYFLYQIL 154
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSP 223
             ++  H   V+HRDLKP N L      +  LK  DFGL+    P         E V + 
Sbjct: 155 RGLKYIHSANVLHRDLKPSNLLI---NTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAE--TEQ-----GV----AQAI 270
           +Y APE++   + Y   +D+WS G IL  +L   P F  +   +Q     G+    +Q  
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 271
Query: 271 IRSVIDFK------------RDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
           +  +I+ K            +  W    PK    A DL+ +ML  +P +R+T EE L HP
Sbjct: 272 LNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHP 331
Query: 315 WLQN 318
           +L+ 
Sbjct: 332 YLEQ 335

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 122/286 (42%), Gaps = 37/286 (12%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD--IEDVRREVQIMKHLPKHPNIVS 121
           LG G+F   Y   D N  +  A K I       A D       RE+++++ L  HPNI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIG 76
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVEVVQVCHEQGVM 179
           L D +   S + +V +  E     + I+       T     A M   ++ ++  H+  ++
Sbjct: 77  LLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRNYG 236
           HRDLKP N L     E+  LK  DFGL+  F  P   +   V + +Y APE+L   R YG
Sbjct: 135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV----------- 285
             VD+W+ G IL  LL  VP    +++      I  ++     + WP +           
Sbjct: 192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 251
Query: 286 -------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                         ++  DL++ +   +P  R+TA + L+  +  N
Sbjct: 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 22/277 (7%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKH 116
           Y +G  LG G +G      D     + A K + KKKLR   + E +V++E+Q+++ L +H
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RH 65
Query: 117 PNIVSLKDTY--EDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
            N++ L D    E+   +++VME C  G  E+ D +  +  +    A      +++ ++ 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEY 124
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP---GEQFNEIVGSPYYMAPE 229
            H QG++H+D+KP N L         LK    G++    P    +      GSP +  PE
Sbjct: 125 LHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 230 V---LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           +   L    G +VD+WSAGV LY +  G+ PF  +    + + I +       D  P +S
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
               DL+K ML  +P +R +  ++ +H W +  KK P
Sbjct: 242 ----DLLKGMLEYEPAKRFSIRQIRQHSWFR--KKHP 272

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 26/273 (9%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           +S  Y+LG  LG G     +L  D+      A K +     R        RRE Q    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 114 PKHPNIVSLKDTYEDDSAV----HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
             HP IV++  T E ++      +IVME  +G  L D +   G  T + A  V+    + 
Sbjct: 70  -NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG----EQFNEIVGSPYY 225
           +   H+ G++HRD+KP N + +    ++ +K +DFG++           Q   ++G+  Y
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           ++PE  + +      DV+S G +LY +L G PPF  ++   VA   +R       DP P 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIPP 239
Query: 285 ------VSENAKDLVKKMLNPDPKQRL-TAEEV 310
                 +S +   +V K L  +P+ R  TA E+
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +++   LG G FG        + GE+ A K   ++   +  + E    E+QIMK L  HP
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL-NHP 73
Query: 118 NIVSLKDTYEDDSAVH------IVMELCEGGEL---FDRIVARGHYTERAAAAVMKTIVE 168
           N+VS ++  +    +       + ME CEGG+L    ++        E     ++  I  
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            ++  HE  ++HRDLKPEN +     +    K ID G +     GE   E VG+  Y+AP
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 193
Query: 229 EVL-KRNYGPEVDVWSAGVILYILLCGVPPF 258
           E+L ++ Y   VD WS G + +  + G  PF
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +++   LG G FG        + GE+ A K   ++   +  + E    E+QIMK L  HP
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL-NHP 72
Query: 118 NIVSLKDTYEDDSAVH------IVMELCEGGEL---FDRIVARGHYTERAAAAVMKTIVE 168
           N+VS ++  +    +       + ME CEGG+L    ++        E     ++  I  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            ++  HE  ++HRDLKPEN +     +    K ID G +     GE   E VG+  Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 229 EVL-KRNYGPEVDVWSAGVILYILLCGVPPF 258
           E+L ++ Y   VD WS G + +  + G  PF
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 102/370 (27%), Positives = 155/370 (41%), Gaps = 62/370 (16%)
Query: 2   GNCCARPDSSSGKRAKGKKEKPNPFYGDEYVV--ANGSTVVHRLCVLKEPSGQDISIDYD 59
           G    RP ++S   +    ++P+ F G   V    +GS V   +    +   +   + Y 
Sbjct: 1   GPMSGRPRTTSFAESCKPVQQPSAF-GSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYT 59
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
             + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ L  H
Sbjct: 60  DTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKL-DH 108
Query: 117 PNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
            NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + + Q+
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQL 167
Query: 173 ------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
                  H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S YY 
Sbjct: 168 FRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 225
Query: 227 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------------I 271
           APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +             I
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQI 283
Query: 272 RSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           R +            K  PW     P+    A  L  ++L   P  RLT  E   H +  
Sbjct: 284 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 343
Query: 318 NAKKAPNVSL 327
             +  PNV L
Sbjct: 344 ELRD-PNVKL 352

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R +G G +G      D    +K A K +S+   ++ +      RE++++KHL KH N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHL-KHENVIG 91
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L D +      ED S V++V  L   G   + IV     ++     ++  ++  ++  H 
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-- 233
            G++HRDLKP N       E S L+ +DFGL+   +  E+    V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNVAV---NEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 234 NYGPEVDVWSAGVILYILLCG-----------------------VPPFWAETEQGVAQAI 270
           +Y   VD+WS G I+  LL G                        P   A+     A+  
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 271 IRSVIDFKRDPWPKVSENAK----DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           I+S+    +     +   A     DL+ +ML  D  QR++A E L H + 
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 101/366 (27%), Positives = 154/366 (42%), Gaps = 62/366 (16%)
Query: 6   ARPDSSSGKRAKGKKEKPNPFYGDEYVV--ANGSTVVHRLCVLKEPSGQDISIDYDLGRE 63
            RP ++S   +    ++P+ F G   V    +GS V   +    +   +   + Y   + 
Sbjct: 3   GRPRTTSFAESCKPVQQPSAF-GSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKHPNIV 120
           +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ L  H NIV
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKL-DHCNIV 110
Query: 121 SLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV---- 172
            L+  +    E    V++ + L    E   R VAR +   +    V+   + + Q+    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 173 --CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
              H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S YY APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 227
Query: 231 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------------IRSV- 274
           +    +Y   +DVWSAG +L  LL G P F  ++  GV Q +             IR + 
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMN 285
Query: 275 --------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                      K  PW     P+    A  L  ++L   P  RLT  E   H +    + 
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345
Query: 322 APNVSL 327
            PNV L
Sbjct: 346 -PNVKL 350

>pdb|3U0K|A Chain A, Crystal Structure Of The Genetically Encoded Calcium Indicator Rcamp Length = 440

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 91/161 (56%), Gaps = 2/161 (1%)
Query: 339 SVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEA 398
           +VM K K +  +   + L+ E++A  KEAF + D +  G I             QN  EA
Sbjct: 280 AVMQK-KTKGWEPTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEA 338
Query: 399 DLQILMEAADVDGDGSLNYGEF-VAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELR 457
           +LQ ++   D DGDG++++ EF + ++  +K   ++E + +AF  FD++ +G+I   ELR
Sbjct: 339 ELQDMINEVDADGDGTIDFPEFLIMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELR 398
Query: 458 NALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           + + +  +   ++ ++ ++ + D D DG+++YEEF  MM A
Sbjct: 399 HVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 439

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 101/366 (27%), Positives = 154/366 (42%), Gaps = 62/366 (16%)
Query: 6   ARPDSSSGKRAKGKKEKPNPFYGDEYVV--ANGSTVVHRLCVLKEPSGQDISIDYDLGRE 63
            RP ++S   +    ++P+ F G   V    +GS V   +    +   +   + Y   + 
Sbjct: 3   GRPRTTSFAESCKPVQQPSAF-GSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKHPNIV 120
           +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ L  H NIV
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKL-DHCNIV 110
Query: 121 SLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV---- 172
            L+  +    E    V++ + L    E   R VAR +   +    V+   + + Q+    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 173 --CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
              H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S YY APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 231 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------------IRSV- 274
           +    +Y   +DVWSAG +L  LL G P F  ++  GV Q +             IR + 
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMN 285
Query: 275 --------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                      K  PW     P+    A  L  ++L   P  RLT  E   H +    + 
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345
Query: 322 APNVSL 327
            PNV L
Sbjct: 346 -PNVKL 350

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 104/368 (28%), Positives = 155/368 (42%), Gaps = 66/368 (17%)
Query: 6   ARPDSSSGKRAKGKKEKPNPFYGDEYVV--ANGSTVVHRLCVLKEPSGQDISIDYDLGRE 63
            RP ++S   +    ++P+ F G   V    +GS V   +    +   +   + Y   + 
Sbjct: 48  GRPRTTSFAESCKPVQQPSAF-GSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 106
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKHPNIV 120
           +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ L  H NIV
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKL-DHCNIV 155
Query: 121 SLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV--------MKTIVE 168
            L+  +    E    V++ + L    E   R VAR HY+ RA   +        M  +  
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VAR-HYS-RAKQTLPVIYVKLYMYQLFR 212
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            +   H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S YY AP
Sbjct: 213 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 270
Query: 229 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------------IRS 273
           E++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +             IR 
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIRE 328
Query: 274 V---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
           +            K  PW     P+    A  L  ++L   P  RLT  E   H +    
Sbjct: 329 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 388
Query: 320 KKAPNVSL 327
           +  PNV L
Sbjct: 389 RD-PNVKL 395

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 25  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 74
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 75  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 132
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 133 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 190
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 248
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 249 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 308
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 309 SFFDELRD-PNVKL 321

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 48  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 97
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 98  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 155
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 156 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 213
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 271
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 272 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 331
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 332 SFFDELRD-PNVKL 344

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 81
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 82  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 139
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 140 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 255
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 256 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 315
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 316 SFFDELRD-PNVKL 328

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 81
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 82  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 139
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 140 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 255
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 256 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 315
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 316 SFFDELRD-PNVKL 328

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 33  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 82
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 83  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 140
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 141 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 198
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 256
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 257 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 316
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 317 SFFDELRD-PNVKL 329

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 58  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 107
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 108 L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 165
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 166 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 223
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 281
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 282 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 341
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 342 SFFDELRD-PNVKL 354

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R +G G +G      D    +K A K +S+   ++ +      RE++++KHL KH N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHL-KHENVIG 91
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L D +      ED S V++V  L   G   + IV     ++     ++  ++  ++  H 
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-- 233
            G++HRDLKP N       E S L+ +DFGL+   +  E+    V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNVAV---NEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 234 NYGPEVDVWSAGVILYILLCG-----------------------VPPFWAETEQGVAQAI 270
           +Y   VD+WS G I+  LL G                        P   A+     A+  
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 271 IRSVIDFKRDPWPKVSENAK----DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           I+S+    +     +   A     DL+ +ML  D  QR++A E L H + 
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 28  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 77
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 78  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 135
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 136 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 193
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 251
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 252 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 311
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 312 SFFDELRD-PNVKL 324

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 133/321 (41%), Gaps = 69/321 (21%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLP 114
           + + R  G+G FG   L  + + G   A K +          I+D R   RE+QIM+ L 
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQIMQDLA 74
Query: 115 --KHPNIVSLKDTY-------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
              HPNIV L+  +         D  +++VME     +   R   R +Y  + A   +  
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHR-CCRNYYRRQVAPPPILI 131
Query: 166 IVEVVQVCHEQG--------VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN 217
            V + Q+    G        V HRD+KP N L  N+ + + LK  DFG +    P E   
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL-VNEADGT-LKLCDFGSAKKLSPSEPNV 189
Query: 218 EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR--- 272
             + S YY APE++   ++Y   VD+WS G I   ++ G P F  +   G    I+R   
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249
Query: 273 -----------------SVIDFKRDPWPKV--------SENAKDLVKKMLNPDPKQRLTA 307
                             + + K  PW  V        ++ A DL+  +L   P++R+  
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 308 EEVLEHPWLQN----AKKAPN 324
            E L HP+       A K PN
Sbjct: 310 YEALCHPYFDELHDPATKLPN 330

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 69
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 70  L-DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 127
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 243
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 304 SFFDELRD-PNVKL 316

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 132/267 (49%), Gaps = 21/267 (7%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G+G FG  +   D    +  A K I  ++    +  ED+++E+ ++      P +   
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQC-DSPYVTKY 90
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y  D+ + I+ME   GG   D ++  G   E   A +++ I++ +   H +  +HRD
Sbjct: 91  YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 149
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K  N L +   E   +K  DFG++      + + N  VG+P++MAPEV+K++ Y  + D
Sbjct: 150 IKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 206
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN----AKDLVKKM 296
           +WS G+    L  G PP        V   I       K +P P +  N     K+ V+  
Sbjct: 207 IWSLGITAIELARGEPPHSELHPMKVLFLIP------KNNP-PTLEGNYSKPLKEFVEAC 259
Query: 297 LNPDPKQRLTAEEVLEHPW-LQNAKKA 322
           LN +P  R TA+E+L+H + L+NAKK 
Sbjct: 260 LNKEPSFRPTAKELLKHKFILRNAKKT 286

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 39  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 88
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 89  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 146
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 147 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 204
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 262
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 263 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 322
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 323 SFFDELRD-PNVKL 335

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 132/311 (42%), Gaps = 53/311 (17%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           + Y   + +G G FGV Y     ++GE  A K + + K           RE+QIM+ L  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKL-D 71
Query: 116 HPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
           H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + + Q
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQ 130
Query: 172 V------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           +       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S YY
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 226 MAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI------------- 270
            APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +             
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQ 246
Query: 271 IR---------SVIDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           IR         +    K  PW     P+    A  L  ++L   P  RLT  E   H + 
Sbjct: 247 IREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 317 QNAKKAPNVSL 327
              +  PNV L
Sbjct: 307 DELRD-PNVKL 316

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 134/267 (50%), Gaps = 21/267 (7%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G+G FG  +   D    +  A K I  ++    +  ED+++E+ ++      P +   
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQC-DSPYVTKY 85
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y  D+ + I+ME   GG   D ++  G   E   A +++ I++ +   H +  +HRD
Sbjct: 86  YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 144
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K  N L +   E   +K  DFG++      + + N  VG+P++MAPEV+K++ Y  + D
Sbjct: 145 IKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKAD 201
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN----AKDLVKKM 296
           +WS G+    L  G PP  +E        +I      K +P P +  N     K+ V+  
Sbjct: 202 IWSLGITAIELARGEPPH-SELHPMKVLFLIP-----KNNP-PTLEGNYSKPLKEFVEAC 254
Query: 297 LNPDPKQRLTAEEVLEHPW-LQNAKKA 322
           LN +P  R TA+E+L+H + L+NAKK 
Sbjct: 255 LNKEPSFRPTAKELLKHKFILRNAKKT 281

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 95/336 (28%), Positives = 141/336 (41%), Gaps = 59/336 (17%)
Query: 34  ANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKK 93
           A GS V   +    +   +   + Y   + +G G FGV Y     ++GE  A K +    
Sbjct: 2   AMGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---- 57
Query: 94  LRTAVDIEDVR---REVQIMKHLPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFD 146
                 ++D R   RE+QIM+ L  H NIV L+  +    E    V++ + L    E   
Sbjct: 58  ------LQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 110
Query: 147 RIVARGHYTERAAAAVMKTIVEVVQV------CHEQGVMHRDLKPENFLFANKKESSPLK 200
           R VAR +   +    V+   + + Q+       H  G+ HRD+KP+N L     +++ LK
Sbjct: 111 R-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLK 167
Query: 201 AIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF 258
             DFG +     GE     + S YY APE++    +Y   +DVWSAG +L  LL G P F
Sbjct: 168 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227
Query: 259 WAETEQGVAQAI-------------IRSV---------IDFKRDPW-----PKVSENAKD 291
             ++  GV Q +             IR +            K  PW     P+    A  
Sbjct: 228 PGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 285
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           L  ++L   P  RLT  E   H +    +  PNV L
Sbjct: 286 LCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 320

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 69
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 70  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 127
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 243
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 304 SFFDELRD-PNVKL 316

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 44/283 (15%)
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV-M 163
           REV ++K L KH NIV+L D    + ++ +V E  +  +L   +   G+        + +
Sbjct: 49  REVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL 106
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGS 222
             ++  +  CH Q V+HRDLKP+N L   + E   LK  DFGL+     P + ++  V +
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVT 163
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
            +Y  P++L    +Y  ++D+W  G I Y +  G P F   T +     I R +     +
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223
Query: 281 PWPKVSEN--------------------------AKDLVKKMLNPDPKQRLTAEEVLEHP 314
            WP +  N                            DL+ K+L  + + R++AE+ ++HP
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
Query: 315 WLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLS 357
           +         +SLGE +  +L   + +  LK+  LQ  A   S
Sbjct: 284 FF--------LSLGERIH-KLPDTTSIFALKEIQLQKEASLRS 317

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 21  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 70
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 71  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 128
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 129 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 186
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 244
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 245 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 304
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 305 SFFDELRD-PNVKL 317

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 21/271 (7%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G+G FG  +   D    +  A K I  ++    +  ED+++E+ ++      P +   
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQC-DSPYVTKY 70
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y  D+ + I+ME   GG   D ++  G   E   A +++ I++ +   H +  +HRD
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K  N L +   E   +K  DFG++      + + N  VG+P++MAPEV+K++ Y  + D
Sbjct: 130 IKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN----AKDLVKKM 296
           +WS G+    L  G PP  +E        +I      K +P P +  N     K+ V+  
Sbjct: 187 IWSLGITAIELARGEPPH-SELHPMKVLFLIP-----KNNP-PTLEGNYSKPLKEFVEAC 239
Query: 297 LNPDPKQRLTAEEVLEHPW-LQNAKKAPNVS 326
           LN +P  R TA+E+L+H + L+NAKK   ++
Sbjct: 240 LNKEPSFRPTAKELLKHKFILRNAKKTSYLT 270

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 21/271 (7%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G+G FG  +   D    +  A K I  ++    +  ED+++E+ ++      P +   
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQC-DSPYVTKY 70
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +Y  D+ + I+ME   GG   D ++  G   E   A +++ I++ +   H +  +HRD
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
           +K  N L +   E   +K  DFG++      + + N  VG+P++MAPEV+K++ Y  + D
Sbjct: 130 IKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN----AKDLVKKM 296
           +WS G+    L  G PP  +E        +I      K +P P +  N     K+ V+  
Sbjct: 187 IWSLGITAIELARGEPPH-SELHPMKVLFLIP-----KNNP-PTLEGNYSKPLKEFVEAC 239
Query: 297 LNPDPKQRLTAEEVLEHPW-LQNAKKAPNVS 326
           LN +P  R TA+E+L+H + L+NAKK   ++
Sbjct: 240 LNKEPSFRPTAKELLKHKFILRNAKKTSYLT 270

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 69
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 70  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 127
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 243
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 304 SFFDELRD-PNVKL 316

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKH 112
           + Y   + +G G FGV Y     ++GE  A K +          ++D R   RE+QIM+ 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRK 69
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           L  H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + 
Sbjct: 70  L-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLY 127
Query: 169 VVQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           + Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------- 270
            YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +          
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPT 243
Query: 271 ---IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              IR +            K  PW     P+    A  L  ++L   P  RLT  E   H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 314 PWLQNAKKAPNVSL 327
            +    +  PNV L
Sbjct: 304 SFFDELRD-PNVKL 316

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 132/311 (42%), Gaps = 53/311 (17%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           + Y   + +G G FGV Y     ++GE  A K + + K           RE+QIM+ L  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKL-D 71
Query: 116 HPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
           H NIV L+  +    E    V++ + L    E   R VAR +   +    V+   + + Q
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQ 130
Query: 172 V------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           +       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S YY
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 226 MAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI------------- 270
            APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +             
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQ 246
Query: 271 IRSV---------IDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           IR +            K  PW     P+    A  L  ++L   P  RLT  E   H + 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 317 QNAKKAPNVSL 327
              +  PNV L
Sbjct: 307 DELRD-PNVKL 316

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G+G FG  Y   D +  E  A K I  ++    +  ED+++E+ ++      P I    
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEI--EDIQQEITVLSQC-DSPYITRYF 83
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            +Y   + + I+ME   GG   D ++  G   E   A +++ I++ +   H +  +HRD+
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 142
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
           K  N L +   E   +K  DFG++      + + N  VG+P++MAPEV+K++ Y  + D+
Sbjct: 143 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADI 199
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV----SENAKDLVKKML 297
           WS G+    L  G PP             +R +    ++  P +    S+  K+ V+  L
Sbjct: 200 WSLGITAIELAKGEPP-------NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACL 252
Query: 298 NPDPKQRLTAEEVLEHPWLQNAKK 321
           N DP+ R TA+E+L+H ++    K
Sbjct: 253 NKDPRFRPTAKELLKHKFITRYTK 276

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 56/303 (18%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+   ++G+G FG  +       G+K A K +  +  +    I  +R E++I++ L KH 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHE 77
Query: 118 NIVSLKDTYEDDSA--------VHIVMELCE---GGELFDRIVARGHYTERAAAAVMKTI 166
           N+V+L +     ++        +++V + CE    G L + +V    +T      VM+ +
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 134
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------RPGEQFNEIV 220
           +  +   H   ++HRD+K  N L         LK  DFGL+  F      +P    N +V
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
            + +Y  PE+L  +R+YGP +D+W AG I+  +    P     TEQ     I +      
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 279 RDPWPKVSE----------------------------NAKDLVKKMLNPDPKQRLTAEEV 310
            + WP V                               A DL+ K+L  DP QR+ +++ 
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 311 LEH 313
           L H
Sbjct: 311 LNH 313

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 133/313 (42%), Gaps = 57/313 (18%)
Query: 56  IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           + Y   + +G G FGV Y     ++GE  A K + + K           RE+QIM+ L  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKL-D 71
Query: 116 HPNIVSLKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           H NIV L+  +      +D+  +++V++           VAR +   +    V+   + +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYR---VARHYSRAKQTLPVIYVKLYM 128
Query: 170 VQV------CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
            Q+       H  G+ HRD+KP+N L     +++ LK  DFG +     GE     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI----------- 270
           YY APE++    +Y   +DVWSAG +L  LL G P F  ++  GV Q +           
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTR 244
Query: 271 --IR---------SVIDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
             IR         +    K  PW     P+    A  L  ++L   P  RLT  E   H 
Sbjct: 245 EQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 315 WLQNAKKAPNVSL 327
           +    +  PNV L
Sbjct: 305 FFDELRD-PNVKL 316

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 56/303 (18%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+   ++G+G FG  +       G+K A K +  +  +    I  +R E++I++ L KH 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHE 77
Query: 118 NIVSLKDTYEDDSA--------VHIVMELCE---GGELFDRIVARGHYTERAAAAVMKTI 166
           N+V+L +     ++        +++V + CE    G L + +V    +T      VM+ +
Sbjct: 78  NVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML 134
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------RPGEQFNEIV 220
           +  +   H   ++HRD+K  N L         LK  DFGL+  F      +P    N +V
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
            + +Y  PE+L  +R+YGP +D+W AG I+  +    P     TEQ     I +      
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 279 RDPWPKVSE----------------------------NAKDLVKKMLNPDPKQRLTAEEV 310
            + WP V                               A DL+ K+L  DP QR+ +++ 
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 311 LEH 313
           L H
Sbjct: 311 LNH 313

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 56/303 (18%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+   ++G+G FG  +       G+K A K +  +  +    I  +R E++I++ L KH 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHE 77
Query: 118 NIVSLKDTYEDDSA--------VHIVMELCE---GGELFDRIVARGHYTERAAAAVMKTI 166
           N+V+L +     ++        +++V + CE    G L + +V    +T      VM+ +
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 134
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------RPGEQFNEIV 220
           +  +   H   ++HRD+K  N L         LK  DFGL+  F      +P    N +V
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
            + +Y  PE+L  +R+YGP +D+W AG I+  +    P     TEQ     I +      
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 279 RDPWPKVSE----------------------------NAKDLVKKMLNPDPKQRLTAEEV 310
            + WP V                               A DL+ K+L  DP QR+ +++ 
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 311 LEH 313
           L H
Sbjct: 311 LNH 313

>pdb|3SG5|A Chain A, Crystal Structure Of Dimeric Gcamp3-D380y, Qp(Linker 1), Lp(Linker 2) Length = 448

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DGDG++
Sbjct: 304 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTI 363
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 364 DFPEFLTMMARKMKYTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 423
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 424 MIREADIDGDGQVNYEEFVQMMTA 447

>pdb|3SG7|A Chain A, Crystal Structure Of Gcamp3-Kf(Linker 1) Length = 448

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DGDG++
Sbjct: 304 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTI 363
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 364 DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 423
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 424 MIREADIDGDGQVNYEEFVQMMTA 447

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 16/272 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ + R +GRG FG  Y C   + G+ +A K + KK+++     E +    +IM  L   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVST 248
Query: 117 ---PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
              P IV +   +     +  +++L  GG+L   +   G ++E         I+  ++  
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H + V++RDLKP N L     E   ++  D GL+  F   +  +  VG+  YMAPEVL++
Sbjct: 309 HNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQK 364
Query: 234 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
              Y    D +S G +L+ LL G  PF     +     I R  +    +     S   + 
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRS 423
Query: 292 LVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
           L++ +L  D  +RL      A+EV E P+ ++
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 56/303 (18%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y+   ++G+G FG  +       G+K A K +  +  +    I  +R E++I++ L KH 
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHE 76
Query: 118 NIVSLKDTYEDDSA--------VHIVMELCE---GGELFDRIVARGHYTERAAAAVMKTI 166
           N+V+L +     ++        +++V + CE    G L + +V    +T      VM+ +
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 133
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------RPGEQFNEIV 220
           +  +   H   ++HRD+K  N L         LK  DFGL+  F      +P    N +V
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
            + +Y  PE+L  +R+YGP +D+W AG I+  +    P     TEQ     I +      
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249
Query: 279 RDPWPKVSE----------------------------NAKDLVKKMLNPDPKQRLTAEEV 310
            + WP V                               A DL+ K+L  DP QR+ +++ 
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309
Query: 311 LEH 313
           L H
Sbjct: 310 LNH 312

>pdb|3SG3|A Chain A, Crystal Structure Of Gcamp3-D380y Length = 449

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DGDG++
Sbjct: 305 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTI 364
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 365 DFPEFLTMMARKMKYTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 424
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 425 MIREADIDGDGQVNYEEFVQMMTA 448

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 16/272 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ + R +GRG FG  Y C   + G+ +A K + KK+++     E +    +IM  L   
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVST 247
Query: 117 ---PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
              P IV +   +     +  +++L  GG+L   +   G ++E         I+  ++  
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 307
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H + V++RDLKP N L     E   ++  D GL+  F   +  +  VG+  YMAPEVL++
Sbjct: 308 HNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQK 363
Query: 234 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
              Y    D +S G +L+ LL G  PF     +     I R  +    +     S   + 
Sbjct: 364 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRS 422
Query: 292 LVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
           L++ +L  D  +RL      A+EV E P+ ++
Sbjct: 423 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 454

>pdb|3SG4|A Chain A, Crystal Structure Of Gcamp3-D380y, Lp(Linker 2) Length = 448

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DGDG++
Sbjct: 304 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTI 363
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 364 DFPEFLTMMARKMKYTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 423
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 424 MIREADIDGDGQVNYEEFVQMMTA 447

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 111/257 (43%), Gaps = 13/257 (5%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG G +G  +      +G  +A K  S    R   D      EV   + + +HP  V L+
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
             +E+   +++  ELC G  L     A G    E      ++  +  +   H QG++H D
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVW 242
           +KP N     +      K  DFGL V            G P YMAPE+L+ +YG   DV+
Sbjct: 183 VKPANIFLGPRGRC---KLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVF 239
Query: 243 SAGVILYILLCGVP-PFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           S G+ +  + C +  P   E  Q + Q  +    +F       +S   + ++  ML PDP
Sbjct: 240 SLGLTILEVACNMELPHGGEGWQQLRQGYLPP--EFTAG----LSSELRSVLVMMLEPDP 293
Query: 302 KQRLTAEEVLEHPWLQN 318
           K R TAE +L  P L+ 
Sbjct: 294 KLRATAEALLALPVLRQ 310

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 44/290 (15%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           R +G G +G      D    +K A K +S+   ++ +      RE++++KHL KH N++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHL-KHENVIG 83
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L D +      ED S V++V  L   G   + IV     ++     ++  ++  ++  H 
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-- 233
            G++HRDLKP N       E   L+ +DFGL+   +  E+    V + +Y APE++    
Sbjct: 142 AGIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 196
Query: 234 NYGPEVDVWSAGVILYILLCG-----------------------VPPFWAETEQGVAQAI 270
           +Y   VD+WS G I+  LL G                        P   A+     A+  
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 271 IRSVIDFKRDPWPKVSENAK----DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           I+S+    +     +   A     DL+ +ML  D  QR++A E L H + 
Sbjct: 257 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 306

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 16/272 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ + R +GRG FG  Y C   + G+ +A K + KK+++     E +    +IM  L   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVST 248
Query: 117 ---PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
              P IV +   +     +  +++L  GG+L   +   G ++E         I+  ++  
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H + V++RDLKP N L     E   ++  D GL+  F   +  +  VG+  YMAPEVL++
Sbjct: 309 HNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQK 364
Query: 234 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
              Y    D +S G +L+ LL G  PF     +     I R  +    +     S   + 
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRS 423
Query: 292 LVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
           L++ +L  D  +RL      A+EV E P+ ++
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 16/272 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ + R +GRG FG  Y C   + G+ +A K + KK+++     E +    +IM  L   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVST 248
Query: 117 ---PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
              P IV +   +     +  +++L  GG+L   +   G ++E         I+  ++  
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H + V++RDLKP N L     E   ++  D GL+  F   +  +  VG+  YMAPEVL++
Sbjct: 309 HNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQK 364
Query: 234 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
              Y    D +S G +L+ LL G  PF     +     I R  +    +     S   + 
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRS 423
Query: 292 LVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
           L++ +L  D  +RL      A+EV E P+ ++
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 48/290 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++  + LGRG FGV +   +  +   +A K I       A   E V REV+ +  L +H
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKL-EH 62
Query: 117 PNIVSLKDTYEDDSA------------VHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
           P IV   + + + +             ++I M+LC    L D +  R    ER  +  + 
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 165 T---IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-- 219
               I E V+  H +G+MHRDLKP N  F        +K  DFGL       E+   +  
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 220 -----------VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 267
                      VG+  YM+PE +  N Y  +VD++S G+IL+ LL    PF  + E+   
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--- 233
Query: 268 QAIIRSVIDFKRDPWPKVSENAKD----LVKKMLNPDPKQRLTAEEVLEH 313
              +R++ D +   +P +          +V+ ML+P P +R  A  ++E+
Sbjct: 234 ---VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E S LK +DFGL       ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDSELKILDFGLCR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 89
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E S LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 148 IIHRDLKPSNLAV---NEDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 203 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 262
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 263 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 93
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E S LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 152 IIHRDLKPSNLAV---NEDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 207 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 266
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 267 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1EXR|A Chain A, The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Calmodulin Length = 148

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 83/145 (57%), Gaps = 1/145 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           AE L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+++    +K+  ++E L +AF  FDR+ +G I   ELR+ + +  +   +D 
Sbjct: 61  GTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMM 496
           ++ ++ + D D DG I+YEEF  MM
Sbjct: 121 VDEMIREADIDGDGHINYEEFVRMM 145

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 83
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCAKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 142 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 257 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2LV6|A Chain A, The Complex Between Ca-calmodulin And Skeletal Muscle Myosin Light Chain Kinase From Combination Of Nmr And Aqueous And Contrast-matched Saxs Data Length = 148

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FD++ +GFI   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 VDEMIREADIDGDGQVNYEEFVTMMTA 147

>pdb|3EK8|A Chain A, Calcium-Saturated Gcamp2 T116vG87R MUTANT MONOMER Length = 449

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 305 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 364
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 365 DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 424
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 425 MIREADIDGDGQVNYEEFVQMMTA 448

>pdb|3EVU|A Chain A, Crystal Structure Of Calcium Bound Dimeric Gcamp2, (#1) Length = 449

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 305 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 364
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 365 DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 424
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 425 MIREADIDGDGQVNYEEFVQMMTA 448

>pdb|3EVR|A Chain A, Crystal Structure Of Calcium Bound Monomeric Gcamp2 Length = 411

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 268 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 327
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 328 DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 387
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 388 MIREADIDGDGQVNYEEFVQMMTA 411

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 107
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 166 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 220
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 221 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 280
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 281 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +SK   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 99
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 158 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 212
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 213 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 272
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 273 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3EKH|A Chain A, Calcium-Saturated Gcamp2 T116vK378W MUTANT MONOMER Length = 449

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 305 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 364
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 365 DFPEFLTMMARWMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 424
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 425 MIREADIDGDGQVNYEEFVQMMTA 448

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 20/254 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG FG   +    N    +A K ++K ++    +    R E  ++ +    
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-GDC 133
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE 175
             I +L   ++D++ +++VM+   GG+L   +        E  A   +  +V  +   H+
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              +HRD+KP+N L      +  ++  DFG  L +      Q +  VG+P Y++PE+L+ 
Sbjct: 194 LHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 250
Query: 234 ------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
                  YGPE D WS GV +Y +L G  PF+AE+       I+     F+   +P    
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHVT 307
Query: 285 -VSENAKDLVKKML 297
            VSE AKDL+++++
Sbjct: 308 DVSEEAKDLIQRLI 321

>pdb|3SG6|A Chain A, Crystal Structure Of Dimeric Gcamp2-Lia(Linker 1) Length = 450

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 306 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 365
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 366 DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 425
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 426 MIREADIDGDGQVNYEEFVQMMTA 449

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 106
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 165 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 219
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 220 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 279
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 280 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3O77|A Chain A, The Structure Of Ca2+ Sensor (Case-16) Length = 415

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 271 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 330
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 331 DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 390
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 391 MIREADIDGDGQVNYEEFVQMMTA 414

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 93
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 152 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 207 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 266
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 267 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3O78|A Chain A, The Structure Of Ca2+ Sensor (Case-12) Length = 415

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 271 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 330
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 331 DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 390
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 391 MIREADIDGDGQVNYEEFVQMMTA 414

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 20/254 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG FG   +    N    +A K ++K ++    +    R E  ++ +    
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-GDC 149
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE 175
             I +L   ++D++ +++VM+   GG+L   +        E  A   +  +V  +   H+
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
              +HRD+KP+N L      +  ++  DFG  L +      Q +  VG+P Y++PE+L+ 
Sbjct: 210 LHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 266
Query: 234 ------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
                  YGPE D WS GV +Y +L G  PF+AE+       I+     F+   +P    
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHVT 323
Query: 285 -VSENAKDLVKKML 297
            VSE AKDL+++++
Sbjct: 324 DVSEEAKDLIQRLI 337

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 97
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 98  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 155
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 156 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 210
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 211 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 270
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 271 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 318

>pdb|2K0J|A Chain A, Solution Structure Of Cam Complexed To Drp1p Length = 148

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DGD
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGD 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 VDEMIREADIDGDGQVNYEEFVQMMTA 147

>pdb|3SG2|A Chain A, Crystal Structure Of Gcamp2-T116v,D381y Length = 449

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 305 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 364
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 365 DFPEFLTMMARKMKYTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 424
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 425 MIREADIDGDGQVNYEEFVQMMTA 448

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 25/277 (9%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L
Sbjct: 124 HKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 175
Query: 232 K-RNYGPEVDVWSAGVILYILLCG---VPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           +  +Y  + D+WS G+ L  +  G   +PP  A+ +     AI   +     +P PK+  
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPS 235
Query: 288 NA-----KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
                  +D V K L  +P +R   ++++ H +++ +
Sbjct: 236 GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 272

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 94
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 153 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 268 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 38/299 (12%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--K 115
           Y+   E+G G +G  Y   D ++G   A KS+        + I  VR EV +++ L   +
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFE 64
Query: 116 HPNIVSLKD---TYEDDSAVHIVMELCEGGE----LFDRIVARGHYTERAAAAVMKTIVE 168
           HPN+V L D   T   D  + + +      +      D+    G   E     +M+  + 
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLR 123
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            +   H   ++HRDLKPEN L  +      +K  DFGL+  +      + +V + +Y AP
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 229 EV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
           EV L+  Y   VD+WS G I   +    P F   +E      I   +     D WP+   
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 240
Query: 285 --------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
                               + E+   L+ +ML  +P +R++A   L+H +L   +  P
Sbjct: 241 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 94
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 153 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 268 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 94
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 153 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 268 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 107
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 166 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMXGXVATRWYRAPEIMLNWMHY 220
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 221 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 280
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 281 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 83
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 142 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 257 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2BKH|B Chain B, Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Structure Length = 149

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 85/148 (57%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E + +AF  FD++ +GFI   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+++YEEF  MM +
Sbjct: 121 EVDEMIREADIDGDGQVNYEEFVTMMTS 148

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRNY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNAMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1CLM|A Chain A, Structure Of Paramecium Tetraurelia Calmodulin At 1.8 Angstroms Resolution Length = 148

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 83/145 (57%), Gaps = 1/145 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   AQELTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+++    +K+  ++E L +AF  FDR+ +G I   ELR+ + +  +   +D 
Sbjct: 61  GTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMM 496
           ++ ++ + D D DG I+YEEF  MM
Sbjct: 121 VDEMIREADIDGDGHINYEEFVRMM 145

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 92
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 151 IIHRDLKPSNLAV---NEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 206 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 265
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 266 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 83
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 142 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHY 196
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 257 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 99
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 158 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 212
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 213 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 272
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 273 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 99
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 158 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 212
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 213 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 272
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 273 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 98
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 157 IIHRDLKPSNLAV---NEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 211
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 212 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 271
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 272 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 98
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 157 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 211
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 212 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 271
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 272 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|2F2O|A Chain A, Structure Of Calmodulin Bound To A Calcineurin Peptide: A New Way Of Making An Old Binding Mode Length = 179

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 85/148 (57%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 EVDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|1OOJ|A Chain A, Structural Genomics Of Caenorhabditis Elegans : Calmodulin Length = 149

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 84/146 (57%), Gaps = 1/146 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E + +AF  FD++ +GFI   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMM 496
            ++ ++ + D D DG+++YEEF  MM
Sbjct: 121 EVDEMIREADIDGDGQVNYEEFVTMM 146

>pdb|2BBM|A Chain A, Solution Structure Of A Calmodulin-Target Peptide Complex By Multidimensional Nmr Length = 148

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FD++ +GFI   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  MM +
Sbjct: 121 VDEMIREADIDGDGQVNYEEFVTMMTS 147

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 89
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 148 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 203 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 262
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 263 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 107
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 166 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 220
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 221 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 280
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 281 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 93
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 152 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 207 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 266
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 267 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 106
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 165 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 219
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 220 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 279
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 280 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 93
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 152 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 207 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 266
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 267 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 92
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 151 IIHRDLKPSNLAV---NEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 206 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 265
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 266 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 110
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 169 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 223
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 224 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 283
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 284 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|2VB6|B Chain B, Myosin Vi (Md-Insert2-Cam, Delta Insert1) Post-Rigor State ( Crystal Form 2) Length = 149

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 85/148 (57%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E + +AF  FD++ +GFI   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+++YEEF  MM +
Sbjct: 121 EVDEMIRESDIDGDGQVNYEEFVTMMTS 148

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 92
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 151 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 206 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 265
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 266 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 92
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 151 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 206 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 265
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 266 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 86
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 144
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 145 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 199
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 200 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 259
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 260 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 307

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 94
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 153 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 207
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 268 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGXVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1XFU|O Chain O, Crystal Structure Of Anthrax Edema Factor (ef) Truncation Mutant, Ef-delta 64 In Complex With Calmodulin Length = 149

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 85/148 (57%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 EVDQMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 89
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 148 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 203 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 262
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 263 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G+G FG  +   D    +  A K I  ++    +  ED+++E+ ++        +    
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVLSQC-DSSYVTKYY 87
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
            +Y   S + I+ME   GG   D + A G + E   A ++K I++ +   H +  +HRD+
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 146
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
           K  N L +   E   +K  DFG++      + + N  VG+P++MAPEV++++ Y  + D+
Sbjct: 147 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 203
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV----SENAKDLVKKML 297
           WS G+    L  G PP             +R +    ++  P +    +++ K+ +   L
Sbjct: 204 WSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACL 256
Query: 298 NPDPKQRLTAEEVLEHPWL-QNAKKAPNVS 326
           N DP  R TA+E+L+H ++ +N+KK   ++
Sbjct: 257 NKDPSFRPTAKELLKHKFIVKNSKKTSYLT 286

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 85
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 143
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 144 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 198
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 199 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 258
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 259 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 306

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 110
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 169 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMXGYVATRWYRAPEIMLNWMHY 223
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 224 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 283
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 284 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/347 (25%), Positives = 132/347 (38%), Gaps = 74/347 (21%)
Query: 40  VHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD 99
           +H +C     SG  +S  Y++   LG G FG    C D   G +     I K   R    
Sbjct: 2   MHLIC----QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-- 55
Query: 100 IEDVRREVQIMKHL-PKHPN----IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY 154
            E  R E+Q+++HL    PN     V + + +E    + IV EL  G   +D I   G  
Sbjct: 56  -EAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFL 113
Query: 155 TERA--AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP-------------- 198
             R      +   I + V   H   + H DLKPEN LF     +                
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 199 --LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVIL---YILL 252
             +K +DFG + +    E  + +V + +Y APEV L   +    DVWS G IL   Y+  
Sbjct: 174 PDIKVVDFGSATY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
Query: 253 CGVPPFWAETEQGVAQAII-------------RSVIDFKRDPWPKVSENAK--------- 290
              P   ++    + + I+             R      R  W + S   +         
Sbjct: 232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL 291
Query: 291 ---------------DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
                          DL++KML  DP +R+T  E L+HP+    KK+
Sbjct: 292 KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 129/275 (46%), Gaps = 27/275 (9%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 82
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L
Sbjct: 143 HKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 194
Query: 232 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-KRDPWPKVSENA 289
           +  +Y  + D+WS G+ L  +  G  P  +    G     I  ++D+   +P PK+    
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPIGS----GSGSMAIFELLDYIVNEPPPKLPSGV 250
Query: 290 -----KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
                +D V K L  +P +R   ++++ H +++ +
Sbjct: 251 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 285

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 83
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 142 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 133/311 (42%), Gaps = 60/311 (19%)
Query: 58  YDLG------RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
           +DLG      + LG G  G+ +   D +  ++ A K I    L     ++   RE++I++
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIR 63
Query: 112 HLPKHPNIVSLKDTY-------EDD-------SAVHIVMELCEGGELFDRIVARGHYTER 157
            L  H NIV + +          DD       ++V+IV E  E       ++ +G   E 
Sbjct: 64  RL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEE 120
Query: 158 AAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--- 214
            A   M  ++  ++  H   V+HRDLKP N LF N  E   LK  DFGL+    P     
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIMDPHYSHK 178
Query: 215 -QFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
              +E + + +Y +P +L    NY   +D+W+AG I   +L G   F    E    Q I+
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238
Query: 272 RSV----------------IDFKRDP----------WPKVSENAKDLVKKMLNPDPKQRL 305
            S+                +  + D            P +S  A D ++++L   P  RL
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
Query: 306 TAEEVLEHPWL 316
           TAEE L HP++
Sbjct: 299 TAEEALSHPYM 309

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 84
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 143 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 197
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 198 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 257
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 258 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 89
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 148 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 203 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 262
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 263 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 84
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+      ++    V + +Y APE++    +Y
Sbjct: 143 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 197
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 198 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 257
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 258 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 38/284 (13%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG F    +      G+ +A K ++K  +    ++   R E  ++ +  + 
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV----MKTIVEVVQV 172
             I  L   ++D++ +++VME   GG+L   +   G   ER  A +    +  IV  +  
Sbjct: 122 -WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDS 177
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV--GSPYYMAPEV 230
            H  G +HRD+KP+N L         ++  DFG  +  R       +V  G+P Y++PE+
Sbjct: 178 VHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 231 LK--------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------SVI 275
           L+         +YGPE D W+ GV  Y +  G  PF+A++       I+         ++
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294
Query: 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWL 316
           D        V E A+D ++++L P P+ RL    A +   HP+ 
Sbjct: 295 D------EGVPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPFF 331

>pdb|2WEL|D Chain D, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 150

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 85/148 (57%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 2   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 61
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++
Sbjct: 62  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDE 121
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+++YEEF  MM A
Sbjct: 122 EVDEMIREADIDGDGQVNYEEFVQMMTA 149

>pdb|2BE6|A Chain A, 2.0 A Crystal Structure Of The Cav1.2 Iq Domain-CaCAM COMPLEX Length = 150

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 85/148 (57%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 EVDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 38/299 (12%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--K 115
           Y+   E+G G +G  Y   D ++G   A KS+        + I  VR EV +++ L   +
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFE 64
Query: 116 HPNIVSLKD---TYEDDSAVHIVMELCEGGE----LFDRIVARGHYTERAAAAVMKTIVE 168
           HPN+V L D   T   D  + + +      +      D+    G   E     +M+  + 
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLR 123
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            +   H   ++HRDLKPEN L  +      +K  DFGL+  +        +V + +Y AP
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 229 EV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
           EV L+  Y   VD+WS G I   +    P F   +E      I   +     D WP+   
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 240
Query: 285 --------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
                               + E+   L+ +ML  +P +R++A   L+H +L   +  P
Sbjct: 241 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|2YGG|B Chain B, Complex Of Cambr And Cam Length = 150

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 85/148 (57%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 EVDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|1IQ5|A Chain A, CalmodulinNEMATODE CA2+CALMODULIN DEPENDENT KINASE KINASE Fragment Length = 149

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 85/148 (57%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 EVDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|4DJC|A Chain A, 1.35 A Crystal Structure Of The Nav1.5 Diii-Iv-CaCAM COMPLEX Length = 152

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 85/149 (57%), Gaps = 1/149 (0%)
Query: 351 VVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVD 410
            +A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D D
Sbjct: 3   AMADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDAD 62
Query: 411 GDGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGE 469
           G+G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   +
Sbjct: 63  GNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTD 122
Query: 470 DVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           + ++ ++ + D D DG+++YEEF  MM A
Sbjct: 123 EEVDEMIREADIDGDGQVNYEEFVQMMTA 151

>pdb|1PRW|A Chain A, Crystal Structure Of Bovine Brain Ca++ Calmodulin In A Compact Form Length = 149

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 2   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 61
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ 
Sbjct: 62  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEXLTDEE 121
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  MM A
Sbjct: 122 VDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|1UP5|B Chain B, Chicken Calmodulin Length = 148

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEXLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 VDEMIREADIDGDGQVNYEEFVQMMTA 147

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 131/290 (45%), Gaps = 44/290 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G K A K + +   ++ +  +   RE++++KH+ +H N++ L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHM-RHENVIGLL 90
Query: 124 DTYEDDSAV------HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +  D  +      ++VM     G    +++      E     ++  +++ ++  H  G
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DFGL+   +   +    V + +Y APEV+     Y
Sbjct: 149 IIHRDLKPGNLAV---NEDCELKILDFGLAR--QADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 236 GPEVDVWSAGVILYILLCG---------------------VPP--FWAETEQGVAQAIIR 272
              VD+WS G I+  ++ G                      PP  F    +   A+  ++
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 273 SVIDFKRDPWPKVSENAK----DLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
            + + ++  +  +  NA     +L++KML  D +QR+TA E L HP+ ++
Sbjct: 264 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

>pdb|3EWT|A Chain A, Crystal Structure Of Calmodulin Complexed With A Peptide Length = 154

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 7   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 66
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ 
Sbjct: 67  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEE 126
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  MM A
Sbjct: 127 VDEMIREADIDGDGQVNYEEFVQMMTA 153

>pdb|1CM1|A Chain A, Motions Of Calmodulin-Single-Conformer Refinement Length = 148

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 VDEMIREADIDGDGQVNYEEFVQMMTA 147

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 38/299 (12%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--K 115
           Y+   E+G G +G  Y   D ++G   A KS+        + I  VR EV +++ L   +
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFE 64
Query: 116 HPNIVSLKD---TYEDDSAVHIVMELCEGGE----LFDRIVARGHYTERAAAAVMKTIVE 168
           HPN+V L D   T   D  + + +      +      D+    G   E     +M+  + 
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLR 123
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            +   H   ++HRDLKPEN L  +      +K  DFGL+  +        +V + +Y AP
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALFPVVVTLWYRAP 180
Query: 229 EV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
           EV L+  Y   VD+WS G I   +    P F   +E      I   +     D WP+   
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 240
Query: 285 --------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
                               + E+   L+ +ML  +P +R++A   L+H +L   +  P
Sbjct: 241 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|1CDL|A Chain A, Target Enzyme Recognition By Calmodulin: 2.4 Angstroms Structure Of A Calmodulin-Peptide Complex Length = 147

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  MM A
Sbjct: 121 VDEMIREADIDGDGQVNYEEFVQMMTA 147

>pdb|2VAY|A Chain A, Calmodulin Complexed With Cav1.1 Iq Peptide Length = 146

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 2   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 61
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 62  DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 121
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 122 MIREADIDGDGQVNYEEFVQMMTA 145

>pdb|1AHR|A Chain A, Calmodulin Mutant With A Two Residue Deletion In The Central Helix Length = 146

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 86/147 (58%), Gaps = 3/147 (2%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVHLKKMAN-DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+  ++  +KM + +E + +AF  FD++ +GFI   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFL--TMMARKMKDSEEEIREAFRVFDKDGNGFISAAELRHVMTNLGEKLTDEE 118
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  MM +
Sbjct: 119 VDEMIREADIDGDGQVNYEEFVTMMTS 145

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 131/305 (42%), Gaps = 55/305 (18%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y   + +G G  G+     D   G   A K +S+   +     +   RE+ ++K +  H 
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCV-NHK 83
Query: 118 NIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
           NI+SL      + T E+   V++VMEL +      +++      ER +  + + +  +  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKH 141
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV- 230
           + H  G++HRDLKP N +    K    LK +DFGL+            V + YY APEV 
Sbjct: 142 L-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 231 LKRNYGPEVDVWSAGVILYILLCGVPPF--------WAET-EQ---------GVAQAIIR 272
           L   Y   VD+WS G I+  L+ G   F        W +  EQ            Q  +R
Sbjct: 198 LGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVR 257
Query: 273 SVIDFKRDPWPKV---------------------SENAKDLVKKMLNPDPKQRLTAEEVL 311
           + ++  R  +P +                     +  A+DL+ KML  DP +R++ +E L
Sbjct: 258 NYVE-NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 316
Query: 312 EHPWL 316
            HP++
Sbjct: 317 RHPYI 321

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +D+GL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDYGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1CDM|A Chain A, Modulation Of Calmodulin Plasticity In Molecular Recognition On The Basis Of X-Ray Structures Length = 144

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 1   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 60
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 61  DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 120
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  MM A
Sbjct: 121 MIREADIDGDGQVNYEEFVQMMTA 144

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 90/347 (25%), Positives = 131/347 (37%), Gaps = 74/347 (21%)
Query: 40  VHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD 99
           +H +C     SG  +S  Y++   LG G FG    C D   G +     I K   R    
Sbjct: 2   MHLIC----QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-- 55
Query: 100 IEDVRREVQIMKHL-PKHPN----IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY 154
            E  R E+Q+++HL    PN     V + + +E    + IV EL  G   +D I   G  
Sbjct: 56  -EAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFL 113
Query: 155 TERA--AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP-------------- 198
             R      +   I + V   H   + H DLKPEN LF     +                
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 199 --LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVIL---YILL 252
             +K +DFG + +    E  + +V   +Y APEV L   +    DVWS G IL   Y+  
Sbjct: 174 PDIKVVDFGSATY--DDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
Query: 253 CGVPPFWAETEQGVAQAII-------------RSVIDFKRDPWPKVS------------- 286
              P   ++    + + I+             R      R  W + S             
Sbjct: 232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL 291
Query: 287 -----------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
                      E   DL++KML  DP +R+T  E L+HP+    KK+
Sbjct: 292 KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 127/311 (40%), Gaps = 41/311 (13%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRR 105
           P G   +  Y+   E+G G +G  Y   D ++G   A KS+   +       + I  VR 
Sbjct: 2   PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR- 60
Query: 106 EVQIMKHLP--KHPNIVSLKD---TYEDDSAVHIVMELCEGGE----LFDRIVARGHYTE 156
           EV +++ L   +HPN+V L D   T   D  + + +      +      D+    G   E
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
                +M+  +  +   H   ++HRDLKPEN L  +      +K  DFGL+  +      
Sbjct: 121 -TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMAL 176
Query: 217 NEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275
             +V + +Y APEV L+  Y   VD+WS G I   +    P F   +E      I   + 
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 276 DFKRDPWPK-----------------------VSENAKDLVKKMLNPDPKQRLTAEEVLE 312
               D WP+                       + E+   L+ +ML  +P +R++A   L+
Sbjct: 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296
Query: 313 HPWLQNAKKAP 323
           H +L   +  P
Sbjct: 297 HSYLHKDEGNP 307

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 131/305 (42%), Gaps = 55/305 (18%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y   + +G G  G+     D   G   A K +S+   +     +   RE+ ++K +  H 
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCV-NHK 81
Query: 118 NIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
           NI+SL      + T E+   V++VMEL +      +++      ER +  + + +  +  
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKH 139
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV- 230
           + H  G++HRDLKP N +    K    LK +DFGL+            V + YY APEV 
Sbjct: 140 L-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 231 LKRNYGPEVDVWSAGVILYILLCGVPPF--------WAET-EQ---------GVAQAIIR 272
           L   Y   VD+WS G I+  L+ G   F        W +  EQ            Q  +R
Sbjct: 196 LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVR 255
Query: 273 SVIDFKRDPWPKV---------------------SENAKDLVKKMLNPDPKQRLTAEEVL 311
           + ++  R  +P +                     +  A+DL+ KML  DP +R++ +E L
Sbjct: 256 NYVE-NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 314
Query: 312 EHPWL 316
            HP++
Sbjct: 315 RHPYI 319

>pdb|1QTX|A Chain A, The 1.65 Angstrom Structure Of Calmodulin Rs20 Peptide Complex Length = 148

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   ADQLTDEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E L +AF  FD++ +GFI   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFLNLMARKMKDTDSEEELKEAFRVFDKDGNGFISAAELRHVMTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  +M A
Sbjct: 121 VDEMIREADVDGDGQVNYEEFVQVMMA 147

>pdb|1VRK|A Chain A, The 1.9 Angstrom Structure Of E84k-Calmodulin Rs20 Peptide Complex Length = 148

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   ADQLTDEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E L +AF  FD++ +GFI   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFLNLMARKMKDTDSEEKLKEAFRVFDKDGNGFISAAELRHVMTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG+++YEEF  +M A
Sbjct: 121 VDEMIREADVDGDGQVNYEEFVQVMMA 147

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 132/308 (42%), Gaps = 49/308 (15%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           R L  G F   Y   DV +G ++A K +    ++K R  +      +EV  MK L  HPN
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII------QEVCFMKKLSGHPN 87
Query: 119 IVSL--------KDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVE 168
           IV          +++    +   ++ ELC+G   E   ++ +RG  +      +      
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 169 VVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFN------- 217
            VQ  H Q   ++HRDLK EN L +N+     +K  DFG   ++   P   ++       
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQ---GTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 218 --EIV--GSPYYMAPEV--LKRNY--GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 269
             EI    +P Y  PE+  L  N+  G + D+W+ G ILY+L     PF    E G    
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLR 260
Query: 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE 329
           I+     +   P          L++ ML  +P++RL+  EV+    LQ    A NV+   
Sbjct: 261 IVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ--LQEIAAARNVNPKS 316
Query: 330 TVKARLKQ 337
            +   L+Q
Sbjct: 317 PITELLEQ 324

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 127/273 (46%), Gaps = 27/273 (9%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 66
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
             +MHRD+KP N L  ++ E   +K  DFG+S      E  NE VG+  YM+PE L+  +
Sbjct: 127 HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DEMANEFVGTRSYMSPERLQGTH 182
Query: 235 YGPEVDVWSAGVILYILLCG---VPPFWAETEQGVAQAIIRSVIDFKRDPWPKV-----S 286
           Y  + D+WS G+ L  +  G    PP           AI   +     +P PK+     S
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGRYPRPPM----------AIFELLDYIVNEPPPKLPSAVFS 232
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
              +D V K L  +P +R   ++++ H +++ +
Sbjct: 233 LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 265

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +DF L+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDFYLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 132/300 (44%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVVAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMK-VVNHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +V +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K  + LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS GVI+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1QS7|A Chain A, The 1.8 Angstrom Structure Of Calmodulin Rs20 Peptide Complex Length = 145

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 82/144 (56%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 1   LTDEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 60
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E L +AF  FD++ +GFI   ELR+ + +  +   ++ ++ 
Sbjct: 61  DFPEFLNLMARKMKDTDSEEELKEAFRVFDKDGNGFISAAELRHVMTNLGEKLTDEEVDE 120
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ + D D DG+++YEEF  +M A
Sbjct: 121 MIREADVDGDGQVNYEEFVQVMMA 144

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK + FGL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILGFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1DMO|A Chain A, Calmodulin, Nmr, 30 Structures Length = 148

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + + D DG+++YEEF  MM A
Sbjct: 121 VDEMIREANIDGDGQVNYEEFVQMMTA 147

>pdb|1Y0V|H Chain H, Crystal Structure Of Anthrax Edema Factor (Ef) In Complex With Calmodulin And Pyrophosphate Length = 146

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 80/141 (56%), Gaps = 1/141 (0%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSLNYG 418
           E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++++ 
Sbjct: 5   EQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFP 64
Query: 419 EFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH 477
           EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ ++ 
Sbjct: 65  EFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIR 124
Query: 478 DVDTDKDGRISYEEFAVMMKA 498
           + D D DG+++YEEF  MM A
Sbjct: 125 EADIDGDGQVNYEEFVQMMTA 145

>pdb|4GOW|D Chain D, Crystal Structure Of Ca2+CAM:KV7.4 (KCNQ4) B HELIX COMPLEX Length = 144

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 81/142 (57%), Gaps = 1/142 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 2   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 61
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 62  DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 121
Query: 475 IMHDVDTDKDGRISYEEFAVMM 496
           ++ + D D DG+++YEEF  MM
Sbjct: 122 MIREADIDGDGQVNYEEFVQMM 143

>pdb|1K93|D Chain D, Crystal Structure Of The Adenylyl Cyclase Domain Of Anthrax Edema Factor (Ef) In Complex With Calmodulin Length = 144

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 80/141 (56%), Gaps = 1/141 (0%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSLNYG 418
           E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++++ 
Sbjct: 3   EQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFP 62
Query: 419 EFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH 477
           EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ ++ 
Sbjct: 63  EFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIR 122
Query: 478 DVDTDKDGRISYEEFAVMMKA 498
           + D D DG+++YEEF  MM A
Sbjct: 123 EADIDGDGQVNYEEFVQMMTA 143

>pdb|4AQR|A Chain A, Crystal Structure Of A Calmodulin In Complex With The Regulatory Domain Of A Plasma-Membrane Ca2+-Atpase Length = 149

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 86/148 (58%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ ++++  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTDDQISEFKEAFSLFDKDGDGCITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E L +AF  FD++++GFI   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLNLMARKMKDTDSEEELKEAFRVFDKDQNGFISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+I+YEEF  +M A
Sbjct: 121 EVDEMIREADVDGDGQINYEEFVKVMMA 148

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 132/300 (44%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMK-VVNHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +V +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K  + LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS GVI+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2IX7|A Chain A, Structure Of Apo-Calmodulin Bound To Unconventional Myosin V Length = 145

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 81/142 (57%), Gaps = 1/142 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++
Sbjct: 3   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 62
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ +    +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ 
Sbjct: 63  DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDE 122
Query: 475 IMHDVDTDKDGRISYEEFAVMM 496
           ++ + D D DG+++YEEF  MM
Sbjct: 123 MIREADIDGDGQVNYEEFVQMM 144

>pdb|1DEG|A Chain A, The Linker Of Des-Glu84 Calmodulin Is Bent As Seen In The Crystal Structure Length = 142

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 78/140 (55%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSLNYG 418
           E++A  KEAF + D +  G I             QN  EA+LQ ++   D DG+G++++ 
Sbjct: 3   EQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFP 62
Query: 419 EFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD 478
           EF+ +     K  + E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ ++ +
Sbjct: 63  EFLTMMARKMKDTDSEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 122
Query: 479 VDTDKDGRISYEEFAVMMKA 498
            + D DG+++YEEF  MM A
Sbjct: 123 ANIDGDGQVNYEEFVQMMTA 142

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/336 (23%), Positives = 134/336 (39%), Gaps = 84/336 (25%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLP 114
           Y LG+ LG G FG+     D+ +G++FA K +          ++D R   RE+ IMK L 
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----------LQDPRYKNRELDIMKVL- 57
Query: 115 KHPNIVSLKDTY--------------------------------------EDDSAVHIVM 136
            H NI+ L D +                                        +  ++++M
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 137 ELCEGG--ELFDRIVARGHYTERAAAAV-MKTIVEVVQVCHEQGVMHRDLKPENFLFANK 193
           E       ++    +  G        ++ +  +   V   H  G+ HRD+KP+N L  N 
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN-LLVNS 176
Query: 194 KESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYIL 251
           K+++ LK  DFG +    P E     + S +Y APE++     Y P +D+WS G +   L
Sbjct: 177 KDNT-LKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 252 LCGVPPFWAET-----------------EQGVAQAIIRSVIDF---KRDPWPKV-----S 286
           + G P F  ET                 EQ +      + + F   K   W K+      
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
             A DL++++L  +P  R+   E + HP+  + + +
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNS 331

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 127/268 (47%), Gaps = 27/268 (10%)
Query: 56  IDY---DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           IDY   ++   +GRG FGV  +C      +  A K I  +  R A  +E +R+  ++   
Sbjct: 5   IDYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVE-LRQLSRV--- 58
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ- 171
              HPNIV L     +   V +VME  EGG L++ +          AA  M   ++  Q 
Sbjct: 59  --NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 172 -----VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
                    + ++HRDLKP N L       + LK  DFG +   +     N+  GS  +M
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNK--GSAAWM 170
Query: 227 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK- 284
           APEV +  NY  + DV+S G+IL+ ++    PF  +   G A  I+ +V +  R P  K 
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKN 228
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLE 312
           + +  + L+ +  + DP QR + EE+++
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/356 (23%), Positives = 142/356 (39%), Gaps = 100/356 (28%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y++   +GRG +G  YL  D N  +  A K +++      +D + + RE+ I+  L K 
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRM-FEDLIDCKRILREITILNRL-KS 86
Query: 117 PNIVSLKDTYEDDSAV-----HIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEV 169
             I+ L D    +  +     +IV+E+ +    +LF   +     TE+    ++  ++  
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEQHVKTILYNLLLG 143
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-------------------VFF 210
            +  HE G++HRDLKP N L     +   +K  DFGL+                      
Sbjct: 144 EKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENE 200
Query: 211 RPG-------EQFNEIVGSPYYMAPE--VLKRNYGPEVDVWSAGVILYILL--------- 252
            PG       +Q    V + +Y APE  +L+ NY   +D+WS G I   LL         
Sbjct: 201 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINN 260
Query: 253 ----------------------------------------CGVPP---FWAETEQGVAQA 269
                                                    G PP       T+Q V + 
Sbjct: 261 PTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKY 320
Query: 270 I----IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           I     R  ID  +  +  +S+   DL++ ML  + ++R+T ++ L HP+L++ +K
Sbjct: 321 IKLFPTRDGIDLSKK-YSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRK 375

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +D GL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDAGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 127/268 (47%), Gaps = 27/268 (10%)
Query: 56  IDY---DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           IDY   ++   +GRG FGV  +C      +  A K I  +  R A  +E +R+  ++   
Sbjct: 6   IDYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVE-LRQLSRV--- 59
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ- 171
              HPNIV L     +   V +VME  EGG L++ +          AA  M   ++  Q 
Sbjct: 60  --NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 115
Query: 172 -----VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
                    + ++HRDLKP N L       + LK  DFG +   +     N+  GS  +M
Sbjct: 116 VAYLHSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNK--GSAAWM 171
Query: 227 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK- 284
           APEV +  NY  + DV+S G+IL+ ++    PF  +   G A  I+ +V +  R P  K 
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKN 229
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLE 312
           + +  + L+ +  + DP QR + EE+++
Sbjct: 230 LPKPIESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|5TNC|A Chain A, Refined Crystal Structure Of Troponin C From Turkey Skeletal Muscle At 2.0 Angstroms Resolution Length = 162

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 79/148 (53%), Gaps = 4/148 (2%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGS 414
           FLS E +A  K AF+M D +  G I+            QN  + +L  ++E  D DG G+
Sbjct: 13  FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGT 72
Query: 415 LNYGEFVAVSV-HLKKMA---NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +++ EF+ + V  +K+ A   ++E L   F  FD+N  GFI+IEEL   L    +   E+
Sbjct: 73  IDFEEFLVMMVRQMKEDAKGKSEEELEDCFRIFDKNADGFIDIEELGEILRATGEHVTEE 132
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            I  +M D D + DGRI ++EF  MM+ 
Sbjct: 133 DIEDLMKDSDKNNDGRIDFDEFLKMMEG 160

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 120/261 (45%), Gaps = 19/261 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +G G FG  Y    +  G++ A K+         +  IE+VR+E ++   L KHPNI++L
Sbjct: 15  IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIAL 71
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG---VM 179
           +     +  + +VME   GG L +R+++               I   +   H++    ++
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 180 HRDLKPENFLFANKKESSP-----LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
           HRDLK  N L   K E+       LK  DFGL+  +    + +   G+  +MAPEV++ +
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEVIRAS 189
Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS-ENAKDL 292
            +    DVWS GV+L+ LL G  PF       VA  +  + +     P P    E    L
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL---PIPSTCPEPFAKL 246
Query: 293 VKKMLNPDPKQRLTAEEVLEH 313
           ++   NPDP  R +   +L+ 
Sbjct: 247 MEDCWNPDPHSRPSFTNILDQ 267

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 118/254 (46%), Gaps = 19/254 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LGRG FG  +   D   G  F C   + KK+R    +E  R E  +       P IV L 
Sbjct: 101 LGRGSFGEVHRMEDKQTG--FQC---AVKKVR----LEVFRAEELMACAGLTSPRIVPLY 151
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
               +   V+I MEL EGG L   +  +G   E  A   +   +E ++  H + ++H D+
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRP---GEQF---NEIVGSPYYMAPE-VLKRNYG 236
           K +N L ++    + L   DFG +V  +P   G+     + I G+  +MAPE VL R+  
Sbjct: 212 KADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
            +VDVWS+  ++  +L G  P W +  +G     I S     R+  P  +      +++ 
Sbjct: 270 AKVDVWSSCCMMLHMLNGCHP-WTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEG 328
Query: 297 LNPDPKQRLTAEEV 310
           L  +P  R++A E+
Sbjct: 329 LRKEPIHRVSAAEL 342

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L  G +L + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +D GL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDRGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 44/288 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G +G      D   G + A K +S+   ++ +  +   RE++++KH+ KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 87
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           D +      E+ + V++V  L   G   + IV     T+     ++  I+  ++  H   
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
           ++HRDLKP N       E   LK +D GL+      ++    V + +Y APE++    +Y
Sbjct: 146 IIHRDLKPSNLAV---NEDCELKILDGGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
              VD+WS G I+  LL G   F         + I+R V     +   K+S         
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                               A DL++KML  D  +R+TA + L H + 
Sbjct: 261 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2W49|0 Chain 0, Isometrically Contracting Insect Asynchronous Flight Muscle Length = 159

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 79/148 (53%), Gaps = 4/148 (2%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGS 414
           FLS E +A  K AF+M D +  G I+            QN  + +L  ++E  D DG G+
Sbjct: 10  FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGT 69
Query: 415 LNYGEFVAVSV-HLKKMA---NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +++ EF+ + V  +K+ A   ++E L   F  FD+N  GFI+IEEL   L    +   E+
Sbjct: 70  IDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEE 129
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            I  +M D D + DGRI ++EF  MM+ 
Sbjct: 130 DIEDLMKDSDKNNDGRIDFDEFLKMMEG 157

>pdb|1YTZ|C Chain C, Crystal Structure Of Skeletal Muscle Troponin In The Ca2+- Activated State Length = 162

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 79/148 (53%), Gaps = 4/148 (2%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGS 414
           FLS E +A  K AF+M D +  G I+            QN  + +L  ++E  D DG G+
Sbjct: 13  FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGT 72
Query: 415 LNYGEFVAVSV-HLKKMA---NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +++ EF+ + V  +K+ A   ++E L   F  FD+N  GFI+IEEL   L    +   E+
Sbjct: 73  IDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEE 132
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            I  +M D D + DGRI ++EF  MM+ 
Sbjct: 133 DIEDLMKDSDKNNDGRIDFDEFLKMMEG 160

>pdb|4TNC|A Chain A, Refined Structure Of Chicken Skeletal Muscle Troponin C In The Two-Calcium State At 2-Angstroms Resolution Length = 162

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 79/148 (53%), Gaps = 4/148 (2%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGS 414
           FLS E +A  K AF+M D +  G I+            QN  + +L  ++E  D DG G+
Sbjct: 13  FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGT 72
Query: 415 LNYGEFVAVSV-HLKKMA---NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +++ EF+ + V  +K+ A   ++E L   F  FD+N  GFI+IEEL   L    +   E+
Sbjct: 73  IDFEEFLVMMVRQMKEDAKGKSEEELADCFRIFDKNADGFIDIEELGEILRATGEHVTEE 132
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            I  +M D D + DGRI ++EF  MM+ 
Sbjct: 133 DIEDLMKDSDKNNDGRIDFDEFLKMMEG 160

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 48/289 (16%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G GEFG  + C    +G  +A K  SKK L  +VD ++  REV     L +H ++V  
Sbjct: 14  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 72
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGV 178
              + +D  + I  E C GG L D I        ++ E     ++  +   ++  H   +
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 132
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFG-------LSVFFRPGE----------QFNEIVG 221
           +H D+KP N   +  + S P  A + G         V F+ G+          Q  E  G
Sbjct: 133 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--G 188
Query: 222 SPYYMAPEVLKRNYG--PEVDVWSAGVILYILLCGVPPF------WAETEQGVAQAIIRS 273
              ++A EVL+ NY   P+ D+++  + + +   G  P       W E  QG    I   
Sbjct: 189 DSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQWHEIRQGRLPRI--- 244
Query: 274 VIDFKRDPWPKV-SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                    P+V S+   +L+K M++PDP++R +A  +++H  L +A +
Sbjct: 245 ---------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 284

>pdb|1RFJ|A Chain A, Crystal Structure Of Potato Calmodulin Pcm6 Length = 149

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 86/148 (58%), Gaps = 1/148 (0%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +A+ L+ ++++  KEAF + D +  G I             QN  EA+LQ ++   D DG
Sbjct: 1   MADQLTEDQISEFKEAFSLFDKDGDGCITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 412 DGSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +G++++ EF+ +    +K   ++E L +AF  FD++++GFI   ELR+ + +  +   ++
Sbjct: 61  NGTIDFPEFLNLMARKMKDTDSEEELKEAFRVFDKDQNGFISAAELRHVMTNLGEKLTDE 120
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            ++ ++ + D D DG+I+Y+EF  +M A
Sbjct: 121 EVDEMIREADVDGDGQINYDEFVKVMMA 148

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 48/289 (16%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G GEFG  + C    +G  +A K  SKK L  +VD ++  REV     L +H ++V  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGV 178
              + +D  + I  E C GG L D I        ++ E     ++  +   ++  H   +
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFG-------LSVFFRPGE----------QFNEIVG 221
           +H D+KP N   +  + S P  A + G         V F+ G+          Q  E  G
Sbjct: 137 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--G 192
Query: 222 SPYYMAPEVLKRNYG--PEVDVWSAGVILYILLCGVPPF------WAETEQGVAQAIIRS 273
              ++A EVL+ NY   P+ D+++  + + +   G  P       W E  QG    I   
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRI--- 248
Query: 274 VIDFKRDPWPKV-SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                    P+V S+   +L+K M++PDP++R +A  +++H  L +A +
Sbjct: 249 ---------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 118/254 (46%), Gaps = 19/254 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LGRG FG  +   D   G  F C   + KK+R    +E  R E  +       P IV L 
Sbjct: 82  LGRGSFGEVHRMEDKQTG--FQC---AVKKVR----LEVFRAEELMACAGLTSPRIVPLY 132
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
               +   V+I MEL EGG L   +  +G   E  A   +   +E ++  H + ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRP---GEQF---NEIVGSPYYMAPE-VLKRNYG 236
           K +N L ++    + L   DFG +V  +P   G+     + I G+  +MAPE VL R+  
Sbjct: 193 KADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD 250
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
            +VDVWS+  ++  +L G  P W +  +G     I S     R+  P  +      +++ 
Sbjct: 251 AKVDVWSSCCMMLHMLNGCHP-WTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEG 309
Query: 297 LNPDPKQRLTAEEV 310
           L  +P  R++A E+
Sbjct: 310 LRKEPIHRVSAAEL 323

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 115/232 (49%), Gaps = 20/232 (8%)
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAV 162
           REVQ+++   +HPN++    T +D    +I +ELC    L + +  +   H        +
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLL 124
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI--DFGLSVFFRPGEQ-FNEI 219
            +T   +  + H   ++HRDLKP N L +       +KA+  DFGL      G   F+  
Sbjct: 125 QQTTSGLAHL-HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 220 VGSPY---YMAPEVL----KRNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 271
            G P    ++APE+L    K N    VD++SAG + Y ++  G  PF    ++     + 
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243
Query: 272 RSVIDFKRDPWPKVSEN--AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
              +D      P+  E+  A++L++KM+  DP++R +A+ VL+HP+  + +K
Sbjct: 244 ACSLDCLH---PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 48/289 (16%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G GEFG  + C    +G  +A K  SKK L  +VD ++  REV     L +H ++V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGV 178
              + +D  + I  E C GG L D I        ++ E     ++  +   ++  H   +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFG-------LSVFFRPGE----------QFNEIVG 221
           +H D+KP N   +  + S P  A + G         V F+ G+          Q  E  G
Sbjct: 135 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--G 190
Query: 222 SPYYMAPEVLKRNYG--PEVDVWSAGVILYILLCGVPPF------WAETEQGVAQAIIRS 273
              ++A EVL+ NY   P+ D+++  + + +   G  P       W E  QG    I   
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRI--- 246
Query: 274 VIDFKRDPWPKV-SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                    P+V S+   +L+K M++PDP++R +A  +++H  L +A +
Sbjct: 247 ---------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 48/289 (16%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           ++G GEFG  + C    +G  +A K  SKK L  +VD ++  REV     L +H ++V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGV 178
              + +D  + I  E C GG L D I        ++ E     ++  +   ++  H   +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFG-------LSVFFRPGE----------QFNEIVG 221
           +H D+KP N   +  + S P  A + G         V F+ G+          Q  E  G
Sbjct: 135 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--G 190
Query: 222 SPYYMAPEVLKRNYG--PEVDVWSAGVILYILLCGVPPF------WAETEQGVAQAIIRS 273
              ++A EVL+ NY   P+ D+++  + + +   G  P       W E  QG    I   
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRI--- 246
Query: 274 VIDFKRDPWPKV-SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                    P+V S+   +L+K M++PDP++R +A  +++H  L +A +
Sbjct: 247 ---------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXV-NHKNIIS 87
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVIL------YILLCGVPPF--WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+       IL  G      W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMK-VVNHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +V +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K  + LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 45/286 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVRREVQIMKHLP------- 114
           LG+G FG      +  +   +A K I  +++KL T +       EV ++  L        
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS------EVMLLASLNHQYVVRY 67
Query: 115 -----KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER-AAAAVMKTIVE 168
                +  N V      +  S + I ME CE G L+D I +     +R     + + I+E
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-------------PG-- 213
            +   H QG++HRDLKP N       ES  +K  DFGL+                 PG  
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 214 EQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
           +     +G+  Y+A EVL    +Y  ++D++S G+I + ++    PF    E+      +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241
Query: 272 RSV-IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           RSV I+F  D      +  K +++ +++ DP +R  A  +L   WL
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1TNW|A Chain A, Nmr Solution Structure Of Calcium Saturated Skeletal Muscle Troponin C Length = 162

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 79/148 (53%), Gaps = 4/148 (2%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGS 414
           FLS E +A  K AF+M D +  G I+            QN  + +L  ++E  D DG G+
Sbjct: 13  FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGT 72
Query: 415 LNYGEFVAVSV-HLKKMA---NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +++ EF+ + V  +K+ A   ++E L   F  FD+N  GFI+IEEL   L    +   E+
Sbjct: 73  IDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEE 132
Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            I  +M D D + DGRI ++EF  MM+ 
Sbjct: 133 DIEDLMKDSDKNNDGRIDFDEFLKMMEG 160

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/331 (24%), Positives = 145/331 (43%), Gaps = 53/331 (16%)
Query: 32  VVANGSTVVHRLCVLKEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSIS 90
           +++N S +++    +KE   +D  I DY + R L +G+F    LC   N    +A K   
Sbjct: 9   ILSNYSNLIYLNKYVKE---KDKYINDYRIIRTLNQGKFNKIILCEKDNKF--YALKKYE 63
Query: 91  KKKLRTAVDI--------------EDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136
           K  L    D               +D + E+QI+  + K+   ++ +    +   V+I+ 
Sbjct: 64  KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIY 122
Query: 137 ELCEGGEL--FDR--IVARGHYTERAAAAVMKTIVEVV-----QVCHEQGVMHRDLKPEN 187
           E  E   +  FD    V   +YT      V+K I++ V      + +E+ + HRD+KP N
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182
Query: 188 FLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRNY-GPEVDVWSA 244
            L     ++  +K  DFG S +    ++     G+  +M PE    + +Y G +VD+WS 
Sbjct: 183 ILMD---KNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238
Query: 245 GVILYILLCGVPPF-----WAETEQGVAQAIIRSVIDFKRDPWPKVSENAK--------- 290
           G+ LY++   V PF       E    +    I   +D     +P  ++ +          
Sbjct: 239 GICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNE 298
Query: 291 --DLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
             D +K  L  +P +R+T+E+ L+H WL + 
Sbjct: 299 DIDFLKLFLRKNPAERITSEDALKHEWLADT 329

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXV-NHKNIIS 87
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVIL------YILLCGVPPF--WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+       IL  G      W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXV-NHKNIIS 87
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVIL------YILLCGVPPF--WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+       IL  G      W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 125
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 182
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 183 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 235 YGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGVAQAIIR 272
           Y   VD+WS G I+                      I   G P P + +  Q   +  + 
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 273 SVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +   +    +PK+                +  A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|1GGZ|A Chain A, Crystal Structure Of The Calmodulin-Like Protein (Hclp) From Human Epithelial Cells Length = 148

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 79/141 (56%), Gaps = 1/141 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E+V   KEAF + D +  G I             QN  EA+L+ +M   D DG+
Sbjct: 1   ADQLTEEQVTEFKEAFSLFDKDGDGCITTRELGTVMRSLGQNPTEAELRDMMSEIDRDGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ +    +K   N+E + +AF  FD++ +GF+   ELR+ +    +   ++ 
Sbjct: 61  GTVDFPEFLGMMARKMKDTDNEEEIREAFRVFDKDGNGFVSAAELRHVMTRLGEKLSDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEF 492
           ++ ++   DTD DG+++YEEF
Sbjct: 121 VDEMIRAADTDGDGQVNYEEF 141

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 87
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVIL------YILLCGVPPF--WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+       IL  G      W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 125
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 182
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 183 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 235 YGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGVAQAIIR 272
           Y   VD+WS G I+                      I   G P P + +  Q   +  + 
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 273 SVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +   +    +PK+                +  A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 80
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKHL-HS 137
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 138 AGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 235 YGPEVDVWSAGVIL------YILLCGVPPF--WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+       IL  G      W +  + +           Q  +R+ ++
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 88
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 145
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 146 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 235 YGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGVAQAIIR 272
           Y   VD+WS G I+                      I   G P P + +  Q   +  + 
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 273 SVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +   +    +PK+                +  A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 88
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 145
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 146 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 235 YGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGVAQAIIR 272
           Y   VD+WS G I+                      I   G P P + +  Q   +  + 
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 273 SVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +   +    +PK+                +  A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 87
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGVAQAIIR 272
           Y   VD+WS G I+                      I   G P P + +  Q   +  + 
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 273 SVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +   +    +PK+                +  A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 87
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGVAQAIIR 272
           Y   VD+WS G I+                      I   G P P + +  Q   +  + 
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 273 SVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +   +    +PK+                +  A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 29  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 86
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 87  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 143
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 144 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 235 YGPEVDVWSAGVIL------YILLCGVPPF--WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+       IL  G      W +  + +           Q  +R+ ++
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|2L1W|A Chain A, The Solution Structure Of Soybean Calmodulin Isoform 4 Complexed With The Vacuolar Calcium Atpase Bca1 Peptide Length = 149

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 81/145 (55%), Gaps = 1/145 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ LS E++   KEAF + D +  G I             QN  E +LQ ++   D DG+
Sbjct: 1   ADILSEEQIVDFKEAFGLFDKDGDGCITVEELATVIRSLDQNPTEEELQDMISEVDADGN 60
Query: 413 GSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++ + EF+++ +  +K    +E L +AF  FD++++G+I   ELR+ + +  +   ++ 
Sbjct: 61  GTIEFDEFLSLMAKKVKDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEFAVMM 496
           +  ++ + D D DG+++YEEF  MM
Sbjct: 121 VEQMIKEADLDGDGQVNYEEFVKMM 145

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 80
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 137
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 138 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 235 YGPEVDVWSAGVIL------YILLCGVPPF--WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+       IL  G      W +  + +           Q  +R+ ++
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 81
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 138
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 139 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 235 YGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGVAQAIIR 272
           Y   VD+WS G I+                      I   G P P + +  Q   +  + 
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 273 SVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           +   +    +PK+                +  A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K  + LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+S
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 81
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L      + T E+   V++VMEL +      +++      ER +  + + +  +  + H 
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 138
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 139 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 235 YGPEVDVWSAGVIL------YILLCGVPPF--WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+       IL  G      W +  + +           Q  +R+ ++
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  DP +R++ ++ L+HP++
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMK-VVNHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K  + LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2LMT|A Chain A, Nmr Structure Of Androcam Length = 148

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 46/142 (32%), Positives = 76/142 (53%), Gaps = 1/142 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  K+AF   D    GKI             QN  EA+LQ L+  A+ + +G L
Sbjct: 4   LTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQL 63
Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           N+ EF  + +  +++   +E + +AF  FDR+  GFI   ELR  + +  +   ++ I+ 
Sbjct: 64  NFTEFCGIMAKQMRETDTEEEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDE 123
Query: 475 IMHDVDTDKDGRISYEEFAVMM 496
           ++ + D D DG I+YEEF  M+
Sbjct: 124 MIREADFDGDGMINYEEFVWMI 145

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI----SKKKLRTAVDIEDVR 104
           P+  D  I+Y+  +++G+G FG+ +    V +    A KS+    S+ +       ++ +
Sbjct: 14  PTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAA-VM 163
           REV IM +L  HPNIV L     +     +VME    G+L+ R++ + H  + +    +M
Sbjct: 72  REVFIMSNL-NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 164 KTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPL--KAIDFGLSVFFRPGEQFNEI 219
             I   ++    Q   ++HRDL+  N    +  E++P+  K  DFGLS   +     + +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGL 186
Query: 220 VGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPF 258
           +G+  +MAPE +   + +Y  + D +S  +ILY +L G  PF
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 35  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 92
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 93  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 149
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 150 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 206
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++C    F        W +  + +           Q  +R+ ++
Sbjct: 207 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 266
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 267 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 326

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G     +       G+ FA K  +       VD++   RE +++K L  H NIV L 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NHKNIVKLF 73
Query: 124 DTYEDDSAVH--IVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVCHEQGV 178
              E+ +  H  ++ME C  G L+  +    +     E     V++ +V  +    E G+
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 179 MHRDLKPENFL-FANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR---- 233
           +HR++KP N +    +   S  K  DFG +      EQF  + G+  Y+ P++ +R    
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLR 193
Query: 234 -----NYGPEVDVWSAGVILYILLCGVPPF 258
                 YG  VD+WS GV  Y    G  PF
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 24  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 81
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 82  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 138
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 139 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++C    F        W +  + +           Q  +R+ ++
Sbjct: 196 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 255
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 256 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 315

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG+G     +       G+ FA K  +       VD++   RE +++K L  H NIV L 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NHKNIVKLF 73
Query: 124 DTYEDDSAVH--IVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVVQVCHEQG 177
              E+ +  H  ++ME C  G L+  +     A G   E     V++ +V  +    E G
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMNHLRENG 132
Query: 178 VMHRDLKPENFL-FANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--- 233
           ++HR++KP N +    +   S  K  DFG +      EQF  + G+  Y+ P++ +R   
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 234 ------NYGPEVDVWSAGVILYILLCGVPPF 258
                  YG  VD+WS GV  Y    G  PF
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 128/312 (41%), Gaps = 41/312 (13%)
Query: 5   CARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGREL 64
           C RP   S    KG  E   P+ G  Y      + + +L       G  ++  Y++   +
Sbjct: 40  CGRPVGRSDSETKGASEGWCPYCGSPY------SFLPQLN-----PGDIVAGQYEVKGCI 88
Query: 65  GRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
             G  G  YL  D N NG     K +       A  +    R  Q +  +  HP+IV + 
Sbjct: 89  AHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER--QFLAEV-VHPSIVQIF 145
Query: 124 DTYE-----DDSAVHIVMELCEGGELFDRIVARGHYTERA-AAAVMKTIVEVVQVCHEQG 177
           +  E      D   +IVME   GG+   R  ++G     A A A +  I+  +   H  G
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYV-GGQSLKR--SKGQKLPVAEAIAYLLEILPALSYLHSIG 202
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           +++ DLKPEN +   ++    LK ID G          F  + G+P + APE+++     
Sbjct: 203 LVYNDLKPENIMLTEEQ----LKLIDLGAVSRI---NSFGYLYGTPGFQAPEIVRTGPTV 255
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
             D+++ G  L  L   +P        G+ +           DP  K  ++   L+++ +
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DDPVLKTYDSYGRLLRRAI 305
Query: 298 NPDPKQRLTAEE 309
           +PDP+QR T  E
Sbjct: 306 DPDPRQRFTTAE 317

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 124/286 (43%), Gaps = 45/286 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVRREVQIMKHLP------- 114
           LG+G FG      +  +   +A K I  +++KL T +       EV ++  L        
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS------EVMLLASLNHQYVVRY 67
Query: 115 -----KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER-AAAAVMKTIVE 168
                +  N V      +  S + I ME CE   L+D I +     +R     + + I+E
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-------------PG-- 213
            +   H QG++HRDLKP N       ES  +K  DFGL+                 PG  
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 214 EQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
           +     +G+  Y+A EVL    +Y  ++D++S G+I + ++    PF    E+      +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241
Query: 272 RSV-IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           RSV I+F  D      +  K +++ +++ DP +R  A  +L   WL
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 88
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 145
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 146 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++C    F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI------EDVRREVQIMKHLP 114
           G ++G G FGV Y    VNN       +++ KKL   VDI      +   +E+++M    
Sbjct: 36  GNKMGEGGFGVVYKGY-VNN------TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC- 87
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQ 171
           +H N+V L     D   + +V      G L DR+         +      + +     + 
Sbjct: 88  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN 147
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE------IVGSPYY 225
             HE   +HRD+K  N L     E+   K  DFGL+   R  E+F +      IVG+  Y
Sbjct: 148 FLHENHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQTVMXXRIVGTTAY 201
Query: 226 MAPEVLKRNYGPEVDVWSAGVILYILLCGVP 256
           MAPE L+    P+ D++S GV+L  ++ G+P
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI------EDVRREVQIMKHLP 114
           G ++G G FGV Y    VNN       +++ KKL   VDI      +   +E+++M    
Sbjct: 36  GNKMGEGGFGVVYKGY-VNN------TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC- 87
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQ 171
           +H N+V L     D   + +V      G L DR+         +      + +     + 
Sbjct: 88  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN 147
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE------IVGSPYY 225
             HE   +HRD+K  N L     E+   K  DFGL+   R  E+F +      IVG+  Y
Sbjct: 148 FLHENHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQTVMXSRIVGTTAY 201
Query: 226 MAPEVLKRNYGPEVDVWSAGVILYILLCGVP 256
           MAPE L+    P+ D++S GV+L  ++ G+P
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++C    F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1XFX|O Chain O, Crystal Structure Of Anthrax Edema Factor (Ef) In Complex With Calmodulin In The Presence Of 10 Millimolar Exogenously Added Calcium Chloride Length = 149

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 43/141 (30%), Positives = 77/141 (54%), Gaps = 1/141 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ  +   D DG+
Sbjct: 2   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVXRSLGQNPTEAELQDXINEVDADGN 61
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+       K   ++E + +AF  FD++ +G+I   ELR+   +  +   ++ 
Sbjct: 62  GTIDFPEFLTXXARKXKDTDSEEEIREAFRVFDKDGNGYISAAELRHVXTNLGEKLTDEE 121
Query: 472 INAIMHDVDTDKDGRISYEEF 492
           ++  + + D D DG+++YEEF
Sbjct: 122 VDQXIREADIDGDGQVNYEEF 142

>pdb|1NIW|A Chain A, Crystal Structure Of Endothelial Nitric Oxide Synthase Peptide Bound To Calmodulin Length = 148

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 43/141 (30%), Positives = 77/141 (54%), Gaps = 1/141 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I             QN  EA+LQ  +   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVXRSLGQNPTEAELQDXINEVDADGN 60
Query: 413 GSLNYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+       K   ++E + +AF  FD++ +G+I   ELR+   +  +   ++ 
Sbjct: 61  GTIDFPEFLTXXARKXKDTDSEEEIREAFRVFDKDGNGYISAAELRHVXTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEF 492
           ++  + + D D DG+++YEEF
Sbjct: 121 VDEXIREADIDGDGQVNYEEF 141

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI------EDVRREVQIMKHLP 114
           G ++G G FGV Y    VNN       +++ KKL   VDI      +   +E+++M    
Sbjct: 30  GNKMGEGGFGVVYKGY-VNN------TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC- 81
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQ 171
           +H N+V L     D   + +V      G L DR+         +      + +     + 
Sbjct: 82  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN 141
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE------IVGSPYY 225
             HE   +HRD+K  N L     E+   K  DFGL+   R  E+F +      IVG+  Y
Sbjct: 142 FLHENHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQXVMXXRIVGTTAY 195
Query: 226 MAPEVLKRNYGPEVDVWSAGVILYILLCGVP 256
           MAPE L+    P+ D++S GV+L  ++ G+P
Sbjct: 196 MAPEALRGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 111/222 (50%), Gaps = 19/222 (8%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI----SKKKLRTAVDIEDVR 104
           P+  D  I+Y+  +++G+G FG+ +    V +    A KS+    S+ +       ++ +
Sbjct: 14  PTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAA-VM 163
           REV IM +L  HPNIV L     +     +VME    G+L+ R++ + H  + +    +M
Sbjct: 72  REVFIMSNL-NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 164 KTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPL--KAIDFGLSVFFRPGEQFNEI 219
             I   ++    Q   ++HRDL+  N    +  E++P+  K  DFG S   +     + +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGL 186
Query: 220 VGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPF 258
           +G+  +MAPE +   + +Y  + D +S  +ILY +L G  PF
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1Y6W|A Chain A, Trapped Intermediate Of Calmodulin Length = 148

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 43/141 (30%), Positives = 76/141 (53%), Gaps = 1/141 (0%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I              N  EA+LQ  +   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVXRSLGCNPTEAELQDXINEVDADGN 60
Query: 413 GSLNYGEFVAVSVHLKKMAN-DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++N+ EF+       K  + +E + +AF  FD++ +G+I   ELR+   +  +   ++ 
Sbjct: 61  GTINFPEFLTXXARCXKDTDSEEEIREAFRVFDKDGNGYISAAELRHVXTNLGEKLTDEE 120
Query: 472 INAIMHDVDTDKDGRISYEEF 492
           ++  + + D D DG+++YEEF
Sbjct: 121 VDEXIREADIDGDGQVNYEEF 141

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 32  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 89
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 90  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 146
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 147 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG 203
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 204 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 263
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 264 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 323

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 111/222 (50%), Gaps = 19/222 (8%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI----SKKKLRTAVDIEDVR 104
           P+  D  I+Y+  +++G+G FG+ +    V +    A KS+    S+ +       ++ +
Sbjct: 14  PTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAA-VM 163
           REV IM +L  HPNIV L     +     +VME    G+L+ R++ + H  + +    +M
Sbjct: 72  REVFIMSNL-NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 164 KTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPL--KAIDFGLSVFFRPGEQFNEI 219
             I   ++    Q   ++HRDL+  N    +  E++P+  K  DF LS   +     + +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGL 186
Query: 220 VGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPF 258
           +G+  +MAPE +   + +Y  + D +S  +ILY +L G  PF
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 132/308 (42%), Gaps = 56/308 (18%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNN-GEKFACKSI--SKKKLRTAVDIED------VRREVQ 108
           Y + R +  G +G   +C  V++ G   A K +  +    RT   + D      V RE++
Sbjct: 24  YTVQRFISSGSYGA--VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 109 IMKHLPKHPNIVSLKDTYE--DDSAVHIVMELCEGGELFDRIVARGHYTERAAAA----- 161
           ++ H   HPNI+ L+D +   ++ A+H   +L    EL    +A+  + +R   +     
Sbjct: 82  LLNHF-HHPNILGLRDIFVHFEEPAMH---KLYLVTELMRTDLAQVIHDQRIVISPQHIQ 137
Query: 162 -VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
             M  I+  + V HE GV+HRDL P N L A+  +   +   DF L+            V
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTHYV 194
Query: 221 GSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------ 272
              +Y APE++   + +   VD+WSAG ++  +      F   T       I+       
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 273 ----------SVIDFKRD--------PW----PKVSENAKDLVKKMLNPDPKQRLTAEEV 310
                     S  D+ R+         W    P     A DL+ KML  +P++R++ E+ 
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 311 LEHPWLQN 318
           L HP+ ++
Sbjct: 315 LRHPYFES 322

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 132/308 (42%), Gaps = 56/308 (18%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNN-GEKFACKSI--SKKKLRTAVDIED------VRREVQ 108
           Y + R +  G +G   +C  V++ G   A K +  +    RT   + D      V RE++
Sbjct: 24  YTVQRFISSGSYGA--VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 109 IMKHLPKHPNIVSLKDTYE--DDSAVHIVMELCEGGELFDRIVARGHYTERAAAA----- 161
           ++ H   HPNI+ L+D +   ++ A+H   +L    EL    +A+  + +R   +     
Sbjct: 82  LLNHF-HHPNILGLRDIFVHFEEPAMH---KLYLVTELMRTDLAQVIHDQRIVISPQHIQ 137
Query: 162 -VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
             M  I+  + V HE GV+HRDL P N L A+  +   +   DF L+            V
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTHYV 194
Query: 221 GSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------ 272
              +Y APE++   + +   VD+WSAG ++  +      F   T       I+       
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 273 ----------SVIDFKRD--------PW----PKVSENAKDLVKKMLNPDPKQRLTAEEV 310
                     S  D+ R+         W    P     A DL+ KML  +P++R++ E+ 
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 311 LEHPWLQN 318
           L HP+ ++
Sbjct: 315 LRHPYFES 322

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           + +G G  G+     D       A K +S+   +     +   RE+ +MK +  H NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           L + +      E+   V+IVMEL +      +++      ER +  + + +  +  + H 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
            G++HRDLKP N +    K    LK +DFGL+            V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
           Y   VD+WS G I+  ++ G   F        W +  + +           Q  +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                        F    +P  SE+       A+DL+ KML  D  +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3EKJ|A Chain A, Calcium-Free Gcamp2 (Calcium Binding Deficient Mutant) Length = 449

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 79/144 (54%), Gaps = 1/144 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I             QN  EA+LQ ++     DG+G++
Sbjct: 305 LTEEQIAEFKEAFSLFDKDGDGGITTKQLGTVMRSLGQNPTEAELQDMINEVGADGNGTI 364
Query: 416 NYGEFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ +F+ +    +K   ++E + +AF  F ++ +G+I   +LR+ + +  +   ++ ++ 
Sbjct: 365 DFPQFLTMMARKMKDTDSEEEIREAFRVFGKDGNGYISAAQLRHVMTNLGEKLTDEEVDE 424
Query: 475 IMHDVDTDKDGRISYEEFAVMMKA 498
           ++ +   D DG+++YE+F  MM A
Sbjct: 425 MIREAGIDGDGQVNYEQFVQMMTA 448

>pdb|1A2X|A Chain A, Complex Of Troponin C With A 47 Residue (1-47) Fragment Of Troponin I Length = 159

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 12/152 (7%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGS 414
           +LS E +A  K AF+M D +  G I+            Q   + +L  ++E  D DG G+
Sbjct: 10  YLSEEMIAEFKAAFDMFDADGGGDISVKELGTVMRMLGQTPTKEELDAIIEEVDEDGSGT 69
Query: 415 LNYGEFVAVSV-HLKKMA---NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +++ EF+ + V  +K+ A   ++E L + F  FDRN  G+I+ EEL          SGE 
Sbjct: 70  IDFEEFLVMMVRQMKEDAKGKSEEELAECFRIFDRNADGYIDAEELAEIFR----ASGEH 125
Query: 471 V----INAIMHDVDTDKDGRISYEEFAVMMKA 498
           V    I ++M D D + DGRI ++EF  MM+ 
Sbjct: 126 VTDEEIESLMKDGDKNNDGRIDFDEFLKMMEG 157

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 125
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
             +MHRD+KP N L  ++ E   +K  DFG+S         N  VG+  YM+PE L+  +
Sbjct: 186 HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 241
Query: 235 YGPEVDVWSAGVILYILLCG---VPP 257
           Y  + D+WS G+ L  +  G   +PP
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/339 (24%), Positives = 131/339 (38%), Gaps = 70/339 (20%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL---- 113
           Y++   LG G FG    C D   G       I K   +     E  R E+ +++ +    
Sbjct: 35  YEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYK---EAARLEINVLEKINEKD 91
Query: 114 PKHPNI-VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVV 170
           P + N+ V + D ++    + I  EL  G   FD +    +  Y       +   + + V
Sbjct: 92  PDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAV 150
Query: 171 QVCHEQGVMHRDLKPENFLFANKK----------------ESSPLKAIDFGLSVFFRPGE 214
           +  H+  + H DLKPEN LF N                  +S+ ++ +DFG + F    E
Sbjct: 151 KFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--DHE 208
Query: 215 QFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--------- 264
             + IV + +Y APEV L+  +    DVWS G I++    G   F     +         
Sbjct: 209 HHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERI 268
Query: 265 --GVAQAIIRSVIDFK-----RDPWPK-------VSENAK-----------------DLV 293
              +   +IR     K     R  W +       V EN K                 DL+
Sbjct: 269 LGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLI 328
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVK 332
           + ML  +P +RLT  E L+HP+    +  P   L ++ +
Sbjct: 329 ESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y +   +GRG +G  YL  D N  +  A K +++      +D + + RE+ I+  L K 
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRL-KS 84
Query: 117 PNIVSLKDTYEDDSAV-----HIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEV 169
             I+ L D    D  +     +IV+E+ +    +LF   +     TE     ++  ++  
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEEHIKTILYNLLLG 141
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR----------------PG 213
               HE G++HRDLKP N L     +   +K  DFGL+                    PG
Sbjct: 142 ENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 214 -------EQFNEIVGSPYYMAPE--VLKRNYGPEVDVWSAGVILYILL 252
                  +Q    V + +Y APE  +L+ NY   +D+WS G I   LL
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 134/309 (43%), Gaps = 57/309 (18%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 90
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L
Sbjct: 151 HKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 202
Query: 232 K-RNYGPEVDVWSAGVILYILLCG---VPP---------FWAETEQGVAQAI-------- 270
           +  +Y  + D+WS G+ L  +  G   +PP         F  + E   A+          
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 271 --------------IRSVIDF-KRDPWPKVSENA-----KDLVKKMLNPDPKQRLTAEEV 310
                         I  ++D+   +P PK+         +D V K L  +P +R   +++
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 311 LEHPWLQNA 319
           + H +++ +
Sbjct: 323 MVHAFIKRS 331

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 134/309 (43%), Gaps = 57/309 (18%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L
Sbjct: 124 HKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 175
Query: 232 K-RNYGPEVDVWSAGVILYILLCG---VPP---------FWAETEQGVAQAI-------- 270
           +  +Y  + D+WS G+ L  +  G   +PP         F  + E   A+          
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 271 --------------IRSVIDF-KRDPWPKVSENA-----KDLVKKMLNPDPKQRLTAEEV 310
                         I  ++D+   +P PK+         +D V K L  +P +R   +++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 311 LEHPWLQNA 319
           + H +++ +
Sbjct: 296 MVHAFIKRS 304

>pdb|1TCF|A Chain A, Crystal Structure Of Calcium-Saturated Rabbit Skeletal Troponin C Length = 159

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 12/152 (7%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGS 414
           +LS E +A  K AF+M D +  G I+            Q   + +L  ++E  D DG G+
Sbjct: 10  YLSEEMIAEFKAAFDMFDADGGGDISVKELGTVMRMLGQTPTKEELDAIIEEVDEDGSGT 69
Query: 415 LNYGEFVAVSV-HLKKMA---NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           +++ EF+ + V  +K+ A   ++E L + F  FDRN  G+I+ EEL          SGE 
Sbjct: 70  IDFEEFLVMMVRQMKEDAKGKSEEELAELFRIFDRNADGYIDAEELAEIFR----ASGEH 125
Query: 471 V----INAIMHDVDTDKDGRISYEEFAVMMKA 498
           V    I ++M D D + DGRI ++EF  MM+ 
Sbjct: 126 VTDEEIESLMKDGDKNNDGRIDFDEFLKMMEG 157

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 134/309 (43%), Gaps = 57/309 (18%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L
Sbjct: 124 HKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 175
Query: 232 K-RNYGPEVDVWSAGVILYILLCG---VPP---------FWAETEQGVAQAI-------- 270
           +  +Y  + D+WS G+ L  +  G   +PP         F  + E   A+          
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 271 --------------IRSVIDF-KRDPWPKVSENA-----KDLVKKMLNPDPKQRLTAEEV 310
                         I  ++D+   +P PK+         +D V K L  +P +R   +++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 311 LEHPWLQNA 319
           + H +++ +
Sbjct: 296 MVHAFIKRS 304

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 134/309 (43%), Gaps = 57/309 (18%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L
Sbjct: 124 HKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 175
Query: 232 K-RNYGPEVDVWSAGVILYILLCG---VPP---------FWAETEQGVAQAI-------- 270
           +  +Y  + D+WS G+ L  +  G   +PP         F  + E   A+          
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 271 --------------IRSVIDF-KRDPWPKVSENA-----KDLVKKMLNPDPKQRLTAEEV 310
                         I  ++D+   +P PK+         +D V K L  +P +R   +++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 311 LEHPWLQNA 319
           + H +++ +
Sbjct: 296 MVHAFIKRS 304

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 134/309 (43%), Gaps = 57/309 (18%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YM+PE L
Sbjct: 124 HKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 175
Query: 232 K-RNYGPEVDVWSAGVILYILLCG---VPP---------FWAETEQGVAQAI-------- 270
           +  +Y  + D+WS G+ L  +  G   +PP         F  + E   A+          
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 271 --------------IRSVIDF-KRDPWPKVSENA-----KDLVKKMLNPDPKQRLTAEEV 310
                         I  ++D+   +P PK+         +D V K L  +P +R   +++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 311 LEHPWLQNA 319
           + H +++ +
Sbjct: 296 MVHAFIKRS 304

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 116/270 (42%), Gaps = 29/270 (10%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSI-----SKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ELGRG +GV      V +G+  A K I     S+++ R  +D++   R V         P
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC-------P 110
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYT-ERAAAAVMKTIVEVVQVCH 174
             V+       +  V I MEL +    + + +++ +G    E     +  +IV+ ++  H
Sbjct: 111 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 170
Query: 175 EQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-- 231
            +  V+HRD+KP N L     +   +K  DFG+S +           G   YMAPE +  
Sbjct: 171 SKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINP 227
Query: 232 ---KRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVIDFKRDPWPKVS 286
              ++ Y  + D+WS G+ +  L     P+  W    Q + Q +         D   K S
Sbjct: 228 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD---KFS 284
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
               D   + L  + K+R T  E+++HP+ 
Sbjct: 285 AEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 40/261 (15%)
Query: 95  RTAVDIEDVR-REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
           R  +D  D+   E++++     HPN++    +   D  ++I +ELC    L D + ++  
Sbjct: 64  RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNV 122
Query: 154 YTERA-------AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK----------ES 196
             E           ++++ I   V   H   ++HRDLKP+N L +             E+
Sbjct: 123 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 197 SPLKAIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVI 247
             +   DFGL      G+       N   G+  + APE+L    KR     +D++S G +
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 248 LYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN-----AKDLVKKMLNPDP 301
            Y +L  G  PF  +  +     IIR +  F  D    + +      A DL+ +M++ DP
Sbjct: 243 FYYILSKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDP 298
Query: 302 KQRLTAEEVLEHP--WLQNAK 320
            +R TA +VL HP  W ++ K
Sbjct: 299 LKRPTAMKVLRHPLFWPKSKK 319

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 115/254 (45%), Gaps = 19/254 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LGRG FG  +   D   G  F C   + KK+R    +E  R E  +       P IV L 
Sbjct: 80  LGRGSFGEVHRMKDKQTG--FQC---AVKKVR----LEVFRVEELVACAGLSSPRIVPLY 130
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
               +   V+I MEL EGG L   I   G   E  A   +   +E ++  H + ++H D+
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRP---GEQF---NEIVGSPYYMAPE-VLKRNYG 236
           K +N L ++    + L   DFG ++  +P   G+     + I G+  +MAPE V+ +   
Sbjct: 191 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
            +VD+WS+  ++  +L G  P W +  +G     I S     R+  P  +      +++ 
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 307
Query: 297 LNPDPKQRLTAEEV 310
           L  +P  R +A E+
Sbjct: 308 LRKEPVHRASAMEL 321

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 40/261 (15%)
Query: 95  RTAVDIEDVR-REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
           R  +D  D+   E++++     HPN++    +   D  ++I +ELC    L D + ++  
Sbjct: 64  RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNV 122
Query: 154 YTERA-------AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK----------ES 196
             E           ++++ I   V   H   ++HRDLKP+N L +             E+
Sbjct: 123 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 197 SPLKAIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVI 247
             +   DFGL      G+       N   G+  + APE+L    KR     +D++S G +
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 248 LYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN-----AKDLVKKMLNPDP 301
            Y +L  G  PF  +  +     IIR +  F  D    + +      A DL+ +M++ DP
Sbjct: 243 FYYILSKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDP 298
Query: 302 KQRLTAEEVLEHP--WLQNAK 320
            +R TA +VL HP  W ++ K
Sbjct: 299 LKRPTAMKVLRHPLFWPKSKK 319

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 117/251 (46%), Gaps = 23/251 (9%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTAVDIEDVRREVQIMK 111
           ++  Y++ + +G+G FG      D    +  A K +  +K   R A +      E++I++
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE------EIRILE 148
Query: 112 HLPKHP-----NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-- 164
           HL K       N++ + + +   + + +  EL     L++ ++ +  +   +   V K  
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYE-LIKKNKFQGFSLPLVRKFA 206
Query: 165 -TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
            +I++ +   H+  ++H DLKPEN L   +  S  +K IDFG S +    ++    + S 
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCY--EHQRVYTXIQSR 263
Query: 224 YYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
           +Y APEV L   YG  +D+WS G IL  LL G P    E E G   A +  ++       
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE-GDQLACMIELLGMPSQKL 322
Query: 283 PKVSENAKDLV 293
              S+ AK+ V
Sbjct: 323 LDASKRAKNFV 333

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 115/249 (46%), Gaps = 19/249 (7%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           ++  Y++ + +G+G FG      D    +  A K +  +K       E++R    I++HL
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHL 150
Query: 114 PKHP-----NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK---T 165
            K       N++ + + +   + + +  EL     L++ ++ +  +   +   V K   +
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYE-LIKKNKFQGFSLPLVRKFAHS 208
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           I++ +   H+  ++H DLKPEN L   +  S  +K IDFG S +    ++    + S +Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCY--EHQRVYTXIQSRFY 265
Query: 226 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
            APEV L   YG  +D+WS G IL  LL G P    E E G   A +  ++         
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE-GDQLACMIELLGMPSQKLLD 324
Query: 285 VSENAKDLV 293
            S+ AK+ V
Sbjct: 325 ASKRAKNFV 333

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           +E+G G+FG+ +L   +N  +K A K+I +     A+  ED   E ++M  L  HP +V 
Sbjct: 13  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREG----AMSEEDFIEEAEVMMKL-SHPKLVQ 66
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           L     + + + +V E  E G L D +   RG +       +   + E +    E  V+H
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIH 126
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLK-RNYG 236
           RDL   N L     E+  +K  DFG++ F    +Q+    G+ +   + +PEV     Y 
Sbjct: 127 RDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 237 PEVDVWSAGVILY 249
            + DVWS GV+++
Sbjct: 183 SKSDVWSFGVLMW 195

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 115/249 (46%), Gaps = 19/249 (7%)
Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           ++  Y++ + +G+G FG      D    +  A K +  +K       E++R    I++HL
Sbjct: 95  VAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHL 150
Query: 114 PKHP-----NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK---T 165
            K       N++ + + +   + + +  EL     L++ ++ +  +   +   V K   +
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYE-LIKKNKFQGFSLPLVRKFAHS 208
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           I++ +   H+  ++H DLKPEN L   +  S  +K IDFG S +    ++    + S +Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCY--EHQRVYXXIQSRFY 265
Query: 226 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
            APEV L   YG  +D+WS G IL  LL G P    E E G   A +  ++         
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE-GDQLACMIELLGMPXQKLLD 324
Query: 285 VSENAKDLV 293
            S+ AK+ V
Sbjct: 325 ASKRAKNFV 333

>pdb|3PM8|A Chain A, Cad Domain Of Pff0520w, Calcium Dependent Protein Kinase Length = 197

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 88/176 (50%), Gaps = 4/176 (2%)
Query: 324 NVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXX 383
           +V L  T+   LK F   N+LKK AL ++A+ L   E+  L+  F  +D +  G ++   
Sbjct: 19  HVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQE 78
Query: 384 XXX-XXXXXXQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSF 442
                     Q IP  D+  ++   D +  G ++Y +F+A ++  +     E     F F
Sbjct: 79  ILDGLKKIGYQKIP-PDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFKF 137
Query: 443 FDRNRSGFIEIEELRNALN-DEVDTSGED-VINAIMHDVDTDKDGRISYEEFAVMM 496
           FD + +G I +EEL+     D+++    D  I++++ +VD + DG I + EF +MM
Sbjct: 138 FDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLNGDGEIDFHEFMLMM 193

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 117/270 (43%), Gaps = 29/270 (10%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSI-----SKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ELGRG +GV      V +G+  A K I     S+++ R  +D++   R V         P
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC-------P 66
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYT-ERAAAAVMKTIVEVVQVCH 174
             V+       +  V I MEL +    + + +++ +G    E     +  +IV+ ++  H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 175 EQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-- 231
            +  V+HRD+KP N L     +   +K  DFG+S +       +   G   YMAPE +  
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 232 ---KRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVIDFKRDPWPKVS 286
              ++ Y  + D+WS G+ +  L     P+  W    Q + Q +         D   K S
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD---KFS 240
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
               D   + L  + K+R T  E+++HP+ 
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/323 (22%), Positives = 135/323 (41%), Gaps = 78/323 (24%)
Query: 61  GRELGRGEFGVTYLCTDVNNGEK--FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
           G ++GRG +G  Y     +  +   +A K I      T + +   R E+ +++ L KHPN
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG----TGISMSACR-EIALLREL-KHPN 79
Query: 119 IVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERA-----------AAAVMKT 165
           ++SL+  +    D  V ++ +  E  +L+   + + H   +A             +++  
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEH-DLWH--IIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGLSVFF----RPGEQFNEIV 220
           I++ +   H   V+HRDLKP N L   +  E   +K  D G +  F    +P    + +V
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------- 258
            + +Y APE+L   R+Y   +D+W+ G I   LL   P F                    
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 259 ------------WAETEQGVAQAIIRSVIDFKRDPWPKVS-------------ENAKDLV 293
                       W + ++    + +    DF+R+ +   S               A  L+
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMK--DFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 314
Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
           +K+L  DP +R+T+E+ ++ P+ 
Sbjct: 315 QKLLTMDPIKRITSEQAMQDPYF 337

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 83/343 (24%), Positives = 132/343 (38%), Gaps = 99/343 (28%)
Query: 63  ELGRGEFGVTYLCT---DVNNGEKFACKSI--SKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++G G F   YL T    V   EK A K +  +   +R A        E+Q +       
Sbjct: 28  KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAA-------ELQCLTVAGGQD 80
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           N++ +K  +  +  V I M   E     D + +      R     M  + + ++  H+ G
Sbjct: 81  NVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVRE---YMLNLFKALKRIHQFG 137
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGL-----------------------------SV 208
           ++HRD+KP NFL+  + +   L  +DFGL                             S+
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYAL--VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI 195
Query: 209 FFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 266
                +Q     G+P + APEVL +  N    +D+WSAGVI   LL G  PF+  ++   
Sbjct: 196 CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT 255
Query: 267 AQAII-----------------RSVIDFKRDP---------------------------- 281
           A A I                 +S++  K  P                            
Sbjct: 256 ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGH 315
Query: 282 ------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                 W +V + A DL+ K+L+ +P  R+TAEE L HP+ ++
Sbjct: 316 ATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           +E+G G+FG+ +L   +N  +K A K+I +     A+  ED   E ++M  L  HP +V 
Sbjct: 16  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREG----AMSEEDFIEEAEVMMKL-SHPKLVQ 69
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           L     + + + +V E  E G L D +   RG +       +   + E +    E  V+H
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 129
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLK-RNYG 236
           RDL   N L     E+  +K  DFG++ F    +Q+    G+ +   + +PEV     Y 
Sbjct: 130 RDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 237 PEVDVWSAGVILY 249
            + DVWS GV+++
Sbjct: 186 SKSDVWSFGVLMW 198

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 10  PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 58
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + A    +  +    + + 
Sbjct: 59  VGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 116
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFNEIVGS 222
               +   H + ++HRDLK  N       E + +K  DFGL+     +    QF ++ GS
Sbjct: 117 TARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGS 173
Query: 223 PYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV++      Y  + DV++ G++LY L+ G  P+
Sbjct: 174 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           +E+G G+FG+ +L   +N  +K A K+I +     A+  ED   E ++M  L  HP +V 
Sbjct: 13  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREG----AMSEEDFIEEAEVMMKL-SHPKLVQ 66
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           L     + + + +V E  E G L D +   RG +       +   + E +    E  V+H
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 126
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLK-RNYG 236
           RDL   N L     E+  +K  DFG++ F    +Q+    G+ +   + +PEV     Y 
Sbjct: 127 RDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 237 PEVDVWSAGVILY 249
            + DVWS GV+++
Sbjct: 183 SKSDVWSFGVLMW 195

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 121/286 (42%), Gaps = 45/286 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVRREVQIMKHLP------- 114
           LG+G FG      +  +   +A K I  +++KL T +       EV ++  L        
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS------EVXLLASLNHQYVVRY 67
Query: 115 -----KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER-AAAAVMKTIVE 168
                +  N V      +  S + I  E CE   L+D I +     +R     + + I+E
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-------------PG-- 213
            +   H QG++HR+LKP N       ES  +K  DFGL+                 PG  
Sbjct: 128 ALSYIHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 214 EQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
           +     +G+  Y+A EVL    +Y  ++D +S G+I +     + PF    E+      +
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF---EXIYPFSTGXERVNILKKL 241
Query: 272 RSV-IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           RSV I+F  D      +  K +++ +++ DP +R  A  +L   WL
Sbjct: 242 RSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           +E+G G+FG+ +L   +N  +K A K+I +     A+  ED   E ++M  L  HP +V 
Sbjct: 14  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREG----AMSEEDFIEEAEVMMKL-SHPKLVQ 67
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           L     + + + +V E  E G L D +   RG +       +   + E +    E  V+H
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLK-RNYG 236
           RDL   N L     E+  +K  DFG++ F    +Q+    G+ +   + +PEV     Y 
Sbjct: 128 RDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 237 PEVDVWSAGVILY 249
            + DVWS GV+++
Sbjct: 184 SKSDVWSFGVLMW 196

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 44/281 (15%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G FG  +      +G+ +  K       R   + E   REV+ +  L  H NIV   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIK-------RVKYNNEKAEREVKALAKLD-HVNIVHYN 70
Query: 124 ---DTYEDD-------------SAVHIVMELCEGGELFDRIVAR-GHYTERAAA-AVMKT 165
              D ++ D               + I ME C+ G L   I  R G   ++  A  + + 
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           I + V   H + +++RDLKP N    + K+   +K  DFGL    +   +     G+  Y
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKNDGKRXRSKGTLRY 187
Query: 226 MAPE-VLKRNYGPEVDVWSAGVILYILL--CGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
           M+PE +  ++YG EVD+++ G+IL  LL  C      ++    +   II  + D K    
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKE--- 244
Query: 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
                  K L++K+L+  P+ R    E+L    L   KK+P
Sbjct: 245 -------KTLLQKLLSKKPEDRPNTSEILRT--LTVWKKSP 276

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           +E+G G+FG+ +L   +N  +K A K+I +     A+  ED   E ++M  L  HP +V 
Sbjct: 11  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREG----AMSEEDFIEEAEVMMKL-SHPKLVQ 64
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           L     + + + +V E  E G L D +   RG +       +   + E +    E  V+H
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 124
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLK-RNYG 236
           RDL   N L     E+  +K  DFG++ F    +Q+    G+ +   + +PEV     Y 
Sbjct: 125 RDLAARNCLVG---ENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 237 PEVDVWSAGVILY 249
            + DVWS GV+++
Sbjct: 181 SKSDVWSFGVLMW 193

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +G G FG  +      +G+ +  +       R   + E   REV+ +  L  H NIV   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIR-------RVKYNNEKAEREVKALAKLD-HVNIVHYN 71
Query: 124 DTYE---------DDS--------------------AVHIVMELCEGGELFDRIVAR-GH 153
             ++         DDS                     + I ME C+ G L   I  R G 
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 154 YTERAAA-AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
             ++  A  + + I + V   H + ++HRDLKP N    + K+   +K  DFGL    + 
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKN 188
Query: 213 GEQFNEIVGSPYYMAPE-VLKRNYGPEVDVWSAGVILYILL--CGVPPFWAETEQGVAQA 269
             +     G+  YM+PE +  ++YG EVD+++ G+IL  LL  C      ++    +   
Sbjct: 189 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 248
Query: 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
           II  + D K           K L++K+L+  P+ R    E+L    L   KK+P
Sbjct: 249 IISDIFDKKE----------KTLLQKLLSKKPEDRPNTSEILRT--LTVWKKSP 290

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 22  PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 70
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + A    +  +    + + 
Sbjct: 71  VGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV---FFRPGEQFNEIVGS 222
               +   H + ++HRDLK  N       E + +K  DFGL+     +    QF ++ GS
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 223 PYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV++      Y  + DV++ G++LY L+ G  P+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 44/265 (16%)
Query: 95  RTAVDIEDVR-REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
           R  +D  D+   E++++     HPN++    +   D  ++I +ELC    L D + ++  
Sbjct: 46  RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNV 104
Query: 154 YTERA-------AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK----------ES 196
             E           ++++ I   V   H   ++HRDLKP+N L +             E+
Sbjct: 105 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 197 SPLKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVL--------KRNYGPEVDVWS 243
             +   DFGL      G+       N   G+  + APE+L        KR     +D++S
Sbjct: 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 244 AGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN-----AKDLVKKML 297
            G + Y +L  G  PF  +  +     IIR +  F  D    + +      A DL+ +M+
Sbjct: 225 MGCVFYYILSKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMI 280
Query: 298 NPDPKQRLTAEEVLEHP--WLQNAK 320
           + DP +R TA +VL HP  W ++ K
Sbjct: 281 DHDPLKRPTAMKVLRHPLFWPKSKK 305

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 19/254 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +GRG FG  +   D   G  F C   + KK+R    +E  R E  +       P IV L 
Sbjct: 66  VGRGSFGEVHRMKDKQTG--FQC---AVKKVR----LEVFRVEELVACAGLSSPRIVPLY 116
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
               +   V+I MEL EGG L   I   G   E  A   +   +E ++  H + ++H D+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRP---GEQF---NEIVGSPYYMAPE-VLKRNYG 236
           K +N L ++    + L   DFG ++  +P   G+     + I G+  +MAPE V+ +   
Sbjct: 177 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
            +VD+WS+  ++  +L G  P W +  +G     I S     R+  P  +      +++ 
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293
Query: 297 LNPDPKQRLTAEEV 310
           L  +P  R +A E+
Sbjct: 294 LRKEPVHRASAMEL 307

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 44/265 (16%)
Query: 95  RTAVDIEDVR-REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
           R  +D  D+   E++++     HPN++    +   D  ++I +ELC    L D + ++  
Sbjct: 46  RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNV 104
Query: 154 YTERA-------AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK----------ES 196
             E           ++++ I   V   H   ++HRDLKP+N L +             E+
Sbjct: 105 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 197 SPLKAIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVL--------KRNYGPEVDVWS 243
             +   DFGL      G+       N   G+  + APE+L        KR     +D++S
Sbjct: 165 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 244 AGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN-----AKDLVKKML 297
            G + Y +L  G  PF  +  +     IIR +  F  D    + +      A DL+ +M+
Sbjct: 225 MGCVFYYILSKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMI 280
Query: 298 NPDPKQRLTAEEVLEHP--WLQNAK 320
           + DP +R TA +VL HP  W ++ K
Sbjct: 281 DHDPLKRPTAMKVLRHPLFWPKSKK 305

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 33/208 (15%)
Query: 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKT---IVEVVQVCHEQGVMHRDLKPENF 188
           ++I M+LC    L D +  R    +R     +     I E V+  H +G+MHRDLKP N 
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 189 LFANKKESSPLKAIDFGLSVFFRPGEQFNEI-------------VGSPYYMAPEVLK-RN 234
            F        +K  DFGL       E+   +             VG+  YM+PE +   N
Sbjct: 196 FFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNN 252
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD--- 291
           Y  +VD++S G+IL+ LL     F  + E+      +R + D +   +P +         
Sbjct: 253 YSHKVDIFSLGLILFELLYS---FSTQMER------VRIITDVRNLKFPLLFTQKYPQEH 303
Query: 292 -LVKKMLNPDPKQRLTAEEVLEHPWLQN 318
            +V+ ML+P P +R  A +++E+   +N
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 50  SGQD--ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           SGQ+  + + Y +GR +G G FGV +  T++ N ++ A K   ++    A  + D  R  
Sbjct: 2   SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTY 59
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVH--IVMELCEGGELFDRIVARGH-YTERAAAAVMK 164
           +++      PN+      Y     +H  +V++L  G  L D +   G  ++ +  A   K
Sbjct: 60  KLLAGCTGIPNVY-----YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAK 113
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFA--NKKESSPLKAIDFGLSVFFR--------PGE 214
            ++  VQ  HE+ +++RD+KP+NFL    N K ++ +  +DFG+  F+R        P  
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 215 QFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF 258
           +   + G+  YM+    L R      D+ + G +    L G  P+
Sbjct: 174 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 19/254 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           +GRG FG  +   D   G  F C   + KK+R    +E  R E  +       P IV L 
Sbjct: 82  VGRGSFGEVHRMKDKQTG--FQC---AVKKVR----LEVFRVEELVACAGLSSPRIVPLY 132
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
               +   V+I MEL EGG L   I   G   E  A   +   +E ++  H + ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRP---GEQF---NEIVGSPYYMAPE-VLKRNYG 236
           K +N L ++    + L   DFG ++  +P   G+     + I G+  +MAPE V+ +   
Sbjct: 193 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
            +VD+WS+  ++  +L G  P W +  +G     I S     R+  P  +      +++ 
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 309
Query: 297 LNPDPKQRLTAEEV 310
           L  +P  R +A E+
Sbjct: 310 LRKEPVHRASAMEL 323

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 22  PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 70
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + A    +  +    + + 
Sbjct: 71  VGVLRK-TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV---FFRPGEQFNEIVGS 222
               +   H + ++HRDLK  N       E + +K  DFGL+     +    QF ++ GS
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 223 PYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV++      Y  + DV++ G++LY L+ G  P+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 50  SGQD--ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           SGQ+  + + Y +GR +G G FGV +  T++ N ++ A K   ++    A  + D  R  
Sbjct: 1   SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTY 58
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVH--IVMELCEGGELFDRIVARGH-YTERAAAAVMK 164
           +++      PN+      Y     +H  +V++L  G  L D +   G  ++ +  A   K
Sbjct: 59  KLLAGCTGIPNVY-----YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAK 112
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFA--NKKESSPLKAIDFGLSVFFR--------PGE 214
            ++  VQ  HE+ +++RD+KP+NFL    N K ++ +  +DFG+  F+R        P  
Sbjct: 113 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 172
Query: 215 QFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF 258
           +   + G+  YM+    L R      D+ + G +    L G  P+
Sbjct: 173 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 217

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 51  GQDISIDYDL-------GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIE 101
           G D S D+++       G+ +G G FG  Y       G+     ++    +   T   ++
Sbjct: 1   GSDSSDDWEIPDGQITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQ 54
Query: 102 DVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAA 160
             + EV +++   +H NI+ L   Y     + IV + CEG  L+  + +    +      
Sbjct: 55  AFKNEVGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI 112
Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFN 217
            + +   + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF 
Sbjct: 113 DIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 218 EIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
           ++ GS  +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 51  GQDISIDYDL-------GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIE 101
           G D S D+++       G+ +G G FG  Y       G+     ++    +   T   ++
Sbjct: 1   GSDSSDDWEIPDGQITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQ 54
Query: 102 DVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAA 160
             + EV +++   +H NI+ L   Y     + IV + CEG  L+  + +    +      
Sbjct: 55  AFKNEVGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI 112
Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFN 217
            + +   + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF 
Sbjct: 113 DIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 218 EIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
           ++ GS  +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
           +E+G G+FG+ +L   +N  +K A K+I +  +      +D   E ++M  L  HP +V 
Sbjct: 33  QEIGSGQFGLVHLGYWLNK-DKVAIKTIKEGSMSE----DDFIEEAEVMMKL-SHPKLVQ 86
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           L     + + + +V E  E G L D +   RG +       +   + E +    E  V+H
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 146
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLK-RNYG 236
           RDL   N L     E+  +K  DFG++ F    +Q+    G+ +   + +PEV     Y 
Sbjct: 147 RDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 237 PEVDVWSAGVILY 249
            + DVWS GV+++
Sbjct: 203 SKSDVWSFGVLMW 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 33  PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 81
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + +    +       + + 
Sbjct: 82  VGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFNEIVGS 222
             + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF ++ GS
Sbjct: 140 TAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 223 PYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 34  PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 82
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + +    +       + + 
Sbjct: 83  VGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFNEIVGS 222
             + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF ++ GS
Sbjct: 141 TAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 223 PYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 6   PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 54
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + +    +       + + 
Sbjct: 55  VGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFNEIVGS 222
             + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF ++ GS
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 223 PYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 8   PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 56
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + +    +       + + 
Sbjct: 57  VGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 114
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFNEIVGS 222
             + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF ++ GS
Sbjct: 115 TAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 223 PYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|1LA0|A Chain A, Solution Structure Of Calcium Saturated Cardiac Troponin C In The Troponin C-Troponin I Complex Length = 161

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 60/110 (54%), Gaps = 4/110 (3%)
Query: 393 QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAFSFFDRNRS 448
           QN    +LQ +++  D DG G++++ EF+ + V       K   +E L   F  FD+N  
Sbjct: 50  QNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRCMKDDSKGKTEEELSDLFRMFDKNAD 109
Query: 449 GFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           G+I++EEL+  L    +T  ED I  +M D D + DGRI Y+EF   MK 
Sbjct: 110 GYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 159

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 6   PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 54
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + +    +       + + 
Sbjct: 55  VGVLRK-TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFNEIVGS 222
             + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF ++ GS
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 223 PYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI------EDVRREVQIMKHLP 114
           G + G G FGV Y    VNN       +++ KKL   VDI      +   +E+++     
Sbjct: 27  GNKXGEGGFGVVYKGY-VNN------TTVAVKKLAAMVDITTEELKQQFDQEIKVXAKC- 78
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQ 171
           +H N+V L     D   + +V      G L DR+         +      + +     + 
Sbjct: 79  QHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGIN 138
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF------NEIVGSPYY 225
             HE   +HRD+K  N L     E+   K  DFGL+   R  E+F      + IVG+  Y
Sbjct: 139 FLHENHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQXVXXSRIVGTTAY 192
Query: 226 MAPEVLKRNYGPEVDVWSAGVILYILLCGVP 256
            APE L+    P+ D++S GV+L  ++ G+P
Sbjct: 193 XAPEALRGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 51  GQDISI---DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           G D+ I   D ++  ++G G FG  +      +G   A K + ++    A  + +  REV
Sbjct: 29  GDDMDIPWCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFH-AERVNEFLREV 85
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVM 163
            IMK L +HPNIV           + IV E    G L+ R++    AR    ER   ++ 
Sbjct: 86  AIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMA 143
Query: 164 KTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NE 218
             + + +   H +   ++HRDLK  N L   K     +K  DFGLS        F     
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRL--KASXFLXSKX 198
Query: 219 IVGSPYYMAPEVLKRNYGPE-VDVWSAGVILYIL 251
             G+P +MAPEVL+     E  DV+S GVIL+ L
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 34  PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 82
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + +    +       + + 
Sbjct: 83  VGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV---FFRPGEQFNEIVGS 222
             + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF ++ GS
Sbjct: 141 TAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 223 PYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 26  PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 74
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + +    +       + + 
Sbjct: 75  VGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV---FFRPGEQFNEIVGS 222
             + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF ++ GS
Sbjct: 133 TAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 223 PYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRRE 106
           P GQ       +G+ +G G FG  Y       G+     ++    +   T   ++  + E
Sbjct: 6   PDGQ-----ITVGQRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNE 54
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT 165
           V +++   +H NI+ L   Y     + IV + CEG  L+  + +    +       + + 
Sbjct: 55  VGVLRK-TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV---FFRPGEQFNEIVGS 222
             + +   H + ++HRDLK  N       E   +K  DFGL+     +    QF ++ GS
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 169
Query: 223 PYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
             +MAPEV+    K  Y  + DV++ G++LY L+ G  P+
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|1AJ4|A Chain A, Structure Of Calcium-Saturated Cardiac Troponin C, Nmr, 1 Structure Length = 161

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 62/112 (55%), Gaps = 8/112 (7%)
Query: 393 QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND------EHLHKAFSFFDRN 446
           QN    +LQ +++  D DG G++++ EF+ + V  + M +D      E L   F  FD+N
Sbjct: 50  QNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMV--RSMKDDSKGKTEEELSDLFRMFDKN 107
Query: 447 RSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
             G+I++EEL+  L    +T  ED I  +M D D + DGRI Y+EF   MK 
Sbjct: 108 ADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 159

>pdb|3K21|A Chain A, Crystal Structure Of Carboxy-Terminus Of Pfc0420w Length = 191

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 90/175 (51%), Gaps = 7/175 (4%)
Query: 328 GETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXX 387
           G  V    K + ++ K +K A+ ++A+  +  +V  LK  F ++D + +G I        
Sbjct: 18  GIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKG 77
Query: 388 XXXXXQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNR 447
                  +P  +  +L++  D DG G ++Y EF+A ++  K+++  + ++ AF  FD + 
Sbjct: 78  LEKDGLKLP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRKQLSK-KLIYCAFRVFDVDN 135
Query: 448 SGFIEIEELRNAL---NDEVDTSGEDV--INAIMHDVDTDKDGRISYEEFAVMMK 497
            G I   EL + L   N + + +  DV  +  ++ DVD + DG+I + EF+ MMK
Sbjct: 136 DGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKNNDGKIDFHEFSEMMK 190

>pdb|1DTL|A Chain A, Crystal Structure Of Calcium-Saturated (3ca2+) Cardiac Troponin C Complexed With The Calcium Sensitizer Bepridil At 2.15 A Resolution Length = 161

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 61/110 (55%), Gaps = 4/110 (3%)
Query: 393 QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAFSFFDRNRS 448
           QN    +LQ +++  D DG G++++ EF+ + V       K  ++E L   F  FD+N  
Sbjct: 50  QNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNAD 109
Query: 449 GFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           G+I++EEL+  L    +T  ED I  +M D D + DGRI Y+EF   MK 
Sbjct: 110 GYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 159

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y    V   +K++     K      +++E+  +E  +MK + KH
Sbjct: 33  DITMKHKLGGGQYGEVY----VGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KH 87
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +IV E    G L D  R   R   T      +   I   ++   
Sbjct: 88  PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE 147
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 148 KKNFIHRDLAARNCLVG---ENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 203
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 204 AYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|2LHI|A Chain A, Solution Structure Of Ca2+CNA1 PEPTIDE-Bound Ycam Length = 176

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 11/159 (6%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I+             +  EA++  LM   DVDG+  +
Sbjct: 5   LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQI 64
Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
            + EF+A+ S  LK   +++ L +AF  FD+N  G I   EL++ L     + GE + +A
Sbjct: 65  EFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLT----SIGEKLTDA 120
Query: 475 IMHDV---DTDKDGRISYEEFAVMMKAGTDW---RKASR 507
            + D+    +D  G I+ ++FA ++  G+     RKA R
Sbjct: 121 EVDDMLREVSDGSGEINIQQFAALLSKGSSTGTRRKALR 159

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 17/226 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV        +G   A K I   +++ A+    + RE+Q++ H    
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +       E     V   ++  +    E+
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
             +MHRD+KP N L  ++ E   +K  DFG+S     G+      N  VG+  YMAPE L
Sbjct: 134 HQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMAPERL 185
Query: 232 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276
           +  +Y  + D+WS G+ L  L  G  P      + +     R V+D
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVD 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 115/262 (43%), Gaps = 14/262 (5%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           E+GRG F   Y   D     + A   +  +KL T  + +  + E + +K L +HPNIV  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEXLKGL-QHPNIVRF 90
Query: 123 KDTYEDD----SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG- 177
            D++E        + +V EL   G L   +        +   +  + I++ +Q  H +  
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 178 -VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYG 236
            ++HRDLK +N        +  +K  D GL+   R       ++G+P + APE  +  Y 
Sbjct: 151 PIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRASFA-KAVIGTPEFXAPEXYEEKYD 207
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS-ENAKDLVKK 295
             VDV++ G           P+ +E  Q  AQ   R     K   + KV+    K++++ 
Sbjct: 208 ESVDVYAFGXCXLEXATSEYPY-SEC-QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ 317
            +  +  +R + +++L H + Q
Sbjct: 266 CIRQNKDERYSIKDLLNHAFFQ 287

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 27  YGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFAC 86
           Y D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     
Sbjct: 22  YVDPHTFEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---L 66
Query: 87  KSISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136
           K  SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVT 125
Query: 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194
           E  E G L D  + +    +T      +++ I   ++   + G +HRDL   N L     
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---N 181
Query: 195 ESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY 249
            +   K  DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 250 -ILLCGVPPFWAETEQGVAQAI 270
            ++  G  P+W  + Q V +A+
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAV 263

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 51  GQDISI---DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           G D+ I   D ++  ++G G FG  +      +G   A K + ++    A  + +  REV
Sbjct: 29  GDDMDIPWCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFH-AERVNEFLREV 85
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVM 163
            IMK L +HPNIV           + IV E    G L+ R++    AR    ER   ++ 
Sbjct: 86  AIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMA 143
Query: 164 KTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NE 218
             + + +   H +   ++HR+LK  N L   K     +K  DFGLS        F     
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRL--KASTFLSSKS 198
Query: 219 IVGSPYYMAPEVLKRNYGPE-VDVWSAGVILYIL 251
             G+P +MAPEVL+     E  DV+S GVIL+ L
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 27  YGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFAC 86
           Y D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     
Sbjct: 22  YVDPHTYEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---L 66
Query: 87  KSISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136
           K  SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVT 125
Query: 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194
           E  E G L D  + +    +T      +++ I   ++   + G +HRDL   N L     
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---N 181
Query: 195 ESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY 249
            +   K  DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 250 -ILLCGVPPFWAETEQGVAQAI 270
            ++  G  P+W  + Q V +A+
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAV 263

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 27  YGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFAC 86
           Y D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     
Sbjct: 20  YVDPHTYEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---L 64
Query: 87  KSISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136
           K  SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV 
Sbjct: 65  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVT 123
Query: 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194
           E  E G L D  + +    +T      +++ I   ++   + G +HRDL   N L     
Sbjct: 124 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---N 179
Query: 195 ESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY 249
            +   K  DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+
Sbjct: 180 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 239
Query: 250 -ILLCGVPPFWAETEQGVAQAI 270
            ++  G  P+W  + Q V +A+
Sbjct: 240 EVMSYGERPYWEMSNQDVIKAV 261

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 112/258 (43%), Gaps = 39/258 (15%)
Query: 32  VVANGST-VVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSIS 90
           +V  GST  VH     KE    +ISID    + +G GEFG      +V +G     K  S
Sbjct: 14  LVPRGSTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---LKLPS 58
Query: 91  KKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140
           KK++  A+        E  RR    E  IM     HPNI+ L+        V IV E  E
Sbjct: 59  KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYME 117
Query: 141 GGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198
            G L D  + +    +T      +++ I   ++   + G +HRDL   N L      +  
Sbjct: 118 NGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLV 173
Query: 199 LKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILL 252
            K  DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+ ++ 
Sbjct: 174 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233
Query: 253 CGVPPFWAETEQGVAQAI 270
            G  P+W  + Q V +A+
Sbjct: 234 YGERPYWEMSNQDVIKAV 251

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 27  YGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFAC 86
           Y D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     
Sbjct: 22  YVDPHTYEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---L 66
Query: 87  KSISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136
           K  SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVT 125
Query: 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194
           E  E G L D  + +    +T      +++ I   ++   + G +HRDL   N L     
Sbjct: 126 EXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---N 181
Query: 195 ESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY 249
            +   K  DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 250 -ILLCGVPPFWAETEQGVAQAI 270
            ++  G  P+W  + Q V +A+
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAV 263

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 66
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R   +      +   I   ++   
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ F    G+ +   + APE L
Sbjct: 127 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESL 182
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 27  YGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFAC 86
           + D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     
Sbjct: 22  FVDPHTFEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---L 66
Query: 87  KSISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136
           K  SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVT 125
Query: 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194
           E  E G L D  + +    +T      +++ I   ++   + G +HRDL   N L     
Sbjct: 126 EXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILI---N 181
Query: 195 ESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY 249
            +   K  DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 250 -ILLCGVPPFWAETEQGVAQAI 270
            ++  G  P+W  + Q V +A+
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAV 263

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 61  GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
           G  LG+G FG     T    GE    K + +    T        +EV++M+ L +HPN++
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCL-EHPNVL 70
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVM 179
                   D  ++ + E  +GG L   I +    Y      +  K I   +   H   ++
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFF--------------RPG-EQFNEIVGSPY 224
           HRDL   N L    +E+  +   DFGL+                 +P  ++   +VG+PY
Sbjct: 131 HRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 225 YMAPEVLK-RNYGPEVDVWSAGVIL 248
           +MAPE++  R+Y  +VDV+S G++L
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVL 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y        +K++     K      +++E+  +E  +MK + KH
Sbjct: 14  DITMKHKLGGGQYGEVY----EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I++E    G L D  R   R   +      +   I   ++   
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 184
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 27  YGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFAC 86
           + D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     
Sbjct: 22  FVDPHTFEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---L 66
Query: 87  KSISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136
           K  SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVT 125
Query: 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194
           E  E G L D  + +    +T      +++ I   ++   + G +HRDL   N L     
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILI---N 181
Query: 195 ESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY 249
            +   K  DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 250 -ILLCGVPPFWAETEQGVAQAI 270
            ++  G  P+W  + Q V +A+
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAV 263

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I++E    G L D  R   R   +      +   I   ++   
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 184
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 119/278 (42%), Gaps = 43/278 (15%)
Query: 49  PSGQDISID---YDLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKK 93
           PS +D  I     +LGR +G G+FG      DV+ G   +            CK+ +   
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFG------DVHQGIYMSPENPAMAVAIKTCKNCTSDS 433
Query: 94  LRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
           +R     E   +E   M+    HP+IV L     ++  V I+MELC  GEL   +  R  
Sbjct: 434 VR-----EKFLQEALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKF 486
Query: 154 YTERAAAAVMK-TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
             + A+  +    +   +     +  +HRD+   N L ++   +  +K  DFGLS +   
Sbjct: 487 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMED 543
Query: 213 GEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ 268
              +    G  P  +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV  
Sbjct: 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKN 598
Query: 269 A-IIRSVIDFKRDPW-PKVSENAKDLVKKMLNPDPKQR 304
             +I  + + +R P  P        L+ K    DP +R
Sbjct: 599 NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++   +G+G FG      D    E  A K I  KK      +   + EV++++ + KH 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHD 111
Query: 118 N-----IVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARG---HYTERAAAAVMKTIV 167
                 IV LK  +   + + +V E+      +L      RG   + T + A  +   ++
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
            +     E  ++H DLKPEN L  N K S+ +K +DFG S   + G++  + + S +Y +
Sbjct: 172 FLA--TPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSC--QLGQRIYQXIQSRFYRS 226
Query: 228 PEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE 263
           PEV L   Y   +D+WS G IL  +  G P F    E
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 27  YGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFAC 86
           + D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     
Sbjct: 22  FVDPHTFEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---L 66
Query: 87  KSISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136
           K  SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVT 125
Query: 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194
           E  E G L D  + +    +T      +++ I   ++   + G +HRDL   N L     
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---N 181
Query: 195 ESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY 249
            +   K  DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 250 -ILLCGVPPFWAETEQGVAQAI 270
            ++  G  P+W  + Q V +A+
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAV 263

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++   +G+G FG      D    E  A K I  KK      +   + EV++++ + KH 
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHD 92
Query: 118 N-----IVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARG---HYTERAAAAVMKTIV 167
                 IV LK  +   + + +V E+      +L      RG   + T + A  +   ++
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 152
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
            +     E  ++H DLKPEN L  N K S+ +K +DFG S   + G++  + + S +Y +
Sbjct: 153 FLA--TPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSC--QLGQRIYQXIQSRFYRS 207
Query: 228 PEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE 263
           PEV L   Y   +D+WS G IL  +  G P F    E
Sbjct: 208 PEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 110/254 (43%), Gaps = 39/254 (15%)
Query: 36  GST-VVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL 94
           GST  VH     KE    +ISID    + +G GEFG      +V +G     K  SKK++
Sbjct: 1   GSTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---LKLPSKKEI 45
Query: 95  RTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGEL 144
             A+        E  RR    E  IM     HPNI+ L+        V IV E  E G L
Sbjct: 46  SVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL 104
Query: 145 FDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202
            D  + +    +T      +++ I   ++   + G +HRDL   N L      +   K  
Sbjct: 105 -DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVS 160
Query: 203 DFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVP 256
           DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+ ++  G  
Sbjct: 161 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 220
Query: 257 PFWAETEQGVAQAI 270
           P+W  + Q V +A+
Sbjct: 221 PYWEMSNQDVIKAV 234

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 111/260 (42%), Gaps = 38/260 (14%)
Query: 29  DEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKS 88
           D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     K 
Sbjct: 24  DPHTYEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---LKL 68
Query: 89  ISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL 138
            SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV E 
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 139 CEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES 196
            E G L D  + +    +T      +++ I   ++   + G +HRDL   N L      +
Sbjct: 128 MENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSN 183
Query: 197 SPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY-I 250
              K  DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+ +
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 251 LLCGVPPFWAETEQGVAQAI 270
           +  G  P+W  + Q V +A+
Sbjct: 244 MSYGERPYWEMSNQDVIKAV 263

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 118/278 (42%), Gaps = 43/278 (15%)
Query: 49  PSGQDISID---YDLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKK 93
           PS +D  I     +LGR +G G+FG      DV+ G   +            CK+ +   
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFG------DVHQGIYMSPENPAMAVAIKTCKNCTSDS 433
Query: 94  LRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
           +R     E   +E   M+    HP+IV L     ++  V I+MELC  GEL   +  R  
Sbjct: 434 VR-----EKFLQEALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKF 486
Query: 154 YTERAAAAVMK-TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
             + A+  +    +   +     +  +HRD+   N L +    +  +K  DFGLS +   
Sbjct: 487 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---ATDCVKLGDFGLSRYMED 543
Query: 213 GEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ 268
              +    G  P  +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV  
Sbjct: 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKN 598
Query: 269 A-IIRSVIDFKRDPW-PKVSENAKDLVKKMLNPDPKQR 304
             +I  + + +R P  P        L+ K    DP +R
Sbjct: 599 NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 110/254 (43%), Gaps = 39/254 (15%)
Query: 36  GST-VVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL 94
           GST  VH     KE    +ISID    + +G GEFG      +V +G     K  SKK++
Sbjct: 1   GSTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---LKLPSKKEI 45
Query: 95  RTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGEL 144
             A+        E  RR    E  IM     HPNI+ L+        V IV E  E G L
Sbjct: 46  SVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL 104
Query: 145 FDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202
            D  + +    +T      +++ I   ++   + G +HRDL   N L      +   K  
Sbjct: 105 -DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVS 160
Query: 203 DFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVP 256
           DFGLS      P   +    G  P  + +PE +  R +    DVWS G++L+ ++  G  
Sbjct: 161 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 220
Query: 257 PFWAETEQGVAQAI 270
           P+W  + Q V +A+
Sbjct: 221 PYWEMSNQDVIKAV 234

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R   +      +   I   ++   
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 133
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 134 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 189
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 19/252 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +G GEFG          G+K +C +I + K   T     +   E  IM    +HPNI+ L
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF-EHPNIIRL 82
Query: 123 KDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           +    +   V I+ E  E G L  F R+   G +T      +++ I   ++   E   +H
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 141
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFR-----PGEQFNEIVGSPY-YMAPEVLK-R 233
           RDL   N L      +   K  DFGLS F       P E  +     P  + APE +  R
Sbjct: 142 RDLAARNILV---NSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 234 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
            +    D WS G++++ ++  G  P+W  + Q V  AI +   D++  P P    +   L
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ---DYRLPPPPDCPTSLHQL 255
Query: 293 VKKMLNPDPKQR 304
           +      D   R
Sbjct: 256 MLDCWQKDRNAR 267

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 40/265 (15%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKKLRTAVDIEDVRRE 106
           +LGR +G G+FG      DV+ G   +            CK+ +   +R     E   +E
Sbjct: 18  ELGRCIGEGQFG------DVHQGIYMSPENPALAVAIKTCKNCTSDSVR-----EKFLQE 66
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-T 165
              M+    HP+IV L     ++  V I+MELC  GEL   +  R +  + A+  +    
Sbjct: 67  ALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY 224
           +   +     +  +HRD+   N L ++   +  +K  DFGLS +      +    G  P 
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVIDFKRD 280
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV    +I  + + +R 
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 236
Query: 281 PW-PKVSENAKDLVKKMLNPDPKQR 304
           P  P        L+ K    DP +R
Sbjct: 237 PMPPNCPPTLYSLMTKCWAYDPSRR 261

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 40/265 (15%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKKLRTAVDIEDVRRE 106
           +LGR +G G+FG      DV+ G   +            CK+ +   +R     E   +E
Sbjct: 41  ELGRCIGEGQFG------DVHQGIYMSPENPALAVAIKTCKNCTSDSVR-----EKFLQE 89
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-T 165
              M+    HP+IV L     ++  V I+MELC  GEL   +  R +  + A+  +    
Sbjct: 90  ALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 147
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY 224
           +   +     +  +HRD+   N L ++   +  +K  DFGLS +      +    G  P 
Sbjct: 148 LSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPI 204
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVIDFKRD 280
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV    +I  + + +R 
Sbjct: 205 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 259
Query: 281 PW-PKVSENAKDLVKKMLNPDPKQR 304
           P  P        L+ K    DP +R
Sbjct: 260 PMPPNCPPTLYSLMTKCWAYDPSRR 284

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R   +      +   I   ++   
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 184
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y        +K++     K      +++E+  +E  +MK + KH
Sbjct: 19  DITMKHKLGGGQYGEVY----EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I++E    G L D  R   R          +   I   ++   
Sbjct: 74  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 134 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 189
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R   +      +   I   ++   
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 184
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 40/265 (15%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKKLRTAVDIEDVRRE 106
           +LGR +G G+FG      DV+ G   +            CK+ +   +R     E   +E
Sbjct: 13  ELGRCIGEGQFG------DVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-----EKFLQE 61
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-T 165
              M+    HP+IV L     ++  V I+MELC  GEL   +  R +  + A+  +    
Sbjct: 62  ALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY 224
           +   +     +  +HRD+   N L ++   +  +K  DFGLS +      +    G  P 
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVIDFKRD 280
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV    +I  + + +R 
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 231
Query: 281 PW-PKVSENAKDLVKKMLNPDPKQR 304
           P  P        L+ K    DP +R
Sbjct: 232 PMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 40/265 (15%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKKLRTAVDIEDVRRE 106
           +LGR +G G+FG      DV+ G   +            CK+ +   +R     E   +E
Sbjct: 16  ELGRCIGEGQFG------DVHQGIYMSPENPALAVAIKTCKNCTSDSVR-----EKFLQE 64
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-T 165
              M+    HP+IV L     ++  V I+MELC  GEL   +  R +  + A+  +    
Sbjct: 65  ALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 122
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY 224
           +   +     +  +HRD+   N L ++   +  +K  DFGLS +      +    G  P 
Sbjct: 123 LSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPI 179
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVIDFKRD 280
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV    +I  + + +R 
Sbjct: 180 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 234
Query: 281 PW-PKVSENAKDLVKKMLNPDPKQR 304
           P  P        L+ K    DP +R
Sbjct: 235 PMPPNCPPTLYSLMTKCWAYDPSRR 259

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 40/265 (15%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKKLRTAVDIEDVRRE 106
           +LGR +G G+FG      DV+ G   +            CK+ +   +R     E   +E
Sbjct: 15  ELGRCIGEGQFG------DVHQGIYMSPENPALAVAIKTCKNCTSDSVR-----EKFLQE 63
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-T 165
              M+    HP+IV L     ++  V I+MELC  GEL   +  R +  + A+  +    
Sbjct: 64  ALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 121
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY 224
           +   +     +  +HRD+   N L ++   +  +K  DFGLS +      +    G  P 
Sbjct: 122 LSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPI 178
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVIDFKRD 280
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV    +I  + + +R 
Sbjct: 179 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 233
Query: 281 PW-PKVSENAKDLVKKMLNPDPKQR 304
           P  P        L+ K    DP +R
Sbjct: 234 PMPPNCPPTLYSLMTKCWAYDPSRR 258

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 40/265 (15%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKKLRTAVDIEDVRRE 106
           +LGR +G G+FG      DV+ G   +            CK+ +   +R     E   +E
Sbjct: 13  ELGRCIGEGQFG------DVHQGIYMSPENPALAVAIKTCKNCTSDSVR-----EKFLQE 61
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-T 165
              M+    HP+IV L     ++  V I+MELC  GEL   +  R +  + A+  +    
Sbjct: 62  ALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY 224
           +   +     +  +HRD+   N L ++   +  +K  DFGLS +      +    G  P 
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVIDFKRD 280
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV    +I  + + +R 
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 231
Query: 281 PW-PKVSENAKDLVKKMLNPDPKQR 304
           P  P        L+ K    DP +R
Sbjct: 232 PMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 40/265 (15%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKKLRTAVDIEDVRRE 106
           +LGR +G G+FG      DV+ G   +            CK+ +   +R     E   +E
Sbjct: 10  ELGRCIGEGQFG------DVHQGIYMSPENPALAVAIKTCKNCTSDSVR-----EKFLQE 58
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-T 165
              M+    HP+IV L     ++  V I+MELC  GEL   +  R +  + A+  +    
Sbjct: 59  ALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY 224
           +   +     +  +HRD+   N L ++   +  +K  DFGLS +      +    G  P 
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVIDFKRD 280
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV    +I  + + +R 
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 228
Query: 281 PW-PKVSENAKDLVKKMLNPDPKQR 304
           P  P        L+ K    DP +R
Sbjct: 229 PMPPNCPPTLYSLMTKCWAYDPSRR 253

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 104/252 (41%), Gaps = 19/252 (7%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +G GEFG          G+K +C +I + K   T     +   E  IM    +HPNI+ L
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF-EHPNIIRL 80
Query: 123 KDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           +    +   V I+ E  E G L  F R+   G +T      +++ I   ++   E   +H
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 139
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPY---YMAPEVLK-R 233
           RDL   N L      +   K  DFGLS F         +   +G      + APE +  R
Sbjct: 140 RDLAARNILV---NSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 234 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
            +    D WS G++++ ++  G  P+W  + Q V  AI +   D++  P P    +   L
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ---DYRLPPPPDCPTSLHQL 253
Query: 293 VKKMLNPDPKQR 304
           +      D   R
Sbjct: 254 MLDCWQKDRNAR 265

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 69
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 70  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 130 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESL 185
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 186 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   L   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 89
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-----------GHYTERAAA- 160
           + KH NI++L      D  +++++E    G L + + AR            H  E   + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS 149
Query: 161 ----AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
               +    +   ++    +  +HRDL   N L     E + +K  DFGL+      + +
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 206
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 33/227 (14%)
Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   L   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 89
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTE 156
           + KH NI++L      D  +++++E    G L + + AR                   + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 149
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
           +   +    +   ++    +  +HRDL   N L     E + +K  DFGL+      + +
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 206
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 131 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESL 186
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   L   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 81
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-----------GHYTERAAA- 160
           + KH NI++L      D  +++++E    G L + + AR            H  E   + 
Sbjct: 82  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 161 ----AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
               +    +   ++    +  +HRDL   N L     E + +K  DFGL+      + +
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 198
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 33/227 (14%)
Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   L   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 82
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTE 156
           + KH NI++L      D  +++++E    G L + + AR                   + 
Sbjct: 83  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
           +   +    +   ++    +  +HRDL   N L     E + +K  DFGL+      + +
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 199
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   L   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 78
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-----------GHYTERAAA- 160
           + KH NI++L      D  +++++E    G L + + AR            H  E   + 
Sbjct: 79  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 161 ----AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
               +    +   ++    +  +HRDL   N L     E + +K  DFGL+      + +
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 195
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y        +K++     K      +++E+  +E  +MK + KH
Sbjct: 16  DITMKHKLGGGQYGEVY----EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 131 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 186
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G+FG  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 66
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R   +      +   I   ++   
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+      G+ +   + APE L
Sbjct: 127 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESL 182
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   L   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 74
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-----------GHYTERAAA- 160
           + KH NI++L      D  +++++E    G L + + AR            H  E   + 
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 161 ----AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
               +    +   ++    +  +HRDL   N L     E + +K  DFGL+      + +
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 191
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 131 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 186
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 187 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y        +K++     K      +++E+  +E  +MK + KH
Sbjct: 19  DITMKHKLGGGQYGEVY----EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 134 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 189
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2JT0|A Chain A, Solution Structure Of F104w Cardiac Troponin C Length = 161

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 61/110 (55%), Gaps = 4/110 (3%)
Query: 393 QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAFSFFDRNRS 448
           QN    +LQ +++  D DG G++++ EF+ + V       K  ++E L   F  +D+N  
Sbjct: 50  QNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMWDKNAD 109
Query: 449 GFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           G+I+++EL+  L    +T  ED I  +M D D + DGRI Y+EF   MK 
Sbjct: 110 GYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 159

>pdb|2JT3|A Chain A, Solution Structure Of F153w Cardiac Troponin C Length = 161

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 61/110 (55%), Gaps = 4/110 (3%)
Query: 393 QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAFSFFDRNRS 448
           QN    +LQ +++  D DG G++++ EF+ + V       K  ++E L   F  FD+N  
Sbjct: 50  QNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNAD 109
Query: 449 GFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           G+I+++EL+  L    +T  ED I  +M D D + DGRI Y+E+   MK 
Sbjct: 110 GYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEWLEFMKG 159

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y        +K++     K      +++E+  +E  +MK + KH
Sbjct: 19  DITMKHKLGGGQYGEVY----EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 134 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 189
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y        +K++     K      +++E+  +E  +MK + KH
Sbjct: 27  DITMKHKLGGGQYGEVY----EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KH 81
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 82  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 141
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 142 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 197
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 198 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|3O4Y|A Chain A, Crystal Structure Of Cad Domain Of The Plasmodium Vivax Cdpk, Pvx_11610 Length = 196

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 88/168 (52%), Gaps = 7/168 (4%)
Query: 335 LKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQN 394
            K +++M + +K A+ ++A+  +  +V  LK AF  +D   +G I               
Sbjct: 28  FKNYALMLRFQKLAMTIIAQQSNDYDVQKLKAAFLHLDEEGKGNITKLQLRKGLERSGLM 87
Query: 395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIE 454
           +P  +  +L++  D DG G+++Y EF+A ++  ++++  + ++ AF  FD +  G I   
Sbjct: 88  LP-PNFDLLLDQIDSDGSGNIDYTEFLAAAIDRRQLSK-KLIYCAFRVFDVDNDGEITTA 145
Query: 455 ELRNAL---NDEVDTSGEDV--INAIMHDVDTDKDGRISYEEFAVMMK 497
           EL + L   N   + +  DV  +  ++ +VD + DG+I + EF+ MMK
Sbjct: 146 ELAHVLFNGNKRGNITERDVNQVKKMIREVDKNGDGKIDFYEFSEMMK 193

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 27  YGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFAC 86
           + D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     
Sbjct: 22  FVDPHTFEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---L 66
Query: 87  KSISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136
           K  SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV 
Sbjct: 67  KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVT 125
Query: 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194
           E  E G L D  + +    +T      +++ I   ++   + G +HRDL   N L     
Sbjct: 126 EYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---N 181
Query: 195 ESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY 249
            +   K  DFGL+      P   +    G  P  + +PE +  R +    DVWS G++L+
Sbjct: 182 SNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 250 -ILLCGVPPFWAETEQGVAQAI 270
            ++  G  P+W  + Q V +A+
Sbjct: 242 EVMSYGERPYWEMSNQDVIKAV 263

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 33/227 (14%)
Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   L   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 89
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTE 156
           + KH NI++L      D  +++++E    G L + + AR                   + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
           +   +    +   ++    +  +HRDL   N L     E + +K  DFGL+      + +
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 206
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 132
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 133 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 188
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 184
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 62  RELGRGEFG-VTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           R+LG G FG V+  C D  N   GE  A K++  K           ++E+ I++ L  H 
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTL-YHE 93
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
           +I+  K   ED  A  + +VME    G L D       Y  R +  + + ++   Q+C  
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-------YLPRHSIGLAQLLLFAQQICEG 146
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV---GSP-YY 225
               H Q  +HRDL   N L  N +    +K  DFGL+     G +   +     SP ++
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEXYRVREDGDSPVFW 203
Query: 226 MAPEVLKR-NYGPEVDVWSAGVILYILL 252
            APE LK   +    DVWS GV LY LL
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   L   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 130
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-----------GHYTERAAA- 160
           + KH NI++L      D  +++++E    G L + + AR            H  E   + 
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 161 ----AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
               +    +   ++    +  +HRDL   N L     E + +K  DFGL+      + +
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 247
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + +  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKN 215
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y        +K++     K      +++E+  +E  +MK + KH
Sbjct: 221 DITMKHKLGGGQYGEVYEGV----WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KH 275
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R   +      +   I   ++   
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HR+L   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 336 KKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 391
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 184
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 115/263 (43%), Gaps = 23/263 (8%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 66
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I++E    G L D  R   R   +      +   I   ++   
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+      G+ +   + APE L
Sbjct: 127 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESL 182
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVI--DFKRDPWPKVSE 287
             N +  + DVW+ GV+L+ I   G+ P+      G+  + +  ++  D++ +      E
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDPSQVYELLEKDYRMERPEGCPE 237
Query: 288 NAKDLVKKMLNPDPKQRLTAEEV 310
              +L++     +P  R +  E+
Sbjct: 238 KVYELMRACWQWNPSDRPSFAEI 260

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI+ L      D  +++++E    G L + + AR                   T + 
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 110/260 (42%), Gaps = 38/260 (14%)
Query: 29  DEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKS 88
           D +   + +  VH     KE    +ISID    + +G GEFG      +V +G     K 
Sbjct: 24  DPHTFEDPTQTVHEFA--KELDATNISID----KVVGAGEFG------EVCSGR---LKL 68
Query: 89  ISKKKLRTAVDI------EDVRR----EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL 138
            SKK++  A+        E  RR    E  IM     HPNI+ L+        V IV E 
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 139 CEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES 196
            E G L D  + +    +T      +++ I   ++   + G +HRDL   N L      +
Sbjct: 128 MENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSN 183
Query: 197 SPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY-I 250
              K  DFGL       P   +    G  P  + +PE +  R +    DVWS G++L+ +
Sbjct: 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 251 LLCGVPPFWAETEQGVAQAI 270
           +  G  P+W  + Q V +A+
Sbjct: 244 MSYGERPYWEMSNQDVIKAV 263

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y++   +G+G FG      D    E  A K I  KK      +   + EV++++ + KH 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHD 111
Query: 118 N-----IVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARG---HYTERAAAAVMKTIV 167
                 IV LK  +   + + +V E+      +L      RG   + T + A  +   ++
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
            +     E  ++H DLKPEN L  N K  + +K +DFG S   + G++  + + S +Y +
Sbjct: 172 FLA--TPELSIIHCDLKPENILLCNPKRXA-IKIVDFGSSC--QLGQRIYQXIQSRFYRS 226
Query: 228 PEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE 263
           PEV L   Y   +D+WS G IL  +  G P F    E
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 62  RELGRGEFG-VTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           R+LG G FG V+  C D  N   GE  A K++  K           ++E+ I++ L  H 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILRTL-YHE 76
Query: 118 NIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
           +I+  K   ED  + ++ +VME    G L D       Y  R +  + + ++   Q+C  
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRD-------YLPRHSIGLAQLLLFAQQICEG 129
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV---GSP-YY 225
               H Q  +HR+L   N L  N +    +K  DFGL+     G ++  +     SP ++
Sbjct: 130 MAYLHSQHYIHRNLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 226 MAPEVLKR-NYGPEVDVWSAGVILYILL 252
            APE LK   +    DVWS GV LY LL
Sbjct: 187 YAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ ++  DFGL+      + + +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADFGLARDINNIDYYKK 215
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHLPKHP 117
           L   +G G FG  Y       G+     ++   K+   T    +  R EV +++   +H 
Sbjct: 40  LSTRIGSGSFGTVY------KGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRK-TRHV 92
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           NI+ L   Y     + IV + CEG  L+  + V    +       + +   + +   H +
Sbjct: 93  NIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK 151
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFNEIVGSPYYMAPEVLKR 233
            ++HRD+K  N       E   +K  DFGL+     +   +Q  +  GS  +MAPEV++ 
Sbjct: 152 NIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 234 N----YGPEVDVWSAGVILYILLCGVPPF 258
                +  + DV+S G++LY L+ G  P+
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 113/265 (42%), Gaps = 40/265 (15%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKKLRTAVDIEDVRRE 106
           +LGR +G G+FG      DV+ G   +            CK+ +   +R     E   +E
Sbjct: 13  ELGRCIGEGQFG------DVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-----EKFLQE 61
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-T 165
              M+    HP+IV L     ++  V I+MELC  GEL   +  R    + A+  +    
Sbjct: 62  ALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY 224
           +   +     +  +HRD+   N L +    +  +K  DFGLS +      +    G  P 
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVS---ATDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVIDFKRD 280
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV    +I  + + +R 
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 231
Query: 281 PW-PKVSENAKDLVKKMLNPDPKQR 304
           P  P        L+ K    DP +R
Sbjct: 232 PMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 90
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 151 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 207
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 62  RELGRGEFG-VTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           R+LG G FG V+  C D  N   GE  A K++  K           ++E+ I++ L  H 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILRTL-YHE 76
Query: 118 NIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
           +I+  K   ED  + ++ +VME    G L D       Y  R +  + + ++   Q+C  
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRD-------YLPRHSIGLAQLLLFAQQICEG 129
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV---GSP-YY 225
               H Q  +HR+L   N L  N +    +K  DFGL+     G ++  +     SP ++
Sbjct: 130 MAYLHAQHYIHRNLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 226 MAPEVLKR-NYGPEVDVWSAGVILYILL 252
            APE LK   +    DVWS GV LY LL
Sbjct: 187 YAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 85
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 146 LVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADFGLARDINNIDYYKK 202
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 87
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 148 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 204
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|1LKJ|A Chain A, Nmr Structure Of Apo Calmodulin From Yeast Saccharomyces Cerevisiae Length = 146

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I+             +  EA++  LM   DVDG+  +
Sbjct: 4   LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQI 63
Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
            + EF+A+ S  LK   +++ L +AF  FD+N  G I   EL++ L     + GE + +A
Sbjct: 64  EFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLT----SIGEKLTDA 119
Query: 475 IMHDV---DTDKDGRISYEEFAVMM 496
            + D+    +D  G I+ ++FA ++
Sbjct: 120 EVDDMLREVSDGSGEINIQQFAALL 144

>pdb|1S6J|A Chain A, N-Terminal Region Of The Ca2+-Saturated Calcium Regulatory Domain (Cld) From Soybean Calcium-Dependent Protein Kinase- Alpha (Cdpk) Length = 87

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 31/75 (41%), Positives = 48/75 (64%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDG 411
           +AE LS EE+ GLKE F+M+DT+  G I               + E++++ LM+AAD+D 
Sbjct: 13  MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDK 72
Query: 412 DGSLNYGEFVAVSVH 426
            G+++YGEF+A +VH
Sbjct: 73  SGTIDYGEFIAATVH 87

>pdb|2JTZ|A Chain A, Solution Structure And Chemical Shift Assignments Of The F104-To-5-Flurotryptophan Mutant Of Cardiac Troponin C Length = 161

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 60/110 (54%), Gaps = 4/110 (3%)
Query: 393 QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAFSFFDRNRS 448
           QN    +LQ +++  D DG G++++ EF+ + V       K  ++E L   F   D+N  
Sbjct: 50  QNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMXDKNAD 109
Query: 449 GFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           G+I+++EL+  L    +T  ED I  +M D D + DGRI Y+EF   MK 
Sbjct: 110 GYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 159

>pdb|2JT8|A Chain A, Solution Structure Of The F153-To-5-Flurotryptophan Mutant Of Human Cardiac Troponin C Length = 161

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 60/110 (54%), Gaps = 4/110 (3%)
Query: 393 QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAFSFFDRNRS 448
           QN    +LQ +++  D DG G++++ EF+ + V       K  ++E L   F  FD+N  
Sbjct: 50  QNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNAD 109
Query: 449 GFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           G+I+++EL+  L    +T  ED I  +M D D + DGRI Y+E    MK 
Sbjct: 110 GYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEXLEFMKG 159

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 69
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I++E    G L D  R   R          +   I   ++   
Sbjct: 70  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+      G+ +   + APE L
Sbjct: 130 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESL 185
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 186 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y        +K++     K      +++E+  +E  +MK + KH
Sbjct: 260 DITMKHKLGGGQYGEVYEGV----WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KH 314
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 315 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 374
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HR+L   N L     E+  +K  DFGLS     G+ +    G+ +   + APE L
Sbjct: 375 KKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 430
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 431 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 33/227 (14%)
Query: 60  LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           LG+ LG G FG   L   +       N   K A K +  K   T  D+ D+  E+++MK 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 89
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTE 156
           + KH NI++L      D  +++++E    G L + + AR                   + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
           +   +    +   ++    +  +HRDL   N L     E + +K  DFGL+      +  
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDXX 206
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
            +         +MAPE L  R Y  + DVWS GV+L+ I   G  P+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 261
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/324 (23%), Positives = 119/324 (36%), Gaps = 72/324 (22%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPKH 116
           Y++   LG G FG    C D   G+      ++ K +R      E  R E+ ++K + + 
Sbjct: 53  YEIVGNLGEGTFGKVVECLDHARGKS----QVALKIIRNVGKYREAARLEINVLKKIKEK 108
Query: 117 PN-----IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
                   V + D +     + I  EL  G   F+ +       Y       +   +   
Sbjct: 109 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 167
Query: 170 VQVCHEQGVMHRDLKPENFLFANKK----------------ESSPLKAIDFGLSVFFRPG 213
           ++  HE  + H DLKPEN LF N +                +++ ++  DFG + F    
Sbjct: 168 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 225
Query: 214 EQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QG 265
           E    IV + +Y  PEV L+  +    DVWS G IL+    G   F            + 
Sbjct: 226 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 285
Query: 266 VAQAIIRSVIDFKRDP---------WPK-------VSENAK-----------------DL 292
           +   I   +I   R           W +       V EN K                 DL
Sbjct: 286 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 345
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
           +++ML  DP QR+T  E L HP+ 
Sbjct: 346 MRRMLEFDPAQRITLAEALLHPFF 369

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/324 (23%), Positives = 119/324 (36%), Gaps = 72/324 (22%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPKH 116
           Y++   LG G FG    C D   G+      ++ K +R      E  R E+ ++K + + 
Sbjct: 30  YEIVGNLGEGTFGKVVECLDHARGKS----QVALKIIRNVGKYREAARLEINVLKKIKEK 85
Query: 117 PN-----IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
                   V + D +     + I  EL  G   F+ +       Y       +   +   
Sbjct: 86  DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 144
Query: 170 VQVCHEQGVMHRDLKPENFLFANKK----------------ESSPLKAIDFGLSVFFRPG 213
           ++  HE  + H DLKPEN LF N +                +++ ++  DFG + F    
Sbjct: 145 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 202
Query: 214 EQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QG 265
           E    IV + +Y  PEV L+  +    DVWS G IL+    G   F            + 
Sbjct: 203 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 262
Query: 266 VAQAIIRSVIDFKRDP---------WPK-------VSENAK-----------------DL 292
           +   I   +I   R           W +       V EN K                 DL
Sbjct: 263 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 322
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
           +++ML  DP QR+T  E L HP+ 
Sbjct: 323 MRRMLEFDPAQRITLAEALLHPFF 346

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDXXKK 215
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++E    G L + + AR                   T + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDXXKK 215
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 109/255 (42%), Gaps = 40/255 (15%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LGR++G G FG  YL TD+  GE+ A K    K     + IE      +I K +    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-----KIYKMMQGGV 65
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            I +++    +     +VMEL  G  L D        ++ +    +   ++  ++  H +
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--------PGEQFNEIVGSPYYMAP 228
             +HRD+KP+NFL    K+ + +  IDFGL+  +R        P  +   + G+  Y + 
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS- 183
Query: 229 EVLKRNYGPEV----DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
             +  + G E     D+ S G +L     G  P+     QG+  A        KR  + +
Sbjct: 184 --INTHLGIEQSRRDDLESLGYVLMYFNLGSLPW-----QGLKAAT-------KRQKYER 229
Query: 285 VSENAKDLVKKMLNP 299
           +SE      KKM  P
Sbjct: 230 ISE------KKMSTP 238

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 109/255 (42%), Gaps = 40/255 (15%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LGR++G G FG  YL TD+  GE+ A K    K     + IE      +I K +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-----KIYKMMQGGV 63
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            I +++    +     +VMEL  G  L D        ++ +    +   ++  ++  H +
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--------PGEQFNEIVGSPYYMAP 228
             +HRD+KP+NFL    K+ + +  IDFGL+  +R        P  +   + G+  Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS- 181
Query: 229 EVLKRNYGPEV----DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
             +  + G E     D+ S G +L     G  P+     QG+  A        KR  + +
Sbjct: 182 --INTHLGIEQSRRDDLESLGYVLMYFNLGSLPW-----QGLKAAT-------KRQKYER 227
Query: 285 VSENAKDLVKKMLNP 299
           +SE      KKM  P
Sbjct: 228 ISE------KKMSTP 236

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D  R   R          +   I   ++   
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
           ++  +HRDL   N L     E+  +K  DFGLS     G+      G+ +   + APE L
Sbjct: 134 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESL 189
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
             N +  + DVW+ GV+L+ I   G+ P+
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/324 (23%), Positives = 119/324 (36%), Gaps = 72/324 (22%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMKHLPKH 116
           Y++   LG G FG    C D   G+      ++ K +R      E  R E+ ++K + + 
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKS----QVALKIIRNVGKYREAARLEINVLKKIKEK 76
Query: 117 PN-----IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
                   V + D +     + I  EL  G   F+ +       Y       +   +   
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 170 VQVCHEQGVMHRDLKPENFLFANKK----------------ESSPLKAIDFGLSVFFRPG 213
           ++  HE  + H DLKPEN LF N +                +++ ++  DFG + F    
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 193
Query: 214 EQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QG 265
           E    IV + +Y  PEV L+  +    DVWS G IL+    G   F            + 
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253
Query: 266 VAQAIIRSVIDFKRDP---------WPK-------VSENAK-----------------DL 292
           +   I   +I   R           W +       V EN K                 DL
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
           +++ML  DP QR+T  E L HP+ 
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFF 337

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++     G L + + AR                   T + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 121/284 (42%), Gaps = 43/284 (15%)
Query: 57  DYDLGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           D  LG ++GRG FG  +   L  D       +C+      L+         +E +I+K  
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-----KFLQEARILKQY 169
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV--- 170
             HPNIV L         ++IVMEL +GG+    +   G      A   +KT++++V   
Sbjct: 170 -SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDA 222
Query: 171 ----QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS------VFFRPGEQFNEIV 220
               +    +  +HRDL   N L   K   + LK  DFG+S      V+   G      V
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 221 GSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
               + APE L    Y  E DVWS G++L+     G  P+   + Q   + + +      
Sbjct: 280 K---WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG----G 332
Query: 279 RDPWPKVSENAK-DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           R P P++  +A   L+++    +P QR +   + +   LQ+ +K
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQE--LQSIRK 374

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 102 DVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAA 159
           D   E  IM     HPN++ L+      + V I+ E  E G L D  + +  G +T    
Sbjct: 80  DFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQL 137
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR---PGEQF 216
             +++ I   ++   +   +HRDL   N L      +   K  DFGLS F         +
Sbjct: 138 VGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTY 194
Query: 217 NEIVGSPY---YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
              +G      + APE ++ R +    DVWS G++++ ++  G  P+W  T Q V  AI
Sbjct: 195 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 253

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI------EDVRR----EVQIMK 111
           R +G GEFG      +V +G     K   K++L  A+        E  RR    E  IM 
Sbjct: 28  RVIGAGEFG------EVCSGR---LKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMG 78
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEV 169
               HPNI+ L+        V IV E  E G L D  + +  G +T      +++ I   
Sbjct: 79  QF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAG 136
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-Y 225
           ++   + G +HRDL   N L      +   K  DFGLS      P   +    G  P  +
Sbjct: 137 MKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 193
Query: 226 MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
            APE +  R +    DVWS G++++ ++  G  P+W  T Q V +A+
Sbjct: 194 TAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAV 240

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 113/265 (42%), Gaps = 40/265 (15%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFA------------CKSISKKKLRTAVDIEDVRRE 106
           +LGR +G G+FG      DV+ G   +            CK+ +   +R     E   +E
Sbjct: 13  ELGRCIGEGQFG------DVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-----EKFLQE 61
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-T 165
              M+    HP+IV L     ++  V I+MELC  GEL   +  R    + A+  +    
Sbjct: 62  ALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY 224
           +   +     +  +HRD+   N L ++   +  +K  DFGLS +           G  P 
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTXXKASKGKLPI 176
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVIDFKRD 280
            +MAPE +  R +    DVW  GV ++ IL+ GV PF     QGV    +I  + + +R 
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 231
Query: 281 PW-PKVSENAKDLVKKMLNPDPKQR 304
           P  P        L+ K    DP +R
Sbjct: 232 PMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 60  LGRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   +     ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERA 158
           KH NI++L      D  +++++     G L + + AR                   T + 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
             +    +   ++    Q  +HRDL   N L     E++ +K  DFGL+      + + +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE L  R Y  + DVWS GV+++ I   G  P+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 113/268 (42%), Gaps = 25/268 (9%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLPKHPNI 119
           ELGRG +GV      V +G+  A K     ++R  V+ ++ +R   ++ I       P  
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVK-----RIRATVNSQEQKRLLXDLDISXRTVDCPFT 95
Query: 120 VSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYT-ERAAAAVMKTIVEVVQVCHEQ 176
           V+       +  V I  EL +    + + +++ +G    E     +  +IV+ ++  H +
Sbjct: 96  VTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 155
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL---- 231
             V+HRD+KP N L     +   +K  DFG+S +       +   G   Y APE +    
Sbjct: 156 LSVIHRDVKPSNVLINALGQ---VKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPEL 212
Query: 232 -KRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
            ++ Y  + D+WS G+    L     P+  W    Q + Q +         D   K S  
Sbjct: 213 NQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD---KFSAE 269
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
             D   + L  + K+R T  E+ +HP+ 
Sbjct: 270 FVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|4DS7|A Chain A, Crystal Structure Of Yeast Calmodulin Bound To The C-Terminal Fragment Of Spindle Pole Body Protein Spc110 Length = 147

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 76/142 (53%), Gaps = 2/142 (1%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I+             +  EA++  LM   DVDG+ ++
Sbjct: 5   LTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAI 64
Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
            + EF+A+ S  LK   +++ L +AF  FD+N  G I   EL++ L    +   +  ++ 
Sbjct: 65  EFSEFLALMSRQLKCNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDE 124
Query: 475 IMHDVDTDKDGRISYEEFAVMM 496
           ++ +V +D  G I+ ++FA ++
Sbjct: 125 MLREV-SDGSGEINIKQFAALL 145

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 19/242 (7%)
Query: 89  ISKKKLRTAVDIEDVRR---EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELF 145
           I+ K++R + + E+ +R   ++ ++      P IV    T+  ++ V I MEL   G   
Sbjct: 53  IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCA 110
Query: 146 DRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAI 202
           +++  R  G   ER    +   IV+ +    E+ GV+HRD+KP N L     E   +K  
Sbjct: 111 EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLC 167
Query: 203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCGVP 256
           DFG+S      +  +   G   YMAPE +      K +Y    DVWS G+ L  L  G  
Sbjct: 168 DFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
Query: 257 PFW-AETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
           P+   +T+  V   +++             S + +  VK  L  D ++R    ++LEH +
Sbjct: 228 PYKNCKTDFEVLTKVLQEEPPLLPGHM-GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286
Query: 316 LQ 317
           ++
Sbjct: 287 IK 288

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKH 116
            G+ LG G FG     T    G++ A   ++ K L++   A + E +  E++IM HL +H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER-AAAAVMKTIVEVVQVCH- 174
            NIV+L         V ++ E C  G+L + +  +    E   A A+  + +    + H 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 175 ----EQGV--------MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
                QG+        +HRD+   N L  N   +   K  DFGL+         N IV  
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM--NDSNYIVKG 224
Query: 223 PY-----YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                  +MAPE +    Y  + DVWS G++L+ I   G+ P+
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 14/218 (6%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHPNIV 120
           R +G GEFG          G++    +I   K+  T     D   E  IM     HPN+V
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQF-DHPNVV 107
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGV 178
            L+        V IV+E  E G L D  + +  G +T      +++ I   ++   + G 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY 166
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-R 233
           +HRDL   N L      +   K  DFGLS      P   +    G  P  + APE ++ R
Sbjct: 167 VHRDLAARNILV---NSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 234 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
            +    DVWS G++++ ++  G  P+W  + Q V +AI
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 261

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 47/286 (16%)
Query: 57  DYDLGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           D  LG ++GRG FG  +   L  D       +C+      L+         +E +I+K  
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-----KFLQEARILKQY 169
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV--- 170
             HPNIV L         ++IVMEL +GG+    +   G      A   +KT++++V   
Sbjct: 170 -SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDA 222
Query: 171 ----QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP--- 223
               +    +  +HRDL   N L   K   + LK  DFG+S      E+ + +  +    
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDFGMS-----REEADGVXAASGGL 274
Query: 224 -----YYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVID 276
                 + APE L    Y  E DVWS G++L+     G  P+   + Q   + + +    
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG--- 331
Query: 277 FKRDPWPKVSENAK-DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
             R P P++  +A   L+++    +P QR +   + +   LQ+ +K
Sbjct: 332 -GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQE--LQSIRK 374

>pdb|3L19|A Chain A, Crystal Structure Of Calcium Binding Domain Of Cpcdpk3, Cgd5_820 Length = 214

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 335 LKQFSVMNKLKKRALQVVAEFL-SVEEVAGLKEAFEMMDTNKRGK------INXXXXXXX 387
           +++F    KL + AL  +A  L S EE   L + F  +D N  G+      I+       
Sbjct: 35  MRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSG 94
Query: 388 XXXXXQNIP--EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDR 445
                 ++P  E+++  ++ AAD D +G ++Y EFV V++  K + + + L  AF  FD+
Sbjct: 95  EEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLSKDKLESAFQKFDQ 154
Query: 446 NRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           + +G I ++EL +     +D         ++  +D++ DG + +EEF  M++
Sbjct: 155 DGNGKISVDELASVFG--LDHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQ 204

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 119/288 (41%), Gaps = 54/288 (18%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLPK 115
           DLG E+GRG +G         +G+  A K     ++R+ VD ++ ++   ++ ++     
Sbjct: 26  DLG-EIGRGAYGSVNKMVHKPSGQIMAVK-----RIRSTVDEKEQKQLLMDLDVVMRSSD 79
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYT-------ERAAAAVMKTIVE 168
            P IV        +    I MEL      FD+     +         E      + T+  
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-----VGSP 223
           +  +     ++HRD+KP N L      S  +K  DFG+S     G+  + I      G  
Sbjct: 138 LNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCR 189
Query: 224 YYMAPEVL-----KRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVID 276
            YMAPE +     ++ Y    DVWS G+ LY L  G  P+  W      + Q +      
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV------ 243
Query: 277 FKRDPWPKVSENAK--------DLVKKMLNPDPKQRLTAEEVLEHPWL 316
            K DP P++S + +        + V   L  D  +R   +E+L+HP++
Sbjct: 244 -KGDP-PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/330 (22%), Positives = 132/330 (40%), Gaps = 78/330 (23%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y L R+LG G F   +L  D+ N    A K +   K+ T    E    E+++++ +    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDAD 76
Query: 118 N----------IVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM-- 163
           N          I+ L D +  +  + VH+VM     GE    ++ +  Y  R    +   
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVK 134
Query: 164 ---KTIVEVVQVCHEQ-GVMHRDLKPENFLFA---NKKESSPLKAIDFGLSVFFRPGEQF 216
              K ++  +   H + G++H D+KPEN L     + +    +K  D G + ++   E +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHY 192
Query: 217 NEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG---------V 266
              + +  Y +PEV L   +G   D+WS   +++ L+ G   F  E ++G         +
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG--DFLFEPDEGHSYTKDDDHI 250
Query: 267 AQAI--------------------------IRSVIDFKRDPWPKV-----------SENA 289
           AQ I                          +R++   K  P   V           ++  
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
            D +  ML  DP++R  A  ++ HPWL++ 
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/330 (22%), Positives = 132/330 (40%), Gaps = 78/330 (23%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y L R+LG G F   +L  D+ N    A K +   K+ T    E    E+++++ +    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDAD 76
Query: 118 N----------IVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM-- 163
           N          I+ L D +  +  + VH+VM     GE    ++ +  Y  R    +   
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVK 134
Query: 164 ---KTIVEVVQVCHEQ-GVMHRDLKPENFLFA---NKKESSPLKAIDFGLSVFFRPGEQF 216
              K ++  +   H + G++H D+KPEN L     + +    +K  D G + ++   E +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHY 192
Query: 217 NEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG---------V 266
              + +  Y +PEV L   +G   D+WS   +++ L+ G   F  E ++G         +
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG--DFLFEPDEGHSYTKDDDHI 250
Query: 267 AQAI--------------------------IRSVIDFKRDPWPKV-----------SENA 289
           AQ I                          +R++   K  P   V           ++  
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
            D +  ML  DP++R  A  ++ HPWL++ 
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKH 116
            G+ LG G FG     T    G++ A   ++ K L++   A + E +  E++IM HL +H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER-AAAAVMKTIVEVVQVCH- 174
            NIV+L         V ++ E C  G+L + +  +    E   A A+  +      + H 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 175 ----EQGV--------MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
                QG+        +HRD+   N L  N   +   K  DFGL+         N IV  
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM--NDSNYIVKG 224
Query: 223 PY-----YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                  +MAPE +    Y  + DVWS G++L+ I   G+ P+
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 35/293 (11%)
Query: 51  GQDISID---YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           G  + ID   Y   ++LG G F    L   +++G  +A K I   + +   D E+ +RE 
Sbjct: 21  GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREA 77
Query: 108 QIMKHLPKHPNIVSL-KDTYEDDSAVH---IVMELCEGGELFD---RIVARGHY-TERAA 159
             M  L  HPNI+ L      +  A H   +++   + G L++   R+  +G++ TE   
Sbjct: 78  D-MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG------ 213
             ++  I   ++  H +G  HRDLKP N L  ++ +   +       +     G      
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 214 -EQFNEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 268
            + +     +  Y APE+             DVWS G +LY ++ G  P+    ++G + 
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
Query: 269 AI-IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQR------LTAEEVLEHP 314
           A+ +++ +   +   P+ S     L+  M+  DP QR      L+  E L+ P
Sbjct: 257 ALAVQNQLSIPQS--PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 74
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH- 174
           NIV  K          + ++ME    G L D + A     +      +K +    Q+C  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDH-----IKLLQYTSQICKG 129
Query: 175 -----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP-----Y 224
                 +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P     +
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESPIF 185
Query: 225 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
           + APE L  + +    DVWS GV+LY L   +
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 40/255 (15%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LGR++G G FG  YL  ++ +GE+ A K    K     + IE      +  K +    
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIES-----KFYKMMQGGV 65
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            I S+K    +     +VMEL  G  L D        ++ +    +   ++  ++  H +
Sbjct: 66  GIPSIKWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--------PGEQFNEIVGSPYYMAP 228
             +HRD+KP+NFL    K+ + +  IDFGL+  +R        P  +   + G+  Y + 
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS- 183
Query: 229 EVLKRNYGPEV----DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
             +  + G E     D+ S G +L     G  P+     QG+  A        KR  + +
Sbjct: 184 --INTHLGIEQSRRDDLESLGYVLMYFNLGSLPW-----QGLKAAT-------KRQKYER 229
Query: 285 VSENAKDLVKKMLNP 299
           +SE      KKM  P
Sbjct: 230 ISE------KKMSTP 238

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           R+LG G FG   LC       N GE+ A KS+  K       I D+++E++I+++L  H 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNL-YHE 83
Query: 118 NIVSLKDTYEDD--SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH- 174
           NIV  K    +D  + + ++ME    G L + +        +    + + +   VQ+C  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-----KNKINLKQQLKYAVQICKG 138
Query: 175 -----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV---GSP-YY 225
                 +  +HRDL   N L  ++ +   +K  DFGL+      ++   +     SP ++
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILL 252
            APE L ++ +    DVWS GV L+ LL
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           R+LG G FG   LC       N GE+ A KS+  K       I D+++E++I+++L  H 
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNL-YHE 71
Query: 118 NIVSLKDTYEDD--SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH- 174
           NIV  K    +D  + + ++ME    G L + +        +    + + +   VQ+C  
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-----KNKINLKQQLKYAVQICKG 126
Query: 175 -----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV---GSP-YY 225
                 +  +HRDL   N L  ++ +   +K  DFGL+      ++   +     SP ++
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILL 252
            APE L ++ +    DVWS GV L+ LL
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 102 DVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAA 159
           D   E  IM     HPN++ L+      + V I+ E  E G L D  + +  G +T    
Sbjct: 54  DFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQL 111
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR---PGEQF 216
             +++ I   ++   +   +HR L   N L      +   K  DFGLS F         +
Sbjct: 112 VGMLRGIAAGMKYLADMNYVHRALAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTY 168
Query: 217 NEIVGSPY---YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
              +G      + APE ++ R +    DVWS G++++ ++  G  P+W  T Q V  AI
Sbjct: 169 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 227

>pdb|3KHE|A Chain A, Crystal Structure Of The Calcium-Loaded Calmodulin-Like Domain Of The Cdpk, 541.M00134 From Toxoplasma Gondii Length = 191

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 16/182 (8%)
Query: 333 ARLKQFSVMNKLKKRALQVV-AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXX 391
             +K+F    KL + A+  + ++  ++EE   L + F  +D N  G+++           
Sbjct: 10  GNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKL 69
Query: 392 XQ-----------NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAF 440
            Q           +  EA++  ++++ D D +G + Y EFV V +  + + + E L  AF
Sbjct: 70  MQWKGDTVSDLDSSQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERLLAAF 129
Query: 441 SFFDRNRSGFIEIEELRNALN-DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG 499
             FD + SG I  EEL       EVD   ++  + ++ + D + DG + +EEF  MM+  
Sbjct: 130 QQFDSDGSGKITNEELGRLFGVTEVD---DETWHQVLQECDKNNDGEVDFEEFVEMMQKI 186
Query: 500 TD 501
            D
Sbjct: 187 CD 188

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 71
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 124
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSP- 223
                   +  +HRDL   N L  N+     +K  DFGL+      ++F    E   SP 
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
           ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 112/270 (41%), Gaps = 43/270 (15%)
Query: 62  RELGRGEFGVTYLCTDVNNGEKFACKSIS--KKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           R++G G FG   LC  ++N + +A K +   KK  R+A    D+ +++Q       +   
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH---EQ 176
              K  Y D    H+ +     G     I+ R +Y       +    +E+++  +   + 
Sbjct: 101 YHGKFMYYD----HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156
Query: 177 GVMHRDLKPENFLFAN----------------------KKESSPLKAIDFGLSVFFRPGE 214
            + H DLKPEN L  +                      + +S+ +K IDFG + F    +
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--KSD 214
Query: 215 QFNEIVGSPYYMAPEVLKRNYGPEV--DVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
               I+ +  Y APEV+  N G +V  D+WS G +L  L  G   F    E     A++ 
Sbjct: 215 YHGSIINTRQYRAPEVI-LNLGWDVSSDMWSFGCVLAELYTGSLLFRTH-EHMEHLAMME 272
Query: 273 SVIDFKRDPWPK--VSENAKDLVKKMLNPD 300
           S+I     P PK  + E  K    K +N D
Sbjct: 273 SII----QPIPKNMLYEATKTNGSKYVNKD 298

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           R+LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 74
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L +       Y ++    +  +K +    Q+C
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLRE-------YLQKHKERIDHIKLLQYTSQIC 127
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 183
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 32/296 (10%)
Query: 31  YVVANGSTVVHRL---CVLKEPSGQDISID-YDLGRE-------LGRGEFGVTYLCTDVN 79
           Y   +   + HRL   C   +P  Q ++ D +++ RE       LG+G FG  ++ T  N
Sbjct: 149 YYSKHADGLCHRLTNVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGT-WN 207
Query: 80  NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC 139
              + A K++    +      E   +E Q+MK L +H  +V L     ++  ++IV E  
Sbjct: 208 GTTRVAIKTLKPGNMSP----EAFLQEAQVMKKL-RHEKLVQLYAVVSEE-PIYIVTEYM 261
Query: 140 EGGELFDRIVAR-GHYTERAAAAVMKT-IVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197
             G L D +    G Y        M   I   +        +HRDL+  N L     E+ 
Sbjct: 262 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENL 318
Query: 198 PLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEV-LKRNYGPEVDVWSAGVILYILLC 253
             K  DFGL       E +    G+ +   + APE  L   +  + DVWS G++L  L  
Sbjct: 319 VCKVADFGLGRLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 377
Query: 254 -GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAE 308
            G  P+     + V   + R    ++    P+  E+  DL+ +    DP++R T E
Sbjct: 378 KGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKDPEERPTFE 430

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 38/283 (13%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  H
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 117 PNIVSL-KDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVVQ 171
            N+V+L     +    + +++E C+ G L   + ++ +    Y E A   + K  + +  
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKE-APEDLYKDFLTLEH 151
Query: 172 -VCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQF 216
            +C+   V            +HRDL   N L +   E + +K  DFGL+  ++  P    
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVR 208
Query: 217 NEIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRS 273
                 P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R 
Sbjct: 209 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRR 265
Query: 274 VIDFKRDPWPKVSENAKDLVKKMLNP---DPKQRLTAEEVLEH 313
           + +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 266 LKEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 117 PNIVS-LKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAA--VMKTIVEVVQ- 171
            N+V+ L    +    + +++E C+ G L   + + R  +     A   + K  + +   
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 172 VCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFN 217
           +C+   V            +HRDL   N L +   E + +K  DFGL+  ++  P     
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDXVRK 207
Query: 218 EIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRL 264
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNP---DPKQRLTAEEVLEH 313
            +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 265 KEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 35/291 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD--IEDVRREVQIMKHLPKHP 117
           L RELG G FG  +L    N   +     ++ K L+ A D   +D  RE +++ +L +H 
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHE 75
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-------------HYTERAAAAVMK 164
           +IV       +   + +V E  + G+L   + A G               T+     + +
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV------FFRPGEQFNE 218
            I   +     Q  +HRDL   N L     E+  +K  DFG+S       ++R G     
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYSTDYYRVG---GH 189
Query: 219 IVGSPYYMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVID 276
            +    +M PE ++ R +  E DVWS GV+L+ I   G  P++  +   V + I +  + 
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249
Query: 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
            +    P   +   +L+      +P  R   + +  H  LQN  KA  V L
Sbjct: 250 QRPRTCP---QEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKASPVYL 295

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 70
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 123
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 124 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 179
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 213

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  H
Sbjct: 68  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 117 PNIVS-LKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAA--VMKTIVEVVQ- 171
            N+V+ L    +    + +++E C+ G L   + + R  +     A   + K  + +   
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 172 VCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFN 217
           +C+   V            +HRDL   N L +   E + +K  DFGL+  ++  P     
Sbjct: 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRK 244
Query: 218 EIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R +
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRL 301
Query: 275 IDFKRDPWPKVSENAKDLVKKMLN---PDPKQRLTAEEVLEH 313
            +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 302 KEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 78
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 131
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 132 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 187
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 221

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 51/235 (21%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMK--- 111
           Y++   +G G +G  ++C   +  EK       KK LR   D+ D +R   E+ I+    
Sbjct: 55  YEIRHLIGTGSYG--HVCEAYDKLEKRVVAI--KKILRVFEDLIDCKRILREIAILNRLN 110
Query: 112 --HLPKHPNIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIV 167
             H+ K  +IV  KD  + D  +++V+E+ +    +LF   V   + TE     ++  ++
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDE-LYVVLEIADSDFKKLFRTPV---YLTELHIKTLLYNLL 166
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS------------VFFRPGEQ 215
             V+  H  G++HRDLKP N L     +   +K  DFGL+            +   P E 
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 216 FNEIVGSP----------------YYMAPE--VLKRNYGPEVDVWSAGVILYILL 252
              +V  P                +Y APE  +L+ NY   +DVWS G I   LL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 74
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 127
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 183
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 71
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 124
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 180
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 76
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 129
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 130 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 185
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 69
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 122
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 123 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 178
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 77
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 130
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 131 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 186
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 220

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 102
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 155
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 211
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 75
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 128
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 129 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 184
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 218

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 117 PNIVS-LKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAA--VMKTIVEVVQ- 171
            N+V+ L    +    + +++E C+ G L   + + R  +     A   + K  + +   
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 172 VCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFN 217
           +C+   V            +HRDL   N L +   E + +K  DFGL+  ++  P     
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRK 207
Query: 218 EIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRL 264
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNP---DPKQRLTAEEVLEH 313
            +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 265 KEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 71
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 124
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 180
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 89
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 142
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 198
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 89
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 142
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
                   +  +HRDL   N L  N+     +K  DFGL+    P ++    V  P    
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVL-PQDKEXXKVKEPGESP 198
Query: 224 -YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
            ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 117 PNIVS-LKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAA--VMKTIVEVVQ- 171
            N+V+ L    +    + ++ E C+ G L   + + R  +     A   + K  + +   
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 172 VCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFN 217
           +C+   V            +HRDL   N L +   E + +K  DFGL+  ++  P     
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRK 198
Query: 218 EIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRL 255
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNP---DPKQRLTAEEVLEH 313
            +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 256 KEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 117 PNIVS-LKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAA--VMKTIVEVVQ- 171
            N+V+ L    +    + ++ E C+ G L   + + R  +     A   + K  + +   
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 172 VCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFN 217
           +C+   V            +HRDL   N L +   E + +K  DFGL+  ++  P     
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRK 198
Query: 218 EIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRL 255
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNP---DPKQRLTAEEVLEH 313
            +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 256 KEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +G GEFG          G++  C +I   K   T     D   E  IM     HPNI+ L
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHL 95
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           +        V I+ E  E G L D  + +  G +T      +++ I   ++   +   +H
Sbjct: 96  EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVH 154
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNY 235
           RDL   N L      +   K  DFG+S      P   +    G  P  + APE +  R +
Sbjct: 155 RDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 236 GPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
               DVWS G++++ ++  G  P+W  + Q V +AI
Sbjct: 212 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 247

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 36/280 (12%)
Query: 57  DYDLGRELGRGEFGVTYL--CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           D  L RELG G FG  +L  C +++  +     ++   K  T    +D +RE +++ +L 
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL- 74
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGEL--FDRI--------------VARGHYTERA 158
           +H +IV       D   + +V E  + G+L  F R                A+G      
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV------FFRP 212
              +   I   +     Q  +HRDL   N L      +  +K  DFG+S       ++R 
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 213 GEQFNEIVGSPYYMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
           G      +    +M PE ++ R +  E DVWS GVIL+ I   G  P++  +   V + I
Sbjct: 192 G---GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
Query: 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV 310
            +  +  +    PK      D++      +P+QRL  +E+
Sbjct: 249 TQGRVLERPRVCPK---EVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 7/161 (4%)
Query: 104 RREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM 163
           +RE +    L + P++V + D  E D  +++   L  G +L   +  +G      A A++
Sbjct: 82  QREARTAGRL-QEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIV 140
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVG 221
           + I   +   H  G  HRD+KPEN L +    +     +DFG++      +  Q    VG
Sbjct: 141 RQIGSALDAAHAAGATHRDVKPENILVSADDFA---YLVDFGIASATTDEKLTQLGNTVG 197
Query: 222 SPYYMAPEVLKRNYGP-EVDVWSAGVILYILLCGVPPFWAE 261
           + YY APE    ++     D+++   +LY  L G PP+  +
Sbjct: 198 TLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 36/271 (13%)
Query: 58  YDLGRELGRGEFGVT---YLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           + LGR LG+GEFG      L  +  +  K A K + K  +  + DIE+  RE   MK   
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF- 82
Query: 115 KHPNI-----VSLKDTYEDDSAV-HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
            HP++     VSL+   +    +  +++   + G+L   ++A     E      ++T+V 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA-SRIGENPFNLPLQTLVR 141
Query: 169 V-------VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
                   ++    +  +HRDL   N + A   E   +   DFGLS     G+ + +   
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 222 SPY---YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVI- 275
           S     ++A E L  N Y    DVW+ GV ++ I+  G  P+      G+  A I + + 
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY-----AGIENAEIYNYLI 253
Query: 276 --DFKRDPWPKVSENAKDLVKKMLNPDPKQR 304
             +  + P P+  E   DL+ +  + DPKQR
Sbjct: 254 GGNRLKQP-PECMEEVYDLMYQCWSADPKQR 283

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKH 116
            G+ LG G FG     T    G++ A   ++ K L++   A + E +  E++IM HL +H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR---------GHYTE-RAAAAVMKTI 166
            NIV+L         V ++ E C  G+L + +  +         G   E R        +
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-- 224
            + +     +  +HRD+   N L  N   +   K  DFGL+         N IV      
Sbjct: 162 AQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM--NDSNYIVKGNARL 216
Query: 225 ---YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 258
              +MAPE +    Y  + DVWS G++L+ I   G+ P+
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|2LHH|A Chain A, Solution Structure Of Ca2+-Bound Ycam Length = 128

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 1/106 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I+             +  EA++  LM   DVDG+  +
Sbjct: 4   LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQI 63
Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL 460
            + EF+A+ S  LK   +++ L +AF  FD+N  G I   EL++ L
Sbjct: 64  EFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVL 109

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKH 116
            G+ LG G FG     T    G++ A   ++ K L++   A + E +  E++IM HL +H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR---------GHYTE-RAAAAVMKTI 166
            NIV+L         V ++ E C  G+L + +  +         G   E R        +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-- 224
            + +     +  +HRD+   N L  N   +   K  DFGL+         N IV      
Sbjct: 170 AQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM--NDSNYIVKGNARL 224
Query: 225 ---YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 258
              +MAPE +    Y  + DVWS G++L+ I   G+ P+
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 117 PNIVS-LKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAA--VMKTIVEVVQ- 171
            N+V+ L    +    + +++E C+ G L   + + R  +     A   + K  + +   
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 172 VCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFN 217
           +C+   V            +HRDL   N L +   E + +K  DFGL+  +   P     
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDXVRK 198
Query: 218 EIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRL 255
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNP---DPKQRLTAEEVLEH 313
            +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 256 KEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +G GEFG          G++  C +I   K   T     D   E  IM     HPNI+ L
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHL 74
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           +        V I+ E  E G L D  + +  G +T      +++ I   ++   +   +H
Sbjct: 75  EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 133
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNY 235
           RDL   N L      +   K  DFG+S      P   +    G  P  + APE +  R +
Sbjct: 134 RDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 236 GPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
               DVWS G++++ ++  G  P+W  + Q V +AI
Sbjct: 191 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +G GEFG          G++  C +I   K   T     D   E  IM     HPNI+ L
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHL 80
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
           +        V I+ E  E G L D  + +  G +T      +++ I   ++   +   +H
Sbjct: 81  EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 139
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFR--PGEQFNEIVGS-PY-YMAPEVLK-RNY 235
           RDL   N L      +   K  DFG+S      P   +    G  P  + APE +  R +
Sbjct: 140 RDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 236 GPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
               DVWS G++++ ++  G  P+W  + Q V +AI
Sbjct: 197 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 232

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 119/282 (42%), Gaps = 35/282 (12%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPK 115
           +LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 116 HPNIVSL-KDTYEDDSAVHIVMELCEGGELFDRI---------------VARGHYTERAA 159
           H N+V+L     +    + +++E C+ G L   +               + +   T    
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFN 217
                 + + ++    +  +HRDL   N L +   E + +K  DFGL+  +   P     
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDXVRK 207
Query: 218 EIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRL 264
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNP---DPKQRLTAEEVLEH 313
            +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 265 KEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 36/282 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 117 PNIVS-LKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAA--VMKTIVEVVQ- 171
            N+V+ L    +    + ++ E C+ G L   + + R  +     A   + K  + +   
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 172 VCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFN 217
           +C+   V            +HRDL   N L +   E + +K  DFGL+  +   P     
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDXVRK 198
Query: 218 EIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRL 255
Query: 275 IDFKRDPWPKVSENAKDLVKKMLN---PDPKQRLTAEEVLEH 313
            +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 256 KEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 62  RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           ++LG+G FG   +C       N GE  A K +      T   + D  RE++I+K L +H 
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHD 72
Query: 118 NIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVC 173
           NIV  K          + ++ME    G L D       Y ++    +  +K +    Q+C
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD-------YLQKHKERIDHIKLLQYTSQIC 125
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG---SP- 223
                   +  +HR+L   N L  N+     +K  DFGL+      +++ ++     SP 
Sbjct: 126 KGMEYLGTKRYIHRNLATRNILVENENR---VKIGDFGLTKVLPQDKEYYKVKEPGESPI 182
Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV 255
           ++ APE L  + +    DVWS GV+LY L   +
Sbjct: 183 FWYAPESLTESKFSVASDVWSFGVVLYELFTYI 215

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+  H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 117 PNIVS-LKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAA--VMKTIVEVVQ- 171
            N+V+ L    +    + +++E C+ G L   + + R  +     A   + K  + +   
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 172 VCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFN 217
           +C+   V            +HRDL   N L +   E + +K  DFGL+  +   P     
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDXVRK 207
Query: 218 EIVGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
                P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRL 264
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNP---DPKQRLTAEEVLEH 313
            +  R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 265 KEGTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L + LG G+FG  ++    NN  K A K++    +     +E    E  +MK L +H  +
Sbjct: 17  LVKRLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTL-QHDKL 70
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQG 177
           V L      +  ++I+ E    G L D + +   G             I E +     + 
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 130
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN 234
            +HRDL+  N L +   ES   K  DFGL+      E +    G+ +   + APE +  N
Sbjct: 131 YIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--N 184
Query: 235 YGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
           +G    + DVWS G++LY I+  G  P+   T   V  A+
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 46/241 (19%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHLPKHPNI 119
           ELG   FG  Y             ++++ K L+   +    E+ R E  +   L +HPN+
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNV 91
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAA---AVMKTIVEVVQVCH-- 174
           V L      D  + ++   C  G+L + +V R  +++  +      +K+ +E     H  
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 175 -----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
                         V+H+DL   N L  +K     +K  D GL         F E+  + 
Sbjct: 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGL---------FREVYAAD 199
Query: 224 YY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
           YY            MAPE ++   +  + D+WS GV+L+ +   G+ P+   + Q V + 
Sbjct: 200 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259
Query: 270 I 270
           I
Sbjct: 260 I 260

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 46/241 (19%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHLPKHPNI 119
           ELG   FG  Y             ++++ K L+   +    E+ R E  +   L +HPN+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNV 74
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAA---AVMKTIVEVVQVCH-- 174
           V L      D  + ++   C  G+L + +V R  +++  +      +K+ +E     H  
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 175 -----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
                         V+H+DL   N L  +K     +K  D GL         F E+  + 
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGL---------FREVYAAD 182
Query: 224 YY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
           YY            MAPE ++   +  + D+WS GV+L+ +   G+ P+   + Q V + 
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 270 I 270
           I
Sbjct: 243 I 243

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 88/212 (41%), Gaps = 18/212 (8%)
Query: 102 DVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAA 159
           D   E  IM     HPNI+ L+          IV E  E G L  F R    G +T    
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQL 153
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--PGEQFN 217
             +++ +   ++   + G +HRDL   N L  +       K  DFGLS      P   + 
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC---KVSDFGLSRVLEDDPDAAYT 210
Query: 218 EIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRS 273
              G  P  + APE +  R +    DVWS GV+++ +L  G  P+W  T + V    I S
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV----ISS 266
Query: 274 VIDFKRDPWPKVSENA-KDLVKKMLNPDPKQR 304
           V +  R P P    +A   L+    + D  QR
Sbjct: 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKH 116
            G+ LG G FG     T    G++ A   ++ K L++   A + E +  E++IM HL +H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-----------GHYTERAAAA---- 161
            NIV+L         V ++ E C  G+L + +  +            H  E   ++    
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 162 -VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
                + + +     +  +HRD+   N L  N   +   K  DFGL+         N IV
Sbjct: 170 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM--NDSNYIV 224
Query: 221 GSPY-----YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                    +MAPE +    Y  + DVWS G++L+ I   G+ P+
Sbjct: 225 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 32/279 (11%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPK 115
           +LG+ LGRG FG           +    ++++ K L+      + R    E++I+ H+  
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 116 HPNIVSLKDT-YEDDSAVHIVMELCEGGELFDRI------------VARGHYTERAAAAV 162
           H N+V+L     +    + +++E C+ G L   +            + +   T       
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIV 220
              + + ++    +  +HRDL   N L +   E + +K  DFGL+  ++  P        
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 221 GSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDF 277
             P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R + + 
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRLKEG 263
Query: 278 KRDPWPKVSENAKDLVKKMLN---PDPKQRLTAEEVLEH 313
            R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 264 TRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 38/235 (16%)
Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHL 113
           +   G+ LG G FG     T    G++ A   ++ K L++   A + E +  E++IM HL
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-----------VARGHYTE------ 156
            +H NIV+L         V ++ E C  G+L + +           +A G   E      
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 157 ------RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210
                 R        + + +     +  +HRD+   N L  N   +   K  DFGL+   
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDI 208
Query: 211 RPGEQFNEIVGSPY-----YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 258
                 N IV         +MAPE +    Y  + DVWS G++L+ I   G+ P+
Sbjct: 209 M--NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 60  LGRELGRGEFGVTYL--CTDVNNGE---KFACKSISKK-KLRTAVDIEDVRREVQIMKHL 113
           L RELG+G FG+ Y     D+  GE   + A K++++   LR  ++  +   E  +MK  
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGF 77
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
             H ++V L           +VMEL   G+L   + +     E        T+ E++Q+ 
Sbjct: 78  TCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 174 HE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGL------SVFFRPGEQFN 217
            E          +  +HRDL   N + A+      +K  DFG+      + ++R G +  
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETAYYRKGGKGL 193
Query: 218 EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA-QAIIRSV 274
             V    +MAPE LK   +    D+WS GV+L+ I      P+     QG++ + +++ V
Sbjct: 194 LPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY-----QGLSNEQVLKFV 245
Query: 275 IDFKRDPWP-KVSENAKDLVKKMLNPDPKQRLTAEEVL 311
           +D      P    E   DL++     +PK R T  E++
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 42/259 (16%)
Query: 37  STVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR- 95
           S  V    +L++P  +    +  LG+ LG GEFG     T  +   +    +++ K L+ 
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 96  --TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELF-----DRI 148
             +  ++ D+  E  ++K +  HP+++ L      D  + +++E  + G L       R 
Sbjct: 64  NASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 149 VARG--------------HYTERAAA-----AVMKTIVEVVQVCHEQGVMHRDLKPENFL 189
           V  G              H  ERA       +    I + +Q   E  ++HRDL   N L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNIL 182
Query: 190 FANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGS-PY-YMAPEVLKRN-YGPEVDVWSAG 245
            A   E   +K  DFGLS   +          G  P  +MA E L  + Y  + DVWS G
Sbjct: 183 VA---EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 246 VILYILLC-------GVPP 257
           V+L+ ++        G+PP
Sbjct: 240 VLLWEIVTLGGNPYPGIPP 258

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 32/279 (11%)
Query: 59  DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPK 115
           +LG+ LGRG FG           +    ++++ K L+      + R    E++I+ H+  
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 116 HPNIVSLKDT-YEDDSAVHIVMELCEGGELFDRI------------VARGHYTERAAAAV 162
           H N+V+L     +    + +++E C+ G L   +            + +   T       
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIV 220
              + + ++    +  +HRDL   N L +   E + +K  DFGL+  ++  P        
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 221 GSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDF 277
             P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R + + 
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFXRRLKEG 263
Query: 278 KRDPWPKVSENAKDLVKKMLN---PDPKQRLTAEEVLEH 313
            R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 264 TRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPNIVS 121
           +LG+G FG   LC     G+        K+   +  D + D +RE+QI+K L     +  
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 122 LKDTY-EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH------ 174
              +Y     ++ +VME    G L D +        RA     + ++   Q+C       
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFL-----QRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP-----YYMAPE 229
            +  +HRDL   N L  ++     +K  DFGL+    P ++   +V  P     ++ APE
Sbjct: 132 SRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYAPE 187
Query: 230 VLKRN-YGPEVDVWSAGVILYILL 252
            L  N +  + DVWS GV+LY L 
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           + LGR++G G FG  YL T++   E+ A K  + K     +  E   +  +I++     P
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES--KIYRILQGGTGIP 66
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           N+       E D  V +VM+L  G  L D         + +    +   ++  V+  H +
Sbjct: 67  NVRWF--GVEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--------PGEQFNEIVGSPYY--- 225
             +HRD+KP+NFL    + ++ +  IDFGL+  +R        P  +   + G+  Y   
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182
Query: 226 ---MAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 266
              +  E  +R+     D+ S G +L   L G  P W   + G 
Sbjct: 183 NTHLGIEQSRRD-----DLESLGYVLMYFLRGSLP-WQGLKAGT 220

>pdb|2LAN|A Chain A, Nmr Structure Of Ca2+-Bound Cabp1 N-Domain With Rdc Length = 167

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 6/147 (4%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L  EE+  L+EAF   D +K G IN                E +L  L +  +++  G +
Sbjct: 19  LRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHV 78
Query: 416 NYGEFVAVS-----VHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTS-GE 469
           ++ +FV +           M   + L  AF  FD N  G I   ELR A+   +    G 
Sbjct: 79  DFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRKLLGHQVGH 138
Query: 470 DVINAIMHDVDTDKDGRISYEEFAVMM 496
             I  I+ DVD + DGR+ +EEF  MM
Sbjct: 139 RDIEEIIRDVDLNGDGRVDFEEFVRMM 165

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 97
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 157
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +  +  +   G+     +MA E L+ + 
Sbjct: 158 RDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPNIVS 121
           +LG+G FG   LC     G+        K+   +  D + D +RE+QI+K L     +  
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 122 LKDTY-EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH------ 174
              +Y     ++ +VME    G L D +        RA     + ++   Q+C       
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFL-----QRHRARLDASRLLLYSSQICKGMEYLG 132
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP-----YYMAPE 229
            +  +HRDL   N L  ++     +K  DFGL+    P ++   +V  P     ++ APE
Sbjct: 133 SRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYAPE 188
Query: 230 VLKRN-YGPEVDVWSAGVILYILL 252
            L  N +  + DVWS GV+LY L 
Sbjct: 189 SLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 42/259 (16%)
Query: 37  STVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR- 95
           S  V    +L++P  +    +  LG+ LG GEFG     T  +   +    +++ K L+ 
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 96  --TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELF-----DRI 148
             +  ++ D+  E  ++K +  HP+++ L      D  + +++E  + G L       R 
Sbjct: 64  NASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 149 VARG--------------HYTERAAA-----AVMKTIVEVVQVCHEQGVMHRDLKPENFL 189
           V  G              H  ERA       +    I + +Q   E  ++HRDL   N L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 190 FANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGS-PY-YMAPEVLKRN-YGPEVDVWSAG 245
            A   E   +K  DFGLS   +          G  P  +MA E L  + Y  + DVWS G
Sbjct: 183 VA---EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 246 VILYILLC-------GVPP 257
           V+L+ ++        G+PP
Sbjct: 240 VLLWEIVTLGGNPYPGIPP 258

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPNIVS 121
           +LG+G FG   LC     G+        K+   +  D + D +RE+QI+K L     +  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 122 LKDTY-EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH------ 174
              +Y     ++ +VME    G L D +        RA     + ++   Q+C       
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL-----QRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP-----YYMAPE 229
            +  +HRDL   N L  ++     +K  DFGL+    P ++   +V  P     ++ APE
Sbjct: 145 SRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYAPE 200
Query: 230 VLKRN-YGPEVDVWSAGVILYILL 252
            L  N +  + DVWS GV+LY L 
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 96
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 156
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +  +  +   G+     +MA E L+ + 
Sbjct: 157 RDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 87/212 (41%), Gaps = 18/212 (8%)
Query: 102 DVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAA 159
           D   E  IM     HPNI+ L+          IV E  E G L  F R    G +T    
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQL 153
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--PGEQFN 217
             +++ +   ++   + G +HRDL   N L  +       K  DFGLS      P     
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC---KVSDFGLSRVLEDDPDAAXT 210
Query: 218 EIVGS-PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRS 273
              G  P  + APE +  R +    DVWS GV+++ +L  G  P+W  T + V    I S
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV----ISS 266
Query: 274 VIDFKRDPWPKVSENA-KDLVKKMLNPDPKQR 304
           V +  R P P    +A   L+    + D  QR
Sbjct: 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 60  LGRELGRGEFGVTYL--CTDVNNGE---KFACKSISKK-KLRTAVDIEDVRREVQIMKHL 113
           L RELG+G FG+ Y     D+  GE   + A K++++   LR  ++  +   E  +MK  
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGF 76
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
             H ++V L           +VMEL   G+L   + +     E        T+ E++Q+ 
Sbjct: 77  TCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 135
Query: 174 HE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSV------FFRPGEQFN 217
            E          +  +HRDL   N + A+      +K  DFG++       ++R G +  
Sbjct: 136 AEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKGGKGL 192
Query: 218 EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA-QAIIRSV 274
             V    +MAPE LK   +    D+WS GV+L+ I      P+     QG++ + +++ V
Sbjct: 193 LPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY-----QGLSNEQVLKFV 244
Query: 275 IDFKRDPWP-KVSENAKDLVKKMLNPDPKQRLTAEEVL 311
           +D      P    E   DL++     +PK R T  E++
Sbjct: 245 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 94
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 154
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +  +  +   G+     +MA E L+ + 
Sbjct: 155 RDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 211
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 155
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 215
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +  +  +   G+     +MA E L+ + 
Sbjct: 216 RDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPY 297

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 42/259 (16%)
Query: 37  STVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR- 95
           S  V    +L++P  +    +  LG+ LG GEFG     T  +   +    +++ K L+ 
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 96  --TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELF-----DRI 148
             +  ++ D+  E  ++K +  HP+++ L      D  + +++E  + G L       R 
Sbjct: 64  NASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 149 VARG--------------HYTERAAA-----AVMKTIVEVVQVCHEQGVMHRDLKPENFL 189
           V  G              H  ERA       +    I + +Q   E  ++HRDL   N L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 190 FANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGS-PY-YMAPEVLKRN-YGPEVDVWSAG 245
            A   E   +K  DFGLS   +          G  P  +MA E L  + Y  + DVWS G
Sbjct: 183 VA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 246 VILYILLC-------GVPP 257
           V+L+ ++        G+PP
Sbjct: 240 VLLWEIVTLGGNPYPGIPP 258

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 101
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 161
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +  +  +   G+     +MA E L+ + 
Sbjct: 162 RDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 218
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 219 FTTKSDVWSFGVLLWELMTRGAPPY 243

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 21/253 (8%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +LG+G FG  ++ T  N   + A K++    +      E   +E Q+MK L +H  +V L
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKL-RHEKLVQL 78
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKT-IVEVVQVCHEQGVMH 180
                ++  ++IVME    G L D +    G Y        M   I   +        +H
Sbjct: 79  YAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEV-LKRNYG 236
           RDL+  N L     E+   K  DFGL+      E +    G+ +   + APE  L   + 
Sbjct: 138 RDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT 193
Query: 237 PEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
            + DVWS G++L  L   G  P+     + V   + R    ++    P+  E+  DL+ +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQ 250
Query: 296 MLNPDPKQRLTAE 308
               DP++R T E
Sbjct: 251 CWRKDPEERPTFE 263

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 96
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 156
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +  +  +   G+     +MA E L+ + 
Sbjct: 157 RDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 60  LGRELGRGEFGVTYL--CTDVNNGE---KFACKSISKK-KLRTAVDIEDVRREVQIMKHL 113
           L RELG+G FG+ Y     D+  GE   + A K++++   LR  ++  +   E  +MK  
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGF 77
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
             H ++V L           +VMEL   G+L   + +     E        T+ E++Q+ 
Sbjct: 78  TCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 174 HE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSV------FFRPGEQFN 217
            E          +  +HRDL   N + A+      +K  DFG++       ++R G +  
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKGGKGL 193
Query: 218 EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA-QAIIRSV 274
             V    +MAPE LK   +    D+WS GV+L+ I      P+     QG++ + +++ V
Sbjct: 194 LPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY-----QGLSNEQVLKFV 245
Query: 275 IDFKRDPWP-KVSENAKDLVKKMLNPDPKQRLTAEEVL 311
           +D      P    E   DL++     +PK R T  E++
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 95
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 155
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +     +   G+     +MA E L+ + 
Sbjct: 156 RDLAARNCML---DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQK 212
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPNIVS 121
           +LG+G FG   LC     G+        K+   +  D + D +RE+QI+K L     +  
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 122 LKDTY-EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH------ 174
              +Y      + +VME    G L D +        RA     + ++   Q+C       
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFL-----QRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP-----YYMAPE 229
            +  +HRDL   N L  ++     +K  DFGL+    P ++   +V  P     ++ APE
Sbjct: 129 SRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDXXVVREPGQSPIFWYAPE 184
Query: 230 VLKRN-YGPEVDVWSAGVILYILL 252
            L  N +  + DVWS GV+LY L 
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|1TCO|B Chain B, Ternary Complex Of A Calcineurin A Fragment, Calcineurin B, Fkbp12 And The Immunosuppressant Drug Fk506 (tacrolimus) Length = 169

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 349 LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEAD----LQILM 404
           L++ + F   +E+  L + F+ +D +  G ++             ++PE      +Q ++
Sbjct: 8   LEMCSHF-DADEIKRLGKRFKKLDLDNSGSLSVEEF--------MSLPELQQNPLVQRVI 58
Query: 405 EAADVDGDGSLNYGEFV-AVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL--- 460
           +  D DG+G +++ EF+  VS    K   ++ L  AF  +D ++ G+I   EL   L   
Sbjct: 59  DIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMM 118
Query: 461 --NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRK 504
             N+  DT  + +++  + + D D DGRIS+EEF  ++  G D  K
Sbjct: 119 VGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVV-GGLDIHK 163

>pdb|1OZS|A Chain A, C-Domain Of Human Cardiac Troponin C In Complex With The Inhibitory Region Of Human Cardiac Troponin I Length = 73

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/70 (41%), Positives = 40/70 (57%)
Query: 429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS 488
           K  ++E L   F  FD+N  G+I++EEL+  L    +T  ED I  +M D D + DGRI 
Sbjct: 2   KGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRID 61
Query: 489 YEEFAVMMKA 498
           Y+EF   MK 
Sbjct: 62  YDEFLEFMKG 71

>pdb|1MF8|B Chain B, Crystal Structure Of Human Calcineurin Complexed With Cyclosporin A And Human Cyclophilin Length = 170

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 349 LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEAD----LQILM 404
           L++ + F   +E+  L + F+ +D +  G ++             ++PE      +Q ++
Sbjct: 9   LEMCSHF-DADEIKRLGKRFKKLDLDNSGSLSVEEF--------MSLPELQQNPLVQRVI 59
Query: 405 EAADVDGDGSLNYGEFV-AVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL--- 460
           +  D DG+G +++ EF+  VS    K   ++ L  AF  +D ++ G+I   EL   L   
Sbjct: 60  DIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMM 119
Query: 461 --NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRK 504
             N+  DT  + +++  + + D D DGRIS+EEF  ++  G D  K
Sbjct: 120 VGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVV-GGLDIHK 164

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 34/280 (12%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKH 116
           LG+ LGRG FG           +    ++++ K L+      + R    E++I+ H+  H
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 117 PNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEV----- 169
            N+V+L     +    + +++E C+ G L   + + R  +       + K  + +     
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 170 --------VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEI 219
                   ++    +  +HRDL   N L +   E + +K  DFGL+  +   P       
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 220 VGSPY-YMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVID 276
              P  +MAPE +  R Y  + DVWS GV+L+ I   G  P+       + +   R + +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRLKE 266
Query: 277 FKRDPWPKVSENAKDLVKKMLN---PDPKQRLTAEEVLEH 313
             R   P  +    ++ + ML+    +P QR T  E++EH
Sbjct: 267 GTRMRAPDYT--TPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 108/253 (42%), Gaps = 21/253 (8%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +LG+G FG  ++ T  N   + A K++    +      E   +E Q+MK L +H  +V L
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKL-RHEKLVQL 78
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKT-IVEVVQVCHEQGVMH 180
                ++  ++IV+E    G L D +    G Y        M   I   +        +H
Sbjct: 79  YAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEV-LKRNYG 236
           RDL+  N L     E+   K  DFGL+      E +    G+ +   + APE  L   + 
Sbjct: 138 RDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT 193
Query: 237 PEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
            + DVWS G++L  L   G  P+     + V   + R    ++    P+  E+  DL+ +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQ 250
Query: 296 MLNPDPKQRLTAE 308
               DP++R T E
Sbjct: 251 CWRKDPEERPTFE 263

>pdb|1FI5|A Chain A, Nmr Structure Of The C Terminal Domain Of Cardiac Troponin C Bound To The N Terminal Domain Of Cardiac Troponin I. Length = 81

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/70 (41%), Positives = 39/70 (55%)
Query: 429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS 488
           K   +E L   F  FD+N  G+I++EEL+  L    +T  ED I  +M D D + DGRI 
Sbjct: 10  KGKTEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRID 69
Query: 489 YEEFAVMMKA 498
           Y+EF   MK 
Sbjct: 70  YDEFLEFMKG 79

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 97
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 157
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  +  +  +  +   G+     +MA E L+ + 
Sbjct: 158 RDLAARNCML---DEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 53/277 (19%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L + +G+GEFG      DV  G+ +    ++ K ++     +    E  +M  L +H N+
Sbjct: 25  LLQTIGKGEFG------DVMLGD-YRGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNL 76
Query: 120 VSLKDTY-EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK---TIVEVVQVCHE 175
           V L     E+   ++IV E    G L D + +RG  +      ++K    + E ++    
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-YMAPEVLK-R 233
              +HRDL   N L +   E +  K  DFGL+   +      +    P  + APE L+ +
Sbjct: 136 NNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREK 189
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            +  + DVWS G++L+                        +  F R P+P++    KD+V
Sbjct: 190 KFSTKSDVWSFGILLW-----------------------EIYSFGRVPYPRIP--LKDVV 224
Query: 294 K------KMLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
                  KM  PD        EV+++ W  +A   P+
Sbjct: 225 PRVEKGYKMDAPDGCPP-AVYEVMKNCWHLDAAMRPS 260

>pdb|3QRX|A Chain A, Chlamydomonas Reinhardtii Centrin Bound To Melittin Length = 169

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 73/143 (51%), Gaps = 1/143 (0%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L+ E+   ++EAF++ DT+  G I+                + +++ ++   D DG G++
Sbjct: 22  LTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTI 81
Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++ EF+ + +  + +  + E + KAF  FD + SG I I++LR    +  +   E+ +  
Sbjct: 82  DFEEFLTMMTAKMGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQE 141
Query: 475 IMHDVDTDKDGRISYEEFAVMMK 497
           ++ + D + D  I  +EF  +MK
Sbjct: 142 MIAEADRNDDNEIDEDEFIRIMK 164

>pdb|3OX5|A Chain A, Crystal Structure Of The Calcium Sensor Calcium-Binding Protein 1 (Cabp1) Length = 153

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 6/147 (4%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L  EE+  L+EAF   D +K G IN                E +L  L +  +++  G +
Sbjct: 5   LRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHV 64
Query: 416 NYGEFVAVS-----VHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTS-GE 469
           ++ +FV +           M   + L  AF  FD N  G I   ELR A+   +    G 
Sbjct: 65  DFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRKLLGHQVGH 124
Query: 470 DVINAIMHDVDTDKDGRISYEEFAVMM 496
             I  I+ DVD + DGR+ +EEF  MM
Sbjct: 125 RDIEEIIRDVDLNGDGRVDFEEFVRMM 151

>pdb|2P6B|B Chain B, Crystal Structure Of Human Calcineurin In Complex With Pvivit Peptide Length = 156

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEAD----LQILMEAADVDG 411
           +  +E+  L + F+ +D +  G ++             ++PE      +Q +++  D DG
Sbjct: 1   MDADEIKRLGKRFKKLDLDNSGSLSVEEF--------MSLPELQQNPLVQRVIDIFDTDG 52
Query: 412 DGSLNYGEFV-AVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL-----NDEVD 465
           +G +++ EF+  VS    K   ++ L  AF  +D ++ G+I   EL   L     N+  D
Sbjct: 53  NGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKD 112
Query: 466 TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRK 504
           T  + +++  + + D D DGRIS+EEF  ++  G D  K
Sbjct: 113 TQLQQIVDKTIINADKDGDGRISFEEFCAVV-GGLDIHK 150

>pdb|3CTN|A Chain A, Structure Of Calcium-Saturated Cardiac Troponin C, Nmr, 30 Structures Length = 76

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/70 (41%), Positives = 39/70 (55%)
Query: 429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS 488
           K   +E L   F  FD+N  G+I++EEL+  L    +T  ED I  +M D D + DGRI 
Sbjct: 5   KGKTEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRID 64
Query: 489 YEEFAVMMKA 498
           Y+EF   MK 
Sbjct: 65  YDEFLEFMKG 74

>pdb|1IH0|A Chain A, Structure Of The C-Domain Of Human Cardiac Troponin C In Complex With Ca2+ Sensitizer Emd 57033 Length = 71

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/65 (43%), Positives = 37/65 (56%)
Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
           E L   F  FD+N  G+I++EEL+  L    +T  ED I  +M D D + DGRI Y+EF 
Sbjct: 5   EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFL 64
Query: 494 VMMKA 498
             MK 
Sbjct: 65  EFMKG 69

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 53/277 (19%)
Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L + +G+GEFG      DV  G+ +    ++ K ++     +    E  +M  L +H N+
Sbjct: 10  LLQTIGKGEFG------DVMLGD-YRGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNL 61
Query: 120 VSLKDTY-EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK---TIVEVVQVCHE 175
           V L     E+   ++IV E    G L D + +RG  +      ++K    + E ++    
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-YMAPEVLK-R 233
              +HRDL   N L +   E +  K  DFGL+   +      +    P  + APE L+ +
Sbjct: 121 NNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREK 174
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            +  + DVWS G++L+                        +  F R P+P++    KD+V
Sbjct: 175 KFSTKSDVWSFGILLW-----------------------EIYSFGRVPYPRIP--LKDVV 209
Query: 294 K------KMLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
                  KM  PD        EV+++ W  +A   P+
Sbjct: 210 PRVEKGYKMDAPDGCPP-AVYEVMKNCWHLDAAMRPS 245

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 114
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 174
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +     +   G+     +MA E L+ + 
Sbjct: 175 RDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 231
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 232 FTTKSDVWSFGVLLWELMTRGAPPY 256

>pdb|3LL8|B Chain B, Crystal Structure Of Calcineurin In Complex With Akap79 Peptide Length = 155

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 400 LQILMEAADVDGDGSLNYGEFV-AVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
           +Q +++  D DG+G +++ EF+  VS    K   ++ L  AF  +D ++ G+I   EL  
Sbjct: 40  VQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQ 99
Query: 459 AL-----NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRK 504
            L     N+  DT  + +++  + + D D DGRIS+EEF  ++  G D  K
Sbjct: 100 VLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVV-GGLDIHK 149

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 96
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 156
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +     +   G+     +MA E L+ + 
Sbjct: 157 RDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 107/253 (42%), Gaps = 21/253 (8%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +LG+G FG  ++ T  N   + A K++    +      E   +E Q+MK L +H  +V L
Sbjct: 25  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKL-RHEKLVQL 78
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKT-IVEVVQVCHEQGVMH 180
                ++  ++IV E    G L D +    G Y        M   I   +        +H
Sbjct: 79  YAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEV-LKRNYG 236
           RDL+  N L     E+   K  DFGL+      E +    G+ +   + APE  L   + 
Sbjct: 138 RDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT 193
Query: 237 PEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
            + DVWS G++L  L   G  P+     + V   + R    ++    P+  E+  DL+ +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQ 250
Query: 296 MLNPDPKQRLTAE 308
               DP++R T E
Sbjct: 251 CWRKDPEERPTFE 263

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 107/253 (42%), Gaps = 21/253 (8%)
Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +LG+G FG  ++ T  N   + A K++    +      E   +E Q+MK L +H  +V L
Sbjct: 16  KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKL-RHEKLVQL 69
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKT-IVEVVQVCHEQGVMH 180
                ++  ++IV E    G L D +    G Y        M   I   +        +H
Sbjct: 70  YAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 128
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEV-LKRNYG 236
           RDL+  N L     E+   K  DFGL+      E +    G+ +   + APE  L   + 
Sbjct: 129 RDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT 184
Query: 237 PEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
            + DVWS G++L  L   G  P+     + V   + R    ++    P+  E+  DL+ +
Sbjct: 185 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQ 241
Query: 296 MLNPDPKQRLTAE 308
               DP++R T E
Sbjct: 242 CWRKDPEERPTFE 254

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 95
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 155
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +     +   G+     +MA E L+ + 
Sbjct: 156 RDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 212
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 94
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 154
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +     +   G+     +MA E L+ + 
Sbjct: 155 RDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 211
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 91
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 151
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +     +   G+     +MA E L+ + 
Sbjct: 152 RDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAPPY 233

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 115
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 175
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +     +   G+     +MA E L+ + 
Sbjct: 176 RDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 232
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 233 FTTKSDVWSFGVLLWELMTRGAPPY 257

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 64  LGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
           +GRG FG  Y  T ++N G+K  C   S  ++    ++     E  IMK    HPN++SL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 96
Query: 123 KD-TYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMH 180
                  + +  +V+   + G+L + I    H  T +        + + ++    +  +H
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 156
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY---YMAPEVLK-RN 234
           RDL   N +     E   +K  DFGL+  ++ +     +   G+     +MA E L+ + 
Sbjct: 157 RDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 235 YGPEVDVWSAGVILYILLC-GVPPF 258
           +  + DVWS GV+L+ L+  G PP+
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3OX6|A Chain A, Crystal Structure Of The Calcium Sensor Calcium-Binding Protein 1 (Cabp1) Length = 153

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 6/147 (4%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAADVDGDGSL 415
           L  EE+  L+EAF   D +K G IN                E +L  L +  +++  G +
Sbjct: 5   LRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHV 64
Query: 416 NYGEFVAVS-----VHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTS-GE 469
           ++ +FV +           M   + L  AF  FD N  G I   ELR A+   +    G 
Sbjct: 65  DFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGH 124
Query: 470 DVINAIMHDVDTDKDGRISYEEFAVMM 496
             I  I+ DVD + DGR+ +EEF  MM
Sbjct: 125 RDIEEIIRDVDLNGDGRVDFEEFVRMM 151

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	531
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	0.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	0.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	0.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	0.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	0.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	0.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	0.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-177
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-176
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-175
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-174
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-174
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-174
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-173
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-173
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-173
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-172
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-172
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-171
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-170
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-168
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-167
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-166
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-164
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-164
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-162
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-162
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-156
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-152
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-152
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-151
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-121
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-112
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-99
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-96
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-96
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-94
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-93
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-91
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-90
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-90
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-89
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-89
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-88
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-87
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-87
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-87
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-86
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-86
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-86
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-86
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-85
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-85
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-85
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	3e-85
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-85
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-84
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-84
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-82
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	1e-81
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-81
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-78
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-77
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-76
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-75
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	4e-72
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-72
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	4e-71
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-70
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	3e-68
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	5e-37
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	2e-09
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-67
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-67
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	8e-66
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	2e-15
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	3e-64
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-63
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	4e-61
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-60
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-58
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-58
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-56
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-55
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-54
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-54
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-53
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-53
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-53
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-53
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-52
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-51
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-51
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-50
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	1e-50
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-50
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-50
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-50
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-50
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-50
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-50
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-50
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-50
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	1e-49
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	3e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-49
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-49
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-49
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-49
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-48
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-48
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	3e-48
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	9e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-48
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-48
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-47
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-47
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-47
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-47
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-47
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-47
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-46
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-46
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-46
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-46
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-45
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-45
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	1e-45
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-45
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-45
3fwb_A	161	Cell division control protein 31; gene gating, com	2e-45
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	6e-45
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-45
2jnf_A	158	Troponin C; stretch activated muscle contraction,	8e-45
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	2e-44
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	3e-19
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	2e-44
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-44
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-44
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	1e-43
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	3e-43
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	3e-43
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-43
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-43
1y1x_A	191	Leishmania major homolog of programmed cell death	8e-43
1y1x_A	191	Leishmania major homolog of programmed cell death	3e-17
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	1e-42
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	1e-42
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-42
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	2e-42
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	3e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-41
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	1e-41
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	1e-41
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	3e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-41
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-40
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	1e-40
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-40
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-40
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-40
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-40
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-39
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-39
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	3e-39
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-39
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-39
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-39
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-38
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-38
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-38
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	1e-37
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	6e-13
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-37
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-37
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-37
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-37
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-37
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	1e-36
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	9e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-36
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	2e-36
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-36
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	5e-36
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	2e-19
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	8e-17
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	8e-36
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	3e-12
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	9e-36
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	9e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-36
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-35
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	4e-35
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	5e-35
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	3e-29
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	2e-34
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	5e-15
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-34
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-34
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	8e-34
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	1e-12
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	9e-34
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-33
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-33
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	5e-33
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	3e-12
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	7e-33
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	6e-04
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	9e-33
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	2e-08
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	3e-06
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	3e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-32
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	4e-32
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	6e-10
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-31
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-31
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-31
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	4e-31
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	1e-26
2hps_A	186	Coelenterazine-binding protein with bound coelent;	5e-31
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	7e-31
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	8e-31
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	3e-14
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	7e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-31
2ct9_A	208	Calcium-binding protein P22; EF-hand, metal bindin	1e-30
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	3e-30
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	1e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-30
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	4e-30
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	6e-12
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	9e-11
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	5e-30
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	1e-29
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	4e-10
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	1e-29
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	2e-29
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	3e-29
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	3e-29
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	2e-15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-29
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-29
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	5e-29
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	1e-22
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-29
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	1e-28
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	5e-09
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	1e-28
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-28
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	4e-28
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-28
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	7e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-27
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-27
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	5e-27
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	5e-23
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	7e-27
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	1e-26
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	1e-26
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	8e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-26
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	1e-25
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	4e-25
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	5e-25
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	6e-24
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	6e-25
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	4e-09
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-23
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	2e-23
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	2e-23
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	1e-22
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	4e-12
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	2e-22
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	3e-22
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	6e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-21
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	1e-21
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	1e-06
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-21
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	3e-21
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	4e-08
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	4e-21
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	1e-08
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-20
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	5e-20
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	6e-14
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-19
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	2e-19
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	2e-12
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-19
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-18
1dgu_A	183	Calcium-saturated CIB; helical, EF-hands, blood cl	1e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-18
3li6_A	66	Calcium-binding protein; calcium signaling protein	2e-18
3li6_A	66	Calcium-binding protein; calcium signaling protein	1e-13
3li6_A	66	Calcium-binding protein; calcium signaling protein	4e-10
3li6_A	66	Calcium-binding protein; calcium signaling protein	5e-04
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-18
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	4e-18
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	8e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-18
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	5e-18
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	1e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-18
2l4h_A	214	Calcium and integrin-binding protein 1; metal bind	7e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-18
2d58_A	107	Allograft inflammatory factor 1; EF-hand, metal bi	8e-18
2d58_A	107	Allograft inflammatory factor 1; EF-hand, metal bi	5e-13
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-17
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	2e-17
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	3e-15
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	2e-17
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	3e-15
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	2e-17
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	1e-13
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	2e-17
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	2e-16
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	2e-17
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	7e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-17
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	4e-17
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	1e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-17
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-17
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	9e-17
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	6e-11
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-16
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	4e-16
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	1e-11
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-16
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	1e-15
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	7e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-15
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	2e-14
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	5e-12
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	3e-14
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	9e-14
1qx2_A	76	Vitamin D-dependent calcium-binding protein, INTE;	5e-14
1qx2_A	76	Vitamin D-dependent calcium-binding protein, INTE;	1e-09
3a4u_B	143	Multiple coagulation factor deficiency protein 2;	2e-13
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	3e-12
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	2e-07
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	9e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-11
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	2e-11
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	7e-09
1c07_A	95	Protein (epidermal growth factor receptor pathway	3e-11
1c07_A	95	Protein (epidermal growth factor receptor pathway	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-11
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	1e-10
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	4e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-04
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	6e-10
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	4e-09
1djx_A	624	PLC-D1, phosphoinositide-specific phospholipase C,	6e-10
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	7e-10
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	3e-08
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	2e-07
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	4e-09
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	4e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
3fia_A	121	Intersectin-1; EH 1 domain, NESG, structural genom	5e-08
3fia_A	121	Intersectin-1; EH 1 domain, NESG, structural genom	2e-05
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	2e-07
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	2e-07
1snl_A	103	Nucleobindin 1, calnuc; EF-hand, calcium-binding,	3e-07
1eh2_A	106	EPS15; calcium binding, signaling domain, NPF bind	5e-07
1eh2_A	106	EPS15; calcium binding, signaling domain, NPF bind	4e-05
1cb1_A	78	Calbindin D9K; calcium-binding protein; NMR {Sus s	8e-07
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-06
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-06
1sjj_A	863	Actinin; 3-helix bundle, calponin homology domain,	5e-06
1sjj_A	863	Actinin; 3-helix bundle, calponin homology domain,	3e-05
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	5e-06
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	8e-06
3nxa_A	100	Protein S100-A16; S100 family, calcium binding pro	1e-05
1a4p_A	96	S100A10; S100 family, EF-hand protein, ligand of a	3e-05
2h2k_A	106	Protein S100-A13; calcium binding protein, metal b	6e-05
2wcb_A	95	Protein S100-A12; calcium signalling, HOST-parasit	7e-05
2jq6_A	139	EH domain-containing protein 1; metal binding prot	7e-05
2jq6_A	139	EH domain-containing protein 1; metal binding prot	3e-04
1xk4_A	93	Calgranulin A; S100 family, heterotetramer, metal	1e-04
1xk4_C	113	Calgranulin B; S100 family, heterotetramer, metal	2e-04
2kax_A	92	Protein S100-A5; EF-hand, calcium binding protien,	3e-04
1k2h_A	93	S100A1, S-100 protein, alpha chain; non-covalent h	3e-04
4eto_A	93	Protein S100-A4; calcium-binding protein, EF-hand,	3e-04
3zwh_A	104	Protein S100-A4; Ca-binding protein-motor protein	4e-04
1psr_A	100	Psoriasin, S100A7; EF-hand protein, MAD phasing, p	4e-04
3rm1_A	92	Protein S100-B; alpha-helical, EF hand, metal bind	5e-04
1k8u_A	90	S100A6, calcyclin, CACY; calcium regulatory protei	5e-04
3nso_A	101	Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta	5e-04
1j55_A	95	S-100P protein; metal binding protein; 2.00A {Homo	7e-04
1qls_A	99	S100C protein, calgizzarin; metal-binding protein/	8e-04
2y5i_A	99	S100Z, S100 calcium binding protein Z; metal-bindi	9e-04
2lnk_A	113	Protein S100-A4; EF-hand, calcium binding, all alp	9e-04

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  688 bits (1777), Expect = 0.0
 Identities = 159/468 (33%), Positives = 251/468 (53%), Gaps = 21/468 (4%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
             +  Y++   LG+G FG    C D    +++A K I+K   +   D   + REV+++K 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKK 77

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           L  HPNI+ L +  ED S+ +IV EL  GGELFD I+ R  ++E  AA ++K +   +  
Sbjct: 78  L-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
            H+  ++HRDLKPEN L  +K++   +K IDFGLS  F+   +  + +G+ YY+APEVL+
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             Y  + DVWSAGVILYILL G PPF+ + E  + + +      F    W  +S++AKDL
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQN----AKKAPNVSLGETVKARLKQFSVMNKLKKRA 348
           ++KML   P  R+TA + LEHPW+Q          ++   E+    ++QF    KL + A
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAA 316

Query: 349 LQVVAEFLS-VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK--------------GGQ 393
           L  +A  L+ ++E   L E F  +DTN  G ++ +EL  G  +                 
Sbjct: 317 LLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEG 376

Query: 394 NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEI 453
           +  E  +  LM   D+DG GS+ Y EF+A ++    + + E + +AF  FD++ SG I  
Sbjct: 377 STIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSRERMERAFKMFDKDGSGKIST 436

Query: 454 EELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
           +EL    +    +   + + +I+  VD +KDG + + EF  M++    
Sbjct: 437 KELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQNFVR 484

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  686 bits (1773), Expect = 0.0
 Identities = 153/482 (31%), Positives = 248/482 (51%), Gaps = 26/482 (5%)

Query: 44  CVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV----- 98
             +++  G  I   Y   R+LG G +G   LC + N   + A K I K +          
Sbjct: 25  MYVRKKEG-KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN 83

Query: 99  -----DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
                  E++  E+ ++K L  HPNI+ L D +ED    ++V E  EGGELF++I+ R  
Sbjct: 84  KNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK 142

Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
           + E  AA +MK I+  +   H+  ++HRD+KPEN L  NK     +K +DFGLS FF   
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

Query: 214 EQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273
            +  + +G+ YY+APEVLK+ Y  + DVWS GVI+YILLCG PPF  + +Q + + + + 
Sbjct: 203 YKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262

Query: 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK---APNVSLGET 330
              F  + W  +S+ AK+L+K ML  D  +R TAEE L   W++         +      
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCG 322

Query: 331 VKARLKQFSVMNKLKKRALQVVAEFLS-VEEVAGLKEAFEMMDTNKRGKINLEELRLGLL 389
             + +++F    KL + A+  +   L+ +EE   L + F+ +D N  G+++ +EL  G  
Sbjct: 323 ALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYN 382

Query: 390 KGGQ--------NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFS 441
                          E ++  +++  D D +G + Y EF++V +  + + ++E L +AF+
Sbjct: 383 VLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMDKQILFSEERLRRAFN 442

Query: 442 FFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
            FD ++SG I  EEL N       +  E   N ++ + D +KD  I ++EF  MM    D
Sbjct: 443 LFDTDKSGKITKEELANLFGL--TSISEKTWNDVLGEADQNKDNMIDFDEFVSMMHKICD 500

Query: 502 WR 503
            +
Sbjct: 501 HK 502

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  685 bits (1769), Expect = 0.0
 Identities = 158/472 (33%), Positives = 251/472 (53%), Gaps = 19/472 (4%)

Query: 45  VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
            ++  +    S  Y   R LG+G FG   LC D   G++ A K ISK++++   D E + 
Sbjct: 16  FVQHSTA-IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
           REVQ++K L  HPNI+ L + +ED    ++V E+  GGELFD I++R  ++E  AA +++
Sbjct: 75  REVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
            ++  +   H+  ++HRDLKPEN L  +K + + ++ IDFGLS  F   ++  + +G+ Y
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY 193

Query: 225 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           Y+APEVL   Y  + DVWS GVILYILL G PPF    E  + + + +    F+   W K
Sbjct: 194 YIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK---APNVSLGETVKARLKQFSVM 341
           VSE+AKDL++KML   P  R++A + L+H W+Q   K   + +V   +     ++QF   
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGT 313

Query: 342 NKLKKRALQVVAEFL-SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK---------- 390
            KL + AL  +   L S +E   L   F  MD N  G+++  EL  G  +          
Sbjct: 314 QKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDAS 373

Query: 391 -GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSG 449
               +  E ++  +++A D D +G + Y EFV V++  K + + E L +AF  FD + SG
Sbjct: 374 MLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSG 433

Query: 450 FIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
            I   EL             +   +++ +VD + DG + ++EF  M+     
Sbjct: 434 KISSTELATIFGV--SDVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKLCG 483

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  671 bits (1734), Expect = 0.0
 Identities = 159/493 (32%), Positives = 257/493 (52%), Gaps = 18/493 (3%)

Query: 22  KPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNG 81
             +   G E +   G         +    G  +S  Y   ++LG G +G   LC D    
Sbjct: 4   HHHHSSGRENLYFQGDLQATPGMFITSKKG-HLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62

Query: 82  EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141
            + A K I K  + T+     +  EV ++K L  HPNI+ L D +ED    ++VME  +G
Sbjct: 63  VERAIKIIRKTSVSTS-SNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKG 120

Query: 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA 201
           GELFD I+ R  + E  AA ++K ++  V   H+  ++HRDLKPEN L  +K++ + +K 
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKI 180

Query: 202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAE 261
           +DFGLS  F   ++  E +G+ YY+APEVL++ Y  + DVWS GVIL+ILL G PPF  +
Sbjct: 181 VDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQ 240

Query: 262 TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           T+Q + + + +    F    W  VSE AKDL+K+ML  D ++R++A++ LEHPW++    
Sbjct: 241 TDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300

Query: 322 AP----NVSLGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLKEAFEMMDTNKR 376
                  +         +++F    KL + AL  +A  L S EE   L + F  +D N  
Sbjct: 301 KKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGD 360

Query: 377 GKINLEELRLGLLKGGQN--------IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK 428
           G+++ +EL  G  K              E+++  ++ AAD D +G ++Y EFV V++  K
Sbjct: 361 GQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRK 420

Query: 429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS 488
            + + + L  AF  FD++ +G I ++EL +      D         ++  +D++ DG + 
Sbjct: 421 SLLSKDKLESAFQKFDQDGNGKISVDELASVFGL--DHLESKTWKEMISGIDSNNDGDVD 478

Query: 489 YEEFAVMMKAGTD 501
           +EEF  M++    
Sbjct: 479 FEEFCKMIQKLCS 491

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  626 bits (1617), Expect = 0.0
 Identities = 135/455 (29%), Positives = 221/455 (48%), Gaps = 23/455 (5%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
           +    + +Y L  ELG+G F V   C  V  G+++A   I+ KKL +A D + + RE +I
Sbjct: 5   TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARI 63

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
            + L KHPNIV L D+  ++   +++ +L  GGELF+ IVAR +Y+E  A+  ++ I+E 
Sbjct: 64  CRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAP 228
           V  CH+ GV+HR+LKPEN L A+K + + +K  DFGL++      + +    G+P Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182

Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           EVL+++ YG  VD+W+ GVILYILL G PPFW E +  + Q I     DF    W  V+ 
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR 347
            AKDL+ KML  +P +R+TA E L+HPW+ +     +    +     LK+F+   KLK  
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302

Query: 348 ALQVVA--EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILME 405
            L V+      SV +   +K   ++++    G                 + +  +     
Sbjct: 303 ILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDFES----------YTKMCDPGMTAFEP 352

Query: 406 AADVDGDGSLNYGEFVAVSVHLKKMANDE-HLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
            A  +    L++  F   ++  +        +         + S  I    +   L+   
Sbjct: 353 EALGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIHLMGDESACIAYIRITQYLDAGG 412

Query: 465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG 499
                    +    V   +DG+    +     ++G
Sbjct: 413 I---PRTAQSEETRVWHRRDGKW---QIVHFHRSG 441

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  536 bits (1382), Expect = 0.0
 Identities = 122/350 (34%), Positives = 189/350 (54%), Gaps = 6/350 (1%)

Query: 34  ANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKK 93
             G   + R       +    S +YD+  ELG+G F V   C     G +FA K I+ KK
Sbjct: 7   MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66

Query: 94  LRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
           L +A D + + RE +I + L +HPNIV L D+ +++S  ++V +L  GGELF+ IVAR  
Sbjct: 67  L-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124

Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
           Y+E  A+  ++ I+E +  CH  G++HR+LKPEN L A+K + + +K  DFGL++     
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184

Query: 214 EQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
           E ++   G+P Y++PEVLK++ Y   VD+W+ GVILYILL G PPFW E +  +   I  
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244

Query: 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVK 332
              D+    W  V+  AK L+  ML  +PK+R+TA++ L+ PW+ N ++  +    +   
Sbjct: 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 304

Query: 333 ARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLE 382
             LK+F+   KLK   L  +    +   ++ L                 E
Sbjct: 305 DCLKKFNARRKLKGAILTTMI---ATRNLSNLGRNLLNKKEQGPPSTIKE 351

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  523 bits (1349), Expect = 0.0
 Identities = 113/325 (34%), Positives = 172/325 (52%), Gaps = 10/325 (3%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHLPK 115
           Y+L   +G+G F V   C +   G++FA K +   K      +  ED++RE  I   L K
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-K 84

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVVQ 171
           HP+IV L +TY  D  +++V E  +G +L   IV R      Y+E  A+  M+ I+E ++
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEV 230
            CH+  ++HRD+KP   L A+K+ S+P+K   FG+++     G      VG+P++MAPEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +KR  YG  VDVW  GVIL+ILL G  PF+  T++ + + II+         W  +SE+A
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESA 263

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 349
           KDLV++ML  DP +R+T  E L HPWL+   +            +L++F+   KLK   L
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVL 323

Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTN 374
             V+            E       +
Sbjct: 324 AAVSSHKFNSFYGDPPEELPDFSED 348

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  514 bits (1325), Expect = 0.0
 Identities = 130/350 (37%), Positives = 188/350 (53%), Gaps = 11/350 (3%)

Query: 7   RPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGR 66
              SS            +            +++V    +        +S  +++  ELGR
Sbjct: 5   HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRD-ALSDFFEVESELGR 63

Query: 67  GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126
           G   + Y C      + +A K + K       D + VR E+ ++  L  HPNI+ LK+ +
Sbjct: 64  GATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIF 117

Query: 127 EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPE 186
           E  + + +V+EL  GGELFDRIV +G+Y+ER AA  +K I+E V   HE G++HRDLKPE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177

Query: 187 NFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAG 245
           N L+A     +PLK  DFGLS           + G+P Y APE+L+   YGPEVD+WS G
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237

Query: 246 VILYILLCGVPPFWAET-EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQR 304
           +I YILLCG  PF+ E  +Q + + I+     F    W +VS NAKDLV+K++  DPK+R
Sbjct: 238 IITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297

Query: 305 LTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAE 354
           LT  + L+HPW+    KA N    +T + +L++F+   KLK     VVA 
Sbjct: 298 LTTFQALQHPWVTG--KAANFVHMDTAQKKLQEFNARRKLKAAVKAVVAS 345

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  511 bits (1317), Expect = 0.0
 Identities = 111/329 (33%), Positives = 173/329 (52%), Gaps = 16/329 (4%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVDIEDVRREVQ 108
           +++   YD G ELG G+F V   C + + G ++A K I K++    R  V  ED+ REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           I+K + +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+ 
Sbjct: 67  ILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
            V   H   + H DLKPEN +  ++      +K IDFGL+     G +F  I G+P ++A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185

Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE++     G E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
             AKD ++++L  DPK+R+T ++ L+HPW++       +S       R      M K KK
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS-------RKASAVNMEKFKK 298

Query: 347 RALQVVAEFLSVEEVAGLKEAFEMMDTNK 375
            A +  +   S     GL + FE      
Sbjct: 299 FAARKKSNNGS---GGGLNDIFEAQKIEW 324

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  499 bits (1287), Expect = e-177
 Identities = 114/281 (40%), Positives = 172/281 (61%), Gaps = 4/281 (1%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
             S +YD+  ELG+G F V   C     G +FA K I+ KKL +A D + + RE +I + 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRK 61

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           L +HPNIV L D+ +++S  ++V +L  GGELF+ IVAR  Y+E  A+  ++ I+E +  
Sbjct: 62  L-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
           CH  G++HR+LKPEN L A+K + + +K  DFGL++     E ++   G+P Y++PEVLK
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180

Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
           ++ Y   VD+W+ GVILYILL G PPFW E +  +   I     D+    W  V+  AK 
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQN-AKKAPNVSLGETV 331
           L+  ML  +PK+R+TA++ L+ PW+ N  + A  +   +TV
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  496 bits (1280), Expect = e-176
 Identities = 117/278 (42%), Positives = 169/278 (60%), Gaps = 4/278 (1%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
           +  DI+  Y L   +GRG +G   +        + A K I K  +    D++  ++E++I
Sbjct: 3   TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEI 59

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           MK L  HPNI+ L +T+ED++ +++VMELC GGELF+R+V +  + E  AA +MK ++  
Sbjct: 60  MKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           V  CH+  V HRDLKPENFLF      SPLK IDFGL+  F+PG+     VG+PYY++P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178

Query: 230 VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           VL+  YGPE D WSAGV++Y+LLCG PPF A T+  V   I      F    W  VS  A
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           + L++++L   PKQR+T+ + LEH W +    +   +L
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  495 bits (1277), Expect = e-175
 Identities = 88/317 (27%), Positives = 162/317 (51%), Gaps = 12/317 (3%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
           +++   Y +  +LGRGEFG+ + C + ++ + +  K +  K      D   V++E+ I+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVV 170
              +H NI+ L +++E    + ++ E   G ++F+RI        ER   + +  + E +
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
           Q  H   + H D++PEN ++  +  SS +K I+FG +   +PG+ F  +  +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
            + +      D+WS G ++Y+LL G+ PF AET Q + + I+ +   F  + + ++S  A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 349
            D V ++L  + K R+TA E L+HPWL+   +  +      V   LK     + L K+ L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK----VIRTLKHRRYYHTLIKKDL 290

Query: 350 QVVAEFLSVEEVAGLKE 366
            +V     +     ++ 
Sbjct: 291 NMVVSAARISCGGAIRS 307

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  492 bits (1269), Expect = e-174
 Identities = 108/266 (40%), Positives = 160/266 (60%), Gaps = 2/266 (0%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
             +  Y++   LG+G FG    C D    +++A K I+K   +   D   + REV+++K 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKK 77

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           L  HPNI+ L +  ED S+ +IV EL  GGELFD I+ R  ++E  AA ++K +   +  
Sbjct: 78  L-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
            H+  ++HRDLKPEN L  +K++   +K IDFGLS  F+   +  + +G+ YY+APEVL+
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             Y  + DVWSAGVILYILL G PPF+ + E  + + +      F    W  +S++AKDL
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQN 318
           ++KML   P  R+TA + LEHPW+Q 
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQK 282

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  495 bits (1275), Expect = e-174
 Identities = 108/381 (28%), Positives = 167/381 (43%), Gaps = 23/381 (6%)

Query: 8   PDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRG 67
             + +          P+P               H    L+      I       + LG G
Sbjct: 14  FPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLG 73

Query: 68  EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127
             G      +    EKFA K +              RREV++     + P+IV + D YE
Sbjct: 74  INGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 125

Query: 128 D----DSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           +       + IVME  +GGELF RI  RG   +TER A+ +MK+I E +Q  H   + HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
           D+KPEN L+ +K+ ++ LK  DFG +              +PYY+APEVL    Y    D
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245

Query: 241 VWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
           +WS GVI+YILLCG PPF++        G+   I     +F    W +VSE  K L++ +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305

Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFL 356
           L  +P QR+T  E + HPW+  + K P   L  +   +  +    +  ++    +    +
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRV 365

Query: 357 SVEEVAGLKEAFEMMDTNKRG 377
             E++    +  ++ D +   
Sbjct: 366 DYEQI----KIKKIEDASNPL 382

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  491 bits (1266), Expect = e-173
 Identities = 109/327 (33%), Positives = 165/327 (50%), Gaps = 19/327 (5%)

Query: 40  VHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD 99
           VH +      +    +  Y++  ++G G + V   C       +FA K I K K      
Sbjct: 6   VHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------ 59

Query: 100 IEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA 159
             D   E++I+    +HPNI++LKD Y+D   V++V EL +GGEL D+I+ +  ++ER A
Sbjct: 60  -RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118

Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGLSVFFRPGEQ-FN 217
           +AV+ TI + V+  H QGV+HRDLKP N L+ ++      ++  DFG +   R       
Sbjct: 119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178

Query: 218 EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRS 273
               +  ++APEVL+R  Y    D+WS GV+LY +L G  PF     +T + +   I   
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238

Query: 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
                   W  VS+ AKDLV KML+ DP QRLTA  VL HPW+ +  + P   L      
Sbjct: 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAP 298

Query: 334 RLKQ------FSVMNKLKKRALQVVAE 354
            L +      +S +N+ +   L+ V  
Sbjct: 299 HLVKGAMAATYSALNRNQSPVLEPVGR 325

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  490 bits (1263), Expect = e-173
 Identities = 86/304 (28%), Positives = 155/304 (50%), Gaps = 6/304 (1%)

Query: 50  SGQDISIDYDL-GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
           S ++ +  Y L  +ELGRG+F V   C   + G+++A K + K++        ++  E+ 
Sbjct: 22  SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIA 80

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTI 166
           +++     P +++L + YE+ S + +++E   GGE+F   +       +E     ++K I
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQI 140

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
           +E V   H+  ++H DLKP+N L ++      +K +DFG+S       +  EI+G+P Y+
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200

Query: 227 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
           APE+L  +      D+W+ G+I Y+LL    PF  E  Q     I +  +D+  + +  V
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGET-VKARLKQFSVMNKL 344
           S+ A D ++ +L  +P++R TAE  L H WLQ           ET   ++ +  SV +  
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSE 320

Query: 345 KKRA 348
            K +
Sbjct: 321 DKTS 324

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  489 bits (1261), Expect = e-173
 Identities = 103/324 (31%), Positives = 158/324 (48%), Gaps = 28/324 (8%)

Query: 52  QDISIDYDLG---RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
                 YDL    + LG G F +   C    + + FA K ISK+         + ++E+ 
Sbjct: 4   SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEIT 57

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
            +K    HPNIV L + + D     +VMEL  GGELF+RI  + H++E  A+ +M+ +V 
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSPYYMA 227
            V   H+ GV+HRDLKPEN LF ++ ++  +K IDFG +    P  +       + +Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177

Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVIDFKR 279
           PE+L +N Y    D+WS GVILY +L G  PF +            + + I +    F+ 
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237

Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL---------GET 330
           + W  VS+ AKDL++ +L  DP +RL    +  + WLQ+  +  +  L         G  
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297

Query: 331 VKARLK-QFSVMNKLKKRALQVVA 353
           V   +K  F   NK K+    +  
Sbjct: 298 VHTCVKATFHAFNKYKREGFCLQN 321

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  490 bits (1263), Expect = e-172
 Identities = 102/325 (31%), Positives = 161/325 (49%), Gaps = 15/325 (4%)

Query: 5   CARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGREL 64
             R D S       + +K N             ++     +    + ++    YD    +
Sbjct: 43  SLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVI 102

Query: 65  GRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-----IEDVRREVQIMKHLPKHPNI 119
           GRG   V   C     G +FA K +     R + +      E  RRE  I++ +  HP+I
Sbjct: 103 GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI 162

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
           ++L D+YE  S + +V +L   GELFD +  +   +E+   ++M++++E V   H   ++
Sbjct: 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIV 222

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK------- 232
           HRDLKPEN L     ++  ++  DFG S    PGE+  E+ G+P Y+APE+LK       
Sbjct: 223 HRDLKPENILLD---DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH 279

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             YG EVD+W+ GVIL+ LL G PPFW   +  + + I+     F    W   S   KDL
Sbjct: 280 PGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDL 339

Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQ 317
           + ++L  DP+ RLTAE+ L+HP+ +
Sbjct: 340 ISRLLQVDPEARLTAEQALQHPFFE 364

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  488 bits (1258), Expect = e-172
 Identities = 110/354 (31%), Positives = 174/354 (49%), Gaps = 10/354 (2%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQ 108
           Q +   YD+G ELG G+F +   C + + G ++A K I K++ R     V  E++ REV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           I++ +  HPNI++L D YE+ + V +++EL  GGELFD +  +   +E  A + +K I++
Sbjct: 68  ILRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
            V   H + + H DLKPEN +  +K    P +K IDFGL+     G +F  I G+P ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE++     G E D+WS GVI YILL G  PF  +T+Q     I     DF  + + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE--TVKARLKQFSVMNKL 344
           E AKD ++K+L  + ++RLT +E L HPW+        +   E        K+  V  + 
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRW 306

Query: 345 KK--RALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP 396
           K     + +                 E +   +         R  L    ++  
Sbjct: 307 KLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRRRSST 360

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  484 bits (1249), Expect = e-171
 Identities = 105/311 (33%), Positives = 167/311 (53%), Gaps = 9/311 (2%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRRE 106
             Q +   YD+G ELG G+F +   C + + G ++A K I K++ R     V  E++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65

Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
           V I++ +  H N+++L D YE+ + V +++EL  GGELFD +  +   +E  A + +K I
Sbjct: 66  VSILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           ++ V   H + + H DLKPEN +  +K    P +K IDFGL+     G +F  I G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           +APE++     G E D+WS GVI YILL G  PF  +T+Q     I     DF  + +  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE--TVKARLKQFSVMN 342
            SE AKD ++K+L  + ++RLT +E L HPW+        +   E        ++  V  
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRR 304

Query: 343 KLKKRALQVVA 353
           + K  +  +V+
Sbjct: 305 RWKL-SFSIVS 314

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  482 bits (1242), Expect = e-170
 Identities = 101/272 (37%), Positives = 157/272 (57%), Gaps = 8/272 (2%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
             I   +   R+LG G FG  +L  + ++G +   K+I+K + +  V +E +  E++++K
Sbjct: 18  GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLK 75

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIV 167
            L  HPNI+ + + +ED   ++IVME CEGGEL +RIV+        +E   A +MK ++
Sbjct: 76  SL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134

Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
             +   H Q V+H+DLKPEN LF +    SP+K IDFGL+  F+  E      G+  YMA
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194

Query: 228 PEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           PEV KR+   + D+WSAGV++Y LL G  PF   + + V Q       ++  +  P ++ 
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTP 253

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
            A DL+K+ML  DP++R +A +VL H W + A
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  476 bits (1227), Expect = e-168
 Identities = 101/276 (36%), Positives = 159/276 (57%), Gaps = 6/276 (2%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVDIEDVRREVQI 109
            +   Y++G ELG G+F +   C     G+++A K I K++L   R  V  E++ REV I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           ++ + +HPNI++L D +E+ + V +++EL  GGELFD +  +   TE  A   +K I++ 
Sbjct: 62  LREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120

Query: 170 VQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
           V   H + + H DLKPEN +  +K   +  +K IDFG++     G +F  I G+P ++AP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180

Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           E++     G E D+WS GVI YILL G  PF  ET+Q     I     DF  + +   SE
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
            AKD ++++L  DPK+R+T  + LEH W++  ++  
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  477 bits (1229), Expect = e-167
 Identities = 107/376 (28%), Positives = 173/376 (46%), Gaps = 31/376 (8%)

Query: 10  SSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEF 69
              G + +GK + P     D++        V +   +K+     +   YD+  ELG G F
Sbjct: 8   HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ---GSVYDYYDILEELGSGAF 64

Query: 70  GVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129
           GV + C +   G  F  K I+       +D   V+ E+ IM  L  HP +++L D +ED 
Sbjct: 65  GVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQL-HHPKLINLHDAFEDK 120

Query: 130 SAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188
             + +++E   GGELFDRI A  +  +E      M+   E ++  HE  ++H D+KPEN 
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 180

Query: 189 LFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVI 247
           +   K ++S +K IDFGL+    P E       +  + APE++ R   G   D+W+ GV+
Sbjct: 181 MCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239

Query: 248 LYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTA 307
            Y+LL G+ PF  E +    Q + R   +F  D +  VS  AKD +K +L  +P++RLT 
Sbjct: 240 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 299

Query: 308 EEVLEHPWLQNAKKAPNVSLGETVK---------------------ARLKQFSVMNKLKK 346
            + LEHPWL+         +  +                        R+  FS + K + 
Sbjct: 300 HDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRP 359

Query: 347 RALQVVAEFLSVEEVA 362
           +  Q+   +   +E  
Sbjct: 360 QEYQIYDSYFDRKEAV 375

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  473 bits (1219), Expect = e-166
 Identities = 99/288 (34%), Positives = 152/288 (52%), Gaps = 16/288 (5%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVR--- 104
           S      +Y+    LGRG   V   C      +++A K I        +A +++++R   
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 105 -REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM 163
            +EV I++ +  HPNI+ LKDTYE ++   +V +L + GELFD +  +   +E+    +M
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130

Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
           + ++EV+   H+  ++HRDLKPEN L     +   +K  DFG S    PGE+  E+ G+P
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTP 187

Query: 224 YYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276
            Y+APE+++         YG EVD+WS GVI+Y LL G PPFW   +  + + I+     
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247

Query: 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
           F    W   S+  KDLV + L   P++R TAEE L HP+ Q       
Sbjct: 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  468 bits (1206), Expect = e-164
 Identities = 111/319 (34%), Positives = 157/319 (49%), Gaps = 18/319 (5%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----RTAVDIEDVRRE 106
           + +  +Y + + LG G  G   L  +    +K A K ISK+K      R A    +V  E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
           ++I+K L  HP I+ +K+ ++ +   +IV+EL EGGELFD++V      E         +
Sbjct: 66  IEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
           +  VQ  HE G++HRDLKPEN L ++++E   +K  DFG S           + G+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183

Query: 227 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDP 281
           APEVL       Y   VD WS GVIL+I L G PPF    T+  +   I     +F  + 
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243

Query: 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 341
           W +VSE A DLVKK+L  DPK R T EE L HPWLQ+             +  L + +  
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK------FQDLLSEENES 297

Query: 342 NKLKKRALQVVAEFLSVEE 360
             L +   Q         E
Sbjct: 298 TALPQVLAQPSTSRKRPRE 316

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  467 bits (1203), Expect = e-164
 Identities = 108/328 (32%), Positives = 162/328 (49%), Gaps = 23/328 (7%)

Query: 47  KEPSGQDISIDYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
            EP    ++ DY L ++ LG G  G    C     G+K A K +              R+
Sbjct: 19  PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQ 70

Query: 106 EVQIMKHLPKHPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGH--YTERAA 159
           EV         P+IV + D YE+       + I+ME  EGGELF RI  RG   +TER A
Sbjct: 71  EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130

Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI 219
           A +M+ I   +Q  H   + HRD+KPEN L+ +K++ + LK  DFG +            
Sbjct: 131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTP 189

Query: 220 VGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---- 274
             +PYY+APEVL    Y    D+WS GVI+YILLCG PPF++ T Q ++  + R +    
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249

Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
             F    W +VSE+AK L++ +L  DP +RLT  + + HPW+  +   P   L      +
Sbjct: 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQ 309

Query: 335 LKQFSVMNKLKKRALQVVAEF-LSVEEV 361
            +     +++K+     +A   +  ++V
Sbjct: 310 -EDKDHWDEVKEEMTSALATMRVDYDQV 336

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  472 bits (1215), Expect = e-162
 Identities = 106/398 (26%), Positives = 171/398 (42%), Gaps = 16/398 (4%)

Query: 6   ARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELG 65
                  GK  +GK    + +  D YV         +   +K      +   YD+  ELG
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNY--DNYVFDIWKQYYPQPVEIKH---DHVLDHYDIHEELG 166

Query: 66  RGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125
            G FGV +  T+   G  FA K +         D E VR+E+Q M  L +HP +V+L D 
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVL-RHPTLVNLHDA 222

Query: 126 YEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLK 184
           +EDD+ + ++ E   GGELF+++       +E  A   M+ + + +   HE   +H DLK
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282

Query: 185 PENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWS 243
           PEN +F  K+ +  LK IDFGL+    P +      G+  + APEV + +  G   D+WS
Sbjct: 283 PENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341

Query: 244 AGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQ 303
            GV+ YILL G+ PF  E +    + +     +     +  +SE+ KD ++K+L  DP  
Sbjct: 342 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401

Query: 304 RLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAG 363
           R+T  + LEHPWL         S  +   +R  +     K K  A         +  ++ 
Sbjct: 402 RMTIHQALEHPWLTPGNAPGRDS--QIPSSRYTKIRDSIKTKYDA--WPEPLPPLGRISN 457

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQ 401
                +        +    +      +        ++ 
Sbjct: 458 YSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVG 495

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  461 bits (1188), Expect = e-162
 Identities = 95/305 (31%), Positives = 143/305 (46%), Gaps = 35/305 (11%)

Query: 53  DISIDYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
                Y L  + LG G       C ++   +++A K I K+          V REV+++ 
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLY 65

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
               H N++ L + +E++   ++V E   GG +   I  R H+ E  A+ V++ +   + 
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI--------VGSP 223
             H +G+ HRDLKPEN L  +  + SP+K  DF L    +     + I         GS 
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 224 YYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE---------------T 262
            YMAPEV++        Y    D+WS GVILYILL G PPF                   
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
           +  + ++I     +F    W  +S  AKDL+ K+L  D KQRL+A +VL+HPW+Q    A
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG--CA 303

Query: 323 PNVSL 327
           P  +L
Sbjct: 304 PENTL 308

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  449 bits (1158), Expect = e-156
 Identities = 101/347 (29%), Positives = 171/347 (49%), Gaps = 18/347 (5%)

Query: 6   ARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGR--E 63
               S++    +   +          + A  +   HR+   K+     ++  Y + +   
Sbjct: 40  KEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQ---GAVNSFYTVSKTEI 96

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
           LG G FG  + C +   G K A K I  + ++   D E+V+ E+ +M  L  H N++ L 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQL-DHANLIQLY 152

Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
           D +E  + + +VME  +GGELFDRI+   +  TE      MK I E ++  H+  ++H D
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212

Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
           LKPEN L  N+ ++  +K IDFGL+  ++P E+     G+P ++APEV+  +      D+
Sbjct: 213 LKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271

Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
           WS GVI Y+LL G+ PF  + +      I+    D + + +  +SE AK+ + K+L  + 
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331

Query: 302 KQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 348
             R++A E L+HPWL + K    +S      A+ K+    +      
Sbjct: 332 SWRISASEALKHPWLSDHKLHSRLS------AQKKKNRGSDAQDFVT 372

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  441 bits (1137), Expect = e-152
 Identities = 109/305 (35%), Positives = 155/305 (50%), Gaps = 16/305 (5%)

Query: 28  GDEYVVANGSTVVHRLCVL----KEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEK 83
             E  ++     V     L    +    + +  +Y + + LG G  G   L  +    +K
Sbjct: 103 NSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKK 162

Query: 84  FACKSISKKKL-----RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL 138
            A + ISK+K      R A    +V  E++I+K L  HP I+ +K+ ++ +   +IV+EL
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIVLEL 220

Query: 139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198
            EGGELFD++V      E         ++  VQ  HE G++HRDLKPEN L ++++E   
Sbjct: 221 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 280

Query: 199 LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCG 254
           +K  DFG S           + G+P Y+APEVL       Y   VD WS GVIL+I L G
Sbjct: 281 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

Query: 255 VPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
            PPF    T+  +   I     +F  + W +VSE A DLVKK+L  DPK R T EE L H
Sbjct: 341 YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400

Query: 314 PWLQN 318
           PWLQ+
Sbjct: 401 PWLQD 405

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  436 bits (1124), Expect = e-152
 Identities = 99/319 (31%), Positives = 144/319 (45%), Gaps = 39/319 (12%)

Query: 45  VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
            L+      I       + LG G  G      +    EKFA K +              R
Sbjct: 7   GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKAR 58

Query: 105 REVQIMKHLPKHPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGH--YTERA 158
           REV++     + P+IV + D YE+       + IVME  +GGELF RI  RG   +TER 
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118

Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
           A+ +MK+I E +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG             
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------ 166

Query: 219 IVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSV 274
                   A E     Y    D+WS GVI+YILLCG PPF++        G+   I    
Sbjct: 167 --------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218

Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
            +F    W +VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L  +   +
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 278

Query: 335 LKQFSVMNKLKKRALQVVA 353
             +      +K+     +A
Sbjct: 279 EDKER-WEDVKEEMTSALA 296

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  436 bits (1123), Expect = e-151
 Identities = 99/341 (29%), Positives = 157/341 (46%), Gaps = 53/341 (15%)

Query: 37  STVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR- 95
            +        +  S  ++   Y L   +G+G +GV  +  +       A K ++K K+R 
Sbjct: 7   HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66

Query: 96  -TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH- 153
               D+E ++ EV++MK L  HPNI  L + YED+  + +VMELC GG L D++      
Sbjct: 67  INPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 154 ---------------------------------------YTERAAAAVMKTIVEVVQVCH 174
                                                    E+  + +M+ I   +   H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPE 229
            QG+ HRD+KPENFLF+   +S  +K +DFGLS  F               G+PY++APE
Sbjct: 186 NQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

Query: 230 VLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           VL     +YGP+ D WSAGV+L++LL G  PF    +      ++   + F+   +  +S
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLS 304

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL-QNAKKAPNVS 326
             A+DL+  +LN +  +R  A   L+HPW+ Q + K   +S
Sbjct: 305 PLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  362 bits (931), Expect = e-121
 Identities = 86/424 (20%), Positives = 171/424 (40%), Gaps = 36/424 (8%)

Query: 55  SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
            I +     LG G  G T +   + +    A K I  +            REVQ+++   
Sbjct: 23  KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVC 173
           +HPN++    T +D    +I +ELC    L + +  +   +       +++     +   
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAI--DFGLSVFFRPGEQ----FNEIVGSPYYMA 227
           H   ++HRDLKP N L +       +KA+  DFGL      G       + + G+  ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 228 PEVL----KRNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
           PE+L    K N    VD++SAG + Y ++  G  PF    ++  A  ++ +       P 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANILLGACSLDCLHPE 253

Query: 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMN 342
                 A++L++KM+  DP++R +A+ VL+HP+  + +K   +   + V  R+++ S+  
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK--QLQFFQDVSDRIEKESLDG 311

Query: 343 KLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN----IPEA 398
            + K+  +     + ++    +       D  K        +R  LL+  +N      E 
Sbjct: 312 PIVKQLERGGRAVVKMDWRENITVPL-QTDLRKFRTYKGGSVR-DLLRAMRNKKHHYREL 369

Query: 399 DLQILMEAADVDGDGSLNY--GEFVAVSVH----LKKMANDEHLHKAFSFFDRNRSGFIE 452
             ++      +  D  + Y    F  +  H    ++  +++      +          + 
Sbjct: 370 PAEVRETLGTLP-DDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVT 428

Query: 453 IEEL 456
            + L
Sbjct: 429 PDAL 432

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  338 bits (869), Expect = e-112
 Identities = 83/401 (20%), Positives = 148/401 (36%), Gaps = 61/401 (15%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
           Q +       + LG G  G          G   A K +           +    E++++ 
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLT 63

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY-------TERAAAAVMK 164
               HPN++    +   D  ++I +ELC    L D + ++           E    ++++
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKK----------ESSPLKAIDFGLSVFFRPGE 214
            I   V   H   ++HRDLKP+N L +             E+  +   DFGL      G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 215 Q-----FNEIVGSPYYMAPEVL--------KRNYGPEVDVWSAGVILYILLC-GVPPFWA 260
                  N   G+  + APE+L        KR     +D++S G + Y +L  G  PF  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

Query: 261 ETEQGVAQAIIRSVIDF---KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           +  +     IIR +      K      +   A DL+ +M++ DP +R TA +VL HP   
Sbjct: 243 KYSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300

Query: 318 NAKKAPN----VSLGETVKARLKQFSVMNKLKKRALQVV-----AEFLSVEEVAGLKE-- 366
              K       VS    ++ R    +++ K    +  V+             +  L+   
Sbjct: 301 PKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYR 360

Query: 367 ---AFEMMDTNK--RGKINL-EELRLGLLKGGQNIPEADLQ 401
              + ++MD  +  R K +   +L   + +    +P+    
Sbjct: 361 KYHSSKLMDLLRALRNKYHHFMDLPEDIAELMGPVPDGFYD 401

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  302 bits (776), Expect = 1e-99
 Identities = 63/309 (20%), Positives = 111/309 (35%), Gaps = 43/309 (13%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            + L   LG+G     +       G+ FA K  +         ++   RE +++K L  H
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL-NH 66

Query: 117 PNIVSLKDTYEDDSAVHI--VMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQ 171
            NIV L    E+ +  H   +ME C  G L+  +    +     E     V++ +V  + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 172 VCHEQGVMHRDLKPENFL-FANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
              E G++HR++KP N +    +   S  K  DFG +      EQF  + G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 231 LKR---------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI------ 275
            +R          YG  VD+WS GV  Y    G  PF         + ++  +I      
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 276 ---------------DFKRDPWPKVSENAKDLVK----KMLNPDPKQRLTAEEVLEHPWL 316
                                   +S   + L+      +L  D ++    ++       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 317 QNAKKAPNV 325
              +   + 
Sbjct: 307 ILHRGNSHH 315

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  295 bits (758), Expect = 5e-97
 Identities = 75/294 (25%), Positives = 128/294 (43%), Gaps = 28/294 (9%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y + +++G G     +   +    + +A K ++ ++      ++  R E+  +  L + 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKL-QQ 85

Query: 117 PN--IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            +  I+ L D    D  +++VME C   +L   +  +         +  K ++E V   H
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE---IVGSPYYMAPEVL 231
           + G++H DLKP NFL  +      LK IDFG++   +P          VG+  YM PE +
Sbjct: 145 QHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 232 KRN------------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFK 278
           K                P+ DVWS G ILY +  G  PF     Q     AII    + +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHE 258

Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVK 332
            +      ++ +D++K  L  DPKQR++  E+L HP++Q      N     T +
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 312

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  295 bits (756), Expect = 3e-96
 Identities = 81/328 (24%), Positives = 139/328 (42%), Gaps = 34/328 (10%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y + +++G G     +   +    + +A K ++ ++      ++  R E+  +  L + 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-QQ 66

Query: 117 PN--IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            +  I+ L D    D  +++VME C   +L   +  +         +  K ++E V   H
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVL 231
           + G++H DLKP NFL  +      LK IDFG++   +P       +  VG+  YM PE +
Sbjct: 126 QHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 232 KR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFK 278
           K                P+ DVWS G ILY +  G  PF     Q     AII    + +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHE 239

Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGET------VK 332
            +      ++ +D++K  L  DPKQR++  E+L HP++Q      N     T      V 
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 299

Query: 333 ARLKQFSVMNKLKKRALQVVAEFLSVEE 360
            +L   +  N + K A  +   +   E 
Sbjct: 300 GQLVGLNSPNSILKAAKTLYEHYSGGES 327

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  292 bits (750), Expect = 4e-96
 Identities = 86/264 (32%), Positives = 125/264 (47%), Gaps = 10/264 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y  GR LG+G F   +  +D +  E FA K + K  L      E +  E+ I + L  H
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            ++V     +ED+  V +V+ELC    L +    R   TE  A   ++ IV   Q  H  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVLKRN- 234
            V+HRDLK  N       E   +K  DFGL+      GE+   + G+P Y+APEVL +  
Sbjct: 135 RVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           +  EVDVWS G I+Y LL G PPF     +     I ++  ++       ++  A  L++
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQ 247

Query: 295 KMLNPDPKQRLTAEEVLEHPWLQN 318
           KML  DP  R T  E+L   +  +
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTS 271

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  292 bits (749), Expect = 1e-95
 Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 41/296 (13%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++    LG+G FG      +  +   +A K I   +      +  +  EV ++  L  H
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL-NH 61

Query: 117 PNIVSLKDTYEDDSAVH-------------IVMELCEGGELFDRIVARGHYTERAAAA-V 162
             +V     + +                  I ME CE G L+D I +     +R     +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--------------- 207
            + I+E +   H QG++HRDLKP N       ES  +K  DFGL+               
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 208 VFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG 265
                 +     +G+  Y+A EVL    +Y  ++D++S G+I + ++   P         
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN 236

Query: 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           + + +    I+F  D      +  K +++ +++ DP +R  A  +L   WL    +
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  293 bits (751), Expect = 1e-95
 Identities = 84/263 (31%), Positives = 122/263 (46%), Gaps = 10/263 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y  GR LG+G F   +  +D +  E FA K + K  L      E +  E+ I + L  H
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 100

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            ++V     +ED+  V +V+ELC    L +    R   TE  A   ++ IV   Q  H  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMAPEVLKRN- 234
            V+HRDLK  N       E   +K  DFGL+       +    + G+P Y+APEVL +  
Sbjct: 161 RVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           +  EVDVWS G I+Y LL G PPF     +     I ++  ++       ++  A  L++
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQ 273

Query: 295 KMLNPDPKQRLTAEEVLEHPWLQ 317
           KML  DP  R T  E+L   +  
Sbjct: 274 KMLQTDPTARPTINELLNDEFFT 296

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  293 bits (752), Expect = 4e-95
 Identities = 64/334 (19%), Positives = 116/334 (34%), Gaps = 45/334 (13%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            + L   LG+G     +       G+ FA K  +         ++   RE +++K L  H
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL-NH 66

Query: 117 PNIVSLKDTYEDDSAVHI--VMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQ 171
            NIV L    E+ +  H   +ME C  G L+  +    +     E     V++ +V  + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 172 VCHEQGVMHRDLKPENFL-FANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
              E G++HR++KP N +    +   S  K  DFG +      EQF  + G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 231 LKRN---------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI------ 275
            +R          YG  VD+WS GV  Y    G  PF         + ++  +I      
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 276 ---------------DFKRDPWPKVSENAKDLVK----KMLNPDPKQRLTAEEVLEHPWL 316
                                   +S   + L+      +L  D ++    ++       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 317 QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQ 350
              +   +V      +    +  + +        
Sbjct: 307 ILHRMVIHVF--SLQQMTAHKIYIHSYNTATIFH 338

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  292 bits (748), Expect = 2e-94
 Identities = 81/327 (24%), Positives = 138/327 (42%), Gaps = 34/327 (10%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y + +++G G     +   +    + +A K ++ ++      ++  R E+  +  L + 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-QQ 113

Query: 117 PN--IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            +  I+ L D    D  +++VME C   +L   +  +         +  K ++E V   H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE---IVGSPYYMAPEVL 231
           + G++H DLKP NFL  +      LK IDFG++   +P          VG+  YM PE +
Sbjct: 173 QHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 232 KR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFK 278
           K                P+ DVWS G ILY +  G  PF     Q     AII    + +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHE 286

Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGET------VK 332
            +      ++ +D++K  L  DPKQR++  E+L HP++Q      N     T      V 
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 346

Query: 333 ARLKQFSVMNKLKKRALQVVAEFLSVE 359
            +L   +  N + K A  +   +   E
Sbjct: 347 GQLVGLNSPNSILKAAKTLYEHYSGGE 373

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  285 bits (733), Expect = 1e-93
 Identities = 88/275 (32%), Positives = 145/275 (52%), Gaps = 11/275 (4%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ +G  LG+G F   Y    ++ G + A K I KK +  A  ++ V+ EV+I   L KH
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHE 175
           P+I+ L + +ED + V++V+E+C  GE+   +  R   ++E  A   M  I+  +   H 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVLKRN 234
            G++HRDL   N L         +K  DFGL+     P E+   + G+P Y++PE+  R+
Sbjct: 131 HGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
            +G E DVWS G + Y LL G PPF  +T +     ++ +  D++   +  +S  AKDL+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF--LSIEAKDLI 243

Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLG 328
            ++L  +P  RL+   VL+HP++       +   G
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  279 bits (716), Expect = 3e-91
 Identities = 95/277 (34%), Positives = 150/277 (54%), Gaps = 11/277 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-Y 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +  ++ G+  Y+ PE+++   +
Sbjct: 129 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH 184

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R   +F    +  V+E A+DL+ +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF--VTEGARDLISR 240

Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
           +L  +P QR    EVLEHPW+  N+ K  N    E+ 
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  281 bits (720), Expect = 1e-90
 Identities = 53/310 (17%), Positives = 92/310 (29%), Gaps = 44/310 (14%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL--- 113
              L   L  G+  V +L  DV   E FA K  +     +  ++E +         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 114 --------------------PKHPNIVSLKDTYEDDSAVH--IVMELCEG------GELF 145
                                  P    L    +D +  +  ++M             L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 146 DRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205
              V RG     A   +   ++ +      +G++H    P+N           L   D  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVS 239

Query: 206 LSVFFRPGEQFNEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAET 262
                + G +         Y   E L  +   +   ++ W  G+ +Y + C   PF   T
Sbjct: 240 ALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 263 EQGVAQAIIRSVIDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                     S+     D         + +  K L+ + LN D ++RL   E +E P   
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357

Query: 318 NAKKAPNVSL 327
             +   + SL
Sbjct: 358 QLQNEISSSL 367

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  279 bits (716), Expect = 2e-90
 Identities = 93/292 (31%), Positives = 156/292 (53%), Gaps = 11/292 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +Y L + +G+G F    L   +  G + A K I K +L     ++ + REV+IMK L  H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NH 73

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNIV L +  E +  ++++ME   GGE+FD +VA G   E+ A +  + IV  VQ CH++
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            ++HRDLK EN L         +K  DFG S  F  G + +   G+P Y APE+ + + Y
Sbjct: 134 RIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190

Query: 236 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
            GPEVDVWS GVILY L+ G  PF  +  + + + ++R    ++   +  +S + ++L+K
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCENLLK 246

Query: 295 KMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
           + L  +P +R T E++++  W+    +   +      +  +     ++ +  
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVG 298

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  274 bits (704), Expect = 3e-89
 Identities = 92/279 (32%), Positives = 157/279 (56%), Gaps = 10/279 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D+GR LG+G+FG  YL  +  N    A K + K +L        +RRE++I  HL +H
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ + + + D   +++++E    GEL+  +   G + E+ +A  M+ + + +  CHE+
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRNY 235
            V+HRD+KPEN L   K E   LK  DFG SV   P  +   + G+  Y+ PE++  + +
Sbjct: 134 KVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKTH 189

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+W AGV+ Y  L G+PPF + +     + I+    D K  P+  +S+ +KDL+ K
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLISK 245

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
           +L   P QRL  + V+EHPW++   +     + ++ +++
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  273 bits (700), Expect = 9e-89
 Identities = 98/268 (36%), Positives = 134/268 (50%), Gaps = 10/268 (3%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LG  LG G FG   +      G K A K ++++K+R+   +  ++RE+Q +K   +HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHP 71

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           +I+ L       +   +VME   GGELFD I   G   E  A  + + I+  V  CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRNY- 235
           V+HRDLKPEN L          K  DFGLS     GE      GSP Y APEV+  R Y 
Sbjct: 132 VVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GPEVD+WS GVILY LLCG  PF  E    + + I      F    +  ++ +   L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLMH 244

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
           ML  DP +R T +++ EH W +    + 
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDLPSY 272

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  285 bits (731), Expect = 1e-88
 Identities = 73/312 (23%), Positives = 124/312 (39%), Gaps = 34/312 (10%)

Query: 47  KEPSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
           + PS    +   +++   LG G FG        + GE+ A K   ++   +  + E    
Sbjct: 4   RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCL 61

Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVH------IVMELCEGGELFDRIVARGH---YTE 156
           E+QIMK L  HPN+VS ++  +    +       + ME CEGG+L   +    +     E
Sbjct: 62  EIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120

Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
                ++  I   ++  HE  ++HRDLKPEN +     +    K ID G +     GE  
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180

Query: 217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275
            E VG+  Y+APE+L+ + Y   VD WS G + +  + G  PF    +       +R   
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240

Query: 276 DFKRDPWPKVSEN--------------------AKDLVKKMLNPDPKQRLTAEEVLEHPW 315
           +     +  ++                       +  ++ ML    +QR T  +      
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

Query: 316 LQNAKKAPNVSL 327
            Q      ++ L
Sbjct: 301 FQALDSILSLKL 312

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  269 bits (691), Expect = 2e-87
 Identities = 78/266 (29%), Positives = 124/266 (46%), Gaps = 14/266 (5%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +DL + LG G +G   L  +    E  A K +  K+       E++++E+ I K L  H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-NHE 65

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-KR 233
           + HRD+KPEN L   +     LK  DFGL+  FR   +    N++ G+  Y+APE+L +R
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 234 NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFKRDPWPKVSENAKD 291
            +    VDVWS G++L  +L G  P+   ++                 +PW K+      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           L+ K+L  +P  R+T  ++ +  W  
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYN 266

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  271 bits (694), Expect = 2e-87
 Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 22/289 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED---VRREVQIMKHL 113
           +Y LG  LG+G FG  +    + +  + A K I + ++     + D      EV ++  +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 114 ---PKHPNIVSLKDTYEDDSAVHIVMEL-CEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
                HP ++ L D +E      +V+E      +LFD I  +G   E  +      +V  
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q CH +GV+HRD+K EN L          K IDFG          + +  G+  Y  PE
Sbjct: 152 IQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPE 208

Query: 230 VLK-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
            +    Y      VWS G++LY ++CG  PF  + E      I+ + + F       VS 
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFP----AHVSP 258

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLK 336
           +   L+++ L P P  R + EE+L  PW+Q   +   ++  +   A L 
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLA 307

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  270 bits (692), Expect = 7e-87
 Identities = 84/284 (29%), Positives = 131/284 (46%), Gaps = 22/284 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-----VRREVQIMK 111
            Y     LG G FG  +   D    ++   K I K+K+     IED     V  E+ I+ 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMEL-CEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
            + +H NI+ + D +E+     +VME    G +LF  I       E  A+ + + +V  V
Sbjct: 85  RV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
                + ++HRD+K EN + A       +K IDFG + +   G+ F    G+  Y APEV
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 231 LKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
           L  N Y GPE+++WS GV LY L+    PF    E       + + I     P+  VS+ 
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI---HPPYL-VSKE 250

Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVK 332
              LV  +L P P++R T E+++  PW+       + +  E  +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFR 294

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  269 bits (689), Expect = 1e-86
 Identities = 78/266 (29%), Positives = 124/266 (46%), Gaps = 14/266 (5%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +DL + LG G +G   L  +    E  A K +  K+       E++++E+ I K L  H 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-NHE 65

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-KR 233
           + HRD+KPEN L   +     LK  DFGL+  FR   +    N++ G+  Y+APE+L +R
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 234 NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFKRDPWPKVSENAKD 291
            +    VDVWS G++L  +L G  P+   ++                 +PW K+      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           L+ K+L  +P  R+T  ++ +  W  
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYN 266

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  269 bits (689), Expect = 4e-86
 Identities = 87/264 (32%), Positives = 129/264 (48%), Gaps = 10/264 (3%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           YD  +++G G FGV  L  D    E  A K I +         E+V+RE+   + L +HP
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSL-RHP 76

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           NIV  K+     + + I+ME   GGEL++RI   G ++E  A    + ++  V  CH   
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRNY- 235
           + HRDLK EN L  +   +  LK  DFG S       Q    VG+P Y+APEVL ++ Y 
Sbjct: 137 ICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI--DFKRDPWPKVSENAKDLV 293
           G   DVWS GV LY++L G  PF    E    +  I+ ++   +      ++S     L+
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255

Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQ 317
            ++   DP  R++  E+  H W  
Sbjct: 256 SRIFVADPATRISIPEIKTHSWFL 279

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  269 bits (690), Expect = 5e-86
 Identities = 47/326 (14%), Positives = 97/326 (29%), Gaps = 66/326 (20%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL--- 113
               G  LG+ +       TD   GE F        +   +  I+ ++ EV  ++ L   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 114 ---------------------PKHPNIVSLKDTYEDDSA--VHIVMELCE------GGEL 144
                                P+   ++ ++    D        +    +      G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 145 FDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204
                        A   +   ++ ++   H  G++H  L+P + +     +   +    F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGF 250

Query: 205 GLSVFFRPGEQFNEIVGSPYYMAPEVLKRN------------YGPEVDVWSAGVILYILL 252
              V             S  +  PE+  R                  D W+ G+++Y + 
Sbjct: 251 EHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 253 CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
           C   P   +   G ++ I RS  +        + +  + L++  L    + RL   + +E
Sbjct: 308 CADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAME 359

Query: 313 HPWLQNAKKAPNVSLGETVKARLKQF 338
            P  +         L   + A L  +
Sbjct: 360 TPEYEQ--------LRTELSAALPLY 377

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  265 bits (679), Expect = 3e-85
 Identities = 85/290 (29%), Positives = 139/290 (47%), Gaps = 37/290 (12%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD------------------ 99
           Y L  E+G+G +GV  L  + N+   +A K +SKKKL                       
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 100 -----IEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI--VMELCEGGELFDRIVARG 152
                IE V +E+ I+K L  HPN+V L +  +D +  H+  V EL   G + + +    
Sbjct: 75  QPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132

Query: 153 HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
             +E  A    + +++ ++  H Q ++HRD+KP N L         +K  DFG+S  F+ 
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEFKG 189

Query: 213 GEQF-NEIVGSPYYMAPEVL---KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA 267
            +   +  VG+P +MAPE L   ++ + G  +DVW+ GV LY  + G  PF  E    + 
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249

Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
             I       +    P ++E+ KDL+ +ML+ +P+ R+   E+  HPW+ 
Sbjct: 250 SKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  266 bits (682), Expect = 3e-85
 Identities = 103/330 (31%), Positives = 161/330 (48%), Gaps = 13/330 (3%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y +   LG G FG   L T     +K A K IS++ L+ +     V RE+  +K L +HP
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHP 69

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           +I+ L D     + + +V+E   GGELFD IV +   TE       + I+  ++ CH   
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY- 235
           ++HRDLKPEN L  +      +K  DFGLS     G       GSP Y APEV+  + Y 
Sbjct: 129 IVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GPEVDVWS G++LY++L G  PF  E    + + +      +    +  +S  A+ L+++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIRR 241

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARL--KQFSVMNKLKKRALQVVA 353
           M+  DP QR+T +E+   PW           + E   +    +  S + +    +   + 
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIV 301

Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEE 383
           E L  +E   +KEA+ ++  N+  +  LE 
Sbjct: 302 EALRSDENNEVKEAYNLLHENQVIQEKLEH 331

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  270 bits (693), Expect = 3e-85
 Identities = 109/337 (32%), Positives = 159/337 (47%), Gaps = 18/337 (5%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LG  LG G FG   +      G K A K ++++K+R+   +  +RRE+Q +K   +HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHP 76

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           +I+ L       S + +VME   GGELFD I   G   E+ +  + + I+  V  CH   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRNY- 235
           V+HRDLKPEN L          K  DFGLS     GE      GSP Y APEV+  R Y 
Sbjct: 137 VVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
           GPEVD+WS+GVILY LLCG  PF  +    + + I      F    +  ++ +   L+K 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLKH 249

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ------FSVMNKLKKRAL 349
           ML  DP +R T +++ EH W +  +  P     E                V  K +    
Sbjct: 250 MLQVDPMKRATIKDIREHEWFK--QDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEE 307

Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRL 386
           +V++   +      L  A+ ++  N+R     ++  L
Sbjct: 308 EVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYL 344

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197

 Score =  260 bits (668), Expect = 3e-85
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 3/193 (1%)

Query: 308 EEVLEHPWL-QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKE 366
                H    +N     +V L  T+   LK F   N+LKK AL ++A+ L   E+  L+ 
Sbjct: 2   HHHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRN 61

Query: 367 AFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH 426
            F  +D +  G ++ +E+  GL K G      D+  ++   D +  G ++Y +F+A ++ 
Sbjct: 62  IFIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATID 121

Query: 427 LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV--DTSGEDVINAIMHDVDTDKD 484
            +     E     F FFD + +G I +EEL+     +   +   +  I++++ +VD + D
Sbjct: 122 KQTYLKKEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLNGD 181

Query: 485 GRISYEEFAVMMK 497
           G I + EF +MM 
Sbjct: 182 GEIDFHEFMLMMS 194

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  264 bits (678), Expect = 5e-85
 Identities = 82/269 (30%), Positives = 129/269 (47%), Gaps = 20/269 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED---VRREVQIMKHL 113
            Y +G  LG G FG  Y    V++    A K + K ++    ++ +   V  EV ++K +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 114 P-KHPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
                 ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
            CH  GV+HRD+K EN L    +    LK IDFG     +    + +  G+  Y  PE +
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWI 220

Query: 232 K-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           +   Y G    VWS G++LY ++CG  PF  + E      IIR  + F+     +VS   
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVSSEC 270

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           + L++  L   P  R T EE+  HPW+Q+
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  265 bits (678), Expect = 1e-84
 Identities = 67/335 (20%), Positives = 122/335 (36%), Gaps = 50/335 (14%)

Query: 47  KEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI----- 100
           K    +D  I DY + R L +G+F    LC    + + +A K   K  L    D      
Sbjct: 21  KYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNN 78

Query: 101 ---------EDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR 151
                    +D + E+QI+  + K+   ++ +    +   V+I+ E  E   +       
Sbjct: 79  DKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137

Query: 152 GH--------YTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAI 202
                        +    ++K+++      H +  + HRD+KP N L         +K  
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKLS 194

Query: 203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFW 259
           DFG S +    ++     G+  +M PE         G +VD+WS G+ LY++   V PF 
Sbjct: 195 DFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

Query: 260 AETEQ----------------GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQ 303
            +                        +              +S    D +K  L  +P +
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313

Query: 304 RLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQF 338
           R+T+E+ L+H WL +          + +  + K+ 
Sbjct: 314 RITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  262 bits (672), Expect = 3e-84
 Identities = 72/263 (27%), Positives = 110/263 (41%), Gaps = 13/263 (4%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            +     LG G +G  +      +G  +A K  S    R   D      EV   + + +H
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHE 175
           P  V L+  +E+   +++  ELC G  L     A G    E      ++  +  +   H 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNY 235
           QG++H D+KP N     +      K  DFGL V            G P YMAPE+L+ +Y
Sbjct: 176 QGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSY 232

Query: 236 GPEVDVWSAGVILYILLCGVP-PFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           G   DV+S G+ +  + C +  P   E  Q + Q  +             +S   + ++ 
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSVLV 286

Query: 295 KMLNPDPKQRLTAEEVLEHPWLQ 317
            ML PDPK R TAE +L  P L+
Sbjct: 287 MMLEPDPKLRATAEALLALPVLR 309

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  256 bits (656), Expect = 3e-82
 Identities = 84/277 (30%), Positives = 134/277 (48%), Gaps = 25/277 (9%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++   +G G +G        ++G+    K +    + T  + + +  EV +++ L KH
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KH 64

Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVV 170
           PNIV   D   D  ++ ++IVME CEGG+L   I      R +  E     VM  +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 171 QVCHEQG-----VMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSP 223
           + CH +      V+HRDLKP N FL   +     +K  DFGL+        F    VG+P
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN----VKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 224 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
           YYM+PE +   +Y  + D+WS G +LY L   +PPF A +++ +A  I            
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----RRI 236

Query: 283 PKV-SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           P   S+   +++ +MLN     R + EE+LE+P +  
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191

 Score =  251 bits (644), Expect = 1e-81
 Identities = 52/192 (27%), Positives = 99/192 (51%), Gaps = 7/192 (3%)

Query: 311 LEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEM 370
           + H    ++ +      G  V    K + ++ K +K A+ ++A+  +  +V  LK  F +
Sbjct: 1   MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60

Query: 371 MDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM 430
           +D + +G I  E+L+ GL K G  +P  +  +L++  D DG G ++Y EF+A ++  K++
Sbjct: 61  LDEDGKGYITKEQLKKGLEKDGLKLPY-NFDLLLDQIDSDGSGKIDYTEFIAAALDRKQL 119

Query: 431 ANDEHLHKAFSFFDRNRSGFIEIEELRNAL-----NDEVDTSGEDVINAIMHDVDTDKDG 485
            + + ++ AF  FD +  G I   EL + L        +     + +  ++ DVD + DG
Sbjct: 120 -SKKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKNNDG 178

Query: 486 RISYEEFAVMMK 497
           +I + EF+ MMK
Sbjct: 179 KIDFHEFSEMMK 190

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  255 bits (654), Expect = 5e-81
 Identities = 71/271 (26%), Positives = 139/271 (51%), Gaps = 16/271 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y   +++G G FG   L     +G ++  K I+  ++ ++ + E+ RREV ++ ++ KH
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-KH 82

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCH 174
           PNIV  ++++E++ +++IVM+ CEGG+LF RI A+    + E         I   ++  H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 175 EQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMAPEVLK 232
           ++ ++HRD+K +N FL  +      ++  DFG++       +     +G+PYY++PE+ +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGT----VQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198

Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVSENAK 290
              Y  + D+W+ G +LY L      F A + + +   II         P     S + +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLR 254

Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
            LV ++   +P+ R +   +LE  ++    +
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  248 bits (634), Expect = 2e-78
 Identities = 65/298 (21%), Positives = 111/298 (37%), Gaps = 34/298 (11%)

Query: 48  EPSGQDISI---DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
              G  + I    Y   ++LG G F    L   +++G  +A K I   + +   D E+ +
Sbjct: 18  YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQ 74

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVAR----GHYTE 156
           RE  + +    HPNI+ L      +        +++   + G L++ I          TE
Sbjct: 75  READMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133

Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG--- 213
                ++  I   ++  H +G  HRDLKP N L  ++ +      +D G           
Sbjct: 134 DQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQACIHVEG 190

Query: 214 -------EQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAET 262
                  + +     +  Y APE+             DVWS G +LY ++ G  P+    
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW-LQNA 319
           ++G + A+            P+ S     L+  M+  DP QR     +L     LQ  
Sbjct: 251 QKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  245 bits (628), Expect = 1e-77
 Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 20/271 (7%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-VRREVQIMKHLPKH 116
           Y +G  LG G +G      D     + A K + KKKLR   + E  V++E+Q+++ L +H
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RH 65

Query: 117 PNIVSLKDTYEDDSAVHI--VMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
            N++ L D   ++    +  VME C  G  E+ D +     +    A      +++ ++ 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEY 124

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFNEIVGSPYYMAPE 229
            H QG++H+D+KP N L         LK    G++     F   +      GSP +  PE
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 230 VL--KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           +      + G +VD+WSAGV LY +  G+ PF  +    + + I +    +         
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--CG 237

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
               DL+K ML  +P +R +  ++ +H W +
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  240 bits (614), Expect = 7e-76
 Identities = 64/284 (22%), Positives = 109/284 (38%), Gaps = 38/284 (13%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+     +G G FG  +      +G+ +  K +           E   REV+ +  L  H
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL-DH 63

Query: 117 PNIVSLKDTYEDDSA----------------VHIVMELCEGGELFDRIVAR--GHYTERA 158
            NIV     ++                    + I ME C+ G L   I  R      +  
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
           A  + + I + V   H + +++RDLKP N    + K+   +K  DFGL    +   +   
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKNDGKRTR 180

Query: 219 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF 277
             G+  YM+PE +  ++YG EVD+++ G+IL  LL                 +   +I  
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGIIS- 237

Query: 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                    +  K L++K+L+  P+ R    E+L    +     
Sbjct: 238 -----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  240 bits (614), Expect = 1e-75
 Identities = 76/278 (27%), Positives = 131/278 (47%), Gaps = 16/278 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           ++ + +++GRG+F   Y    + +G   A K +    L  A    D  +E+ ++K L  H
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 91

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----HYTERAAAAVMKTIVEVVQV 172
           PN++    ++ +D+ ++IV+EL + G+L   I           ER        +   ++ 
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 173 CHEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEV 230
            H + VMHRD+KP N F+ A       +K  D GL   F       + +VG+PYYM+PE 
Sbjct: 152 MHSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVIDFKRDPWPKVSE 287
           +  N Y  + D+WS G +LY +     PF+ +      + + I +   D+   P    SE
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 265

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
             + LV   +NPDP++R     V +     +A  A ++
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score =  227 bits (580), Expect = 4e-72
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 14/187 (7%)

Query: 329 ETVKARLKQFSVMNKLKKRALQVVAEFLS-VEEVAGLKEAFEMMDTNKRGKINLEELRLG 387
                 +K+F    KL + A+  +   L+ +EE   L + F  +D N  G+++ +EL  G
Sbjct: 6   TGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEG 65

Query: 388 LLKG-----------GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHL 436
             K              +  EA++  ++++ D D +G + Y EFV V +  + + + E L
Sbjct: 66  YRKLMQWKGDTVSDLDSSQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERL 125

Query: 437 HKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
             AF  FD + SG I  EEL            ++  + ++ + D + DG + +EEF  MM
Sbjct: 126 LAAFQQFDSDGSGKITNEELGRLFGVT--EVDDETWHQVLQECDKNNDGEVDFEEFVEMM 183

Query: 497 KAGTDWR 503
           +   D +
Sbjct: 184 QKICDVK 190

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  230 bits (589), Expect = 5e-72
 Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 40/300 (13%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++  + LGRG FGV +   +  +   +A K I        +  E V REV+ +  L +H
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EH 62

Query: 117 PNIVSLKDTYEDDSA------------VHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
           P IV   + + + +             ++I M+LC    L D +  R    ER  +  + 
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 165 T---IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-------------V 208
               I E V+  H +G+MHRDLKP N  F        +K  DFGL               
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLT 179

Query: 209 FFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 267
                 +    VG+  YM+PE +   +Y  +VD++S G+IL+ LL    PF  + E+   
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236

Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
              +R+ + F      +       +V+ ML+P P +R  A  ++E+   ++        L
Sbjct: 237 LTDVRN-LKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166

 Score =  223 bits (571), Expect = 4e-71
 Identities = 80/165 (48%), Positives = 114/165 (69%), Gaps = 2/165 (1%)

Query: 336 KQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNI 395
           KQFS MNK KK AL+V+AE LS EE+AGLKE F M+D +K G+I  EEL+ GL + G N+
Sbjct: 1   KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANL 60

Query: 396 PEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEE 455
            E+++  LM+AADVD  G+++Y EF+A ++HL K+  ++HL  AF++FD++ SG+I  +E
Sbjct: 61  KESEILDLMQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFAAFTYFDKDGSGYITPDE 120

Query: 456 LRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT 500
           L+ A  +      +  I  +M DVD D DGRI Y EF  MM+ G+
Sbjct: 121 LQQACEE--FGVEDVRIEELMRDVDQDNDGRIDYNEFVAMMQKGS 163

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  228 bits (583), Expect = 1e-70
 Identities = 75/308 (24%), Positives = 116/308 (37%), Gaps = 44/308 (14%)

Query: 51  GQDISID---YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           GQ + +      + R L  G F   Y   DV +G ++A K +   +         + +EV
Sbjct: 20  GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEV 76

Query: 108 QIMKHLPKHPNIVSLKDTYEDDSA--------VHIVMELCEGG--ELFDRIVARGHYTER 157
             MK L  HPNIV                     ++ ELC+G   E   ++ +RG  +  
Sbjct: 77  CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136

Query: 158 AAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-- 213
               +       VQ  H Q   ++HRDLK EN L +N+     +K  DFG +        
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPD 193

Query: 214 -----------EQFNEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
                      E+      +P Y  PE++        G + D+W+ G ILY+L     PF
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

Query: 259 WAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
               E G    I+         P          L++ ML  +P++RL+  EV+       
Sbjct: 254 ----EDGAKLRIVNGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307

Query: 319 AKKAPNVS 326
           A +  N  
Sbjct: 308 AARNVNPK 315

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score =  221 bits (565), Expect = 3e-68
 Identities = 46/248 (18%), Positives = 97/248 (39%), Gaps = 18/248 (7%)

Query: 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 341
             ++++  ++   K+   D K +       E    + A++    + G+    + +  S++
Sbjct: 43  EAQIAQKEQEQKAKLAEYDQKVQN------EFDARERAEREREAARGDAAAEKQRLASLL 96

Query: 342 NKLKKRA-----LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP 396
             L+  A     L+     LS E+   L++ F     +  GK + ++L+  L K    IP
Sbjct: 97  KDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIP 156

Query: 397 EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEEL 456
           E  L+ L    + D  G ++Y   VAV+  L        L   F   D N +G +  +E 
Sbjct: 157 EGPLKKLFVMVENDTKGRMSYITLVAVANDLAA------LVADFRKIDTNSNGTLSRKEF 210

Query: 457 RNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNS 516
           R      +    + V +A+    D D+   + + E+  +       R        ++   
Sbjct: 211 REHFV-RLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFADFDKSGQ 269

Query: 517 ISLKLMRE 524
           +S + +++
Sbjct: 270 LSKEEVQK 277

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score =  138 bits (350), Expect = 5e-37
 Identities = 33/145 (22%), Positives = 62/145 (42%), Gaps = 9/145 (6%)

Query: 354 EFLSV-EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
             ++V  ++A L   F  +DTN  G ++ +E R   ++ G +        L   AD D  
Sbjct: 179 TLVAVANDLAALVADFRKIDTNSNGTLSRKEFREHFVRLGFDKKS-VQDALFRYADEDES 237

Query: 413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL-NDEVDTSGEDV 471
             + + E+V +            L   ++F D ++SG +  EE++  L +  +  S    
Sbjct: 238 DDVGFSEYVHL------GLCLLVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKK 291

Query: 472 INAIMHDVDTDKDGRISYEEFAVMM 496
                  VD D    +SY+EF +++
Sbjct: 292 FEHQFSVVDVDDSKSLSYQEFVMLV 316

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 16/67 (23%), Positives = 29/67 (43%), Gaps = 1/67 (1%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAADVDGDGSLNYGEFVA 422
           L+  +   D +K G+++ EE++  L             +      DVD   SL+Y EFV 
Sbjct: 255 LRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVM 314

Query: 423 VSVHLKK 429
           + + +  
Sbjct: 315 LVLLMFH 321

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  219 bits (559), Expect = 1e-67
 Identities = 65/291 (22%), Positives = 118/291 (40%), Gaps = 32/291 (10%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
             + ++    ++G GEFG  + C    +G  +A K  SKK L  +VD ++  REV     
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAV 66

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVE 168
           L +H ++V     + +D  + I  E C GG L D I        ++ E     ++  +  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI----------------DFGLSVFFRP 212
            ++  H   ++H D+KP N   +     +                     D G       
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TR 183

Query: 213 GEQFNEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 270
                   G   ++A EVL+ N  + P+ D+++  + +       P        G     
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP----RNGDQWHE 239

Query: 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           IR      R P   +S+   +L+K M++PDP++R +A  +++H  L +A +
Sbjct: 240 IRQ-GRLPRIP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  221 bits (565), Expect = 3e-67
 Identities = 44/303 (14%), Positives = 91/303 (30%), Gaps = 55/303 (18%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL---- 113
              G  LG+ +       TD   GE F        +   +  I+ ++ EV  ++ L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 114 --------------------PKHPNIVSLKDTYEDDSAVH--IVMELCEG------GELF 145
                               P+   ++ ++    D   +    +    +         L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 146 DRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205
                       A   +   ++ ++   H  G++H  L+P + +     +   +    F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFE 256

Query: 206 LSVFFRPGE----QFNEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCGV 255
             V  R G             P   A  +L              D W+ G+ +Y + C  
Sbjct: 257 HLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

Query: 256 PPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
            P   +   G ++ I RS  +        + +  + L++  L    + RL   + +E P 
Sbjct: 315 LPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366

Query: 316 LQN 318
            + 
Sbjct: 367 YEQ 369

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188

 Score =  210 bits (537), Expect = 8e-66
 Identities = 69/178 (38%), Positives = 112/178 (62%), Gaps = 3/178 (1%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           AE LS EE+ GLKE F+M+DT+  G I  +EL+ GL + G  + E++++ LM+AAD+D  
Sbjct: 1   AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKS 60

Query: 413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVI 472
           G+++YGEF+A +VHL K+  +E+L  AFS+FD++ SG+I ++E++ A  D      +  I
Sbjct: 61  GTIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQACKD--FGLDDIHI 118

Query: 473 NAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFN-SISLKLMREEGLQL 529
           + ++ ++D D DG+I Y EFA MM+         R+  R+  N   +L L+     Q+
Sbjct: 119 DDMIKEIDQDNDGQIDYGEFAAMMRKRKGNGGIGRRTMRKTLNLRDALGLVDNGSNQV 176

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 25/118 (21%), Positives = 45/118 (38%), Gaps = 10/118 (8%)

Query: 349 LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAAD 408
           +        +E    L  AF   D +  G I L+E++      G  + +  +  +++  D
Sbjct: 69  IAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEID 126

Query: 409 VDGDGSLNYGEFVAV--------SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
            D DG ++YGEF A+         +  + M    +L  A    D   +  IE     +
Sbjct: 127 QDNDGQIDYGEFAAMMRKRKGNGGIGRRTMRKTLNLRDALGLVDNGSNQVIEGYFKHH 184

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score =  205 bits (525), Expect = 3e-64
 Identities = 41/182 (22%), Positives = 84/182 (46%), Gaps = 15/182 (8%)

Query: 327 LGETVKARLKQFSVMNKLKKRALQVVAEFLSV--EEVAGLKEAFEMMDTNKRGKINLEEL 384
           +   V   +K +   + ++   + ++A  LSV    +  + E F  +DTN  G ++  E+
Sbjct: 2   ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61

Query: 385 RLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFD 444
              L   G    + D+  +++A D++  G++ Y EF+A     K +     L  AF+  D
Sbjct: 62  YTVLASVGI--KKWDINRILQALDINDRGNITYTEFMAGCYRWKNI-ESTFLKAAFNKID 118

Query: 445 RNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDG--------RISYEEFAVMM 496
           ++  G+I   ++ + ++D+V     + I+     V + K G        +IS++EF   M
Sbjct: 119 KDEDGYISKSDIVSLVHDKVLD--NNDIDNFFLSVHSIKKGIPREHIINKISFQEFKDYM 176

Query: 497 KA 498
            +
Sbjct: 177 LS 178

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  209 bits (534), Expect = 3e-63
 Identities = 54/314 (17%), Positives = 102/314 (32%), Gaps = 38/314 (12%)

Query: 57  DYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
              +   LG G F   Y  T     D  N +KF  K           +     + ++ +K
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLK 122

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERA-----AAAVMKTI 166
                   +     +   +   +V EL   G L + I    +  E+        +    +
Sbjct: 123 PS-MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSP--------LKAIDFGLSV---FFRPGEQ 215
           + +++  H+  ++H D+KP+NF+  N              L  ID G S+    F  G  
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241

Query: 216 FNEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
           F     +  +   E+L  + +  ++D +     +Y +L G                +   
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
           +    D W        +    MLN      L + ++L        KK         ++A 
Sbjct: 302 L-PHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL----KKVFQQHYTNKIRAL 349

Query: 335 LKQFSVMNKLKKRA 348
             +  V+    KR+
Sbjct: 350 RNRLIVLLLECKRS 363

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204

 Score =  198 bits (506), Expect = 4e-61
 Identities = 40/185 (21%), Positives = 79/185 (42%), Gaps = 16/185 (8%)

Query: 321 KAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKIN 380
             P   LG          + M KL+ + L   A       + GL   F  +D +    ++
Sbjct: 4   LVPRGPLGS---HMDAVDATMEKLRAQCLSRGAS-----GIQGLARFFRQLDRDGSRSLD 55

Query: 381 LEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAF 440
            +E R GL K G  + +A+ + +    D +G G+L+  EF+         A +  +  AF
Sbjct: 56  ADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIAAAF 115

Query: 441 SFFDRNRSGFIEIEELRNALNDEV-------DTSGEDVINAIMHDVD-TDKDGRISYEEF 492
           +  DR+  G + +++LR   +          + + ++V+   + + D ++KDG+++  EF
Sbjct: 116 AKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEF 175

Query: 493 AVMMK 497
                
Sbjct: 176 QDYYS 180

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  200 bits (510), Expect = 4e-60
 Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 24/272 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 89

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AAVMKTIVEVVQVC 173
           P  V L  T++DD  ++  +   + GEL   I   G + E       A    IV  ++  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYL 146

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS---VFFRPGEQFNEIVGSPYYMAPEV 230
           H +G++HRDLKPEN L         ++  DFG +          + N  VG+  Y++PE+
Sbjct: 147 HGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           L         D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF      K    A
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKA 259

Query: 290 KDLVKKMLNPDPKQRLT------AEEVLEHPW 315
           +DLV+K+L  D  +RL          +  HP+
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  196 bits (500), Expect = 2e-58
 Identities = 67/326 (20%), Positives = 118/326 (36%), Gaps = 26/326 (7%)

Query: 5   CARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGREL 64
            +   + S   AK ++  P           N   ++       +   ++          +
Sbjct: 14  ASLAKTWSSGSAKLQRLGPET-------EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRV 66

Query: 65  GRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD 124
           GRG FG  +   D   G + A K +  +  R          E+     L   P IV L  
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGL-SSPRIVPLYG 117

Query: 125 TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLK 184
              +   V+I MEL EGG L   I   G   E  A   +   +E ++  H + ++H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177

Query: 185 PENFLFANKKESSPLKAIDFGLS------VFFRPGEQFNEIVGSPYYMAPEVLKRN-YGP 237
            +N L ++    S     DFG +         +     + I G+  +MAPEV+       
Sbjct: 178 ADNVLLSSD--GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235

Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
           +VD+WS+  ++  +L G  P+       +   I       +  P P  +      +++ L
Sbjct: 236 KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPLTAQAIQEGL 294

Query: 298 NPDPKQRLTAEEVLEHPWLQNAKKAP 323
             +P  R +A E+         +   
Sbjct: 295 RKEPVHRASAMELRRKVGKALQEVGG 320

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  194 bits (494), Expect = 4e-58
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 25/289 (8%)

Query: 48  EPSGQDISIDYDLGRE-----LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED 102
           +     +  DY+         LG+G +G+ Y   D++N  + A K I     R +   + 
Sbjct: 9   DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQP 65

Query: 103 VRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG---HYTERAA 159
           +  E+ + KHL KH NIV    ++ ++  + I ME   GG L   + ++       E+  
Sbjct: 66  LHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124

Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNE 218
               K I+E ++  H+  ++HRD+K +N L      S  LK  DFG S            
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTET 182

Query: 219 IVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275
             G+  YMAPE++ +    YG   D+WS G  +  +  G PP + E  +  A A+ +  +
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP-FYELGEPQA-AMFK--V 238

Query: 276 DFKRDPWP---KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
              +        +S  AK  + K   PDP +R  A ++L   +L+ + K
Sbjct: 239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  190 bits (485), Expect = 5e-56
 Identities = 78/279 (27%), Positives = 135/279 (48%), Gaps = 23/279 (8%)

Query: 47  KEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
           + PS     +  +D  + LG G FG   L     +G  +A K + K+K+     IE    
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN 90

Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AAV 162
           E +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A   AA 
Sbjct: 91  EKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA- 148

Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
              IV   +  H   +++RDLKPEN L   +     ++  DFG +   R   +   + G+
Sbjct: 149 --QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAK--RVKGRTWTLCGT 201

Query: 223 PYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281
           P  +APE++    Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F    
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH- 260

Query: 282 WPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
               S + KDL++ +L  D  +R         ++  H W
Sbjct: 261 ---FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  187 bits (476), Expect = 2e-55
 Identities = 67/267 (25%), Positives = 123/267 (46%), Gaps = 16/267 (5%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
              E+GRG F   Y   D     + A   +  +KL T  + +  + E +++K L +HPNI
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNI 87

Query: 120 V----SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           V    S + T +    + +V EL   G L   +        +   +  + I++ +Q  H 
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 176 QG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           +   ++HRDLK +N +F      S +K  D GL+   R       ++G+P +MAPE+ + 
Sbjct: 148 RTPPIIHRDLKCDN-IFITGPTGS-VKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE 204

Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI-DFKRDPWPKV-SENAKD 291
            Y   VDV++ G+ +  +     P ++E +   A  I R V    K   + KV     K+
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP-YSECQN--AAQIYRRVTSGVKPASFDKVAIPEVKE 261

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           +++  +  +  +R + +++L H + Q 
Sbjct: 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  186 bits (474), Expect = 4e-54
 Identities = 70/270 (25%), Positives = 131/270 (48%), Gaps = 16/270 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            +++ R +G+G FG   +    +  + +A K ++K+K     ++ +V +E+QIM+ L +H
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EH 74

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V+L  +++D+  + +V++L  GG+L   +    H+ E      +  +V  +     Q
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-- 234
            ++HRD+KP+N L     E   +   DF ++       Q   + G+  YMAPE+      
Sbjct: 135 RIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191

Query: 235 --YGPEVDVWSAGVILYILLCGVPPFW---AETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
             Y   VD WS GV  Y LL G  P+    + + + +      +V+ +        S+  
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEM 247

Query: 290 KDLVKKMLNPDPKQRL-TAEEVLEHPWLQN 318
             L+KK+L P+P QR     +V   P++ +
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  186 bits (474), Expect = 8e-54
 Identities = 82/269 (30%), Positives = 126/269 (46%), Gaps = 16/269 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++ + +GRG FG   L    +  + +A K +SK ++    D      E  IM      
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NS 128

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++DD  +++VME   GG+L   +++     E+ A      +V  +   H  
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSM 187

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKR- 233
           G +HRD+KP+N L     +S  LK  DFG  +          +  VG+P Y++PEVLK  
Sbjct: 188 GFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 234 ----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
                YG E D WS GV LY +L G  PF+A++  G    I+             +S+ A
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304

Query: 290 KDLVKKMLNPDPKQRLT---AEEVLEHPW 315
           K+L+   L  D + RL     EE+  H +
Sbjct: 305 KNLICAFLT-DREVRLGRNGVEEIKRHLF 332

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  183 bits (466), Expect = 1e-53
 Identities = 75/268 (27%), Positives = 128/268 (47%), Gaps = 22/268 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ + R LG G FG  +L    +NG  +A K + K+ +     +E    E  ++  +  H
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-TH 65

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AAVMKTIVEVVQVC 173
           P I+ +  T++D   + ++M+  EGGELF  +     +    A   AA    +   ++  
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EVCLALEYL 122

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
           H + +++RDLKPEN L         +K  DFG +      +    + G+P Y+APEV+  
Sbjct: 123 HSKDIIYRDLKPENILLDKNGH---IKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177

Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
             Y   +D WS G+++Y +L G  PF+        + I+ + + F        +E+ KDL
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----FNEDVKDL 233

Query: 293 VKKMLNPDPKQRL-----TAEEVLEHPW 315
           + +++  D  QRL       E+V  HPW
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  182 bits (465), Expect = 1e-53
 Identities = 89/334 (26%), Positives = 156/334 (46%), Gaps = 23/334 (6%)

Query: 6   ARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELG 65
               S      +    +       E   A    VV            D  +  D   ++G
Sbjct: 5   HHHSSGVDLGTENLYFQS-GVVTHEQFKAALRMVV---------DQGDPRLLLDSYVKIG 54

Query: 66  RGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125
            G  G+  L  + ++G + A K +    LR     E +  EV IM+   +H N+V +  +
Sbjct: 55  EGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKS 110

Query: 126 YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP 185
           Y     + ++ME  +GG L D IV++    E   A V + +++ +   H QGV+HRD+K 
Sbjct: 111 YLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169

Query: 186 ENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWS 243
           ++ L         +K  DFG      +   +   +VG+PY+MAPEV+ R+ Y  EVD+WS
Sbjct: 170 DSILLTLDGR---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWS 226

Query: 244 AGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQ 303
            G+++  ++ G PP+++++     + +  S     ++   KVS   +D +++ML  DP++
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS-HKVSPVLRDFLERMLVRDPQE 285

Query: 304 RLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
           R TA+E+L+HP+L          L   ++   KQ
Sbjct: 286 RATAQELLDHPFLLQTG--LPECLVPLIQLYRKQ 317

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  182 bits (463), Expect = 3e-53
 Identities = 72/334 (21%), Positives = 119/334 (35%), Gaps = 81/334 (24%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI-------SKKKLRTAVDI--------- 100
           D++  + +GRG FGV +   +  +   +A K I       +++K+   V           
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 101 ---------------------------------------EDVRREVQIMKHLPKHPNIVS 121
                                                  +    +++ M       N V 
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF-STKNTVG 125

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV---MKTIVEVVQVCHEQGV 178
                     ++I M+LC    L D +  R    +R           I E V+  H +G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLS-------------VFFRPGEQFNEIVGSPYY 225
           MHRDLKP N  F        +K  DFGL                          VG+  Y
Sbjct: 186 MHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 226 MAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           M+PE +   NY  +VD++S G+IL+ LL     F  + E+      +R+ + F      K
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN-LKFPLLFTQK 298

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                  +V+ ML+P P +R  A +++E+   +N
Sbjct: 299 -YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  180 bits (460), Expect = 5e-53
 Identities = 87/286 (30%), Positives = 143/286 (50%), Gaps = 13/286 (4%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
           S  D    Y    ++G+G  G  Y   DV  G++ A + +    L+     E +  E+ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILV 70

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           M+   K+PNIV+  D+Y     + +VME   GG L D +V      E   AAV +  ++ 
Sbjct: 71  MREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQA 128

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAP 228
           ++  H   V+HRD+K +N L         +K  DFG          + + +VG+PY+MAP
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           EV+ R  YGP+VD+WS G++   ++ G PP+  E        I  +     ++P  K+S 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSA 244

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
             +D + + L  D ++R +A+E+L+H +L+ AK  P  SL   + A
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK--PLSSLTPLIAA 288

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  185 bits (472), Expect = 3e-52
 Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 13/288 (4%)

Query: 37  STVVHRLCVLKEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR 95
           S   +R    K    Q ++   +   R LG+G FG    C     G+ +ACK + KK+++
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223

Query: 96  TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI--VARGH 153
                     E QI++ +     +VSL   YE   A+ +V+ L  GG+L   I  + +  
Sbjct: 224 KRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG 282

Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
           + E  A      I   ++  H + +++RDLKPEN L     +   ++  D GL+V    G
Sbjct: 283 FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEG 339

Query: 214 EQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
           +     VG+  YMAPEV+K   Y    D W+ G +LY ++ G  PF    ++   + + R
Sbjct: 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399

Query: 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
            V +   +   + S  A+ L  ++L  DP +RL     +A EV EHP 
Sbjct: 400 LVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  175 bits (447), Expect = 4e-51
 Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 28/287 (9%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY+L   +G G   V          EK A K I+ +K +T   ++++ +E+Q M     H
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQC-HH 72

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--------RIVARGHYTERAAAAVMKTIVE 168
           PNIVS   ++     + +VM+L  GG + D             G   E   A +++ ++E
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF------NEIVGS 222
            ++  H+ G +HRD+K  N L         ++  DFG+S F   G            VG+
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 223 PYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS------V 274
           P +MAPEV+++   Y  + D+WS G+    L  G  P+       V    +++       
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249

Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
               ++   K  ++ + ++   L  DP++R TA E+L H + Q AK 
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  183 bits (467), Expect = 8e-51
 Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 22/293 (7%)

Query: 37  STVVHRLCVLKEPSGQD-ISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL 94
           S    R C  K       +++ D+ + R +GRG FG  Y C   + G+ +A K + KK++
Sbjct: 168 SDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227

Query: 95  RTAVDIEDVRREVQIMK--HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG 152
           +          E  ++        P IV +   +     +  +++L  GG+L   +   G
Sbjct: 228 KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG 287

Query: 153 HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
            ++E         I+  ++  H + V++RDLKP N L     E   ++  D GL+  F  
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF-S 343

Query: 213 GEQFNEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETE---QGVA 267
            ++ +  VG+  YMAPEVL++   Y    D +S G +L+ LL G  PF          + 
Sbjct: 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
           +  +   ++         S   + L++ +L  D  +RL      A+EV E P+
Sbjct: 404 RMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  178 bits (453), Expect = 1e-50
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 18/272 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG FG   +    N  + FA K ++K ++    +    R E  ++ +    
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DS 133

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHE 175
             I +L   ++DD+ +++VM+   GG+L   +        E  A   +  +V  +   H+
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVL-- 231
              +HRD+KP+N L      +  ++  DFG  +          +  VG+P Y++PE+L  
Sbjct: 194 LHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250

Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW-PKVS 286
               K  YGPE D WS GV +Y +L G  PF+AE+       I+     F+       VS
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310

Query: 287 ENAKDLVKKMLNPDPKQRLT---AEEVLEHPW 315
           ENAKDL+++++    + RL     E+  +HP+
Sbjct: 311 ENAKDLIRRLIC-SREHRLGQNGIEDFKKHPF 341

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219

 Score =  172 bits (436), Expect = 1e-50
 Identities = 35/190 (18%), Positives = 77/190 (40%), Gaps = 17/190 (8%)

Query: 326 SLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAG----LKEAFEMMDTNKRGKINL 381
                      +     K +K A + + + +  E+ A       E F+  D N+ GK+  
Sbjct: 8   GSTSDKGLASDKDGKKAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNETGKLCY 67

Query: 382 EELRLGLLK-GGQNIPEADLQILMEAA---------DVDGDGSLNYGEFVAVSVHLKKMA 431
           +E+  G L+    +   + ++ + + A          ++  GS ++ EF+   + L  + 
Sbjct: 68  DEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEFLEFRLMLCYIY 127

Query: 432 NDEHLHKAFSFFDRNRSGFIEIEELRNALN--DEVDTSGEDVINAIMHDVDTDKDGRISY 489
           +   L   F   D + +  ++ EE + A+   +      ED   A+  ++D +  G +++
Sbjct: 128 DFFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVED-PAALFKELDKNGTGSVTF 186

Query: 490 EEFAVMMKAG 499
           +EFA    A 
Sbjct: 187 DEFAAWASAV 196

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  174 bits (443), Expect = 2e-50
 Identities = 72/280 (25%), Positives = 131/280 (46%), Gaps = 12/280 (4%)

Query: 48  EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           +    D    +    ++G+G FG  +   D    +  A K I  ++     +IED+++E+
Sbjct: 14  QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEI 71

Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
            ++      P +     +Y  D+ + I+ME   GG   D ++  G   E   A +++ I+
Sbjct: 72  TVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREIL 129

Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYM 226
           + +   H +  +HRD+K  N L +   E   +K  DFG++        + N  VG+P++M
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 186

Query: 227 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
           APEV+K++ Y  + D+WS G+    L  G PP        V   I ++        +   
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY--- 243

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
           S+  K+ V+  LN +P  R TA+E+L+H ++    K  + 
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  175 bits (447), Expect = 2e-50
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 15/270 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +++  R LG+G FG   L      G+ +A K + K  +    D+E    E +I+     H
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  L   ++    +  VME   GG+L   I     + E  A      I+  +   H++
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
           G+++RDLK +N L          K  DFG+       G       G+P Y+APE+L+   
Sbjct: 144 GIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YGP VD W+ GV+LY +LCG  PF AE E  + +AI+   + +       + E+A  ++K
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----LHEDATGILK 256

Query: 295 KMLNPDPKQRL------TAEEVLEHPWLQN 318
             +  +P  RL          +L HP+ + 
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  175 bits (445), Expect = 3e-50
 Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 14/269 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++    LG+G FG   L       E +A K + K  +    D+E    E +++    K 
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  L   ++    ++ VME   GG+L   I   G + E  A      I   +     +
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
           G+++RDLK +N +         +K  DFG+       G       G+P Y+APE++    
Sbjct: 141 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 197

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W+ GV+LY +L G  PF  E E  + Q+I+   + + +     +S+ A  + K
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICK 253

Query: 295 KMLNPDPKQRL-----TAEEVLEHPWLQN 318
            ++   P +RL        ++ EH + + 
Sbjct: 254 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 282

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  175 bits (445), Expect = 3e-50
 Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 10/265 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ L + LG+G FG  +L       + FA K++ K  +    D+E    E +++    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  +  T++    +  VME   GG+L   I +   +    A      I+  +Q  H +
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
           G+++RDLK +N L     +   +K  DFG+         + N   G+P Y+APE+L    
Sbjct: 138 GIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 194

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           Y   VD WS GV+LY +L G  PF  + E+ +  +I      + R     + + AKDL+ 
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLV 250

Query: 295 KMLNPDPKQRLTA-EEVLEHPWLQN 318
           K+   +P++RL    ++ +HP  + 
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPLFRE 275

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  176 bits (449), Expect = 3e-50
 Identities = 86/349 (24%), Positives = 141/349 (40%), Gaps = 49/349 (14%)

Query: 7   RPDSSSGKRAKGKKEKPNPFYGDEYVV-ANGSTVVHRLCVLKEPSGQDISIDYDLGRELG 65
           RP ++S   +    ++P+ F   +     +GS V   +    +   +   + Y   + +G
Sbjct: 4   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63

Query: 66  RGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125
            G FGV Y     ++GE  A K + + K           RE+QIM+ L  H NIV L+  
Sbjct: 64  NGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHCNIVRLRYF 115

Query: 126 Y------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT----IVEVVQVCHE 175
           +      +D+  +++V++      ++          +      +K     +   +   H 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KR 233
            G+ HRD+KP+N L  +  +++ LK  DFG +     GE     + S YY APE++    
Sbjct: 175 FGICHRDIKPQNLL-LD-PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 232

Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII-------RSVIDF--------- 277
           +Y   +DVWSAG +L  LL G P F  ++       II       R  I           
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292

Query: 278 ----KRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
               K  PW     P+    A  L  ++L   P  RLT  E   H +  
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  174 bits (443), Expect = 5e-50
 Identities = 79/312 (25%), Positives = 132/312 (42%), Gaps = 29/312 (9%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
              D    +   RE+G G FG  Y   DV N E  A K +S    ++    +D+ +EV+ 
Sbjct: 48  FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 107

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           ++ L +HPN +  +  Y  +    +VME C G       V +    E   AAV    ++ 
Sbjct: 108 LQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 166

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYM 226
           +   H   ++HRD+K  N L +   E   +K  DFG +            N  VG+PY+M
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA------SIMAPANSFVGTPYWM 217

Query: 227 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP- 281
           APEV+    +  Y  +VDVWS G+    L    PP +          I       + +  
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNESP 271

Query: 282 ---WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQF 338
                  SE  ++ V   L   P+ R T+E +L+H ++   +  P   + + ++      
Sbjct: 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAV 329

Query: 339 SVMNKLKKRALQ 350
             ++ L+ R ++
Sbjct: 330 RELDNLQYRKMK 341

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  173 bits (440), Expect = 7e-50
 Identities = 80/306 (26%), Positives = 142/306 (46%), Gaps = 47/306 (15%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKH 112
            Y+   ++G G +GV + C + + G+  A K     K   + D   ++    RE++++K 
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQ 58

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEVV 170
           L KHPN+V+L + +     +H+V E C+       DR   +    E    ++    ++ V
Sbjct: 59  L-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAV 115

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPE 229
             CH+   +HRD+KPEN L         +K  DFG +     P + +++ V + +Y +PE
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172

Query: 230 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------------QGVAQ 268
           +L     YGP VDVW+ G +   LL GVP +  +++                   Q  + 
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232

Query: 269 AIIRSVIDFK--------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320
               S +              +P +S  A  L+K  L+ DP +RLT E++L HP+ +N +
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292

Query: 321 KAPNVS 326
           +  +++
Sbjct: 293 EIEDLA 298

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  172 bits (439), Expect = 9e-50
 Identities = 76/301 (25%), Positives = 140/301 (46%), Gaps = 15/301 (4%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
             +     +D+  +LG G +G  Y       G+  A K +  +      D++++ +E+ I
Sbjct: 23  LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISI 77

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVE 168
           M+     P++V    +Y  ++ + IVME C  G + D I  R    TE   A ++++ ++
Sbjct: 78  MQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMA 227
            ++  H    +HRD+K  N L   +      K  DFG++        + N ++G+P++MA
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGH---AKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193

Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PEV++   Y    D+WS G+    +  G PP+           I  +     R P    S
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP-ELWS 252

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
           +N  D VK+ L   P+QR TA ++L+HP++++AK      L + +   +       + ++
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK--GVSILRDLINEAMDVKLKRQESQQ 310

Query: 347 R 347
           R
Sbjct: 311 R 311

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134

 Score =  166 bits (422), Expect = 1e-49
 Identities = 29/136 (21%), Positives = 57/136 (41%), Gaps = 7/136 (5%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
            +  F+ +D N  G ++ EE++  + K      E  LQ++ ++ D DG+G ++  EF   
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61

Query: 424 SVHLKKMA---NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVD 480
              ++      +   L   +   D +  G +  EE+ +         G + +   +   D
Sbjct: 62  YGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKK----HGIEKVAEQVMKAD 117

Query: 481 TDKDGRISYEEFAVMM 496
            + DG I+ EEF    
Sbjct: 118 ANGDGYITLEEFLEFS 133

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134

 Score = 63.3 bits (155), Expect = 3e-12
 Identities = 15/63 (23%), Positives = 26/63 (41%)

Query: 436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVM 495
               F   D N  G +  EE++  ++ +     E ++  I   +D D +G I   EFA  
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61

Query: 496 MKA 498
             +
Sbjct: 62  YGS 64

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  174 bits (443), Expect = 2e-49
 Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 20/274 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++ + +GRG F    +      G+ +A K ++K  +    ++   R E  ++ +    
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DR 120

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHE 175
             I  L   ++D++ +++VME   GG+L   +   G       A   +  IV  +   H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKR 233
            G +HRD+KP+N L         ++  DFG  +  R          VG+P Y++PE+L+ 
Sbjct: 181 LGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 234 --------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK- 284
                   +YGPE D W+ GV  Y +  G  PF+A++       I+            + 
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297

Query: 285 VSENAKDLVKKMLNPDPKQRLT---AEEVLEHPW 315
           V E A+D ++++L   P+ RL    A +   HP+
Sbjct: 298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  171 bits (435), Expect = 6e-49
 Identities = 84/269 (31%), Positives = 136/269 (50%), Gaps = 15/269 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+D  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++  +H
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RH 64

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P + +LK  ++    +  VME   GGELF  +     +TE  A      IV  ++  H +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
            V++RD+K EN +     +   +K  DFGL       G       G+P Y+APEVL+ N 
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F R     +S  AK L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLA 237

Query: 295 KMLNPDPKQRL-----TAEEVLEHPWLQN 318
            +L  DPKQRL      A+EV+EH +  +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  178 bits (453), Expect = 6e-49
 Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 14/269 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++    LG+G FG   L       E +A K + K  +    D+E    E +++    K 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  L   ++    ++ VME   GG+L   I   G + E  A      I   +     +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
           G+++RDLK +N +         +K  DFG+       G       G+P Y+APE++    
Sbjct: 462 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 518

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           YG  VD W+ GV+LY +L G  PF  E E  + Q+I+   + + +     +S+ A  + K
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICK 574

Query: 295 KMLNPDPKQRL-----TAEEVLEHPWLQN 318
            ++   P +RL        ++ EH + + 
Sbjct: 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 603

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  169 bits (431), Expect = 7e-49
 Identities = 77/283 (27%), Positives = 129/283 (45%), Gaps = 26/283 (9%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
            D +  +++  ELG G FG  Y   +   G   A K I     ++  ++ED   E++I+ 
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILA 71

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVV 170
               HP IV L   Y  D  + I++E C GG +   ++      TE     V + ++E +
Sbjct: 72  TC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSPYYMAPE 229
              H + ++HRDLK  N L   + +   ++  DFG+S       ++ +  +G+PY+MAPE
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187

Query: 230 VL------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP-- 281
           V+         Y  + D+WS G+ L  +    PP        V   I       K DP  
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA------KSDPPT 241

Query: 282 ---WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                K S   +D +K  L+ +P+ R +A ++LEHP++ +   
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  169 bits (430), Expect = 2e-48
 Identities = 83/270 (30%), Positives = 137/270 (50%), Gaps = 19/270 (7%)

Query: 57  DYDLGRELGRGEFGVTYLC---TDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKH 112
            ++L R LG+G +G  +     T  N G+ FA K + K  + R A D    + E  I++ 
Sbjct: 18  CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           + KHP IV L   ++    +++++E   GGELF ++   G + E  A   +  I   +  
Sbjct: 78  V-KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL 231
            H++G+++RDLKPEN +  ++     +K  DFGL       G   +   G+  YMAPE+L
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193

Query: 232 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
            R+ +   VD WS G ++Y +L G PPF  E  +     I++  ++        +++ A+
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY----LTQEAR 249

Query: 291 DLVKKMLNPDPKQRL-----TAEEVLEHPW 315
           DL+KK+L  +   RL      A EV  HP+
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  170 bits (432), Expect = 2e-48
 Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 24/279 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+DL R +GRG +    L         +A K + K+ +    DI+ V+ E  + +    H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++ +S +  V+E   GG+L   +  +    E  A      I   +   HE+
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
           G+++RDLK +N L         +K  D+G+     RPG+  +   G+P Y+APE+L+   
Sbjct: 130 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 186

Query: 235 YGPEVDVWSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVIDFKRDPWPKV 285
           YG  VD W+ GV+++ ++ G  PF            TE  + Q I+   I   R     +
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----L 242

Query: 286 SENAKDLVKKMLNPDPKQRL------TAEEVLEHPWLQN 318
           S  A  ++K  LN DPK+RL         ++  HP+ +N
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220

 Score =  165 bits (420), Expect = 3e-48
 Identities = 29/196 (14%), Positives = 68/196 (34%), Gaps = 21/196 (10%)

Query: 312 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMM 371
            +  L N +      +G         + +   ++      +   + +++   + + F  +
Sbjct: 6   ANFCLWNLQPIQGSWMG-----AACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGV 60

Query: 372 DTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMA 431
           D ++ G + + EL +G   GG  +       +M   D D +G +++ EF+A+   ++   
Sbjct: 61  DRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHISFYEFMAMYKFMELA- 119

Query: 432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV---INAIMHDVDTDKDGRIS 488
                +  F    R RSG +E  E+  AL       G  +    + ++H +         
Sbjct: 120 -----YNLFVMNARARSGTLEPHEILPALQQ----LGFYINQRTSLLLHRLFARGMAFCD 170

Query: 489 YEEF---AVMMKAGTD 501
              +            
Sbjct: 171 LNCWIAICAFAAQTRS 186

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220

 Score = 75.6 bits (186), Expect = 9e-16
 Identities = 23/92 (25%), Positives = 35/92 (38%)

Query: 433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEF 492
              +++ F   DR+RSG +EI EL                  +M   DTD +G IS+ EF
Sbjct: 50  YTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHISFYEF 109

Query: 493 AVMMKAGTDWRKASRQYSRERFNSISLKLMRE 524
             M K            +R R  ++    +  
Sbjct: 110 MAMYKFMELAYNLFVMNARARSGTLEPHEILP 141

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  173 bits (441), Expect = 5e-48
 Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 22/294 (7%)

Query: 37  STVVHRLCVLKEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR 95
           S    R    K    Q +    +   R LGRG FG  + C     G+ +ACK ++KK+L+
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224

Query: 96  TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYT 155
                +    E +I+  +     IVSL   +E  + + +VM +  GG++   I       
Sbjct: 225 KRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283

Query: 156 -----ERAA--AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208
                 RA    A    IV  ++  H++ +++RDLKPEN L  +      ++  D GL+V
Sbjct: 284 PGFQEPRAIFYTA---QIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAV 337

Query: 209 -FFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV 266
                  +     G+P +MAPE+L    Y   VD ++ GV LY ++    PF A  E+  
Sbjct: 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

Query: 267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
            + + + V++       K S  +KD  + +L  DP++RL     + + +  HP 
Sbjct: 398 NKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  167 bits (425), Expect = 2e-47
 Identities = 74/318 (23%), Positives = 131/318 (41%), Gaps = 51/318 (16%)

Query: 41  HRLCVLKEPSGQDISID----YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT 96
           H      +   +++       Y+    +G G +G+   C + + G   A K     K   
Sbjct: 6   HHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLE 60

Query: 97  AVDIEDVR----REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVA 150
           + D + V+    RE++++K L +H N+V+L +  +     ++V E  +    +  +    
Sbjct: 61  SDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-- 117

Query: 151 RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210
                 +     +  I+  +  CH   ++HRD+KPEN L +       +K  DFG +   
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTL 174

Query: 211 R-PGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 267
             PGE +++ V + +Y APE+L     YG  VDVW+ G ++  +  G P F  +++    
Sbjct: 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234

Query: 268 QAIIR--------------SVIDFK-------------RDPWPKVSENAKDLVKKMLNPD 300
             I+                   F                 +PK+SE   DL KK L+ D
Sbjct: 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID 294

Query: 301 PKQRLTAEEVLEHPWLQN 318
           P +R    E+L H + Q 
Sbjct: 295 PDKRPFCAELLHHDFFQM 312

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  167 bits (424), Expect = 2e-47
 Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 26/292 (8%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
           + +D +  ++L   +G G +G  Y    V  G+  A K +    +    + E++++E+ +
Sbjct: 18  ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGD-EEEEIKQEINM 73

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVH------IVMELCEGGELFD--RIVARGHYTERAAAA 161
           +K    H NI +    +   +         +VME C  G + D  +        E   A 
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133

Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIV 220
           + + I+  +   H+  V+HRD+K +N L     E   +K +DFG+S    R   + N  +
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFI 190

Query: 221 GSPYYMAPEVLKRN------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
           G+PY+MAPEV+  +      Y  + D+WS G+    +  G PP            I R+ 
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250

Query: 275 I-DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
               K   W   S+  +  ++  L  +  QR   E++++HP++++      V
Sbjct: 251 APRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQV 299

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  168 bits (427), Expect = 3e-47
 Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 24/279 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+DL R +GRG +    L         +A + + K+ +    DI+ V+ E  + +    H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +V L   ++ +S +  V+E   GG+L   +  +    E  A      I   +   HE+
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
           G+++RDLK +N L         +K  D+G+     RPG+  +   G+P Y+APE+L+   
Sbjct: 173 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 229

Query: 235 YGPEVDVWSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVIDFKRDPWPKV 285
           YG  VD W+ GV+++ ++ G  PF            TE  + Q I+   I   R     +
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----L 285

Query: 286 SENAKDLVKKMLNPDPKQRL------TAEEVLEHPWLQN 318
           S  A  ++K  LN DPK+RL         ++  HP+ +N
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  167 bits (425), Expect = 4e-47
 Identities = 73/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)

Query: 46  LKEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
           L   S       D+   + +G+G FG   L         +A K + KK +    + + + 
Sbjct: 27  LGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM 86

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AA 161
            E  ++    KHP +V L  +++    ++ V++   GGELF  +     + E  A   AA
Sbjct: 87  SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146

Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL------KAIDFGLS-VFFRPGE 214
               I   +   H   +++RDLKPEN L         L         DFGL         
Sbjct: 147 ---EIASALGYLHSLNIVYRDLKPENIL---------LDSQGHIVLTDFGLCKENIEHNS 194

Query: 215 QFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273
             +   G+P Y+APEVL +  Y   VD W  G +LY +L G+PPF++     +   I+  
Sbjct: 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254

Query: 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL----TAEEVLEHPWLQN 318
            +  K +    ++ +A+ L++ +L  D  +RL       E+  H +   
Sbjct: 255 PLQLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  169 bits (429), Expect = 4e-47
 Identities = 84/309 (27%), Positives = 149/309 (48%), Gaps = 17/309 (5%)

Query: 16  AKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISI-DYDLGRELGRGEFGVTYL 74
           A G K++            + ++    + V        +++ +++  + LG+G FG   L
Sbjct: 107 ADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVIL 166

Query: 75  CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134
             +   G  +A K + K+ +    ++     E +++++  +HP + +LK +++    +  
Sbjct: 167 VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCF 225

Query: 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-EQGVMHRDLKPENFLFANK 193
           VME   GGELF  +     ++E  A      IV  +   H E+ V++RDLK EN +    
Sbjct: 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-- 283

Query: 194 KESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYIL 251
            +   +K  DFGL     + G       G+P Y+APEVL+ N YG  VD W  GV++Y +
Sbjct: 284 -KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342

Query: 252 LCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL-----T 306
           +CG  PF+ +  + + + I+   I F R     +   AK L+  +L  DPKQRL      
Sbjct: 343 MCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSED 398

Query: 307 AEEVLEHPW 315
           A+E+++H +
Sbjct: 399 AKEIMQHRF 407

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  165 bits (421), Expect = 4e-47
 Identities = 69/269 (25%), Positives = 126/269 (46%), Gaps = 19/269 (7%)

Query: 57  DYDLGRELGRGEFGVTYLC---TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
            ++L + LG+G FG  +L    +  +  + +A K + K  L    D    + E  I+  +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVRDRVRTKMERDILVEV 83

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
             HP IV L   ++ +  ++++++   GG+LF R+     +TE      +  +   +   
Sbjct: 84  -NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK 232
           H  G+++RDLKPEN L   +     +K  DFGLS       ++     G+  YMAPEV+ 
Sbjct: 143 HSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199

Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
           R  +    D WS GV+++ +L G  PF  +  +     I+++ +   +     +S  A+ 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LSPEAQS 255

Query: 292 LVKKMLNPDPKQRL-----TAEEVLEHPW 315
           L++ +   +P  RL       EE+  H +
Sbjct: 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  164 bits (418), Expect = 3e-46
 Identities = 82/274 (29%), Positives = 146/274 (53%), Gaps = 19/274 (6%)

Query: 57  DYDLGRELGRGEFGVTYLC---TDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKH 112
           +++L + LG G +G  +L    +  + G+ +A K + K  + + A   E  R E Q+++H
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
           + + P +V+L   ++ ++ +H++++   GGELF  +  R  +TE      +  IV  ++ 
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 174

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPYYMAPEV 230
            H+ G+++RD+K EN L  +      +   DFGLS        E+  +  G+  YMAP++
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231

Query: 231 LKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VS 286
           ++     +   VD WS GV++Y LL G  PF  + E+     I R  I     P+P+ +S
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-ILKSEPPYPQEMS 290

Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
             AKDL++++L  DPK+RL      A+E+ EH +
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  163 bits (415), Expect = 4e-46
 Identities = 79/308 (25%), Positives = 134/308 (43%), Gaps = 59/308 (19%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
               DY L R+LGRG++   +   ++ N EK   K +        V  + ++RE++I+++
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILEN 86

Query: 113 LPKHPNIVSLKDTYEDDSA---VHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIV 167
           L   PNI++L D  +D  +     +   +      +L+  +      T+      M  I+
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL------TDYDIRFYMYEIL 140

Query: 168 EVVQVCHEQGVMHRDLKPENFLF--ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           + +  CH  G+MHRD+KP N +    ++K    L+ ID+GL+ F+ PG+++N  V S Y+
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRK----LRLIDWGLAEFYHPGQEYNVRVASRYF 196

Query: 226 MAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA-----------------ETEQGV 266
             PE+L   + Y   +D+WS G +L  ++    PF+                  E     
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256

Query: 267 AQAI--------IRSVIDFKRDPW---------PKVSENAKDLVKKMLNPDPKQRLTAEE 309
                          +    R  W           VS  A D + K+L  D + RLTA E
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316

Query: 310 VLEHPWLQ 317
            +EHP+  
Sbjct: 317 AMEHPYFY 324

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  163 bits (414), Expect = 5e-46
 Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 55/301 (18%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-------RTAVDIEDVRREVQI 109
            Y    +LG G +   Y           A K I   +L        TA+      REV +
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAI------REVSL 53

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIV 167
           +K L KH NIV+L D    + ++ +V E  +    +  D                +  ++
Sbjct: 54  LKDL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQLL 110

Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPYY 225
             +  CH Q V+HRDLKP+N L   + E   LK  DFGL+     P + + NE+V + +Y
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVV-TLWY 166

Query: 226 MAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----------- 272
             P++L    +Y  ++D+W  G I Y +  G P F   T +     I R           
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 273 --------SVIDFKRDP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                      ++ +          P++  +  DL+ K+L  + + R++AE+ ++HP+  
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

Query: 318 N 318
           +
Sbjct: 287 S 287

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  161 bits (410), Expect = 7e-46
 Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 56/302 (18%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--------RTAVDIEDVRREVQ 108
            Y+   ++G G +G  +   +    E  A K +   +L         +A+      RE+ 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSAL------REIC 53

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTI 166
           ++K L KH NIV L D    D  + +V E C+    + FD     G        + +  +
Sbjct: 54  LLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQL 110

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPY 224
           ++ +  CH + V+HRDLKP+N L     E   LK  +FGL+  F  P   +  E+V + +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVV-TLW 166

Query: 225 YMAPEVL--KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR--------- 272
           Y  P+VL   + Y   +D+WSAG I   +   G P F         + I R         
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 273 -----SVIDFKRDP-----------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                 + D+K  P            PK++   +DL++ +L  +P QR++AEE L+HP+ 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

Query: 317 QN 318
            +
Sbjct: 287 SD 288

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  161 bits (409), Expect = 1e-45
 Identities = 88/301 (29%), Positives = 133/301 (44%), Gaps = 56/301 (18%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--------RTAVDIEDVRREVQ 108
            Y    ++G G +GV Y   + N GE FA K I   +L         T +      RE+ 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKI---RLEKEDEGIPSTTI------REIS 52

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTI 166
           I+K L KH NIV L D       + +V E  +    +L D     G      A + +  +
Sbjct: 53  ILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQL 109

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPY 224
           +  +  CH++ V+HRDLKP+N L   + E   LK  DFGL+  F  P  ++ +EIV + +
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIV-TLW 165

Query: 225 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---------- 272
           Y AP+VL   + Y   +D+WS G I   ++ G P F   +E      I R          
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225

Query: 273 ----SVIDFK-----------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                +  +                  + E+  DL+ KML  DP QR+TA++ LEH + +
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

Query: 318 N 318
            
Sbjct: 286 E 286

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  164 bits (416), Expect = 1e-45
 Identities = 82/305 (26%), Positives = 132/305 (43%), Gaps = 49/305 (16%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
           +G+   I Y   + +G G FGV +    V + E  A K + + K           RE+QI
Sbjct: 34  TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN-------RELQI 85

Query: 110 MKHLPKHPNIVSLKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM 163
           M+ + KHPN+V LK  +      +D+  +++V+E      ++          +     ++
Sbjct: 86  MRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLI 143

Query: 164 KT----IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI 219
           K     ++  +   H  G+ HRD+KP+N L  +   S  LK IDFG +     GE     
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLL-LD-PPSGVLKLIDFGSAKILIAGEPNVSY 201

Query: 220 VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----- 272
           + S YY APE++    NY   +D+WS G ++  L+ G P F  E+       II+     
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261

Query: 273 --SVIDF-------------KRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
               I               +  P+     P+   +A DL+ ++L   P  RLTA E L 
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321

Query: 313 HPWLQ 317
           HP+  
Sbjct: 322 HPFFD 326

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226

 Score =  158 bits (402), Expect = 1e-45
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 13/192 (6%)

Query: 333 ARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTN--KRGKINLEELRLGLLK 390
             L  +     L    L       SV E+  L E F+ + +     G IN EE +L L K
Sbjct: 19  FDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK 78

Query: 391 GGQNIPEADLQILMEAADVDGDGSLNYGEFV-AVSVHLKKMANDEHLHKAFSFFDRNRSG 449
             +         + +  D   +G L + EF  A+SV       D+ +H +F  +D  + G
Sbjct: 79  TNKK-ESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQG 137

Query: 450 FIEIEELRNALNDEVDTSG--------EDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
           FIE +E++  +   +  SG        ED+I+    + DT  DG+I  EE+  ++     
Sbjct: 138 FIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVLRHPS 197

Query: 502 -WRKASRQYSRE 512
             +  + QY ++
Sbjct: 198 LLKNMTLQYLKD 209

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  162 bits (411), Expect = 1e-45
 Identities = 83/304 (27%), Positives = 126/304 (41%), Gaps = 46/304 (15%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMK 111
            Y    +LG G +G  Y   D    E  A K I  +        TA+      REV ++K
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI------REVSLLK 88

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L +H NI+ LK     +  +H++ E  E  +L   +      + R   + +  ++  V 
Sbjct: 89  EL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVN 146

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSP--LKAIDFGLSVFF-RPGEQF-NEIVGSPYYMA 227
            CH +  +HRDLKP+N L +    S    LK  DFGL+  F  P  QF +EI+ + +Y  
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRP 205

Query: 228 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 272
           PE+L   R+Y   VD+WS   I   +L   P F  ++E      I               
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265

Query: 273 -------------SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
                             KR     + +   DL+  ML  DP +R++A+  LEHP+  + 
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

Query: 320 KKAP 323
              P
Sbjct: 326 DFDP 329

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  161 bits (410), Expect = 2e-45
 Identities = 77/308 (25%), Positives = 121/308 (39%), Gaps = 60/308 (19%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-------RTAVDIEDVRREVQI 109
            +    +LG G +   Y   +   G   A K +   KL        TA+      RE+ +
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAI------REISL 56

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGG-----ELFDRIVARGHYTERAAAAVMK 164
           MK L KH NIV L D    ++ + +V E  +       +                     
Sbjct: 57  MKEL-KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGS 222
            +++ +  CHE  ++HRDLKP+N L   + +   LK  DFGL+  F  P   F +E+V +
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVV-T 171

Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------- 272
            +Y AP+VL   R Y   +D+WS G IL  ++ G P F    ++   + I          
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 273 ---SVID-------------------FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV 310
              SV                      +      +  N  D +  +L  +P  RL+A++ 
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 311 LEHPWLQN 318
           L HPW   
Sbjct: 292 LHHPWFAE 299

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161

 Score =  156 bits (396), Expect = 2e-45
 Identities = 39/159 (24%), Positives = 76/159 (47%), Gaps = 2/159 (1%)

Query: 341 MNKLKK-RALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
           M+K +       +   L  E+   + EAF + D N  G ++  EL++ +   G  +P+ +
Sbjct: 1   MSKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE 60

Query: 400 LQILMEAADVDGDGSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
           +  L++  D +G   + Y +F  V    + K    + + +AF  FD + +G I I+ LR 
Sbjct: 61  ILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDPLDEIKRAFQLFDDDHTGKISIKNLRR 120

Query: 459 ALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
              +  +T  ++ + A++ + D D DG I+  EF  +  
Sbjct: 121 VAKELGETLTDEELRAMIEEFDLDGDGEINENEFIAICT 159

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169

 Score =  155 bits (393), Expect = 6e-45
 Identities = 40/168 (23%), Positives = 87/168 (51%), Gaps = 5/168 (2%)

Query: 334 RLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ 393
           + K      + +K+        L+ E+   ++EAF++ DT+  G I+ +EL++ +   G 
Sbjct: 4   KAKTVVSARRDQKKG----RVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGF 59

Query: 394 NIPEADLQILMEAADVDGDGSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIE 452
              + +++ ++   D DG G++++ EF+ + +  + +  + E + KAF  FD + SG I 
Sbjct: 60  EPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSREEILKAFRLFDDDNSGTIT 119

Query: 453 IEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT 500
           I++LR    +  +   E+ +  ++ + D + D  I  +EF  +MK  +
Sbjct: 120 IKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS 167

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  159 bits (405), Expect = 7e-45
 Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 51/302 (16%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMK 111
            Y    ++G G +GV Y   D + G   A K I           TA+      RE+ ++K
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI------REISLLK 74

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEV 169
            L  HPNIVSL D    +  + +V E  E    ++ D    +    +      +  ++  
Sbjct: 75  EL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRG 131

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPYYMA 227
           V  CH+  ++HRDLKP+N L  +      LK  DFGL+  F  P   + +E+V + +Y A
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187

Query: 228 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 272
           P+VL   + Y   VD+WS G I   ++ G P F   T+      I               
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247

Query: 273 -SVIDFK------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
             +  +K                P   +   DL+  ML  DP +R++A + + HP+ ++ 
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

Query: 320 KK 321
             
Sbjct: 308 DP 309

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158

 Score =  154 bits (391), Expect = 8e-45
 Identities = 33/155 (21%), Positives = 76/155 (49%), Gaps = 6/155 (3%)

Query: 353 AEFLSVEEVAGLKEAFEMMDT-NKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDG 411
              LS  +V  L+ AF   +T    G+++ +++ + L   G    ++ ++ L++  D  G
Sbjct: 4   VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFG 63

Query: 412 DGSLNYGEFVAV-----SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDT 466
           +G +++  F  +        +      + L +AF  +D+  +G+I  + +R  L +  +T
Sbjct: 64  NGDIDFDSFKIIGARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTDVMREILAELDET 123

Query: 467 SGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
              + ++A++ ++D D  G + +EEF  +M  G +
Sbjct: 124 LSSEDLDAMIDEIDADGSGTVDFEEFMGVMTGGDE 158

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179

 Score =  154 bits (391), Expect = 2e-44
 Identities = 51/166 (30%), Positives = 96/166 (57%), Gaps = 3/166 (1%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           A+ L+ E++A  KEAF + D +  G I  +EL   +   GQN  EA+LQ ++   D DG+
Sbjct: 2   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 61

Query: 413 GSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+ + +  +K   ++E + +AF  FD++ +G+I   ELR+ + +  +   ++ 
Sbjct: 62  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEE 121

Query: 472 INAIMHDVDTDKDGRISYEEFAVMM--KAGTDWRKASRQYSRERFN 515
           ++ ++ + D D DG+++YEEF  MM  K G     A ++  R +  
Sbjct: 122 VDEMIREADIDGDGQVNYEEFVQMMTAKGGGGGAAARKEVIRNKIR 167

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179

 Score = 84.5 bits (210), Expect = 3e-19
 Identities = 24/92 (26%), Positives = 42/92 (45%), Gaps = 4/92 (4%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           ++EAF + D +  G I+  ELR  +   G+ + + ++  ++  AD+DGDG +NY EFV +
Sbjct: 86  IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQM 145

Query: 424 ----SVHLKKMANDEHLHKAFSFFDRNRSGFI 451
                      A  E +        +    F 
Sbjct: 146 MTAKGGGGGAAARKEVIRNKIRAIGKMARVFS 177

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161

 Score =  153 bits (389), Expect = 2e-44
 Identities = 54/163 (33%), Positives = 85/163 (52%), Gaps = 9/163 (5%)

Query: 341 MNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEAD 399
           M+ + K A     E L+ E+    K AF++     + G I+ +EL   +   GQN    +
Sbjct: 1   MDDIYKAA----VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE 56

Query: 400 LQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAFSFFDRNRSGFIEIEE 455
           LQ +++  D DG G++++ EF+ + V       K  ++E L   F  FD+N  G+I++EE
Sbjct: 57  LQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEE 116

Query: 456 LRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           L+  L    +T  ED I  +M D D + DGRI Y+EF   MK 
Sbjct: 117 LKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 159

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  160 bits (405), Expect = 3e-44
 Identities = 57/339 (16%), Positives = 115/339 (33%), Gaps = 62/339 (18%)

Query: 53  DISIDYDLGRELGRGE--FGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
                Y+L   +G+G        L      GE    + I+ +       +  ++ E+ + 
Sbjct: 22  PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE-MVTFLQGELHVS 80

Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVE 168
           K    HPNIV  + T+  D+ + +V      G   D           E A A +++ +++
Sbjct: 81  KLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP--------GEQFNEIV 220
            +   H  G +HR +K  + L +   +   +       ++             +     V
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 221 GSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF------------------- 258
               +++PEVL++N   Y  + D++S G+    L  G  PF                   
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256

Query: 259 ----------------------WAETEQGVAQAIIRSVIDFKRDPWPKV-SENAKDLVKK 295
                                    ++         S  D    P+ +  S +    V++
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
            L  +P  R +A  +L H + +  K+  + +L E ++  
Sbjct: 317 CLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPV 355

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  157 bits (400), Expect = 8e-44
 Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 45/297 (15%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-----VRREVQIMK 111
            Y+    LG G+F   Y   D N  +  A K I   KL    + +D       RE+++++
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQ 67

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEV 169
            L  HPNI+ L D +   S + +V +  E     +          T     A M   ++ 
Sbjct: 68  EL-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQG 124

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPYYMA 227
           ++  H+  ++HRDLKP N L         LK  DFGL+  F  P   + +++V + +Y A
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVV-TRWYRA 180

Query: 228 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----------- 274
           PE+L   R YG  VD+W+ G IL  LL  VP    +++      I  ++           
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240

Query: 275 ------IDFKRDP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                 + FK  P       +    ++  DL++ +   +P  R+TA + L+  +  N
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143

 Score =  150 bits (382), Expect = 1e-43
 Identities = 35/140 (25%), Positives = 77/140 (55%), Gaps = 1/140 (0%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
           E+   ++EAF++ D +  G I+++EL++ +   G    + +++ ++   D +G G +N+G
Sbjct: 3   EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFG 62

Query: 419 EFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH 477
           +F+ V +  + +    E + KAF  FD + +G I  + L+    +  +   ++ +  ++ 
Sbjct: 63  DFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMID 122

Query: 478 DVDTDKDGRISYEEFAVMMK 497
           + D D DG +S +EF  +MK
Sbjct: 123 EADRDGDGEVSEQEFLRIMK 142

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155

 Score =  150 bits (380), Expect = 3e-43
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 11/152 (7%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
           +E+  L + F+ +D +  G +++EE                +Q +++  D DG+G +++ 
Sbjct: 3   DEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQ----NPLVQRVIDIFDTDGNGEVDFK 58

Query: 419 EFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-----DTSGEDVI 472
           EF+   S    K   ++ L  AF  +D ++ G+I   EL   L   V     DT  + ++
Sbjct: 59  EFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIV 118

Query: 473 NAIMHDVDTDKDGRISYEEFAVMMKAGTDWRK 504
           +  + + D D DGRIS+EEF  ++  G D  K
Sbjct: 119 DKTIINADKDGDGRISFEEFCAVVG-GLDIHK 149

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207

 Score =  151 bits (384), Expect = 3e-43
 Identities = 43/188 (22%), Positives = 79/188 (42%), Gaps = 14/188 (7%)

Query: 331 VKARLKQFSVMNKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTN--KRGKINLEELRL 386
             ++ K+ + M        +++A     +VEEV  L E F+ + ++    G I+ EE +L
Sbjct: 4   SVSKKKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQL 63

Query: 387 GLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFV-AVSVHLKKMANDEHLHKAFSFFDR 445
            L +            + +  DV  +G + +GEFV ++ V        E +  AF  +D 
Sbjct: 64  ALFRNRNR-RNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYDL 122

Query: 446 NRSGFIEIEELRNALNDEVDTSG--------EDVINAIMHDVDTDKDGRISYEEFAVMMK 497
            ++GFIE EEL+  +   +  S         E +++      D   DG+I  +E+   + 
Sbjct: 123 RQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFVS 182

Query: 498 AGTDWRKA 505
                 K 
Sbjct: 183 LNPSLIKN 190

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  155 bits (393), Expect = 3e-43
 Identities = 70/312 (22%), Positives = 122/312 (39%), Gaps = 40/312 (12%)

Query: 48  EPSGQDISI---DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
              GQ       D +   E+G G  G  +       G   A K + +       + + + 
Sbjct: 14  TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRIL 71

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
            ++ ++      P IV    T+  ++ V I MEL        +   +G   ER    +  
Sbjct: 72  MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131

Query: 165 TIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI---- 219
            IV+ +    E+ GV+HRD+KP N L   + +   +K  DFG+S     G   ++     
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGIS-----GRLVDDKAKDR 183

Query: 220 -VGSPYYMAPEVLKRN------YGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAII 271
             G   YMAPE +         Y    DVWS G+ L  L  G  P+   +T+  V   ++
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243

Query: 272 RSVIDFKRDPWPKV------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
                  ++  P +      S + +  VK  L  D ++R    ++LEH +++  +    V
Sbjct: 244 -------QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET-LEV 295

Query: 326 SLGETVKARLKQ 337
            +    K  + +
Sbjct: 296 DVASWFKDVMAK 307

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  154 bits (392), Expect = 7e-43
 Identities = 69/320 (21%), Positives = 113/320 (35%), Gaps = 35/320 (10%)

Query: 40  VHRLCVLKEPSGQDISI---DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT 96
           +     LK    Q       D     E+GRG +G         +G+  A K I       
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--D 60

Query: 97  AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----- 151
             + + +  ++ ++      P IV        +    I MEL      FD+         
Sbjct: 61  EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVL 118

Query: 152 -GHYTERAAAAVMKTIVEVVQVCHEQG-VMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209
                E     +    V+ +    E   ++HRD+KP N L         +K  DFG+S  
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGIS-- 173

Query: 210 FRPGEQFNEI-----VGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFW 259
              G+  + I      G   YMAPE +      + Y    DVWS G+ LY L  G  P+ 
Sbjct: 174 ---GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230

Query: 260 A-ETEQGVAQAIIRS-VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
              +       +++            + S +  + V   L  D  +R   +E+L+HP++ 
Sbjct: 231 KWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

Query: 318 NAKKAPNVSLGETVKARLKQ 337
             ++   V +   V   L Q
Sbjct: 291 MYEERA-VEVACYVCKILDQ 309

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191

 Score =  150 bits (380), Expect = 8e-43
 Identities = 34/164 (20%), Positives = 62/164 (37%), Gaps = 6/164 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
             + +   L E F  +DT+  G I++ EL   L   G     A  + L+   D +  G +
Sbjct: 21  RHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEI 80

Query: 416 NYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAI 475
            + EF  +            + + F   D +  G ++  E+R AL        E    A+
Sbjct: 81  TFDEFKDL------HHFILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQAL 134

Query: 476 MHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISL 519
           M   D  + G + ++++  +       R     Y RER   ++ 
Sbjct: 135 MRKFDRQRRGSLGFDDYVELSIFVCRVRNVFAFYDRERTGQVTF 178

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191

 Score = 79.3 bits (196), Expect = 3e-17
 Identities = 20/95 (21%), Positives = 38/95 (40%)

Query: 430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISY 489
           M +++ L + F   D + SG I + EL  AL+             ++H  D +  G I++
Sbjct: 23  MNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITF 82

Query: 490 EEFAVMMKAGTDWRKASRQYSRERFNSISLKLMRE 524
           +EF  +       R+  R+        +    +R 
Sbjct: 83  DEFKDLHHFILSMREGFRKRDSSGDGRLDSNEVRA 117

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162

 Score =  148 bits (377), Expect = 1e-42
 Identities = 56/164 (34%), Positives = 85/164 (51%), Gaps = 8/164 (4%)

Query: 339 SVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA 398
           + M   +  A      FLS E +A  K AF+M D +  G I+ +EL   +   GQN  + 
Sbjct: 1   ASMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56

Query: 399 DLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAFSFFDRNRSGFIEIE 454
           +L  ++E  D DG G++++ EF+ + V       K  ++E L   F  FD+N  GFI+IE
Sbjct: 57  ELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIE 116

Query: 455 ELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           EL   L    +   E+ I  +M D D + DGRI ++EF  MM+ 
Sbjct: 117 ELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG 160

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153

 Score =  148 bits (376), Expect = 1e-42
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 6/151 (3%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
              L  EE+  L+EAF   D +K G IN  +L   +   G    E +L  L +  +++  
Sbjct: 2   DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLG 61

Query: 413 GSLNYGEFVAVSVHL-----KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DT 466
           G +++ +FV +           M   + L  AF  FD N  G I   ELR A+   +   
Sbjct: 62  GHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQ 121

Query: 467 SGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
            G   I  I+ DVD + DGR+ +EEF  MM 
Sbjct: 122 VGHRDIEEIIRDVDLNGDGRVDFEEFVRMMS 152

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  160 bits (407), Expect = 1e-42
 Identities = 68/265 (25%), Positives = 108/265 (40%), Gaps = 35/265 (13%)

Query: 58  YDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDV---RREVQIMKHL 113
           Y++   +  G  G  YL  D N NG     K      L  + D E       E Q +  +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAERQFLAEV 136

Query: 114 PKHPNIVSLKDTYED-----DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
             HP+IV + +  E      D   +IVME   G  L              A A +  I+ 
Sbjct: 137 -VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILP 193

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            +   H  G+++ DLKPEN +   ++    LK ID G          F  + G+P + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV---SRINSFGYLYGTPGFQAP 246

Query: 229 EVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
           E+++       D+++ G  L  L   +P        G+ +           DP  K  ++
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DDPVLKTYDS 296

Query: 289 AKDLVKKMLNPDPKQR-LTAEEVLE 312
              L+++ ++PDP+QR  TAEE+  
Sbjct: 297 YGRLLRRAIDPDPRQRFTTAEEMSA 321

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195

 Score =  149 bits (377), Expect = 2e-42
 Identities = 33/175 (18%), Positives = 61/175 (34%), Gaps = 21/175 (12%)

Query: 345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-----GQNIPEAD 399
            K A+++  +F +   +   K  F+ +D N  GKI L+E+                 +  
Sbjct: 3   SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62

Query: 400 LQILMEAADVDGDG-----SLNYGEFVA-----VSVHLKKMANDEH------LHKAFSFF 443
              +   A   G G      + + +F+       +  LKK A +E           F  F
Sbjct: 63  RHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIF 122

Query: 444 DRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           D++ SG I ++E +        +  ++   A     D D  G +  +E       
Sbjct: 123 DKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLG 177

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195

 Score = 64.8 bits (158), Expect = 3e-12
 Identities = 18/94 (19%), Positives = 30/94 (31%), Gaps = 2/94 (2%)

Query: 339 SVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA 398
               +L    L+  A              F++ D +  G I L+E +      G +  + 
Sbjct: 90  DGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQE 149

Query: 399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN 432
           D +      D+D  G L+  E      HL     
Sbjct: 150 DCEATFRHCDLDNAGDLDVDEMTR--QHLGFWYT 181

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  150 bits (382), Expect = 1e-41
 Identities = 76/316 (24%), Positives = 123/316 (38%), Gaps = 51/316 (16%)

Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---- 104
           P G   +  Y+   E+G G +G  Y   D ++G   A K      +R             
Sbjct: 2   PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPI 56

Query: 105 ---REVQIMKHL--PKHPNIVSLKD-----TYEDDSAVHIVMELCEG--GELFDRIVARG 152
              REV +++ L   +HPN+V L D       + +  V +V E  +       D+    G
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116

Query: 153 HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
                    +M+  +  +   H   ++HRDLKPEN L  +      +K  DFGL+  +  
Sbjct: 117 -LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSY 172

Query: 213 GEQF-NEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 270
                  +V + +Y APEVL +  Y   VD+WS G I   +    P F   +E      I
Sbjct: 173 QMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

Query: 271 IR--------------SVIDFKRDPW---------PKVSENAKDLVKKMLNPDPKQRLTA 307
                           S+      P          P++ E+   L+ +ML  +P +R++A
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291

Query: 308 EEVLEHPWLQNAKKAP 323
              L+H +L   +  P
Sbjct: 292 FRALQHSYLHKDEGNP 307

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148

 Score =  145 bits (368), Expect = 1e-41
 Identities = 52/147 (35%), Positives = 90/147 (61%), Gaps = 1/147 (0%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           AE L+ E++A  KEAF + D +  G I  +EL   +   GQN  EA+LQ ++   D DG+
Sbjct: 1   AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60

Query: 413 GSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
           G++++ EF+++ +  +K+  ++E L +AF  FDR+ +G I   ELR+ + +  +   +D 
Sbjct: 61  GTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDE 120

Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++ + D D DG I+YEEF  MM +
Sbjct: 121 VDEMIREADIDGDGHINYEEFVRMMVS 147

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147

 Score =  145 bits (368), Expect = 1e-41
 Identities = 44/146 (30%), Positives = 81/146 (55%), Gaps = 2/146 (1%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           ++ L+ E++A  KEAF + D +  G I+  EL   +   G +  EA++  LM   DVDG+
Sbjct: 2   SQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGN 61

Query: 413 GSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
            ++ + EF+A+ S  LK   +++ L +AF  FD+N  G I   EL++ L    +   +  
Sbjct: 62  HAIEFSEFLALMSRQLKCNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAE 121

Query: 472 INAIMHDVDTDKDGRISYEEFAVMMK 497
           ++ ++ +V  D  G I+ ++FA ++ 
Sbjct: 122 VDEMLREVS-DGSGEINIKQFAALLS 146

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142

 Score =  144 bits (365), Expect = 3e-41
 Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 2/140 (1%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
           ++V+  KEAFE+ D+ + G I  E L+  L + G  +  A    +   AD  G+G + + 
Sbjct: 3   DQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFP 62

Query: 419 EFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH 477
           EF+++    +K+  +++ L +AF  FD   +G+I    L++AL +  D          + 
Sbjct: 63  EFLSMMGRRMKQTTSEDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLG 122

Query: 478 DVDTDKDGRISYEEFAVMMK 497
             +T+  G+I Y+ F   M 
Sbjct: 123 ITETE-KGQIRYDNFINTMF 141

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  151 bits (382), Expect = 3e-41
 Identities = 71/337 (21%), Positives = 127/337 (37%), Gaps = 58/337 (17%)

Query: 47  KEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRRE 106
           K+  G+    D++   ELG G  GV +  +   +G   A K I  +          + RE
Sbjct: 24  KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRE 81

Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
           +Q++      P IV     +  D  + I ME  +GG L   +   G   E+    V   +
Sbjct: 82  LQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140

Query: 167 VEVVQVCHEQG-VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VG 221
           ++ +    E+  +MHRD+KP N L  ++ E   +K  DFG+S     G+  + +    VG
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVG 192

Query: 222 SPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
           +  YM+PE L+   Y  + D+WS G+ L  +  G  P      + +       V     +
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 281 PWPKV----------------------------------------SENAKDLVKKMLNPD 300
             P+                                         S   +D V K L  +
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312

Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
           P +R   ++++ H +++ +     V     + + +  
Sbjct: 313 PAERADLKQLMVHAFIKRSDA-EEVDFAGWLCSTIGL 348

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  147 bits (373), Expect = 1e-40
 Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 30/292 (10%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D +   ELGRG +GV      V +G+  A K I       + + + +  ++ I       
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDC 65

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVAR-GHYTERAAAAVMKTIVEVVQVC 173
           P  V+       +  V I MEL +    + + +++ +     E     +  +IV+ ++  
Sbjct: 66  PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 174 HEQG-VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-----VGSPYYMA 227
           H +  V+HRD+KP N L     +   +K  DFG+S     G   +++      G   YMA
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQ---VKMCDFGIS-----GYLVDDVAKDIDAGCKPYMA 177

Query: 228 PEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVI-DFKRD 280
           PE +      + Y  + D+WS G+ +  L     P+ +  T     + ++         D
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237

Query: 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVK 332
            +   S    D   + L  + K+R T  E+++HP+    +      +   VK
Sbjct: 238 KF---SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES-KGTDVASFVK 285

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211

 Score =  144 bits (366), Expect = 1e-40
 Identities = 36/172 (20%), Positives = 68/172 (39%), Gaps = 9/172 (5%)

Query: 345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNI-PEADLQIL 403
             +++    + +  +E       F  M     G   L E +  L   G N      +  +
Sbjct: 5   NGKSIAGDQKAVPTQETHVWYRTF--MMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQV 62

Query: 404 MEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL--- 460
               D + DG +++ EF+A    + +   ++ L   F  +D + +G I+  EL +     
Sbjct: 63  YNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDADGNGSIDKNELLDMFMAV 122

Query: 461 ---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQY 509
              N +   S E+ IN + H +D + DG ++ EEF   M    D  +   + 
Sbjct: 123 QALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGMAKDQDLLEIVYKS 174

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  147 bits (373), Expect = 3e-40
 Identities = 71/310 (22%), Positives = 128/310 (41%), Gaps = 57/310 (18%)

Query: 57  DYDLGRELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLR--------TAVDIEDVRREV 107
            Y+   E+G G +G  +   D+ N G   A K +   +++        + +      REV
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTI------REV 62

Query: 108 QIMKHL--PKHPNIVSLKD-----TYEDDSAVHIVMELCEG--GELFDRIVARGHYTERA 158
            +++HL   +HPN+V L D       + ++ + +V E  +       D++          
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTET 121

Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-N 217
              +M  ++  +   H   V+HRDLKP+N L  +  +   +K  DFGL+  +       +
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTS 178

Query: 218 EIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---- 272
            +V + +Y APEVL + +Y   VD+WS G I   +    P F   ++      I+     
Sbjct: 179 VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237

Query: 273 ---------------SVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
                          +       P       + E  KDL+ K L  +P +R++A   L H
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297

Query: 314 PWLQNAKKAP 323
           P+ Q+ ++  
Sbjct: 298 PYFQDLERCK 307

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  147 bits (373), Expect = 6e-40
 Identities = 81/326 (24%), Positives = 125/326 (38%), Gaps = 55/326 (16%)

Query: 36  GSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR 95
           GS +        +   +     + + R  G+G FG   L  + + G   A K + +   R
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-R 61

Query: 96  TAVDIEDVRREVQIMKHLP--KHPNIVSLKDTY-------EDDSAVHIVMELCEGGELFD 146
                    RE+QIM+ L    HPNIV L+  +         D  +++VME      L  
Sbjct: 62  FR------NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114

Query: 147 RIVARGHYTERAAAAVMKT----IVEVVQVCHEQ--GVMHRDLKPENFLFANKKESSPLK 200
                          ++K     ++  +   H     V HRD+KP N L  N+     LK
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL-VNE-ADGTLK 172

Query: 201 AIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF 258
             DFG +    P E     + S YY APE++   ++Y   VD+WS G I   ++ G P F
Sbjct: 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

Query: 259 WAETEQGVAQAII-------RSVIDF-------------KRDPWPKV--------SENAK 290
             +   G    I+       R V+               K  PW  V        ++ A 
Sbjct: 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292

Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
           DL+  +L   P++R+   E L HP+ 
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPYF 318

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  146 bits (372), Expect = 8e-40
 Identities = 71/314 (22%), Positives = 122/314 (38%), Gaps = 66/314 (21%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKH 112
            Y+   ++G+G FG  +       G+K A K     K+    + E       RE++I++ 
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQL 72

Query: 113 LPKHPNIVSLKD--------TYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAV 162
           L KH N+V+L +              ++++V + CE     L   +     +T      V
Sbjct: 73  L-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRV 129

Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
           M+ ++  +   H   ++HRD+K  N L         LK  DFGL+  F   +       +
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQP---N 183

Query: 223 PY--------YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
            Y        Y  PE+L  +R+YGP +D+W AG I+  +    P     TEQ     I +
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243

Query: 273 -------------------SVIDFKRD---------PWPKVSENAKDLVKKMLNPDPKQR 304
                                ++  +                  A DL+ K+L  DP QR
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303

Query: 305 LTAEEVLEHPWLQN 318
           + +++ L H +  +
Sbjct: 304 IDSDDALNHDFFWS 317

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  144 bits (366), Expect = 1e-39
 Identities = 76/263 (28%), Positives = 122/263 (46%), Gaps = 15/263 (5%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV---RREVQIMKHLP 114
           Y +  +LG G     YL  D     K A K+I    +      E +    REV     L 
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFEREVHNSSQL- 68

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            H NIVS+ D  E+D   ++VME  EG  L + I + G  +   A      I++ ++  H
Sbjct: 69  SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLK 232
           +  ++HRD+KP+N L  + K    LK  DFG++         Q N ++G+  Y +PE  K
Sbjct: 129 DMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185

Query: 233 RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFKRDPWPKVSENAK 290
                   D++S G++LY +L G PPF  ET   +A + I  SV +   D    + ++  
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245

Query: 291 DLVKKMLNPDPKQR-LTAEEVLE 312
           +++ +    D   R  T +E+ +
Sbjct: 246 NVILRATEKDKANRYKTIQEMKD 268

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  143 bits (363), Expect = 3e-39
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 22/281 (7%)

Query: 49  PSGQDISIDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR----TAVDIE 101
           P  +  ++  +     +++G+G FG+ +    V +    A KS+               +
Sbjct: 9   PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68

Query: 102 DVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAA 160
           + +REV IM +L  HPNIV L     +     +VME    G+L+ R++ + H        
Sbjct: 69  EFQREVFIMSNL-NHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125

Query: 161 AVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSP--LKAIDFGLSVFFRPGEQF 216
            +M  I   ++    Q   ++HRDL+  N    +  E++P   K  DFGLS         
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSV 183

Query: 217 NEIVGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273
           + ++G+  +MAPE +   + +Y  + D +S  +ILY +L G  P + E   G  + I   
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGKIKFINMI 242

Query: 274 VIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
             +  R   P+      +++++   + DPK+R     +++ 
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156

 Score =  139 bits (352), Expect = 3e-39
 Identities = 34/157 (21%), Positives = 77/157 (49%), Gaps = 6/157 (3%)

Query: 346 KRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILME 405
            +A   V   L  +++  +KEAF M+D ++ G ++ E+++    + G+   + +L  +++
Sbjct: 2   DKAASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK 61

Query: 406 AADVDGDGSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
               +  G LN+  F+++ S  L    ++E +  AF+ FD   +  + IE +++ L +  
Sbjct: 62  ----EAPGPLNFTMFLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLENMG 117

Query: 465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
           D   +D +     +   +  G+  Y +F  M+K   +
Sbjct: 118 DNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGSGE 153

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  145 bits (368), Expect = 4e-39
 Identities = 76/303 (25%), Positives = 130/303 (42%), Gaps = 50/303 (16%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           ++   Y     +G G +G      D   G + A K +S+   ++ +  +   RE++++KH
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 84

Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMK 164
           + KH N++ L D      + E+ + V++V  L       D   IV     T+     ++ 
Sbjct: 85  M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIY 139

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSP 223
            I+  ++  H   ++HRDLKP N       E   LK +DFGL+   R         V + 
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA---RHTADEMTGYVATR 193

Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAET 262
           +Y APE++    +Y   VD+WS G I+  LL G   F                    AE 
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253

Query: 263 EQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
            + +    A+  I+S+    +  +       +  A DL++KML  D  +R+TA + L H 
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

Query: 315 WLQ 317
           +  
Sbjct: 314 YFA 316

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  144 bits (364), Expect = 4e-39
 Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 27/269 (10%)

Query: 56  IDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           IDY    +   +GRG FGV          +  A K     ++ +  + +    E++ +  
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAK--WRAKDVAIK-----QIESESERKAFIVELRQLSR 57

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ- 171
           +  HPNIV L     +   V +VME  EGG L++ +          AA  M   ++  Q 
Sbjct: 58  V-NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114

Query: 172 -----VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
                    + ++HRDLKP N L         LK  DFG +   +         GS  +M
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDIQ--THMTNNKGSAAWM 170

Query: 227 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK- 284
           APEV + + Y  + DV+S G+IL+ ++    PF  +   G A  I+ +V +  R P  K 
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKN 228

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
           + +  + L+ +  + DP QR + EE+++ 
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKI 257

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  145 bits (367), Expect = 4e-39
 Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 51/303 (16%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           ++   Y     +G G +G      D  +GEK A K +S+   ++ +  +   RE+ ++KH
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKH 79

Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMK 164
           + +H N++ L D      +  +    ++VM   +     D  +I+    ++E     ++ 
Sbjct: 80  M-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIM-GLKFSEEKIQYLVY 133

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSP 223
            +++ ++  H  GV+HRDLKP N       E   LK +DFGL+   R    +    V + 
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA---RHADAEMTGYVVTR 187

Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF----------------------- 258
           +Y APEV+    +Y   VD+WS G I+  +L G   F                       
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247

Query: 259 WAETEQGVAQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
             +     A++ I+S+    R  +    P+ S  A DL++KML  D  +RLTA + L HP
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307

Query: 315 WLQ 317
           + +
Sbjct: 308 FFE 310

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  145 bits (367), Expect = 6e-39
 Identities = 76/331 (22%), Positives = 117/331 (35%), Gaps = 78/331 (23%)

Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
            S  Y LG+ LG G FG+     D+ +G++FA K + +             RE+ IMK L
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVL 57

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAA------------ 161
             H NI+ L D +                         G      +              
Sbjct: 58  -DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 162 ----------VMKTIVEVVQV-------------------CHEQGVMHRDLKPENFLFAN 192
                     V+K+ +   +                     H  G+ HRD+KP+N L  N
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL-VN 175

Query: 193 KKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYI 250
             + + LK  DFG +    P E     + S +Y APE++     Y P +D+WS G +   
Sbjct: 176 -SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234

Query: 251 LLCGVPPFWAETEQGVAQAII-------RSVIDF-------------KRDPWPKV----- 285
           L+ G P F  ET       II       +  +               K   W K+     
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
              A DL++++L  +P  R+   E + HP+ 
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  144 bits (364), Expect = 1e-38
 Identities = 74/303 (24%), Positives = 135/303 (44%), Gaps = 50/303 (16%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           ++   Y   + +G G +G      D   G K A K + +   ++ +  +   RE++++KH
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKH 80

Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMK 164
           + +H N++ L D      T +D +  ++VM         D  +++      E     ++ 
Sbjct: 81  M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVY 135

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSP 223
            +++ ++  H  G++HRDLKP N       E   LK +DFGL+   R  +      V + 
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA---RQADSEMTGYVVTR 189

Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAET 262
           +Y APEV+     Y   VD+WS G I+  ++ G   F                    AE 
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249

Query: 263 EQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
            Q +    A+  ++ + + ++  +       S  A +L++KML  D +QR+TA E L HP
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309

Query: 315 WLQ 317
           + +
Sbjct: 310 YFE 312

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  143 bits (363), Expect = 2e-38
 Identities = 81/305 (26%), Positives = 126/305 (41%), Gaps = 50/305 (16%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           D+   Y     +G G +G+     D  N  + A K IS          +   RE++I+  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLR 81

Query: 113 LPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKT 165
             +H NI+ + D     T E    V+IV +L E     D  +++   H +       +  
Sbjct: 82  F-RHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQ 136

Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN----EIVG 221
           I+  ++  H   V+HRDLKP N L  N   +  LK  DFGL+    P         E V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSN-LLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 222 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WA 260
           + +Y APE++   + Y   +D+WS G IL  +L   P F                     
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253

Query: 261 ETEQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
           E    +    A+  + S+    + PW    P     A DL+ KML  +P +R+  E+ L 
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313

Query: 313 HPWLQ 317
           HP+L+
Sbjct: 314 HPYLE 318

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  142 bits (360), Expect = 2e-38
 Identities = 82/313 (26%), Positives = 132/313 (42%), Gaps = 58/313 (18%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           D+   Y   + LG G  G+ +   D +  ++ A K I    L     ++   RE++I++ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRR 64

Query: 113 LPKHPNIVSLKD--------------TYEDDSAVHIVMELCEGGELFD--RIVARGHYTE 156
           L  H NIV + +              +  + ++V+IV E  E     D   ++ +G   E
Sbjct: 65  L-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLE 119

Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
             A   M  ++  ++  H   V+HRDLKP N LF N ++   LK  DFGL+    P    
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINTEDLV-LKIGDFGLARIMDPHYSH 177

Query: 217 N----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF------------ 258
                E + + +Y +P +L    NY   +D+W+AG I   +L G   F            
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 259 -------WAETEQGV---AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQR 304
                    E  Q +       IR+ +     P     P +S  A D ++++L   P  R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297

Query: 305 LTAEEVLEHPWLQ 317
           LTAEE L HP++ 
Sbjct: 298 LTAEEALSHPYMS 310

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108

 Score =  133 bits (337), Expect = 1e-37
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 7/108 (6%)

Query: 394 NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEI 453
            + +AD+   + A       S  + EF A      K  + + + KAF   D+++SGFIE 
Sbjct: 5   GLKDADVAAALAACS--AADSFKHKEFFAKVGLASK--SLDDVKKAFYVIDQDKSGFIEE 60

Query: 454 EELRNAL---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           +EL+  L   +       +    A + D D D DG I  +EFA M+KA
Sbjct: 61  DELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMIKA 108

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108

 Score = 64.1 bits (157), Expect = 6e-13
 Identities = 19/62 (30%), Positives = 33/62 (53%), Gaps = 3/62 (4%)

Query: 364 LKEAFEMMDTNKRGKINLEELRL---GLLKGGQNIPEADLQILMEAADVDGDGSLNYGEF 420
           +K+AF ++D +K G I  +EL+L         + + +A+ +  +   D DGDG +   EF
Sbjct: 43  VKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEF 102

Query: 421 VA 422
            A
Sbjct: 103 AA 104

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  140 bits (354), Expect = 1e-37
 Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 20/268 (7%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV---RREVQIMKHLP 114
           Y+LG  LG G     +L  D+ +    A K +   +   A D       RRE Q    L 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRREAQNAAAL- 69

Query: 115 KHPNIVSLKDTYEDDSAVH----IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
            HP IV++ DT E ++       IVME  +G  L D +   G  T + A  V+    + +
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE----QFNEIVGSPYYM 226
              H+ G++HRD+KP N + +       +K +DFG++           Q   ++G+  Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 227 APEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
           +PE  + +      DV+S G +LY +L G PPF  ++   VA   +R            +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246

Query: 286 SENAKDLVKKMLNPDPKQR-LTAEEVLE 312
           S +   +V K L  +P+ R  TA E+  
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRA 274

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  140 bits (354), Expect = 3e-37
 Identities = 91/327 (27%), Positives = 137/327 (41%), Gaps = 86/327 (26%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQI 109
           +IS D+ L   LG G +GV    T    GE  A   I  KK+             RE++I
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVA---I--KKIEPFDKPLFALRTLREIKI 62

Query: 110 MKHLPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFD--RIVARGHYTE------ 156
           +KH  KH NI+++ +     ++E+ + V+I+ EL +     D  R+++    ++      
Sbjct: 63  LKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYF 117

Query: 157 -----RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211
                RA    +K +       H   V+HRDLKP N L  N   +  LK  DFGL+    
Sbjct: 118 IYQTLRA----VKVL-------HGSNVIHRDLKPSN-LLIN--SNCDLKVCDFGLARIID 163

Query: 212 PGEQFNEIVGSP-----------YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVP-- 256
                N                 +Y APEV+     Y   +DVWS G IL  L    P  
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

Query: 257 ------------------PFWAETEQGV----AQAIIRSVIDFKRDPW----PKVSENAK 290
                             P      + +    A+  I+S+  +   P     P+V+    
Sbjct: 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI 283

Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           DL+++ML  DP +R+TA+E LEHP+LQ
Sbjct: 284 DLLQRMLVFDPAKRITAKEALEHPYLQ 310

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  141 bits (358), Expect = 4e-37
 Identities = 72/311 (23%), Positives = 127/311 (40%), Gaps = 55/311 (17%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
            +   Y   + +G G  G+     D       A K +S+   +     +   RE+ +MK 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 117

Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD-RIVARGHYTERAAAAVMKT 165
           +  H NI+SL +      T E+   V++VMEL +     +   V +        + ++  
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQ 172

Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           ++  ++  H  G++HRDLKP N +    K    LK +DFGL+            V + YY
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229

Query: 226 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 265
            APEV L   Y   VD+WS G I+  ++     F                     E  + 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289

Query: 266 V---AQAIIRSVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLT 306
           +    +  + +   +    +PK+                +  A+DL+ KML  DP +R++
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349

Query: 307 AEEVLEHPWLQ 317
            ++ L+HP++ 
Sbjct: 350 VDDALQHPYIN 360

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  138 bits (350), Expect = 4e-37
 Identities = 55/294 (18%), Positives = 116/294 (39%), Gaps = 55/294 (18%)

Query: 52  QDISIDYD---LGRELGRGEFGVTYLCT---DVNNGEKFACKSISKKKLRTAVDIEDVRR 105
           Q+  I ++   +G  +G+G FG  Y      +V      A + I  ++      ++  +R
Sbjct: 26  QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEV------AIRLIDIERD-NEDQLKAFKR 78

Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
           EV   +   +H N+V           + I+  LC+G  L+  +       +      +  
Sbjct: 79  EVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD------VNK 131

Query: 166 IVEV-VQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS------VFFRP 212
             ++  ++       H +G++H+DLK +N  + N K    +   DFGL          R 
Sbjct: 132 TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRR 187

Query: 213 GEQFNEIVGSPYYMAPEVLKRN----------YGPEVDVWSAGVILYILLCGVPPFWAET 262
            ++     G   ++APE++++           +    DV++ G I Y L     PF    
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF---- 243

Query: 263 EQGV-AQAIIRSVIDFKRDPWPKVS--ENAKDLVKKMLNPDPKQRLTAEEVLEH 313
            +   A+AII  +    +    ++   +   D++      + ++R T  ++++ 
Sbjct: 244 -KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  137 bits (347), Expect = 9e-37
 Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 33/282 (11%)

Query: 49  PSGQDISIDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
             G D+ I +    +  ++G G FG  +      +G   A K + ++    A  + +  R
Sbjct: 27  MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDF-HAERVNEFLR 83

Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
           EV IMK L +HPNIV           + IV E    G L+  +    H +        + 
Sbjct: 84  EVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKSGAREQLDERR 138

Query: 166 IVEV-VQVC------HEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQ 215
            + +   V       H +   ++HR+LK  N L   K     +K  DFGLS +       
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLS 195

Query: 216 FNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIR 272
                G+P +MAPEVL+      + DV+S GVIL+ L     P+       +  AQ +  
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW-----GNLNPAQVVAA 250

Query: 273 SVIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
                KR   P+ ++     +++     +P +R +   +++ 
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109

 Score =  130 bits (330), Expect = 1e-36
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 7/110 (6%)

Query: 392 GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFI 451
              + +AD+   ++A   +   S NY  F A      K A+D  + KAF   D+++SGFI
Sbjct: 4   SGILADADVAAALKA--CEAADSFNYKAFFAKVGLTAKSADD--IKKAFFVIDQDKSGFI 59

Query: 452 EIEELRNAL---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           E +EL+  L   +       +    A +   D+D DG I  +E+A ++KA
Sbjct: 60  EEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGDGAIGVDEWAALVKA 109

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109

 Score = 63.8 bits (156), Expect = 9e-13
 Identities = 21/62 (33%), Positives = 38/62 (61%), Gaps = 3/62 (4%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGL---LKGGQNIPEADLQILMEAADVDGDGSLNYGEF 420
           +K+AF ++D +K G I  +EL+L L     G + + +A+ +  ++A D DGDG++   E+
Sbjct: 44  IKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGDGAIGVDEW 103

Query: 421 VA 422
            A
Sbjct: 104 AA 105

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  136 bits (346), Expect = 1e-36
 Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 15/262 (5%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y L R +GRG  G  Y   D       A K +S+      V    ++RE +    L + P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEP 94

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
           ++V + D  E D  +++ M L  G +L   +  +G      A A+++ I   +   H  G
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVLK 232
             HRD+KPEN L +          +DFG++            Q    VG+ YYMAPE   
Sbjct: 155 ATHRDVKPENILVS---ADDFAYLVDFGIA---SATTDEKLTQLGNTVGTLYYMAPERFS 208

Query: 233 RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
            ++     D+++   +LY  L G PP+  +    V  A I   I       P +      
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDA 267

Query: 292 LVKKMLNPDPKQR-LTAEEVLE 312
           ++ + +  +P+ R +T  ++  
Sbjct: 268 VIARGMAKNPEDRYVTCGDLSA 289

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204

 Score =  133 bits (336), Expect = 2e-36
 Identities = 33/200 (16%), Positives = 75/200 (37%), Gaps = 32/200 (16%)

Query: 342 NKLKKRALQVVAEFLSVEEVAGLKEAFE-MMDTNKRGKINLEELRLGLLKGGQNIPEADL 400
            +      +     +   + A L+E ++  ++    G + + E +              +
Sbjct: 3   QQFSWEEAEENGA-VGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYV 61

Query: 401 QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL 460
           + +  A D +GD ++++ E+VA    + +   +  L   F  +D++R+G I+ +EL + +
Sbjct: 62  EAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIV 121

Query: 461 -----------------NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA----- 498
                                  + E+V++ I   VD + DG++S  EF    +      
Sbjct: 122 ESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKWVM 181

Query: 499 --------GTDWRKASRQYS 510
                    + W    R+ S
Sbjct: 182 KMLQMDLNPSSWISQQRRKS 201

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  138 bits (348), Expect = 4e-36
 Identities = 71/325 (21%), Positives = 123/325 (37%), Gaps = 70/325 (21%)

Query: 60  LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKH 116
            G ++GRG +G  Y     D  + + +A K I    +  +A       RE+ +++ L KH
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC------REIALLREL-KH 77

Query: 117 PNIVSLKD--TYEDDSAVHIVMELCE--------GGELFDRIVARGHYTERAAAAVMKTI 166
           PN++SL+       D  V ++ +  E                            +++  I
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESS-PLKAIDFGLSVFF----RPGEQFNEIVG 221
           ++ +   H   V+HRDLKP N L   +      +K  D G +  F    +P    + +V 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 222 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA---------I 270
           + +Y APE+L   R+Y   +D+W+ G I   LL   P F    E               I
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257

Query: 271 IR---------------------SVIDFKRDPW-------------PKVSENAKDLVKKM 296
                                   + DF+R+ +              K    A  L++K+
Sbjct: 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317

Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKK 321
           L  DP +R+T+E+ ++ P+      
Sbjct: 318 LTMDPIKRITSEQAMQDPYFLEDPL 342

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172

 Score =  131 bits (331), Expect = 5e-36
 Identities = 31/164 (18%), Positives = 68/164 (41%), Gaps = 7/164 (4%)

Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDGDGSL 415
           ++ + + L   F+ +D ++ G I+  EL+  L  G         ++ ++   D +    +
Sbjct: 2   ALPDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGV 61

Query: 416 NYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAI 475
           N+ EF  V  ++            F  +DR+ SG I+  EL+ AL+       +   + +
Sbjct: 62  NFSEFTGVWKYITDW------QNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDIL 115

Query: 476 MHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISL 519
           +   D    G+I++++F              R+Y  ++   I +
Sbjct: 116 IRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQV 159

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172

 Score = 84.6 bits (210), Expect = 2e-19
 Identities = 22/103 (21%), Positives = 45/103 (43%), Gaps = 7/103 (6%)

Query: 354 EFLSV-EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           EF  V + +   +  F   D +  G I+  EL+  L   G  + +    IL+   D  G 
Sbjct: 65  EFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGR 124

Query: 413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEE 455
           G + + +F+   + L+++         F  +D ++ G+I++  
Sbjct: 125 GQIAFDDFIQGCIVLQRLT------DIFRRYDTDQDGWIQVSY 161

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172

 Score = 77.3 bits (191), Expect = 8e-17
 Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 3/97 (3%)

Query: 430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRI 487
           + +   L   F   D++RSG I   EL+ AL++    +      + +I+   D +    +
Sbjct: 3   LPDQSFLWNVFQRVDKDRSGVISDTELQQALSN-GTWTPFNPVTVRSIISMFDRENKAGV 61

Query: 488 SYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMRE 524
           ++ EF  + K  TDW+   R Y R+    I    +++
Sbjct: 62  NFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQ 98

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166

 Score =  130 bits (329), Expect = 8e-36
 Identities = 36/163 (22%), Positives = 63/163 (38%), Gaps = 7/163 (4%)

Query: 343 KLKKRALQV---VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
           K K+RA +    V       E+   KEAF ++D N  G I+ ++LR      G+   + +
Sbjct: 3   KAKRRAAEGSSNVFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNE 62

Query: 400 LQILMEAADVDGDGSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
               M     +  G +N+  F+ +    LK    ++ +  AF   D +  G I+   L  
Sbjct: 63  ELDAM---IKEASGPINFTVFLTMFGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEE 119

Query: 459 ALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
            L         + I  +      D  G + Y+    ++  G D
Sbjct: 120 LLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHGED 162

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 15/71 (21%), Positives = 30/71 (42%), Gaps = 3/71 (4%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           +  AF+++D + +G I    L   L  GG      +++ +  A   D  G+++Y     V
Sbjct: 97  IMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYV 156

Query: 424 SVHLKKMANDE 434
              +    + E
Sbjct: 157 ---ITHGEDAE 164

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109

 Score =  128 bits (323), Expect = 9e-36
 Identities = 27/108 (25%), Positives = 47/108 (43%), Gaps = 7/108 (6%)

Query: 395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIE 454
           +   D+   +        G+ +Y  F  +     K   D  + + F   D+++SGFIE E
Sbjct: 6   LKADDINKAIS--AFKDPGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEE 61

Query: 455 ELRNAL---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG 499
           EL+  L   +       +    A++   D+D DG+I  +EFA M+   
Sbjct: 62  ELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMVAQA 109

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109

 Score = 63.7 bits (156), Expect = 9e-13
 Identities = 20/62 (32%), Positives = 34/62 (54%), Gaps = 3/62 (4%)

Query: 364 LKEAFEMMDTNKRGKINLEELRL---GLLKGGQNIPEADLQILMEAADVDGDGSLNYGEF 420
           +KE FE++D ++ G I  EEL+    G    G+++ + + + L+ A D D DG +   EF
Sbjct: 43  VKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEF 102

Query: 421 VA 422
             
Sbjct: 103 AK 104

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  136 bits (344), Expect = 9e-36
 Identities = 70/311 (22%), Positives = 123/311 (39%), Gaps = 55/311 (17%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
            +   Y   + +G G  G+     D       A K +S+   +     +   RE+ +MK 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 80

Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD-RIVARGHYTERAAAAVMKT 165
           +  H NI+ L +      + E+   V+IVMEL +     +   V +        + ++  
Sbjct: 81  V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 135

Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           ++  ++  H  G++HRDLKP N +    K    LK +DFGL+            V + YY
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 226 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 265
            APEV L   Y   VD+WS G I+  ++ G   F                     E  + 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

Query: 266 V---AQAIIRSVIDFKRDPW----------------PKVSENAKDLVKKMLNPDPKQRLT 306
           +    +  + +   +    +                   +  A+DL+ KML  D  +R++
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312

Query: 307 AEEVLEHPWLQ 317
            +E L+HP++ 
Sbjct: 313 VDEALQHPYIN 323

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  134 bits (340), Expect = 2e-35
 Identities = 67/312 (21%), Positives = 119/312 (38%), Gaps = 56/312 (17%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----DIEDVR--- 104
            +   Y + R +  G +G      D + G   A K +              D    +   
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 105 REVQIMKHLPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFD--RIVARGHY--T 155
           RE++++ H   HPNI+ L+D            +++V EL       D  +++       +
Sbjct: 78  REIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVIS 132

Query: 156 ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
            +     M  I+  + V HE GV+HRDL P N L     +++ +   DF L+        
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADAN 189

Query: 216 FNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF--------------- 258
               V   +Y APE++   + +   VD+WSAG ++  +      F               
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249

Query: 259 --------WAETEQGVAQAIIRSVI-DFKRDPW----PKVSENAKDLVKKMLNPDPKQRL 305
                           A+  +R+ + +     W    P     A DL+ KML  +P++R+
Sbjct: 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309

Query: 306 TAEEVLEHPWLQ 317
           + E+ L HP+ +
Sbjct: 310 STEQALRHPYFE 321

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143

 Score =  127 bits (322), Expect = 4e-35
 Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 5/146 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
               ++   KEAF M+D N+ G I+ E+L   L   G+N  +  L+ +M     +  G +
Sbjct: 1   FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMS----EAPGPI 56

Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           N+  F+ +    L     ++ +  AF+ FD   SGFI  + LR  L    D   ++ ++ 
Sbjct: 57  NFTMFLTMFGEKLNGTDPEDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDE 116

Query: 475 IMHDVDTDKDGRISYEEFAVMMKAGT 500
           +  +   DK G  +Y EF  ++K G 
Sbjct: 117 MYREAPIDKKGNFNYVEFTRILKHGA 142

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263

 Score =  131 bits (331), Expect = 5e-35
 Identities = 38/200 (19%), Positives = 75/200 (37%), Gaps = 37/200 (18%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD------LQILMEAADV 409
            S+   +   E +   D +  G +  +EL+  + +  Q   +A       ++  ++    
Sbjct: 10  SSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQ 69

Query: 410 DGDGSLNYGEFVAV---------SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL 460
             DG +   E   V             +++ + E   K +  +D + SGFIE EEL+N L
Sbjct: 70  RDDGKIGIVELAHVLPTEENFLLLFRCQQLKSCEEFMKTWRKYDTDHSGFIETEELKNFL 129

Query: 461 ND--------EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK--------------A 498
            D          DT   +  + ++   D++ DG++   E A ++                
Sbjct: 130 KDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFLLKFQGIKMC 189

Query: 499 GTDWRKASRQYSRERFNSIS 518
           G ++ KA   Y ++    I 
Sbjct: 190 GKEFNKAFELYDQDGNGYID 209

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263

 Score =  115 bits (289), Expect = 3e-29
 Identities = 27/157 (17%), Positives = 58/157 (36%), Gaps = 21/157 (13%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNI--------PEADLQILMEAADVDGDGSL 415
             + +   DT+  G I  EEL+  L    +                ++++  D + DG L
Sbjct: 105 FMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKL 164

Query: 416 NYGEFVAV--------SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALND----- 462
              E   +                  +  +KAF  +D++ +G+I+  EL   L D     
Sbjct: 165 ELTEMARLLPVQENFLLKFQGIKMCGKEFNKAFELYDQDGNGYIDENELDALLKDLCEKN 224

Query: 463 EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG 499
           + +    ++     + +     G++   + A+++ AG
Sbjct: 225 KQELDINNISTYKKNIMALSDGGKLYRTDLALILSAG 261

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110

 Score =  124 bits (314), Expect = 2e-34
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 9/109 (8%)

Query: 395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIE 454
           +   D++  ++A  V  +GS N+ +F A+ V LK M+ ++ + K F   D + SGFIE E
Sbjct: 7   LKADDIKKALDA--VKAEGSFNHKKFFAL-VGLKAMSAND-VKKVFKAIDADASGFIEEE 62

Query: 455 ELRNALNDEVDTSGEDV----INAIMHDVDTDKDGRISYEEFAVMMKAG 499
           EL+  L       G D+      A +   D D DG+I  +EF  ++   
Sbjct: 63  ELKFVLK-SFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLVHEA 110

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110

 Score = 70.3 bits (173), Expect = 5e-15
 Identities = 23/105 (21%), Positives = 44/105 (41%), Gaps = 6/105 (5%)

Query: 322 APNVSLGETVKARLKQFSVMNKLKKRA-LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKIN 380
           A ++   + +K  L           +    +V           +K+ F+ +D +  G I 
Sbjct: 3   AKDLLKADDIKKALDAVKAEGSFNHKKFFALVGLKAMSAN--DVKKVFKAIDADASGFIE 60

Query: 381 LEELRL---GLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVA 422
            EEL+         G+++ +A+ +  ++AAD DGDG +   EF  
Sbjct: 61  EEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFET 105

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  129 bits (327), Expect = 2e-34
 Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 26/274 (9%)

Query: 56  IDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-TAVDIEDVRREVQIMK 111
           ID+    L   +G G FG  Y       G++ A K+         +  IE+VR+E ++  
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L KHPNI++L+     +  + +VME   GG L   +++               I   + 
Sbjct: 62  ML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMN 119

Query: 172 VCHEQG---VMHRDLKPENFLFANKKESSP-----LKAIDFGLSVFFRPGEQFNEIVGSP 223
             H++    ++HRDLK  N L   K E+       LK  DFGL+  +    + +   G+ 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAY 178

Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVIDFKRD 280
            +MAPEV++ + +    DVWS GV+L+ LL G  PF     +G+          ++    
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGIDGLAVAYGVAMNKLAL 233

Query: 281 PWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
           P P    E    L++   NPDP  R +   +L+ 
Sbjct: 234 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  129 bits (325), Expect = 6e-34
 Identities = 38/258 (14%), Positives = 69/258 (26%), Gaps = 35/258 (13%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y L    G       +   D     + A   +  + +     +++       +  +   P
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
            +  + D     +   +V E   GG L +  VA    +   A   M+++       H  G
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
           V      P     +             G  V           +  P  M          P
Sbjct: 150 VALSIDHPSRVRVS-----------IDGDVV-----------LAYPATMPDA------NP 181

Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW---PKVSENAKDLVK 294
           + D+   G  LY LL    P      +       R       +P      +      +  
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241

Query: 295 KMLNPDPKQRLTAEEVLE 312
           + +  D   R +A  +L 
Sbjct: 242 RSVQGDGGIR-SASTLLN 258

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191

 Score =  125 bits (316), Expect = 8e-34
 Identities = 25/171 (14%), Positives = 55/171 (32%), Gaps = 21/171 (12%)

Query: 348 ALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-----GQNIPEADLQI 402
             ++ ++F +   +   K  F  +D N  GKI+L+E+            G    +A    
Sbjct: 2   NSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHK 61

Query: 403 LMEAADVDGDG-----SLNYGEFVAVSVHLKKMANDEH-----------LHKAFSFFDRN 446
               A   G G       ++  ++     L     +++               F   D++
Sbjct: 62  DAVEAFFGGAGMKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKD 121

Query: 447 RSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           ++G I ++E +            +         D D+ G++  +E      
Sbjct: 122 QNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHL 172

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191

 Score = 65.6 bits (160), Expect = 1e-12
 Identities = 17/86 (19%), Positives = 30/86 (34%)

Query: 341 MNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL 400
             KL    L+  A+             F+++D ++ G I L+E +      G      D 
Sbjct: 88  WKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDC 147

Query: 401 QILMEAADVDGDGSLNYGEFVAVSVH 426
           +      D+D  G L+  E     + 
Sbjct: 148 EETFRVCDIDESGQLDVDEMTRQHLG 173

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198

 Score =  126 bits (317), Expect = 9e-34
 Identities = 34/150 (22%), Positives = 61/150 (40%), Gaps = 10/150 (6%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL-QILMEAADVDGDGS 414
           LS  E     + F  M     G++ L E +        +       + + E  D + DG 
Sbjct: 11  LSATECHQWYKKF--MTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNKDGY 68

Query: 415 LNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL-------NDEVDTS 467
           +++ E+VA    + K   D+ L   F  +D + +G I+  EL N +             +
Sbjct: 69  IDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMT 128

Query: 468 GEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
            E+  N +   +D + DG +S EEF   ++
Sbjct: 129 AEEFTNMVFDKIDINGDGELSLEEFMEGVQ 158

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  130 bits (329), Expect = 3e-33
 Identities = 83/376 (22%), Positives = 135/376 (35%), Gaps = 81/376 (21%)

Query: 12  SGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGV 71
            G  AK ++          Y    GS V              ++  Y++ + +G+G FG 
Sbjct: 61  LGLNAKKRQGMTGGPNNGGYDDDQGSYVQV--------PHDHVAYRYEVLKVIGKGSFGQ 112

Query: 72  TYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPKHP-----NIVSLKDT 125
                D    +  A K + ++K+       E     ++I++HL K       N++ + + 
Sbjct: 113 VVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-----IRILEHLRKQDKDNTMNVIHMLEN 167

Query: 126 YEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
           +   + + +  EL     L++ I       ++         +I++ +   H+  ++H DL
Sbjct: 168 FTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDL 226

Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNYGPEVDVW 242
           KPEN L   +   S +K IDFG S +    ++    + S +Y APEV L   YG  +D+W
Sbjct: 227 KPENILLKQQG-RSGIKVIDFGSSCY--EHQRVYTYIQSRFYRAPEVILGARYGMPIDMW 283

Query: 243 SAGVILYILLCGVPPFWAETEQG------------------------------------- 265
           S G IL  LL G P    E E                                       
Sbjct: 284 SLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCT 343

Query: 266 --------VAQAIIRSVIDFKRDP-----WPKVSENAKD-----LVKKMLNPDPKQRLTA 307
                   V     RS     R P     W    +   D      +K+ L  DP  R+T 
Sbjct: 344 VTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403

Query: 308 EEVLEHPWLQNAKKAP 323
            + L HPWL+     P
Sbjct: 404 GQALRHPWLRRRLPKP 419

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  129 bits (326), Expect = 3e-33
 Identities = 70/336 (20%), Positives = 121/336 (36%), Gaps = 74/336 (22%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHL--- 113
           Y L R+LG G F   +L  D+ N    A K +   K    A + E     +++++ +   
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE-----IKLLQRVNDA 75

Query: 114 -------PKHPNIVSLKD--TYEDDSAVH--IVMELCEGGELFDRIVARGH--YTERAAA 160
                      +I+ L D   ++  + VH  +V E+  G  L   I    H         
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134

Query: 161 AVMKTIVEVVQVCH-EQGVMHRDLKPENFLFANKKES---SPLKAIDFGLSVFFRPGEQF 216
            + K ++  +   H   G++H D+KPEN L            +K  D G + +    E +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHY 192

Query: 217 NEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV-------AQ 268
              + +  Y +PEV L   +G   D+WS   +++ L+ G   F  +            AQ
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252

Query: 269 AI--------------------------IRSVIDFKRDPWPKVSENA-----------KD 291
            I                          +R++   K  P   V                D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
            +  ML  DP++R  A  ++ HPWL++      + +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109

 Score =  120 bits (304), Expect = 5e-33
 Identities = 32/110 (29%), Positives = 50/110 (45%), Gaps = 7/110 (6%)

Query: 392 GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFI 451
              +   D++  + +       S NY  F + +V L     D+ + K F   D+++SGFI
Sbjct: 4   TDILSAKDIESALSS--CQAADSFNYKSFFS-TVGLSSKTPDQ-IKKVFGILDQDKSGFI 59

Query: 452 EIEELRNAL---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           E EEL+  L   +            A +   DTD DG+I  EEF  ++KA
Sbjct: 60  EEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGDGKIGVEEFQSLVKA 109

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109

 Score = 62.3 bits (152), Expect = 3e-12
 Identities = 22/70 (31%), Positives = 36/70 (51%), Gaps = 3/70 (4%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK---GGQNIPEADLQILMEAADVDGD 412
           LS +    +K+ F ++D +K G I  EEL+L L       + +  A+ +  + A D DGD
Sbjct: 36  LSSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGD 95

Query: 413 GSLNYGEFVA 422
           G +   EF +
Sbjct: 96  GKIGVEEFQS 105

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208

 Score =  123 bits (311), Expect = 7e-33
 Identities = 26/168 (15%), Positives = 60/168 (35%), Gaps = 22/168 (13%)

Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD---------L 400
           Q   E L  + ++ L + F+  D +  GK+ ++E+     +  Q +   D         +
Sbjct: 24  QFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAV 83

Query: 401 QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEH-----------LHKAFSFFDRNRSG 449
           ++      V+    L   ++V  +    +   +              +  +   D +  G
Sbjct: 84  RVFFLHKGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDG 143

Query: 450 FIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
            ++++EL+  +    D   E          DTDK G++   E   + +
Sbjct: 144 TVDVDELKTMM-KAFDVPQEAA-YTFFEKADTDKSGKLERTELVHLFR 189

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208

 Score = 40.2 bits (94), Expect = 6e-04
 Identities = 18/113 (15%), Positives = 38/113 (33%), Gaps = 15/113 (13%)

Query: 362 AGLKEAFEMMDTNKRGKINLEE-------LRLGLLKGGQNIPEADLQILMEAA----DVD 410
             ++  F          +  E+             +  +    + + +L  +     D D
Sbjct: 81  DAVRVFFLHKGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDD 140

Query: 411 GDGSLNYGEFVAVSVHLKKM-ANDEHLHKAFSFFDRNRSGFIEIEELRNALND 462
           GDG+++  E   +   +K      E  +  F   D ++SG +E  EL +    
Sbjct: 141 GDGTVDVDELKTM---MKAFDVPQEAAYTFFEKADTDKSGKLERTELVHLFRK 190

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score =  122 bits (307), Expect = 9e-33
 Identities = 29/157 (18%), Positives = 52/157 (33%), Gaps = 18/157 (11%)

Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD--LQILMEA-------- 406
           S   V  +K  F  +D +K G I   +      +  +         ++LM++        
Sbjct: 1   SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNF 60

Query: 407 -ADVDGDGSLNYGEFVAVSVHLKKMANDEH-----LHKAFSFFDRNRSGFIEIEELRNAL 460
              V G   ++   F+     + K    +      L   F   D N    I  +E     
Sbjct: 61  LTAVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFF 120

Query: 461 NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
              +    + +  A    +DT+ DG +S EEF +   
Sbjct: 121 --GMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGS 155

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 12/95 (12%), Positives = 24/95 (25%), Gaps = 14/95 (14%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNAL-----NDEVDTSGEDVINAIMHDV------DTD 482
           + +   F+  D ++ G I   +  +         E+      V+   +  V         
Sbjct: 6   QKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVA 65

Query: 483 KDGRISYEEFAVMMKA---GTDWRKASRQYSRERF 514
               I    F   MK      + +          F
Sbjct: 66  GGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFF 100

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 17/119 (14%), Positives = 38/119 (31%), Gaps = 15/119 (12%)

Query: 356 LSVEEVAGLKEAFEMM------DTNKRGKINLEE-----LRLGLLKGGQNIPEADLQILM 404
           +  E    L ++   +             I+          +      +++ E  L +  
Sbjct: 41  MKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFF 100

Query: 405 EAADVDGDGSLNYGEFVAVSVHLKKM-ANDEHLHKAFSFFDRNRSGFIEIEELRNALND 462
            A D + D +++  E+         +  +      +F   D N  G + +EE   A +D
Sbjct: 101 RAVDTNEDNNISRDEYGIF---FGMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGSD 156

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229

 Score =  122 bits (308), Expect = 3e-32
 Identities = 35/190 (18%), Positives = 75/190 (39%), Gaps = 15/190 (7%)

Query: 321 KAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKIN 380
                 L ++V+  L+  +V ++ +   L       + +E+  L   F+    +  G +N
Sbjct: 26  GLIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNECPS--GVVN 83

Query: 381 LEELRLGL-LKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKA 439
            E  +        Q         L  A D D +G++++ +F+     L +    E L+ A
Sbjct: 84  EETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWA 143

Query: 440 FSFFDRNRSGFIEIEELRNAL------------NDEVDTSGEDVINAIMHDVDTDKDGRI 487
           F+ +D N+ G+I  EE+ + +                + +    +      +D +KDG +
Sbjct: 144 FNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVV 203

Query: 488 SYEEFAVMMK 497
           + +EF    +
Sbjct: 204 TIDEFIESCQ 213

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  124 bits (314), Expect = 4e-32
 Identities = 62/319 (19%), Positives = 114/319 (35%), Gaps = 44/319 (13%)

Query: 56  IDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
                   G  LG+G FG     T    GE    K + +             +EV++M+ 
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRC 63

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQ 171
           L +HPN++        D  ++ + E  +GG L   I +                V     
Sbjct: 64  L-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP------WSQRVSFAKD 116

Query: 172 VC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS---------------VFF 210
           +       H   ++HRDL   N L    +E+  +   DFGL+               +  
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173

Query: 211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 269
              ++   +VG+PY+MAPE++  R+Y  +VDV+S G++L  ++  V              
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYLPRTMD 231

Query: 270 IIRSVIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLG 328
              +V  F     P     +   +  +  + DP++R +  ++    WL+  +      L 
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMHLAGHLP 289

Query: 329 ETVKARLKQFSVMNKLKKR 347
              +            ++ 
Sbjct: 290 LGPQLEQLDRGFWETYRRG 308

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  122 bits (309), Expect = 1e-31
 Identities = 70/290 (24%), Positives = 115/290 (39%), Gaps = 60/290 (20%)

Query: 56  IDYD---LGRELGRGEFGVTYL---CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
           I      +G+ +G G FG  Y      DV      A K ++     T   ++  + EV +
Sbjct: 21  IPDGQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAP-TPQQLQAFKNEVGV 73

Query: 110 MKHLPKHPNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
           ++   +H NI+                  IV + CEG  L+  + A     E      MK
Sbjct: 74  LRKT-RHVNILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASETKFE------MK 120

Query: 165 TIVEV-VQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS---VFFRPGE 214
            ++++  Q        H + ++HRDLK  N       E + +K  DFGL+     +    
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSH 177

Query: 215 QFNEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQ 268
           QF ++ GS  +MAPEV++      Y  + DV++ G++LY L+ G  P+       +    
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRD 232

Query: 269 AIIRSVI-DFKRDPWPKVSENA----KDLVKKMLNPDPKQRLTAEEVLEH 313
            II  V          KV  N     K L+ + L     +R +   +L  
Sbjct: 233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  125 bits (315), Expect = 2e-31
 Identities = 75/362 (20%), Positives = 128/362 (35%), Gaps = 113/362 (31%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
            +  +Y +   +GRG +G  YL  D N  +  A K ++ +     +D + + RE+ I+  
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNR 81

Query: 113 LPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTE----------- 156
           L K   I+ L D            ++IV+E+ +  +L          TE           
Sbjct: 82  L-KSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLL 139

Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
                    I       HE G++HRDLKP N L  N  +   +K  DFGL+      +  
Sbjct: 140 LG----ENFI-------HESGIIHRDLKPANCL-LN--QDCSVKVCDFGLARTINSEKDT 185

Query: 217 NEIVGSP-----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYIL 251
           N +                           +Y APE++  + NY   +D+WS G I   L
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 252 LC-----------------GVPPFWAETEQGVAQAIIRSVID------------------ 276
           L                  G   F    ++   +   +S  D                  
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305

Query: 277 ----------------FKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
                            K        P +S++  +L++ ML  +P +R+T ++ L+HP+L
Sbjct: 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

Query: 317 QN 318
           ++
Sbjct: 366 KD 367

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  121 bits (306), Expect = 2e-31
 Identities = 41/276 (14%), Positives = 91/276 (32%), Gaps = 36/276 (13%)

Query: 56  IDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           ID+       +L     G  +       G     K +  +   +     D   E   ++ 
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRI 63

Query: 113 LPKHPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
              HPN++ +             ++      G L++ +    ++    + AV   +    
Sbjct: 64  F-SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL---- 118

Query: 171 QVC--------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
            +          E  +    L   + +          +     +   F    Q    + +
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDM---TARISMADVKFSF----QSPGRMYA 171

Query: 223 PYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
           P ++APE L++          D+WS  V+L+ L+    PF    +    +  ++  ++  
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADLSNMEIGMKVALEGL 228

Query: 279 RDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
           R   P  +S +   L+K  +N DP +R   + ++  
Sbjct: 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  123 bits (311), Expect = 2e-31
 Identities = 72/379 (18%), Positives = 130/379 (34%), Gaps = 98/379 (25%)

Query: 14  KRAKGKKEKPNPFYGDE---YVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFG 70
                 +E       DE   +    G  + +                + + R++G G FG
Sbjct: 5   HHHSSGRENLYFQGDDEIVHFSWKKGMLLNNA---------------FLVIRKMGDGTFG 49

Query: 71  VTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPKHP----NIVSLKDT 125
              LC  ++N + +A K + + KK   +  IE       I+K +        NIV     
Sbjct: 50  RVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADILKKIQNDDINNNNIVKYHGK 104

Query: 126 YEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
           +     + ++ E   G  L++ I    +  +           I++ +    +  + H DL
Sbjct: 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDL 163

Query: 184 KPENFLFAN----------------------KKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
           KPEN L  +                      + +S+ +K IDFG + F    +    I+ 
Sbjct: 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIIN 221

Query: 222 SPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRS 273
           +  Y APEV L   +    D+WS G +L  L  G   F              + Q I ++
Sbjct: 222 TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKN 281

Query: 274 VID----------FKRDP----WPKVSENAK---------------------DLVKKMLN 298
           ++             +D     WP+ + +                       D +  +L 
Sbjct: 282 MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341

Query: 299 PDPKQRLTAEEVLEHPWLQ 317
            DP  R +  E+L+H +L+
Sbjct: 342 IDPTLRPSPAELLKHKFLE 360

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272

 Score =  120 bits (303), Expect = 4e-31
 Identities = 37/203 (18%), Positives = 66/203 (32%), Gaps = 35/203 (17%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD----------LQILME 405
            +  + AG  + ++  D +  G I  +EL        + +   D           +  M 
Sbjct: 5   FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMS 64

Query: 406 AADVDGDGSLNYGEFVAV-----------SVHLKKMANDEHLHKAFSFFDRNRSGFIEIE 454
           A D   DG L   E   +                 + N     K +  +D + SG+I   
Sbjct: 65  AYDATFDGRLQIEELANMILPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAA 124

Query: 455 ELRNALNDEVDTSG--------EDVINAIMHDVDTDKDGRISYEEFAVMMK------AGT 500
           EL+N L D              ++  +A+M   D +KDGR+   + A ++          
Sbjct: 125 ELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFLLQF 184

Query: 501 DWRKASRQYSRERFNSISLKLMR 523
               +S+   +  F  I      
Sbjct: 185 KMDASSQVERKRDFEKIFAHYDV 207

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272

 Score =  108 bits (271), Expect = 1e-26
 Identities = 31/188 (16%), Positives = 68/188 (36%), Gaps = 28/188 (14%)

Query: 339 SVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGL----LKGGQN 394
           +++   ++  L +      ++      + +   D +  G I+  EL+  L    L+  + 
Sbjct: 81  NMILPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKK 140

Query: 395 IPEADL----QILMEAADVDGDGSLNYGEFVAV------------SVHLKKMANDEHLHK 438
           IP   L      +M+  D + DG L+  +   +                 ++       K
Sbjct: 141 IPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFLLQFKMDASSQVERKRDFEK 200

Query: 439 AFSFFDRNRSGFIEIEELRNALND--------EVDTSGEDVINAIMHDVDTDKDGRISYE 490
            F+ +D +R+G +E  E+   + D              +     ++   D +KDG+I   
Sbjct: 201 IFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKS 260

Query: 491 EFAVMMKA 498
           E A+ +  
Sbjct: 261 ELALCLGL 268

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186

 Score =  117 bits (296), Expect = 5e-31
 Identities = 27/177 (15%), Positives = 64/177 (36%), Gaps = 19/177 (10%)

Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK----GGQNIPEAD-----LQI 402
           + E      +  +K   + +D    G I+ E+  L  ++       +  +A+        
Sbjct: 4   ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLR 63

Query: 403 LMEAADVDGDGSLNYGEFVAVSVH-LKKMANDEHLHK------AFSFFDRNRSGFIEIEE 455
           + +   +     ++  E    +   L KM  +E           +   D ++ G++ + E
Sbjct: 64  VADQLGLAPGVRISVEEAAVNATDSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPE 123

Query: 456 LRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK---AGTDWRKASRQY 509
            +  L        +D      + +D +K+G+IS +EF V +     G +    +  +
Sbjct: 124 FKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRDEFLVTVNDFLFGLEETALANAF 180

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256

 Score =  119 bits (300), Expect = 7e-31
 Identities = 37/231 (16%), Positives = 85/231 (36%), Gaps = 15/231 (6%)

Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFS 339
           D           L K+      + R T + ++    ++    +      ++  + L+  +
Sbjct: 12  DGNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCLIKWILSSAAPQGSDSSDSELELST 71

Query: 340 VMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEA 398
           V ++ +           + +E+  L   F+       G ++ +  +L   +   Q     
Sbjct: 72  VRHQPEGLDQLQAQTKFTKKELQSLYRGFKNECPT--GLVDEDTFKLIYSQFFPQGDATT 129

Query: 399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
               L  A D DG+G++++ +FV     L +    E L  AF+ +D N+ G I  EE+  
Sbjct: 130 YAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGCITKEEMLA 189

Query: 459 AL------------NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
            +                + +  + +      +D ++DG ++ +EF    +
Sbjct: 190 IMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQ 240

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450

 Score =  123 bits (311), Expect = 8e-31
 Identities = 49/158 (31%), Positives = 89/158 (56%), Gaps = 9/158 (5%)

Query: 346 KRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILME 405
            +      + L+ E++A  KEAF + D +  G I  +EL   +   GQN  EA+LQ ++ 
Sbjct: 296 HKLEYNTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMIN 355

Query: 406 AADVDGDGSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
             D DG+G++++ EF+ + +  +K   ++E + +AF  FD++ +G+I   ELR+ +    
Sbjct: 356 EVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVM---- 411

Query: 465 DTSGEDV----INAIMHDVDTDKDGRISYEEFAVMMKA 498
              GE +    ++ ++ + D D DG+++YEEF  MM A
Sbjct: 412 TNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 449

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 28/155 (18%), Positives = 55/155 (35%), Gaps = 33/155 (21%)

Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA--ADVDGD 412
           F       G  +   +   +                 G     A+++   +     ++  
Sbjct: 240 FFKSAMPEGYIQERTIFFKD----------------DGNYKTRAEVKFEGDTLVNRIELK 283

Query: 413 GSLNYGEFVAVSVHLKKMANDEHL--------HKAFSFFDRNRSGFIEIEELRN---ALN 461
           G +++ E   +  H  +    + L         +AFS FD++  G I  +EL     +L 
Sbjct: 284 G-IDFKEDGNILGHKLEYNTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLG 342

Query: 462 DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
                  E  +  ++++VD D +G I + EF  MM
Sbjct: 343 QNPT---EAELQDMINEVDADGNGTIDFPEFLTMM 374

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 19/119 (15%), Positives = 37/119 (31%), Gaps = 34/119 (28%)

Query: 414 SLNYGEFVAVSVHLK-----KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG 468
           +L    F     H+K     K A  E   +  + F ++   +    E++   +  V+   
Sbjct: 222 TLXVQCFSRYPDHMKQHDFFKSAMPEGYIQERTIFFKDDGNYKTRAEVKFEGDTLVNRIE 281

Query: 469 EDVIN-----AIMHD------------------------VDTDKDGRISYEEFAVMMKA 498
              I+      I+                           D D DG I+ +E   +M++
Sbjct: 282 LKGIDFKEDGNILGHKLEYNTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRS 340

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  122 bits (308), Expect = 8e-31
 Identities = 77/347 (22%), Positives = 131/347 (37%), Gaps = 101/347 (29%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
            +   Y+L ++LG+G +G+ +   D   GE  A K I     + + D +   RE+ I+  
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTE 64

Query: 113 LPKHPNIVSLKD--TYEDDSAVHIVMELCEGGELFD--RIVARGHYTE-----------R 157
           L  H NIV+L +    ++D  V++V +  E     D   ++                  +
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMET----DLHAVIRANILEPVHKQYVVYQLIK 120

Query: 158 AAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN 217
                +K +       H  G++HRD+KP N +  N      +K  DFGLS  F    +  
Sbjct: 121 V----IKYL-------HSGGLLHRDMKPSN-ILLN--AECHVKVADFGLSRSFVNIRRVT 166

Query: 218 EIVGSP----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYILLC 253
             +                         +Y APE+L     Y   +D+WS G IL  +LC
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226

Query: 254 GVPPF-------------------WAETEQGV----AQAIIRSVIDFKRDPW-------- 282
           G P F                     E  + +    A+ +I S+ +              
Sbjct: 227 GKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFT 286

Query: 283 ------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                          +E A DL+ K+L  +P +R++A + L+HP++ 
Sbjct: 287 KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333

>2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208

 Score =  117 bits (295), Expect = 1e-30
 Identities = 34/182 (18%), Positives = 70/182 (38%), Gaps = 27/182 (14%)

Query: 339 SVMNKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP 396
                L+   L+ + +    S  ++  L   F  +D  + G ++ E+    + +   N P
Sbjct: 4   RASTLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDF-QRIPELAIN-P 61

Query: 397 EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN----------------DEHLHKAF 440
             D   ++ A   +G+  +N+  F+    H + + +                   LH AF
Sbjct: 62  LGDR--IINAFFSEGEDQVNFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAF 119

Query: 441 SFFDRNRSGFIEIEELRNALNDEVDTSGED-----VINAIMHDVDTDKDGRISYEEFAVM 495
             +D ++   I  +EL   L   V  +  D     + +  + + D D D  IS+ EF  +
Sbjct: 120 RLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEFVKV 179

Query: 496 MK 497
           ++
Sbjct: 180 LE 181

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176

 Score =  115 bits (289), Expect = 3e-30
 Identities = 32/158 (20%), Positives = 58/158 (36%), Gaps = 25/158 (15%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLK----GGQNIPEADLQILMEA-----------AD 408
           LK+ F+  D +  G +   +            G++   A++Q L  A           A 
Sbjct: 9   LKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAG 68

Query: 409 VDGDGSLNYGEFVAVSVHLKKMANDEH--------LHKAFSFFDRNRSGFIEIEELRNAL 460
           V  DGSL   +F+ V+ +L     +          +       D+N  G I  +E    L
Sbjct: 69  VGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWL 128

Query: 461 NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
              +  S  +      + VDT+ +G +S +E    ++ 
Sbjct: 129 -TALGMSKAE-AAEAFNQVDTNGNGELSLDELLTAVRD 164

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176

 Score = 59.4 bits (144), Expect = 1e-10
 Identities = 12/107 (11%), Positives = 34/107 (31%), Gaps = 21/107 (19%)

Query: 433 DEHLHKAFSFFDRNRSGFIEIEELRNALN---------------DEVDTSGEDVINAIMH 477
            + L K F  +D + +G +E  +                       +  +   + + +  
Sbjct: 6   SDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAK 65

Query: 478 DVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMRE 524
           +     DG ++ E+F  + +          +     FN +   +++ 
Sbjct: 66  EAGVGSDGSLTEEQFIRVTE------NLIFEQGEASFNRVLGPVVKG 106

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  121 bits (306), Expect = 4e-30
 Identities = 69/359 (19%), Positives = 120/359 (33%), Gaps = 99/359 (27%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
            I   Y++   +G G +G      D       A K I  +     +D + + RE+ I+  
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNR 108

Query: 113 LPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
           L  H ++V + D       E    +++V+E+ +  +         + TE     ++  ++
Sbjct: 109 L-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLL 166

Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
             V+  H  G++HRDLKP N L  N  +   +K  DFGL+      E  N  +       
Sbjct: 167 VGVKYVHSAGILHRDLKPANCL-VN--QDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 224 ------------------------YYMAPEVL--KRNYGPEVDVWSAGVIL--------- 248
                                   +Y APE++  + NY   +DVWS G I          
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

Query: 249 ----------------YILLCGVPPFWAETEQGVAQAI-----IRSVI------------ 275
                              L        + +            I +++            
Sbjct: 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343

Query: 276 -----DFKRD--PWPKV---------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                 + R                 S +A  L+K+ML  +P +R+T  E L HP+ + 
Sbjct: 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166

 Score =  114 bits (288), Expect = 4e-30
 Identities = 32/157 (20%), Positives = 48/157 (30%), Gaps = 24/157 (15%)

Query: 364 LKEAFEMMDTNKRGKINLEEL-----RLGLLKGG----------QNIPEADLQILMEAAD 408
           +   F   D +  G I+  +       +    G               EA  Q L   AD
Sbjct: 6   IAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIAD 65

Query: 409 VDGDGSLNYGEFVAVSVHLKKMANDE-------HLHKAFSFFDRNRSGFIEIEELRNALN 461
            DGD  +   EFV  +V   +   D         LH A    D +  G + + +   AL 
Sbjct: 66  RDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARAL- 124

Query: 462 DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
                  +         +DTD DG++   E       
Sbjct: 125 TAFGVPEDL-ARQAAAALDTDGDGKVGETEIVPAFAR 160

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166

 Score = 63.2 bits (154), Expect = 6e-12
 Identities = 15/80 (18%), Positives = 27/80 (33%), Gaps = 15/80 (18%)

Query: 433 DEHLHKAFSFFDRNRSGFIEIEELRNALN---------------DEVDTSGEDVINAIMH 477
           +  +   F+ FD++ +G I+  +   A                   +    E +   +  
Sbjct: 3   ERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAG 62

Query: 478 DVDTDKDGRISYEEFAVMMK 497
             D D D RI+ EEF     
Sbjct: 63  IADRDGDQRITREEFVTGAV 82

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166

 Score = 59.8 bits (145), Expect = 9e-11
 Identities = 17/61 (27%), Positives = 25/61 (40%), Gaps = 2/61 (3%)

Query: 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFV 421
             L  A  + DT+  G + + +    L   G  +PE   +    A D DGDG +   E V
Sbjct: 98  PFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDTDGDGKVGETEIV 155

Query: 422 A 422
            
Sbjct: 156 P 156

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202

 Score =  115 bits (290), Expect = 5e-30
 Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 26/165 (15%)

Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGS 414
             S   +  L   F  +D NK+G ++  +L   +     N P  D   ++E+   DG   
Sbjct: 22  GFSQASLLRLHHRFRALDRNKKGYLSRMDL-QQIGALAVN-PLGDR--IIESFFPDGSQR 77

Query: 415 LNYGEFVAVSVHLKKMAN-----------------DEHLHKAFSFFDRNRSGFIEIEELR 457
           +++  FV V  H + + +                    LH AF  +D +R G I   E+ 
Sbjct: 78  VDFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEML 137

Query: 458 NALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
             L   V     +   E++ +  + + D D DG +S+ EF   ++
Sbjct: 138 QVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSLE 182

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196

 Score =  114 bits (288), Expect = 1e-29
 Identities = 36/184 (19%), Positives = 77/184 (41%), Gaps = 6/184 (3%)

Query: 319 AKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGK 378
            KKA              +     +  +R+   V    +  +V   KEAF+++D +K G 
Sbjct: 14  KKKAEEEGGDAPAAPPAPKPPSQKRRAQRSGSNVFAMFTQHQVQEFKEAFQLIDQDKDGF 73

Query: 379 INLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV-SVHLKKMANDEHLH 437
           I+  ++R      G+   E +L  ++     +  G +N+  F+ +    +     ++ + 
Sbjct: 74  ISKNDIRATFDSLGRLCTEQELDSMVA----EAPGPINFTMFLTIFGDRIAGTDEEDVIV 129

Query: 438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
            AF+ FD    G  + E L+ +L    +   +D ++  + +   D +G I  ++FA ++ 
Sbjct: 130 NAFNLFDEG-DGKCKEETLKRSLTTWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQILT 188

Query: 498 AGTD 501
            G  
Sbjct: 189 KGAK 192

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196

 Score = 58.5 bits (142), Expect = 4e-10
 Identities = 18/71 (25%), Positives = 33/71 (46%), Gaps = 4/71 (5%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           +  AF + D    GK   E L+  L   G+   + ++   +  A +DG+G ++  +F  +
Sbjct: 128 IVNAFNLFDEGD-GKCKEETLKRSLTTWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQI 186

Query: 424 SVHLKKMANDE 434
              L K A +E
Sbjct: 187 ---LTKGAKEE 194

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193

 Score =  114 bits (287), Expect = 1e-29
 Identities = 34/171 (19%), Positives = 69/171 (40%), Gaps = 17/171 (9%)

Query: 342 NKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
           +KL+   +Q + E    +  E+    + F  +     G +++EE +            + 
Sbjct: 6   SKLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASK 63

Query: 400 L-QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
             + +    D +GDG++++ EF+       +   ++ L  AFS +D + +G+I   E+  
Sbjct: 64  FAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLE 123

Query: 459 ALNDEVDTSG------------EDVINAIMHDVDTDKDGRISYEEFAVMMK 497
            +                    E     I   +DT++DG++S EEF    K
Sbjct: 124 IVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAK 174

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151

 Score =  111 bits (281), Expect = 2e-29
 Identities = 32/148 (21%), Positives = 63/148 (42%), Gaps = 6/148 (4%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD--GDG 413
            + +++   KEAFE+ D    GKI   +    +   GQN   A++  ++     D     
Sbjct: 4   FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSR 63

Query: 414 SLNYGEFVAVSVHLKKMAN---DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
            +++  F+ +   + K       E   + F  FD+  +G +   ELR+ L    +   E+
Sbjct: 64  RVDFETFLPMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEE 123

Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
            +  ++     D +G I+YE F   + +
Sbjct: 124 EVETVLAG-HEDSNGCINYEAFLKHILS 150

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145

 Score =  111 bits (280), Expect = 3e-29
 Identities = 35/147 (23%), Positives = 60/147 (40%), Gaps = 13/147 (8%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
                ++E F++ D +  GK+++EEL   L   G+N   A+L  +    +       +  
Sbjct: 2   ASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQLNAKE---FDLA 58

Query: 419 EFVAV--SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV----I 472
            F  V            + +  AF   D+  +G I+  ELR  L       G+ +    +
Sbjct: 59  TFKTVYRKPIKTPTEQSKEMLDAFRALDKEGNGTIQEAELRQLLL----NLGDALTSSEV 114

Query: 473 NAIMHDVDTDKDGRISYEEFAVMMKAG 499
             +M +V    DG I+YE F  M+  G
Sbjct: 115 EELMKEVSVSGDGAINYESFVDMLVTG 141

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87

 Score =  109 bits (275), Expect = 3e-29
 Identities = 36/77 (46%), Positives = 57/77 (74%)

Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADV 409
           + +AE LS EE+ GLKE F+M+DT+  G I  +EL+ GL + G  + E++++ LM+AAD+
Sbjct: 11  KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70

Query: 410 DGDGSLNYGEFVAVSVH 426
           D  G+++YGEF+A +VH
Sbjct: 71  DKSGTIDYGEFIAATVH 87

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87

 Score = 70.2 bits (173), Expect = 2e-15
 Identities = 24/93 (25%), Positives = 33/93 (35%), Gaps = 14/93 (15%)

Query: 410 DGDGSLNYGEFVAVSVHLKKMAND------EHLHKAFSFFDRNRSGFIEIEELRNALNDE 463
              G ++  +        K MA          L + F   D + SG I  +EL++ L   
Sbjct: 1   HSSGHIDDDD--------KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV 52

Query: 464 VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
                E  I  +M   D DK G I Y EF    
Sbjct: 53  GSELMESEIKDLMDAADIDKSGTIDYGEFIAAT 85

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  116 bits (294), Expect = 4e-29
 Identities = 78/331 (23%), Positives = 118/331 (35%), Gaps = 74/331 (22%)

Query: 58  YDLGRELGRGEFGVTYLCTDV-NNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPK 115
           Y++   LG G FG    C D    G   A K + +  +   A   E     +Q+++HL  
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNT 70

Query: 116 H-----PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVE 168
                    V + + +E    + IV EL  G   +D I   G   +       +   I +
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKK----------------ESSPLKAIDFGLSVFFRP 212
            V   H   + H DLKPEN LF                     +  +K +DFG + +   
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--D 187

Query: 213 GEQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG------ 265
            E  + +V + +Y APEV L   +    DVWS G IL     G   F     +       
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247

Query: 266 ----------VAQAIIRSVIDFKRDPWPKVSENAK------------------------D 291
                     + +   R      R  W + S   +                        D
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
           L++KML  DP +R+T  E L+HP+    KK+
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  117 bits (295), Expect = 4e-29
 Identities = 73/327 (22%), Positives = 116/327 (35%), Gaps = 74/327 (22%)

Query: 58  YDLGRELGRGEFGVTYLCTD-VNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPK 115
           Y++   LG G FG    C D      + A K I +  K R A      R E+ ++K + +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLKKIKE 75

Query: 116 H-----PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVE 168
                    V + D +     + I  EL  G   F+ +       Y       +   +  
Sbjct: 76  KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKK----------------ESSPLKAIDFGLSVFFRP 212
            ++  HE  + H DLKPEN LF N +                +++ ++  DFG + F   
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--D 192

Query: 213 GEQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG------ 265
            E    IV + +Y  PEV L+  +    DVWS G IL+    G   F     +       
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252

Query: 266 ----------VAQAIIRSVIDFKRDPWPKVSENAK------------------------D 291
                     + +   +         W + S + +                        D
Sbjct: 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           L+++ML  DP QR+T  E L HP+   
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFFAG 339

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108

 Score =  109 bits (275), Expect = 5e-29
 Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)

Query: 398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELR 457
           +   I     D     S +  +F  +S   KK +    L + F   D ++SGFIE +EL+
Sbjct: 7   SPSDIAAALRDCQAPDSFSPKKFFQISGMSKKSS--SQLKEIFRILDNDQSGFIEEDELK 64

Query: 458 NAL---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
             L                  +   D D DG+I  EEF  M+++
Sbjct: 65  YFLQRFESGARVLTASETKTFLAAADHDGDGKIGAEEFQEMVQS 108

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108

 Score = 92.0 bits (229), Expect = 1e-22
 Identities = 23/97 (23%), Positives = 46/97 (47%), Gaps = 4/97 (4%)

Query: 329 ETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGL 388
             + A L+     +    +    ++  +S +  + LKE F ++D ++ G I  +EL+  L
Sbjct: 9   SDIAAALRDCQAPDSFSPKKFFQISG-MSKKSSSQLKEIFRILDNDQSGFIEEDELKYFL 67

Query: 389 LK---GGQNIPEADLQILMEAADVDGDGSLNYGEFVA 422
            +   G + +  ++ +  + AAD DGDG +   EF  
Sbjct: 68  QRFESGARVLTASETKTFLAAADHDGDGKIGAEEFQE 104

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  115 bits (290), Expect = 6e-29
 Identities = 64/302 (21%), Positives = 115/302 (38%), Gaps = 55/302 (18%)

Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK-H 112
           ++ D  L   +G+G +G  +  +    GE  A K  S +      D +   RE ++    
Sbjct: 6   VARDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSR------DEKSWFRETELYNTV 57

Query: 113 LPKHPNIVSLK--DTYEDDSAVH--IVMELCEGGELFDRIVARGHYTERAAAAVMKTIV- 167
           + +H NI+     D     S+    ++    E G L+D  +        +   ++ +I  
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIAS 116

Query: 168 -------EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI- 219
                  E+     +  + HRDLK +N L    K++      D GL+V         ++ 
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVG 173

Query: 220 ----VGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGV----------PPF 258
               VG+  YMAPEVL         +    VD+W+ G++L+ +   +          PPF
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233

Query: 259 WAETEQGVAQAIIRSVIDFK--RDPWPKVSENA------KDLVKKMLNPDPKQRLTAEEV 310
           +       +   +R V+     R   P    +         L+K+    +P  RLTA  +
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

Query: 311 LE 312
            +
Sbjct: 294 KK 295

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148

 Score =  109 bits (276), Expect = 1e-28
 Identities = 33/149 (22%), Positives = 59/149 (39%), Gaps = 15/149 (10%)

Query: 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQ-ILMEAADVDGDGSLNYG 418
                K+ F + D   +G I  + L   L   G N     +Q I+   + +    SL   
Sbjct: 2   ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLD 61

Query: 419 EFVAVSVHLKK------MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV- 471
           +   +    +K       A  E   KAF  FD+  +G + + +LR  L       GE + 
Sbjct: 62  QITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLT----GLGEKLT 117

Query: 472 ---INAIMHDVDTDKDGRISYEEFAVMMK 497
              ++ ++  V+ D +G I Y++F   + 
Sbjct: 118 DAEVDELLKGVEVDSNGEIDYKKFIEDVL 146

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148

 Score = 54.1 bits (131), Expect = 5e-09
 Identities = 16/85 (18%), Positives = 31/85 (36%), Gaps = 15/85 (17%)

Query: 436 LHKAFSFFDRNRSGFIEIEELRNAL--------NDEVDTSGEDVINAIMHDVDTDKDGRI 487
               F+ FD+   G I  + L + L        N  V    +D+INA   D        +
Sbjct: 6   NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLV----QDIINA---DSSLRDASSL 58

Query: 488 SYEEFAVMMKAGTDWRKASRQYSRE 512
           + ++   +++       A+ +   E
Sbjct: 59  TLDQITGLIEVNEKELDATTKAKTE 83

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173

 Score =  110 bits (278), Expect = 1e-28
 Identities = 33/172 (19%), Positives = 63/172 (36%), Gaps = 16/172 (9%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD--------LQILMEAADVD 410
           EEV   +  F  +      +++  EL   L K     P+           + ++   D D
Sbjct: 1   EEVRQFRRLFAQLAG-DDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSD 59

Query: 411 GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
             G L + EF  +  ++KK          +  FD +RSG I   EL  A         E 
Sbjct: 60  TTGKLGFEEFKYLWNNIKK------WQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEH 113

Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLM 522
           + + I+    +D+ G + ++ F   +       +A +   ++    I + + 
Sbjct: 114 LYSMIIR-RYSDEGGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQ 164

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190

 Score =  109 bits (275), Expect = 4e-28
 Identities = 35/172 (20%), Positives = 69/172 (40%), Gaps = 17/172 (9%)

Query: 341 MNKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNI-PE 397
            +KL +  LQ +        +E+    + F        G +N  E +    +      P 
Sbjct: 5   QSKLSQDQLQDLVRSTRFDKKELQQWYKGF--FKDCPSGHLNKSEFQKIYKQFFPFGDPS 62

Query: 398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELR 457
           A  + +    D D +G +++ EF+       +   ++ L  AF  +D + +G I  +E+ 
Sbjct: 63  AFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEML 122

Query: 458 NAL------------NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
             +              E + + E  +N I + +D +KDG+++ EEF    K
Sbjct: 123 RIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFCEGSK 174

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  114 bits (286), Expect = 6e-28
 Identities = 79/386 (20%), Positives = 136/386 (35%), Gaps = 100/386 (25%)

Query: 8   PDSSSGKRAKGKKEKP--NPFYGDE---YVVANGSTVVHRLCVLKEPSGQDISIDYDLGR 62
            +      +  KKE+   N  Y D+   Y+V NG   + R               Y++  
Sbjct: 16  ENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDR---------------YEIDS 60

Query: 63  ELGRGEFGVTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPKHP---- 117
            +G+G FG      D    E  A K I +KK           + EV++++ + KH     
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELMNKHDTEMK 115

Query: 118 -NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCH 174
             IV LK  +   + + +V E+     L+D +        +        + +   +    
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 175 --EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-L 231
             E  ++H DLKPEN L  N K  S +K +DFG S     G++  + + S +Y +PEV L
Sbjct: 175 TPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLL 231

Query: 232 KRNYGPEVDVWSA---------GVILY------------ILLCGVPPFW----------- 259
              Y   +D+WS          G  L+            + + G+PP             
Sbjct: 232 GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKF 291

Query: 260 -----------------AETEQGVAQAIIRSVIDFKRDPWPKVSENA-----------KD 291
                                +      + +++  +                      KD
Sbjct: 292 FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           L+ +ML+ DPK R+     L+H + +
Sbjct: 352 LILRMLDYDPKTRIQPYYALQHSFFK 377

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  113 bits (284), Expect = 7e-28
 Identities = 60/302 (19%), Positives = 111/302 (36%), Gaps = 55/302 (18%)

Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR-REVQIMKH 112
           I+    L   +G+G FG  +       GE+ A K        +  +    R  E+     
Sbjct: 40  IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVK-----IFSSREERSWFREAEIYQTVM 92

Query: 113 LPKHPNIVSLK--DTYEDDSAVH--IVMELCEGGELFDRIVARGHYTERAAAAVMKTIV- 167
           L +H NI+     D  ++ +     +V +  E G LFD  + R   T      +  +   
Sbjct: 93  L-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTAS 150

Query: 168 -------EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI- 219
                  E+V    +  + HRDLK +N L    K++      D GL+V         +I 
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA 207

Query: 220 ----VGSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV----------PPF 258
               VG+  YMAPEVL  +   +        D+++ G++ + +               P+
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

Query: 259 WAETEQGVAQAIIRSVIDFK--RDPWPKVSENA------KDLVKKMLNPDPKQRLTAEEV 310
           +       +   +R V+  +  R   P   ++         ++++    +   RLTA  +
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327

Query: 311 LE 312
            +
Sbjct: 328 KK 329

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156

 Score =  108 bits (271), Expect = 7e-28
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 19/157 (12%)

Query: 356 LSVEEVAGLKEAFEMMD--TNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDG 413
           LS +E+  LK+ FE+ D    + G ++  +L       G N    D+  +       G+ 
Sbjct: 3   LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGGT-HKMGEK 61

Query: 414 SLNYGEFVAV--SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL--------NDE 463
           SL + EF+     +   +        +AF  FDR   GFI   ELR+ L        +++
Sbjct: 62  SLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDED 121

Query: 464 VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT 500
           VD    ++I     D+  D +G + YE+F   + AG 
Sbjct: 122 VD----EIIKLT--DLQEDLEGNVKYEDFVKKVMAGP 152

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  112 bits (283), Expect = 1e-27
 Identities = 63/312 (20%), Positives = 115/312 (36%), Gaps = 59/312 (18%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI--MKHLPKHP 117
           + +++G+G +G  ++      GEK A K           +     RE +I     + +H 
Sbjct: 41  MVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTT------EEASWFRETEIYQTVLM-RHE 91

Query: 118 NIVSLK--DTYEDDSAVH--IVMELCEGGELFDRIVARGHYTERAAAAVMKTIV------ 167
           NI+     D     S     ++ +  E G L+D  +       ++   +  + V      
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHL 150

Query: 168 --EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-----V 220
             E+     +  + HRDLK +N L    K++      D GL+V F       +I     V
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 221 GSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV----------PPFWAETE 263
           G+  YM PEVL  +            D++S G+IL+ +               P+     
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

Query: 264 QGVAQAIIRSVIDFK--RDPWPKVSENA------KDLVKKMLNPDPKQRLTAEEVLEHPW 315
              +   +R ++  K  R  +P    +         L+ +    +P  RLTA  V +   
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT-- 325

Query: 316 LQNAKKAPNVSL 327
           L    ++ ++ L
Sbjct: 326 LAKMSESQDIKL 337

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  110 bits (277), Expect = 4e-27
 Identities = 69/310 (22%), Positives = 114/310 (36%), Gaps = 73/310 (23%)

Query: 55  SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           S+   L     RG FG  +        E  A K                  EV  +  + 
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPI----QDKQSWQNEYEVYSLPGM- 75

Query: 115 KHPNIVSL--KDTYEDDSAVH--IVMELCEGGELFD-------------RI---VARG-- 152
           KH NI+     +       V   ++    E G L D              I   +ARG  
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLA 135

Query: 153 --HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210
             H             +  ++  H+  + HRD+K +N L  N   +      DFGL++ F
Sbjct: 136 YLH-----------EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA---CIADFGLALKF 181

Query: 211 RPGEQF---NEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCG------- 254
             G+     +  VG+  YMAPEVL      +R+    +D+++ G++L+ L          
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 255 ----VPPFWAETEQGVAQAIIRSVIDFKR------DPWPKVSENAK--DLVKKMLNPDPK 302
               + PF  E  Q  +   ++ V+  K+      D W K +  A   + +++  + D +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 303 QRLTAEEVLE 312
            RL+A  V E
Sbjct: 302 ARLSAGCVGE 311

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109

 Score =  103 bits (260), Expect = 5e-27
 Identities = 23/104 (22%), Positives = 45/104 (43%), Gaps = 4/104 (3%)

Query: 323 PNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLE 382
            ++   E +K  +  F+  +    +    +   L  +    +K+ F ++D +K G I  +
Sbjct: 3   TDLLSAEDIKKAIGAFTAADSFDHKKFFQMVG-LKKKSADDVKKVFHILDKDKSGFIEED 61

Query: 383 ELRLGL---LKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           EL   L       +++   + + LM A D DGDG +   EF  +
Sbjct: 62  ELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTL 105

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109

 Score = 92.7 bits (231), Expect = 5e-23
 Identities = 30/110 (27%), Positives = 53/110 (48%), Gaps = 9/110 (8%)

Query: 392 GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFI 451
              +   D++  + A       S ++ +F  + V LKK + D+ + K F   D+++SGFI
Sbjct: 3   TDLLSAEDIKKAIGA--FTAADSFDHKKFFQM-VGLKKKSADD-VKKVFHILDKDKSGFI 58

Query: 452 EIEELRNALNDEVDTSGEDV----INAIMHDVDTDKDGRISYEEFAVMMK 497
           E +EL + L     +   D+       +M   D D DG+I  EEF+ ++ 
Sbjct: 59  EEDELGSILK-GFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149

 Score =  104 bits (263), Expect = 7e-27
 Identities = 32/152 (21%), Positives = 58/152 (38%), Gaps = 14/152 (9%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD--GDG 413
            S       KEAF + D     KI   ++       GQN   A++  ++     +     
Sbjct: 2   FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAA 61

Query: 414 SLNYGEFVAVSVHLKK---MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           ++ + EF+ +             E   +    FD+  +G +   ELR+ L     T GE 
Sbjct: 62  AITFEEFLPMLQAAANNKDQGTFEDFVEGLRVFDKEGNGTVMGAELRHVLA----TLGEK 117

Query: 471 V----INAIMHDVDTDKDGRISYEEFAVMMKA 498
           +    +  +M   + D +G I+YE F   + +
Sbjct: 118 MTEEEVEELMKGQE-DSNGCINYEAFVKHIMS 148

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146

 Score =  104 bits (261), Expect = 1e-26
 Identities = 27/142 (19%), Positives = 54/142 (38%), Gaps = 7/142 (4%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
              E+V          + +  GKI+++       K G      D + + E        +L
Sbjct: 9   QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKE----LYGDNL 64

Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
            Y +++   S+ +    N E L K F+ FD N +G++   +++N L    D   +     
Sbjct: 65  TYEQYLEYLSICVHDKDNVEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAID 124

Query: 475 IMHDVDTDKDGRISYEEFAVMM 496
            ++      +  I Y+ F   +
Sbjct: 125 ALNAF--SSEDNIDYKLFCEDI 144

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146

 Score = 53.4 bits (129), Expect = 8e-09
 Identities = 9/63 (14%), Positives = 23/63 (36%), Gaps = 2/63 (3%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           L + F   D N  G +   +++  L   G  + + +    +       + +++Y  F   
Sbjct: 86  LIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDAL--NAFSSEDNIDYKLFCED 143

Query: 424 SVH 426
            + 
Sbjct: 144 ILQ 146

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  109 bits (274), Expect = 3e-26
 Identities = 73/373 (19%), Positives = 122/373 (32%), Gaps = 112/373 (30%)

Query: 51  GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
           G   +  Y + R+LG G F   +L  D+   +  A K + K         E    E++++
Sbjct: 32  GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVK---SAEHYTETALDEIRLL 87

Query: 111 KHL----PKHPN---IVSLKDTYEDDSA--VHI--VMELCEGGELFDRIVARGH--YTER 157
           K +    P  PN   +V L D ++       HI  V E+  G  L   I+   +      
Sbjct: 88  KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLP 146

Query: 158 AAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFA------------------------- 191
               +++ +++ +   H +  ++H D+KPEN L +                         
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206

Query: 192 ---------------------NKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
                                   E   +K  D G +      + F E + +  Y + EV
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEV 264

Query: 231 -LKRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVID----------- 276
            +   Y    D+WS   + + L  G   F   +  E    +  I  +I+           
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324

Query: 277 --------FKRD----------PWPKVS----------ENAK---DLVKKMLNPDPKQRL 305
                   F +           PW              E A    D +  ML   P++R 
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384

Query: 306 TAEEVLEHPWLQN 318
           TA E L HPWL +
Sbjct: 385 TAAECLRHPWLNS 397

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167

 Score =  102 bits (255), Expect = 1e-25
 Identities = 30/175 (17%), Positives = 68/175 (38%), Gaps = 16/175 (9%)

Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL-----QILMEAADVDGDGSL 415
           +  L   F  +   + G+I+ +EL+  L + G             ++++   D D  G++
Sbjct: 1   MDPLYGYFASV-AGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTM 59

Query: 416 NYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAI 475
            + EF  +   L          + F  FD +RSG ++ +EL+ AL           +N+I
Sbjct: 60  GFNEFKELWAVLN------GWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSI 113

Query: 476 MHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLA 530
                    G+I+++++            + R+    +   ++     ++ +Q  
Sbjct: 114 AKRY--STSGKITFDDYIACCVKLRALTDSFRRRDSAQQGMVNFSY--DDFIQCV 164

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191

 Score =  101 bits (253), Expect = 4e-25
 Identities = 24/172 (13%), Positives = 51/172 (29%), Gaps = 27/172 (15%)

Query: 351 VVAEFLSVEEVAGLKEAFE-MMDTNKRGKINLEEL-----RLGLLKGG----------QN 394
           + A  LS  +   +   F    D N  G I  ++      ++  L             + 
Sbjct: 1   MAAHQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARA 60

Query: 395 IPEADLQILMEAADVDGDGSLNYGEFVA-VSVHLKKMANDEH--------LHKAFSFFDR 445
             +     L + AD + D  +   E++   +  +K +   E         ++  F   D 
Sbjct: 61  TLKLIWDGLRKYADENEDEQVTKEEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDT 120

Query: 446 NRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           +    I+  E             +   +A    +       ++ E FA +  
Sbjct: 121 SGDNIIDKHEYSTVYMSYGIP--KSDCDAAFDTLSDGGKTMVTREIFARLWT 170

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108

 Score = 98.5 bits (246), Expect = 5e-25
 Identities = 22/108 (20%), Positives = 49/108 (45%), Gaps = 9/108 (8%)

Query: 395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIE 454
           +   D+   ++        +    +F   +  L KM+  + +   F F D ++SG+++ +
Sbjct: 6   LSAEDIAAALQE--CQDPDTFEPQKFFQ-TSGLSKMSASQ-VKDIFRFIDNDQSGYLDGD 61

Query: 455 ELRNALNDEVDTSGEDV----INAIMHDVDTDKDGRISYEEFAVMMKA 498
           EL+  L  +  +   ++      ++M   D D DG+I  +EF  M+ +
Sbjct: 62  ELKYFLQ-KFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMVHS 108

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108

 Score = 95.4 bits (238), Expect = 6e-24
 Identities = 24/96 (25%), Positives = 48/96 (50%), Gaps = 4/96 (4%)

Query: 331 VKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK 390
           + A L++    +  + +        LS    + +K+ F  +D ++ G ++ +EL+  L K
Sbjct: 11  IAAALQECQDPDTFEPQKF-FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQK 69

Query: 391 ---GGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
                + + E++ + LM+AAD DGDG +   EF  +
Sbjct: 70  FQSDARELTESETKSLMDAADNDGDGKIGADEFQEM 105

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140

 Score = 99.5 bits (249), Expect = 6e-25
 Identities = 33/147 (22%), Positives = 62/147 (42%), Gaps = 16/147 (10%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
            + +  K+AF + D +  G+I    +   L   GQN   A++       +      ++  
Sbjct: 2   TDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEIT----EIESTLPAEVDME 57

Query: 419 EFVAVSVHLKKM---ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV---- 471
           +F+ V           + E   K F  FD++ +G I + ELR  L     + GE +    
Sbjct: 58  QFLQVLNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVLT----SLGEKLSNEE 113

Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKA 498
           ++ ++  V    DG ++Y +F  M+ A
Sbjct: 114 MDELLKGVPVK-DGMVNYHDFVQMILA 139

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140

 Score = 54.4 bits (132), Expect = 4e-09
 Identities = 19/67 (28%), Positives = 33/67 (49%), Gaps = 4/67 (5%)

Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLN 416
             EE     + F++ D +  G I + ELR  L   G+ +   ++  L++   V  DG +N
Sbjct: 74  DPEE---FVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVN 129

Query: 417 YGEFVAV 423
           Y +FV +
Sbjct: 130 YHDFVQM 136

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  104 bits (261), Expect = 2e-24
 Identities = 68/285 (23%), Positives = 108/285 (37%), Gaps = 47/285 (16%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           LG ++GRG FG  +      +    A KS   ++           +E +I+K    HPNI
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQY-SHPNI 174

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC----- 173
           V L         ++IVMEL +GG+    +   G          +KT+++ V         
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR------VKTLLQMVGDAAAGMEY 228

Query: 174 -HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
              +  +HRDL   N L   K     LK  DFG+S   R      E     Y        
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNV---LKISDFGMS---R------EEADGVYAASGGLRQ 276

Query: 226 -----MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
                 APE L    Y  E DVWS G++L+     G  P+   + Q   + + +     +
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK---GGR 333

Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
                   +    L+++    +P QR +   + +   LQ+ +K  
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ--ELQSIRKRH 376

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  101 bits (252), Expect = 1e-23
 Identities = 63/323 (19%), Positives = 114/323 (35%), Gaps = 71/323 (21%)

Query: 48  EPSGQDISIDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
           E +  + S+D D   L   +GRG +G  Y  +   +    A K  S        + ++  
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFA------NRQNFI 53

Query: 105 REVQIMKHLPK--HPNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER 157
            E  I + +P   H NI        + T +      +VME    G L    ++       
Sbjct: 54  NEKNIYR-VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWV 111

Query: 158 AAAAVMKTIV--------EVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208
           ++  +  ++         E+ +  H +  + HRDL   N L    K        DFGLS+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSM 168

Query: 209 FFRPGEQF---------NEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYIL 251
                               VG+  YMAPEVL+         +   +VD+++ G+I + +
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 252 LCGV-------------PPFWAETEQGVAQAIIRSVIDFKR------DPWPKVSENAKDL 292
                              F  E         ++ ++  ++      + W + S   + L
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 293 VKKML---NPDPKQRLTAEEVLE 312
            + +    + D + RLTA+   E
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEE 311

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 Length = 224

 Score = 97.7 bits (243), Expect = 2e-23
 Identities = 36/195 (18%), Positives = 70/195 (35%), Gaps = 18/195 (9%)

Query: 316 LQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNK 375
           LQ  ++ P+    + ++  L+   V ++ +           +  E+  L   F   +   
Sbjct: 11  LQTKQRRPS---KDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGF--KNECP 65

Query: 376 RGKINLEELRLGL-LKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDE 434
            G +N E  +                  L  A D    GS+ + +FV     L +    E
Sbjct: 66  SGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHE 125

Query: 435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG------------EDVINAIMHDVDTD 482
            L   F+ +D N+ G+I  EE+ + +    D  G               ++     +D +
Sbjct: 126 KLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKN 185

Query: 483 KDGRISYEEFAVMMK 497
           KDG ++ +EF    +
Sbjct: 186 KDGIVTLDEFLESCQ 200

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165

 Score = 95.9 bits (239), Expect = 2e-23
 Identities = 31/172 (18%), Positives = 63/172 (36%), Gaps = 16/172 (9%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQI-----LMEAADVDGDGSLNYG 418
           +   F  +   + G+++ EEL+  L + G N   +   +     ++   D D  G + + 
Sbjct: 2   VYTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFN 60

Query: 419 EFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD 478
            F  +       A      + F   D++ SG +E  ELR A+           +  I+  
Sbjct: 61  AFKEL------WAALNAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKR 114

Query: 479 VDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLA 530
               K+GRI ++++              R+    +  S +     ++ LQ  
Sbjct: 115 Y--SKNGRIFFDDYVACCVKLRALTDFFRKRDHLQQGSANFIY--DDFLQGT 162

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135

 Score = 92.4 bits (230), Expect = 1e-22
 Identities = 19/123 (15%), Positives = 42/123 (34%), Gaps = 3/123 (2%)

Query: 397 EADLQILMEAADVDGDGSLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEE 455
           E   + ++            Y + + V +  +        L K FS         I  E 
Sbjct: 2   EPTEKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAES 61

Query: 456 LRNALND-EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT-DWRKASRQYSRER 513
           LR       ++   ++    ++ + D D DG ++  EF V+M   + +  + +  +  + 
Sbjct: 62  LRRNSGILGIEGMSKEDAQGMVREGDLDGDGALNQTEFCVLMVRLSPEMMEDAETWLEKA 121

Query: 514 FNS 516
              
Sbjct: 122 LTQ 124

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135

 Score = 62.7 bits (153), Expect = 4e-12
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 11/100 (11%)

Query: 349 LQVVAEFLSVEE-VAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEA 406
           L V+AE + VEE V+ L + F ++   +R  I  E LR      G + + + D Q ++  
Sbjct: 26  LPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVRE 85

Query: 407 ADVDGDGSLNYGEFVAVSVHLKKMA------NDEHLHKAF 440
            D+DGDG+LN  EF  +   + +++       +  L KA 
Sbjct: 86  GDLDGDGALNQTEFCVL---MVRLSPEMMEDAETWLEKAL 122

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198

 Score = 94.1 bits (234), Expect = 2e-22
 Identities = 29/169 (17%), Positives = 63/169 (37%), Gaps = 14/169 (8%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQI-----LMEAADVDGDG 413
           +    L   F      + G+I+ +EL+  L + G         +     ++   D D  G
Sbjct: 30  QTQDPLYGYFAA-VAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSG 88

Query: 414 SLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVIN 473
           ++ + EF  +       A      + F  FD +RSG ++ +EL+ AL           +N
Sbjct: 89  TMGFNEFKEL------WAVLNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVN 142

Query: 474 AIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLM 522
           +I        +G+I+++++            + R+    +   ++    
Sbjct: 143 SIAKRY--STNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPYD 189

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E Length = 183

 Score = 93.0 bits (231), Expect = 3e-22
 Identities = 29/156 (18%), Positives = 56/156 (35%), Gaps = 15/156 (9%)

Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL-QILMEAADVDGDG 413
             +  E+  L   F   +    G +N E  +    +   +   +     L  A D    G
Sbjct: 14  NFTKRELQVLYRGF--KNEXPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTG 71

Query: 414 SLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELR------------NALN 461
           S+ + +FV     L +    E L   F+ +D N+ G+I  EE+                 
Sbjct: 72  SVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYP 131

Query: 462 DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
              + +    ++     +D +KDG ++ +EF    +
Sbjct: 132 VLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQ 167

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A Length = 190

 Score = 92.6 bits (230), Expect = 6e-22
 Identities = 31/170 (18%), Positives = 67/170 (39%), Gaps = 17/170 (10%)

Query: 343 KLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNI-PEAD 399
           KLK   ++ +    + + +EV    + F  +     G+++    +    +      P   
Sbjct: 7   KLKPEVVEELTRKTYFTEKEVQQWYKGF--IKDCPSGQLDAAGFQKIYKQFFPFGDPTKF 64

Query: 400 LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNA 459
              +    D + DG + + EF+       +   DE L  AF  +D +  G+I   E+ + 
Sbjct: 65  ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDI 124

Query: 460 LN------------DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           ++             E + + E  ++ I   +D + DG+++ +EF    K
Sbjct: 125 VDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSK 174

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.5 bits (238), Expect = 8e-22
 Identities = 65/287 (22%), Positives = 100/287 (34%), Gaps = 54/287 (18%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           LGR LG+GEFG             F   A K + K  +  + DIE+  RE   MK    H
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF-DH 84

Query: 117 PNIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
           P++  L                 +++   + G+L   ++A           +   +  +V
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 171 QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
            +         +  +HRDL   N + A   E   +   DFGLS   R      +I    Y
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS---R------KIYSGDY 192

Query: 225 Y------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
           Y            +A E L    Y    DVW+ GV ++ I+  G  P+       +    
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---- 248

Query: 271 IRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
              +I   R   P       + V   M    + DPKQR +   +   
Sbjct: 249 YNYLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 68/296 (22%), Positives = 108/296 (36%), Gaps = 51/296 (17%)

Query: 60  LGRELGRGEFGVTY--LCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           L R LG G FG  Y    + + N       A K++   ++ +  D  D   E  I+    
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF- 90

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVC 173
            H NIV             I+MEL  GG+L   +        + ++  M  ++ V   + 
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
                  E   +HRD+   N L          K  DFG++   R      +I  + YY  
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRASYYRK 201

Query: 226 ----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRS 273
                     M PE      +  + D WS GV+L+ I   G  P+ +++ Q V    +  
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEF 257

Query: 274 VIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
           V    R   P   +N    V + M       P+ R     +LE   ++   + P+V
Sbjct: 258 VTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYCTQDPDV 308

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185

 Score = 91.5 bits (227), Expect = 1e-21
 Identities = 25/167 (14%), Positives = 54/167 (32%), Gaps = 27/167 (16%)

Query: 356 LSVEEVAGLKEAFE-MMDTNKRGKINLEEL-----RLGLLKGG----------QNIPEAD 399
           L+  +   +K  F+  +D N  G I   +      R   +  G          Q   E +
Sbjct: 2   LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDE 61

Query: 400 LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDE---------HLHKAFSFFDRNRSGF 450
            + L   AD++ D  +++ E++A+                     +   F   D +  G 
Sbjct: 62  WRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGI 121

Query: 451 IEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           +++EE +N           D + A+ + +            +  +  
Sbjct: 122 VDLEEFQNYCK-NFQLQCAD-VPAVYNVITDGGKVTFDLNRYKELYY 166

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185

 Score = 47.6 bits (113), Expect = 1e-06
 Identities = 18/121 (14%), Positives = 40/121 (33%), Gaps = 11/121 (9%)

Query: 365 KEAFEMMDTNKRGKINLEEL------RLGLLKGGQNIPEA---DLQILMEAADVDGDGSL 415
           ++     D NK   ++ EE        +   K   ++P      +  L +  DV GDG +
Sbjct: 63  RDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIV 122

Query: 416 NYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAI 475
           +  EF     + +       +   ++          ++   +      + +   D  N +
Sbjct: 123 DLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYKELYYRLLTSPAADAGNTL 180

Query: 476 M 476
           M
Sbjct: 181 M 181

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 67/296 (22%), Positives = 108/296 (36%), Gaps = 51/296 (17%)

Query: 60  LGRELGRGEFGVTY--LCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           L R LG G FG  Y    + + N       A K++   ++ +  D  D   E  I+    
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF- 131

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVC 173
            H NIV             I++EL  GG+L   +        + ++  M  ++ V   + 
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
                  E   +HRD+   N L          K  DFG++   R      +I  + YY  
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRAGYYRK 242

Query: 226 ----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRS 273
                     M PE      +  + D WS GV+L+ I   G  P+ +++ Q V    +  
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEF 298

Query: 274 VIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
           V    R   P   +N    V + M       P+ R     +LE   ++   + P+V
Sbjct: 299 VTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYCTQDPDV 349

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A Length = 207

 Score = 90.8 bits (225), Expect = 3e-21
 Identities = 31/173 (17%), Positives = 63/173 (36%), Gaps = 19/173 (10%)

Query: 342 NKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
             L K  L+ +      S EE+    ++F  +     G+I  ++ +    K   +     
Sbjct: 14  GALSKEILEELQLNTKFSEEELCSWYQSF--LKDCPTGRITQQQFQSIYAKFFPDTDPKA 71

Query: 400 L-QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
             Q +  + D + DG+L++ E+V           ++ L  AFS +D + +G I   E+  
Sbjct: 72  YAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVLE 131

Query: 459 --------------ALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
                          L  + + + E     I      + D +++ +EF     
Sbjct: 132 IVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEGTL 184

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A Length = 207

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 25/130 (19%), Positives = 46/130 (35%), Gaps = 4/130 (3%)

Query: 371 MDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA-ADVDGDGSLNYGEFVAV-SVHLK 428
           M  +K G ++ E L    L+      E +L    ++       G +   +F ++ +    
Sbjct: 8   MGNSKSGALSKEILEE--LQLNTKFSEEELCSWYQSFLKDCPTGRITQQQFQSIYAKFFP 65

Query: 429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS 488
                 +    F  FD N  G ++ +E   AL+          +       D D +G IS
Sbjct: 66  DTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTIS 125

Query: 489 YEEFAVMMKA 498
             E   ++ A
Sbjct: 126 KNEVLEIVMA 135

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A Length = 190

 Score = 90.3 bits (224), Expect = 4e-21
 Identities = 35/170 (20%), Positives = 66/170 (38%), Gaps = 17/170 (10%)

Query: 343 KLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL 400
           KL K  L  + +  +    E+    + F  +     G++  E+      +        D 
Sbjct: 7   KLSKDDLTCLKQSTYFDRREIQQWHKGF--LRDCPSGQLAREDFVKIYKQFFPFGSPEDF 64

Query: 401 -QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNA 459
              L    D D +G +++ EF+ V     +   +E L  AF  +D N  G+I  +E+   
Sbjct: 65  ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTI 124

Query: 460 L------------NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           +             +E + + E  +  I   +D ++DG I+ +EF    K
Sbjct: 125 VASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSK 174

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A Length = 190

 Score = 53.7 bits (129), Expect = 1e-08
 Identities = 25/127 (19%), Positives = 54/127 (42%), Gaps = 4/127 (3%)

Query: 374 NKRGKINLEELRLGLLKGGQNIPEADLQILMEA-ADVDGDGSLNYGEFVAV-SVHLKKMA 431
            K  K++ ++L    LK        ++Q   +        G L   +FV +        +
Sbjct: 3   AKTSKLSKDDLTC--LKQSTYFDRREIQQWHKGFLRDCPSGQLAREDFVKIYKQFFPFGS 60

Query: 432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEE 491
            ++  +  F+ FD++ +GFI  EE    L+     + E+ ++      D + DG I+++E
Sbjct: 61  PEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDE 120

Query: 492 FAVMMKA 498
              ++ +
Sbjct: 121 MLTIVAS 127

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 59/286 (20%), Positives = 102/286 (35%), Gaps = 53/286 (18%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           LG+ LG GEFG                 A K++ K    +  +IE+   E   MK    H
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDF-SH 95

Query: 117 PNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
           PN++ L     + + +      +++   + G+L   ++     T      +   +  +V 
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 172 VCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           +         +  +HRDL   N +     +   +   DFGLS   +      +I    YY
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLS---K------KIYSGDYY 203

Query: 226 ------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 271
                       +A E L  R Y  + DVW+ GV ++ I   G+ P+       +     
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----Y 259

Query: 272 RSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
             ++   R   P   E+  D + + M      DP  R T   +   
Sbjct: 260 DYLLHGHRLKQP---EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 44/215 (20%)

Query: 60  LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             R+LG G FG   LC       N GE+ A KS+  K       I D+++E++I+++L  
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNL-Y 81

Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
           H NIV  K   T +  + + ++ME    G L + +    +   +    + + +   VQ+C
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKN---KNKINLKQQLKYAVQIC 136

Query: 174 ------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
                   +  +HRDL   N L  ++ +   +K  DFGL+      ++        YY  
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKE--------YYTV 185

Query: 226 ----------MAPEVLK-RNYGPEVDVWSAGVILY 249
                      APE L    +    DVWS GV L+
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 48/236 (20%), Positives = 90/236 (38%), Gaps = 47/236 (19%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             + LG G FG  Y    +  GEK     A K +  ++  +    +++  E  +M  +  
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASV-D 75

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVE-VVQVC 173
           +P++  L       + V ++ +L   G L D +   + +          + ++   VQ+ 
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG-------SQYLLNWCVQIA 127

Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
                  ++ ++HRDL   N L         +K  DFGL+      E+         Y  
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEK--------EYHA 176

Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
                    MA E +  R Y  + DVWS GV ++ ++  G  P+       ++  +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 55/287 (19%)

Query: 60  LGRELGRGEFGVTYLCT--DVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
           + RELG+G FG+ Y      V   E     A K++   +  +  +  +   E  +MK   
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEF- 85

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
              ++V L           ++MEL   G+L   + +              ++ +++Q+  
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 175 ----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
                         +HRDL   N + A   E   +K  DFG++   R      +I  + Y
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---R------DIYETDY 193

Query: 225 Y------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
           Y            M+PE LK   +    DVWS GV+L+ I      P+   + + V    
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---- 249

Query: 271 IRSVIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEH 313
           +R V++      P   +N  D++ + M      +PK R +  E++  
Sbjct: 250 LRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71

 Score = 82.9 bits (206), Expect = 5e-20
 Identities = 24/64 (37%), Positives = 40/64 (62%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
           E L  AF  FD++  G I ++ELR A+        ++ ++A++ + D D+DGR++YEEFA
Sbjct: 6   EDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFA 65

Query: 494 VMMK 497
            M+ 
Sbjct: 66  RMLA 69

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71

 Score = 66.0 bits (162), Expect = 6e-14
 Identities = 23/67 (34%), Positives = 37/67 (55%)

Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLN 416
           +   +  L+ AF   D +  G I ++ELR  +   GQ +P+ +L  ++  ADVD DG +N
Sbjct: 1   ARAGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVN 60

Query: 417 YGEFVAV 423
           Y EF  +
Sbjct: 61  YEEFARM 67

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 91.8 bits (228), Expect = 7e-20
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 30/227 (13%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           +  +LG G++G  Y           A K++ +      +++E+  +E  +MK + KHPN+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEI-KHPNL 278

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVE-VVQVC--- 173
           V L      +   +I+ E    G L D  R   R   +          ++    Q+    
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-------AVVLLYMATQISSAM 331

Query: 174 ---HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS--PY-YMA 227
               ++  +HR+L   N L     E+  +K  DFGLS     G+ +    G+  P  + A
Sbjct: 332 EYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 387

Query: 228 PEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
           PE L    +  + DVW+ GV+L+ I   G+ P+       V + + +
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 88.4 bits (220), Expect = 9e-20
 Identities = 54/233 (23%), Positives = 88/233 (37%), Gaps = 44/233 (18%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L +ELG G+FGV  L          A K I +     ++  ++  +E Q M  L  HP +
Sbjct: 12  LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKE----GSMSEDEFFQEAQTMMKL-SHPKL 65

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVCH---- 174
           V        +  ++IV E    G L + + + G   E         ++E+   VC     
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLE------PSQLLEMCYDVCEGMAF 119

Query: 175 --EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
                 +HRDL   N L         +K  DFG++   R       ++   Y        
Sbjct: 120 LESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT---R------YVLDDQYVSSVGTKF 167

Query: 226 ----MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
                APEV     Y  + DVW+ G++++ +   G  P+   T   V   + +
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 48/236 (20%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           +  +LG G++G  Y           A K++ +      +++E+  +E  +MK + KHPN+
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEI-KHPNL 71

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEV-VQVCH-- 174
           V L      +   +I+ E    G L D  R   R   +          ++ +  Q+    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-------AVVLLYMATQISSAM 124

Query: 175 ----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY----- 225
               ++  +HRDL   N L     E+  +K  DFGLS   R       ++    Y     
Sbjct: 125 EYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS---R-------LMTGDTYTAHAG 171

Query: 226 -------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
                   APE L    +  + DVW+ GV+L+ I   G+ P+       V + + +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77

 Score = 81.8 bits (203), Expect = 2e-19
 Identities = 24/77 (31%), Positives = 46/77 (59%), Gaps = 2/77 (2%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           LS E+   +KEAF++ DTNK G I+  EL++ +   G ++ + ++  LM   D +G+G +
Sbjct: 1   LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYI 60

Query: 416 NYGEFVAVSVHLKKMAN 432
            + +F  + +  +K+ N
Sbjct: 61  GFDDF--LDIMTEKIKN 75

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77

 Score = 61.4 bits (150), Expect = 2e-12
 Identities = 20/67 (29%), Positives = 37/67 (55%), Gaps = 8/67 (11%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV----INAIMHDVDTDKDGRISY 489
           + + +AF  FD N++G I+  EL+ A+       G DV    I  +M++ D + +G I +
Sbjct: 7   QEIKEAFDLFDTNKTGSIDYHELKVAMR----ALGFDVKKPEILELMNEYDREGNGYIGF 62

Query: 490 EEFAVMM 496
           ++F  +M
Sbjct: 63  DDFLDIM 69

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 70/303 (23%), Positives = 112/303 (36%), Gaps = 57/303 (18%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE--DVRREVQIMKHLPKHP 117
           L  ELG G FG  +L    N   +     ++ K L+ A +    D +RE +++  L +H 
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQ 103

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFD-----RIVARGHYTERAAAAVMKTIVEVVQV 172
           +IV       +   + +V E    G+L          A+        A     + +++ V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 173 CH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
                           +HRDL   N L     +   +K  DFG+S   R      +I  +
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---R------DIYST 211

Query: 223 PYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ 268
            YY            M PE +  R +  E DVWS GV+L+ I   G  P++  +      
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-- 269

Query: 269 AIIRSVIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEHPWLQNAKKAPN 324
             I  +   +    P         V   M      +P+QR + ++V     LQ   +AP 
Sbjct: 270 --IDCITQGRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQALAQAPP 322

Query: 325 VSL 327
           V L
Sbjct: 323 VYL 325

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 53/289 (18%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
            G+ LG G FG     T    G++ A   ++ K L+    A + E +  E++IM HL +H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD-------RIVARGHYTERAAAAVMKTIVEV 169
            NIV+L         V ++ E C  G+L +        +     +    + A  + ++  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 170 -VQVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
             QV         +  +HRD+   N L  N       K  DFGL+   R      +I+  
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV---AKIGDFGLA---R------DIMND 217

Query: 223 PYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ 268
             Y            MAPE +    Y  + DVWS G++L+ I   G+ P+       V  
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL---VNS 274

Query: 269 AIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
              + V D  +   P     A   +   M      +P  R T +++   
Sbjct: 275 KFYKLVKDGYQMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 7/155 (4%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LGR++G G FG  YL TD+  GE+ A K    K          +  E +I K +    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGV 65

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFD-RIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            I +++    +     +VMEL  G  L D        ++ +    +   ++  ++  H +
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211
             +HRD+KP+NFL    K+ + +  IDFGL+  +R
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 46/215 (21%)

Query: 60  LGRELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             R+LG G FG   L     T+   GE  A K++  K           ++E+ I++ L  
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTL-Y 91

Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
           H +I+  K        +++ +VME    G L D       Y  R +  + + ++   Q+C
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-------YLPRHSIGLAQLLLFAQQIC 144

Query: 174 ------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
                 H Q  +HRDL   N L         +K  DFGL+   +   + +E     YY  
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLA---KAVPEGHE-----YYRV 193

Query: 226 ----------MAPEVLK-RNYGPEVDVWSAGVILY 249
                      APE LK   +    DVWS GV LY
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 89.7 bits (222), Expect = 3e-19
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 21/214 (9%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           + LGR++G G FG  YL T++   E+ A K  + K          +  E +I + L    
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGT 63

Query: 118 NIVSLKDTYEDDSAVHIVMELCEG---GELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
            I +++    +     +VM+L  G    +LF+        + +    +   ++  V+  H
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVH 120

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--------PGEQFNEIVGSPYYM 226
            +  +HRD+KP+NFL    + ++ +  IDFGL+  +R        P  +   + G+  Y 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 227 APEV-LKRNYGPEVDVWSAGVILYILLCGVPPFW 259
           +    L        D+ S G +L   L G  P W
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 47/216 (21%)

Query: 60  LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             ++LG+G FG   +C       N GE  A K +   +  T   + D  RE++I+K L +
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSL-Q 100

Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQV 172
           H NIV  K          + ++ME    G L D +       +         +++   Q+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI 154

Query: 173 C------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY- 225
           C        +  +HRDL   N L  N+     +K  DFGL+      ++        YY 
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKE--------YYK 203

Query: 226 -----------MAPEVLK-RNYGPEVDVWSAGVILY 249
                       APE L    +    DVWS GV+LY
Sbjct: 204 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 55/232 (23%), Positives = 81/232 (34%), Gaps = 50/232 (21%)

Query: 60  LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
              +LG+G FG   LC       N G   A K +   +        D +RE+QI+K L  
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKAL-H 82

Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVE-VVQ 171
              IV  +         ++ +VME    G L D +   R              ++    Q
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD-------ASRLLLYSSQ 135

Query: 172 VC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           +C        +  +HRDL   N L  ++     +K  DFGL+      +         YY
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKD--------YY 184

Query: 226 ------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 263
                        APE L    +  + DVWS GV+LY +            E
Sbjct: 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 54/254 (21%)

Query: 45  VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIE 101
           V+  PS   +         +GRG FG  Y  T ++N  K    A KS+   ++    ++ 
Sbjct: 18  VVIGPSSLIVH----FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVS 71

Query: 102 DVRREVQIMKHLPKHPNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAA 159
               E  IMK    HPN++SL       + +  +V+   + G+L + I     + T    
Sbjct: 72  QFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---- 126

Query: 160 AAVMKTIVEV-VQVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
              +K ++   +QV         +  +HRDL   N +     E   +K  DFGL+   R 
Sbjct: 127 ---VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---R- 176

Query: 213 GEQFNEIVGSPYY--------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVP 256
                ++    YY              MA E L+ + +  + DVWS GV+L+ ++  G P
Sbjct: 177 -----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

Query: 257 PFWAETEQGVAQAI 270
           P+       +   +
Sbjct: 232 PYPDVNTFDITVYL 245

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 52/233 (22%), Positives = 88/233 (37%), Gaps = 44/233 (18%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
             +ELG G+FGV             A K I +     ++  ++   E ++M +L  H  +
Sbjct: 28  FLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNL-SHEKL 81

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVCH---- 174
           V L         + I+ E    G L + +    H  +       + ++E+   VC     
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ------TQQLLEMCKDVCEAMEY 135

Query: 175 --EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
              +  +HRDL   N L     +   +K  DFGLS   R       ++   Y        
Sbjct: 136 LESKQFLHRDLAARNCLVN---DQGVVKVSDFGLS---R------YVLDDEYTSSVGSKF 183

Query: 226 ----MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
                 PEVL    +  + D+W+ GV+++ I   G  P+   T    A+ I +
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 47/216 (21%)

Query: 60  LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             ++LG+G FG   +C       N GE  A K +   +  T   + D  RE++I+K L +
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSL-Q 69

Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQV 172
           H NIV  K          + ++ME    G L D +       +         +++   Q+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI 123

Query: 173 C------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY- 225
           C        +  +HRDL   N L  N+     +K  DFGL+      ++        ++ 
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKE--------FFK 172

Query: 226 -----------MAPEVLK-RNYGPEVDVWSAGVILY 249
                       APE L    +    DVWS GV+LY
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 44/231 (19%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
             +E+G G+FG+ +L     N +K A K+I +     A+  ED   E ++M  L  HP +
Sbjct: 12  FVQEIGSGQFGLVHLGY-WLNKDKVAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 65

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVCH---- 174
           V L     + + + +V E  E G L D +  +            +T++ + + VC     
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFA------AETLLGMCLDVCEGMAY 119

Query: 175 --EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
             E  V+HRDL   N L     E+  +K  DFG++   R       ++   Y        
Sbjct: 120 LEEACVIHRDLAARNCLVG---ENQVIKVSDFGMT---R------FVLDDQYTSSTGTKF 167

Query: 226 ----MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
                +PEV     Y  + DVWS GV+++ +   G  P+   +   V + I
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 38/226 (16%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L + +G+GEFG   L      G K A K      ++     +    E  +M  L +H N+
Sbjct: 197 LLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQL-RHSNL 248

Query: 120 VSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
           V L        E+   ++IV E    G L D + +RG    R+       +   + VC  
Sbjct: 249 VQL---LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEA 301

Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS--PY-YM 226
                    +HRDL   N L +   E +  K  DFGL+   +  E  +       P  + 
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K--EASSTQDTGKLPVKWT 353

Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
           APE L+   +  + DVWS G++L+ I   G  P+     + V   +
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.1 bits (214), Expect = 9e-19
 Identities = 61/295 (20%), Positives = 109/295 (36%), Gaps = 61/295 (20%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
            G+ LG G FG     T     +  A  +++ K L+      + E +  E++++ +L  H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--------RIVARGHYTERAAAAVMKTIVE 168
            NIV+L           ++ E C  G+L +         I ++          +   + +
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 169 VVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
           ++   +           +  +HRDL   N L          K  DFGL+   R      +
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---R------D 194

Query: 219 IVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
           I     Y            MAPE +    Y  E DVWS G+ L+ +   G  P+      
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----P 249

Query: 265 GVA--QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
           G+       + + +  R   P   E+A   +   M    + DP +R T +++++ 
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 59/239 (24%), Positives = 84/239 (35%), Gaps = 45/239 (18%)

Query: 60  LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           L  +LG G FGV                A K +    L     ++D  REV  M  L  H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DH 80

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVE-VVQVC- 173
            N++ L         + +V EL   G L DR+   +GH+        + T+    VQV  
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL-------LGTLSRYAVQVAE 132

Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
                  +  +HRDL   N L A +     +K  DFGL       +         +Y   
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDD--------HYVMQ 181

Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRS 273
                     APE LK R +    D W  GV L+ +   G  P+       +   I + 
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 70/297 (23%), Positives = 116/297 (39%), Gaps = 66/297 (22%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+   T  +   +  E++I+ H+  H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 117 PNIVSLKDTY----EDDSAVHIVMELCEGGELFD------RIVARGHYTERAAAAVMKTI 166
            N+V+L        +    + +++E C+ G L                          T+
Sbjct: 91  LNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 167 VEVVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
             ++               +  +HRDL   N L +   E + +K  DFGL+   R     
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA---R----- 196

Query: 217 NEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 262
            +I   P Y            MAPE +  R Y  + DVWS GV+L+ I   G  P+    
Sbjct: 197 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 251

Query: 263 EQGVA--QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
             GV   +   R + +  R   P   +     + + ML   + +P QR T  E++EH
Sbjct: 252 -PGVKIDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* Length = 183

 Score = 82.9 bits (205), Expect = 1e-18
 Identities = 34/166 (20%), Positives = 67/166 (40%), Gaps = 23/166 (13%)

Query: 355 FLSVEEVAGLKEAF--------EMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA 406
           FL+ +E+      F          ++++ R ++  E++ L L +   N P  +   +   
Sbjct: 13  FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQI-LSLPELKAN-PFKER--ICRV 68

Query: 407 ADVD-GDGSLNYGEFV-AVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL---- 460
                   SL++ +F+  +SV       D   H AF  FD +  G +  E+L   +    
Sbjct: 69  FSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLT 128

Query: 461 -----NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
                     +  + +I+ I+ + D D+DG I+  EF  ++    D
Sbjct: 129 GEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISRSPD 174

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 41/238 (17%), Positives = 74/238 (31%), Gaps = 41/238 (17%)

Query: 60  LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPK 115
               LG+G F   +  +  +V +  +     +  K L        E       +M  L  
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-S 70

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVCH 174
           H ++V             +V E  + G L   +    +         +   +EV  Q+  
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCIN------ILWKLEVAKQLAA 124

Query: 175 ------EQGVMHRDLKPENFLFANKKESSPL-----KAIDFGLSVFFRPGEQFNEIVGSP 223
                 E  ++H ++  +N L   +++         K  D G+S           ++   
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---I------TVLPKD 175

Query: 224 YY------MAPEVLK--RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
                   + PE ++  +N     D WS G  L+ I   G  P  A   Q   Q    
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 68/308 (22%), Positives = 106/308 (34%), Gaps = 62/308 (20%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKF--ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
               +G G FG         +G +   A K +  K+  +  D  D   E++++  L  HP
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHP 86

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFD------RIVARGHYTERAAAAVMKTIVEVVQ 171
           NI++L    E    +++ +E    G L D       +     +    + A   +  +++ 
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 172 VCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
                        ++  +HRDL   N L          K  DFGLS   R  E       
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIADFGLS---RGQE------- 193

Query: 222 SPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 267
              Y            MA E L    Y    DVWS GV+L+ I+  G  P+   T     
Sbjct: 194 --VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----C 247

Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH--PWLQNAKK 321
             +   +    R   P    N  D V   M       P +R +  ++L      L+  K 
Sbjct: 248 AELYEKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304

Query: 322 APNVSLGE 329
             N +L E
Sbjct: 305 YVNTTLYE 312

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 27/227 (11%)

Query: 50  SGQDISID--YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           SGQ+  +   Y +GR +G G FGV +  T++ N ++ A K   ++      D   +R E 
Sbjct: 2   SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEY 56

Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFD-RIVARGHYTERAAAAVMKTI 166
           +  K L     I ++    ++     +V++L  G  L D   +    ++ +  A   K +
Sbjct: 57  RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQM 115

Query: 167 VEVVQVCHEQGVMHRDLKPENFLF--ANKKESSPLKAIDFGLSVFFR--------PGEQF 216
           +  VQ  HE+ +++RD+KP+NFL    N K ++ +  +DFG+  F+R        P  + 
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

Query: 217 NEIVGSPYYMAPEVLKRNYGPEV----DVWSAGVILYILLCGVPPFW 259
             + G+  YM+   +  + G E     D+ + G +    L G  P W
Sbjct: 176 KNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 44/231 (19%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L + +G+GEFG   L      G K A K      ++     +    E  +M  L +H N+
Sbjct: 25  LLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQL-RHSNL 76

Query: 120 VSLKDTY----EDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEV-VQV 172
           V L        E+   ++IV E    G L D  R   R              +++  + V
Sbjct: 77  VQL---LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG-------GDCLLKFSLDV 126

Query: 173 CH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS--PY 224
           C           +HRDL   N L +   E +  K  DFGL+   +  E  +       P 
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K--EASSTQDTGKLPV 178

Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
            + APE L+ + +  + DVWS G++L+ I   G  P+     + V   + +
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 78.4 bits (194), Expect = 2e-18
 Identities = 16/65 (24%), Positives = 33/65 (50%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
            +  F+ +D N  G ++ EE++  + K      E  LQ++ ++ D DG+G ++  EF   
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61

Query: 424 SVHLK 428
              ++
Sbjct: 62  YGSIQ 66

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 64.9 bits (159), Expect = 1e-13
 Identities = 15/63 (23%), Positives = 26/63 (41%)

Query: 436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVM 495
               F   D N  G +  EE++  ++ +     E ++  I   +D D +G I   EFA  
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61

Query: 496 MKA 498
             +
Sbjct: 62  YGS 64

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 54.5 bits (132), Expect = 4e-10
 Identities = 16/61 (26%), Positives = 29/61 (47%)

Query: 400 LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNA 459
            + L +  DV+GDG+++Y E  A     + + N++ L   F   D + +G I+  E    
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61

Query: 460 L 460
            
Sbjct: 62  Y 62

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 37.5 bits (88), Expect = 5e-04
 Identities = 8/28 (28%), Positives = 15/28 (53%)

Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKA 498
           +  A+  ++D + DG +SYEE    +  
Sbjct: 1   MAEALFKEIDVNGDGAVSYEEVKAFVSK 28

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 54/243 (22%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
             R +G+G FGV Y    ++  +     A KS+   ++     +E   RE  +M+ L  H
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGL-NH 81

Query: 117 PNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQ 171
           PN+++L          +   H+++     G+L   I +            +K ++   +Q
Sbjct: 82  PNVLAL---IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR------NPTVKDLISFGLQ 132

Query: 172 VCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           V        EQ  +HRDL   N +     ES  +K  DFGL+   R      +I+   YY
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---R------DILDREYY 180

Query: 226 --------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
                          A E L+   +  + DVWS GV+L+ +L  G PP+       +   
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240

Query: 270 IIR 272
           + +
Sbjct: 241 LAQ 243

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 49/236 (20%), Positives = 82/236 (34%), Gaps = 47/236 (19%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             + LG G FG  +    +  GE        K I  +        + V   +  +  L  
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSL-D 73

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVE-VVQVC 173
           H +IV L       S + +V +    G L D +   RG           + ++   VQ+ 
Sbjct: 74  HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALG-------PQLLLNWGVQIA 125

Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
                  E G++HR+L   N L       S ++  DFG++    P ++            
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDK--------QLLY 174

Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
                    MA E +    Y  + DVWS GV ++ ++  G  P+       V   +
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 58/240 (24%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L   LG G+FG  ++    N   K A KS+ +     ++  +    E  +MK L +H  +
Sbjct: 17  LVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQL-QHQRL 70

Query: 120 VSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVEV-VQ 171
           V L     ++       ++I+ E  E G L D       +  T       +  ++++  Q
Sbjct: 71  VRLYAVVTQE------PIYIITEYMENGSLVD-------FLKTPSGIKLTINKLLDMAAQ 117

Query: 172 VCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
           +        E+  +HRDL+  N L +   ++   K  DFGL+   R       I  + Y 
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA---R------LIEDNEYT 165

Query: 226 -----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
                       APE +    +  + DVWS G++L  I+  G  P+   T   V Q + R
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 48/235 (20%), Positives = 88/235 (37%), Gaps = 45/235 (19%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             + LG G FG  Y    +  GEK     A K +  ++  +    +++  E  +M  +  
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASV-D 75

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC- 173
           +P++  L       + V ++ +L   G L D +               + ++   VQ+  
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG------SQYLLNWCVQIAK 128

Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
                 ++ ++HRDL   N L         +K  DFGL+      E+         Y   
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 226 --------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
                   MA E +  R Y  + DVWS GV ++ ++  G  P+       ++  +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67

 Score = 77.5 bits (192), Expect = 4e-18
 Identities = 23/62 (37%), Positives = 31/62 (50%)

Query: 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFV 421
           +  K  FE  D NK GK++L+E R   L       + D+    E  DVDG+G LN  EF 
Sbjct: 1   SSAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFT 60

Query: 422 AV 423
           + 
Sbjct: 61  SC 62

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67

 Score = 71.0 bits (175), Expect = 8e-16
 Identities = 13/62 (20%), Positives = 29/62 (46%)

Query: 436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVM 495
             + F  FD+N+ G + ++E R           ++ I     ++D D +G ++ +EF   
Sbjct: 3   AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSC 62

Query: 496 MK 497
           ++
Sbjct: 63  IE 64

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 86.0 bits (213), Expect = 4e-18
 Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 34/228 (14%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L  +LG+G FG  ++ T  N   + A K++        +  E   +E Q+MK L +H  +
Sbjct: 188 LEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKL 241

Query: 120 VSLKDTYE--DDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVE-VVQVC- 173
           V L   Y    +  ++IV E    G L D       +   E      +  +V+   Q+  
Sbjct: 242 VQL---YAVVSEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIAS 291

Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY-YM 226
                     +HRDL+  N L     E+   K  DFGL+      E         P  + 
Sbjct: 292 GMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 348

Query: 227 APEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
           APE      +  + DVWS G++L  +   G  P+     + V   + R
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86

 Score = 78.1 bits (193), Expect = 5e-18
 Identities = 23/88 (26%), Positives = 41/88 (46%), Gaps = 3/88 (3%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           A   + +++A  +  F+  DTN  GKI+  EL   L   G ++   +++ +M   D DGD
Sbjct: 2   AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGD 60

Query: 413 GSLNYGEFVAVSVHLKKMANDEHLHKAF 440
           G +++ EF             + + K F
Sbjct: 61  GFISFDEFTD--FARANRGLVKDVSKIF 86

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86

 Score = 71.1 bits (175), Expect = 1e-15
 Identities = 23/71 (32%), Positives = 34/71 (47%), Gaps = 1/71 (1%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
               + F  FD N  G I   EL +AL   + +   D +  +M ++DTD DG IS++EF 
Sbjct: 11  ADRERIFKRFDTNGDGKISSSELGDALK-TLGSVTPDEVRRMMAEIDTDGDGFISFDEFT 69

Query: 494 VMMKAGTDWRK 504
              +A     K
Sbjct: 70  DFARANRGLVK 80

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 40/183 (21%), Positives = 73/183 (39%), Gaps = 23/183 (12%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           + +G+++G G FG   L  ++   E  A K +   K R       +  E +  K L    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQLGSGD 65

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGG----ELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
            I  +           +V+EL   G    +LFD       ++ +    +   ++  ++  
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEYV 121

Query: 174 HEQGVMHRDLKPENFLF--ANKKESSPLKAIDFGLSVFFR--------PGEQFNEIVGSP 223
           H + +++RD+KPENFL      K    +  IDF L+  +         P  +   + G+ 
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181

Query: 224 YYM 226
            YM
Sbjct: 182 RYM 184

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 85.5 bits (212), Expect = 5e-18
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 42/232 (18%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L ++LG G+FG  ++ T  N   K A K++       ++ +E    E  +MK L +H  +
Sbjct: 192 LEKKLGAGQFGEVWMATY-NKHTKVAVKTMKP----GSMSVEAFLAEANVMKTL-QHDKL 245

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH----- 174
           V L      +  ++I+ E    G L D + +     E +   + K I    Q+       
Sbjct: 246 VKLHAVVTKEP-IYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFI 300

Query: 175 -EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-------- 225
            ++  +HRDL+  N L +    S   K  DFGL+           I  + Y         
Sbjct: 301 EQRNYIHRDLRAANILVS---ASLVCKIADFGLARV---------IEDNEYTAREGAKFP 348

Query: 226 ---MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
               APE +   ++  + DVWS G++L  I+  G  P+   +   V +A+ R
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 83.4 bits (207), Expect = 5e-18
 Identities = 63/241 (26%), Positives = 95/241 (39%), Gaps = 55/241 (22%)

Query: 60  LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           LGR +G G+FG  +     +  N     A K+   K   +    E   +E   M+    H
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQF-DH 75

Query: 117 PNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VV 170
           P+IV L     ++       V I+MELC  GEL   +  R +  +      + +++    
Sbjct: 76  PHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKYSLD------LASLILYAY 123

Query: 171 QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
           Q+         +  +HRD+   N L +    +  +K  DFGLS   R       +  S Y
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---R------YMEDSTY 171

Query: 225 Y-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 271
           Y           MAPE +  R +    DVW  GV ++ IL+ GV PF       V   I 
Sbjct: 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

Query: 272 R 272
            
Sbjct: 232 N 232

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 83.4 bits (207), Expect = 5e-18
 Identities = 71/300 (23%), Positives = 113/300 (37%), Gaps = 58/300 (19%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE--DVRREVQIMKHLPKHP 117
           L RELG G FG  +L    N         ++ K L+        D +RE +++ +L +H 
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHE 77

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK------TIVEVVQ 171
           +IV       D   + +V E  + G+L   + A G           +       + +++ 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 172 VCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
           +             Q  +HRDL   N L      +  +K  DFG+S   R      ++  
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---R------DVYS 185

Query: 222 SPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 267
           + YY            M PE +  R +  E DVWS GVIL+ I   G  P++  +   V 
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV- 244

Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEHPWLQNAKKAP 323
              I  +   +    P         V   ML     +P+QRL  +E+ +   L    KA 
Sbjct: 245 ---IECITQGRVLERP---RVCPKEVYDVMLGCWQREPQQRLNIKEIYKI--LHALGKAT 296

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 85.7 bits (212), Expect = 6e-18
 Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 34/228 (14%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           L  +LG+G FG  ++ T  N   + A K++        +  E   +E Q+MK L +H  +
Sbjct: 271 LEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKL 324

Query: 120 VSLKDTYE--DDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVE-VVQVC- 173
           V L   Y    +  ++IV E    G L D       +   E      +  +V+   Q+  
Sbjct: 325 VQL---YAVVSEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIAS 374

Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY-YM 226
                     +HRDL+  N L     E+   K  DFGL+      E         P  + 
Sbjct: 375 GMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 431

Query: 227 APEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
           APE      +  + DVWS G++L  +   G  P+     + V   + R
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A Length = 214

 Score = 81.4 bits (201), Expect = 7e-18
 Identities = 38/180 (21%), Positives = 72/180 (40%), Gaps = 25/180 (13%)

Query: 343 KLKKRALQVVAE--FLSVEEVAGLKEAF--------EMMDTNKRGKINLEELRLGLLKGG 392
           +L K  L    +  FL+ +E+      F          ++++ R ++  E++ L L +  
Sbjct: 30  RLSKELLAEYQDLTFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQI-LSLPELK 88

Query: 393 QNIPEADLQILMEAADVD-GDGSLNYGEFV-AVSVHLKKMANDEHLHKAFSFFDRNRSGF 450
            N P  +   +           SL++ +F+  +SV       D   H AF  FD +  G 
Sbjct: 89  AN-PFKER--ICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGT 145

Query: 451 IEIEELRNALNDEVDTSG---------EDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
           +  E+L   +N                + +I+ I+ + D D+DG I+  EF  ++    D
Sbjct: 146 LNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISRSPD 205

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 83.0 bits (206), Expect = 7e-18
 Identities = 66/236 (27%), Positives = 92/236 (38%), Gaps = 45/236 (19%)

Query: 60  LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           L R LG G FG  Y              A K+   KK  T  + E    E  IMK+L  H
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNL-DH 72

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH- 174
           P+IV L    E++    I+MEL   GEL   +    +  +      + T+V   +Q+C  
Sbjct: 73  PHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLK------VLTLVLYSLQICKA 125

Query: 175 -----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY---- 225
                    +HRD+   N L A       +K  DFGLS   R       I    YY    
Sbjct: 126 MAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---R------YIEDEDYYKASV 173

Query: 226 -------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
                  M+PE +  R +    DVW   V ++ IL  G  PF+    + V   + +
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229

>2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107

 Score = 78.2 bits (193), Expect = 8e-18
 Identities = 18/93 (19%), Positives = 42/93 (45%), Gaps = 3/93 (3%)

Query: 334 RLKQFSVMNKLKKRAL---QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK 390
           + +Q   ++++ K+ L   +  ++     ++ G KE +   D N  G I++  L+  L K
Sbjct: 1   KAQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60

Query: 391 GGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
            G      +L+ L+         + +Y +F+ +
Sbjct: 61  LGVPKTHLELKKLIGEVSSGSGETFSYPDFLRM 93

>2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107

 Score = 64.3 bits (157), Expect = 5e-13
 Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 4/66 (6%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALN--DEVDTSGEDVINAIMHDVDTDKDGRISYEE 491
           E   + +  FD N +G I+I  L+  L       T  E  +  ++ +V +      SY +
Sbjct: 32  EGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLE--LKKLIGEVSSGSGETFSYPD 89

Query: 492 FAVMMK 497
           F  MM 
Sbjct: 90  FLRMML 95

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 85.3 bits (211), Expect = 1e-17
 Identities = 63/236 (26%), Positives = 94/236 (39%), Gaps = 45/236 (19%)

Query: 60  LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           LGR +G G+FG  +     +  N     A K+   K   +    E   +E   M+    H
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQF-DH 450

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC-- 173
           P+IV L     ++  V I+MELC  GEL   +  R    +      + +++    Q+   
Sbjct: 451 PHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLD------LASLILYAYQLSTA 503

Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY---- 225
                 +  +HRD+   N L +    +  +K  DFGLS   R       +  S YY    
Sbjct: 504 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---R------YMEDSTYYKASK 551

Query: 226 -------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
                  MAPE +  R +    DVW  GV ++ IL+ GV PF       V   I  
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 50/239 (20%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
               +GRG FG  Y  T ++N  K    A KS+   ++    ++     E  IMK    H
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF-SH 149

Query: 117 PNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEV-VQVC 173
           PN++SL       + +  +V+   + G+L + I     + T       +K ++   +QV 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT-------VKDLIGFGLQVA 202

Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
                   +  +HRDL   N +     E   +K  DFGL+   R      ++    +   
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---R------DMYDKEFDSV 250

Query: 226 ------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
                       MA E L+ + +  + DVWS GV+L+ ++  G PP+       +   +
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 58/293 (19%)

Query: 60  LGRELGRGEFGVTYLCT--DVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG   L     ++  +      ++ K L+   T  D+ D+  E+++MK + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV---- 170
           KH NI++L      D  +++++E    G L + + AR       +        E +    
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 171 ------QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
                 QV         +  +HRDL   N L     E + +K  DFGL+   R      +
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---R------D 240

Query: 219 IVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
           I    YY            MAPE L  R Y  + DVWS GV+L+ I   G  P+     +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300

Query: 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
            +     + + +  R   P    N  + +   M    +  P QR T ++++E 
Sbjct: 301 EL----FKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 61/293 (20%)

Query: 60  LGRELGRGEFGVTYLCT--DVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
              ELG   FG  Y         GE+    A K++  K        E+ R E  +   L 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARL- 69

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK------TIVE 168
           +HPN+V L      D  + ++   C  G+L + +V R  +++  +    +         +
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 169 VVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
            V +               V+H+DL   N L     +   +K  D GL    R      E
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---R------E 177

Query: 219 IVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
           +  + YY            MAPE +    +  + D+WS GV+L+ +   G+ P+   + Q
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237

Query: 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
            V    +  + + +  P P   ++    V   M+   N  P +R   +++   
Sbjct: 238 DV----VEMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78

 Score = 76.1 bits (188), Expect = 2e-17
 Identities = 22/71 (30%), Positives = 35/71 (49%), Gaps = 1/71 (1%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
           + + + F  FD N  G I + EL +AL   + ++  D +  +M ++DTD DG I + EF 
Sbjct: 3   DDMERIFKRFDTNGDGKISLSELTDALR-TLGSTSADEVQRMMAEIDTDGDGFIDFNEFI 61

Query: 494 VMMKAGTDWRK 504
               A     K
Sbjct: 62  SFCNANPGLMK 72

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78

 Score = 69.9 bits (172), Expect = 3e-15
 Identities = 23/77 (29%), Positives = 37/77 (48%), Gaps = 3/77 (3%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           ++  F+  DTN  GKI+L EL   L   G      ++Q +M   D DGDG +++ EF++ 
Sbjct: 5   MERIFKRFDTNGDGKISLSELTDALRTLGST-SADEVQRMMAEIDTDGDGFIDFNEFIS- 62

Query: 424 SVHLKKMANDEHLHKAF 440
                     + + K F
Sbjct: 63  -FCNANPGLMKDVAKVF 78

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92

 Score = 76.5 bits (189), Expect = 2e-17
 Identities = 24/85 (28%), Positives = 47/85 (55%), Gaps = 1/85 (1%)

Query: 433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEF 492
           +E L +AF  FD++++G+I   ELR+ + +  +   ++ +  ++ + D D DG+++YEEF
Sbjct: 8   EEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEF 67

Query: 493 -AVMMKAGTDWRKASRQYSRERFNS 516
             +MM              R +F+S
Sbjct: 68  VKMMMTVRGGGGGNGWSRLRRKFSS 92

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92

 Score = 69.9 bits (172), Expect = 3e-15
 Identities = 26/90 (28%), Positives = 51/90 (56%), Gaps = 3/90 (3%)

Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGS 414
            +  +    LKEAF++ D ++ G I+  ELR  ++  G+ + + +++ +++ AD+DGDG 
Sbjct: 2   HMDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQ 61

Query: 415 LNYGEFVAVSVHLKKMAN---DEHLHKAFS 441
           +NY EFV + + ++          L + FS
Sbjct: 62  VNYEEFVKMMMTVRGGGGGNGWSRLRRKFS 91

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81

 Score = 76.1 bits (188), Expect = 2e-17
 Identities = 18/74 (24%), Positives = 34/74 (45%), Gaps = 1/74 (1%)

Query: 429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV-INAIMHDVDTDKDGRI 487
           +  ++E + +AF  FD N  G I+ +E +  +    +    D  +   M + D D +G I
Sbjct: 3   RQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVI 62

Query: 488 SYEEFAVMMKAGTD 501
              EF  ++K   +
Sbjct: 63  DIPEFMDLIKKSKN 76

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81

 Score = 64.9 bits (159), Expect = 1e-13
 Identities = 18/70 (25%), Positives = 41/70 (58%), Gaps = 1/70 (1%)

Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDGDG 413
           ++  ++   +  AF++ D N  G I+ +E +  + K G+  + +A+++  M+ AD DG+G
Sbjct: 1   WVRQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNG 60

Query: 414 SLNYGEFVAV 423
            ++  EF+ +
Sbjct: 61  VIDIPEFMDL 70

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91

 Score = 76.2 bits (188), Expect = 2e-17
 Identities = 20/85 (23%), Positives = 34/85 (40%), Gaps = 2/85 (2%)

Query: 338 FSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPE 397
               +   +  L         EE+A L+  F   D N+ G++  EE R    +       
Sbjct: 3   HHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELRVR--P 60

Query: 398 ADLQILMEAADVDGDGSLNYGEFVA 422
           AD + + +  D D DG++ + EF  
Sbjct: 61  ADAEAVFQRLDADRDGAITFQEFAR 85

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91

 Score = 73.2 bits (180), Expect = 2e-16
 Identities = 22/65 (33%), Positives = 31/65 (47%), Gaps = 2/65 (3%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
             L   F+  D NRSG +E EE R     E+     D   A+   +D D+DG I+++EFA
Sbjct: 27  ARLRSVFAACDANRSGRLEREEFRALC-TELRVRPADA-EAVFQRLDADRDGAITFQEFA 84

Query: 494 VMMKA 498
                
Sbjct: 85  RGFLG 89

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94

 Score = 76.5 bits (189), Expect = 2e-17
 Identities = 23/83 (27%), Positives = 48/83 (57%)

Query: 416 NYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAI 475
           + GE +     +K   ++E + +AF   D++ +G+I   ELR+ + +  +   ++ ++ +
Sbjct: 11  SSGENLYFQSLMKDTDSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEM 70

Query: 476 MHDVDTDKDGRISYEEFAVMMKA 498
           + + D D DG+++YEEF  MM A
Sbjct: 71  IREADIDGDGQVNYEEFVQMMTA 93

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94

 Score = 63.4 bits (155), Expect = 7e-13
 Identities = 21/60 (35%), Positives = 37/60 (61%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           ++EAF + D +  G I+  ELR  +   G+ + + ++  ++  AD+DGDG +NY EFV +
Sbjct: 31  IREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQM 90

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 72/294 (24%), Positives = 119/294 (40%), Gaps = 60/294 (20%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISK---KKLR---TAVDIEDVRREVQIMKHL 113
           LG+ LG G FG   +       +K   K       K L+   T  D+ D+  E+++MK +
Sbjct: 85  LGKPLGEGCFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV--- 170
            KH NI++L      D  +++++E    G L + + AR       +  + +   E +   
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 171 -------QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN 217
                  Q+         Q  +HRDL   N L     E++ +K  DFGL+   R      
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R------ 251

Query: 218 EIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 263
           +I    YY            MAPE L  R Y  + DVWS GV+++ I   G  P+     
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311

Query: 264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
           + +     + + +  R   P    N  + +   M    +  P QR T ++++E 
Sbjct: 312 EEL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 58/293 (19%)

Query: 60  LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
           LG+ LG G FG         ++  +     +++ K L+   T  D+ D+  E+++MK + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV---- 170
           KH NI++L      D  +++++E    G L + + AR       +  + +   E +    
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 171 ------QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
                 Q+         Q  +HRDL   N L         +K  DFGL+   R      +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLA---R------D 206

Query: 219 IVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
           I    YY            MAPE L  R Y  + DVWS GV+++ I   G  P+     +
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

Query: 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEH 313
            +     + + +  R   P    N  + +   M    +  P QR T ++++E 
Sbjct: 267 EL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105

 Score = 76.0 bits (187), Expect = 4e-17
 Identities = 15/77 (19%), Positives = 33/77 (42%)

Query: 425 VHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKD 484
           +H    ++   + + F  FD  ++  I  EE R   N  V    ++  + + +++  +  
Sbjct: 15  LHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAK 74

Query: 485 GRISYEEFAVMMKAGTD 501
           GR+ Y +F     + T 
Sbjct: 75  GRLKYPDFLSRFSSETA 91

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105

 Score = 71.7 bits (176), Expect = 1e-15
 Identities = 16/64 (25%), Positives = 26/64 (40%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
                + + FE  DT K   I+ EE R    +  Q + +     L     V+  G L Y 
Sbjct: 21  SHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYP 80

Query: 419 EFVA 422
           +F++
Sbjct: 81  DFLS 84

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 60/300 (20%), Positives = 105/300 (35%), Gaps = 66/300 (22%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
            G+ LG G FG     T     +      ++ K L+    + + E +  E+++M  L  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD-------------RIVARGHYTERAAAAVM 163
            NIV+L         ++++ E C  G+L +                      E      +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 164 KTIVEVVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
            T  +++   +           +  +HRDL   N L         +K  DFGL+   R  
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLA---R-- 220

Query: 214 EQFNEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 259
               +I+    Y            MAPE L    Y  + DVWS G++L+ I   GV P+ 
Sbjct: 221 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY- 275

Query: 260 AETEQGVA--QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
                G+       + + +  +   P     A + +   M      D ++R +   +   
Sbjct: 276 ----PGIPVDANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 55/237 (23%), Positives = 82/237 (34%), Gaps = 43/237 (18%)

Query: 60  LGRELGRGEFGV----TYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
             + +G GEFG         +        A K++  K   T     D   E  IM     
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQF-S 104

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVCH 174
           H NI+ L+        + I+ E  E G L           E+     +  +V +   +  
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDK------FLREKDGEFSVLQLVGMLRGIAA 158

Query: 175 ------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
                     +HRDL   N L      +   K  DFGLS   R  E   E      Y   
Sbjct: 159 GMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLS---RVLEDDPE----ATYTTS 208

Query: 226 --------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
                    APE +  R +    DVWS G++++ ++  G  P+W  +   V +AI  
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 83.1 bits (205), Expect = 6e-17
 Identities = 66/274 (24%), Positives = 99/274 (36%), Gaps = 50/274 (18%)

Query: 20  KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTY--LCTD 77
           +  P      E   ++   +  +   LK  +     I      ELG G FG     +   
Sbjct: 306 RPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI------ELGCGNFGSVRQGVYRM 359

Query: 78  VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137
                  A K +  K+     D E++ RE QIM  L  +P IV L    + ++ + +VME
Sbjct: 360 RKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAEA-LMLVME 415

Query: 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH------EQGVMHRDLKPENFLF 190
           +  GG L   +V +           +  + E + QV        E+  +HR+L   N L 
Sbjct: 416 MAGGGPLHKFLVGKREEIP------VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469

Query: 191 ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------------MAPEVLK-RNYGP 237
            N+      K  DFGLS      +         YY             APE +  R +  
Sbjct: 470 VNRHY---AKISDFGLSKALGADD--------SYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 238 EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
             DVWS GV ++  L  G  P+       V   I
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 81.2 bits (201), Expect = 6e-17
 Identities = 55/234 (23%), Positives = 80/234 (34%), Gaps = 42/234 (17%)

Query: 60  LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           + + +G G+ G      L          A K++  K   T     D   E  IM     H
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQF-DH 109

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH- 174
           PNI+ L+          IV E  E G L   +              +  +V  +  V   
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG------QFTIMQLVGMLRGVGAG 163

Query: 175 -----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY---- 225
                + G +HRDL   N L      +   K  DFGLS                 Y    
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPD-------AAYTTTG 213

Query: 226 -------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
                   APE +  R +    DVWS GV+++ +L  G  P+W  T + V  ++
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 57/236 (24%), Positives = 84/236 (35%), Gaps = 48/236 (20%)

Query: 60  LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
             +ELG G FG             +  A K + K +       +++  E  +M+ L  +P
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNP 78

Query: 118 NIVSLKDTYE--DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH 174
            IV +       +  +  +VME+ E G L   +    H          K I+E V QV  
Sbjct: 79  YIVRM---IGICEAESWMLVMEMAELGPLNKYLQQNRHVK-------DKNIIELVHQVSM 128

Query: 175 ------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
                 E   +HRDL   N L   +      K  DFGLS   R  E         YY   
Sbjct: 129 GMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADEN--------YYKAQ 177

Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
                     APE +    +  + DVWS GV+++     G  P+       V   +
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83

 Score = 74.2 bits (183), Expect = 9e-17
 Identities = 16/70 (22%), Positives = 26/70 (37%), Gaps = 6/70 (8%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNAL------NDEVDTSGEDVINAIMHDVDTDKDGRI 487
             L  AF   D N  G++   EL+  +              ++    ++   D + DG+I
Sbjct: 7   AELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADKNSDGKI 66

Query: 488 SYEEFAVMMK 497
           S EEF     
Sbjct: 67  SKEEFLNANA 76

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83

 Score = 57.6 bits (140), Expect = 6e-11
 Identities = 17/74 (22%), Positives = 34/74 (45%), Gaps = 6/74 (8%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELR-----LGL-LKGGQNIPEADLQILMEAADV 409
           ++ +  A L+ AF+ +D N  G +   EL+     L       ++  +     L++ AD 
Sbjct: 1   MACKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADK 60

Query: 410 DGDGSLNYGEFVAV 423
           + DG ++  EF+  
Sbjct: 61  NSDGKISKEEFLNA 74

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 62/232 (26%), Positives = 88/232 (37%), Gaps = 44/232 (18%)

Query: 62  RELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
            ELG G FG     +          A K +  K+     D E++ RE QIM  L  +P I
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL-DNPYI 72

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH---- 174
           V L    + ++ + +VME+  GG L   +V +           +  + E + QV      
Sbjct: 73  VRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIP------VSNVAELLHQVSMGMKY 125

Query: 175 --EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
             E+  +HRDL   N L  N+      K  DFGLS      +         YY       
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGADD--------SYYTARSAGK 174

Query: 226 -----MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
                 APE +  R +    DVWS GV ++  L  G  P+       V   I
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 36/180 (20%), Positives = 67/180 (37%), Gaps = 24/180 (13%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           + LG+++G G FG+ YL    N  EK A   +  +          +  E++  + + K  
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LFSELKFYQRVAKKD 94

Query: 118 NIVSLKDTYEDDSA----VH--------------IVMELCEGGELFDRIVARGHYTERAA 159
            I    +  + D       +              +VME   G +L       G + +   
Sbjct: 95  CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV 153

Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI 219
             +   +++V++  HE   +H D+K  N L   K     +   D+GLS  + P     + 
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGLSYRYCPNGNHKQY 212

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 61/233 (26%), Positives = 90/233 (38%), Gaps = 40/233 (17%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           + + +G GEFG           +K    A K++  K   T     D   E  IM     H
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF-DH 105

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-- 174
           PNI+ L+        V IV E  E G L   +  R H    A   V++ +  +  +    
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKH---DAQFTVIQLVGMLRGIASGM 160

Query: 175 ----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY----- 225
               + G +HRDL   N L      +   K  DFGL    R  E   E      Y     
Sbjct: 161 KYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLG---RVLEDDPE----AAYTTRGG 210

Query: 226 ------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
                  +PE +  R +    DVWS G++L+ ++  G  P+W  + Q V +A+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150

 Score = 74.5 bits (183), Expect = 4e-16
 Identities = 22/125 (17%), Positives = 47/125 (37%), Gaps = 16/125 (12%)

Query: 336 KQFSVMNKLKKRALQVVAEF-----------LSVEEVAGLKEAFEMMDTNKRGKINLEEL 384
           K F ++   ++R L  +                 E++   KE +   D N  G+I+L  L
Sbjct: 13  KAFGILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSL 72

Query: 385 RLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFD 444
           +  + K G      +++ ++         +++Y +FV +   L K      + K    F+
Sbjct: 73  KRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMM--LGKR---SAVLKLVMMFE 127

Query: 445 RNRSG 449
              + 
Sbjct: 128 GKANE 132

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150

 Score = 61.8 bits (150), Expect = 1e-11
 Identities = 15/66 (22%), Positives = 26/66 (39%), Gaps = 4/66 (6%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALN--DEVDTSGEDVINAIMHDVDTDKDGRISYEE 491
               + +  FD N  G I++  L+  +       T  E  +  ++ +V       ISY +
Sbjct: 50  TAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLE--MKKMISEVTGGVSDTISYRD 107

Query: 492 FAVMMK 497
           F  MM 
Sbjct: 108 FVNMML 113

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 69/316 (21%), Positives = 110/316 (34%), Gaps = 71/316 (22%)

Query: 60  LGRELGRGEFGVTYLCT--DVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
             R++G G FG  +      +   E F   A K +  K+  +A    D +RE  +M    
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF- 107

Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFD-----RIVARGHYTERAAAAVMK----- 164
            +PNIV L         + ++ E    G+L +             +    +   +     
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 165 ----TIVEVVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210
               +  E + +            E+  +HRDL   N L     E+  +K  DFGLS   
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS--- 221

Query: 211 RPGEQFNEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVP 256
           R       I  + YY            M PE +    Y  E DVW+ GV+L+ I   G+ 
Sbjct: 222 R------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275

Query: 257 PFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLE 312
           P++    + V    I  V D      P   EN    +   M    +  P  R +   +  
Sbjct: 276 PYYGMAHEEV----IYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHR 328

Query: 313 HPWLQNAKKAPNVSLG 328
              LQ   +    ++G
Sbjct: 329 I--LQRMCERAEGTVG 342

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90

 Score = 71.5 bits (176), Expect = 1e-15
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 4/85 (4%)

Query: 339 SVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA 398
           + M   +  A      FLS E +A  K AF+M D +  G I+ +EL   +   GQN  + 
Sbjct: 1   ASMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56

Query: 399 DLQILMEAADVDGDGSLNYGEFVAV 423
           +L  ++E  D DG G++++ EF+ +
Sbjct: 57  ELDAIIEEVDEDGSGTIDFEEFLVM 81

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90

 Score = 63.4 bits (155), Expect = 7e-13
 Identities = 23/63 (36%), Positives = 32/63 (50%), Gaps = 4/63 (6%)

Query: 436 LHKAFSFFDRNRSGFIEIEELRNALN--DEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
              AF  FD +  G I  +EL   +    +  T  E  ++AI+ +VD D  G I +EEF 
Sbjct: 22  FKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEE--LDAIIEEVDEDGSGTIDFEEFL 79

Query: 494 VMM 496
           VMM
Sbjct: 80  VMM 82

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 64/300 (21%), Positives = 117/300 (39%), Gaps = 67/300 (22%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
           LG+ LG GEFG     T  +   +    +++ K L+   +  ++ D+  E  ++K +  H
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NH 85

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD-----RIVARGHYTERAAAAVMK------- 164
           P+++ L      D  + +++E  + G L       R V  G+     +            
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 165 --TIVEVVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
             T+ +++              E  ++HRDL   N L A  ++   +K  DFGLS   R 
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKISDFGLS---R- 198

Query: 213 GEQFNEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPF 258
                ++     Y            MA E L    Y  + DVWS GV+L+ I+  G  P+
Sbjct: 199 -----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

Query: 259 WAETEQGVA-QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
                 G+  + +   +    R   P   +N  + + + ML     +P +R    ++ + 
Sbjct: 254 -----PGIPPERLFNLLKTGHRMERP---DNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147

 Score = 69.2 bits (169), Expect = 3e-14
 Identities = 18/99 (18%), Positives = 34/99 (34%), Gaps = 3/99 (3%)

Query: 403 LMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALND 462
             E  +      L+  ++        K+   E     +  FD N +G I+I  L+  L  
Sbjct: 20  QEERLEGINKQFLDDPKYSNDEDLPSKL---EAFKVKYMEFDLNGNGDIDIMSLKRMLEK 76

Query: 463 EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD 501
                    +  ++ +V +  +   SY +F  MM     
Sbjct: 77  LGVPKTHLELKRLIREVSSGSEETFSYSDFLRMMLGKRS 115

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147

 Score = 67.6 bits (165), Expect = 9e-14
 Identities = 17/107 (15%), Positives = 40/107 (37%)

Query: 317 QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKR 376
           Q+       + G     + ++   +NK      +   +     ++   K  +   D N  
Sbjct: 3   QSRDLQGGKAFGLLKAQQEERLEGINKQFLDDPKYSNDEDLPSKLEAFKVKYMEFDLNGN 62

Query: 377 GKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           G I++  L+  L K G      +L+ L+       + + +Y +F+ +
Sbjct: 63  GDIDIMSLKRMLEKLGVPKTHLELKRLIREVSSGSEETFSYSDFLRM 109

>1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A Length = 76

 Score = 66.1 bits (162), Expect = 5e-14
 Identities = 22/75 (29%), Positives = 35/75 (46%), Gaps = 4/75 (5%)

Query: 430 MANDEHLHKAFSFFDRNR--SGFIEIEELRNALN--DEVDTSGEDVINAIMHDVDTDKDG 485
           M + E +  AF  F         I  EEL+  +         G   ++ ++ +VD + DG
Sbjct: 1   MKSPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDG 60

Query: 486 RISYEEFAVMMKAGT 500
            +S+EEF VMMK  +
Sbjct: 61  EVSFEEFLVMMKKIS 75

>1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A Length = 76

 Score = 53.8 bits (130), Expect = 1e-09
 Identities = 18/64 (28%), Positives = 35/64 (54%), Gaps = 4/64 (6%)

Query: 364 LKEAFEMMDTN--KRGKINLEELRLGLLKGGQNI--PEADLQILMEAADVDGDGSLNYGE 419
           +K AFE+         +I+ EEL+L +   G ++    + L  ++E  D +GDG +++ E
Sbjct: 7   IKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEE 66

Query: 420 FVAV 423
           F+ +
Sbjct: 67  FLVM 70

>3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C Length = 143

 Score = 66.5 bits (162), Expect = 2e-13
 Identities = 25/118 (21%), Positives = 45/118 (38%), Gaps = 25/118 (21%)

Query: 381 LEELRLGLLKGGQNIPEADLQI-LMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKA 439
           +E L   + K    +   +LQ+   +  D DG+  L+  E      H+ K    E     
Sbjct: 50  MEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQ---- 105

Query: 440 FSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
                   +  +  +EL             ++I+ ++ D D + DG I Y EFA  ++
Sbjct: 106 --------APLMSEDEL------------INIIDGVLRDDDKNNDGYIDYAEFAKSLQ 143

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} Length = 174

 Score = 64.2 bits (156), Expect = 3e-12
 Identities = 23/146 (15%), Positives = 48/146 (32%), Gaps = 19/146 (13%)

Query: 363 GLKEAFEMMDT---NKRGKINLEELRLGLLKGGQNIPEADL------QILMEAADVDGDG 413
           G         +    +   I+  +L+  L +     P  D+      + L+   ++  +G
Sbjct: 2   GSSHHHHHHSSGLVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNG 61

Query: 414 SLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVIN 473
            L+  EF  +           H    F        G +   +L  A+ +     G  +  
Sbjct: 62  RLDQEEFARL------WKRLVHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISR 114

Query: 474 AIMHDV---DTDKDGRISYEEFAVMM 496
            ++H V    +D  GR+S+      +
Sbjct: 115 ELLHLVTLRYSDSVGRVSFPSLVCFL 140

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} Length = 174

 Score = 49.9 bits (119), Expect = 2e-07
 Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 7/86 (8%)

Query: 430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGE------DVINAIMHDVDTDK 483
           M +  H H   S     R   I+  +L+  LN E+ T         D   +++  ++   
Sbjct: 1   MGSSHHHHHHSSGL-VPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKV 59

Query: 484 DGRISYEEFAVMMKAGTDWRKASRQY 509
           +GR+  EEFA + K    ++   ++ 
Sbjct: 60  NGRLDQEEFARLWKRLVHYQHVFQKV 85

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} Length = 174

 Score = 48.0 bits (114), Expect = 9e-07
 Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 10/91 (10%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA---DLQILMEAADVDGDGSLNYGEF 420
            +  F+ + T+  G +   +L   +             +L  L+     D  G +++   
Sbjct: 78  YQHVFQKVQTSP-GVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYSDSVGRVSFPSL 136

Query: 421 VAVSVHLKKMANDEHLHKAFSFFDRNRSGFI 451
           V   + L+ M       K F    ++  G  
Sbjct: 137 VCFLMRLEAM------AKTFRNLSKDGKGLY 161

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 24/179 (13%), Positives = 58/179 (32%), Gaps = 27/179 (15%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE----DVRREVQIMKHL 113
           + L     R   G+ Y     +     +      +K + ++ ++     +  E    +  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDS----GPQKQKFSLKLDAKDGRLFNEQNFFQRA 99

Query: 114 PKHPNIVSLKDTY---------------EDDSAVHIVMELCEGGELFD--RIVARGHYTE 156
            K   +   K  Y                 D    +V+    G  L     +  +   +E
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE 158

Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
           R+   V   +++ ++  HE   +H ++  EN     + +S  +    +G +  + P  +
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSGK 216

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 31/186 (16%), Positives = 61/186 (32%), Gaps = 33/186 (17%)

Query: 58  YDLGRELGRGEFGVTYLC-----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           + +G  +G+G FG  YL        V +      K               +  E++  + 
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-------LFTELKFYQR 89

Query: 113 LPKHPNIVSLKDTYEDDSA----VH--------------IVMELCEGGELFDRIVARG-H 153
             K   I     T +                        ++M+   G +L     A    
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR 148

Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
           ++ +    +   I+++++  HE   +H D+K  N L  N K    +  +D+GL+  + P 
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYKNPDQVYLVDYGLAYRYCPE 207

Query: 214 EQFNEI 219
                 
Sbjct: 208 GVHKAY 213

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 110

 Score = 59.8 bits (145), Expect = 2e-11
 Identities = 15/76 (19%), Positives = 28/76 (36%), Gaps = 3/76 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           ++ E+       F  +  +    I+    +    K    +   +L  + E +D D DG+L
Sbjct: 16  ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGAL 73

Query: 416 NYGEFVAVSVHLKKMA 431
              EF   + HL    
Sbjct: 74  TLPEF-CAAFHLIVAR 88

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 110

 Score = 52.4 bits (126), Expect = 7e-09
 Identities = 13/62 (20%), Positives = 19/62 (30%), Gaps = 6/62 (9%)

Query: 438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEEFAVM 495
             F     + S FI     +N        S      ++ I    D D DG ++  EF   
Sbjct: 26  NQFRSLQPDPSSFISGSVAKNFFT----KSKLSIPELSYIWELSDADCDGALTLPEFCAA 81

Query: 496 MK 497
             
Sbjct: 82  FH 83

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 95

 Score = 58.9 bits (143), Expect = 3e-11
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 3/76 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           +S  E A   E F   D +  G ++  E+R   LK G  +P   L  +    D    G L
Sbjct: 4   VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKL 61

Query: 416 NYGEFVAVSVHLKKMA 431
           +  +F  ++ HL    
Sbjct: 62  SKDQFA-LAFHLISQK 76

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 95

 Score = 54.7 bits (132), Expect = 1e-09
 Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 6/66 (9%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEE 491
               + F   D++  GF+   E+R         +G    ++  I    DT   G++S ++
Sbjct: 10  AKYDEIFLKTDKDMDGFVSGLEVREIFL----KTGLPSTLLAHIWSLCDTKDCGKLSKDQ 65

Query: 492 FAVMMK 497
           FA+   
Sbjct: 66  FALAFH 71

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.5 bits (156), Expect = 5e-11
 Identities = 75/507 (14%), Positives = 143/507 (28%), Gaps = 186/507 (36%)

Query: 56  IDYDLGRELGRGEFGVTYLCTDV--NNGEKFA----CKSISKKKLRTAVDIEDVRREV-- 107
           +D++ G           Y   D+     + F     CK           D++D+ + +  
Sbjct: 7   MDFETGE--------HQYQYKDILSVFEDAFVDNFDCK-----------DVQDMPKSILS 47

Query: 108 -QIMKHLPKHPNIVS------------------------LKDTYE-----------DDSA 131
            + + H+    + VS                        L+  Y+             S 
Sbjct: 48  KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSM 107

Query: 132 VHIVME-----LCEGGELFDRI-VARGH-YTE--------RAAAAV----M----KTIVE 168
           +  +       L    ++F +  V+R   Y +        R A  V    +    KT V 
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV- 166

Query: 169 VVQVCHEQGVMHRDLKPENFL--------FANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
            + VC          K +  +          N      +  +   L     P        
Sbjct: 167 ALDVC-------LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219

Query: 221 GSPYYMAPEVLK---------RNYGPEV-----DVWSAGVILY------ILLCGVPPFWA 260
            S   +    ++         + Y         +V +A           ILL        
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPY-ENCLLVLLNVQNAKAWNAFNLSCKILL-------- 270

Query: 261 ET--EQGVAQAII---RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
            T   + V   +     + I           +  K L+ K L+  P Q L  E +  +P 
Sbjct: 271 -TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP-QDLPREVLTTNPR 328

Query: 316 LQNAKKAPNVSL-GETVK---ARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMM 371
                    +S+  E+++   A    +  +N  K     ++   L+V E A  ++ F+  
Sbjct: 329 R--------LSIIAESIRDGLATWDNWKHVNCDKLT--TIIESSLNVLEPAEYRKMFDR- 377

Query: 372 DTNKRGKINLEELRLGLLKGGQNIPEADLQIL---MEAADVDG------DGSL---NYGE 419
                         L +     +IP   L ++   +  +DV          SL      E
Sbjct: 378 --------------LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423

Query: 420 FVAVSVH------LKKMANDEHLHKAF 440
              +S+         K+ N+  LH++ 
Sbjct: 424 ST-ISIPSIYLELKVKLENEYALHRSI 449

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 Length = 92

 Score = 57.0 bits (138), Expect = 1e-10
 Identities = 17/76 (22%), Positives = 30/76 (39%), Gaps = 3/76 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           ++ E+       F+ +  +  G I     +    K    +P  +L  + E +D D DG+L
Sbjct: 3   ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGAL 60

Query: 416 NYGEFVAVSVHLKKMA 431
              EF   + HL    
Sbjct: 61  TLDEFC-AAFHLVVAR 75

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 Length = 92

 Score = 52.8 bits (127), Expect = 4e-09
 Identities = 13/66 (19%), Positives = 23/66 (34%), Gaps = 6/66 (9%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEE 491
           ++    F     + +GFI     +         S      ++ I    D DKDG ++ +E
Sbjct: 9   QYYVNQFKTIQPDLNGFIPGSAAKEFFT----KSKLPILELSHIWELSDFDKDGALTLDE 64

Query: 492 FAVMMK 497
           F     
Sbjct: 65  FCAAFH 70

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 23/91 (25%), Positives = 44/91 (48%), Gaps = 4/91 (4%)

Query: 60  LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
           LG+ LGRG FG           +   C++++ K L+   T  +   +  E++I+ H+  H
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 117 PNIVSLK-DTYEDDSAVHIVMELCEGGELFD 146
            N+V+L     +    + +++E C+ G L  
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 26/97 (26%)

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--------- 225
            +  +HRDL   N L +   E + +K  DFGL+   R      +I   P Y         
Sbjct: 211 SRKCIHRDLAARNILLS---EKNVVKICDFGLA---R------DIYKDPDYVRKGDARLP 258

Query: 226 ---MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPP 257
              MAPE +    Y  + DVWS GV+L+ I   G  P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} Length = 111

 Score = 55.9 bits (135), Expect = 6e-10
 Identities = 18/76 (23%), Positives = 35/76 (46%), Gaps = 3/76 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           +        ++ F   D    G +   + R  L++    +P+A L  +   +D+D DG L
Sbjct: 8   VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQSS--LPQAQLASIWNLSDIDQDGKL 65

Query: 416 NYGEFVAVSVHLKKMA 431
              EF+ +++HL  +A
Sbjct: 66  TAEEFI-LAMHLIDVA 80

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} Length = 111

 Score = 53.2 bits (128), Expect = 4e-09
 Identities = 16/66 (24%), Positives = 30/66 (45%), Gaps = 6/66 (9%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEE 491
               + F+  D+  SG +   + R  L      S   +  + +I +  D D+DG+++ EE
Sbjct: 14  LKYRQLFNSHDKTMSGHLTGPQARTILM----QSSLPQAQLASIWNLSDIDQDGKLTAEE 69

Query: 492 FAVMMK 497
           F + M 
Sbjct: 70  FILAMH 75

>1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A Length = 624

 Score = 60.7 bits (146), Expect = 6e-10
 Identities = 20/139 (14%), Positives = 43/139 (30%), Gaps = 10/139 (7%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           +       D NK  K+N +EL+  L +    + +   + +    D     SL   E    
Sbjct: 13  IHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSLEDEEIET- 71

Query: 424 SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE------VDTSGEDVINAIMH 477
               K +     + +AF     +    + +E L   L  +             +I     
Sbjct: 72  --FYKMLTQRAEIDRAFEEAAGSAE-TLSVERLVTFLQHQQREEEAGPALALSLIERYEP 128

Query: 478 DVDTDKDGRISYEEFAVMM 496
                   +++ + F + +
Sbjct: 129 SETAKAQRQMTKDGFLMYL 147

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900

 Score = 60.9 bits (147), Expect = 7e-10
 Identities = 37/183 (20%), Positives = 67/183 (36%), Gaps = 24/183 (13%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL--------QILMEAADVD 410
           EE    ++ F  +      +++  EL   L K     P+           + ++   D D
Sbjct: 728 EEERQFRKLFVQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSD 786

Query: 411 GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
             G L + EF  +  ++KK          +  F+ +RSG I   EL  A         + 
Sbjct: 787 TTGKLGFEEFKYLWNNIKK------WQGIYKRFETDRSGTIGSNELPGAFEAAGFHLNQH 840

Query: 471 VINAIMHDVDTDKDGRISYEEF---AVMMKAGTDWRKASRQYSRERFNSISLKLMREEGL 527
           + + I+     D+ G + ++ F    V + A      A R   +     I + +  +E L
Sbjct: 841 IYSMIIRRYS-DETGNMDFDNFISCLVRLDAMFR---AFRSLDKNGTGQIQVNI--QEWL 894

Query: 528 QLA 530
           QL 
Sbjct: 895 QLT 897

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900

 Score = 55.6 bits (133), Expect = 3e-08
 Identities = 25/125 (20%), Positives = 47/125 (37%), Gaps = 13/125 (10%)

Query: 401 QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL 460
           + ++   D DG+G L   EF  +   ++           F  FD ++SG +   E+R A+
Sbjct: 580 RSMVNLMDRDGNGKLGLVEFNILWNRIRNY------LTIFRKFDLDKSGSMSAYEMRMAI 633

Query: 461 NDEVDTSGEDVINAIMHDVDTDKDGRISYEEF---AVMMKAGTDWRKASRQYSRERFNSI 517
                     +   I+     D +  I ++ F    V ++         +Q   E   +I
Sbjct: 634 EAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFK---IFKQLDPENTGTI 689

Query: 518 SLKLM 522
            L L+
Sbjct: 690 QLDLI 694

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900

 Score = 52.9 bits (126), Expect = 2e-07
 Identities = 28/161 (17%), Positives = 57/161 (35%), Gaps = 30/161 (18%)

Query: 354 EFLSV-EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           EF  +   +      F   D +K G ++  E+R+ +   G  +P    Q+++     D +
Sbjct: 598 EFNILWNRIRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDE 656

Query: 413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEI---EELRNALNDEVDTSGE 469
             +++  FV   V L+ +       K F   D   +G I++     L  ++  ++  + E
Sbjct: 657 LIIDFDNFVRCLVRLEIL------FKIFKQLDPENTGTIQLDLISWLSFSVLGKLAAAIE 710

Query: 470 DVINAIMHDVDT-------------------DKDGRISYEE 491
              +  MH  +                      D  +S  E
Sbjct: 711 HHHHHHMHYSNIEANESEEERQFRKLFVQLAGDDMEVSATE 751

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L Length = 714

 Score = 58.3 bits (140), Expect = 4e-09
 Identities = 29/133 (21%), Positives = 51/133 (38%), Gaps = 15/133 (11%)

Query: 401 QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL 460
           +I+++  D DG G L   EF  +   ++K        K +   D +RSG +   E+R AL
Sbjct: 578 KIMVDMLDEDGSGKLGLKEFYILWTKIQKY------QKIYREIDVDRSGTMNSYEMRKAL 631

Query: 461 NDEVDTSGEDVINAIMHDVDTDKDGRISYEEF---AVMMKAGTDWRKASRQYSRERFNSI 517
            +        +   I+     D +  I ++ F    V ++         +Q   E   +I
Sbjct: 632 EEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFK---IFKQLDPENTGTI 687

Query: 518 SLKLMREEGLQLA 530
            L L     L  +
Sbjct: 688 QLDL--ISWLSFS 698

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L Length = 714

 Score = 48.6 bits (115), Expect = 4e-06
 Identities = 19/89 (21%), Positives = 41/89 (46%), Gaps = 7/89 (7%)

Query: 365 KEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVS 424
           ++ +  +D ++ G +N  E+R  L + G  +P    Q+++     D +  +++  FV   
Sbjct: 608 QKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCL 666

Query: 425 VHLKKMANDEHLHKAFSFFDRNRSGFIEI 453
           V L+ +       K F   D   +G I++
Sbjct: 667 VRLEIL------FKIFKQLDPENTGTIQL 689

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.0 bits (134), Expect = 1e-08
 Identities = 38/248 (15%), Positives = 71/248 (28%), Gaps = 68/248 (27%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA-----VDIEDVRREVQIMK 111
                 ++G G FG  +      +    A K I+ +             E++  E+ I K
Sbjct: 21  KLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 112 HL--------PKHPNIVSLKDTY------------------------------EDDSAVH 133
            L         +    + L   +                                D  + 
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFAN 192
           IV+E   GG   +++  +   +   A +++  +   + V        HRDL   N L   
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197

Query: 193 ---------------KKESSPLKA--IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNY 235
                             S  L+   ID+ LS   R G     +V     M  ++   + 
Sbjct: 198 TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG 253

Query: 236 GPEVDVWS 243
             + D++ 
Sbjct: 254 DYQFDIYR 261

>3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A Length = 121

 Score = 50.6 bits (121), Expect = 5e-08
 Identities = 18/72 (25%), Positives = 35/72 (48%), Gaps = 4/72 (5%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           ++VEE A   + F  +     G I  ++ R    + G  +P+  L  +   AD++ DG +
Sbjct: 27  ITVEERAKHDQQFHSLKPIS-GFITGDQARNFFFQSG--LPQPVLAQIWALADMNNDGRM 83

Query: 416 NYGEFVAVSVHL 427
           +  EF  +++ L
Sbjct: 84  DQVEFS-IAMKL 94

>3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A Length = 121

 Score = 43.3 bits (102), Expect = 2e-05
 Identities = 18/54 (33%), Positives = 26/54 (48%), Gaps = 6/54 (11%)

Query: 446 NRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEEFAVMMK 497
             SGFI  ++ RN        SG  + V+  I    D + DGR+   EF++ MK
Sbjct: 44  PISGFITGDQARNFFFQ----SGLPQPVLAQIWALADMNNDGRMDQVEFSIAMK 93

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 Length = 99

 Score = 48.3 bits (115), Expect = 2e-07
 Identities = 17/76 (22%), Positives = 32/76 (42%), Gaps = 3/76 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
                    ++ +  ++    G++   +    L K G  +P+  L  + + AD DG G L
Sbjct: 5   QLSSGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVL 62

Query: 416 NYGEFVAVSVHLKKMA 431
           +  EF  V++ L   A
Sbjct: 63  SKQEF-FVALRLVACA 77

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 Length = 99

 Score = 48.3 bits (115), Expect = 2e-07
 Identities = 14/62 (22%), Positives = 26/62 (41%), Gaps = 6/62 (9%)

Query: 438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEEFAVM 495
           K +   +   +G +   +    L      SG  + ++  I    DTD  G +S +EF V 
Sbjct: 15  KYYRQVEAGNTGRVLALDAAAFLK----KSGLPDLILGKIWDLADTDGKGVLSKQEFFVA 70

Query: 496 MK 497
           ++
Sbjct: 71  LR 72

>1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 Length = 103

 Score = 48.0 bits (114), Expect = 3e-07
 Identities = 18/100 (18%), Positives = 34/100 (34%), Gaps = 20/100 (20%)

Query: 399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRN 458
           + +      D++ DG L+  E  A+            L K +   +         EE   
Sbjct: 21  NPKTFFILHDINSDGVLDEQELEALFTK--------ELEKVYDPKNEEDDMREMEEER-- 70

Query: 459 ALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
                       +   +M +VDT++D  ++ EEF    + 
Sbjct: 71  ----------LRMREHVMKNVDTNQDRLVTLEEFLASTQR 100

>1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A Length = 106

 Score = 47.1 bits (112), Expect = 5e-07
 Identities = 19/76 (25%), Positives = 36/76 (47%), Gaps = 4/76 (5%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           +  E+ A     F+ +     G ++ ++++  LL     +P   L  + E +D+D DG L
Sbjct: 9   VKPEDKAKYDAIFDSLSPVN-GFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGML 65

Query: 416 NYGEFVAVSVHLKKMA 431
           +  EF  V++ L   A
Sbjct: 66  DRDEFA-VAMFLVYCA 80

>1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A Length = 106

 Score = 41.7 bits (98), Expect = 4e-05
 Identities = 15/62 (24%), Positives = 27/62 (43%), Gaps = 7/62 (11%)

Query: 438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEEFAVM 495
             F       +GF+  ++++  L +    S    D++  +    D D DG +  +EFAV 
Sbjct: 19  AIFDSLS-PVNGFLSGDKVKPVLLN----SKLPVDILGRVWELSDIDHDGMLDRDEFAVA 73

Query: 496 MK 497
           M 
Sbjct: 74  MF 75

>1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 Length = 78

 Score = 45.8 bits (109), Expect = 8e-07
 Identities = 13/51 (25%), Positives = 26/51 (50%), Gaps = 2/51 (3%)

Query: 448 SGFIEIEELRNALNDEV--DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
              +  EEL+  +  E      G   ++ +  ++D + DG +S+EEF V++
Sbjct: 23  PNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLV 73

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 49.1 bits (118), Expect = 2e-06
 Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 52/227 (22%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           ++D    +G G FG  Y    + +G K A K  + +  +    IE+   E++ +    +H
Sbjct: 40  NFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQ---GIEEFETEIETLSFC-RH 94

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD------------------RI---VARG-HY 154
           P++VSL    ++ + + ++ +  E G L                     I    ARG HY
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154

Query: 155 TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214
                              H + ++HRD+K  N L          K  DFG+S      +
Sbjct: 155 L------------------HTRAIIHRDVKSINILLDENFVP---KITDFGISKKGTELD 193

Query: 215 QFN---EIVGSPYYMAPEVLKRNYGPE-VDVWSAGVILYILLCGVPP 257
           Q +    + G+  Y+ PE   +    E  DV+S GV+L+ +LC    
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 41/175 (23%), Positives = 61/175 (34%), Gaps = 59/175 (33%)

Query: 174 HEQGVMHRDLKPENFL----FANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYM 226
           HE   +HRD+K  N L    F   K S      DFGL+       Q    + IVG+  YM
Sbjct: 150 HENHHIHRDIKSANILLDEAF-TAKIS------DFGLARASEKFAQTVMTSRIVGTTAYM 202

Query: 227 APEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP----- 281
           APE L+    P+ D++S GV+L  ++ G                    +D  R+P     
Sbjct: 203 APEALRGEITPKSDIYSFGVVLLEIITG-----------------LPAVDEHREPQLLLD 245

Query: 282 --WPKVSENAK--------------DLVKKM-------LNPDPKQRLTAEEVLEH 313
                  E                   V+ M       L+    +R   ++V + 
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

>1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 Length = 863

 Score = 48.4 bits (114), Expect = 5e-06
 Identities = 26/123 (21%), Positives = 57/123 (46%), Gaps = 2/123 (1%)

Query: 342 NKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQ 401
           N+++ + L   A+ +S E++   + +F   D  K G ++ E+ R  L+  G N+ EA+  
Sbjct: 705 NEVENQILTRDAKGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFA 764

Query: 402 ILMEAADVDGDGSLNYGEFVAVSVHLKKMAND-EHLHKAFSFFDRNRSGFIEIEELRNAL 460
            +M   D +  G + +  F+          +  + +  +F     ++  +I ++ELR  L
Sbjct: 765 RIMSIVDPNRMGVVTFQAFIDFMSRETADTDTADQVMASFKILAGDK-NYITVDELRREL 823

Query: 461 NDE 463
             +
Sbjct: 824 PPD 826

>1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 Length = 863

 Score = 46.0 bits (108), Expect = 3e-05
 Identities = 16/59 (27%), Positives = 29/59 (49%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEF 492
                +F+ FDR ++G ++ E+ R  L       GE     IM  VD ++ G ++++ F
Sbjct: 725 NEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPNRMGVVTFQAF 783

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} Length = 179

 Score = 46.2 bits (109), Expect = 5e-06
 Identities = 17/96 (17%), Positives = 30/96 (31%), Gaps = 8/96 (8%)

Query: 410 DGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG- 468
                L   E       L     D  L   F   D+N  G +  EE++  +      +  
Sbjct: 74  IVKQVLTKDELKDFYEQLTDQGFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKL 133

Query: 469 -------EDVINAIMHDVDTDKDGRISYEEFAVMMK 497
                  ++    IM ++D    G I  E+   ++ 
Sbjct: 134 SKIKERADEYTALIMEELDPTNLGYIEMEDLEALLL 169

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} Length = 179

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 18/107 (16%), Positives = 35/107 (32%), Gaps = 11/107 (10%)

Query: 365 KEAFEMMDTNKR---GKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFV 421
            + F+ +   +      +  +EL+    +      +  L+   +  D + DG L   E  
Sbjct: 62  VQMFDSLARKRGIVKQVLTKDELKDFYEQLTDQGFDNRLRTFFDMVDKNADGRLTAEEVK 121

Query: 422 AVSVHLKKMAN--------DEHLHKAFSFFDRNRSGFIEIEELRNAL 460
            +                 DE+        D    G+IE+E+L   L
Sbjct: 122 EIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIEMEDLEALL 168

>3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A Length = 100

 Score = 43.3 bits (102), Expect = 1e-05
 Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 6/65 (9%)

Query: 437 HKAFSFFDRNRSGFIEIEELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEE 491
           +K +          I     R  L  E+     DT      + ++ ++D + DGRIS++E
Sbjct: 18  YK-YVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDE 76

Query: 492 FAVMM 496
           +  ++
Sbjct: 77  YWTLI 81

>1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A Length = 96

 Score = 41.7 bits (98), Expect = 3e-05
 Identities = 12/55 (21%), Positives = 27/55 (49%), Gaps = 5/55 (9%)

Query: 447 RSGFIEIEELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
             G++  E+LR  +  E      +      ++ IM D+D  +DG++ ++ F  ++
Sbjct: 21  DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLI 75

>2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A Length = 106

 Score = 41.3 bits (97), Expect = 6e-05
 Identities = 8/63 (12%), Positives = 26/63 (41%), Gaps = 3/63 (4%)

Query: 454 EELRNALNDEV--DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM-KAGTDWRKASRQYS 510
            E +  +  ++         ++  M  +D ++D  + + E+  ++ +   + RK      
Sbjct: 44  NEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELAKEIRKKKDLKI 103

Query: 511 RER 513
           R++
Sbjct: 104 RKK 106

>2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A Length = 95

 Score = 40.9 bits (96), Expect = 7e-05
 Identities = 11/48 (22%), Positives = 25/48 (52%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            EL+  L  E+     +   + VI+ I   +D ++D ++ ++EF  ++
Sbjct: 34  GELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLV 81

>2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A Length = 139

 Score = 41.8 bits (98), Expect = 7e-05
 Identities = 21/78 (26%), Positives = 36/78 (46%), Gaps = 4/78 (5%)

Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDG 413
           E++  ++     E F  +     GKI     +  ++K    +P   L  + + ADVD DG
Sbjct: 43  EWVVGKDKPTYDEIFYTLSPVN-GKITGANAKKEMVKSK--LPNTVLGKIWKLADVDKDG 99

Query: 414 SLNYGEFVAVSVHLKKMA 431
            L+  EF  ++ HL K+ 
Sbjct: 100 LLDDEEFA-LANHLIKVK 116

>2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A Length = 139

 Score = 40.3 bits (94), Expect = 3e-04
 Identities = 14/54 (25%), Positives = 20/54 (37%), Gaps = 6/54 (11%)

Query: 446 NRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEEFAVMMK 497
             +G I     +  +      S     V+  I    D DKDG +  EEFA+   
Sbjct: 62  PVNGKITGANAKKEMV----KSKLPNTVLGKIWKLADVDKDGLLDDEEFALANH 111

>1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A Length = 93

 Score = 40.5 bits (95), Expect = 1e-04
 Identities = 8/44 (18%), Positives = 23/44 (52%), Gaps = 1/44 (2%)

Query: 454 EELRNALNDEV-DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
           ++L+  L  E      +   +    ++D + DG ++++EF +++
Sbjct: 32  DDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILV 75

>1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* Length = 113

 Score = 39.9 bits (93), Expect = 2e-04
 Identities = 15/49 (30%), Positives = 27/49 (55%), Gaps = 6/49 (12%)

Query: 454 EELRNALNDEV------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            E +  +  ++      +   E VI  IM D+DT+ D ++S+EEF ++M
Sbjct: 34  GEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLM 82

>2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A Length = 92

 Score = 39.0 bits (91), Expect = 3e-04
 Identities = 11/45 (24%), Positives = 24/45 (53%), Gaps = 2/45 (4%)

Query: 454 EELRNALNDEV--DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
           +EL+  +  E+      E  I+ +M  +D + D  I ++E++V +
Sbjct: 32  KELKELIKKELCLGEMKESSIDDLMKSLDKNSDQEIDFKEYSVFL 76

>1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A Length = 93

 Score = 39.0 bits (91), Expect = 3e-04
 Identities = 13/48 (27%), Positives = 27/48 (56%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
           +EL++ L  E+          D ++ IM ++D + DG + ++EF V++
Sbjct: 31  KELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLV 78

>4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* Length = 93

 Score = 39.0 bits (91), Expect = 3e-04
 Identities = 10/54 (18%), Positives = 25/54 (46%), Gaps = 5/54 (9%)

Query: 448 SGFIEIEELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
              +   EL+  L  E+       + E     +M ++D+++D  + ++E+ V +
Sbjct: 26  KFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFL 79

>3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} Length = 104

 Score = 39.1 bits (91), Expect = 4e-04
 Identities = 10/54 (18%), Positives = 25/54 (46%), Gaps = 5/54 (9%)

Query: 448 SGFIEIEELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
              +   EL+  L  E+       + E     +M ++D+++D  + ++E+ V +
Sbjct: 29  KFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFL 82

>1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A Length = 100

 Score = 38.6 bits (90), Expect = 4e-04
 Identities = 10/57 (17%), Positives = 22/57 (38%), Gaps = 7/57 (12%)

Query: 447 RSGFIEIEELRNALNDE-------VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
           R   I+   L   + +         D  G + +  +    D ++D +I + EF  ++
Sbjct: 22  RDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLL 78

>3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... Length = 92

 Score = 38.6 bits (90), Expect = 5e-04
 Identities = 11/48 (22%), Positives = 27/48 (56%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            EL+  +N+E+     +   ++V++ +M  +D++ DG   ++EF   +
Sbjct: 31  SELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFV 78

>1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A Length = 90

 Score = 38.2 bits (89), Expect = 5e-04
 Identities = 10/46 (21%), Positives = 24/46 (52%), Gaps = 3/46 (6%)

Query: 454 EELRNALNDEV---DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
           +EL+  +  E+       +  I  +M D+D +KD  ++++E+   +
Sbjct: 32  KELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFL 77

>3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A Length = 101

 Score = 38.7 bits (90), Expect = 5e-04
 Identities = 12/48 (25%), Positives = 20/48 (41%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            EL+  L  E+         E   N  M  +DT+KD  + + E+   +
Sbjct: 32  AELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSL 79

>1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A Length = 95

 Score = 37.9 bits (88), Expect = 7e-04
 Identities = 10/48 (20%), Positives = 24/48 (50%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            EL+  +  E+         +D ++ ++ D+D + D ++ + EF V +
Sbjct: 31  GELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFV 78

>1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A Length = 99

 Score = 37.9 bits (88), Expect = 8e-04
 Identities = 11/48 (22%), Positives = 24/48 (50%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            E    +N E+     +     V++ +M  +D D DG++ ++EF  ++
Sbjct: 35  TEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLI 82

>2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} Length = 99

 Score = 37.9 bits (88), Expect = 9e-04
 Identities = 14/48 (29%), Positives = 26/48 (54%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            EL+  LN E+           ++  IM+D+D++KD  + + EF V++
Sbjct: 32  GELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLV 79

>2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A Length = 113

 Score = 38.4 bits (89), Expect = 9e-04
 Identities = 14/87 (16%), Positives = 32/87 (36%), Gaps = 12/87 (13%)

Query: 422 AVSVHLKKMAND-----EHLHKAFSFFDRN--RSGFIEIEELRNALNDEV-----DTSGE 469
               H   MA       + +   F  +         +   EL+  L  E+       + E
Sbjct: 5   HHHHHHGSMACPLEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDE 64

Query: 470 DVINAIMHDVDTDKDGRISYEEFAVMM 496
                +M ++D+++D  + ++E+ V +
Sbjct: 65  AAFQKLMSNLDSNRDNEVDFQEYCVFL 91

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	531
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	99.95
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	99.94
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	99.94
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	99.94
1y1x_A	191	Leishmania major homolog of programmed cell death	99.94
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	99.93
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	99.92
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	99.92
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	99.92
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	99.92
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	99.92
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	99.92
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	99.92
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	99.92
3u0k_A	440	Rcamp; fluorescent protein, calcium binding, EF-ha	99.92
3i5g_C	159	Myosin catalytic light chain LC-1, mantle muscle;	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	99.91
3i5g_B	153	Myosin regulatory light chain LC-2, mantle muscle;	99.91
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	99.91
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	99.91
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	99.9
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	99.9
2jnf_A	158	Troponin C; stretch activated muscle contraction,	99.9
3fwb_A	161	Cell division control protein 31; gene gating, com	99.9
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	99.9
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	99.89
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	99.89
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	99.89
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	99.89
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	99.89
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	99.89
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	99.89
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	99.88
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	99.88
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	99.88
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	99.88
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	99.88
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	99.88
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	99.88
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	99.88
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	99.88
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	99.87
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	99.87
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	99.87
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	99.86
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	99.86
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	99.86
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	99.86
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	99.85
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	99.85
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	99.85
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	99.85
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	99.85
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	99.85
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	99.85
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	99.84
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	99.84
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	99.84
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	99.84
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	99.84
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	99.84
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	99.84
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	99.84
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	99.84
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	99.83
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	99.83
2lvv_A	226	Flagellar calcium-binding protein TB-24; EF-hand,	99.83
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	99.83
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	99.83
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	99.83
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	99.83
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	99.82
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	99.82
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	99.82
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	99.82
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	99.82
1dgu_A	183	Calcium-saturated CIB; helical, EF-hands, blood cl	99.82
2ct9_A	208	Calcium-binding protein P22; EF-hand, metal bindin	99.82
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	99.81
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	99.81
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	99.8
2l4h_A	214	Calcium and integrin-binding protein 1; metal bind	99.8
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	99.8
2hps_A	186	Coelenterazine-binding protein with bound coelent;	99.8
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	99.79
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	99.79
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	99.79
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	99.77
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	99.77
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	99.76
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	99.75
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	99.75
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	99.74
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	99.74
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	99.74
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	99.73
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	99.72
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	99.71
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	99.71
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	99.7
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	99.7
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	99.69
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	99.69
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	99.69
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	99.69
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	99.68
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	99.68
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	99.68
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	99.68
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	99.68
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	99.68
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	99.68
1djx_A	624	PLC-D1, phosphoinositide-specific phospholipase C,	99.68
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	99.68
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	99.68
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	99.67
2jnf_A	158	Troponin C; stretch activated muscle contraction,	99.67
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	99.67
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	99.67
3fwb_A	161	Cell division control protein 31; gene gating, com	99.67
3u0k_A	440	Rcamp; fluorescent protein, calcium binding, EF-ha	99.66
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	99.66
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	99.66
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	99.66
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	99.66
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	99.66
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	99.66
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	99.66
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	99.65
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	99.65
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	99.65
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	99.65
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	99.65
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	99.65
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	99.64
1y1x_A	191	Leishmania major homolog of programmed cell death	99.64
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.64
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.64
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	99.63
1sjj_A	863	Actinin; 3-helix bundle, calponin homology domain,	99.63
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	99.63
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	99.63
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	99.62
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	99.62
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	99.62
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	99.62
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	99.62
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	99.61
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	99.61
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	99.61
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	99.61
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	99.6
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	99.6
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.6
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	99.6
2ct9_A	208	Calcium-binding protein P22; EF-hand, metal bindin	99.59
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	99.59
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	99.59
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	99.58
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.57
3i5g_C	159	Myosin catalytic light chain LC-1, mantle muscle;	99.57
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	99.56
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	99.56
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	99.55
2lvv_A	226	Flagellar calcium-binding protein TB-24; EF-hand,	99.55
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	99.55
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	99.55
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	99.54
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	99.54
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	99.54
2zkm_X	799	1-phosphatidylinositol-4,5-bisphosphate phosphodie	99.53
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	99.52
2hps_A	186	Coelenterazine-binding protein with bound coelent;	99.52
2l4h_A	214	Calcium and integrin-binding protein 1; metal bind	99.52
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	99.51
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	99.51
3i5g_B	153	Myosin regulatory light chain LC-2, mantle muscle;	99.48
3a4u_B	143	Multiple coagulation factor deficiency protein 2;	99.48
1dgu_A	183	Calcium-saturated CIB; helical, EF-hands, blood cl	99.46
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	99.45
4drw_A	121	Protein S100-A10/annexin A2 chimeric protein; atyp	99.44
1eg3_A	261	Dystrophin; EF-hand like domain, WW domain, struct	99.42
2kld_A	123	Polycystin-2; PC2, PKD2, calcium binding domain, E	99.42
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	99.41
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	99.39
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	99.36
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	99.36
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	99.35
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	99.33
3ohm_B	885	1-phosphatidylinositol-4,5-bisphosphate phosphodi	99.31
3nso_A	101	Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta	99.3
4drw_A	121	Protein S100-A10/annexin A2 chimeric protein; atyp	99.29
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	99.29
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	99.29
1djx_A	624	PLC-D1, phosphoinositide-specific phospholipase C,	99.28
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	99.27
1sjj_A	863	Actinin; 3-helix bundle, calponin homology domain,	99.26
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	99.26
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	99.25
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	99.25
3n22_A	98	Protein S100-A2; EF-hand, calcium-binding, zinc-bi	99.24
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	99.23
1xk4_C	113	Calgranulin B; S100 family, heterotetramer, metal	99.23
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	99.22
3zwh_A	104	Protein S100-A4; Ca-binding protein-motor protein	99.22
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	99.21
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	99.21
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	99.21
2lnk_A	113	Protein S100-A4; EF-hand, calcium binding, all alp	99.21
3a4u_B	143	Multiple coagulation factor deficiency protein 2;	99.2
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	99.2
4eto_A	93	Protein S100-A4; calcium-binding protein, EF-hand,	99.2
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	99.2
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	99.2
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	99.19
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	99.19
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	99.19
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	99.19
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	99.18
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	99.17
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	99.16
2y5i_A	99	S100Z, S100 calcium binding protein Z; metal-bindi	99.16
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	99.15
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	99.15
3nso_A	101	Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta	99.15
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	99.15
3rm1_A	92	Protein S100-B; alpha-helical, EF hand, metal bind	99.14
3qr0_A	816	Phospholipase C-beta (PLC-beta); PH domain, EF han	99.14
2wcb_A	95	Protein S100-A12; calcium signalling, HOST-parasit	99.14
1j55_A	95	S-100P protein; metal binding protein; 2.00A {Homo	99.14
3li6_A	66	Calcium-binding protein; calcium signaling protein	99.14
1j7q_A	86	CAVP, calcium vector protein; EF-hand family, calc	99.13
1c07_A	95	Protein (epidermal growth factor receptor pathway	99.12
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	99.12
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	99.12
1xk4_C	113	Calgranulin B; S100 family, heterotetramer, metal	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.11
1qx2_A	76	Vitamin D-dependent calcium-binding protein, INTE;	99.11
1eg3_A	261	Dystrophin; EF-hand like domain, WW domain, struct	99.11
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	99.1
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	99.1

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.6e-78  Score=631.17  Aligned_cols=447  Identities=36%  Similarity=0.635  Sum_probs=399.1

Q ss_pred             CCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++...
T Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~   98 (484)
T 3nyv_A           20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDK   98 (484)
T ss_dssp             CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred             CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC
Confidence            3456788999999999999999999999999999999999876655455578899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +..++||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+|..
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999999999999888999999999999999999999999999999999999997666667899999999988


Q ss_pred             cCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ...........||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+.......+......+..+.|..+++.+
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence            77666666678999999999999899999999999999999999999999999999888888888777777788899999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccccC---CCCCchhHHHHHHhhhhHHHHHHHhhhhhhHhhh-hhHHHhhHH
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA---PNVSLGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLK  365 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~i~  365 (531)
                      .+||.+||.++|++|||+.++|+||||+.....   ...+........+++|...+++++..+..++..+ ++++..+++
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~  338 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELT  338 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHH
Confidence            999999999999999999999999999865432   1233445677889999999999999999998775 889999999


Q ss_pred             HHhcccccCCCCcccHHHH----HHHHHhCCCCCC-------HHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHH
Q 009594          366 EAFEMMDTNKRGKINLEEL----RLGLLKGGQNIP-------EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDE  434 (531)
Q Consensus       366 ~~F~~~D~~~~g~i~~~el----~~~l~~~~~~~~-------~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~  434 (531)
                      ++|..+|.|++|.|+.+||    ..+++.+|..++       ..+++.+|..+|.|++|.|+|+||+.++.........+
T Consensus       339 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~  418 (484)
T 3nyv_A          339 AIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRE  418 (484)
T ss_dssp             HHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhccccCcHH
Confidence            9999999999999999999    455555677777       78899999999999999999999999876655555678


Q ss_pred             HHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       435 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .+..+|+.||.|+||+|+.+||..++..  ..+++++++.+|+.+|.|+||.|+|+||+.+|...
T Consensus       419 ~~~~~F~~~D~d~dG~I~~~El~~~l~~--~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~~~  481 (484)
T 3nyv_A          419 RLERAFRMFDSDNSGKISSTELATIFGV--SDVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKL  481 (484)
T ss_dssp             HHHHHHHHHCTTCCSEEEHHHHHHHHHH--TTCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHT
T ss_pred             HHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHhh
Confidence            8999999999999999999999999987  56789999999999999999999999999998753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-78  Score=634.60  Aligned_cols=444  Identities=35%  Similarity=0.615  Sum_probs=393.3

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ...+..+|++++.||+|+||+||+|.+..++..||+|++........ ....+.+|+.+++.+ +||||+++++++.+..
T Consensus        32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  109 (494)
T 3lij_A           32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKR  109 (494)
T ss_dssp             BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred             CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCC
Confidence            34577899999999999999999999999999999999986543222 346788999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .+++|||||+||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||+|...
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999999999999988888999999999999999999999999999999999999987666778999999999887


Q ss_pred             CCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ..........||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+..+....+......+..+.|+.+++.+.
T Consensus       190 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          190 ENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             BTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             CCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence            76666667789999999999988899999999999999999999999999999999999988888877777889999999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCcccccccC----CCCCchhHHHHHHhhhhHHHHHHHhhhhhhHhhh-hhHHHhhHH
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA----PNVSLGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLK  365 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~i~  365 (531)
                      +||.+||+.+|.+|||+.++|+||||+.....    ...+........+++|...+++++..+..++..+ ++++..+++
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~  349 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELT  349 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHHH
T ss_pred             HHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHHH
Confidence            99999999999999999999999999864221    2233345677889999999999999999998887 889999999


Q ss_pred             HHhcccccCCCCcccHHHHHHHHHhCCC--------CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHH
Q 009594          366 EAFEMMDTNKRGKINLEELRLGLLKGGQ--------NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLH  437 (531)
Q Consensus       366 ~~F~~~D~~~~g~i~~~el~~~l~~~~~--------~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  437 (531)
                      ++|+.+|.|++|.|+.+||..+++.++.        .++..+++.+|+.+|.|++|.|+|+||+.++.........+.+.
T Consensus       350 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~~  429 (494)
T 3lij_A          350 DIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLSKDKLE  429 (494)
T ss_dssp             HHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTCHHHHH
T ss_pred             HHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhccccHHHHH
Confidence            9999999999999999999999998754        44578899999999999999999999999876555556778899


Q ss_pred             HhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       438 ~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+|+.||.|+||+|+.+||+.++..  ..+++++++.+|+.+|.|+||.|+|+||+.+++.
T Consensus       430 ~~F~~~D~d~~G~Is~~El~~~l~~--~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~  488 (494)
T 3lij_A          430 SAFQKFDQDGNGKISVDELASVFGL--DHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQK  488 (494)
T ss_dssp             HHHHHHCTTCSSEECHHHHHHHC-C--CSCCCHHHHHHHHTTCSSSSSSEEHHHHHHHHHH
T ss_pred             HHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHh
Confidence            9999999999999999999999976  5677889999999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.2e-78  Score=630.26  Aligned_cols=446  Identities=34%  Similarity=0.596  Sum_probs=395.2

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh----------hhHHHHHHHHHHHHhCCCCCCee
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA----------VDIEDVRREVQIMKHLPKHPNIV  120 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~niv  120 (531)
                      +..+..+|++++.||+|+||+||+|.+..+++.||+|++........          ...+.+.+|+.+++++ +||||+
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  109 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNII  109 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCC
Confidence            34578899999999999999999999999999999999986543221          2356788999999999 999999


Q ss_pred             ecceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeE
Q 009594          121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK  200 (531)
Q Consensus       121 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ik  200 (531)
                      ++++++.+...+++|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999999999998888899999999999999999999999999999999999998766556799


Q ss_pred             EEeeccccccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 009594          201 AIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD  280 (531)
Q Consensus       201 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  280 (531)
                      |+|||+|.............||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+..+....+......+...
T Consensus       190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             EEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            99999999877666666778999999999999889999999999999999999999999999998888888877766666


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCC---CchhHHHHHHhhhhHHHHHHHhhhhhhHhhh-
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV---SLGETVKARLKQFSVMNKLKKRALQVVAEFL-  356 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-  356 (531)
                      .|+.+++.+.+||.+||.++|.+|||+.++|+||||+........   ........++++|...+++++..+..++..+ 
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~~  349 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLT  349 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHTS
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Confidence            677899999999999999999999999999999999875543221   1223457788888999999999998888776 


Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhC--------CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG--------GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK  428 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~--------~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~  428 (531)
                      +++++.+++++|+.+|+|++|.|+.+||..++..+        +..++..+++.+|..+|.|++|.|+|+||+.++....
T Consensus       350 ~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~  429 (504)
T 3q5i_A          350 TLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMDKQ  429 (504)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHH
T ss_pred             cHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhhh
Confidence            88999999999999999999999999999999887        5577889999999999999999999999999876555


Q ss_pred             ccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       429 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .....+.++.+|+.||.|+||+|+.+||+.++..  ..+++++++.+|..+|.|+||.|+|+||+.+|...
T Consensus       430 ~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~--~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~  498 (504)
T 3q5i_A          430 ILFSEERLRRAFNLFDTDKSGKITKEELANLFGL--TSISEKTWNDVLGEADQNKDNMIDFDEFVSMMHKI  498 (504)
T ss_dssp             HHTCHHHHHHHHHHHCTTCCSEECHHHHHHHTTC--SCCCHHHHHHHHHTTCSSCSSSEEHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh--CCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh
Confidence            5567789999999999999999999999999987  34789999999999999999999999999999854

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-78  Score=630.82  Aligned_cols=444  Identities=36%  Similarity=0.657  Sum_probs=376.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+..+|++.+.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.+++++ +||||+++++++.+...+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKL-DHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEE
Confidence            46778999999999999999999999999999999997644322 2357788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++|||||+|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+|.....
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999999998888999999999999999999999999999999999999998776677899999999987766


Q ss_pred             CCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ........||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+..+....+......+..+.|..+++.+.+|
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  256 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence            66666778999999999999889999999999999999999999999999988888888887777777788899999999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcccccccCCCC----CchhHHHHHHhhhhHHHHHHHhhhhhhHhhh-hhHHHhhHHHH
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV----SLGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLKEA  367 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~i~~~  367 (531)
                      |.+||..+|++|||+.++|+||||+........    .........+++|...+++++..+.+++..+ +.++..+++++
T Consensus       257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~  336 (486)
T 3mwu_A          257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEI  336 (486)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHH
Confidence            999999999999999999999999875543321    1224457788889999999999999998877 88999999999


Q ss_pred             hcccccCCCCcccHHHHHHHHHh----CCCCCC----------HHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcH
Q 009594          368 FEMMDTNKRGKINLEELRLGLLK----GGQNIP----------EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND  433 (531)
Q Consensus       368 F~~~D~~~~g~i~~~el~~~l~~----~~~~~~----------~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  433 (531)
                      |+.+|+|+||.|+.+||..++..    +|..++          .++++.+|..+|.|++|.|+|+||+..+.........
T Consensus       337 F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~  416 (486)
T 3mwu_A          337 FRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSR  416 (486)
T ss_dssp             HHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHSCTTTTCCH
T ss_pred             HHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHHhhhccchH
Confidence            99999999999999999655544    465555          7889999999999999999999999877655555677


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +.+..+|+.||.|+||+|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++..
T Consensus       417 ~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~  481 (486)
T 3mwu_A          417 ERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQN  481 (486)
T ss_dssp             HHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCSSCSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence            88999999999999999999999999999999999999999999999999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.6e-63  Score=477.48  Aligned_cols=257  Identities=32%  Similarity=0.581  Sum_probs=231.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|++| +|||||+++++|.+.+.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence            5799999999999999999999999999999999876544444567899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      ||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|+.+.... 
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~---~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE---DMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC---CCCEEEEEcCCceecCCCCC
Confidence            999999999999999889999999999999999999999999999999999999964   4569999999999775432 


Q ss_pred             --ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          215 --QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       215 --~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                        ...+.+||+.|||||++. ..|+.++|||||||++|+|+||.+||.+.+..+...++.+....++    ..+++++++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d  263 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARD  263 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHHH
Confidence              345678999999999988 4699999999999999999999999999999888888888765543    468999999


Q ss_pred             HHHHccccCcCCCCCHHH------HhcCCcccccc
Q 009594          292 LVKKMLNPDPKQRLTAEE------VLEHPWLQNAK  320 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~------~l~h~~~~~~~  320 (531)
                      ||.+||.+||++|||+.|      +++||||+...
T Consensus       264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            999999999999999988      58999998753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.4e-63  Score=469.05  Aligned_cols=254  Identities=37%  Similarity=0.654  Sum_probs=211.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++++ +|||||++++++.+.+.+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEE
Confidence            5799999999999999999999999999999999877655555567899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |||| +|+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+|+.......
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~---~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE---HLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT---TCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC---CCCEEEeecCCCeecCCCCc
Confidence            9999 6799999999999999999999999999999999999999999999999964   44599999999988766666


Q ss_pred             cccccCCcccccchhccc-cC-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ..+.+||+.|||||++.+ .| +.++|||||||++|+|+||++||.+.+.......+......++    ..+|+++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            667899999999999985 44 6799999999999999999999999888888888877654433    45899999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      .+||++||++|||+.|+++||||+.
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-62  Score=480.46  Aligned_cols=259  Identities=32%  Similarity=0.545  Sum_probs=229.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ....|+++++||+|+||+||+|+++.+|+.||||++.......   .+.+.+|+.+|+++ +|||||+++++|.+.+.+|
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDY-QHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence            3567999999999999999999999999999999997654332   35678999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||||+||+|.+++.+ +.+++..++.|+.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+.+...
T Consensus       148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC---CCEEEecCcCceecCCC
Confidence            99999999999998865 579999999999999999999999999999999999999644   46999999999876543


Q ss_pred             -CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 -EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                       ....+.+||+.|||||++. ..|+.++|||||||++|+|++|.+||.+.+..+....+.... ......+..+|+++++
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~d  302 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKG  302 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCCCSCGGGSCHHHHH
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccccCCHHHHH
Confidence             3456789999999999987 579999999999999999999999999988888777776543 2233445679999999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ||.+||.+||++|||+.|+|+||||++...
T Consensus       303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          303 FLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            999999999999999999999999986543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-61  Score=463.50  Aligned_cols=256  Identities=23%  Similarity=0.407  Sum_probs=218.4

Q ss_pred             cce-eeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc----CC
Q 009594           56 IDY-DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----DS  130 (531)
Q Consensus        56 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~  130 (531)
                      .+| ++.++||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.++++| +|||||+++++|.+    .+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCc
Confidence            344 788889999999999999999999999999986654 344567899999999999 99999999999864    45


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      .+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+|||+++.  ++.+||+|||+|+
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~--~g~vKl~DFGla~  180 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST--TSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC--CCCEEEEeCcCCE
Confidence            68999999999999999999889999999999999999999999998  9999999999999632  3469999999998


Q ss_pred             ccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHhcccCCCCCCCCCCCH
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV-AQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ... .....+.+||+.|||||++.+.|+.++|||||||++|+|+||++||.+...... ...+......  ......+++
T Consensus       181 ~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~  257 (290)
T 3fpq_A          181 LKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIP  257 (290)
T ss_dssp             GCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCH
T ss_pred             eCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC--CCCCccCCH
Confidence            644 334456789999999999998999999999999999999999999977554443 3333332211  112245789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      ++.+||.+||.+||++|||+.|+|+||||+.
T Consensus       258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.8e-62  Score=475.25  Aligned_cols=256  Identities=27%  Similarity=0.555  Sum_probs=222.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++| +|||||++++++.+.+.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEE
Confidence            479999999999999999999999999999999987654 344567899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          136 MELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||+||+|.+++...+  .+++..++.|+.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+.....
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---GTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT---CCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---CCEEEcccccceeecCC
Confidence            99999999999997543  47999999999999999999999999999999999999654   46999999999876543


Q ss_pred             C-ccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 E-QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      . .....+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+.+..+....+......   +.+..+|+++.+
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHH
Confidence            2 2345689999999999884 6999999999999999999999999999988888888776542   234578999999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ||.+||++||++|||+.|+|+||||++.
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.5e-60  Score=474.01  Aligned_cols=258  Identities=32%  Similarity=0.545  Sum_probs=228.7

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ....|++++.||+|+||.||+|+++.+|+.||||++.......   .+.+.+|+.+|+.+ +|||||+++++|.+.+.+|
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDY-QHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEE
Confidence            4567999999999999999999999999999999997654332   35688999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||||+||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|..+...
T Consensus       225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~---g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT---CCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---CCEEEecCccceECCCC
Confidence            99999999999998865 469999999999999999999999999999999999999644   46999999999876543


Q ss_pred             -CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 -EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                       ....+.+||+.|||||++. ..|+.++|||||||++|+|++|.+||.+.+.......+..... .....+..+++++++
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHH
Confidence             3456789999999999987 5699999999999999999999999999888887777765432 233445689999999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ||.+||.+||++|||+.|+|+||||++..
T Consensus       380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.4e-61  Score=461.96  Aligned_cols=255  Identities=27%  Similarity=0.520  Sum_probs=219.2

Q ss_pred             cceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+|++++.||+|+||+||+|++.   .+++.||+|++.+...... ....+.+|+.+|+++ +|||||++++++.+.+.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCC-CCTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEE
Confidence            47999999999999999999974   4678999999976543322 234677899999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|+....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---SCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC---CCEEecccccceeccC
Confidence            9999999999999999998899999999999999999999999999999999999999644   4599999999986543


Q ss_pred             C-CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          213 G-EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       213 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      . ....+.+||+.|||||++. ..|+.++|||||||++|+|+||.+||.+.+..+....+.+....++    ..+|+++.
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  254 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ  254 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHH
Confidence            3 3445678999999999987 5799999999999999999999999999999888888887655432    46899999


Q ss_pred             HHHHHccccCcCCCCC-----HHHHhcCCccccc
Q 009594          291 DLVKKMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      +||.+||++||++|||     ++|+++||||+..
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999999998     5899999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.7e-60  Score=459.80  Aligned_cols=254  Identities=26%  Similarity=0.377  Sum_probs=220.3

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ..|++.++||+|+||+||+|+++.+|+.||||++......        .+|+.+++++ +|||||++++++.+.+.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l-~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGL-SSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999999765432        3699999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      ||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.++  ..+||+|||+|+.......
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS--CCEEECCCTTCEEC-----
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC--CEEEEeeCCCCeEccCCCc
Confidence            99999999999999988999999999999999999999999999999999999997543  2499999999987654321


Q ss_pred             ------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          216 ------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       216 ------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                            ....+||+.|||||++. ..|+.++|||||||++|+|+||.+||.+.+.......+........ ..++.+|+.
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~  285 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAPL  285 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCHH
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCHH
Confidence                  23457999999999987 5699999999999999999999999988877777777766543322 234678999


Q ss_pred             HHHHHHHccccCcCCCCCHHHH-------------hcCCccccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEV-------------LEHPWLQNAKK  321 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~-------------l~h~~~~~~~~  321 (531)
                      +.+||.+||.+||++|||+.|+             |+|||+.....
T Consensus       286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence            9999999999999999999997             67999986543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-57  Score=454.26  Aligned_cols=261  Identities=27%  Similarity=0.433  Sum_probs=223.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-----  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-----  128 (531)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.... ........+.+|+.+|++| +|||||++++++..     
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTT
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccc
Confidence            5578999999999999999999999999999999997543 2334456788999999999 99999999998753     


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          129 -DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       129 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                       .+.+|||||||+ |+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.   ++.+||+|||+|
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~---~~~~Ki~DFGla  205 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE---NCELKIGDFGMA  205 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TCCEEECCCTTC
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC---CCCEEEeeccee
Confidence             467999999995 689999988889999999999999999999999999999999999999964   445999999999


Q ss_pred             cccCCC-----CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 009594          208 VFFRPG-----EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD  280 (531)
Q Consensus       208 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  280 (531)
                      +.+...     ....+.+||+.|||||++.+  .++.++||||+||++|+|++|.+||.+.+..+....+......+...
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            865432     23456789999999998764  47999999999999999999999999999888888776543322111


Q ss_pred             ---------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          281 ---------------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       281 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                                 .++.+++++++||.+||.+||++|||+.|+|+||||+...
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                                       1245789999999999999999999999999999998753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.6e-57  Score=435.97  Aligned_cols=253  Identities=30%  Similarity=0.501  Sum_probs=198.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-----
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-----  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  130 (531)
                      .+|++++.||+|+||+||+|+++.+|+.||||++....  .....+.+.+|+.+|++| +|||||+++++|...+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccc
Confidence            46999999999999999999999999999999997543  334457889999999999 9999999999986543     


Q ss_pred             -------eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeE
Q 009594          131 -------AVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK  200 (531)
Q Consensus       131 -------~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ik  200 (531)
                             .+|||||||+||+|.+++.....   .++..++.|+.||+.||+|||++||+||||||+|||++.+   +.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~---~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC---CcEE
Confidence                   47999999999999999987655   3456789999999999999999999999999999999654   4699


Q ss_pred             EEeeccccccCCCCc-------------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH-
Q 009594          201 AIDFGLSVFFRPGEQ-------------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-  265 (531)
Q Consensus       201 l~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-  265 (531)
                      |+|||+|+.......             ..+.+||+.|||||++. ..|+.++|||||||++|||++   ||....... 
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            999999987654321             23457999999999988 569999999999999999996   775433221 


Q ss_pred             HHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ....+...  .+ ++.++..++.+.+||.+||++||++|||+.|+|+||||+...
T Consensus       236 ~~~~~~~~--~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          236 TLTDVRNL--KF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHTT--CC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHhcC--CC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            11122211  11 112334567789999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.1e-57  Score=435.94  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=216.4

Q ss_pred             ccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      ..+|.+.+.||+|+||+||+|++.     .++..||||++...   .....+.+.+|+.+|+++ +|||||++++++.+.
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC
Confidence            457999999999999999999865     35789999999643   344567899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCC
Q 009594          130 SAVHIVMELCEGGELFDRIVAR-------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES  196 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~  196 (531)
                      +.++||||||++|+|.++|...             ..+++..++.|+.||+.||.|||+++||||||||+|||++.+   
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~---  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN---  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC---
Confidence            9999999999999999999764             358999999999999999999999999999999999999654   


Q ss_pred             CCeEEEeeccccccCCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 009594          197 SPLKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII  271 (531)
Q Consensus       197 ~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~  271 (531)
                      +.+||+|||+|+........   ....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..++...+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            45999999999876543322   2346899999999987 679999999999999999999 999999999888888777


Q ss_pred             hcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .....   +..+.+|+++.+||.+||+.||++|||+.++  ++|+++..
T Consensus       245 ~~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          245 QGRVL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             cCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            65432   1224689999999999999999999999999  56776543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4e-56  Score=442.14  Aligned_cols=257  Identities=28%  Similarity=0.497  Sum_probs=210.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .+.++|++.+.||+|+||+||+|+++   .+++.||+|++....     ....+.+|+++|+.+.+||||++++++|.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            36678999999999999999999875   457899999986542     2356788999999997899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +++|||||||+||+|.+++   +.+++..++.++.||+.||+|||++||+||||||+|||++.+  .+.+||+|||+|+.
T Consensus        93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~--~~~~kl~DFGla~~  167 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR--LKKYALVDFGLAQG  167 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--TTEEEECCCTTCEE
T ss_pred             CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC--CCeEEECcCCCCcc
Confidence            9999999999999999988   358999999999999999999999999999999999999754  24599999999975


Q ss_pred             cCCCC-----------------------------ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCC
Q 009594          210 FRPGE-----------------------------QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPF  258 (531)
Q Consensus       210 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf  258 (531)
                      .....                             ...+.+||+.|||||++.+  .|+.++||||+||++|+|+||++||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            43321                             1234579999999998864  4899999999999999999999999


Q ss_pred             CCCC-HHHHHHHHHhcc--------------------------------------------------cCCCCCCCCCCCH
Q 009594          259 WAET-EQGVAQAIIRSV--------------------------------------------------IDFKRDPWPKVSE  287 (531)
Q Consensus       259 ~~~~-~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~  287 (531)
                      .... ..+....+....                                                  .......|..+|+
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            6543 333333332100                                                  0001123567899


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ++.+||.+||.+||++|||+.|+|+||||++.
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-56  Score=428.32  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=203.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .++++.++||+|+||+||+|+..   ..||||+++... ......+.+.+|+.+++++ +|||||++++++.. +.++||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEEE
Confidence            46889999999999999999843   369999986543 2344567899999999999 99999999998754 568999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      ||||+||+|.++|... +.+++..+..|+.||+.||.|||+++||||||||+|||++.+   +.+||+|||+|+..... 
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~---~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG---LTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT---EEEEECCCSSCBC-----
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC---CcEEEeeccCceecccCC
Confidence            9999999999999764 579999999999999999999999999999999999999654   45999999999876432 


Q ss_pred             --CccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--CCCCCCC
Q 009594          214 --EQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--RDPWPKV  285 (531)
Q Consensus       214 --~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  285 (531)
                        ......+||+.|||||++.    +.|+.++|||||||++|||+||+.||.+.+.......+.......+  ...++.+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence              2334568999999999985    2488999999999999999999999988766555554444332221  2334578


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      |+.+.+||.+||+.+|++|||+.+++++
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999988654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.5e-56  Score=466.29  Aligned_cols=264  Identities=36%  Similarity=0.668  Sum_probs=240.0

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..+.++|++++.||+|+||+||+|.++.+|+.||+|++....   ....+.+.+|+.+|+.| +|||||+++++|.+.+.
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE
Confidence            345578999999999999999999999999999999997643   33457788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      +|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+. .+.+||+|||+|+.+
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~-~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCSSCEEC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCC-CCCEEEeeccceeEc
Confidence            9999999999999999864 45799999999999999999999999999999999999997542 356999999999988


Q ss_pred             CCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      .+.......+||+.|||||++. ..|+.++|||||||++|+|++|.+||.+.+..+....+......++...++.+|+++
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            8777777789999999999987 468999999999999999999999999999999998888887777777788899999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ++||.+||..||++|||+.|+|+||||+...
T Consensus       388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            9999999999999999999999999998654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-55  Score=428.52  Aligned_cols=249  Identities=22%  Similarity=0.349  Sum_probs=212.9

Q ss_pred             cceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      .++++.++||+|+||+||+|...     .+++.||||++....  .....+.+.+|+.+++++ +|||||++++++...+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECC
Confidence            46889999999999999999853     467899999996543  233457899999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC
Q 009594          131 AVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK  194 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~  194 (531)
                      .++||||||++|+|.++|...                ..+++..+..|+.||+.||.|||+++||||||||+|||++++ 
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~-  181 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-  181 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC-
Confidence            999999999999999999653                358999999999999999999999999999999999999654 


Q ss_pred             CCCCeEEEeeccccccCCCC---ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 009594          195 ESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA  269 (531)
Q Consensus       195 ~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~  269 (531)
                        +.+||+|||+|+......   ......||+.|||||++. +.|+.++|||||||++|||+| |..||.+.+..++...
T Consensus       182 --~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          182 --LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             --GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             --CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence              459999999998764432   234467999999999887 679999999999999999998 8999999998888777


Q ss_pred             HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +......   +..+.+|+.+.+|+.+||+.||++|||+.+|+++
T Consensus       260 i~~~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7654321   2234689999999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.9e-56  Score=462.56  Aligned_cols=256  Identities=27%  Similarity=0.471  Sum_probs=217.9

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHH---HHHHHhCCCCCCeeecceEEEcCCe
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRRE---VQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      -++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|   +.+++.+ +|||||+++++|.+.+.
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCE
Confidence            3579999999999999999999999999999999986544322233344444   5566667 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +|||||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.   ++++||+|||+|+...
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~---~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE---HGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT---TSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeC---CCCEEecccceeeecC
Confidence            9999999999999999999999999999999999999999999999999999999999964   4569999999998765


Q ss_pred             CCCccccccCCcccccchhcc-c-cCCCccchhHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHhcccCCCCCCCCCCC
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .. ...+.+||+.|||||++. + .|+.++|||||||++|+|++|.+||.+.+.   ..+...+.....    ..+..+|
T Consensus       344 ~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~----~~p~~~S  418 (689)
T 3v5w_A          344 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----ELPDSFS  418 (689)
T ss_dssp             SC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC----CCCTTSC
T ss_pred             CC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC----CCCccCC
Confidence            43 345679999999999986 4 599999999999999999999999976432   233334443332    3335689


Q ss_pred             HHHHHHHHHccccCcCCCCC-----HHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      +++++||.+||.+||++|++     +.||++||||+..
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            99999999999999999998     7999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.5e-55  Score=429.00  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=207.6

Q ss_pred             ccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      ..+|.+.++||+|+||+||+|+..     .+++.||||++...   .....+.+.+|+.+|+++ +|||||++++++.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTML-QHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence            357999999999999999999864     36889999999643   344567899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC
Q 009594          130 SAVHIVMELCEGGELFDRIVAR---------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK  194 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~  194 (531)
                      +.+|||||||++|+|.+++...               +++++..++.|+.||+.||.|||+++||||||||+|||++.+ 
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~-  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-
Confidence            9999999999999999998753               358999999999999999999999999999999999999654 


Q ss_pred             CCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 009594          195 ESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA  269 (531)
Q Consensus       195 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~  269 (531)
                        ..+||+|||+|+.......   .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..+....
T Consensus       195 --~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          195 --LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             --TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             --CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              4599999999987654332   23467999999999987 579999999999999999999 8999999988888777


Q ss_pred             HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.+...   .+....+|+++.+|+.+||+.||++|||+.||+++
T Consensus       273 i~~g~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTCC---CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCCC---CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            766532   12224689999999999999999999999999764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.5e-55  Score=445.78  Aligned_cols=323  Identities=38%  Similarity=0.684  Sum_probs=274.2

Q ss_pred             CCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      ++..+.++|++.+.||+|+||.||+|.+..+|+.+|+|++...... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus         5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~   82 (444)
T 3soa_A            5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLL-KHPNIVRLHDSISEE   82 (444)
T ss_dssp             --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECS
T ss_pred             ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEEC
Confidence            3456778999999999999999999999999999999999865532 33456788999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +..++||||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+..++.+||+|||+|..
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999999999999988999999999999999999999999999999999999998765667899999999987


Q ss_pred             cCCCC-ccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          210 FRPGE-QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       210 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ..... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+......++.+.|+.+++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence            65433 3355789999999999874 699999999999999999999999999999999999999888888888899999


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhhhHHHHHHHhhhhhhH--hhh--hhHHHhh
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVA--EFL--SVEEVAG  363 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~--~~~~~~~  363 (531)
                      .+.+||.+||..||++|||+.|+|+||||+...........+.....+++|...++++..++..+.  ..+  .++++.+
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~~~~~~~~~~~e~~~  322 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIK  322 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEECCCCSCCHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccchHHHHH
Confidence            999999999999999999999999999998654433333446678889999999999988887663  222  3344444


Q ss_pred             HHHHhcccccC
Q 009594          364 LKEAFEMMDTN  374 (531)
Q Consensus       364 i~~~F~~~D~~  374 (531)
                      +.+.|.....+
T Consensus       323 ~~~~~l~~i~~  333 (444)
T 3soa_A          323 VTEQLIEAISN  333 (444)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHhhhhc
Confidence            44444443333

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-54  Score=433.18  Aligned_cols=300  Identities=39%  Similarity=0.738  Sum_probs=264.3

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      +..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEES  101 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCC
Confidence            45677889999999999999999999999999999999986544 344567889999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ..++||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999999999988888999999999999999999999999999999999999987766677999999999887


Q ss_pred             CCCCccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ..........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+......++...|..+++.+
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            66555566789999999999874 69999999999999999999999999998888888888887777777788899999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhhhHHHHHHHhhhhhh
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV  352 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~  352 (531)
                      .+||.+||..||++|||+.++|+||||............+.....+++|...++++...+..+
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  324 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTM  324 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999865433333334566778888888888777666544

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.1e-54  Score=426.86  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=210.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      -.++|++.+.||+|+||+||+|.+...     ++.||+|.+....  .......+.+|+.+|+++..|||||++++++..
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            456899999999999999999997654     3679999986543  334467899999999999666999999999865


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEee
Q 009594          129 -DSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFA  191 (531)
Q Consensus       129 -~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~  191 (531)
                       .+.++||||||++|+|.++|...                ..+++..+..|+.||+.||.|||+++||||||||+|||++
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  219 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence             46789999999999999999753                3489999999999999999999999999999999999996


Q ss_pred             cCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHH
Q 009594          192 NKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV  266 (531)
Q Consensus       192 ~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~  266 (531)
                      .+   +.+||+|||+|+.......   .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+......
T Consensus       220 ~~---~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          220 EK---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             GG---GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             CC---CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            54   4599999999987654432   23467899999999887 679999999999999999998 9999988765444


Q ss_pred             HHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .............  ...+++++.+||.+||+.||++|||+.+|++|
T Consensus       297 ~~~~i~~g~~~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4433333222222  24589999999999999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-52  Score=419.05  Aligned_cols=268  Identities=38%  Similarity=0.704  Sum_probs=239.7

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.+++++ +||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~   85 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYE   85 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEE
Confidence            35678899999999999999999999999999999999987543221   2357788999999999 8999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC-CCCeEEEeecc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGL  206 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~-~~~ikl~Dfg~  206 (531)
                      +...+++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||+
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            99999999999999999999988888999999999999999999999999999999999999975442 23699999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      +.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+....+......+....|+.+
T Consensus       166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            98877666666778999999999987 47999999999999999999999999999988888888877666665556789


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ++.+++||.+||..||++|||+.++|+||||+..
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            9999999999999999999999999999999854

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.8e-51  Score=405.67  Aligned_cols=260  Identities=36%  Similarity=0.655  Sum_probs=232.3

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCE
Confidence            4455689999999999999999999999999999999976543 344567788999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TSCEEECSTTCCGGGS
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC---CCCEEEeeccCceecC
Confidence            9999999999999999988889999999999999999999999999999999999999964   4459999999998877


Q ss_pred             CCCccccccCCcccccchhccc-cC-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ........+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+    ..+++.+
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  241 (328)
T 3fe3_A          166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDC  241 (328)
T ss_dssp             SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence            6666677889999999999874 44 4789999999999999999999999988888888877654433    3578999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .+||.+||..||.+|||+.++++||||+...
T Consensus       242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999998644

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.2e-52  Score=416.94  Aligned_cols=300  Identities=36%  Similarity=0.651  Sum_probs=240.2

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      +..+.++|++.+.||+|+||.||+|.+..+|+.||+|++......  .....+.+.+|+.+++.+ +||||+++++++..
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~   97 (351)
T 3c0i_A           19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS   97 (351)
T ss_dssp             -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE
T ss_pred             CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence            345677899999999999999999999999999999999754321  112357789999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      .+.+++||||++|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+||
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence            99999999999999998877543    24899999999999999999999999999999999999987766677999999


Q ss_pred             ccccccCCCCc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          205 GLSVFFRPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       205 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      |++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+. .......+...........|
T Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH
T ss_pred             cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc
Confidence            99987654432 34567999999999987 56899999999999999999999999875 34555566665554444445


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhhhHHHHHHHhhhhhh
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV  352 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~  352 (531)
                      +.+++.+.+||.+||..||++|||+.++|+||||+.................++++...++++......+
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  326 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAV  326 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC---------
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHH
Confidence            6789999999999999999999999999999999875432221122334455666666666555554444

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=407.41  Aligned_cols=267  Identities=37%  Similarity=0.713  Sum_probs=236.5

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.......   ....+.+.+|+.+++++ +||||+++++++..
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence            457778999999999999999999999999999999997654322   12357889999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC-CCCCeEEEeeccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLS  207 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~-~~~~ikl~Dfg~a  207 (531)
                      ....++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999999998888899999999999999999999999999999999999997654 2336999999999


Q ss_pred             cccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......+....++.++
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            8876555556678999999999987 578999999999999999999999999988888877777665555544456789


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +.+.+||.+||..||++|||+.++|+||||+..
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            999999999999999999999999999999754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-52  Score=410.26  Aligned_cols=263  Identities=31%  Similarity=0.642  Sum_probs=235.9

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+.++|++.+.||+|+||.||+|.+..+++.+|+|++...    ......+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIA-RHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEE
Confidence            3567899999999999999999999999999999998643    23456788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+. ++.+||+|||++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~-~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC-CCCEEEEECCCCeECC
Confidence            99999999999999997653 699999999999999999999999999999999999997532 4679999999999887


Q ss_pred             CCCccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+......+....|+.+++.+.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            6666666789999999999874 578999999999999999999999999998888888888777666666778999999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +||.+||..||.+|||+.|+|+||||+....
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence            9999999999999999999999999986543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8e-52  Score=414.20  Aligned_cols=258  Identities=34%  Similarity=0.553  Sum_probs=207.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++......    ...+.+|+.+++++ +||||+++++++...+.++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEE
Confidence            446799999999999999999999999999999999764322    25678999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+|......
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~-~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-SCCEEECCCCCC------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CceEEEeecCcccccccc
Confidence            9999999999999998888899999999999999999999999999999999999996543 345999999999865544


Q ss_pred             CccccccCCcccccchhcc-ccCCCc-cchhHHHHHHHHHhhCCCCCCCCCHH----HHHHHHHhcccCCCCCCCCCCCH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPE-VDVWSAGVILYILLCGVPPFWAETEQ----GVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~-~Di~slG~il~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      .......||+.|+|||++. ..++.+ +|||||||++|+|++|..||.+....    .....+......  .+....+++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~  249 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS--IPDDIRISP  249 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC--CCTTSCCCH
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC--CCCcCCCCH
Confidence            4455678999999999886 445444 89999999999999999999775432    233333332222  222346899


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+.+||.+||..+|++|||+.++++||||...
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            99999999999999999999999999999754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.4e-51  Score=407.03  Aligned_cols=296  Identities=42%  Similarity=0.731  Sum_probs=235.4

Q ss_pred             CCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      ....+.++|++.+.||+|+||.||+|.+..+++.||+|++....     ..+.+.+|+.+++++ +||||+++++++...
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  120 (349)
T 2w4o_A           47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETP  120 (349)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHC-CCTTBCCEEEEEECS
T ss_pred             ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhC-CCCCCcceeeeEecC
Confidence            34567788999999999999999999999999999999997542     235677899999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999999999998888899999999999999999999999999999999999998655567799999999987


Q ss_pred             cCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhcccCCCCCCCCCCCH
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ...........||+.|+|||++. ..++.++|||||||++|+|++|..||....... ....+.........+.++.++.
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            66554455678999999999987 468999999999999999999999997765544 5556666555555566678999


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhhhHHHHHHHhhhhhhH
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVA  353 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~  353 (531)
                      .+.+||.+||..||++|||+.++|+||||......  .........+++++....++++......+
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN--FVHMDTAQKKLQEFNARRKLKAAVKAVVA  344 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC--CSCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc--hhhhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999865432  22335667778888777777776665543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.3e-51  Score=394.14  Aligned_cols=268  Identities=41%  Similarity=0.793  Sum_probs=244.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++...+.
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF   79 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCE
Confidence            4577899999999999999999999999999999999976554 344567788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999999999999888889999999999999999999999999999999999999877766779999999998776


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .........||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.......+...+..+++.+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 3kk8_A          160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  239 (284)
T ss_dssp             SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence            666556678999999999887 4689999999999999999999999999998888888888887777777788999999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +||.+||+.+|++|||+.++++||||++...
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            9999999999999999999999999987544

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-51  Score=408.88  Aligned_cols=258  Identities=30%  Similarity=0.542  Sum_probs=225.3

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|..+++.+.+||||+++++++.+.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            35799999999999999999999999999999999865443344567788999999998789999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-C
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-G  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~  213 (531)
                      ||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|..... .
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC---CCEEEccccceeecccCC
Confidence            99999999999999988899999999999999999999999999999999999999644   4699999999986432 3


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ......+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+....+......++    ..+++.+.+|
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  254 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGI  254 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence            3345678999999999987 5699999999999999999999999999999888888887655443    3478999999


Q ss_pred             HHHccccCcCCCCCH------HHHhcCCccccc
Q 009594          293 VKKMLNPDPKQRLTA------EEVLEHPWLQNA  319 (531)
Q Consensus       293 i~~~l~~~p~~Rps~------~~~l~h~~~~~~  319 (531)
                      |.+||.++|++||++      .++++||||+..
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999999998      899999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.7e-51  Score=402.34  Aligned_cols=256  Identities=32%  Similarity=0.581  Sum_probs=227.0

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++...+.+|+|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEE
Confidence            5799999999999999999999999999999999765432333457788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-CCC
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-~~~  214 (531)
                      |||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC---CCEEEeeccchhhcccCCC
Confidence            9999999999999888889999999999999999999999999999999999999644   469999999998643 333


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      .....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+......++    ..+++.+.+||
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  236 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            445678999999999987 5689999999999999999999999999888887777776554433    35799999999


Q ss_pred             HHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          294 KKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       294 ~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      .+||..||++||     ++.++++||||+..
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            999999999999     99999999999764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.8e-51  Score=393.93  Aligned_cols=266  Identities=44%  Similarity=0.831  Sum_probs=240.1

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+.++|++.+.||+|+||.||+|.+..++..+|+|++......   ..+.+.+|+.+++++ +||||+++++++......
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeE
Confidence            4677899999999999999999999999999999999765433   356788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||++..++.+..+||+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999999999998888899999999999999999999999999999999999996655667799999999988776


Q ss_pred             CCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ........||+.|+|||++.+.++.++||||||+++|+|++|..||...........+.......+...+..+++.+.+|
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (277)
T 3f3z_A          162 GKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL  241 (277)
T ss_dssp             TSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred             ccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence            66666778999999999998889999999999999999999999999988888888887776665555556789999999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                      |.+||+.+|++|||+.++|+||||++....
T Consensus       242 i~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          242 IRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence            999999999999999999999999875443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-50  Score=405.90  Aligned_cols=264  Identities=35%  Similarity=0.659  Sum_probs=235.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++.+ +||||+++++++.+....
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEE
Confidence            45678999999999999999999999999999999997542   33456788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||++....
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceecC
Confidence            99999999999999887654 69999999999999999999999999999999999999743 23569999999998876


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .........||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......+....+..+++.+.
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            655555668999999999987 5688999999999999999999999999888888888888777777777788999999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +||.+||..||++|||+.++|+||||+....
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            9999999999999999999999999986543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-50  Score=390.59  Aligned_cols=263  Identities=38%  Similarity=0.667  Sum_probs=223.9

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+.++|++.+.||+|+||.||+|.+..++..+|+|++.....  ....+.+.+|+.+++++ +||||+++++++......
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeE
Confidence            467789999999999999999999999999999999976542  23457888999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          133 HIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ++||||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++..+..+.+||+|||++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            999999999999998854    3679999999999999999999999999999999999999766556779999999998


Q ss_pred             ccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ............||+.|+|||++.+.++.++||||||+++|+|++|..||.+................... ....+++.
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  254 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQ  254 (285)
T ss_dssp             C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred             ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHH
Confidence            77655555667899999999999888999999999999999999999999998877766666554433322 22357899


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +.+||.+||..||++|||+.|+|+||||+++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999999863

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2e-50  Score=406.49  Aligned_cols=258  Identities=29%  Similarity=0.544  Sum_probs=221.2

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|..+++++.+||||+++++++...+.+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            35799999999999999999999999999999999876655544556788899999988789999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc-CCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~-~~~  213 (531)
                      ||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|+.. ...
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~---g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC---CCEEEeecceeeecccCC
Confidence            99999999999999988899999999999999999999999999999999999999644   56999999999863 334


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC---------HHHHHHHHHhcccCCCCCCCC
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      ......+||+.|+|||++. ..++.++|||||||++|+|++|.+||....         .......+......++    .
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~  283 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R  283 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----T
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----C
Confidence            4556778999999999987 568999999999999999999999996432         2233444444433332    3


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCH------HHHhcCCccccc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTA------EEVLEHPWLQNA  319 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~------~~~l~h~~~~~~  319 (531)
                      .+++.+.+||.+||+.||++||++      .++++||||+..
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            589999999999999999999984      899999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.2e-51  Score=403.42  Aligned_cols=266  Identities=38%  Similarity=0.666  Sum_probs=231.0

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      +..+.++|++.+.||+|+||.||+|.+..+|+.||+|++......       ..+|+.++.++.+||||+++++++.+..
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            346778899999999999999999999999999999999765422       2468888888878999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC-CCCCeEEEeeccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVF  209 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~-~~~~ikl~Dfg~a~~  209 (531)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+...+ ....+||+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999999999999888899999999999999999999999999999999999986442 334599999999987


Q ss_pred             cCCC-CccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCC---CCHHHHHHHHHhcccCCCCCCCCC
Q 009594          210 FRPG-EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       210 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~---~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      .... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||..   ....+....+...........|+.
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            6543 23445688999999999874 588999999999999999999999976   355667777777777777777888


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCC
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP  323 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~  323 (531)
                      +++.+.+||.+||..||++|||+.++++||||......+
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~  288 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP  288 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSC
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccccc
Confidence            999999999999999999999999999999997654443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.5e-50  Score=389.39  Aligned_cols=260  Identities=30%  Similarity=0.523  Sum_probs=224.5

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ....+|++.+.||+|+||+||+|.+..+++.||+|++.......   .+.+.+|+.+++++ +||||+++++++...+..
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMREN-KNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEE
Confidence            35668999999999999999999999999999999997654332   46788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++||||++|++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC---CCEEEeeCCCceecCC
Confidence            9999999999999998765 68999999999999999999999999999999999999644   4599999999887654


Q ss_pred             CC-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          213 GE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       213 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .. ......||+.|+|||++. ..++.++|||||||++|+|+||..||...........+....... ......+++.+.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  247 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIFR  247 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSCHHHH
T ss_pred             cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccCHHHH
Confidence            43 334567999999999886 568999999999999999999999998887766655554433221 122346899999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +||.+||+.||++|||+.++++||||+....
T Consensus       248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            9999999999999999999999999986554

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.4e-51  Score=395.58  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=188.6

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC----
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS----  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  130 (531)
                      ..+|.+.+.||+|+||+||+|++  +|+.||||++.....    .......|+..+.++ +|||||++++++...+    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCce
Confidence            45799999999999999999985  689999999864321    112233466666778 9999999999987543    


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCceEeecCCCCCCeEEE
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ--------GVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                      .+|||||||++|+|.+++... .+++..+..++.|++.||.|||++        +||||||||+|||++.   ++.+||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~---~~~~Ki~  150 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT---TSCEEEC
T ss_pred             EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC---CCCEEEE
Confidence            689999999999999999765 689999999999999999999987        9999999999999964   4569999


Q ss_pred             eeccccccCCCCc-----cccccCCcccccchhccc-------cCCCccchhHHHHHHHHHhhCCCCCCCC---------
Q 009594          203 DFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAE---------  261 (531)
Q Consensus       203 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~---------  261 (531)
                      |||+|+.......     ....+||+.|||||++.+       .++.++|||||||++|||+||.+||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            9999987654332     234579999999999864       3567899999999999999997765321         


Q ss_pred             ------CHHHHHHHHHhcccCCCCCC-CC--CCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          262 ------TEQGVAQAIIRSVIDFKRDP-WP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       262 ------~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                            ........+.........+. +.  ..++.+.+|+.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                  11222222222222111111 11  133578899999999999999999999763

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-50  Score=394.29  Aligned_cols=254  Identities=29%  Similarity=0.592  Sum_probs=226.5

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+...+|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEE
Confidence            5799999999999999999999999999999999765433333457788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.....  .
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~g~~kL~Dfg~a~~~~~--~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK---NGHIKITDFGFAKYVPD--V  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT---TSCEEECCCSSCEECSS--C
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcC---CCCEEEeecCcceecCC--c
Confidence            999999999999998888999999999999999999999999999999999999964   45699999999987543  2


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      ....+||+.|+|||++. ..++.++|||||||++|+|++|.+||...+.......+......++    +.+++.+.++|.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  235 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  235 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence            34568999999999887 5689999999999999999999999999888888888877654433    357899999999


Q ss_pred             HccccCcCCCC-----CHHHHhcCCccccc
Q 009594          295 KMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       295 ~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +||..+|++||     ++.++++||||+..
T Consensus       236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            99999999999     99999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.3e-50  Score=396.31  Aligned_cols=257  Identities=30%  Similarity=0.544  Sum_probs=223.5

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++++.+||||+++++++...+.+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999998776666666778889999999987899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-CCC
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-~~~  214 (531)
                      |||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.... ...
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TSCEEECCGGGCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC---CCCEEEEeccccccccCCCC
Confidence            999999999999988888999999999999999999999999999999999999964   4469999999998643 333


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCC---------CHHHHHHHHHhcccCCCCCCCCC
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE---------TEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      .....+||+.|+|||++. ..++.++|||||||++|+|++|.+||...         ........+......++    ..
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~  241 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RS  241 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----TT
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----CC
Confidence            455678999999999987 56899999999999999999999999652         22333444444433322    35


Q ss_pred             CCHHHHHHHHHccccCcCCCCCH------HHHhcCCccccc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTA------EEVLEHPWLQNA  319 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~------~~~l~h~~~~~~  319 (531)
                      +++.+.+||.+||..||.+||++      .++++||||+..
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            79999999999999999999995      899999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-50  Score=400.13  Aligned_cols=259  Identities=28%  Similarity=0.469  Sum_probs=227.3

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|..+++.+.+||||+++++++.+.+.+|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            35799999999999999999999999999999999765432223456778899999887699999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-C
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-G  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~  213 (531)
                      ||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|..... .
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC---CCEEEeEChhhhhcccCC
Confidence            99999999999999888889999999999999999999999999999999999999644   4699999999986433 2


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ......+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+......++    ..+++.+.+|
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  248 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL  248 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHH
Confidence            3345678999999999987 4689999999999999999999999999888888877776544332    3579999999


Q ss_pred             HHHccccCcCCCCCHH-HHhcCCcccccc
Q 009594          293 VKKMLNPDPKQRLTAE-EVLEHPWLQNAK  320 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~-~~l~h~~~~~~~  320 (531)
                      |.+||..+|++||++. ++++||||+...
T Consensus       249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          249 LVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            9999999999999998 999999998653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4e-50  Score=396.24  Aligned_cols=267  Identities=35%  Similarity=0.658  Sum_probs=210.0

Q ss_pred             ccccceeec---cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           53 DISIDYDLG---RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        53 ~~~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .+-.+|++.   +.||+|+||.||+|.+..+++.||+|++...      ....+.+|+.+++.+.+||||+++++++.+.
T Consensus         5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~   78 (325)
T 3kn6_A            5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ   78 (325)
T ss_dssp             HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            344567775   7899999999999999999999999999653      2456778999999996699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      ...++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999999999999999988899999999999999999999999999999999999998766556799999999986


Q ss_pred             cCCCC-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhcccCCCCC
Q 009594          210 FRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGVAQAIIRSVIDFKRD  280 (531)
Q Consensus       210 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~-------~~~~~~~~~~~~~~~~~  280 (531)
                      ..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....       .+....+......+...
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            65432 334567899999999987 5689999999999999999999999976432       34555555555555555


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCC
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV  325 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~  325 (531)
                      .|+.+++.+.+||.+||..||++|||+.++++||||+.....+..
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~  283 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN  283 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCS
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCC
Confidence            556789999999999999999999999999999999976554433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.4e-50  Score=399.25  Aligned_cols=258  Identities=27%  Similarity=0.476  Sum_probs=228.0

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|..++..+..||||+++++++...+.+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            35799999999999999999999999999999999865433333457788899999988789999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-CC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-~~  213 (531)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|.... ..
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC---CcEEEEeCCcccccccCC
Confidence            99999999999999888889999999999999999999999999999999999999644   469999999998643 23


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ......+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+......++    ..+++.+.+|
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  251 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  251 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            3445678999999999987 5689999999999999999999999999988888888887655443    3689999999


Q ss_pred             HHHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          293 VKKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       293 i~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      |.+||..+|++||     ++.++++||||+..
T Consensus       252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            9999999999999     47999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.9e-50  Score=408.94  Aligned_cols=262  Identities=31%  Similarity=0.489  Sum_probs=226.7

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+...+|
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence            345799999999999999999999999999999999764322222234577899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||++||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|......
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~---~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECC---CCCEEEeccceeEeeccC
Confidence            99999999999998865 46999999999999999999999999999999999999964   446999999999876544


Q ss_pred             Cc--cccccCCcccccchhccc-c----CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          214 EQ--FNEIVGSPYYMAPEVLKR-N----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       214 ~~--~~~~~gt~~y~aPE~~~~-~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ..  ....+||+.|+|||++.+ .    ++.++|||||||++|+|++|.+||.+.+.......+.........+.+..++
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            32  346789999999998863 2    7889999999999999999999999999888888887654334444456789


Q ss_pred             HHHHHHHHHccccCcCC--CCCHHHHhcCCcccccc
Q 009594          287 ENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~--Rps~~~~l~h~~~~~~~  320 (531)
                      +.+++||.+||..+|.+  ||++.++++||||+...
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            99999999999999998  99999999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.6e-50  Score=400.28  Aligned_cols=261  Identities=26%  Similarity=0.517  Sum_probs=226.4

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      +....++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCC
Confidence            344456899999999999999999999999999999999765443344567888999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .+|+||||+.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|...
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~---~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE---HGHVHITDFNIAAML  165 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECC---CCCEEEeccceeeec
Confidence            99999999999999999998888999999999999999999999999999999999999964   446999999999987


Q ss_pred             CCCCccccccCCcccccchhccc----cCCCccchhHHHHHHHHHhhCCCCCCCCC---HHHHHHHHHhcccCCCCCCCC
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      .........+||+.|+|||++.+    .++.++|||||||++|+|++|..||....   .......+......+    ..
T Consensus       166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----p~  241 (384)
T 4fr4_A          166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY----PS  241 (384)
T ss_dssp             CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC----CT
T ss_pred             cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC----CC
Confidence            76666677889999999999852    48899999999999999999999997543   333334444333322    24


Q ss_pred             CCCHHHHHHHHHccccCcCCCCC-HHHHhcCCccccc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLT-AEEVLEHPWLQNA  319 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps-~~~~l~h~~~~~~  319 (531)
                      .+++.+.+||.+||..+|++||+ +.++++||||+..
T Consensus       242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            67999999999999999999998 9999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.7e-50  Score=394.43  Aligned_cols=268  Identities=37%  Similarity=0.696  Sum_probs=235.0

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.+++++ +||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   85 (321)
T 2a2a_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYE   85 (321)
T ss_dssp             CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEe
Confidence            45677889999999999999999999999999999999976543221   2357789999999999 8999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC-CCCeEEEeecc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGL  206 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~-~~~ikl~Dfg~  206 (531)
                      ..+..++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++. ...+||+|||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            99999999999999999999988888999999999999999999999999999999999999975442 12699999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      +.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+...........+..+
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence            98876655556678999999999887 56899999999999999999999999998888877777665544443334578


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ++.+.+||.+||..+|++|||+.++++||||+..
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999999754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=389.92  Aligned_cols=269  Identities=28%  Similarity=0.455  Sum_probs=217.1

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCC--CCCCeeecce
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT--AVDIEDVRREVQIMKHLP--KHPNIVSLKD  124 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~--~h~niv~l~~  124 (531)
                      +.|..+..+|++.+.||+|+||+||+|.+..+++.||+|++.......  ......+.+|+.+++++.  +||||+++++
T Consensus         2 p~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~   81 (308)
T 3g33_A            2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD   81 (308)
T ss_dssp             --------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             CCCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence            345677789999999999999999999999999999999997543211  111245667888877773  4999999999


Q ss_pred             EEEcCC-----eEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCC
Q 009594          125 TYEDDS-----AVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       125 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~  197 (531)
                      ++....     ..++||||+. ++|.+++.....  +++..++.++.||+.||.|||++||+||||||+||+++.+   +
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~---~  157 (308)
T 3g33_A           82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---G  157 (308)
T ss_dssp             EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT---S
T ss_pred             eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC---C
Confidence            997654     5899999997 599999987654  9999999999999999999999999999999999999644   4


Q ss_pred             CeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 009594          198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      .+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus       158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            59999999998776655566678999999999886 67999999999999999999999999999888877777654332


Q ss_pred             CCCCCC-----------------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          277 FKRDPW-----------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       277 ~~~~~~-----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .+...|                       +.+++.+.+||.+||+.||++|||+.++|+||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            222222                       357889999999999999999999999999999987543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-49  Score=391.70  Aligned_cols=266  Identities=34%  Similarity=0.588  Sum_probs=220.2

Q ss_pred             Cccccceeec-cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           52 QDISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        52 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ..+.++|++. +.||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.+++++.+||||+++++++...+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            3466789995 789999999999999999999999999976532   235678899999999768999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999988888999999999999999999999999999999999999987665566999999998765


Q ss_pred             CCCC--------ccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCH-------------
Q 009594          211 RPGE--------QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------  263 (531)
Q Consensus       211 ~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~-------------  263 (531)
                      ....        ......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+...             
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            3221        122356999999999885      3588999999999999999999999977542             


Q ss_pred             --HHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          264 --QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       264 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                        ......+......++...+..+++.+.+||.+||..||++|||+.++|+||||+...
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence              234445555544444434457899999999999999999999999999999998654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-49  Score=395.64  Aligned_cols=257  Identities=28%  Similarity=0.546  Sum_probs=228.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ....+|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEE
Confidence            3456899999999999999999999999999999999765443333467888999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.....
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECC---CCCEEEcccccceeccC
Confidence            999999999999999998888999999999999999999999999999999999999964   44699999999987643


Q ss_pred             CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      .  ....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+......++    ..+++.+.+
T Consensus       194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  267 (350)
T 1rdq_E          194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKD  267 (350)
T ss_dssp             C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHH
T ss_pred             C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence            3  34567999999999887 5689999999999999999999999999888888888877654433    357999999


Q ss_pred             HHHHccccCcCCCCC-----HHHHhcCCccccc
Q 009594          292 LVKKMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       292 li~~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      ||.+||+.||++||+     +.++++||||+..
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            999999999999998     9999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-50  Score=401.04  Aligned_cols=257  Identities=36%  Similarity=0.610  Sum_probs=219.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      .-++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEE
Confidence            345799999999999999999999999999999999765332222345788999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++......
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN---LNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT---CCEEECCSSCTBTTTTS
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC---CCEEEEEeccceeccCC
Confidence            999999 78999999888899999999999999999999999999999999999999644   45999999999887766


Q ss_pred             CccccccCCcccccchhcccc-C-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      ......+||+.|+|||++.+. + +.++|||||||++|+|++|..||...........+    ..........+++.+.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----~~~~~~~p~~~s~~~~~  237 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----NSCVYVMPDFLSPGAQS  237 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----CSSCCCCCTTSCHHHHH
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----HcCCCCCcccCCHHHHH
Confidence            666777899999999998753 3 67999999999999999999999775443222111    11111122357899999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ||.+||..||.+|||+.|+++||||+..
T Consensus       238 li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-49  Score=393.37  Aligned_cols=272  Identities=30%  Similarity=0.552  Sum_probs=235.6

Q ss_pred             CCCCccccceeec-cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           49 PSGQDISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        49 ~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ..++.+.++|.+. +.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+..||||+++++++.
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            3346678889998 8999999999999999999999999999765432 2345678899999999978899999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          128 DDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                      ..+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.....+.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            999999999999999999988553  569999999999999999999999999999999999999764445679999999


Q ss_pred             cccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      ++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+...........++.
T Consensus       180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  259 (327)
T 3lm5_A          180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS  259 (327)
T ss_dssp             GCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred             cccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence            998876655556678999999999987 5689999999999999999999999999988888888887777777777788


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +++.+.+||.+||..+|++|||+.++|+||||+....
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            9999999999999999999999999999999987544

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-49  Score=403.38  Aligned_cols=264  Identities=39%  Similarity=0.688  Sum_probs=218.3

Q ss_pred             ccccceeec-cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc---
Q 009594           53 DISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED---  128 (531)
Q Consensus        53 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  128 (531)
                      .+.++|.+. +.||+|+||.||+|.+..+|+.||+|++...        ..+.+|+.++.++.+||||+++++++..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            355567776 7899999999999999999999999998632        3567899988766699999999999875   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          129 -DSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       129 -~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                       ...+||||||++||+|.+++...+  .+++..++.|+.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             667999999999999999998654  49999999999999999999999999999999999999875556789999999


Q ss_pred             cccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH----HHHHHHhcccCCCCC
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG----VAQAIIRSVIDFKRD  280 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~  280 (531)
                      ++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.....    ....+......++..
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            998776555556678999999999986 579999999999999999999999997754322    344555666666666


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCC
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN  324 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~  324 (531)
                      .|..+++.+.+||.+||..||++|||+.++++||||......+.
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  333 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  333 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCC
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCC
Confidence            77889999999999999999999999999999999987554443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2e-49  Score=388.94  Aligned_cols=265  Identities=28%  Similarity=0.473  Sum_probs=218.0

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..++.+.++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++++ +||||+++++++.+
T Consensus        14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~   90 (311)
T 3niz_A           14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS   90 (311)
T ss_dssp             -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC
T ss_pred             eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc
Confidence            445678889999999999999999999984 589999999965432 222346788999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      .+..++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a  166 (311)
T 3niz_A           91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLA  166 (311)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTC
T ss_pred             CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC---CCEEEccCcCc
Confidence            9999999999975 888877664 359999999999999999999999999999999999999654   45999999999


Q ss_pred             cccCCC-CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC---
Q 009594          208 VFFRPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP---  281 (531)
Q Consensus       208 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~---  281 (531)
                      ...... .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+....+...........   
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred             eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence            876533 23345678999999998864  589999999999999999999999988877766666654332222111   


Q ss_pred             -----------------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          282 -----------------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       282 -----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                             .+.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                   134678999999999999999999999999999998653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.6e-50  Score=408.04  Aligned_cols=264  Identities=27%  Similarity=0.479  Sum_probs=225.9

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ....+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEE
Confidence            3456899999999999999999999999999999999764322222234578899999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|+...
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~---~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLM  226 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcC---CCCEEEcchhhhhhcc
Confidence            999999999999999987 467999999999999999999999999999999999999964   4469999999997665


Q ss_pred             CCCc--cccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-CCC
Q 009594          212 PGEQ--FNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-DPW  282 (531)
Q Consensus       212 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~  282 (531)
                      ....  ....+||+.|+|||++.      +.++.++|||||||++|+|++|.+||.+.+..+....+......... ..+
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  306 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV  306 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence            4332  23468999999999875      35899999999999999999999999999888888877654322222 223


Q ss_pred             CCCCHHHHHHHHHccccCcCC--CCCHHHHhcCCcccccc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~--Rps~~~~l~h~~~~~~~  320 (531)
                      ..+++.+++||.+||..+|++  ||++.++++||||+...
T Consensus       307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            568999999999999998988  99999999999998653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.6e-49  Score=382.49  Aligned_cols=258  Identities=28%  Similarity=0.494  Sum_probs=214.6

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEE
Confidence            469999999999999999999999999999999976543 233456788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          136 MELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      |||+++ +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++...... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceecCCcc
Confidence            999976 5555554 46679999999999999999999999999999999999999654   45999999999876533 


Q ss_pred             CccccccCCcccccchhccc-c-CCCccchhHHHHHHHHHhhCCCC-CCCCCHHHHHHHHHhcccCCCCC----------
Q 009594          214 EQFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPP-FWAETEQGVAQAIIRSVIDFKRD----------  280 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~----------  280 (531)
                      .......||+.|+|||++.+ . ++.++|||||||++|+|++|..| |.+.........+.+........          
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            23345678999999998864 3 79999999999999999988776 55555566666555432222111          


Q ss_pred             ---------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          281 ---------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       281 ---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                                     ..+.+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                           123578899999999999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.6e-49  Score=386.12  Aligned_cols=265  Identities=41%  Similarity=0.744  Sum_probs=232.7

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..+..+|++.+.||+|+||.||+|.+..+|+.||+|++.....   .....+.+|+.+++++ +||||+++++++...+.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKI-KHENIVTLEDIYESTTH   80 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhC-CCCCeeehhhhcccCCE
Confidence            4577889999999999999999999999999999999975432   2235688999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++...+..+.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999999999999888889999999999999999999999999999999999999655556679999999987644


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......+....+..+++.+.
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            32 234457899999999987 5689999999999999999999999999888888888888777666666778999999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +||.+||..||++|||+.++++||||+....
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence            9999999999999999999999999986543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=396.92  Aligned_cols=261  Identities=35%  Similarity=0.657  Sum_probs=225.9

Q ss_pred             cccceee--ccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           54 ISIDYDL--GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        54 ~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      +...|.+  .+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND  160 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE
Confidence            3344555  678999999999999999999999999997643   23457889999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++ .+.+||+|||++...
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD-AKQIKIIDFGLARRY  239 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-TTEEEECCCSSCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-CCcEEEEeCCCceec
Confidence            99999999999999988654 4699999999999999999999999999999999999996432 356999999999987


Q ss_pred             CCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ..........||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+.......+...........++.+++.+
T Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  319 (373)
T 2x4f_A          240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA  319 (373)
T ss_dssp             CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred             CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence            7666666678999999999887 568899999999999999999999999999888888888877666666667899999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+||.+||..+|.+|||+.++|+||||+..
T Consensus       320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          320 KEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.4e-49  Score=384.16  Aligned_cols=266  Identities=41%  Similarity=0.755  Sum_probs=238.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..+..+|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++++ +||||+++++++...+.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCe
Confidence            34567899999999999999999999999999999999765432 23457888999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .++|+||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++..+....+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888889999999999999999999999999999999999999876666779999999998776


Q ss_pred             CCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      .........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+.......+.........+.+..+++.+.+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            55555556789999999999888999999999999999999999999998888877777776665555556778999999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +|.+||..+|++|||+.++++||||+..
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-49  Score=409.53  Aligned_cols=263  Identities=37%  Similarity=0.629  Sum_probs=231.8

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..+....++|.+.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++..
T Consensus         9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~   87 (476)
T 2y94_A            9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVIST   87 (476)
T ss_dssp             CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred             cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE
Confidence            34555667899999999999999999999999999999999765433333456788999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      .+..++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~---~~vkL~DFG~a~  164 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH---MNAKIADFGLSN  164 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT---CCEEECCCSSCE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC---CCeEEEeccchh
Confidence            99999999999999999999888889999999999999999999999999999999999999644   459999999998


Q ss_pred             ccCCCCccccccCCcccccchhcccc--CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ...........+||+.|+|||++.+.  .+.++|||||||++|+|++|..||...........+.......+    ..++
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s  240 (476)
T 2y94_A          165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLN  240 (476)
T ss_dssp             ECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCC
T ss_pred             hccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCC
Confidence            87766666677899999999998753  36799999999999999999999998887777777766544322    3578


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +.+.+||.+||..||++|||+.++++||||+..
T Consensus       241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            999999999999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.2e-49  Score=394.23  Aligned_cols=258  Identities=28%  Similarity=0.514  Sum_probs=218.0

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHH-HhCCCCCCeeecceEEEcCCeE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM-KHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ...+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|..++ +.+ +||||+++++++...+.+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEE
Confidence            345799999999999999999999999999999999877655444556677787774 556 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-  211 (531)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++... 
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCBCGGGBC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---CCEEEeeCcccccccc
Confidence            9999999999999999988889999999999999999999999999999999999999644   469999999998643 


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ........+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+....+......++    +.+++.+.
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~  267 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSAR  267 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Confidence            333445678999999999987 5689999999999999999999999999888888888877644332    46899999


Q ss_pred             HHHHHccccCcCCCCCH----HHHhcCCccccc
Q 009594          291 DLVKKMLNPDPKQRLTA----EEVLEHPWLQNA  319 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~----~~~l~h~~~~~~  319 (531)
                      +||.+||+.||.+||++    .++++||||+..
T Consensus       268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            99999999999999986    699999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-49  Score=401.40  Aligned_cols=263  Identities=26%  Similarity=0.463  Sum_probs=223.4

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..++..+ +||||+++++++.+.+.+
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEE
Confidence            3456899999999999999999999999999999999764332223345578899999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++....
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~---~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR---CGHIRLADFGSCLKLR  213 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecC---CCCEEEeechhheecc
Confidence            99999999999999998754 7999999999999999999999999999999999999964   4569999999998765


Q ss_pred             CCCc--cccccCCcccccchhcc--------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC-
Q 009594          212 PGEQ--FNEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD-  280 (531)
Q Consensus       212 ~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-  280 (531)
                      ....  ....+||+.|+|||++.        +.++.++|||||||++|+|++|.+||.+.+..+....+.........+ 
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  293 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL  293 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence            4433  23468999999999886        358999999999999999999999999998888777776533222111 


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCC---CCHHHHhcCCcccccc
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQR---LTAEEVLEHPWLQNAK  320 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~R---ps~~~~l~h~~~~~~~  320 (531)
                      ....+|+++++||.+||. +|.+|   |++.++++||||+...
T Consensus       294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence            124689999999999999 99998   5999999999998653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.7e-49  Score=382.92  Aligned_cols=267  Identities=37%  Similarity=0.739  Sum_probs=228.7

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++........   ...+.+.+|+.+++++ +||||+++++++....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCC
Confidence            55789999999999999999999999999999999986543321   2367889999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC-CCCCeEEEeeccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVF  209 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~-~~~~ikl~Dfg~a~~  209 (531)
                      ..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999999999998888899999999999999999999999999999999999997654 233699999999987


Q ss_pred             cCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ...........||+.|+|||++. ..++.++||||||+++|+|++|..||...........+...........++.+++.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            76555555667999999999887 56899999999999999999999999998887777766655444433334578999


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +.+++.+||..+|++|||+.++++||||+....
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            999999999999999999999999999987544

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.1e-49  Score=390.03  Aligned_cols=267  Identities=28%  Similarity=0.465  Sum_probs=215.9

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++...+.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGC-CCTTBCCEEEEEEETTE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCE
Confidence            4456689999999999999999999999999999999975532 222345677899999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC--CCCCeEEEeeccccc
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVF  209 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~--~~~~ikl~Dfg~a~~  209 (531)
                      .++||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  ....+||+|||++..
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999999974 9999999888899999999999999999999999999999999999996543  334599999999986


Q ss_pred             cCCC-CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC---
Q 009594          210 FRPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP---  283 (531)
Q Consensus       210 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  283 (531)
                      .... .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.........+...........|+   
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            6433 23345678999999998864  48999999999999999999999999988877777666543222222111   


Q ss_pred             -----------------------CCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          284 -----------------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       284 -----------------------~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                             .+++.+.+||.+||+.||++|||+.|+|+||||+....
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                                   16789999999999999999999999999999987543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3e-49  Score=407.23  Aligned_cols=260  Identities=30%  Similarity=0.557  Sum_probs=219.3

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++...+.
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCE
Confidence            44556899999999999999999999999999999999865444444556778899999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      +++||||+++++|..++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.+   +.+||+|||+|...
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~---~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEG  299 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS---SCEEECCCCCCCTT
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC---CCEEEccCCCceec
Confidence            99999999999999999888889999999999999999999998 999999999999999654   45999999999864


Q ss_pred             CC-CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          211 RP-GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       211 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      .. .......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++    ..+++.
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~  375 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPE  375 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHH
Confidence            33 33445678999999999886 5799999999999999999999999999888888777776654433    357899


Q ss_pred             HHHHHHHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          289 AKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +.+||.+||..||.+||     |+.++++||||+..
T Consensus       376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            99999999999999999     99999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-49  Score=389.54  Aligned_cols=262  Identities=31%  Similarity=0.531  Sum_probs=218.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.+ +||||+++++++...+..
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeE
Confidence            3567899999999999999999999999999999999755422  1235678999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRY  157 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECEE
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC---CCEEEEEeeccceecc
Confidence            9999999999999999888789999999999999999999999999999999999999644   4599999999986543


Q ss_pred             CC---ccccccCCcccccchhccc-c-CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          213 GE---QFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       213 ~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ..   ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||................ ......+..+++
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  236 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDS  236 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-CTTSTTGGGSCH
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-cccCCccccCCH
Confidence            22   2345679999999999864 3 4778999999999999999999997765432222222211 222334567899


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .+.+||.+||..||++|||+.|+++||||+....
T Consensus       237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            9999999999999999999999999999986543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.3e-50  Score=407.55  Aligned_cols=265  Identities=40%  Similarity=0.677  Sum_probs=216.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----AVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|++.......     ......+.+|+.+++++ +||||+++++++.
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence            35678999999999999999999999999999999998654321     11223578899999999 9999999999986


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      . +..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||+|
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence            5 457999999999999999988888999999999999999999999999999999999999987766778999999999


Q ss_pred             cccCCCCccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCCCCCC
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  282 (531)
                      .............||+.|+|||++.    ..++.++|||||||++|+|+||.+||...... .....+...........+
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            8876655556678999999999874    45788999999999999999999999765433 233344444444433445


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ..+++.+.+||.+||+.+|++|||+.++|+||||+..
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            6789999999999999999999999999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7e-49  Score=393.61  Aligned_cols=262  Identities=37%  Similarity=0.721  Sum_probs=230.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----AVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      +..+|++.+.||+|+||.||+|.+..+|+.||||++.......     ....+.+.+|+.+++++.+||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            3457999999999999999999998899999999997543211     11245678899999999789999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ....++||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.   ++.+||+|||++.
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~---~~~ikl~DfG~~~  248 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD---NMQIRLSDFGFSC  248 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTCE
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEEEecCccc
Confidence            9999999999999999999988888999999999999999999999999999999999999964   4459999999998


Q ss_pred             ccCCCCccccccCCcccccchhccc-------cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  281 (531)
                      ............||+.|+|||++.+       .++.++|||||||++|+|++|..||...........+......+..+.
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            8776666667789999999998752       478899999999999999999999999888777777777666555555


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      |..+++.+.+||.+||..+|++|||+.++|+||||++
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            6678999999999999999999999999999999973

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-49  Score=413.37  Aligned_cols=259  Identities=31%  Similarity=0.504  Sum_probs=223.7

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ....+|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEE
Confidence            4456799999999999999999999999999999999765443333456788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          133 HIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      |+||||++||+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|...
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~---~g~vKL~DFGla~~~  336 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD---HGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeC---CCCeEEEecccceec
Confidence            999999999999999976543  999999999999999999999999999999999999964   456999999999887


Q ss_pred             CCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH----HHHHHHHHhcccCCCCCCCCCC
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      .........+||+.|+|||++. ..++.++|||||||++|+|++|.+||.....    ..+...+.....    .....+
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~----~~p~~~  412 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----EYSERF  412 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC----CCCTTS
T ss_pred             ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc----cCCccC
Confidence            6665556678999999999987 4689999999999999999999999987542    333333333322    222468


Q ss_pred             CHHHHHHHHHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          286 SENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      ++.+.+||.+||..||++||     ++.++++||||+..
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            99999999999999999999     89999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.1e-48  Score=379.54  Aligned_cols=266  Identities=36%  Similarity=0.679  Sum_probs=234.2

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC------hhhHHHHHHHHHHHHhCCCCCCeeecceE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT------AVDIEDVRREVQIMKHLPKHPNIVSLKDT  125 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~l~~~  125 (531)
                      ..+..+|++.+.||+|+||.||+|.+..+|+.||+|++.......      ....+.+.+|+.+++++.+||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            446678999999999999999999999999999999997543211      12245678999999999669999999999


Q ss_pred             EEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          126 YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       126 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                      +...+..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg  169 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD---MNIKLTDFG  169 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCT
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC---CcEEEeccc
Confidence            99999999999999999999999888889999999999999999999999999999999999999644   459999999


Q ss_pred             cccccCCCCccccccCCcccccchhcc-------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK  278 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  278 (531)
                      ++.............||+.|+|||++.       ..++.++||||||+++|+|++|..||...........+........
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (298)
T 1phk_A          170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  249 (298)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence            998876666566678999999999874       3478899999999999999999999999888888788877776666


Q ss_pred             CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       279 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .+.++.+++.+.++|.+||..+|++|||+.++++||||+...
T Consensus       250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            666778999999999999999999999999999999998654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.7e-49  Score=380.35  Aligned_cols=256  Identities=32%  Similarity=0.512  Sum_probs=212.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++++.||+|+||.||+|.+ .+|+.||+|++...... ......+.+|+.+++++ +||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEE
Confidence            4699999999999999999998 67999999999654322 22236678999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      |||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPV  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCTTHHHHHCC--
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEEeECccccccCccc
Confidence            999975 999888764 569999999999999999999999999999999999999644   45999999999865432 


Q ss_pred             CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC-----------
Q 009594          214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD-----------  280 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  280 (531)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+....+.+........           
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            23344578999999998863  58999999999999999999999999988777766665432211111           


Q ss_pred             --------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          281 --------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       281 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                    ....+++.+.+||.+||+.||++|||+.++|+||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                          12357899999999999999999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-48  Score=384.00  Aligned_cols=259  Identities=27%  Similarity=0.460  Sum_probs=206.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++++.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++++ +||||+++++++...+..++|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEE
Confidence            479999999999999999999999999999999975532  22346778899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          136 MELCEGGELFDRIVAR------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      |||++ ++|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR---GQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC---CCEEECcCcccee
Confidence            99998 5999988654      358999999999999999999999999999999999999654   4599999999987


Q ss_pred             cCCC-CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC------
Q 009594          210 FRPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD------  280 (531)
Q Consensus       210 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------  280 (531)
                      .... .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+..........      
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            6533 23345678999999999864  58999999999999999999999999988877776665432211111      


Q ss_pred             ------------------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          281 ------------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       281 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                              ....+++.+.+||.+||+.||++|||+.|+|+||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                    01246889999999999999999999999999999987544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.3e-48  Score=384.13  Aligned_cols=259  Identities=31%  Similarity=0.553  Sum_probs=215.3

Q ss_pred             ccccceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ....+|++.+.||+|+||.||+|++.   .+|+.||+|++.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~   92 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc
Confidence            34568999999999999999999985   68999999999765432 222345678899999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      .+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~~  169 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ---GHVKLTDFGLCK  169 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT---SCEEECCCSCC-
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC---CcEEEEeCCccc
Confidence            99999999999999999999888889999999999999999999999999999999999999644   469999999987


Q ss_pred             ccCCC-CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          209 FFRPG-EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       209 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+.......+    +.++
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~  245 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLT  245 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence            54322 2334567999999999886 5689999999999999999999999999888887777776654332    4578


Q ss_pred             HHHHHHHHHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +.+.+||.+||..+|++||     ++.++++||||+..
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            9999999999999999999     89999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=381.62  Aligned_cols=256  Identities=33%  Similarity=0.613  Sum_probs=214.0

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC-----------------------hhhHHHHHHHHHHHH
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----------------------AVDIEDVRREVQIMK  111 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~  111 (531)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.......                       ....+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            457999999999999999999999999999999997654221                       112356889999999


Q ss_pred             hCCCCCCeeecceEEEc--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceE
Q 009594          112 HLPKHPNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL  189 (531)
Q Consensus       112 ~l~~h~niv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIl  189 (531)
                      ++ +||||+++++++.+  ....++||||+++++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            99 99999999999986  57899999999999998864 3457999999999999999999999999999999999999


Q ss_pred             eecCCCCCCeEEEeeccccccCCCC-ccccccCCcccccchhcccc----CCCccchhHHHHHHHHHhhCCCCCCCCCHH
Q 009594          190 FANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQ  264 (531)
Q Consensus       190 l~~~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~  264 (531)
                      ++.+   +.+||+|||++....... ......||+.|+|||++.+.    ++.++|||||||++|+|++|..||......
T Consensus       170 ~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          170 VGED---GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             ECTT---SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ECCC---CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            9644   459999999998765433 23456799999999998743    367899999999999999999999888777


Q ss_pred             HHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      .....+.......+  ..+.+++.+.+||.+||..||++|||+.++++||||+
T Consensus       247 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 CLHSKIKSQALEFP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHHhcccCCCC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            66666665544333  2357899999999999999999999999999999996

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-48  Score=377.40  Aligned_cols=261  Identities=35%  Similarity=0.632  Sum_probs=224.0

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++++ +||||+++++++.+....+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEE
Confidence            345799999999999999999999999999999999765433333456788999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++......
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~---~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT---SCEEECSCCEESCC---
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC---CCEEEEeccccccCCcc
Confidence            999999999999999888889999999999999999999999999999999999999644   45999999998654432


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                       ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.......+    ..+++.+.+|
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  237 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL  237 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence             234567899999999887 4678899999999999999999999998888777777666543332    3578999999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcccccccCC
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP  323 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~  323 (531)
                      |.+||..+|++|||+.++++||||+.....+
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence            9999999999999999999999998765544

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.2e-49  Score=396.94  Aligned_cols=262  Identities=31%  Similarity=0.530  Sum_probs=209.9

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--  129 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  129 (531)
                      ..+..+|++++.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++++.+||||+++++++...  
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            34566899999999999999999999999999999998644 234455677889999999996699999999999754  


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      ..+|+||||++ ++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||+|+.
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRS  158 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTCEE
T ss_pred             CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC---CCCEEecCCccccc
Confidence            47999999997 589888866 47999999999999999999999999999999999999964   44699999999986


Q ss_pred             cCCC----------------------CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHH
Q 009594          210 FRPG----------------------EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQG  265 (531)
Q Consensus       210 ~~~~----------------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~  265 (531)
                      ....                      ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5321                      11234679999999998864  68999999999999999999999999988877


Q ss_pred             HHHHHHhcccCCC------------------------------C-------------CCCCCCCHHHHHHHHHccccCcC
Q 009594          266 VAQAIIRSVIDFK------------------------------R-------------DPWPKVSENAKDLVKKMLNPDPK  302 (531)
Q Consensus       266 ~~~~~~~~~~~~~------------------------------~-------------~~~~~~~~~~~~li~~~l~~~p~  302 (531)
                      ....+........                              .             .+...+++.+.+||.+||..||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            7766653221110                              0             01126789999999999999999


Q ss_pred             CCCCHHHHhcCCccccc
Q 009594          303 QRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       303 ~Rps~~~~l~h~~~~~~  319 (531)
                      +|||+.|+|+||||+..
T Consensus       319 ~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          319 KRISANDALKHPFVSIF  335 (388)
T ss_dssp             GSCCHHHHTTSTTTTTT
T ss_pred             cCCCHHHHhCCHHHHHh
Confidence            99999999999999754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.6e-49  Score=398.31  Aligned_cols=264  Identities=30%  Similarity=0.472  Sum_probs=214.5

Q ss_pred             cCCCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE
Q 009594           47 KEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY  126 (531)
Q Consensus        47 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  126 (531)
                      ....+.....+|++.+.||+|+||.||+|++..++. +|+|++......       ..+|+.+++.+ +||||+++++++
T Consensus        31 ~~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l-~h~niv~l~~~~  101 (394)
T 4e7w_A           31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIV-KHPNVVDLKAFF  101 (394)
T ss_dssp             ESSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTC-CCTTBCCEEEEE
T ss_pred             CCCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhC-CCCCcceEEEEE
Confidence            445677788899999999999999999999876665 888877543321       12699999999 999999999998


Q ss_pred             EcCC------eEEEEEeccCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCC
Q 009594          127 EDDS------AVHIVMELCEGGELFDRI---VARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       127 ~~~~------~~~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~  197 (531)
                      ....      .+++||||++++.+....   .....+++..++.++.||+.||.|||++||+||||||+|||++.  .++
T Consensus       102 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~  179 (394)
T 4e7w_A          102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSG  179 (394)
T ss_dssp             EEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTT
T ss_pred             EecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CCC
Confidence            5433      388999999875433322   22567999999999999999999999999999999999999972  234


Q ss_pred             CeEEEeeccccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc
Q 009594          198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI  275 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  275 (531)
                      .+||+|||+|.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+.+...
T Consensus       180 ~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  259 (394)
T 4e7w_A          180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG  259 (394)
T ss_dssp             EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            599999999988766666667789999999998863  589999999999999999999999999887777666654211


Q ss_pred             CC-----------------C---CC-----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          276 DF-----------------K---RD-----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       276 ~~-----------------~---~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ..                 +   ..     ..+.+++++.+||.+||.+||++|||+.++++||||+....
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            10                 0   00     11247899999999999999999999999999999987654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=383.58  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=212.9

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..+..+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... ..........|+..+.++.+||||+++++++..
T Consensus        50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            3456677899999999999999999999999999999999865432 333445556677777666699999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      .+..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~---~~kl~DFG~a  204 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG---RCKLGDFGLL  204 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG---CEEECCCTTC
T ss_pred             CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC---CEEEccceee
Confidence            99999999999 66898887764 4599999999999999999999999999999999999996544   5999999999


Q ss_pred             cccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      .............||+.|+|||++.+.++.++|||||||++|+|++|..|+....   ....+.....  +......+++
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~  279 (311)
T 3p1a_A          205 VELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAGLSS  279 (311)
T ss_dssp             EECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTTSCH
T ss_pred             eecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccCCCH
Confidence            8776555555667999999999998899999999999999999999977765432   2222322221  1111246799


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      .+.+||.+||+.+|++|||+.++|+||||++
T Consensus       280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.4e-48  Score=392.63  Aligned_cols=263  Identities=20%  Similarity=0.310  Sum_probs=214.9

Q ss_pred             ccceeeccccCcc--CceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           55 SIDYDLGRELGRG--EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        55 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .++|++.+.||+|  +||.||+|++..+|+.||+|++..... .......+.+|+.+++++ +||||+++++++...+.+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEE
Confidence            3579999999999  999999999999999999999986543 334567788999999999 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          133 HIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||.+...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~---~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEcccccceee
Confidence            9999999999999999875  669999999999999999999999999999999999999644   46999999988654


Q ss_pred             CCCC--------ccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--
Q 009594          211 RPGE--------QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--  277 (531)
Q Consensus       211 ~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--  277 (531)
                      ....        ......||+.|+|||++.+   .++.++|||||||++|+|++|..||.+.........+.......  
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            2211        1123478999999998874   58999999999999999999999998765544433322211100  


Q ss_pred             ----------------------------------------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          278 ----------------------------------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       278 ----------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                                                              ....+..+++.+.+||.+||+.||++|||+.++|+||||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                    0012235788999999999999999999999999999998


Q ss_pred             ccccC
Q 009594          318 NAKKA  322 (531)
Q Consensus       318 ~~~~~  322 (531)
                      .....
T Consensus       339 ~~~~~  343 (389)
T 3gni_B          339 QIKRR  343 (389)
T ss_dssp             GC---
T ss_pred             HHhhc
Confidence            76543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.5e-49  Score=388.27  Aligned_cols=260  Identities=27%  Similarity=0.473  Sum_probs=212.3

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.......  ....+.+|+.+++++ +||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEE
Confidence            46999999999999999999999999999999996543211  112344699999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      |||++ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++...... 
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT---CCEEECSSSEEECC----
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC---CCEEEccCcccccccCCc
Confidence            99997 58988887654 48999999999999999999999999999999999999654   45999999999865433 


Q ss_pred             CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC---------
Q 009594          214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW---------  282 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------  282 (531)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+.+.........|         
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            23345578999999998864  5899999999999999999999999999888877777664433332222         


Q ss_pred             -----------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          283 -----------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       283 -----------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                                       +.+++.+.+||.+||+.||++|||+.|+|+||||......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                             2468899999999999999999999999999999876543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.4e-49  Score=387.61  Aligned_cols=265  Identities=40%  Similarity=0.684  Sum_probs=220.5

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHhCCCCCCeeecceEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMKHLPKHPNIVSLKDTY  126 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  126 (531)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++......     .......+.+|+.+++++ +||||+++++++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~   84 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF   84 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEE
Confidence            34667899999999999999999999999999999999764321     112234578899999999 999999999998


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          127 EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       127 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      .... .++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||+
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            7665 899999999999999998888899999999999999999999999999999999999998766666799999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcccCCCCCC
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~  281 (531)
                      +.............||+.|+|||++.    ..++.++|||||||++|+|++|..||...... .....+...........
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            98776554445567999999999873    46889999999999999999999999765433 23333444433333333


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      +..+++.+.+||.+||..||++|||+.++|+||||+.
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            4568999999999999999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-49  Score=392.35  Aligned_cols=267  Identities=36%  Similarity=0.680  Sum_probs=227.0

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      .+..+|++.+.||+|+||.||+|.+..++..||+|++......  .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCC
Confidence            3567899999999999999999999999999999999765321  233467889999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHH
Q 009594          131 AVHIVMELCEGGELFDRIVA----------------------------------------RGHYTERAAAAVMKTIVEVV  170 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qi~~~l  170 (531)
                      ..++||||++||+|.+++..                                        ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            99999999999999998742                                        11236778899999999999


Q ss_pred             HHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-----ccccccCCcccccchhcc---ccCCCccchh
Q 009594          171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVLK---RNYGPEVDVW  242 (531)
Q Consensus       171 ~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~Di~  242 (531)
                      .|||++||+||||||+||+++.++ ...+||+|||++.......     ......||+.|+|||++.   ..++.++|||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSS-SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCC-CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            999999999999999999997543 3469999999998653321     134567999999999886   4688999999


Q ss_pred             HHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          243 SAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       243 slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ||||++|+|++|..||.+....+....+......+..+.+..+++.+.+||.+||..+|.+|||+.++|+||||+....
T Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            9999999999999999999988888888887766666666678999999999999999999999999999999987543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=380.23  Aligned_cols=263  Identities=30%  Similarity=0.575  Sum_probs=216.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++++ +||||+++++++...+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEE
Confidence            357999999999999999999999999999999986543 2333456788999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      ||||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++...... 
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH---SVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECC---
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC---CCEEEeeCCCchhccCcc
Confidence            99999999999988888889999999999999999999999999999999999999644   46999999999876533 


Q ss_pred             CccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--------------
Q 009594          214 EQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--------------  277 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------------  277 (531)
                      .......||+.|+|||++.  ..++.++||||||+++|+|++|.+||.+....+....+.......              
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            2334567899999999886  358999999999999999999999999888776655544321110              


Q ss_pred             -----CCC--------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccC
Q 009594          278 -----KRD--------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA  322 (531)
Q Consensus       278 -----~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  322 (531)
                           +..        .++.+++.+.+||.+||..||++|||+.++|+||||++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence                 000        124678999999999999999999999999999999976543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-48  Score=402.13  Aligned_cols=258  Identities=26%  Similarity=0.418  Sum_probs=209.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC---
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  129 (531)
                      .+..+|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...   
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCST
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcc
Confidence            34568999999999999999999999999999999997643 2344567888999999999 999999999999654   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       130 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                         ..+|+||||+++ +|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~---~~~kl~DFG~  210 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGL  210 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCC
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC---CCEEEEEEEe
Confidence               468999999976 5666663  358999999999999999999999999999999999999654   4599999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-------
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-------  278 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-------  278 (531)
                      |+...........+||+.|+|||++. ..|+.++|||||||++|+|++|++||.+.+..+....+.+......       
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            98776655566678999999999887 5799999999999999999999999999888777766654322110       


Q ss_pred             ---------------CCCC----CC------------CCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          279 ---------------RDPW----PK------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       279 ---------------~~~~----~~------------~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                     ...+    +.            .++.+.+||.+||..||++|||+.|+|+||||+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                           0000    00            1467899999999999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.5e-48  Score=374.59  Aligned_cols=261  Identities=34%  Similarity=0.663  Sum_probs=226.3

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ....++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++++ +||||+++++++...+.
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   88 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKR   88 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCE
Confidence            34456899999999999999999999999999999999765432223346788999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .++||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAP  165 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---CCEEECCCTTCEECS
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC---CCEEEecccccccCc
Confidence            99999999999999999888889999999999999999999999999999999999999644   459999999987654


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......++    +.+++.+.
T Consensus       166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  240 (284)
T 2vgo_A          166 SL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSK  240 (284)
T ss_dssp             SS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHH
T ss_pred             cc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHH
Confidence            32 234567899999999887 4689999999999999999999999988887776666665433322    45789999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++|.+||..+|.+|||+.++++||||+....
T Consensus       241 ~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            9999999999999999999999999986554

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5e-48  Score=399.79  Aligned_cols=263  Identities=27%  Similarity=0.431  Sum_probs=201.3

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc---
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED---  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  128 (531)
                      -.+.++|++++.||+|+||.||+|.+..+++.||||++... .........+.+|+.+|+++ +||||+++++++..   
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT
T ss_pred             CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCc
Confidence            34667899999999999999999999999999999999653 33445567889999999999 99999999999843   


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          129 --DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       129 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                        ...+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---~~~~kl~DFGl  202 (458)
T 3rp9_A          127 EKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ---DCSVKVCDFGL  202 (458)
T ss_dssp             TTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TCCEEECCCTT
T ss_pred             ccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC---CCCEeeccccc
Confidence              36799999998 5799999988888999999999999999999999999999999999999964   44699999999


Q ss_pred             ccccCCCC----------------------------ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhh---
Q 009594          207 SVFFRPGE----------------------------QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLC---  253 (531)
Q Consensus       207 a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~t---  253 (531)
                      |+......                            .....+||+.|+|||++.  ..++.++|||||||++|+|+|   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            98764221                            223467899999999763  469999999999999999999   


Q ss_pred             --------CCCCCCCCCH--------------------HHHHHHHHhcc-----------------------cCC----C
Q 009594          254 --------GVPPFWAETE--------------------QGVAQAIIRSV-----------------------IDF----K  278 (531)
Q Consensus       254 --------g~~pf~~~~~--------------------~~~~~~~~~~~-----------------------~~~----~  278 (531)
                              |.++|.+...                    .+....+....                       ...    .
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    6777766431                    11222221110                       000    0


Q ss_pred             CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       279 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ...++..++.+.+||.+||..||++|||+.|+|+||||+...
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            112456799999999999999999999999999999998754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3e-48  Score=374.12  Aligned_cols=262  Identities=37%  Similarity=0.638  Sum_probs=217.8

Q ss_pred             CCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .|....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++...
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTP   83 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC
Confidence            4556667899999999999999999999989999999999765433333456788999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +..++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~  160 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH---MNAKIADFGLSNM  160 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT---SCEEECCCCGGGC
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC---CCEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999644   4599999999987


Q ss_pred             cCCCCccccccCCcccccchhcccc-C-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ...........||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+.......+    ..+++
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  236 (276)
T 2h6d_A          161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNR  236 (276)
T ss_dssp             CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCH
Confidence            7655544566789999999998753 3 5789999999999999999999988877776666665543222    35789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+.++|.+||+.+|++|||+.++++||||+..
T Consensus       237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            99999999999999999999999999999754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.9e-49  Score=386.46  Aligned_cols=266  Identities=27%  Similarity=0.426  Sum_probs=222.7

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  130 (531)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++.... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEET
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCC
Confidence            46778999999999999999999999999999999999876555555567889999999999 9999999999987543 


Q ss_pred             ---eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          131 ---AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       131 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                         ..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a  163 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIA  163 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS---CEEECCCSCC
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC---CEEEeeccCc
Confidence               3599999999999999998888899999999999999999999999999999999999997544   5999999999


Q ss_pred             cccCCCC----ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          208 VFFRPGE----QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       208 ~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      .......    ......||+.|+|||++. ..++.++||||||+++|+|+||..||.+.....................+
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  243 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence            8664332    223456899999999887 46899999999999999999999999998887776666665443333334


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ..+++.+.++|.+||+.||++||++.+++.|+|++....
T Consensus       244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            568999999999999999999999999999999985443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.8e-48  Score=386.38  Aligned_cols=265  Identities=24%  Similarity=0.402  Sum_probs=222.2

Q ss_pred             ccCCCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC----CCCCeee
Q 009594           46 LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP----KHPNIVS  121 (531)
Q Consensus        46 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~  121 (531)
                      .+-..|..+.++|++++.||+|+||.||+|.+..+++.||+|++...    .........|+.+++.+.    .||||++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34566788899999999999999999999999999999999998642    233466778999999994    3999999


Q ss_pred             cceEEEcCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC------
Q 009594          122 LKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK------  193 (531)
Q Consensus       122 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~------  193 (531)
                      +++++...+..++||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++..      
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence            999999999999999999 899999998754  48999999999999999999999999999999999999642      


Q ss_pred             ----------------CCCCCeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCC
Q 009594          194 ----------------KESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVP  256 (531)
Q Consensus       194 ----------------~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~  256 (531)
                                      .....+||+|||+|.....  ......||+.|+|||++. ..++.++|||||||++|+|+||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  257 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL  257 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence                            1245699999999986543  234567899999999887 579999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCC---------------------CCCC---------------------CCCHHHHHHHH
Q 009594          257 PFWAETEQGVAQAIIRSVIDFKR---------------------DPWP---------------------KVSENAKDLVK  294 (531)
Q Consensus       257 pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~---------------------~~~~~~~~li~  294 (531)
                      ||......+....+.......+.                     ..|+                     ..++.+.+||.
T Consensus       258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  337 (360)
T 3llt_A          258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY  337 (360)
T ss_dssp             SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence            99988877766655443222110                     0011                     12367889999


Q ss_pred             HccccCcCCCCCHHHHhcCCccc
Q 009594          295 KMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       295 ~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      +||+.||++|||+.++|+||||+
T Consensus       338 ~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          338 SILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999996

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.3e-48  Score=416.08  Aligned_cols=258  Identities=27%  Similarity=0.477  Sum_probs=229.7

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++++.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+..||+|+++++++.+.+.+||
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            35799999999999999999999999999999999865433333456788899999998889999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC-CC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~-~~  213 (531)
                      ||||++||+|..++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|+... ..
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~---g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS---SCEEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC---CcEEEeecceeeccccCC
Confidence            99999999999999988899999999999999999999999999999999999999654   469999999998643 33


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      ......+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+....+......++    ..+++++.+|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  572 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  572 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence            4455678999999999987 5799999999999999999999999999998888888887655443    3689999999


Q ss_pred             HHHccccCcCCCCCH-----HHHhcCCccccc
Q 009594          293 VKKMLNPDPKQRLTA-----EEVLEHPWLQNA  319 (531)
Q Consensus       293 i~~~l~~~p~~Rps~-----~~~l~h~~~~~~  319 (531)
                      |.+||.+||++||++     .+|++||||+..
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            999999999999997     999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-47  Score=382.03  Aligned_cols=258  Identities=29%  Similarity=0.477  Sum_probs=221.3

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .....|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++...+..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeE
Confidence            4556799999999999999999999999999999999765444444557788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+. |+|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++....
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMA  205 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSS
T ss_pred             EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEeeccCceecC
Confidence            99999997 57877775 45679999999999999999999999999999999999999754   459999999998654


Q ss_pred             CCCccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ..   ....||+.|+|||++.    +.++.++|||||||++|+|++|.+||...+.......+.......  .....+++
T Consensus       206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  280 (348)
T 1u5q_A          206 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSE  280 (348)
T ss_dssp             SB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCH
T ss_pred             CC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCCCH
Confidence            32   3467999999999873    468999999999999999999999998888776666665543221  12246789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .+.+||.+||+.+|++|||+.++++||||....
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            999999999999999999999999999997643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.8e-48  Score=375.05  Aligned_cols=265  Identities=27%  Similarity=0.427  Sum_probs=221.6

Q ss_pred             CCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .|..+.++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++++ +||||+++++++...
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A            5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEED   83 (294)
T ss_dssp             CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECS
T ss_pred             hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeC
Confidence            3677888999999999999999999999999999999999766555566677899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +..++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++..
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN---KTLKIFDFGIAKA  160 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCSSSTT
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEEeCCCccc
Confidence            9999999999999999999988889999999999999999999999999999999999999644   4599999999987


Q ss_pred             cCCCC--ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-CCCCCCCC
Q 009594          210 FRPGE--QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-KRDPWPKV  285 (531)
Q Consensus       210 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  285 (531)
                      .....  ......||+.|+|||++. ..++.++||||||+++|+|+||..||.+.+............... .....+.+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T 4eqm_A          161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI  240 (294)
T ss_dssp             C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred             cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence            65332  233457999999999887 468899999999999999999999999888766555444432221 12234568


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      |+.+.++|.+||..+|++||+..+.+.+.|..-
T Consensus       241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            999999999999999999996666666666543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.4e-47  Score=371.31  Aligned_cols=261  Identities=32%  Similarity=0.492  Sum_probs=228.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ....+|++.+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+.+++.+ +||||+++++++...+..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEE
Confidence            3456899999999999999999999999999999999876655566677889999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++.....
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC---CCEEEEeccCceeccc
Confidence            9999999999999999888889999999999999999999999999999999999999644   4599999999987653


Q ss_pred             C-CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          213 G-EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       213 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      . .......||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+.......+    ..+++.+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  243 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAA  243 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHH
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHH
Confidence            2 2334567899999999887 4588999999999999999999999998887776666655433222    35789999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++|.+||..+|++|||+.++++||||.....
T Consensus       244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          244 SLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence            9999999999999999999999999986543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.3e-48  Score=403.89  Aligned_cols=258  Identities=29%  Similarity=0.504  Sum_probs=221.9

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      -.++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++++ +||||+++++++.....+|
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEE
Confidence            346899999999999999999999999999999999765543334457788999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          134 IVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +||||++||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++..
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~---~g~vkL~DFGla~~  338 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD---DGNVRISDLGLAVE  338 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TSCEEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeC---CCCEEEeecceeee
Confidence            999999999999998763    36999999999999999999999999999999999999964   44699999999987


Q ss_pred             cCCCCc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHhcccCCCCCCCC
Q 009594          210 FRPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       210 ~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      ...... ....+||+.|+|||++. ..++.++|||||||++|+|+||.+||.+..    .......+......++    .
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~  414 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----D  414 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----T
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----c
Confidence            655433 34468999999999987 468999999999999999999999998753    3444555554433322    4


Q ss_pred             CCCHHHHHHHHHccccCcCCCCC-----HHHHhcCCccccc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      .+++.+.+||.+||.+||++||+     +.++++||||+..
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            68999999999999999999996     5899999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=384.76  Aligned_cols=254  Identities=31%  Similarity=0.548  Sum_probs=217.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA-----VDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      .+..+|++.+.||+|+||.||+|.+..+++.||+|++........     .....+.+|+.+++++ +||||+++++++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~   99 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFE   99 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence            466789999999999999999999999999999999986543221     1234567799999999 9999999999999


Q ss_pred             cCCeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          128 DDSAVHIVMELCEGG-ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      ..+..++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~  176 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE---DFTIKLIDFGS  176 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTT
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC---CCcEEEeeccc
Confidence            999999999999766 99999988888999999999999999999999999999999999999964   45699999999


Q ss_pred             ccccCCCCccccccCCcccccchhccc-cC-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      +.............||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.....          ...........
T Consensus       177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~~~~~  246 (335)
T 3dls_A          177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYL  246 (335)
T ss_dssp             CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCCCSSC
T ss_pred             ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccCCCcc
Confidence            988776666666789999999998874 34 7789999999999999999999965322          11111122235


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      +++.+.+||.+||..+|++|||+.++++||||+...
T Consensus       247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            799999999999999999999999999999998643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.3e-47  Score=374.79  Aligned_cols=256  Identities=30%  Similarity=0.521  Sum_probs=220.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ..|...+.||+|+||.||+|.+..+|+.||+|++.....   ...+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEE
Confidence            358888899999999999999998999999999975432   2356788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      |||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++....... 
T Consensus       121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSSSC
T ss_pred             EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CcEEEeeeeeeeecccCcc
Confidence            999999999998754 469999999999999999999999999999999999999644   459999999988765432 


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ......||+.|+|||++. +.++.++||||||+++|+|++|..||...........+....... ......+++.+.++|
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  275 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFL  275 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHH
Confidence            334567999999999887 568999999999999999999999998888776666555443221 122346789999999


Q ss_pred             HHccccCcCCCCCHHHHhcCCcccccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .+||..||++|||+.++++||||....
T Consensus       276 ~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          276 ERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999999998643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-47  Score=381.33  Aligned_cols=261  Identities=27%  Similarity=0.483  Sum_probs=218.7

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc------
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED------  128 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~------  128 (531)
                      ..+|++++.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+.+++.+ +||||+++++++..      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLL-KHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS-SCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc-chHHHHHHHHHHHhc-cCCCcccHhheeeccccccc
Confidence            3579999999999999999999999999999999876543322 235677899999999 89999999999876      


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          129 --DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       129 --~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                        .+..++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg  169 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFG  169 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCT
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC---CCEEEccch
Confidence              4578999999975 777766553 569999999999999999999999999999999999999644   459999999


Q ss_pred             cccccCCC-----CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC
Q 009594          206 LSVFFRPG-----EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK  278 (531)
Q Consensus       206 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  278 (531)
                      ++......     .......||+.|+|||++.+  .++.++|||||||++|+|+||.+||.+.........+........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99866422     22344678999999998863  589999999999999999999999999888887777766554444


Q ss_pred             CCCCCCC----------------------------CHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          279 RDPWPKV----------------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       279 ~~~~~~~----------------------------~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ...|+..                            ++.+.+||.+||..||++|||+.|+|+||||+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            4444332                            678999999999999999999999999999986433

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.2e-47  Score=377.42  Aligned_cols=260  Identities=32%  Similarity=0.494  Sum_probs=229.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEE
Confidence            456899999999999999999999999999999999876655566677889999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++......
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC---CCEEEeeccCceecccC
Confidence            999999999999999888889999999999999999999999999999999999999644   45999999999876532


Q ss_pred             -CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 -EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                       .......||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+.......+    ..+++.+.+
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  270 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAAS  270 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHH
Confidence             2334567999999999887 4688999999999999999999999998887776666665543322    357899999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ||.+||..||++|||+.++++||||.....
T Consensus       271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            999999999999999999999999986543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.5e-47  Score=390.98  Aligned_cols=264  Identities=28%  Similarity=0.516  Sum_probs=211.4

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--  129 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--  129 (531)
                      -.+.++|++.+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++++ +||||+++++++...  
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCC
Confidence            34567899999999999999999999999999999999654 23445567889999999999 899999999998765  


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       130 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                         ..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~~kL~DFGl  175 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ---DCSVKVCDFGL  175 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTT
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC---CCCEEEccCCC
Confidence               67999999996 599999988888999999999999999999999999999999999999964   45699999999


Q ss_pred             ccccCCCC-----------------------ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhC-------
Q 009594          207 SVFFRPGE-----------------------QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCG-------  254 (531)
Q Consensus       207 a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg-------  254 (531)
                      |+......                       .....+||+.|+|||++.  ..++.++|||||||++|+|++|       
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence            98764332                       135578999999999863  4699999999999999999984       


Q ss_pred             ----CCCCCCCC-----------------HHHHHHHHHhcc-----------------------cCCCCC----CCCCCC
Q 009594          255 ----VPPFWAET-----------------EQGVAQAIIRSV-----------------------IDFKRD----PWPKVS  286 (531)
Q Consensus       255 ----~~pf~~~~-----------------~~~~~~~~~~~~-----------------------~~~~~~----~~~~~~  286 (531)
                          .++|.+.+                 ..+....+....                       ......    .++.++
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence                44444432                 111222221110                       000000    135689


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      +.+.+||.+||..||++|||+.|+|+||||+....
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            99999999999999999999999999999987644

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-47  Score=382.76  Aligned_cols=259  Identities=27%  Similarity=0.462  Sum_probs=213.5

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC---
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  129 (531)
                      .+..+|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...   
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCcc
Confidence            35668999999999999999999999999999999986543 2344467788999999999 899999999999765   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       130 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                         ..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.   ++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  174 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---DCELKILDFGL  174 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTT
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC---CCCEEEEeeec
Confidence               3469999999 8899998866 57999999999999999999999999999999999999964   44599999999


Q ss_pred             ccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC--------
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--------  276 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------  276 (531)
                      ++....  ......+|+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+....+......        
T Consensus       175 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          175 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            987543  2345678999999998764  6899999999999999999999999998877766655432211        


Q ss_pred             ---------------CCC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          277 ---------------FKR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       277 ---------------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                     ...    ..++..++.+.+||.+||..||++|||+.++|+||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                           111    12346789999999999999999999999999999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.4e-47  Score=368.77  Aligned_cols=257  Identities=23%  Similarity=0.393  Sum_probs=216.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc----CCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----DSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~  131 (531)
                      ..|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++++ +||||+++++++..    ...
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCce
Confidence            358999999999999999999999999999999976544 344567889999999999 99999999999865    466


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      +++||||+++++|.+++.....+++..++.++.||+.||.|||+.|  |+||||||+||+++.  .++.+||+|||++..
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGGG
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeCCCccc
Confidence            8999999999999999988888999999999999999999999999  999999999999962  334699999999976


Q ss_pred             cCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      .... ......||+.|+|||++.+.++.++||||||+++|+|++|..||.................. +.......++.+
T Consensus       182 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  259 (290)
T 1t4h_A          182 KRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVAIPEV  259 (290)
T ss_dssp             CCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGCCCHHH
T ss_pred             cccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-ccccCCCCCHHH
Confidence            5433 33456799999999999888999999999999999999999999875544333322222111 111123467899


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      .++|.+||..+|++|||+.++++||||+.
T Consensus       260 ~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            99999999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.9e-48  Score=371.27  Aligned_cols=257  Identities=33%  Similarity=0.589  Sum_probs=195.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEE
Confidence            4699999999999999999999999999999999765432223357788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      |||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++...... 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN---MNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT---CCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEEEeecceeeccCCC
Confidence            9999999999999865 568999999999999999999999999999999999999644   45999999999876532 


Q ss_pred             CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                      .......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+....    ......+++.+.++
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l  242 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD----YEMPSFLSIEAKDL  242 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC----CCCCTTSCHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc----cCCccccCHHHHHH
Confidence            2233467899999999887 468899999999999999999999997765444333222111    11223578999999


Q ss_pred             HHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          293 VKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      |.+||..||++|||+.++++||||....
T Consensus       243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          243 IHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            9999999999999999999999998643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.7e-47  Score=385.24  Aligned_cols=257  Identities=28%  Similarity=0.486  Sum_probs=212.2

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCCeeecceEEEcCCeEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-HPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~  133 (531)
                      ..+|++.+.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++++.. ||||+++++++...+.++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            3469999999999999999999754 99999999976543 34456788999999999953 699999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+++    +.+||+|||++......
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~----~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS----SCEEECCCSSSCCC---
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC----CeEEEEecCccccccCC
Confidence            9999 568899999998888999999999999999999999999999999999999942    45999999999876543


Q ss_pred             Cc---cccccCCcccccchhccc------------cCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcccCC
Q 009594          214 EQ---FNEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDF  277 (531)
Q Consensus       214 ~~---~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~  277 (531)
                      ..   ....+||+.|+|||++.+            .++.++|||||||++|+|++|.+||...... .....+.......
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            32   245679999999998853            5888999999999999999999999775433 3334444332222


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       278 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ..+  ...++.+.+||.+||..||++|||+.++|+||||+...
T Consensus       288 ~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          288 EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            222  23478999999999999999999999999999998543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.7e-47  Score=374.09  Aligned_cols=257  Identities=30%  Similarity=0.558  Sum_probs=213.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--CCe
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSA  131 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~  131 (531)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...      ....+.+|+.+++++.+||||+++++++..  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            346899999999999999999999999999999998643      246788999999999669999999999987  678


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .++||||+++++|.+++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++  ..+||+|||++....
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCCTTCEECC
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC--CEEEEEeCCCceEcC
Confidence            999999999999988874   489999999999999999999999999999999999997543  259999999998877


Q ss_pred             CCCccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhc-------------cc
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRS-------------VI  275 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~-------------~~  275 (531)
                      .........||+.|+|||++.  ..++.++|||||||++|+|++|..||... ........+...             ..
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            666666778999999999876  45899999999999999999999999543 222222222110             00


Q ss_pred             CC--------------------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          276 DF--------------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       276 ~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ..                    .......+++.+.+||.+||+.||++|||+.++|+||||+...+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            00                    00111237899999999999999999999999999999987543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-47  Score=378.14  Aligned_cols=268  Identities=38%  Similarity=0.705  Sum_probs=196.6

Q ss_pred             CCCCccccceeecc-ccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           49 PSGQDISIDYDLGR-ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        49 ~~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      +....+.++|++.+ .||+|+||.||+|.+..+|+.||+|++...        ....+|+..+.++.+||||+++++++.
T Consensus        21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~   92 (336)
T 3fhr_A           21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYE   92 (336)
T ss_dssp             CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHh
Confidence            33456778999965 599999999999999999999999998643        122334444333349999999999987


Q ss_pred             c----CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEE
Q 009594          128 D----DSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       128 ~----~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                      .    ....++||||++||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++....+||
T Consensus        93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence            5    456899999999999999998754  5999999999999999999999999999999999999987666778999


Q ss_pred             EeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHH----HHHHhcccC
Q 009594          202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA----QAIIRSVID  276 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~----~~~~~~~~~  276 (531)
                      +|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.........    ..+......
T Consensus       173 ~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          173 TDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             CCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             eccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            999999865432 234567899999999886 56888999999999999999999999776554432    222233334


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCC
Q 009594          277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV  325 (531)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~  325 (531)
                      .+...+..+++.+.+||.+||..+|++|||+.++|+||||+.....+..
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~  300 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT  300 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCC
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCC
Confidence            4455567889999999999999999999999999999999876654443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.4e-47  Score=365.84  Aligned_cols=258  Identities=22%  Similarity=0.350  Sum_probs=213.5

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+..+|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+..+..+.+||||+++++++...+..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            45678999999999999999999999999999999997654333 34567888999999998999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC--------------
Q 009594          133 HIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--------------  194 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~--------------  194 (531)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+||+++.++              
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999999764    6699999999999999999999999999999999999997554              


Q ss_pred             --CCCCeEEEeeccccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHH
Q 009594          195 --ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI  270 (531)
Q Consensus       195 --~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~  270 (531)
                        ....+||+|||.+.......   ...||+.|+|||++.+  .++.++|||||||++|+|++|.+|+....   ....+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred             cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence              44569999999998765432   3458999999999875  35579999999999999999998775432   23333


Q ss_pred             HhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ......   .....+++.+.++|.+||..||++|||+.++++||||+...
T Consensus       241 ~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          241 RQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            333221   12246899999999999999999999999999999998643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.6e-47  Score=377.64  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=205.3

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC---
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS---  130 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  130 (531)
                      +..+|++.+.||+|+||.||+|++..+|+.||+|++....  .....+.+.+|+.+++++ +||||+++++++....   
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccch
Confidence            4568999999999999999999999999999999997544  233457889999999999 8999999999885433   


Q ss_pred             ------------------------------------------------------eEEEEEeccCCCchHHHHHhcCC---
Q 009594          131 ------------------------------------------------------AVHIVMELCEGGELFDRIVARGH---  153 (531)
Q Consensus       131 ------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---  153 (531)
                                                                            ..++||||+++++|.+++.....   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999987543   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-------------cccccc
Q 009594          154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-------------QFNEIV  220 (531)
Q Consensus       154 l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-------------~~~~~~  220 (531)
                      .++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.......             ......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC---CCEEEeecCcccccccchhhccccccccccccccccC
Confidence            5666789999999999999999999999999999999644   469999999998765432             123457


Q ss_pred             CCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHcccc
Q 009594          221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP  299 (531)
Q Consensus       221 gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  299 (531)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..|+..  .......+...   .....+...++.+.+||.+||+.
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL---KFPLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT---CCCHHHHHHCHHHHHHHHHHHCS
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc---CCCcccccCChhHHHHHHHHccC
Confidence            999999999887 5689999999999999999998777521  11111112111   11111234577889999999999


Q ss_pred             CcCCCCCHHHHhcCCcccc
Q 009594          300 DPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       300 ~p~~Rps~~~~l~h~~~~~  318 (531)
                      ||++|||+.++++||||++
T Consensus       313 ~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCC
T ss_pred             CCCcCCCHHHHhhchhhhc
Confidence            9999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.5e-47  Score=388.31  Aligned_cols=266  Identities=26%  Similarity=0.428  Sum_probs=216.8

Q ss_pred             CCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----CCCCeeecce
Q 009594           50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-----KHPNIVSLKD  124 (531)
Q Consensus        50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~~  124 (531)
                      .+..+..+|++++.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.+.     .|+||+++++
T Consensus        91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            3466788999999999999999999999999999999999643    233456778888888772     5779999999


Q ss_pred             EEEcCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEE
Q 009594          125 TYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       125 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                      ++...+.+++||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~  244 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVI  244 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEEC
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEe
Confidence            9999999999999996 69999887654  4899999999999999999999999999999999999975432 349999


Q ss_pred             eeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC--
Q 009594          203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR--  279 (531)
Q Consensus       203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--  279 (531)
                      |||+|.....  ......||+.|+|||++. ..++.++|||||||++|+|+||.+||.+.+..+....+.......+.  
T Consensus       245 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          245 DFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL  322 (429)
T ss_dssp             CCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9999976432  334568999999999887 56999999999999999999999999998887776655532111000  


Q ss_pred             ------------------------------------------------CC-----CCCCCHHHHHHHHHccccCcCCCCC
Q 009594          280 ------------------------------------------------DP-----WPKVSENAKDLVKKMLNPDPKQRLT  306 (531)
Q Consensus       280 ------------------------------------------------~~-----~~~~~~~~~~li~~~l~~~p~~Rps  306 (531)
                                                                      ..     ....++.+.+||.+||+.||++|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                                                            00     0123788999999999999999999


Q ss_pred             HHHHhcCCcccccccCC
Q 009594          307 AEEVLEHPWLQNAKKAP  323 (531)
Q Consensus       307 ~~~~l~h~~~~~~~~~~  323 (531)
                      +.|+|+||||+.....+
T Consensus       403 a~e~L~Hpw~~~~~~~~  419 (429)
T 3kvw_A          403 PGQALRHPWLRRRLPKP  419 (429)
T ss_dssp             HHHHHTSTTTC------
T ss_pred             HHHHhCChhhccCCCCC
Confidence            99999999999765443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=378.49  Aligned_cols=262  Identities=28%  Similarity=0.442  Sum_probs=213.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChh--hHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV--DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++.........  ....+.+|+.+++++ +||||+++++++...+.
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCc
Confidence            346799999999999999999999999999999999754322111  124677899999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++||||+++ +|..++.... .+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++...
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---GVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC---CCEEEEecccceec
Confidence            9999999976 8888886643 58999999999999999999999999999999999999644   46999999999876


Q ss_pred             CCC-CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----
Q 009594          211 RPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW-----  282 (531)
Q Consensus       211 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----  282 (531)
                      ... .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.........+...........|     
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            433 23445678999999998863  4788999999999999999999999998887777776654322222211     


Q ss_pred             -------------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          283 -------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       283 -------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                         ..+++.+.+||.+||..||++|||+.|+|+||||++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                               34578999999999999999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.9e-47  Score=365.62  Aligned_cols=260  Identities=31%  Similarity=0.532  Sum_probs=219.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      +..+|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEE
Confidence            456799999999999999999999999999999999765432  2357788999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC---CCEEEeeCCCccccCCC
Confidence            999999999999999877789999999999999999999999999999999999999644   45999999999765432


Q ss_pred             C---ccccccCCcccccchhccc-c-CCCccchhHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhcccCCCCCCCCCCCH
Q 009594          214 E---QFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       214 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      .   ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||....... .........  .....+..+++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  236 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDS  236 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC--TTSTTGGGSCH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc--cccCchhhcCH
Confidence            2   2345678999999999874 3 4678999999999999999999997765432 222222221  12233467899


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .+.+||.+||..+|++|||+.++++||||+....
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            9999999999999999999999999999987544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.6e-47  Score=376.54  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=215.6

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++++ +||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEE
Confidence            3479999999999999999999999999999999875532 333456678999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      ||||+++++|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++...... 
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCTTC-------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC---CcEEEEeCCCceeecCCc
Confidence            99999999999888777789999999999999999999999999999999999999644   46999999999765433 


Q ss_pred             CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC--------------
Q 009594          214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--------------  277 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------------  277 (531)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.........+.......              
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            23345678999999998874  58899999999999999999999999888766655544321110              


Q ss_pred             ---CC----------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          278 ---KR----------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       278 ---~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                         ..          ..++.+++.+.+||.+||..||++|||+.|+|+||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence               00          0123578999999999999999999999999999999753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.5e-47  Score=389.28  Aligned_cols=259  Identities=29%  Similarity=0.488  Sum_probs=213.1

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--  128 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--  128 (531)
                      ......+|++.+.||+|+||.||+|++..+|+.||||++.....       ...+|+.+++.+ +||||+++++++..  
T Consensus        49 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l-~hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSSG  120 (420)
T ss_dssp             CCCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTC-CCTTBCCEEEEEEEEE
T ss_pred             CCcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHc-CCCCccceeeEEeccC
Confidence            34556689999999999999999999999999999999865421       123699999999 99999999998843  


Q ss_pred             ----CCeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeE
Q 009594          129 ----DSAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK  200 (531)
Q Consensus       129 ----~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ik  200 (531)
                          ...+++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++  ..+|
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--~~~k  197 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLK  197 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT--TEEE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC--CeEE
Confidence                2247799999976 6655553    346799999999999999999999999999999999999997432  3589


Q ss_pred             EEeeccccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC--
Q 009594          201 AIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--  276 (531)
Q Consensus       201 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--  276 (531)
                      |+|||+++............||+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+....+.+....  
T Consensus       198 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~  277 (420)
T 1j1b_A          198 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  277 (420)
T ss_dssp             ECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             eccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999987766555566789999999998863  6899999999999999999999999998877766665542110  


Q ss_pred             ---------------CC---CCCC-----CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          277 ---------------FK---RDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       277 ---------------~~---~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                     ++   ...|     +.+++++.+||.+||.+||.+|||+.|+++||||+...
T Consensus       278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                           00   0111     34689999999999999999999999999999998654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6e-47  Score=382.48  Aligned_cols=256  Identities=29%  Similarity=0.484  Sum_probs=212.7

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-----  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-----  128 (531)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++......       ..+|+.+++.+ +||||+++++++..     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVL-DHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTC-CCTTBCCEEEEEEEC----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHc-CCCCccchhheeeecCccc
Confidence            456799999999999999999999999999999998654321       23699999999 99999999999843     


Q ss_pred             ---------------------------------CCeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 009594          129 ---------------------------------DSAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVVQ  171 (531)
Q Consensus       129 ---------------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~l~  171 (531)
                                                       ...+++||||+++ +|.+.+.    ....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             3458999999985 7766654    3567999999999999999999


Q ss_pred             HHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHH
Q 009594          172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILY  249 (531)
Q Consensus       172 ~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~  249 (531)
                      |||++||+||||||+|||++..  ++.+||+|||+|.............||+.|+|||++.+  .++.++|||||||++|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSK--DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETT--TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCC--CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            9999999999999999999732  34599999999998766666667789999999998764  4899999999999999


Q ss_pred             HHhhCCCCCCCCCHHHHHHHHHhcccCC-----------------C---CCC-----CCCCCHHHHHHHHHccccCcCCC
Q 009594          250 ILLCGVPPFWAETEQGVAQAIIRSVIDF-----------------K---RDP-----WPKVSENAKDLVKKMLNPDPKQR  304 (531)
Q Consensus       250 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~-----------------~---~~~-----~~~~~~~~~~li~~~l~~~p~~R  304 (531)
                      +|++|.+||.+.+..+....+.+.....                 +   ...     ...+++.+.+||.+||..+|++|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            9999999999988877776665422111                 0   000     12478899999999999999999


Q ss_pred             CCHHHHhcCCcccccc
Q 009594          305 LTAEEVLEHPWLQNAK  320 (531)
Q Consensus       305 ps~~~~l~h~~~~~~~  320 (531)
                      ||+.|+|+||||+...
T Consensus       314 ~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          314 INPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CCHHHHHTSGGGHHHH
T ss_pred             CCHHHHhcCHHHHHHH
Confidence            9999999999998653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-47  Score=380.69  Aligned_cols=259  Identities=27%  Similarity=0.464  Sum_probs=201.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC---
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  129 (531)
                      .+..+|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...   
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL  103 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcc
Confidence            34568999999999999999999999999999999986542 3344567788999999999 899999999998653   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       130 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                         ...++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||+
T Consensus       104 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~---~~~~kL~DFG~  178 (367)
T 2fst_X          104 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILDFGL  178 (367)
T ss_dssp             GGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEECC---
T ss_pred             ccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC---CCCEEEeeccc
Confidence               5689999999 7899998865 57999999999999999999999999999999999999964   44699999999


Q ss_pred             ccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-------
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-------  277 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------  277 (531)
                      ++....  ......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+.......+.+.....       
T Consensus       179 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          179 ARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            986543  2345679999999998764  68999999999999999999999999988777666655422111       


Q ss_pred             ----------------CCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          278 ----------------KRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       278 ----------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                      +..    .++..++.+.+||.+||..||++|||+.++|+||||+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                            111    1245688999999999999999999999999999998654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=377.44  Aligned_cols=260  Identities=23%  Similarity=0.379  Sum_probs=213.5

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  130 (531)
                      ..+..+|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++++ +||||+++++++.... 
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCCcceEEEEeecCCC
Confidence            45667899999999999999999999999999999999754432  2356778999999999 8999999999988654 


Q ss_pred             -eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeec-CCCCCCeEEEeec
Q 009594          131 -AVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFAN-KKESSPLKAIDFG  205 (531)
Q Consensus       131 -~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~-~~~~~~ikl~Dfg  205 (531)
                       ..++||||+++++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+.. .+....+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence             78999999999999999976433   899999999999999999999999999999999999832 2334569999999


Q ss_pred             cccccCCCCccccccCCcccccchhcc---------ccCCCccchhHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHh
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIR  272 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~  272 (531)
                      ++.............||+.|+|||++.         ..++.++|||||||++|+|+||..||....    .......+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            999877666666678999999999874         468899999999999999999999996433    2333444443


Q ss_pred             cccCC-------------------CC--CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCC
Q 009594          273 SVIDF-------------------KR--DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP  314 (531)
Q Consensus       273 ~~~~~-------------------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~  314 (531)
                      .....                   +.  .....+++.+.++|.+||+.||++|||+.|+|+||
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            32210                   00  00112356789999999999999999999999997

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.4e-47  Score=381.06  Aligned_cols=257  Identities=27%  Similarity=0.431  Sum_probs=204.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC---
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS---  130 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  130 (531)
                      +..+|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++++++....   
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccc
Confidence            4568999999999999999999999999999999997543 2344557788999999999 9999999999997654   


Q ss_pred             ---eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          131 ---AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       131 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                         ..++||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++
T Consensus       101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~a  174 (371)
T 2xrw_A          101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLA  174 (371)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCCCC-
T ss_pred             cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---CCEEEEEeecc
Confidence               78999999975 7888775  458999999999999999999999999999999999999644   45999999999


Q ss_pred             cccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC--------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--------  278 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------  278 (531)
                      .............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+........        
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            8765544445678999999999887 5689999999999999999999999999887776666654321110        


Q ss_pred             ---------CCCC--------------C-------CCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          279 ---------RDPW--------------P-------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       279 ---------~~~~--------------~-------~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                               .+.+              +       ..++.+.+||.+||..||++|||+.++|+||||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                     0000              0       01467899999999999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.6e-47  Score=379.19  Aligned_cols=266  Identities=25%  Similarity=0.395  Sum_probs=221.0

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..+....++|++.+.||+|+||.||+|.+..++..||+|++....  .......+.+|+.+++++ +||||+++++++..
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  102 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS  102 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEE
Confidence            445677789999999999999999999999999999999997642  344467889999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      .+..++||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+||+++.+   +.+||+|||++
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~  179 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVS  179 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---CCEEECCCCCC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC---CCEEEEECCCC
Confidence            999999999999999999999888899999999999999999999996 99999999999999654   45999999998


Q ss_pred             cccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHH---------------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII---------------  271 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~---------------  271 (531)
                      ...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.               
T Consensus       180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          180 GQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             cccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            754321 223457899999999887 568999999999999999999999998766544322211               


Q ss_pred             -----------------------hccc--CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          272 -----------------------RSVI--DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       272 -----------------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                             ....  .....+...+++.+.+||.+||..||++|||+.++|+||||+....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence                                   0000  0111112347889999999999999999999999999999986543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-46  Score=377.72  Aligned_cols=259  Identities=28%  Similarity=0.474  Sum_probs=216.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  129 (531)
                      +..+|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++++ +||||+++++++...    
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTT
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccc
Confidence            3468999999999999999999999999999999996432  344457788999999999 899999999998654    


Q ss_pred             -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 -SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                       ...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.
T Consensus       102 ~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~  176 (364)
T 3qyz_A          102 MKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLAR  176 (364)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCE
T ss_pred             cceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC---CCEEEEeCcceE
Confidence             46999999997 599998865 469999999999999999999999999999999999999644   459999999998


Q ss_pred             ccCCCCc----cccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC----
Q 009594          209 FFRPGEQ----FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK----  278 (531)
Q Consensus       209 ~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~----  278 (531)
                      .......    .....||+.|+|||++.  ..++.++|||||||++|+|++|.+||.+....+....+........    
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            7654322    23457999999999865  3489999999999999999999999988877666665543221110    


Q ss_pred             -------------------CC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          279 -------------------RD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       279 -------------------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                         ..    .++.+++.+.+||.+||..||++|||+.++|+||||+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                               00    1245789999999999999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.4e-46  Score=363.42  Aligned_cols=258  Identities=27%  Similarity=0.458  Sum_probs=222.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ....|++.+.||+|+||.||+|.+..+++.||+|++......  .....+.+|+.+++.+ +||||+++++++......+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEE
Confidence            455799999999999999999999999999999999765432  3467889999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++......
T Consensus        97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECBTT
T ss_pred             EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC---CCEEEeecccceecCcc
Confidence            99999999999998854 579999999999999999999999999999999999999644   45999999999876543


Q ss_pred             C-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 E-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      . ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.....   ......+++.+.+
T Consensus       173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~  249 (303)
T 3a7i_A          173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKE  249 (303)
T ss_dssp             BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCCSSCCHHHHH
T ss_pred             ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC---CCCccccCHHHHH
Confidence            3 234567899999999887 5688999999999999999999999988877666555544322   1223468999999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ||.+||..+|++|||+.++++||||.....
T Consensus       250 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          250 FVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             HHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence            999999999999999999999999976443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=373.11  Aligned_cols=257  Identities=28%  Similarity=0.469  Sum_probs=208.7

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC--CCeeecceEEEcCCe
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH--PNIVSLKDTYEDDSA  131 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~  131 (531)
                      ...+|++.+.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+++++ .|  |||+++++++...+.
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEECSSE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEeeCCE
Confidence            345799999999999999999997 5689999999976543 344567889999999999 55  999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .++|||+ .+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+++    +.+||+|||++....
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~----~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCCC-
T ss_pred             EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC----CcEEEeecccccccC
Confidence            9999995 57899999999888999999999999999999999999999999999999952    359999999998765


Q ss_pred             CCCc---cccccCCcccccchhcc------------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhccc
Q 009594          212 PGEQ---FNEIVGSPYYMAPEVLK------------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVI  275 (531)
Q Consensus       212 ~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~  275 (531)
                      ....   .....||+.|+|||++.            +.++.++|||||||++|+|++|..||...... .....+.....
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  238 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  238 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence            4332   23567999999999874            45788999999999999999999999775433 22223322211


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ..  ......++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus       239 ~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          239 EI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             CC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cc--CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            11  11234578999999999999999999999999999998543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-47  Score=380.78  Aligned_cols=258  Identities=31%  Similarity=0.583  Sum_probs=214.0

Q ss_pred             ccceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ..+|++.+.||+|+||.||+|++.   .+++.||+|++...... .......+.+|+.+++++..||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            368999999999999999999984   48999999998754321 11123456679999999977999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TSCEEESCSSEEEEC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCcEEEeeCCCCeec
Confidence            99999999999999999988888999999999999999999999999999999999999964   446999999999865


Q ss_pred             CCCC--ccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCH----HHHHHHHHhcccCCCCCC
Q 009594          211 RPGE--QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       211 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~  281 (531)
                      ....  ......||+.|+|||++.+   .++.++|||||||++|+|++|..||.....    ......+....    ...
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~  285 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----PPY  285 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----CCC
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC----CCC
Confidence            4322  2334679999999999873   478899999999999999999999965432    23333333322    222


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      ...+++.+.+||.+||..||++||     |+.++++||||+..
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            356889999999999999999999     99999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-47  Score=380.63  Aligned_cols=265  Identities=25%  Similarity=0.465  Sum_probs=222.2

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhh--------------HHHHHHHHHHHHhCC
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD--------------IEDVRREVQIMKHLP  114 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l~  114 (531)
                      ..+....++|++.+.||+|+||.||+|.+  +|+.||+|++..........              ...+.+|+.+++++ 
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  100 (348)
T 2pml_X           24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-  100 (348)
T ss_dssp             SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-
T ss_pred             hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-
Confidence            33455667899999999999999999997  89999999997654332211              27888999999999 


Q ss_pred             CCCCeeecceEEEcCCeEEEEEeccCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCC
Q 009594          115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDR------IVA--RGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKP  185 (531)
Q Consensus       115 ~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp  185 (531)
                      +||||+++++++...+..++||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||
T Consensus       101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p  180 (348)
T 2pml_X          101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP  180 (348)
T ss_dssp             CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred             CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence            899999999999999999999999999999998      655  5679999999999999999999999 9999999999


Q ss_pred             CceEeecCCCCCCeEEEeeccccccCCCCccccccCCcccccchhccc--cCCC-ccchhHHHHHHHHHhhCCCCCCCCC
Q 009594          186 ENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGP-EVDVWSAGVILYILLCGVPPFWAET  262 (531)
Q Consensus       186 ~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~-~~Di~slG~il~~l~tg~~pf~~~~  262 (531)
                      +||+++.+   +.+||+|||++...... ......||+.|+|||++.+  .++. ++||||||+++|+|++|..||....
T Consensus       181 ~Nil~~~~---~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          181 SNILMDKN---GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGEEECTT---SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HhEEEcCC---CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999644   45999999999876443 3445679999999999874  3555 8999999999999999999998877


Q ss_pred             H-HHHHHHHHhcccCCCCCC---------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          263 E-QGVAQAIIRSVIDFKRDP---------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       263 ~-~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      . ......+.......+...               ...+++.+.+||.+||..+|++|||+.++++||||+...
T Consensus       257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             CSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            6 556666655443333210               146789999999999999999999999999999998643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.8e-47  Score=384.58  Aligned_cols=262  Identities=26%  Similarity=0.498  Sum_probs=198.1

Q ss_pred             Cccccceee-ccccCccCceEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE-
Q 009594           52 QDISIDYDL-GRELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-  127 (531)
Q Consensus        52 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-  127 (531)
                      ..+.+.|++ .++||+|+||.||+|.+.  .+++.||+|++.....     ...+.+|+.+++++ +||||+++++++. 
T Consensus        16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l-~hpniv~~~~~~~~   89 (405)
T 3rgf_A           16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLREL-KHPNVISLQKVFLS   89 (405)
T ss_dssp             CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHC-CCTTBCCCCEEEEE
T ss_pred             hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhc-CCCCeeeEeeEEec
Confidence            456667887 457999999999999965  5789999999965432     24677899999999 8999999999995 


Q ss_pred             -cCCeEEEEEeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC-CCC
Q 009594          128 -DDSAVHIVMELCEGGELFDRIVAR---------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-KES  196 (531)
Q Consensus       128 -~~~~~~lv~e~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~-~~~  196 (531)
                       ....+++||||+. ++|.+++...         ..+++..++.|+.||+.||.|||++||+||||||+|||+... ...
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred             CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence             4678999999996 5888777532         248999999999999999999999999999999999999643 345


Q ss_pred             CCeEEEeeccccccCCC----CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHH------
Q 009594          197 SPLKAIDFGLSVFFRPG----EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ------  264 (531)
Q Consensus       197 ~~ikl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~------  264 (531)
                      +.+||+|||+|......    .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....      
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            67999999999876532    22345678999999998874  4899999999999999999999999765542      


Q ss_pred             ---HHHHHHHhcccCCCCCCCC----------------------------------CCCHHHHHHHHHccccCcCCCCCH
Q 009594          265 ---GVAQAIIRSVIDFKRDPWP----------------------------------KVSENAKDLVKKMLNPDPKQRLTA  307 (531)
Q Consensus       265 ---~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~li~~~l~~~p~~Rps~  307 (531)
                         +....+...........|.                                  ..++.+.+||.+||..||++|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence               3344443332222222222                                  126788999999999999999999


Q ss_pred             HHHhcCCcccccc
Q 009594          308 EEVLEHPWLQNAK  320 (531)
Q Consensus       308 ~~~l~h~~~~~~~  320 (531)
                      .|+|+||||+...
T Consensus       329 ~e~L~hp~f~~~~  341 (405)
T 3rgf_A          329 EQAMQDPYFLEDP  341 (405)
T ss_dssp             HHHHTSGGGTSSS
T ss_pred             HHHhcChhhccCC
Confidence            9999999998643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.6e-48  Score=389.80  Aligned_cols=250  Identities=16%  Similarity=0.217  Sum_probs=202.7

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCCeeecc-------eE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLK-------DT  125 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~-------~~  125 (531)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.  +||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            468999999999999999999998899999999998665545556788999995555443  899999998       66


Q ss_pred             EEcCC-----------------eEEEEEeccCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCeec
Q 009594          126 YEDDS-----------------AVHIVMELCEGGELFDRIVARGHYTE-------RAAAAVMKTIVEVVQVCHEQGVMHR  181 (531)
Q Consensus       126 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~qi~~~l~~LH~~~iiH~  181 (531)
                      +...+                 ..|+||||+ +|+|.+++...+.+++       ..++.|+.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            66553                 389999999 6799999987555555       7888899999999999999999999


Q ss_pred             CCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccCCcccccchhcc-c-----------cCCCccchhHHHHHHH
Q 009594          182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-R-----------NYGPEVDVWSAGVILY  249 (531)
Q Consensus       182 Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----------~~~~~~Di~slG~il~  249 (531)
                      ||||+|||++.+   +.+||+|||+|....  .......| +.|+|||++. .           .++.++|||||||++|
T Consensus       231 Dikp~NIll~~~---~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          231 YLRPVDIVLDQR---GGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CCCGGGEEECTT---CCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCC---CCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            999999999654   469999999998643  23445677 9999999887 4           5899999999999999


Q ss_pred             HHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          250 ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       250 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +|+||..||.+.........        ....++.+++.+.+||.+||..||++|||+.++++||||+..
T Consensus       305 elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEW--------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHSSCCC------CCSGG--------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHCCCCCcccccccchhh--------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            99999999966543221111        112235789999999999999999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.7e-46  Score=362.13  Aligned_cols=261  Identities=25%  Similarity=0.321  Sum_probs=198.9

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+..+...++.+ +||||+++++++...+..
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCE
Confidence            345689999999999999999999999999999999965432 122223333444446666 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          133 HIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      ++||||+++ +|.+++..    ...+++..++.++.|++.||.|||++ ||+||||||+||+++.+   +.+||+|||++
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~  157 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL---GQVKMCDFGIS  157 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT---CCEEBCCC---
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC---CCEEEeecCCc
Confidence            999999975 88776643    46799999999999999999999998 99999999999999643   45999999999


Q ss_pred             cccCCCCccccccCCcccccchhcc-----ccCCCccchhHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhcccCCCCCC
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~  281 (531)
                      .............||+.|+|||++.     ..++.++||||||+++|+|+||..||... ..............  ....
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~  235 (290)
T 3fme_A          158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQLP  235 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCCC
T ss_pred             ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCcc
Confidence            8776555555567999999999862     45888999999999999999999999763 33333333333322  2222


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ...+++.+.++|.+||+.+|++|||+.++++||||+....
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~  275 (290)
T 3fme_A          236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES  275 (290)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence            3468999999999999999999999999999999986544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-46  Score=366.38  Aligned_cols=259  Identities=26%  Similarity=0.468  Sum_probs=213.8

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc---
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED---  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  128 (531)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++.....    ....+.+|+.+++++.+||||+++++++..   
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            4466789999999999999999999999999999999975432    236788999999999789999999999876   


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEe
Q 009594          129 ---DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       129 ---~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                         .+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~---~~~~kl~D  172 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE---NAEVKLVD  172 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT---TCCEEECC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC---CCCEEEee
Confidence               56899999999999999999764  46899999999999999999999999999999999999964   44599999


Q ss_pred             eccccccCCCC-ccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 009594          204 FGLSVFFRPGE-QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       204 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      ||++....... ......||+.|+|||++.      ..++.++|||||||++|+|++|..||...........+......
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            99988654322 234457899999999874      35889999999999999999999999888776665555443221


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                        ......+++.+.+||.+||..+|++|||+.++++||||+..
T Consensus       253 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          253 --RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             --CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             --cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence              22234679999999999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3e-46  Score=365.08  Aligned_cols=262  Identities=29%  Similarity=0.472  Sum_probs=217.0

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      +.....+|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+|+.+++.+ +||||+++++++...+
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATC-DHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCC
Confidence            3456778999999999999999999999999999999986543   23457888999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          131 AVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++..
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE---GDIRLADFGVSAK  166 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---SCEEECCCHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC---CCEEEEECCCCcc
Confidence            99999999999999998875 4569999999999999999999999999999999999999644   4599999998754


Q ss_pred             cCCC-CccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          210 FRPG-EQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       210 ~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      .... .......||+.|+|||++.      ..++.++||||||+++|+|++|..||...........+....... ....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~  245 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTP  245 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSG
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCc
Confidence            3211 1223457899999999873      458889999999999999999999999888776666665543221 1122


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ..++..+.++|.+||..+|++|||+.++++||||+...
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            45789999999999999999999999999999998654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-46  Score=372.63  Aligned_cols=266  Identities=30%  Similarity=0.478  Sum_probs=219.7

Q ss_pred             CCCCCccccceeeccccCccCceEEEEEEE-ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC------Cee
Q 009594           48 EPSGQDISIDYDLGRELGRGEFGVTYLCTD-VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP------NIV  120 (531)
Q Consensus        48 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~------niv  120 (531)
                      ...|+.+..+|++.+.||+|+||.||+|.+ ..+++.||+|++...    ......+.+|+.+++.+ .|+      +|+
T Consensus         6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~   80 (339)
T 1z57_A            6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHL-NTTDPNSTFRCV   80 (339)
T ss_dssp             CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHH-HHHCTTCTTCBC
T ss_pred             eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHh-hhcCCCCceeeE
Confidence            356778889999999999999999999998 568899999998643    23456788899999988 555      499


Q ss_pred             ecceEEEcCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC---
Q 009594          121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE---  195 (531)
Q Consensus       121 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~---  195 (531)
                      ++++++...+..++||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++..+.   
T Consensus        81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  159 (339)
T 1z57_A           81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA  159 (339)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred             eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence            9999999999999999999 889999998765  5899999999999999999999999999999999999975331   


Q ss_pred             -------------CCCeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCC
Q 009594          196 -------------SSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE  261 (531)
Q Consensus       196 -------------~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~  261 (531)
                                   +..+||+|||++.....  ......||+.|+|||++. ..++.++|||||||++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          160 YNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             EC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                         45699999999986543  234567899999999887 47899999999999999999999999988


Q ss_pred             CHHHHHHHHHhcccCCCC----------------CCC------------------------CCCCHHHHHHHHHccccCc
Q 009594          262 TEQGVAQAIIRSVIDFKR----------------DPW------------------------PKVSENAKDLVKKMLNPDP  301 (531)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~----------------~~~------------------------~~~~~~~~~li~~~l~~~p  301 (531)
                      +..+....+.+.....+.                ..|                        ...++.+.+||.+||..||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            776655544332211110                001                        1234678999999999999


Q ss_pred             CCCCCHHHHhcCCccccccc
Q 009594          302 KQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       302 ~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .+|||+.|+++||||+...+
T Consensus       318 ~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          318 AKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             TTSCCHHHHTTSGGGGGGGC
T ss_pred             ccccCHHHHhcCHHHHHHhc
Confidence            99999999999999986543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.3e-46  Score=364.74  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=209.7

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ......+|++.+.||+|+||.||+|.+  +|+.||+|++..... .......+.+|+.+++++ +||||+++++++...+
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTT
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECC
Confidence            345566899999999999999999985  688999999976543 344467888999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          131 AVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                      ..++||||+++++|.+++...+.   +++..++.++.||+.||.|||++|  |+||||||+||+++.   ++.+||+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg  184 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK---KYTVKVCDFG  184 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT---TCCEEECCCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC---CCcEEECCCC
Confidence            99999999999999999987553   899999999999999999999999  999999999999964   4469999999


Q ss_pred             cccccCCCC-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          206 LSVFFRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       206 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      ++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+........  ...
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~  262 (309)
T 3p86_A          185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPR  262 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--CCT
T ss_pred             CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCc
Confidence            997654332 234567999999999987 4689999999999999999999999998887776665543332222  224


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhc--CCccccc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLE--HPWLQNA  319 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~--h~~~~~~  319 (531)
                      .+++.+.+||.+||..+|.+|||+.++++  +++++..
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            68999999999999999999999999987  4555543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.7e-46  Score=377.59  Aligned_cols=263  Identities=27%  Similarity=0.424  Sum_probs=216.7

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCC-----eeecc
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN-----IVSLK  123 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-----iv~l~  123 (531)
                      ..+..+.++|++.+.||+|+||+||+|.+..+++.||+|++...    ......+.+|+.+++.+..|++     |++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            44667788999999999999999999999999999999999643    2335667789999988855664     99999


Q ss_pred             eEEEcCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCceEeecCCCCCCe
Q 009594          124 DTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCH--EQGVMHRDLKPENFLFANKKESSPL  199 (531)
Q Consensus       124 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH--~~~iiH~Dlkp~NIll~~~~~~~~i  199 (531)
                      +++...+..++||||++ ++|.+++...  ..+++..++.++.|++.||.|||  +.||+||||||+|||++.+ ..+.+
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~-~~~~~  200 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP-KRSAI  200 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-TSCCE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-CCCcE
Confidence            99999999999999996 5999998765  35899999999999999999999  5799999999999999643 24569


Q ss_pred             EEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC
Q 009594          200 KAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK  278 (531)
Q Consensus       200 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  278 (531)
                      ||+|||+|.....  ......||+.|+|||++. ..++.++|||||||++|+|+||.+||.+.+..+....+.......+
T Consensus       201 kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          201 KIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             EECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999999987643  234568999999999887 4689999999999999999999999999888777766654321110


Q ss_pred             ------------------CCCC-----------------CC-------------------------CCHHHHHHHHHccc
Q 009594          279 ------------------RDPW-----------------PK-------------------------VSENAKDLVKKMLN  298 (531)
Q Consensus       279 ------------------~~~~-----------------~~-------------------------~~~~~~~li~~~l~  298 (531)
                                        ...|                 ..                         .++.+.+||.+||+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence                              0000                 00                         01378999999999


Q ss_pred             cCcCCCCCHHHHhcCCccccc
Q 009594          299 PDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       299 ~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .||++|||+.|+|+||||+..
T Consensus       359 ~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGGCC-
T ss_pred             CChhhCCCHHHHhcCcccccC
Confidence            999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=375.60  Aligned_cols=260  Identities=22%  Similarity=0.258  Sum_probs=220.0

Q ss_pred             CccccceeeccccCccCceEEEEEE-----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY  126 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  126 (531)
                      .....+|++.+.||+|+||.||+|.     +..++..||+|++....  .......+.+|+.+++++ +||||+++++++
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  143 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQNIVRCIGVS  143 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhC-CCCCCCeEEEEE
Confidence            4456789999999999999999999     44577899999986432  344456788999999999 999999999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCe
Q 009594          127 EDDSAVHIVMELCEGGELFDRIVARG-------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL  199 (531)
Q Consensus       127 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~i  199 (531)
                      ......++||||++||+|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.++....+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99999999999999999999997643       48999999999999999999999999999999999999876666779


Q ss_pred             EEEeeccccccCCC---CccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcc
Q 009594          200 KAIDFGLSVFFRPG---EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV  274 (531)
Q Consensus       200 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  274 (531)
                      ||+|||+|+.....   .......||+.|+|||++. +.++.++|||||||++|+|+| |..||...........+....
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999754221   2223456799999999886 678999999999999999998 999999988877777666543


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      ..   .....+++.+.+||.+||+.+|++|||+.+++++.++-
T Consensus       304 ~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          304 RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            22   22346899999999999999999999999999997764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7e-46  Score=366.53  Aligned_cols=264  Identities=27%  Similarity=0.439  Sum_probs=217.1

Q ss_pred             ccccceeeccccCccCceEEEEEEEc-cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCCeeecceEEE--
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYE--  127 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~--  127 (531)
                      ....+|++.+.||+|+||.||+|.+. .+|+.||+|++........ ....+.+|+.+++.+.  +||||+++++++.  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            34568999999999999999999985 6789999999975443221 1234556777666553  7999999999987  


Q ss_pred             ---cCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEE
Q 009594          128 ---DDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       128 ---~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                         .....++||||++ ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~---~~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEEC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC---CCEEEe
Confidence               5677999999997 59999987753  48999999999999999999999999999999999999654   459999


Q ss_pred             eeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC---
Q 009594          203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK---  278 (531)
Q Consensus       203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---  278 (531)
                      |||++.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.........+........   
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            999998765544455677899999999886 5689999999999999999999999999888777766654221110   


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          279 --------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       279 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                          ...++.+++.+.+||.+||..||++|||+.++++||||+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                0112457899999999999999999999999999999987654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=362.65  Aligned_cols=259  Identities=27%  Similarity=0.470  Sum_probs=214.0

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .....+|++.+.||+|+||.||+|.+..+|+.||+|++....     ....+.+|+.+++++ +||||+++++++...+.
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCE
Confidence            445668999999999999999999999999999999997543     236788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++||||+++++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+||+++.+   +.+||+|||++...
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~  175 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE---GHAKLADFGVAGQL  175 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEEC
T ss_pred             EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC---CCEEEeecccchhh
Confidence            999999999999999986 45679999999999999999999999999999999999999654   45999999999766


Q ss_pred             CCCC-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          211 RPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       211 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      .... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+...... .......+++.
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  254 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDN  254 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHH
T ss_pred             hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHH
Confidence            5432 234567899999999887 46899999999999999999999999887766555444333211 11112347899


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      +.+||.+||..+|.+|||+.++++||||+...
T Consensus       255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            99999999999999999999999999998654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-45  Score=369.46  Aligned_cols=263  Identities=33%  Similarity=0.492  Sum_probs=216.5

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC-
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-  129 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-  129 (531)
                      +..+..+|++.+.||+|+||.||+|.+..+|+.||+|++...  ........+.+|+.+++++ +||||+++++++... 
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHF-KHENIITIFNIQRPDS   82 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSC
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccc
Confidence            455778899999999999999999999999999999999643  2344456788999999999 899999999987653 


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          130 ----SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       130 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                          ...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg  157 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFG  157 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TCCEEECCCT
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC---CCcEEEEecc
Confidence                67999999997 589988866 47999999999999999999999999999999999999964   4459999999


Q ss_pred             cccccCCCCc-----------cccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 009594          206 LSVFFRPGEQ-----------FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR  272 (531)
Q Consensus       206 ~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~  272 (531)
                      ++........           .....||+.|+|||++.  ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            9986643211           22357899999999875  4688999999999999999999999998876665544432


Q ss_pred             cccCC------------------------CCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          273 SVIDF------------------------KRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       273 ~~~~~------------------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      .....                        ...    .++.+++.+.+||.+||..||++|||+.++++||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            21110                        000    12467899999999999999999999999999999987543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-46  Score=367.69  Aligned_cols=263  Identities=29%  Similarity=0.496  Sum_probs=197.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++++ +||||+++++++...+..
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCC-CCTTBCCEEEEEESSSCE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCc
Confidence            445689999999999999999999888999999999865432  22346788899999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          133 HIVMELCEGGELFDRIVA--------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      ++||||+++++|.+++..        ...+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED---GSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---CCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC---CCEEEEec
Confidence            999999999999999864        3458999999999999999999999999999999999999644   45999999


Q ss_pred             ccccccCCCC------ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 009594          205 GLSVFFRPGE------QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       205 g~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      |++.......      ......||+.|+|||++.  ..++.++||||||+++|+|++|..||..................
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            9987654322      123457899999999886  36899999999999999999999999887766555444433221


Q ss_pred             CC------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          277 FK------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       277 ~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ..      ......+++.+.++|.+||..||.+|||+.++++||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            11      1123467899999999999999999999999999999987544

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.6e-46  Score=378.85  Aligned_cols=262  Identities=24%  Similarity=0.425  Sum_probs=210.0

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-------CCCCeee
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-------KHPNIVS  121 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~h~niv~  121 (531)
                      ..|+.+.++|++.+.||+|+||.||+|++..+++.||+|++...    ......+.+|+.+++.+.       .||||++
T Consensus        30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            44677888999999999999999999999999999999999643    334567889999999983       2888999


Q ss_pred             cceEEE----cCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCC
Q 009594          122 LKDTYE----DDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKK  194 (531)
Q Consensus       122 l~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~  194 (531)
                      +++++.    .....++||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            999987    567899999999 56776666554  4599999999999999999999998 999999999999997543


Q ss_pred             ----------------------------------------------CCCCeEEEeeccccccCCCCccccccCCcccccc
Q 009594          195 ----------------------------------------------ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP  228 (531)
Q Consensus       195 ----------------------------------------------~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  228 (531)
                                                                    ....+||+|||+|......  .....||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP  262 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence                                                          1136999999999876432  3456799999999


Q ss_pred             hhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC------HHHHHHHHHhcccCCCC----------------------
Q 009594          229 EVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET------EQGVAQAIIRSVIDFKR----------------------  279 (531)
Q Consensus       229 E~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~------~~~~~~~~~~~~~~~~~----------------------  279 (531)
                      |++. ..++.++|||||||++|+|+||..||...+      .......+.......+.                      
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            9887 468999999999999999999999997654      22222222221111000                      


Q ss_pred             ---CC-------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          280 ---DP-------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       280 ---~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                         .+             ....++.+.+||.+||+.||++|||+.|+|+||||+
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence               00             012345788999999999999999999999999996

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8e-46  Score=372.49  Aligned_cols=258  Identities=29%  Similarity=0.493  Sum_probs=212.9

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...+..
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSL  116 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSS
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCc
Confidence            46678999999999999999999999999999999997543 2344467788999999999 899999999999876654


Q ss_pred             ------EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          133 ------HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       133 ------~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                            ++||||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+
T Consensus       117 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kL~Dfg~  190 (371)
T 4exu_A          117 RNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---CELKILDFGL  190 (371)
T ss_dssp             TTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECSTTC
T ss_pred             ccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC---CCEEEEecCc
Confidence                  99999997 58887763  359999999999999999999999999999999999999644   4599999999


Q ss_pred             ccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-------
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-------  277 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------  277 (531)
                      +.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......       
T Consensus       191 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          191 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            986543  2345678999999998864  68999999999999999999999999888777666654321110       


Q ss_pred             ----------------CCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          278 ----------------KRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       278 ----------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                      ...    .++.+++.+.+||.+||+.||++|||+.++|+||||+...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                            111    1245789999999999999999999999999999998643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=366.66  Aligned_cols=263  Identities=30%  Similarity=0.463  Sum_probs=213.0

Q ss_pred             CCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE--
Q 009594           50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--  127 (531)
Q Consensus        50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--  127 (531)
                      .|..+..+|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++++ +||||+++++++.  
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   80 (320)
T 2i6l_A            5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRL-DHDNIVKVFEILGPS   80 (320)
T ss_dssp             -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTT
T ss_pred             ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccc
Confidence            3556778999999999999999999999999999999998654   344567888999999999 9999999999873  


Q ss_pred             ------------cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC
Q 009594          128 ------------DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE  195 (531)
Q Consensus       128 ------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~  195 (531)
                                  .....++||||++ ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++..  
T Consensus        81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~--  156 (320)
T 2i6l_A           81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE--  156 (320)
T ss_dssp             SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT--
T ss_pred             ccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC--
Confidence                        3468999999997 599998854 579999999999999999999999999999999999999743  


Q ss_pred             CCCeEEEeeccccccCCCC----ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHH
Q 009594          196 SSPLKAIDFGLSVFFRPGE----QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA  269 (531)
Q Consensus       196 ~~~ikl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~  269 (531)
                      +..+||+|||++.......    ......+|+.|+|||++.  ..++.++||||||+++|+|++|..||.+.........
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  236 (320)
T 2i6l_A          157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL  236 (320)
T ss_dssp             TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            3459999999998764321    223456799999999875  4688999999999999999999999998887776666


Q ss_pred             HHhcccCC----------------------CCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          270 IIRSVIDF----------------------KRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       270 ~~~~~~~~----------------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      +.......                      ...    .++.+++.+.+||.+||+.||++|||+.++|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            55432111                      000    1245799999999999999999999999999999998643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-45  Score=370.43  Aligned_cols=259  Identities=26%  Similarity=0.392  Sum_probs=202.6

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe---
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA---  131 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  131 (531)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++......    .....+++..++.+ +||||+++++++.....   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhc-CCCCcccHHHhhhccccccc
Confidence            34799999999999999999999999999999998654322    23456678888888 99999999999865332   


Q ss_pred             ----EEEEEeccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCceEeecCCCCCCeEE
Q 009594          132 ----VHIVMELCEGGELFDRI----VARGHYTERAAAAVMKTIVEVVQVCH--EQGVMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       132 ----~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                          +++||||+++ +|...+    .....+++..+..++.|++.||.|||  ++||+||||||+|||++..  ++.+||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT--TTEEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC--CCcEEE
Confidence                8899999986 444333    34567899999999999999999999  9999999999999999742  345999


Q ss_pred             EeeccccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC-
Q 009594          202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-  278 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-  278 (531)
                      +|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+.......+.+...... 
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            99999988776666666789999999998853  489999999999999999999999999888777776654321110 


Q ss_pred             ---------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          279 ---------------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       279 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                                 .......++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence                                       0011125678999999999999999999999999999987654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=363.71  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=213.6

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ......+|++.+.||+|+||.||+|.+..++.   .||+|++....  .......+.+|+.+++++ +||||+++++++.
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  120 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQF-DHPNIIRLEGVVT  120 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEE
Confidence            35566789999999999999999999876554   59999996542  344457889999999999 8999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      ..+..++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  197 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS---NLVCKVSDFGL  197 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCSS
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC---CCCEEECCCCc
Confidence            999999999999999999999654 57999999999999999999999999999999999999954   45699999999


Q ss_pred             ccccCCCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCC
Q 009594          207 SVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRD  280 (531)
Q Consensus       207 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~  280 (531)
                      +........    .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||...........+.....   .+
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~  274 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR---LP  274 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---CC
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC---CC
Confidence            987654322    12234677899999987 578999999999999999999 9999999888877776665422   22


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ....+++.+.+||.+||..+|++|||+.++++.
T Consensus       275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            234689999999999999999999999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.3e-47  Score=380.27  Aligned_cols=259  Identities=17%  Similarity=0.222  Sum_probs=197.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCCeeecc-------eEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-KHPNIVSLK-------DTYE  127 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~l~-------~~~~  127 (531)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.|. +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            35999999999999999999999999999999998766545556678888977777663 599988754       4544


Q ss_pred             cC-----------------CeEEEEEeccCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHcCCeecCC
Q 009594          128 DD-----------------SAVHIVMELCEGGELFDRIVAR-GHYTERAA------AAVMKTIVEVVQVCHEQGVMHRDL  183 (531)
Q Consensus       128 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~------~~i~~qi~~~l~~LH~~~iiH~Dl  183 (531)
                      ..                 ..+||||||++ ++|.+++... ..+++..+      ..++.||+.||.|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            32                 34899999998 8999999763 33455555      677799999999999999999999


Q ss_pred             CCCceEeecCCCCCCeEEEeeccccccCCCCccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCC
Q 009594          184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWA  260 (531)
Q Consensus       184 kp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~  260 (531)
                      ||+|||++.+   +.+||+|||+|.....  ......+|+.|+|||++.+   .++.++|||||||++|+|+||..||..
T Consensus       221 kp~NIll~~~---~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          221 TPDNLFIMPD---GRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             SGGGEEECTT---SCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CHHHEEECCC---CCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9999999654   4599999999986543  2224567799999998863   689999999999999999999999977


Q ss_pred             CCHHHHH--HH---HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          261 ETEQGVA--QA---IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       261 ~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .......  ..   ..........+.++.+++.+.+||.+||+.||++|||+.++|+||||+...
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            6432100  00   000011122233457899999999999999999999999999999998643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.5e-46  Score=357.23  Aligned_cols=257  Identities=31%  Similarity=0.536  Sum_probs=217.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE--cCCeE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--DDSAV  132 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~~~~  132 (531)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++++ +||||+++++++.  .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceE
Confidence            4579999999999999999999999999999999976543 334567889999999999 9999999999875  46789


Q ss_pred             EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCceEeecCCCCCCeEEEe
Q 009594          133 HIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQG-----VMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~-----iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                      ++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.|     |+||||||+||+++.+   +.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~---~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS---SCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC---CCEEEec
Confidence            9999999999999998753    34899999999999999999999999     9999999999999644   4599999


Q ss_pred             eccccccCCCCc-cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 009594          204 FGLSVFFRPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       204 fg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  281 (531)
                      ||++........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.......   .
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~  236 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---I  236 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---C
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---C
Confidence            999987654332 23457899999999887 468899999999999999999999999888777766666554321   1


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ...+++.+.++|.+||..+|++|||+.++++|+|+...
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            23678999999999999999999999999999999753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.9e-46  Score=361.89  Aligned_cols=259  Identities=27%  Similarity=0.484  Sum_probs=215.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCCeeecceEEE--cCC
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--DDS  130 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~~  130 (531)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++++ +||||+++++++.  ...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence            446799999999999999999999999999999999764321 123457789999999999 8999999999984  456


Q ss_pred             eEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          131 AVHIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ..++||||++++ |.+++..  ...+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC---CcEEeecccccc
Confidence            899999999876 7777765  3469999999999999999999999999999999999999654   459999999998


Q ss_pred             ccCCC---CccccccCCcccccchhccc-c--CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          209 FFRPG---EQFNEIVGSPYYMAPEVLKR-N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       209 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      .....   .......||+.|+|||++.+ .  ++.++||||||+++|+|++|..||...........+.......    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----~  233 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI----P  233 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC----C
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC----C
Confidence            76432   22345578999999998864 2  4678999999999999999999999888777777766654332    2


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ..+++.+.+||.+||..||++|||+.++++||||+....
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            467899999999999999999999999999999986543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.3e-46  Score=371.53  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=206.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC--------ChhhHHHHHHHHHHHHhCCCCCCeeecce
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--------TAVDIEDVRREVQIMKHLPKHPNIVSLKD  124 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~l~~  124 (531)
                      .+..+|++.+.||+|+||.||+|.+. +|..||+|++......        .....+.+.+|+.+++++ +||||+++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~   96 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRD   96 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceee
Confidence            45678999999999999999999975 4999999999654322        222347889999999999 8999999999


Q ss_pred             EEEc-----CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCC
Q 009594          125 TYED-----DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       125 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                      ++..     ...+++||||++ |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.+   +.
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~---~~  172 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN---ND  172 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CC
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC---CC
Confidence            9843     346899999997 5888877654 369999999999999999999999999999999999999644   45


Q ss_pred             eEEEeeccccccCCCCccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccC
Q 009594          199 LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      +||+|||++.............||+.|+|||++.  ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9999999998665555555678999999999876  46899999999999999999999999998877766665432211


Q ss_pred             C------------------------CCCC----CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          277 F------------------------KRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       277 ~------------------------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      .                        +...    .+..++.+.+||.+||+.||++|||+.++|+||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            1                        1111    235688999999999999999999999999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.6e-45  Score=368.23  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=214.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEc-------cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecce
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD  124 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~  124 (531)
                      ....++|++.+.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++++.+||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            344568999999999999999999874       345689999996542  34456788999999999988999999999


Q ss_pred             EEEcCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCce
Q 009594          125 TYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF  188 (531)
Q Consensus       125 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NI  188 (531)
                      ++...+.+|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999997653                478999999999999999999999999999999999


Q ss_pred             EeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCH
Q 009594          189 LFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETE  263 (531)
Q Consensus       189 ll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~  263 (531)
                      |++.   ++.+||+|||++........   .....+|+.|+|||++. ..++.++|||||||++|+|+| |..||.+...
T Consensus       235 ll~~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          235 LVTE---NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             EECT---TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EECC---CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9964   44699999999986654322   23345788999999886 568999999999999999999 9999988877


Q ss_pred             HHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ......+.....   ......+++.+.++|.+||..+|++|||+.+++++
T Consensus       312 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 EELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGHHHHHHTTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            766665554432   12224689999999999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=356.03  Aligned_cols=257  Identities=28%  Similarity=0.478  Sum_probs=207.4

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      |.....||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEE
Confidence            334458999999999999999999999999997543   22356788999999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          138 LCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |+++++|.+++....   .+++..+..++.|++.||.|||++||+||||||+||+++..  ++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC--CCCEEEeecccccccCCCC
Confidence            999999999997652   46789999999999999999999999999999999999752  3459999999998765332


Q ss_pred             -ccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          215 -QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                       ......||+.|+|||++.+   .++.++||||||+++|+|++|..||............. ............+++.+.
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  256 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFKVHPEIPESMSAEAK  256 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHHCCCCCCCTTSCHHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-ccccccccccccCCHHHH
Confidence             2345678999999998863   37889999999999999999999997654332211111 111112222356899999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++|.+||..+|++|||+.++++||||+...+
T Consensus       257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          257 AFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            9999999999999999999999999986554

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=364.80  Aligned_cols=258  Identities=28%  Similarity=0.491  Sum_probs=212.0

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe-
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA-  131 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-  131 (531)
                      .+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++..... 
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccc
Confidence            35568999999999999999999999999999999997543 2334456788999999999 89999999999986653 


Q ss_pred             -----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          132 -----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       132 -----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                           +++||||+. ++|.+++.  ..+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~  172 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---CELKILDFGL  172 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---CCEEECSTTC
T ss_pred             ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC---CcEEEeeccc
Confidence                 599999997 58887763  358999999999999999999999999999999999999644   4599999999


Q ss_pred             ccccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc---------
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI---------  275 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~---------  275 (531)
                      +.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.+...         
T Consensus       173 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          173 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             ccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            986543  2344678999999998764  689999999999999999999999998877666555543210         


Q ss_pred             --------------CCC----CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          276 --------------DFK----RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       276 --------------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                    ...    ...++.+++.+.+||.+||..||++|||+.++|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                          111    122346789999999999999999999999999999998643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.9e-45  Score=357.99  Aligned_cols=255  Identities=25%  Similarity=0.483  Sum_probs=205.5

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-----
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-----  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-----  128 (531)
                      +..+|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++++ +||||+++++++..     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchh
Confidence            456899999999999999999999999999999999643    23457788999999999 99999999998754     


Q ss_pred             --------CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCe
Q 009594          129 --------DSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL  199 (531)
Q Consensus       129 --------~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~i  199 (531)
                              ....++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~---~~~  155 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES---RNV  155 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC---CCE
Confidence                    467899999999999999997644 57889999999999999999999999999999999999644   459


Q ss_pred             EEEeeccccccCCC---------------CccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCC
Q 009594          200 KAIDFGLSVFFRPG---------------EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET  262 (531)
Q Consensus       200 kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~  262 (531)
                      ||+|||++......               .......||+.|+|||++.+  .++.++|||||||++|+|++   ||....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999998765421               12234568999999999863  58999999999999999998   554322


Q ss_pred             -HHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          263 -EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       263 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                       .......+.......+.......++.+.++|.+||..||++|||+.++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence             223333444333334443345678889999999999999999999999999999753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-45  Score=368.88  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=209.9

Q ss_pred             cccceeeccccCccCceEEEEEE-----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..++|++.+.||+|+||.||+|.     +..+++.||+|++....  .......+.+|+.+++++.+||||+++++++..
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            45689999999999999999998     45567899999996542  334457789999999999889999999999887


Q ss_pred             CC-eEEEEEeccCCCchHHHHHhcCC------------------------------------------------------
Q 009594          129 DS-AVHIVMELCEGGELFDRIVARGH------------------------------------------------------  153 (531)
Q Consensus       129 ~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  153 (531)
                      .+ ..++||||+++|+|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            54 49999999999999999976533                                                      


Q ss_pred             ------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---ccc
Q 009594          154 ------------YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNE  218 (531)
Q Consensus       154 ------------l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~  218 (531)
                                  +++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++........   ...
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC---CcEEEEeccceeeecccccchhccc
Confidence                        8999999999999999999999999999999999999654   4599999999986643322   234


Q ss_pred             ccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHc
Q 009594          219 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM  296 (531)
Q Consensus       219 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  296 (531)
                      ..||+.|+|||++. ..++.++|||||||++|+|+| |..||.+..................  ....+++.+.+++.+|
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDC  332 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHH
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHH
Confidence            56889999999886 578999999999999999998 9999988765544444433322222  2245789999999999


Q ss_pred             cccCcCCCCCHHHHhcC
Q 009594          297 LNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       297 l~~~p~~Rps~~~~l~h  313 (531)
                      |+.+|++|||+.++++|
T Consensus       333 l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHH
Confidence            99999999999999876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3e-45  Score=361.56  Aligned_cols=264  Identities=25%  Similarity=0.370  Sum_probs=196.8

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      .....+|++.+.||+|+||.||+|.+..++.   .||+|++...... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~   96 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEF-DHPHVAKLVGVSLR   96 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEEC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHC-CCCceehhhceeec
Confidence            3455679999999999999999999877665   8999999765433 33467889999999999 99999999999987


Q ss_pred             CCeE------EEEEeccCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCC
Q 009594          129 DSAV------HIVMELCEGGELFDRIVARG------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES  196 (531)
Q Consensus       129 ~~~~------~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~  196 (531)
                      ....      ++||||+++++|.+++....      .+++..++.++.||+.||.|||++||+||||||+||+++.+   
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~---  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC---
Confidence            6554      99999999999999986532      58999999999999999999999999999999999999644   


Q ss_pred             CCeEEEeeccccccCCCCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 009594          197 SPLKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII  271 (531)
Q Consensus       197 ~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~  271 (531)
                      +.+||+|||++.........   ....+++.|+|||++. ..++.++|||||||++|+|++ |.+||.+.........+.
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            46999999999876543322   2345678899999887 568999999999999999999 999999888777766665


Q ss_pred             hcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCC-------HHHHhcCCcccccccCC
Q 009594          272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT-------AEEVLEHPWLQNAKKAP  323 (531)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~~~l~h~~~~~~~~~~  323 (531)
                      ....   ....+.+++.+.+|+.+||..+|++|||       +.++++|||+......|
T Consensus       254 ~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          254 GGNR---LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             TTCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred             cCCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence            5432   2223568999999999999999999999       78889999998765544

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.1e-45  Score=365.31  Aligned_cols=264  Identities=27%  Similarity=0.441  Sum_probs=215.6

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCC-cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCC------eee
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNG-EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN------IVS  121 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n------iv~  121 (531)
                      ..|+.+..+|++.+.||+|+||.||+|.+..++ ..||+|++...    ......+.+|+.+++.+ .|++      ++.
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~   86 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKI-KEKDKENKFLCVL   86 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHH-HHHCTTSCSCBCC
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHH-hhcCCCCceeEEE
Confidence            446678889999999999999999999998776 78999998642    23456788899999998 6655      899


Q ss_pred             cceEEEcCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC------
Q 009594          122 LKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK------  193 (531)
Q Consensus       122 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~------  193 (531)
                      +++++...+..++||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||+...      
T Consensus        87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence            999999999999999999 667777776653  69999999999999999999999999999999999999543      


Q ss_pred             ----------CCCCCeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC
Q 009594          194 ----------KESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET  262 (531)
Q Consensus       194 ----------~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~  262 (531)
                                .....+||+|||++.....  ......||+.|+|||++. ..++.++|||||||++|+|++|..||....
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                      2356699999999986443  234567999999999886 578999999999999999999999999887


Q ss_pred             HHHHHHHHHhcccCCCC----------------CCC------------------------CCCCHHHHHHHHHccccCcC
Q 009594          263 EQGVAQAIIRSVIDFKR----------------DPW------------------------PKVSENAKDLVKKMLNPDPK  302 (531)
Q Consensus       263 ~~~~~~~~~~~~~~~~~----------------~~~------------------------~~~~~~~~~li~~~l~~~p~  302 (531)
                      .......+.......+.                ..|                        ...++.+.+||.+||..||+
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            76655544432211110                001                        11245788999999999999


Q ss_pred             CCCCHHHHhcCCcccccc
Q 009594          303 QRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       303 ~Rps~~~~l~h~~~~~~~  320 (531)
                      +|||+.++|+||||+...
T Consensus       324 ~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          324 QRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             TSCCHHHHTTSGGGGGCC
T ss_pred             hCcCHHHHhcChhhcCCC
Confidence            999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=360.75  Aligned_cols=245  Identities=24%  Similarity=0.385  Sum_probs=205.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++++ +||||+++++++.+.+..++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEE
Confidence            35799999999999999999999999999999988543   344567889999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          135 VMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE---NKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECT---TSCEEECCCTTCEECC--
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECC---CCCEEEeecccceecccc
Confidence            9999999999999987 467999999999999999999999999999999999999964   445999999999865433


Q ss_pred             Ccc---------------ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH-----HHHHHHh
Q 009594          214 EQF---------------NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-----VAQAIIR  272 (531)
Q Consensus       214 ~~~---------------~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-----~~~~~~~  272 (531)
                      ...               ....||+.|+|||++. ..++.++||||||+++|+|++|..||.......     .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            211               1457999999999987 568999999999999999999999986532211     0111111


Q ss_pred             cccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .      ...+.+++.+.+++.+||+.+|++|||+.++++
T Consensus       242 ~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          242 R------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             H------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1      112467889999999999999999999999976

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.1e-45  Score=356.27  Aligned_cols=258  Identities=21%  Similarity=0.306  Sum_probs=213.0

Q ss_pred             CCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .+..+..+|++.+.||+|+||.||+|.+..+|+.||+|++.....     ...+.+|+.+++.+.+|||++++++++...
T Consensus         4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A            4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            346677889999999999999999999999999999999865432     235678999999998899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC--CCCCeEEEeecc
Q 009594          130 SAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGL  206 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~--~~~~ikl~Dfg~  206 (531)
                      ...++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++  ....+||+|||+
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999999999 999999998754 599999999999999999999999999999999999997653  234599999999


Q ss_pred             ccccCCCCc--------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC---HHHHHHHHHhcc
Q 009594          207 SVFFRPGEQ--------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSV  274 (531)
Q Consensus       207 a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~  274 (531)
                      +........        .....||+.|+|||++. ..++.++||||||+++|+|++|..||....   .......+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            987654322        23457999999999987 468999999999999999999999997743   333333333222


Q ss_pred             cCCC-CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          275 IDFK-RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       275 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ...+ ....+.+|+.+.+++.+||+.+|++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1111 11224689999999999999999999999999753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-45  Score=362.89  Aligned_cols=260  Identities=30%  Similarity=0.534  Sum_probs=215.0

Q ss_pred             CCCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCC-CCCCeeecc
Q 009594           48 EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP-KHPNIVSLK  123 (531)
Q Consensus        48 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~niv~l~  123 (531)
                      ...+..+..+|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.+++++. .||||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            44567788899999999999999999999999999999999976543321   11234567999999995 369999999


Q ss_pred             eEEEcCCeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEE
Q 009594          124 DTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       124 ~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                      +++...+..++|+|++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.  .++.+||+
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~  192 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLI  192 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEEC
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEe
Confidence            999999999999999976 899999988888999999999999999999999999999999999999973  23459999


Q ss_pred             eeccccccCCCCccccccCCcccccchhccc-c-CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 009594          203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD  280 (531)
Q Consensus       203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  280 (531)
                      |||++...... ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||....      .+......    
T Consensus       193 Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~----  261 (320)
T 3a99_A          193 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF----  261 (320)
T ss_dssp             CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC----
T ss_pred             eCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccc----
Confidence            99999876533 3345679999999998863 3 3678999999999999999999996532      12222221    


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ....+++.+.+||.+||..+|++|||+.++++||||+...
T Consensus       262 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            1246899999999999999999999999999999998653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.5e-45  Score=355.52  Aligned_cols=254  Identities=26%  Similarity=0.390  Sum_probs=206.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      .-++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++...+..+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEE
Confidence            345799999999999999999999999999999999766554555567889999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++......
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD---DFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSCCC-------
T ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC---CCEEEecCccCcccccc
Confidence            999999999999999988889999999999999999999999999999999999999654   45999999998765443


Q ss_pred             C--ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          214 E--QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       214 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .  ......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...............+.+|+.+.
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCTHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCHHHH
Confidence            2  223457899999999886 5689999999999999999999999987655433 33333333333333467899999


Q ss_pred             HHHHHccccCcCCCC-CHHHHhc
Q 009594          291 DLVKKMLNPDPKQRL-TAEEVLE  312 (531)
Q Consensus       291 ~li~~~l~~~p~~Rp-s~~~~l~  312 (531)
                      ++|.+||..+|++|| |+.++++
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999 7888765

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=364.39  Aligned_cols=257  Identities=24%  Similarity=0.357  Sum_probs=218.0

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccC-------CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeee
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNN-------GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS  121 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~  121 (531)
                      +......++|++.+.||+|+||.||+|.+..+       +..||+|++....  .......+.+|+.+++++.+||||++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            34456677999999999999999999997543       3579999997542  34456788999999999988999999


Q ss_pred             cceEEEcCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 009594          122 LKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP  185 (531)
Q Consensus       122 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp  185 (531)
                      +++++...+..++||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999998753                489999999999999999999999999999999


Q ss_pred             CceEeecCCCCCCeEEEeeccccccCCCC---ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCC
Q 009594          186 ENFLFANKKESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWA  260 (531)
Q Consensus       186 ~NIll~~~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~  260 (531)
                      +|||++.+   +.+||+|||+|.......   ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+
T Consensus       220 ~NIll~~~---~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          220 RNVLVTED---NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             GGEEECTT---CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ceEEEcCC---CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999644   459999999998665432   223346788999999887 568999999999999999999 9999998


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          261 ETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .........+......   .....+++.+.+||.+||+.+|++|||+.+++++
T Consensus       297 ~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          297 VPVEELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CCHHHHHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8877776666554321   2224689999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-45  Score=357.67  Aligned_cols=259  Identities=23%  Similarity=0.321  Sum_probs=217.4

Q ss_pred             ccCCCCCccccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCee
Q 009594           46 LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV  120 (531)
Q Consensus        46 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv  120 (531)
                      ...+.......+|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++++ +||||+
T Consensus        13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv   89 (314)
T 2ivs_A           13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQV-NHPHVI   89 (314)
T ss_dssp             -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBC
T ss_pred             cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCcee
Confidence            344555566778999999999999999999973     456899999986542  344567889999999999 999999


Q ss_pred             ecceEEEcCCeEEEEEeccCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHc
Q 009594          121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGH------------------------YTERAAAAVMKTIVEVVQVCHEQ  176 (531)
Q Consensus       121 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~qi~~~l~~LH~~  176 (531)
                      ++++++...+..++||||+++++|.+++.....                        +++..++.++.||+.||.|||++
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  169 (314)
T 2ivs_A           90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM  169 (314)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence            999999999999999999999999999986543                        89999999999999999999999


Q ss_pred             CCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHh
Q 009594          177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILL  252 (531)
Q Consensus       177 ~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~  252 (531)
                      ||+||||||+||+++.+   +.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|+
T Consensus       170 ~ivH~dikp~NIli~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  246 (314)
T 2ivs_A          170 KLVHRDLAARNILVAEG---RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV  246 (314)
T ss_dssp             TEECCCCSGGGEEEETT---TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccccchheEEEcCC---CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHH
Confidence            99999999999999754   4599999999987654332   22345788899999887 56899999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          253 C-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       253 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      | |..||.+.........+.....   ......+++.+.++|.+||..+|++|||+.+++++
T Consensus       247 t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          247 TLGGNPYPGIPPERLFNLLKTGHR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hCCCCCCCCCCHHHHHHHhhcCCc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9 9999988877666655554322   22234689999999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8e-45  Score=348.82  Aligned_cols=246  Identities=24%  Similarity=0.401  Sum_probs=211.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEE
Confidence            57999999999999999999975 577899999975432    236788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG---GCEEECCTTGGGGBCCHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC---CCEEeccccccccccccc
Confidence            9999999999999654 458999999999999999999999999999999999999654   459999999998654332


Q ss_pred             --ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          215 --QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       215 --~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                        ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+.......   .....++.+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  237 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVY  237 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHHH
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---CCCcCCHHHH
Confidence              123345678899999987 678999999999999999999 999999988877777666543221   2235789999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcC
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +++.+||+.+|++|||+.++++|
T Consensus       238 ~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          238 QIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999876

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9e-45  Score=348.83  Aligned_cols=251  Identities=29%  Similarity=0.453  Sum_probs=200.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC-hhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .+|++.+.||+|+||.||+|.+  +++.||+|++....... ....+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEE
Confidence            4799999999999999999996  48999999987543322 23357788999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCceEeecCCC-----CCCeEEEeecc
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG---VMHRDLKPENFLFANKKE-----SSPLKAIDFGL  206 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iiH~Dlkp~NIll~~~~~-----~~~ikl~Dfg~  206 (531)
                      ||||+++++|.+++. ...+++..++.++.|++.||.|||++|   |+||||||+||+++....     .+.+||+|||+
T Consensus        84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999998885 457999999999999999999999999   899999999999975322     55699999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      +........ ....||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+........  ....+
T Consensus       163 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  239 (271)
T 3dtc_A          163 AREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPSTC  239 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred             ccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--CCccc
Confidence            986544332 3457899999999887 5689999999999999999999999998887766665554433322  22468


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ++.+.+++.+||..+|++|||+.+++++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            9999999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.3e-45  Score=362.32  Aligned_cols=253  Identities=18%  Similarity=0.230  Sum_probs=207.7

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+..+|++.+.||+|+||.||+|.+..+|+.||+|++......     ..+.+|+.+++++.+||||+++++++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            3556899999999999999999999999999999998754322     35778999999998999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC--CCCeEEEeeccccc
Q 009594          133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE--SSPLKAIDFGLSVF  209 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~--~~~ikl~Dfg~a~~  209 (531)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  ...+||+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 9999999976 467999999999999999999999999999999999999975442  22399999999987


Q ss_pred             cCCCCc--------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHhcccCC
Q 009594          210 FRPGEQ--------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVIDF  277 (531)
Q Consensus       210 ~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~  277 (531)
                      ......        .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+...   ......+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            643322        23567999999999987 4689999999999999999999999987433   23333333322222


Q ss_pred             CCCC-CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          278 KRDP-WPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       278 ~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +... ...+| .+.+++..||..+|.+||++.++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1111 12244 9999999999999999999999876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-44  Score=346.23  Aligned_cols=248  Identities=22%  Similarity=0.321  Sum_probs=211.8

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|++.....    ....+.+|+.+++++ +||||+++++++...+..+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceE
Confidence            4567999999999999999999864 677899999975432    236788999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR---DLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT---TCCEEECCTTCEEECCT
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC---CCCEEEccCccceecch
Confidence            9999999999999997754 4999999999999999999999999999999999999964   44599999999987654


Q ss_pred             CCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          213 GEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       213 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ...  .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||...........+........   ....++.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  233 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---PHLASDT  233 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTSCHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC---CCcChHH
Confidence            432  22345677899999987 478999999999999999999 9999998888777666655432222   2356899


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcC
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.+++.+||+.+|++|||+.+++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.3e-45  Score=367.16  Aligned_cols=262  Identities=24%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC----------CCCCeeecce
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP----------KHPNIVSLKD  124 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~niv~l~~  124 (531)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++++.          .||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            45799999999999999999999999999999998643    234567788999999883          1899999999


Q ss_pred             EEEcCC----eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCC---
Q 009594          125 TYEDDS----AVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKK---  194 (531)
Q Consensus       125 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~---  194 (531)
                      ++...+    .+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++..+   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            987544    799999999 88999999763  4599999999999999999999998 999999999999996432   


Q ss_pred             CCCCeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC------HHHHH
Q 009594          195 ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET------EQGVA  267 (531)
Q Consensus       195 ~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~------~~~~~  267 (531)
                      ....+||+|||++......  .....||+.|+|||++. ..++.++|||||||++|+|+||..||....      .....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            2336999999999876432  34457899999999887 468999999999999999999999997654      22222


Q ss_pred             HHHHhcccCCCC--------------------------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHH
Q 009594          268 QAIIRSVIDFKR--------------------------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEE  309 (531)
Q Consensus       268 ~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  309 (531)
                      ..+.......+.                                      .....+++.+.+||.+||+.||++|||+.+
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            222221111000                                      000123567899999999999999999999


Q ss_pred             HhcCCcccccccCC
Q 009594          310 VLEHPWLQNAKKAP  323 (531)
Q Consensus       310 ~l~h~~~~~~~~~~  323 (531)
                      +|+||||+......
T Consensus       331 ll~hp~f~~~~~~~  344 (373)
T 1q8y_A          331 LVNHPWLKDTLGME  344 (373)
T ss_dssp             HHTCGGGTTCTTCT
T ss_pred             HhhChhhhcccCcc
Confidence            99999999765443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.5e-45  Score=367.70  Aligned_cols=250  Identities=24%  Similarity=0.336  Sum_probs=211.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      -..+|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++++ +||||+++++++...+..+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcE
Confidence            3458999999999999999999998899999999986432  233445688899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.   ++.+||+|||++.....
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~---~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE---KNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCGGGCEECTT
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC---CCcEEECcCCCceecCC
Confidence            9999999999999997654 5999999999999999999999999999999999999964   44699999999986543


Q ss_pred             CCcc---ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          213 GEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       213 ~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ....   ....+++.|+|||++. +.++.++|||||||++|+|+| |..||...........+.....   .+....+|+
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  342 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---LPCPELCPD  342 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC---CCCCTTCCH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence            3211   1123567899999887 678999999999999999998 9999998887766655544321   112245899


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.+||.+||+.+|++|||+.++++
T Consensus       343 ~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          343 AVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-44  Score=358.21  Aligned_cols=260  Identities=22%  Similarity=0.260  Sum_probs=216.3

Q ss_pred             CccccceeeccccCccCceEEEEEE-----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY  126 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  126 (531)
                      .....+|++.+.||+|+||.||+|.     +..++..||+|++....  .......+.+|+.+++++ +||||+++++++
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  102 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQNIVRCIGVS  102 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhC-CCCCCCeEEEEE
Confidence            4556789999999999999999998     55678899999986432  344556788999999999 999999999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCe
Q 009594          127 EDDSAVHIVMELCEGGELFDRIVARG-------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL  199 (531)
Q Consensus       127 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~i  199 (531)
                      ......++||||+++++|.+++....       .+++..++.++.||+.||.|||++||+||||||+||+++.++....+
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence            99999999999999999999998753       48999999999999999999999999999999999999876666779


Q ss_pred             EEEeeccccccCCCC---ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcc
Q 009594          200 KAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV  274 (531)
Q Consensus       200 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  274 (531)
                      ||+|||++.......   ......||+.|+|||++. +.++.++||||||+++|+|+| |..||...........+....
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  262 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  262 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence            999999987543322   223456789999999886 678999999999999999998 999998888777666665543


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      ..   .....+++.+.++|.+||..+|.+|||+.+++++.|+-
T Consensus       263 ~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          263 RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            21   22346899999999999999999999999999998874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-44  Score=348.13  Aligned_cols=249  Identities=22%  Similarity=0.335  Sum_probs=209.9

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .-..+|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++++ +||||+++++++...+..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCe
Confidence            34567999999999999999999864 678899999975432    236788999999999 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~---~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND---QGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT---TSCEEECSTTGGGGBC
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcC---CCCEEEcccccccccc
Confidence            999999999999999976 456999999999999999999999999999999999999964   4459999999998664


Q ss_pred             CCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ....  .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||...........+........   ....++
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  248 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASE  248 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCH
T ss_pred             ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCH
Confidence            3321  22345678899999887 678999999999999999998 9999998888777776665432222   245789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+.+++.+||+.+|++|||+.++++|
T Consensus       249 ~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999999876

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=353.67  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=194.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      -.+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+..+..+++.+ +||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEE
Confidence            35799999999999999999999999999999999755321 11223333444556666 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.+   +.+||+|||++.....
T Consensus       102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER---GQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT---SCEEECCCTTC-----
T ss_pred             EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC---CCEEEEECCCchhccC
Confidence            99999 5555555443 46799999999999999999999995 99999999999999644   4599999999987655


Q ss_pred             CCccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhcccCCCCCCCCCC
Q 009594          213 GEQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ........||+.|+|||++.      ..++.++||||||+++|+|++|..||... ........+....... .+....+
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  256 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-LPGHMGF  256 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-CCSSSCC
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-CCccCCC
Confidence            54445567999999999884      35888999999999999999999999774 3444445554443221 2223468


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ++.+.+||.+||..+|.+|||+.++++||||+....
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence            999999999999999999999999999999986544

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3e-44  Score=348.27  Aligned_cols=253  Identities=24%  Similarity=0.381  Sum_probs=208.0

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhh----HHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD----IEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++..........    .+.+.+|+.+++++ +||||+++++++.+
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecC
Confidence            44568999999999999999999999999999999997654332222    16788999999999 89999999999876


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCceEeecCCC--CCCeEEEe
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKE--SSPLKAID  203 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~NIll~~~~~--~~~ikl~D  203 (531)
                      ..  ++||||+++++|.+++... ..+++..++.++.|++.||.|||++|  |+||||||+||+++.++.  ...+||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            65  6999999999999888654 46999999999999999999999999  999999999999975432  23489999


Q ss_pred             eccccccCCCCccccccCCcccccchhcc---ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHH--HHHHHhcccCCC
Q 009594          204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVIDFK  278 (531)
Q Consensus       204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~--~~~~~~~~~~~~  278 (531)
                      ||++.....  ......||+.|+|||++.   ..++.++|||||||++|+|++|..||........  ...+.....  .
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~  248 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--R  248 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--C
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--C
Confidence            999975433  334567999999999984   3578899999999999999999999977654433  233333222  2


Q ss_pred             CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       279 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ......+++.+.++|.+||+.+|++|||+.++++
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            2233568999999999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=359.96  Aligned_cols=253  Identities=20%  Similarity=0.291  Sum_probs=214.3

Q ss_pred             CccccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY  126 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  126 (531)
                      ....++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++++ +||||+++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~  119 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVC  119 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence            445678999999999999999999986     345899999997543  334457889999999999 999999999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecC
Q 009594          127 EDDSAVHIVMELCEGGELFDRIVAR------------------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRD  182 (531)
Q Consensus       127 ~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~D  182 (531)
                      ...+..++||||+++++|.+++...                        ..+++..++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999763                        4689999999999999999999999999999


Q ss_pred             CCCCceEeecCCCCCCeEEEeeccccccCCCC---ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCC
Q 009594          183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPP  257 (531)
Q Consensus       183 lkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p  257 (531)
                      |||+||+++.+   +.+||+|||++.......   ......+|+.|+|||++. +.++.++||||||+++|+|+| |..|
T Consensus       200 lkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          200 LATRNCLVGEN---MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSGGGEEECGG---GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCcceEEECCC---CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            99999999654   459999999997654322   123456789999999887 578999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          258 FWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       258 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      |.+....+....+......   .....+++.+.++|.+||..+|++|||+.+++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCcC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            9998887777666554332   1224688999999999999999999999999764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-44  Score=353.92  Aligned_cols=261  Identities=28%  Similarity=0.470  Sum_probs=209.4

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCCeeecceEEEcCC
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-HPNIVSLKDTYEDDS  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~  130 (531)
                      .....+|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++++.. ||||+++++++...+
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            344567999999999999999999974 589999999976543 34456788999999999943 699999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ..++||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++++    +.+||+|||++...
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCC-
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC----CeEEEeeccccccc
Confidence            9999999 558899999998888999999999999999999999999999999999999953    45999999999876


Q ss_pred             CCCCc---cccccCCcccccchhccc------------cCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcc
Q 009594          211 RPGEQ---FNEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV  274 (531)
Q Consensus       211 ~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~  274 (531)
                      .....   .....||+.|+|||++.+            .++.++||||||+++|+|++|..||...... .....+....
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  256 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  256 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence            54322   234578999999998763            5788999999999999999999999775433 2222332222


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ...  ......++.+.++|.+||..+|++|||+.++++||||+....
T Consensus       257 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          257 HEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             SCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             ccc--CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            111  112345889999999999999999999999999999986543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.8e-45  Score=359.21  Aligned_cols=261  Identities=23%  Similarity=0.330  Sum_probs=190.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCCeeecceEEEcCCeE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ-IMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+..|+. +++.+ +||||+++++++...+..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCce
Confidence            3457999999999999999999999999999999997543  2334455666776 55555 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          133 HIVMELCEGGELFDRIVA-----RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      ++||||+++ +|.+++..     ...+++..+..++.|++.||.|||+. ||+||||||+||+++.+   +.+||+|||+
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~  172 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS---GNIKLCDFGI  172 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT---TEEEECCCSS
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC---CCEEEccCCC
Confidence            999999975 88777753     56789999999999999999999999 99999999999999654   4599999999


Q ss_pred             ccccCCCCccccccCCcccccchhcc-----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcc-cCCCC
Q 009594          207 SVFFRPGEQFNEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-IDFKR  279 (531)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~-~~~~~  279 (531)
                      +.............||+.|+|||++.     ..++.++||||||+++|+|++|..||...... .....+.... .....
T Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3aln_A          173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN  252 (327)
T ss_dssp             SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred             ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence            98765544444557999999999873     45889999999999999999999999764322 1111111111 11112


Q ss_pred             CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       280 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                      ..+..+++.+.+||.+||..||++|||+.++++||||.....
T Consensus       253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence            223458999999999999999999999999999999986543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-44  Score=348.70  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=201.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      .....+|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.+++++ +||||+++++++. 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-   86 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-   86 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-
Confidence            44566899999999999999999998654   4579999886432  344467788999999999 9999999999984 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      .+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~  163 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS  163 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC----
T ss_pred             cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC---CEEECccccc
Confidence            467899999999999999997654 689999999999999999999999999999999999997654   5999999999


Q ss_pred             cccCCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          208 VFFRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       208 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      ........  .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+.....   ....+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~  240 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPP  240 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCT
T ss_pred             cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---CCCCC
Confidence            87654332  22345678999999887 578999999999999999997 9999988877776666654432   12235


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+++.+.+++.+||..+|++|||+.+++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            789999999999999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=360.06  Aligned_cols=255  Identities=21%  Similarity=0.297  Sum_probs=210.8

Q ss_pred             ccccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ....+|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++++.+||||+++++++.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34568999999999999999999973     356789999997543  22234678899999999988999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARG-----------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLK  184 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlk  184 (531)
                      ..+..++||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+|||||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  199 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  199 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            9999999999999999999997643                       27899999999999999999999999999999


Q ss_pred             CCceEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCC
Q 009594          185 PENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFW  259 (531)
Q Consensus       185 p~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~  259 (531)
                      |+||+++.+   +.+||+|||++........   .....||+.|+|||++. +.++.++||||||+++|+|+| |..||.
T Consensus       200 p~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          200 ARNVLVTHG---KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             GGGEEEETT---TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hhhEEEcCC---CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            999999754   4599999999986644322   23345788999999886 678999999999999999998 999998


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCC
Q 009594          260 AETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP  314 (531)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~  314 (531)
                      +..................  ....+++.+.+||.+||..+|.+|||+.++++|-
T Consensus       277 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            8776555555544433222  2245799999999999999999999999999863

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.8e-44  Score=354.27  Aligned_cols=254  Identities=21%  Similarity=0.308  Sum_probs=213.3

Q ss_pred             ccccceeeccccCccCceEEEEEEE-----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTD-----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ....+|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            3456899999999999999999985     3567899999997543  33446788999999999988999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceE
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARG------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL  189 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIl  189 (531)
                      ..+..++||||+++++|.+++....                  .+++..++.++.||+.||.|||++||+||||||+||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  177 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence            9999999999999999999997654                  3899999999999999999999999999999999999


Q ss_pred             eecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHH
Q 009594          190 FANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ  264 (531)
Q Consensus       190 l~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~  264 (531)
                      ++.+   +.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||.+....
T Consensus       178 ~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          178 LTHG---RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             EETT---TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             EcCC---CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            9654   4599999999987654432   22345788999999876 578999999999999999999 99999887655


Q ss_pred             HHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ..............  ....+++.+.+++.+||..+|.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          255 SKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            54444444332222  224689999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.1e-44  Score=350.61  Aligned_cols=257  Identities=28%  Similarity=0.527  Sum_probs=202.6

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      +.....+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++...+
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDN  105 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETT
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCC
Confidence            344556899999999999999999999999999999999875555566677889999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          131 AVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      ..++||||+++++|.+++..    ...+++..++.++.|++.||.|||++||+||||||+||+++.+   +.+||+|||+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~---~~~kl~Dfg~  182 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGL  182 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCC--
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC---CCEEEEeccc
Confidence            99999999999999998864    4568999999999999999999999999999999999999644   4599999999


Q ss_pred             ccccCCCC-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHhcccCCCCCCC
Q 009594          207 SVFFRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       207 a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~  282 (531)
                      +....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+...  ......+....  .+....
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  260 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPS  260 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCT
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCcc
Confidence            87654332 223457899999999887 5688999999999999999999999976432  23333333222  222223


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ..+++.+.++|.+||..||++|||+.+++++
T Consensus       261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            5689999999999999999999999999863

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.7e-44  Score=348.94  Aligned_cols=247  Identities=38%  Similarity=0.691  Sum_probs=199.0

Q ss_pred             ccccceeec-cccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc---
Q 009594           53 DISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED---  128 (531)
Q Consensus        53 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  128 (531)
                      .+..+|.+. +.||+|+||.||+|.+..+++.||+|++...        ..+.+|+.++.++.+||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            355568777 7899999999999999999999999998632        4567899998666699999999999876   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          129 -DSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       129 -~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                       ....++||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++..+.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             678999999999999999998764  59999999999999999999999999999999999999875556779999999


Q ss_pred             cccccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc----CCCCCC
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----DFKRDP  281 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----~~~~~~  281 (531)
                      ++.....                    ..++.++|||||||++|+|+||..||.................    ..+...
T Consensus       166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (299)
T 3m2w_A          166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  225 (299)
T ss_dssp             TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred             ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence            9865431                    3356789999999999999999999977654332211111111    111111


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL  327 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~  327 (531)
                      +..+++.+.+||.+||..||++|||+.++++||||+.....+....
T Consensus       226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~  271 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  271 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred             cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence            2467999999999999999999999999999999998776555443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.9e-44  Score=351.15  Aligned_cols=254  Identities=23%  Similarity=0.333  Sum_probs=202.0

Q ss_pred             CccccceeeccccCccCceEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      .....+|++++.||+|+||.||+|+    +..+++.||+|++...   .....+.+.+|+.+++++ +||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence            4566789999999999999999998    5678999999998643   344567889999999999 8999999999985


Q ss_pred             c--CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          128 D--DSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       128 ~--~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      .  ...+++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+||
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~---~~kl~Df  158 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---RVKIGDF  158 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC---eEEEccC
Confidence            4  456899999999999999997754 499999999999999999999999999999999999997654   4999999


Q ss_pred             ccccccCCCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH------------HH
Q 009594          205 GLSVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG------------VA  267 (531)
Q Consensus       205 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~------------~~  267 (531)
                      |++........    .....+++.|+|||++. ..++.++||||||+++|+|+||..||.......            ..
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            99987654322    22345677899999887 578999999999999999999999985432110            00


Q ss_pred             HHHHhccc-CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          268 QAIIRSVI-DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       268 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ..+..... ....+....+++.+.++|.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            01111111 1112223468999999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.8e-44  Score=356.57  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=208.5

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEE--EEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKF--ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      .+|++.+.||+|+||.||+|.+..++..+  |+|.+....  .......+.+|+.+++++.+||||+++++++...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            57999999999999999999998888865  899886432  22335678899999999988999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCC
Q 009594          134 IVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~  197 (531)
                      +||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+||+++.+   +
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~---~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---Y  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---G
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC---C
Confidence            9999999999999997654                68999999999999999999999999999999999999654   4


Q ss_pred             CeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhccc
Q 009594          198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVI  275 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  275 (531)
                      .+||+|||++.............+++.|+|||++. ..++.++||||||+++|+|+| |..||.+.........+.....
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            59999999987544333333445788999999887 468999999999999999998 9999988887766665544321


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                         ......+++.+.+||.+||..+|++|||+.+++++
T Consensus       260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               12234678999999999999999999999999976

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.8e-44  Score=353.46  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=214.5

Q ss_pred             CCccccceeeccccCccCceEEEEEEEc-------cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecc
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK  123 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~  123 (531)
                      -....++|++.+.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++++.+||||++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            3445678999999999999999999975       457789999987543  3445678899999999998899999999


Q ss_pred             eEEEcCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 009594          124 DTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPEN  187 (531)
Q Consensus       124 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~N  187 (531)
                      +++...+..++||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            99999999999999999999999997653                38999999999999999999999999999999999


Q ss_pred             eEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCC
Q 009594          188 FLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET  262 (531)
Q Consensus       188 Ill~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~  262 (531)
                      |+++.   ++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||.+..
T Consensus       188 Ill~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          188 VLVTE---NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             EEECT---TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEEcC---CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            99964   44599999999987654332   22345688999999886 568999999999999999999 999999888


Q ss_pred             HHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ..+....+......   .....+++.+.++|.+||..+|.+|||+.+++++
T Consensus       265 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          265 VEELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            77766666554321   2224689999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.7e-44  Score=361.10  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             CccccceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      .....+|++.+.||+|+||.||+|++.   .++..||+|++....  .......+.+|+.+++++ +||||+++++++..
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  117 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK  117 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee
Confidence            344568999999999999999999876   467889999986542  344567889999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      .+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a  194 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLG  194 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCC---
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC---CCCEEECcCccc
Confidence            999999999999999999997654 6999999999999999999999999999999999999964   456999999999


Q ss_pred             cccCCCCcc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 009594          208 VFFRPGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       208 ~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  281 (531)
                      .........    ....+++.|+|||++. +.++.++|||||||++|+|++ |..||...........+.....   .+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~---~~~  271 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR---LPP  271 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---CCC
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCC
Confidence            876543211    1223577899999887 678999999999999999998 9999999888777666654432   122


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ...+++.+.+++.+||+.+|++|||+.++++
T Consensus       272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            3468899999999999999999999999976

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-44  Score=355.10  Aligned_cols=249  Identities=21%  Similarity=0.307  Sum_probs=201.6

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEE----EEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ..+|++.+.||+|+||.||+|.+..+++.+    |+|.+....  .......+.+|+.+++++ +||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC
Confidence            457999999999999999999988777765    666664322  223457889999999999 9999999999998754


Q ss_pred             eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          131 AVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                       .++|+||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+|..
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC---CEEEccCcceeE
Confidence             7899999999999999977 45699999999999999999999999999999999999997654   499999999987


Q ss_pred             cCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          210 FRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       210 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      ......   .....+|+.|+|||++. +.++.++|||||||++|+|+| |..||.+.........+.....   ....+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~  243 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPI  243 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC---CCCCcc
Confidence            654332   22345688999999887 568999999999999999999 9999988877666555544322   122246


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ++..+.+++.+||+.+|++|||+.+++++
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            78999999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=368.69  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=210.5

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  130 (531)
                      ..+..+|++.+.||+|+||.||+|.+..+|+.||+|++......  .....+.+|+.+++++ +||||+++++++...+ 
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCC
Confidence            45677899999999999999999999999999999999754432  2356778999999999 8999999999998654 


Q ss_pred             -eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeec-CCCCCCeEEEeec
Q 009594          131 -AVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFAN-KKESSPLKAIDFG  205 (531)
Q Consensus       131 -~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~-~~~~~~ikl~Dfg  205 (531)
                       ..++||||+++++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+.. .+....+||+|||
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence             78999999999999999875432   899999999999999999999999999999999999832 2234459999999


Q ss_pred             cccccCCCCccccccCCcccccchhcc---------ccCCCccchhHHHHHHHHHhhCCCCCCCC----CHHHHHHHHHh
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIR  272 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Di~slG~il~~l~tg~~pf~~~----~~~~~~~~~~~  272 (531)
                      ++.............||+.|+|||++.         ..++.++|||||||++|+|+||..||...    ...+....+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            998876665556678999999999875         35778999999999999999999999643    23344444444


Q ss_pred             cccCCC-----------------CCC----CCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          273 SVIDFK-----------------RDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       273 ~~~~~~-----------------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ......                 .+.    ...+++.+.++|.+||..||++|||+.+++++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            322100                 000    01235678899999999999999999998553

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.6e-44  Score=354.62  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=211.7

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCc-----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGE-----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ....+|++.+.||+|+||.||+|.+..++.     .||+|++....  .......+.+|+.+++++.+||||+++++++.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            345679999999999999999999876654     79999986543  33456778899999999978999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC
Q 009594          128 DDSAVHIVMELCEGGELFDRIVAR--------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK  193 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~  193 (531)
                      ..+..++||||+++|+|.+++...              ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence            999999999999999999998653              357999999999999999999999999999999999999754


Q ss_pred             CCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHH
Q 009594          194 KESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ  268 (531)
Q Consensus       194 ~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~  268 (531)
                      +   .+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||.+........
T Consensus       201 ~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          201 H---VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             G---EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             C---eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            4   499999999986543322   22345688999999876 578999999999999999999 999998876655555


Q ss_pred             HHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          269 AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.........  ...+++.+.++|.+||+.+|.+|||+.++++
T Consensus       278 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          278 KLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            55444332222  2457899999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.8e-44  Score=347.20  Aligned_cols=253  Identities=24%  Similarity=0.354  Sum_probs=203.6

Q ss_pred             CccccceeeccccCccCceEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      .....+|++.+.||+|+||.||+|.    +..+++.||+|++....  .......+.+|+.+++.+ +||||+++++++.
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~   93 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICT   93 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCeeeeeeEEe
Confidence            3445679999999999999999998    56789999999997553  223457888999999999 8999999999998


Q ss_pred             cC--CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          128 DD--SAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       128 ~~--~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      ..  ..+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+||
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~kl~Df  170 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH---QVKIGDF  170 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCC
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC---CEEECcc
Confidence            76  679999999999999999954 45699999999999999999999999999999999999997654   5999999


Q ss_pred             ccccccCCCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCC--------------CHHH
Q 009594          205 GLSVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE--------------TEQG  265 (531)
Q Consensus       205 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~--------------~~~~  265 (531)
                      |++........    .....||+.|+|||++. ..++.++||||||+++|+|+||..|+...              ....
T Consensus       171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred             cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence            99987654432    23456788899999886 56888999999999999999999876322              1111


Q ss_pred             HHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ..........  .....+.+++.+.+||.+||..+|++|||+.++++
T Consensus       251 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          251 RLVNTLKEGK--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccC--CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            1111111111  12223568999999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.4e-44  Score=344.87  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=214.5

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      +....+|++.+.||+|+||.||+|.+..++..||+|++....    ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCC
Confidence            445668999999999999999999999999999999986432    2457788999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          132 VHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      .++||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++..
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG---GCEEECCCCGGGT
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC---CCEEEccCcccee
Confidence            99999999999999999864  348999999999999999999999999999999999999654   4599999999987


Q ss_pred             cCCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          210 FRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       210 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ......  .....+|+.|+|||++. ..++.++||||||+++|+|++ |.+||...........+.....   ......+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  237 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGC  237 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTC
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---CCCCCCC
Confidence            654332  23345688899999887 678999999999999999999 9999988777666655544322   2223568


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ++.+.+|+.+||..+|++|||+.++++
T Consensus       238 ~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          238 PEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            999999999999999999999999965

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.1e-44  Score=349.71  Aligned_cols=249  Identities=17%  Similarity=0.236  Sum_probs=205.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCC-------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNG-------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT  125 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~  125 (531)
                      ....+|++.+.||+|+||.||+|.+..++       ..||+|++....   ....+.+.+|+.+++++ +||||++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   80 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKL-SHKHLVLNYGV   80 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTS-CCTTBCCEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhC-CCCCEeEEEEE
Confidence            34568999999999999999999988777       479999986543   23457789999999999 89999999999


Q ss_pred             EEcCCeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCC-----CCe
Q 009594          126 YEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES-----SPL  199 (531)
Q Consensus       126 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~-----~~i  199 (531)
                      +...+..++||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++..     ..+
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 9999999999999999999999999999999999999765431     129


Q ss_pred             EEEeeccccccCCCCccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCC-CCCCCCCHHHHHHHHHhcccC
Q 009594          200 KAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVID  276 (531)
Q Consensus       200 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~~~  276 (531)
                      ||+|||++......   ....||+.|+|||++.  ..++.++||||||+++|+|++|. +||........ .........
T Consensus       161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~  236 (289)
T 4fvq_A          161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDRHQ  236 (289)
T ss_dssp             EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCC
T ss_pred             eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhccCC
Confidence            99999998755332   2345789999999886  45899999999999999999954 55555444333 333332222


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .    ....++.+.+|+.+||+.+|++|||+.+++++
T Consensus       237 ~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          237 L----PAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             C----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2    23457789999999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-44  Score=356.34  Aligned_cols=250  Identities=22%  Similarity=0.297  Sum_probs=204.8

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcE----EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEK----FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      -..+|++.+.||+|+||.||+|.+..+++.    ||+|.+.....  ......+.+|+.+++++ +||||+++++++. .
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-B
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-C
Confidence            345799999999999999999999888876    66776643321  12234566799999999 9999999999886 4


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 SAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      +..++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~---~~~kl~Dfg~a~  163 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP---SQVQVADFGVAD  163 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS---SCEEECSCSGGG
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC---CeEEECCCCccc
Confidence            5689999999999999999764 468999999999999999999999999999999999999644   459999999998


Q ss_pred             ccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          209 FFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       209 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      .......   .....||+.|+|||++. +.++.++|||||||++|+|+| |..||.+.........+.......   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  240 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA---QPQ  240 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC---CCT
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC---CCC
Confidence            7654332   23456788999999987 678999999999999999999 999998887766666555432211   113


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+++.+.+++.+||..+|++|||+.+++++
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          241 ICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            467789999999999999999999999886

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.8e-44  Score=350.87  Aligned_cols=254  Identities=20%  Similarity=0.289  Sum_probs=214.7

Q ss_pred             CCccccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceE
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT  125 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~  125 (531)
                      ......+|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.+ +||||++++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~   96 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGV   96 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhc-CCCCEeeeEEE
Confidence            3556678999999999999999999876     357899999986442  334456788999999999 99999999999


Q ss_pred             EEcCCeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC
Q 009594          126 YEDDSAVHIVMELCEGGELFDRIVAR----------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE  195 (531)
Q Consensus       126 ~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~  195 (531)
                      +...+..++||||+++++|.+++...          ..+++..++.++.||+.||.|||++||+||||||+||+++.+  
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~--  174 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--  174 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT--
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC--
Confidence            99999999999999999999998652          357999999999999999999999999999999999999644  


Q ss_pred             CCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 009594          196 SSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI  270 (531)
Q Consensus       196 ~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~  270 (531)
                       +.+||+|||++........   .....+|+.|+|||++. +.++.++||||||+++|+|+| |..||...........+
T Consensus       175 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          175 -FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             -CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             -CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence             4699999999976543321   22345688999999887 568999999999999999999 89999888877776666


Q ss_pred             HhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ......   .....+++.+.++|.+||..+|++|||+.+++++
T Consensus       254 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          254 MEGGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcCCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            554322   2224689999999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.8e-44  Score=347.72  Aligned_cols=248  Identities=25%  Similarity=0.442  Sum_probs=209.8

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc---
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED---  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  128 (531)
                      ..+..+|++.+.||+|+||.||+|.+..+++.||+|++....       ..+.+|+.+++++ +||||+++++++..   
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL-DHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhC-CCCCEEEEeeeEecccc
Confidence            456678999999999999999999999899999999997542       3456899999999 99999999998854   


Q ss_pred             -------------CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecC
Q 009594          129 -------------DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK  193 (531)
Q Consensus       129 -------------~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~  193 (531)
                                   ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence                         45589999999999999999754  569999999999999999999999999999999999999765


Q ss_pred             CCCCCeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 009594          194 KESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR  272 (531)
Q Consensus       194 ~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~  272 (531)
                      +   .+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..|+...  ......+..
T Consensus       159 ~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~  233 (284)
T 2a19_B          159 K---QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD  233 (284)
T ss_dssp             T---EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred             C---CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence            4   49999999998776655555667999999999887 56899999999999999999999887432  122222222


Q ss_pred             cccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      ..      ....+++.+.++|.+||..+|++|||+.++++|.|...
T Consensus       234 ~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 GI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            11      12357899999999999999999999999999987654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.7e-45  Score=356.43  Aligned_cols=260  Identities=29%  Similarity=0.561  Sum_probs=203.0

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCC---CCCCeeec
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP---KHPNIVSL  122 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~niv~l  122 (531)
                      ..+..+.++|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.+++++.   +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            3456778899999999999999999999999999999999976543221   12234556888888874   79999999


Q ss_pred             ceEEEcCCeEEEEEec-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEE
Q 009594          123 KDTYEDDSAVHIVMEL-CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       123 ~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                      ++++...+..++|+|| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.  .++.+||
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl  181 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKL  181 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEE
Confidence            9999998999999999 789999999998888999999999999999999999999999999999999972  2345999


Q ss_pred             EeeccccccCCCCccccccCCcccccchhccc-cC-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC
Q 009594          202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR  279 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  279 (531)
                      +|||++...... ......||+.|+|||++.+ .+ +.++||||||+++|+|++|..||....      .+......+  
T Consensus       182 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~--  252 (312)
T 2iwi_A          182 IDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHF--  252 (312)
T ss_dssp             CCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCC--
T ss_pred             EEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCC--
Confidence            999999876543 3345678999999998863 33 458999999999999999999996531      122222221  


Q ss_pred             CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       280 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                        ...+++.+.++|.+||..+|++|||+.++++||||+....
T Consensus       253 --~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          253 --PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             --cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence              2467899999999999999999999999999999987543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5e-44  Score=351.57  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=208.8

Q ss_pred             cccceeeccccCccCceEEEEEEE-----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTD-----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .......+.+|+.+++++.+||||+++++++..
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            456899999999999999999985     3467899999997543  334456788999999999789999999999876


Q ss_pred             C-CeEEEEEeccCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEee
Q 009594          129 D-SAVHIVMELCEGGELFDRIVARGH----------------YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFA  191 (531)
Q Consensus       129 ~-~~~~lv~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~  191 (531)
                      . ..+++||||+++++|.+++.....                +++..++.++.||+.||.|||++||+||||||+||+++
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  182 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence            5 459999999999999999987543                88999999999999999999999999999999999996


Q ss_pred             cCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHH
Q 009594          192 NKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV  266 (531)
Q Consensus       192 ~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~  266 (531)
                      .+   +.+||+|||++........   .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.+......
T Consensus       183 ~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          183 EK---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             GG---GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CC---CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            54   4599999999986644322   23456788999999886 568999999999999999998 9999987664443


Q ss_pred             HHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ............  ....+++.+.++|.+||+.+|.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333332222111  124578999999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.9e-44  Score=364.65  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=201.0

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++....      .+.+.+|+.+++++.+||||+++++++...+.
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            4566678888999999999998754 4689999999986532      35677899999987689999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC----------
Q 009594          132 VHIVMELCEGGELFDRIVARGHY-------TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK----------  194 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l-------~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~----------  194 (531)
                      .+||||||+ |+|.+++......       ++..++.++.||+.||.|||++||+||||||+|||++..+          
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence            999999996 5999999765432       2234578999999999999999999999999999997542          


Q ss_pred             CCCCeEEEeeccccccCCCCc-----cccccCCcccccchhcc--------ccCCCccchhHHHHHHHHHhh-CCCCCCC
Q 009594          195 ESSPLKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLC-GVPPFWA  260 (531)
Q Consensus       195 ~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~il~~l~t-g~~pf~~  260 (531)
                      ....+||+|||++........     .....||+.|+|||++.        ..++.++|||||||++|+|+| |..||..
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            345699999999987654332     23457999999999885        357889999999999999999 9999976


Q ss_pred             CCHHHHHHHHHhcccCCCCCC---CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          261 ETEQGVAQAIIRSVIDFKRDP---WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      .....  ..+...........   ...+++++.+||.+||+.||++|||+.++++||||+.
T Consensus       243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            55433  33444433332221   1234578999999999999999999999999999974

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3e-44  Score=360.22  Aligned_cols=256  Identities=15%  Similarity=0.197  Sum_probs=195.9

Q ss_pred             cccceeeccccCccCceEEEEEEEccC-----CcEEEEEEeeccccCChhh--------HHHHHHHHHHHHhCCCCCCee
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVD--------IEDVRREVQIMKHLPKHPNIV  120 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~~h~niv  120 (531)
                      ...+|++.+.||+|+||.||+|.+..+     ++.||+|++.........+        ......|+..++.+ +||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCC
Confidence            344899999999999999999998664     5889999987543110000        11233455556666 799999


Q ss_pred             ecceEEEcC----CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC
Q 009594          121 SLKDTYEDD----SAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE  195 (531)
Q Consensus       121 ~l~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~  195 (531)
                      ++++++...    ...+|||||+ |++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.. .
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~  189 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-N  189 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-C
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-C
Confidence            999998754    5689999999 99999999875 579999999999999999999999999999999999999732 3


Q ss_pred             CCCeEEEeeccccccCCCCc--------cccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHH
Q 009594          196 SSPLKAIDFGLSVFFRPGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV  266 (531)
Q Consensus       196 ~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~  266 (531)
                      .+.+||+|||+|..+.....        .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+......
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            45699999999976643321        123459999999999874 589999999999999999999999976432222


Q ss_pred             HHHHHh-c----ccCCCCC--CCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          267 AQAIIR-S----VIDFKRD--PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       267 ~~~~~~-~----~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ...... .    .......  ....+|+.+.+++..||..+|++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            111111 0    0000000  11467999999999999999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-43  Score=339.34  Aligned_cols=246  Identities=24%  Similarity=0.398  Sum_probs=210.6

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEE
Confidence            47999999999999999999975 678999999976432    236788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||++.......
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG---GCEEECCTTGGGGBCCHH
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC---CCEEEccccccccccccc
Confidence            9999999999999765 458999999999999999999999999999999999999654   459999999998654322


Q ss_pred             --ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          215 --QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       215 --~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                        ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+.......   ....+++.+.
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~  235 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVY  235 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHHH
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC---CCccCcHHHH
Confidence              122345678899999987 578999999999999999999 899999888777776665543221   1235789999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcC
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +++.+||..+|++|||+.+++++
T Consensus       236 ~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          236 QIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.2e-43  Score=342.80  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=207.7

Q ss_pred             ccceeecc-ccCccCceEEEEEEE--ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           55 SIDYDLGR-ELGRGEFGVTYLCTD--VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        55 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..+|++.+ .||+|+||.||+|.+  ..++..||+|++..... .....+.+.+|+.+++.+ +||||+++++++ ..+.
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCC
Confidence            45799998 999999999999954  56678999999975532 233357789999999999 999999999999 5667


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      .++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++....
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEECC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC---cEEEccCCcceeec
Confidence            899999999999999999888899999999999999999999999999999999999997654   59999999998765


Q ss_pred             CCCcc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          212 PGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       212 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      .....    ....+|+.|+|||++. ..++.++||||||+++|+|+| |..||...........+.....   ......+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  245 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGC  245 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence            44321    2234678899999887 468889999999999999999 9999998887776665554322   1122468


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ++.+.++|.+||..+|++|||+.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999975

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-43  Score=344.45  Aligned_cols=255  Identities=22%  Similarity=0.401  Sum_probs=198.9

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      +.++...++|++.+.||+|+||.||+|.+.   ..+|+|++.... ......+.+.+|+.+++++ +||||++++++. .
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~   90 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-T   90 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-C
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-c
Confidence            445677788999999999999999999843   359999986543 2444567889999999999 999999999965 5


Q ss_pred             CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      ....++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~---~~kl~Dfg~~  167 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN---TVKIGDFGLA  167 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT---EEEECCCC--
T ss_pred             CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC---CEEEccceec
Confidence            5678999999999999999864 34699999999999999999999999999999999999997544   5999999999


Q ss_pred             cccCCC---CccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-hcccCCC-
Q 009594          208 VFFRPG---EQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII-RSVIDFK-  278 (531)
Q Consensus       208 ~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~~~~-  278 (531)
                      ......   .......||+.|+|||++.    ..++.++||||||+++|+|++|..||............. ....... 
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence            765432   2234457899999999875    357889999999999999999999998866554444333 3322222 


Q ss_pred             CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       279 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ......+|+.+.+||.+||..+|++|||+.++++
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2223468999999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=348.64  Aligned_cols=253  Identities=21%  Similarity=0.308  Sum_probs=206.2

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNG----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      +....+|++.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++++ +||||+++++++.
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  116 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVIS  116 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEe
Confidence            344567999999999999999999876543    459999986543  334456788999999999 9999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||+
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~---~~~~kl~Dfg~  193 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS---NLVCKVSDFGL  193 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCCCC
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC---CCcEEECCCCc
Confidence            999999999999999999999764 56999999999999999999999999999999999999964   44699999999


Q ss_pred             ccccCCCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCC
Q 009594          207 SVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRD  280 (531)
Q Consensus       207 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~  280 (531)
                      +........    .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+.....   .+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---~~  270 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LP  270 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CC
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc---CC
Confidence            987653321    12234678899999887 578999999999999999999 9999988887777666654421   12


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ....+++.+.+++.+||..+|++|||+.+++++
T Consensus       271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            234688999999999999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.5e-44  Score=354.54  Aligned_cols=254  Identities=20%  Similarity=0.313  Sum_probs=204.8

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ....++|++.+.||+|+||.||+|.+ .+++.||+|++....   ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCe
Confidence            34567899999999999999999995 578999999886542   23457889999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          132 VHIVMELCEGGELFDRIVARG----HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      .++||||+++++|.+++....    .+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE---NFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT---TCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC---CCCEEEeecccc
Confidence            999999999999999886543    4899999999999999999999999999999999999964   456999999999


Q ss_pred             cccCCCC---ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHH-------HHHhccc-
Q 009594          208 VFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-------AIIRSVI-  275 (531)
Q Consensus       208 ~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~-------~~~~~~~-  275 (531)
                      .......   ......||+.|+|||++. +.++.++||||||+++|+|+||..||..........       ....... 
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            8654322   223456899999999876 679999999999999999999999997644321110       0111110 


Q ss_pred             CCCC-----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          276 DFKR-----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       276 ~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ....     ...+..++.+.+++.+||..+|++|||+.+++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0000     1112345678999999999999999999999976

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.7e-43  Score=340.42  Aligned_cols=252  Identities=25%  Similarity=0.301  Sum_probs=207.2

Q ss_pred             CccccceeeccccCccCceEEEEEEEcc---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      .....+|++.+.||+|+||.||+|.+..   ++..||+|++....  .....+.+.+|+.+++++ +||||+++++++..
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE   84 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC
Confidence            3445689999999999999999998654   34569999987542  334567889999999999 99999999999875


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      . ..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||++
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~  160 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLS  160 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT---EEEECCCCGG
T ss_pred             C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC---cEEeCccCCC
Confidence            4 5689999999999999997654 599999999999999999999999999999999999997654   5999999999


Q ss_pred             cccCCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          208 VFFRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       208 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      ........  .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||...........+......   ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  237 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---PKPD  237 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---CCCT
T ss_pred             cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---CCCC
Confidence            87654322  23345788999999887 578999999999999999998 99999887776666555544221   1224


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+++.+.+++.+||..+|++|||+.+++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            578999999999999999999999999865

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-43  Score=345.81  Aligned_cols=253  Identities=21%  Similarity=0.267  Sum_probs=204.0

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecce-EEEcCCe
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD-TYEDDSA  131 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~-~~~~~~~  131 (531)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++......     ..+.+|+.+++.+ .|++++..+. ++.....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHh-hcCCCCCccccccCCCCc
Confidence            4567899999999999999999999999999999998754322     3578899999999 6666555554 4467788


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++..+.++.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999999 8999999974 456999999999999999999999999999999999999964334566999999999876


Q ss_pred             CCCCc--------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHhcccCCC
Q 009594          211 RPGEQ--------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVIDFK  278 (531)
Q Consensus       211 ~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~  278 (531)
                      .....        .....||+.|+|||++. ..++.++|||||||++|+|++|..||.....   ......+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            54322        23457999999999987 4689999999999999999999999976432   122223322222111


Q ss_pred             C-CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          279 R-DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       279 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      . ...+.+|+.+.+++.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1 112467899999999999999999999999976

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-43  Score=340.90  Aligned_cols=250  Identities=25%  Similarity=0.336  Sum_probs=209.9

Q ss_pred             ccceeecc-ccCccCceEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           55 SIDYDLGR-ELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        55 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++++ +||||+++++++ ..+.
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCC
Confidence            45688877 9999999999999854  468889999997542  344567889999999999 999999999999 4566


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT---EEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC---CEEECcccceeee
Confidence            89999999999999998654 4599999999999999999999999999999999999997544   5999999999876


Q ss_pred             CCCCcc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          211 RPGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       211 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      ......    ....+|+.|+|||++. ..++.++||||||+++|+|+| |..||...........+.....   ....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~  237 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPE  237 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCTT
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc---CCCCCC
Confidence            543321    2335688999999887 568999999999999999998 9999988877776666555432   122246


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcCC
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHP  314 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h~  314 (531)
                      +++.+.++|.+||..+|++|||+.+++++.
T Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          238 CPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            899999999999999999999999999873

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=366.34  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=197.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||+||. ....+|+.||||++.....      ..+.+|+.+++.+.+||||+++++++.+....|||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            3699999999999999764 3347899999999965432      22457999999997899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC--CCCCeEEEeeccccccCC
Q 009594          136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~--~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+  ....+||+|||+|.....
T Consensus        97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            99996 59999987654 356667789999999999999999999999999999996433  234578999999987654


Q ss_pred             CC----ccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          213 GE----QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       213 ~~----~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      ..    ......||+.|+|||++.    ..++.++|||||||++|+|+| |..||.......... +.............
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~  254 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACSLDCLHPEK  254 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCCCTTSCTTC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCCccccCccc
Confidence            32    234467999999999886    356789999999999999999 999996654433222 22111111111112


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ..+..+.+||.+||+.||++|||+.++++||||+..
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            245668999999999999999999999999999754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-43  Score=363.41  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=205.3

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-eE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-AV  132 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~~  132 (531)
                      -..+|++.+.||+|+||.||+|..  .|+.||+|++....     ..+.+.+|+.+++++ +||||+++++++.... ..
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCce
Confidence            345799999999999999999986  47899999997543     346788999999999 9999999999987654 79


Q ss_pred             EEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          133 HIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ++||||+++|+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC---CCCEEEeeCCCcccc
Confidence            999999999999999987654  799999999999999999999999999999999999964   446999999999865


Q ss_pred             CCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ....  ....+++.|+|||++. +.++.++|||||||++|+|+| |..||......+....+.....   ......+|+.
T Consensus       340 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~~~~  414 (450)
T 1k9a_A          340 SSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPA  414 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTCCHH
T ss_pred             cccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHH
Confidence            3322  2336788999999886 578999999999999999998 9999988877776666654421   1223468999


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +.+||.+||..+|++|||+.++++
T Consensus       415 l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          415 VYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999975

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.1e-43  Score=339.09  Aligned_cols=246  Identities=15%  Similarity=0.232  Sum_probs=208.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC--Ce
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SA  131 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~  131 (531)
                      -..+|++.+.||+|+||.||+|.+  .++.||+|++..... .....+.+.+|+.+++++ +||||+++++++...  +.
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCC
Confidence            345799999999999999999996  488999999976533 334457789999999999 999999999999876  78


Q ss_pred             EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          132 VHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      .++||||+++++|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+||+++.+   +.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~---~~~~l~~~~~~  160 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED---MTARISMADVK  160 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT---SCEEEEGGGSC
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC---cceeEEeccce
Confidence            999999999999999998765  4899999999999999999999999  9999999999999644   45899999887


Q ss_pred             cccCCCCccccccCCcccccchhccc-cCC---CccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKR-NYG---PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~---~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      .....    ....||+.|+|||++.+ .++   .++||||||+++|+|++|..||...........+.......  ....
T Consensus       161 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  234 (271)
T 3kmu_A          161 FSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TIPP  234 (271)
T ss_dssp             CTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--CCCT
T ss_pred             eeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--CCCC
Confidence            54322    34578999999998874 233   37999999999999999999999888877766665543332  2235


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+++.+.+++.+||+.+|++|||+.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            68999999999999999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-43  Score=368.18  Aligned_cols=248  Identities=21%  Similarity=0.353  Sum_probs=212.6

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      -..+|++.+.||+|+||.||+|.+..++..||+|++.....    ..+.+.+|+.+++++ +||||+++++++......+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEE
Confidence            44579999999999999999999988899999999865432    357889999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          134 IVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++...
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN---HLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---GCEEECCTTCEECCT
T ss_pred             EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC---CcEEEeecccceecc
Confidence            999999999999999764  358999999999999999999999999999999999999654   459999999998765


Q ss_pred             CCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ....  .....+++.|+|||++. +.++.++|||||||++|+|+| |..||.+.........+.... .  ......+++
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~  446 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-R--MERPEGCPE  446 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-C--CCCCTTCCH
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C--CCCCCCCCH
Confidence            4322  12344678899999887 678999999999999999999 999998887766665554432 1  222356899


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+.+||.+||+.+|++|||+.++++
T Consensus       447 ~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          447 KVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCcChhHCcCHHHHHH
Confidence            9999999999999999999999976

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=348.51  Aligned_cols=249  Identities=21%  Similarity=0.310  Sum_probs=201.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEE----EEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ..+|++++.||+|+||.||+|.+..+++.+    |+|.+....  .......+.+|+.+++++ +||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC
Confidence            457999999999999999999998888766    555554322  233457889999999999 9999999999998765


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          131 AVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                       .++|+||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++..
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTC---
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC---CEEEccCcceeE
Confidence             78999999999999999764 5699999999999999999999999999999999999997654   499999999987


Q ss_pred             cCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          210 FRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       210 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      ......   .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+.........+.....   ....+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~  243 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPI  243 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence            643322   22345678899999887 568999999999999999999 9999988877766655554332   122246


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +++.+.++|.+||..+|.+|||+.++++.
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            79999999999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=358.56  Aligned_cols=257  Identities=18%  Similarity=0.215  Sum_probs=198.7

Q ss_pred             cccceeeccccCccCceEEEEEEEcc---CCcEEEEEEeeccccCChh--------hHHHHHHHHHHHHhCCCCCCeeec
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAV--------DIEDVRREVQIMKHLPKHPNIVSL  122 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l  122 (531)
                      ...+|++.+.||+|+||.||+|.+..   ++..+|+|++.........        ....+.+|+..++.+ +||||+++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~  113 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLF  113 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCccee
Confidence            34589999999999999999999987   7889999998754321100        113456788899999 99999999


Q ss_pred             ceEEEc----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCC
Q 009594          123 KDTYED----DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       123 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                      ++++..    ....++||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~  191 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQ  191 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TTS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CCc
Confidence            999887    78899999999 999999998777899999999999999999999999999999999999997654 236


Q ss_pred             eEEEeeccccccCCCC--------ccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHH
Q 009594          199 LKAIDFGLSVFFRPGE--------QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQ  268 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~  268 (531)
                      +||+|||++..+....        ......||+.|+|||++.+ .++.++|||||||++|+|+||..||...... ....
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            9999999998664321        1134579999999999874 5899999999999999999999999653221 1111


Q ss_pred             HHHhcc-cCCCC-----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          269 AIIRSV-IDFKR-----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       269 ~~~~~~-~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ...... ...+.     .....+++.+.++|.+||..+|++|||+.++++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            111111 11110     0112688999999999999999999999999764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.1e-44  Score=351.35  Aligned_cols=246  Identities=23%  Similarity=0.322  Sum_probs=194.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC----e
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS----A  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~  131 (531)
                      .+|++.+.||+|+||.||+|++.  ++.||+|++....    .......+|+.+++++ +||||+++++++....    .
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCce
Confidence            47999999999999999999864  8999999996532    2234556689999999 8999999999997643    4


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeecCCCCCceEeecCCCCCCeEE
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ----------GVMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                      +++||||+++|+|.+++... .+++..++.++.|++.||.|||+.          ||+||||||+|||++.   ++.+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~---~~~~kL  172 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN---NLTACI  172 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT---TCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC---CCeEEE
Confidence            79999999999999999764 599999999999999999999999          9999999999999964   456999


Q ss_pred             EeeccccccCCCCc---cccccCCcccccchhccc------cCCCccchhHHHHHHHHHhhCCCCCCCCCH---------
Q 009594          202 IDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETE---------  263 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~---------  263 (531)
                      +|||+|........   .....||+.|+|||++.+      .++.++|||||||++|+|+||..||.+...         
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987654332   234579999999998864      456688999999999999999999965421         


Q ss_pred             -------HHHHHHHHhcccCCCC-CCCC--CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          264 -------QGVAQAIIRSVIDFKR-DPWP--KVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       264 -------~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                             ......+......... ..+.  ..++.+.+||.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                   1111112111111110 0011  12456999999999999999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.2e-43  Score=362.84  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=210.4

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .....+|++.+.||+|+||.||+|.+. .+..||||++....    ...+.+.+|+.+++++ +||||+++++++. .+.
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSS
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCc
Confidence            344568999999999999999999974 57889999997543    2357889999999999 9999999999986 567


Q ss_pred             EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          132 VHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      .++||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARV  333 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT---TCCEEECSTTGGGG
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC---CCcEEEeeCCCceE
Confidence            89999999999999999754  36899999999999999999999999999999999999964   45699999999987


Q ss_pred             cCCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          210 FRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       210 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ......  .....+|+.|+|||++. +.++.++|||||||++|+|+| |..||.+....+....+.....   .+....+
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~  410 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENC  410 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---CCCCTTS
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence            643221  12334678899999987 679999999999999999999 9999999888877777665432   1222468


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      |+.+.+||.+||..+|++|||+.++++
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            999999999999999999999999975

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-43  Score=344.34  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=198.7

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecce-EEEcCCe
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD-TYEDDSA  131 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~-~~~~~~~  131 (531)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++......     ..+.+|+.+++.+ .|++++..+. ++.....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHh-cCCCCCCeeeeecCCCCc
Confidence            4567899999999999999999999999999999987654322     3467899999999 6666555554 4577888


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            99999999 8999999875 456999999999999999999999999999999999999954344556999999999876


Q ss_pred             CCCCc--------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHhcccCCC
Q 009594          211 RPGEQ--------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVIDFK  278 (531)
Q Consensus       211 ~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~  278 (531)
                      .....        .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+....   .....+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            54322        23467899999999887 46899999999999999999999999764322   12222222211111


Q ss_pred             -CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          279 -RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       279 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                       ......+|+.+.+++.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence             1112467899999999999999999999999976

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.7e-43  Score=343.51  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=202.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEcc-CCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVN-NGE--KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      ....+|++.+.||+|+||.||+|.+.. ++.  .||+|++...........+.+.+|+.+++++ +||||+++++++...
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP   93 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC
Confidence            345689999999999999999998643 333  6899998766544455677899999999999 899999999999876


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 SAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      . .++|+||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~---~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC---CEEEccccccc
Confidence            5 88999999999999998764 5699999999999999999999999999999999999997654   49999999998


Q ss_pred             ccCCCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          209 FFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       209 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      .......    .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+.......+  ..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~  247 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RP  247 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CC
Confidence            7654332    12345788899999887 568889999999999999999 9999998888777776665433322  23


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ..+++.+.++|.+||..+|++|||+.++++
T Consensus       248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            468999999999999999999999999987

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=348.00  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=201.7

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE----cCC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE----DDS  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~----~~~  130 (531)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.+ +||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCc
Confidence            35799999999999999999999999999999998653   344567888999999999 9999999999986    345


Q ss_pred             eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecc
Q 009594          131 AVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL  206 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~  206 (531)
                      ..++||||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE---GQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC---CCEEEEecCc
Confidence            78999999999999998875    4569999999999999999999999999999999999999644   4599999999


Q ss_pred             ccccCCCCc----------cccccCCcccccchhccc----cCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHH
Q 009594          207 SVFFRPGEQ----------FNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAII  271 (531)
Q Consensus       207 a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~  271 (531)
                      +........          .....||+.|+|||++.+    .++.++||||||+++|+|++|..||...... .......
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            876532111          123457999999998863    3689999999999999999999999431110 0111112


Q ss_pred             hcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ....  ..+..+.+++.+.++|.+||+.+|.+|||+.+++++
T Consensus       261 ~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          261 QNQL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccC--CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            2211  222235689999999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-44  Score=381.49  Aligned_cols=262  Identities=27%  Similarity=0.422  Sum_probs=212.3

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc------
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED------  128 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~------  128 (531)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++++ +||||+++++++..      
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccC
Confidence            367999999999999999999999999999999986542  344567889999999999 99999999998755      


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          129 DSAVHIVMELCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                      .+..++||||++|++|.+++....   .+++..++.++.|++.||.|||+.||+||||||+||+++.++....+||+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            677899999999999999997644   58999999999999999999999999999999999999877666669999999


Q ss_pred             cccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHH---------H-----
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA---------I-----  270 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~---------~-----  270 (531)
                      ++.............||+.|+|||++. +.++.++|||||||++|+|++|..||.+.........         .     
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            998877666566678999999999887 5789999999999999999999999976533221000         0     


Q ss_pred             HhcccCC------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          271 IRSVIDF------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       271 ~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      ......+      +....+.+++.+.+||.+||..||++|||+.++++||||+..
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence            0000000      111122357889999999999999999999999999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.3e-43  Score=344.49  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=200.7

Q ss_pred             cccceeeccccCccCceEEEEEEEcc---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  130 (531)
                      ...+|++.+.||+|+||.||+|.+..   ++..||+|++..... .......+.+|+.+++++ +||||+++++++....
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC--
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeecc
Confidence            34579999999999999999998765   456899999875432 344567789999999999 8999999999987654


Q ss_pred             -----eEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCe
Q 009594          131 -----AVHIVMELCEGGELFDRIVA------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL  199 (531)
Q Consensus       131 -----~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~i  199 (531)
                           ..++||||+++++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~---~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT---SCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CcE
Confidence                 45999999999999999843      3469999999999999999999999999999999999999644   459


Q ss_pred             EEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcc
Q 009594          200 KAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV  274 (531)
Q Consensus       200 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  274 (531)
                      ||+|||++........   .....+++.|+|||++. ..++.++||||||+++|+|++ |.+||...........+....
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            9999999986654322   22345788999999886 568999999999999999999 999998887777666665543


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .   ......+++.+.++|.+||..+|++|||+.+++++
T Consensus       267 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 R---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             C---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             C---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2   12234688999999999999999999999999865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.7e-43  Score=347.15  Aligned_cols=249  Identities=23%  Similarity=0.342  Sum_probs=205.0

Q ss_pred             cceeeccccCccCceEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE--cC
Q 009594           56 IDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--DD  129 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~  129 (531)
                      .+|++.+.||+|+||.||+|.    +..+++.||+|++...   .....+.+.+|+.+++++ +||||+++++++.  ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCC
Confidence            579999999999999999998    5678999999998654   344456789999999999 9999999999886  45


Q ss_pred             CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 SAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ...++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~---~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA---HVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC---CEEEcccccce
Confidence            679999999999999999976 44699999999999999999999999999999999999997654   49999999998


Q ss_pred             ccCCCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH--------------HHHH
Q 009594          209 FFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------VAQA  269 (531)
Q Consensus       209 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~--------------~~~~  269 (531)
                      .......    .....||+.|+|||++. ..++.++||||||+++|+|++|..||.......              ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            7654332    22345788899999887 568899999999999999999999985533211              1111


Q ss_pred             HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ......  .....+.+++.+.+||.+||..+|++|||+.+++++
T Consensus       256 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          256 LLEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhhccc--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111111  122235689999999999999999999999999765

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-43  Score=344.93  Aligned_cols=246  Identities=25%  Similarity=0.399  Sum_probs=195.2

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHh--CCCCCCeeecceEEEc-
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH--LPKHPNIVSLKDTYED-  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~~~-  128 (531)
                      ..+.++|++.+.||+|+||.||+|.+  +++.||+|++...      ....+.+|.+++..  + +||||+++++++.. 
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS   74 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence            45778999999999999999999986  6899999998643      23556667777776  6 89999999998643 


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCceEeecCCCCC
Q 009594          129 ---DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH--------EQGVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       129 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~iiH~Dlkp~NIll~~~~~~~  197 (531)
                         ....++||||+++|+|.+++. ...+++..++.++.||+.||.|||        ++||+||||||+|||++.+   +
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~---~  150 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN---G  150 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT---S
T ss_pred             cCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC---C
Confidence               356899999999999999995 457999999999999999999999        9999999999999999644   4


Q ss_pred             CeEEEeeccccccCCCCc-----cccccCCcccccchhccc-------cCCCccchhHHHHHHHHHhhC----------C
Q 009594          198 PLKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCG----------V  255 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg----------~  255 (531)
                      .+||+|||+|........     .....||+.|+|||++.+       .++.++|||||||++|+|+||          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            599999999976543322     223479999999999874       344689999999999999999          8


Q ss_pred             CCCCCCCH----HHHHHHHHhcccCCCCCCCC------CCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          256 PPFWAETE----QGVAQAIIRSVIDFKRDPWP------KVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       256 ~pf~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .||.....    ............  .....+      ..++.+.+|+.+||+.||++|||+.++++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQ--QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSC--CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccC--CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            88855322    122222221111  111111      24578999999999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=353.35  Aligned_cols=248  Identities=16%  Similarity=0.201  Sum_probs=199.8

Q ss_pred             ccceeeccccCccCceEEEEEEEcc--------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeee-----
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVN--------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS-----  121 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~-----  121 (531)
                      .++|++.+.||+|+||.||+|.+..        .++.||+|++...        ..+.+|+.+++++ +||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRA-AKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHH-CCHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHh-cccchhhhhhhh
Confidence            4689999999999999999999887        4889999998643        3567899999999 8999887     


Q ss_pred             ----------cceEEEc-CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCce
Q 009594          122 ----------LKDTYED-DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF  188 (531)
Q Consensus       122 ----------l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NI  188 (531)
                                +++++.. ....++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      5666665 78899999999 99999999875  6799999999999999999999999999999999999


Q ss_pred             EeecCCCCCCeEEEeeccccccCCCCc--------cccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCC
Q 009594          189 LFANKKESSPLKAIDFGLSVFFRPGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFW  259 (531)
Q Consensus       189 ll~~~~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~  259 (531)
                      |++.++ ...+||+|||++........        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus       191 l~~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          191 FVDPED-QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEETTE-EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEcCCC-CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            997543 12599999999976643221        133478999999999874 68999999999999999999999997


Q ss_pred             CCC-HHHHHHHHHh----cccCCC--CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          260 AET-EQGVAQAIIR----SVIDFK--RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       260 ~~~-~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ... ..........    ......  ...+..+++.+.+||.+||..+|++|||+.++++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            764 2222222221    111111  11234579999999999999999999999999763

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-42  Score=334.87  Aligned_cols=248  Identities=24%  Similarity=0.327  Sum_probs=208.9

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .....+|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++++ +||||+++++++.. +.
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SS
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhC-CCcCcceEEEEEcC-CC
Confidence            345568999999999999999999964 677899999865432    246788999999999 99999999999864 56


Q ss_pred             EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          132 VHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++..
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARL  158 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEE
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC---CCCEEECCCccccc
Confidence            899999999999999986543  6899999999999999999999999999999999999964   44599999999987


Q ss_pred             cCCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          210 FRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       210 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ......  .....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+.....   ......+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  235 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPDNC  235 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTC
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---CCCcccc
Confidence            654332  22345678899999887 568999999999999999999 9999998887777666655422   1222468


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ++.+.+++.+||..+|++|||+.++++
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999999999976

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-42  Score=339.05  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=204.5

Q ss_pred             cccceeeccccCccCceEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE-EcC
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY-EDD  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~-~~~  129 (531)
                      ...+|++.+.||+|+||.||+|.+..+   ...+|+|.+...  ......+.+.+|+.+++++ +||||+++++++ ...
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSE   99 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCC
Confidence            345799999999999999999997543   346889988643  2444567889999999999 899999999985 456


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 SAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      +..++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++.
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~a~  176 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE---KFTVKVADFGLAR  176 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TCCEEECSCGGGC
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECC---CCCEEECcccccc
Confidence            7889999999999999999763 45899999999999999999999999999999999999954   4469999999998


Q ss_pred             ccCCCCc-----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 009594          209 FFRPGEQ-----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDP  281 (531)
Q Consensus       209 ~~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  281 (531)
                      .......     .....+|+.|+|||++. ..++.++||||||+++|+|++ |.+||...........+........   
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  253 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---  253 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---
Confidence            6643321     22345788999999887 568999999999999999999 6778877766666655555432222   


Q ss_pred             CCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       282 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ...+++.+.+++.+||..+|++|||+.++++
T Consensus       254 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          254 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2457899999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.4e-43  Score=350.02  Aligned_cols=258  Identities=19%  Similarity=0.239  Sum_probs=203.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ....++|++.+.||+|+||.||+|.+ .+|+.||+|++.......  ....+.+|+.+++.+ +||||+++++++...+.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  101 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE  101 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSC
T ss_pred             HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhc-cCCCccceEEEEecCCc
Confidence            44567899999999999999999984 578999999997644221  123678999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          132 VHIVMELCEGGELFDRIVARG----HYTERAAAAVMKTIVEVVQVCHEQ---GVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~---~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      .++||||+++++|.+++....    .+++..+..++.|++.||.|||++   ||+||||||+|||++.   ++.+||+||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~---~~~~kl~Df  178 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF  178 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT---TCCEEECCC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC---CCCEEeccC
Confidence            999999999999999997643    389999999999999999999999   9999999999999964   445999999


Q ss_pred             ccccccCCCC--ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHhcccCC
Q 009594          205 GLSVFFRPGE--QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVIDF  277 (531)
Q Consensus       205 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~  277 (531)
                      |++.......  ......||+.|+|||++. +.++.++|||||||++|+|+||..||....    ...............
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            9998765332  233456999999999886 578999999999999999999999994210    000011111111110


Q ss_pred             C------C-----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          278 K------R-----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       278 ~------~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      .      .     ......++.+.+++.+||+.+|++|||+.++++|-.-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            0      0     0011234679999999999999999999999988543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-43  Score=351.85  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=196.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE-cCCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNG---EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-DDSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-~~~~  131 (531)
                      ..|++.+.||+|+||.||+|.+..++   ..||+|.+...  ........+.+|+.+++++ +||||+++++++. ..+.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC
Confidence            46889999999999999999875433   46899988643  2344567899999999999 9999999999864 4568


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE---KFTVKVADFGLARDM  242 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCC------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC---CCCEEEeeccccccc
Confidence            899999999999999997643 5899999999999999999999999999999999999964   446999999999865


Q ss_pred             CCCCc-----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Q 009594          211 RPGEQ-----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP  283 (531)
Q Consensus       211 ~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  283 (531)
                      .....     .....+|+.|+|||++. +.++.++|||||||++|+|+| |.+||......+....+......   ....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~---~~p~  319 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---LQPE  319 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC---CCCT
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence            43321     12345778899999887 578999999999999999999 78888777666555555543321   1124


Q ss_pred             CCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       284 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+++.+.++|.+||..+|++|||+.+++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            589999999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.4e-42  Score=357.73  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=206.5

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ....+|++.+.||+|+||.||+|.+.. +..||+|++.....    ..+.+.+|+.+++++ +||||+++++++.. +..
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-Cce
Confidence            445679999999999999999999754 56799999975432    246789999999999 99999999999876 678


Q ss_pred             EEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          133 HIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      ++||||+++|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++...
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLI  330 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC--
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC---CCEEECCCccceec
Confidence            999999999999999964  3468999999999999999999999999999999999999644   45999999999876


Q ss_pred             CCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          211 RPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       211 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .....  .....+++.|+|||++. +.++.++|||||||++|+|+| |..||.+....+....+.....   .+..+.+|
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~  407 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECP  407 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSC
T ss_pred             CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence            53321  12345678899999886 678999999999999999999 9999999888777776655422   12224689


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcC--Cccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEH--PWLQ  317 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h--~~~~  317 (531)
                      +.+.+||.+||..+|++|||+.++++.  .++.
T Consensus       408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            999999999999999999999999863  4444

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-42  Score=336.25  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=203.0

Q ss_pred             ceeeccccCccCceEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE-
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV-  132 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~-  132 (531)
                      .|++.+.||+|+||.||+|.+..++.   .+|+|++...  ......+.+.+|+.+++++ +||||+++++++...+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCc
Confidence            57888999999999999999765544   7999998643  2444567888999999999 999999999999766554 


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~---~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE---SFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC---CCcEEeCcCCCccccc
Confidence            999999999999999976 456899999999999999999999999999999999999964   4469999999997654


Q ss_pred             CCC-----ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          212 PGE-----QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       212 ~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      ...     ......+|+.|+|||.+. ..++.++||||||+++|+|++ |.+||...........+.....   ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  252 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---LPQPEY  252 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---CCCCTT
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---CCCCcc
Confidence            322     223456788999999987 468999999999999999999 5555665555555554444332   112245


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +++.+.+++.+||..+|.+|||+.++++.
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78999999999999999999999999763

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-42  Score=357.64  Aligned_cols=254  Identities=20%  Similarity=0.274  Sum_probs=207.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++......     ..+.+|+.+++.+..|++|+.+..++......
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4567899999999999999999999999999999988754322     34678999999995557777777777888899


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +|||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+...+..+.+||+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 8999999975 4579999999999999999999999999999999999999644445679999999998765


Q ss_pred             CCCc--------cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHhcccCCC-
Q 009594          212 PGEQ--------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVIDFK-  278 (531)
Q Consensus       212 ~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~-  278 (531)
                      ....        .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+...   ......+........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            4322        12567999999999987 5689999999999999999999999977543   222333322221111 


Q ss_pred             CCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       279 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ......+++++.+||..||..+|++||++.+|++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1112467899999999999999999999998875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.3e-43  Score=342.82  Aligned_cols=252  Identities=25%  Similarity=0.333  Sum_probs=203.0

Q ss_pred             Cccccce-eeccccCccCceEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE
Q 009594           52 QDISIDY-DLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY  126 (531)
Q Consensus        52 ~~~~~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  126 (531)
                      ..+..+| ++++.||+|+||.||++.    +..+++.||+|++....  .......+.+|+.+++++ +||||+++++++
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  102 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTL-YHEHIIKYKGCC  102 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCcchhhEEEEE
Confidence            3466666 999999999999998875    34578999999997542  344567789999999999 899999999999


Q ss_pred             Ec--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          127 ED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       127 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      .+  ...+++||||+++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.   ++.+||+||
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~---~~~~kl~Df  178 (318)
T 3lxp_A          103 EDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN---DRLVKIGDF  178 (318)
T ss_dssp             EETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCG
T ss_pred             ecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC---CCCEEECCc
Confidence            86  46799999999999999998665 5999999999999999999999999999999999999964   445999999


Q ss_pred             ccccccCCCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH--------------
Q 009594          205 GLSVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------  265 (531)
Q Consensus       205 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~--------------  265 (531)
                      |++........    .....+|+.|+|||++. ..++.++||||||+++|+|+||..||.......              
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL  258 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence            99987765432    23356788899999887 468889999999999999999999986532210              


Q ss_pred             HHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ..........  .......+++.+.+||.+||+.+|++|||+.++++
T Consensus       259 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          259 RLTELLERGE--RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccc--CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            0111111111  12223468999999999999999999999999974

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.3e-43  Score=342.32  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=201.8

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeecccc-CChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      |...+.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEE
Confidence            45558999999999999984  688999999875432 2233457788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          137 ELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       137 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE---AFTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TCCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC---CCcEEEeecccccccccc
Confidence            99999999999864   345899999999999999999999999999999999999964   446999999999866543


Q ss_pred             Cc---cccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc-----------CCCC
Q 009594          214 EQ---FNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI-----------DFKR  279 (531)
Q Consensus       214 ~~---~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-----------~~~~  279 (531)
                      ..   .....||+.|+|||++.+.++.++||||||+++|+|++|.+||...........+.....           ....
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence            22   234578999999999988899999999999999999999999976543322211111100           0001


Q ss_pred             CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       280 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ......++.+.+++.+||..+|.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1112345678999999999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.7e-43  Score=335.97  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=197.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-CCeEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DSAVH  133 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~~~  133 (531)
                      ..+|++.+.||+|+||.||+|.+  +|+.||+|++....     ..+.+.+|+.+++++ +||||+++++++.. .+..+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceE
Confidence            45799999999999999999986  58899999986432     346788999999999 89999999998754 45789


Q ss_pred             EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          134 IVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +||||+++++|.+++...+.  +++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TSCEEECCCCC-----
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeC---CCcEEEeecccccccc
Confidence            99999999999999976543  899999999999999999999999999999999999964   3469999999987654


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                      ...  ....+++.|+|||++. ..++.++||||||+++|+|+| |..||...........+....   .......+++.+
T Consensus       169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  243 (278)
T 1byg_A          169 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAV  243 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---CCCCCTTCCHHH
T ss_pred             ccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCcccCCHHH
Confidence            322  2345788999999887 568999999999999999998 999998877766665554432   122235689999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .++|.+||..+|++|||+.++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=345.08  Aligned_cols=247  Identities=27%  Similarity=0.474  Sum_probs=186.2

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE-------
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-------  127 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~-------  127 (531)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++++.+||||+++++++.       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            44799999999999999999999999999999998544   33445678899999999966999999999984       


Q ss_pred             -cCCeEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCceEeecCCCCCCeEE
Q 009594          128 -DDSAVHIVMELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKA  201 (531)
Q Consensus       128 -~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~NIll~~~~~~~~ikl  201 (531)
                       ....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.+   +.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~---~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ---GTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT---SCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC---CCEEE
Confidence             3456899999996 699888764   456999999999999999999999999  9999999999999654   45999


Q ss_pred             EeeccccccCCCCcc-------------ccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH
Q 009594          202 IDFGLSVFFRPGEQF-------------NEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ  264 (531)
Q Consensus       202 ~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~  264 (531)
                      +|||++.........             ....||+.|+|||++.    ..++.++|||||||++|+|+||..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876543221             1346899999999873    35788999999999999999999999665433


Q ss_pred             HHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCC
Q 009594          265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP  314 (531)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~  314 (531)
                      ..    ......  .......++.+.+||.+||+.+|++|||+.+++++-
T Consensus       260 ~~----~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          260 RI----VNGKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ----------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             Hh----hcCccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            22    222211  122345678899999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=350.37  Aligned_cols=246  Identities=19%  Similarity=0.240  Sum_probs=196.1

Q ss_pred             cccceeeccccCccCceEEEEE-----EEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC--CCCeeecceEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLC-----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK--HPNIVSLKDTY  126 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~niv~l~~~~  126 (531)
                      ...+|++.+.||+|+||.||+|     .+..+++.||+|++....      ...+.+|+.+++++..  |+||+++++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            3457999999999999999999     467789999999986432      3567788888888832  89999999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeec--------C
Q 009594          127 EDDSAVHIVMELCEGGELFDRIVA-----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFAN--------K  193 (531)
Q Consensus       127 ~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~--------~  193 (531)
                      ...+..++||||+++|+|.+++..     ...+++..++.|+.||+.||.|||++||+||||||+|||++.        .
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999999974     456999999999999999999999999999999999999976        2


Q ss_pred             CCCCCeEEEeeccccccC---CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHH
Q 009594          194 KESSPLKAIDFGLSVFFR---PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA  269 (531)
Q Consensus       194 ~~~~~ikl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~  269 (531)
                      ...+.+||+|||+|....   ........+||+.|+|||++. ..++.++|||||||++|+|+||+.||.......    
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence            225679999999996543   333445678999999999987 458999999999999999999999995543210    


Q ss_pred             HHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                         ......... ...++.+.+++..||+.+|.+|++..+.+.+
T Consensus       293 ---~~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 ---CKPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ---EEECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ---eeechhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence               000000111 1246789999999999999999765555544

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.2e-42  Score=367.94  Aligned_cols=242  Identities=22%  Similarity=0.302  Sum_probs=203.0

Q ss_pred             cccCccCceEEEEEEE--ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           62 RELGRGEFGVTYLCTD--VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      +.||+|+||.||+|.+  ..++..||||++..... .....+.+.+|+.+++++ +||||+++++++.. +..++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCEEEEEEcc
Confidence            4799999999999954  45678999999975432 334467899999999999 89999999999975 4588999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc----
Q 009594          140 EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----  215 (531)
Q Consensus       140 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~----  215 (531)
                      ++|+|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||++.++   .+||+|||+|+.......    
T Consensus       452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCTTHHHHTTC-------
T ss_pred             CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC---CEEEEEcCCccccccCcccccc
Confidence            9999999999888899999999999999999999999999999999999997654   599999999987654332    


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+......   .....+++.+.+||
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li  605 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM  605 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence            12234678899999987 579999999999999999998 99999998888777766654322   12246899999999


Q ss_pred             HHccccCcCCCCCHHHHhc
Q 009594          294 KKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+||..+|++|||+.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=338.11  Aligned_cols=241  Identities=28%  Similarity=0.432  Sum_probs=193.2

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++.+.||+|+||.||+|.+  .++.||+|++...     ...+.+.+|+.+++++ +||||+++++++.+  ..++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEEE
Confidence            4799999999999999999985  4789999998532     2356788999999999 99999999998764  47899


Q ss_pred             EeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          136 MELCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHE---QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~---~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      |||+++++|.+++....   .++...++.++.|++.||.|||+   +||+||||||+||+++.++.  .+||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT--VLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--EEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--EEEEcccccccc
Confidence            99999999999998654   37899999999999999999999   89999999999999975432  379999999976


Q ss_pred             cCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH--HHHHHHhcccCCCCCCCCCCC
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--VAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ....  .....||+.|+|||++. ..++.++||||||+++|+|+||..||.......  ....+...   ........++
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG---TRPPLIKNLP  230 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT---CCCCCBTTCC
T ss_pred             cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC---CCCCcccccC
Confidence            5432  23446899999999887 468999999999999999999999997643322  22222222   1222335689


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.+.+++.+||..+|++|||+.+++++
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999999873

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.6e-42  Score=364.65  Aligned_cols=247  Identities=25%  Similarity=0.341  Sum_probs=202.9

Q ss_pred             cceeecc-ccCccCceEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGR-ELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .++.+.. .||+|+||.||+|.+.  .++..||||++....  .....+.+.+|+.+++++ +||||+++++++.. +..
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCe
Confidence            3455555 7999999999999875  356789999997543  233467899999999999 99999999999976 569


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++...
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH---YAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC---cEEEeeccCccccc
Confidence            9999999999999998754 4599999999999999999999999999999999999997544   59999999998765


Q ss_pred             CCCcc----ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          212 PGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       212 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      .....    ....+|+.|+|||++. +.++.++|||||||++|+|+| |..||.+....+....+.....   ....+.+
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~  564 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPEC  564 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC---CCCCTTC
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcC
Confidence            33221    1234568899999987 679999999999999999998 9999999888777776665432   1122468


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ++.+.+||.+||..+|++|||+.++++
T Consensus       565 ~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999853

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=337.79  Aligned_cols=254  Identities=23%  Similarity=0.336  Sum_probs=203.5

Q ss_pred             CccccceeeccccCccCceEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      .....+|++++.||+|+||.||+|.    +..+++.||+|++...   .....+.+.+|+.+++++ +||||+++++++.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  112 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCY  112 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Confidence            4456679999999999999999998    4568999999998653   334457889999999999 8999999999986


Q ss_pred             cC--CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEee
Q 009594          128 DD--SAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       128 ~~--~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      ..  ...++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+||
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~---~~kL~Df  189 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---RVKIGDF  189 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC---cEEEecC
Confidence            54  4789999999999999999875 4599999999999999999999999999999999999997654   4999999


Q ss_pred             ccccccCCCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH------------HHH
Q 009594          205 GLSVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ------------GVA  267 (531)
Q Consensus       205 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~------------~~~  267 (531)
                      |++........    .....+++.|+|||++. ..++.++||||||+++|+|+||..||......            ...
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence            99987654432    12345677899999887 56888999999999999999999988542110            001


Q ss_pred             HHHHhcccC-CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          268 QAIIRSVID-FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       268 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ..+...... ...+....+++.+.++|.+||..+|++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            111111111 111223468999999999999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.4e-42  Score=359.66  Aligned_cols=248  Identities=24%  Similarity=0.309  Sum_probs=209.0

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ....+|++.+.||+|+||.||+|.+.. +..||||++.....    ..+.+.+|+.+|+++ +||||+++++++.. +..
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccc
Confidence            445679999999999999999999754 56799999975432    246789999999999 99999999999876 678


Q ss_pred             EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          133 HIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      +|||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++...
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLI  413 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCTTSTTTC
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC---CcEEEcccccceec
Confidence            9999999999999999643  468999999999999999999999999999999999999644   45999999999876


Q ss_pred             CCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          211 RPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       211 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .....  .....++..|+|||++. +.++.++|||||||++|+|+| |..||.+....+....+.....   ......++
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~  490 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECP  490 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCC
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence            43221  12345678899999876 678999999999999999999 9999999888777776655422   12224689


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.+.+||.+||..+|++|||+.++++.
T Consensus       491 ~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          491 ESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-43  Score=351.23  Aligned_cols=251  Identities=18%  Similarity=0.256  Sum_probs=194.5

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHhCC--------CCCCeee
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMKHLP--------KHPNIVS  121 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~niv~  121 (531)
                      ..+|++.+.||+|+||+||+|++  +|+.||+|++......     .......+.+|+.+++.+.        .||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35799999999999999999997  7899999999865432     2233577889999999884        3655555


Q ss_pred             cceE-----------------EEc-------------CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 009594          122 LKDT-----------------YED-------------DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ  171 (531)
Q Consensus       122 l~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~  171 (531)
                      +.++                 +..             .+.+||||||+++|++.+.+.+ ..+++..++.++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            5554                 333             6889999999999987776644 56899999999999999999


Q ss_pred             HHH-HcCCeecCCCCCceEeecCCC-----------------CCCeEEEeeccccccCCCCccccccCCcccccchhccc
Q 009594          172 VCH-EQGVMHRDLKPENFLFANKKE-----------------SSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR  233 (531)
Q Consensus       172 ~LH-~~~iiH~Dlkp~NIll~~~~~-----------------~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  233 (531)
                      ||| ++||+||||||+|||++.++.                 ...+||+|||+|+.....    ..+||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 999999999999999987641                 126999999999876532    3479999999999987


Q ss_pred             cCCCccchhHHHHH-HHHHhhCCCCCCCCCH-HHHHHHHHhcccCCCC---CCCCCCCHHHHHHHHHccccCcCCCCCHH
Q 009594          234 NYGPEVDVWSAGVI-LYILLCGVPPFWAETE-QGVAQAIIRSVIDFKR---DPWPKVSENAKDLVKKMLNPDPKQRLTAE  308 (531)
Q Consensus       234 ~~~~~~Di~slG~i-l~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~  308 (531)
                      ..+.++||||||++ .+++++|..||..... ......+.........   ..++.+++++.+||.+||+++     |+.
T Consensus       252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            77889999998887 6688999999843211 1122233322111111   112346889999999999976     999


Q ss_pred             HHh-cCCccc
Q 009594          309 EVL-EHPWLQ  317 (531)
Q Consensus       309 ~~l-~h~~~~  317 (531)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999995

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-42  Score=339.84  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=193.1

Q ss_pred             CCccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCCeeecceEEEcC
Q 009594           51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL-PKHPNIVSLKDTYEDD  129 (531)
Q Consensus        51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~  129 (531)
                      +..+.++|++.+.||+|+||.||+|.+.  ++.||+|++....      .....+|.+++..+ .+||||+++++++...
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3556778999999999999999999964  8999999986432      23444555555543 2899999999998876


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCceEeecCCCCC
Q 009594          130 ----SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ--------GVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       130 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~iiH~Dlkp~NIll~~~~~~~  197 (531)
                          ...++||||+++++|.+++... .+++..++.++.|++.||.|||++        ||+||||||+|||++.+   +
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~---~  179 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN---G  179 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT---S
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC---C
Confidence                7899999999999999999654 699999999999999999999998        99999999999999644   4


Q ss_pred             CeEEEeeccccccCCCCcc-----ccccCCcccccchhcccc-CCCc------cchhHHHHHHHHHhhC----------C
Q 009594          198 PLKAIDFGLSVFFRPGEQF-----NEIVGSPYYMAPEVLKRN-YGPE------VDVWSAGVILYILLCG----------V  255 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~------~Di~slG~il~~l~tg----------~  255 (531)
                      .+||+|||++.........     ....||+.|+|||++.+. ++..      +|||||||++|+|+||          .
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            5999999999765433221     245799999999998743 4443      8999999999999999          7


Q ss_pred             CCCCCCCH----HHHHHHHHh-cccCCCCCC---CCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          256 PPFWAETE----QGVAQAIIR-SVIDFKRDP---WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       256 ~pf~~~~~----~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .||.....    ......... .......+.   ...+++.+.+||.+||+.||++|||+.++++|
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            77754321    111222211 111111100   01356779999999999999999999999876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=338.76  Aligned_cols=251  Identities=19%  Similarity=0.308  Sum_probs=205.1

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .....+|++.+.||+|+||.||+|.+..   .+|+|++...... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPH  103 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSC
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCc
Confidence            3445679999999999999999998643   4999998754322 22234567899999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++    ++.+||+|||++...
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC--
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcccc
Confidence            999999999999999997654 689999999999999999999999999999999999996    235999999998754


Q ss_pred             CCC------CccccccCCcccccchhccc----------cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcc
Q 009594          211 RPG------EQFNEIVGSPYYMAPEVLKR----------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV  274 (531)
Q Consensus       211 ~~~------~~~~~~~gt~~y~aPE~~~~----------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  274 (531)
                      ...      .......||+.|+|||++.+          .++.++||||||+++|+|++|..||...........+....
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  259 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM  259 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence            321      12234568999999998853          36789999999999999999999999888777666665543


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ...  .....+++.+.+++.+||..+|++|||+.++++.
T Consensus       260 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          260 KPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            222  1223578899999999999999999999999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-42  Score=374.65  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=205.0

Q ss_pred             CCCCccccceeeccccCccCceEEEEEEEcc-CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ..|..+.++|++.+.||+|+||.||+|.+.. +|+.||||++....  .......+.+|+.+++++ +||||+++++++.
T Consensus        73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~  149 (681)
T 2pzi_A           73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV-VHPSIVQIFNFVE  149 (681)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEE
T ss_pred             CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEe
Confidence            4567788999999999999999999999976 78999999986432  334456788999999999 8999999999998


Q ss_pred             cCCe-----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEE
Q 009594          128 DDSA-----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       128 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                      ..+.     .||||||++|++|.+++..  .+++..++.|+.||+.||.|||++||+||||||+|||++.+    .+||+
T Consensus       150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~  223 (681)
T 2pzi_A          150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLI  223 (681)
T ss_dssp             EECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEEC
T ss_pred             ecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEE
Confidence            6554     7999999999999987754  79999999999999999999999999999999999999642    59999


Q ss_pred             eeccccccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      |||++......   ....||+.|+|||++.+.++.++|||||||++|+|++|.+||.+....        .. . .....
T Consensus       224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~-~-~~~~~  290 (681)
T 2pzi_A          224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GL-P-EDDPV  290 (681)
T ss_dssp             CCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SC-C-TTCHH
T ss_pred             ecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc--------cc-c-ccccc
Confidence            99999876543   456799999999999877789999999999999999999988653211        00 0 01111


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      ...++.+.++|.+||.++|++||+..+++.|+|+.
T Consensus       291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            23467899999999999999999999999998874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.3e-41  Score=360.52  Aligned_cols=250  Identities=25%  Similarity=0.339  Sum_probs=207.5

Q ss_pred             ccccceeeccccCccCceEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      ....+|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.+++++ +||||+++++++. .
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-E  462 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-S
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-c
Confidence            3456799999999999999999998653   4679999876432  334457889999999999 9999999999985 4


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      +..++||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||++.
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~---~vkL~DFG~a~  539 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSR  539 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC---CEEEEecCCCe
Confidence            56899999999999999997654 689999999999999999999999999999999999997654   59999999998


Q ss_pred             ccCCCCcc--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          209 FFRPGEQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       209 ~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      ........  ....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+......   +..+.
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~  616 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPN  616 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---CCCTT
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence            76543322  2345678999999887 578999999999999999997 99999998887777766654321   12346


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +++.+.++|.+||..+|++|||+.++++
T Consensus       617 ~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          617 CPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8999999999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=341.91  Aligned_cols=255  Identities=22%  Similarity=0.310  Sum_probs=188.6

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHH--HHhCCCCCCeeecceEEE-----
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI--MKHLPKHPNIVSLKDTYE-----  127 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~--l~~l~~h~niv~l~~~~~-----  127 (531)
                      .++|++.+.||+|+||.||+|++  +++.||+|++....      ...+..|..+  +..+ +||||+++++.+.     
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTT
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheecccccccC
Confidence            35799999999999999999975  78999999996432      2334444444  4446 9999999998653     


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCceEeecCCCCCC
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ---------GVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                      ....+++||||+++|+|.+++... ..++..++.++.||+.||.|||+.         ||+||||||+|||++.+   +.
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~---~~  158 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND---GT  158 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT---SC
T ss_pred             CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC---Cc
Confidence            234678999999999999999665 458999999999999999999999         99999999999999644   46


Q ss_pred             eEEEeeccccccCCCC---------ccccccCCcccccchhccc--------cCCCccchhHHHHHHHHHhhCCCCCCCC
Q 009594          199 LKAIDFGLSVFFRPGE---------QFNEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLCGVPPFWAE  261 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~tg~~pf~~~  261 (531)
                      +||+|||++.......         ......||+.|+|||++.+        .++.++|||||||++|+|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            9999999998664321         1224579999999998864        3567899999999999999997765332


Q ss_pred             CH-----------------HHHHHHHHh-cccCC-CCCCCC---CCCHHHHHHHHHccccCcCCCCCHHHHh------cC
Q 009594          262 TE-----------------QGVAQAIIR-SVIDF-KRDPWP---KVSENAKDLVKKMLNPDPKQRLTAEEVL------EH  313 (531)
Q Consensus       262 ~~-----------------~~~~~~~~~-~~~~~-~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~l------~h  313 (531)
                      ..                 ......... ..... ....++   .+++.+.+||.+||..||++|||+.+++      -+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            11                 111111111 11110 011111   2455799999999999999999999994      46


Q ss_pred             CcccccccC
Q 009594          314 PWLQNAKKA  322 (531)
Q Consensus       314 ~~~~~~~~~  322 (531)
                      +|-++....
T Consensus       319 ~~~~~~~~~  327 (336)
T 3g2f_A          319 IWERNKSVS  327 (336)
T ss_dssp             CCCC-----
T ss_pred             HHHhcccCC
Confidence            777765443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.9e-41  Score=335.69  Aligned_cols=250  Identities=22%  Similarity=0.345  Sum_probs=199.7

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCCeeecceEEEcCC
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL-PKHPNIVSLKDTYEDDS  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~  130 (531)
                      ..+..+|++.+.||+|+||.||+|.+  +|+.||+|++...      ....+.+|+++++.+ .+||||+++++++....
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            44567899999999999999999996  5899999998543      245677899999883 28999999999998765


Q ss_pred             ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCceEeecCCCCCC
Q 009594          131 ----AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH--------EQGVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       131 ----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                          ..++||||+++++|.+++.+. .+++..++.++.|++.||.|||        +.||+||||||+||+++.+   +.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~---~~  185 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GT  185 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT---SC
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC---CC
Confidence                899999999999999999664 6899999999999999999999        8999999999999999654   45


Q ss_pred             eEEEeeccccccCCCCc-----cccccCCcccccchhcccc-------CCCccchhHHHHHHHHHhhC----------CC
Q 009594          199 LKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCG----------VP  256 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~Di~slG~il~~l~tg----------~~  256 (531)
                      +||+|||++........     .....||+.|+|||++.+.       ++.++|||||||++|+|+||          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            99999999976654332     2345799999999998753       23689999999999999999          78


Q ss_pred             CCCCCC-----HHHHHHHHHhcccCCCCC-CC--CCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          257 PFWAET-----EQGVAQAIIRSVIDFKRD-PW--PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       257 pf~~~~-----~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ||....     .......+.........+ .+  ..+++.+.+|+.+||+.+|++|||+.++++|
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            886642     222222222222111111 01  1234679999999999999999999999876

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-42  Score=350.13  Aligned_cols=248  Identities=16%  Similarity=0.187  Sum_probs=191.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-CCeeec------------
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVSL------------  122 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l------------  122 (531)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+ .| +|...+            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhh
Confidence            3588899999999999999999999999999998754443444467889999999999 55 322111            


Q ss_pred             ---------ceEEEc-----CCeEEEEEeccCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 009594          123 ---------KDTYED-----DSAVHIVMELCEGGELFDRIVA-------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHR  181 (531)
Q Consensus       123 ---------~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~  181 (531)
                               ..++..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                     111111     23467888877 6799988841       2347788999999999999999999999999


Q ss_pred             CCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccCCcccccchhc----------c-ccCCCccchhHHHHHHHH
Q 009594          182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----------K-RNYGPEVDVWSAGVILYI  250 (531)
Q Consensus       182 Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~-~~~~~~~Di~slG~il~~  250 (531)
                      ||||+|||++.++   .+||+|||++......  .....| +.|+|||++          . ..++.++|||||||++|+
T Consensus       236 DiKp~NILl~~~~---~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLDQRG---GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEECTTC---CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCC---eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            9999999996544   4999999998765432  445677 999999988          3 247789999999999999


Q ss_pred             HhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          251 LLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       251 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      |+||+.||...........        ....++.+|+.+.+||.+||..+|++|||+.++++||||+..
T Consensus       310 lltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEW--------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGG--------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHH--------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            9999999977654322111        112235789999999999999999999999999999999753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.6e-41  Score=328.26  Aligned_cols=233  Identities=14%  Similarity=0.087  Sum_probs=190.6

Q ss_pred             CCCC-ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           49 PSGQ-DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        49 ~~~~-~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      ..|. .+.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++.
T Consensus        23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~  101 (286)
T 3uqc_A           23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVH  101 (286)
T ss_dssp             CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred             CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEE
Confidence            3455 6778899999999999999999999999999999999876555555567889999999999 9999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      ..+..|+||||++|++|.+++...  .....+..++.||+.||.|||++||+||||||+|||++.++   .+||+++|  
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g---~~kl~~~~--  174 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG---DVVLAYPA--  174 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS---CEEECSCC--
T ss_pred             ECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC---CEEEEecc--
Confidence            999999999999999999998543  46667899999999999999999999999999999997544   48887433  


Q ss_pred             cccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHH---HHHhcccCCCCCCCCC
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ---AIIRSVIDFKRDPWPK  284 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~  284 (531)
                                       |++|      ++.++|||||||++|+|+||..||.+.+......   ..............+.
T Consensus       175 -----------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T 3uqc_A          175 -----------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD  231 (286)
T ss_dssp             -----------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred             -----------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence                             4443      6789999999999999999999998765422110   0001111111112346


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +++.+.++|.+||+.||++| |+.++++.
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            89999999999999999999 99999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=7e-35  Score=306.77  Aligned_cols=233  Identities=17%  Similarity=0.165  Sum_probs=158.6

Q ss_pred             cccCccCceEEEEEEEccCCcEEEEEEeeccccCC-------hhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-------AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ...+.|+.|.+..++....|+.+|+|++.+.....       ....+.+.+|+++|+++..|+||+++++++++.+.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            34677888888888877889999999997653221       23456799999999999899999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      ||||++|++|.++|.+.+++++.   .|+.||+.||.|+|++|||||||||+|||++.+   +.+||+|||+|+..... 
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d---g~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR---QHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT---SCEEECCCTTEESCC---
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC---CCEEEeecccCeeCCCCC
Confidence            99999999999999998888765   488999999999999999999999999999644   46999999999876543 


Q ss_pred             CccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      ....+.+||+.|||||++.+.+..++|+||+|++++++.++..|+        ...+..    .+...+     .+..+.
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~----~~~~~~-----~~~~l~  456 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQ----EPVERW-----NFVLLL  456 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHT----SCGGGC-----SHHHHH
T ss_pred             ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhc----CCCCCC-----cHHHHH
Confidence            334567899999999999998889999999999998887664443        111111    111111     245566


Q ss_pred             HHccccCcCCCCCHHHHhcCCccc
Q 009594          294 KKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      ..+...+|..||.......++|..
T Consensus       457 ~~l~~~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          457 ALFEKKAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             HHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred             HHHhCCCCCCCCChhhhccchhHH
Confidence            666777777777665555555543

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A

Probab=99.95  E-value=5.6e-28  Score=223.58  Aligned_cols=188  Identities=15%  Similarity=0.179  Sum_probs=173.2

Q ss_pred             hhhhHHHHHHHhhhhhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCce
Q 009594          336 KQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL  415 (531)
Q Consensus       336 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i  415 (531)
                      ..+...+.+++.+...++..++.+++.+++++|..+|.|++|.|+.+||..+++.+|..++..+++.+|..+|.|++|.|
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I  104 (220)
T 3sjs_A           25 CIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHI  104 (220)
T ss_dssp             HHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCTTCSSCB
T ss_pred             hccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcC
Confidence            34555666777788888899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHH
Q 009594          416 NYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVM  495 (531)
Q Consensus       416 ~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~  495 (531)
                      +|+||+.++...      +.++.+|+.+|.|++|+|+.+||+.++..+|..+++++++.+++.+| |+||.|+|+||+.+
T Consensus       105 ~~~EF~~~~~~~------~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d-d~dg~I~~~eF~~~  177 (220)
T 3sjs_A          105 SFYEFMAMYKFM------ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA-RGMAFCDLNCWIAI  177 (220)
T ss_dssp             CHHHHHHHHHHH------HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC---CCSEEHHHHHHH
T ss_pred             CHHHHHHHHHHH------HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHH
Confidence            999999987653      56899999999999999999999999999999999999999999999 99999999999999


Q ss_pred             HHhCchHHHHHhhh-CccCCC------cCCHHHHHHHHhhcC
Q 009594          496 MKAGTDWRKASRQY-SRERFN------SISLKLMREEGLQLA  530 (531)
Q Consensus       496 ~~~~~~~~~~f~~~-D~~~~G------~i~~~e~~~~~~~~~  530 (531)
                      +.....++..|+.+ |++++|      .|+.+||.+.+..+.
T Consensus       178 ~~~l~~~~~~F~~~~D~~~~G~i~~~~~i~~~ef~~~~~~~~  219 (220)
T 3sjs_A          178 CAFAAQTRSAYQMIFMNPYYGPMKPFNPMEFGKFLDVVTSLL  219 (220)
T ss_dssp             HHHHHHHHHHHHHHHTSGGGCSCCCCCHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhcccCCCCCcccccceeHHHHHHHHHHhc
Confidence            99999999999999 999999      889999999988764

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1}

Probab=99.95  E-value=3.7e-28  Score=220.99  Aligned_cols=187  Identities=27%  Similarity=0.443  Sum_probs=153.9

Q ss_pred             cCCcccccccCCCCCchhHHHHHHhhhhHHHHHHHhhhhhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhC
Q 009594          312 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG  391 (531)
Q Consensus       312 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~  391 (531)
                      .|||.+... .+..++...+..++++|...+++++..+..++..++.+++..++++|..+|.|++|.|+.+||..++..+
T Consensus         8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~   86 (197)
T 3pm8_A            8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKI   86 (197)
T ss_dssp             ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred             cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence            489998654 4566777889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc--CCCCCH
Q 009594          392 GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE--VDTSGE  469 (531)
Q Consensus       392 ~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~--~~~~~~  469 (531)
                      |..++..++..+|..+|.|++|.|+|+||+.++.........+.++.+|+.+|.|++|+|+.+||+.++..+  +..+++
T Consensus        87 g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~  166 (197)
T 3pm8_A           87 GYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLID  166 (197)
T ss_dssp             C----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCSHHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHHH
T ss_pred             CCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCH
Confidence            999999999999999999999999999999877665556678899999999999999999999999999988  777888


Q ss_pred             HHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          470 DVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       470 ~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ++++.+|..+|.|+||.|+|+||+.+|++.
T Consensus       167 ~~~~~l~~~~D~d~dG~Is~~EF~~~l~~~  196 (197)
T 3pm8_A          167 KAIDSLLQEVDLNGDGEIDFHEFMLMMSKK  196 (197)
T ss_dssp             HHHHHHHHHHCTTCSSSEEHHHHHHHHHCC
T ss_pred             HHHHHHHHHHcCCCCCcCcHHHHHHHHHcC
Confidence            999999999999999999999999999864

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.5e-28  Score=257.13  Aligned_cols=184  Identities=22%  Similarity=0.193  Sum_probs=145.9

Q ss_pred             eeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChh-----hHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        59 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+.||+|+||.||+|.  ..+..+++|+..........     ..+.+.+|+.+++++ +||||+++..++...+..|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccE
Confidence            345689999999999995  67889999987654433221     234578999999999 9999997666666777789


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |||||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++.     .+||+|||+|+.....
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCCc
Confidence            99999999999998865        6789999999999999999999999999999964     5999999999987653


Q ss_pred             Cc--------cccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCC
Q 009594          214 EQ--------FNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPF  258 (531)
Q Consensus       214 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf  258 (531)
                      ..        .....||+.|||||++.+   .|+..+|+||..+-..+-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            22        135679999999999873   5788899999999888888777776

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A

Probab=99.94  E-value=2.2e-26  Score=204.57  Aligned_cols=163  Identities=19%  Similarity=0.312  Sum_probs=150.4

Q ss_pred             HHhhHHHHhcccccCCCCcccHHHHHHHHHhCC-CCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHH
Q 009594          360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHK  438 (531)
Q Consensus       360 ~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~-~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~  438 (531)
                      +..+++++|..+|.|++|.|+.+||..+++.++ ..++..++..+|..+|.|++|.|+|+||+.++...      ..++.
T Consensus         5 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~~~~~------~~~~~   78 (172)
T 2znd_A            5 DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYI------TDWQN   78 (172)
T ss_dssp             -CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHHHH------HHHHH
T ss_pred             chhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHH
Confidence            456899999999999999999999999999998 77899999999999999999999999999877542      56899


Q ss_pred             hhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCCcCC
Q 009594          439 AFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSIS  518 (531)
Q Consensus       439 ~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G~i~  518 (531)
                      +|+.+|.|++|.|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++.....+..+|+.+|+|++|.|+
T Consensus        79 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~dG~i~  158 (172)
T 2znd_A           79 VFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQ  158 (172)
T ss_dssp             HHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHCTTSSSCCC
T ss_pred             HHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEe
Confidence            99999999999999999999999999999999999999999999999999999999999889999999999999999997


Q ss_pred             --HHHHHHHHhh
Q 009594          519 --LKLMREEGLQ  528 (531)
Q Consensus       519 --~~e~~~~~~~  528 (531)
                        .+||.+++..
T Consensus       159 ~~~~ef~~~~~~  170 (172)
T 2znd_A          159 VSYEQYLSMVFS  170 (172)
T ss_dssp             CCHHHHHHHHHT
T ss_pred             eeHHHHHHHHHh
Confidence              4777776653

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A

Probab=99.94  E-value=2.5e-26  Score=207.79  Aligned_cols=183  Identities=28%  Similarity=0.508  Sum_probs=156.4

Q ss_pred             cCCcccccccCCCCCchhHHHHHHhhhhHHHHHHHhhhhhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhC
Q 009594          312 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG  391 (531)
Q Consensus       312 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~  391 (531)
                      .|||+-... .+...+...+..++++|...+++++..+..++..++.+++.+++++|..+|.|++|.|+.+||..+++.+
T Consensus         3 ~~~~~~~~~-~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~   81 (191)
T 3k21_A            3 HHHHHSSGR-ENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD   81 (191)
T ss_dssp             ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred             CCccccCCc-cccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence            477775433 3445567789999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhh--cCCCCCH
Q 009594          392 GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALND--EVDTSGE  469 (531)
Q Consensus       392 ~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~--~~~~~~~  469 (531)
                      |..++ .++..+|..+|.|++|.|+|+||+.++.... ....+.+..+|+.+|.|++|+|+.+||+.++..  .+..+++
T Consensus        82 g~~~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~  159 (191)
T 3k21_A           82 GLKLP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRK-QLSKKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQ  159 (191)
T ss_dssp             TCCCC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGG-GCCHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCH
T ss_pred             CCCcH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhh-hccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCH
Confidence            98888 8899999999999999999999999765433 256788999999999999999999999999987  4566665


Q ss_pred             ---HHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          470 ---DVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       470 ---~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                         ++++.+|..+|.|+||.|+|+||+.+++
T Consensus       160 ~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~  190 (191)
T 3k21_A          160 RDVNRVKRMIRDVDKNNDGKIDFHEFSEMMK  190 (191)
T ss_dssp             HHHHHHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred             hHHHHHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence               3689999999999999999999999874

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A

Probab=99.94  E-value=3e-28  Score=237.93  Aligned_cols=235  Identities=20%  Similarity=0.212  Sum_probs=187.2

Q ss_pred             CCCCHHHHHHHHHcc---ccCcCCCCCHHHHhcC------CcccccccCC----------------CC-------CchhH
Q 009594          283 PKVSENAKDLVKKML---NPDPKQRLTAEEVLEH------PWLQNAKKAP----------------NV-------SLGET  330 (531)
Q Consensus       283 ~~~~~~~~~li~~~l---~~~p~~Rps~~~~l~h------~~~~~~~~~~----------------~~-------~~~~~  330 (531)
                      .+...++.+|..++.   ..+|++|....+.+.|      +|+....+..                ..       .....
T Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~   94 (323)
T 1ij5_A           15 KKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLAS   94 (323)
T ss_dssp             HHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHH
Confidence            345677888999888   8899999999999988      8886542110                00       01112


Q ss_pred             HHHHHh-hhhHHHHHHHhhhhhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCC
Q 009594          331 VKARLK-QFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADV  409 (531)
Q Consensus       331 ~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~  409 (531)
                      +..+++ +|..++.+++     ++..++++++..+..+|..+|.|++|.|+.+||..+|..+|..++..++..+|..+|.
T Consensus        95 vl~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D~  169 (323)
T 1ij5_A           95 LLKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVEN  169 (323)
T ss_dssp             HHHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcC
Confidence            344444 4545555544     3567888999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHH-HHHhccCCCCccee
Q 009594          410 DGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA-IMHDVDTDKDGRIS  488 (531)
Q Consensus       410 ~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~-~~~~~D~~~dG~i~  488 (531)
                      |++|.|+|.+|+.+..      ....+..+|+.+|.|++|+|+.+||..+|  +|..++..++.. +|..+|.|+||.|+
T Consensus       170 d~~G~I~f~ef~~l~~------~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~g~~~~~~ei~~~l~~~~D~d~dG~Is  241 (323)
T 1ij5_A          170 DTKGRMSYITLVAVAN------DLAALVADFRKIDTNSNGTLSRKEFREHF--VRLGFDKKSVQDALFRYADEDESDDVG  241 (323)
T ss_dssp             CCSSTHHHHHHTTSHH------HHHTSCCCHHHHCTTCCSEECHHHHHHHH--HHTTCCCHHHHHHHHHHHCTTCSSCEE
T ss_pred             CCCCcCcHHHHHhhhh------HHHHHHHHHHHHCCCCCCcCcHHHHHHHH--cCCCCCHHHHHHHHHHHhcCCCCCEEe
Confidence            9999999999987642      23457789999999999999999999999  788888899999 99999999999999


Q ss_pred             HHHHHHHHHhCchHHHHHhhhCccCCCcCCHHHHHHHH-hhcC
Q 009594          489 YEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEG-LQLA  530 (531)
Q Consensus       489 ~~Ef~~~~~~~~~~~~~f~~~D~~~~G~i~~~e~~~~~-~~~~  530 (531)
                      |+||+.++.....+..+|+.+|+|++|.||.+||++++ ..+|
T Consensus       242 ~~EF~~~l~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g  284 (323)
T 1ij5_A          242 FSEYVHLGLCLLVLRILYAFADFDKSGQLSKEEVQKVLEDAHI  284 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHcC
Confidence            99999999987799999999999999999999999999 7765

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8

Probab=99.94  E-value=3.1e-26  Score=207.34  Aligned_cols=162  Identities=21%  Similarity=0.331  Sum_probs=152.4

Q ss_pred             HhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhh
Q 009594          361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAF  440 (531)
Q Consensus       361 ~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  440 (531)
                      ..+++++|..+|.|++|.|+.+||..++..++..++..++..+|..+|.|++|.|+|+||+.++...      +.++.+|
T Consensus        26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~------~~~~~~F   99 (191)
T 1y1x_A           26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHFI------LSMREGF   99 (191)
T ss_dssp             TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHH------HHHHHHH
Confidence            4689999999999999999999999999888888999999999999999999999999999987542      5689999


Q ss_pred             cccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCCc--CC
Q 009594          441 SFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNS--IS  518 (531)
Q Consensus       441 ~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G~--i~  518 (531)
                      +.+|.|++|.|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++.....++.+|+.+|+|++|.  ++
T Consensus       100 ~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~dG~i~~~  179 (191)
T 1y1x_A          100 RKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFVCRVRNVFAFYDRERTGQVTFT  179 (191)
T ss_dssp             HHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEEE
T ss_pred             HHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHHHHHHHHHHHhCcCCCceEEee
Confidence            9999999999999999999999999999999999999999999999999999999999899999999999999999  77


Q ss_pred             HHHHHHHHhh
Q 009594          519 LKLMREEGLQ  528 (531)
Q Consensus       519 ~~e~~~~~~~  528 (531)
                      .+||.+++..
T Consensus       180 ~~eF~~~~~~  189 (191)
T 1y1x_A          180 FDTFIGGSVS  189 (191)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHh
Confidence            9999988764

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A

Probab=99.93  E-value=2.2e-26  Score=204.90  Aligned_cols=160  Identities=19%  Similarity=0.263  Sum_probs=149.3

Q ss_pred             HHHhhHHHHhcccccCCCCcccHHHHHHHHHhC-C-------CCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc
Q 009594          359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-G-------QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM  430 (531)
Q Consensus       359 ~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~-~-------~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~  430 (531)
                      +++.+++++|..+| +++|.|+.+||..+++.+ |       ..++..++..+|..+|.|++|.|+|+||+.++...   
T Consensus         1 e~~~~l~~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~---   76 (173)
T 1alv_A            1 EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNI---   76 (173)
T ss_dssp             CHHHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH---
T ss_pred             CchhHHHHHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHHH---
Confidence            35778999999999 999999999999999997 5       67889999999999999999999999999887642   


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYS  510 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D  510 (531)
                         ..++.+|+.+|.|++|.|+.+||+.++..+|..+++++++.++..+| |++|.|+|+||+.++.....+..+|+.+|
T Consensus        77 ---~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~~~~~~~~~~F~~~D  152 (173)
T 1alv_A           77 ---KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCLVRLDAMFRAFKSLD  152 (173)
T ss_dssp             ---HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             ---HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHHHHHHHHHHHhC
Confidence               56899999999999999999999999999999999999999999999 99999999999999999899999999999


Q ss_pred             ccCCCcCCHHHHHHHHh
Q 009594          511 RERFNSISLKLMREEGL  527 (531)
Q Consensus       511 ~~~~G~i~~~e~~~~~~  527 (531)
                      +|++|.|+.+ +.+.+.
T Consensus       153 ~d~~G~i~~~-~~~~l~  168 (173)
T 1alv_A          153 KDGTGQIQVN-IQEWLQ  168 (173)
T ss_dssp             SSCCSEEEEE-HHHHHH
T ss_pred             CCCCCeecHh-HHHHHH
Confidence            9999999998 887765

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=99.92  E-value=1.5e-25  Score=193.90  Aligned_cols=144  Identities=34%  Similarity=0.548  Sum_probs=134.4

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCcH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMAND  433 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~  433 (531)
                      .+|++++.+|+++|..+|+|++|.|+.+||..+++.++..++..++..++..+|.+++|.|+|.||+..+... ......
T Consensus         3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~   82 (148)
T 2lmt_A            3 ELTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDTE   82 (148)
T ss_dssp             SCCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTTH
T ss_pred             CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccCCCCcccHHHHHHHHHHHhcccCcH
Confidence            3688999999999999999999999999999999999999999999999999999999999999999866543 344567


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +.++.+|+.||.|++|+|+.+||+.+|..+|..++.++++.+|..+|.|+||.|+|+||+++|.+
T Consensus        83 ~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~m~~  147 (148)
T 2lmt_A           83 EEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYEEFVWMISQ  147 (148)
T ss_dssp             HHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHHHHHHHHTT
T ss_pred             HHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            88999999999999999999999999999999999999999999999999999999999999864

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=99.92  E-value=1.2e-25  Score=199.96  Aligned_cols=145  Identities=30%  Similarity=0.525  Sum_probs=134.4

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc-Cc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM-AN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~-~~  432 (531)
                      ..++++++.+++++|..+|+|++|.|+.+||..+++.+|..++..++..++..+|.+++|.|+|.||+.++...... ..
T Consensus         3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~   82 (176)
T 2lhi_A            3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDS   82 (176)
T ss_dssp             CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHH
T ss_pred             CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCCc
Confidence            46789999999999999999999999999999999999999999999999999999999999999999876543332 34


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .+.++.+|+.||.|++|+|+.+||+.+|..+|..+++++++.+|..+| |+||.|+|+||+++|++.
T Consensus        83 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~~~m~k~  148 (176)
T 2lhi_A           83 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSKG  148 (176)
T ss_dssp             HHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTTHHHHHHTCC
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHHHHHHHHHhc
Confidence            578999999999999999999999999999999999999999999999 999999999999999854

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A

Probab=99.92  E-value=2.1e-25  Score=203.13  Aligned_cols=162  Identities=17%  Similarity=0.271  Sum_probs=148.7

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCC-----CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-----NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM  430 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~-----~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~  430 (531)
                      .+.+++.++++ |..+|+|++|.|+.+||..+++.+|.     .++..+++.+|..+|.|++|.|+|+||+.++...   
T Consensus        27 ~~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~---  102 (198)
T 1juo_A           27 FPGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL---  102 (198)
T ss_dssp             CTTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH---
T ss_pred             CCccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHHH---
Confidence            45567888999 99999999999999999999999876     6789999999999999999999999999987643   


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYS  510 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D  510 (531)
                         +.++.+|+.+|.|++|.|+.+||+.++..+|..+++++++.++..+  |+||.|+|+||+.++.....+..+|+.+|
T Consensus       103 ---~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~--d~dg~i~~~eF~~~~~~~~~~~~~F~~~D  177 (198)
T 1juo_A          103 ---NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY--STNGKITFDDYIACCVKLRALTDSFRRRD  177 (198)
T ss_dssp             ---HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT--CSSSSEEHHHHHHHHHHHHHHHHHHHHTC
T ss_pred             ---HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHHHHHHHHHHHhC
Confidence               5689999999999999999999999999999999999999999999  89999999999999999999999999999


Q ss_pred             ccCCCcCCHHHHHHHHh
Q 009594          511 RERFNSISLKLMREEGL  527 (531)
Q Consensus       511 ~~~~G~i~~~e~~~~~~  527 (531)
                      +|++|.|+.+ +.+.+.
T Consensus       178 ~d~~G~is~~-~~~~l~  193 (198)
T 1juo_A          178 TAQQGVVNFP-YDDFIQ  193 (198)
T ss_dssp             TTCCSEEEEE-HHHHHH
T ss_pred             CCCCCeEeec-HHHHHH
Confidence            9999999995 555543

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens}

Probab=99.92  E-value=6.1e-25  Score=194.65  Aligned_cols=149  Identities=15%  Similarity=0.184  Sum_probs=135.9

Q ss_pred             cccCCCCcccHHHHHHHHHhC------CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccC
Q 009594          371 MDTNKRGKINLEELRLGLLKG------GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFD  444 (531)
Q Consensus       371 ~D~~~~g~i~~~el~~~l~~~------~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D  444 (531)
                      -++|++|.|+.+||+.+|+.+      +..++.++++.+|..+|.|++|.|+|+||+.++...      ..++.+|+.||
T Consensus        13 ~~~~~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I~f~EF~~~~~~~------~~l~~aF~~fD   86 (174)
T 2i7a_A           13 GLVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFARLWKRL------VHYQHVFQKVQ   86 (174)
T ss_dssp             CSCC-CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHCSSCSSEECHHHHHHHHHHH------HHHHHHHHHHC
T ss_pred             ccCCCCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHHHHHhc
Confidence            468999999999999999998      668889999999999999999999999999987543      46899999999


Q ss_pred             CCCCcceeHHHHHHHHhhc----CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCC-cCCH
Q 009594          445 RNRSGFIEIEELRNALNDE----VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFN-SISL  519 (531)
Q Consensus       445 ~~~~G~i~~~el~~~l~~~----~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G-~i~~  519 (531)
                       |++|+|+.+||+.+|..+    |..+++++++.++..+| |+||.|+|+||+.++...+.+..+|+.+|+|++| .++.
T Consensus        87 -d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d-d~dG~I~~~EF~~~~~~~~~~~~~F~~~D~d~~GI~~~~  164 (174)
T 2i7a_A           87 -TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS-DSVGRVSFPSLVCFLMRLEAMAKTFRNLSKDGKGLYLTE  164 (174)
T ss_dssp             -SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS-CTTSEECHHHHHHHHHHHHHHHHHHHHHCSSSSCCCCCH
T ss_pred             -CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCceecH
Confidence             999999999999999999    99999999999999999 9999999999999999888999999999999999 3488


Q ss_pred             HHHHHHHh
Q 009594          520 KLMREEGL  527 (531)
Q Consensus       520 ~e~~~~~~  527 (531)
                      +||.+.+.
T Consensus       165 ~Ef~~~~~  172 (174)
T 2i7a_A          165 MEWMSLVM  172 (174)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99888753

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8

Probab=99.92  E-value=4.8e-25  Score=194.93  Aligned_cols=154  Identities=18%  Similarity=0.273  Sum_probs=142.6

Q ss_pred             HHhcccccCCCCcccHHHHHHHHHhCCC-----CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhh
Q 009594          366 EAFEMMDTNKRGKINLEELRLGLLKGGQ-----NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAF  440 (531)
Q Consensus       366 ~~F~~~D~~~~g~i~~~el~~~l~~~~~-----~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  440 (531)
                      +.|..+|.|++|.|+.+|+..+++.+|.     .++..+++.+|..+|.|++|.|+|+||+.++...      +.++.+|
T Consensus         5 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F   78 (167)
T 1gjy_A            5 YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL------NGWRQHF   78 (167)
T ss_dssp             HHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHH------HHHHHHH
T ss_pred             HHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHHH
Confidence            4588999999999999999999999886     6789999999999999999999999999987543      5689999


Q ss_pred             cccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCCcCCHH
Q 009594          441 SFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLK  520 (531)
Q Consensus       441 ~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G~i~~~  520 (531)
                      +.+|.|++|.|+.+||+.++..+|..+++++++.++..+  |++|.|+|+||+.++.....+..+|+.+|+|++|.|+.+
T Consensus        79 ~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~i~~~  156 (167)
T 1gjy_A           79 ISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY--STSGKITFDDYIACCVKLRALTDSFRRRDSAQQGMVNFS  156 (167)
T ss_dssp             HHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT--CBTTBEEHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEEE
T ss_pred             HHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh--CcCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCeeEEee
Confidence            999999999999999999999999999999999999999  899999999999999998999999999999999999998


Q ss_pred             HHHHHHhh
Q 009594          521 LMREEGLQ  528 (531)
Q Consensus       521 e~~~~~~~  528 (531)
                       +.+.+..
T Consensus       157 -~~~~l~~  163 (167)
T 1gjy_A          157 -YDDFIQC  163 (167)
T ss_dssp             -HHHHHHH
T ss_pred             -HHHHHHH
Confidence             7766643

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A

Probab=99.92  E-value=4.2e-25  Score=194.86  Aligned_cols=154  Identities=18%  Similarity=0.244  Sum_probs=143.9

Q ss_pred             HHhcccccCCCCcccHHHHHHHHHhCCC-----CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhh
Q 009594          366 EAFEMMDTNKRGKINLEELRLGLLKGGQ-----NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAF  440 (531)
Q Consensus       366 ~~F~~~D~~~~g~i~~~el~~~l~~~~~-----~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  440 (531)
                      ..|..+|+|++|.|+.+||..+++.+|.     .++..++..+|+.+|.|++|.|+|+||+.++...      +.++.+|
T Consensus         3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F   76 (165)
T 1k94_A            3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENF   76 (165)
T ss_dssp             HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHH
T ss_pred             HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHHHH
Confidence            4588999999999999999999999886     6789999999999999999999999999977543      5689999


Q ss_pred             cccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCCcCCHH
Q 009594          441 SFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLK  520 (531)
Q Consensus       441 ~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G~i~~~  520 (531)
                      +.+|.|++|+|+.+||+.++..+|..+++++++.++..+  |++|.|+|+||+.++...+.+..+|+.+|+|++|.|+.+
T Consensus        77 ~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~i~~~  154 (165)
T 1k94_A           77 MTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIFFDDYVACCVKLRALTDFFRKRDHLQQGSANFI  154 (165)
T ss_dssp             HHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH--CBTTBCBHHHHHHHHHHHHHHHHHHHTTCTTCCSEEEEE
T ss_pred             HHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEeee
Confidence            999999999999999999999999999999999999999  899999999999999998999999999999999999999


Q ss_pred             HHHHHHhh
Q 009594          521 LMREEGLQ  528 (531)
Q Consensus       521 e~~~~~~~  528 (531)
                       +++.+..
T Consensus       155 -~~~~l~~  161 (165)
T 1k94_A          155 -YDDFLQG  161 (165)
T ss_dssp             -HHHHHHH
T ss_pred             -HHHHHHH
Confidence             9888764

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A

Probab=99.92  E-value=1.3e-25  Score=213.94  Aligned_cols=177  Identities=21%  Similarity=0.295  Sum_probs=156.2

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCH------HHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPE------ADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~------~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      ..+++.+..+++++|..+|+|++|.|+.+||..+++.+|..++.      .++..+|..+|.|++|.|+|+||+.++...
T Consensus         8 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~Ef~~~~~~~   87 (263)
T 2f33_A            8 LQSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQRDDGKIGIVELAHVLPTE   87 (263)
T ss_dssp             TTTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHTTGGGCCBCHHHHHHHTTSC
T ss_pred             hhcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhhcCCCccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHhhh
Confidence            34667778899999999999999999999999999988655443      788999999999999999999999876432


Q ss_pred             ---------hccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc----CCCCCHHHHHH----HHHhccCCCCcceeHH
Q 009594          428 ---------KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE----VDTSGEDVINA----IMHDVDTDKDGRISYE  490 (531)
Q Consensus       428 ---------~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~~~~~~~~~----~~~~~D~~~dG~i~~~  490 (531)
                               ......+.++.+|+.+|.|++|.|+.+||..++..+    |..++.+++..    ++..+|.|++|.|+|+
T Consensus        88 ~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~  167 (263)
T 2f33_A           88 ENFLLLFRCQQLKSCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELT  167 (263)
T ss_dssp             TTHHHHHGGGTSSCHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCBCHH
T ss_pred             hhHHHHHHHhhccHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeEcHH
Confidence                     334567889999999999999999999999999988    88889888877    9999999999999999


Q ss_pred             HHHHHHHh--------------CchHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          491 EFAVMMKA--------------GTDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       491 Ef~~~~~~--------------~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      ||+.++..              ...++.+|+.+|+|++|.|+.+||++++..+|
T Consensus       168 ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~El~~~l~~~~  221 (263)
T 2f33_A          168 EMARLLPVQENFLLKFQGIKMCGKEFNKAFELYDQDGNGYIDENELDALLKDLC  221 (263)
T ss_dssp             HHHHHSCTTTCSHHHHHHTCCCHHHHHHHHHHHCCSSSSCEEHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCcchHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHH
Confidence            99998753              24589999999999999999999999998764

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A

Probab=99.92  E-value=9.1e-25  Score=187.81  Aligned_cols=140  Identities=25%  Similarity=0.536  Sum_probs=128.8

Q ss_pred             hHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-ccCcHHHH
Q 009594          358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-KMANDEHL  436 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~~~~  436 (531)
                      ++++.+++++|..+|.|++|.|+.+||..+++.+|..++..++..++..+|.|++|.|+|+||+.++.... .....+.+
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l   81 (143)
T 2obh_A            2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEI   81 (143)
T ss_dssp             HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHHhccccHHHHH
Confidence            56788999999999999999999999999999999999999999999999999999999999998765432 22335678


Q ss_pred             HHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          437 HKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       437 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +.+|+.||.|++|+|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++.
T Consensus        82 ~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~~~~~  142 (143)
T 2obh_A           82 LKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIMK  142 (143)
T ss_dssp             HHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHC
T ss_pred             HHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence            9999999999999999999999999999999999999999999999999999999999874

>3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor}

Probab=99.92  E-value=8.6e-25  Score=212.47  Aligned_cols=151  Identities=32%  Similarity=0.594  Sum_probs=136.1

Q ss_pred             hhhhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          348 ALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       348 ~~~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      .+.-..+.++++|+.+|+++|+.+|.|++|.|+.+||..+|+.+|..++.++++.+|..+|.|++|.|+|+||+.++...
T Consensus       288 ~wePs~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~  367 (440)
T 3u0k_A          288 GWEPTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLIMMARK  367 (440)
T ss_dssp             EECCBCBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC
T ss_pred             hhHhhHhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            33444578899999999999999999999999999999999999999999999999999999999999999999876543


Q ss_pred             -hccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          428 -KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       428 -~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                       .....++.++.+|+.||.|++|+|+.+||+.+|..+|..+++++++.+|+.+|.|+||.|+|+||+++|..
T Consensus       368 lk~~d~eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~DgDGkIsyeEFvkmMtS  439 (440)
T 3u0k_A          368 MKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA  439 (440)
T ss_dssp             ------CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC-
T ss_pred             hcCCChHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHhCC
Confidence             33345678999999999999999999999999999999999999999999999999999999999999853

>3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C

Probab=99.92  E-value=7.1e-25  Score=191.53  Aligned_cols=144  Identities=26%  Similarity=0.374  Sum_probs=130.0

Q ss_pred             hhhhHHHhhHHHHhccccc--CCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc---
Q 009594          355 FLSVEEVAGLKEAFEMMDT--NKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK---  429 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~--~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~---  429 (531)
                      +++++++.+++++|..||.  |++|+|+..||..+|+++|..++..++..++. .|.+++|.|+|+||+.++.....   
T Consensus         2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~-~d~~~~g~i~f~eFl~~~~~~~~~~~   80 (159)
T 3i5g_C            2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGG-TKKMGEKAYKLEEILPIYEEMSSKDT   80 (159)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTC-CSSTTSCEECHHHHHHHHHHHTTCCT
T ss_pred             CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHc-ccccCCCcccHHHHHHHHHHhhcccc
Confidence            4688999999999999996  89999999999999999999999999998764 47788999999999998765433   


Q ss_pred             cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccC--CCCcceeHHHHHHHHHhC
Q 009594          430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDT--DKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       430 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~--~~dG~i~~~Ef~~~~~~~  499 (531)
                      ....+.++.+|+.||.|++|+|+.+||+.+|..+|..+++++++.+++.+|.  |+||.|+|+||+++|...
T Consensus        81 ~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m~~~  152 (159)
T 3i5g_C           81 GTAADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKVMAG  152 (159)
T ss_dssp             TCCHHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHHHHC
T ss_pred             cchHHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHHHCC
Confidence            3456789999999999999999999999999999999999999999999995  889999999999988754

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=7e-25  Score=210.51  Aligned_cols=158  Identities=24%  Similarity=0.334  Sum_probs=121.9

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh---------------hhHHHHHHHHHHHHhCCCCCCeeec
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---------------VDIEDVRREVQIMKHLPKHPNIVSL  122 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~niv~l  122 (531)
                      |.+.+.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|+.+++++ +  | +++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~v  166 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LAV  166 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SSS
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CCc
Confidence            55569999999999999998 8899999999964322110               1345788999999999 4  5 666


Q ss_pred             ceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEE
Q 009594          123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       123 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                      .+++.. +..++||||++|++|.+ +.      ......++.|++.||.|||+.||+||||||+|||++    ++.+||+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vkl~  234 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII  234 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEEEE
Confidence            666544 45699999999999987 41      123457999999999999999999999999999997    3459999


Q ss_pred             eeccccccCCCCccccccCCcccccchhccc-----------cCCCccchhHH
Q 009594          203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-----------NYGPEVDVWSA  244 (531)
Q Consensus       203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~Di~sl  244 (531)
                      |||+|..            +..++|||.+..           .|+..+|+|++
T Consensus       235 DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          235 DFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             CCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             ECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            9999864            345789998742           34556666653

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii}

Probab=99.91  E-value=1.9e-24  Score=195.53  Aligned_cols=170  Identities=28%  Similarity=0.473  Sum_probs=156.6

Q ss_pred             chhHHHHHHhhhhHHHHHHHhhhhhhHhhh-hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhC-----------CCC
Q 009594          327 LGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-----------GQN  394 (531)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~-----------~~~  394 (531)
                      +...+..++++|...+.+++..+..++..+ +++++.+++++|..+|.|++|.|+.+||..++..+           +..
T Consensus         4 ~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~   83 (191)
T 3khe_A            4 ALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDSS   83 (191)
T ss_dssp             HHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccch
Confidence            456788899999999999999999999888 88999999999999999999999999999999987           556


Q ss_pred             CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHH
Q 009594          395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA  474 (531)
Q Consensus       395 ~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~  474 (531)
                      ++..++..+|..+|.|++|.|+|+||+.++.........+.+..+|+.+|.|++|.|+.+||..++.  +..+++++++.
T Consensus        84 ~~~~~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~~~~~~~~~~  161 (191)
T 3khe_A           84 QIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERLLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQ  161 (191)
T ss_dssp             HHHHHHHHHHHHTCTTCSSSEEHHHHHHHHSCHHHHCCHHHHHHHHHHHCTTCSSEECHHHHHHHTT--SSCCCHHHHHH
T ss_pred             hhHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhcccchHHHHHHHHHHHCCCCcCcCCHHHHHHHHc--cCCCCHHHHHH
Confidence            6778899999999999999999999999876555556778899999999999999999999999999  78889999999


Q ss_pred             HHHhccCCCCcceeHHHHHHHHHh
Q 009594          475 IMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       475 ~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +|..+|.|+||.|+|+||+.++..
T Consensus       162 ~~~~~D~~~dg~i~~~eF~~~~~~  185 (191)
T 3khe_A          162 VLQECDKNNDGEVDFEEFVEMMQK  185 (191)
T ss_dssp             HHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999999999999875

>3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B

Probab=99.91  E-value=4.7e-24  Score=185.01  Aligned_cols=141  Identities=25%  Similarity=0.443  Sum_probs=128.2

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCcH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMAND  433 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~  433 (531)
                      .++++++.+|+++|+.+|+|++|.|+.+||..+++++|..++..++..++.    +.+|.|+|.+|+.++... ......
T Consensus         9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~----~~~~~i~f~ef~~~~~~~~~~~~~~   84 (153)
T 3i5g_B            9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLK----ECPGQLNFTAFLTLFGEKVSGTDPE   84 (153)
T ss_dssp             TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHH----TSSSCCCSHHHHHTTTTTTTTCCCH
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHH----hccCCccHHHHHHHHHhhhcccccH
Confidence            478999999999999999999999999999999999999999998888775    456789999999976544 333467


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      +.++.+|+.||.|++|+|+.+||+.+|..+|..+++++++.+|+.+|.| ||.|+|+||+++|.+..
T Consensus        85 ~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~-dG~I~y~EF~~~m~~~~  150 (153)
T 3i5g_B           85 DALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLK-NKQFNYNKMVDIKGKAE  150 (153)
T ss_dssp             HHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEE-TTEECHHHHHHHHHCSC
T ss_pred             HHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCC-cCEEcHHHHHHHhcCCC
Confidence            8899999999999999999999999999999999999999999999988 99999999999998754

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ...

Probab=99.91  E-value=6.2e-24  Score=183.74  Aligned_cols=144  Identities=35%  Similarity=0.609  Sum_probs=132.3

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCcH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMAND  433 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~  433 (531)
                      .++++++.+++++|..+|.|++|.|+.+||..+++.+|..++..++..+|..+|.|++|.|+|+||+.++... ......
T Consensus         3 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~   82 (148)
T 1exr_A            3 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSE   82 (148)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCcH
Confidence            4677888999999999999999999999999999999999999999999999999999999999999876543 223345


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +.+..+|+.+|.|++|+|+.+||+.+|..+|..+++++++.+|..+|.|+||.|+|+||+.+|..
T Consensus        83 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~  147 (148)
T 1exr_A           83 EELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMVS  147 (148)
T ss_dssp             HHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHHC
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHcc
Confidence            77899999999999999999999999999999999999999999999999999999999998863

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum}

Probab=99.91  E-value=1e-23  Score=188.77  Aligned_cols=165  Identities=22%  Similarity=0.391  Sum_probs=147.6

Q ss_pred             hHHHHHHhhhhHHHHHHHhhhhhhHhhhh--hHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHh
Q 009594          329 ETVKARLKQFSVMNKLKKRALQVVAEFLS--VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA  406 (531)
Q Consensus       329 ~~~~~~~~~~~~~~~~~k~~~~~~~~~~~--~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~  406 (531)
                      ..+..++++|...+++++..+..++..++  ++++..++++|..+|.|++|.|+.+||..+++.+|..  +.++..+|..
T Consensus         4 ~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~--~~~~~~~~~~   81 (180)
T 3mse_B            4 PNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGIK--KWDINRILQA   81 (180)
T ss_dssp             HHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCC--HHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCC--HHHHHHHHHH
Confidence            56788999999999999999999999987  8999999999999999999999999999999999854  6889999999


Q ss_pred             cCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCC--
Q 009594          407 ADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKD--  484 (531)
Q Consensus       407 ~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~d--  484 (531)
                      +|.|++|.|+|+||+.++..... ...+.+..+|+.+|.|++|+|+.+||+.++.  +..+++++++.+|..+|.|+|  
T Consensus        82 ~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~--~~~~~~~~~~~~~~~~d~~~d~~  158 (180)
T 3mse_B           82 LDINDRGNITYTEFMAGCYRWKN-IESTFLKAAFNKIDKDEDGYISKSDIVSLVH--DKVLDNNDIDNFFLSVHSIKKGI  158 (180)
T ss_dssp             HCTTCCSEECHHHHHHHHSCCTT-C--CHHHHHHHHHCTTCSSCBCHHHHHHHTT--TSSCCHHHHHHHHHHHHTC----
T ss_pred             hCCCCCCcCcHHHHHHHHHhccc-CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHc--CCCCCHHHHHHHHHHhhhccCcc
Confidence            99999999999999987754333 2346799999999999999999999999998  567899999999999999998  


Q ss_pred             ------cceeHHHHHHHHHh
Q 009594          485 ------GRISYEEFAVMMKA  498 (531)
Q Consensus       485 ------G~i~~~Ef~~~~~~  498 (531)
                            |.|+|+||+.+|..
T Consensus       159 ~~~~~~G~i~~~eF~~~l~~  178 (180)
T 3mse_B          159 PREHIINKISFQEFKDYMLS  178 (180)
T ss_dssp             -----CCCBCHHHHHHHHHT
T ss_pred             cccccCCeeeHHHHHHHHHh
Confidence                  99999999999874

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A

Probab=99.90  E-value=1.7e-24  Score=207.33  Aligned_cols=175  Identities=23%  Similarity=0.318  Sum_probs=152.2

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHH----hCCC--CCCHHHHHHH----HHhcCCCCCCceecchhHhHH-
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLL----KGGQ--NIPEADLQIL----MEAADVDGDGSLNYGEFVAVS-  424 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~----~~~~--~~~~~~~~~~----f~~~D~~~~g~i~~~ef~~~~-  424 (531)
                      +++.+..+++++|..+|.|++|.|+.+||..+++    .+|.  .++..++..+    |..+|.|++|.|+|+||+.++ 
T Consensus         5 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~   84 (272)
T 2be4_A            5 FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGRLQIEELANMIL   84 (272)
T ss_dssp             CCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHHHHSCHHHHTCCSEEEHHHHHHHHS
T ss_pred             HHhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhcCCCCCcEeHHHHHHHHh
Confidence            3455677899999999999999999999999999    8888  8899888764    578899999999999999883 


Q ss_pred             ----------HHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc----CCCCCHHHHH----HHHHhccCCCCcc
Q 009594          425 ----------VHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE----VDTSGEDVIN----AIMHDVDTDKDGR  486 (531)
Q Consensus       425 ----------~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~~~~~~~~----~~~~~~D~~~dG~  486 (531)
                                .........+.++.+|+.+|.|++|.|+.+||..++..+    |..++.+++.    .+|..+|.|++|.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg~  164 (272)
T 2be4_A           85 PQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGR  164 (272)
T ss_dssp             CHHHHHHHHHHHHSCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSE
T ss_pred             hhhHHHHHHHhhccCcccHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCCc
Confidence                      223334567889999999999999999999999999987    8888888765    4999999999999


Q ss_pred             eeHHHHHHHHHh------------------CchHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          487 ISYEEFAVMMKA------------------GTDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       487 i~~~Ef~~~~~~------------------~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      |+++||+.++..                  ...+..+|+.+|+|++|.|+.+||++++..++
T Consensus       165 i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~  226 (272)
T 2be4_A          165 LDLNDLARILALQENFLLQFKMDASSQVERKRDFEKIFAHYDVSRTGALEGPEVDGFVKDMM  226 (272)
T ss_dssp             EEHHHHGGGSCCSSCSSTTSCCCHHHHHHHHHHHHHHHHHHCTTCCSEEETHHHHHHHHHHH
T ss_pred             CcHHHHHHHHhhhHHHHhhhhhhhccccccHHHHHHHHHHhCCCCCCeecHHHHHHHHHHHH
Confidence            999999998743                  24599999999999999999999999998653

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana}

Probab=99.90  E-value=7.6e-24  Score=186.90  Aligned_cols=160  Identities=49%  Similarity=0.816  Sum_probs=137.3

Q ss_pred             hhhHHHHHHHhhhhhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCcee
Q 009594          337 QFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLN  416 (531)
Q Consensus       337 ~~~~~~~~~k~~~~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~  416 (531)
                      +|+..+.+++..+..++..++++++.+++++|..+|.+++|.|+.+||..++..++..++..++..+|..+|.|++|.|+
T Consensus         2 ~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~   81 (166)
T 2aao_A            2 QFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTID   81 (166)
T ss_dssp             ----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCTTCCSSBC
T ss_pred             chhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEc
Confidence            57778889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHH
Q 009594          417 YGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       417 ~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      |.||+.++.........+.+..+|+.+|.|++|.|+.+||+.++..+|  +++++++.+|..+|.|++|.|+|+||+.++
T Consensus        82 ~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~--~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~  159 (166)
T 2aao_A           82 YKEFIAATLHLNKIEREDHLFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRDVDQDNDGRIDYNEFVAMM  159 (166)
T ss_dssp             HHHHHHHHTTCHHHHTTHHHHHHHHHHCTTCSSSBCHHHHHHHTCC----------CCHHHHHCTTCSSSBCHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence            999998775544434567899999999999999999999999999886  567889999999999999999999999998


Q ss_pred             Hh
Q 009594          497 KA  498 (531)
Q Consensus       497 ~~  498 (531)
                      ..
T Consensus       160 ~~  161 (166)
T 2aao_A          160 QK  161 (166)
T ss_dssp             C-
T ss_pred             Hh
Confidence            75

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A

Probab=99.90  E-value=1.7e-23  Score=182.93  Aligned_cols=147  Identities=22%  Similarity=0.458  Sum_probs=134.7

Q ss_pred             hhhhhHHHhhHHHHhcccc-cCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc--
Q 009594          354 EFLSVEEVAGLKEAFEMMD-TNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM--  430 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D-~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~--  430 (531)
                      ..++++++.+++++|..+| .+++|.|+.+||..+++.+|..++..++..+|..+|.|++|.|+|+||+.++......  
T Consensus         5 ~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~   84 (158)
T 2jnf_A            5 SKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEV   84 (158)
T ss_dssp             TTSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCC
T ss_pred             hhCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccc
Confidence            3567888999999999999 9999999999999999999999999999999999999999999999999987654332  


Q ss_pred             ---CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          431 ---ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       431 ---~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                         .....++.+|+.+|.|++|+|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++...+
T Consensus        85 ~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~  157 (158)
T 2jnf_A           85 NPEQMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDADGSGTVDFEEFMGVMTGGD  157 (158)
T ss_dssp             CTTTTSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSSCCSEECSHHHHHHTSSCC
T ss_pred             chhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhccC
Confidence               3456799999999999999999999999999999999999999999999999999999999999987643

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A

Probab=99.90  E-value=5.4e-23  Score=180.34  Aligned_cols=147  Identities=25%  Similarity=0.443  Sum_probs=136.2

Q ss_pred             hHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hcc
Q 009594          352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKM  430 (531)
Q Consensus       352 ~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~  430 (531)
                      ....++++++.+++++|..+|.+++|.|+.+||..+++.+|..++..++..+|..+|.+++|.|+|+||+.++... ...
T Consensus        13 ~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~   92 (161)
T 3fwb_A           13 LNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEKILKR   92 (161)
T ss_dssp             TTTTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHHTC
T ss_pred             CCCCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHhcC
Confidence            3456788999999999999999999999999999999999999999999999999999999999999999977643 333


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ...+.+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.+|..+|.|++|.|+|+||+.++.+
T Consensus        93 ~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~  160 (161)
T 3fwb_A           93 DPLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLDGDGEINENEFIAICTD  160 (161)
T ss_dssp             CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSSSSSSEEHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhc
Confidence            45678999999999999999999999999999999999999999999999999999999999999875

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ...

Probab=99.90  E-value=3.2e-23  Score=181.81  Aligned_cols=148  Identities=34%  Similarity=0.560  Sum_probs=134.2

Q ss_pred             hhHhhhhhHHHhhHHHHhcccccCC-CCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-
Q 009594          351 VVAEFLSVEEVAGLKEAFEMMDTNK-RGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-  428 (531)
Q Consensus       351 ~~~~~~~~~~~~~i~~~F~~~D~~~-~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-  428 (531)
                      .++..++++++.+++++|..+|.++ +|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+.++.... 
T Consensus         7 ~~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~   86 (161)
T 1dtl_A            7 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMK   86 (161)
T ss_dssp             TGGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC
T ss_pred             HHHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhc
Confidence            3456778899999999999999999 99999999999999999999999999999999999999999999999776554 


Q ss_pred             ---ccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          429 ---KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       429 ---~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                         .....+.+..+|+.+|.|++|.|+.+||+.++..+|..++.++++.+|..+|.|+||.|+|+||+.++..
T Consensus        87 ~~~~~~~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~  159 (161)
T 1dtl_A           87 DDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG  159 (161)
T ss_dssp             -----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC
T ss_pred             ccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence               2345678999999999999999999999999999999999999999999999999999999999999864

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A

Probab=99.89  E-value=1.7e-23  Score=180.88  Aligned_cols=139  Identities=22%  Similarity=0.332  Sum_probs=126.3

Q ss_pred             HHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhc-CCCCCCceecchhHhHHHHh------hccCc
Q 009594          360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAA-DVDGDGSLNYGEFVAVSVHL------KKMAN  432 (531)
Q Consensus       360 ~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~-D~~~~g~i~~~ef~~~~~~~------~~~~~  432 (531)
                      ++.+++++|..+|.|++|.|+.+||..+++.+|..++..++..+|..+ |.|++|.|+|+||+.++...      .....
T Consensus         2 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~   81 (148)
T 1m45_A            2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAK   81 (148)
T ss_dssp             -CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCC
T ss_pred             hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhcccccccc
Confidence            456788999999999999999999999999999999999999999999 99999999999999987665      44456


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+.++.+|+.+|.|++|.|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++.+
T Consensus        82 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~  147 (148)
T 1m45_A           82 TEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR  147 (148)
T ss_dssp             THHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            688999999999999999999999999999999999999999999999999999999999999864

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=99.89  E-value=2.5e-23  Score=178.42  Aligned_cols=139  Identities=27%  Similarity=0.462  Sum_probs=129.4

Q ss_pred             hHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH-hhccCcHHHH
Q 009594          358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH-LKKMANDEHL  436 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~-~~~~~~~~~~  436 (531)
                      ++++.+++++|..+|.+++|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+.++.. .......+.+
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~   81 (142)
T 2bl0_C            2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDIL   81 (142)
T ss_dssp             CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCCHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCChHHHH
Confidence            567889999999999999999999999999999999999999999999999999999999999997765 3344567889


Q ss_pred             HHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          437 HKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       437 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ..+|+.+|.|++|.|+.+||+.++..+|..+++++++.+|..+| |++|.|+|+||+.++.
T Consensus        82 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~  141 (142)
T 2bl0_C           82 RQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-TEKGQIRYDNFINTMF  141 (142)
T ss_dssp             HHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-CSSSEECSHHHHTTTC
T ss_pred             HHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCcEeHHHHHHHHc
Confidence            99999999999999999999999999999999999999999999 9999999999998764

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A

Probab=99.89  E-value=2e-23  Score=181.31  Aligned_cols=145  Identities=32%  Similarity=0.442  Sum_probs=133.2

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccC-
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMA-  431 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~-  431 (531)
                      +..++++++.+++++|..+|.+++|.|+.+||..++..+|..++..++..+|..+|.+++|.|+|+||+.++....... 
T Consensus         2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~   81 (153)
T 3ox6_A            2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAET   81 (153)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCC
T ss_pred             cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhccc
Confidence            3567889999999999999999999999999999999999999999999999999999999999999999775443332 


Q ss_pred             ----cHHHHHHhhcccCCCCCcceeHHHHHHHHhh-cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          432 ----NDEHLHKAFSFFDRNRSGFIEIEELRNALND-EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       432 ----~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                          ..+.+..+|+.+|.|++|.|+.+||+.++.. +|..+++++++.+|..+|.|++|.|+|+||+.+++
T Consensus        82 ~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~  152 (153)
T 3ox6_A           82 ADMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMS  152 (153)
T ss_dssp             HHHHCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHTC
T ss_pred             cccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence                2577899999999999999999999999999 89999999999999999999999999999999875

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A

Probab=99.89  E-value=4.5e-23  Score=177.79  Aligned_cols=145  Identities=28%  Similarity=0.505  Sum_probs=132.1

Q ss_pred             hHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-cc
Q 009594          352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-KM  430 (531)
Q Consensus       352 ~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~~  430 (531)
                      |++.++++++.+++++|..+|.+++|.|+.+||..++..++..++..++..+|..+|.+++|.|+|+||+.++.... ..
T Consensus         1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~   80 (147)
T 4ds7_A            1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQLKCN   80 (147)
T ss_dssp             ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTH
T ss_pred             CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHhccCC
Confidence            35667889999999999999999999999999999999999999999999999999999999999999999775442 23


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ...+.+..+|+.+|.|++|.|+.+||+.++..+|..+++++++.++..+| |++|.|+|+||+.+++
T Consensus        81 ~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~l~  146 (147)
T 4ds7_A           81 DSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS-DGSGEINIKQFAALLS  146 (147)
T ss_dssp             HHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS-SSCSSEEHHHHHHHTT
T ss_pred             CcHHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHh
Confidence            44578899999999999999999999999999999999999999999999 9999999999999875

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A

Probab=99.89  E-value=7.8e-23  Score=180.92  Aligned_cols=146  Identities=26%  Similarity=0.495  Sum_probs=132.5

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-ccCcH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-KMAND  433 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~  433 (531)
                      .++++++.+++++|..+|.|++|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+.++.... .....
T Consensus        21 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~  100 (169)
T 3qrx_A           21 GLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSR  100 (169)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccCcH
Confidence            46778899999999999999999999999999999999999999999999999999999999999999765432 22345


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      +.+..+|+.+|.|++|.|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++++.+
T Consensus       101 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~  167 (169)
T 3qrx_A          101 EEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS  167 (169)
T ss_dssp             HHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHHC---
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHhcc
Confidence            6789999999999999999999999999999999999999999999999999999999999997643

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ...

Probab=99.89  E-value=8.4e-23  Score=178.20  Aligned_cols=144  Identities=27%  Similarity=0.395  Sum_probs=133.7

Q ss_pred             hhhhHHHhhHHHHhccccc--CCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc--c
Q 009594          355 FLSVEEVAGLKEAFEMMDT--NKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK--M  430 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~--~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~--~  430 (531)
                      .++++++.+++++|..+|.  +++|.|+.+||..+++.+|..++..++..+ ..+|.|++|.|+|+||+.++.....  .
T Consensus         2 ~ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~~   80 (156)
T 1wdc_C            2 KLSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQ   80 (156)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCC
T ss_pred             CCCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhccC
Confidence            3577889999999999999  999999999999999999999999999999 9999999999999999998776543  4


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHh--ccCCCCcceeHHHHHHHHHhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD--VDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~--~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ...+.++.+|+.+|.|++|+|+.+||+.++..+|..+++++++.+|..  +|.|++|.|+|+||+.++...
T Consensus        81 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~  151 (156)
T 1wdc_C           81 GTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAG  151 (156)
T ss_dssp             CCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHC
T ss_pred             ChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHHHHHhcC
Confidence            567889999999999999999999999999999999999999999999  999999999999999999864

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ...

Probab=99.89  E-value=1.7e-22  Score=177.26  Aligned_cols=149  Identities=37%  Similarity=0.618  Sum_probs=136.0

Q ss_pred             hhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc
Q 009594          350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK  429 (531)
Q Consensus       350 ~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~  429 (531)
                      ..++..++++++.+++++|..+|.|++|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+.++.....
T Consensus         8 ~~~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~   87 (162)
T 1top_A            8 AEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMK   87 (162)
T ss_dssp             HHHHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHH
T ss_pred             HHhhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHHhc
Confidence            34566789999999999999999999999999999999999999999999999999999999999999999987654322


Q ss_pred             c-C---cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          430 M-A---NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       430 ~-~---~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      . .   ..+.+..+|+.+|.|++|.|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++..
T Consensus        88 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~  160 (162)
T 1top_A           88 EDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG  160 (162)
T ss_dssp             HHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHS
T ss_pred             cccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence            1 1   4567899999999999999999999999999999999999999999999999999999999999875

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A

Probab=99.88  E-value=1e-22  Score=182.01  Aligned_cols=146  Identities=32%  Similarity=0.609  Sum_probs=130.1

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-ccC
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-KMA  431 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~~~  431 (531)
                      +..++++++.+++++|..+|.|++|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+.++.... ...
T Consensus         2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~   81 (179)
T 2f2o_A            2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD   81 (179)
T ss_dssp             ----CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHHccCcc
Confidence            4567888999999999999999999999999999999999999999999999999999999999999998765432 223


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..+.+..+|+.+|.|++|.|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++..
T Consensus        82 ~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~  148 (179)
T 2f2o_A           82 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA  148 (179)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHSCC
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHH
Confidence            4567899999999999999999999999999999999999999999999999999999999999974

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L

Probab=99.88  E-value=4.6e-23  Score=221.71  Aligned_cols=166  Identities=20%  Similarity=0.273  Sum_probs=156.4

Q ss_pred             hhhHH-HhhHHHHhcccccCCCCcccHHHHHHHHHhC--------CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          356 LSVEE-VAGLKEAFEMMDTNKRGKINLEELRLGLLKG--------GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       356 ~~~~~-~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~--------~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      +++++ ..+++++|+.+| |++|.|+.+||..+|..+        +..++.++++.+|..+|.|++|.|+|+||..++..
T Consensus       525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I~f~EF~~l~~~  603 (714)
T 3bow_A          525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK  603 (714)
T ss_dssp             CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSBCHHHHHHHHHH
T ss_pred             CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            56777 889999999999 999999999999999997        77899999999999999999999999999998765


Q ss_pred             hhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHH
Q 009594          427 LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKAS  506 (531)
Q Consensus       427 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f  506 (531)
                      .      +.++.+|+.||.|++|+|+.+||+.+|..+|..+++++++.++..+| |+||.|+|+||+.++...+.+..+|
T Consensus       604 ~------~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~~~l~~~~~l~~~F  676 (714)
T 3bow_A          604 I------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFKIF  676 (714)
T ss_dssp             H------HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS-CTTCEECHHHHHHHHHHHHHHHHHH
T ss_pred             H------HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHH
Confidence            4      56899999999999999999999999999999999999999999999 9999999999999999989999999


Q ss_pred             hhhCccCCCcCCHHHHHHHHhhc
Q 009594          507 RQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       507 ~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      +.+|+|++|.|+.+|++.++..+
T Consensus       677 ~~~D~d~dG~Is~~el~~l~~~~  699 (714)
T 3bow_A          677 KQLDPENTGTIQLDLISWLSFSV  699 (714)
T ss_dssp             SSSCSSCCSEEEEEHHHHHHHHH
T ss_pred             HHhCCCCCCcEEHHHHHHHHHHH
Confidence            99999999999999999988765

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus}

Probab=99.88  E-value=9.5e-23  Score=175.04  Aligned_cols=141  Identities=28%  Similarity=0.486  Sum_probs=129.1

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCcHH
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMANDE  434 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~~  434 (531)
                      ++++++.+++++|..+|.|++|.|+.+||..+++.+|..++..++..++..    ++|.|+|+||+.++... ......+
T Consensus         1 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~----~~g~i~~~eF~~~~~~~~~~~~~~~   76 (143)
T 3j04_B            1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE----APGPINFTMFLTMFGEKLNGTDPED   76 (143)
T ss_dssp             CCHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT----SSSCCCHHHHHHHHHHTTTSSCCHH
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh----CCCCcCHHHHHHHHHHHhccCCcHH
Confidence            467889999999999999999999999999999999999999998888766    78999999999987643 3345678


Q ss_pred             HHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       435 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      .+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||+.++...+
T Consensus        77 ~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~  142 (143)
T 3j04_B           77 VIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRILKHGA  142 (143)
T ss_dssp             HHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCCSSSCCCSTHHHHHHHSSC
T ss_pred             HHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHhccC
Confidence            899999999999999999999999999999999999999999999999999999999999998653

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A*

Probab=99.88  E-value=1.5e-22  Score=183.65  Aligned_cols=161  Identities=16%  Similarity=0.207  Sum_probs=133.4

Q ss_pred             hhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHH-----HHHHhCCCCCCHH-----HHHHHHHhcCCCCCCceecch
Q 009594          350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELR-----LGLLKGGQNIPEA-----DLQILMEAADVDGDGSLNYGE  419 (531)
Q Consensus       350 ~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~-----~~l~~~~~~~~~~-----~~~~~f~~~D~~~~g~i~~~e  419 (531)
                      ..+...++++++.+++++|..+|.|++|.|+.+||.     .+++.+|..++..     ++..+|..+|.|++|.|+|+|
T Consensus         8 ~~~~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~E   87 (195)
T 1qv0_A            8 KLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQ   87 (195)
T ss_dssp             CCSCCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHH
T ss_pred             hcCcccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCCCCCceEcHHH
Confidence            334455688999999999999999999999999999     6888888887776     588999999999999999999


Q ss_pred             hHhHHHHhhc-------cCcHHHHH----HhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCccee
Q 009594          420 FVAVSVHLKK-------MANDEHLH----KAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS  488 (531)
Q Consensus       420 f~~~~~~~~~-------~~~~~~~~----~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~  488 (531)
                      |+.++.....       ....+.++    .+|+.+|.|++|+|+.+||+.++..+|..+++++++.+|..+|.|+||.|+
T Consensus        88 F~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~  167 (195)
T 1qv0_A           88 FLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLD  167 (195)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEE
T ss_pred             HHHHHHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCC
Confidence            9987654322       11112343    899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCchHHHHHhhhCccCCCc
Q 009594          489 YEEFAVMMKAGTDWRKASRQYSRERFNS  516 (531)
Q Consensus       489 ~~Ef~~~~~~~~~~~~~f~~~D~~~~G~  516 (531)
                      |+||+.++.      ..|...|.+..|.
T Consensus       168 ~~eF~~~~~------~~~~s~d~~~~g~  189 (195)
T 1qv0_A          168 VDEMTRQHL------GFWYTLDPEADGL  189 (195)
T ss_dssp             HHHHHHHHH------HHHTTCCGGGTTT
T ss_pred             HHHHHHHHH------HHccCCCccCccc
Confidence            999998875      4566677777774

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A

Probab=99.88  E-value=1.7e-22  Score=182.54  Aligned_cols=157  Identities=15%  Similarity=0.219  Sum_probs=135.9

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHH-----HHHHhCCCCCCHH-----HHHHHHHhcCCCCCCceecchhHh
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELR-----LGLLKGGQNIPEA-----DLQILMEAADVDGDGSLNYGEFVA  422 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~-----~~l~~~~~~~~~~-----~~~~~f~~~D~~~~g~i~~~ef~~  422 (531)
                      ....+++++.+++++|..+|.|++|.|+.+||.     .+++.+|..++..     ++..+|..+|.|++|.|+|+||+.
T Consensus         7 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~   86 (191)
T 1uhk_A            7 SDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIE   86 (191)
T ss_dssp             CCTTCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHH
T ss_pred             hccCCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHH
Confidence            344578889999999999999999999999999     7899999888877     689999999999999999999998


Q ss_pred             HHHHhhc-------cCcHHHHH----HhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHH
Q 009594          423 VSVHLKK-------MANDEHLH----KAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEE  491 (531)
Q Consensus       423 ~~~~~~~-------~~~~~~~~----~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~E  491 (531)
                      ++.....       ....+.++    .+|+.+|.|++|+|+.+||+.++..+|..++.++++.+|..+|.|+||.|+|+|
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~e  166 (191)
T 1uhk_A           87 GWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDE  166 (191)
T ss_dssp             HHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHH
T ss_pred             HHHHHhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHH
Confidence            7654322       11122333    899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCchHHHHHhhhCccCCC
Q 009594          492 FAVMMKAGTDWRKASRQYSRERFN  515 (531)
Q Consensus       492 f~~~~~~~~~~~~~f~~~D~~~~G  515 (531)
                      |+.++.      ..|...|.+..|
T Consensus       167 F~~~~~------~~~~s~d~~~~g  184 (191)
T 1uhk_A          167 MTRQHL------GFWYTMDPACEK  184 (191)
T ss_dssp             HHHHHH------HHHTTCCGGGTT
T ss_pred             HHHHHH------HHhcCCCCCCcc
Confidence            999887      456667777777

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C*

Probab=99.88  E-value=5.2e-22  Score=171.51  Aligned_cols=141  Identities=22%  Similarity=0.361  Sum_probs=130.4

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhc---CCCCCCceecchhHhHHHHh---hc
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAA---DVDGDGSLNYGEFVAVSVHL---KK  429 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~---D~~~~g~i~~~ef~~~~~~~---~~  429 (531)
                      ++++++.+++++|..+|.+++|.|+.+||..++..+|..++..++..+|..+   |.++ |.|+|+||+.++...   ..
T Consensus         2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~~   80 (149)
T 2mys_C            2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNA-AAITFEEFLPMLQAAANNKD   80 (149)
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccCC
Confidence            5678899999999999999999999999999999999999999999999999   9999 999999999977654   22


Q ss_pred             cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       430 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ....+.+..+|+.+|.|++|.|+.+||+.++..+|..+++++++.+|.. |.|++|.|+|+||+.++.+
T Consensus        81 ~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~~~~~~  148 (149)
T 2mys_C           81 QGTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS  148 (149)
T ss_pred             cchHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCcEeHHHHHHHHhc
Confidence            3456789999999999999999999999999999999999999999999 9999999999999998864

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C

Probab=99.88  E-value=4.9e-23  Score=178.59  Aligned_cols=143  Identities=22%  Similarity=0.350  Sum_probs=122.3

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC--CCCceecchhHhHHHHhhcc--
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD--GDGSLNYGEFVAVSVHLKKM--  430 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~--~~g~i~~~ef~~~~~~~~~~--  430 (531)
                      .++++++.+++++|..+|.|++|.|+.+||..++..+|..++..++..+|..+|.+  ++|.|+|+||+.++......  
T Consensus         3 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~   82 (151)
T 1w7j_B            3 EFNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRG   82 (151)
T ss_dssp             --------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC---
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCC
Confidence            36778899999999999999999999999999999999999999999999999999  99999999999987654321  


Q ss_pred             -CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          431 -ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       431 -~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                       ...+.+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.+|..+| |+||.|+|+||+.++.+
T Consensus        83 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~~  150 (151)
T 1w7j_B           83 QGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE-DSNGCINYEAFLKHILS  150 (151)
T ss_dssp             -----CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CTTSEEEHHHHHHHTC-
T ss_pred             CCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc-CCCCeEeHHHHHHHHhc
Confidence             23456788999999999999999999999999999999999999999999 99999999999998754

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5

Probab=99.88  E-value=1.9e-22  Score=182.62  Aligned_cols=154  Identities=19%  Similarity=0.280  Sum_probs=127.8

Q ss_pred             hHHHHhcccccC-CCCcccHHHHHHHHHhCCCCC-CHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhh
Q 009594          363 GLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNI-PEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAF  440 (531)
Q Consensus       363 ~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~-~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  440 (531)
                      +++++|..+|.+ ++|.|+.+||..++..++... +...++.+|..+|.|++|.|++.||..++.........+.+..+|
T Consensus        26 ~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f  105 (193)
T 1bjf_A           26 EIQEWYKGFLRDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAF  105 (193)
T ss_dssp             HHHHHHHHHHHHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHH
Confidence            456778888888 899999999999999987654 456789999999999999999999999887665556678899999


Q ss_pred             cccCCCCCcceeHHHHHHHHhhc----C--CCCC------HHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhh
Q 009594          441 SFFDRNRSGFIEIEELRNALNDE----V--DTSG------EDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQ  508 (531)
Q Consensus       441 ~~~D~~~~G~i~~~el~~~l~~~----~--~~~~------~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~  508 (531)
                      +.+|.|++|.|+.+||..++..+    |  ..++      .+.+..+|..+|.|+||.|+++||+.++...+.+..+| .
T Consensus       106 ~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~-~  184 (193)
T 1bjf_A          106 SMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKSDPSIVRLL-Q  184 (193)
T ss_dssp             HHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEECHHHHHHHHHHCTHHHHTT-C
T ss_pred             hhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCCCCCeEeHHHHHHHHhcCHHHHHHh-c
Confidence            99999999999999999999763    4  2233      35599999999999999999999999999999999999 9


Q ss_pred             hCccCCCcC
Q 009594          509 YSRERFNSI  517 (531)
Q Consensus       509 ~D~~~~G~i  517 (531)
                      +|+|+||.|
T Consensus       185 ~D~~~dG~i  193 (193)
T 1bjf_A          185 CDPSSAGQF  193 (193)
T ss_dssp             C--------
T ss_pred             cCCCCCCCC
Confidence            999999986

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B

Probab=99.87  E-value=1e-21  Score=173.26  Aligned_cols=142  Identities=22%  Similarity=0.395  Sum_probs=130.1

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCC-CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccC
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMA  431 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~-~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~  431 (531)
                      ..++++++.+++++|..+|.|++|.|+.+||..++..+|. .++..++..+|...    +|.|+|+||+.++... ....
T Consensus        17 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~----dg~i~~~eF~~~~~~~~~~~~   92 (166)
T 2mys_B           17 SMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA----SGPINFTVFLTMFGEKLKGAD   92 (166)
T ss_pred             hhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC----CCCcCHHHHHHHHHHHhccCC
Confidence            4678889999999999999999999999999999999999 99999999999865    7999999999977654 3334


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..+.++.+|+.||.|++|+|+.+||+.+|..+|..+++++++.+|..+|.|+||.|+|+||+.++...
T Consensus        93 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~~~~~~~  160 (166)
T 2mys_B           93 PEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHG  160 (166)
T ss_pred             cHHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHHhc
Confidence            66889999999999999999999999999999999999999999999999999999999999999864

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=99.87  E-value=5.5e-23  Score=185.27  Aligned_cols=143  Identities=43%  Similarity=0.792  Sum_probs=130.3

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcH
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND  433 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  433 (531)
                      +.++++++.+++++|..+|.|++|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+.++.........
T Consensus         2 ~~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~   81 (188)
T 1s6i_A            2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLERE   81 (188)
T ss_dssp             CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCC
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHH
Confidence            35677889999999999999999999999999999999999999999999999999999999999999987655444445


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +.+..+|+.+|.|++|+|+.+||+.++..+|  +++++++.+|..+|.|+||.|+|+||+.++..
T Consensus        82 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~~  144 (188)
T 1s6i_A           82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRK  144 (188)
T ss_dssp             CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHHHTTSC
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHH
Confidence            6789999999999999999999999999887  56778999999999999999999999999963

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5

Probab=99.87  E-value=1.4e-21  Score=173.96  Aligned_cols=140  Identities=21%  Similarity=0.294  Sum_probs=126.8

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHH----HHHhCCCCCCHHHHH-----------HHHHhcCCCCCCceecchhH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRL----GLLKGGQNIPEADLQ-----------ILMEAADVDGDGSLNYGEFV  421 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~----~l~~~~~~~~~~~~~-----------~~f~~~D~~~~g~i~~~ef~  421 (531)
                      +++++.+++++|..+|.|++|.|+.+||..    +++.+|..++..++.           .+|..+|.|++|.|+++||+
T Consensus         2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~   81 (176)
T 1nya_A            2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFI   81 (176)
T ss_dssp             CSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHH
T ss_pred             cHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence            567888999999999999999999999998    688899999988877           88999999999999999999


Q ss_pred             hHHHHhhccCc--------HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHH
Q 009594          422 AVSVHLKKMAN--------DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA  493 (531)
Q Consensus       422 ~~~~~~~~~~~--------~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~  493 (531)
                      .++........        ...++.+|+.+|.|++|.|+.+||+.++..+|  +++++++.+|..+|.|+||.|+|+||+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d~dg~i~~~ef~  159 (176)
T 1nya_A           82 RVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELL  159 (176)
T ss_dssp             HHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred             HHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence            98766544333        36689999999999999999999999999998  889999999999999999999999999


Q ss_pred             HHHHh
Q 009594          494 VMMKA  498 (531)
Q Consensus       494 ~~~~~  498 (531)
                      .++..
T Consensus       160 ~~~~~  164 (176)
T 1nya_A          160 TAVRD  164 (176)
T ss_dssp             HHHSC
T ss_pred             HHHHH
Confidence            99874

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ...

Probab=99.86  E-value=1.7e-21  Score=169.93  Aligned_cols=143  Identities=22%  Similarity=0.449  Sum_probs=127.9

Q ss_pred             hHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hcc
Q 009594          352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKM  430 (531)
Q Consensus       352 ~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~  430 (531)
                      +...++++++.+++++|..+|.|++|.|+.+||..++..+|..++..++..++.    +++|.|+|+||+.++... ...
T Consensus         8 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~   83 (156)
T 1wdc_B            8 VLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGT   83 (156)
T ss_dssp             ----CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSC
T ss_pred             hhccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHH----hCCCcCcHHHHHHHHHHHhcCC
Confidence            345678889999999999999999999999999999999999999999999885    478999999999977644 334


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ...+.++.+|+.+|.|++|+|+.+||+.+|..+|..+++++++.+|..+|.| ||.|+|+||+.++...
T Consensus        84 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~-dg~i~~~eF~~~~~~~  151 (156)
T 1wdc_B           84 DSEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGS  151 (156)
T ss_dssp             CCHHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTS
T ss_pred             ChHHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCC-CCEEeHHHHHHHHhcC
Confidence            5678899999999999999999999999999999999999999999999999 9999999999999864

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=99.86  E-value=1.2e-21  Score=168.47  Aligned_cols=133  Identities=26%  Similarity=0.437  Sum_probs=123.4

Q ss_pred             HHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh--hccCcHHHHHHhhc
Q 009594          364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL--KKMANDEHLHKAFS  441 (531)
Q Consensus       364 i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~--~~~~~~~~~~~~F~  441 (531)
                      ++++|..+|.|++|.|+.+||..++..+|..++..++..+|..   +++|.|+|+||+.++...  ........++.+|+
T Consensus         7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~   83 (145)
T 2bl0_B            7 IQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQSKEMLDAFR   83 (145)
T ss_dssp             HHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGGHHHHHHHHH
T ss_pred             HHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh---cCCCeEcHHHHHHHHHHHhhcCcccHHHHHHHHH
Confidence            8999999999999999999999999999999999999999998   889999999999987654  23345678999999


Q ss_pred             ccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          442 FFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       442 ~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .+|.|++|+|+.+||+.+|..+|..++.++++.+|..+|.|+||.|+|+||+.++.+.
T Consensus        84 ~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~  141 (145)
T 2bl0_B           84 ALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAINYESFVDMLVTG  141 (145)
T ss_dssp             HHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHHS
T ss_pred             HhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHHHhc
Confidence            9999999999999999999999999999999999999999999999999999998753

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A

Probab=99.86  E-value=3.5e-21  Score=179.16  Aligned_cols=156  Identities=19%  Similarity=0.320  Sum_probs=137.3

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhC-CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~-~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~  432 (531)
                      ..++++++..+.+.|..  .+++|.|+.+||..++..+ +...+...++.+|+.+|.|++|.|+|+||+.++........
T Consensus        59 ~~~s~~ei~~l~~~F~~--~d~~G~Is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~  136 (229)
T 3dd4_A           59 SKFTKKELQILYRGFKN--ECPSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTV  136 (229)
T ss_dssp             HHHHHHHHHHHHHHHHT--TCCSCCCCHHHHHHHHHHHSCSSSHHHHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCH
T ss_pred             cCCCHHHHHHHHHHHHh--hCCCCCcCHHHHHHHHHHHCCCCCcHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCCh
Confidence            45788888899999877  5778999999999999985 45566777899999999999999999999998877666667


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhc------------CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDE------------VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~------------~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      .+.++.+|+.||.|++|+|+.+||..++..+            +...++++++.+|..+|.|+||.||++||+.++...+
T Consensus       137 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~  216 (229)
T 3dd4_A          137 QEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDE  216 (229)
T ss_dssp             HHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSSCSSBCCHHHHHHHHHTCH
T ss_pred             HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhCH
Confidence            7889999999999999999999999999876            4566778899999999999999999999999999999


Q ss_pred             hHHHHHhhhCc
Q 009594          501 DWRKASRQYSR  511 (531)
Q Consensus       501 ~~~~~f~~~D~  511 (531)
                      .+...|..||.
T Consensus       217 ~~~~~~~~~D~  227 (229)
T 3dd4_A          217 NIMRSMQLFEN  227 (229)
T ss_dssp             HHHHHHHHHTT
T ss_pred             HHHHHHHhccc
Confidence            99999999986

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola}

Probab=99.85  E-value=1.6e-21  Score=178.81  Aligned_cols=144  Identities=16%  Similarity=0.261  Sum_probs=121.7

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCC--CCCHHHHHHHH-------HhcCCCCCCceecchhHhH
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ--NIPEADLQILM-------EAADVDGDGSLNYGEFVAV  423 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~--~~~~~~~~~~f-------~~~D~~~~g~i~~~ef~~~  423 (531)
                      ...++++++.+++++|..+|.|++|.|+.+||..++..+|.  .++..++..++       ..+|.|++|.|+|+||+.+
T Consensus        27 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~  106 (208)
T 2hpk_A           27 VEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEA  106 (208)
T ss_dssp             ---------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHH
T ss_pred             HHHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHH
Confidence            36778889999999999999999999999999999999887  88999999999       9999999999999999997


Q ss_pred             HH---------Hhhcc-CcHHH-HHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHH
Q 009594          424 SV---------HLKKM-ANDEH-LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEF  492 (531)
Q Consensus       424 ~~---------~~~~~-~~~~~-~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef  492 (531)
                      +.         ..... ...+. ++.+|+.+|.|++|.|+.+||+.++..+|  +++++++.+|..+|.|+||.|+|+||
T Consensus       107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~I~~~EF  184 (208)
T 2hpk_A          107 NRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEAAYTFFEKADTDKSGKLERTEL  184 (208)
T ss_dssp             HHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SCTTHHHHHHHHHCTTCCSSBCHHHH
T ss_pred             HHHHhhhhhhhhccCChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cCHHHHHHHHHHhCCCCCCcCcHHHH
Confidence            65         22222 22333 78999999999999999999999999998  78889999999999999999999999


Q ss_pred             HHHHHh
Q 009594          493 AVMMKA  498 (531)
Q Consensus       493 ~~~~~~  498 (531)
                      +.++..
T Consensus       185 ~~~~~~  190 (208)
T 2hpk_A          185 VHLFRK  190 (208)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999874

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii}

Probab=99.85  E-value=2.6e-21  Score=174.86  Aligned_cols=142  Identities=15%  Similarity=0.128  Sum_probs=127.5

Q ss_pred             hhhhhHHHhhHHHHhccc-ccCCCCcccHHHHHHHHHhC----CCCCCHHHHHHHH-----------HhcCCCCCCceec
Q 009594          354 EFLSVEEVAGLKEAFEMM-DTNKRGKINLEELRLGLLKG----GQNIPEADLQILM-----------EAADVDGDGSLNY  417 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~-D~~~~g~i~~~el~~~l~~~----~~~~~~~~~~~~f-----------~~~D~~~~g~i~~  417 (531)
                      ..+++++..+++++|..+ |.|++|.|+.+||..++..+    |..++..++..++           ..+|.|++|.|++
T Consensus         4 ~~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~   83 (191)
T 2ccm_A            4 HQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVTK   83 (191)
T ss_dssp             CCCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEH
T ss_pred             hhccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECH
Confidence            445778888999999999 99999999999999999998    8888888898888           9999999999999


Q ss_pred             chhHhHHHHhhc---------cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCccee
Q 009594          418 GEFVAVSVHLKK---------MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS  488 (531)
Q Consensus       418 ~ef~~~~~~~~~---------~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~  488 (531)
                      +||+.++.....         ......+..+|+.+|.|++|.|+.+||..++..+|  +++++++.+|..+|.|+||.|+
T Consensus        84 ~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~~~~~~~~~~~~D~d~dG~i~  161 (191)
T 2ccm_A           84 EEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPKSDCDAAFDTLSDGGKTMVT  161 (191)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CCHHHHHHHHHHHTTTTTSCCB
T ss_pred             HHHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCCcC
Confidence            999987765421         12346789999999999999999999999999987  7899999999999999999999


Q ss_pred             HHHHHHHHH
Q 009594          489 YEEFAVMMK  497 (531)
Q Consensus       489 ~~Ef~~~~~  497 (531)
                      ++||+.++.
T Consensus       162 ~~Ef~~~~~  170 (191)
T 2ccm_A          162 REIFARLWT  170 (191)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999999886

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E

Probab=99.85  E-value=3.9e-21  Score=172.38  Aligned_cols=155  Identities=19%  Similarity=0.284  Sum_probs=134.3

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND  433 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  433 (531)
                      .++.+++.++.+.|+.+  |++|.|+.+||..++..++.. .+..+++.+|+.+|.|++|.|+++||+.++.........
T Consensus        14 ~~s~~~i~~l~~~fd~~--d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~   91 (183)
T 1s6c_A           14 NFTKRELQVLYRGFKNE--XPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVH   91 (183)
T ss_dssp             SCCHHHHHHHHHHHHHH--CTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHH
T ss_pred             CCCHHHHHHHHHHHHHh--CCCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHH
Confidence            45777777777766664  689999999999999998765 788999999999999999999999999988766666677


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhc----CCC----CC----HHHHHHHHHhccCCCCcceeHHHHHHHHHhCch
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDE----VDT----SG----EDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD  501 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~----~~----~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~  501 (531)
                      +.+..+|+.+|.|++|+|+.+||..++..+    |..    ++    .++++.+|+.+|.|+||.|+++||+.++...+.
T Consensus        92 ~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~~  171 (183)
T 1s6c_A           92 EKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQEDDN  171 (183)
T ss_dssp             HHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCCH
T ss_pred             HHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHhcChH
Confidence            889999999999999999999999999876    532    33    388999999999999999999999999999999


Q ss_pred             HHHHHhhhCc
Q 009594          502 WRKASRQYSR  511 (531)
Q Consensus       502 ~~~~f~~~D~  511 (531)
                      +...|..+|+
T Consensus       172 ~~~~l~~~d~  181 (183)
T 1s6c_A          172 IMRSLQLFQN  181 (183)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHhhc
Confidence            9999998874

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia}

Probab=99.85  E-value=1.9e-21  Score=176.45  Aligned_cols=142  Identities=21%  Similarity=0.363  Sum_probs=130.2

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccC
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMA  431 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~  431 (531)
                      ...++.+++..|+++|..+|.|++|.|+..||..+|..+|..++..++..++..+    +|.|+|.||+.++... ....
T Consensus        48 ~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~----~g~i~~~eF~~~~~~~~~~~~  123 (196)
T 3dtp_E           48 FAMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA----PGPINFTMFLTIFGDRIAGTD  123 (196)
T ss_dssp             SCSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS----SSCCBHHHHHHHHHHCCCSSC
T ss_pred             hhhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc----cCCCcHHHHHHHHHHHhcCCC
Confidence            3456788899999999999999999999999999999999999999999999887    8999999999987643 3345


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..+.+..+|+.||.|++|+|+.+||+.+| .+|..++.++++.+|..+|.|+||.|+|+||+.+|...
T Consensus       124 ~~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~l~~~  190 (196)
T 3dtp_E          124 EEDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQILTKG  190 (196)
T ss_dssp             CHHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSCEETTEECHHHHHHHHHSSC
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcCCCCCCEEeHHHHHHHHHcC
Confidence            57889999999999999999999999999 99999999999999999999999999999999999864

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A

Probab=99.85  E-value=2.9e-21  Score=176.92  Aligned_cols=156  Identities=17%  Similarity=0.190  Sum_probs=122.5

Q ss_pred             hHHHHhcccccC-CCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhh
Q 009594          363 GLKEAFEMMDTN-KRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAF  440 (531)
Q Consensus       363 ~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~-~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  440 (531)
                      ++.++|..+|.+ ++|.|+.+||..++..++.. .+..++..+|..+|.|++|.|+++||+.++.........+.+..+|
T Consensus        34 ~i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f  113 (207)
T 2d8n_A           34 ELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAF  113 (207)
T ss_dssp             HHHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHH
Confidence            556667777777 68888888888888887654 6777788888888888888888888888776655455567788888


Q ss_pred             cccCCCCCcceeHHHHHHHHhhc----C----CCCC------HHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHH
Q 009594          441 SFFDRNRSGFIEIEELRNALNDE----V----DTSG------EDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKAS  506 (531)
Q Consensus       441 ~~~D~~~~G~i~~~el~~~l~~~----~----~~~~------~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f  506 (531)
                      +.+|.|++|.|+.+||..++..+    |    ..++      .++++.+|..+|.|+||.|+|+||+.++...+.+...|
T Consensus       114 ~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~  193 (207)
T 2d8n_A          114 SLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEGTLANKEILRLI  193 (207)
T ss_dssp             HHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCCTTCCEEHHHHHHHHHHCHHHHHHH
T ss_pred             HHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHhChHHHHHH
Confidence            88888888888888888888775    5    3333      35688888888888888888888888888888888888


Q ss_pred             hhhCccCCCcCC
Q 009594          507 RQYSRERFNSIS  518 (531)
Q Consensus       507 ~~~D~~~~G~i~  518 (531)
                      ..||..-++.++
T Consensus       194 ~~~~~~~~~~~~  205 (207)
T 2d8n_A          194 QFEPQKVKEKMK  205 (207)
T ss_dssp             SCCCSSCCCCC-
T ss_pred             hhhhHHHHHHhc
Confidence            888877766654

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens}

Probab=99.85  E-value=2.8e-21  Score=177.56  Aligned_cols=161  Identities=20%  Similarity=0.266  Sum_probs=136.8

Q ss_pred             hhHHHHhcccccC-CCCcccHHHHHHHHHhCCCCCCH-HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHh
Q 009594          362 AGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPE-ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKA  439 (531)
Q Consensus       362 ~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~-~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~  439 (531)
                      .+++++|+.||.+ ++|.|+.+||..++..++..++. .+++.+|..+|.|++|.|+|.||+.++.........+.++.+
T Consensus        19 ~ei~~~f~~fD~~~~~G~is~~El~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~   98 (211)
T 2ggz_A           19 QETHVWYRTFMMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWY   98 (211)
T ss_dssp             -----CCCSHHHHCTTSEEEHHHHHHHTTCCSCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHH
Confidence            4568899999998 89999999999999998876544 459999999999999999999999988766555667889999


Q ss_pred             hcccCCCCCcceeHHHHHHHHhhcC-----CCCCH-HHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccC
Q 009594          440 FSFFDRNRSGFIEIEELRNALNDEV-----DTSGE-DVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRER  513 (531)
Q Consensus       440 F~~~D~~~~G~i~~~el~~~l~~~~-----~~~~~-~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~  513 (531)
                      |+.+|.|++|+|+.+||..++..++     ...+. +.++.+|..+|.|+||.|+++||+.++...+.+.++|..     
T Consensus        99 F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~-----  173 (211)
T 2ggz_A           99 FKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGMAKDQDLLEIVYK-----  173 (211)
T ss_dssp             HHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHTTTTTHHHHHH-----
T ss_pred             HHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCHHHHHHHhc-----
Confidence            9999999999999999999999875     55555 458999999999999999999999999999999999883     


Q ss_pred             CCcCCHHHHHHHHhhc
Q 009594          514 FNSISLKLMREEGLQL  529 (531)
Q Consensus       514 ~G~i~~~e~~~~~~~~  529 (531)
                        .++.+||.+++...
T Consensus       174 --~~d~~~f~~~~~~~  187 (211)
T 2ggz_A          174 --SFDFSNVLRVICNG  187 (211)
T ss_dssp             --HSCTTHHHHHHHHH
T ss_pred             --cCCHHHHHHHHhcC
Confidence              34477888888754

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5

Probab=99.85  E-value=9.2e-21  Score=173.14  Aligned_cols=149  Identities=21%  Similarity=0.324  Sum_probs=134.3

Q ss_pred             HHhhHHHHhcccccC-CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHH
Q 009594          360 EVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHK  438 (531)
Q Consensus       360 ~~~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~  438 (531)
                      ...+++++|..+|.+ ++|.|+.+||..++..++...+..+++.+|..+|.|++|.|+|+||+.++.........+.+..
T Consensus        20 ~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~   99 (204)
T 1jba_A           20 DAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKW   99 (204)
T ss_dssp             HHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHH
T ss_pred             CHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhcCCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHH
Confidence            445678899999999 8999999999999999998888999999999999999999999999998877666667788999


Q ss_pred             hhcccCCCCCcceeHHHHHHHHhhc----C------------C-CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCch
Q 009594          439 AFSFFDRNRSGFIEIEELRNALNDE----V------------D-TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD  501 (531)
Q Consensus       439 ~F~~~D~~~~G~i~~~el~~~l~~~----~------------~-~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~  501 (531)
                      +|+.+|.|++|.|+.+||..++..+    |            . ..+.++++.+|..+|.|+||.|+++||+.++...+.
T Consensus       100 ~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~~  179 (204)
T 1jba_A          100 TFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKW  179 (204)
T ss_dssp             HHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTTTT
T ss_pred             HHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHcChH
Confidence            9999999999999999999999876    3            1 145678999999999999999999999999999999


Q ss_pred             HHHHHhh
Q 009594          502 WRKASRQ  508 (531)
Q Consensus       502 ~~~~f~~  508 (531)
                      +...+..
T Consensus       180 ~~~~~~~  186 (204)
T 1jba_A          180 VMKMLQM  186 (204)
T ss_dssp             HHHHHHS
T ss_pred             HHHHHHh
Confidence            9988883

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens}

Probab=99.84  E-value=2.6e-21  Score=176.80  Aligned_cols=143  Identities=22%  Similarity=0.425  Sum_probs=123.4

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHL  436 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~  436 (531)
                      ...++.+++++|..+|.|++|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+.++.........+.+
T Consensus        32 ~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~~~~~  111 (204)
T 3e3r_A           32 GASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVI  111 (204)
T ss_dssp             --------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHHHHHH
T ss_pred             CchhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchHHHHH
Confidence            35677899999999999999999999999999999999999999999999999999999999999987644333456789


Q ss_pred             HHhhcccCCCCCcceeHHHHHHHHhh-------cCCCCCHHHHHHHHHhccC-CCCcceeHHHHHHHHHhC
Q 009594          437 HKAFSFFDRNRSGFIEIEELRNALND-------EVDTSGEDVINAIMHDVDT-DKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       437 ~~~F~~~D~~~~G~i~~~el~~~l~~-------~~~~~~~~~~~~~~~~~D~-~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..+|+.+|.|++|+|+.+||..++..       .|...++++++.+|..+|. |+||.|+|+||+.++...
T Consensus       112 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~~~~~~~  182 (204)
T 3e3r_A          112 AAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQDYYSGV  182 (204)
T ss_dssp             HHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHHHHHHHH
T ss_pred             HHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHc
Confidence            99999999999999999999999984       4666778889999999998 999999999999999853

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A

Probab=99.84  E-value=5.6e-21  Score=175.01  Aligned_cols=158  Identities=19%  Similarity=0.177  Sum_probs=142.5

Q ss_pred             ccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhcc-CcHHHHHHhhcccCCCC
Q 009594          370 MMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKKM-ANDEHLHKAFSFFDRNR  447 (531)
Q Consensus       370 ~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~~~  447 (531)
                      .|+.+++|.|+.+++..+++.++  ++.+++..+|..+|.+ ++|.|+++||..++...... ...+.+..+|+.+|.|+
T Consensus         7 ~mg~~~~g~l~~~el~~~~~~~~--~~~~~i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~   84 (207)
T 2d8n_A            7 GMGNSKSGALSKEILEELQLNTK--FSEEELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNL   84 (207)
T ss_dssp             -CTTCCTTCCCHHHHHHHHHHSS--CCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTC
T ss_pred             hhccccCCCCCHHHHHHHHHHcC--CCHHHHHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCC
Confidence            48899999999999999999876  5899999999999998 79999999999988765432 56788999999999999


Q ss_pred             CcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC--------------------chHHHHHh
Q 009594          448 SGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG--------------------TDWRKASR  507 (531)
Q Consensus       448 ~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~--------------------~~~~~~f~  507 (531)
                      +|.|+.+||..++..++...+.+++..+|..+|.|++|.|+++||..++...                    ..+..+|.
T Consensus        85 ~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~  164 (207)
T 2d8n_A           85 DGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWK  164 (207)
T ss_dssp             CSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHH
T ss_pred             CCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHH
Confidence            9999999999999998877788899999999999999999999999998752                    34899999


Q ss_pred             hhCccCCCcCCHHHHHHHHhhc
Q 009594          508 QYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       508 ~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      .+|+|+||.|+.+||.+.+...
T Consensus       165 ~~D~d~dG~I~~~Ef~~~~~~~  186 (207)
T 2d8n_A          165 YFGKNDDDKLTEKEFIEGTLAN  186 (207)
T ss_dssp             HTTCCTTCCEEHHHHHHHHHHC
T ss_pred             HcCCCCCCcCcHHHHHHHHHhC
Confidence            9999999999999999998764

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens}

Probab=99.84  E-value=2e-21  Score=177.27  Aligned_cols=141  Identities=25%  Similarity=0.322  Sum_probs=126.9

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh------
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK------  428 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~------  428 (531)
                      .++++++.+++++|..+|.|++|.|+.+||..+ ..+|..++   +..+|..+|.|++|.|+|+||+.++....      
T Consensus        22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~   97 (202)
T 2bec_A           22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDED   97 (202)
T ss_dssp             CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHHH
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchhc
Confidence            567889999999999999999999999999988 77776654   88999999999999999999999876554      


Q ss_pred             -----------ccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHHHh----ccCCCCcceeHHHH
Q 009594          429 -----------KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIMHD----VDTDKDGRISYEEF  492 (531)
Q Consensus       429 -----------~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~~----~D~~~dG~i~~~Ef  492 (531)
                                 .....+.++.+|+.+|.|++|+|+.+||+.++..+ |..+++++++.++..    +|.|+||.|+|+||
T Consensus        98 ~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~EF  177 (202)
T 2bec_A           98 TETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEF  177 (202)
T ss_dssp             HC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHHH
T ss_pred             ccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHHH
Confidence                       23446789999999999999999999999999999 999999999999888    99999999999999


Q ss_pred             HHHHHhC
Q 009594          493 AVMMKAG  499 (531)
Q Consensus       493 ~~~~~~~  499 (531)
                      +.++...
T Consensus       178 ~~~~~~~  184 (202)
T 2bec_A          178 TKSLEKM  184 (202)
T ss_dssp             HHTTTTS
T ss_pred             HHHHHHh
Confidence            9998753

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5

Probab=99.84  E-value=3.3e-21  Score=164.69  Aligned_cols=134  Identities=24%  Similarity=0.405  Sum_probs=121.6

Q ss_pred             HHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc---CcHHHH
Q 009594          360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM---ANDEHL  436 (531)
Q Consensus       360 ~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~---~~~~~~  436 (531)
                      ++.+++++|..+|.|++|.|+.+||..+++.+|..++..++..++.    +++|.|+|+||+.++......   ...+.+
T Consensus         3 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~   78 (140)
T 1ggw_A            3 DDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES----TLPAEVDMEQFLQVLNRPNGFDMPGDPEEF   78 (140)
T ss_dssp             CCTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT----TSCSSEEHHHHHHHHCTTSSSSSSCCHHHH
T ss_pred             hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh----CCCCcCcHHHHHHHHHHHhcccCcccHHHH
Confidence            3567899999999999999999999999999999999999998887    889999999999987654322   234789


Q ss_pred             HHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          437 HKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       437 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..+|+.+|.|++|+|+.+||+.+|..+|..+++++++.+|..+|. +||.|+|+||+.++.+
T Consensus        79 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~-~dg~i~~~eF~~~~~~  139 (140)
T 1ggw_A           79 VKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV-KDGMVNYHDFVQMILA  139 (140)
T ss_dssp             HHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC-SSCCSTTTHHHHHHHC
T ss_pred             HHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC-CCCcEeHHHHHHHHhc
Confidence            999999999999999999999999999999999999999999999 9999999999999864

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus}

Probab=99.84  E-value=7.5e-21  Score=172.90  Aligned_cols=164  Identities=18%  Similarity=0.242  Sum_probs=131.1

Q ss_pred             HHhhHHHHhcccccC-CCCcccHHHHHHHHHhCCCCCCH-HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHH
Q 009594          360 EVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPE-ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLH  437 (531)
Q Consensus       360 ~~~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~-~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  437 (531)
                      ...+++++|..+|.+ ++|.|+.+||..+++.++..++. .+++.+|..+|.|++|.|++.||+.++.........+.+.
T Consensus        12 ~~~el~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~   91 (198)
T 2r2i_A           12 SATECHQWYKKFMTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLR   91 (198)
T ss_dssp             HTSCHHHHHHHHHHHCTTSEECHHHHHHHHTCCSCCHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHH
Confidence            344678889999988 89999999999999998876654 4599999999999999999999999887766666678899


Q ss_pred             HhhcccCCCCCcceeHHHHHHHHhhcC------CCCCHH-HHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHh---
Q 009594          438 KAFSFFDRNRSGFIEIEELRNALNDEV------DTSGED-VINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASR---  507 (531)
Q Consensus       438 ~~F~~~D~~~~G~i~~~el~~~l~~~~------~~~~~~-~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~---  507 (531)
                      .+|+.+|.|++|.|+.+||..++..++      ...+.+ .+..+|..+|.|+||.|+++||+.++...+.+..++.   
T Consensus        92 ~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~~  171 (198)
T 2r2i_A           92 WYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDINGDGELSLEEFMEGVQKDEVLLDILTRSL  171 (198)
T ss_dssp             HHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHTTCHHHHHHHHSTT
T ss_pred             HHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcCHHHHHHHhccc
Confidence            999999999999999999999999875      455554 4999999999999999999999999997766555554   


Q ss_pred             -------hhCccCCCcCCHHHHH
Q 009594          508 -------QYSRERFNSISLKLMR  523 (531)
Q Consensus       508 -------~~D~~~~G~i~~~e~~  523 (531)
                             ..+.++.+..+.+|..
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~  194 (198)
T 2r2i_A          172 DLTHIVKLIQNDGKNPHAPEEAE  194 (198)
T ss_dssp             CHHHHHHHHTTCC----------
T ss_pred             cchhhHHHHhccCCCCCCchhhh
Confidence                   3555556666665543

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe}

Probab=99.84  E-value=1e-20  Score=170.79  Aligned_cols=150  Identities=21%  Similarity=0.299  Sum_probs=132.2

Q ss_pred             hhHHHHhcccccC-CCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHh
Q 009594          362 AGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKA  439 (531)
Q Consensus       362 ~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~-~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~  439 (531)
                      .+++++|..+|.+ ++|.|+.+||..++..++.. .+..++..+|..+|.|++|.|++.||..++.........+.+..+
T Consensus        25 ~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~  104 (190)
T 2l2e_A           25 KELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWA  104 (190)
T ss_dssp             HHHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHH
Confidence            3577788899999 89999999999999988643 556779999999999999999999999988766555677889999


Q ss_pred             hcccCCCCCcceeHHHHHHHHhhc------------CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHh
Q 009594          440 FSFFDRNRSGFIEIEELRNALNDE------------VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASR  507 (531)
Q Consensus       440 F~~~D~~~~G~i~~~el~~~l~~~------------~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~  507 (531)
                      |+.+|.|++|.|+.+||..++..+            +...+.++++.+|..+|.|+||.|+++||+.++...+.+...|.
T Consensus       105 f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~l~  184 (190)
T 2l2e_A          105 FQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFCEGSKRDPTIVSALS  184 (190)
T ss_dssp             HHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCCSSCCBCHHHHHHHHHTCTHHHHHHH
T ss_pred             HhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCcHHHHHHH
Confidence            999999999999999999999772            33567889999999999999999999999999999999999999


Q ss_pred             hhCc
Q 009594          508 QYSR  511 (531)
Q Consensus       508 ~~D~  511 (531)
                      .+|+
T Consensus       185 ~~d~  188 (190)
T 2l2e_A          185 LYDG  188 (190)
T ss_dssp             TTCS
T ss_pred             HHhc
Confidence            8885

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B*

Probab=99.84  E-value=4.2e-21  Score=167.01  Aligned_cols=139  Identities=27%  Similarity=0.479  Sum_probs=123.4

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc-cCcHHH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK-MANDEH  435 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~~~  435 (531)
                      +++++.+++++|..+|.|++|.|+.+|| ..+..++..+   ++..+|..+|.|++|.|+|+||+.++..... ....+.
T Consensus         1 s~~~~~~l~~~F~~~D~d~~G~i~~~el-~~l~~~~~~~---~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~   76 (155)
T 3ll8_B            1 DADEIKRLGKRFKKLDLDNSGSLSVEEF-MSLPELQQNP---LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQK   76 (155)
T ss_dssp             CCHHHHHHHHHHHHHCTTCSSSBCHHHH-TTSGGGTTCT---THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHH
T ss_pred             CHHHHHHHHHHHHHhCcCCCCeEcHHHH-HHhhccccch---HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHH
Confidence            3578899999999999999999999999 6777766554   7889999999999999999999998765432 245678


Q ss_pred             HHHhhcccCCCCCcceeHHHHHHHHhh-cCCCCCHHHHHHHHHh----ccCCCCcceeHHHHHHHHHhC
Q 009594          436 LHKAFSFFDRNRSGFIEIEELRNALND-EVDTSGEDVINAIMHD----VDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       436 ~~~~F~~~D~~~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~----~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ++.+|+.+|.|++|.|+.+||+.++.. .|..++.++++.++..    +|.|+||.|+|+||+.++...
T Consensus        77 ~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~  145 (155)
T 3ll8_B           77 LRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGL  145 (155)
T ss_dssp             HHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHHHHGGG
T ss_pred             HHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHhcc
Confidence            999999999999999999999999999 6889999999999988    999999999999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=2.9e-21  Score=183.11  Aligned_cols=140  Identities=17%  Similarity=0.208  Sum_probs=107.6

Q ss_pred             eeeccccCccCceEEEEEEEccCCcE--EEEEEeeccccCC---------------------hhhHHHHHHHHHHHHhCC
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEK--FACKSISKKKLRT---------------------AVDIEDVRREVQIMKHLP  114 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~  114 (531)
                      |++.+.||+|+||.||+|.+..+|+.  ||||++.......                     ......+.+|+.+++++ 
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  127 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA-  127 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-
Confidence            78899999999999999998778999  9999975432110                     01123678899999999 


Q ss_pred             CCCCe--eecceEEEcCCeEEEEEeccCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCC
Q 009594          115 KHPNI--VSLKDTYEDDSAVHIVMELCEG-G----ELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-EQGVMHRDLKPE  186 (531)
Q Consensus       115 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~iiH~Dlkp~  186 (531)
                      .|+++  +.++++    ...+|||||+.+ |    +|.+....   .++..+..++.|++.||.||| +.||+||||||+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            77764  333332    356899999942 3    66655322   235578899999999999999 999999999999


Q ss_pred             ceEeecCCCCCCeEEEeecccccc
Q 009594          187 NFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       187 NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      |||++.     .++|+|||+|...
T Consensus       201 NILl~~-----~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID-----KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS-----SEEECCCTTCEET
T ss_pred             HEEEcC-----cEEEEECcccccC
Confidence            999964     5999999999764

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi}

Probab=99.84  E-value=1.8e-21  Score=179.84  Aligned_cols=148  Identities=20%  Similarity=0.285  Sum_probs=126.7

Q ss_pred             hhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHh-CCCCCCHHHHHHHHHhc---------CCCCCCceecchh
Q 009594          351 VVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAA---------DVDGDGSLNYGEF  420 (531)
Q Consensus       351 ~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~-~~~~~~~~~~~~~f~~~---------D~~~~g~i~~~ef  420 (531)
                      .+...++++++.+++++|..+|.|++|.|+.+||..++.. +|..++..++..++..+         |.|++|.|+|.||
T Consensus        37 ~~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I~~~EF  116 (219)
T 3cs1_A           37 AIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEF  116 (219)
T ss_dssp             HSCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHHHHTSCCCSSBCH
T ss_pred             HhcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhccCCCCcCCHHHH
Confidence            3445678899999999999999999999999999999987 78777776666654422         3488999999999


Q ss_pred             HhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCC-CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          421 VAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +.++.........+.++.+|+.||.|++|+|+.+||+.+|..+|. .++.++++.+|..+|.|+||.|+|+||+.++..
T Consensus       117 ~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~~  195 (219)
T 3cs1_A          117 LEFRLMLCYIYDFFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTFDEFAAWASA  195 (219)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTTSSSEEEHHHHHHHHHH
T ss_pred             HHHHHHHhccchHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence            987654433344678999999999999999999999999999886 778888999999999999999999999999985

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A

Probab=99.84  E-value=1.6e-20  Score=165.29  Aligned_cols=137  Identities=23%  Similarity=0.271  Sum_probs=118.8

Q ss_pred             HHhhHHHHhcccccCCCCcccHHHHHHHH----HhCCCCCCHHHHHHH-----------HHhcCCCCCCceecchhHhHH
Q 009594          360 EVAGLKEAFEMMDTNKRGKINLEELRLGL----LKGGQNIPEADLQIL-----------MEAADVDGDGSLNYGEFVAVS  424 (531)
Q Consensus       360 ~~~~i~~~F~~~D~~~~g~i~~~el~~~l----~~~~~~~~~~~~~~~-----------f~~~D~~~~g~i~~~ef~~~~  424 (531)
                      ++.+++++|..+|.|++|.|+.+||..++    ..+|..++..++..+           |..+|.|++|.|+++||+.++
T Consensus         2 ~~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~   81 (166)
T 3akb_A            2 YERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTGA   81 (166)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHTH
T ss_pred             HHHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence            35689999999999999999999999875    455888888877654           799999999999999999876


Q ss_pred             HHhhccCc-------HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          425 VHLKKMAN-------DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       425 ~~~~~~~~-------~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ........       .+.+..+|+.+|.|++|.|+.+||+.++..+|  ++.++++.+|..+|.|+||.|+++||+.++.
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~  159 (166)
T 3akb_A           82 VKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDTDGDGKVGETEIVPAFA  159 (166)
T ss_dssp             HHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSBCCHHHHHHHHH
T ss_pred             HHHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence            55432221       34489999999999999999999999999998  8899999999999999999999999999886


Q ss_pred             h
Q 009594          498 A  498 (531)
Q Consensus       498 ~  498 (531)
                      .
T Consensus       160 ~  160 (166)
T 3akb_A          160 R  160 (166)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A

Probab=99.83  E-value=2.1e-20  Score=186.75  Aligned_cols=144  Identities=32%  Similarity=0.617  Sum_probs=131.1

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMAN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~  432 (531)
                      ..++.+++.+++++|+.+|.|++|.|+.+||..+|..++..++.++++.+|+.+|.|++|.|+|+||+.++... .....
T Consensus       304 ~~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~~  383 (450)
T 3sg6_A          304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDS  383 (450)
T ss_dssp             -CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTSSSSEEHHHHHHHHHC------C
T ss_pred             ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcccHHHHHHHHHhhccccch
Confidence            45667788999999999999999999999999999999999999999999999999999999999999987643 33345


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .+.++.+|+.+|.|++|+|+.+||+.+|..+|..+++++++.+|..+|.|+||.|+|+||+.+|.
T Consensus       384 ~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv~~L~  448 (450)
T 3sg6_A          384 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT  448 (450)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTSSSSEEHHHHHHHHC
T ss_pred             hhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence            67899999999999999999999999999999999999999999999999999999999999885

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A

Probab=99.83  E-value=2.9e-20  Score=170.21  Aligned_cols=166  Identities=25%  Similarity=0.379  Sum_probs=135.9

Q ss_pred             hhhhHHHhhHHHHhcccccC--CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc-cC
Q 009594          355 FLSVEEVAGLKEAFEMMDTN--KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK-MA  431 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~--~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~-~~  431 (531)
                      .++.+++.+++++|..+|.|  ++|.|+.+||..++.. ........++.+|..+|.|++|.|+|.||+.++..... ..
T Consensus        30 ~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~  108 (207)
T 2ehb_A           30 PFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRRNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAP  108 (207)
T ss_dssp             SCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCCCHHHHHHHHHHCTTCSSEECHHHHHHHHGGGSTTSC
T ss_pred             CCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-cccccHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHccCCC
Confidence            57888999999999999999  9999999999999987 33444556788999999999999999999998765542 34


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHh----hcCCCCCHHHHHH----HHHhccCCCCcceeHHHHHHHHHhCchHH
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALN----DEVDTSGEDVINA----IMHDVDTDKDGRISYEEFAVMMKAGTDWR  503 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~----~~~~~~~~~~~~~----~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~  503 (531)
                      ..+.++.+|+.+|.|++|+|+.+||..++.    ..|..+++++++.    +|..+|.|+||.|+|+||+.++...+.+.
T Consensus       109 ~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~  188 (207)
T 2ehb_A          109 VHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFVSLNPSLI  188 (207)
T ss_dssp             HHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCGGGG
T ss_pred             HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhChHHH
Confidence            567899999999999999999999999996    5588888887655    45699999999999999999999888777


Q ss_pred             HHHhhhCccCCCcCCHHHH
Q 009594          504 KASRQYSRERFNSISLKLM  522 (531)
Q Consensus       504 ~~f~~~D~~~~G~i~~~e~  522 (531)
                      ..|.. .--+++.++..+|
T Consensus       189 ~~~~~-~~~~~~~~~f~~~  206 (207)
T 2ehb_A          189 KNMTL-PYLKDINRTFPSF  206 (207)
T ss_dssp             GGGCC-TTTTSTTTC----
T ss_pred             HHhcc-hhhhhhhhcCcCc
Confidence            66653 2344666666554

>2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei}

Probab=99.83  E-value=4.9e-21  Score=177.76  Aligned_cols=147  Identities=20%  Similarity=0.255  Sum_probs=125.2

Q ss_pred             hhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHH-HHHhCCCCCCHHHHHHHHHhc---------CCCCCCceecchh
Q 009594          351 VVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRL-GLLKGGQNIPEADLQILMEAA---------DVDGDGSLNYGEF  420 (531)
Q Consensus       351 ~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~-~l~~~~~~~~~~~~~~~f~~~---------D~~~~g~i~~~ef  420 (531)
                      .+...++++++.+++++|..+|.|++|.|+.+||.. +++.++..++..++..++..+         |.|++|.|+|+||
T Consensus        40 ~l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~~EF  119 (226)
T 2lvv_A           40 AIPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDLVEF  119 (226)
T ss_dssp             HSCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSCBCH
T ss_pred             HhchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCHHHH
Confidence            345567889999999999999999999999999998 556678877777777777766         9999999999999


Q ss_pred             HhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          421 VAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +.++.........+.+..+|+.||.|++|+|+.+||+.+|..+   |....  +++.+|..+|.|+||.|+|+||+.++.
T Consensus       120 ~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~--e~~~~~~~~D~d~dG~Is~~EF~~~~~  197 (226)
T 2lvv_A          120 LEFRLMLCYIYDIFELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDIT--DATTVFNEIDTNGSGVVTFDEFSCWAV  197 (226)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCC--SCHHHHHHHCCSCSSCEEHHHHHHHHH
T ss_pred             HHHHHHHHhccCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHH--HHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence            9864433333445789999999999999999999999999887   65544  599999999999999999999999998


Q ss_pred             hC
Q 009594          498 AG  499 (531)
Q Consensus       498 ~~  499 (531)
                      ..
T Consensus       198 ~~  199 (226)
T 2lvv_A          198 TK  199 (226)
T ss_dssp             HH
T ss_pred             hc
Confidence            53

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A

Probab=99.83  E-value=2.2e-20  Score=160.89  Aligned_cols=136  Identities=19%  Similarity=0.264  Sum_probs=124.4

Q ss_pred             hhhHHHhhHHHHhcccccCC-CCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCcH
Q 009594          356 LSVEEVAGLKEAFEMMDTNK-RGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMAND  433 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~-~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~  433 (531)
                      -..+++.+++++|..+|.|+ +|.|+.+|+..+++.+|..++..++..+|..+|.+    |+|+||+.++... ......
T Consensus         8 ~~~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~----i~~~eF~~~~~~~~~~~~~~   83 (146)
T 2qac_A            8 QQLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDN----LTYEQYLEYLSICVHDKDNV   83 (146)
T ss_dssp             HHHHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSE----ECHHHHHHHHHHTCCTTCCH
T ss_pred             HHHHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC----CCHHHHHHHHHHHhcCcchH
Confidence            34567788999999999999 99999999999999999999999999999999987    9999999987643 334457


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +.+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.+|..+  |+||.|+|+||+.++.
T Consensus        84 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~l~  145 (146)
T 2qac_A           84 EELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF--SSEDNIDYKLFCEDIL  145 (146)
T ss_dssp             HHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH--CSSSEEEHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc--CCCCcCcHHHHHHHHh
Confidence            8899999999999999999999999999999999999999999999  9999999999999875

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A

Probab=99.83  E-value=2.2e-20  Score=168.45  Aligned_cols=150  Identities=18%  Similarity=0.296  Sum_probs=130.7

Q ss_pred             hhHHHHhcccccC-CCCcccHHHHHHHHHhC-CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHh
Q 009594          362 AGLKEAFEMMDTN-KRGKINLEELRLGLLKG-GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKA  439 (531)
Q Consensus       362 ~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~-~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~  439 (531)
                      .+++++|..||.+ ++|.|+.+||..++..+ +...+..++..+|..+|.|++|.|+++||..++.........+.+..+
T Consensus        25 ~~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~  104 (190)
T 1g8i_A           25 KEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWA  104 (190)
T ss_dssp             HHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHH
Confidence            3566677777777 89999999999999987 334567789999999999999999999999987766555677889999


Q ss_pred             hcccCCCCCcceeHHHHHHHHhhc----C--------CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHh
Q 009594          440 FSFFDRNRSGFIEIEELRNALNDE----V--------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASR  507 (531)
Q Consensus       440 F~~~D~~~~G~i~~~el~~~l~~~----~--------~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~  507 (531)
                      |+.+|.|++|.|+.+||..++..+    |        ...+.++++.+|..+|.|+||.|+++||+.++...+.+...|.
T Consensus       105 f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~ef~~~~~~~~~~~~~~~  184 (190)
T 1g8i_A          105 FKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPSIVQALS  184 (190)
T ss_dssp             HHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHCHHHHHHHC
T ss_pred             HHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhChHHHHHHh
Confidence            999999999999999999999872    3        3467788999999999999999999999999999999999998


Q ss_pred             hhCc
Q 009594          508 QYSR  511 (531)
Q Consensus       508 ~~D~  511 (531)
                      .||.
T Consensus       185 ~~~~  188 (190)
T 1g8i_A          185 LYDG  188 (190)
T ss_dssp             CBTT
T ss_pred             hhcc
Confidence            8774

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5

Probab=99.83  E-value=8.7e-21  Score=170.19  Aligned_cols=141  Identities=15%  Similarity=0.218  Sum_probs=124.4

Q ss_pred             hhhHHHhhHHHHhccc-ccCCCCcccHHHHHHHHHhCC----CCCCHHHHHHH-----------HHhcCCCCCCceecch
Q 009594          356 LSVEEVAGLKEAFEMM-DTNKRGKINLEELRLGLLKGG----QNIPEADLQIL-----------MEAADVDGDGSLNYGE  419 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~-D~~~~g~i~~~el~~~l~~~~----~~~~~~~~~~~-----------f~~~D~~~~g~i~~~e  419 (531)
                      +++++..+++++|..+ |.|++|.|+.+||..++..++    ..++..++..+           |..+|.|++|.|+++|
T Consensus         2 ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~E   81 (185)
T 2sas_A            2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE   81 (185)
T ss_dssp             CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred             cCHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHH
Confidence            3567788999999999 999999999999999999987    78888888755           9999999999999999


Q ss_pred             hHhHHHHhhcc---------CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHH
Q 009594          420 FVAVSVHLKKM---------ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYE  490 (531)
Q Consensus       420 f~~~~~~~~~~---------~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~  490 (531)
                      |+.++......         .....+..+|+.+|.|++|.|+.+||..++..+|  ++.+++..+|..+|.|+||.|+++
T Consensus        82 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g--~~~~~~~~~~~~~D~d~dG~i~~~  159 (185)
T 2sas_A           82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLN  159 (185)
T ss_dssp             HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTTTTSCCSHH
T ss_pred             HHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC--CCHHHHHHHHHHhcCCCCCcCcHH
Confidence            99877654221         2347789999999999999999999999999887  567789999999999999999999


Q ss_pred             HHHHHHHh
Q 009594          491 EFAVMMKA  498 (531)
Q Consensus       491 Ef~~~~~~  498 (531)
                      ||+.++..
T Consensus       160 ef~~~~~~  167 (185)
T 2sas_A          160 RYKELYYR  167 (185)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998864

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A

Probab=99.83  E-value=8.6e-21  Score=168.53  Aligned_cols=149  Identities=20%  Similarity=0.185  Sum_probs=127.2

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCC----CCCCHHH-H--------HHHHHhcCCCCCCceecchhHhH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG----QNIPEAD-L--------QILMEAADVDGDGSLNYGEFVAV  423 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~----~~~~~~~-~--------~~~f~~~D~~~~g~i~~~ef~~~  423 (531)
                      +++++.+++++|..+|.|++|.|+.+||..++..++    ..++..+ +        +.+|..+|  ++|.|+|+||+.+
T Consensus         1 s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~l~~~~D--~~g~i~~~EF~~~   78 (174)
T 1q80_A            1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVA--GGKGIDETTFINS   78 (174)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSCCTTHHHHHHHHHHHHHHHTGGGTT--TTSCEEHHHHHHH
T ss_pred             CHHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHhcC--CCCeEcHHHHHHH
Confidence            356788999999999999999999999999999987    8888877 6        45788888  8999999999997


Q ss_pred             HHHhhcc-----CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          424 SVHLKKM-----ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       424 ~~~~~~~-----~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +......     ...+.++.+|+.+|.|++|+|+.+||+.++..+|  +++++++.+|..+|.|+||.|+|+||+.++..
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~  156 (174)
T 1q80_A           79 MKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAIDTNNDGLLSLEEFVIAGSD  156 (174)
T ss_dssp             HHHHTTSTTCHHHHHTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CCGGGHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             HHHHcCcccHHHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCceEeHHHHHHHHHH
Confidence            7655431     2246789999999999999999999999999986  67889999999999999999999999998864


Q ss_pred             CchHHHHHhhhCccCCCc
Q 009594          499 GTDWRKASRQYSRERFNS  516 (531)
Q Consensus       499 ~~~~~~~f~~~D~~~~G~  516 (531)
                            .+ .-|.+..|.
T Consensus       157 ------~~-~~~~~~~g~  167 (174)
T 1q80_A          157 ------FF-MNDGDSTNK  167 (174)
T ss_dssp             ------HH-HCCCCSSTT
T ss_pred             ------Hh-ccCcccCCC
Confidence                  34 456665553

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe}

Probab=99.82  E-value=5.3e-20  Score=166.02  Aligned_cols=155  Identities=19%  Similarity=0.240  Sum_probs=137.8

Q ss_pred             CCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhc-cCcHHHHHHhhcccCCCCCcce
Q 009594          374 NKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKK-MANDEHLHKAFSFFDRNRSGFI  451 (531)
Q Consensus       374 ~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~~~~G~i  451 (531)
                      +.+|.|+.+++..+....+  ++.++++.+|..+|.+ ++|.|+++||..++..... ....+.+..+|+.+|.|++|.|
T Consensus         3 ~~~~~l~~~el~~~~~~~~--~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i   80 (190)
T 2l2e_A            3 KSQSKLSQDQLQDLVRSTR--FDKKELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYI   80 (190)
T ss_dssp             CSSCCSCHHHHHHHHHHHC--SCSHHHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCE
T ss_pred             cccccCCHHHHHHHHHhcC--CCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeE
Confidence            4578999999999888754  5888999999999999 8999999999998876532 2455778999999999999999


Q ss_pred             eHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh------------------CchHHHHHhhhCccC
Q 009594          452 EIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA------------------GTDWRKASRQYSRER  513 (531)
Q Consensus       452 ~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~------------------~~~~~~~f~~~D~~~  513 (531)
                      +.+||..++..++...+.+++..+|..+|.|++|.|+++||..++..                  ...+..+|+.+|+|+
T Consensus        81 ~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~  160 (190)
T 2l2e_A           81 DFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNK  160 (190)
T ss_dssp             EHHHHHHHHTTSSCSCSHHHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCCS
T ss_pred             eHHHHHHHHHHHcCCCHHHHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCCC
Confidence            99999999999988888999999999999999999999999999875                  134899999999999


Q ss_pred             CCcCCHHHHHHHHhhcC
Q 009594          514 FNSISLKLMREEGLQLA  530 (531)
Q Consensus       514 ~G~i~~~e~~~~~~~~~  530 (531)
                      ||.|+.+||.+.+...+
T Consensus       161 dG~I~~~Ef~~~~~~~~  177 (190)
T 2l2e_A          161 DGQLTLEEFCEGSKRDP  177 (190)
T ss_dssp             SCCBCHHHHHHHHHTCT
T ss_pred             CCcCcHHHHHHHHHhCc
Confidence            99999999999998754

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A

Probab=99.82  E-value=1.4e-20  Score=159.19  Aligned_cols=130  Identities=22%  Similarity=0.312  Sum_probs=114.9

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH---hhccCcHHHHHHh
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH---LKKMANDEHLHKA  439 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~---~~~~~~~~~~~~~  439 (531)
                      .++++|..+|.+++|.|+.+||..++..++..++..++..+|+.+|.|++|.|+++||..++..   .......+.+..+
T Consensus         1 ~l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~   80 (134)
T 1jfj_A            1 MAEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVL   80 (134)
T ss_dssp             CHHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHH
T ss_pred             CHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHHHHHH
Confidence            3678999999999999999999999999999999999999999999999999999999987741   1111234568999


Q ss_pred             hcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHH
Q 009594          440 FSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       440 F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      |+.+|.|++|.|+.+||..++..++...    +..+|..+|.|++|.|+++||+.++
T Consensus        81 f~~~D~d~~G~i~~~e~~~~l~~~~~~~----~~~~~~~~D~~~dg~i~~~ef~~~l  133 (134)
T 1jfj_A           81 YKLMDVDGDGKLTKEEVTSFFKKHGIEK----VAEQVMKADANGDGYITLEEFLEFS  133 (134)
T ss_dssp             HHHHCCSSSSEEEHHHHHHHHTTTTCHH----HHHHHHHHHCSSSSEEEHHHHHHHH
T ss_pred             HHHHCCCCCCccCHHHHHHHHHHhCHHH----HHHHHHHhCCCCCCcEeHHHHHHHh
Confidence            9999999999999999999999887543    8999999999999999999999876

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A

Probab=99.82  E-value=5.4e-20  Score=170.85  Aligned_cols=152  Identities=26%  Similarity=0.420  Sum_probs=129.6

Q ss_pred             hhhhHHHhhHHHHhcccccC--CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-ccC
Q 009594          355 FLSVEEVAGLKEAFEMMDTN--KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-KMA  431 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~--~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~~~  431 (531)
                      .++.+++.+++++|..+|.|  ++|.|+.+||..++.. ........++.+|..+|.|++|.|+|+||+.++.... ...
T Consensus        41 ~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~  119 (226)
T 2zfd_A           41 VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TNKKESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNAP  119 (226)
T ss_dssp             SCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CSSCCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSC
T ss_pred             CCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cCcccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHccCCC
Confidence            57889999999999999999  9999999999999987 3344445678899999999999999999999876554 334


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHh----hcCCCCCHHHHHHH----HHhccCCCCcceeHHHHHHHHHhCchHH
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALN----DEVDTSGEDVINAI----MHDVDTDKDGRISYEEFAVMMKAGTDWR  503 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~----~~~~~~~~~~~~~~----~~~~D~~~dG~i~~~Ef~~~~~~~~~~~  503 (531)
                      ..+.++.+|+.+|.|++|+|+.+||..++.    ..|..+++++++.+    |..+|.|+||.|+|+||+.++...+.+.
T Consensus       120 ~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~EF~~~~~~~~~~~  199 (226)
T 2zfd_A          120 IDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVLRHPSLL  199 (226)
T ss_dssp             HHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHHHSGGGG
T ss_pred             HHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhChHHH
Confidence            567899999999999999999999999996    56888888876554    4599999999999999999999876655


Q ss_pred             HHHh
Q 009594          504 KASR  507 (531)
Q Consensus       504 ~~f~  507 (531)
                      ..|.
T Consensus       200 ~~~~  203 (226)
T 2zfd_A          200 KNMT  203 (226)
T ss_dssp             GGGC
T ss_pred             HHhc
Confidence            5443

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A

Probab=99.82  E-value=4.5e-20  Score=166.43  Aligned_cols=154  Identities=21%  Similarity=0.300  Sum_probs=131.4

Q ss_pred             hhhhHHHhhHHHHhcccccC-CCCcccHHHHHHHHHhCCC-CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCc
Q 009594          355 FLSVEEVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQ-NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN  432 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~-~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~  432 (531)
                      .++.+++   .++|..||.+ ++|.|+.+||..++..++. ..+...++.+|..+|.|++|.|++.||..++........
T Consensus        21 ~~~~~~i---~~~~~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~   97 (190)
T 1fpw_A           21 YFDRREI---QQWHKGFLRDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTL   97 (190)
T ss_dssp             CSTHHHH---HHHHHHHHHHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCS
T ss_pred             CCCHHHH---HHHHHHHHHHCCCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCc
Confidence            3455554   4555556665 8999999999999998853 355677999999999999999999999998876665567


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhh----cC--------CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALND----EV--------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~----~~--------~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      .+.+..+|+.+|.|++|.|+.+||..++..    +|        ...+.++++.+|+.+|.|+||.|+++||+.++...+
T Consensus        98 ~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~  177 (190)
T 1fpw_A           98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDP  177 (190)
T ss_dssp             THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSST
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCh
Confidence            788999999999999999999999999987    34        236678899999999999999999999999999999


Q ss_pred             hHHHHHhhhCc
Q 009594          501 DWRKASRQYSR  511 (531)
Q Consensus       501 ~~~~~f~~~D~  511 (531)
                      .+...|..+|.
T Consensus       178 ~~~~~~~~~d~  188 (190)
T 1fpw_A          178 SIIGALNLYDG  188 (190)
T ss_dssp             THHHHHHHHHC
T ss_pred             HHHHHHhhccc
Confidence            99999998874

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5

Probab=99.82  E-value=8.6e-20  Score=169.05  Aligned_cols=156  Identities=19%  Similarity=0.285  Sum_probs=133.6

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND  433 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  433 (531)
                      .++.+++..+.+.|+..  |++|.|+.+||..++..++.. .+..+++.+|+.+|.|++|.|+|+||+.++.........
T Consensus        47 ~~s~~ei~~l~~~Fd~~--d~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~  124 (224)
T 1s1e_A           47 NFTKRELQVLYRGFKNE--CPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVH  124 (224)
T ss_dssp             SCCHHHHHHHHHHHHHH--CTTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCHH
T ss_pred             CCCHHHHHHHHHHHHhh--CCCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCHH
Confidence            36667666666666553  489999999999999999754 788999999999999999999999999988766666677


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhc----CCC--------CCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCch
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDE----VDT--------SGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD  501 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~--------~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~  501 (531)
                      +.++.+|+.+|.|++|+|+.+||..++..+    |..        .+.++++.+|+.+|.|+||.|+++||+.++...+.
T Consensus       125 ~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~~  204 (224)
T 1s1e_A          125 EKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDDN  204 (224)
T ss_dssp             HHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHTCHH
T ss_pred             HHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCHH
Confidence            889999999999999999999999999875    532        23478999999999999999999999999999999


Q ss_pred             HHHHHhhhCcc
Q 009594          502 WRKASRQYSRE  512 (531)
Q Consensus       502 ~~~~f~~~D~~  512 (531)
                      +...|..++..
T Consensus       205 l~~~l~~~~~~  215 (224)
T 1s1e_A          205 IMRSLQLFQNV  215 (224)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHHHhcCCCCC
Confidence            98888866543

>1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A*

Probab=99.82  E-value=1.7e-20  Score=168.27  Aligned_cols=149  Identities=19%  Similarity=0.289  Sum_probs=128.9

Q ss_pred             hhhhhHHHhhHHHHhccccc-----CC-C--CcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCc-eecchhHhHH
Q 009594          354 EFLSVEEVAGLKEAFEMMDT-----NK-R--GKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGS-LNYGEFVAVS  424 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~-----~~-~--g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~-i~~~ef~~~~  424 (531)
                      ..++++++.++.++|..+|.     |+ +  |.|+.+||.. +..+|..++..   .+|..+|.|++|. |+|+||+.++
T Consensus        12 ~~ls~~~~~~l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~~g~~~~~~---~l~~~~D~d~~G~~I~~~EF~~~~   87 (183)
T 1dgu_A           12 TFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFKE---RICRVFSTSPAKDSLSFEDFLDLL   87 (183)
T ss_dssp             CSCCHHHHHHHHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STTSSSCTTHH---HHHHHHSCSSSSCCCCHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHHHHhCccccccccccccCcCcHHHHHH-HHhhhcCcHHH---HHHHHhCCCCCCCEecHHHHHHHH
Confidence            35678899999999999999     68 8  9999999999 88888887754   5788899999999 9999999987


Q ss_pred             HHhhcc-CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCC-----CCCHHHHHH----HHHhccCCCCcceeHHHHHH
Q 009594          425 VHLKKM-ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-----TSGEDVINA----IMHDVDTDKDGRISYEEFAV  494 (531)
Q Consensus       425 ~~~~~~-~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-----~~~~~~~~~----~~~~~D~~~dG~i~~~Ef~~  494 (531)
                      ...... ...+.++.+|+.||.|++|+|+.+||+.++..++.     .+++++++.    +|..+|.|+||.|+|+||+.
T Consensus        88 ~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~  167 (183)
T 1dgu_A           88 SVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQH  167 (183)
T ss_dssp             HHHSTTCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEEEHHHHHH
T ss_pred             HHhcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeEcHHHHHH
Confidence            655433 33568999999999999999999999999998876     567777775    99999999999999999999


Q ss_pred             HHHhCchHHHHH
Q 009594          495 MMKAGTDWRKAS  506 (531)
Q Consensus       495 ~~~~~~~~~~~f  506 (531)
                      ++...+.+...|
T Consensus       168 ~~~~~~~~~~~~  179 (183)
T 1dgu_A          168 VISRSPDFASSF  179 (183)
T ss_dssp             HHCSSCHHHHCC
T ss_pred             HHHhChHHHHhc
Confidence            999877666544

>2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A

Probab=99.82  E-value=1.5e-20  Score=172.27  Aligned_cols=142  Identities=20%  Similarity=0.347  Sum_probs=123.9

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc---
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM---  430 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~---  430 (531)
                      ..++++++.+++++|..+|.|++|+|+.+||..++ .+|..++.   +.+|..+|.+++|.|+|+||+.++......   
T Consensus        21 ~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~~~~---~~l~~~~d~~~~g~i~~~EF~~~~~~~~~~~~~   96 (208)
T 2ct9_A           21 TGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAINPLG---DRIINAFFSEGEDQVNFRGFMRTLAHFRPIEDN   96 (208)
T ss_dssp             HCCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTSTTH---HHHHHTTSCTTCSCEEHHHHHHHHHTTSCCC--
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCcH---HHHHHHHcCCCCCcCcHHHHHHHHHhhccccch
Confidence            45688899999999999999999999999998864 66666554   468999999999999999999987654321   


Q ss_pred             -------------CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHH----HHhccCCCCcceeHHHH
Q 009594          431 -------------ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAI----MHDVDTDKDGRISYEEF  492 (531)
Q Consensus       431 -------------~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~----~~~~D~~~dG~i~~~Ef  492 (531)
                                   ...+.++.+|+.||.|++|+|+.+||+.++..+ |..+++++++.+    |..+|.|+||.|+|+||
T Consensus        97 ~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF  176 (208)
T 2ct9_A           97 EKSKDVNGPEPLNSRSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEF  176 (208)
T ss_dssp             ---------CCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHHH
T ss_pred             hhhcccccccccccHHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHH
Confidence                         156789999999999999999999999999986 999999998887    99999999999999999


Q ss_pred             HHHHHhC
Q 009594          493 AVMMKAG  499 (531)
Q Consensus       493 ~~~~~~~  499 (531)
                      +.++...
T Consensus       177 ~~~~~~~  183 (208)
T 2ct9_A          177 VKVLEKV  183 (208)
T ss_dssp             HHTTTTS
T ss_pred             HHHHhcc
Confidence            9999854

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus}

Probab=99.81  E-value=8.3e-20  Score=172.90  Aligned_cols=155  Identities=19%  Similarity=0.319  Sum_probs=134.5

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCC-CCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND  433 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~-~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  433 (531)
                      .++++++..+.+.|+.  .+++|.|+.+||..++..++ ...+..++..+|..+|.|++|.|+|+||..++.........
T Consensus        87 ~~s~~ei~~l~~~fd~--~~~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~  164 (256)
T 2jul_A           87 KFTKKELQSLYRGFKN--ECPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVH  164 (256)
T ss_dssp             TSCHHHHHHHHHHHHH--HCTTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCHH
T ss_pred             CCCHHHHHHHHHHHHh--hCCCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccChH
Confidence            3566766666555553  24799999999999999985 56778889999999999999999999999988776666677


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhc----C--------CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCch
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDE----V--------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD  501 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~--------~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~  501 (531)
                      +.+..+|+.+|.|++|+|+.+||..++..+    |        ...+.++++.+|..+|.|+||.|+++||+.++...+.
T Consensus       165 ~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~~  244 (256)
T 2jul_A          165 EKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQKDEN  244 (256)
T ss_dssp             HHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhCHH
Confidence            889999999999999999999999999876    4        3446788999999999999999999999999999999


Q ss_pred             HHHHHhhhCc
Q 009594          502 WRKASRQYSR  511 (531)
Q Consensus       502 ~~~~f~~~D~  511 (531)
                      +.+.|..+|+
T Consensus       245 l~~~l~~~d~  254 (256)
T 2jul_A          245 IMNSMQLFEN  254 (256)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHhhcc
Confidence            9999998874

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group}

Probab=99.81  E-value=4.4e-20  Score=164.49  Aligned_cols=146  Identities=16%  Similarity=0.244  Sum_probs=124.0

Q ss_pred             hhhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcC---CCCCCceecchhHhHHH
Q 009594          349 LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAAD---VDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       349 ~~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D---~~~~g~i~~~ef~~~~~  425 (531)
                      +.+++...+..++.++++.|..+|  ++|.|+.+||..++   |..++...+..+|..+|   .+++|.|+|.||..++.
T Consensus        15 l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~l---g~~~~~~~~~~i~~~~d~~~~~~~~~i~~~ef~~~~~   89 (179)
T 3a8r_A           15 LQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKCI---GMDGSDEFAVQMFDSLARKRGIVKQVLTKDELKDFYE   89 (179)
T ss_dssp             HHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHHH---TCCSCHHHHHHHHHHHHHHHTCCSSEECHHHHHHHHH
T ss_pred             HHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHHH---CCCCcHHHHHHHHHHHHHhccCCCCCcCHHHHHHHHH
Confidence            344555555567789999999999  89999999999865   67778888999999887   56788999999998876


Q ss_pred             HhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHh-hcCCC-C------CHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          426 HLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN-DEVDT-S------GEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       426 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~-~~~~~-~------~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .+......+.++.+|+.||.|++|+|+.+||+.+|. .+|.. +      ++++++.+|..+|.|+||.|+|+||+.++.
T Consensus        90 ~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~  169 (179)
T 3a8r_A           90 QLTDQGFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIEMEDLEALLL  169 (179)
T ss_dssp             HHHCCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEECHHHHHHHHC
T ss_pred             HHcCCCHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence            655445678899999999999999999999999998 88876 5      778899999999999999999999999987


Q ss_pred             hC
Q 009594          498 AG  499 (531)
Q Consensus       498 ~~  499 (531)
                      ..
T Consensus       170 ~~  171 (179)
T 3a8r_A          170 QS  171 (179)
T ss_dssp             --
T ss_pred             hC
Confidence            54

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3

Probab=99.80  E-value=2.6e-20  Score=206.59  Aligned_cols=156  Identities=22%  Similarity=0.234  Sum_probs=129.7

Q ss_pred             hhhHH-HhhHHHHhcccccCCCCcccHHHHHHHHHhCCC--------CCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          356 LSVEE-VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ--------NIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       356 ~~~~~-~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~--------~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      +++++ ..+++++|..+| +++|.|+.+||..+|..++.        .++.++++.+|..+|.|++|.|+|+||+.++..
T Consensus       527 l~~~e~~~~l~~~F~~~D-~~dG~Is~~El~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~  605 (900)
T 1qxp_A          527 LSEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNR  605 (900)
T ss_dssp             --------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHH
T ss_pred             CCcchHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHhhcccccccCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence            33444 778999999999 99999999999999998865        789999999999999999999999999998765


Q ss_pred             hhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHH
Q 009594          427 LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKAS  506 (531)
Q Consensus       427 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f  506 (531)
                      .      +.++.+|+.||.|++|+|+.+||+.+|..+|..++.++++.++..+| |++|.|+|+||+.++.....+..+|
T Consensus       606 ~------~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~~~l~~~F  678 (900)
T 1qxp_A          606 I------RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFKIF  678 (900)
T ss_dssp             H------HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHHHHHHHHH
T ss_pred             H------HHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHH
Confidence            4      66999999999999999999999999999999999999999999999 9999999999999999888889999


Q ss_pred             hhhCccCCCcCCH
Q 009594          507 RQYSRERFNSISL  519 (531)
Q Consensus       507 ~~~D~~~~G~i~~  519 (531)
                      +.+|++++|.|+.
T Consensus       679 ~~~D~d~~G~It~  691 (900)
T 1qxp_A          679 KQLDPENTGTIQL  691 (900)
T ss_dssp             HHSCSSCCSCEEE
T ss_pred             HhhCCCCCceEEe
Confidence            9999999998743

>2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A

Probab=99.80  E-value=1.9e-20  Score=172.18  Aligned_cols=150  Identities=19%  Similarity=0.296  Sum_probs=129.3

Q ss_pred             hhhhhHHHhhHHHHhccccc-----CC-C--CcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCc-eecchhHhHH
Q 009594          354 EFLSVEEVAGLKEAFEMMDT-----NK-R--GKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGS-LNYGEFVAVS  424 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~-----~~-~--g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~-i~~~ef~~~~  424 (531)
                      +.++++++.++.+.|..+|.     |+ +  |.|+.+||.. +..++.+++.   .++|..+|.|++|. |+|+||+.++
T Consensus        43 t~~s~~ei~~l~~~F~~~D~~~~~~d~~~~dG~I~~~E~~~-l~~lg~~~~~---~~lf~~~D~d~dG~~I~f~EF~~~~  118 (214)
T 2l4h_A           43 TFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFK---ERICRVFSTSPAKDSLSFEDFLDLL  118 (214)
T ss_dssp             CSCCHHHHHHHHHHHHHHSCGGGCCHHHHTTSEECHHHHTT-CHHHHTSTTH---HHHHHHHCCSSSCCSEEHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHhCcccccccccccCCcCCHHHHHH-hhccCCChHH---HHHHHHhCcCCCCCEecHHHHHHHH
Confidence            46789999999999999998     66 6  9999999998 8888877664   46899999999999 9999999987


Q ss_pred             HHhhcc-CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCC-----CCCHHHHHH----HHHhccCCCCcceeHHHHHH
Q 009594          425 VHLKKM-ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-----TSGEDVINA----IMHDVDTDKDGRISYEEFAV  494 (531)
Q Consensus       425 ~~~~~~-~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-----~~~~~~~~~----~~~~~D~~~dG~i~~~Ef~~  494 (531)
                      ...... ...+.++.+|+.||.|++|+|+.+||+.++..++.     .+++++++.    +|..+|.|+||.|+|+||+.
T Consensus       119 ~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~d~dG~Is~~EF~~  198 (214)
T 2l4h_A          119 SVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQH  198 (214)
T ss_dssp             HHTSSCSCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCCSCCSSBCSHHHHH
T ss_pred             HHHcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCCCCCCcCCHHHHHH
Confidence            655433 34568999999999999999999999999998864     667666664    99999999999999999999


Q ss_pred             HHHhCchHHHHHh
Q 009594          495 MMKAGTDWRKASR  507 (531)
Q Consensus       495 ~~~~~~~~~~~f~  507 (531)
                      ++...+.+...|.
T Consensus       199 ~~~~~p~~~~~l~  211 (214)
T 2l4h_A          199 VISRSPDFASSFK  211 (214)
T ss_dssp             HHHTCHHHHHHTS
T ss_pred             HHHhChHHHHhcc
Confidence            9998888777664

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A

Probab=99.80  E-value=2.7e-19  Score=161.35  Aligned_cols=155  Identities=19%  Similarity=0.267  Sum_probs=135.4

Q ss_pred             CCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhc-cCcHHHHHHhhcccCCCCCcce
Q 009594          374 NKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKK-MANDEHLHKAFSFFDRNRSGFI  451 (531)
Q Consensus       374 ~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~~~~G~i  451 (531)
                      ++.+.|+.+++..+...  ..++.+++..+|..+|.+ ++|.|+++||..++..... ....+.+..+|+.+|.|++|.|
T Consensus         3 ~~~~~l~~~~l~~l~~~--~~~~~~~i~~~~~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i   80 (190)
T 1fpw_A            3 AKTSKLSKDDLTCLKQS--TYFDRREIQQWHKGFLRDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFI   80 (190)
T ss_dssp             CCSCCSTTHHHHHHTTT--CCSTHHHHHHHHHHHHHHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEE
T ss_pred             cccCCCCHHHHHHHHHh--cCCCHHHHHHHHHHHHHHCCCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcE
Confidence            35678999999877765  357899999999999987 8999999999998776522 2345678999999999999999


Q ss_pred             eHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccC
Q 009594          452 EIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRER  513 (531)
Q Consensus       452 ~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~  513 (531)
                      +.+||..++..++...+.+++..+|+.+|.|++|.|+++||..++...                  ..+..+|+.+|+|+
T Consensus        81 ~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~  160 (190)
T 1fpw_A           81 HFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNE  160 (190)
T ss_dssp             CHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTC
T ss_pred             eHHHHHHHHHHHccCCcHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCC
Confidence            999999999999888888999999999999999999999999998751                  34899999999999


Q ss_pred             CCcCCHHHHHHHHhhcC
Q 009594          514 FNSISLKLMREEGLQLA  530 (531)
Q Consensus       514 ~G~i~~~e~~~~~~~~~  530 (531)
                      ||.|+.+||.+.+...+
T Consensus       161 dG~I~~~Ef~~~~~~~~  177 (190)
T 1fpw_A          161 DGYITLDEFREGSKVDP  177 (190)
T ss_dssp             SSEEEHHHHHHHHHSST
T ss_pred             CCcCcHHHHHHHHHhCh
Confidence            99999999999988754

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A

Probab=99.80  E-value=1.2e-20  Score=169.55  Aligned_cols=145  Identities=16%  Similarity=0.228  Sum_probs=123.1

Q ss_pred             hHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhC------CCCCCHHHHHHH---------HHhcCCCCCCcee
Q 009594          352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG------GQNIPEADLQIL---------MEAADVDGDGSLN  416 (531)
Q Consensus       352 ~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~------~~~~~~~~~~~~---------f~~~D~~~~g~i~  416 (531)
                      ++..++++++.+++++|..+|.|++|.|+.+||..++..+      |..++..++..+         |..+|.|++|.|+
T Consensus         4 ~~~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I~   83 (186)
T 2hps_A            4 ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLRVADQLGLAPGVRISVEEAAV   83 (186)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCTTCEEEHHHHHH
T ss_pred             ccccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHhcCCCCCCccc
Confidence            3456788899999999999999999999999999999866      777888888888         5999999999999


Q ss_pred             cchhHhHHHHhhc-cCcHHHHHHhh--cccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHH
Q 009594          417 YGEFVAVSVHLKK-MANDEHLHKAF--SFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA  493 (531)
Q Consensus       417 ~~ef~~~~~~~~~-~~~~~~~~~~F--~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~  493 (531)
                      |+|  .++..... ....+.+..+|  +.||.|++|+|+.+||+.++..+|..+++++++.+|..+|.|+||.|+++||+
T Consensus        84 ~~E--~~~~~~~~~~~~~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~ef~  161 (186)
T 2hps_A           84 NAT--DSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRDEFL  161 (186)
T ss_dssp             HHH--HHHHHCCTHHHHHTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred             HHH--HHHHHhcCChHHHHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence            999  33332211 11223455555  77899999999999999999999998999999999999999999999999999


Q ss_pred             HHHHh
Q 009594          494 VMMKA  498 (531)
Q Consensus       494 ~~~~~  498 (531)
                      .++..
T Consensus       162 ~~~~~  166 (186)
T 2hps_A          162 VTVND  166 (186)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99874

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A

Probab=99.79  E-value=2.3e-19  Score=171.49  Aligned_cols=176  Identities=17%  Similarity=0.193  Sum_probs=142.2

Q ss_pred             hhhhHHHhhH-HHHhcccccCCCCcccHHHHHHH-----------HHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHh
Q 009594          355 FLSVEEVAGL-KEAFEMMDTNKRGKINLEELRLG-----------LLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVA  422 (531)
Q Consensus       355 ~~~~~~~~~i-~~~F~~~D~~~~g~i~~~el~~~-----------l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~  422 (531)
                      .++.+++..+ ..+|..+|.|++|.|+.+||..+           +...+...+..++..+|..+|.|++|.|+.+||..
T Consensus        49 ~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~  128 (272)
T 2be4_A           49 KITDERVQQIKKSFMSAYDATFDGRLQIEELANMILPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAAELKN  128 (272)
T ss_dssp             CCCHHHHHHHHHHHSCHHHHTCCSEEEHHHHHHHHSCHHHHHHHHHHHHSCCCCHHHHHHHHHHHCTTCCSEEEGGGHHH
T ss_pred             CCCHHHHHHHHHHHHHHhcCCCCCcEeHHHHHHHHhhhhHHHHHHHhhccCcccHHHHHHHHHHhCCCCCCccCHHHHHH
Confidence            4456666654 46789999999999999999988           55666677889999999999999999999999998


Q ss_pred             HHHHh----hccCcHHHH----HHhhcccCCCCCcceeHHHHHHHHhhc------------CCCCCHHHHHHHHHhccCC
Q 009594          423 VSVHL----KKMANDEHL----HKAFSFFDRNRSGFIEIEELRNALNDE------------VDTSGEDVINAIMHDVDTD  482 (531)
Q Consensus       423 ~~~~~----~~~~~~~~~----~~~F~~~D~~~~G~i~~~el~~~l~~~------------~~~~~~~~~~~~~~~~D~~  482 (531)
                      ++...    ......+.+    ..+|+.+|.|++|.|+.+||..++...            +.....+.+..+|..+|.|
T Consensus       129 ~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d  208 (272)
T 2be4_A          129 FLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFLLQFKMDASSQVERKRDFEKIFAHYDVS  208 (272)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEEEHHHHGGGSCCSSCSSTTSCCCHHHHHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCCcCcHHHHHHHHhhhHHHHhhhhhhhccccccHHHHHHHHHHhCCC
Confidence            87654    223344444    459999999999999999999987641            1123456799999999999


Q ss_pred             CCcceeHHHHHHHHHhC----------chHHH----HHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          483 KDGRISYEEFAVMMKAG----------TDWRK----ASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       483 ~dG~i~~~Ef~~~~~~~----------~~~~~----~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      ++|.|+.+||..++...          ..+..    +|..+|+|+||.|+.+||.+.+...+
T Consensus       209 ~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~d~dG~is~~EF~~~~~~~p  270 (272)
T 2be4_A          209 RTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKSELALCLGLKH  270 (272)
T ss_dssp             CCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCCSTTCEEEHHHHHHHTTCCC
T ss_pred             CCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHccCC
Confidence            99999999999988631          22333    89999999999999999999987554

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E

Probab=99.79  E-value=3.6e-19  Score=159.49  Aligned_cols=150  Identities=19%  Similarity=0.196  Sum_probs=127.7

Q ss_pred             ccHHHHHHHHHhCCCCCCHHHHHHHHHhcCC-CCCCceecchhHhHHHHhhcc-CcHHHHHHhhcccCCCCCcceeHHHH
Q 009594          379 INLEELRLGLLKGGQNIPEADLQILMEAADV-DGDGSLNYGEFVAVSVHLKKM-ANDEHLHKAFSFFDRNRSGFIEIEEL  456 (531)
Q Consensus       379 i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~-~~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~~~~G~i~~~el  456 (531)
                      ++.+++..+++..  .++.+++..++..+|. |++|.|+++||..++...... .....+..+|+.+|.|++|.|+.+||
T Consensus         1 l~~~el~~l~~~~--~~s~~~i~~l~~~fd~~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef   78 (183)
T 1s6c_A            1 HRPEGLEQLEAQT--NFTKRELQVLYRGFKNEXPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDF   78 (183)
T ss_dssp             -----CHHHHHHS--SCCHHHHHHHHHHHHHHCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred             CChHHHHHHHHhc--CCCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHH
Confidence            4567777777764  4588899999999988 899999999999987765433 56788999999999999999999999


Q ss_pred             HHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCCCcCC
Q 009594          457 RNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERFNSIS  518 (531)
Q Consensus       457 ~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~G~i~  518 (531)
                      ..++..++...+.+++..+|+.+|.|++|.|+++||..++...                  ..+..+|+.+|+|+||.|+
T Consensus        79 ~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~  158 (183)
T 1s6c_A           79 VTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVT  158 (183)
T ss_dssp             HHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEEC
T ss_pred             HHHHHHHcCCCHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEe
Confidence            9999988767778899999999999999999999999998742                  5589999999999999999


Q ss_pred             HHHHHHHHhhcC
Q 009594          519 LKLMREEGLQLA  530 (531)
Q Consensus       519 ~~e~~~~~~~~~  530 (531)
                      .+||.+.+...+
T Consensus       159 ~~Ef~~~~~~~~  170 (183)
T 1s6c_A          159 LDEFLESXQEDD  170 (183)
T ss_dssp             HHHHHHHTTSCC
T ss_pred             HHHHHHHHhcCh
Confidence            999999987643

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3

Probab=99.79  E-value=9e-20  Score=202.33  Aligned_cols=168  Identities=20%  Similarity=0.354  Sum_probs=130.1

Q ss_pred             HhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc-----------
Q 009594          361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK-----------  429 (531)
Q Consensus       361 ~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~-----------  429 (531)
                      ..+++.+|+.+|.|++|+|+.+||+.+++.+|..++.++++.+|..+| |++|.|+|+||+.++.....           
T Consensus       606 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~~~l~~~F~~~D~d  684 (900)
T 1qxp_A          606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFKIFKQLDPE  684 (900)
T ss_dssp             HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHHHHHHHHHHHSCSS
T ss_pred             HHHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHHHhhCCC
Confidence            367899999999999999999999999999999999999999999999 99999999999887643210           


Q ss_pred             ------------------------------------------cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC---
Q 009594          430 ------------------------------------------MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV---  464 (531)
Q Consensus       430 ------------------------------------------~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~---  464 (531)
                                                                ....+.++.+|+.+|.+ +|.|+.+||+.+|..++   
T Consensus       685 ~~G~It~~~~efl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~~-~G~Is~~El~~~L~~~~~~~  763 (900)
T 1qxp_A          685 NTGTIQLDLISWLSFSVLGKLAAAIEHHHHHHMHYSNIEANESEEERQFRKLFVQLAGD-DMEVSATELMNILNKVVTRH  763 (900)
T ss_dssp             CCSCEEEEHHHHHHHTCC--------------CCCCCC--------------CCCCTTC-SSCBCHHHHTTTSCC----C
T ss_pred             CCceEEecHHHHHHHhhhccccccccccccccccccCCCCCChHHHHHHHHHHHHhcCC-CCccCHHHHHHHHHHhcccc
Confidence                                                      00123456777888876 88889999999998876   


Q ss_pred             -----CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          465 -----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       465 -----~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                           ...+.++++.++..+|.|+||.|+|+||..++.....++.+|+.+|+|++|.|+.+||+++++.+|
T Consensus       764 ~~~~~~~~s~~~~~~l~~~~D~d~dG~Is~~EF~~l~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g  834 (900)
T 1qxp_A          764 PDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKKWQGIYKRFETDRSGTIGSNELPGAFEAAG  834 (900)
T ss_dssp             CSCC--CCCHHHHHHHHHHHCCSSSSSBCSHHHHHHHHHHHHHSSCC----CCSCC-------CCTTGGGT
T ss_pred             cccccCCCCHHHHHHHHHHHCCCCCCeECHHHHHHHHHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHhcC
Confidence                 356788999999999999999999999999999888999999999999999999999999998875

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5

Probab=99.77  E-value=6.7e-19  Score=163.04  Aligned_cols=153  Identities=18%  Similarity=0.166  Sum_probs=128.7

Q ss_pred             CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhc-cCcHHHHHHhhcccCCCCCccee
Q 009594          375 KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKK-MANDEHLHKAFSFFDRNRSGFIE  452 (531)
Q Consensus       375 ~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~~~~G~i~  452 (531)
                      ..+.++.+++..++...+  ++.++++.+|..+|.+ ++|.|+++||..++..... ......+..+|+.+|.|++|.|+
T Consensus        30 ~~~~l~~~~l~~l~~~~~--~s~~ei~~l~~~Fd~~d~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~  107 (224)
T 1s1e_A           30 TMVCHRPEGLEQLEAQTN--FTKRELQVLYRGFKNECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVK  107 (224)
T ss_dssp             --------CHHHHHHHSS--CCHHHHHHHHHHHHHHCTTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBC
T ss_pred             CccCCCHHHHHHHHHHcC--CCHHHHHHHHHHHHhhCCCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEe
Confidence            457899999998888765  7899999999999884 9999999999998775533 25678899999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCC
Q 009594          453 IEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERF  514 (531)
Q Consensus       453 ~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~  514 (531)
                      .+||..++..++...+.+++..+|+.+|.|++|.|+++||..++...                  ..+..+|+.+|+|+|
T Consensus       108 ~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~d  187 (224)
T 1s1e_A          108 FEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKD  187 (224)
T ss_dssp             HHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCS
T ss_pred             HHHHHHHHHHHccCCHHHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCC
Confidence            99999999987766678889999999999999999999999998642                  458999999999999


Q ss_pred             CcCCHHHHHHHHhhc
Q 009594          515 NSISLKLMREEGLQL  529 (531)
Q Consensus       515 G~i~~~e~~~~~~~~  529 (531)
                      |.|+.+||.+.+...
T Consensus       188 G~Is~~EF~~~~~~~  202 (224)
T 1s1e_A          188 GIVTLDEFLESCQED  202 (224)
T ss_dssp             SCEEHHHHHHHHHTC
T ss_pred             CcEeHHHHHHHHHhC
Confidence            999999999998764

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5

Probab=99.77  E-value=2.6e-18  Score=155.23  Aligned_cols=152  Identities=22%  Similarity=0.197  Sum_probs=131.6

Q ss_pred             CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhc-cCcHHHHHHhhcccCCCCCccee
Q 009594          375 KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKK-MANDEHLHKAFSFFDRNRSGFIE  452 (531)
Q Consensus       375 ~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~~~~G~i~  452 (531)
                      ..+.++..++..+...  ..++.+++..+|..+|.+ ++|.|+++||..++..... ......+..+|+.+|.|++|.|+
T Consensus         4 ~~s~l~~~~l~~l~~~--~~~~~~~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~   81 (193)
T 1bjf_A            4 QNSKLRPEVMQDLLES--TDFTEHEIQEWYKGFLRDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTID   81 (193)
T ss_dssp             -CCCCCHHHHHHHHHH--SSCCHHHHHHHHHHHHHHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEE
T ss_pred             ccccCCHHHHHHHHHH--cCCCHHHHHHHHHHHHHHCCCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhCCCCCCcCc
Confidence            4567899999886665  357889999999999998 8999999999998765433 23456789999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCC
Q 009594          453 IEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERF  514 (531)
Q Consensus       453 ~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~  514 (531)
                      .+||..++..++...+.+++..+|..+|.|++|.|+++||..++...                  ..+..+|+.+|+|+|
T Consensus        82 ~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~d  161 (193)
T 1bjf_A           82 FREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRD  161 (193)
T ss_dssp             HHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCS
T ss_pred             HHHHHHHHHHHcCCCHHHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCCCC
Confidence            99999999988877788899999999999999999999999998641                  128899999999999


Q ss_pred             CcCCHHHHHHHHhh
Q 009594          515 NSISLKLMREEGLQ  528 (531)
Q Consensus       515 G~i~~~e~~~~~~~  528 (531)
                      |.|+.+||.+++..
T Consensus       162 G~I~~~Ef~~~~~~  175 (193)
T 1bjf_A          162 GKLSLEEFIRGAKS  175 (193)
T ss_dssp             SEECHHHHHHHHHH
T ss_pred             CeEeHHHHHHHHhc
Confidence            99999999998864

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A

Probab=99.76  E-value=1.8e-18  Score=155.84  Aligned_cols=153  Identities=18%  Similarity=0.177  Sum_probs=133.1

Q ss_pred             CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHh-hccCcHHHHHHhhcccCCCCCccee
Q 009594          375 KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHL-KKMANDEHLHKAFSFFDRNRSGFIE  452 (531)
Q Consensus       375 ~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~-~~~~~~~~~~~~F~~~D~~~~G~i~  452 (531)
                      ..+.++.+++..+....  .++.++++.+|..+|.+ ++|.|+++||..++... ........+..+|+.+|.|++|.|+
T Consensus         4 ~~~~l~~~~l~~l~~~~--~~~~~~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~   81 (190)
T 1g8i_A            4 SNSKLKPEVVEELTRKT--YFTEKEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIE   81 (190)
T ss_dssp             CCCSCCHHHHHHHHHTS--SSCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEE
T ss_pred             ccccCCHHHHHHHHHcc--CCCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEe
Confidence            34578999998877754  56889999999999988 89999999999987765 2224556799999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCC
Q 009594          453 IEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERF  514 (531)
Q Consensus       453 ~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~  514 (531)
                      .+||..++..++...+.+++..+|..+|.|++|.|+++||..++...                  ..+..+|+.+|+|+|
T Consensus        82 ~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~d  161 (190)
T 1g8i_A           82 FSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNAD  161 (190)
T ss_dssp             HHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCS
T ss_pred             HHHHHHHHHHhcCCCHHHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCCC
Confidence            99999999988777778889999999999999999999999998751                  348999999999999


Q ss_pred             CcCCHHHHHHHHhhc
Q 009594          515 NSISLKLMREEGLQL  529 (531)
Q Consensus       515 G~i~~~e~~~~~~~~  529 (531)
                      |.|+.+||.+.+...
T Consensus       162 G~i~~~ef~~~~~~~  176 (190)
T 1g8i_A          162 GKLTLQEFQEGSKAD  176 (190)
T ss_dssp             SEEEHHHHHHHHHHC
T ss_pred             CcEeHHHHHHHHHhC
Confidence            999999999998764

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A

Probab=99.75  E-value=8.9e-19  Score=170.84  Aligned_cols=132  Identities=25%  Similarity=0.420  Sum_probs=121.3

Q ss_pred             HHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHH-HHHhcCCCCCCceecchhHhHHHHhhccCcHHHHH
Q 009594          359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQI-LMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLH  437 (531)
Q Consensus       359 ~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~-~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  437 (531)
                      .....+..+|..+|.|++|+|+.+||..++  +|..++..++.. +|..+|.|++|.|+|.||+.++....      .+.
T Consensus       185 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~g~~~~~~ei~~~l~~~~D~d~dG~Is~~EF~~~l~~~~------~l~  256 (323)
T 1ij5_A          185 NDLAALVADFRKIDTNSNGTLSRKEFREHF--VRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLL------VLR  256 (323)
T ss_dssp             HHHHTSCCCHHHHCTTCCSEECHHHHHHHH--HHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH------HHH
T ss_pred             hHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--cCCCCCHHHHHHHHHHHhcCCCCCEEeHHHHHHHHHHHH------HHH
Confidence            445678889999999999999999999999  778888999999 99999999999999999999876543      689


Q ss_pred             HhhcccCCCCCcceeHHHHHHHH-hhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          438 KAFSFFDRNRSGFIEIEELRNAL-NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       438 ~~F~~~D~~~~G~i~~~el~~~l-~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+|+.||.|++|+||.+||..++ ..+|..++++++..+|..+|.|+||.|+|+||+.++..
T Consensus       257 ~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D~d~dG~Is~~EF~~~~~~  318 (323)
T 1ij5_A          257 ILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVLL  318 (323)
T ss_dssp             HHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHH
Confidence            99999999999999999999999 99998888889999999999999999999999998863

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A

Probab=99.75  E-value=6.3e-18  Score=160.61  Aligned_cols=168  Identities=18%  Similarity=0.145  Sum_probs=121.2

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhC---------CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh----h
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG---------GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL----K  428 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~---------~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~----~  428 (531)
                      ..+..+|..+|.+++|.|+.+||..++...         ....+..++..+|..+|.|++|.|+.+||..++...    .
T Consensus        58 ~~~~~l~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g  137 (263)
T 2f33_A           58 PEMKTFVDQYGQRDDGKIGIVELAHVLPTEENFLLLFRCQQLKSCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKAN  137 (263)
T ss_dssp             HHHHHHHHHHTTGGGCCBCHHHHHHHTTSCTTHHHHHGGGTSSCHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHhhhhhHHHHHHHhhccHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcC
Confidence            356677778888888888888887776543         234456778888888888888888888888766544    2


Q ss_pred             ccCcHHHHHH----hhcccCCCCCcceeHHHHHHHHhh-------c-CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHH
Q 009594          429 KMANDEHLHK----AFSFFDRNRSGFIEIEELRNALND-------E-VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       429 ~~~~~~~~~~----~F~~~D~~~~G~i~~~el~~~l~~-------~-~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      .....+.+..    +|+.+|.|++|.|+.+||..++..       . +.....+.+..+|+.+|.|++|.|+.+||..++
T Consensus       138 ~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~El~~~l  217 (263)
T 2f33_A          138 KTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFLLKFQGIKMCGKEFNKAFELYDQDGNGYIDENELDALL  217 (263)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHHHHSCTTTCSHHHHHHTCCCHHHHHHHHHHHCCSSSSCEEHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHHHHHHHhcCcchHHHHHHHHHHHhCCCCCCcccHHHHHHHH
Confidence            3334444444    888888888888888888887753       1 234556778888888888888888888888877


Q ss_pred             Hh----------CchHHHHHhh-hCccCCCcCCHHHHHHHHhhc
Q 009594          497 KA----------GTDWRKASRQ-YSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       497 ~~----------~~~~~~~f~~-~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ..          ..++...+.. +|.|+||.|+.+||.+.+...
T Consensus       218 ~~~~~~~~~~~~~~e~~~~~~~~~D~d~dG~i~~~EF~~~~~~~  261 (263)
T 2f33_A          218 KDLCEKNKQELDINNISTYKKNIMALSDGGKLYRTDLALILSAG  261 (263)
T ss_dssp             HHHHHHCTTTCCTTTHHHHHHHHHTTSBTTEECGGGTHHHHCCS
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHhhccCCCCeEcHHHHHHHHhcc
Confidence            52          1346666665 688888888888888877653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=6.9e-19  Score=173.00  Aligned_cols=142  Identities=18%  Similarity=0.268  Sum_probs=100.0

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC-----------ChhhHH--------HHHHHHHHHHhCCCCCC
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----------TAVDIE--------DVRREVQIMKHLPKHPN  118 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~~--------~~~~E~~~l~~l~~h~n  118 (531)
                      |++...||.|++|.||+|.+ .+|+.||||++......           ......        ...+|...|.++ .+++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g  174 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG  174 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence            89999999999999999997 57999999998643211           000011        123467777777 3333


Q ss_pred             eeecceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCC-
Q 009594          119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS-  197 (531)
Q Consensus       119 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~-  197 (531)
                      +. ....+.... .+|||||++|++|..+.      .......++.||+.+|.|||+.|||||||||.|||++.+++.. 
T Consensus       175 v~-vp~p~~~~~-~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          175 FP-VPEPIAQSR-HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             CS-CCCEEEEET-TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CC-CCeeeeccC-ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            32 222222222 36999999999986542      1224567889999999999999999999999999998755211 


Q ss_pred             ------CeEEEeeccccc
Q 009594          198 ------PLKAIDFGLSVF  209 (531)
Q Consensus       198 ------~ikl~Dfg~a~~  209 (531)
                            .+.|+||+.+..
T Consensus       247 ~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECCCTTCEE
T ss_pred             ccccccceEEEEeCCccc
Confidence                  278999997654

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A

Probab=99.74  E-value=3.4e-18  Score=144.40  Aligned_cols=127  Identities=20%  Similarity=0.277  Sum_probs=112.7

Q ss_pred             HHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHh---hcCCCCCHHHHHHHH
Q 009594          400 LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN---DEVDTSGEDVINAIM  476 (531)
Q Consensus       400 ~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~---~~~~~~~~~~~~~~~  476 (531)
                      ++.+|..+|.|++|.|+++||..++.........+.+..+|+.+|.|++|.|+.+||..++.   ..+...+.+++..+|
T Consensus         2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~f   81 (134)
T 1jfj_A            2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLY   81 (134)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHHHHHHH
Confidence            67899999999999999999999887665556678899999999999999999999999996   333334566799999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhCch--HHHHHhhhCccCCCcCCHHHHHHHH
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAGTD--WRKASRQYSRERFNSISLKLMREEG  526 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~~~--~~~~f~~~D~~~~G~i~~~e~~~~~  526 (531)
                      +.+|.|++|.|+++||..++.....  +..+|..+|+|++|.|+.+||.+.+
T Consensus        82 ~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~l  133 (134)
T 1jfj_A           82 KLMDVDGDGKLTKEEVTSFFKKHGIEKVAEQVMKADANGDGYITLEEFLEFS  133 (134)
T ss_dssp             HHHCCSSSSEEEHHHHHHHHTTTTCHHHHHHHHHHHCSSSSEEEHHHHHHHH
T ss_pred             HHHCCCCCCccCHHHHHHHHHHhCHHHHHHHHHHhCCCCCCcEeHHHHHHHh
Confidence            9999999999999999999986554  8999999999999999999999876

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus}

Probab=99.74  E-value=8.2e-18  Score=159.16  Aligned_cols=154  Identities=17%  Similarity=0.172  Sum_probs=129.9

Q ss_pred             CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhh-ccCcHHHHHHhhcccCCCCCccee
Q 009594          375 KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLK-KMANDEHLHKAFSFFDRNRSGFIE  452 (531)
Q Consensus       375 ~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~-~~~~~~~~~~~F~~~D~~~~G~i~  452 (531)
                      ..+.++.+++..++...  .++.+++..+|..+|.+ ++|.|+++||..++.... .......+..+|+.+|.|++|.|+
T Consensus        70 ~~~~l~~e~l~~l~~~~--~~s~~ei~~l~~~fd~~~~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~  147 (256)
T 2jul_A           70 STVRHQPEGLDQLQAQT--KFTKKELQSLYRGFKNECPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIH  147 (256)
T ss_dssp             ------CTHHHHHHHHT--TSCHHHHHHHHHHHHHHCTTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEEC
T ss_pred             ccccCCHHHHHHHHHHh--CCCHHHHHHHHHHHHhhCCCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCc
Confidence            34557777888777764  47889999999999875 799999999999877653 345667899999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCC
Q 009594          453 IEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERF  514 (531)
Q Consensus       453 ~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~  514 (531)
                      .+||..++..++...+.+++..+|+.+|.|++|.|+++||..++...                  ..+..+|..+|+|+|
T Consensus       148 ~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~d  227 (256)
T 2jul_A          148 FEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQD  227 (256)
T ss_dssp             SHHHHHHHHHHHSCCHHHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTT
T ss_pred             HHHHHHHHHHHhccChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCC
Confidence            99999999988777788899999999999999999999999998732                  458999999999999


Q ss_pred             CcCCHHHHHHHHhhcC
Q 009594          515 NSISLKLMREEGLQLA  530 (531)
Q Consensus       515 G~i~~~e~~~~~~~~~  530 (531)
                      |.|+.+||.+.+...+
T Consensus       228 G~Is~~Ef~~~~~~~~  243 (256)
T 2jul_A          228 GVVTIDEFLETCQKDE  243 (256)
T ss_dssp             CSBCHHHHHHHHHHCS
T ss_pred             CcEeHHHHHHHHHhCH
Confidence            9999999999988754

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5

Probab=99.74  E-value=9.9e-18  Score=152.91  Aligned_cols=136  Identities=18%  Similarity=0.117  Sum_probs=121.8

Q ss_pred             CCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHH
Q 009594          394 NIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVI  472 (531)
Q Consensus       394 ~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~  472 (531)
                      .++.++++.+|..+|.+ ++|.|+++||..++.........+.+..+|+.+|.|++|.|+.+||..++..++...+.+++
T Consensus        18 ~~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~   97 (204)
T 1jba_A           18 AADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKL   97 (204)
T ss_dssp             HHHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHH
T ss_pred             CCCHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhcCCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHH
Confidence            45678899999999999 89999999999988765545667889999999999999999999999999988877788899


Q ss_pred             HHHHHhccCCCCcceeHHHHHHHHHhC-----------------------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          473 NAIMHDVDTDKDGRISYEEFAVMMKAG-----------------------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       473 ~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----------------------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ..+|..+|.|++|.|+++||..++...                       ..+..+|+.+|+|+||.|+.+||.+.+...
T Consensus        98 ~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~  177 (204)
T 1jba_A           98 KWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRD  177 (204)
T ss_dssp             HHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTT
T ss_pred             HHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHcC
Confidence            999999999999999999999988642                       248899999999999999999999998754

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A

Probab=99.73  E-value=1.5e-17  Score=152.01  Aligned_cols=155  Identities=19%  Similarity=0.158  Sum_probs=119.0

Q ss_pred             cCCCCcccHHHHHHHHHhCCCCCCHHH---HHHHHHhcCCC--CCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCC
Q 009594          373 TNKRGKINLEELRLGLLKGGQNIPEAD---LQILMEAADVD--GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNR  447 (531)
Q Consensus       373 ~~~~g~i~~~el~~~l~~~~~~~~~~~---~~~~f~~~D~~--~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~  447 (531)
                      +|++|.|+.+++..+....+  ++.++   +..+|..+|.|  ++|.|+++||..++.. ........+..+|+.+|.|+
T Consensus        11 ~~~~g~l~~~el~~l~~~~~--~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~f~~~D~d~   87 (207)
T 2ehb_A           11 KNAMRPPGYEDPELLASVTP--FTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRRNLFADRIFDVFDVKR   87 (207)
T ss_dssp             ----------CHHHHHHHSS--CCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCCCHHHHHHHHHHCTTC
T ss_pred             hccccccCHHHHHHHHHhCC--CCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-cccccHHHHHHHHHHhcCCC
Confidence            47789999999988887654  44444   55678899999  9999999999987754 22233456788999999999


Q ss_pred             CcceeHHHHHHHHhhcCCC-CCHHHHHHHHHhccCCCCcceeHHHHHHHHHh-----C---------chHHHHHhhhCcc
Q 009594          448 SGFIEIEELRNALNDEVDT-SGEDVINAIMHDVDTDKDGRISYEEFAVMMKA-----G---------TDWRKASRQYSRE  512 (531)
Q Consensus       448 ~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~-----~---------~~~~~~f~~~D~~  512 (531)
                      +|.|+.+||..++...+.. ...+.+..+|+.+|.|++|.|+.+||..++..     .         ..+..+|..+|+|
T Consensus        88 ~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d  167 (207)
T 2ehb_A           88 NGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRK  167 (207)
T ss_dssp             SSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTT
T ss_pred             CCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCC
Confidence            9999999999999987643 45677999999999999999999999999851     1         1157788899999


Q ss_pred             CCCcCCHHHHHHHHhhcC
Q 009594          513 RFNSISLKLMREEGLQLA  530 (531)
Q Consensus       513 ~~G~i~~~e~~~~~~~~~  530 (531)
                      +||.|+.+||.+.+...+
T Consensus       168 ~dG~I~~~Ef~~~~~~~~  185 (207)
T 2ehb_A          168 NDGKIDIDEWKDFVSLNP  185 (207)
T ss_dssp             CSSEECHHHHHHHHHHCG
T ss_pred             CCCcCcHHHHHHHHHhCh
Confidence            999999999999998654

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=99.72  E-value=3.5e-17  Score=141.06  Aligned_cols=131  Identities=18%  Similarity=0.185  Sum_probs=116.8

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~  476 (531)
                      ++++++|..+|.|++|.|++.||..++...........+..+|..+|.+++|.|+..||..++... ....+.+.+..+|
T Consensus        10 ~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~aF   89 (148)
T 2lmt_A           10 AEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDTEEEMREAF   89 (148)
T ss_dssp             HHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTTHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccCCCCcccHHHHHHHHHHHhcccCcHHHHHHHH
Confidence            346678999999999999999999988877777888899999999999999999999999988654 4455678899999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +.+|.|++|.|+.+||..++...      ..+..+|+.+|+|+||.|+.+||.++|++
T Consensus        90 ~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~m~~  147 (148)
T 2lmt_A           90 KIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYEEFVWMISQ  147 (148)
T ss_dssp             HHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHHHHHHHHTT
T ss_pred             HHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            99999999999999999998742      45899999999999999999999999864

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A

Probab=99.71  E-value=3.1e-17  Score=140.47  Aligned_cols=130  Identities=15%  Similarity=0.246  Sum_probs=113.2

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~  476 (531)
                      .+++.+|..+|.|++|.|+.+||..++..+........+..+|+.+|.|++|.|+.+||..++... ....+.+++..+|
T Consensus         6 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F   85 (143)
T 2obh_A            6 QEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAF   85 (143)
T ss_dssp             HHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHHhccccHHHHHHHHH
Confidence            467889999999999999999999988776666778889999999999999999999999988643 2222346788999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      +.+|.|++|.|+.+||..++...      ..+..+|+.+|+|+||.|+.+||.+++.
T Consensus        86 ~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~~~~~  142 (143)
T 2obh_A           86 KLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIMK  142 (143)
T ss_dssp             HHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHC
T ss_pred             HHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence            99999999999999999999743      4599999999999999999999999875

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii}

Probab=99.71  E-value=2.9e-17  Score=148.00  Aligned_cols=137  Identities=18%  Similarity=0.302  Sum_probs=119.6

Q ss_pred             CCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-----------hccCcHHHHHHhhcccCCCCCcceeHHHHHHHHh
Q 009594          393 QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-----------KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       393 ~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-----------~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~  461 (531)
                      ......++..+|..+|.|++|.|+++||..++...           ......+.+..+|+.+|.|++|.|+.+||..++.
T Consensus        35 ~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~ef~~~~~  114 (191)
T 3khe_A           35 TLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSVDFDRNGYIEYSEFVTVCM  114 (191)
T ss_dssp             CTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHHHHHHHHHHHHHHHTCTTCSSSEEHHHHHHHHS
T ss_pred             CHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccchhhHHHHHHHHHHhCCCCCCcCCHHHHHHHHH
Confidence            33445778999999999999999999999977655           3334567889999999999999999999999987


Q ss_pred             hcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh----CchHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          462 DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA----GTDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       462 ~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~----~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ........+.+..+|..+|.|++|.|+.+||..++..    .+.+..+|..+|+|++|.|+.+||.+.+..+
T Consensus       115 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~  186 (191)
T 3khe_A          115 DKQLLLSRERLLAAFQQFDSDGSGKITNEELGRLFGVTEVDDETWHQVLQECDKNNDGEVDFEEFVEMMQKI  186 (191)
T ss_dssp             CHHHHCCHHHHHHHHHHHCTTCSSEECHHHHHHHTTSSCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred             HhcccchHHHHHHHHHHHCCCCcCcCCHHHHHHHHccCCCCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            6655567788999999999999999999999999982    2559999999999999999999999999875

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=99.70  E-value=1.1e-16  Score=136.71  Aligned_cols=129  Identities=12%  Similarity=0.154  Sum_probs=115.5

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhh-cCCCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALND-EVDTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~  476 (531)
                      .++..+|..+|.|++|.|+++||..++...........+..+|+.+|.|++|.|+.+||..++.. .......+.+..+|
T Consensus         6 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F   85 (142)
T 2bl0_C            6 SEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDILRQAF   85 (142)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCChHHHHHHHH
Confidence            45788999999999999999999998877666677888999999999999999999999999986 44555788899999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      +.+|.|++|.|+.+||..++...      ..+..+|..+| |++|.|+.+||.+.+.
T Consensus        86 ~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~  141 (142)
T 2bl0_C           86 RTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-TEKGQIRYDNFINTMF  141 (142)
T ss_dssp             HHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-CSSSEECSHHHHTTTC
T ss_pred             HHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCcEeHHHHHHHHc
Confidence            99999999999999999999853      45899999999 9999999999998764

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus}

Probab=99.70  E-value=1.5e-17  Score=151.03  Aligned_cols=133  Identities=17%  Similarity=0.146  Sum_probs=115.6

Q ss_pred             CHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhccCc-HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHH
Q 009594          396 PEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKKMAN-DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVIN  473 (531)
Q Consensus       396 ~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~~~~-~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~  473 (531)
                      +.++++.+|..+|.+ ++|.|++.||..++........ .+.+..+|+.+|.|++|.|+.+||..++..++...+.+++.
T Consensus        12 ~~~el~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~   91 (198)
T 2r2i_A           12 SATECHQWYKKFMTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLR   91 (198)
T ss_dssp             HTSCHHHHHHHHHHHCTTSEECHHHHHHHHTCCSCCHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHH
Confidence            345688999999988 8999999999988764332222 35689999999999999999999999999988877888999


Q ss_pred             HHHHhccCCCCcceeHHHHHHHHHhC-------------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          474 AIMHDVDTDKDGRISYEEFAVMMKAG-------------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       474 ~~~~~~D~~~dG~i~~~Ef~~~~~~~-------------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|..+|.|++|.|+++||..++...             +.+..+|+.+|+|+||.|+.+||.+.+..
T Consensus        92 ~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~  159 (198)
T 2r2i_A           92 WYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDINGDGELSLEEFMEGVQK  159 (198)
T ss_dssp             HHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHTT
T ss_pred             HHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHc
Confidence            99999999999999999999999843             23889999999999999999999998864

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5

Probab=99.69  E-value=8.5e-17  Score=143.97  Aligned_cols=132  Identities=17%  Similarity=0.207  Sum_probs=111.2

Q ss_pred             HHHHHHHHhc-CCCCCCceecchhHhHHHHhh----ccCcHHHHH-----------HhhcccCCCCCcceeHHHHHHHHh
Q 009594          398 ADLQILMEAA-DVDGDGSLNYGEFVAVSVHLK----KMANDEHLH-----------KAFSFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       398 ~~~~~~f~~~-D~~~~g~i~~~ef~~~~~~~~----~~~~~~~~~-----------~~F~~~D~~~~G~i~~~el~~~l~  461 (531)
                      ++++.+|..+ |.|++|.|+++||..++....    .......+.           .+|+.+|.|++|.|+.+||..++.
T Consensus         8 ~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~   87 (185)
T 2sas_A            8 QKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAMWE   87 (185)
T ss_dssp             HHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred             HHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHH
Confidence            4578899999 999999999999988776554    344444444           349999999999999999999987


Q ss_pred             hcCC---------CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC----chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          462 DEVD---------TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG----TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       462 ~~~~---------~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      ....         ......+..+|..+|.|+||.|+++||..++...    ..+..+|..+|+|+||.|+.+||.+.+.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g~~~~~~~~~~~~~D~d~dG~i~~~ef~~~~~~  167 (185)
T 2sas_A           88 KTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVITDGGKVTFDLNRYKELYYR  167 (185)
T ss_dssp             HHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHHTTTTSCCSHHHHHHHHHH
T ss_pred             HHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH
Confidence            6521         2244779999999999999999999999999753    67999999999999999999999999876


Q ss_pred             c
Q 009594          529 L  529 (531)
Q Consensus       529 ~  529 (531)
                      .
T Consensus       168 ~  168 (185)
T 2sas_A          168 L  168 (185)
T ss_dssp             H
T ss_pred             H
Confidence            4

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5

Probab=99.69  E-value=1.5e-16  Score=141.09  Aligned_cols=133  Identities=20%  Similarity=0.239  Sum_probs=111.4

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhH----HHHhhccCcHHHHH-----------HhhcccCCCCCcceeHHHHHHHHhh
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAV----SVHLKKMANDEHLH-----------KAFSFFDRNRSGFIEIEELRNALND  462 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~----~~~~~~~~~~~~~~-----------~~F~~~D~~~~G~i~~~el~~~l~~  462 (531)
                      ++++.+|..+|.|++|.|+++||..+    +...........+.           .+|+.+|.|++|.|+.+||..++..
T Consensus         7 ~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~~~~~~   86 (176)
T 1nya_A            7 DRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVTEN   86 (176)
T ss_dssp             HHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence            45778999999999999999999984    33333333444443           8999999999999999999999987


Q ss_pred             cCCCCCH--------HHHHHHHHhccCCCCcceeHHHHHHHHHhC----chHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          463 EVDTSGE--------DVINAIMHDVDTDKDGRISYEEFAVMMKAG----TDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       463 ~~~~~~~--------~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      .......        ..+..+|..+|.|++|.|+++||..++...    ..+..+|+.+|+|++|.|+.+||.+.+..+.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~  166 (176)
T 1nya_A           87 LIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELLTAVRDFH  166 (176)
T ss_dssp             HHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHSCCS
T ss_pred             HhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHh
Confidence            6544443        568999999999999999999999999753    4689999999999999999999999998764

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A

Probab=99.69  E-value=1e-16  Score=130.03  Aligned_cols=103  Identities=30%  Similarity=0.408  Sum_probs=94.0

Q ss_pred             hCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCC
Q 009594          390 KGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDT  466 (531)
Q Consensus       390 ~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~  466 (531)
                      ++|. ++.++++.+|..+|  ++|.|+|+||+.++..  .....+.++.+|+.||.|++|+|+.+||..++..+   |..
T Consensus         2 slG~-~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~   76 (108)
T 2pvb_A            2 SFAG-LKDADVAAALAACS--AADSFKHKEFFAKVGL--ASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARA   76 (108)
T ss_dssp             CCTT-SCHHHHHHHHHHTC--STTCCCHHHHHHHHTG--GGSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCC
T ss_pred             CcCC-CCHHHHHHHHHHhC--CCCcCcHHHHHHHHhC--ChhHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCC
Confidence            5788 99999999999998  7899999999987643  23567889999999999999999999999999998   788


Q ss_pred             CCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          467 SGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       467 ~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +++++++.+|..+|.|+||.|+|+||+.++.
T Consensus        77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~  107 (108)
T 2pvb_A           77 LTDAETKAFLADGDKDGDGMIGVDEFAAMIK  107 (108)
T ss_dssp             CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence            9999999999999999999999999999875

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A

Probab=99.69  E-value=6.1e-17  Score=131.62  Aligned_cols=104  Identities=27%  Similarity=0.419  Sum_probs=94.6

Q ss_pred             hCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCC
Q 009594          390 KGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDT  466 (531)
Q Consensus       390 ~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~  466 (531)
                      +++..++.++++.+|+.+|  ++|.|+|+||+.++..  .....+.++.+|+.||.|++|+|+.+||+.++..+   |..
T Consensus         2 al~~~~~~~ei~~~~~~~D--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~   77 (109)
T 3fs7_A            2 AITDILSAKDIESALSSCQ--AADSFNYKSFFSTVGL--SSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARV   77 (109)
T ss_dssp             CGGGTSCHHHHHHHHHHTC--STTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCC
T ss_pred             CccCcCCHHHHHHHHHhcC--CCCcCcHHHHHHHHhc--CCCcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhccccc
Confidence            3567789999999999998  7999999999988753  33567889999999999999999999999999999   889


Q ss_pred             CCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          467 SGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       467 ~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +++++++.+|..+|.|+||.|+|+||+.+++
T Consensus        78 ~~~~~~~~~~~~~D~~~dg~i~~~EF~~~~~  108 (109)
T 3fs7_A           78 LTSAETKAFLAAGDTDGDGKIGVEEFQSLVK  108 (109)
T ss_dssp             CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHT
T ss_pred             CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence            9999999999999999999999999999875

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4

Probab=99.68  E-value=1.2e-16  Score=129.96  Aligned_cols=104  Identities=28%  Similarity=0.415  Sum_probs=94.9

Q ss_pred             hCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCC
Q 009594          390 KGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDT  466 (531)
Q Consensus       390 ~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~  466 (531)
                      ++|..++.++++.+|..+|  ++|.|+|+||+.++..  .....+.++.+|+.||.|++|+|+.+||+.++..+   |..
T Consensus         2 slg~~~~~~e~~~~~~~~d--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~   77 (109)
T 1bu3_A            2 AFSGILADADVAAALKACE--AADSFNYKAFFAKVGL--TAKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARA   77 (109)
T ss_dssp             CCSCSSCHHHHHHHHHHTC--STTCCCHHHHHHHHTG--GGSCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCC
T ss_pred             cccccCCHHHHHHHHHHhC--CCCcCcHHHHHHHHHc--ChhhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCC
Confidence            5788999999999999998  8899999999987643  23467889999999999999999999999999998   788


Q ss_pred             CCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          467 SGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       467 ~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +++++++.+|..+|.|+||.|+|+||+.++.
T Consensus        78 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~  108 (109)
T 1bu3_A           78 LTDAETKAFLKAGDSDGDGAIGVDEWAALVK  108 (109)
T ss_dssp             CCHHHHHHHHHHHCTTCSSEECHHHHHHHHT
T ss_pred             CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence            9999999999999999999999999999875

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A

Probab=99.68  E-value=8.3e-17  Score=149.47  Aligned_cols=148  Identities=20%  Similarity=0.223  Sum_probs=122.9

Q ss_pred             cHHHHHHHHHhCCCCCCHHHHHHHHHhc-CCCCCCceecchhHhHHHHhh-ccCcHHHHHHhhcccCCCCCcceeHHHHH
Q 009594          380 NLEELRLGLLKGGQNIPEADLQILMEAA-DVDGDGSLNYGEFVAVSVHLK-KMANDEHLHKAFSFFDRNRSGFIEIEELR  457 (531)
Q Consensus       380 ~~~el~~~l~~~~~~~~~~~~~~~f~~~-D~~~~g~i~~~ef~~~~~~~~-~~~~~~~~~~~F~~~D~~~~G~i~~~el~  457 (531)
                      +.+++......  ..++.+++..+++.+ +.|++|.|+++||..++.... .......+..+|+.+|.|++|.|+.+||.
T Consensus        48 ~~~~l~~l~~~--~~~s~~ei~~l~~~F~~~d~~G~Is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~d~~G~I~~~Ef~  125 (229)
T 3dd4_A           48 RPEALELLEAQ--SKFTKKELQILYRGFKNECPSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFI  125 (229)
T ss_dssp             HHHHHHHHHHH--HHHHHHHHHHHHHHHHTTCCSCCCCHHHHHHHHHHHSCSSSHHHHHHHHHHTTCSSCCSSCCHHHHH
T ss_pred             CHHHHHHHHHh--cCCCHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHHCCCCCcHHHHHHHHHHcCCCCCCeEeHHHHH
Confidence            35555444433  345677888888877 678899999999999876543 33455678899999999999999999999


Q ss_pred             HHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCCCcCCH
Q 009594          458 NALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERFNSISL  519 (531)
Q Consensus       458 ~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~G~i~~  519 (531)
                      .++..+.....++.+..+|+.+|.|+||.|+++||..++...                  ..+..+|+.+|+|+||.|+.
T Consensus       126 ~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~  205 (229)
T 3dd4_A          126 KGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTI  205 (229)
T ss_dssp             HHHHHHHHSCHHHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSSCSSBCCH
T ss_pred             HHHHHHcCCChHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcEeH
Confidence            999887666677889999999999999999999999998742                  45999999999999999999


Q ss_pred             HHHHHHHhhc
Q 009594          520 KLMREEGLQL  529 (531)
Q Consensus       520 ~e~~~~~~~~  529 (531)
                      +||.+.+...
T Consensus       206 ~EF~~~~~~~  215 (229)
T 3dd4_A          206 DEFIESCQKD  215 (229)
T ss_dssp             HHHHHHHHTC
T ss_pred             HHHHHHHHhC
Confidence            9999998764

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A

Probab=99.68  E-value=7e-17  Score=139.03  Aligned_cols=129  Identities=9%  Similarity=0.132  Sum_probs=112.5

Q ss_pred             HHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhccc-CCCCCcceeHHHHHHHHhhc------CCCCCHHHH
Q 009594          400 LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFF-DRNRSGFIEIEELRNALNDE------VDTSGEDVI  472 (531)
Q Consensus       400 ~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~-D~~~~G~i~~~el~~~l~~~------~~~~~~~~~  472 (531)
                      ++.+|..+|.|++|.|+..||..++...........+..+|+.+ |.|++|.|+.+||..++...      ......+.+
T Consensus         6 l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~   85 (148)
T 1m45_A            6 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTEDF   85 (148)
T ss_dssp             CTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHHH
T ss_pred             HHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhccccccccHHHH
Confidence            56689999999999999999999887776667788999999999 99999999999999999876      445567889


Q ss_pred             HHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          473 NAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       473 ~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      ..+|+.+|.|++|.|+.+||..++...      ..+..+|..+|+|++|.|+.+||.+.+..
T Consensus        86 ~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~  147 (148)
T 1m45_A           86 VKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR  147 (148)
T ss_dssp             HHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred             HHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            999999999999999999999999853      45899999999999999999999998863

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4

Probab=99.68  E-value=1e-16  Score=130.25  Aligned_cols=104  Identities=27%  Similarity=0.436  Sum_probs=94.5

Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCCC
Q 009594          391 GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDTS  467 (531)
Q Consensus       391 ~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~  467 (531)
                      ++..++.++++.+|+.+|.  +|.|+|+||+.++..  .....+.++.+|+.||.|++|+|+.+||+.++..+   |..+
T Consensus         2 l~~~~s~~ei~~~~~~~d~--~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~   77 (109)
T 5pal_A            2 MTKVLKADDINKAISAFKD--PGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDL   77 (109)
T ss_dssp             GGGTSCHHHHHHHHHHTCS--TTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCC
T ss_pred             CCCcCCHHHHHHHHHHhCC--CCcCcHHHHHHHHhh--ccCcHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCC
Confidence            4567899999999999997  899999999997753  23567889999999999999999999999999998   8999


Q ss_pred             CHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          468 GEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       468 ~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ++++++.+|..+|.|+||.|+|+||+.+++.
T Consensus        78 ~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~  108 (109)
T 5pal_A           78 NDTETKALLAAGDSDHDGKIGADEFAKMVAQ  108 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhCCCCCCcCcHHHHHHHHHh
Confidence            9999999999999999999999999999874

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii}

Probab=99.68  E-value=1.4e-16  Score=143.63  Aligned_cols=132  Identities=14%  Similarity=0.166  Sum_probs=110.7

Q ss_pred             HHHHHHHHhc-CCCCCCceecchhHhHHHHh----hccCcHHHHHHhh-----------cccCCCCCcceeHHHHHHHHh
Q 009594          398 ADLQILMEAA-DVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAF-----------SFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       398 ~~~~~~f~~~-D~~~~g~i~~~ef~~~~~~~----~~~~~~~~~~~~F-----------~~~D~~~~G~i~~~el~~~l~  461 (531)
                      ++++.+|..+ |.|++|.|+++||..++...    ........+..+|           +.+|.|++|.|+.+||..++.
T Consensus        12 ~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~   91 (191)
T 2ccm_A           12 NKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVTKEEWLKMWA   91 (191)
T ss_dssp             HHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred             HHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECHHHHHHHHH
Confidence            4577899999 99999999999999887665    3334455566666           999999999999999999987


Q ss_pred             hcC------C---CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC----chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          462 DEV------D---TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG----TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       462 ~~~------~---~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      ...      .   ......+..+|+.+|.|++|.|+++||..++...    ..+..+|+.+|+|+||.|+.+||.+.+.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~~  171 (191)
T 2ccm_A           92 ECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYGIPKSDCDAAFDTLSDGGKTMVTREIFARLWTE  171 (191)
T ss_dssp             HHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTTCCHHHHHHHHHHHTTTTTSCCBHHHHHHHHHH
T ss_pred             HHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCCcCHHHHHHHHHH
Confidence            652      1   1224568899999999999999999999999753    46899999999999999999999999876


Q ss_pred             c
Q 009594          529 L  529 (531)
Q Consensus       529 ~  529 (531)
                      .
T Consensus       172 ~  172 (191)
T 2ccm_A          172 Y  172 (191)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A

Probab=99.68  E-value=2.4e-16  Score=142.08  Aligned_cols=128  Identities=19%  Similarity=0.200  Sum_probs=112.1

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      .++..+|..+|.|++|.|+.+||..++........ ..+..+|+.+|.|++|.|+.+||..++.... ....+.+..+|+
T Consensus        52 ~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~-~~~~~~l~~~F~  129 (191)
T 3k21_A           52 EKLKSTFLVLDEDGKGYITKEQLKKGLEKDGLKLP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRK-QLSKKLIYCAFR  129 (191)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGG-GCCHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCCCcH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhh-hccHHHHHHHHH
Confidence            45778899999999999999999998876544444 7789999999999999999999999885543 356788999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC-----------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG-----------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~-----------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      .+|.|++|.|+.+||..++...           ..+..+|..+|+|+||.|+.+||.++|+
T Consensus       130 ~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~  190 (191)
T 3k21_A          130 VFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKNNDGKIDFHEFSEMMK  190 (191)
T ss_dssp             HHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred             HhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence            9999999999999999999752           2488999999999999999999999885

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A

Probab=99.68  E-value=1.4e-16  Score=140.51  Aligned_cols=133  Identities=18%  Similarity=0.242  Sum_probs=114.2

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~  476 (531)
                      .++..+|..+|.|++|.|+..||..++...........+..+|+.+|.|++|.|+.+||..++... ......+.+..+|
T Consensus        28 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F  107 (169)
T 3qrx_A           28 QEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSREEILKAF  107 (169)
T ss_dssp             HHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccCcHHHHHHHH
Confidence            346778999999999999999999988776666778899999999999999999999999998753 2222356788999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      +.+|.|++|.|+.+||..++...      +.+..+|..+|+|+||.|+.+||.+.+...+
T Consensus       108 ~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~  167 (169)
T 3qrx_A          108 RLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS  167 (169)
T ss_dssp             HHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHHC---
T ss_pred             HHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHhcc
Confidence            99999999999999999999843      4699999999999999999999999987643

>1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A

Probab=99.68  E-value=2.4e-17  Score=173.18  Aligned_cols=133  Identities=15%  Similarity=0.235  Sum_probs=67.5

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcc
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSF  442 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~  442 (531)
                      .++++|..+|.|++|.|+.+||..+|+.+|..++.++++.+|+.+|.|++|.|+|+||+.++.....   .++++.+|+.
T Consensus        12 ~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D~d~~G~I~f~EF~~~~~~l~~---~~el~~aF~~   88 (624)
T 1djx_A           12 WIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSLEDEEIETFYKMLTQ---RAEIDRAFEE   88 (624)
T ss_dssp             --------------------------------------------------------CTTHHHHHHTC---CHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhcc---HHHHHHHHHH
Confidence            5889999999999999999999999999999999999999999999999999999999998765432   4679999999


Q ss_pred             cCCCCCcceeHHHHHHHHhhc-CCC-CCHHHHHHHHHhccCC----CCcceeHHHHHHHHHhC
Q 009594          443 FDRNRSGFIEIEELRNALNDE-VDT-SGEDVINAIMHDVDTD----KDGRISYEEFAVMMKAG  499 (531)
Q Consensus       443 ~D~~~~G~i~~~el~~~l~~~-~~~-~~~~~~~~~~~~~D~~----~dG~i~~~Ef~~~~~~~  499 (531)
                      ||.+ +|+|+.+||+.+|... |.. +++++++++|+.+|.|    ++|.|+|+||+.+|...
T Consensus        89 fD~~-~G~Is~~EL~~fL~~~qge~~ls~ee~~~ii~~~d~d~~~~~dG~Is~deF~~~L~s~  150 (624)
T 1djx_A           89 AAGS-AETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSA  150 (624)
T ss_dssp             HHTT-SSSEEHHHHHHHHHHTSCCSSCSHHHHHHHHHHHCCCHHHHHTTEECHHHHHHHHHST
T ss_pred             hcCC-CCeecHHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCChhhccCCCCCHHHHHHHhcCc
Confidence            9986 9999999999999965 666 8999999999999998    79999999999999853

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1}

Probab=99.68  E-value=6e-17  Score=146.74  Aligned_cols=131  Identities=19%  Similarity=0.177  Sum_probs=105.2

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      .++..+|..+|.|++|.|+++||..++...........+..+|+.+|.|++|.|+.+||..++.........+.+..+|+
T Consensus        57 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~  136 (197)
T 3pm8_A           57 NNLRNIFIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFK  136 (197)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHHC----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCSHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence            34677899999999999999999998876655566788999999999999999999999998866544456788999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC--------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG--------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~--------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|.|++|.|+.+||..++...        +.+..+|..+|.|+||.|+.+||.+.|+.
T Consensus       137 ~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~  195 (197)
T 3pm8_A          137 FFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLNGDGEIDFHEFMLMMSK  195 (197)
T ss_dssp             HHCTTCSSEECHHHHHHHHC----CCHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHC
T ss_pred             HHCCCCCCCCCHHHHHHHHHhcccCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHc
Confidence            9999999999999999999854        35899999999999999999999999875

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens}

Probab=99.68  E-value=5e-17  Score=148.16  Aligned_cols=133  Identities=21%  Similarity=0.302  Sum_probs=116.3

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      .++..+|..+|.|++|.|+++||..++...........+..+|+.+|.|++|.|+.+||..++.........+.+..+|.
T Consensus        37 ~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~~~~~~~~F~  116 (204)
T 3e3r_A           37 QGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIAAAFA  116 (204)
T ss_dssp             ---CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchHHHHHHHHHH
Confidence            56778999999999999999999998877666677889999999999999999999999999987655455677999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC-------------chHHHHHhhhCc-cCCCcCCHHHHHHHHhhcC
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG-------------TDWRKASRQYSR-ERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~-------------~~~~~~f~~~D~-~~~G~i~~~e~~~~~~~~~  530 (531)
                      .+|.|++|.|+.+||..++...             +.+..+|..+|+ |+||.|+.+||.+.+..++
T Consensus       117 ~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~~~~~~~~  183 (204)
T 3e3r_A          117 KLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQDYYSGVS  183 (204)
T ss_dssp             HHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHHHHHHHHH
T ss_pred             HhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHcC
Confidence            9999999999999999999731             348899999999 9999999999999998764

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens}

Probab=99.67  E-value=2.6e-17  Score=150.98  Aligned_cols=137  Identities=16%  Similarity=0.199  Sum_probs=110.6

Q ss_pred             CCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhccC-cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHH
Q 009594          393 QNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKKMA-NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED  470 (531)
Q Consensus       393 ~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~~~-~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~  470 (531)
                      ..++.++++.+|..+|.+ ++|.|+.+||..++....... ..+.+..+|+.+|.|++|.|+.+||..++..++...+.+
T Consensus        14 t~ls~~ei~~~f~~fD~~~~~G~is~~El~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~   93 (211)
T 2ggz_A           14 KAVPTQETHVWYRTFMMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQ   93 (211)
T ss_dssp             ----------CCCSHHHHCTTSEEEHHHHHHHTTCCSCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHH
T ss_pred             CCCCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHH
Confidence            346778899999999988 899999999998775432222 235689999999999999999999999999888777788


Q ss_pred             HHHHHHHhccCCCCcceeHHHHHHHHHhC------------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          471 VINAIMHDVDTDKDGRISYEEFAVMMKAG------------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       471 ~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ++..+|+.+|.|++|.|+++||..++...            +.+..+|+.+|+|+||.|+.+||.+.+...
T Consensus        94 ~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~  164 (211)
T 2ggz_A           94 KLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGMAKD  164 (211)
T ss_dssp             HHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHTT
T ss_pred             HHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhC
Confidence            89999999999999999999999998742            237889999999999999999999998754

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A

Probab=99.67  E-value=1.9e-16  Score=137.95  Aligned_cols=132  Identities=10%  Similarity=0.095  Sum_probs=115.5

Q ss_pred             HHHHHHHhcC-CCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCC-----CCHHHH
Q 009594          399 DLQILMEAAD-VDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDT-----SGEDVI  472 (531)
Q Consensus       399 ~~~~~f~~~D-~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-----~~~~~~  472 (531)
                      ++..+|..+| .|++|.|+.+||..++...........+..+|+.+|.|++|.|+.+||..++......     .....+
T Consensus        14 ~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~   93 (158)
T 2jnf_A           14 LLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEVNPEQMQQEL   93 (158)
T ss_dssp             HHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCCCTTTTSSTH
T ss_pred             HHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccccchhhHHHHH
Confidence            4677899999 9999999999999988776656778889999999999999999999999999765322     445679


Q ss_pred             HHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          473 NAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       473 ~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      ..+|..+|.|++|.|+.+||..++...      ..+..+|..+|.|++|.|+.+||.+.+..-.
T Consensus        94 ~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~  157 (158)
T 2jnf_A           94 REAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDADGSGTVDFEEFMGVMTGGD  157 (158)
T ss_dssp             HHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSSCCSEECSHHHHHHTSSCC
T ss_pred             HHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhccC
Confidence            999999999999999999999999842      4589999999999999999999999987643

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ...

Probab=99.67  E-value=1.1e-16  Score=139.76  Aligned_cols=132  Identities=18%  Similarity=0.265  Sum_probs=114.8

Q ss_pred             HHHHHHHHhcCCCC-CCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC----CCCCHHHH
Q 009594          398 ADLQILMEAADVDG-DGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV----DTSGEDVI  472 (531)
Q Consensus       398 ~~~~~~f~~~D~~~-~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~----~~~~~~~~  472 (531)
                      .++..+|..+|.|+ +|.|+.+||..++...........+..+|+.+|.|++|.|+.+||..++....    .....+.+
T Consensus        18 ~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~   97 (161)
T 1dtl_A           18 NEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEEL   97 (161)
T ss_dssp             HHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcccccchHHHHH
Confidence            34667899999999 99999999999887766667788899999999999999999999999997653    33456779


Q ss_pred             HHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          473 NAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       473 ~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ..+|..+|.|++|.|+.+||..++...      ..+..+|..+|.|+||.|+.+||.+.+..+
T Consensus        98 ~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~  160 (161)
T 1dtl_A           98 SDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV  160 (161)
T ss_dssp             HHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC-
T ss_pred             HHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHcC
Confidence            999999999999999999999998743      458999999999999999999999998764

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ...

Probab=99.67  E-value=2.4e-16  Score=135.78  Aligned_cols=129  Identities=18%  Similarity=0.234  Sum_probs=112.3

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIMH  477 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~  477 (531)
                      ++..+|..+|.|++|.|++.||..++...........+..+|+.+|.|++|.|+.+||..++... ....+.+++..+|+
T Consensus        11 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~   90 (148)
T 1exr_A           11 EFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFK   90 (148)
T ss_dssp             HHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCcHHHHHHHHH
Confidence            46778999999999999999999988776666778889999999999999999999999988643 22224567888999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      .+|.|++|.|+.+||..++...      ..+..+|..+|+|+||.|+.+||.+.|.
T Consensus        91 ~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~  146 (148)
T 1exr_A           91 VFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMV  146 (148)
T ss_dssp             HHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHH
T ss_pred             HhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence            9999999999999999999743      4589999999999999999999999875

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A

Probab=99.67  E-value=4.2e-16  Score=136.09  Aligned_cols=130  Identities=14%  Similarity=0.198  Sum_probs=115.2

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIMH  477 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~  477 (531)
                      ++..+|..+|.|++|.|+++||..++...........+..+|+.+|.+++|.|+.+||..++... ......+.+..+|.
T Consensus        24 ~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~  103 (161)
T 3fwb_A           24 EIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDPLDEIKRAFQ  103 (161)
T ss_dssp             HHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHHTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHhcCCcHHHHHHHHH
Confidence            46678999999999999999999988776666778889999999999999999999999998754 33445678999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|.|++|.|+.+||..++...      ..+..+|..+|.|++|.|+.+||.+.+.+
T Consensus       104 ~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~  160 (161)
T 3fwb_A          104 LFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLDGDGEINENEFIAICTD  160 (161)
T ss_dssp             HHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSSSSSSEEHHHHHHHHHH
T ss_pred             HHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhc
Confidence            9999999999999999999843      46999999999999999999999999864

>3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor}

Probab=99.66  E-value=2.5e-16  Score=153.31  Aligned_cols=129  Identities=19%  Similarity=0.243  Sum_probs=112.7

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIMH  477 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~  477 (531)
                      +++++|+.+|.|++|.|+.+||..++..+......+++..+|+.+|.|++|.|+.+||..++... ....+++++..+|+
T Consensus       303 ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~d~eeeLreAFk  382 (440)
T 3u0k_A          303 EFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLIMMARKMKDTDSEEEIREAFR  382 (440)
T ss_dssp             HHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC------CHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCChHHHHHHHHH
Confidence            46678999999999999999999988877667788999999999999999999999999988654 33335678999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      .+|.|++|.|+.+||..++...      +++..+|+.+|.|+||.|+.+||.++|+
T Consensus       383 ~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~DgDGkIsyeEFvkmMt  438 (440)
T 3u0k_A          383 VFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT  438 (440)
T ss_dssp             HHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC
T ss_pred             HHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHhC
Confidence            9999999999999999999742      5689999999999999999999999985

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ...

Probab=99.66  E-value=3.6e-16  Score=136.69  Aligned_cols=133  Identities=20%  Similarity=0.281  Sum_probs=115.1

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCC-CC---CHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-TS---GEDVIN  473 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~---~~~~~~  473 (531)
                      .++..+|..+|.|++|.|++.||..++...........+..+|+.+|.|++|.|+.+||..++..... ..   ..+.+.
T Consensus        20 ~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~   99 (162)
T 1top_A           20 AEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELA   99 (162)
T ss_dssp             HHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHHhccccccccHHHHH
Confidence            34677899999999999999999998877665667888999999999999999999999999865421 11   355688


Q ss_pred             HHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          474 AIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       474 ~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      .+|+.+|.|++|.|+.+||..++...      ..+..+|..+|.|++|.|+.+||.+.+..++
T Consensus       100 ~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~~  162 (162)
T 1top_A          100 NCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGVQ  162 (162)
T ss_dssp             HHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHSCC
T ss_pred             HHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhhcC
Confidence            99999999999999999999999843      4589999999999999999999999998754

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=99.66  E-value=3.8e-16  Score=138.51  Aligned_cols=130  Identities=17%  Similarity=0.223  Sum_probs=115.3

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCC-CCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD-TSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~  476 (531)
                      +++++.|..+|.|++|.|+++||..++..+....+...+..++..+|.|++|.|+..||..++..... ..+.+++..+|
T Consensus        11 ~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~~~~l~~aF   90 (176)
T 2lhi_A           11 AEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLEAF   90 (176)
T ss_dssp             GHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCCcHHHHHHHH
Confidence            45777899999999999999999998887777788899999999999999999999999998876543 33456799999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +.+|.|++|.|+.+||..++...      .++.++++.+| |+||.|+.+||.++|+.
T Consensus        91 ~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~~~m~k  147 (176)
T 2lhi_A           91 KVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSK  147 (176)
T ss_dssp             HHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTTHHHHHHTC
T ss_pred             HHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHHHHHHHHHh
Confidence            99999999999999999999843      45889999999 99999999999999975

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A

Probab=99.66  E-value=1.4e-16  Score=129.42  Aligned_cols=103  Identities=24%  Similarity=0.401  Sum_probs=93.1

Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCCCC
Q 009594          392 GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDTSG  468 (531)
Q Consensus       392 ~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~  468 (531)
                      |..++.++++.+|..+|  ++|.|+|+||+.++..  .....+.++.+|+.+|.|++|+|+.+||+.++..+   |..++
T Consensus         3 g~~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~   78 (109)
T 1rwy_A            3 TDLLSAEDIKKAIGAFT--AADSFDHKKFFQMVGL--KKKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLS   78 (109)
T ss_dssp             HHHSCHHHHHHHHHTTC--STTCCCHHHHHHHHTG--GGSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCC
T ss_pred             CCcCCHHHHHHHHHHcC--CCCcEeHHHHHHHHhc--CcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCC
Confidence            55688999999999998  8899999999987642  23567889999999999999999999999999998   78899


Q ss_pred             HHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          469 EDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       469 ~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +++++.++..+|.|++|.|+|+||+.++..
T Consensus        79 ~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~  108 (109)
T 1rwy_A           79 AKETKTLMAAGDKDGDGKIGVEEFSTLVAE  108 (109)
T ss_dssp             HHHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHc
Confidence            999999999999999999999999998864

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A

Probab=99.66  E-value=1.2e-16  Score=130.16  Aligned_cols=105  Identities=27%  Similarity=0.422  Sum_probs=94.4

Q ss_pred             hCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCC
Q 009594          390 KGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDT  466 (531)
Q Consensus       390 ~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~  466 (531)
                      ++|..++..+++.++..+|  ++|.|+|+||+.++..  .....+.++.+|+.||.|++|+|+.+||+.++..+   |..
T Consensus         2 alG~~~t~~e~~~~~~~~d--~~g~i~~~ef~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~   77 (110)
T 1pva_A            2 AAKDLLKADDIKKALDAVK--AEGSFNHKKFFALVGL--KAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRD   77 (110)
T ss_dssp             CHHHHSCHHHHHHHHHHTC--STTCCCHHHHHHHHTC--TTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCC
T ss_pred             cccccCCHHHHHHHHHhcC--CCCcCcHHHHHHHHcc--CcchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCC
Confidence            3566789999999999998  8899999999988642  23567889999999999999999999999999998   788


Q ss_pred             CCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          467 SGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       467 ~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ++.++++.+|..+|.|++|.|+|+||+.++..
T Consensus        78 ~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~  109 (110)
T 1pva_A           78 LTDAETKAFLKAADKDGDGKIGIDEFETLVHE  109 (110)
T ss_dssp             CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHh
Confidence            99999999999999999999999999998864

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ...

Probab=99.66  E-value=8.7e-16  Score=133.41  Aligned_cols=131  Identities=15%  Similarity=0.107  Sum_probs=116.2

Q ss_pred             HHHHHHHhcCC--CCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCC--CCCHHHHHH
Q 009594          399 DLQILMEAADV--DGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD--TSGEDVINA  474 (531)
Q Consensus       399 ~~~~~f~~~D~--~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~--~~~~~~~~~  474 (531)
                      ++..+|..+|.  |++|.|+++||..++..+........+..+ +.+|.|++|.|+.+||..++.....  ....+.+..
T Consensus        10 ~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~   88 (156)
T 1wdc_C           10 DLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYME   88 (156)
T ss_dssp             HHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHH
T ss_pred             HHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhccCChHHHHHH
Confidence            46778999999  999999999999988776666677888999 9999999999999999999987643  556788999


Q ss_pred             HHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhh--hCccCCCcCCHHHHHHHHhhcC
Q 009594          475 IMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQ--YSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       475 ~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~--~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      +|..+|.|++|.|+.+||..++...      ..+..+|+.  +|+|++|.|+.+||.+.+...+
T Consensus        89 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~  152 (156)
T 1wdc_C           89 AFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGP  152 (156)
T ss_dssp             HHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHCS
T ss_pred             HHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHHHHHhcCC
Confidence            9999999999999999999999843      458999999  9999999999999999998754

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=99.66  E-value=6.7e-16  Score=132.21  Aligned_cols=131  Identities=12%  Similarity=0.145  Sum_probs=114.8

Q ss_pred             CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc--CCCCCHHHH
Q 009594          395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE--VDTSGEDVI  472 (531)
Q Consensus       395 ~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~--~~~~~~~~~  472 (531)
                      +++++++.+|..+|.|++|.|+.+||..++...........+..+|+.   |++|.|+.+||..++...  ......+.+
T Consensus         2 ls~~el~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~~~~l   78 (145)
T 2bl0_B            2 ASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQSKEM   78 (145)
T ss_dssp             CCHHHHHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGGHHHH
T ss_pred             CCHHHHHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh---cCCCeEcHHHHHHHHHHHhhcCcccHHHH
Confidence            466779999999999999999999999988776666677888888887   899999999999999775  333456789


Q ss_pred             HHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          473 NAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       473 ~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      ..+|..+|.|++|.|+.+||..++...      ..+..+|+.+|.|++|.|+.+||.+.+..
T Consensus        79 ~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~  140 (145)
T 2bl0_B           79 LDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAINYESFVDMLVT  140 (145)
T ss_dssp             HHHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHHHh
Confidence            999999999999999999999999853      45899999999999999999999999875

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A

Probab=99.66  E-value=2.3e-16  Score=128.00  Aligned_cols=103  Identities=20%  Similarity=0.367  Sum_probs=92.8

Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCCC
Q 009594          391 GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDTS  467 (531)
Q Consensus       391 ~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~  467 (531)
                      ++..++.++++.+|..+|  ++|.|+|+||+.++..  .....+.++.+|+.||.|++|+|+.+||+.++..+   |..+
T Consensus         2 l~~~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~   77 (108)
T 1rro_A            2 ITDILSAEDIAAALQECQ--DPDTFEPQKFFQTSGL--SKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDAREL   77 (108)
T ss_dssp             GGGTSCHHHHHHHHHHTC--STTCCCHHHHHHHHSG--GGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCC
T ss_pred             ccccCCHHHHHHHHHHcc--CCCCcCHHHHHHHHhc--CcccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCC
Confidence            456789999999999998  8899999999987642  23567789999999999999999999999999998   6788


Q ss_pred             CHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          468 GEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       468 ~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +.++++.+|..+|.|+||.|+|+||+.+++
T Consensus        78 ~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~  107 (108)
T 1rro_A           78 TESETKSLMDAADNDGDGKIGADEFQEMVH  107 (108)
T ss_dssp             CHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred             CHHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence            999999999999999999999999999875

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A

Probab=99.65  E-value=3.9e-16  Score=134.01  Aligned_cols=129  Identities=18%  Similarity=0.199  Sum_probs=112.9

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~  476 (531)
                      .++..+|..+|.|++|.|+.+||..++...........+..+|+.+|.+++|.|+.+||..++... ......+.+..+|
T Consensus        11 ~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F   90 (147)
T 4ds7_A           11 AEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQLKCNDSEQELLEAF   90 (147)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHhccCCCcHHHHHHHH
Confidence            346678999999999999999999988776666788889999999999999999999999999754 2233456789999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      ..+|.|++|.|+.+||..++...      ..+..+|..+| |++|.|+.+||.+.+.
T Consensus        91 ~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~l~  146 (147)
T 4ds7_A           91 KVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS-DGSGEINIKQFAALLS  146 (147)
T ss_dssp             HHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS-SSCSSEEHHHHHHHTT
T ss_pred             HHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHh
Confidence            99999999999999999999843      45889999999 9999999999999875

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=99.65  E-value=1.4e-16  Score=143.16  Aligned_cols=131  Identities=15%  Similarity=0.172  Sum_probs=116.0

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      .++..+|..+|.|++|.|+++||..++...........+..+|+.+|.|++|.|+.+||..++..+......+.+..+|.
T Consensus        10 ~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~l~~~F~   89 (188)
T 1s6i_A           10 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLVSAFS   89 (188)
T ss_dssp             CSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHHHHHHHHHH
Confidence            45788999999999999999999998876655567788999999999999999999999999987654444567899999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC----chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG----TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|.|++|.|+.+||..++...    ..+..+|+.+|+|+||.|+.+||.+.+..
T Consensus        90 ~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~~  144 (188)
T 1s6i_A           90 YFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRK  144 (188)
T ss_dssp             HTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHCSSSSSEEETTHHHHTTSC
T ss_pred             HHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHH
Confidence            9999999999999999998743    56899999999999999999999999864

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens}

Probab=99.65  E-value=1.9e-16  Score=144.15  Aligned_cols=148  Identities=14%  Similarity=0.102  Sum_probs=114.5

Q ss_pred             CCcccHHHHHHHHHhCCCCCCHHH---HHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCccee
Q 009594          376 RGKINLEELRLGLLKGGQNIPEAD---LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIE  452 (531)
Q Consensus       376 ~g~i~~~el~~~l~~~~~~~~~~~---~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~  452 (531)
                      ++.++.+++..+....+  ++.++   +..+|..+|.|++|.|+++||..+ ..+.....   +..+|+.+|.|++|.|+
T Consensus         6 s~~l~~~~~~~~~~~~~--ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D~d~dg~i~   79 (202)
T 2bec_A            6 SHAAVIPDGDSIRRETG--FSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFFPDGSQRVD   79 (202)
T ss_dssp             -----CCSTTTHHHHHC--CCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTSCSSCCCCC
T ss_pred             cCCcCHHHHHHHHHccC--CCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhCCCCCCcCc
Confidence            33466666666655533  34444   566799999999999999999987 43332222   88999999999999999


Q ss_pred             HHHHHHHHhhcC-----------------CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-------chHHHHHhh
Q 009594          453 IEELRNALNDEV-----------------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-------TDWRKASRQ  508 (531)
Q Consensus       453 ~~el~~~l~~~~-----------------~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-------~~~~~~f~~  508 (531)
                      .+||..++....                 .....+.+..+|..+|.|++|.|+.+||..++...       .++..+|..
T Consensus        80 ~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~  159 (202)
T 2bec_A           80 FPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADR  159 (202)
T ss_dssp             HHHHHHHHGGGSCCCHHHHC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcccchhcccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence            999999998764                 23345679999999999999999999999999854       235555666


Q ss_pred             ----hCccCCCcCCHHHHHHHHhhc
Q 009594          509 ----YSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       509 ----~D~~~~G~i~~~e~~~~~~~~  529 (531)
                          +|+|+||.|+.+||.+.+...
T Consensus       160 ~~~~~D~d~dG~Is~~EF~~~~~~~  184 (202)
T 2bec_A          160 TVQEADEDGDGAVSFVEFTKSLEKM  184 (202)
T ss_dssp             HHHHHCSSCSSSEEHHHHHHTTTTS
T ss_pred             HHHHcCCCCCCcCcHHHHHHHHHHh
Confidence                999999999999999998765

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A

Probab=99.65  E-value=2.7e-16  Score=140.06  Aligned_cols=132  Identities=20%  Similarity=0.256  Sum_probs=114.9

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC-CCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~  476 (531)
                      .++..+|..+|.|++|.|+++||..++...........+..+|+.+|.|++|.|+.+||..++.... .....+.+..+|
T Consensus        11 ~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~F   90 (179)
T 2f2o_A           11 AEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAF   90 (179)
T ss_dssp             HHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHHccCcccHHHHHHHH
Confidence            4577899999999999999999999887766667788899999999999999999999999886542 222345689999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ..+|.|++|.|+.+||..++...      ..+..+|..+|+|+||.|+.+||.+.+...
T Consensus        91 ~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~  149 (179)
T 2f2o_A           91 RVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK  149 (179)
T ss_dssp             HHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHSCC-
T ss_pred             HHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHc
Confidence            99999999999999999999853      469999999999999999999999998764

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A

Probab=99.65  E-value=3.5e-16  Score=135.21  Aligned_cols=129  Identities=17%  Similarity=0.229  Sum_probs=112.9

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCC-----CHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTS-----GEDVIN  473 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~-----~~~~~~  473 (531)
                      ++..+|..+|.|++|.|+++||..++...........+..+|+.+|.|++|.|+.+||..++.......     ..+.+.
T Consensus        12 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~   91 (153)
T 3ox6_A           12 ELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIGVKELR   91 (153)
T ss_dssp             HHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCCHHHHCHHHHH
T ss_pred             HHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhccccccccHHHHH
Confidence            456689999999999999999999887766667788899999999999999999999999997543322     256789


Q ss_pred             HHHHhccCCCCcceeHHHHHHHHHh-C------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          474 AIMHDVDTDKDGRISYEEFAVMMKA-G------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       474 ~~~~~~D~~~dG~i~~~Ef~~~~~~-~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      .+|..+|.|++|.|+.+||..++.. .      ..+..+|..+|.|++|.|+.+||.+.+.
T Consensus        92 ~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~  152 (153)
T 3ox6_A           92 DAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMS  152 (153)
T ss_dssp             HHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHTC
T ss_pred             HHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence            9999999999999999999999975 2      4589999999999999999999999875

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A

Probab=99.65  E-value=4.7e-16  Score=136.45  Aligned_cols=133  Identities=17%  Similarity=0.176  Sum_probs=108.2

Q ss_pred             HHHHHHHHHhcCCCCCCceecchhHhHHHHh----hccCcHHHH-----------HHhhcccCCCCCcceeHHHHHHHHh
Q 009594          397 EADLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHL-----------HKAFSFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       397 ~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~----~~~~~~~~~-----------~~~F~~~D~~~~G~i~~~el~~~l~  461 (531)
                      .+++..+|..+|.|++|.|+++||..++...    ........+           ..+|+.+|.|++|.|+.+||..++.
T Consensus         3 ~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~~   82 (166)
T 3akb_A            3 ERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTGAV   82 (166)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHTHH
T ss_pred             HHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence            3578899999999999999999999865321    222233333           3568999999999999999999887


Q ss_pred             hcCCCCC-------HHHHHHHHHhccCCCCcceeHHHHHHHHHhC----chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          462 DEVDTSG-------EDVINAIMHDVDTDKDGRISYEEFAVMMKAG----TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       462 ~~~~~~~-------~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ......+       .+.+..+|+.+|.|++|.|+.+||..++...    ..+..+|..+|+|+||.|+.+||.+.+.++
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~  161 (166)
T 3akb_A           83 KRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFGVPEDLARQAAAALDTDGDGKVGETEIVPAFARY  161 (166)
T ss_dssp             HHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSBCCHHHHHHHHHHH
T ss_pred             HHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            6532221       2348899999999999999999999999753    468999999999999999999999999765

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A

Probab=99.64  E-value=5.2e-16  Score=143.88  Aligned_cols=150  Identities=21%  Similarity=0.197  Sum_probs=116.3

Q ss_pred             cccHHHHHHHHHhCCCCCCHHH---HHHHHHhcCCC--CCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCccee
Q 009594          378 KINLEELRLGLLKGGQNIPEAD---LQILMEAADVD--GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIE  452 (531)
Q Consensus       378 ~i~~~el~~~l~~~~~~~~~~~---~~~~f~~~D~~--~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~  452 (531)
                      .++.+++.......+  ++.++   +..+|..+|.|  ++|.|+.+||..++.. ........+..+|+.+|.|++|.|+
T Consensus        27 ~l~~~~~~~l~~~~~--ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~~~~~~~~~~~f~~~D~d~dG~I~  103 (226)
T 2zfd_A           27 SGGLGDPELLARDTV--FSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TNKKESLFADRVFDLFDTKHNGILG  103 (226)
T ss_dssp             -----CTHHHHHHSS--CCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CSSCCCHHHHHHHHHHCSSCSSSBC
T ss_pred             cCCHHHHHHHHHhCC--CCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cCcccHHHHHHHHHHHcCCCCCcCc
Confidence            455566666665543  34444   55678899999  9999999999987754 2223345577899999999999999


Q ss_pred             HHHHHHHHhhcCC-CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh-----C-----c----hHHHHHhhhCccCCCcC
Q 009594          453 IEELRNALNDEVD-TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA-----G-----T----DWRKASRQYSRERFNSI  517 (531)
Q Consensus       453 ~~el~~~l~~~~~-~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~-----~-----~----~~~~~f~~~D~~~~G~i  517 (531)
                      .+||..++...+. ....+.+..+|..+|.|++|.|+++||..++..     .     .    .+..+|+.+|+|+||.|
T Consensus       104 ~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I  183 (226)
T 2zfd_A          104 FEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKI  183 (226)
T ss_dssp             HHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEE
T ss_pred             HHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcC
Confidence            9999999988763 345677999999999999999999999999851     1     1    15677889999999999


Q ss_pred             CHHHHHHHHhhcC
Q 009594          518 SLKLMREEGLQLA  530 (531)
Q Consensus       518 ~~~e~~~~~~~~~  530 (531)
                      +.+||.+.+...+
T Consensus       184 ~~~EF~~~~~~~~  196 (226)
T 2zfd_A          184 DKEEWRSLVLRHP  196 (226)
T ss_dssp             CHHHHHHHHHHSG
T ss_pred             cHHHHHHHHHhCh
Confidence            9999999988653

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8

Probab=99.64  E-value=6.3e-16  Score=139.30  Aligned_cols=127  Identities=20%  Similarity=0.279  Sum_probs=112.9

Q ss_pred             CHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHH
Q 009594          396 PEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAI  475 (531)
Q Consensus       396 ~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~  475 (531)
                      +.++++.+|..+|.|++|.|+++||..++.........+.+..+|+.+|.|++|.|+.+||..++...      +.+..+
T Consensus        25 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~------~~~~~~   98 (191)
T 1y1x_A           25 DNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHFI------LSMREG   98 (191)
T ss_dssp             TTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHHH
T ss_pred             CHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHH------HHHHHH
Confidence            35678999999999999999999999987544345677889999999999999999999999998753      578999


Q ss_pred             HHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          476 MHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       476 ~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      |+.+|.|++|.|+.+||..++...      ..+..+|+.+|+|+||.|+.+||.+.+..
T Consensus        99 F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~  157 (191)
T 1y1x_A           99 FRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIF  157 (191)
T ss_dssp             HHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             HHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            999999999999999999999853      45899999999999999999999998864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.64  E-value=2.5e-16  Score=163.71  Aligned_cols=135  Identities=18%  Similarity=0.313  Sum_probs=117.9

Q ss_pred             HHHHHHHHHhcCCCCCCceecchhHhHHHHhhc--------cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCC
Q 009594          397 EADLQILMEAADVDGDGSLNYGEFVAVSVHLKK--------MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG  468 (531)
Q Consensus       397 ~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~--------~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~  468 (531)
                      .++++++|..+|.|+||.|+++||..++.....        ....+.+..+|+.+|.|++|.|+.+||..++...+...+
T Consensus       345 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~  424 (494)
T 3lij_A          345 TKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLS  424 (494)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTC
T ss_pred             HHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhcccc
Confidence            356888999999999999999999987765532        234678999999999999999999999999877665667


Q ss_pred             HHHHHHHHHhccCCCCcceeHHHHHHHHHh----CchHHHHHhhhCccCCCcCCHHHHHHHHhhcCC
Q 009594          469 EDVINAIMHDVDTDKDGRISYEEFAVMMKA----GTDWRKASRQYSRERFNSISLKLMREEGLQLAN  531 (531)
Q Consensus       469 ~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~----~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~~  531 (531)
                      .+++..+|+.+|.|+||.|+.+||..++..    .+++.++|+.+|+|+||.|+.+||.++|.++++
T Consensus       425 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~  491 (494)
T 3lij_A          425 KDKLESAFQKFDQDGNGKISVDELASVFGLDHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQKLCS  491 (494)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHC-CCSCCCHHHHHHHHTTCSSSSSSEEHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhhcc
Confidence            889999999999999999999999999973    356999999999999999999999999998763

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.64  E-value=3.6e-16  Score=162.99  Aligned_cols=154  Identities=19%  Similarity=0.247  Sum_probs=125.0

Q ss_pred             CcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc--------cCcHHHHHHhhcccCCCCC
Q 009594          377 GKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK--------MANDEHLHKAFSFFDRNRS  448 (531)
Q Consensus       377 g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~--------~~~~~~~~~~F~~~D~~~~  448 (531)
                      ..+....+......+......++++++|..+|.|+||.|+++||..++.....        ....+.+..+|+.+|.|+|
T Consensus       334 ~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~d  413 (504)
T 3q5i_A          334 QKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKN  413 (504)
T ss_dssp             SHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCS
T ss_pred             HHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCC
Confidence            33444434333333322223355788999999999999999999987765522        3456889999999999999


Q ss_pred             cceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh----CchHHHHHhhhCccCCCcCCHHHHHH
Q 009594          449 GFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA----GTDWRKASRQYSRERFNSISLKLMRE  524 (531)
Q Consensus       449 G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~----~~~~~~~f~~~D~~~~G~i~~~e~~~  524 (531)
                      |.|+.+||..++.......+++++..+|+.+|.|+||.|+.+||..++..    .+++.++|+.+|+|+||.|+.+||.+
T Consensus       414 G~I~~~EF~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~  493 (504)
T 3q5i_A          414 GYIEYSEFISVCMDKQILFSEERLRRAFNLFDTDKSGKITKEELANLFGLTSISEKTWNDVLGEADQNKDNMIDFDEFVS  493 (504)
T ss_dssp             SSEEHHHHHHHHSCHHHHTCHHHHHHHHHHHCTTCCSEECHHHHHHHTTCSCCCHHHHHHHHHTTCSSCSSSEEHHHHHH
T ss_pred             CcEeHHHHHHHHHhhhcccCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhhCCCCHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence            99999999999976655567889999999999999999999999999874    25699999999999999999999999


Q ss_pred             HHhhcC
Q 009594          525 EGLQLA  530 (531)
Q Consensus       525 ~~~~~~  530 (531)
                      .|.+.+
T Consensus       494 ~~~~~~  499 (504)
T 3q5i_A          494 MMHKIC  499 (504)
T ss_dssp             HHHHHC
T ss_pred             HHHHhc
Confidence            998875

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana}

Probab=99.63  E-value=3e-16  Score=137.87  Aligned_cols=130  Identities=17%  Similarity=0.181  Sum_probs=110.7

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHh
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD  478 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~  478 (531)
                      ++..+|..+|.|++|.|+++||..++...........+..+|+.+|.|++|.|+.+||..++.........+.+..+|..
T Consensus        28 ~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~  107 (166)
T 2aao_A           28 GLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFAAFTY  107 (166)
T ss_dssp             HHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCTTCCSSBCHHHHHHHHTTCHHHHTTHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhcccHHHHHHHHHH
Confidence            46678999999999999999999988776556677889999999999999999999999998765433345679999999


Q ss_pred             ccCCCCcceeHHHHHHHHHh----CchHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          479 VDTDKDGRISYEEFAVMMKA----GTDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       479 ~D~~~dG~i~~~Ef~~~~~~----~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +|.|++|.|+.+||..++..    .+.+..+|..+|+|++|.|+.+||.+.+..
T Consensus       108 ~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~  161 (166)
T 2aao_A          108 FDKDGSGYITPDELQQACEEFGVEDVRIEELMRDVDQDNDGRIDYNEFVAMMQK  161 (166)
T ss_dssp             HCTTCSSSBCHHHHHHHTCC--------CCHHHHHCTTCSSSBCHHHHHHHHC-
T ss_pred             hCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            99999999999999999874    355888999999999999999999998865

>1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1

Probab=99.63  E-value=4.3e-16  Score=172.90  Aligned_cols=139  Identities=19%  Similarity=0.383  Sum_probs=124.4

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-ccCc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-KMAN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~~~~  432 (531)
                      ..++.++...+..+|..||.|++|.|+.+||..++..+|..++..+++.+|..+|.|++|.|+|+||+.++.... ....
T Consensus       717 ~~l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~  796 (863)
T 1sjj_A          717 KGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPNRMGVVTFQAFIDFMSRETADTDT  796 (863)
T ss_dssp             CCSSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCTTSCSEEETTHHHHTHHHHSTTCSS
T ss_pred             cCCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCC
Confidence            345677888999999999999999999999999999999999999999999999999999999999999776543 2345


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCC-----CCcceeHHHHHHHHHhCc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTD-----KDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~-----~dG~i~~~Ef~~~~~~~~  500 (531)
                      .+.+..+|+.| .|++|+|+.+||+.+|.       +++++.+|..+|.+     +||.|+|+||+.+|...+
T Consensus       797 ~~~l~~aF~~~-~d~~G~Is~~El~~~l~-------~~~~~~l~~~~d~~~~~~~~dg~I~~~eF~~~~~~~~  861 (863)
T 1sjj_A          797 ADQVMASFKIL-AGDKNYITVDELRRELP-------PDQAEYCIARMAPYNGRDAVPGALDYMSFSTALYGES  861 (863)
T ss_dssp             SHHHHHHHHGG-GTSSSEEEHHHHHHHSC-------HHHHHHHHHHSEECCSSCCCTTEEESHHHHHHHSCCS
T ss_pred             HHHHHHHHHHH-hCCCCcCcHHHHHHHCC-------HHHHHHHHHHcchhcCCCCCCCceeHHHHHHHHhcCC
Confidence            67899999999 89999999999999984       77899999999987     799999999999987654

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B*

Probab=99.63  E-value=1.3e-15  Score=132.04  Aligned_cols=129  Identities=21%  Similarity=0.282  Sum_probs=106.7

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCC-CCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDT-SGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~  476 (531)
                      +++..+|..+|.|++|.|+.+||..+ ....   ....+..+|+.+|.|++|.|+.+||..++...... ...+.+..+|
T Consensus         6 ~~l~~~F~~~D~d~~G~i~~~el~~l-~~~~---~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F   81 (155)
T 3ll8_B            6 KRLGKRFKKLDLDNSGSLSVEEFMSL-PELQ---QNPLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAF   81 (155)
T ss_dssp             HHHHHHHHHHCTTCSSSBCHHHHTTS-GGGT---TCTTHHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHH
T ss_pred             HHHHHHHHHhCcCCCCeEcHHHHHHh-hccc---cchHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHH
Confidence            45778899999999999999999433 2222   22368889999999999999999999999877543 4557799999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC-------chHHHHHhh----hCccCCCcCCHHHHHHHHhhcC
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG-------TDWRKASRQ----YSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~-------~~~~~~f~~----~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      +.+|.|++|.|+.+||..++...       ..+...|..    +|+|++|.|+.+||.+.+..++
T Consensus        82 ~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~  146 (155)
T 3ll8_B           82 RIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLD  146 (155)
T ss_dssp             HHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHHHHGGGC
T ss_pred             HHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHhccC
Confidence            99999999999999999998751       335555665    9999999999999999998764

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola}

Probab=99.63  E-value=1.9e-15  Score=138.08  Aligned_cols=132  Identities=17%  Similarity=0.157  Sum_probs=112.7

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhc--cCcHHHHHHhh-------cccCCCCCcceeHHHHHHHHh-------
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKK--MANDEHLHKAF-------SFFDRNRSGFIEIEELRNALN-------  461 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~--~~~~~~~~~~F-------~~~D~~~~G~i~~~el~~~l~-------  461 (531)
                      .++..+|..+|.|++|.|+.+||..++.....  ....+.+..+|       +.+|.|++|.|+.+||..++.       
T Consensus        36 ~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~~~~~~~~~~  115 (208)
T 2hpk_A           36 SRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEANRVFAEAER  115 (208)
T ss_dssp             CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhhhh
Confidence            45788999999999999999999998776554  56677788888       999999999999999999986       


Q ss_pred             --hcCC-CCCHHH-HHHHHHhccCCCCcceeHHHHHHHHHh----CchHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          462 --DEVD-TSGEDV-INAIMHDVDTDKDGRISYEEFAVMMKA----GTDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       462 --~~~~-~~~~~~-~~~~~~~~D~~~dG~i~~~Ef~~~~~~----~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                        .+.. ....++ +..+|+.+|.|++|.|+.+||..++..    ...+..+|..+|+|+||.|+.+||.+.+...
T Consensus       116 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~  191 (208)
T 2hpk_A          116 ERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFDVPQEAAYTFFEKADTDKSGKLERTELVHLFRKF  191 (208)
T ss_dssp             HHHHTTCCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTSCTTHHHHHHHHHCTTCCSSBCHHHHHHHHHHH
T ss_pred             hhhccCChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCcCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence              3432 222334 788999999999999999999999974    3569999999999999999999999998764

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A

Probab=99.62  E-value=4.6e-16  Score=155.46  Aligned_cols=157  Identities=20%  Similarity=0.254  Sum_probs=128.4

Q ss_pred             cccccCCCCcccHHHHHHHHHhCCCCCCH---HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCC
Q 009594          369 EMMDTNKRGKINLEELRLGLLKGGQNIPE---ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDR  445 (531)
Q Consensus       369 ~~~D~~~~g~i~~~el~~~l~~~~~~~~~---~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~  445 (531)
                      ..+|.+.+|.|...++.....   ..++.   ++++++|..+|.|++|.|+.+||..++..+......+.+..+|+.+|.
T Consensus       283 k~iD~de~g~i~~~e~~~~~~---~~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~  359 (450)
T 3sg6_A          283 KGIDFKEDGNILGHKLEYNTR---DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA  359 (450)
T ss_dssp             EEESCCTTSTTTTTCBCCC------CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCT
T ss_pred             ccCCccccccchhhhhhhhhc---ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhcc
Confidence            457888888887776532211   12333   457789999999999999999999988876666788899999999999


Q ss_pred             CCCcceeHHHHHHHHhhc-CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCC
Q 009594          446 NRSGFIEIEELRNALNDE-VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSIS  518 (531)
Q Consensus       446 ~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~  518 (531)
                      |++|.|+.+||..++... ......+.+..+|+.+|.|++|.|+.+||..++...      +.+..+|..+|.|+||.|+
T Consensus       360 DgdG~IsfeEFl~ll~~~~~~~~~~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D~DG~Is  439 (450)
T 3sg6_A          360 DGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVN  439 (450)
T ss_dssp             TSSSSEEHHHHHHHHHC------CHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTSSSSEE
T ss_pred             CCCCcccHHHHHHHHHhhccccchhhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEe
Confidence            999999999999999764 344567789999999999999999999999999843      4599999999999999999


Q ss_pred             HHHHHHHHhh
Q 009594          519 LKLMREEGLQ  528 (531)
Q Consensus       519 ~~e~~~~~~~  528 (531)
                      .+||.+.|..
T Consensus       440 fdEFv~~L~~  449 (450)
T 3sg6_A          440 YEEFVQMMTA  449 (450)
T ss_dssp             HHHHHHHHC-
T ss_pred             HHHHHHHHhc
Confidence            9999998863

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A

Probab=99.62  E-value=1.4e-15  Score=134.51  Aligned_cols=127  Identities=15%  Similarity=0.158  Sum_probs=111.9

Q ss_pred             CHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-ccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHH
Q 009594          396 PEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA  474 (531)
Q Consensus       396 ~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~  474 (531)
                      +.+++..+|..+|.|++|.|+.+||..++.... .......+..+|+.+|.|++|.|+.+||..++...      ..+..
T Consensus         5 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~~~~~------~~~~~   78 (172)
T 2znd_A            5 DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYI------TDWQN   78 (172)
T ss_dssp             -CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHHHH------HHHHH
T ss_pred             chhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHH
Confidence            557799999999999999999999998876544 34567889999999999999999999999988753      57899


Q ss_pred             HHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          475 IMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       475 ~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +|..+|.|++|.|+.+||..++...      ..+..+|+.+|+|++|.|+.+||.+.+..
T Consensus        79 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~  138 (172)
T 2znd_A           79 VFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIV  138 (172)
T ss_dssp             HHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            9999999999999999999999843      45899999999999999999999988764

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana}

Probab=99.62  E-value=3.8e-16  Score=132.09  Aligned_cols=100  Identities=18%  Similarity=0.214  Sum_probs=69.2

Q ss_pred             HHHHHHhcCCCCCCceecchhHhHHHHh-hccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC-CCCCHHHHHHHHH
Q 009594          400 LQILMEAADVDGDGSLNYGEFVAVSVHL-KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DTSGEDVINAIMH  477 (531)
Q Consensus       400 ~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~~  477 (531)
                      ++.+|..+|.|++|.|+|+||+.++... ......+.++.+|+.||.|++|+|+.+||+.++..+| ..++.++++.+|.
T Consensus         5 ~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~   84 (135)
T 3h4s_E            5 EKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVR   84 (135)
T ss_dssp             --------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHH
Confidence            4679999999999999999999876542 2223457899999999999999999999999999999 5999999999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .+|.|+||.|+|+||+.++...
T Consensus        85 ~~D~d~dG~I~~~EF~~~~~~~  106 (135)
T 3h4s_E           85 EGDLDGDGALNQTEFCVLMVRL  106 (135)
T ss_dssp             HHCSSCSSSBCHHHHHHHHHHH
T ss_pred             HhCCCCCCCCcHHHHHHHHHHh
Confidence            9999999999999999999853

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C

Probab=99.62  E-value=1e-15  Score=132.14  Aligned_cols=130  Identities=13%  Similarity=0.139  Sum_probs=110.6

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCC--CCcceeHHHHHHHHhhcCCC---CCHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRN--RSGFIEIEELRNALNDEVDT---SGEDVI  472 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~--~~G~i~~~el~~~l~~~~~~---~~~~~~  472 (531)
                      .++..+|..+|.|++|.|+++||..++...........+..+|+.+|.|  ++|.|+.+||..++......   ...+.+
T Consensus        10 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~l   89 (151)
T 1w7j_B           10 EEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDY   89 (151)
T ss_dssp             -CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CC
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCCCCcHHHH
Confidence            3477899999999999999999999887766667788899999999999  99999999999999875422   234557


Q ss_pred             HHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          473 NAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       473 ~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      ..+|+.+|.|++|.|+.+||..++...      ..+..+|+.+| |++|.|+.+||.+.+..
T Consensus        90 ~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~~  150 (151)
T 1w7j_B           90 LEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE-DSNGCINYEAFLKHILS  150 (151)
T ss_dssp             HHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CTTSEEEHHHHHHHTC-
T ss_pred             HHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc-CCCCeEeHHHHHHHHhc
Confidence            889999999999999999999999853      45899999999 99999999999998753

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C*

Probab=99.62  E-value=3.6e-15  Score=128.23  Aligned_cols=129  Identities=12%  Similarity=0.143  Sum_probs=113.5

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhccc---CCCCCcceeHHHHHHHHhhc---CCCCCHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFF---DRNRSGFIEIEELRNALNDE---VDTSGEDV  471 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~---D~~~~G~i~~~el~~~l~~~---~~~~~~~~  471 (531)
                      .++..+|..+|.|++|.|++.||..++...........+..+|+.+   |.++ |.|+.+||..++...   ......+.
T Consensus         8 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~~~~~~~~   86 (149)
T 2mys_C            8 DDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNA-AAITFEEFLPMLQAAANNKDQGTFED   86 (149)
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccCCcchHHH
Confidence            4577889999999999999999999877666666788899999999   9999 999999999999774   34455678


Q ss_pred             HHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          472 INAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       472 ~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +..+|..+|.|++|.|+.+||..++...      ..+..+|.. |.|++|.|+.+||.+.+..
T Consensus        87 ~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~~~~~~  148 (149)
T 2mys_C           87 FVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS  148 (149)
T ss_pred             HHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCcEeHHHHHHHHhc
Confidence            9999999999999999999999999743      468999999 9999999999999999875

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A

Probab=99.61  E-value=3.1e-16  Score=135.20  Aligned_cols=114  Identities=17%  Similarity=0.177  Sum_probs=91.5

Q ss_pred             CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHH
Q 009594          394 NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVIN  473 (531)
Q Consensus       394 ~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~  473 (531)
                      .++..+++.++..+|.+++    +.+|..+      ....+.++.+|+.||.|++|+|+.+||+.+|..+|..+++++++
T Consensus        20 ~~~~~~~~~i~~~~d~~~~----~~~~~~l------~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~   89 (150)
T 2jjz_A           20 ARQERRLAEINREFLCDQK----YSDEENL------PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMK   89 (150)
T ss_dssp             HHHHHHHHHHHHHHHTCGG----GSSCTTH------HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHH
T ss_pred             CCcHHHHHHHHHHhccCCC----chhhHhH------HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHH
Confidence            3567789999999987764    5555444      12356789999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCcceeHHHHHHHHHh-CchHHHHHhhhCccCCCcC
Q 009594          474 AIMHDVDTDKDGRISYEEFAVMMKA-GTDWRKASRQYSRERFNSI  517 (531)
Q Consensus       474 ~~~~~~D~~~dG~i~~~Ef~~~~~~-~~~~~~~f~~~D~~~~G~i  517 (531)
                      .+|..+|.|++|.|+|+||+.++.. ...+..+|+.||++++|.-
T Consensus        90 ~l~~~~D~d~dg~I~~~eF~~~~~~~~~~i~~aF~~~D~d~~G~~  134 (150)
T 2jjz_A           90 KMISEVTGGVSDTISYRDFVNMMLGKRSAVLKLVMMFEGKANESS  134 (150)
T ss_dssp             HHHHHHHTTSCSSBCHHHHHHHHHSSSCCHHHHHHC---------
T ss_pred             HHHHHHCCCCCCcEeHHHHHHHHHHhHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999985 5779999999999999984

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum}

Probab=99.61  E-value=2.5e-15  Score=133.96  Aligned_cols=128  Identities=19%  Similarity=0.223  Sum_probs=108.8

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      .++..+|..+|.|++|.|+++||..++....  .....+..+|+.+|.|++|.|+.+||..++..... ...+.+..+|.
T Consensus        39 ~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g--~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~F~  115 (180)
T 3mse_B           39 KYINELFYKLDTNHNGSLSHREIYTVLASVG--IKKWDINRILQALDINDRGNITYTEFMAGCYRWKN-IESTFLKAAFN  115 (180)
T ss_dssp             HHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCCSEECHHHHHHHHSCCTT-C--CHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhccc-CCHHHHHHHHH
Confidence            4578899999999999999999999876543  23578999999999999999999999999876543 23468999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC----chHHHHHhhhCccCC--------CcCCHHHHHHHHhh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG----TDWRKASRQYSRERF--------NSISLKLMREEGLQ  528 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~----~~~~~~f~~~D~~~~--------G~i~~~e~~~~~~~  528 (531)
                      .+|.|++|.|+.+||..++...    .++..+|..+|+|+|        |.|+.+||.+.|..
T Consensus       116 ~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~d~~~d~~~~~~~~G~i~~~eF~~~l~~  178 (180)
T 3mse_B          116 KIDKDEDGYISKSDIVSLVHDKVLDNNDIDNFFLSVHSIKKGIPREHIINKISFQEFKDYMLS  178 (180)
T ss_dssp             HHCTTCSSCBCHHHHHHHTTTSSCCHHHHHHHHHHHHTC---------CCCBCHHHHHHHHHT
T ss_pred             HHCCCCCCCCCHHHHHHHHcCCCCCHHHHHHHHHHhhhccCcccccccCCeeeHHHHHHHHHh
Confidence            9999999999999999999842    458999999999999        99999999998864

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A

Probab=99.61  E-value=1.2e-15  Score=137.22  Aligned_cols=132  Identities=17%  Similarity=0.231  Sum_probs=105.6

Q ss_pred             HHHHHHHHhcCCCCCCceecchhH-----hHHHHhhccCcHH-----HHHHhhcccCCCCCcceeHHHHHHHHhhcCC--
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFV-----AVSVHLKKMANDE-----HLHKAFSFFDRNRSGFIEIEELRNALNDEVD--  465 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~-----~~~~~~~~~~~~~-----~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~--  465 (531)
                      +++..+|..+|.|++|.|+++||.     .++..........     .+..+|+.+|.|++|.|+.+||..++.....  
T Consensus        16 ~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~   95 (191)
T 1uhk_A           16 GRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKKLATDE   95 (191)
T ss_dssp             HHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHHHHHHhcch
Confidence            346789999999999999999998     4443332222333     5888999999999999999999998865411  


Q ss_pred             -----CCCHHHH----HHHHHhccCCCCcceeHHHHHHHHHh------CchHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          466 -----TSGEDVI----NAIMHDVDTDKDGRISYEEFAVMMKA------GTDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       466 -----~~~~~~~----~~~~~~~D~~~dG~i~~~Ef~~~~~~------~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                           ....+.+    +.+|+.+|.|++|.|+.+||..++..      ...+..+|..+|+|+||.|+.+||.+.+.+.
T Consensus        96 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~eF~~~~~~~  174 (191)
T 1uhk_A           96 LEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHLGF  174 (191)
T ss_dssp             HHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHHHHHH
T ss_pred             hhhhhhhhHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence                 1111223    38999999999999999999999974      2458999999999999999999999998764

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A

Probab=99.60  E-value=4.2e-15  Score=131.53  Aligned_cols=130  Identities=17%  Similarity=0.233  Sum_probs=108.9

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhh----ccCcHHH-H--------HHhhcccCCCCCcceeHHHHHHHHhhcC
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLK----KMANDEH-L--------HKAFSFFDRNRSGFIEIEELRNALNDEV  464 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~----~~~~~~~-~--------~~~F~~~D~~~~G~i~~~el~~~l~~~~  464 (531)
                      .+++.+|..+|.|++|.|+.+||..++....    ....... +        ..+|+.+|  ++|.|+.+||..++....
T Consensus         6 ~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~l~~~~D--~~g~i~~~EF~~~~~~~~   83 (174)
T 1q80_A            6 QKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVA--GGKGIDETTFINSMKEMV   83 (174)
T ss_dssp             HHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSCCTTHHHHHHHHHHHHHHHTGGGTT--TTSCEEHHHHHHHHHHHT
T ss_pred             HHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHhcC--CCCeEcHHHHHHHHHHHc
Confidence            4578899999999999999999999877654    3444444 4        46899999  999999999999987664


Q ss_pred             CC-----CCHHHHHHHHHhccCCCCcceeHHHHHHHHHh----CchHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          465 DT-----SGEDVINAIMHDVDTDKDGRISYEEFAVMMKA----GTDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       465 ~~-----~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~----~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ..     ...+.+..+|+.+|.|++|.|+.+||..++..    ...+..+|+.+|+|+||.|+.+||.+.+.+.
T Consensus        84 ~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~  157 (174)
T 1q80_A           84 KNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGSDF  157 (174)
T ss_dssp             TSTTCHHHHHTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHTCCGGGHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred             CcccHHHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHcCCCHHHHHHHHHHhCCCCCceEeHHHHHHHHHHH
Confidence            31     12356899999999999999999999999974    3569999999999999999999999998753

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A

Probab=99.60  E-value=2.1e-15  Score=138.96  Aligned_cols=124  Identities=11%  Similarity=0.075  Sum_probs=109.0

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHh
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD  478 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~  478 (531)
                      ++.++|..+|.|++|.|+.+||..++.........+.+..+|+.+|.|++|.|+.+||..++..+      +.+..+|+.
T Consensus        52 ~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I~~~EF~~~~~~~------~~l~~~F~~  125 (220)
T 3sjs_A           52 RIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHISFYEFMAMYKFM------ELAYNLFVM  125 (220)
T ss_dssp             HHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHHHHHH
Confidence            35668999999999999999999887766666778899999999999999999999999998774      678999999


Q ss_pred             ccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          479 VDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       479 ~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      +|.|++|.|+.+||..++...      +.+...|+.+| |+||.|+.+||.+.+..+
T Consensus       126 ~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~l  181 (220)
T 3sjs_A          126 NARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA-RGMAFCDLNCWIAICAFA  181 (220)
T ss_dssp             HCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC---CCSEEHHHHHHHHHHH
T ss_pred             HCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHH
Confidence            999999999999999999842      45899999999 999999999999998765

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.60  E-value=1e-15  Score=158.85  Aligned_cols=133  Identities=19%  Similarity=0.371  Sum_probs=114.4

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhc----cCc-------HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCC
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKK----MAN-------DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDT  466 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~----~~~-------~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~  466 (531)
                      ++++.+|..+|.|+||.|+++||..++.....    ...       .+.+..+|+.+|.|++|.|+.+||..++......
T Consensus       335 ~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~  414 (484)
T 3nyv_A          335 KELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTL  414 (484)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhcccc
Confidence            46788999999999999999999765543321    122       5788999999999999999999999998776555


Q ss_pred             CCHHHHHHHHHhccCCCCcceeHHHHHHHHHh----CchHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          467 SGEDVINAIMHDVDTDKDGRISYEEFAVMMKA----GTDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       467 ~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~----~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      .+.+++..+|+.+|.|+||.|+.+||..++..    .+++..+|+.+|+|+||.|+.+||.+.|.++.
T Consensus       415 ~~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~~~~  482 (484)
T 3nyv_A          415 LSRERLERAFRMFDSDNSGKISSTELATIFGVSDVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKLC  482 (484)
T ss_dssp             HHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHTT
T ss_pred             CcHHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHhhh
Confidence            56778999999999999999999999999984    25689999999999999999999999998873

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A*

Probab=99.60  E-value=1.6e-15  Score=136.94  Aligned_cols=131  Identities=15%  Similarity=0.264  Sum_probs=100.8

Q ss_pred             HHHHHHHhcCCCCCCceecchhH-----hHHHHhhccCcHH-----HHHHhhcccCCCCCcceeHHHHHHHHhhcCC---
Q 009594          399 DLQILMEAADVDGDGSLNYGEFV-----AVSVHLKKMANDE-----HLHKAFSFFDRNRSGFIEIEELRNALNDEVD---  465 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~-----~~~~~~~~~~~~~-----~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~---  465 (531)
                      ++..+|..+|.|++|.|+++||.     .++..........     .+..+|+.+|.|++|.|+.+||..++.....   
T Consensus        21 ~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~  100 (195)
T 1qv0_A           21 RHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSEL  100 (195)
T ss_dssp             HHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCCCCCceEcHHHHHHHHHHHHhhhh
Confidence            46678999999999999999998     3433332222222     5888999999999999999999998865421   


Q ss_pred             ----CCCHHHHH----HHHHhccCCCCcceeHHHHHHHHHh------CchHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          466 ----TSGEDVIN----AIMHDVDTDKDGRISYEEFAVMMKA------GTDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       466 ----~~~~~~~~----~~~~~~D~~~dG~i~~~Ef~~~~~~------~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                          ....+.++    .+|+.+|.|++|.|+.+||..++..      ...+..+|..+|+|+||.|+.+||.+.+.+.
T Consensus       101 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~  178 (195)
T 1qv0_A          101 KKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLGF  178 (195)
T ss_dssp             HHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHHHHHH
T ss_pred             hcccccHHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH
Confidence                11112233    8999999999999999999999974      2459999999999999999999999998875

>2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A

Probab=99.59  E-value=7.1e-15  Score=134.31  Aligned_cols=146  Identities=15%  Similarity=0.142  Sum_probs=114.9

Q ss_pred             cccHHHHHHHHHhCCCCCCHHH---HHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHH
Q 009594          378 KINLEELRLGLLKGGQNIPEAD---LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIE  454 (531)
Q Consensus       378 ~i~~~el~~~l~~~~~~~~~~~---~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~  454 (531)
                      .++.+++..+....+  +++++   +..+|..+|.|++|.|+.+||..+. .......   ...+|+.+|.|++|.|+.+
T Consensus         8 ~l~~~~~~~l~~~~~--ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~~~---~~~l~~~~d~~~~g~i~~~   81 (208)
T 2ct9_A            8 LLRDEELEEIKKETG--FSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAINPL---GDRIINAFFSEGEDQVNFR   81 (208)
T ss_dssp             CCCHHHHHHHHHHHC--CCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTSTT---HHHHHHTTSCTTCSCEEHH
T ss_pred             CCCHHHHHHHHHcCC--CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCc---HHHHHHHHcCCCCCcCcHH
Confidence            477888877776643  34444   5667999999999999999998853 2222222   2467888999999999999


Q ss_pred             HHHHHHhhcCCC----------------CCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-------chHHHH----Hh
Q 009594          455 ELRNALNDEVDT----------------SGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-------TDWRKA----SR  507 (531)
Q Consensus       455 el~~~l~~~~~~----------------~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-------~~~~~~----f~  507 (531)
                      ||..++......                ...+.+..+|+.+|.|++|.|+.+||..++...       ..+..+    |.
T Consensus        82 EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~  161 (208)
T 2ct9_A           82 GFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQ  161 (208)
T ss_dssp             HHHHHHHTTSCCC-----------CCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhccccchhhhcccccccccccHHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHH
Confidence            999999865321                145678999999999999999999999999742       234444    99


Q ss_pred             hhCccCCCcCCHHHHHHHHhhc
Q 009594          508 QYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       508 ~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      .+|+|+||.|+.+||.+.+...
T Consensus       162 ~~D~d~dG~Is~~EF~~~~~~~  183 (208)
T 2ct9_A          162 EADQDGDSAISFTEFVKVLEKV  183 (208)
T ss_dssp             HHCSSSSSSEEHHHHHHTTTTS
T ss_pred             HhCCCCCCcCcHHHHHHHHhcc
Confidence            9999999999999999998764

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A

Probab=99.59  E-value=1.4e-16  Score=129.20  Aligned_cols=103  Identities=23%  Similarity=0.368  Sum_probs=92.2

Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCCC
Q 009594          391 GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDTS  467 (531)
Q Consensus       391 ~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~  467 (531)
                      ++..+++++++.+|..+|  ++|.|+|+||+.++..  .....+.++.+|+.||.|++|+|+.+||+.++..+   |..+
T Consensus         2 l~~~~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~   77 (108)
T 2kyc_A            2 LTDILSPSDIAAALRDCQ--APDSFSPKKFFQISGM--SKKSSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVL   77 (108)
T ss_dssp             TTSSSCHHHHHHHHTTSC--STTTCCHHHHHHHHTC--TTCCSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCC
T ss_pred             ccccCCHHHHHHHHHHcC--CCCcCCHHHHHHHHhh--CcccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCC
Confidence            577889999999999998  8899999999987742  23345678999999999999999999999999998   7788


Q ss_pred             CHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          468 GEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       468 ~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ++++++.++..+|.|++|.|+|+||+.+++
T Consensus        78 ~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~  107 (108)
T 2kyc_A           78 TASETKTFLAAADHDGDGKIGAEEFQEMVQ  107 (108)
T ss_dssp             CTTTTHHHHTTTCCSSSSCCCSSHHHHHHH
T ss_pred             CHHHHHHHHHHhCCCCCCcCCHHHHHHHHh
Confidence            899999999999999999999999999875

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus}

Probab=99.59  E-value=5.7e-15  Score=126.14  Aligned_cols=129  Identities=16%  Similarity=0.174  Sum_probs=112.1

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~  476 (531)
                      +++..+|..+|.|++|.|+..||..++...........+..+|..    ++|.|+.+||..++... ......+.+..+|
T Consensus         7 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~----~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F   82 (143)
T 3j04_B            7 QEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE----APGPINFTMFLTMFGEKLNGTDPEDVIRNAF   82 (143)
T ss_dssp             HHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT----SSSCCCHHHHHHHHHHTTTSSCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh----CCCCcCHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            356778999999999999999999988776666677778877776    89999999999999854 4455678899999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      ..+|.|++|.|+.+||..++...      ..+..+|..+|+|+||.|+.+||.+.+..-+
T Consensus        83 ~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~  142 (143)
T 3j04_B           83 ACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRILKHGA  142 (143)
T ss_dssp             TTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCCSSSCCCSTHHHHHHHSSC
T ss_pred             HHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHhccC
Confidence            99999999999999999999843      4599999999999999999999999998643

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5

Probab=99.58  E-value=8.7e-15  Score=124.51  Aligned_cols=127  Identities=10%  Similarity=0.074  Sum_probs=109.2

Q ss_pred             HHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCC---CCHHHHH
Q 009594          397 EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDT---SGEDVIN  473 (531)
Q Consensus       397 ~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~---~~~~~~~  473 (531)
                      .++++.+|..+|.|++|.|+.+||..++.........+.+..+|.    +++|.|+.+||..++......   ...+.+.
T Consensus         4 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~   79 (140)
T 1ggw_A            4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES----TLPAEVDMEQFLQVLNRPNGFDMPGDPEEFV   79 (140)
T ss_dssp             CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT----TSCSSEEHHHHHHHHCTTSSSSSSCCHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh----CCCCcCcHHHHHHHHHHHhcccCcccHHHHH
Confidence            346788999999999999999999998876655566777888877    899999999999999876432   2347899


Q ss_pred             HHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          474 AIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       474 ~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|..+|.|++|.|+.+||..++...      ..+..+|+.+|+ ++|.|+.+||.+.+..
T Consensus        80 ~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~-~dg~i~~~eF~~~~~~  139 (140)
T 1ggw_A           80 KGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV-KDGMVNYHDFVQMILA  139 (140)
T ss_dssp             HHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC-SSCCSTTTHHHHHHHC
T ss_pred             HHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC-CCCcEeHHHHHHHHhc
Confidence            99999999999999999999999742      458999999999 9999999999998864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.57  E-value=2.9e-15  Score=155.44  Aligned_cols=132  Identities=17%  Similarity=0.241  Sum_probs=103.7

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhc--------------cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKK--------------MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE  463 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~--------------~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~  463 (531)
                      +++..+|..+|.|+||.|+++||...+.....              ....+.+..+|+.+|.|+||.|+.+||..++...
T Consensus       331 ~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~~~  410 (486)
T 3mwu_A          331 KQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDR  410 (486)
T ss_dssp             HHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHSCT
T ss_pred             HHHHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHHhh
Confidence            56788999999999999999999765443211              1236789999999999999999999999998777


Q ss_pred             CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          464 VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       464 ~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ....+.+.+..+|+.+|.|+||.|+.+||..++...      +++..+|+.+|+|+||.|+.+||.+.+.++
T Consensus       411 ~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~  482 (486)
T 3mwu_A          411 TILLSRERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQNF  482 (486)
T ss_dssp             TTTCCHHHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCSSCSSSBCHHHHHHHHHHH
T ss_pred             hccchHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh
Confidence            666788899999999999999999999999998743      568999999999999999999999999865

>3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C

Probab=99.57  E-value=2.8e-14  Score=124.12  Aligned_cols=129  Identities=12%  Similarity=0.133  Sum_probs=109.2

Q ss_pred             HHHHHHHhcCC--CCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCC---CCCHHHHH
Q 009594          399 DLQILMEAADV--DGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD---TSGEDVIN  473 (531)
Q Consensus       399 ~~~~~f~~~D~--~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~---~~~~~~~~  473 (531)
                      ++++.|..+|.  |++|.|+..|+..++..+...+++..+..++. .|.+++|.|+.+||..++.....   ....+++.
T Consensus        10 elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~-~d~~~~g~i~f~eFl~~~~~~~~~~~~~~~~~l~   88 (159)
T 3i5g_C           10 EVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGG-TKKMGEKAYKLEEILPIYEEMSSKDTGTAADEFM   88 (159)
T ss_dssp             HHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTC-CSSTTSCEECHHHHHHHHHHHTTCCTTCCHHHHH
T ss_pred             HHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHc-ccccCCCcccHHHHHHHHHHhhcccccchHHHHH
Confidence            45667999984  89999999999998877666677788887765 47889999999999999876532   34577899


Q ss_pred             HHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhC--ccCCCcCCHHHHHHHHhh
Q 009594          474 AIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYS--RERFNSISLKLMREEGLQ  528 (531)
Q Consensus       474 ~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D--~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|+.+|.|++|.|+.+||.+++...      .++..+++.+|  .|+||.|+.+||.+.|..
T Consensus        89 ~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m~~  151 (159)
T 3i5g_C           89 EAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKVMA  151 (159)
T ss_dssp             HHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHHHC
Confidence            99999999999999999999999853      45899999998  489999999999998875

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group}

Probab=99.56  E-value=2e-14  Score=127.66  Aligned_cols=146  Identities=17%  Similarity=0.171  Sum_probs=114.5

Q ss_pred             ccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccC---CCCCcceeHHH
Q 009594          379 INLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFD---RNRSGFIEIEE  455 (531)
Q Consensus       379 i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D---~~~~G~i~~~e  455 (531)
                      ++.+++..+-+.... ....+++..|..+|  ++|.|+.+||...+   ........+..+|+.+|   .+++|.|+.+|
T Consensus        10 ~~~~~l~~~~~~~~~-~~~~~~~~~F~~~D--~dG~I~~~el~~~l---g~~~~~~~~~~i~~~~d~~~~~~~~~i~~~e   83 (179)
T 3a8r_A           10 VALKGLQFVTAKVGN-DGWAAVEKRFNQLQ--VDGVLLRSRFGKCI---GMDGSDEFAVQMFDSLARKRGIVKQVLTKDE   83 (179)
T ss_dssp             HHHHHHHHHHHHHCC-CCHHHHHHHHHHHC--BTTBEEGGGHHHHH---TCCSCHHHHHHHHHHHHHHHTCCSSEECHHH
T ss_pred             hhHHHHHHHHhccch-hhHHHHHHHHhccC--CCCCCcHHHHHHHH---CCCCcHHHHHHHHHHHHHhccCCCCCcCHHH
Confidence            356666554444322 34577888999999  79999999998854   22345566778888887   56789999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH-h-------------CchHHHHHhhhCccCCCcCCHHH
Q 009594          456 LRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK-A-------------GTDWRKASRQYSRERFNSISLKL  521 (531)
Q Consensus       456 l~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~-~-------------~~~~~~~f~~~D~~~~G~i~~~e  521 (531)
                      |..++..+......+.+..+|+.+|.|+||.|+.+||..+++ .             ...+..+|..+|+|+||.|+.+|
T Consensus        84 f~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~E  163 (179)
T 3a8r_A           84 LKDFYEQLTDQGFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIEMED  163 (179)
T ss_dssp             HHHHHHHHHCCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEECHHH
T ss_pred             HHHHHHHHcCCCHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCCCCCcCcHHH
Confidence            999987665444567899999999999999999999999887 2             23588999999999999999999


Q ss_pred             HHHHHhhcC
Q 009594          522 MREEGLQLA  530 (531)
Q Consensus       522 ~~~~~~~~~  530 (531)
                      |.+++...+
T Consensus       164 F~~~~~~~p  172 (179)
T 3a8r_A          164 LEALLLQSP  172 (179)
T ss_dssp             HHHHHC---
T ss_pred             HHHHHHhCc
Confidence            999998764

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B

Probab=99.56  E-value=2.8e-14  Score=125.22  Aligned_cols=128  Identities=15%  Similarity=0.205  Sum_probs=110.3

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhc-cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKK-MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAI  475 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~  475 (531)
                      .++..+|..+|.|++|.|+.+||..++..... ......+..+|+..    +|.|+.+||..++... ....+.+.+..+
T Consensus        25 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~----dg~i~~~eF~~~~~~~~~~~~~~~~l~~~  100 (166)
T 2mys_B           25 EDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA----SGPINFTVFLTMFGEKLKGADPEDVIMGA  100 (166)
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC----CCCcCHHHHHHHHHHHhccCCcHHHHHHH
Confidence            34677899999999999999999998877665 56777788888754    7999999999998764 344467789999


Q ss_pred             HHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          476 MHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       476 ~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      |..+|.|++|.|+.+||..++...      ..+..+|..+|+|+||.|+.+||.+.+...
T Consensus       101 F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~~~~~~~  160 (166)
T 2mys_B          101 FKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHG  160 (166)
T ss_pred             HHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHHhc
Confidence            999999999999999999999743      458999999999999999999999998765

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi}

Probab=99.55  E-value=3.3e-16  Score=144.40  Aligned_cols=154  Identities=14%  Similarity=0.096  Sum_probs=113.8

Q ss_pred             ccCCCCcccHHHHHHHHHhCCCCCCHH---HHHHHHHhcCCCCCCceecchhHhHHHH-hhccCcH----HHHHHhhccc
Q 009594          372 DTNKRGKINLEELRLGLLKGGQNIPEA---DLQILMEAADVDGDGSLNYGEFVAVSVH-LKKMAND----EHLHKAFSFF  443 (531)
Q Consensus       372 D~~~~g~i~~~el~~~l~~~~~~~~~~---~~~~~f~~~D~~~~g~i~~~ef~~~~~~-~~~~~~~----~~~~~~F~~~  443 (531)
                      ++++++.++.+++...+.   ..++.+   ++..+|..+|.|++|.|+++||..++.. +......    ..+..+|..+
T Consensus        22 ~~~~~~~~~~~~l~~~~~---~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~   98 (219)
T 3cs1_A           22 KKAKDRKEAWERIRQAIP---REKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKS   98 (219)
T ss_dssp             CCHHHHHHHHHHHHHHSC---CSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHH
T ss_pred             hhHHhHHHHHHHHHHHhc---ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHH
Confidence            344556677776655543   344544   4667899999999999999999886654 2222222    2233344332


Q ss_pred             -----CCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh-------CchHHHHHhhhCc
Q 009594          444 -----DRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA-------GTDWRKASRQYSR  511 (531)
Q Consensus       444 -----D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~-------~~~~~~~f~~~D~  511 (531)
                           |.|++|.|+.+||..++..+....+.+.+..+|+.+|.|++|.|+.+||..++..       ..++..+|..+|+
T Consensus        99 ~~~~~~~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~  178 (219)
T 3cs1_A           99 RTLGSKLENKGSEDFVEFLEFRLMLCYIYDFFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDK  178 (219)
T ss_dssp             HHHHHHHHTSCCCSSBCHHHHHHHHHHHHHHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCT
T ss_pred             HhhhhccCCCCcCCHHHHHHHHHHHhccchHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCC
Confidence                 3489999999999998754432224567999999999999999999999999852       2468999999999


Q ss_pred             cCCCcCCHHHHHHHHhh
Q 009594          512 ERFNSISLKLMREEGLQ  528 (531)
Q Consensus       512 ~~~G~i~~~e~~~~~~~  528 (531)
                      |+||.|+.+||.+.+..
T Consensus       179 d~dG~I~~~EF~~~~~~  195 (219)
T 3cs1_A          179 NGTGSVTFDEFAAWASA  195 (219)
T ss_dssp             TSSSEEEHHHHHHHHHH
T ss_pred             CCCCcEeHHHHHHHHHH
Confidence            99999999999999875

>2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei}

Probab=99.55  E-value=7.7e-16  Score=142.61  Aligned_cols=138  Identities=12%  Similarity=0.067  Sum_probs=106.4

Q ss_pred             CCCCCCHH---HHHHHHHhcCCCCCCceecchhHhHHHHh-hccC----cHHHHHHhhccc-----CCCCCcceeHHHHH
Q 009594          391 GGQNIPEA---DLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMA----NDEHLHKAFSFF-----DRNRSGFIEIEELR  457 (531)
Q Consensus       391 ~~~~~~~~---~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~----~~~~~~~~F~~~-----D~~~~G~i~~~el~  457 (531)
                      +...++.+   ++..+|..+|.|++|.|+++||...+... ....    ....+..+|..+     |.|++|.|+.+||.
T Consensus        41 l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~~EF~  120 (226)
T 2lvv_A           41 IPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDLVEFL  120 (226)
T ss_dssp             SCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSCBCHH
T ss_pred             hchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCHHHHH
Confidence            34445554   46678999999999999999999844332 2112    234445556655     99999999999999


Q ss_pred             HHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          458 NALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       458 ~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .++.........+.+..+|+.+|.|++|.|+.+||..++...       .++..+|..+|+|+||.|+.+||.+.|..
T Consensus       121 ~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~e~~~~~~~~D~d~dG~Is~~EF~~~~~~  198 (226)
T 2lvv_A          121 EFRLMLCYIYDIFELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDITDATTVFNEIDTNGSGVVTFDEFSCWAVT  198 (226)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCCSCHHHHHHHCCSCSSCEEHHHHHHHHHH
T ss_pred             HHHHHHHhccCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            964332211234679999999999999999999999998742       45999999999999999999999999865

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ...

Probab=99.55  E-value=6e-14  Score=121.72  Aligned_cols=126  Identities=15%  Similarity=0.209  Sum_probs=109.3

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIMH  477 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~  477 (531)
                      ++..+|..+|.|++|.|+.+||..++...........+..+|+    +++|.|+.+||..++... ....+.+.+..+|.
T Consensus        19 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~   94 (156)
T 1wdc_B           19 EMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGTDSEETIRNAFA   94 (156)
T ss_dssp             HHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSCCCHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHH----hCCCcCcHHHHHHHHHHHhcCCChHHHHHHHHH
Confidence            4677899999999999999999998877665667777888775    579999999999999754 44456788999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      .+|.|++|.|+.+||..++...      ..+..+|+.+|.| +|.|+.+||.+.+...
T Consensus        95 ~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~-dg~i~~~eF~~~~~~~  151 (156)
T 1wdc_B           95 MFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGS  151 (156)
T ss_dssp             TTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTS
T ss_pred             HHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCC-CCEEeHHHHHHHHhcC
Confidence            9999999999999999999843      4599999999999 9999999999998764

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens}

Probab=99.55  E-value=2.9e-14  Score=125.86  Aligned_cols=122  Identities=13%  Similarity=0.181  Sum_probs=105.3

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh----hccCcHHHHH
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLH  437 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~----~~~~~~~~~~  437 (531)
                      ..++.+|..+|.|++|.|+.+||..++...      .+++..|+.+| |++|.|+.+||..++...    ....+.+.+.
T Consensus        46 ~~~~~l~~~~D~d~~G~I~f~EF~~~~~~~------~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~  118 (174)
T 2i7a_A           46 DECRSLVALMELKVNGRLDQEEFARLWKRL------VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLH  118 (174)
T ss_dssp             HHHHHHHHHHCSSCSSEECHHHHHHHHHHH------HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHH
Confidence            356778889999999999999998887653      57899999999 999999999999987765    4445678899


Q ss_pred             HhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCc-ceeHHHHHHHHH
Q 009594          438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDG-RISYEEFAVMMK  497 (531)
Q Consensus       438 ~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG-~i~~~Ef~~~~~  497 (531)
                      .+++.+| |++|.|+.+||..++...      +.+..+|+.+|+|++| .++++||+.++.
T Consensus       119 ~l~~~~d-d~dG~I~~~EF~~~~~~~------~~~~~~F~~~D~d~~GI~~~~~Ef~~~~~  172 (174)
T 2i7a_A          119 LVTLRYS-DSVGRVSFPSLVCFLMRL------EAMAKTFRNLSKDGKGLYLTEMEWMSLVM  172 (174)
T ss_dssp             HHHHHHS-CTTSEECHHHHHHHHHHH------HHHHHHHHHHCSSSSCCCCCHHHHHHHHH
T ss_pred             HHHHHHc-CCCCeEcHHHHHHHHHHH------HHHHHHHHHhCCCCCCceecHHHHHHHHH
Confidence            9999999 999999999999998764      5688999999999999 348999998764

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A

Probab=99.54  E-value=8.3e-15  Score=128.54  Aligned_cols=118  Identities=13%  Similarity=0.133  Sum_probs=95.5

Q ss_pred             HHHhcCCCCCCceecchhHhHHHHhhc-----cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          403 LMEAADVDGDGSLNYGEFVAVSVHLKK-----MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       403 ~f~~~D~~~~g~i~~~ef~~~~~~~~~-----~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      -|..+|.|++|.|+.+||..++..+..     ....+.+..+|+.+|.|++|.|+.+||..++...      +.+..+|.
T Consensus         4 ~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F~   77 (165)
T 1k94_A            4 TYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENFM   77 (165)
T ss_dssp             HHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHHH
T ss_pred             HHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHHHHH
Confidence            377888889999999998887765443     3567788888999999999999999998887653      57888899


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|.|++|.|+.+||..++...      ..+..+|..+  |++|.|+.+||.+.+..
T Consensus        78 ~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~  132 (165)
T 1k94_A           78 TVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIFFDDYVACCVK  132 (165)
T ss_dssp             HHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH--CBTTBCBHHHHHHHHHH
T ss_pred             HhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHH
Confidence            9999999999999998888743      3577888877  88899999999888764

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8

Probab=99.54  E-value=1.1e-14  Score=128.09  Aligned_cols=118  Identities=15%  Similarity=0.152  Sum_probs=100.5

Q ss_pred             HHHhcCCCCCCceecchhHhHHHHhhc-----cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          403 LMEAADVDGDGSLNYGEFVAVSVHLKK-----MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       403 ~f~~~D~~~~g~i~~~ef~~~~~~~~~-----~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      .|..+|.|++|.|+.+||..++..+..     ....+.+..+|+.+|.|++|.|+.+||..++...      +.+..+|.
T Consensus         6 ~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F~   79 (167)
T 1gjy_A            6 GYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL------NGWRQHFI   79 (167)
T ss_dssp             HHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHH------HHHHHHHH
T ss_pred             HHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHHHH
Confidence            478889999999999999988776543     4567889999999999999999999999988764      57888999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|.|++|.|+.+||..++...      ..+..+|..+  |++|.|+.+||.+.+..
T Consensus        80 ~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~  134 (167)
T 1gjy_A           80 SFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY--STSGKITFDDYIACCVK  134 (167)
T ss_dssp             HHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT--CBTTBEEHHHHHHHHHH
T ss_pred             HhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh--CcCCcCcHHHHHHHHHH
Confidence            9999999999999999998843      4588888888  89999999999988764

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A

Probab=99.54  E-value=7.5e-15  Score=129.94  Aligned_cols=123  Identities=15%  Similarity=0.217  Sum_probs=108.7

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHh-h-------ccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHL-K-------KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGE  469 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~-------~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~  469 (531)
                      ++++.+|..+| |++|.|+.+||..++... .       .....+.+..+|+.+|.|++|.|+.+||..++...      
T Consensus         4 ~~l~~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------   76 (173)
T 1alv_A            4 RQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNI------   76 (173)
T ss_dssp             HHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------
T ss_pred             hHHHHHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHHH------
Confidence            56889999999 999999999999987765 2       34567889999999999999999999999998753      


Q ss_pred             HHHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          470 DVINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       470 ~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +.+..+|..+|.|++|.|+.+||..++...      ..+..+|+.+| |++|.|+.+||.+.+..
T Consensus        77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~~~  140 (173)
T 1alv_A           77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCLVR  140 (173)
T ss_dssp             HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHH
Confidence            578999999999999999999999999742      45889999999 99999999999998864

>2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B

Probab=99.53  E-value=1.3e-14  Score=156.07  Aligned_cols=131  Identities=13%  Similarity=0.219  Sum_probs=99.9

Q ss_pred             HhhHHHHhc--ccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCC-------CCCCceecchhHhHHHHhhccC
Q 009594          361 VAGLKEAFE--MMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADV-------DGDGSLNYGEFVAVSVHLKKMA  431 (531)
Q Consensus       361 ~~~i~~~F~--~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~-------~~~g~i~~~ef~~~~~~~~~~~  431 (531)
                      ...+++.|.  .||+|++|.|+.+|+..+|..     ..++++.+++.+|.       +++|.|+|+||+.++..+.   
T Consensus       145 ~~~Lk~~F~~~~fD~d~dG~Is~~EL~~~l~~-----~~~ev~~li~~~d~~~~~~D~d~~g~idf~EF~~~~~~l~---  216 (799)
T 2zkm_X          145 STFLDKILVKLKMQLNSEGKIPVKNFFQMFPA-----DRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLC---  216 (799)
T ss_dssp             HHHHHHHHHHHHHSCCTTSCEEHHHHHHHSCS-----CHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHS---
T ss_pred             HHHHHHHhHHhccCCCCCCeECHHHHHHHHhh-----hHHHHHHHHHHhCcCccccccCCCCcCCHHHHHHHHHHcc---
Confidence            346889999  799999999999999998865     46889999999985       7889999999999886543   


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCC---------CCHHHHHHHHHhccCC----CCcceeHHHHHHHHH
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDT---------SGEDVINAIMHDVDTD----KDGRISYEEFAVMMK  497 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~---------~~~~~~~~~~~~~D~~----~dG~i~~~Ef~~~~~  497 (531)
                      ..++++.+|+.||.+++|+||.+||+.+|..+ |+.         ++++++++||+.+|.|    ++|.|+|+||+.+|.
T Consensus       217 ~r~el~~aF~~fD~d~~g~Is~~eL~~fL~~~Qge~~~~~~~~~~~t~ee~~~iI~~~d~d~~~~~dg~is~eeF~~~L~  296 (799)
T 2zkm_X          217 PRPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFLC  296 (799)
T ss_dssp             CCHHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHHHH
T ss_pred             CHHHHHHHHHHhccCCCCeEcHHHHHHHHHHhcCCcccccccccCCCHHHHHHHHHHhhcccccccCCccchhhhhhccc
Confidence            34779999999999999999999999999987 665         6788999999999999    899999999999998


Q ss_pred             hC
Q 009594          498 AG  499 (531)
Q Consensus       498 ~~  499 (531)
                      ..
T Consensus       297 S~  298 (799)
T 2zkm_X          297 GP  298 (799)
T ss_dssp             ST
T ss_pred             Cc
Confidence            54

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia}

Probab=99.52  E-value=4.8e-14  Score=127.47  Aligned_cols=128  Identities=15%  Similarity=0.111  Sum_probs=112.5

Q ss_pred             HHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHH
Q 009594          397 EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAI  475 (531)
Q Consensus       397 ~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~  475 (531)
                      ..++..+|..+|.|++|.|+..||..++..+........+..+|..+    +|.|+.+||..++... ......+.+..+
T Consensus        56 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~----~g~i~~~eF~~~~~~~~~~~~~~~~l~~~  131 (196)
T 3dtp_E           56 VQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA----PGPINFTMFLTIFGDRIAGTDEEDVIVNA  131 (196)
T ss_dssp             HHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS----SSCCBHHHHHHHHHHCCCSSCCHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc----cCCCcHHHHHHHHHHHhcCCCcHHHHHHH
Confidence            35678899999999999999999999887766667788888888887    8999999999999764 445567889999


Q ss_pred             HHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          476 MHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       476 ~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      |..+|.|++|.|+.+||..++ ..      ..+..+|..+|.|+||.|+.+||.+.|...
T Consensus       132 F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~l~~~  190 (196)
T 3dtp_E          132 FNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQILTKG  190 (196)
T ss_dssp             HHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSCEETTEECHHHHHHHHHSSC
T ss_pred             HHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcCCCCCCEEeHHHHHHHHHcC
Confidence            999999999999999999999 54      458999999999999999999999998764

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A

Probab=99.52  E-value=5.1e-15  Score=132.62  Aligned_cols=130  Identities=18%  Similarity=0.188  Sum_probs=101.3

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHh------hccCcHHHHHHh---------hcccCCCCCcceeHHHHHHHHhh
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHL------KKMANDEHLHKA---------FSFFDRNRSGFIEIEELRNALND  462 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~------~~~~~~~~~~~~---------F~~~D~~~~G~i~~~el~~~l~~  462 (531)
                      .+++.+|..+|.|++|.|+++||..++...      ......+.+..+         |+.+|.|++|.|+.+|  .++..
T Consensus        14 ~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I~~~E--~~~~~   91 (186)
T 2hps_A           14 RKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLRVADQLGLAPGVRISVEEAAVNAT--DSLLK   91 (186)
T ss_dssp             HHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCTTCEEEHHHHHHHHH--HHHHH
T ss_pred             HHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHhcCCCCCCcccHHH--HHHHH
Confidence            457789999999999999999999887644      222334445544         8999999999999999  66665


Q ss_pred             cCCCCC-HHHHHHHH--HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          463 EVDTSG-EDVINAIM--HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       463 ~~~~~~-~~~~~~~~--~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      .+...+ .+++...|  ..+|.|++|.|+++||..++...      ..+..+|+.+|+|+||.|+.+||.+.+..+
T Consensus        92 ~~~~~~~~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~ef~~~~~~~  167 (186)
T 2hps_A           92 MKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRDEFLVTVNDF  167 (186)
T ss_dssp             CCTHHHHHTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred             hcCChHHHHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence            543211 12333333  66699999999999999999743      459999999999999999999999998765

>2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A

Probab=99.52  E-value=3.3e-14  Score=130.33  Aligned_cols=147  Identities=12%  Similarity=0.104  Sum_probs=112.0

Q ss_pred             CcccHHHHHHHHHhCCCCCCHHHHHHH---HHhcCC-----CC-C--CceecchhHhHHHHhhccCcHHHHHHhhcccCC
Q 009594          377 GKINLEELRLGLLKGGQNIPEADLQIL---MEAADV-----DG-D--GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDR  445 (531)
Q Consensus       377 g~i~~~el~~~l~~~~~~~~~~~~~~~---f~~~D~-----~~-~--g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~  445 (531)
                      ..++.+++..+...  ..++.+++..+   |..+|.     |+ +  |.|+.+||.. +........   ...+|+.+|.
T Consensus        29 s~l~~e~l~~l~~~--t~~s~~ei~~l~~~F~~~D~~~~~~d~~~~dG~I~~~E~~~-l~~lg~~~~---~~~lf~~~D~  102 (214)
T 2l4h_A           29 SRLSKELLAEYQDL--TFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPF---KERICRVFST  102 (214)
T ss_dssp             --CCHHHHHHHHSC--CSCCHHHHHHHHHHHHHHSCGGGCCHHHHTTSEECHHHHTT-CHHHHTSTT---HHHHHHHHCC
T ss_pred             CCCCHHHHHHHHHh--CCCCHHHHHHHHHHHHHhCcccccccccccCCcCCHHHHHH-hhccCCChH---HHHHHHHhCc
Confidence            34677777554433  35677777665   555676     55 6  9999999988 443333333   3467899999


Q ss_pred             CCCcc-eeHHHHHHHHhhcCCCC-CHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-----------chHH----HHHhh
Q 009594          446 NRSGF-IEIEELRNALNDEVDTS-GEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-----------TDWR----KASRQ  508 (531)
Q Consensus       446 ~~~G~-i~~~el~~~l~~~~~~~-~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----------~~~~----~~f~~  508 (531)
                      |++|. |+.+||..++....... ..+.+..+|+.+|.|++|.|+.+||..++...           .++.    .+|..
T Consensus       103 d~dG~~I~f~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~  182 (214)
T 2l4h_A          103 SPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEE  182 (214)
T ss_dssp             SSSCCSEEHHHHHHHHHHTSSCSCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHH
T ss_pred             CCCCCEecHHHHHHHHHHHcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHH
Confidence            99999 99999999998765443 35689999999999999999999999988631           2233    48999


Q ss_pred             hCccCCCcCCHHHHHHHHhhc
Q 009594          509 YSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       509 ~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      +|+|+||.|+.+||.+.+...
T Consensus       183 ~D~d~dG~Is~~EF~~~~~~~  203 (214)
T 2l4h_A          183 SDIDRDGTINLSEFQHVISRS  203 (214)
T ss_dssp             HCCSCCSSBCSHHHHHHHHTC
T ss_pred             hCCCCCCcCCHHHHHHHHHhC
Confidence            999999999999999998764

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A

Probab=99.51  E-value=2.1e-14  Score=130.03  Aligned_cols=123  Identities=18%  Similarity=0.165  Sum_probs=104.9

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhc-----cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKK-----MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVI  472 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~-----~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~  472 (531)
                      ++++. |..+|.|++|.|+.+||..++..+..     ....+.+..+|+.+|.|++|.|+.+||..++...      +.+
T Consensus        33 ~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~------~~~  105 (198)
T 1juo_A           33 DPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL------NGW  105 (198)
T ss_dssp             CTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH------HHH
T ss_pred             HHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHHH------HHH
Confidence            55778 99999999999999999988776542     3567889999999999999999999999988764      578


Q ss_pred             HHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          473 NAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       473 ~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ..+|+.+|.|++|.|+.+||..++...      ..+..+|..+  |+||.|+.+||.+.+..+
T Consensus       106 ~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~--d~dg~i~~~eF~~~~~~~  166 (198)
T 1juo_A          106 RQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY--STNGKITFDDYIACCVKL  166 (198)
T ss_dssp             HHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT--CSSSSEEHHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHH
Confidence            899999999999999999999998743      4588888888  899999999999987653

>3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B

Probab=99.48  E-value=1.6e-13  Score=118.40  Aligned_cols=130  Identities=14%  Similarity=0.238  Sum_probs=107.8

Q ss_pred             CCCHH---HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC-CCCCH
Q 009594          394 NIPEA---DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DTSGE  469 (531)
Q Consensus       394 ~~~~~---~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~  469 (531)
                      .++++   ++++.|..+|.|++|.|+..||..++..+........+..++    .+++|.|+..||..++.... ...+.
T Consensus         9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~----~~~~~~i~f~ef~~~~~~~~~~~~~~   84 (153)
T 3i5g_B            9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAML----KECPGQLNFTAFLTLFGEKVSGTDPE   84 (153)
T ss_dssp             TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHH----HTSSSCCCSHHHHHTTTTTTTTCCCH
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHH----HhccCCccHHHHHHHHHhhhcccccH
Confidence            34554   456679999999999999999999888776667776666554    46678899999999886553 34467


Q ss_pred             HHHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          470 DVINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       470 ~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +++..+|+.+|.|++|.|+.+|+..++...      +++..+++.+|.+ ||.|+.+||.++|+.
T Consensus        85 ~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~-dG~I~y~EF~~~m~~  148 (153)
T 3i5g_B           85 DALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLK-NKQFNYNKMVDIKGK  148 (153)
T ss_dssp             HHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEE-TTEECHHHHHHHHHC
T ss_pred             HHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCC-cCEEcHHHHHHHhcC
Confidence            889999999999999999999999999853      4599999999988 999999999999875

>3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C

Probab=99.48  E-value=1.7e-14  Score=123.03  Aligned_cols=95  Identities=21%  Similarity=0.261  Sum_probs=51.0

Q ss_pred             HHHHhcCCCCCCceecchhHhHHHHhhc-----cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC--------CCCC
Q 009594          402 ILMEAADVDGDGSLNYGEFVAVSVHLKK-----MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV--------DTSG  468 (531)
Q Consensus       402 ~~f~~~D~~~~g~i~~~ef~~~~~~~~~-----~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~--------~~~~  468 (531)
                      .+|..+|.|++|.|+++||..++.....     ....+.++.+|+.||.|++|+|+.+||+.++..++        ..++
T Consensus        31 ~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s  110 (143)
T 3a4u_B           31 SQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMS  110 (143)
T ss_dssp             --------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CC
T ss_pred             HHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCC
Confidence            4677778888888888888765543311     13456788999999999999999999999998874        4677


Q ss_pred             HHHHHHHH----HhccCCCCcceeHHHHHHHH
Q 009594          469 EDVINAIM----HDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       469 ~~~~~~~~----~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      .+++..++    ..+|.|+||.|+++||+.++
T Consensus       111 ~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~  142 (143)
T 3a4u_B          111 EDELINIIDGVLRDDDKNNDGYIDYAEFAKSL  142 (143)
T ss_dssp             HHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence            77775555    88899999999999998765

>1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A*

Probab=99.46  E-value=1.7e-13  Score=122.34  Aligned_cols=126  Identities=12%  Similarity=0.107  Sum_probs=101.8

Q ss_pred             HHHHHHhcCC-----CC-C--CceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcc-eeHHHHHHHHhhcCCCC-CH
Q 009594          400 LQILMEAADV-----DG-D--GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGF-IEIEELRNALNDEVDTS-GE  469 (531)
Q Consensus       400 ~~~~f~~~D~-----~~-~--g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~-i~~~el~~~l~~~~~~~-~~  469 (531)
                      +..+|..+|.     |+ +  |.|+..||.. +........   ...+|+.+|.|++|. |+.+||..++....... ..
T Consensus        22 l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~~g~~~~---~~~l~~~~D~d~~G~~I~~~EF~~~~~~~~~~~~~~   97 (183)
T 1dgu_A           22 AHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPF---KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPD   97 (183)
T ss_dssp             HHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STTSSSCTT---HHHHHHHHSCSSSSCCCCHHHHHHHHHHHSTTCCHH
T ss_pred             HHHHHHHhCccccccccccccCcCcHHHHHH-HHhhhcCcH---HHHHHHHhCCCCCCCEecHHHHHHHHHHhcCCCCHH
Confidence            4567888898     68 8  9999999988 443322222   346788899999999 99999999998765433 35


Q ss_pred             HHHHHHHHhccCCCCcceeHHHHHHHHHhC-----------chHH----HHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          470 DVINAIMHDVDTDKDGRISYEEFAVMMKAG-----------TDWR----KASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       470 ~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----------~~~~----~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      +.+..+|..+|.|++|.|+.+||..++...           ..+.    .+|..+|+|+||.|+.+||.+.+...
T Consensus        98 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~  172 (183)
T 1dgu_A           98 IKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISRS  172 (183)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEEEHHHHHHHHCSS
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhC
Confidence            689999999999999999999999988632           1233    38999999999999999999998764

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A

Probab=99.45  E-value=2.2e-13  Score=116.61  Aligned_cols=123  Identities=13%  Similarity=0.121  Sum_probs=108.1

Q ss_pred             HHHHHHHhcCCCC-CCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHH
Q 009594          399 DLQILMEAADVDG-DGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIM  476 (531)
Q Consensus       399 ~~~~~f~~~D~~~-~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~  476 (531)
                      +++.+|..+|.|+ +|.|+..||..++...........+..+|+.+|.+    |+.+||..++... ......+.+..+|
T Consensus        15 ~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~----i~~~eF~~~~~~~~~~~~~~~~l~~~F   90 (146)
T 2qac_A           15 DESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDN----LTYEQYLEYLSICVHDKDNVEELIKMF   90 (146)
T ss_dssp             CHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSE----ECHHHHHHHHHHTCCTTCCHHHHHHHH
T ss_pred             HHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC----CCHHHHHHHHHHHhcCcchHHHHHHHH
Confidence            4778999999999 99999999999887766667788899999999987    9999999999754 4455678899999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      +.+|.|++|.|+.+||..++...      ..+..+|..+  |+||.|+.+||.+.+.
T Consensus        91 ~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~l~  145 (146)
T 2qac_A           91 AHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF--SSEDNIDYKLFCEDIL  145 (146)
T ss_dssp             HTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH--CSSSEEEHHHHHHHHT
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc--CCCCcCcHHHHHHHHh
Confidence            99999999999999999999853      4588889988  9999999999999886

>4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens}

Probab=99.44  E-value=1.2e-13  Score=112.41  Aligned_cols=82  Identities=18%  Similarity=0.294  Sum_probs=64.3

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCch-HHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD-WRKASR  507 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~-~~~~f~  507 (531)
                      +.+..+|+.||.| +|+||.+||+.+|+.     ++...++++++.+|+.+|.|+||+|+|+||+.+|..... ..+.|.
T Consensus        15 e~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~~~~he~f~   93 (121)
T 4drw_A           15 ETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTIACNDYFV   93 (121)
T ss_dssp             HHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHHHHHH
Confidence            6788999999988 899999999999987     688888999999999999999999999999999875322 233344


Q ss_pred             hhCccCCCc
Q 009594          508 QYSRERFNS  516 (531)
Q Consensus       508 ~~D~~~~G~  516 (531)
                      ...+..++.
T Consensus        94 ~~~k~~~~~  102 (121)
T 4drw_A           94 VHMKQENLY  102 (121)
T ss_dssp             TSCC-----
T ss_pred             HHHHHhccC
Confidence            444444433

>1eg3_A Dystrophin; EF-hand like domain, WW domain, structural protein; 2.00A {Homo sapiens} SCOP: a.39.1.7 a.39.1.7 b.72.1.1 PDB: 1eg4_A

Probab=99.42  E-value=7.9e-13  Score=121.73  Aligned_cols=138  Identities=14%  Similarity=0.155  Sum_probs=108.2

Q ss_pred             HhhHHHHhcccccC-CCCcccHHHHHHHHHhCCCC--------CC-----HHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          361 VAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQN--------IP-----EADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       361 ~~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~--------~~-----~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      +..+.++|+....+ ++..++..++...|..+...        ..     ..-+..+|+.+|.|++|.|+|.||+..+..
T Consensus        81 l~~~~~~f~~~~l~~~~~~l~~~~l~~~L~~lY~~l~~~~p~~v~~~~~~~~~a~~lf~~FD~~~~G~I~f~ef~~aLs~  160 (261)
T 1eg3_A           81 LSAACDALDQHNLKQNDQPMDILQIINCLTTIYDRLEQEHNNLVNVPLCVDMCLNWLLNVYDTGRTGRIRVLSFKTGIIS  160 (261)
T ss_dssp             HHHHHHHHHHTTCCCTTSEEEHHHHHHHHHHHHHHHHHHSTTTCCHHHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHHHHHHHhhCcCcCCchhhHHHHHHHHHHHccCCCCceEeHHHHHHHHHH
Confidence            34556666664433 55679999998877765221        11     122455899999999999999999998877


Q ss_pred             hhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhh-------c------CCCCCHHHHHHHHHhccCCCCcceeHHHHH
Q 009594          427 LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALND-------E------VDTSGEDVINAIMHDVDTDKDGRISYEEFA  493 (531)
Q Consensus       427 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-------~------~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~  493 (531)
                      ......+++++.+|+.|| |+||+|+.+|+..+++.       +      +....++.++.+|..+|  +||.|+.+||+
T Consensus       161 l~rG~leeKL~w~F~lyD-D~~G~I~~~El~~il~~i~~i~~~vge~~~~~~~~~e~~v~~~F~~~d--~dg~It~~EFl  237 (261)
T 1eg3_A          161 LCKAHLEDKYRYLFKQVA-SSTGFCDQRRLGLLLHDSIQIPRQLGEVASFGGSNIEPSVRSCFQFAN--NKPEIEAALFL  237 (261)
T ss_dssp             TSSSCHHHHHHHHHHHHS-CTTSCBCHHHHHHHHHHHHHHHHHTTCGGGGTCSCCHHHHHHHHHHTT--TCSCBCHHHHH
T ss_pred             HcCCCHHHHHHHHHheee-CCCCCCcHHHHHHHHHHHHHHHHhcCCcccCCCCCHHHHHHHHHHhCC--CCCcCCHHHHH
Confidence            777788899999999999 99999999999999864       2      33345777999999986  88999999999


Q ss_pred             HHHHhCch
Q 009594          494 VMMKAGTD  501 (531)
Q Consensus       494 ~~~~~~~~  501 (531)
                      ..++..+.
T Consensus       238 ~~~~~dp~  245 (261)
T 1eg3_A          238 DWMRLEPQ  245 (261)
T ss_dssp             HHHHTCCT
T ss_pred             HHHHhCcH
Confidence            99987654

>2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A

Probab=99.42  E-value=2.8e-14  Score=117.96  Aligned_cols=102  Identities=19%  Similarity=0.240  Sum_probs=55.0

Q ss_pred             HHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHh-----HHHHhh-ccCcHHHHHHhhcccCCCCCcceeHHHHHHHHh
Q 009594          388 LLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVA-----VSVHLK-KMANDEHLHKAFSFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       388 l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~-----~~~~~~-~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~  461 (531)
                      |+++|.+++..++..++..+    +|.|+|+||+.     ++.... .....+.++.+|+.||    |+|+.+||+.+|+
T Consensus         2 lr~lG~~~t~~ei~~~~~~~----~g~i~f~EF~~~~~~~~~~~~~~~~~~~~~l~~aF~~fD----G~I~~~El~~~l~   73 (123)
T 2kld_A            2 STAIGINDTYSEVKSDLAQQ----KAEMELSDLIRKGYHKALVKLKLKKNTVDDISESLRQGG----GKLNFDELRQDLK   73 (123)
T ss_dssp             -----------------------------------------------------CCSCSSTTTT----TCEEHHHHHHHTT
T ss_pred             hhhcCCCCCHHHHHHHHHHc----CCCccHHHHHhHhHHHHHHHhhcChhHHHHHHHHHHHhC----CCCCHHHHHHHHH
Confidence            56788999999999999876    78999999998     554322 2223356889999998    9999999999999


Q ss_pred             hcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          462 DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       462 ~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .+|.  ++++++.++..+|.|+||.|+|+||+.++...
T Consensus        74 ~lG~--t~~ei~~~~~~~D~d~dG~I~~~EF~~~~~~~  109 (123)
T 2kld_A           74 GKGH--TDAEIEAIFTKYDQDGDQELTEHEHQQMRDDL  109 (123)
T ss_dssp             TCCS--SHHHHHHHHHHHSSSSCCEECSHHHHHCSCTT
T ss_pred             HhCC--CHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence            9997  89999999999999999999999999988643

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A

Probab=99.41  E-value=2.8e-13  Score=116.12  Aligned_cols=110  Identities=17%  Similarity=0.193  Sum_probs=86.7

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      ..++.+...+..+.    .+.+|..+ .     ...+.++.+|+.||.|++|.|+.+||+.+|..+|..+++++++.+|.
T Consensus        22 ~~l~~~~~~~~~~~----~~~~~~~l-~-----~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~   91 (147)
T 1wy9_A           22 ERLEGINKQFLDDP----KYSNDEDL-P-----SKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIR   91 (147)
T ss_dssp             HHHHHHHHHHTTCH----HHHTCTTH-H-----HHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCc----chhHHHHH-H-----HHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHH
Confidence            34555555553222    45555444 1     23466899999999999999999999999999999999999999999


Q ss_pred             hccCCCCcceeHHHHHHHHHh-CchHHHHHhhhCccCCCcC
Q 009594          478 DVDTDKDGRISYEEFAVMMKA-GTDWRKASRQYSRERFNSI  517 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~-~~~~~~~f~~~D~~~~G~i  517 (531)
                      .+|.|++|.|+|+||+.++.. ...+..+|+.+|++++|..
T Consensus        92 ~~D~d~dg~I~~~eF~~~~~~~~~~~~~aF~~~D~d~~g~~  132 (147)
T 1wy9_A           92 EVSSGSEETFSYSDFLRMMLGKRSAILRMILMYEEKNKEHK  132 (147)
T ss_dssp             HHCSSCTTEECHHHHHHHHCSSGGGGGGGGGGCCCC-----
T ss_pred             HhCCCCCCcEeHHHHHHHHHHhHHHHHHHHHHHccCCCCCC
Confidence            999999999999999999975 4679999999999999984

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=99.39  E-value=2.4e-13  Score=107.63  Aligned_cols=66  Identities=32%  Similarity=0.582  Sum_probs=62.2

Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ..++++.+|+.||.|++|+|+.+||+.+|+.+|..+++++++.+|+.+|.|+||.|+|+||+++|.
T Consensus        34 ~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m~   99 (100)
T 2lv7_A           34 ELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLLG   99 (100)
T ss_dssp             GHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHTC
T ss_pred             HHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHhC
Confidence            346799999999999999999999999999999999999999999999999999999999999863

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=2.2e-12  Score=122.28  Aligned_cols=140  Identities=18%  Similarity=0.173  Sum_probs=111.1

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|++...++.|+.+.||++..  .+..+++|+........   ...+.+|+.+++.+..+..++++++++...+..++||
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            488888999999999999873  47899999986532111   2357889999999966788999999998889999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-----------------------------------------  175 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-----------------------------------------  175 (531)
                      ||++|.+|.+.+     .+......++.+++.+|..||+                                         
T Consensus        90 e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           90 SEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             EecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            999999987652     1223345788999999999998                                         


Q ss_pred             ------------------cCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          176 ------------------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       176 ------------------~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                                        ..++|+|++|.||+++..   ..+.|+||+.+..
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~lIDwe~a~~  213 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSGR  213 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC---cEEEEEEchhccc
Confidence                              448999999999999632   2356999987653

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=99.36  E-value=4.5e-13  Score=106.08  Aligned_cols=71  Identities=28%  Similarity=0.528  Sum_probs=66.8

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHH
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVS  424 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~  424 (531)
                      ..+++++..+|+++|+.+|+|++|+|+.+||+.+|+.+|..++.++++.+|+.+|.|++|.|+|+||+.++
T Consensus        28 ~~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m   98 (100)
T 2lv7_A           28 VDIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLL   98 (100)
T ss_dssp             CCCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHT
T ss_pred             ccCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHh
Confidence            34677888999999999999999999999999999999999999999999999999999999999999865

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=99.36  E-value=1.7e-13  Score=106.02  Aligned_cols=85  Identities=26%  Similarity=0.386  Sum_probs=71.5

Q ss_pred             CCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeH
Q 009594          410 DGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISY  489 (531)
Q Consensus       410 ~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~  489 (531)
                      |++|.|+|+|++.. ..+ .......++.+|+.+|.|++|+|+.+||+.+|..+|..++.++++.+|..+|.|++|.|+|
T Consensus         1 ~~~G~i~~~e~~~~-~~l-~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~   78 (87)
T 1s6j_A            1 HSSGHIDDDDKHMA-ERL-SEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDY   78 (87)
T ss_dssp             CCSSSSSSHHHHSS-SSS-CSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECH
T ss_pred             CCCCccCccHHHHH-HHC-CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcH
Confidence            57899999994322 111 2223356889999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHH
Q 009594          490 EEFAVMM  496 (531)
Q Consensus       490 ~Ef~~~~  496 (531)
                      +||+.++
T Consensus        79 ~eF~~~~   85 (87)
T 1s6j_A           79 GEFIAAT   85 (87)
T ss_dssp             HHHTTCC
T ss_pred             HHHHHHH
Confidence            9998654

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A

Probab=99.35  E-value=1.5e-12  Score=111.43  Aligned_cols=89  Identities=15%  Similarity=0.287  Sum_probs=77.4

Q ss_pred             hHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHH
Q 009594          358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLH  437 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  437 (531)
                      .++..+++++|..+|.|++|+|+.+||..++..+|..++..+++.+|..+|.|++|.|+|+||+.++...     .+.+.
T Consensus        44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I~~~eF~~~~~~~-----~~~~~  118 (147)
T 1wy9_A           44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVSSGSEETFSYSDFLRMMLGK-----RSAIL  118 (147)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCTTEECHHHHHHHHCSS-----GGGGG
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh-----HHHHH
Confidence            5778899999999999999999999999999999999999999999999999999999999999887532     45588


Q ss_pred             HhhcccCCCCCcce
Q 009594          438 KAFSFFDRNRSGFI  451 (531)
Q Consensus       438 ~~F~~~D~~~~G~i  451 (531)
                      .+|+.||.+++|..
T Consensus       119 ~aF~~~D~d~~g~~  132 (147)
T 1wy9_A          119 RMILMYEEKNKEHK  132 (147)
T ss_dssp             GGGGGCCCC-----
T ss_pred             HHHHHHccCCCCCC
Confidence            99999999999984

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L

Probab=99.33  E-value=3.3e-12  Score=137.41  Aligned_cols=124  Identities=12%  Similarity=0.148  Sum_probs=110.5

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHh--------hccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHL--------KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGE  469 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~--------~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~  469 (531)
                      ++++.+|..+| |++|.|+.+||..++...        ......+.+..+|+.+|.|++|.|+.+||..++..+      
T Consensus       532 ~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I~f~EF~~l~~~~------  604 (714)
T 3bow_A          532 DGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTKI------  604 (714)
T ss_dssp             HHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSBCHHHHHHHHHHH------
T ss_pred             HHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH------
Confidence            45888999999 999999999999987765        334677889999999999999999999999999765      


Q ss_pred             HHHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          470 DVINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       470 ~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      +++..+|+.+|.|++|.|+.+||..++...      ..+..+|..+| |+||.|+.+||.+.+..+
T Consensus       605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~~~l~~~  669 (714)
T 3bow_A          605 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL  669 (714)
T ss_dssp             HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS-CTTCEECHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH
Confidence            679999999999999999999999999753      45899999999 999999999999988643

>3ohm_B 1-phosphatidylinositol-4,5-bisphosphate phosphodi beta-3; PH domain, EF hand, TIM barrel, C2 domain, GTPase, lipase, C binding, GTP binding; HET: GDP; 2.70A {Homo sapiens}

Probab=99.31  E-value=6.5e-12  Score=135.06  Aligned_cols=130  Identities=12%  Similarity=0.229  Sum_probs=113.2

Q ss_pred             hhHHHHhcc--cccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-------CCCceecchhHhHHHHhhccCc
Q 009594          362 AGLKEAFEM--MDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD-------GDGSLNYGEFVAVSVHLKKMAN  432 (531)
Q Consensus       362 ~~i~~~F~~--~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-------~~g~i~~~ef~~~~~~~~~~~~  432 (531)
                      .-+++.|..  +|+|++|.|+.+|+...+..     ..+++..+|+.+|.+       ++|.|+|+||..++..+.   .
T Consensus       150 ~~L~kaf~~~~~D~n~dGkIs~kel~~~l~~-----~~~~v~~l~~~~d~~~~~~d~~~~g~i~feEF~~f~~~l~---~  221 (885)
T 3ohm_B          150 TFLRKAYTKLKLQVNQDGRIPVKNILKMFSA-----DKKRVETALESCGLKFNRSESIRPDEFSLEIFERFLNKLC---L  221 (885)
T ss_dssp             HHHHHHHHHHHHSCCTTSCEEHHHHHHTTGG-----GHHHHHHHHHTTTCCCSTTCEECGGGCCHHHHHHHHHHHS---C
T ss_pred             HHHHHHHHHhcCccCCCCccCHHHHHHHHhc-----CHHHHHHHHHHhCCCccccccCCCCcCCHHHHHHHHHhcC---C
Confidence            457778887  89999999999999888875     467899999999987       789999999999887543   2


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcC-C---------CCCHHHHHHHHHhccCC----CCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-D---------TSGEDVINAIMHDVDTD----KDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~---------~~~~~~~~~~~~~~D~~----~dG~i~~~Ef~~~~~~  498 (531)
                      ..+++.+|+.||.+++|.||.+||+.+|...+ +         ..+.++++.||+.++.+    ++|.|++++|..+|..
T Consensus       222 R~EI~eiF~~ydsd~~g~mT~~EL~~FL~~~Q~e~~~~e~~~~~~t~e~~~~iI~k~e~~~~~~~~g~LsldgF~~yL~S  301 (885)
T 3ohm_B          222 RPDIDKILLEIGAKGKPYLTLEQLMDFINQKQRDPRLNEVLYPPLRPSQARLLIEKYEPNQQFLERDQMSMEGFSRYLGG  301 (885)
T ss_dssp             CHHHHHHHHHTTCCSTTCEEHHHHHHHHHHHSSCTTSCTTTSCCCCHHHHHHHHHHHCCCHHHHHTTEECHHHHHHHHTS
T ss_pred             HHHHHHHHHHHhcCCCCccCHHHHHHHHHHhcCcccccccccccCCHHHHHHHHHHhcCChhhhccCccchhhhhhhccC
Confidence            46799999999999999999999999999874 3         26789999999999998    7899999999999985


Q ss_pred             C
Q 009594          499 G  499 (531)
Q Consensus       499 ~  499 (531)
                      .
T Consensus       302 ~  302 (885)
T 3ohm_B          302 E  302 (885)
T ss_dssp             T
T ss_pred             c
Confidence            3

>3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A

Probab=99.30  E-value=2.8e-12  Score=101.08  Aligned_cols=66  Identities=20%  Similarity=0.198  Sum_probs=60.2

Q ss_pred             HHHHHhhcccC-CCCC-cceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSFFD-RNRS-GFIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..++.+|+.|| +|++ |+||.+||+.+|+.     +|..+++++++.+|+.+|.|+||.|+|+||+.++...
T Consensus        10 ~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~~   82 (101)
T 3nso_A           10 AAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACL   82 (101)
T ss_dssp             HHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            56899999997 8987 99999999999986     4678889999999999999999999999999998753

>4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens}

Probab=99.29  E-value=1.3e-12  Score=106.24  Aligned_cols=106  Identities=15%  Similarity=0.288  Sum_probs=76.5

Q ss_pred             hHHHhhHHHHhcccccCCCCcccHHHHHHHHHh-----CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCc
Q 009594          358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK-----GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN  432 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~-----~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~  432 (531)
                      +..+..|..+|+.||.| +|+|+.+||+.+|++     ++...++++++++++.+|.|+||.|+|+||+.++..+...  
T Consensus        11 E~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~~~--   87 (121)
T 4drw_A           11 EHAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTIA--   87 (121)
T ss_dssp             HHHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHH--
Confidence            34567899999999988 899999999999987     6888899999999999999999999999999988655431  


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCC
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKD  484 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~d  484 (531)
                         ....|....+..+.+..               ++..+.++|+++|.|||
T Consensus        88 ---~he~f~~~~k~~~~~~~---------------~d~~~~e~~~~~d~~gd  121 (121)
T 4drw_A           88 ---CNDYFVVHMKQENLYFQ---------------GDSTVHEILSKLSLEGD  121 (121)
T ss_dssp             ---HHHHHTTSCC------------------------CCHHHHHHHCCC---
T ss_pred             ---HHHHHHHHHHHhccCCC---------------CchHHHHHHHHhcccCC
Confidence               23444444433333221               23347778888888775

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A

Probab=99.29  E-value=2.2e-12  Score=110.92  Aligned_cols=89  Identities=18%  Similarity=0.288  Sum_probs=73.2

Q ss_pred             hHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHH
Q 009594          358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLH  437 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  437 (531)
                      .++..+++++|..+|.|++|+|+.+||..++..+|..++..+++.+|..+|.|++|.|+|+||+.++...     ...+.
T Consensus        46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~~~~-----~~~i~  120 (150)
T 2jjz_A           46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGK-----RSAVL  120 (150)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSCSSBCHHHHHHHHHSS-----SCCHH
T ss_pred             HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHh-----HHHHH
Confidence            4667889999999999999999999999999999999999999999999999999999999999987643     34589


Q ss_pred             HhhcccCCCCCcce
Q 009594          438 KAFSFFDRNRSGFI  451 (531)
Q Consensus       438 ~~F~~~D~~~~G~i  451 (531)
                      .+|+.||.|++|.-
T Consensus       121 ~aF~~~D~d~~G~~  134 (150)
T 2jjz_A          121 KLVMMFEGKANESS  134 (150)
T ss_dssp             HHHHC---------
T ss_pred             HHHHHHcCCCCCCC
Confidence            99999999999984

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A

Probab=99.29  E-value=1.1e-11  Score=100.14  Aligned_cols=94  Identities=14%  Similarity=0.145  Sum_probs=83.6

Q ss_pred             cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC---------c
Q 009594          430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG---------T  500 (531)
Q Consensus       430 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~---------~  500 (531)
                      ..+.+++..+|+.+|  ++|.|+.+||..++...  ....+++..+|..+|.|++|.|+.+||..++...         .
T Consensus         6 ~~~~~ei~~~~~~~D--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~   81 (109)
T 3fs7_A            6 ILSAKDIESALSSCQ--AADSFNYKSFFSTVGLS--SKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSA   81 (109)
T ss_dssp             TSCHHHHHHHHHHTC--STTCCCHHHHHHHHTCT--TCCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHH
T ss_pred             cCCHHHHHHHHHhcC--CCCcCcHHHHHHHHhcC--CCcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHH
Confidence            456788999999998  89999999999998753  3467889999999999999999999999998854         3


Q ss_pred             hHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          501 DWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       501 ~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      .+..+|+.+|+|+||.|+.+||.++++
T Consensus        82 ~~~~~~~~~D~~~dg~i~~~EF~~~~~  108 (109)
T 3fs7_A           82 ETKAFLAAGDTDGDGKIGVEEFQSLVK  108 (109)
T ss_dssp             HHHHHHHHHCTTCSSSBCHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence            589999999999999999999999886

>1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A

Probab=99.28  E-value=1.5e-12  Score=136.87  Aligned_cols=128  Identities=14%  Similarity=0.136  Sum_probs=60.7

Q ss_pred             HHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHH
Q 009594          397 EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIM  476 (531)
Q Consensus       397 ~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~  476 (531)
                      ..+++++|..+|.|++|.|+++||..++..+.....++.++.+|+.+|.|++|.|+.+||..++..+..   .+++..+|
T Consensus        10 e~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D~d~~G~I~f~EF~~~~~~l~~---~~el~~aF   86 (624)
T 1djx_A           10 QHWIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSLEDEEIETFYKMLTQ---RAEIDRAF   86 (624)
T ss_dssp             ----------------------------------------------------------CTTHHHHHHTC---CHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhcc---HHHHHHHH
Confidence            345788999999999999999999998776655566788999999999999999999999999987753   46899999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC--------chHHHHHhhhCcc----CCCcCCHHHHHHHHhh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG--------TDWRKASRQYSRE----RFNSISLKLMREEGLQ  528 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~--------~~~~~~f~~~D~~----~~G~i~~~e~~~~~~~  528 (531)
                      +.+|.+ +|.|+++||..+|...        +++.++++.+|.|    ++|.|+.+||.+.|..
T Consensus        87 ~~fD~~-~G~Is~~EL~~fL~~~qge~~ls~ee~~~ii~~~d~d~~~~~dG~Is~deF~~~L~s  149 (624)
T 1djx_A           87 EEAAGS-AETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLS  149 (624)
T ss_dssp             HHHHTT-SSSEEHHHHHHHHHHTSCCSSCSHHHHHHHHHHHCCCHHHHHTTEECHHHHHHHHHS
T ss_pred             HHhcCC-CCeecHHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCChhhccCCCCCHHHHHHHhcC
Confidence            999986 8999999999999842        2488999999998    7999999999998864

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A

Probab=99.27  E-value=9.2e-12  Score=95.91  Aligned_cols=85  Identities=27%  Similarity=0.398  Sum_probs=71.0

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCc
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN  432 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~  432 (531)
                      +..+++++..+++++|..+|.|++|+|+.+|+..++..+| .++..+++.+|..+|.|++|.|+|+||+.++.....  .
T Consensus         2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~--~   78 (86)
T 2opo_A            2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANRG--L   78 (86)
T ss_dssp             ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCTT--T
T ss_pred             CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCcc--H
Confidence            4567888899999999999999999999999999999999 999999999999999999999999999998765432  2


Q ss_pred             HHHHHHhh
Q 009594          433 DEHLHKAF  440 (531)
Q Consensus       433 ~~~~~~~F  440 (531)
                      .+.+..+|
T Consensus        79 ~~~~~~aF   86 (86)
T 2opo_A           79 VKDVSKIF   86 (86)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHHHhC
Confidence            34455554

>1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1

Probab=99.26  E-value=4.2e-12  Score=140.88  Aligned_cols=131  Identities=12%  Similarity=0.167  Sum_probs=112.8

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC-CCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~  476 (531)
                      .++..+|..+|.|++|.|+..||..++.........+.+..+|+.+|.|++|.|+.+||..++.... ...+.+.+..+|
T Consensus       725 ~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~~l~~aF  804 (863)
T 1sjj_A          725 NEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPNRMGVVTFQAFIDFMSRETADTDTADQVMASF  804 (863)
T ss_dssp             HHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCTTSCSEEETTHHHHTHHHHSTTCSSSHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHH
Confidence            3467789999999999999999999887665556678899999999999999999999999987653 344567899999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCcc-----CCCcCCHHHHHHHHhhcC
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRE-----RFNSISLKLMREEGLQLA  530 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~-----~~G~i~~~e~~~~~~~~~  530 (531)
                      +.+ .|++|.|+.+||..++. ...+..+|..+|++     +||.|+.+||.+.+...+
T Consensus       805 ~~~-~d~~G~Is~~El~~~l~-~~~~~~l~~~~d~~~~~~~~dg~I~~~eF~~~~~~~~  861 (863)
T 1sjj_A          805 KIL-AGDKNYITVDELRRELP-PDQAEYCIARMAPYNGRDAVPGALDYMSFSTALYGES  861 (863)
T ss_dssp             HGG-GTSSSEEEHHHHHHHSC-HHHHHHHHHHSEECCSSCCCTTEEESHHHHHHHSCCS
T ss_pred             HHH-hCCCCcCcHHHHHHHCC-HHHHHHHHHHcchhcCCCCCCCceeHHHHHHHHhcCC
Confidence            999 89999999999999986 46688899999987     799999999999987643

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens}

Probab=99.26  E-value=1.2e-11  Score=91.39  Aligned_cols=67  Identities=36%  Similarity=0.641  Sum_probs=63.1

Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..+.++.+|+.+|.|++|+|+.+||..++..+|..++.++++.+|..+|.|++|.|+|+||+.++..
T Consensus         4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~   70 (71)
T 2b1u_A            4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFARMLAQ   70 (71)
T ss_dssp             THHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHHTC
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence            4577999999999999999999999999999999999999999999999999999999999998753

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5

Probab=99.25  E-value=9.2e-12  Score=90.76  Aligned_cols=64  Identities=20%  Similarity=0.420  Sum_probs=60.7

Q ss_pred             HHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       435 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .++.+|+.+|.|++|.|+.+||..++..+|..++.++++.+|..+|.|++|.|+++||+.++..
T Consensus         2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~   65 (67)
T 1tiz_A            2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK   65 (67)
T ss_dssp             THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence            3688999999999999999999999999999999999999999999999999999999998864

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus}

Probab=99.25  E-value=2e-11  Score=95.61  Aligned_cols=80  Identities=26%  Similarity=0.501  Sum_probs=69.9

Q ss_pred             hhHhHHHH-hhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          419 EFVAVSVH-LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       419 ef~~~~~~-~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      -|+.++.. .......+.++.+|+.||.|++|+|+.+||+.+|..+|..+++++++.+|..+|.|+||.|+|+||+.++.
T Consensus        13 ~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~   92 (94)
T 2kz2_A           13 GENLYFQSLMKDTDSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT   92 (94)
T ss_dssp             CCTHHHHHHHCCCSCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             cHHHHHHHHhcCCCHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence            35554433 34456678899999999999999999999999999999999999999999999999999999999999886


Q ss_pred             h
Q 009594          498 A  498 (531)
Q Consensus       498 ~  498 (531)
                      .
T Consensus        93 ~   93 (94)
T 2kz2_A           93 A   93 (94)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max}

Probab=99.23  E-value=2.1e-11  Score=95.19  Aligned_cols=85  Identities=31%  Similarity=0.584  Sum_probs=72.2

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccC---cH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMA---ND  433 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~---~~  433 (531)
                      +.++..+++++|..+|.+++|+|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+.++.......   ..
T Consensus         4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~~~~~~~~~~   83 (92)
T 2kn2_A            4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTVRGGGGGNGW   83 (92)
T ss_dssp             CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHHTTTCCCHHH
T ss_pred             CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhccCCCCCchH
Confidence            455677899999999999999999999999999999999999999999999999999999999999876544322   22


Q ss_pred             HHHHHhhc
Q 009594          434 EHLHKAFS  441 (531)
Q Consensus       434 ~~~~~~F~  441 (531)
                      +.++.+|+
T Consensus        84 ~~l~~aF~   91 (92)
T 2kn2_A           84 SRLRRKFS   91 (92)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHhc
Confidence            45666664

>1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A*

Probab=99.23  E-value=8.3e-12  Score=101.39  Aligned_cols=84  Identities=23%  Similarity=0.292  Sum_probs=62.6

Q ss_pred             HHHHHhhcccCC-CCCc-ceeHHHHHHHHh-hcCCC-----CCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-chHHH
Q 009594          434 EHLHKAFSFFDR-NRSG-FIEIEELRNALN-DEVDT-----SGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-TDWRK  504 (531)
Q Consensus       434 ~~~~~~F~~~D~-~~~G-~i~~~el~~~l~-~~~~~-----~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-~~~~~  504 (531)
                      +.++.+|+.||. |++| +|+.+||+.+|+ .+|..     .++++++.+|..+|.|+||.|+|+||+.++... ....+
T Consensus        12 ~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~~~~~~   91 (113)
T 1xk4_C           12 ETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLTWASHE   91 (113)
T ss_dssp             HHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHHHHHHHH
Confidence            568999999995 9999 999999999999 77753     578899999999999999999999999998753 45777


Q ss_pred             HHhhhCccCCCcCC
Q 009594          505 ASRQYSRERFNSIS  518 (531)
Q Consensus       505 ~f~~~D~~~~G~i~  518 (531)
                      .|...| +++|.-.
T Consensus        92 ~f~~~~-~~~g~~~  104 (113)
T 1xk4_C           92 KMHEGD-EGPGHHH  104 (113)
T ss_dssp             --------------
T ss_pred             HHhhCC-CCCcccc
Confidence            888889 9988643

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10

Probab=99.22  E-value=1.9e-11  Score=92.15  Aligned_cols=68  Identities=31%  Similarity=0.544  Sum_probs=63.2

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDW  502 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~  502 (531)
                      +.++.+|+.+|.|++|+|+.+||..++..+| .+++++++.++..+|.|++|.|+|+||+.++......
T Consensus         3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~~   70 (78)
T 1k9u_A            3 DDMERIFKRFDTNGDGKISLSELTDALRTLG-STSADEVQRMMAEIDTDGDGFIDFNEFISFCNANPGL   70 (78)
T ss_dssp             CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH-TCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHCHHH
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHCchh
Confidence            4688999999999999999999999999999 8999999999999999999999999999999876543

>3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens}

Probab=99.22  E-value=2.4e-11  Score=96.45  Aligned_cols=74  Identities=14%  Similarity=0.301  Sum_probs=62.0

Q ss_pred             HHHHHhhcccC-CCCC-cceeHHHHHHHHhh-cC----CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc-hHHHH
Q 009594          434 EHLHKAFSFFD-RNRS-GFIEIEELRNALND-EV----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT-DWRKA  505 (531)
Q Consensus       434 ~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-~~----~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~-~~~~~  505 (531)
                      +.++.+|+.|| .|++ |+|+.+||+.+|+. +|    ...++++++.+|+.+|.|+||.|+|+||+.++.... ...+.
T Consensus        13 ~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~~~~~~~~   92 (104)
T 3zwh_A           13 DVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSIAMMSNEF   92 (104)
T ss_dssp             HHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHHHHHHH
Confidence            67899999997 7785 89999999999985 54    456899999999999999999999999999998643 34444


Q ss_pred             Hh
Q 009594          506 SR  507 (531)
Q Consensus       506 f~  507 (531)
                      |.
T Consensus        93 ~~   94 (104)
T 3zwh_A           93 FE   94 (104)
T ss_dssp             HH
T ss_pred             HH
Confidence            44

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A

Probab=99.21  E-value=3.5e-11  Score=92.58  Aligned_cols=67  Identities=33%  Similarity=0.473  Sum_probs=63.1

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      .+.++.+|+.+|.|++|+|+.+||..++..+| .++.++++.+|..+|.|+||.|+|+||+.++....
T Consensus        10 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~   76 (86)
T 2opo_A           10 IADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANR   76 (86)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCc
Confidence            46789999999999999999999999999999 89999999999999999999999999999998654

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max}

Probab=99.21  E-value=3e-11  Score=94.32  Aligned_cols=67  Identities=31%  Similarity=0.663  Sum_probs=63.0

Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..+.++.+|+.||.|++|+|+.+||+.+|..+|..++.++++.+|..+|.|++|.|+|+||+.++..
T Consensus         7 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~   73 (92)
T 2kn2_A            7 AEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMT   73 (92)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            3467899999999999999999999999999999999999999999999999999999999998873

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4

Probab=99.21  E-value=5.2e-11  Score=96.18  Aligned_cols=96  Identities=16%  Similarity=0.206  Sum_probs=82.1

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh---hccCcHHHHHHh
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL---KKMANDEHLHKA  439 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~~~~~~~  439 (531)
                      ++.++|..+|.  +|.|+.+||..++..  ...+.+++..+|+.+|.|++|.|+.+||..++...   ......+.+..+
T Consensus        10 ei~~~~~~~d~--~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~   85 (109)
T 5pal_A           10 DINKAISAFKD--PGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKAL   85 (109)
T ss_dssp             HHHHHHHHTCS--TTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHH
T ss_pred             HHHHHHHHhCC--CCcCcHHHHHHHHhh--ccCcHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHH
Confidence            45666667776  899999999888764  34567889999999999999999999999988766   555678889999


Q ss_pred             hcccCCCCCcceeHHHHHHHHhh
Q 009594          440 FSFFDRNRSGFIEIEELRNALND  462 (531)
Q Consensus       440 F~~~D~~~~G~i~~~el~~~l~~  462 (531)
                      |+.+|.|++|.|+.+||..++..
T Consensus        86 ~~~~D~~~dg~i~~~eF~~~~~~  108 (109)
T 5pal_A           86 LAAGDSDHDGKIGADEFAKMVAQ  108 (109)
T ss_dssp             HHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHhCCCCCCcCcHHHHHHHHHh
Confidence            99999999999999999998864

>2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A

Probab=99.21  E-value=1.8e-11  Score=98.53  Aligned_cols=67  Identities=15%  Similarity=0.367  Sum_probs=61.0

Q ss_pred             HHHHHHhhcccC-CCCCc-ceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          433 DEHLHKAFSFFD-RNRSG-FIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       433 ~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .+.++.+|+.|| .|++| +|+.+||+.+|+.     +|..+++++++.+|..+|.|+||.|+|+||+.++...
T Consensus        21 ~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~~   94 (113)
T 2lnk_A           21 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI   94 (113)
T ss_dssp             HHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHH
Confidence            467899999999 89997 9999999999986     6777888999999999999999999999999998753

>3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C

Probab=99.20  E-value=6.4e-12  Score=106.95  Aligned_cols=91  Identities=9%  Similarity=0.042  Sum_probs=48.6

Q ss_pred             HHHhhcccCCCCCcceeHHHHHHHHhhcCC-----CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-----------
Q 009594          436 LHKAFSFFDRNRSGFIEIEELRNALNDEVD-----TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-----------  499 (531)
Q Consensus       436 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-----~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----------  499 (531)
                      ....|+.+|.|++|.|+.+||..++.....     ..+.+++..+|+.+|.|+||.|+++||..++...           
T Consensus        29 ~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~  108 (143)
T 3a4u_B           29 SFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPL  108 (143)
T ss_dssp             ----------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------
T ss_pred             CHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCC
Confidence            456899999999999999999998876521     2345678999999999999999999999988642           


Q ss_pred             ---ch----HHHHHhhhCccCCCcCCHHHHHHHH
Q 009594          500 ---TD----WRKASRQYSRERFNSISLKLMREEG  526 (531)
Q Consensus       500 ---~~----~~~~f~~~D~~~~G~i~~~e~~~~~  526 (531)
                         .+    +..+|+.+|+|+||.|+.+||.+++
T Consensus       109 ~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~  142 (143)
T 3a4u_B          109 MSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSL  142 (143)
T ss_dssp             CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred             CCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence               12    3667799999999999999998765

>4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A*

Probab=99.20  E-value=2.2e-11  Score=94.76  Aligned_cols=66  Identities=15%  Similarity=0.380  Sum_probs=57.5

Q ss_pred             HHHHHhhcccC-CCCC-cceeHHHHHHHHhh-cC----CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSFFD-RNRS-GFIEIEELRNALND-EV----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-~~----~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      +.++.+|+.|| .||+ |+|+.+||+.+|+. +|    ...++++++.+++.+|.|+||.|+|+||+.++...
T Consensus        10 ~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~~   82 (93)
T 4eto_A           10 DVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI   82 (93)
T ss_dssp             HHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHH
Confidence            57899999998 6885 89999999999985 54    45578999999999999999999999999998864

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A

Probab=99.20  E-value=3.9e-11  Score=93.24  Aligned_cols=76  Identities=34%  Similarity=0.566  Sum_probs=70.6

Q ss_pred             hhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          351 VVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       351 ~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      .++..+++++..+++++|..+|.|++|+|+.+||..++..+|..++..+++.+|..+|.|++|.|+|+||+.++..
T Consensus         9 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~   84 (90)
T 1avs_A            9 EARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR   84 (90)
T ss_dssp             SHHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred             HHHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            3556778889999999999999999999999999999999999999999999999999999999999999987754

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A

Probab=99.20  E-value=5.5e-11  Score=95.88  Aligned_cols=93  Identities=12%  Similarity=0.103  Sum_probs=81.8

Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC---------ch
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG---------TD  501 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~---------~~  501 (531)
                      .+.+.+..+|+.+|  ++|.|+.+||..++...  ....+.+..+|+.+|.|++|.|+.+||..++...         ..
T Consensus         6 ~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~   81 (108)
T 2pvb_A            6 LKDADVAAALAACS--AADSFKHKEFFAKVGLA--SKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAE   81 (108)
T ss_dssp             SCHHHHHHHHHHTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHH
T ss_pred             CCHHHHHHHHHHhC--CCCcCcHHHHHHHHhCC--hhHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHH
Confidence            56778999999998  89999999999998543  3357789999999999999999999999999854         34


Q ss_pred             HHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          502 WRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       502 ~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      +..+|+.+|+|++|.|+.+||.+++.
T Consensus        82 ~~~~~~~~D~~~dg~i~~~eF~~~~~  107 (108)
T 2pvb_A           82 TKAFLADGDKDGDGMIGVDEFAAMIK  107 (108)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence            89999999999999999999999875

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus}

Probab=99.19  E-value=2.9e-11  Score=90.84  Aligned_cols=66  Identities=26%  Similarity=0.489  Sum_probs=62.1

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+.++.+|+.+|.|++|.|+.+||..++..+|..++.++++.+|..+|.|++|.|+|+||+.++..
T Consensus         6 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~   71 (77)
T 2joj_A            6 KQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYIGFDDFLDIMTE   71 (77)
T ss_dssp             HHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTH
T ss_pred             HHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence            456899999999999999999999999999999999999999999999999999999999998863

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A

Probab=99.19  E-value=3e-11  Score=93.90  Aligned_cols=67  Identities=31%  Similarity=0.495  Sum_probs=62.8

Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ....++.+|+.||.|++|+|+.+||..+|..+|..++.++++.+|..+|.|++|.|+|+||+.++..
T Consensus        18 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~   84 (90)
T 1avs_A           18 MIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR   84 (90)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            3467899999999999999999999999999999999999999999999999999999999998864

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A

Probab=99.19  E-value=2.5e-11  Score=92.28  Aligned_cols=68  Identities=26%  Similarity=0.483  Sum_probs=63.3

Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC-CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ...+.++ +|+.||.|++|+|+.+||..+|..+| ..++.++++.+|..+|.|++|.|+|+||+.++...
T Consensus         6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~   74 (81)
T 1c7v_A            6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKKS   74 (81)
T ss_dssp             -CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHCC
T ss_pred             cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhh
Confidence            4567789 99999999999999999999999999 99999999999999999999999999999998753

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7

Probab=99.18  E-value=4.3e-11  Score=95.98  Aligned_cols=84  Identities=17%  Similarity=0.308  Sum_probs=72.7

Q ss_pred             ceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHH
Q 009594          414 SLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA  493 (531)
Q Consensus       414 ~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~  493 (531)
                      .++++++...+..... ...+.++.+|+.||.|++|+|+.+||+.+|..+|..++.++++.++..+|.|++|.|+|+||+
T Consensus         5 ~~~~~~~~~~l~~~~~-~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d~~~~g~i~~~eF~   83 (105)
T 1wlz_A            5 ATADRDILARLHKAVT-SHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFL   83 (105)
T ss_dssp             TTCCHHHHHHHHHHHH-HTHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHH
T ss_pred             chhHHHHHHHHHHHHH-chHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence            4567777775544332 346789999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHh
Q 009594          494 VMMKA  498 (531)
Q Consensus       494 ~~~~~  498 (531)
                      .++..
T Consensus        84 ~~~~~   88 (105)
T 1wlz_A           84 SRFSS   88 (105)
T ss_dssp             HHHC-
T ss_pred             HHHhc
Confidence            99875

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6

Probab=99.17  E-value=6.1e-11  Score=92.39  Aligned_cols=64  Identities=19%  Similarity=0.250  Sum_probs=59.0

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ...++.+|+.||.|++|+|+.+|++.+|..+|  ++.++++.++..+|.|+||.|+|+||+.++..
T Consensus         8 ~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~   71 (92)
T 1fi6_A            8 RQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAFHL   71 (92)
T ss_dssp             HHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            45688999999999999999999999999886  57889999999999999999999999998863

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A

Probab=99.17  E-value=9.3e-11  Score=94.84  Aligned_cols=94  Identities=12%  Similarity=0.183  Sum_probs=82.4

Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC---------ch
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG---------TD  501 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~---------~~  501 (531)
                      .+.+++..+|+.+|  ++|.|+.+||..++..  .....+.+..+|..+|.|++|.|+.+||..++...         ..
T Consensus         7 ~t~~e~~~~~~~~d--~~g~i~~~ef~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~   82 (110)
T 1pva_A            7 LKADDIKKALDAVK--AEGSFNHKKFFALVGL--KAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAE   82 (110)
T ss_dssp             SCHHHHHHHHHHTC--STTCCCHHHHHHHHTC--TTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHH
T ss_pred             CCHHHHHHHHHhcC--CCCcCcHHHHHHHHcc--CcchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHH
Confidence            46678999999998  8999999999999853  23457789999999999999999999999999854         35


Q ss_pred             HHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          502 WRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       502 ~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +..+|+.+|+|++|.|+.+||.+++..
T Consensus        83 ~~~~~~~~d~~~dg~i~~~eF~~~~~~  109 (110)
T 1pva_A           83 TKAFLKAADKDGDGKIGIDEFETLVHE  109 (110)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred             HHHHHHHhCCCCCCeEcHHHHHHHHHh
Confidence            899999999999999999999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.17  E-value=4.3e-11  Score=113.06  Aligned_cols=135  Identities=14%  Similarity=0.163  Sum_probs=97.5

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-CeeecceEEEcCCeEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-NIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~lv  135 (531)
                      .|.+....+.|..+.||++. ..+|..+++|+.....      ...+.+|+.+++.+..+. .+++++++....+..++|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            35554444567779999986 3567889999875431      235678999999985442 266788888888889999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG--------------------------------------  177 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------  177 (531)
                      |||++|.+|.  .   ...+   ...++.+++..|..||+..                                      
T Consensus        94 ~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           94 LGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             EECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999998884  2   1122   2356677777788887643                                      


Q ss_pred             --------------------CeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          178 --------------------VMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       178 --------------------iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                                          ++|+|++|.||+++.+   ..+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENG---RFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC---cEEEEEcchhccc
Confidence                                9999999999999642   2356999998754

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana}

Probab=99.16  E-value=1.3e-11  Score=103.98  Aligned_cols=100  Identities=9%  Similarity=-0.066  Sum_probs=65.1

Q ss_pred             HHHHhcccccCCCCcccHHHHHHHHHhC-CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-ccCcHHHHHHhhc
Q 009594          364 LKEAFEMMDTNKRGKINLEELRLGLLKG-GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-KMANDEHLHKAFS  441 (531)
Q Consensus       364 i~~~F~~~D~~~~g~i~~~el~~~l~~~-~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~~~~~~~F~  441 (531)
                      .+++|..+|.|++|.|+.+||..++... .......++...|+.+|.|++|.|+.+||..++.... .....+.+..+|+
T Consensus         5 ~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~   84 (135)
T 3h4s_E            5 EKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVR   84 (135)
T ss_dssp             --------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHH
Confidence            4678999999999999999998887653 2222356788999999999999999999999887665 3667888999999


Q ss_pred             ccCCCCCcceeHHHHHHHHhhc
Q 009594          442 FFDRNRSGFIEIEELRNALNDE  463 (531)
Q Consensus       442 ~~D~~~~G~i~~~el~~~l~~~  463 (531)
                      .+|.|++|.|+.+||..++...
T Consensus        85 ~~D~d~dG~I~~~EF~~~~~~~  106 (135)
T 3h4s_E           85 EGDLDGDGALNQTEFCVLMVRL  106 (135)
T ss_dssp             HHCSSCSSSBCHHHHHHHHHHH
T ss_pred             HhCCCCCCCCcHHHHHHHHHHh
Confidence            9999999999999999999765

>2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio}

Probab=99.16  E-value=5.6e-11  Score=93.78  Aligned_cols=67  Identities=24%  Similarity=0.418  Sum_probs=60.7

Q ss_pred             HHHHHHhhcccC-CCCCc-ceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          433 DEHLHKAFSFFD-RNRSG-FIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       433 ~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .+.++.+|+.|| .|++| +|+.+||+.+|+.     +|..+++++++.+|..+|.|+||.|+|+||+.++...
T Consensus         9 ~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~   82 (99)
T 2y5i_A            9 MDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLVAAL   82 (99)
T ss_dssp             HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHH
Confidence            457899999997 89998 9999999999986     6777899999999999999999999999999998753

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus}

Probab=99.15  E-value=3.8e-11  Score=90.17  Aligned_cols=70  Identities=30%  Similarity=0.590  Sum_probs=65.5

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      ++++..+++++|..+|.+++|.|+.+||..+++.+|..++..+++.+|..+|.|++|.|+|+||+.++..
T Consensus         2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~   71 (77)
T 2joj_A            2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYIGFDDFLDIMTE   71 (77)
T ss_dssp             CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTH
T ss_pred             CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence            5677889999999999999999999999999999999999999999999999999999999999987654

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A

Probab=99.15  E-value=1.4e-10  Score=93.55  Aligned_cols=96  Identities=13%  Similarity=0.170  Sum_probs=81.2

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh---hccCcHHHHHHh
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL---KKMANDEHLHKA  439 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~~~~~~~  439 (531)
                      ++.++|..+|  ++|.|+.+||..++...  ....+++..+|+.+|.|++|.|+.+||..++...   ......+.+..+
T Consensus        10 e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~   85 (109)
T 1rwy_A           10 DIKKAIGAFT--AADSFDHKKFFQMVGLK--KKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTL   85 (109)
T ss_dssp             HHHHHHHTTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHH
T ss_pred             HHHHHHHHcC--CCCcEeHHHHHHHHhcC--cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHH
Confidence            4566677777  89999999998887432  3457789999999999999999999999988766   344677889999


Q ss_pred             hcccCCCCCcceeHHHHHHHHhh
Q 009594          440 FSFFDRNRSGFIEIEELRNALND  462 (531)
Q Consensus       440 F~~~D~~~~G~i~~~el~~~l~~  462 (531)
                      |+.+|.|++|.|+.+||..++..
T Consensus        86 ~~~~D~~~dg~i~~~eF~~~~~~  108 (109)
T 1rwy_A           86 MAAGDKDGDGKIGVEEFSTLVAE  108 (109)
T ss_dssp             HHHHCTTCSSSEEHHHHHHHHHT
T ss_pred             HHHHCCCCCCcCCHHHHHHHHHc
Confidence            99999999999999999998764

>3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A

Probab=99.15  E-value=4.4e-11  Score=94.14  Aligned_cols=70  Identities=23%  Similarity=0.248  Sum_probs=62.0

Q ss_pred             hHHHhhHHHHhcccc-cCCC-CcccHHHHHHHHHh-----CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          358 VEEVAGLKEAFEMMD-TNKR-GKINLEELRLGLLK-----GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D-~~~~-g~i~~~el~~~l~~-----~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      +..+..|.++|+.|| +|++ |+|+.+||+.+++.     +|..++.++++.+++.+|.|+||.|+|+||+.++...
T Consensus         6 e~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~~   82 (101)
T 3nso_A            6 EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACL   82 (101)
T ss_dssp             HHHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            345678999999998 8887 99999999999986     4678889999999999999999999999999977543

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4

Probab=99.15  E-value=1.3e-10  Score=93.72  Aligned_cols=95  Identities=13%  Similarity=0.128  Sum_probs=80.1

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh---hccCcHHHHHHh
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL---KKMANDEHLHKA  439 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~~~~~~~  439 (531)
                      ++.++|..+|  ++|.|+.+||..++...  ....+++..+|+.+|.|++|.|+.+||..++...   ......+.+..+
T Consensus        11 e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~   86 (109)
T 1bu3_A           11 DVAAALKACE--AADSFNYKAFFAKVGLT--AKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAF   86 (109)
T ss_dssp             HHHHHHHHTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHH
T ss_pred             HHHHHHHHhC--CCCcCcHHHHHHHHHcC--hhhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHH
Confidence            4556666777  89999999998887532  3456789999999999999999999999988766   444677889999


Q ss_pred             hcccCCCCCcceeHHHHHHHHh
Q 009594          440 FSFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       440 F~~~D~~~~G~i~~~el~~~l~  461 (531)
                      |+.+|.|++|.|+.+||..++.
T Consensus        87 ~~~~D~~~dg~i~~~eF~~~~~  108 (109)
T 1bu3_A           87 LKAGDSDGDGAIGVDEWAALVK  108 (109)
T ss_dssp             HHHHCTTCSSEECHHHHHHHHT
T ss_pred             HHHhCCCCCCcEeHHHHHHHHh
Confidence            9999999999999999998875

>3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ...

Probab=99.14  E-value=6.4e-11  Score=92.28  Aligned_cols=64  Identities=22%  Similarity=0.497  Sum_probs=59.6

Q ss_pred             HHHHHhhcccCCCCCc---ceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSG---FIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G---~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +.++.+|+.|| +++|   +|+.+||+.+|+.     +|..+++++++.+|+.+|.|+||.|+|+||+.++..
T Consensus         9 ~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~   80 (92)
T 3rm1_A            9 VALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFVAM   80 (92)
T ss_dssp             HHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence            56899999999 7776   9999999999998     888899999999999999999999999999999875

>3qr0_A Phospholipase C-beta (PLC-beta); PH domain, EF hand, C2 domain, TIM barrel domain, hydrolase, calcium binding, phospholipid binding; 2.00A {Sepia officinalis} PDB: 3qr1_A

Probab=99.14  E-value=4.4e-11  Score=128.00  Aligned_cols=124  Identities=16%  Similarity=0.283  Sum_probs=104.3

Q ss_pred             ccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhc-------CCCCCCceecchhHhHHHHhhccCcHHHHHHhhcc
Q 009594          370 MMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAA-------DVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSF  442 (531)
Q Consensus       370 ~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~-------D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~  442 (531)
                      .+|+|+||.|+.+|+...+...+.  ...++..+++..       |.+++|.|+|+||..++..+.   ..++++.+|+.
T Consensus       163 ~fd~n~dG~Is~kEl~~~l~~~~~--~~~el~~~~~~~~~~~~k~D~~~~g~L~FeEF~~f~~~L~---~R~EI~eiF~~  237 (816)
T 3qr0_A          163 TTVEMEKNKIPVKAIQKCLSKDKD--DRARISKALEKIGWPSGKNDAIDLKAFDFDTFFKFYLALL---ERSEIEGIFKE  237 (816)
T ss_dssp             HHTSCCSSEEEHHHHHHHHCSCHH--HHHHHHHHHHHHTSCCSTTCEEETTTCCHHHHHHHHHHHC---CCTHHHHHHHH
T ss_pred             hccCCCCCCCCHHHHHHHHHhcCC--hHHHHHHHHHHhcccccccccCCCCcCCHHHHHHHHHhcC---CHHHHHHHHHH
Confidence            378999999999999998876431  135688888877       677899999999999887654   24579999999


Q ss_pred             cCCCCCcceeHHHHHHHHhhcC-CC---------CCHHHHHHHHHhccC--C----CCcceeHHHHHHHHHhC
Q 009594          443 FDRNRSGFIEIEELRNALNDEV-DT---------SGEDVINAIMHDVDT--D----KDGRISYEEFAVMMKAG  499 (531)
Q Consensus       443 ~D~~~~G~i~~~el~~~l~~~~-~~---------~~~~~~~~~~~~~D~--~----~dG~i~~~Ef~~~~~~~  499 (531)
                      ||.|++|.||. ||+.+|...+ +.         .+.++++.++..++.  |    ++|.|++++|..+|...
T Consensus       238 y~~dg~~~mT~-eL~~FL~~~Q~E~~~~~~~~~~~t~e~~~~iI~kye~~~~~~~~~~g~LsldgF~~yL~S~  309 (816)
T 3qr0_A          238 LSKNKGNITTV-MFRDFLNDMQRHPSLHKTLFPLYTDAQCEALINDYESAVNKKGKKKGQLTKEGLLYFLMCE  309 (816)
T ss_dssp             HTTTSSSEEHH-HHHHHHHHTSSCTTSCTTTSCCCCHHHHHHHHHHHHHHHHGGGCBTTEECHHHHHHHHHSG
T ss_pred             HccCCCCcccH-HHHHHHHHhCCccccccccccccCHHHHHHHHHHhccccchhhhccCCccHHHHHHHhhcc
Confidence            99999999999 9999999875 43         578899999999887  5    78999999999999853

>2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A

Probab=99.14  E-value=3.8e-11  Score=94.12  Aligned_cols=66  Identities=20%  Similarity=0.375  Sum_probs=60.2

Q ss_pred             HHHHHHhhcccC-CCCCc-ceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFD-RNRSG-FIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D-~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+.++.+|+.|| .|++| +|+.+||+.+|+.     +|..+++++++.++..+|.|+||.|+|+||+.++..
T Consensus        11 ~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~   83 (95)
T 2wcb_A           11 LEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAI   83 (95)
T ss_dssp             HHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence            357899999999 89998 9999999999986     566788999999999999999999999999999875

>1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A

Probab=99.14  E-value=5.1e-11  Score=93.37  Aligned_cols=66  Identities=18%  Similarity=0.385  Sum_probs=54.8

Q ss_pred             HHHHHHhhcccC-CCC-CcceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFD-RNR-SGFIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D-~~~-~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+.++.+|+.|| .|+ +|+|+.+||+.+|+.     +|..+++++++.++..+|.|+||.|+|+||+.++..
T Consensus         8 ~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~   80 (95)
T 1j55_A            8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAA   80 (95)
T ss_dssp             HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence            356899999999 788 589999999999986     566678889999999999999999999999999875

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica}

Probab=99.14  E-value=8.6e-12  Score=90.65  Aligned_cols=63  Identities=24%  Similarity=0.418  Sum_probs=57.7

Q ss_pred             HHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       436 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ++.+|+.+|.|++|.|+.+||..++..+|..++.++++.+|..+|.|++|.|+++||+.++..
T Consensus         2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~   64 (66)
T 3li6_A            2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGS   64 (66)
T ss_dssp             CCHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHTC
T ss_pred             HHHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            357899999999999999999999999888788889999999999999999999999998864

>1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A

Probab=99.13  E-value=6e-11  Score=91.27  Aligned_cols=73  Identities=18%  Similarity=0.150  Sum_probs=67.5

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHH---HHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD---LQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~---~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      +..++++++.+++++|..+|.+++|+|+.+||..+++.+|..++..+   +..+|..+|.|++|.|+| ||+.++..
T Consensus         5 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~~~   80 (86)
T 1j7q_A            5 ARALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLCSK   80 (86)
T ss_dssp             CCCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHHHH
Confidence            34567788899999999999999999999999999999999999999   999999999999999999 99987754

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=99.12  E-value=6.3e-11  Score=92.91  Aligned_cols=64  Identities=20%  Similarity=0.301  Sum_probs=59.0

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+.++.+|+.||.|++|+|+.+|++.+|..+|  +++++++.++..+|.|+||.|+|+||+.+|..
T Consensus         9 ~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~   72 (95)
T 1c07_A            9 KAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAFHL   72 (95)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence            46789999999999999999999999999886  57889999999999999999999999998853

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A

Probab=99.12  E-value=1.7e-10  Score=92.99  Aligned_cols=95  Identities=11%  Similarity=0.149  Sum_probs=79.0

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh---hccCcHHHHHHh
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL---KKMANDEHLHKA  439 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~~~~~~~  439 (531)
                      ++.++|..+|  ++|.|+.+||..++..  .....+++..+|+.+|.|++|.|+.+||..++...   ......+.+..+
T Consensus        10 e~~~~~~~~d--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~   85 (108)
T 1rro_A           10 DIAAALQECQ--DPDTFEPQKFFQTSGL--SKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSL   85 (108)
T ss_dssp             HHHHHHHHTC--STTCCCHHHHHHHHSG--GGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHH
T ss_pred             HHHHHHHHcc--CCCCcCHHHHHHHHhc--CcccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHH
Confidence            4555666667  8999999999888743  23457789999999999999999999999887765   234567889999


Q ss_pred             hcccCCCCCcceeHHHHHHHHh
Q 009594          440 FSFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       440 F~~~D~~~~G~i~~~el~~~l~  461 (531)
                      |+.+|.|++|.|+.+||..++.
T Consensus        86 ~~~~D~~~dg~i~~~eF~~~~~  107 (108)
T 1rro_A           86 MDAADNDGDGKIGADEFQEMVH  107 (108)
T ss_dssp             HHHHCCSSSSSEEHHHHHHHHT
T ss_pred             HHHhCCCCCCcCcHHHHHHHHc
Confidence            9999999999999999998875

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6

Probab=99.12  E-value=4.6e-11  Score=94.27  Aligned_cols=64  Identities=19%  Similarity=0.234  Sum_probs=59.3

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+.++.+|+.||+|++|+|+.+|++.+|+.+|  ++++++..++..+|.|+||.|+|+||+.+|..
T Consensus        10 ~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~--l~~~~l~~i~~~~D~d~dG~i~~~EF~~~~~~   73 (99)
T 1qjt_A           10 NPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVALRL   73 (99)
T ss_dssp             CTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence            45689999999999999999999999999886  57899999999999999999999999999863

>1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A*

Probab=99.12  E-value=1.2e-10  Score=94.56  Aligned_cols=88  Identities=17%  Similarity=0.197  Sum_probs=64.5

Q ss_pred             hHHHhhHHHHhccccc-CCCC-cccHHHHHHHHH-hCCCC-----CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc
Q 009594          358 VEEVAGLKEAFEMMDT-NKRG-KINLEELRLGLL-KGGQN-----IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK  429 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~-~~~g-~i~~~el~~~l~-~~~~~-----~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~  429 (531)
                      ++++..++++|..||. |++| +|+.+||+.+++ .++..     ++..+++.+|..+|.|+||.|+|+||+.++.... 
T Consensus         8 ~~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~-   86 (113)
T 1xk4_C            8 ERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLT-   86 (113)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHHH-
Confidence            3456789999999995 9999 999999999999 77742     5788999999999999999999999999876443 


Q ss_pred             cCcHHHHHHhhcccCCCCCcce
Q 009594          430 MANDEHLHKAFSFFDRNRSGFI  451 (531)
Q Consensus       430 ~~~~~~~~~~F~~~D~~~~G~i  451 (531)
                          ......|...| +++|.-
T Consensus        87 ----~~~~~~f~~~~-~~~g~~  103 (113)
T 1xk4_C           87 ----WASHEKMHEGD-EGPGHH  103 (113)
T ss_dssp             ----HHHHC-------------
T ss_pred             ----HHHHHHHhhCC-CCCccc
Confidence                34567788888 888863

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.11  E-value=1.5e-10  Score=114.98  Aligned_cols=144  Identities=19%  Similarity=0.343  Sum_probs=105.6

Q ss_pred             eccccCccCceEEEEEEEccCCcEEEEEEee--ccccCChhhHHHHHHHHHHHHhCCC-CCCeeecceEEEcC---CeEE
Q 009594           60 LGRELGRGEFGVTYLCTDVNNGEKFACKSIS--KKKLRTAVDIEDVRREVQIMKHLPK-HPNIVSLKDTYEDD---SAVH  133 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~---~~~~  133 (531)
                      .++.|+.|.++.||++..  .+..+++|+..  ....  ......+.+|+.+++.|.. +..+++++.++.+.   +..+
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            356789999999999874  35688888775  3221  1123467789999999943 34578888888765   4589


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE--------------------------------------  175 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~--------------------------------------  175 (531)
                      +||||++|.++.+..  ...++......++.+++.+|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999999998885421  2346788889999999999999997                                      


Q ss_pred             --------------------cCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          176 --------------------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       176 --------------------~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                                          ..++|+|++|.||+++.++. ..+.|+||+.+...
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~g  249 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECccccccC
Confidence                                35899999999999975432 33589999988653

>1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A

Probab=99.11  E-value=5.1e-11  Score=89.22  Aligned_cols=67  Identities=31%  Similarity=0.550  Sum_probs=62.1

Q ss_pred             cHHHHHHhhccc-CCCCC-cceeHHHHHHHHhhcCCCC--CHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          432 NDEHLHKAFSFF-DRNRS-GFIEIEELRNALNDEVDTS--GEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       432 ~~~~~~~~F~~~-D~~~~-G~i~~~el~~~l~~~~~~~--~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..+.++.+|+.| |.|++ |+|+.+||..+|..+|..+  +.++++.++..+|.|++|.|+|+||+.++..
T Consensus         3 ~~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~   73 (76)
T 1qx2_A            3 SPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKK   73 (76)
T ss_dssp             CHHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence            356789999999 99999 9999999999999999888  8889999999999999999999999998864

>1eg3_A Dystrophin; EF-hand like domain, WW domain, structural protein; 2.00A {Homo sapiens} SCOP: a.39.1.7 a.39.1.7 b.72.1.1 PDB: 1eg4_A

Probab=99.11  E-value=7e-10  Score=102.13  Aligned_cols=93  Identities=13%  Similarity=0.143  Sum_probs=80.9

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC--------------
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG--------------  499 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~--------------  499 (531)
                      ..+..+|+.||.|++|.|++.||+.+|..+.....++.++-+|+.+| |+||.|+.+|+..+++..              
T Consensus       132 ~~a~~lf~~FD~~~~G~I~f~ef~~aLs~l~rG~leeKL~w~F~lyD-D~~G~I~~~El~~il~~i~~i~~~vge~~~~~  210 (261)
T 1eg3_A          132 MCLNWLLNVYDTGRTGRIRVLSFKTGIISLCKAHLEDKYRYLFKQVA-SSTGFCDQRRLGLLLHDSIQIPRQLGEVASFG  210 (261)
T ss_dssp             HHHHHHHHHHCTTCCSEEEHHHHHHHHHHTSSSCHHHHHHHHHHHHS-CTTSCBCHHHHHHHHHHHHHHHHHTTCGGGGT
T ss_pred             HHHHHHHHHccCCCCceEeHHHHHHHHHHHcCCCHHHHHHHHHheee-CCCCCCcHHHHHHHHHHHHHHHHhcCCcccCC
Confidence            34677999999999999999999999998876667788999999999 999999999999988530              


Q ss_pred             -----chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          500 -----TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       500 -----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                           +.++..|...|  +||.||.+||.+.++.-
T Consensus       211 ~~~~e~~v~~~F~~~d--~dg~It~~EFl~~~~~d  243 (261)
T 1eg3_A          211 GSNIEPSVRSCFQFAN--NKPEIEAALFLDWMRLE  243 (261)
T ss_dssp             CSCCHHHHHHHHHHTT--TCSCBCHHHHHHHHHTC
T ss_pred             CCCHHHHHHHHHHhCC--CCCcCCHHHHHHHHHhC
Confidence                 12788999886  89999999999988753

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens}

Probab=99.10  E-value=2e-10  Score=92.75  Aligned_cols=64  Identities=23%  Similarity=0.349  Sum_probs=59.0

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+.++.+|+.||.|++|+|+.+||+.+|.  +..++.++++.++..+|.|+||.|+|+||+.++..
T Consensus        13 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~~   76 (111)
T 2kgr_A           13 RLKYRQLFNSHDKTMSGHLTGPQARTILM--QSSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHL   76 (111)
T ss_dssp             HHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TTCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence            46788999999999999999999999998  56678999999999999999999999999998864

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6

Probab=99.10  E-value=1.2e-10  Score=90.81  Aligned_cols=69  Identities=23%  Similarity=0.283  Sum_probs=62.7

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      ++.++..+++++|+.+|+|++|+|+.+|++.+++.+|  ++..+++.++..+|.|++|.|+|+||+.++..
T Consensus         3 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~   71 (92)
T 1fi6_A            3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAFHL   71 (92)
T ss_dssp             CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            3567888999999999999999999999999999886  67889999999999999999999999987653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	531
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-94
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-92
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-89
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-89
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-87
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-86
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-86
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-84
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-84
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-84
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-83
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-81
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-81
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-77
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-76
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-76
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-76
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-74
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-73
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-73
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-73
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-70
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-69
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-68
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-68
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-68
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-67
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-66
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-66
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-65
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-65
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-65
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-65
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-64
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-61
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-61
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-60
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-56
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-55
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-49
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-46
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-45
d1topa_	162	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	2e-28
d1exra_	146	a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr	1e-27
d1exra_	146	a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr	5e-07
d1lkja_	146	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	6e-27
d1lkja_	146	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	2e-06
d1s6ia_	182	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	1e-26
d1bjfa_	181	a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId	1e-23
d2obha1	141	a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien	2e-23
d2obha1	141	a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien	2e-05
d1dtla_	156	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	5e-23
d1g8ia_	187	a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1	6e-23
d2zfda1	183	a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {	3e-22
d2pvba_	107	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	3e-21
d2pvba_	107	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	2e-09
d1fpwa_	190	a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1	4e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-21
d1jbaa_	189	a.39.1.5 (A:) Guanylate cyclase activating protein	1e-20
d1jbaa_	189	a.39.1.5 (A:) Guanylate cyclase activating protein	2e-07
d1qxpa2	188	a.39.1.8 (A:515-702) Calpain large subunit, C-term	3e-20
d1rroa_	108	a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus)	1e-19
d1rroa_	108	a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus)	4e-11
d1w7jb1	139	a.39.1.5 (B:11-149) Myosin Essential Chain {Human	2e-19
d1k94a_	165	a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [Ta	2e-19
d1k94a_	165	a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [Ta	8e-11
d1pvaa_	109	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	2e-19
d1pvaa_	109	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	7e-11
d1juoa_	172	a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId:	4e-19
d5pala_	109	a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis	4e-19
d5pala_	109	a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis	3e-10
d1uhka1	187	a.39.1.5 (A:3-189) Calcium-regulated photoprotein	1e-18
d1uhka1	187	a.39.1.5 (A:3-189) Calcium-regulated photoprotein	7e-06
d1s6ca_	178	a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera	2e-18
d1s6ca_	178	a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera	4e-06
d1rwya_	109	a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta	2e-18
d1rwya_	109	a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta	2e-10
d1rwya_	109	a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta	2e-05
d1s6ja_	87	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	2e-18
d1s6ja_	87	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	1e-12
d1df0a1	186	a.39.1.8 (A:515-700) Calpain large subunit, C-term	4e-18
d1xo5a_	180	a.39.1.5 (A:) Calcium- and integrin-binding protei	7e-18
d1alva_	173	a.39.1.8 (A:) Calpain small (regulatory) subunit (	1e-17
d1nyaa_	176	a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth	3e-17
d1nyaa_	176	a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth	4e-06
d1wdcc_	152	a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop	3e-17
d1wdcb_	142	a.39.1.5 (B:) Myosin Essential Chain {Bay scallop	3e-17
d1qv0a_	189	a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr	3e-17
d2scpa_	174	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	2e-16
d2sasa_	185	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	6e-16
d2sasa_	185	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	5e-04
d2sasa_	185	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	6e-04
d1ggwa_	140	a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharo	9e-16
d1jc2a_	75	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	2e-15
d1jc2a_	75	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	5e-11
d1omra_	201	a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId:	2e-15
d1omra_	201	a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId:	4e-05
d1m45a_	146	a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye	4e-15
d1fi5a_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus),	6e-15
d1fi5a_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus),	4e-11
d1fi5a_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus),	8e-04
d2zkmx1	170	a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human	6e-15
d1oqpa_	77	a.39.1.5 (A:) Caltractin (centrin 2) {Green algae	2e-14
d1oqpa_	77	a.39.1.5 (A:) Caltractin (centrin 2) {Green algae	3e-12
d1c7va_	68	a.39.1.5 (A:) Calcium vector protein {Amphioxus (B	2e-14
d1c7va_	68	a.39.1.5 (A:) Calcium vector protein {Amphioxus (B	9e-13
d1avsa_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	4e-14
d1avsa_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	2e-11
d1tiza_	67	a.39.1.5 (A:) Calmodulin-related protein T21P5.17	4e-14
d1tiza_	67	a.39.1.5 (A:) Calmodulin-related protein T21P5.17	5e-12
d1auib_	165	a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch	8e-14
d2pq3a1	73	a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T	2e-13
d2pq3a1	73	a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T	2e-10
d1jfja_	134	a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histoly	3e-13
d2opoa1	81	a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che	3e-13
d2opoa1	81	a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che	4e-12
d2opoa1	81	a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che	9e-05
d1ij5a_	321	a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind	7e-13
d1ij5a_	321	a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind	2e-11
d1ij5a_	321	a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind	7e-07
d1ij5a_	321	a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind	4e-05
d1wrka1	82	a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens)	7e-13
d1wrka1	82	a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens)	1e-10
d1f54a_	77	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	7e-13
d1f54a_	77	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	2e-10
d1f54a_	77	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	4e-04
d1hqva_	181	a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous	1e-12
d1y1xa_	182	a.39.1.8 (A:) Programmed cell death 6 protein-like	2e-12
d1y1xa_	182	a.39.1.8 (A:) Programmed cell death 6 protein-like	9e-05
d1fw4a_	65	a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId:	4e-12
d1fw4a_	65	a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId:	6e-10
d1fw4a_	65	a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId:	0.003
d1qx2a_	76	a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax	1e-11
d1qx2a_	76	a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax	1e-06
d1cb1a_	78	a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [Tax	4e-11
d1cb1a_	78	a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [Tax	3e-09
d2fcea1	61	a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [	1e-10
d2fcea1	61	a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [	2e-10
d1snla_	99	a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo	4e-10
d1snla_	99	a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo	1e-06
d1a4pa_	92	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	9e-10
d1a4pa_	92	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	5e-09
d3c1va1	93	a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sa	5e-09
d3c1va1	93	a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sa	2e-08
d1yuta1	98	a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sa	5e-09
d1yuta1	98	a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sa	5e-06
d1c07a_	95	a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId:	1e-08
d1c07a_	95	a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId:	3e-08
d1qjta_	99	a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId:	2e-08
d1qjta_	99	a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId:	5e-04
d1wlza1	83	a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {H	2e-08
d1wlza1	83	a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {H	1e-07
d1xk4a1	87	a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sa	2e-08
d1xk4a1	87	a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sa	1e-05
d1ksoa_	93	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	4e-08
d1ksoa_	93	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	3e-04
d1zfsa1	93	a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus no	5e-08
d1zfsa1	93	a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus no	1e-07
d1k8ua_	89	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	7e-08
d1k8ua_	89	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	5e-05
d1fi6a_	92	a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId:	2e-07
d1fi6a_	92	a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId:	4e-06
d1psra_	100	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	2e-07
d1psra_	100	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	4e-06
d2jxca1	95	a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [	9e-07
d2jxca1	95	a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [	3e-05
d1e8aa_	87	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	2e-06
d1e8aa_	87	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	4e-04
d2pula1	392	d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {	6e-06
d1iq3a_	110	a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9	2e-05
d1iq3a_	110	a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9	2e-05
d2hf5a1	33	a.39.1.5 (A:81-113) Troponin C {Human (Homo sapien	7e-05
d1xk4c1	83	a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sa	7e-05
d1j55a_	94	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	1e-04
d3cr5x1	90	a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos tauru	2e-04
d1qlsa_	95	a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa),	3e-04

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  288 bits (738), Expect = 1e-94
 Identities = 112/297 (37%), Positives = 174/297 (58%), Gaps = 5/297 (1%)

Query: 51  GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
            +DI   YD    LG G F    L  D    +  A K I+KK L        +  E+ ++
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVL 61

Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
             + KHPNIV+L D YE    ++++M+L  GGELFDRIV +G YTER A+ ++  +++ V
Sbjct: 62  HKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
           +  H+ G++HRDLKPEN L+ +  E S +   DFGLS    PG   +   G+P Y+APEV
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180

Query: 231 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
           L  + Y   VD WS GVI YILLCG PPF+ E +  + + I+++  +F    W  +S++A
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
           KD ++ ++  DP++R T E+ L+HPW+     A + ++ ++V  ++K+    +K K+
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAG-DTALDKNIHQSVSEQIKKNFAKSKWKQ 296

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  284 bits (728), Expect = 2e-92
 Identities = 104/336 (30%), Positives = 161/336 (47%), Gaps = 28/336 (8%)

Query: 48  EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           E     +   YD+  ELG G FGV + C +   G  F  K I+       +D   V+ E+
Sbjct: 21  EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEI 77

Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTI 166
            IM  L  HP +++L D +ED   + +++E   GGELFDRI A  +  +E      M+  
Sbjct: 78  SIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
            E ++  HE  ++H D+KPEN +   KK SS +K IDFGL+    P E       +  + 
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFA 195

Query: 227 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
           APE++ R   G   D+W+ GV+ Y+LL G+ PF  E +    Q + R   +F  D +  V
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN---------------------AKKAPN 324
           S  AKD +K +L  +P++RLT  + LEHPWL+                       +K  +
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315

Query: 325 VSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
               +    R+  FS + K + +  Q+   +   +E
Sbjct: 316 WPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  275 bits (705), Expect = 1e-89
 Identities = 87/305 (28%), Positives = 160/305 (52%), Gaps = 12/305 (3%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
           +++   Y +  +LGRGEFG+ + C + ++ + +  K +  K      D   V++E+ I+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVV 170
              +H NI+ L +++E    + ++ E   G ++F+RI        ER   + +  + E +
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
           Q  H   + H D++PEN ++  ++ S  +K I+FG +   +PG+ F  +  +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
            + +      D+WS G ++Y+LL G+ PF AET Q + + I+ +   F  + + ++S  A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 349
            D V ++L  + K R+TA E L+HPWL+   +  +  +  T    LK     + L K+ L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT----LKHRRYYHTLIKKDL 290

Query: 350 QVVAE 354
            +V  
Sbjct: 291 NMVVS 295

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  276 bits (707), Expect = 2e-89
 Identities = 95/272 (34%), Positives = 142/272 (52%), Gaps = 7/272 (2%)

Query: 48  EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           E     +   YD+  ELG G FGV +  T+   G  FA K +         D E VR+E+
Sbjct: 18  EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEI 74

Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTI 166
           Q M  L +HP +V+L D +EDD+ + ++ E   GGELF+++       +E  A   M+ +
Sbjct: 75  QTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
            + +   HE   +H DLKPEN +F  K  S+ LK IDFGL+    P +      G+  + 
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 192

Query: 227 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
           APEV + +  G   D+WS GV+ YILL G+ PF  E +    + +     +     +  +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           SE+ KD ++K+L  DP  R+T  + LEHPWL 
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  268 bits (686), Expect = 2e-87
 Identities = 97/274 (35%), Positives = 144/274 (52%), Gaps = 16/274 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD------IEDVRREVQIM 110
           +Y+    LGRG   V   C      +++A K I      +          E   +EV I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
           + +  HPNI+ LKDTYE ++   +V +L + GELFD +  +   +E+    +M+ ++EV+
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
              H+  ++HRDLKPEN L  +      +K  DFG S    PGE+  E+ G+P Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 231 L-------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
           +          YG EVD+WS GVI+Y LL G PPFW   +  + + I+     F    W 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
             S+  KDLV + L   P++R TAEE L HP+ Q
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  266 bits (680), Expect = 1e-86
 Identities = 92/262 (35%), Positives = 142/262 (54%), Gaps = 10/262 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+++GR LG+G+FG  YL  +  +    A K + K +L  A     +RREV+I  HL +H
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 65

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           PNI+ L   + D + V++++E    G ++  +     + E+  A  +  +   +  CH +
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            V+HRD+KPEN L  +  E   LK  DFG SV   P  +   + G+  Y+ PE+++ R +
Sbjct: 126 RVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
             +VD+WS GV+ Y  L G PPF A T Q   + I R    F       V+E A+DL+ +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLISR 237

Query: 296 MLNPDPKQRLTAEEVLEHPWLQ 317
           +L  +P QR    EVLEHPW+ 
Sbjct: 238 LLKHNPSQRPMLREVLEHPWIT 259

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  267 bits (682), Expect = 1e-86
 Identities = 100/272 (36%), Positives = 158/272 (58%), Gaps = 6/272 (2%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVDIEDVRREVQ 108
           +++   YD G ELG G+F V   C + + G ++A K I K++    R  V  ED+ REV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           I+K + +HPN+++L + YE+ + V +++EL  GGELFD +  +   TE  A   +K I+ 
Sbjct: 66  ILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
            V   H   + H DLKPEN +  ++    P +K IDFGL+     G +F  I G+P ++A
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184

Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           PE++     G E D+WS GVI YILL G  PF  +T+Q     +     +F+ + +   S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
             AKD ++++L  DPK+R+T ++ L+HPW++ 
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  260 bits (665), Expect = 5e-84
 Identities = 85/287 (29%), Positives = 136/287 (47%), Gaps = 25/287 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+  G+ LG G F    L  ++    ++A K + K+ +     +  V RE  +M  L  H
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P  V L  T++DD  ++  +   + GEL   I   G + E         IV  ++  H +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK- 232
           G++HRDLKPEN L     E   ++  DFG +    P  +    N  VG+  Y++PE+L  
Sbjct: 128 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
           ++     D+W+ G I+Y L+ G+PPF A  E  + Q II+   DF      K    A+DL
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARDL 240

Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN-------AKKAPNVS 326
           V+K+L  D  +RL  EE      +  HP+ ++        +  P ++
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (663), Expect = 7e-84
 Identities = 81/270 (30%), Positives = 129/270 (47%), Gaps = 12/270 (4%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+DL + LG G +G   L  +    E  A K +  K+       E++++E+ I K L  H
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-NH 62

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            N+V       + +  ++ +E C GGELFDRI       E  A      ++  V   H  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLKR 233
           G+ HRD+KPEN L   +     LK  DFGL+  FR   +    N++ G+  Y+APE+LKR
Sbjct: 123 GITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 234 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
              +   VDVWS G++L  +L G  P+   ++     +  +    +  +PW K+      
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPLA 238

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
           L+ K+L  +P  R+T  ++ +  W     K
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNKPLK 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  260 bits (666), Expect = 7e-84
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 15/303 (4%)

Query: 52  QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
            D    +   RE+G G FG  Y   DV N E  A K +S    ++    +D+ +EV+ ++
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
            L +HPN +  +  Y  +    +VME C G       V +    E   AAV    ++ + 
Sbjct: 71  KL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
             H   ++HRD+K  N L +       +K  DFG +    P   F   VG+PY+MAPEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAPANSF---VGTPYWMAPEVI 183

Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
               +  Y  +VDVWS G+    L    PP +          I ++  +         SE
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSE 241

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR 347
             ++ V   L   P+ R T+E +L+H ++   +  P   + + ++        ++ L+ R
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQYR 299

Query: 348 ALQ 350
            ++
Sbjct: 300 KMK 302

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (663), Expect = 1e-83
 Identities = 82/279 (29%), Positives = 143/279 (51%), Gaps = 11/279 (3%)

Query: 50  SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
           S  D    Y    ++G+G  G  Y   DV  G++ A + ++ ++       E +  E+ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILV 70

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
           M+   K+PNIV+  D+Y     + +VME   GG L D +V      E   AAV +  ++ 
Sbjct: 71  MREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQA 128

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAP 228
           ++  H   V+HRD+K +N L         +K  DFG          + + +VG+PY+MAP
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           EV+ R  YGP+VD+WS G++   ++ G PP+  E        I  +     ++P  K+S 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSA 244

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVS 326
             +D + + L+ D ++R +A+E+L+H +L+ AK   +++
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  253 bits (647), Expect = 3e-81
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 16/279 (5%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           +    +++  ELG G FG  Y   +       A K I  K      ++ED   E+ I+  
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILAS 65

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQ 171
              HPNIV L D +  ++ + I++E C GG +   ++      TE     V K  ++ + 
Sbjct: 66  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEV 230
             H+  ++HRDLK  N LF    +   +K  DFG+S    R  ++ +  +G+PY+MAPEV
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181

Query: 231 L------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           +       R Y  + DVWS G+ L  +    PP        V   I +S       P  +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SR 240

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
            S N KD +KK L  +   R T  ++L+HP++      P
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (650), Expect = 4e-81
 Identities = 105/316 (33%), Positives = 154/316 (48%), Gaps = 21/316 (6%)

Query: 57  DYD-LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
           DY    + LG G  G      +    EKFA K +              RREV++     +
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQ 63

Query: 116 HPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
            P+IV + D YE+       + IVME  +GGELF RI  RG   +TER A+ +MK+I E 
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
           +Q  H   + HRD+KPEN L+ +K+ ++ LK  DFG +              +PYY+APE
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183

Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----IDFKRDPWPK 284
           VL    Y    D+WS GVI+YILLCG PPF++     ++  +   +     +F    W +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 344
           VSE  K L++ +L  +P QR+T  E + HPW+  + K P   L  T +   +       +
Sbjct: 244 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-HTSRVLKEDKERWEDV 302

Query: 345 KKRALQVVAEFLSVEE 360
           K+     +A      E
Sbjct: 303 KEEMTSALATMRVDYE 318

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (618), Expect = 3e-77
 Identities = 60/273 (21%), Positives = 116/273 (42%), Gaps = 15/273 (5%)

Query: 54  ISID---YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
           +S D        E+GRG F   Y   D     + A   +  +KL T  + +  + E +++
Sbjct: 4   MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEML 62

Query: 111 KHLPKHPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
           K L +HPNIV   D++E        + +V EL   G L   +        +   +  + I
Sbjct: 63  KGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 121

Query: 167 VEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
           ++ +Q  H +   ++HRDLK +N        +  +K  D GL+   R       ++G+P 
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKR-ASFAKAVIGTPE 178

Query: 225 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           +MAPE+ +  Y   VDV++ G+ +  +     P+            + S +         
Sbjct: 179 FMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV 237

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                K++++  +  +  +R + +++L H + Q
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (612), Expect = 2e-76
 Identities = 84/273 (30%), Positives = 134/273 (49%), Gaps = 21/273 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY++   +G G +G        ++G+    K +    + T  + + +  EV +++ L KH
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KH 62

Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVV 170
           PNIV   D   D  ++ ++IVME CEGG+L   I      R +  E     VM  +   +
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 171 QVCHEQG-----VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPY 224
           + CH +      V+HRDLKP N     K+    +K  DFGL+        F    VG+PY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPY 179

Query: 225 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
           YM+PE + R  Y  + D+WS G +LY L   +PPF A +++ +A  I        R    
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPY 236

Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
           + S+   +++ +MLN     R + EE+LE+P +
Sbjct: 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (615), Expect = 4e-76
 Identities = 69/322 (21%), Positives = 120/322 (37%), Gaps = 50/322 (15%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D++   ELG G  GV +  +   +G   A K I  +          + RE+Q++      
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NS 63

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P IV     +  D  + I ME  +GG L   +   G   E+    V   +++ +    E+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
             +MHRD+KP N L  ++ E   +K  DFG+S         N  VG+  YM+PE L+  +
Sbjct: 124 HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTH 179

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI------------------- 275
           Y  + D+WS G+ L  +  G  P      + +       V                    
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 276 ---------------------DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
                                   + P    S   +D V K L  +P +R   ++++ H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 315 WLQNAKKAPNVSLGETVKARLK 336
           +++ +     V     + + + 
Sbjct: 300 FIKRSDAEE-VDFAGWLCSTIG 320

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 5e-76
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 10/265 (3%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ L + LG+G FG  +L       + FA K++ K  +    D+E    E +++    +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P +  +  T++    +  VME   GG+L   I +   +    A      I+  +Q  H +
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLK-RN 234
           G+++RDLK +N L     +   +K  DFG+      G+ + N   G+P Y+APE+L  + 
Sbjct: 123 GIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
           Y   VD WS GV+LY +L G  PF  + E+ +  +I      +       + + AKDL+ 
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLLV 235

Query: 295 KMLNPDPKQRLTAE-EVLEHPWLQN 318
           K+   +P++RL    ++ +HP  + 
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFRE 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  235 bits (600), Expect = 2e-74
 Identities = 68/270 (25%), Positives = 114/270 (42%), Gaps = 7/270 (2%)

Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           +S  Y+LG  LG G     +L  D+      A K +     R        RRE Q    L
Sbjct: 5   LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64

Query: 114 PKHPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
             HP IV++ DT E ++      +IVME  +G  L D +   G  T + A  V+    + 
Sbjct: 65  -NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123

Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG-LSVFFRPGEQFNEIVGSPYYMAP 228
           +   H+ G++HRD+KP N + +       +       ++       Q   ++G+  Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 229 EVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
           E  +  +     DV+S G +LY +L G PPF  ++   VA   +R            +S 
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243

Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
           +   +V K L  +P+ R      +    ++
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  236 bits (602), Expect = 1e-73
 Identities = 71/275 (25%), Positives = 126/275 (45%), Gaps = 15/275 (5%)

Query: 54  ISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK- 111
           +++ D+ + R +GRG FG  Y C   + G+ +A K + KK+++          E  ++  
Sbjct: 1   LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 112 -HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
                 P IV +   +     +  +++L  GG+L   +   G ++E         I+  +
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
           +  H + V++RDLKP N L     E   ++  D GL+  F    + +  VG+  YMAPEV
Sbjct: 121 EHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEV 176

Query: 231 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
           L++   Y    D +S G +L+ LL G  PF     +   + I R  +    +     S  
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPE 235

Query: 289 AKDLVKKMLNPDPKQRLT-----AEEVLEHPWLQN 318
            + L++ +L  D  +RL      A+EV E P+ ++
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  233 bits (596), Expect = 2e-73
 Identities = 74/268 (27%), Positives = 132/268 (49%), Gaps = 16/268 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D+ + R LG G FG  +L    +NG  +A K + K+ +     +E    E  ++  +  H
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-TH 63

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
           P I+ +  T++D   + ++M+  EGGELF  +     +    A      +   ++  H +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
            +++RDLKPEN L     ++  +K  DFG + +    +    + G+P Y+APEV+  + Y
Sbjct: 124 DIIYRDLKPENILLD---KNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
              +D WS G+++Y +L G  PF+        + I+ + + F     P  +E+ KDL+ +
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSR 234

Query: 296 MLNPDPKQRL-----TAEEVLEHPWLQN 318
           ++  D  QRL       E+V  HPW + 
Sbjct: 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 3e-73
 Identities = 82/269 (30%), Positives = 129/269 (47%), Gaps = 20/269 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED---VRREVQIMKHL 113
            Y +G  LG G FG  Y    V++    A K + K ++    ++ +   V  EV ++K +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 114 -PKHPNIVSLKDTYEDDSAVHIVMELCEGG-ELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
                 ++ L D +E   +  +++E  E   +LFD I  RG   E  A +    ++E V+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
            CH  GV+HRD+K EN L    +    LK IDFG     +    + +  G+  Y  PE +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWI 181

Query: 232 --KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
              R +G    VWS G++LY ++CG  PF  + E      IIR  + F+     +VS   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVSSEC 231

Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
           + L++  L   P  R T EE+  HPW+Q+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 1e-70
 Identities = 83/273 (30%), Positives = 138/273 (50%), Gaps = 16/273 (5%)

Query: 54  ISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           +++ D+D  + LG+G FG   L  +   G  +A K + K+ +    ++     E +++++
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
             +HP + +LK  ++    +  VME   GGELF  +     +TE  A      IV  ++ 
Sbjct: 62  T-RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL 231
            H + V++RD+K EN +     +   +K  DFGL       G       G+P Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 232 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
           + N YG  VD W  GV++Y ++CG  PF+ +  + + + I+   I F       +S  AK
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAK 233

Query: 291 DLVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
            L+  +L  DPKQRL      A+EV+EH +  +
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 8e-69
 Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 33/284 (11%)

Query: 64  LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD--IEDVRREVQIMKHLPKHPNIVS 121
           LG G+F   Y   D N  +  A K I       A D       RE+++++ L  HPNI+ 
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIG 64

Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
           L D +   S + +V +  E              T     A M   ++ ++  H+  ++HR
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124

Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVLK--RNYGPE 238
           DLKP N L     E+  LK  DFGL+  F  P   +   V + +Y APE+L   R YG  
Sbjct: 125 DLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP--------------- 283
           VD+W+ G IL  LL  VP    +++      I  ++     + WP               
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241

Query: 284 ---------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                       ++  DL++ +   +P  R+TA + L+  +  N
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  221 bits (563), Expect = 2e-68
 Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 49/303 (16%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           DY L R+LGRG++   +   ++ N EK   K +   K       + ++RE++I+++L   
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89

Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
           PNI++L D  +D  +    +V E     +           T+      M  I++ +  CH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-- 232
             G+MHRD+KP N +  +  E   L+ ID+GL+ F+ PG+++N  V S Y+  PE+L   
Sbjct: 147 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204

Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----------------- 275
           + Y   +D+WS G +L  ++    PF+   +       I  V+                 
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 276 -----------------DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                                +    VS  A D + K+L  D + RLTA E +EHP+   
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

Query: 319 AKK 321
             K
Sbjct: 325 VVK 327

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 5e-68
 Identities = 78/316 (24%), Positives = 125/316 (39%), Gaps = 47/316 (14%)

Query: 48  EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
           +   +   + Y   + +G G FGV Y     ++GE  A K + + K           RE+
Sbjct: 12  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNREL 64

Query: 108 QIMKHLPKHPNIVSLKDTY------EDDSAVHIVMELCEGG---ELFDRIVARGHYTERA 158
           QIM+ L  H NIV L+  +      +D+  +++V++               A+       
Sbjct: 65  QIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123

Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
               M  +   +   H  G+ HRD+KP+N L     +++ LK  DFG +     GE    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS 181

Query: 219 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-- 274
            + S YY APE++    +Y   +DVWSAG +L  LL G P F  ++       II+ +  
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241

Query: 275 -----------------------IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVL 311
                                    + +   P+    A  L  ++L   P  RLT  E  
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301

Query: 312 EHPWLQNAKKAPNVSL 327
            H +    +  PNV L
Sbjct: 302 AHSFFDELRD-PNVKL 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 9e-68
 Identities = 82/283 (28%), Positives = 150/283 (53%), Gaps = 18/283 (6%)

Query: 51  GQDISID-YDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKL-RTAVDIEDVRR 105
            + + I+ ++L + LG G +G  +L   ++    G+ +A K + K  + + A   E  R 
Sbjct: 18  AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77

Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
           E Q+++H+ + P +V+L   ++ ++ +H++++   GGELF  +  R  +TE      +  
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137

Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP--GEQFNEIVGSP 223
           IV  ++  H+ G+++RD+K EN L      +  +   DFGLS  F     E+  +  G+ 
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 224 YYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
            YMAP++++     +   VD WS GV++Y LL G  PF  + E+     I R ++  +  
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254

Query: 281 PWPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
              ++S  AKDL++++L  DPK+RL      A+E+ EH + Q 
Sbjct: 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 5e-67
 Identities = 74/313 (23%), Positives = 129/313 (41%), Gaps = 49/313 (15%)

Query: 49  PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
           P   ++S  Y+   ++G+G FG  +       G+K A K +  +  +    I    RE++
Sbjct: 4   PFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIK 61

Query: 109 IMKHLPKHPNIVSLKDTYEDDSA--------VHIVMELCEGGELFDRIVARGHYTERAAA 160
           I++ L KH N+V+L +     ++        +++V + CE             +T     
Sbjct: 62  ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120

Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----Q 215
            VM+ ++  +   H   ++HRD+K  N L         LK  DFGL+  F   +     +
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 216 FNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273
           +   V + +Y  PE+L  +R+YGP +D+W AG I+  +    P     TEQ     I + 
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 274 VIDFKRDPWPKV----------------------------SENAKDLVKKMLNPDPKQRL 305
                 + WP V                               A DL+ K+L  DP QR+
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 306 TAEEVLEHPWLQN 318
            +++ L H +  +
Sbjct: 298 DSDDALNHDFFWS 310

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 2e-66
 Identities = 56/267 (20%), Positives = 105/267 (39%), Gaps = 19/267 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
              +G+ +G G FG  Y           A K ++     T   ++  + EV +++   +H
Sbjct: 9   QITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RH 63

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHE 175
            NI+     Y     + IV + CEG  L+  + +    +       + +   + +   H 
Sbjct: 64  VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK 232
           + ++HRDLK  N           +K  DFGL+          QF ++ GS  +MAPEV++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 233 RN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP--WPKVS 286
                 Y  + DV++ G++LY L+ G  P+     +     ++                 
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEH 313
           +  K L+ + L     +R    ++L  
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (552), Expect = 2e-66
 Identities = 83/357 (23%), Positives = 138/357 (38%), Gaps = 53/357 (14%)

Query: 51  GQ--DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
           GQ  D+   Y     +G G +G+     D  N  + A K IS  + +T    +   RE++
Sbjct: 1   GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIK 58

Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVH----IVMELCEGGELFDRIVARGHYTERAAAAVMK 164
           I+    +H NI+ + D     +        ++    G +L+  +    H +       + 
Sbjct: 59  ILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLY 116

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE----QFNEIV 220
            I+  ++  H   V+HRDLKP N L     +   LK  DFGL+    P         E V
Sbjct: 117 QILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYV 173

Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
            + +Y APE++   + Y   +D+WS G IL  +L   P F  +        I+  +    
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233

Query: 279 RDPW---------------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVL 311
           ++                             P     A DL+ KML  +P +R+  E+ L
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

Query: 312 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAF 368
            HP+L+      +  + E   A  K    ++ L K  L+     L  EE A  +  +
Sbjct: 294 AHPYLEQYYDPSDEPIAE---APFKFDMELDDLPKEKLKE----LIFEETARFQPGY 343

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-65
 Identities = 71/297 (23%), Positives = 124/297 (41%), Gaps = 35/297 (11%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL--P 114
            Y+   E+G G +G  +   D+ NG +F      + +           REV +++HL   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 115 KHPNIVSLKD-----TYEDDSAVHIVMELCEGGEL-FDRIVARGHYTERAAAAVMKTIVE 168
           +HPN+V L D       + ++ + +V E  +     +   V            +M  ++ 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            +   H   V+HRDLKP+N L  +  +    K  DFGL+  +        +V + +Y AP
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
           EVL ++ Y   VD+WS G I   +    P F   ++      I+  +     + WP+   
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 285 --------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
                               + E  KDL+ K L  +P +R++A   L HP+ Q+ ++
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  210 bits (535), Expect = 7e-65
 Identities = 85/289 (29%), Positives = 128/289 (44%), Gaps = 34/289 (11%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y    ++G G +GV Y   + N GE FA K I  +K    +      RE+ I+K L KH
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGI-PSTTIREISILKEL-KH 59

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            NIV L D       + +V E  +        V  G      A + +  ++  +  CH++
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL--KR 233
            V+HRDLKP+N L   + E   LK  DFGL+  F  P  ++   + + +Y AP+VL   +
Sbjct: 120 RVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP---------- 283
            Y   +D+WS G I   ++ G P F   +E      I R +       WP          
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 284 ---------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                           + E+  DL+ KML  DP QR+TA++ LEH + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 9e-65
 Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 35/301 (11%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           ++    ++G G +GV Y   +   GE  A K I +    T        RE+ ++K L  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL-NH 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCE-GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
           PNIV L D    ++ +++V E      + F    A          + +  +++ +  CH 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVLKRN 234
             V+HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 235 --YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW---------- 282
             Y   VD+WS G I   ++     F  ++E      I R++       W          
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 283 ---------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA-KKAPNVS 326
                          P + E+ + L+ +ML+ DP +R++A+  L HP+ Q+  K  P++ 
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297

Query: 327 L 327
           L
Sbjct: 298 L 298

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 9e-65
 Identities = 74/291 (25%), Positives = 121/291 (41%), Gaps = 34/291 (11%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y+   ++G G +G  +   +    E  A K +        V      RE+ ++K L KH
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-KH 60

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
            NIV L D    D  + +V E C+           G        + +  +++ +  CH +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVL--KR 233
            V+HRDLKP+N L     E    K  +FGL+  F  P   ++  V + +Y  P+VL   +
Sbjct: 121 NVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 234 NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPW---------- 282
            Y   +D+WSAG I   L     P F         + I R +     + W          
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 283 ---------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
                          PK++   +DL++ +L  +P QR++AEE L+HP+  +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  211 bits (537), Expect = 3e-64
 Identities = 76/280 (27%), Positives = 135/280 (48%), Gaps = 17/280 (6%)

Query: 46  LKEPSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
            + PS     +D +D  + LG G FG   L     +G  +A K + K+K+     IE   
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL 89

Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
            E +I++ +   P +V L+ +++D+S +++VME   GGE+F  +   G ++E  A     
Sbjct: 90  NEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148

Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
            IV   +  H   +++RDLKPEN L   +     ++  DFG +   +   +   + G+P 
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVK--GRTWTLCGTPE 203

Query: 225 YMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
            +APE++  + Y   VD W+ GV++Y +  G PPF+A+    + + I+   + F      
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PS 259

Query: 284 KVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
             S + KDL++ +L  D  +R         ++  H W   
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 4e-62
 Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 44/301 (14%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           ++   Y   + +G G +G      D   G K A K +  +  ++ +  +   RE++++KH
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKH 73

Query: 113 LPKHPNIVSLKDTYEDDSA------VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
           + +H N++ L D +  D         ++VM     G    +++      E     ++  +
Sbjct: 74  M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
           ++ ++  H  G++HRDLKP N       E   LK +DFGL+       +    V + +Y 
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTRWYR 185

Query: 227 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW-- 282
           APEV+     Y   VD+WS G I+  ++ G   F         + I++       +    
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 283 -------------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
                                       S  A +L++KML  D +QR+TA E L HP+ +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

Query: 318 N 318
           +
Sbjct: 306 S 306

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 2e-61
 Identities = 59/262 (22%), Positives = 101/262 (38%), Gaps = 21/262 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +  L + +G+GEFG   L      G K A K I           +    E  +M  L +H
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RH 59

Query: 117 PNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVC 173
            N+V L     E+   ++IV E    G L D + +RG               + E ++  
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK- 232
                +HRDL   N L +        K  DFGL+      +  +       + APE L+ 
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE 174

Query: 233 RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
           + +  + DVWS G++L+ +   G  P+     + V   + +    +K D          +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYE 231

Query: 292 LVKKMLNPDPKQRLTAEEVLEH 313
           ++K   + D   R +  ++ E 
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQ 253

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-61
 Identities = 59/288 (20%), Positives = 107/288 (37%), Gaps = 36/288 (12%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHL 113
           + + G+ LG G FG     T     +      ++ K L+   D    E +  E+++M  L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-------------------- 153
             H NIV+L         ++++ E C  G+L + + ++                      
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 154 ---YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210
               T          + + ++    +  +HRDL   N L  + K    +K  DFGL+   
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV---VKICDFGLARDI 214

Query: 211 RPGEQF---NEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQG 265
                +           +MAPE L    Y  + DVWS G++L+ I   GV P+       
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
               +I++   FK D     +E    +++     D ++R +   +   
Sbjct: 275 NFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-61
 Identities = 59/293 (20%), Positives = 108/293 (36%), Gaps = 26/293 (8%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D      +G G FG         +G +        K+  +  D  D   E++++  L  H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI----------------VARGHYTERAAA 160
           PNI++L    E    +++ +E    G L D +                      + +   
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
                +   +    ++  +HRDL   N L     E+   K  DFGLS       +     
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 221 GSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFK 278
               +MA E L  + Y    DVWS GV+L+ ++  G  P+   T   + + + +    ++
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYR 244

Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH--PWLQNAKKAPNVSLGE 329
            +      +   DL+++     P +R +  ++L      L+  K   N +L E
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  201 bits (512), Expect = 3e-61
 Identities = 52/277 (18%), Positives = 95/277 (34%), Gaps = 21/277 (7%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y LGR++G G FG  YL TD+  GE+ A K    K          +  E +I K +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGV 63

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
            I +++    +     +VMEL               ++ +    +   ++  ++  H + 
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--------QFNEIVGSPYYMAPE 229
            +HRD+KP+NFL    K+ + +  IDFGL+  +R           +   + G+  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 230 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP----WPK 284
                      D+ S G +L     G  P+         Q   R        P       
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEV---LEHPWLQN 318
                   +    +     +     +     + + + 
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 2e-60
 Identities = 71/337 (21%), Positives = 133/337 (39%), Gaps = 41/337 (12%)

Query: 53  DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
           ++   Y     +G G +G      D   G + A K +  +  ++ +  +   RE++++KH
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73

Query: 113 LPKHPNIVSLKDTYEDDSAV----HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
           + KH N++ L D +    ++     + +     G   + IV     T+     ++  I+ 
Sbjct: 74  M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
            ++  H   ++HRDLKP N       E   LK +DFGL+      ++    V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187

Query: 229 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-------- 278
           E++    +Y   VD+WS G I+  LL G   F         + I+R V            
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 279 -------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
                               + +   +  A DL++KML  D  +R+TA + L H +    
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

Query: 320 KKAPNVSLGETVKARLKQFSV-MNKLKKRALQVVAEF 355
               +  + +      +   + +++ K      V  F
Sbjct: 308 HDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISF 344

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-59
 Identities = 62/274 (22%), Positives = 98/274 (35%), Gaps = 19/274 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCT---DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           D  L  +LG G FGV                A K +    L     ++D  REV  M  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQV 172
             H N++ L         + +V EL   G L DR+    GH+     +     + E +  
Sbjct: 69  -DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAP 228
              +  +HRDL   N L A +     +K  DFGL       +              + AP
Sbjct: 127 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 229 EVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           E LK R +    D W  GV L+ +   G  P+       +   I +      R       
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCP 241

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320
           ++  +++ +     P+ R T   + +  +L  A+
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 273

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 3e-59
 Identities = 58/263 (22%), Positives = 103/263 (39%), Gaps = 19/263 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D    +ELG G+FGV             A K I +  +      ++   E ++M +L  H
Sbjct: 5   DLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SH 58

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHE 175
             +V L         + I+ E    G L + +   R  +  +    + K + E ++    
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLKR 233
           +  +HRDL   N L  ++     +K  DFGLS +    E            +  PEVL  
Sbjct: 119 KQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 234 N-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAK 290
           + +  + D+W+ GV+++ I   G  P+   T    A+ I +      R   P   SE   
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG----LRLYRPHLASEKVY 231

Query: 291 DLVKKMLNPDPKQRLTAEEVLEH 313
            ++    +    +R T + +L +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 4e-59
 Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 20/271 (7%)

Query: 62  RELGRGEFGVTYLCTDVNN--GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
           +ELG G FG             +  A K + K +       +++  E  +M+ L  +P I
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNPYI 70

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
           V +    E +S   +VME+ E G L   +    H  ++    ++  +   ++   E   +
Sbjct: 71  VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129

Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE----IVGSPYYMAPEVLKRN- 234
           HRDL   N L   +      K  DFGLS   R  E + +          + APE +    
Sbjct: 130 HRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 235 YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
           +  + DVWS GV+++     G  P+       V   + +     +            DL+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDLM 243

Query: 294 KKMLNPDPKQRLTAEEV---LEHPWLQNAKK 321
                 D + R     V   L + +     +
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-58
 Identities = 59/262 (22%), Positives = 106/262 (40%), Gaps = 17/262 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           +    +E+G G+FG+ +L   +N  +K A K+I +  +      ED   E ++M  L  H
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SH 59

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
           P +V L     + + + +V E  E G L D +  +   +       +   + E +    E
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLKR 233
             V+HRDL   N L    +    +K  DFG++ F    +            + +PEV   
Sbjct: 120 ACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 234 N-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
           + Y  + DVWS GV+++ +   G  P+   +   V + I      F+       S +   
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTHVYQ 233

Query: 292 LVKKMLNPDPKQRLTAEEVLEH 313
           ++       P+ R     +L  
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQ 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (490), Expect = 5e-58
 Identities = 64/278 (23%), Positives = 104/278 (37%), Gaps = 19/278 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISK-KKLRTAVDIEDVRREVQIMKHLPK 115
              + + +G GEFG          G++    +I   K   T     D   E  IM     
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-D 85

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCH 174
           HPN++ L+      + V I+ E  E G L   +    G +T      +++ I   ++   
Sbjct: 86  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE------IVGSPYYMAP 228
           +   +HRDL   N L  +       K  DFGLS F                     + AP
Sbjct: 146 DMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 229 EVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
           E ++ R +    DVWS G++++ ++  G  P+W  T Q V  AI +   D++  P     
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCP 259

Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
                L+      D   R    +++    L    + PN
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNT--LDKMIRNPN 295

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-57
 Identities = 64/272 (23%), Positives = 103/272 (37%), Gaps = 22/272 (8%)

Query: 62  RELGRGEFGVTYLCTDVNNGEK--FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
            ELG G FG           ++   A K + +   +   D E++ RE QIM  L  +P I
Sbjct: 15  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQL-DNPYI 71

Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGV 178
           V L    + ++ + +VME+  GG L   +V  R        A ++  +   ++   E+  
Sbjct: 72  VRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130

Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE----IVGSPYYMAPEVLK-R 233
           +HRDL   N L  N+      K  DFGLS      + +            + APE +  R
Sbjct: 131 VHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187

Query: 234 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
            +    DVWS GV ++  L  G  P+       V   I +     + +  P+       L
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPECPPELYAL 244

Query: 293 VKKMLNPDPKQRLTAEEV---LEHPWLQNAKK 321
           +        + R     V   +   +   A K
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (484), Expect = 3e-57
 Identities = 54/275 (19%), Positives = 106/275 (38%), Gaps = 17/275 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
           D  +  +LG G++G  Y           A K++ +  +    ++E+  +E  +MK + KH
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 72

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVEVVQVCH 174
           PN+V L      +   +I+ E    G L D +        +      +   I   ++   
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGSPYYMAPEVLK 232
           ++  +HRDL   N L         +K  DFGLS                   + APE L 
Sbjct: 133 KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
            N +  + DVW+ GV+L+ +       +   +      ++    D++ +      E   +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--DYRMERPEGCPEKVYE 247

Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVS 326
           L++     +P  R +  E+ +    +   +  ++S
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQ--AFETMFQESSIS 280

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-57
 Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 21/270 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
              L  +LG+G FG  ++ T  N   + A K++    +      E   +E Q+MK L +H
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RH 71

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCH 174
             +V L     ++  ++IV E    G L D +      +        +   I   +    
Sbjct: 72  EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLK 232
               +HRDL+  N L          K  DFGL+      E            + APE   
Sbjct: 131 RMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 233 RN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
              +  + DVWS G++L  L   G  P+     + V   + R    ++    P+  E+  
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLH 244

Query: 291 DLVKKMLNPDPKQRLTAEEVLE--HPWLQN 318
           DL+ +    +P++R T E +      +  +
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 4e-57
 Identities = 60/262 (22%), Positives = 100/262 (38%), Gaps = 19/262 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
              L   LG G+FG  ++    N   K A KS+ +  +      +    E  +MK L +H
Sbjct: 14  TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL-QH 67

Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCH 174
             +V L      +  ++I+ E  E G L D +        T      +   I E +    
Sbjct: 68  QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE--IVGSPYYMAPEVLK 232
           E+  +HRDL+  N L ++       K  DFGL+      E            + APE + 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 233 RN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
              +  + DVWS G++L  ++  G  P+   T   V Q + R    ++        E   
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNCPEELY 240

Query: 291 DLVKKMLNPDPKQRLTAEEVLE 312
            L++      P+ R T + +  
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRS 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 5e-56
 Identities = 63/263 (23%), Positives = 102/263 (38%), Gaps = 14/263 (5%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPK 115
             +LGR +G G+FG  +    ++        +I + K   +    E   +E   M+    
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-D 66

Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCH 174
           HP+IV L     ++  V I+MELC  GEL   +  R       +       +   +    
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLK 232
            +  +HRD+   N L ++      +K  DFGLS +      +  ++      +MAPE + 
Sbjct: 126 SKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 233 -RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
            R +    DVW  GV ++ IL+ GV PF       V   I       +    P       
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLY 239

Query: 291 DLVKKMLNPDPKQRLTAEEVLEH 313
            L+ K    DP +R    E+   
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-55
 Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 53/307 (17%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
            Y   + +G G  G+     D       A K +  +  +     +   RE+ +MK +  H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCV-NH 75

Query: 117 PNIVSLKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
            NI+SL + +      E+   V++VMEL +          +        + ++  ++  +
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 132

Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE- 229
           +  H  G++HRDLKP N +  +       K +DFGL+            V + YY APE 
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 230 VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----------------- 272
           +L   Y   VD+WS G I+  ++     F           +I                  
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 273 -----SVIDFKRDPWPK----------------VSENAKDLVKKMLNPDPKQRLTAEEVL 311
                +   +    +PK                 +  A+DL+ KML  DP +R++ ++ L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 312 EHPWLQN 318
           +HP++  
Sbjct: 310 QHPYINV 316

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  185 bits (469), Expect = 4e-55
 Identities = 53/270 (19%), Positives = 101/270 (37%), Gaps = 20/270 (7%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           Y +GR +G G FGV +  T++ N ++ A K   ++      D   +R E +  K L    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCT 61

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
            I ++    ++     +V++L          +    ++ +  A   K ++  VQ  HE+ 
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 178 VMHRDLKPENFLFANK--KESSPLKAIDFGLSVFFRPGE--------QFNEIVGSPYYMA 227
           +++RD+KP+NFL      K ++ +  +DFG+  F+R           +   + G+  YM+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP----W 282
                 R      D+ + G +    L G  P+         Q   R     +  P     
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
               E     +    N         + +  
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 8e-54
 Identities = 55/284 (19%), Positives = 101/284 (35%), Gaps = 35/284 (12%)

Query: 57  DYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
               G+ LG G FG     T       +     A K +      T  + E +  E++++ 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLS 81

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH------------------ 153
           +L  H NIV+L           ++ E C  G+L + +  +                    
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
                  +    + + +     +  +HRDL   N L  + + +   K  DFGL+   +  
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKND 198

Query: 214 EQF---NEIVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 268
             +           +MAPE +       E DVWS G+ L+ L   G  P+          
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 269 AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
            +I+    F+            D++K   + DP +R T +++++
Sbjct: 259 KMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 9e-54
 Identities = 52/265 (19%), Positives = 100/265 (37%), Gaps = 16/265 (6%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHL 113
           ++   + LG G FG  Y    +  GEK     ++ K+LR A      +++  E  +M  +
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASV 68

Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
             +P++  L       +   I   +  G  L      + +   +        I + +   
Sbjct: 69  -DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEV 230
            ++ ++HRDL   N L    +    +K  DFGL+      E+            +MA E 
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 231 LK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
           +  R Y  + DVWS GV ++ L+  G  P+       ++  + +     +    P  + +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTID 241

Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEH 313
              ++ K    D   R    E++  
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIE 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-53
 Identities = 55/282 (19%), Positives = 102/282 (36%), Gaps = 30/282 (10%)

Query: 57  DYDLGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
              LG+ LG G FG   L   +       N   K A K +         D+ D+  E+++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEM 71

Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI----------------VARGH 153
           MK + KH NI++L      D  +++++E    G L + +                     
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
            + +   +    +   ++    +  +HRDL   N L                        
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 271
           ++         +MAPE L  R Y  + DVWS GV+L+ I   G  P+     + + + + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
                 + D     +     +++   +  P QR T ++++E 
Sbjct: 252 E---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 3e-49
 Identities = 57/279 (20%), Positives = 103/279 (36%), Gaps = 22/279 (7%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEK----FACKSISKKKLRTAVDIEDVRREVQIMKH 112
                + +G GEFG  Y      +  K     A K++  K   T     D   E  IM  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQ 65

Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQ 171
              H NI+ L+        + I+ E  E G L   +  + G ++      +++ I   ++
Sbjct: 66  F-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMA 227
                  +HRDL   N L  +       K  DFGLS       +     +       + A
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-V 285
           PE +  R +    DVWS G++++ ++      + E        +++++ D  R P P   
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRLPTPMDC 238

Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
                 L+ +    +  +R    +++    L    +AP+
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSI--LDKLIRAPD 275

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (429), Expect = 3e-49
 Identities = 54/291 (18%), Positives = 102/291 (35%), Gaps = 45/291 (15%)

Query: 57  DYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
           + +  R++G G FG  +                A K + ++   +A    D +RE  +M 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY----------------- 154
               +PNIV L         + ++ E    G+L + + +   +                 
Sbjct: 72  EF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 155 -------TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207
                  +      + + +   +    E+  +HRDL   N L         +K  DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGLS 187

Query: 208 VFFRPGEQF---NEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAET 262
                 + +           +M PE +  N Y  E DVW+ GV+L+ +   G+ P++   
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 263 EQGVAQAIIRSVIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLE 312
                + +I  V D      P+       +L++   +  P  R +   +  
Sbjct: 248 H----EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 4e-49
 Identities = 61/270 (22%), Positives = 113/270 (41%), Gaps = 19/270 (7%)

Query: 55  SIDYDLGRELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           S+       +GRG FG  Y  T + N+G+K  C   S  ++    ++     E  IMK  
Sbjct: 26  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85

Query: 114 PKHPNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQ 171
             HPN++SL       + +  +V+   + G+L + I    H  T +        + + ++
Sbjct: 86  -SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144

Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----QFNEIVGSPYYM 226
               +  +HRDL   N +     E   +K  DFGL+      E               +M
Sbjct: 145 FLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 227 APEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
           A E L+ + +  + DVWS GV+L+ L+  G PP+       +   +++     +R   P+
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----RRLLQPE 257

Query: 285 -VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              +   +++ K  +P  + R +  E++  
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 3e-47
 Identities = 58/300 (19%), Positives = 104/300 (34%), Gaps = 51/300 (17%)

Query: 54  ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
           I+    L   +G+G FG  +       GE+ A K  S ++ R+         E+     L
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVML 54

Query: 114 PKHPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGHYTERA-------AAAV 162
            +H NI+        D+     + +V +  E G LFD +       E         A+ +
Sbjct: 55  -RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113

Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-----FN 217
               +E+V    +  + HRDLK +N L             D GL+V             N
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPN 170

Query: 218 EIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAETEQG----- 265
             VG+  YMAPEVL  +            D+++ G++ + +           +       
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 266 ------VAQAIIRSVIDFKRDP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
                   + + + V + K  P         +       ++++    +   RLTA  + +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 5e-47
 Identities = 56/282 (19%), Positives = 108/282 (38%), Gaps = 30/282 (10%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHL 113
              LG+ LGRG FG           +   C++++ K L+      + R    E++I+ H+
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 114 PKHPNIVSLKD-TYEDDSAVHIVMELCEGGELFDRIVARGHY----------------TE 156
             H N+V+L     +    + +++E C+ G L   + ++ +                 T 
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
                    + + ++    +  +HRDL   N L + K     +K  DFGL+        +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKDPDY 190

Query: 217 ---NEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAII 271
               +      +MAPE +    Y  + DVWS GV+L+ +      P+            +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250

Query: 272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
           +     +   +   +      +    + +P QR T  E++EH
Sbjct: 251 KEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-46
 Identities = 52/277 (18%), Positives = 104/277 (37%), Gaps = 29/277 (10%)

Query: 57  DYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
              + RELG+G FG+ Y              + A K++++       +  +   E  +MK
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMK 78

Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----------YTERAAAA 161
                 ++V L           ++MEL   G+L   + +              +      
Sbjct: 79  EF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NE 218
           +   I + +   +    +HRDL   N + A       +K  DFG++      + +    +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYRKGGK 194

Query: 219 IVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVID 276
            +    +M+PE LK   +    DVWS GV+L+ I      P+   + + V + ++   + 
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 253

Query: 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
              D      +   +L++     +PK R +  E++  
Sbjct: 254 --LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  159 bits (403), Expect = 7e-45
 Identities = 62/332 (18%), Positives = 118/332 (35%), Gaps = 66/332 (19%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL---- 113
           Y L R+LG G F   +L  D+ N    A K +   K+ T    E    E+++++ +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDAD 70

Query: 114 ------PKHPNIVSLKDTYED--DSAVHIVMELCEGG---ELFDRIVARGHYTERAAAAV 162
                     +I+ L D +     + VH+VM     G       +              +
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130

Query: 163 MKTIVEVVQ-VCHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
            K ++  +  +    G++H D+KPEN L        + ++     L       E +   +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV------------- 266
            +  Y +PEVL    +G   D+WS   +++ L+ G   F  +                  
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250

Query: 267 --------------------AQAIIRSVIDFKRDPWPKV-----------SENAKDLVKK 295
                               ++ ++R++   K  P   V           ++   D +  
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310

Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
           ML  DP++R  A  ++ HPWL++      + +
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score =  108 bits (271), Expect = 2e-28
 Identities = 56/163 (34%), Positives = 85/163 (52%), Gaps = 8/163 (4%)

Query: 339 SVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA 398
           + M   +  A      FLS E +A  K AF+M D +  G I+ +EL   +   GQN  + 
Sbjct: 1   ASMTDQQAEARA----FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56

Query: 399 DLQILMEAADVDGDGSLNYGEFVAVSVHL----KKMANDEHLHKAFSFFDRNRSGFIEIE 454
           +L  ++E  D DG G++++ EF+ + V       K  ++E L   F  FD+N  GFI+IE
Sbjct: 57  ELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIE 116

Query: 455 ELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           EL   L    +   E+ I  +M D D + DGRI ++EF  MM+
Sbjct: 117 ELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMME 159

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

 Score =  106 bits (264), Expect = 1e-27
 Identities = 51/146 (34%), Positives = 89/146 (60%), Gaps = 1/146 (0%)

Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDG 413
           E L+ E++A  KEAF + D +  G I  +EL   +   GQN  EA+LQ ++   D DG+G
Sbjct: 1   EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 60

Query: 414 SLNYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVI 472
           ++++ EF+++ +  +K+  ++E L +AF  FDR+ +G I   ELR+ + +  +   +D +
Sbjct: 61  TIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEV 120

Query: 473 NAIMHDVDTDKDGRISYEEFAVMMKA 498
           + ++ + D D DG I+YEEF  MM +
Sbjct: 121 DEMIREADIDGDGHINYEEFVRMMVS 146

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

 Score = 47.2 bits (111), Expect = 5e-07
 Identities = 22/97 (22%), Positives = 42/97 (43%), Gaps = 7/97 (7%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
               +AF+ FD++  G I  +EL   +        E  +  ++++VD D +G I + EF 
Sbjct: 9   AEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFL 68

Query: 494 VMMKAGT-------DWRKASRQYSRERFNSISLKLMR 523
            +M           +  +A + + R+    IS   +R
Sbjct: 69  SLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELR 105

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (259), Expect = 6e-27
 Identities = 44/143 (30%), Positives = 78/143 (54%), Gaps = 2/143 (1%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I+  EL   +   G +  EA++  LM   DVDG+  +
Sbjct: 4   LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQI 63

Query: 416 NYGEFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
            + EF+A+ S  LK   +++ L +AF  FD+N  G I   EL++ L    +   +  ++ 
Sbjct: 64  EFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDD 123

Query: 475 IMHDVDTDKDGRISYEEFAVMMK 497
           ++ +V  D  G I+ ++FA ++ 
Sbjct: 124 MLREVS-DGSGEINIQQFAALLS 145

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 45.6 bits (107), Expect = 2e-06
 Identities = 20/97 (20%), Positives = 43/97 (44%), Gaps = 7/97 (7%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
               +AF+ FD++ +G I   EL   +     +  E  +N +M+++D D + +I + EF 
Sbjct: 10  AEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFL 69

Query: 494 VMMKAGT-------DWRKASRQYSRERFNSISLKLMR 523
            +M           +  +A + + +     IS   ++
Sbjct: 70  ALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELK 106

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  104 bits (259), Expect = 1e-26
 Identities = 67/178 (37%), Positives = 111/178 (62%), Gaps = 3/178 (1%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
           AE LS EE+ GLKE F+M+DT+  G I  +EL+ GL + G  + E++++ LM+AAD+D  
Sbjct: 1   AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKS 60

Query: 413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVI 472
           G+++YGEF+A +VHL K+  +E+L  AFS+FD++ SG+I ++E++     +     +  I
Sbjct: 61  GTIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQ--ACKDFGLDDIHI 118

Query: 473 NAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFN-SISLKLMREEGLQL 529
           + ++ ++D D DG+I Y EFA MM+         R+  R+  N   +L L+     Q+
Sbjct: 119 DDMIKEIDQDNDGQIDYGEFAAMMRKRKGNGGIGRRTMRKTLNLRDALGLVDNGSNQV 176

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 95.7 bits (237), Expect = 1e-23
 Identities = 35/170 (20%), Positives = 72/170 (42%), Gaps = 17/170 (10%)

Query: 343 KLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL 400
           KL+   +Q + E    +  E+    + F  +     G +++EE +            +  
Sbjct: 3   KLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASKF 60

Query: 401 -QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNA 459
            + +    D +GDG++++ EF+       +   ++ L  AFS +D + +G+I   E+   
Sbjct: 61  AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEI 120

Query: 460 LN------------DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           +              E +++ E     I   +DT++DG++S EEF    K
Sbjct: 121 VQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAK 170

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.9 bits (232), Expect = 2e-23
 Identities = 34/139 (24%), Positives = 76/139 (54%), Gaps = 1/139 (0%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
           E+   ++EAF++ D +  G I+++EL++ +   G    + +++ ++   D +G G +N+G
Sbjct: 3   EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFG 62

Query: 419 EFVAV-SVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH 477
           +F+ V +  + +    E + KAF  FD + +G I  + L+    +  +   ++ +  ++ 
Sbjct: 63  DFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMID 122

Query: 478 DVDTDKDGRISYEEFAVMM 496
           + D D DG +S +EF  +M
Sbjct: 123 EADRDGDGEVSEQEFLRIM 141

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (98), Expect = 2e-05
 Identities = 16/84 (19%), Positives = 43/84 (51%), Gaps = 1/84 (1%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
           + + +AF  FD + +G I+++EL+ A+        ++ I  ++ ++D +  G++++ +F 
Sbjct: 6   QEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFL 65

Query: 494 VMMKAGTDWRKASRQYSRERFNSI 517
            +M       K +++   + F   
Sbjct: 66  TVMTQK-MSEKDTKEEILKAFKLF 88

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 93.5 bits (231), Expect = 5e-23
 Identities = 51/153 (33%), Positives = 80/153 (52%), Gaps = 5/153 (3%)

Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNKR-GKINLEELRLGLLKGGQNIPEADLQILMEAAD 408
           +   E L+ E+    K AF++       G I+ +EL   +   GQN    +LQ +++  D
Sbjct: 2   KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD 61

Query: 409 VDGDGSLNYGEFVAVSVHLKKM----ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
            DG G++++ EF+ + V   K      ++E L   F  FD+N  G+I++EEL+  L    
Sbjct: 62  EDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATG 121

Query: 465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           +T  ED I  +M D D + DGRI Y+EF   MK
Sbjct: 122 ETITEDDIEELMKDGDKNNDGRIDYDEFLEFMK 154

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 6e-23
 Identities = 30/170 (17%), Positives = 66/170 (38%), Gaps = 17/170 (10%)

Query: 343 KLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL 400
           KLK   ++ +    + + +EV    + F  +     G+++    +    +          
Sbjct: 4   KLKPEVVEELTRKTYFTEKEVQQWYKGF--IKDCPSGQLDAAGFQKIYKQFFPFGDPTKF 61

Query: 401 -QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNA 459
              +    D + DG + + EF+       +   DE L  AF  +D +  G+I   E+ + 
Sbjct: 62  ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDI 121

Query: 460 LN------------DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           ++             E + + E  ++ I   +D + DG+++ +EF    K
Sbjct: 122 VDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSK 171

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 92.3 bits (228), Expect = 3e-22
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 13/170 (7%)

Query: 355 FLSVEEVAGLKEAFEMMDTN--KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
             SV E+  L E F+ + +     G IN EE +L L K  +         + +  D   +
Sbjct: 10  VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKK-ESLFADRVFDLFDTKHN 68

Query: 413 GSLNYGEFVAVS-VHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN--------DE 463
           G L + EF     V       D+ +H +F  +D  + GFIE +E++  +         + 
Sbjct: 69  GILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNL 128

Query: 464 VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD-WRKASRQYSRE 512
            DT  ED+I+    + DT  DG+I  EE+  ++       +  + QY ++
Sbjct: 129 KDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVLRHPSLLKNMTLQYLKD 178

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 86.5 bits (214), Expect = 3e-21
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 7/108 (6%)

Query: 394 NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEI 453
            + +AD+   + A       S  + EF A  V L   + D+ + KAF   D+++SGFIE 
Sbjct: 4   GLKDADVAAALAA--CSAADSFKHKEFFAK-VGLASKSLDD-VKKAFYVIDQDKSGFIEE 59

Query: 454 EELRNA---LNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           +EL+      +       +    A + D D D DG I  +EFA M+KA
Sbjct: 60  DELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMIKA 107

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 52.6 bits (126), Expect = 2e-09
 Identities = 21/71 (29%), Positives = 39/71 (54%), Gaps = 3/71 (4%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK---GGQNIPEADLQILMEAADVDGD 412
           L+ + +  +K+AF ++D +K G I  +EL+L L       + + +A+ +  +   D DGD
Sbjct: 34  LASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGD 93

Query: 413 GSLNYGEFVAV 423
           G +   EF A+
Sbjct: 94  GMIGVDEFAAM 104

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 88.7 bits (219), Expect = 4e-21
 Identities = 35/170 (20%), Positives = 66/170 (38%), Gaps = 17/170 (10%)

Query: 343 KLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL 400
           KL K  L  + +  +    E+    + F  +     G++  E+      +        D 
Sbjct: 7   KLSKDDLTCLKQSTYFDRREIQQWHKGF--LRDCPSGQLAREDFVKIYKQFFPFGSPEDF 64

Query: 401 -QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNA 459
              L    D D +G +++ EF+ V     +   +E L  AF  +D N  G+I  +E+   
Sbjct: 65  ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTI 124

Query: 460 L------------NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           +             +E + + E  +  I   +D ++DG I+ +EF    K
Sbjct: 125 VASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSK 174

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 88.7 bits (219), Expect = 4e-21
 Identities = 42/204 (20%), Positives = 70/204 (34%), Gaps = 25/204 (12%)

Query: 58  YDLGRELGRGEFGVTYLCTDVNNGEKFACK-----SISKKKLRTAVDIEDVR-REVQIMK 111
             +G+ +G G+    + C       +   K       S KK++   D  D+    + I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 112 HLPKHPNIVSLKDTYE----DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
              +   +  L+              ++MEL +  E                  V+  I+
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMIL 113

Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
           E V   + +G++H DL   N L + +     +  IDF  SV     E + EI+       
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGE-EGWREILERDVRNI 168

Query: 228 PEVLKRNYGPEVDVWSAGVILYIL 251
                R Y  E D+ S   I  IL
Sbjct: 169 ITYFSRTYRTEKDINS--AIDRIL 190

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.6 bits (216), Expect = 1e-20
 Identities = 30/160 (18%), Positives = 66/160 (41%), Gaps = 18/160 (11%)

Query: 356 LSVEEVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGS 414
           +   + A L+E ++        G + + E +              ++ +  A D +GD +
Sbjct: 15  VGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNT 74

Query: 415 LNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNAL-------------- 460
           +++ E+VA    + +   +  L   F  +D++R+G I+ +EL + +              
Sbjct: 75  IDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEV 134

Query: 461 ---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
                    + E+V++ I   VD + DG++S  EF    +
Sbjct: 135 EAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGAR 174

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.5 bits (117), Expect = 2e-07
 Identities = 27/136 (19%), Positives = 48/136 (35%), Gaps = 3/136 (2%)

Query: 378 KINLEELRLGLLKGGQNIPEADLQILMEAADVDG-DGSLNYGEFVAVSVHLKKMANDEHL 436
           + + EE       G  +   A LQ   +    +   G+L   EF             +++
Sbjct: 3   QFSWEEAEENGAVGAADA--AQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYV 60

Query: 437 HKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
              F  FD N    I+  E   ALN  +  + E  +       D D++G I  +E   ++
Sbjct: 61  EAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIV 120

Query: 497 KAGTDWRKASRQYSRE 512
           ++    +KA       
Sbjct: 121 ESIYKLKKACSVEVEA 136

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

 Score = 86.3 bits (213), Expect = 3e-20
 Identities = 36/186 (19%), Positives = 65/186 (34%), Gaps = 19/186 (10%)

Query: 354 EFLSVEEVA-GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA--------DLQILM 404
           + LS EE+    K  F  +      +I+++EL+  L +      +           + ++
Sbjct: 11  KVLSEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMV 69

Query: 405 EAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
              D DG+G L   EF              +    F  FD ++SG +   E+R A+    
Sbjct: 70  NLMDRDGNGKLGLVEFNI------LWNRIRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAG 123

Query: 465 DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMRE 524
                 +   I+     D +  I ++ F   +       K  +Q   E   +I L L   
Sbjct: 124 FKLPCQLHQVIV-ARFADDELIIDFDNFVRCLVRLEILFKIFKQLDPENTGTIQLDL--I 180

Query: 525 EGLQLA 530
             L  +
Sbjct: 181 SWLSFS 186

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 82.3 bits (203), Expect = 1e-19
 Identities = 23/110 (20%), Positives = 47/110 (42%), Gaps = 7/110 (6%)

Query: 392 GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFI 451
              +   D+   ++  +     +    +F      L KM+  + +   F F D ++SG++
Sbjct: 3   TDILSAEDIAAALQ--ECQDPDTFEPQKFFQT-SGLSKMSASQ-VKDIFRFIDNDQSGYL 58

Query: 452 EIEELRNALNDEVDTSG---EDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
           + +EL+  L      +    E    ++M   D D DG+I  +EF  M+ +
Sbjct: 59  DGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMVHS 108

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 58.0 bits (140), Expect = 4e-11
 Identities = 22/71 (30%), Positives = 40/71 (56%), Gaps = 3/71 (4%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK---GGQNIPEADLQILMEAADVDGD 412
           LS    + +K+ F  +D ++ G ++ +EL+  L K     + + E++ + LM+AAD DGD
Sbjct: 35  LSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGD 94

Query: 413 GSLNYGEFVAV 423
           G +   EF  +
Sbjct: 95  GKIGADEFQEM 105

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.7 bits (203), Expect = 2e-19
 Identities = 31/138 (22%), Positives = 53/138 (38%), Gaps = 6/138 (4%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
            KEAFE+ D    GKI   +    +   GQN   A++  ++     D   S        +
Sbjct: 2   FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFL 61

Query: 424 SVHLKKM-----ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD 478
            +             E   + F  FD+  +G +   ELR+ L    +   E+ +  ++  
Sbjct: 62  PMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVL-A 120

Query: 479 VDTDKDGRISYEEFAVMM 496
              D +G I+YE F   +
Sbjct: 121 GHEDSNGCINYEAFLKHI 138

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.1 bits (205), Expect = 2e-19
 Identities = 30/162 (18%), Positives = 60/162 (37%), Gaps = 15/162 (9%)

Query: 374 NKRGKINLEELRLGLLKGGQNIPEADLQI-----LMEAADVDGDGSLNYGEFVAVSVHLK 428
            + G+++ EEL+  L + G N   +   +     ++   D D  G + +  F       +
Sbjct: 11  GQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAF------KE 64

Query: 429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS 488
             A      + F   D++ SG +E  ELR A+           +  I+      K+GRI 
Sbjct: 65  LWAALNAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIF 122

Query: 489 YEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLA 530
           ++++              R+    +  S +     ++ LQ  
Sbjct: 123 FDDYVACCVKLRALTDFFRKRDHLQQGSANFIY--DDFLQGT 162

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.5 bits (141), Expect = 8e-11
 Identities = 16/86 (18%), Positives = 32/86 (37%), Gaps = 8/86 (9%)

Query: 368 FEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL 427
           F  +D +  G +   ELR  +   G  +    L  +++      +G + + ++VA  V L
Sbjct: 76  FMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVK--RYSKNGRIFFDDYVACCVKL 133

Query: 428 KKMANDEHLHKAFSFFDRNRSGFIEI 453
           + +         F   D  + G    
Sbjct: 134 RALT------DFFRKRDHLQQGSANF 153

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 81.1 bits (200), Expect = 2e-19
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 7/106 (6%)

Query: 395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIE 454
           +   D++  ++A  V  +GS N+ +F A+     K  +   + K F   D + SGFIE E
Sbjct: 6   LKADDIKKALDA--VKAEGSFNHKKFFALVGL--KAMSANDVKKVFKAIDADASGFIEEE 61

Query: 455 ELRNAL---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           EL+  L     +     +    A +   D D DG+I  +EF  ++ 
Sbjct: 62  ELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLVH 107

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 57.2 bits (138), Expect = 7e-11
 Identities = 20/63 (31%), Positives = 36/63 (57%), Gaps = 3/63 (4%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGL---LKGGQNIPEADLQILMEAADVDGDGSLNYGEF 420
           +K+ F+ +D +  G I  EEL+  L      G+++ +A+ +  ++AAD DGDG +   EF
Sbjct: 43  VKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEF 102

Query: 421 VAV 423
             +
Sbjct: 103 ETL 105

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} Length = 172

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.9 bits (204), Expect = 4e-19
 Identities = 30/180 (16%), Positives = 69/180 (38%), Gaps = 16/180 (8%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL-----QILMEAADVD 410
              +    L   F  +   + G+I+ +EL+  L + G             ++++   D D
Sbjct: 1   FPGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRD 59

Query: 411 GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
             G++ + EF  +       A      + F  FD +RSG ++ +EL+ AL          
Sbjct: 60  MSGTMGFNEFKEL------WAVLNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQ 113

Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLA 530
            +N+I        +G+I+++++            + R+    +   ++     ++ +Q  
Sbjct: 114 AVNSIAKRY--STNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPY--DDFIQCV 169

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

 Score = 80.4 bits (198), Expect = 4e-19
 Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 7/106 (6%)

Query: 395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIE 454
           +   D+   + A      G+ +Y  F  +     K   D  + + F   D+++SGFIE E
Sbjct: 6   LKADDINKAISA--FKDPGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEE 61

Query: 455 ELRNAL---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           EL+  L   +       +    A++   D+D DG+I  +EFA M+ 
Sbjct: 62  ELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMVA 107

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

 Score = 55.4 bits (133), Expect = 3e-10
 Identities = 20/63 (31%), Positives = 35/63 (55%), Gaps = 3/63 (4%)

Query: 364 LKEAFEMMDTNKRGKINLEELR---LGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEF 420
           +KE FE++D ++ G I  EEL+    G    G+++ + + + L+ A D D DG +   EF
Sbjct: 43  VKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEF 102

Query: 421 VAV 423
             +
Sbjct: 103 AKM 105

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

 Score = 81.9 bits (201), Expect = 1e-18
 Identities = 23/165 (13%), Positives = 51/165 (30%), Gaps = 21/165 (12%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-----QNIPEADLQILMEAA 407
           ++F +   +   K  F  +D N  GKI+L+E+                 +A        A
Sbjct: 3   SDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEA 62

Query: 408 DVDG-----DGSLNYGEFVAVSVHLKKMANDEH-----------LHKAFSFFDRNRSGFI 451
              G         ++  ++     L     +++               F   D++++G I
Sbjct: 63  FFGGAGMKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAI 122

Query: 452 EIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            ++E +            +         D D+ G++  +E     
Sbjct: 123 TLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQH 167

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

 Score = 44.6 bits (104), Expect = 7e-06
 Identities = 17/81 (20%), Positives = 29/81 (35%)

Query: 341 MNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL 400
             KL    L+  A+             F+++D ++ G I L+E +      G      D 
Sbjct: 84  WKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDC 143

Query: 401 QILMEAADVDGDGSLNYGEFV 421
           +      D+D  G L+  E  
Sbjct: 144 EETFRVCDIDESGQLDVDEMT 164

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 80.6 bits (198), Expect = 2e-18
 Identities = 31/156 (19%), Positives = 58/156 (37%), Gaps = 15/156 (9%)

Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL-QILMEAADVDGDG 413
             +  E+  L   F   +    G +N E  +    +   +   +     L  A D    G
Sbjct: 9   NFTKRELQVLYRGF--KNECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTG 66

Query: 414 SLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG----- 468
           S+ + +FV     L +    E L   F+ +D N+ G+I  EE+ + +    D  G     
Sbjct: 67  SVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYP 126

Query: 469 -------EDVINAIMHDVDTDKDGRISYEEFAVMMK 497
                     ++     +D +KDG ++ +EF    +
Sbjct: 127 VLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQ 162

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.2 bits (106), Expect = 4e-06
 Identities = 19/107 (17%), Positives = 39/107 (36%), Gaps = 12/107 (11%)

Query: 368 FEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL 427
           F   DT + G +  E+    L    +      L+      D++ DG +N  E + +   +
Sbjct: 57  FNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAI 116

Query: 428 KKMAN------------DEHLHKAFSFFDRNRSGFIEIEELRNALND 462
             M               +H+   F   D+N+ G + ++E   +  +
Sbjct: 117 YDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQE 163

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

 Score = 78.5 bits (193), Expect = 2e-18
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 7/106 (6%)

Query: 395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIE 454
           +   D++  + A       S ++ +F  + V LKK + D+ + K F   D+++SGFIE +
Sbjct: 6   LSAEDIKKAIGA--FTAADSFDHKKFFQM-VGLKKKSADD-VKKVFHILDKDKSGFIEED 61

Query: 455 ELRNAL---NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           EL + L   + +           +M   D D DG+I  EEF+ ++ 
Sbjct: 62  ELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

 Score = 55.8 bits (134), Expect = 2e-10
 Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 6/99 (6%)

Query: 329 ETVKARLKQFSVMNKLKKRA-LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLG 387
           E +K  +  F+  +    +   Q+V   L  +    +K+ F ++D +K G I  +EL   
Sbjct: 9   EDIKKAIGAFTAADSFDHKKFFQMVG--LKKKSADDVKKVFHILDKDKSGFIEEDELGSI 66

Query: 388 LLK---GGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           L       +++   + + LM A D DGDG +   EF  +
Sbjct: 67  LKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTL 105

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

 Score = 41.9 bits (98), Expect = 2e-05
 Identities = 19/115 (16%), Positives = 43/115 (37%), Gaps = 12/115 (10%)

Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEE-LRLGLLKGGQNIPEADLQILMEAADVD 410
           + + LS E++     AF   D+      + ++  ++  LK        D++ +    D D
Sbjct: 2   MTDLLSAEDIKKAIGAFTAADS-----FDHKKFFQMVGLKKKS---ADDVKKVFHILDKD 53

Query: 411 GDGSLNYGEFVAVSVHLKKMA---NDEHLHKAFSFFDRNRSGFIEIEELRNALND 462
             G +   E  ++       A   + +      +  D++  G I +EE    + +
Sbjct: 54  KSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLVAE 108

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 77.7 bits (191), Expect = 2e-18
 Identities = 36/77 (46%), Positives = 57/77 (74%)

Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADV 409
           + +AE LS EE+ GLKE F+M+DT+  G I  +EL+ GL + G  + E++++ LM+AAD+
Sbjct: 11  KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70

Query: 410 DGDGSLNYGEFVAVSVH 426
           D  G+++YGEF+A +VH
Sbjct: 71  DKSGTIDYGEFIAATVH 87

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 61.5 bits (149), Expect = 1e-12
 Identities = 23/75 (30%), Positives = 29/75 (38%), Gaps = 6/75 (8%)

Query: 428 KKMAND------EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDT 481
           K MA          L + F   D + SG I  +EL++ L        E  I  +M   D 
Sbjct: 11  KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70

Query: 482 DKDGRISYEEFAVMM 496
           DK G I Y EF    
Sbjct: 71  DKSGTIDYGEFIAAT 85

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

 Score = 80.2 bits (197), Expect = 4e-18
 Identities = 34/180 (18%), Positives = 64/180 (35%), Gaps = 18/180 (10%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD--------LQILMEAADVD 410
           +   G +  F  +   +  +I+  EL+  L +      +           +I+++  D D
Sbjct: 15  DIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDED 73

Query: 411 GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
           G G L   EF  +          +   K +   D +RSG +   E+R AL  E       
Sbjct: 74  GSGKLGLKEFYIL------WTKIQKYQKIYREIDVDRSGTMNSYEMRKALE-EAGFKLPC 126

Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLA 530
            ++ ++     D +  I ++ F   +       K  +Q   E   +I L L     L  +
Sbjct: 127 QLHQVIVARFADDELIIDFDNFVRCLVRLEILFKIFKQLDPENTGTIQLDL--ISWLSFS 184

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} Length = 180

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.4 bits (195), Expect = 7e-18
 Identities = 30/158 (18%), Positives = 60/158 (37%), Gaps = 15/158 (9%)

Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD----LQILMEAADVD 410
           FL+ +E+      F  +   ++  +          +   ++PE       + +       
Sbjct: 10  FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKANPFKERICRVFSTS 69

Query: 411 -GDGSLNYGEFV-AVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG 468
               SL++ +F+  +SV       D   H AF  FD +  G +  E+L   +N       
Sbjct: 70  PAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGE 129

Query: 469 ---------EDVINAIMHDVDTDKDGRISYEEFAVMMK 497
                    + +I+ I+ + D D+DG I+  EF  ++ 
Sbjct: 130 DTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVIS 167

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 78.8 bits (193), Expect = 1e-17
 Identities = 34/180 (18%), Positives = 62/180 (34%), Gaps = 18/180 (10%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD--------LQILMEAADVD 410
           EEV   +  F  +      +++  EL   L K     P+           + ++   D D
Sbjct: 1   EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSD 59

Query: 411 GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED 470
             G L +              N +     +  FD +RSG I   EL  A         E 
Sbjct: 60  TTGKLGF------EEFKYLWNNIKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEH 113

Query: 471 VINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLA 530
           + + I+     D+ G + ++ F   +       +A +   ++    I + +  +E LQL 
Sbjct: 114 LYSMIIRRYS-DEGGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNI--QEWLQLT 170

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

 Score = 77.4 bits (189), Expect = 3e-17
 Identities = 27/158 (17%), Positives = 50/158 (31%), Gaps = 25/158 (15%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP---------------EADLQILMEAAD 408
           LK+ F+  D +  G +   +         +                        L + A 
Sbjct: 9   LKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAG 68

Query: 409 VDGDGSLNYGEFVAVSVHLK--------KMANDEHLHKAFSFFDRNRSGFIEIEELRNAL 460
           V  DGSL   +F+ V+ +L                +       D+N  G I  +E    L
Sbjct: 69  VGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWL 128

Query: 461 NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA 498
                +  +       + VDT+ +G +S +E    ++ 
Sbjct: 129 TALGMS--KAEAAEAFNQVDTNGNGELSLDELLTAVRD 164

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

 Score = 45.0 bits (105), Expect = 4e-06
 Identities = 10/85 (11%), Positives = 27/85 (31%), Gaps = 15/85 (17%)

Query: 433 DEHLHKAFSFFDRNRSGFIEIEELRNALN---------------DEVDTSGEDVINAIMH 477
            + L K F  +D + +G +E  +                       +  +   + + +  
Sbjct: 6   SDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAK 65

Query: 478 DVDTDKDGRISYEEFAVMMKAGTDW 502
           +     DG ++ E+F  + +     
Sbjct: 66  EAGVGSDGSLTEEQFIRVTENLIFE 90

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

 Score = 76.6 bits (187), Expect = 3e-17
 Identities = 34/149 (22%), Positives = 60/149 (40%), Gaps = 5/149 (3%)

Query: 356 LSVEEVAGLKEAFEMMDT--NKRGKINLEELRLGLLKGGQNIPEADL-QILMEAADVDGD 412
           LS +E+  LK+ FE+ D    + G ++  +L       G N    D+  +       +  
Sbjct: 1   LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGGTHKMGEKS 60

Query: 413 GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVI 472
                       +   +        +AF  FDR   GFI   ELR+ L    +   ++ +
Sbjct: 61  LPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDV 120

Query: 473 NAIMH--DVDTDKDGRISYEEFAVMMKAG 499
           + I+   D+  D +G + YE+F   + AG
Sbjct: 121 DEIIKLTDLQEDLEGNVKYEDFVKKVMAG 149

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

 Score = 76.2 bits (186), Expect = 3e-17
 Identities = 29/147 (19%), Positives = 70/147 (47%), Gaps = 6/147 (4%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           L  +++  +KEAF M+D ++ G ++ E+++    + G+   + +L  +++    +  G L
Sbjct: 1   LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPL 56

Query: 416 NYGEFVAVSVHLKKMANDEHLHKA-FSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           N+  F+++        + E   +  F+ FD   +  + IE +++ L +  D   +D +  
Sbjct: 57  NFTMFLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRM 116

Query: 475 IMHDVDTDKDGRISYEEFAVMMKAGTD 501
              +   +  G+  Y +F  M+K   +
Sbjct: 117 TFKEAPVE-GGKFDYVKFTAMIKGSGE 142

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

 Score = 77.8 bits (190), Expect = 3e-17
 Identities = 26/170 (15%), Positives = 54/170 (31%), Gaps = 21/170 (12%)

Query: 349 LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK-----GGQNIPEADLQIL 403
           +++  +F +   +   K  F+ +D N  GKI L+E+                 +     +
Sbjct: 1   VKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQV 60

Query: 404 MEAAD-----VDGDGSLNYGEFVAVSVHLKKM-----------ANDEHLHKAFSFFDRNR 447
              A      ++    + + +F+     L                 E     F  FD++ 
Sbjct: 61  CVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDG 120

Query: 448 SGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           SG I ++E +        +  ++   A     D D  G +  +E      
Sbjct: 121 SGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHL 170

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

 Score = 75.1 bits (183), Expect = 2e-16
 Identities = 27/157 (17%), Positives = 45/157 (28%), Gaps = 18/157 (11%)

Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA-----------DLQILME 405
           S   V  +K  F  +D +K G I   +      +  +                       
Sbjct: 1   SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNF 60

Query: 406 AADVDGDGSLNYGEFVAVSVHLKKMANDEH-----LHKAFSFFDRNRSGFIEIEELRNAL 460
              V G   ++   F+     + K    +      L   F   D N    I  +E     
Sbjct: 61  LTAVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFF 120

Query: 461 NDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
                   + +  A    +DT+ DG +S EEF +   
Sbjct: 121 GMLGLD--KTMAPASFDAIDTNNDGLLSLEEFVIAGS 155

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 73.9 bits (180), Expect = 6e-16
 Identities = 22/167 (13%), Positives = 53/167 (31%), Gaps = 27/167 (16%)

Query: 356 LSVEEVAGLKEAFE-MMDTNKRGKINLEELRLGLLKGG---------------QNIPEAD 399
           L+  +   +K  F+  +D N  G I   +    + +                 Q   E +
Sbjct: 2   LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDE 61

Query: 400 LQILMEAADVDGDGSLNYGEFVAVSVHLKKM---------ANDEHLHKAFSFFDRNRSGF 450
            + L   AD++ D  +++ E++A+                     +   F   D +  G 
Sbjct: 62  WRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGI 121

Query: 451 IEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           +++EE +N   +         + A+ + +            +  +  
Sbjct: 122 VDLEEFQNYCKNFQLQ--CADVPAVYNVITDGGKVTFDLNRYKELYY 166

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 38.8 bits (89), Expect = 5e-04
 Identities = 19/98 (19%), Positives = 32/98 (32%), Gaps = 16/98 (16%)

Query: 436 LHKAFS-FFDRNRSGFIEIEELRNALN---------------DEVDTSGEDVINAIMHDV 479
           +   F  F D N  G I+  +  + +                  +  S ED    +    
Sbjct: 10  IKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRA 69

Query: 480 DTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSI 517
           D +KD  +S+EE+  M +      K+         N I
Sbjct: 70  DINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRI 107

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 38.8 bits (89), Expect = 6e-04
 Identities = 17/122 (13%), Positives = 36/122 (29%), Gaps = 11/122 (9%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD---------LQILMEAADVDGDGS 414
            ++     D NK   ++ EE      K                  +  L +  DV GDG 
Sbjct: 62  WRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGI 121

Query: 415 LNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINA 474
           ++  EF     + +       +   ++          ++   +      + +   D  N 
Sbjct: 122 VDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYKELYYRLLTSPAADAGNT 179

Query: 475 IM 476
           +M
Sbjct: 180 LM 181

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 140

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 72.0 bits (175), Expect = 9e-16
 Identities = 30/140 (21%), Positives = 59/140 (42%), Gaps = 2/140 (1%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
            + +  K+AF + D +  G+I    +   L   GQN   A++  +      + D    + 
Sbjct: 2   TDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIESTLPAEVDME-QFL 60

Query: 419 EFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHD 478
           + +          + E   K F  FD++ +G I + ELR  L    +    + ++ ++  
Sbjct: 61  QVLNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKG 120

Query: 479 VDTDKDGRISYEEFAVMMKA 498
           V    DG ++Y +F  M+ A
Sbjct: 121 VPVK-DGMVNYHDFVQMILA 139

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 69.2 bits (169), Expect = 2e-15
 Identities = 28/70 (40%), Positives = 39/70 (55%)

Query: 429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS 488
           K  ++E L   F  FD+N  GFI+IEEL   L    +   E+ I  +M D D + DGRI 
Sbjct: 4   KGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRID 63

Query: 489 YEEFAVMMKA 498
           ++EF  MM+ 
Sbjct: 64  FDEFLKMMEG 73

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 56.5 bits (136), Expect = 5e-11
 Identities = 20/60 (33%), Positives = 36/60 (60%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           L   F + D N  G I++EEL   L   G+++ E D++ LM+ +D + DG +++ EF+ +
Sbjct: 11  LANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKM 70

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 72.6 bits (177), Expect = 2e-15
 Identities = 32/176 (18%), Positives = 63/176 (35%), Gaps = 19/176 (10%)

Query: 339 SVMNKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP 396
           S    L K  L+ +      + EE++   ++F  +     G+I  +E +    K      
Sbjct: 3   SKSGALSKEILEELQLNTKFTEEELSSWYQSF--LKECPSGRITRQEFQTIYSKFFPEAD 60

Query: 397 EADL-QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEE 455
                Q +  + D + DG+L++ E+V           ++ L  AFS +D + +G I   E
Sbjct: 61  PKAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNE 120

Query: 456 LRNALN--------------DEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           +   +                E + + E     I        D +++ +EF     
Sbjct: 121 VLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKLTEKEFIEGTL 176

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 42.5 bits (99), Expect = 4e-05
 Identities = 26/127 (20%), Positives = 45/127 (35%), Gaps = 4/127 (3%)

Query: 374 NKRGKINLEELRLGLLKGGQNIPEADLQILMEA-ADVDGDGSLNYGEFVAVSVHLKKMAN 432
           +K G ++ E L    L+      E +L    ++       G +   EF  +       A+
Sbjct: 3   SKSGALSKEILEE--LQLNTKFTEEELSSWYQSFLKECPSGRITRQEFQTIYSKFFPEAD 60

Query: 433 DEHL-HKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEE 491
            +      F  FD N  G ++ +E   AL+          +       D D +G IS  E
Sbjct: 61  PKAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNE 120

Query: 492 FAVMMKA 498
              ++ A
Sbjct: 121 VLEIVTA 127

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 70.5 bits (171), Expect = 4e-15
 Identities = 30/140 (21%), Positives = 58/140 (41%), Gaps = 7/140 (5%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
            K+ F + D   +G I  + L   L   G N     +Q ++ A     D S    + +  
Sbjct: 4   NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITG 63

Query: 424 SVHLKK-------MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIM 476
            + + +        A  E   KAF  FD+  +G + + +LR  L    +   +  ++ ++
Sbjct: 64  LIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELL 123

Query: 477 HDVDTDKDGRISYEEFAVMM 496
             V+ D +G I Y++F   +
Sbjct: 124 KGVEVDSNGEIDYKKFIEDV 143

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

 Score = 67.7 bits (165), Expect = 6e-15
 Identities = 29/71 (40%), Positives = 39/71 (54%)

Query: 428 KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRI 487
            K   +E L   F  FD+N  G+I++EEL+  L    +T  ED I  +M D D + DGRI
Sbjct: 9   SKGKTEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRI 68

Query: 488 SYEEFAVMMKA 498
            Y+EF   MK 
Sbjct: 69  DYDEFLEFMKG 79

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

 Score = 56.9 bits (137), Expect = 4e-11
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 3/77 (3%)

Query: 347 RALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA 406
           R ++  ++  + EE   L + F M D N  G I+LEEL++ L   G+ I E D++ LM+ 
Sbjct: 3   RCMKDDSKGKTEEE---LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKD 59

Query: 407 ADVDGDGSLNYGEFVAV 423
            D + DG ++Y EF+  
Sbjct: 60  GDKNNDGRIDYDEFLEF 76

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

 Score = 36.1 bits (83), Expect = 8e-04
 Identities = 12/65 (18%), Positives = 26/65 (40%)

Query: 396 PEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEE 455
            E +L  L    D + DG ++  E   +     +   ++ + +     D+N  G I+ +E
Sbjct: 13  TEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDE 72

Query: 456 LRNAL 460
               +
Sbjct: 73  FLEFM 77

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 170

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.5 bits (172), Expect = 6e-15
 Identities = 16/143 (11%), Positives = 38/143 (26%), Gaps = 19/143 (13%)

Query: 370 MMDTNKRGKINLEELRLGLLKGGQNIPEA--DLQILMEAADVDGDGSLNYGEFVAVSVHL 427
            M  N  GKI ++          + +  A     +     D           + +     
Sbjct: 15  KMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFL--- 71

Query: 428 KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGE--------------DVIN 473
             +     + + F+ +      ++  E L   +N +   S                 +I+
Sbjct: 72  MSLCPRPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLID 131

Query: 474 AIMHDVDTDKDGRISYEEFAVMM 496
                    + G++S E     +
Sbjct: 132 KYEPSGINAQRGQLSPEGMVWFL 154

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 66.0 bits (161), Expect = 2e-14
 Identities = 20/65 (30%), Positives = 34/65 (52%)

Query: 433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEF 492
            E + KAF  FD + SG I I++LR    +  +   E+ +  ++ + D + D  I  +EF
Sbjct: 8   REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEF 67

Query: 493 AVMMK 497
             +MK
Sbjct: 68  IRIMK 72

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 60.3 bits (146), Expect = 3e-12
 Identities = 17/60 (28%), Positives = 35/60 (58%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           + +AF + D +  G I +++LR    + G+N+ E +LQ ++  AD + D  ++  EF+ +
Sbjct: 11  ILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRI 70

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 66.0 bits (161), Expect = 2e-14
 Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 1/66 (1%)

Query: 433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG-EDVINAIMHDVDTDKDGRISYEE 491
           +E + +AF  FD N  G I+ +E +  +    +    +  +   M + D D +G I   E
Sbjct: 1   EEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPE 60

Query: 492 FAVMMK 497
           F  ++K
Sbjct: 61  FMDLIK 66

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 61.0 bits (148), Expect = 9e-13
 Identities = 18/61 (29%), Positives = 37/61 (60%), Gaps = 1/61 (1%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAADVDGDGSLNYGEFVA 422
           +  AF++ D N  G I+ +E +  + K G + + +A+++  M+ AD DG+G ++  EF+ 
Sbjct: 4   ILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMD 63

Query: 423 V 423
           +
Sbjct: 64  L 64

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 65.4 bits (159), Expect = 4e-14
 Identities = 26/77 (33%), Positives = 45/77 (58%), Gaps = 2/77 (2%)

Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDG 413
            FLS E +A  K AF+M D +  G I+ +EL   +   GQN  + +L  ++E  D DG G
Sbjct: 6   AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSG 65

Query: 414 SLNYGEFVAVSVHLKKM 430
           ++++ EF+   + +++M
Sbjct: 66  TIDFEEFLV--MMVRQM 80

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 57.7 bits (139), Expect = 2e-11
 Identities = 21/63 (33%), Positives = 31/63 (49%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
                AF  FD +  G I  +EL   +        ++ ++AI+ +VD D  G I +EEF 
Sbjct: 14  AEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFL 73

Query: 494 VMM 496
           VMM
Sbjct: 74  VMM 76

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 65.0 bits (158), Expect = 4e-14
 Identities = 13/62 (20%), Positives = 29/62 (46%)

Query: 436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVM 495
             + F  FD+N+ G + ++E R           ++ I     ++D D +G ++ +EF   
Sbjct: 3   AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSC 62

Query: 496 MK 497
           ++
Sbjct: 63  IE 64

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 59.2 bits (143), Expect = 5e-12
 Identities = 25/67 (37%), Positives = 34/67 (50%), Gaps = 3/67 (4%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
            K  FE  D NK GK++L+E R   L       + D+    E  DVDG+G LN  EF + 
Sbjct: 3   AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSC 62

Query: 424 SVHLKKM 430
              ++KM
Sbjct: 63  ---IEKM 66

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (163), Expect = 8e-14
 Identities = 36/151 (23%), Positives = 69/151 (45%), Gaps = 10/151 (6%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGD 412
                 +E+  L + F+ +D +  G +++EE                +Q +++  D DG+
Sbjct: 7   CSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQ----NPLVQRVIDIFDTDGN 62

Query: 413 GSLNYGEFVAVSVHLKKMANDEH-LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED- 470
           G +++ EF+          + E  L  AF  +D ++ G+I   EL   L   V  + +D 
Sbjct: 63  GEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDT 122

Query: 471 ----VINAIMHDVDTDKDGRISYEEFAVMMK 497
               +++  + + D D DGRIS+EEF  ++ 
Sbjct: 123 QLQQIVDKTIINADKDGDGRISFEEFCAVVG 153

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

 Score = 63.1 bits (153), Expect = 2e-13
 Identities = 25/68 (36%), Positives = 42/68 (61%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I  +EL   +   GQN  EA+LQ ++   D DG+G++
Sbjct: 2   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 61

Query: 416 NYGEFVAV 423
           ++ EF+ +
Sbjct: 62  DFPEFLTM 69

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

 Score = 55.0 bits (132), Expect = 2e-10
 Identities = 19/63 (30%), Positives = 31/63 (49%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
               +AFS FD++  G I  +EL   +        E  +  ++++VD D +G I + EF 
Sbjct: 8   AEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFL 67

Query: 494 VMM 496
            MM
Sbjct: 68  TMM 70

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} Length = 134

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

 Score = 64.8 bits (156), Expect = 3e-13
 Identities = 31/137 (22%), Positives = 57/137 (41%), Gaps = 8/137 (5%)

Query: 364 LKEA-FEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVA 422
           + EA F+ +D N  G ++ EE++  + K      E  LQ++ ++ D DG+G ++  EF  
Sbjct: 1   MAEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAK 60

Query: 423 ---VSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDV 479
                       +   L   +   D +  G +  EE+ +         G + +   +   
Sbjct: 61  FYGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKH----GIEKVAEQVMKA 116

Query: 480 DTDKDGRISYEEFAVMM 496
           D + DG I+ EEF    
Sbjct: 117 DANGDGYITLEEFLEFS 133

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

 Score = 63.0 bits (153), Expect = 3e-13
 Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 1/71 (1%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
               + F  FD N  G I   EL +AL      + ++ +  +M ++DTD DG IS++EF 
Sbjct: 6   ADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDE-VRRMMAEIDTDGDGFISFDEFT 64

Query: 494 VMMKAGTDWRK 504
              +A     K
Sbjct: 65  DFARANRGLVK 75

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

 Score = 59.9 bits (145), Expect = 4e-12
 Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 3/82 (3%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYG 418
           +++A  +  F+  DTN  GKI+  EL    LK   ++   +++ +M   D DGDG +++ 
Sbjct: 3   QDIADRERIFKRFDTNGDGKISSSELGD-ALKTLGSVTPDEVRRMMAEIDTDGDGFISFD 61

Query: 419 EFVAVSVHLKKMANDEHLHKAF 440
           EF             + + K F
Sbjct: 62  EFTD--FARANRGLVKDVSKIF 81

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

 Score = 39.1 bits (91), Expect = 9e-05
 Identities = 15/72 (20%), Positives = 28/72 (38%), Gaps = 1/72 (1%)

Query: 398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELR 457
           AD + + +  D +GDG ++  E       L  +  DE   +  +  D +  GFI  +E  
Sbjct: 6   ADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEV-RRMMAEIDTDGDGFISFDEFT 64

Query: 458 NALNDEVDTSGE 469
           +          +
Sbjct: 65  DFARANRGLVKD 76

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

 Score = 67.3 bits (163), Expect = 7e-13
 Identities = 43/237 (18%), Positives = 81/237 (34%), Gaps = 24/237 (10%)

Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 344
           +++  ++   K+   D K +   +        + A +    +  + + + LK     +  
Sbjct: 46  IAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLKDLED-DAS 104

Query: 345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILM 404
               L+     LS E+   L++ F     +  GK + ++L+  L K    IPE  L+ L 
Sbjct: 105 GYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLF 164

Query: 405 EAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV 464
              + D  G ++Y   VAV+  L  +  D       S    +R  F E           V
Sbjct: 165 VMVENDTKGRMSYITLVAVANDLAALVADFRKIDTNSNGTLSRKEFREHFVRLGFDKKSV 224

Query: 465 DTSGEDVINAIMHDV-----------------------DTDKDGRISYEEFAVMMKA 498
             +     +    D                        D DK G++S EE   +++ 
Sbjct: 225 QDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFADFDKSGQLSKEEVQKVLED 281

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

 Score = 62.7 bits (151), Expect = 2e-11
 Identities = 16/61 (26%), Positives = 29/61 (47%), Gaps = 1/61 (1%)

Query: 437 HKAFSFFDRNRSGFIEIEELRNALND-EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVM 495
              ++F D ++SG +  EE++  L D  +  S           VD D    +SY+EF ++
Sbjct: 256 RILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVML 315

Query: 496 M 496
           +
Sbjct: 316 V 316

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

 Score = 48.9 bits (115), Expect = 7e-07
 Identities = 15/59 (25%), Positives = 25/59 (42%), Gaps = 1/59 (1%)

Query: 366 EAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
             +   D +K G+++ EE++  L             +      DVD   SL+Y EFV +
Sbjct: 257 ILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVML 315

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

 Score = 43.5 bits (101), Expect = 4e-05
 Identities = 16/82 (19%), Positives = 27/82 (32%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
             L + F     + SG    ++L+  L    DT  E  +  +   V+ D  GR+SY    
Sbjct: 122 NILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLV 181

Query: 494 VMMKAGTDWRKASRQYSRERFN 515
            +           R+       
Sbjct: 182 AVANDLAALVADFRKIDTNSNG 203

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

 Score = 61.9 bits (150), Expect = 7e-13
 Identities = 22/82 (26%), Positives = 43/82 (52%), Gaps = 3/82 (3%)

Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEADLQILMEAAD 408
           +   E L+ E+    K AF++     + G I+ +EL   +   GQN    +LQ +++  D
Sbjct: 3   KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD 62

Query: 409 VDGDGSLNYGEFVAVSVHLKKM 430
            DG G++++ EF+   + ++ M
Sbjct: 63  EDGSGTVDFDEFLV--MMVRSM 82

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

 Score = 55.4 bits (133), Expect = 1e-10
 Identities = 16/64 (25%), Positives = 26/64 (40%), Gaps = 1/64 (1%)

Query: 434 EHLHKAFSFFDRN-RSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEF 492
                AF  F      G I  +EL   +         + +  ++ +VD D  G + ++EF
Sbjct: 15  NEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEF 74

Query: 493 AVMM 496
            VMM
Sbjct: 75  LVMM 78

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 61.6 bits (149), Expect = 7e-13
 Identities = 24/68 (35%), Positives = 39/68 (57%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           L+ E++A  KEAF + D +  G I+  EL   +   G +  EA++  LM   DVDG+  +
Sbjct: 4   LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQI 63

Query: 416 NYGEFVAV 423
            + EF+A+
Sbjct: 64  EFSEFLAL 71

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.6 bits (131), Expect = 2e-10
 Identities = 17/63 (26%), Positives = 33/63 (52%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
               +AF+ FD++ +G I   EL   +     +  E  +N +M+++D D + +I + EF 
Sbjct: 10  AEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFL 69

Query: 494 VMM 496
            +M
Sbjct: 70  ALM 72

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 36.9 bits (85), Expect = 4e-04
 Identities = 15/65 (23%), Positives = 27/65 (41%), Gaps = 3/65 (4%)

Query: 394 NIPEADLQILMEA---ADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGF 450
           N+ E  +    EA    D D +GS++  E   V   L    ++  ++   +  D + +  
Sbjct: 3   NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQ 62

Query: 451 IEIEE 455
           IE  E
Sbjct: 63  IEFSE 67

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 64.0 bits (154), Expect = 1e-12
 Identities = 33/179 (18%), Positives = 70/179 (39%), Gaps = 9/179 (5%)

Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDG 411
           A   ++ + + L   F+ +D ++ G I+  EL+  L  G         ++ ++   D + 
Sbjct: 10  AAGAALPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDREN 69

Query: 412 DGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV 471
              +N+ EF                   F  +DR+ SG I+  EL+ AL+       +  
Sbjct: 70  KAGVNFSEF------TGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQF 123

Query: 472 INAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISLKLMREEGLQLA 530
            + ++   D    G+I++++F              R+Y  ++   I +    E+ L + 
Sbjct: 124 HDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSY--EQYLSMV 180

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

 Score = 63.9 bits (154), Expect = 2e-12
 Identities = 29/163 (17%), Positives = 54/163 (33%), Gaps = 6/163 (3%)

Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLN 416
            + +   L E F  +DT+  G I++ EL   L   G                +      N
Sbjct: 13  HMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSL------ATTEKLLHMYDKN 66

Query: 417 YGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIM 476
           +   +              + + F   D +  G ++  E+R AL        E    A+M
Sbjct: 67  HSGEITFDEFKDLHHFILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALM 126

Query: 477 HDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSISL 519
              D  + G + ++++  +       R     Y RER   ++ 
Sbjct: 127 RKFDRQRRGSLGFDDYVELSIFVCRVRNVFAFYDRERTGQVTF 169

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

 Score = 41.2 bits (95), Expect = 9e-05
 Identities = 11/34 (32%), Positives = 19/34 (55%)

Query: 428 KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN 461
           + M +++ L + F   D + SG I + EL  AL+
Sbjct: 12  RHMNDNQELMEWFRAVDTDGSGAISVPELNAALS 45

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 65

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 59.3 bits (143), Expect = 4e-12
 Identities = 20/64 (31%), Positives = 41/64 (64%)

Query: 433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEF 492
           +E + +AF  FD++ +G+I   ELR+ + +  +   ++ ++ ++ + D D DG+++YEEF
Sbjct: 2   EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEF 61

Query: 493 AVMM 496
             MM
Sbjct: 62  VQMM 65

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 65

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 53.1 bits (127), Expect = 6e-10
 Identities = 21/60 (35%), Positives = 37/60 (61%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV 423
           ++EAF + D +  G I+  ELR  +   G+ + + ++  ++  AD+DGDG +NY EFV +
Sbjct: 5   IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQM 64

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 65

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 34.2 bits (78), Expect = 0.003
 Identities = 14/59 (23%), Positives = 26/59 (44%)

Query: 397 EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEE 455
           E +++      D DG+G ++  E   V  +L +   DE + +     D +  G +  EE
Sbjct: 2   EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEE 60

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 58.0 bits (140), Expect = 1e-11
 Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 4/72 (5%)

Query: 430 MANDEHLHKAFSFFDR--NRSGFIEIEELRNALND--EVDTSGEDVINAIMHDVDTDKDG 485
           M + E +  AF  F         I  EEL+  +         G   ++ ++ +VD + DG
Sbjct: 1   MKSPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDG 60

Query: 486 RISYEEFAVMMK 497
            +S+EEF VMMK
Sbjct: 61  EVSFEEFLVMMK 72

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 44.2 bits (104), Expect = 1e-06
 Identities = 21/71 (29%), Positives = 39/71 (54%), Gaps = 7/71 (9%)

Query: 357 SVEEVAGLKEAFEMMDTNK--RGKINLEELRLGLLKGGQNI--PEADLQILMEAADVDGD 412
           S EE   +K AFE+    +    +I+ EEL+L +   G ++    + L  ++E  D +GD
Sbjct: 3   SPEE---IKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGD 59

Query: 413 GSLNYGEFVAV 423
           G +++ EF+ +
Sbjct: 60  GEVSFEEFLVM 70

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} Length = 78

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 56.8 bits (137), Expect = 4e-11
 Identities = 16/68 (23%), Positives = 30/68 (44%), Gaps = 4/68 (5%)

Query: 434 EHLHKAFSFFDRN--RSGFIEIEELRNALNDEV--DTSGEDVINAIMHDVDTDKDGRISY 489
             L   F  +         +  EEL+  +  E      G   ++ +  ++D + DG +S+
Sbjct: 7   AELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSF 66

Query: 490 EEFAVMMK 497
           EEF V++K
Sbjct: 67  EEFQVLVK 74

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} Length = 78

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 51.4 bits (123), Expect = 3e-09
 Identities = 16/77 (20%), Positives = 32/77 (41%), Gaps = 4/77 (5%)

Query: 357 SVEEVAGLKEAFEMMDTNK--RGKINLEELRLGL--LKGGQNIPEADLQILMEAADVDGD 412
           + +  A LK  FE     +    +++ EEL+  +             L  L +  D +GD
Sbjct: 2   AQKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGD 61

Query: 413 GSLNYGEFVAVSVHLKK 429
           G +++ EF  +   + +
Sbjct: 62  GEVSFEEFQVLVKKISQ 78

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.6 bits (131), Expect = 1e-10
 Identities = 16/58 (27%), Positives = 36/58 (62%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFV 421
             +AF++ D    GK+++ +LR  L   G+ + +A++  L++  +VD +G ++Y +F+
Sbjct: 3   FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFI 60

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.6 bits (131), Expect = 2e-10
 Identities = 16/59 (27%), Positives = 31/59 (52%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEF 492
           E   KAF  FD+  +G + + +LR  L    +   +  ++ ++  V+ D +G I Y++F
Sbjct: 1   EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKF 59

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.7 bits (131), Expect = 4e-10
 Identities = 16/82 (19%), Positives = 30/82 (36%), Gaps = 16/82 (19%)

Query: 432 NDEHLHKAFSFFDRNRSGFIEIEELRNALN----------------DEVDTSGEDVINAI 475
           N  +    F   D N  G ++ +EL                      E++     +   +
Sbjct: 14  NRFNPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHV 73

Query: 476 MHDVDTDKDGRISYEEFAVMMK 497
           M +VDT++D  ++ EEF    +
Sbjct: 74  MKNVDTNQDRLVTLEEFLASTQ 95

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (106), Expect = 1e-06
 Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 16/75 (21%)

Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNI----------------PEADLQILMEAA 407
            K  F + D N  G ++ +EL     K  + +                     + +M+  
Sbjct: 18  PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNV 77

Query: 408 DVDGDGSLNYGEFVA 422
           D + D  +   EF+A
Sbjct: 78  DTNQDRLVTLEEFLA 92

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} Length = 92

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

 Score = 53.4 bits (128), Expect = 9e-10
 Identities = 15/68 (22%), Positives = 32/68 (47%), Gaps = 6/68 (8%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRIS 488
           E +   F  F  +  G++  E+LR  +  E      +      ++ IM D+D  +DG++ 
Sbjct: 9   ETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVG 67

Query: 489 YEEFAVMM 496
           ++ F  ++
Sbjct: 68  FQSFFSLI 75

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} Length = 92

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

 Score = 51.5 bits (123), Expect = 5e-09
 Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 9/88 (10%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP-----EADLQILMEAADVDGDG 413
             +  +   F     +K G +  E+LR+ + K              +  +M+  D   DG
Sbjct: 6   HAMETMMFTFHKFAGDK-GYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDG 64

Query: 414 SLNYGEFVAVSVHLKKMAND---EHLHK 438
            + +  F ++   L    ND    H+ +
Sbjct: 65  KVGFQSFFSLIAGLTIACNDYFVVHMKQ 92

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

 Score = 51.4 bits (123), Expect = 5e-09
 Identities = 11/70 (15%), Positives = 30/70 (42%), Gaps = 7/70 (10%)

Query: 434 EHLHKAF-SFFDRN-RSGFIEIEELRNALNDEVDTSG-----EDVINAIMHDVDTDKDGR 486
           + +   F  +  +      +   EL+  L  E+ +       E     +M ++D+++D  
Sbjct: 9   DVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNE 68

Query: 487 ISYEEFAVMM 496
           + ++E+ V +
Sbjct: 69  VDFQEYCVFL 78

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

 Score = 49.9 bits (119), Expect = 2e-08
 Identities = 16/84 (19%), Positives = 32/84 (38%), Gaps = 7/84 (8%)

Query: 359 EEVAGLKEAFEMMDTNK--RGKINLEELRLGLLKGGQNIP-----EADLQILMEAADVDG 411
           + +  +   F      +  + K+N  EL+  L +   +       EA  Q LM   D + 
Sbjct: 6   KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNR 65

Query: 412 DGSLNYGEFVAVSVHLKKMANDEH 435
           D  +++ E+      +  M N+  
Sbjct: 66  DNEVDFQEYCVFLSCIAMMCNEFF 89

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} Length = 98

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

 Score = 51.4 bits (123), Expect = 5e-09
 Identities = 9/67 (13%), Positives = 28/67 (41%), Gaps = 4/67 (5%)

Query: 434 EHLHKAF-SFFDRN-RSGFIEIEELRNALNDEVD--TSGEDVINAIMHDVDTDKDGRISY 489
           E +   F +F  +  R   + + E +  +  ++         ++  M  +D ++D  + +
Sbjct: 14  ETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKF 73

Query: 490 EEFAVMM 496
            E+  ++
Sbjct: 74  NEYWRLI 80

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} Length = 98

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

 Score = 43.0 bits (101), Expect = 5e-06
 Identities = 12/80 (15%), Positives = 28/80 (35%), Gaps = 4/80 (5%)

Query: 359 EEVAGLKEAFEMMDTN--KRGKINLEELRLGL--LKGGQNIPEADLQILMEAADVDGDGS 414
           E +  +   F        ++  +++ E +  +             L   M++ DV+ D  
Sbjct: 11  ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSE 70

Query: 415 LNYGEFVAVSVHLKKMANDE 434
           L + E+  +   L K    +
Sbjct: 71  LKFNEYWRLIGELAKEIRKK 90

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (120), Expect = 1e-08
 Identities = 19/79 (24%), Positives = 31/79 (39%), Gaps = 3/79 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           +S  E A   E F   D +  G ++  E+R   LK    +P   L  +    D    G L
Sbjct: 4   VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLK--TGLPSTLLAHIWSLCDTKDCGKL 61

Query: 416 NYGEFVAVSVHLKKMANDE 434
           +  +F  ++ HL      +
Sbjct: 62  SKDQFA-LAFHLISQKLIK 79

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (117), Expect = 3e-08
 Identities = 13/60 (21%), Positives = 25/60 (41%), Gaps = 2/60 (3%)

Query: 438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK 497
           + F   D++  GF+   E+R             ++  I    DT   G++S ++FA+   
Sbjct: 14  EIFLKTDKDMDGFVSGLEVREIFLKTGLP--STLLAHIWSLCDTKDCGKLSKDQFALAFH 71

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} Length = 99

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 50.1 bits (119), Expect = 2e-08
 Identities = 13/74 (17%), Positives = 32/74 (43%), Gaps = 3/74 (4%)

Query: 425 VHLKKMANDEHLH-KAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDK 483
           + L ++++   ++ K +   +   +G +   +    L        + ++  I    DTD 
Sbjct: 1   LSLTQLSSGNPVYEKYYRQVEAGNTGRVLALDAAAFLKK--SGLPDLILGKIWDLADTDG 58

Query: 484 DGRISYEEFAVMMK 497
            G +S +EF V ++
Sbjct: 59  KGVLSKQEFFVALR 72

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} Length = 99

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 37.3 bits (86), Expect = 5e-04
 Identities = 16/67 (23%), Positives = 29/67 (43%), Gaps = 3/67 (4%)

Query: 365 KEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVS 424
           ++ +  ++    G++   +    L K G       L  + + AD DG G L+  EF  V+
Sbjct: 14  EKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLI--LGKIWDLADTDGKGVLSKQEF-FVA 70

Query: 425 VHLKKMA 431
           + L   A
Sbjct: 71  LRLVACA 77

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} Length = 83

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.8 bits (118), Expect = 2e-08
 Identities = 14/72 (19%), Positives = 31/72 (43%)

Query: 425 VHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKD 484
           +H    ++   + + F  FD  ++  I  EE R   N  V    ++  + + +++  +  
Sbjct: 11  LHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAK 70

Query: 485 GRISYEEFAVMM 496
           GR+ Y +F    
Sbjct: 71  GRLKYPDFLSRF 82

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} Length = 83

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (112), Expect = 1e-07
 Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 9/83 (10%)

Query: 340 VMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
           ++ +L K    V + + +      + + FE  DT K   I+ EE R    +  Q + +  
Sbjct: 7   ILARLHKA---VTSHYHA------ITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQ 57

Query: 400 LQILMEAADVDGDGSLNYGEFVA 422
              L     V+  G L Y +F++
Sbjct: 58  FDRLWNEMPVNAKGRLKYPDFLS 80

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

 Score = 49.4 bits (118), Expect = 2e-08
 Identities = 8/66 (12%), Positives = 27/66 (40%), Gaps = 3/66 (4%)

Query: 434 EHLHKAF-SFFDRNRSGFIEI-EELRNALNDEV-DTSGEDVINAIMHDVDTDKDGRISYE 490
             +   +  +     +      ++L+  L  E      +   +    ++D + DG ++++
Sbjct: 10  NSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQ 69

Query: 491 EFAVMM 496
           EF +++
Sbjct: 70  EFLILV 75

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

 Score = 41.7 bits (98), Expect = 1e-05
 Identities = 12/82 (14%), Positives = 33/82 (40%), Gaps = 4/82 (4%)

Query: 359 EEVAGLKEAFEM-MDTNKRGKINLEELRLGLLK--GGQNIPEADLQILMEAADVDGDGSL 415
           + +  + + +               +    LL+    Q I +    +  +  D++ DG++
Sbjct: 7   KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAV 66

Query: 416 NYGEFVAVSVHLKKMANDEHLH 437
           N+ EF+ + + +   A+ +  H
Sbjct: 67  NFQEFLILVIKMGVAAH-KKSH 87

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

 Score = 48.7 bits (116), Expect = 4e-08
 Identities = 14/61 (22%), Positives = 25/61 (40%), Gaps = 6/61 (9%)

Query: 442 FFDRNRSGF-IEIEELRNALNDEVDTSG-----EDVINAIMHDVDTDKDGRISYEEFAVM 495
           +  R    + +   EL+  L  E+ T       E   N  M  +DT+KD  + + E+   
Sbjct: 18  YAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRS 77

Query: 496 M 496
           +
Sbjct: 78  L 78

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

 Score = 37.5 bits (87), Expect = 3e-04
 Identities = 16/82 (19%), Positives = 28/82 (34%), Gaps = 7/82 (8%)

Query: 359 EEVAGLKEAFEM-MDTNKRG-KINLEELRLGLLKGGQNIP-----EADLQILMEAADVDG 411
           + VA +   F+          K+   EL+  L K           E D    M   D + 
Sbjct: 6   QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNK 65

Query: 412 DGSLNYGEFVAVSVHLKKMAND 433
           D  +++ E+V     L    ++
Sbjct: 66  DCEVDFVEYVRSLACLCLYCHE 87

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

 Score = 48.4 bits (115), Expect = 5e-08
 Identities = 15/88 (17%), Positives = 31/88 (35%), Gaps = 7/88 (7%)

Query: 359 EEVAGLKEAFEMMDTN--KRGKINLEELR-----LGLLKGGQNIPEADLQILMEAADVDG 411
             +  L   F         + K++ +EL+                   +  +M+  D +G
Sbjct: 6   TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENG 65

Query: 412 DGSLNYGEFVAVSVHLKKMANDEHLHKA 439
           DG +++ EFV +   L    N+     +
Sbjct: 66  DGEVDFQEFVVLVAALTVACNNFFWENS 93

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

 Score = 47.6 bits (113), Expect = 1e-07
 Identities = 18/76 (23%), Positives = 36/76 (47%), Gaps = 7/76 (9%)

Query: 434 EHLHKAF-SFFDRN-RSGFIEIEELRNALNDEVDTSG-----EDVINAIMHDVDTDKDGR 486
           E L   F +   +      +  +EL++ L  E+ +        D ++ IM ++D + DG 
Sbjct: 9   ETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGE 68

Query: 487 ISYEEFAVMMKAGTDW 502
           + ++EF V++ A T  
Sbjct: 69  VDFQEFVVLVAALTVA 84

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} Length = 89

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

 Score = 47.9 bits (114), Expect = 7e-08
 Identities = 13/68 (19%), Positives = 26/68 (38%), Gaps = 5/68 (7%)

Query: 434 EHLHKAF-SFFDRNRSGFI----EIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRIS 488
             L   F  +  R          E++EL            +  I  +M D+D +KD  ++
Sbjct: 9   GLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVN 68

Query: 489 YEEFAVMM 496
           ++E+   +
Sbjct: 69  FQEYVTFL 76

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} Length = 89

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

 Score = 39.8 bits (93), Expect = 5e-05
 Identities = 20/80 (25%), Positives = 34/80 (42%), Gaps = 5/80 (6%)

Query: 359 EEVAGLKEAFEMM-----DTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDG 413
           + +  L   F        D +   K  L+EL    L  G  + +A++  LME  D + D 
Sbjct: 6   QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQ 65

Query: 414 SLNYGEFVAVSVHLKKMAND 433
            +N+ E+V     L  + N+
Sbjct: 66  EVNFQEYVTFLGALALIYNE 85

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 92

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 46.6 bits (110), Expect = 2e-07
 Identities = 17/80 (21%), Positives = 32/80 (40%), Gaps = 3/80 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           ++ E+       F+ +  +  G I     +    K    +P  +L  + E +D D DG+L
Sbjct: 3   ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK--SKLPILELSHIWELSDFDKDGAL 60

Query: 416 NYGEFVAVSVHLKKMANDEH 435
              EF   + HL     + +
Sbjct: 61  TLDEFC-AAFHLVVARKNGY 79

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 92

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 43.1 bits (101), Expect = 4e-06
 Identities = 12/64 (18%), Positives = 22/64 (34%), Gaps = 2/64 (3%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
           ++    F     + +GFI     +              ++ I    D DKDG ++ +EF 
Sbjct: 9   QYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLP--ILELSHIWELSDFDKDGALTLDEFC 66

Query: 494 VMMK 497
               
Sbjct: 67  AAFH 70

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} Length = 100

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

 Score = 46.9 bits (111), Expect = 2e-07
 Identities = 11/73 (15%), Positives = 26/73 (35%), Gaps = 9/73 (12%)

Query: 433 DEHLHKAFSFFDR--NRSGFIEIEELRNALNDE-------VDTSGEDVINAIMHDVDTDK 483
           +  +      F +   R   I+   L   + +         D  G + +  +    D ++
Sbjct: 6   ERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNE 65

Query: 484 DGRISYEEFAVMM 496
           D +I + EF  ++
Sbjct: 66  DKKIDFSEFLSLL 78

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} Length = 100

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

 Score = 43.0 bits (101), Expect = 4e-06
 Identities = 18/90 (20%), Positives = 34/90 (37%), Gaps = 13/90 (14%)

Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP-------EADLQILMEAADVDG 411
             + G+ + F      +  KI+   L   + +   N            L  + E  D + 
Sbjct: 7   RSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNE 65

Query: 412 DGSLNYGEFVAVSVHLKKMANDEH--LHKA 439
           D  +++ EF+++   L  +A D H   H A
Sbjct: 66  DKKIDFSEFLSL---LGDIATDYHKQSHGA 92

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (106), Expect = 9e-07
 Identities = 19/80 (23%), Positives = 38/80 (47%), Gaps = 4/80 (5%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           +  E+ A     F+ +     G ++ ++++  LL     +P   L  + E +D+D DG L
Sbjct: 4   VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGML 60

Query: 416 NYGEFVAVSVHLKKMANDEH 435
           +  EF  V++ L   A ++ 
Sbjct: 61  DRDEFA-VAMFLVYCALEKE 79

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (95), Expect = 3e-05
 Identities = 14/62 (22%), Positives = 26/62 (41%), Gaps = 7/62 (11%)

Query: 438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEEFAVM 495
             F       +GF+  ++++      +  S    D++  +    D D DG +  +EFAV 
Sbjct: 14  AIFDSLS-PVNGFLSGDKVKPV----LLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVA 68

Query: 496 MK 497
           M 
Sbjct: 69  MF 70

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

 Score = 43.6 bits (103), Expect = 2e-06
 Identities = 14/70 (20%), Positives = 30/70 (42%), Gaps = 7/70 (10%)

Query: 434 EHLHKAF-SFFDRNRSGF-IEIEELRNALNDE-----VDTSGEDVINAIMHDVDTDKDGR 486
           E +   F  +  R      +   EL+  L  E      +   + VI+ I   +D ++D +
Sbjct: 8   EGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQ 67

Query: 487 ISYEEFAVMM 496
           + ++EF  ++
Sbjct: 68  VDFQEFISLV 77

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

 Score = 37.1 bits (86), Expect = 4e-04
 Identities = 16/86 (18%), Positives = 33/86 (38%), Gaps = 10/86 (11%)

Query: 359 EEVAGLKEAFEMMDTNK--RGKINLEELRLGLLKGGQNIP-----EADLQILMEAADVDG 411
           E + G+   F      K     ++  EL+  L K   N       +A +  + +  D + 
Sbjct: 5   EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQ 64

Query: 412 DGSLNYGEFVAVSVHLKKMANDEHLH 437
           D  +++ EF+++   +       H H
Sbjct: 65  DEQVDFQEFISL---VAIALKAAHYH 87

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

 Score = 46.0 bits (108), Expect = 6e-06
 Identities = 23/161 (14%), Positives = 49/161 (30%), Gaps = 4/161 (2%)

Query: 62  RELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
           +E+G G     +   D  +      K A            + I+  R E   +    +H 
Sbjct: 32  QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91

Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
             +  +  Y D      VME     ++  + +  G      +  + + + + +    +  
Sbjct: 92  PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151

Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
           +  +  K     F N +     + + F    F      F E
Sbjct: 152 LEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTNDFEE 192

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} Length = 110

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (97), Expect = 2e-05
 Identities = 13/64 (20%), Positives = 21/64 (32%), Gaps = 2/64 (3%)

Query: 434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFA 493
           E+    F     + S FI     +N       +     ++ I    D D DG ++  EF 
Sbjct: 22  EYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLS--IPELSYIWELSDADCDGALTLPEFC 79

Query: 494 VMMK 497
               
Sbjct: 80  AAFH 83

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} Length = 110

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (96), Expect = 2e-05
 Identities = 14/76 (18%), Positives = 27/76 (35%), Gaps = 3/76 (3%)

Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSL 415
           ++ E+       F  +  +    I+    +         +   +L  + E +D D DG+L
Sbjct: 16  ITEEQREYYVNQFRSLQPDPSSFISGSVAKN--FFTKSKLSIPELSYIWELSDADCDGAL 73

Query: 416 NYGEFVAVSVHLKKMA 431
              EF   + HL    
Sbjct: 74  TLPEF-CAAFHLIVAR 88

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 33

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

 Score = 37.6 bits (88), Expect = 7e-05
 Identities = 10/29 (34%), Positives = 20/29 (68%)

Query: 432 NDEHLHKAFSFFDRNRSGFIEIEELRNAL 460
           ++E + +AF  FD++ +G+I   ELR+ +
Sbjct: 1   SEEEIREAFRVFDKDGNGYISAAELRHVM 29

>d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} Length = 83

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]

 Score = 39.3 bits (92), Expect = 7e-05
 Identities = 15/49 (30%), Positives = 27/49 (55%), Gaps = 6/49 (12%)

Query: 454 EELRNALNDEV------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            E +  +  ++      +   E VI  IM D+DT+ D ++S+EEF ++M
Sbjct: 32  GEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLM 80

>d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} Length = 94

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100p [TaxId: 9606]

 Score = 39.0 bits (91), Expect = 1e-04
 Identities = 10/48 (20%), Positives = 24/48 (50%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            EL+  +  E+         +D ++ ++ D+D + D ++ + EF V +
Sbjct: 31  GELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFV 78

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} Length = 90

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

 Score = 38.2 bits (89), Expect = 2e-04
 Identities = 12/48 (25%), Positives = 27/48 (56%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            EL+  +N+E+     +   ++V++ +M  +D+D DG   ++EF   +
Sbjct: 31  SELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFV 78

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

 Score = 37.8 bits (88), Expect = 3e-04
 Identities = 11/48 (22%), Positives = 24/48 (50%), Gaps = 5/48 (10%)

Query: 454 EELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMM 496
            E    +N E+     +     V++ +M  +D D DG++ ++EF  ++
Sbjct: 31  TEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLI 78

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	531
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1hqva_	181	Apoptosis-linked protein alg-2 {Mouse (Mus musculu	99.92
d1y1xa_	182	Programmed cell death 6 protein-like protein {Leis	99.92
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1k94a_	165	Grancalcin {Human (Homo sapiens) [TaxId: 9606]}	99.91
d1juoa_	172	Sorcin {Human (Homo sapiens) [TaxId: 9606]}	99.9
d1qxpa2	188	Calpain large subunit, C-terminal domain (domain I	99.9
d1df0a1	186	Calpain large subunit, C-terminal domain (domain I	99.9
d1exra_	146	Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI	99.9
d1alva_	173	Calpain small (regulatory) subunit (domain VI) {Pi	99.9
d1wdcb_	142	Myosin Essential Chain {Bay scallop (Aequipecten i	99.9
d1lkja_	146	Calmodulin {Baker's yeast (Saccharomyces cerevisia	99.89
d2obha1	141	Calmodulin {Human (Homo sapiens) [TaxId: 9606]}	99.88
d1dtla_	156	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.88
d1topa_	162	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.88
d1wdcc_	152	Myosin Regulatory Chain {Bay scallop (Aequipecten	99.87
d2mysb_	145	Myosin Essential Chain {Chicken (Gallus gallus) [T	99.87
d2mysc_	145	Myosin Regulatory Chain {Chicken (Gallus gallus) [	99.86
d1s6ia_	182	Calcium-dependent protein kinase sk5 CLD {Soybean	99.86
d1ggwa_	140	Cdc4p {Fission yeast (Schizosaccharomyces pombe) [	99.85
d1m45a_	146	Myosin Light Chain Mlc1p {Baker's yeast (Saccharom	99.85
d1jfja_	134	EHCABP {Entamoeba (Entamoeba histolytica) [TaxId:	99.84
d1jbaa_	189	Guanylate cyclase activating protein 2, GCAP-2 {Co	99.83
d1fpwa_	190	Frequenin (neuronal calcium sensor 1) {Baker's yea	99.83
d1g8ia_	187	Frequenin (neuronal calcium sensor 1) {Human (Homo	99.83
d1auib_	165	Calcineurin regulatory subunit (B-chain) {Human (H	99.82
d1w7jb1	139	Myosin Essential Chain {Human (Homo sapiens) [TaxI	99.82
d1bjfa_	181	Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}	99.81
d2zfda1	183	Calcineurin B-like protein 2 {Thale cress (Arabido	99.81
d1omra_	201	Recoverin {Cow (Bos taurus) [TaxId: 9913]}	99.8
d1s6ca_	178	Kchip1, Kv4 potassium channel-interacting protein	99.8
d1ij5a_	321	Cbp40 (plasmodial specific CaII-binding protein LA	99.76
d1qv0a_	189	Calcium-regulated photoprotein {Hydrozoa (Obelia l	99.75
d1xo5a_	180	Calcium- and integrin-binding protein, CIB {Human	99.75
d1jfja_	134	EHCABP {Entamoeba (Entamoeba histolytica) [TaxId:	99.73
d1fpwa_	190	Frequenin (neuronal calcium sensor 1) {Baker's yea	99.73
d1uhka1	187	Calcium-regulated photoprotein {Jellyfish (Aequore	99.72
d2sasa_	185	Sarcoplasmic calcium-binding protein {Amphioxus (B	99.71
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	99.71
d1omra_	201	Recoverin {Cow (Bos taurus) [TaxId: 9913]}	99.71
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	99.71
d2scpa_	174	Sarcoplasmic calcium-binding protein {Sandworm (Ne	99.7
d1jbaa_	189	Guanylate cyclase activating protein 2, GCAP-2 {Co	99.69
d1nyaa_	176	Calerythrin {Saccharopolyspora erythraea [TaxId: 1	99.66
d1exra_	146	Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI	99.66
d1g8ia_	187	Frequenin (neuronal calcium sensor 1) {Human (Homo	99.65
d1bjfa_	181	Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}	99.64
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	99.64
d2obha1	141	Calmodulin {Human (Homo sapiens) [TaxId: 9606]}	99.63
d1s6ca_	178	Kchip1, Kv4 potassium channel-interacting protein	99.63
d1rwya_	109	Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}	99.6
d1topa_	162	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.6
d1auib_	165	Calcineurin regulatory subunit (B-chain) {Human (H	99.6
d1lkja_	146	Calmodulin {Baker's yeast (Saccharomyces cerevisia	99.58
d1s6ia_	182	Calcium-dependent protein kinase sk5 CLD {Soybean	99.58
d1rroa_	108	Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116	99.57
d1y1xa_	182	Programmed cell death 6 protein-like protein {Leis	99.57
d2zfda1	183	Calcineurin B-like protein 2 {Thale cress (Arabido	99.56
d1wdcb_	142	Myosin Essential Chain {Bay scallop (Aequipecten i	99.56
d2mysc_	145	Myosin Regulatory Chain {Chicken (Gallus gallus) [	99.55
d1hqva_	181	Apoptosis-linked protein alg-2 {Mouse (Mus musculu	99.53
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.52
d1k94a_	165	Grancalcin {Human (Homo sapiens) [TaxId: 9606]}	99.52
d2scpa_	174	Sarcoplasmic calcium-binding protein {Sandworm (Ne	99.5
d1dtla_	156	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.5
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.5
d1w7jb1	139	Myosin Essential Chain {Human (Homo sapiens) [TaxI	99.49
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	99.49
d2sasa_	185	Sarcoplasmic calcium-binding protein {Amphioxus (B	99.48
d1ggwa_	140	Cdc4p {Fission yeast (Schizosaccharomyces pombe) [	99.48
d1m45a_	146	Myosin Light Chain Mlc1p {Baker's yeast (Saccharom	99.47
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	99.47
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	99.46
d1df0a1	186	Calpain large subunit, C-terminal domain (domain I	99.45
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.45
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	99.45
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	99.45
d1wrka1	82	Troponin C {Human (Homo sapiens), cardiac isoform	99.45
d1xo5a_	180	Calcium- and integrin-binding protein, CIB {Human	99.45
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	99.44
d1wdcc_	152	Myosin Regulatory Chain {Bay scallop (Aequipecten	99.44
d1nyaa_	176	Calerythrin {Saccharopolyspora erythraea [TaxId: 1	99.43
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	99.43
d1qxpa2	188	Calpain large subunit, C-terminal domain (domain I	99.43
d2zkmx1	170	Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI	99.43
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	99.42
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.42
d1juoa_	172	Sorcin {Human (Homo sapiens) [TaxId: 9606]}	99.42
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.41
d2mysb_	145	Myosin Essential Chain {Chicken (Gallus gallus) [T	99.41
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	99.4
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	99.39
d1ij5a_	321	Cbp40 (plasmodial specific CaII-binding protein LA	99.39
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	99.39
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	99.38
d1wrka1	82	Troponin C {Human (Homo sapiens), cardiac isoform	99.37
d1alva_	173	Calpain small (regulatory) subunit (domain VI) {Pi	99.37
d1qv0a_	189	Calcium-regulated photoprotein {Hydrozoa (Obelia l	99.33
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.32
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.31
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	99.29
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.27
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	99.26
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	99.26
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	99.25
d1uhka1	187	Calcium-regulated photoprotein {Jellyfish (Aequore	99.23
d1qx2a_	76	Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}	99.22
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	99.22
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	99.21
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	99.21
d1rwya_	109	Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}	99.12
d1cb1a_	78	Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}	99.09
d1zfsa1	93	Calcyclin (S100) {Rat (Rattus norvegicus), s100a1	99.08
d1rroa_	108	Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116	99.05
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	99.05
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	99.05
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	99.04
d3c1va1	93	Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta	99.04
d1qx2a_	76	Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}	99.03
d1snla_	99	Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax	99.02
d1a4pa_	92	Calcyclin (S100) {Human (Homo sapiens), P11 s100a1	99.01
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	99.0
d1ksoa_	93	Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta	99.0
d2zkmx1	170	Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI	98.99
d1yuta1	98	Calcyclin (S100) {Human (Homo sapiens), s100a13 [T	98.99
d1fi6a_	92	Reps1 {Mouse (Mus musculus) [TaxId: 10090]}	98.98
d1fi6a_	92	Reps1 {Mouse (Mus musculus) [TaxId: 10090]}	98.98
d1k8ua_	89	Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta	98.96
d1cb1a_	78	Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}	98.94
d1a4pa_	92	Calcyclin (S100) {Human (Homo sapiens), P11 s100a1	98.94
d1yuta1	98	Calcyclin (S100) {Human (Homo sapiens), s100a13 [T	98.93
d1zfsa1	93	Calcyclin (S100) {Rat (Rattus norvegicus), s100a1	98.93
d3c1va1	93	Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta	98.89
d1xk4a1	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.88
d1ksoa_	93	Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta	98.86
d2jxca1	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	98.85
d2jxca1	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	98.84
d1k8ua_	89	Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta	98.83
d1e8aa_	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.83
d1iq3a_	110	Pob1 {Human (Homo sapiens) [TaxId: 9606]}	98.79
d1qjta_	99	Eps15 {Mouse (Mus musculus) [TaxId: 10090]}	98.78
d1psra_	100	Calcyclin (S100) {Human (Homo sapiens), psoriasin	98.77
d2hf5a1	33	Troponin C {Human (Homo sapiens), cardiac isoform	98.76
d1xk4a1	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.75
d1e8aa_	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.74
d1iq3a_	110	Pob1 {Human (Homo sapiens) [TaxId: 9606]}	98.71
d2hf5a1	33	Troponin C {Human (Homo sapiens), cardiac isoform	98.7
d1psra_	100	Calcyclin (S100) {Human (Homo sapiens), psoriasin	98.69
d1snla_	99	Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax	98.65
d1qjta_	99	Eps15 {Mouse (Mus musculus) [TaxId: 10090]}	98.57
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.55
d3cr5x1	90	Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId:	98.51
d3cr5x1	90	Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId:	98.41
d1qlsa_	95	Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1	98.36
d1ctda_	34	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.31
d1j55a_	94	Calcyclin (S100) {Human (Homo sapiens), s100p [Tax	98.25
d1qlsa_	95	Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1	98.23
d1j55a_	94	Calcyclin (S100) {Human (Homo sapiens), s100p [Tax	98.16
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.14
d1xk4c1	83	Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr	97.96
d1xk4c1	83	Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr	97.95
d1ctda_	34	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	97.93
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.85
d1tuza_	118	Diacylglycerol kinase alpha, N-terminal domain {Hu	97.85
d1tuza_	118	Diacylglycerol kinase alpha, N-terminal domain {Hu	97.65
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.04
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.04
d1sraa_	151	C-terminal (EC) domain of BM-40/SPARC/osteonectin	97.03
d1sraa_	151	C-terminal (EC) domain of BM-40/SPARC/osteonectin	95.97
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.16
d1qasa1	94	Phosphoinositide-specific phospholipase C, isozyme	94.93
d1j7qa_	86	Calcium vector protein {Amphioxus (Branchiostoma l	94.15
d1h8ba_	73	alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]}	93.92
d1j7qa_	86	Calcium vector protein {Amphioxus (Branchiostoma l	92.01
d2cclb1	59	Endo-1,4-beta-xylanase Y {Clostridium thermocellum	91.25
d2cclb1	59	Endo-1,4-beta-xylanase Y {Clostridium thermocellum	90.38
d1qasa1	94	Phosphoinositide-specific phospholipase C, isozyme	89.79
d1dava_	71	Cellulosome endoglucanase SS {Clostridium thermoce	87.61
d1eg3a2	97	Dystrophin {Human (Homo sapiens) [TaxId: 9606]}	87.5
d1eg3a1	125	Dystrophin {Human (Homo sapiens) [TaxId: 9606]}	86.94
d1dava_	71	Cellulosome endoglucanase SS {Clostridium thermoce	84.19
d1wlma1	138	Protein cgi-38 {Mouse (Mus musculus) [TaxId: 10090	82.51

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-62  Score=473.94  Aligned_cols=283  Identities=39%  Similarity=0.743  Sum_probs=230.5

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      +.+.+.|++.+.||+|+||+||+|+++.+|+.||+|++.......  ....+.+|+.+|+++ +||||+++++++.+.+.
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKI-KHPNIVALDDIYESGGH   81 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence            467888999999999999999999999999999999998665432  235678999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +|||||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+|+...
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999999999999988899999999999999999999999999999999999999876667789999999998877


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ........+||+.|||||++. +.|+.++|||||||++|+|+||.+||.+.........+.+....++.+.++.+|+++.
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            666666788999999999987 5699999999999999999999999999998888888888877777777788999999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcCCcccccccCCCCCchhHHHHHHhhh
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQF  338 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~  338 (531)
                      +||.+||.+||++|||+.|+++||||+..... ..++...+...+++.
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~-~~~~~~~~~~~~~~~  288 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL-DKNIHQSVSEQIKKN  288 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCC-CCCCHHHHHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCCCcc-ccccchhHHHHHHHH
Confidence            99999999999999999999999999864332 223334444444443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-61  Score=454.00  Aligned_cols=254  Identities=35%  Similarity=0.633  Sum_probs=227.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++++ +||||+++++++.+.+.+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEE
Confidence            4799999999999999999999999999999999865544444467888999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+|...... .
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCSCSCCCCC-C
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC---CCEeecccceeeecCCC-c
Confidence            9999999999999988899999999999999999999999999999999999999654   45999999999876543 3


Q ss_pred             cccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....||+.|+|||++.+ .++.++|||||||++|+|+||++||.+.+..+....+.+....++    ..+|+++.+||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence            345689999999999884 689999999999999999999999999888888877776544332    358999999999


Q ss_pred             HccccCcCCCCCHHHHhcCCcccc
Q 009594          295 KMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       295 ~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      +||++||++|||+.|+|+||||+.
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-61  Score=455.40  Aligned_cols=259  Identities=31%  Similarity=0.550  Sum_probs=219.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++.......  ..+.+.+|+.+++++ +||||+++++++.+.+.+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKML-NHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeE
Confidence            4568999999999999999999999999999999997654322  235688999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|+.....
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~---~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC---CCEEEccchhheeeccC
Confidence            999999999999999888889999999999999999999999999999999999999654   45999999999876543


Q ss_pred             C---ccccccCCcccccchhccc-cC-CCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          214 E---QFNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       214 ~---~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      .   .....+||+.|||||++.+ .+ +.++|||||||++|+|+||++||................ .....+++.++++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~  235 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSA  235 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-CTTSTTGGGSCHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCccccCCHH
Confidence            2   2345689999999999874 44 678999999999999999999997765443333222222 2233445778999


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +.+||.+||++||++|||+.|+|+||||++.
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            9999999999999999999999999999854

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-60  Score=457.69  Aligned_cols=268  Identities=37%  Similarity=0.709  Sum_probs=239.7

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      ..+.++|++++.||+|+||+||+|+++.+|+.||+|++.+.....   ....+.+.+|+.+|+++ +|||||++++++.+
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~   84 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN   84 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE
Confidence            447788999999999999999999999999999999998654432   22367899999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCC-CCCeEEEeeccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGLS  207 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~-~~~ikl~Dfg~a  207 (531)
                      .+.+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ...+||+|||+|
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            9999999999999999999998889999999999999999999999999999999999999976553 346999999999


Q ss_pred             cccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .............||+.|+|||++. ..++.++|||||||++|+|+||..||.+.+..+....+......++...++.+|
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence            9887766667788999999999987 468999999999999999999999999999888888887776665555556789


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      +.+.+||.+||.+||++|||+.|+|+||||+...
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999998643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-59  Score=450.12  Aligned_cols=258  Identities=30%  Similarity=0.529  Sum_probs=225.5

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ...+|++++.||+|+||+||+|.+..+|+.||+|++......   ..+.+.+|+.+++++ +|||||++++++.+.+.+|
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEE
Confidence            345799999999999999999999999999999999765433   346789999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|......
T Consensus        94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCST
T ss_pred             EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC---CcEeeccchhheeeccc
Confidence            99999999999998765 469999999999999999999999999999999999999654   45999999999876544


Q ss_pred             C-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          214 E-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      . .....+||+.|+|||++. +.++.++|||||||++|+|+||.+||.+.+.......+...... ....++.+|+.+++
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  248 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD  248 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence            3 345668999999999987 46899999999999999999999999988877766666554322 12233568999999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ||.+||.+||++|||+.|+|+||||+...
T Consensus       249 li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999999999999998643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.3e-59  Score=459.53  Aligned_cols=262  Identities=35%  Similarity=0.664  Sum_probs=237.7

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      +.++|++++.||+|+||+||+|++..+|+.||+|++....   ......+.+|+.+|+++ +|||||+++++|.+.+.+|
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence            4567999999999999999999999999999999997543   33456788999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||||+||+|.+++...+ ++++..++.|+.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|.....
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecCC
Confidence            9999999999998876544 69999999999999999999999999999999999999643 245799999999998877


Q ss_pred             CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      ........||+.|+|||++. ..++.++|||||||++|+|+||.+||.+.+.......+.+....++...++.+|+++.+
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            76667788999999999987 46899999999999999999999999999998888888888877777778889999999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ||.+||++||++|||+.|+|+||||+...
T Consensus       262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            99999999999999999999999998643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-59  Score=443.01  Aligned_cols=255  Identities=23%  Similarity=0.413  Sum_probs=217.4

Q ss_pred             cce-eeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc----CC
Q 009594           56 IDY-DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----DS  130 (531)
Q Consensus        56 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~  130 (531)
                      ++| ++.++||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+++|+++ +|||||++++++.+    ..
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCC
Confidence            344 778899999999999999999999999999976654 344567889999999999 89999999999864    45


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       131 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      .+|||||||+||+|.+++.+...+++..++.++.||+.||+|||+++  |+||||||+|||++++  ++.+||+|||+|+
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~--~~~~Kl~DFGla~  163 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST--TSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC--CCCEEEeecCcce
Confidence            68999999999999999998889999999999999999999999998  9999999999999632  3469999999998


Q ss_pred             ccCCCCccccccCCcccccchhccccCCCccchhHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhcccCCCCCCCCCCCH
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      .... ......+||+.|||||++.+.++.++|||||||++|+|+||+.||.+..... ....+......  .......++
T Consensus       164 ~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~  240 (270)
T d1t4ha_         164 LKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIP  240 (270)
T ss_dssp             GCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCH
T ss_pred             eccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccCCH
Confidence            6543 3345678999999999999899999999999999999999999997765443 33444332211  112245789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      ++.+||.+||++||++|||+.|+|+||||+
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.6e-59  Score=458.91  Aligned_cols=262  Identities=36%  Similarity=0.671  Sum_probs=237.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      +-++|++++.||+|+||.||+|+++.+|+.||+|++....   ....+.+.+|+.+|+++ +|||||++++++.+.+.+|
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence            4568999999999999999999999999999999996543   33457888999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+|||++.+. ++.+||+|||+|+....
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~-~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-SCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCC-CCeEEEeecchheeccc
Confidence            99999999999999854 45799999999999999999999999999999999999997543 45799999999998877


Q ss_pred             CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      ........||+.|||||++. ..++.++|||||||++|+|+||++||.+.+..+....+......+....++.+|+.+++
T Consensus       179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  258 (350)
T ss_dssp             TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred             ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            66667788999999999987 46899999999999999999999999999998888888887777666667789999999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ||.+||.+||++|||+.|+|+||||+...
T Consensus       259 li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999998654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-59  Score=448.15  Aligned_cols=256  Identities=32%  Similarity=0.586  Sum_probs=225.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++++ +||||+++++++.+.+.+|||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEE
Confidence            5799999999999999999999999999999999865543344567899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      ||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+|+...... 
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~---~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED---MHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC---ceEEecccccceecccCCc
Confidence            9999999999999988899999999999999999999999999999999999999644   459999999998765332 


Q ss_pred             --ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          215 --QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       215 --~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                        .....+||+.|+|||++. ..++.++|||||||++|+|+||.+||.+.+......++.+....++    ..+++.+++
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  239 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD  239 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence              234568999999999987 5689999999999999999999999999988888888877654433    468999999


Q ss_pred             HHHHccccCcCCCCCHHH------HhcCCccccc
Q 009594          292 LVKKMLNPDPKQRLTAEE------VLEHPWLQNA  319 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~------~l~h~~~~~~  319 (531)
                      ||.+||++||++|||+.|      +++||||+..
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999999988      5889999765

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-59  Score=451.04  Aligned_cols=257  Identities=29%  Similarity=0.454  Sum_probs=227.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ....|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++++ +|||||++++++.+.+.+|
T Consensus        13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~   91 (309)
T d1u5ra_          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW   91 (309)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred             cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEE
Confidence            345699999999999999999999999999999999876655555567899999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      ||||||++|+|..++....++++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|..... 
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSSS-
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC---CCEEEeecccccccCC-
Confidence            999999999998888888889999999999999999999999999999999999999754   4599999999986543 


Q ss_pred             CccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHH
Q 009594          214 EQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA  289 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (531)
                        .....||+.|||||++.    +.|+.++|||||||++|+|++|..||.+.+.......+........  ....+|+.+
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~  243 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYF  243 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSCHHH
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCCCHHH
Confidence              34568999999999885    3589999999999999999999999999888777777766543322  224689999


Q ss_pred             HHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       290 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+||.+||++||++|||+.|+|+||||.+.
T Consensus       244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            999999999999999999999999999754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-58  Score=440.22  Aligned_cols=262  Identities=37%  Similarity=0.688  Sum_probs=235.9

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCCh------hhHHHHHHHHHHHHhCCCCCCeeecceEEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA------VDIEDVRREVQIMKHLPKHPNIVSLKDTYE  127 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~  127 (531)
                      |.++|++++.||+|+||+||+|++..+|+.||+|++.+......      ...+.+.+|+.+++++..||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            34689999999999999999999999999999999987654321      123467899999999966999999999999


Q ss_pred             cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       128 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                      +++.+|||||||+||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+|
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~---~~~~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD---DMNIKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcC---CCCeEEccchhe
Confidence            99999999999999999999999889999999999999999999999999999999999999954   455999999999


Q ss_pred             cccCCCCccccccCCcccccchhccc-------cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD  280 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  280 (531)
                      ....+........||+.|+|||.+.+       .++.++||||+||++|+|+||+.||.+.+.......+.......+.+
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            98776666666789999999998752       36789999999999999999999999999888888888887777777


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      .++.+|+++.+||.+||+++|++|||+.|+|+||||+.
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            77789999999999999999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-59  Score=447.47  Aligned_cols=256  Identities=30%  Similarity=0.484  Sum_probs=223.1

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .+.|++++.||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|+++|+++ +|||||++++++.+.+.++|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEE
Confidence            456999999999999999999999999999999997643   23456788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          135 VMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|......
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~---~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC---CCEEEEechhhhccCCC
Confidence            9999999999998765 4569999999999999999999999999999999999999654   45999999999765432


Q ss_pred             -CccccccCCcccccchhcc------ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          214 -EQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                       .......||+.|+|||++.      ..|+.++|||||||++|+|+||.+||.+.+..+....+.+...... ...+.+|
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s  242 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWS  242 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSC
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCC
Confidence             2234578999999999873      3488999999999999999999999999888888777776543221 2235689


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                      +++.+||.+||++||++|||+.|+|+||||+.
T Consensus       243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999999974

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-58  Score=449.50  Aligned_cols=256  Identities=32%  Similarity=0.581  Sum_probs=230.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|+++ +||||+++++++.+.+.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccc
Confidence            4799999999999999999999999999999999876543344567888999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC-CC
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~-~~  214 (531)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|+.... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~---g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC---CCEEEeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999654   5699999999987643 34


Q ss_pred             ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      .....+||+.|+|||++. ..|+.++|||||||++|+|++|++||.+.+.......+......++    ..+|+++++||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  236 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence            455678999999999987 5699999999999999999999999999999888888877655443    46899999999


Q ss_pred             HHccccCcCCCCC-----HHHHhcCCccccc
Q 009594          294 KKMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       294 ~~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      .+||++||++||+     +.++++||||+..
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccC
Confidence            9999999999994     9999999999764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-58  Score=438.13  Aligned_cols=253  Identities=32%  Similarity=0.555  Sum_probs=210.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--CCeEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAVH  133 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~  133 (531)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+++++++ +|||||++++++.+  .+.+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence            579999999999999999999999999999999977654 344567889999999999 99999999999864  46689


Q ss_pred             EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCceEeecCCCCCCeEEEee
Q 009594          134 IVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQG-----VMHRDLKPENFLFANKKESSPLKAIDF  204 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~-----iiH~Dlkp~NIll~~~~~~~~ikl~Df  204 (531)
                      ||||||+||+|.+++.+    ...+++..++.++.||+.||.|||++|     |+||||||+|||++.+   +.+||+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~---~~vkl~DF  158 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGDF  158 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT---SCEEECCH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC---CcEEEeec
Confidence            99999999999998864    457999999999999999999999976     9999999999999654   45999999


Q ss_pred             ccccccCCCC-ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          205 GLSVFFRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       205 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      |+|+...... ......||+.|+|||++. ..|+.++|||||||++|+|+||.+||.+.+..+....+.......   ..
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IP  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CC
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence            9998776543 334578999999999987 569999999999999999999999999988888877777654332   22


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL  316 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~  316 (531)
                      ..+|+++.+||.+||+.||++|||+.|+|+|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            4689999999999999999999999999999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-58  Score=448.97  Aligned_cols=261  Identities=31%  Similarity=0.639  Sum_probs=236.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      +-++|++++.||+|+||+||+|.++.+|+.||+|++....    .+...+.+|+.+|+++ +||||++++++|.+.+.+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA-RHRNILHLHESFESMEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence            5568999999999999999999999999999999997543    2345688999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||||+||+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++.++ ...+||+|||++.....
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~-~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC-ceEEEEcccchhhcccc
Confidence            9999999999999997665 699999999999999999999999999999999999997543 45699999999998776


Q ss_pred             CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD  291 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (531)
                      ........+|+.|+|||.+. ..++.++|||||||++|+|++|.+||.+.+..+....+.+....++...++.+|+++++
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            66666778999999999887 56899999999999999999999999999999998999888777666667789999999


Q ss_pred             HHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       292 li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                      ||.+||.+||++|||+.|+|+||||+...
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999997643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=452.37  Aligned_cols=262  Identities=25%  Similarity=0.393  Sum_probs=217.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ...++|++++.||+|+||+||+|+++.+|+.||+|++....  .......+.+|+.+|+++ +|||||+++++|.+.+.+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence            45678999999999999999999999999999999997653  233356788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+   +.+||+|||+|....
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~---~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---CCEEECCCCCCHHHH
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC---CCEEEeeCCCccccC
Confidence            9999999999999999988899999999999999999999997 599999999999999654   459999999998654


Q ss_pred             CCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHh------------------
Q 009594          212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------------  272 (531)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~------------------  272 (531)
                      +. ...+.+||+.|+|||++. ..|+.++||||+||++|+|++|+.||.+.+..........                  
T Consensus       157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence            32 234578999999999987 4799999999999999999999999977653322110000                  


Q ss_pred             --------------------cccCCCCC--CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          273 --------------------SVIDFKRD--PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       273 --------------------~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                          .......+  +...+++++.+||.+||..||++|||+.|+|+||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                                00000001  11135789999999999999999999999999999986543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-57  Score=442.91  Aligned_cols=254  Identities=29%  Similarity=0.585  Sum_probs=228.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++++ +||||+++++++.+.+.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeE
Confidence            4699999999999999999999999999999999865443344567889999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      ||||+||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|+.....  
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~---g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN---GHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---SCEEECCCSSCEECSSC--
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC---CCEEEecCccceEeccc--
Confidence            9999999999999999899999999999999999999999999999999999999654   45999999999876533  


Q ss_pred             cccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+.+..+....+.+....++    +.+|+++.++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            345789999999999884 689999999999999999999999999998888888877654332    468999999999


Q ss_pred             HccccCcCCCC-----CHHHHhcCCccccc
Q 009594          295 KMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       295 ~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +||.+||++|+     |++++++||||+..
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            99999999996     99999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-58  Score=450.64  Aligned_cols=266  Identities=38%  Similarity=0.690  Sum_probs=223.7

Q ss_pred             ccccceeecc-ccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc---
Q 009594           53 DISIDYDLGR-ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED---  128 (531)
Q Consensus        53 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  128 (531)
                      .+-++|+++. .||+|+||+||+|++..+|+.||||++...        ..+.+|+.++.++.+|||||+++++|.+   
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            3456899875 599999999999999999999999998642        4567899998766689999999999875   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          129 -DSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       129 -~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                       ...+|||||||+||+|.+++.+.+  .+++..++.|+.||+.||+|||++||+||||||+|||++..+..+.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence             467999999999999999998743  59999999999999999999999999999999999999877777789999999


Q ss_pred             cccccCCCCccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcc----cCCCCC
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----IDFKRD  280 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~----~~~~~~  280 (531)
                      +|+............||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+.+.......+....    ..++.+
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~  239 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  239 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred             eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence            9998777666677889999999999874 69999999999999999999999998776555444443322    233333


Q ss_pred             CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccccCCCCC
Q 009594          281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVS  326 (531)
Q Consensus       281 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~~  326 (531)
                      .++.+|+++.+||.+||++||++|||+.|+++||||++....+..+
T Consensus       240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~  285 (335)
T d2ozaa1         240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  285 (335)
T ss_dssp             HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence            4456899999999999999999999999999999998765555443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.5e-57  Score=443.48  Aligned_cols=254  Identities=29%  Similarity=0.554  Sum_probs=228.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+++ +||||+++++++.+....++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccc
Confidence            6899999999999999999999999999999999765544444567889999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ  215 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~  215 (531)
                      |||+.||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+   +.+||+|||+|+.....  
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~---g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSSC--
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC---CCEEeeeceeeeecccc--
Confidence            9999999999999988899999999999999999999999999999999999999654   46999999999876543  


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK  294 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  294 (531)
                      .....||+.|||||++. ..++.++|||||||++|+|+||.+||.+.+.......+.......    ...+++++.+||.
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC----CccCCHHHHHHHH
Confidence            34568999999999987 468999999999999999999999999998888888887765433    2468999999999


Q ss_pred             HccccCcCCCC-----CHHHHhcCCccccc
Q 009594          295 KMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       295 ~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +||.+||.+|+     |+.++++||||+..
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccCC
Confidence            99999999995     99999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=436.70  Aligned_cols=256  Identities=29%  Similarity=0.496  Sum_probs=225.0

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHH-hCCCCCCeeecceEEEcCCeEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK-HLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|..++. .+ +||||+++++++.+.+.+||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence            47999999999999999999999999999999997654333334566777887776 56 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++++   +.+||+|||+|+......
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~---~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC---Cceeccccchhhhccccc
Confidence            99999999999999998899999999999999999999999999999999999999644   459999999998665433


Q ss_pred             -ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHH
Q 009594          215 -QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL  292 (531)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (531)
                       ......||+.|+|||++. +.++.++|||||||++|+|+||+.||.+.+.......+......++    +.+|+.+.+|
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  233 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL  233 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence             344578999999999987 5799999999999999999999999999998888887776544332    3579999999


Q ss_pred             HHHccccCcCCCCCHH-HHhcCCccccc
Q 009594          293 VKKMLNPDPKQRLTAE-EVLEHPWLQNA  319 (531)
Q Consensus       293 i~~~l~~~p~~Rps~~-~~l~h~~~~~~  319 (531)
                      |.+||.+||++|||+. ++++||||+..
T Consensus       234 i~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         234 LVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            9999999999999995 89999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-56  Score=443.02  Aligned_cols=258  Identities=27%  Similarity=0.466  Sum_probs=218.6

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHH---HHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRRE---VQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|   +.+++.+ +|||||++++++.+.+.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence            469999999999999999999999999999999976544322223334444   6666677 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |||||||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|+....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~---g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---SCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC---CcEEEeeeceeeecCC
Confidence            9999999999999999998899999999999999999999999999999999999999644   4599999999987654


Q ss_pred             CCccccccCCcccccchhcc-c-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      . ......||+.|+|||++. + .|+.++|||||||++|+|+||+.||.+....... .+.+.........+..+|+++.
T Consensus       160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSSSCCCCCCSSSCHHHH
T ss_pred             C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCCCCHHHH
Confidence            3 334568999999999986 3 5899999999999999999999999876543332 2333344444444567999999


Q ss_pred             HHHHHccccCcCCCCC-----HHHHhcCCccccc
Q 009594          291 DLVKKMLNPDPKQRLT-----AEEVLEHPWLQNA  319 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps-----~~~~l~h~~~~~~  319 (531)
                      +||.+||.+||++|||     ++++++||||+..
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999999     7999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-56  Score=429.79  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=214.2

Q ss_pred             eccccCccCceEEEEEEEccCCcEEEEEEeeccccCChh--hHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEe
Q 009594           60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV--DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME  137 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  137 (531)
                      .++.||+|+||+||+|++..+|+.||||++.........  ....+.+|+.+++++ +|||||++++++...+.+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhh
Confidence            457899999999999999999999999999755432211  134688999999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-cc
Q 009594          138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QF  216 (531)
Q Consensus       138 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-~~  216 (531)
                      |+.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+|....... ..
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~---~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---GVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---CccccccCccccccCCCcccc
Confidence            99988887776667779999999999999999999999999999999999999644   459999999998765433 34


Q ss_pred             ccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC-------------
Q 009594          217 NEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP-------------  281 (531)
Q Consensus       217 ~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------  281 (531)
                      ...+||+.|+|||++.  ..|+.++|||||||++|+|+||.+||.+.+..+....+.+.........             
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            4568999999999876  3579999999999999999999999999998888777765432211111             


Q ss_pred             -----------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          282 -----------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       282 -----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                 ++.+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                       235688999999999999999999999999999998654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=419.62  Aligned_cols=253  Identities=32%  Similarity=0.567  Sum_probs=214.8

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChh---hHHHHHHHHHHHHhCC-CCCCeeecceEEEcC
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV---DIEDVRREVQIMKHLP-KHPNIVSLKDTYEDD  129 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~  129 (531)
                      +.++|++.+.||+|+||+||+|++..+|+.||||++.+.......   ....+.+|+.+++++. .||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            567899999999999999999999999999999999865443221   1233567999999984 399999999999999


Q ss_pred             CeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          130 SAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       130 ~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      +..++||||+.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+  .+.+||+|||+|.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~--~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--TTEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecC--CCeEEECccccce
Confidence            999999999976 6788888888899999999999999999999999999999999999999743  2459999999998


Q ss_pred             ccCCCCccccccCCcccccchhccc-c-CCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .... .......||+.|+|||++.+ . ++.++|||||||++|+|+||..||....      .+.+....+    .+.+|
T Consensus       160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~----~~~~s  228 (273)
T d1xwsa_         160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF----RQRVS  228 (273)
T ss_dssp             ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC----SSCCC
T ss_pred             eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCC----CCCCC
Confidence            6543 33456789999999999874 3 4677999999999999999999996532      233433322    24689


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +++.+||.+||.+||++|||+.|+|+||||++.
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.5e-55  Score=419.56  Aligned_cols=262  Identities=27%  Similarity=0.430  Sum_probs=220.9

Q ss_pred             CccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC-
Q 009594           52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-  130 (531)
Q Consensus        52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-  130 (531)
                      ..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++...+ 
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECS
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccC
Confidence            34678899999999999999999999999999999999877666666677899999999999 9999999999987543 


Q ss_pred             ---eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          131 ---AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       131 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                         .+|||||||+|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .++|+|||.+
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~---~~~l~d~~~~  158 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIA  158 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS---CEEECCCTTC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc---cceeehhhhh
Confidence               4899999999999999999888999999999999999999999999999999999999997554   4899999998


Q ss_pred             cccCCCC----ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          208 VFFRPGE----QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       208 ~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      .......    .....+||+.|+|||++. ..++.++|||||||++|+|+||.+||.+.+..+....+.+.....+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence            7654322    234567999999999987 46899999999999999999999999999888888777777665555566


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccc
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ  317 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~  317 (531)
                      +.+|+.+.+||.+||++||++||+..+.|.|+|.+
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            78999999999999999999999544445566664

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=420.32  Aligned_cols=261  Identities=27%  Similarity=0.444  Sum_probs=215.4

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||+||+|++..+|+.||+|++...... ....+.+.+|+.+++++ +|||||++++++.+.+.+|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEE
Confidence            4799999999999999999999999999999999654322 22346788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 009594          136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-  213 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~-  213 (531)
                      |||+.++.+...... ...+++..++.++.||+.||.|||++|||||||||+|||++.+   ..+||+|||.|+..... 
T Consensus        80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~---~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSTTHHHHHCCCS
T ss_pred             EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc---CcceeccCCcceeccCCc
Confidence            999976544433333 4469999999999999999999999999999999999999644   45999999999876543 


Q ss_pred             CccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCC----------
Q 009594          214 EQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP----------  281 (531)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  281 (531)
                      .......||+.|+|||++.  ..++.++|||||||++|+|++|+.||.+.+..+....+.+.........          
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            3345568999999999866  3468899999999999999999999999888777766654322211111          


Q ss_pred             ---------------CCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          282 ---------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       282 ---------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                     ++.+++++++||.+||.+||++|||+.|+|+||||++..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                           2346789999999999999999999999999999987654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=420.09  Aligned_cols=263  Identities=26%  Similarity=0.419  Sum_probs=216.0

Q ss_pred             ccceeeccccCccCceEEEEEEEccC-CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCCeeecceEEEc---
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYED---  128 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---  128 (531)
                      .++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+++.|.  +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            46899999999999999999999765 67799999976543221 1234556777776653  79999999999852   


Q ss_pred             --CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeec
Q 009594          129 --DSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG  205 (531)
Q Consensus       129 --~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg  205 (531)
                        ....+++|||+.++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||++..   +.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~---~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC---CCeeecchh
Confidence              3578999999998777544433 4468999999999999999999999999999999999999644   459999999


Q ss_pred             cccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCC-----
Q 009594          206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-----  279 (531)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-----  279 (531)
                      ++.............||+.|+|||++. ..|+.++|||||||++|+|+||.+||.+.+..+....+.........     
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            998776666667788999999999886 67999999999999999999999999999888877776543211110     


Q ss_pred             ------------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          280 ------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       280 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                        ..++.+++.+.+||.+||++||++|||+.|+|+||||+...+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence                              112457899999999999999999999999999999997654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-53  Score=411.31  Aligned_cols=257  Identities=31%  Similarity=0.487  Sum_probs=214.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||+||+|++. +|+.||||++...... ....+.+.+|+.+|+++ +||||+++++++.+.+..+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEE
Confidence            47999999999999999999985 7899999999765432 22356888999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      +||+.++.+..+....+.+++..+..++.||+.||+|||+.|||||||||+|||++.+   +.+||+|||.|....... 
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~---~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCTTHHHHHCC---
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC---CCEEecccccceecccCcc
Confidence            9999887777777767789999999999999999999999999999999999999654   459999999998765432 


Q ss_pred             ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC------------
Q 009594          215 QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD------------  280 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------------  280 (531)
                      ......|++.|+|||.+.  ..++.++|||||||++|+|++|++||.+.+..+....+.+........            
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            234557899999999886  357999999999999999999999999988877766665432211111            


Q ss_pred             -------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          281 -------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       281 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                   ..+.+++.+.+||.+||++||++|||+.|+|+||||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                         12346889999999999999999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-53  Score=408.72  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=211.1

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++....    ...+.+.+|+.+|+++ +|||||++++++.+.+.++|
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEE
Confidence            457999999999999999999999999999999986543    2356789999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |||||++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+|+....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~---~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCCTTTCCS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC---CcEEEccccceeecCC
Confidence            99999999999998764  468999999999999999999999999999999999999654   4599999999987654


Q ss_pred             CCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          213 GEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFW-AETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       213 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ...  .....||+.|+|||++. +.|+.++|||||||++|||++|..||. +.+.......+... ..  ......+|+.
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~--~~~~~~~~~~  244 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR--MERPEGCPEK  244 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC--CCCCTTCCHH
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CC--CCCCccchHH
Confidence            432  23345789999999877 679999999999999999999666554 44444444433332 22  2223568999


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      +.+||.+||+.||++|||+.++++  +|+..
T Consensus       245 l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         245 VYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence            999999999999999999999965  45443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=406.46  Aligned_cols=250  Identities=22%  Similarity=0.390  Sum_probs=204.2

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .++|++.+.||+|+||+||+|+.   +..||||++..... .....+.+.+|+.+++++ +|||||++++++. .+.++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEEE
Confidence            45799999999999999999973   34699999975543 334567899999999999 9999999999875 456899


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 009594          135 VMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG  213 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~  213 (531)
                      |||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.+   +.+||+|||+|+.....
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~---~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---SSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC---CCEEEccccceeecccc
Confidence            99999999999999754 569999999999999999999999999999999999999654   45999999999876533


Q ss_pred             C---ccccccCCcccccchhcc----ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcc-cCCC-CCCCCC
Q 009594          214 E---QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-IDFK-RDPWPK  284 (531)
Q Consensus       214 ~---~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~  284 (531)
                      .   ......||+.|||||++.    +.|+.++|||||||++|||+||+.||.+.+............ .... ......
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  237 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN  237 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence            2   234568999999999985    247889999999999999999999998877655544444332 2211 223456


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +|+.+.+||.+||..+|++|||+.+++++
T Consensus       238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         238 CPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999999876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=417.69  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=211.4

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCc-----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGE-----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .++|++.+.||+|+||+||+|++..+++     .||+|.+....  .......+.+|+.+++++.+|||||++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            3679999999999999999999866543     68999886543  2233467889999999987899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 009594          130 SAVHIVMELCEGGELFDRIVARG-----------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPE  186 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~  186 (531)
                      +.++||||||++|+|.+++....                       .+++..++.|+.||+.||.|||++|||||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            99999999999999999997542                       4789999999999999999999999999999999


Q ss_pred             ceEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCC
Q 009594          187 NFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAE  261 (531)
Q Consensus       187 NIll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~  261 (531)
                      |||++.+   +.+||+|||+|+.......   .....||+.|||||++. +.++.++|||||||++|||+| |.+||.+.
T Consensus       194 Nill~~~---~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         194 NVLVTHG---KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GEEEETT---TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ccccccC---CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            9999654   4599999999987654432   23456899999999886 679999999999999999998 89999887


Q ss_pred             CHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          262 TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.......+......+..  ...+|+++.+||.+||+.+|++|||++||++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         271 PVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            766666666655443322  34689999999999999999999999999876

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-53  Score=408.59  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..+|++.+.||+|+||+||+|.+..+++   .||+|.+....  .....+.+.+|+.+|+++ +|||||++++++...+.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCE
Confidence            4579999999999999999999876654   58888875433  344567899999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      +++|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|+..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~---~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECC---CCcEEECCcccceEc
Confidence            99999999999999988764 46999999999999999999999999999999999999964   456999999999876


Q ss_pred             CCCCcc------ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 009594          211 RPGEQF------NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPW  282 (531)
Q Consensus       211 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  282 (531)
                      ......      ....||+.|+|||++. +.++.++|||||||++|||+| |.+||.+.+..+....+.+...   .+..
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~~~~  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---LPPP  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCC
Confidence            543221      1245789999999887 679999999999999999998 8999999888877777665432   2233


Q ss_pred             CCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       283 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ..+|+.+.+||.+||+.+|++|||+.+++++
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            5689999999999999999999999999865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=406.45  Aligned_cols=246  Identities=22%  Similarity=0.307  Sum_probs=204.6

Q ss_pred             cccCccCceEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEEecc
Q 009594           62 RELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC  139 (531)
Q Consensus        62 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  139 (531)
                      ++||+|+||+||+|.+.  .+++.||||++..... .....+.+.+|+.+|+++ +|||||++++++.. +..+||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-CCEEEEEEcC
Confidence            46999999999999864  3567899999965433 333457899999999999 99999999999865 4578999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc----
Q 009594          140 EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----  215 (531)
Q Consensus       140 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~----  215 (531)
                      ++|+|.+++.+...+++..++.|+.||+.||.|||++||+||||||+|||++.++   .+||+|||+|+.......    
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~---~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEECCTTCSEEEC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC---cccccchhhhhhcccccccccc
Confidence            9999999999888999999999999999999999999999999999999997654   499999999987654432    


Q ss_pred             cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHH
Q 009594          216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV  293 (531)
Q Consensus       216 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  293 (531)
                      .....||+.|+|||++. +.++.++|||||||++|||+| |.+||.+.+..+....+.+...   .+....+|+++.+||
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~~~~~~~li  243 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDLM  243 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHHHHHHH
Confidence            12356899999999886 678999999999999999998 8999999888777766655432   122246899999999


Q ss_pred             HHccccCcCCCCCHHHHh---cCCcc
Q 009594          294 KKMLNPDPKQRLTAEEVL---EHPWL  316 (531)
Q Consensus       294 ~~~l~~~p~~Rps~~~~l---~h~~~  316 (531)
                      .+||+.||++|||+.+++   +|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999999984   55554

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=403.72  Aligned_cols=252  Identities=25%  Similarity=0.323  Sum_probs=211.7

Q ss_pred             cceeeccc-cCccCceEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRE-LGRGEFGVTYLCTDVN--NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||++....  .....+.+.+|+.+|+++ +|||||++++++.. +.+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeE
Confidence            46778774 9999999999998654  45689999996542  344567899999999999 99999999999875 468


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |||||||++|+|.+++.. +..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+|+...
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~---~~Kl~DFGla~~~~  160 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALG  160 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT---EEEECCCTTCEECT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC---ceeeccchhhhccc
Confidence            999999999999998765 45699999999999999999999999999999999999997654   59999999998775


Q ss_pred             CCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          212 PGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       212 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ....    .....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..+....+.+...   .+..+.+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~  237 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPEC  237 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCTTC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcC
Confidence            4432    22356899999999987 679999999999999999998 9999998887777766665432   1223568


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHH---hcCCccc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEV---LEHPWLQ  317 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~---l~h~~~~  317 (531)
                      |+++.+||.+||+.+|++|||+.++   |+|+|+.
T Consensus       238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999888   5677764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=401.43  Aligned_cols=246  Identities=24%  Similarity=0.399  Sum_probs=201.1

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      .+|++++.||+|+||+||+|.+. +++.||||++.....    ..+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEE
Confidence            36999999999999999999975 577899999865332    246789999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+   +.+||+|||+|+......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~---~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG---GCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC---CCeEecccchheeccCCC
Confidence            9999999999988754 458999999999999999999999999999999999999754   459999999998765443


Q ss_pred             c--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          215 Q--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       215 ~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .  .....||+.|+|||++. +.++.++|||||||++|||+| |.+||...+..+....+.......   ....+++++.
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~  232 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVY  232 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC---CCTTSCHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHH
Confidence            2  23457899999999987 579999999999999999999 577777777777777666543221   1245789999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcC
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +|+.+||+.||++|||+.++++|
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=396.24  Aligned_cols=246  Identities=22%  Similarity=0.337  Sum_probs=213.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++.++||+|+||+||+|++ .+++.||||++.....    ..+.+.+|+.+++++ +||||+++++++.+.+.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC----CHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Confidence            4699999999999999999997 4788999999976543    246789999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      |||+++|+|..++.. ...+++..+..++.||++||.|||++||+||||||+||++++   ++.+||+|||+|+......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~---~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND---QGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT---TCCEEECCCSSCCBCSSSS
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC---CCcEEECcchhheeccCCC
Confidence            999999999998654 456899999999999999999999999999999999999964   4569999999998765443


Q ss_pred             cc--ccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          215 QF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       215 ~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      ..  ....||+.|+|||++. +.++.++|||||||++|||+| |+.||.+.+..++...+......   .....+++.+.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---CCCTTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---CCcccccHHHH
Confidence            32  2356899999999987 679999999999999999998 89999999888877777654321   22246889999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcC
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +||.+||+.+|++|||+.++++|
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.5e-52  Score=410.12  Aligned_cols=256  Identities=31%  Similarity=0.574  Sum_probs=213.1

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc--CCeE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAV  132 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~  132 (531)
                      .++|+++++||+|+||+||+|+++.+|+.||||++....      .+.+.+|+.+|+.+.+||||++++++|..  ....
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            368999999999999999999999999999999986432      46788999999999779999999999974  4679


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ++|||||.+++|....   ..+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+||+|||+|....+
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~--~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC--CeeeecccccceeccC
Confidence            9999999999997753   4699999999999999999999999999999999999997543  3489999999998877


Q ss_pred             CCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhcc-------------cC
Q 009594          213 GEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-------------ID  276 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~-------------~~  276 (531)
                      ........+|+.|+|||++.+  .++.++||||+||++|+|++|..||...... .....+....             ..
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            766677889999999998763  4799999999999999999999999765432 2222221100             00


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          277 --------------------FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       277 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                          .....+..+++++.+||.+||.+||++|||++|+|+||||+...+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                                001112347889999999999999999999999999999987543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=413.60  Aligned_cols=259  Identities=28%  Similarity=0.422  Sum_probs=214.7

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc----
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----  128 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----  128 (531)
                      ....+|+.+++||+|+||+||+|++..+|+.||||++......       ..+|+.+|+++ +||||++++++|..    
T Consensus        17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l-~h~niv~~~~~~~~~~~~   88 (350)
T d1q5ka_          17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKL-DHCNIVRLRYFFYSSGEK   88 (350)
T ss_dssp             CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHC-CCTTBCCEEEEEEEC--C
T ss_pred             cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhc-CCCCCCcEEEEEEecCcc
Confidence            3345799999999999999999999999999999999765321       23699999999 99999999999853    


Q ss_pred             --CCeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEe
Q 009594          129 --DSAVHIVMELCEGGELFDR---IVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID  203 (531)
Q Consensus       129 --~~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~D  203 (531)
                        ..+++||||||+++.+..+   ......+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+||+|
T Consensus        89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~--~~~kl~D  166 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCD  166 (350)
T ss_dssp             CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT--CCEEECC
T ss_pred             CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC--CceeEec
Confidence              3458999999987643332   23455799999999999999999999999999999999999997543  3599999


Q ss_pred             eccccccCCCCccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC----
Q 009594          204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF----  277 (531)
Q Consensus       204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----  277 (531)
                      ||+|..........+..||+.|+|||.+.  ..++.++||||+||++|+|++|++||...+..+....+.+.....    
T Consensus       167 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  246 (350)
T d1q5ka_         167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  246 (350)
T ss_dssp             CTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence            99999887766667788999999999865  368999999999999999999999999988777766654321100    


Q ss_pred             ---------------------CCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          278 ---------------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       278 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                           .....+..++++.+||.+||.+||++|||+.|+|+||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                                 00112457899999999999999999999999999999987543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=402.72  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=210.8

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      -..+|++.+.||+|+||+||+|.+. +++.||||++.....    ..+.+.+|+.+++++ +|||||++++++.+ +..+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeE
Confidence            3467999999999999999999964 678999999965432    346789999999999 99999999998755 5678


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          134 IVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      |||||+++|+|.+++...  .++++..++.|+.||+.||.|||+++|+||||||+|||++.   ++.+||+|||+|+...
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~---~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIE  160 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEECS
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec---ccceeeccccceEEcc
Confidence            999999999999877543  35899999999999999999999999999999999999964   4569999999999876


Q ss_pred             CCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          212 PGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       212 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      ....  .....||+.|+|||++. +.++.++|||||||++|||+|| .+||...+..+....+......   .....+|+
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~---~~p~~~~~  237 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNCPE  237 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred             CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CCcccChH
Confidence            5432  23457899999999887 6799999999999999999995 5666666666666666554221   12246899


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhc--CCcccc
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLE--HPWLQN  318 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~--h~~~~~  318 (531)
                      .+.+|+.+||+.||++|||+.++++  |+||..
T Consensus       238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999999999998  788753

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=407.66  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=213.7

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-------
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-------  128 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-------  128 (531)
                      ++|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|+++ +||||+++++++..       
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence            6799999999999999999999999999999998765433 23346788999999999 89999999998754       


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          129 -DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       129 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                       ..+.|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~---~~~kl~dfg~~  164 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLA  164 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC---CcEEeeeccee
Confidence             45689999999887776665566679999999999999999999999999999999999999654   45999999999


Q ss_pred             cccCCCC-----ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 009594          208 VFFRPGE-----QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD  280 (531)
Q Consensus       208 ~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  280 (531)
                      .......     .....+||+.|+|||++.  ..++.++|||||||++|+|++|++||.+.+.......+.+....+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            7665322     223457999999999876  358999999999999999999999999988888777776654443332


Q ss_pred             CCCC----------------------------CCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          281 PWPK----------------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       281 ~~~~----------------------------~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                      .+..                            .++.+.+||.+||++||++|||+.|+|+||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            2211                            25678899999999999999999999999999853

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=410.52  Aligned_cols=258  Identities=27%  Similarity=0.465  Sum_probs=211.3

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC---
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS---  130 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  130 (531)
                      +..+|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+|+++ +|||||+++++|...+   
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCcccc
Confidence            6778999999999999999999999999999999997543 3444567888999999999 9999999999997654   


Q ss_pred             ---eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccc
Q 009594          131 ---AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS  207 (531)
Q Consensus       131 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a  207 (531)
                         .+|+||||+ +.+|..++ +...+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~---~~~~kl~Dfg~a  168 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---DCELKILDFGLA  168 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTC
T ss_pred             ccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc---ccccccccccce
Confidence               579999999 56777665 4557999999999999999999999999999999999999964   445999999999


Q ss_pred             cccCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhccc----------
Q 009594          208 VFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----------  275 (531)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----------  275 (531)
                      .....  ......||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+.......+.....          
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         169 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             eccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            87643  3455789999999998763  578999999999999999999999998877666554433211          


Q ss_pred             -------------CCCCC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccccc
Q 009594          276 -------------DFKRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK  320 (531)
Q Consensus       276 -------------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  320 (531)
                                   .....    ..+.+++.+.+||.+||..||++|||+.|+|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                         11111    2245789999999999999999999999999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=408.34  Aligned_cols=260  Identities=27%  Similarity=0.472  Sum_probs=211.4

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCC---
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS---  130 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  130 (531)
                      ++.+|++++.||+|+||+||+|.+..+|+.||||++.+..  .....+.+.+|+.+|+++ +||||+++++++....   
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTT
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccc
Confidence            4468999999999999999999999999999999997543  344567888999999999 9999999999986543   


Q ss_pred             --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          131 --AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       131 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                        .+|++ +|+.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||+++   ++.+||+|||+|.
T Consensus        83 ~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~---~~~~kl~DfG~a~  157 (345)
T d1pmea_          83 MKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLAR  157 (345)
T ss_dssp             CCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTCE
T ss_pred             cceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC---CCCEEEcccCcee
Confidence              34554 556689999998654 7999999999999999999999999999999999999964   4469999999998


Q ss_pred             ccCCCC----ccccccCCcccccchhcc--ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC-----
Q 009594          209 FFRPGE----QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-----  277 (531)
Q Consensus       209 ~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-----  277 (531)
                      ......    .....+||+.|+|||++.  ..++.++||||+||++|+|++|++||.+....+............     
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            664432    234567999999999875  357889999999999999999999998887666555443221111     


Q ss_pred             ------------------CC----CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          278 ------------------KR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       278 ------------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                        ..    ..++.+++++++||.+||.+||++|||+.|+|+||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                              00    113467889999999999999999999999999999986554

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-53  Score=409.85  Aligned_cols=261  Identities=31%  Similarity=0.576  Sum_probs=219.3

Q ss_pred             cceeeccccCccCceEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ++|++++.||+|+||+||+|++.   .+|+.||+|++.+.... .....+.+.+|+.+++++..||||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999974   46899999999765432 222345677899999999545899999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      +++||||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+|....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC---CCEEEeeccchhhhc
Confidence            99999999999999999998899999999999999999999999999999999999999654   459999999998764


Q ss_pred             CCC--ccccccCCcccccchhccc---cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          212 PGE--QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       212 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ...  ......|++.|+|||.+.+   .++.++|||||||+||+|+||..||.+.+.......+.+............++
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            332  2345679999999998863   47889999999999999999999998876555555555444333333345689


Q ss_pred             HHHHHHHHHccccCcCCCC-----CHHHHhcCCccccc
Q 009594          287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA  319 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rp-----s~~~~l~h~~~~~~  319 (531)
                      +++.+||.+||.+||++||     |++|+++||||+..
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            9999999999999999999     58999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=396.16  Aligned_cols=259  Identities=27%  Similarity=0.453  Sum_probs=218.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV  135 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv  135 (531)
                      ++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.+ +||||+++++++.+....++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEE
Confidence            479999999999999999999999999999999976543 334567889999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 009594          136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~-  214 (531)
                      ++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+   ..+||+|||.|....... 
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~---~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSCCS
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC---CceeeeecchhhcccCCCc
Confidence            9999999999988888889999999999999999999999999999999999999654   459999999998776443 


Q ss_pred             ccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCC-CCCCHHHHHHHHHhcccCCCC------------
Q 009594          215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRSVIDFKR------------  279 (531)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf-~~~~~~~~~~~~~~~~~~~~~------------  279 (531)
                      ......+++.|+|||++.+  .++.++|||||||++|+|++|..|| .+.+..+....+.........            
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            3344567889999998763  3789999999999999999999885 444555555554432221111            


Q ss_pred             -------------CCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccc
Q 009594          280 -------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA  319 (531)
Q Consensus       280 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  319 (531)
                                   ...+.+++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                         1123568899999999999999999999999999999753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=390.43  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=199.9

Q ss_pred             cceeeccccCccCceEEEEEEEccCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNG----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      ..|++.+.||+|+||+||+|....++    ..||||++....  .......+.+|+.+++++ +|||||++++++...+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCc
Confidence            36999999999999999999976554    479999986543  334456788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      .++|||||.++++.+.+... ..+++..++.++.||+.||.|||+++|+||||||+|||++.   ++.+||+|||+|+..
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~---~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS---NLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC---CCeEEEcccchhhcc
Confidence            99999999999999887654 56999999999999999999999999999999999999964   456999999999876


Q ss_pred             CCCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Q 009594          211 RPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPWPK  284 (531)
Q Consensus       211 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (531)
                      .....    .....||+.|+|||++. +.++.++|||||||++|||+|| .+|+...+..+....+.....   .+....
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---~~~~~~  237 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LPTPMD  237 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCCTT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC---CCCchh
Confidence            54322    22346899999999887 5799999999999999999995 555666666666555544322   122346


Q ss_pred             CCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          285 VSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       285 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      +|+.+.+||.+||+.+|++|||+.+|++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            8999999999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=392.06  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=201.6

Q ss_pred             ccceeeccccCccCceEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCe
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA  131 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  131 (531)
                      .++|++.+.||+|+||.||+|.+..+   +..||+|.+...  ......+.+.+|+.+++++ +||||+++++++. .+.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCe
Confidence            46899999999999999999998654   356888887543  2444567899999999999 9999999999986 467


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccccc
Q 009594          132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF  210 (531)
Q Consensus       132 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~  210 (531)
                      +++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+||++++++   .+||+|||+|+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~---~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC---cEEEccchhheec
Confidence            8999999999999998765 44689999999999999999999999999999999999997654   4999999999876


Q ss_pred             CCCCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          211 RPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       211 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      .....  .....||+.|+|||++. +.++.++|||||||++|||+| |.+||...+..+....+.....   .+.++.+|
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence            54332  23456899999999987 679999999999999999998 8999999888887777765432   23346789


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.+.+||.+||..||++|||+.++++|
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=390.04  Aligned_cols=253  Identities=23%  Similarity=0.310  Sum_probs=205.9

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEE
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~l  134 (531)
                      .++|++.+.||+|+||+||+|++.. ++.||||++.....    ..+.+.+|+.+++++ +|||||++++++.+ +..++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC----CHHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEE
Confidence            4579999999999999999999754 46799999965432    246799999999999 99999999999855 55789


Q ss_pred             EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      |||||++|+|..++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+|+....
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~---~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIED  165 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC----
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC---CcEEEcccchhhhccC
Confidence            9999999999988754  3569999999999999999999999999999999999999654   4599999999987654


Q ss_pred             CCc--cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHH
Q 009594          213 GEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN  288 (531)
Q Consensus       213 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (531)
                      ...  .....||+.|+|||++. +.++.++|||||||++|||+|| .+|+......+....+.+...   .+..+.+|++
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~  242 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPES  242 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCHH
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCCcccCHH
Confidence            332  23457899999999887 6799999999999999999995 555666666666666554321   2234578999


Q ss_pred             HHHHHHHccccCcCCCCCHHHHhc--CCcccccc
Q 009594          289 AKDLVKKMLNPDPKQRLTAEEVLE--HPWLQNAK  320 (531)
Q Consensus       289 ~~~li~~~l~~~p~~Rps~~~~l~--h~~~~~~~  320 (531)
                      +.+||.+||+.||++|||+.+|++  ++||....
T Consensus       243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            999999999999999999999988  88997653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=390.40  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=202.0

Q ss_pred             cceeeccccCccCceEEEEEEEcc-CC--cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVN-NG--EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+|++.+.||+|+||+||+|+... ++  ..||||++.+.........+.+.+|+.+++++ +||||+++++++.+ +..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cch
Confidence            469999999999999999998643 33  47899999876655555667899999999999 99999999999966 467


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++|||||++|++.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~---~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc---ceeeccchhhhhcc
Confidence            899999999999987765 45699999999999999999999999999999999999998654   49999999999765


Q ss_pred             CCCc----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Q 009594          212 PGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV  285 (531)
Q Consensus       212 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (531)
                      ....    .....|++.|+|||++. ..++.++|||||||++|||+| |.+||.+.+..+....+.+....++  ..+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~  240 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDC  240 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Ccccc
Confidence            4332    22345788999999887 568999999999999999998 8999999999888888776644332  33578


Q ss_pred             CHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          286 SENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       286 ~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      |+.+.+||.+||..||++|||+.+|++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999963

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=403.74  Aligned_cols=256  Identities=26%  Similarity=0.394  Sum_probs=201.6

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEE------c
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE------D  128 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~------~  128 (531)
                      .++|+++++||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+++++ +||||++++++|.      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeccccccc
Confidence            3679999999999999999999999999999999976543 344556788999999999 9999999999995      3


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      ..++|+|||||.++.+ +.+  ...+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+|++|||++.
T Consensus        94 ~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~---~~~kl~df~~~~  167 (355)
T d2b1pa1          94 FQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLAR  167 (355)
T ss_dssp             CCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCCCC--
T ss_pred             CceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc---cceeeechhhhh
Confidence            4789999999976544 444  3468999999999999999999999999999999999999654   459999999998


Q ss_pred             ccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCC----------
Q 009594          209 FFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF----------  277 (531)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------  277 (531)
                      ............+|+.|+|||++. ..+++++||||+||++|+|++|++||.+.+.......+.......          
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            777666666778999999999987 568999999999999999999999999888776666554322110          


Q ss_pred             ------------CCCCC----------------CCCCHHHHHHHHHccccCcCCCCCHHHHhcCCcccc
Q 009594          278 ------------KRDPW----------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN  318 (531)
Q Consensus       278 ------------~~~~~----------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~  318 (531)
                                  ....+                ...++++.+||.+||..||++|||++|+|+||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                        00000                013567899999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=398.36  Aligned_cols=250  Identities=21%  Similarity=0.297  Sum_probs=208.6

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcE--EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEK--FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ++|++.+.||+|+||+||+|.+..+|..  ||||.+....  .....+.+.+|+.+|+++.+|||||++++++.+.+.++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            4799999999999999999999888875  5667664332  23345678999999999977999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCC
Q 009594          134 IVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS  197 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~  197 (531)
                      +||||+++|+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||++.++   
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~---  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG---
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC---
Confidence            999999999999998654                4689999999999999999999999999999999999996554   


Q ss_pred             CeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCC-CCCCCCCHHHHHHHHHhccc
Q 009594          198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVI  275 (531)
Q Consensus       198 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~~  275 (531)
                      .+||+|||+|+............||+.|+|||.+. +.++.++|||||||++|||++|. +||.+.+..+....+.+.. 
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~-  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-
Confidence            59999999998765544445567899999999887 67999999999999999999965 6788888777776665532 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                        ....+..+++++.+||.+||+.||++|||+.+|+++
T Consensus       244 --~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              122335689999999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-51  Score=395.74  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=203.3

Q ss_pred             ceeeccccCccCceEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      +|++++.||+|+||+||+|.+..+|+    .||+|.+....  .....+.+.+|+.+++++ +|||||++++++.+. ..
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-Ce
Confidence            69999999999999999999888776    57778775432  233457899999999999 999999999999865 56


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 009594          133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR  211 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~  211 (531)
                      ++++||+.+++|.+.+... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++   .+||+|||+|+...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~---~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC---CeEeeccccceecc
Confidence            7888999999999887664 5699999999999999999999999999999999999997654   59999999998765


Q ss_pred             CCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCC
Q 009594          212 PGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS  286 (531)
Q Consensus       212 ~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (531)
                      ....   .....||+.|+|||++. +.++.++|||||||++|||+| |.+||.+.+..+....+.+....   +..+.++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~~~  239 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPICT  239 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---CCCTTBC
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccC
Confidence            4432   23346899999999876 679999999999999999998 89999888877766666554321   2224689


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          287 ENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       287 ~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +.+.+|+.+||+.+|++|||+.++++|
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            999999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-51  Score=403.14  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=213.0

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC-----
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-----  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-----  129 (531)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+.. ........+.+|+.+|+++ +|||||++++++...     
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc
Confidence            458999999999999999999999999999999997553 3444556788999999999 999999999998632     


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                      ...+++++|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+   +.+|++|||+|..
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~---~~~kl~dfg~a~~  170 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARH  170 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCC----C
T ss_pred             CceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc---ccccccccchhcc
Confidence            334566777789999998854 479999999999999999999999999999999999999654   4599999999876


Q ss_pred             cCCCCccccccCCcccccchhccc--cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHhcccCCC---------
Q 009594          210 FRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK---------  278 (531)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------  278 (531)
                      ..  .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+.......+........         
T Consensus       171 ~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             CT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            43  33455678999999998653  468899999999999999999999999887777666654332211         


Q ss_pred             --------------CC----CCCCCCHHHHHHHHHccccCcCCCCCHHHHhcCCccccccc
Q 009594          279 --------------RD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK  321 (531)
Q Consensus       279 --------------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  321 (531)
                                    ..    .+..+++.+++||.+||..||++|||+.|+|+||||+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                          00    12457899999999999999999999999999999987543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=391.82  Aligned_cols=252  Identities=22%  Similarity=0.328  Sum_probs=199.5

Q ss_pred             ccceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-  128 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  128 (531)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|++....  .......+.+|..++.++.+||||+.+++++.. 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            3579999999999999999999754     34689999986433  334456788899999988789999999998765 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeec
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFAN  192 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~  192 (531)
                      ...+++|||||++|+|.+++...                ..+++..++.++.||+.||.|||++||+||||||+|||+++
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence            45789999999999999999653                24889999999999999999999999999999999999965


Q ss_pred             CCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhC-CCCCCCCCHHHHH
Q 009594          193 KKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVA  267 (531)
Q Consensus       193 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~  267 (531)
                      +   +.+||+|||+|+.......   .....||+.|+|||++. +.++.++|||||||++|||+|| .+||.+.......
T Consensus       170 ~---~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         170 K---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             G---GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             C---CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            4   4599999999986654322   23467999999999887 5689999999999999999986 5688776655444


Q ss_pred             HHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      ..........  .....+++++.+||.+||+.||++|||+.|+++|
T Consensus       247 ~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4444332222  2224689999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-50  Score=388.98  Aligned_cols=249  Identities=20%  Similarity=0.283  Sum_probs=211.5

Q ss_pred             ccceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .++|++++.||+|+||+||+|+.+.     +++.||||++....  .......+.+|+.+++++ +||||+++++++...
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhc-CCCCcccceeeeccC
Confidence            4679999999999999999998653     56789999986543  333457799999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 009594          130 SAVHIVMELCEGGELFDRIVARG------------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP  185 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp  185 (531)
                      +..++||||+++|+|.+++....                        .+++..++.|+.|++.||+|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999986532                        378999999999999999999999999999999


Q ss_pred             CceEeecCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCC-CCCCC
Q 009594          186 ENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWA  260 (531)
Q Consensus       186 ~NIll~~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~-~pf~~  260 (531)
                      +|||++.+   +.+||+|||+|+...+...   .....||+.|+|||.+. ..++.++|||||||++|||++|. +||.+
T Consensus       169 ~NILld~~---~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLVGEN---MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEECGG---GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEECCC---CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999654   4599999999986654322   23467889999999887 57999999999999999999985 78988


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          261 ETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      .+..+....+......   +....+|+++.+||.+||+.+|++|||+.||++
T Consensus       246 ~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8888887777655421   223468999999999999999999999999954

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=385.72  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=208.1

Q ss_pred             cccceeeccccCccCceEEEEEEEccCC-------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNG-------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY  126 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~  126 (531)
                      -.++|++++.||+|+||.||+|++..++       ..||+|++....  .......+.+|...+.++.+|||||++++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            3568999999999999999999976544       479999986543  3345678889999999998899999999999


Q ss_pred             EcCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEe
Q 009594          127 EDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLF  190 (531)
Q Consensus       127 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll  190 (531)
                      .+.+..++|||||++|+|.+++...                ..+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            9999999999999999999999754                248999999999999999999999999999999999999


Q ss_pred             ecCCCCCCeEEEeeccccccCCCC---ccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHH
Q 009594          191 ANKKESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG  265 (531)
Q Consensus       191 ~~~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~  265 (531)
                      +.+   +.+||+|||++.......   ......||+.|+|||.+. +.|+.++|||||||++|+|+| |.+||.+.+...
T Consensus       169 ~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         169 TED---NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             CTT---CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             cCC---CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            654   459999999998765433   233467899999999886 689999999999999999998 799998888777


Q ss_pred             HHHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ....+.... .+  .....+++.+.+||.+||+.||++|||+.||++
T Consensus       246 ~~~~i~~~~-~~--~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKLLKEGH-RM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTTC-CC--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCC-CC--CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            666555432 22  223468999999999999999999999999976

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=380.97  Aligned_cols=242  Identities=24%  Similarity=0.349  Sum_probs=198.8

Q ss_pred             cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-CCeEEE
Q 009594           56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DSAVHI  134 (531)
Q Consensus        56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~~~l  134 (531)
                      ++|++++.||+|+||.||+|.+  .|+.||+|+++...     ..+.+.+|+.+++++ +||||+++++++.+ .+.+++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEE
Confidence            4699999999999999999996  57899999996532     346789999999999 99999999998854 567899


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       135 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      ||||+++|+|.+++...+  .+++..++.|+.||+.||.|||+++|+||||||+|||++.   ++.+||+|||+++....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~---~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC---CCCEeecccccceecCC
Confidence            999999999999997643  4899999999999999999999999999999999999965   45599999999986543


Q ss_pred             CCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCCHHHH
Q 009594          213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK  290 (531)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (531)
                      .  .....+|+.|+|||++. +.++.++|||||||++|||+| |++||...+..+....+.+....   +..+.+++.+.
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~  230 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVY  230 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHHH
T ss_pred             C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHHH
Confidence            3  23456889999999886 679999999999999999998 79999888877777766543221   22246889999


Q ss_pred             HHHHHccccCcCCCCCHHHHhcC
Q 009594          291 DLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       291 ~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      +||.+||..||++|||+.+++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999999764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=383.78  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=212.3

Q ss_pred             ccceeeccccCccCceEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcC
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD  129 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  129 (531)
                      .++|++.+.||+|+||.||+|+..     .++..||||++....  .......+.+|+.+++.+.+|||||++++++...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            468999999999999999999863     456799999997543  3445567889999999997899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEee
Q 009594          130 SAVHIVMELCEGGELFDRIVARG------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFA  191 (531)
Q Consensus       130 ~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~  191 (531)
                      +..++|||||++|+|.+++....                  .+++..+..++.||+.||+|||+++|+||||||+||+++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            99999999999999999987543                  589999999999999999999999999999999999996


Q ss_pred             cCCCCCCeEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhh-CCCCCCCCCHHHH
Q 009594          192 NKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV  266 (531)
Q Consensus       192 ~~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~  266 (531)
                      .+   +.+||+|||.++.......   .....||+.|+|||++. +.++.++|||||||++|+|+| |.+||...+..+.
T Consensus       180 ~~---~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         180 HG---RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             TT---TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cc---CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            54   4599999999987654332   23457899999999887 678999999999999999998 6777777766666


Q ss_pred             HHHHHhcccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ...+.........  ...+|+.+.+||.+||++||++|||+.+|++
T Consensus       257 ~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6666554433222  2457899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-49  Score=382.55  Aligned_cols=259  Identities=20%  Similarity=0.279  Sum_probs=204.2

Q ss_pred             cccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      +.++|++++.||+|+||+||+|++..+|+.||||++......     ..+.+|+++++.+..|++|+.+..++...+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            456899999999999999999999999999999998754322     346789999999944455666666778889999


Q ss_pred             EEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 009594          134 IVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP  212 (531)
Q Consensus       134 lv~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~  212 (531)
                      +||||+. ++|...+. ....+++..+..++.|++.||+|||++||+||||||+|||++..+.+..+||+|||+|+....
T Consensus        80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9999995 56655554 455799999999999999999999999999999999999998766677899999999987654


Q ss_pred             CC--------ccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHHHHHHHHHh---cccCC-CC
Q 009594          213 GE--------QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---SVIDF-KR  279 (531)
Q Consensus       213 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~---~~~~~-~~  279 (531)
                      ..        ......||+.|+|||++.+ .++.++|||||||++|+|+||..||...........+..   ..... ..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            32        2235679999999999874 689999999999999999999999987655443332211   11111 11


Q ss_pred             CCCCCCCHHHHHHHHHccccCcCCCCCHHH---HhcCCcccc
Q 009594          280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEE---VLEHPWLQN  318 (531)
Q Consensus       280 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~---~l~h~~~~~  318 (531)
                      ...+.+|+++.++|.+||+.+|++||++.+   +|+|+|.+.
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            123568999999999999999999999875   467776543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=381.45  Aligned_cols=250  Identities=20%  Similarity=0.296  Sum_probs=212.6

Q ss_pred             cccceeeccccCccCceEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc
Q 009594           54 ISIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED  128 (531)
Q Consensus        54 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  128 (531)
                      -.++|++.+.||+|+||+||+|.+..     +++.||||++....  .......+.+|+.+++++ +||||+++++++..
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec
Confidence            34689999999999999999998753     35789999986432  344556789999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCC
Q 009594          129 DSAVHIVMELCEGGELFDRIVAR----------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP  198 (531)
Q Consensus       129 ~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~  198 (531)
                      .+..++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.   +.+
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~---~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE---DFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT---TCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC---Cce
Confidence            99999999999999999988642          24688999999999999999999999999999999999964   456


Q ss_pred             eEEEeeccccccCCCCc---cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhc
Q 009594          199 LKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRS  273 (531)
Q Consensus       199 ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~  273 (531)
                      +||+|||+|+.......   .....||+.|+|||.+. +.++.++|||||||++|||+|| .+||.+.+..+....+.+.
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            99999999986654322   23346899999999887 6788899999999999999998 5889888888888777664


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ..   .+..+.+|+.+.++|.+||+.+|++|||+.+|++
T Consensus       252 ~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         252 GL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            32   1222468899999999999999999999999997

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=374.74  Aligned_cols=245  Identities=22%  Similarity=0.319  Sum_probs=197.9

Q ss_pred             eccccCccCceEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEc-CCeEEEE
Q 009594           60 LGRELGRGEFGVTYLCTDVNNG---EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DSAVHIV  135 (531)
Q Consensus        60 ~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-~~~~~lv  135 (531)
                      +.++||+|+||+||+|.+..++   ..||||++...  ......+.+.+|+.+++++ +||||+++++++.. ++..++|
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEE
Confidence            3578999999999999986543   36899998642  3455678899999999999 89999999999764 5689999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 009594          136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE  214 (531)
Q Consensus       136 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~~~~~~  214 (531)
                      ||||++|+|.+++.... .+++..++.++.|++.||.|||+.+|+||||||+|||+++   +..+||+|||+++......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~---~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE---KFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TCCEEECSSGGGCCTTTTT
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC---CCCEEEecccchhhccccc
Confidence            99999999999887544 4788899999999999999999999999999999999964   4569999999998765432


Q ss_pred             c-----cccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHhcccCCCCCCCCCCCH
Q 009594          215 Q-----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVIDFKRDPWPKVSE  287 (531)
Q Consensus       215 ~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  287 (531)
                      .     .....||+.|+|||.+. +.++.++||||||+++|||+||..||.... ..+....+..... ...  .+.+++
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~~~--p~~~~~  261 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQ--PEYCPD  261 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-CCC--CTTCCH
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCC--cccCcH
Confidence            2     22356899999999876 679999999999999999999777765543 3333444443322 111  245789


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          288 NAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       288 ~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                      .+.+||.+||..||++|||+.||++|
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-47  Score=368.00  Aligned_cols=254  Identities=21%  Similarity=0.298  Sum_probs=207.2

Q ss_pred             ccccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeE
Q 009594           53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV  132 (531)
Q Consensus        53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  132 (531)
                      .+.++|++++.||+|+||+||+|++..+|+.||+|++.....     ...+.+|+++++.|.+|+||+.+++++......
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            356789999999999999999999999999999999865432     234678999999997779999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCC--CCCCeEEEeeccccc
Q 009594          133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVF  209 (531)
Q Consensus       133 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~--~~~~ikl~Dfg~a~~  209 (531)
                      ++||||+ +++|.+++...+ .++...+..++.|++.||.|||++||+||||||+|||++...  ..+.+||+|||+|+.
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9999999 689999887654 699999999999999999999999999999999999997532  245699999999987


Q ss_pred             cCCCC--------ccccccCCcccccchhccc-cCCCccchhHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHhcccC-
Q 009594          210 FRPGE--------QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVID-  276 (531)
Q Consensus       210 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---~~~~~~~~~~~~-  276 (531)
                      .....        ......||+.|||||++.+ .++.++|||||||++|+|+||..||.+....   .....+...... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            64321        2234679999999999874 6999999999999999999999999764332   222222222111 


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCcCCCCCHHHHhc
Q 009594          277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE  312 (531)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  312 (531)
                      ......+.+|+++.+++..|+..+|++||+++.+.+
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            111123568999999999999999999999877643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=364.07  Aligned_cols=246  Identities=21%  Similarity=0.297  Sum_probs=187.6

Q ss_pred             ccceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHH--HHHHHHHhCCCCCCeeecceEEEcCC--
Q 009594           55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR--REVQIMKHLPKHPNIVSLKDTYEDDS--  130 (531)
Q Consensus        55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~--~E~~~l~~l~~h~niv~l~~~~~~~~--  130 (531)
                      ..+|.+.+.||+|+||.||+|+.  +|+.||||++....      .....  .|+..+.++ +||||+++++++...+  
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVML-RHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCc
Confidence            45689999999999999999984  68999999986432      22333  455555677 8999999999987543  


Q ss_pred             --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeecCCCCCceEeecCCCCCCeE
Q 009594          131 --AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE--------QGVMHRDLKPENFLFANKKESSPLK  200 (531)
Q Consensus       131 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~--------~~iiH~Dlkp~NIll~~~~~~~~ik  200 (531)
                        .+++|||||++|+|.+++.+. .+++..++.++.|++.||.|||+        +||+||||||+|||++.   ++.+|
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~---~~~~K  148 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NGTCC  148 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT---TSCEE
T ss_pred             ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC---CCCeE
Confidence              689999999999999999765 68999999999999999999996        59999999999999964   45699


Q ss_pred             EEeeccccccCCCC-----ccccccCCcccccchhcccc-------CCCccchhHHHHHHHHHhhCCCCCCCC-------
Q 009594          201 AIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAE-------  261 (531)
Q Consensus       201 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~Di~slG~il~~l~tg~~pf~~~-------  261 (531)
                      |+|||++.......     ......||+.|+|||++.+.       ++.++|||||||++|||+||.+||...       
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999998765432     22346799999999998643       566899999999999999998876321       


Q ss_pred             --------CHHHHHHHHHhcccCCCCC-CCC--CCCHHHHHHHHHccccCcCCCCCHHHHhcC
Q 009594          262 --------TEQGVAQAIIRSVIDFKRD-PWP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEH  313 (531)
Q Consensus       262 --------~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  313 (531)
                              ..................+ .+.  ..+..+.+|+.+||+.||++|||+.||+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                    1122222222221111110 111  123468999999999999999999999763

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-44  Score=358.22  Aligned_cols=264  Identities=25%  Similarity=0.434  Sum_probs=198.7

Q ss_pred             CCccc-cceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC----------CCCCe
Q 009594           51 GQDIS-IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP----------KHPNI  119 (531)
Q Consensus        51 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~ni  119 (531)
                      |+.+. .+|++++.||+|+||+||+|++..+|+.||||++.+..    ...+.+.+|+.+++.+.          .||||
T Consensus         7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_           7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            56665 46999999999999999999999999999999997542    23456778999888872          35789


Q ss_pred             eecceEEEc--CCeEEEEEeccCCCchHHH-H--HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCceEeecC
Q 009594          120 VSLKDTYED--DSAVHIVMELCEGGELFDR-I--VARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANK  193 (531)
Q Consensus       120 v~l~~~~~~--~~~~~lv~e~~~~~~L~~~-l--~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~NIll~~~  193 (531)
                      +++++++..  ....+++++++..+..... .  .....+++..+..++.||+.||.|||+ .||+||||||+|||++.+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999998753  4567777777655443322 2  234468999999999999999999998 899999999999999765


Q ss_pred             CCCC---CeEEEeeccccccCCCCccccccCCcccccchhcc-ccCCCccchhHHHHHHHHHhhCCCCCCCCCHH-----
Q 009594          194 KESS---PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-----  264 (531)
Q Consensus       194 ~~~~---~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-----  264 (531)
                      +...   .++++|||.|.....  ......||+.|+|||++. ..++.++||||+||++++|++|+.||......     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence            4322   389999999876543  334567999999999876 57999999999999999999999999654321     


Q ss_pred             -HHHHHHHhccc------------------------CCCC--------------CCCCCCCHHHHHHHHHccccCcCCCC
Q 009594          265 -GVAQAIIRSVI------------------------DFKR--------------DPWPKVSENAKDLVKKMLNPDPKQRL  305 (531)
Q Consensus       265 -~~~~~~~~~~~------------------------~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rp  305 (531)
                       ...........                        ....              ..+...++.+.+||.+||.+||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             11111111000                        0000              00112356799999999999999999


Q ss_pred             CHHHHhcCCcccccc
Q 009594          306 TAEEVLEHPWLQNAK  320 (531)
Q Consensus       306 s~~~~l~h~~~~~~~  320 (531)
                      |+.|+|+||||++..
T Consensus       321 ta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         321 DAGGLVNHPWLKDTL  335 (362)
T ss_dssp             CHHHHHTCGGGTTCT
T ss_pred             CHHHHhcCcccCCCC
Confidence            999999999999654

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.92  E-value=2.5e-25  Score=196.69  Aligned_cols=163  Identities=20%  Similarity=0.314  Sum_probs=149.1

Q ss_pred             hHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHH
Q 009594          358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHL  436 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~  436 (531)
                      ..+.++|..+|+.+|++++|+|+.+||..+|+.++.. .+.++++.+++.+|.|++|.|+|+||+.++...      ..+
T Consensus        15 ~~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~------~~~   88 (181)
T d1hqva_          15 LPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYI------TDW   88 (181)
T ss_dssp             CSCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHHHHH------HHH
T ss_pred             CccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhhhhc------ccc
Confidence            3456789999999999999999999999999988754 688999999999999999999999999987643      347


Q ss_pred             HHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCCc
Q 009594          437 HKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNS  516 (531)
Q Consensus       437 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G~  516 (531)
                      +.+|+.+|.+++|.|+.+||+.++...+..+++++++.++..+|.+++|.|+|+||+.++...+.+.+.|+.+|+++||.
T Consensus        89 ~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~~~~~~l~~l~~~F~~~D~~~dG~  168 (181)
T d1hqva_          89 QNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGW  168 (181)
T ss_dssp             HHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHHHHHCTTCSSC
T ss_pred             ccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            89999999999999999999999999999999999999999999999999999999999998888999999999999997


Q ss_pred             C--CHHHHHHHH
Q 009594          517 I--SLKLMREEG  526 (531)
Q Consensus       517 i--~~~e~~~~~  526 (531)
                      |  +.+||.+++
T Consensus       169 i~~~~~ef~~~~  180 (181)
T d1hqva_         169 IQVSYEQYLSMV  180 (181)
T ss_dssp             CCCCHHHHHHHH
T ss_pred             EEecHHHHHHHh
Confidence            7  678888765

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

Probab=99.92  E-value=2.4e-25  Score=197.02  Aligned_cols=162  Identities=21%  Similarity=0.325  Sum_probs=150.0

Q ss_pred             HHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHH
Q 009594          359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHK  438 (531)
Q Consensus       359 ~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~  438 (531)
                      ++..+|+++|+.+|.|++|+|+.+||..+|+.++..++..+++.++..+|.|++|.|+|.+|...+..      ...+..
T Consensus        15 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~~~~------~~~~~~   88 (182)
T d1y1xa_          15 NDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF------ILSMRE   88 (182)
T ss_dssp             CTTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH------HHHHHH
T ss_pred             CcHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhcccccccccccccccccccccc------cccccc
Confidence            34468999999999999999999999999999999999999999999999999999999999887643      245788


Q ss_pred             hhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCCcC-
Q 009594          439 AFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSI-  517 (531)
Q Consensus       439 ~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G~i-  517 (531)
                      +|+.+|.+++|.|+.+||+.+|..+|..+++++++.+|+.+|.|+||.|+|+||+.++.....+..+|+.+|.+++|.| 
T Consensus        89 ~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l~~~~~~F~~~D~~~~G~is  168 (182)
T d1y1xa_          89 GFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFVCRVRNVFAFYDRERTGQVT  168 (182)
T ss_dssp             HHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHCTTCCSEEE
T ss_pred             chhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHHHHHHHHHHhCCCCCCcEE
Confidence            9999999999999999999999999999999999999999999999999999999999988899999999999999996 


Q ss_pred             -CHHHHHHHH
Q 009594          518 -SLKLMREEG  526 (531)
Q Consensus       518 -~~~e~~~~~  526 (531)
                       +.+||.+..
T Consensus       169 ~~~~~f~~~~  178 (182)
T d1y1xa_         169 FTFDTFIGGS  178 (182)
T ss_dssp             EEHHHHHHHH
T ss_pred             eeHHHHHHHH
Confidence             467887654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=5.7e-26  Score=203.17  Aligned_cols=167  Identities=21%  Similarity=0.260  Sum_probs=122.7

Q ss_pred             eeeccccCccCceEEEEEEEccCCcEEEEEEeeccccC-----C----------hhhHHHHHHHHHHHHhCCCCCCeeec
Q 009594           58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----T----------AVDIEDVRREVQIMKHLPKHPNIVSL  122 (531)
Q Consensus        58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~----------~~~~~~~~~E~~~l~~l~~h~niv~l  122 (531)
                      +.+.++||+|+||+||+|.+ .+|+.||||++......     .          ........+|...+.++ .|++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence            45778999999999999997 47899999987532111     0          01123455689999999 89999988


Q ss_pred             ceEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCceEeecCCCCCCeEEE
Q 009594          123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI  202 (531)
Q Consensus       123 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~NIll~~~~~~~~ikl~  202 (531)
                      +++..    .+++|||+++..+..       ++...+..++.|++.||.|||++||+||||||+|||++.++    ++|+
T Consensus        80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~----~~li  144 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWII  144 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE----EEEC
T ss_pred             EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC----EEEE
Confidence            76532    279999998876543       45566778999999999999999999999999999997432    8999


Q ss_pred             eeccccccCCCCccccccCCccccc------chhccccCCCccchhHHHHHH
Q 009594          203 DFGLSVFFRPGEQFNEIVGSPYYMA------PEVLKRNYGPEVDVWSAGVIL  248 (531)
Q Consensus       203 Dfg~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~Di~slG~il  248 (531)
                      |||.|.....+..       ..|..      .+.+.+.|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999876542211       11211      123346789999999975433

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.5e-24  Score=187.26  Aligned_cols=156  Identities=19%  Similarity=0.266  Sum_probs=140.0

Q ss_pred             HHHHhcccccCCCCcccHHHHHHHHHhCCCCC-----CHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHH
Q 009594          364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNI-----PEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHK  438 (531)
Q Consensus       364 i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~-----~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~  438 (531)
                      +..+|+.+ .+.+|.|+.+||+.+|+..|.+.     +.+.++.++..+|.|++|.|+|+||+.++...      ..++.
T Consensus         2 ~~~~F~~~-a~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~~l~~~~------~~~~~   74 (165)
T d1k94a_           2 VYTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKE   74 (165)
T ss_dssp             HHHHHHHH-HGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHH
T ss_pred             hHHHHHHh-cCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHhhcc------chhHH
Confidence            45677777 68899999999999999987644     56789999999999999999999999887543      45899


Q ss_pred             hhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCccCCCcC-
Q 009594          439 AFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRERFNSI-  517 (531)
Q Consensus       439 ~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~~~G~i-  517 (531)
                      +|+.||.|++|+|+.+||+.+|..+|..+++++++.++..+|.  +|.|+|+||+.++...+.+.++|+.+|++++|.| 
T Consensus        75 ~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d~--~g~i~~~eFi~~~~~l~~~~~~F~~~D~d~~G~i~  152 (165)
T d1k94a_          75 NFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSK--NGRIFFDDYVACCVKLRALTDFFRKRDHLQQGSAN  152 (165)
T ss_dssp             HHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCB--TTBCBHHHHHHHHHHHHHHHHHHHTTCTTCCSEEE
T ss_pred             HHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcCC--CCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCcEE
Confidence            9999999999999999999999999999999999999999975  5899999999999988899999999999999988 


Q ss_pred             -CHHHHHHHHhh
Q 009594          518 -SLKLMREEGLQ  528 (531)
Q Consensus       518 -~~~e~~~~~~~  528 (531)
                       +.+||.++...
T Consensus       153 l~~~ef~~~~~~  164 (165)
T d1k94a_         153 FIYDDFLQGTMA  164 (165)
T ss_dssp             EEHHHHHHHHHT
T ss_pred             ecHHHHHHHHHc
Confidence             57999887654

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5.3e-24  Score=186.59  Aligned_cols=162  Identities=18%  Similarity=0.283  Sum_probs=144.9

Q ss_pred             hHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCC-----CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCc
Q 009594          358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-----IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN  432 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-----~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~  432 (531)
                      .++...+++.|..++ ++||.|+..||+.+|.++|..     ++.++++.++..+|.|++|.|+|+||+.++...     
T Consensus         3 ~~~~~~~~~~F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~-----   76 (172)
T d1juoa_           3 GQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL-----   76 (172)
T ss_dssp             TCCCCTTHHHHHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH-----
T ss_pred             cchHHHHHHHHHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHHHhh-----
Confidence            455667899999996 889999999999999998754     456889999999999999999999999877543     


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhCcc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYSRE  512 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D~~  512 (531)
                       ..+..+|+.+|.|++|.|+.+|++.+|..+|..+++++++.+++.+|  .+|.|+|+||+.++.....+..+|+.+|+|
T Consensus        77 -~~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d--~~g~i~~~eF~~~~~~~~~~~~~f~~~D~d  153 (172)
T d1juoa_          77 -NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYS--TNGKITFDDYIACCVKLRALTDSFRRRDTA  153 (172)
T ss_dssp             -HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTC--SSSSEEHHHHHHHHHHHHHHHHHHHHTCTT
T ss_pred             -hhhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence             44788999999999999999999999999999999999999999996  468899999999999999999999999999


Q ss_pred             CCCcC--CHHHHHHHHhh
Q 009594          513 RFNSI--SLKLMREEGLQ  528 (531)
Q Consensus       513 ~~G~i--~~~e~~~~~~~  528 (531)
                      ++|.|  +.+||..++..
T Consensus       154 ~~G~Itl~~~eFl~~~l~  171 (172)
T d1juoa_         154 QQGVVNFPYDDFIQCVMS  171 (172)
T ss_dssp             CCSEEEEEHHHHHHHHTT
T ss_pred             CCCcEEecHHHHHHHHHc
Confidence            99998  55999887754

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

Probab=99.90  E-value=1.3e-24  Score=191.87  Aligned_cols=163  Identities=21%  Similarity=0.208  Sum_probs=127.5

Q ss_pred             hhhhHHHh-hHHHHhcccccCCCCcccHHHHHHHHHhCCCC--------CCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          355 FLSVEEVA-GLKEAFEMMDTNKRGKINLEELRLGLLKGGQN--------IPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       355 ~~~~~~~~-~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~--------~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      .++++++. .++++|+.+| +++|.|+..||..+|.+.+..        ++.+.++.++..+|.|++|.|+|+||..++.
T Consensus        12 ~ls~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF~~l~~   90 (188)
T d1qxpa2          12 VLSEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWN   90 (188)
T ss_dssp             ---------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHHHHHHh
Confidence            35666665 5999999999 558999999999888776433        4567899999999999999999999998875


Q ss_pred             HhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHH
Q 009594          426 HLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKA  505 (531)
Q Consensus       426 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~  505 (531)
                      ..      ..++.+|+.||+|++|.|+..||+.+|..+|..++++.++.++.. |.|++|.|+|+||+.++.....+..+
T Consensus        91 ~~------~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~-~~~~dg~i~f~eFi~~~~~l~~~~~~  163 (188)
T d1qxpa2          91 RI------RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR-FADDELIIDFDNFVRCLVRLEILFKI  163 (188)
T ss_dssp             HH------HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHH-TSCSSSBCCHHHHHHHHHHHHHHHHH
T ss_pred             hh------HHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHH-hcCCCCcCCHHHHHHHHHHHHHHHHH
Confidence            43      458899999999999999999999999999999998888877776 56999999999999999988889999


Q ss_pred             HhhhCccCCCcC--CHHHHHHH
Q 009594          506 SRQYSRERFNSI--SLKLMREE  525 (531)
Q Consensus       506 f~~~D~~~~G~i--~~~e~~~~  525 (531)
                      |+.+|++++|.|  +.+||..+
T Consensus       164 F~~~D~~~~G~i~l~~~efl~~  185 (188)
T d1qxpa2         164 FKQLDPENTGTIQLDLISWLSF  185 (188)
T ss_dssp             HHHSCSSCCSCEEEEHHHHHHH
T ss_pred             HHHhCCCCCCeEEeeHHHHHHH
Confidence            999999999988  66777654

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

Probab=99.90  E-value=1.3e-24  Score=193.13  Aligned_cols=163  Identities=20%  Similarity=0.236  Sum_probs=142.4

Q ss_pred             hhhHHHh-hHHHHhcccccCCCCcccHHHHHHHHHhCCC--------CCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          356 LSVEEVA-GLKEAFEMMDTNKRGKINLEELRLGLLKGGQ--------NIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       356 ~~~~~~~-~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~--------~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      .+++++. .++++|..+| +++|.|+..||..+|..++.        ..+.+.+..++..+|.|++|.|+|.||+.++..
T Consensus        11 ~~~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~   89 (186)
T d1df0a1          11 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK   89 (186)
T ss_dssp             CCCSCSCHHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHHHHHHh
Confidence            3445554 5899999998 99999999999999987642        356788999999999999999999999988754


Q ss_pred             hhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHH
Q 009594          427 LKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKAS  506 (531)
Q Consensus       427 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f  506 (531)
                      .      ..+..+|+.+|+|++|+|+.+||+.+|+.+|..++.+.++ ++...|.|++|.|+|+||+.++...+.+..+|
T Consensus        90 ~------~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~-~~~~~d~d~dg~I~f~eFi~~~~~l~~~~~~F  162 (186)
T d1df0a1          90 I------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQ-VIVARFADDELIIDFDNFVRCLVRLEILFKIF  162 (186)
T ss_dssp             H------HHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHH-HHHHHHCCSTTEECHHHHHHHHHHHHHHHHHH
T ss_pred             H------HHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHH-HHHHHHcCCCCeEeHHHHHHHHHHHHHHHHHH
Confidence            3      4588999999999999999999999999999998877665 55568999999999999999999999999999


Q ss_pred             hhhCccCCCcC--CHHHHHHHH
Q 009594          507 RQYSRERFNSI--SLKLMREEG  526 (531)
Q Consensus       507 ~~~D~~~~G~i--~~~e~~~~~  526 (531)
                      +.+|++++|.|  +.+||..+.
T Consensus       163 ~~~D~~~~G~i~l~~~ef~~~~  184 (186)
T d1df0a1         163 KQLDPENTGTIQLDLISWLSFS  184 (186)
T ss_dssp             HHHCTTCCSEEEEEHHHHHHHH
T ss_pred             HHhCCCCCCcEEecHHHHHHHh
Confidence            99999999988  668887653

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

Probab=99.90  E-value=8e-24  Score=180.48  Aligned_cols=143  Identities=35%  Similarity=0.604  Sum_probs=132.6

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc-cCcH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK-MAND  433 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~  433 (531)
                      +++++++.+|+++|+.+|.+++|.|+.+||..++...+..++...+..++..+|.+++|.|+|+||+..+..... ....
T Consensus         2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~   81 (146)
T d1exra_           2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSE   81 (146)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChH
Confidence            568899999999999999999999999999999999999999999999999999999999999999987654322 2346


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +.++.+|+.+|.|++|.|+.+||+.++..+|..+++++++.+|..+|.|+||+|+|+||+++|.
T Consensus        82 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l~  145 (146)
T d1exra_          82 EELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMV  145 (146)
T ss_dssp             HHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhc
Confidence            7899999999999999999999999999999999999999999999999999999999999885

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=99.90  E-value=4.8e-24  Score=187.17  Aligned_cols=160  Identities=19%  Similarity=0.239  Sum_probs=140.9

Q ss_pred             HHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCC--------CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc
Q 009594          359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ--------NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM  430 (531)
Q Consensus       359 ~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~--------~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~  430 (531)
                      +|+.+++++|..+|. .+|.|+..||..+|.+++.        ..+.+.+..++..+|.|++|.|+|+||+.++...   
T Consensus         1 ee~~~~r~~F~~~d~-~dg~I~~~EL~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i~~~ef~~~~~~~---   76 (173)
T d1alva_           1 EEVRQFRRLFAQLAG-DDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNI---   76 (173)
T ss_dssp             CHHHHHHHHHHHHHG-GGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH---
T ss_pred             ChHHHHHHHHHHHcC-CCCcCCHHHHHHHHHHhCCCcchhhhccCCHHHHHHHHHHhccCCCCcccchhhhhhhhhh---
Confidence            467899999999994 5899999999999988743        3567889999999999999999999999877543   


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHHHHHhhhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWRKASRQYS  510 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~~~f~~~D  510 (531)
                         ..+..+|+.||.|++|.|+.+||+.+|...|..+++++++.++ .+|.|++|.|+|+||+.++.....+..+|+.+|
T Consensus        77 ---~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~-~~d~d~~G~i~~~EF~~~~~~~~~~~~~f~~~D  152 (173)
T d1alva_          77 ---KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMII-RRYSDEGGNMDFDNFISCLVRLDAMFRAFKSLD  152 (173)
T ss_dssp             ---HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHH-HHHTCSSSCBCHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             ---hHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhh-ccccCCCCeEeHHHHHHHHHHHHHHHHHHHHhC
Confidence               4578899999999999999999999999999999998887666 556699999999999999998889999999999


Q ss_pred             ccCCCcCC--HHHHHHHH
Q 009594          511 RERFNSIS--LKLMREEG  526 (531)
Q Consensus       511 ~~~~G~i~--~~e~~~~~  526 (531)
                      +|++|.||  .+||.++.
T Consensus       153 ~d~~G~it~~~~efl~~~  170 (173)
T d1alva_         153 KDGTGQIQVNIQEWLQLT  170 (173)
T ss_dssp             SSCCSEEEEEHHHHHHHH
T ss_pred             CCCCCcEEecHHHHHHHH
Confidence            99999985  67877653

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=99.90  E-value=1.6e-23  Score=177.33  Aligned_cols=140  Identities=21%  Similarity=0.459  Sum_probs=127.6

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCcHH
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMANDE  434 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~~  434 (531)
                      ++++++.+|+++|..+|.+++|.|+..||..+|+.+|..++..++..++.    +++|.|+|.+|+.++... .....++
T Consensus         1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~----~~~~~i~~~eF~~~~~~~~~~~~~~~   76 (142)
T d1wdcb_           1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGTDSEE   76 (142)
T ss_dssp             CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSCCCHH
T ss_pred             CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHH----hccCccccccccccccccccccchhh
Confidence            36789999999999999999999999999999999999999999988874    567999999999977654 3445678


Q ss_pred             HHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       435 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      .++.+|+.||.|++|+|+.+||+.+|..+|..+++++++.+|+.+|.| +|+|+|+||+++|++..
T Consensus        77 ~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-~G~I~y~eF~~~l~~~~  141 (142)
T d1wdcb_          77 TIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGSG  141 (142)
T ss_dssp             HHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTSC
T ss_pred             hHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCC-CCEEcHHHHHHHHhcCC
Confidence            899999999999999999999999999999999999999999999998 69999999999998653

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.89  E-value=4.3e-23  Score=175.79  Aligned_cols=143  Identities=29%  Similarity=0.518  Sum_probs=132.6

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc-Cc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM-AN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~-~~  432 (531)
                      ..++++++.+++++|+.+|.|++|+|+.+||..++...|..++..++..++...+.++++.++|++|.......... ..
T Consensus         2 ~~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (146)
T d1lkja_           2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDS   81 (146)
T ss_dssp             CCCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCCH
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccCCcccccHHHHHHHHHHhhccccH
Confidence            35788999999999999999999999999999999999999999999999999999999999999999876654443 34


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .+.++.+|+.||+|++|+|+.+||+.+|..+|..+++++++.+|..+| |+||+|+|+||+++|.
T Consensus        82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~~~m~  145 (146)
T d1lkja_          82 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLS  145 (146)
T ss_dssp             HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC-CSSSEEEHHHHHHHHC
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc-CCCCeEeHHHHHHHhC
Confidence            678999999999999999999999999999999999999999999999 9999999999999885

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.5e-22  Score=171.47  Aligned_cols=140  Identities=24%  Similarity=0.535  Sum_probs=129.5

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCcHHH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMANDEH  435 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~~~  435 (531)
                      |+++..+|+++|..+|++++|.|+..||..+++..+..++...+..++..+|.+++|.|++.||...+... ......+.
T Consensus         1 t~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~   80 (141)
T d2obha1           1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEE   80 (141)
T ss_dssp             CHHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhccHHH
Confidence            46788899999999999999999999999999999999999999999999999999999999999876433 22334577


Q ss_pred             HHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHH
Q 009594          436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       436 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      ++.+|..+|.+++|.|+..||..++..+|..++++++..+|+.+|.|+||.|+|+||+++|
T Consensus        81 l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~~~m  141 (141)
T d2obha1          81 ILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM  141 (141)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence            9999999999999999999999999999999999999999999999999999999999986

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.88  E-value=1.7e-22  Score=174.10  Aligned_cols=148  Identities=34%  Similarity=0.564  Sum_probs=132.0

Q ss_pred             hhHhhhhhHHHhhHHHHhcccccCC-CCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh--
Q 009594          351 VVAEFLSVEEVAGLKEAFEMMDTNK-RGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL--  427 (531)
Q Consensus       351 ~~~~~~~~~~~~~i~~~F~~~D~~~-~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~--  427 (531)
                      ...+.++++++.+|+++|..+|.++ +|.|+..||..+|+++|..++..++..++..++.+++|.+++.+|.......  
T Consensus         3 ~~~~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (156)
T d1dtla_           3 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMK   82 (156)
T ss_dssp             TGGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC
T ss_pred             HHHHHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhhccCCCccchhhhhhhhhhccc
Confidence            3457889999999999999999995 8999999999999999999999999999999999999999999998754432  


Q ss_pred             --hccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          428 --KKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       428 --~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                        ......+.++.+|+.||.|++|+|+.+||+.++..+|..+++++++.+|+.+|.|+||.|+|+||+++|+.
T Consensus        83 ~~~~~~~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l~g  155 (156)
T d1dtla_          83 DDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG  155 (156)
T ss_dssp             -----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC
T ss_pred             ccccccHHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHcC
Confidence              22245678999999999999999999999999999999999999999999999999999999999999974

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.88  E-value=2.2e-22  Score=174.57  Aligned_cols=147  Identities=37%  Similarity=0.614  Sum_probs=133.3

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh----
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK----  428 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~----  428 (531)
                      ...++.+++.+++++|..+|++++|+|+.+||..+++..+..++...+..++..+|.+++|.+++.||........    
T Consensus        11 ~~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~   90 (162)
T d1topa_          11 RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDA   90 (162)
T ss_dssp             HHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHH
T ss_pred             HccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhhc
Confidence            4567889999999999999999999999999999999999999999999999999999999999999987554322    


Q ss_pred             ccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          429 KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       429 ~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .....+.++.+|+.+|.|++|+|+.+||+.+|...+...+.++++.+|..+|.|+||.|+|+||+++|++.
T Consensus        91 ~~~~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~~  161 (162)
T d1topa_          91 KGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV  161 (162)
T ss_dssp             HHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHSC
T ss_pred             ccCcHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHHHcC
Confidence            22345678889999999999999999999999999999999999999999999999999999999998753

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=99.87  E-value=1.9e-22  Score=172.83  Aligned_cols=143  Identities=27%  Similarity=0.392  Sum_probs=127.1

Q ss_pred             hhhHHHhhHHHHhccccc--CCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc--cC
Q 009594          356 LSVEEVAGLKEAFEMMDT--NKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK--MA  431 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~--~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~--~~  431 (531)
                      +|++|+.+++++|..||.  +++|.|+..||..+|+++|..++..++..+. ..|.+++|.|+|+||+.++.....  ..
T Consensus         1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~-~~~~~~~~~i~~~eFl~~~~~~~~~~~~   79 (152)
T d1wdcc_           1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVG-GTHKMGEKSLPFEEFLPAYEGLMDCEQG   79 (152)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTT-CCSSTTSCEECHHHHHHHHHHHTTSCCC
T ss_pred             CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhh-hhhccccccccccccccccccccccchh
Confidence            367889999999999995  8899999999999999999999999988764 468888999999999998765433  34


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCC--CCcceeHHHHHHHHHhC
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTD--KDGRISYEEFAVMMKAG  499 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~--~dG~i~~~Ef~~~~~~~  499 (531)
                      ..+.+..+|+.||.+++|+|+.+||+.+|..+|..+++++++.+++.+|.+  ++|+|+|+||++.|...
T Consensus        80 ~~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~~~~  149 (152)
T d1wdcc_          80 TFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAG  149 (152)
T ss_dssp             CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHC
T ss_pred             HHHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHHhcC
Confidence            567899999999999999999999999999999999999999999999865  56899999999988754

>d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.87  E-value=2.3e-22  Score=170.84  Aligned_cols=143  Identities=21%  Similarity=0.341  Sum_probs=125.4

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh-hccCcHH
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL-KKMANDE  434 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-~~~~~~~  434 (531)
                      |+++++.+++++|..+|.+++|.|+.+||..+|+.+|..++..+   ++..++.+.+|.|+|.+|+..+... ......+
T Consensus         1 f~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~---~~~~~~~~~~g~i~~~eF~~~~~~~~~~~~~~~   77 (145)
T d2mysb_           1 FDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNE---ELDAMIKEASGPINFTVFLTMFGEKLKGADPED   77 (145)
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHH---HHHHHHHhccCceeechhhhhhhhcccccchHH
Confidence            57889999999999999999999999999999999987655543   3444556788999999999976543 3344567


Q ss_pred             HHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCch
Q 009594          435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD  501 (531)
Q Consensus       435 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~  501 (531)
                      .+..+|+.||.+++|+|+.+||+.+|+.+|..+++++++.++..+|.|++|+|+|.||+++|.++++
T Consensus        78 ~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l~~~~~  144 (145)
T d2mysb_          78 VIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHGED  144 (145)
T ss_pred             HHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhccCCC
Confidence            8999999999999999999999999999999999999999999999999999999999999987654

>d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.86  E-value=4e-22  Score=169.48  Aligned_cols=137  Identities=21%  Similarity=0.344  Sum_probs=121.7

Q ss_pred             HhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC--CCCceecchhHhHHHHhhc---cCcHHH
Q 009594          361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVD--GDGSLNYGEFVAVSVHLKK---MANDEH  435 (531)
Q Consensus       361 ~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~--~~g~i~~~ef~~~~~~~~~---~~~~~~  435 (531)
                      .++++++|+.+|.|++|+|+.+||..+|+.+|..++..++..++..++.+  ++|.|+|.||+.++.....   ....+.
T Consensus         3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~   82 (145)
T d2mysc_           3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQGTFED   82 (145)
T ss_pred             HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccchHHH
Confidence            45789999999999999999999999999999999999999999987655  6889999999987654322   235567


Q ss_pred             HHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       436 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +..+|+.+|.|++|+|+.+||+.+|..+|..++.++++.+++. |.|+||+|+|+||++.+.+
T Consensus        83 l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dG~I~y~eF~~~ll~  144 (145)
T d2mysc_          83 FVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS  144 (145)
T ss_pred             HHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh-cCCCCCeEEHHHHHHHHhc
Confidence            9999999999999999999999999999999999999999975 7899999999999998753

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.86  E-value=6.5e-23  Score=181.21  Aligned_cols=144  Identities=43%  Similarity=0.784  Sum_probs=133.6

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcH
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND  433 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  433 (531)
                      ..++++|+..|+++|+.+|.|++|+|+.+||..++++++..++..+++.+|..+|.+++|.|+|.+|+.++.........
T Consensus         2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~   81 (182)
T d1s6ia_           2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLERE   81 (182)
T ss_dssp             CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCC
T ss_pred             CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhccccccchHHHHHHHHHhhcccccH
Confidence            46788999999999999999999999999999999999999999999999999999999999999999987666666666


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      +.++.+|+.+|.+++|+|+.+||+.++..+|  +++++++.+|+.+|.|+||+|+|+||+++|+..
T Consensus        82 e~l~~aF~~~D~d~~G~i~~~el~~~l~~~g--l~~~ev~~~f~~~D~d~DG~Is~~EF~~~m~~~  145 (182)
T d1s6ia_          82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKR  145 (182)
T ss_dssp             CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCC
T ss_pred             HHHHHHHHHHhhcCCCccchhhhhhhhhhcC--ccHHHHHHHHHHhhcCCCCeEeHHHHHHHHHhC
Confidence            7789999999999999999999999999887  578899999999999999999999999999843

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.85  E-value=5.8e-22  Score=167.07  Aligned_cols=133  Identities=23%  Similarity=0.393  Sum_probs=119.4

Q ss_pred             HhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc---cCcHHHHH
Q 009594          361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK---MANDEHLH  437 (531)
Q Consensus       361 ~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~---~~~~~~~~  437 (531)
                      ...++++|..+|.+++|.|+.+||..+|+++|.+++.+++..+    +.+.+|.|+|++|+.++.....   ....+.+.
T Consensus         4 ~~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~~----~~~~~~~i~~~eF~~~~~~~~~~~~~~~~~~l~   79 (140)
T d1ggwa_           4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEI----ESTLPAEVDMEQFLQVLNRPNGFDMPGDPEEFV   79 (140)
T ss_dssp             CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHH----HTTSCSSEEHHHHHHHHCTTSSSSSSCCHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhhh----hccccccccchhhhhhhhhhhhcchhhHHHHHH
Confidence            3678999999999999999999999999999999999887654    5688899999999998754322   23567899


Q ss_pred             HhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       438 ~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      .+|+.+|.|++|+|+.+||+.+|..+|.++++++++.+++.+|.| ||.|+|+||+++|..
T Consensus        80 ~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m~s  139 (140)
T d1ggwa_          80 KGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVNYHDFVQMILA  139 (140)
T ss_dssp             HHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCS-SCCSTTTHHHHHHHC
T ss_pred             HHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCC-CCEEeHHHHHHHHhc
Confidence            999999999999999999999999999999999999999999988 999999999998864

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.85  E-value=1.5e-21  Score=166.01  Aligned_cols=135  Identities=22%  Similarity=0.349  Sum_probs=119.5

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHh-cCCCCCCceecchhHhHHHHh------hccCcHHH
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA-ADVDGDGSLNYGEFVAVSVHL------KKMANDEH  435 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~-~D~~~~g~i~~~ef~~~~~~~------~~~~~~~~  435 (531)
                      .++++|..+|.+++|+|+.+||..+|+++|..++.+++..++.. .+.+.+|.|+|.+|..++...      ......+.
T Consensus         3 ~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~   82 (146)
T d1m45a_           3 ANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTED   82 (146)
T ss_dssp             CCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHH
T ss_pred             HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccccccccccccccchhhhhhhhhcccccccccchHHH
Confidence            46789999999999999999999999999999999999999874 556677899999999876533      22244578


Q ss_pred             HHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       436 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +..+|+.+|.+++|+|+.+||+.+|..+|..+++++++.+|..+|.|+||.|+|+||++.+.
T Consensus        83 l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~  144 (146)
T d1m45a_          83 FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVL  144 (146)
T ss_dssp             HHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred             HHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHHH
Confidence            99999999999999999999999999999999999999999999999999999999998765

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

Probab=99.84  E-value=3.8e-21  Score=161.02  Aligned_cols=128  Identities=22%  Similarity=0.349  Sum_probs=114.8

Q ss_pred             HHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccC---cHHHHHHhhc
Q 009594          365 KEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMA---NDEHLHKAFS  441 (531)
Q Consensus       365 ~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~---~~~~~~~~F~  441 (531)
                      .++|+.+|.|++|.|+..||..++..++...+.++++.+|..+|.+++|.|+|+||+.++.......   ....++.+|+
T Consensus         3 e~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~F~   82 (134)
T d1jfja_           3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYK   82 (134)
T ss_dssp             HHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhccccccccccccccccccccccccccccccccccc
Confidence            5799999999999999999999999999999999999999999999999999999998765433222   2467889999


Q ss_pred             ccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHH
Q 009594          442 FFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       442 ~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      .+|.+++|+|+.+|++.++..++.    +.+..+|..+|.|+||.|||+||+++|
T Consensus        83 ~~D~~~~g~i~~~el~~~~~~~~~----~~~~~~~~~~D~d~dG~is~~EF~~~~  133 (134)
T d1jfja_          83 LMDVDGDGKLTKEEVTSFFKKHGI----EKVAEQVMKADANGDGYITLEEFLEFS  133 (134)
T ss_dssp             HHCCSSSSEEEHHHHHHHHTTTTC----HHHHHHHHHHHCSSSSEEEHHHHHHHH
T ss_pred             ccccccCCcccHHHHHHHHHhcCc----HHHHHHHHHHCCCCCCCCCHHHHHHHh
Confidence            999999999999999999987764    578889999999999999999999986

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.83  E-value=1.6e-20  Score=166.87  Aligned_cols=149  Identities=21%  Similarity=0.323  Sum_probs=126.7

Q ss_pred             HHHhhHHHHhcccccC-CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHH
Q 009594          359 EEVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLH  437 (531)
Q Consensus       359 ~~~~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  437 (531)
                      -...+|+++|..|+.+ ++|+|+.+||..++...+...+...++.+|+.+|.|++|.|+|.||+..+........++.++
T Consensus        18 ~~~~ei~~~~~~F~~~~~~G~i~~~Ef~~~l~~~~~~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~   97 (189)
T d1jbaa_          18 ADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLK   97 (189)
T ss_dssp             HHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHH
T ss_pred             cCHHHHHHHHHHhcccCCCCeeeHHHHHHHHHHcCCCccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHH
Confidence            3444556666665544 589999999999999988888999999999999999999999999999888777777788999


Q ss_pred             HhhcccCCCCCcceeHHHHHHHHhhc----------------CC-CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          438 KAFSFFDRNRSGFIEIEELRNALNDE----------------VD-TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       438 ~~F~~~D~~~~G~i~~~el~~~l~~~----------------~~-~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      .+|+.||.|++|.|+..|+..++..+                +. ..+++.++.+|..+|.|+||+|||+||+.+++..+
T Consensus        98 ~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p  177 (189)
T d1jbaa_          98 WTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDK  177 (189)
T ss_dssp             HHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTTT
T ss_pred             HHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCH
Confidence            99999999999999999999987542                11 12245678999999999999999999999999999


Q ss_pred             hHHHHHh
Q 009594          501 DWRKASR  507 (531)
Q Consensus       501 ~~~~~f~  507 (531)
                      .+...+.
T Consensus       178 ~i~~~l~  184 (189)
T d1jbaa_         178 WVMKMLQ  184 (189)
T ss_dssp             THHHHHH
T ss_pred             HHHHHhc
Confidence            8888776

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.83  E-value=9.4e-21  Score=168.50  Aligned_cols=156  Identities=20%  Similarity=0.271  Sum_probs=135.0

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCH-HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPE-ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~-~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~  432 (531)
                      +.|++.|+..+.+.|.  +.+++|.|+..|+..++..++..... ..++++|..+|.+++|.|+|.||+..+........
T Consensus        20 t~fs~~Ei~~l~~~F~--~~~~~G~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~   97 (190)
T d1fpwa_          20 TYFDRREIQQWHKGFL--RDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTL   97 (190)
T ss_dssp             CCSTHHHHHHHHHHHH--HHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCS
T ss_pred             cCCCHHHHHHHHHHHH--HHCCCCCccHHHHHHHHHHHCCCCChHHHHHHHHHHhCcCCCCcccHHHHHHHHHHHccCch
Confidence            3578889999988885  45679999999999999988765554 44689999999999999999999998887777778


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCC------------CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVD------------TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~------------~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      ++.++.+|+.||.|++|.|+.+|+..++.....            ...++.++.+|..+|.|+||.||++||.++++..+
T Consensus        98 ~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p  177 (190)
T d1fpwa_          98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDP  177 (190)
T ss_dssp             THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSST
T ss_pred             HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCH
Confidence            899999999999999999999999999975421            12246789999999999999999999999999999


Q ss_pred             hHHHHHhhhCc
Q 009594          501 DWRKASRQYSR  511 (531)
Q Consensus       501 ~~~~~f~~~D~  511 (531)
                      .+...|..||.
T Consensus       178 ~i~~~l~~~d~  188 (190)
T d1fpwa_         178 SIIGALNLYDG  188 (190)
T ss_dssp             THHHHHHHHHC
T ss_pred             HHHHHhhhhcc
Confidence            99999998874

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=1.1e-20  Score=167.77  Aligned_cols=155  Identities=19%  Similarity=0.297  Sum_probs=134.0

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHH-HHHHHHhcCCCCCCceecchhHhHHHHhhccCcH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD-LQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND  433 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~-~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  433 (531)
                      .+++.|+..+.+.|..  .+++|.++..++..++..++....... ++.+|+.+|.+++|.|+|.||+..+.........
T Consensus        18 ~fs~~Ei~~l~~~F~~--~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~   95 (187)
T d1g8ia_          18 YFTEKEVQQWYKGFIK--DCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLD   95 (187)
T ss_dssp             SSCHHHHHHHHHHHHH--HCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHH
T ss_pred             CCCHHHHHHHHHHHHH--HCCCCCcCHHHHHHHHHHhcCCCCHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchh
Confidence            4788888888888865  457899999999999998876665444 5789999999999999999999988777777778


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcC------------CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCch
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEV------------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD  501 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~------------~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~  501 (531)
                      +.++.+|+.||.|++|.|+.+|+..++..+.            ....++.++.+|..+|.|+||+||++||..++...+.
T Consensus        96 e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p~  175 (187)
T d1g8ia_          96 EKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPS  175 (187)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHCHH
T ss_pred             hhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCHH
Confidence            8899999999999999999999999986431            1233567899999999999999999999999999999


Q ss_pred             HHHHHhhhCc
Q 009594          502 WRKASRQYSR  511 (531)
Q Consensus       502 ~~~~f~~~D~  511 (531)
                      +.+.|..||.
T Consensus       176 ~~~~l~~~~~  185 (187)
T d1g8ia_         176 IVQALSLYDG  185 (187)
T ss_dssp             HHHHHCCBTT
T ss_pred             HHHHHHHhhc
Confidence            9999998874

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=6e-21  Score=165.79  Aligned_cols=144  Identities=23%  Similarity=0.432  Sum_probs=122.0

Q ss_pred             hHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc-
Q 009594          352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM-  430 (531)
Q Consensus       352 ~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~-  430 (531)
                      |.++++++|+.+++++|+.+|+|++|+|+.+||..++.....    ..++.+|..+|.+++|.|+|.||+..+...... 
T Consensus         6 ~~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~~----~~~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~   81 (165)
T d1auib_           6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQN----PLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKG   81 (165)
T ss_dssp             CCCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHTC----TTHHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTC
T ss_pred             HcCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccCC----HHHHHHHHHHccccchhhhhhhhhhhccccccch
Confidence            467899999999999999999999999999999876554322    246789999999999999999999977665433 


Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCC----HHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSG----EDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~----~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ...+.++.+|+.+|.|++|.|+.+|+..+++.. +..++    ++.++.+|..+|.|+||.||++||+++|.+.
T Consensus        82 ~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~i~~~~  155 (165)
T d1auib_          82 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGL  155 (165)
T ss_dssp             CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHHHHGGG
T ss_pred             hhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHHhcC
Confidence            455779999999999999999999999999764 55444    4557889999999999999999999999854

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=9.3e-21  Score=159.67  Aligned_cols=133  Identities=23%  Similarity=0.347  Sum_probs=116.5

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCC--CCCCceecchhHhHHHHhhcc---CcHHHHH
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADV--DGDGSLNYGEFVAVSVHLKKM---ANDEHLH  437 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~--~~~g~i~~~ef~~~~~~~~~~---~~~~~~~  437 (531)
                      +|+++|..+|.+++|.|+.+||..+|+.+|..++..++..++..++.  +++|.|+|.+|..++......   ...+.+.
T Consensus         1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~l~   80 (139)
T d1w7jb1           1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYL   80 (139)
T ss_dssp             CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCH
T ss_pred             CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhccccHHHHHH
Confidence            47899999999999999999999999999999999999999988774  678999999999876543222   2345688


Q ss_pred             HhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHH
Q 009594          438 KAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       438 ~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      .+|+.+|.+++|+|+.+||+.+|..+|..+++++++.++.. |.|+||.|+|+||+++|
T Consensus        81 ~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dg~I~~~eF~~~l  138 (139)
T d1w7jb1          81 EGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG-HEDSNGCINYEAFLKHI  138 (139)
T ss_dssp             HHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT-CCCTTSEEEHHHHHHHT
T ss_pred             HhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCeEeHHHHHHHh
Confidence            99999999999999999999999999999999999999875 88999999999999875

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.81  E-value=3.5e-20  Score=163.65  Aligned_cols=151  Identities=20%  Similarity=0.295  Sum_probs=130.4

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCC-HHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP-EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~-~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~  432 (531)
                      +.++.+++..+.+.|..  .+++|.|+.+||..++..++.... ...++++|..+|.+++|.|+|+||+..+........
T Consensus        16 t~fs~~ei~~l~~~F~~--~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~   93 (181)
T d1bjfa_          16 TDFTEHEIQEWYKGFLR--DCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKL   93 (181)
T ss_dssp             SSCCHHHHHHHHHHHHH--HSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCH
T ss_pred             cCCCHHHHHHHHHHHHh--hCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhch
Confidence            45888999999988854  567999999999999998875554 456789999999999999999999998887777777


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcC------------CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEV------------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~------------~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      ++.++.+|+.+|.|++|+|+.+|+..++..+.            ....++.++.+|+.+|.|+||+|||+||.+++.+.+
T Consensus        94 ~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p  173 (181)
T d1bjfa_          94 EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKSDP  173 (181)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEECHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCH
Confidence            88999999999999999999999999998542            234567799999999999999999999999999888


Q ss_pred             hHHHHH
Q 009594          501 DWRKAS  506 (531)
Q Consensus       501 ~~~~~f  506 (531)
                      .+...+
T Consensus       174 ~~~~~l  179 (181)
T d1bjfa_         174 SIVRLL  179 (181)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            776654

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=99.81  E-value=8.2e-20  Score=161.40  Aligned_cols=154  Identities=25%  Similarity=0.399  Sum_probs=130.6

Q ss_pred             HhhhhhHHHhhHHHHhcccccC--CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh-c
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTN--KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK-K  429 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~--~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~-~  429 (531)
                      .+.|+++|+..+++.|+.+|.+  ++|.|+.+||..++...+..... .++.+|+.+|.|++|.|+|+||+..+.... .
T Consensus         8 ~t~Fs~~ei~~L~~~F~~~d~~~~~~G~i~~~ef~~~l~~~~~~~~~-~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~   86 (183)
T d2zfda1           8 DTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESL-FADRVFDLFDTKHNGILGFEEFARALSVFHPN   86 (183)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCSSCCCH-HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTT
T ss_pred             hCCCCHHHHHHHHHHHHHHCcCCCCCCcCcHHHHHHHHHhcCCCCCH-HHHHHHHHHccCCCCcCcHHHHHHHHHhhhcc
Confidence            4678999999999999999876  68999999999999887766544 578999999999999999999998765543 3


Q ss_pred             cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhh----cCCCCCHHH----HHHHHHhccCCCCcceeHHHHHHHHHhCch
Q 009594          430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALND----EVDTSGEDV----INAIMHDVDTDKDGRISYEEFAVMMKAGTD  501 (531)
Q Consensus       430 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~----~~~~~~~~~----~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~  501 (531)
                      ...++.++.+|+.||.|++|.|+.+|++.++..    .+....+++    ++.+|..+|.|+||.|+|+||.+++...+.
T Consensus        87 ~~~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p~  166 (183)
T d2zfda1          87 APIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVLRHPS  166 (183)
T ss_dssp             SCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHHHSGG
T ss_pred             CcHHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHCHH
Confidence            456778999999999999999999999998764    355555544    667889999999999999999999998887


Q ss_pred             HHHHHh
Q 009594          502 WRKASR  507 (531)
Q Consensus       502 ~~~~f~  507 (531)
                      +.+.|.
T Consensus       167 ~~~~~~  172 (183)
T d2zfda1         167 LLKNMT  172 (183)
T ss_dssp             GGGGGC
T ss_pred             HHHHcC
Confidence            776655

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.80  E-value=7.1e-20  Score=164.47  Aligned_cols=152  Identities=19%  Similarity=0.217  Sum_probs=129.2

Q ss_pred             HhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCC-HHHHHHHHHhcCCCCCCceecchhHhHHHHhhccC
Q 009594          353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP-EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMA  431 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~-~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~  431 (531)
                      .+.++.+|+..+.+.|.  +.+++|.|+.+||..++..++.... ...++.+|..+|.|++|.|+|.||+..+.......
T Consensus        19 ~t~f~~~ei~~l~~~F~--~~~~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~   96 (201)
T d1omra_          19 NTKFTEEELSSWYQSFL--KECPSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGK   96 (201)
T ss_dssp             GCSSCHHHHHHHHHHHH--HHCTTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSC
T ss_pred             hCCCCHHHHHHHHHHHH--HHCcCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccc
Confidence            34578899999988884  4567999999999999999876544 45568899999999999999999999887777767


Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCC--------------CHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTS--------------GEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~--------------~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .++.++.+|+.||.|++|.|+.+|+..++..+....              .++.++.+|..+|.|+||+|||+||+.++.
T Consensus        97 ~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~  176 (201)
T d1omra_          97 TNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKLTEKEFIEGTL  176 (201)
T ss_dssp             GGGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCCTTCCBCHHHHHHHHH
T ss_pred             hHHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence            778899999999999999999999999987653322              234578899999999999999999999999


Q ss_pred             hCchHHHHH
Q 009594          498 AGTDWRKAS  506 (531)
Q Consensus       498 ~~~~~~~~f  506 (531)
                      ..+.+.+.+
T Consensus       177 ~~~~~~~~l  185 (201)
T d1omra_         177 ANKEILRLI  185 (201)
T ss_dssp             HCHHHHHHH
T ss_pred             HCHHHHHHh
Confidence            888877766

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.80  E-value=1e-19  Score=160.10  Aligned_cols=155  Identities=19%  Similarity=0.299  Sum_probs=130.1

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCC-HHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCc
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP-EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAN  432 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~-~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~  432 (531)
                      +.|++.|+..+.+.|..  .+++|.|+.+||..++..++.... ...++.+|..+|.|++|.|+|.||+..+........
T Consensus         8 t~ft~~ei~~l~~~F~~--~~~~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~   85 (178)
T d1s6ca_           8 TNFTKRELQVLYRGFKN--ECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV   85 (178)
T ss_dssp             SSCCHHHHHHHHHHHHH--HCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCH
T ss_pred             CCCCHHHHHHHHHHHHH--HCcCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHHhccch
Confidence            45788888888888854  567899999999999998876554 445689999999999999999999998877777777


Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhc----C--------CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDE----V--------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~--------~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      .+.++.+|+.||.|++|.|+.+|+..++..+    +        ....++.++.+|+.+|.|+||.||++||..++...+
T Consensus        86 ~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~~~i~~~~  165 (178)
T d1s6ca_          86 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD  165 (178)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCC
T ss_pred             HHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCH
Confidence            8899999999999999999999999887643    1        122355688999999999999999999999999998


Q ss_pred             hHHHHHhhhC
Q 009594          501 DWRKASRQYS  510 (531)
Q Consensus       501 ~~~~~f~~~D  510 (531)
                      .+.+.+..|+
T Consensus       166 ~~~~~l~~~~  175 (178)
T d1s6ca_         166 NIMRSLQLFQ  175 (178)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHhhhhc
Confidence            8888876554

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

Probab=99.76  E-value=4.4e-19  Score=171.58  Aligned_cols=169  Identities=24%  Similarity=0.283  Sum_probs=141.2

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcH
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMAND  433 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  433 (531)
                      ..++.++...++++|..+|.|++|.|+.+||+.+|..+|..++..+++.+|..+|.|++|.|+|.||...+.....    
T Consensus       114 ~~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~----  189 (321)
T d1ij5a_         114 PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAA----  189 (321)
T ss_dssp             CCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHCCSSTHHHHHHTTSHHHHHT----
T ss_pred             ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHhhcCCccccchhhhhhhhhhhh----
Confidence            3456788889999999999999999999999999999999999999999999999999999999999987654332    


Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHH-----------------------------HHHHHHHhccCCCC
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED-----------------------------VINAIMHDVDTDKD  484 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~-----------------------------~~~~~~~~~D~~~d  484 (531)
                        +..+|+.+|.+++|.++..++...+...+......                             .+..+|..+|.|++
T Consensus       190 --~~~~F~~~d~d~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~F~~~D~d~~  267 (321)
T d1ij5a_         190 --LVADFRKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFADFDKS  267 (321)
T ss_dssp             --SCCCHHHHCTTCCSEECHHHHHHHHHHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHHHHHTCSSSC
T ss_pred             --hhHHHHHHhhcccccchhHHHhhhhhcccccchHHHHHHHHhhhcccccccccccccchhhhhhHHHHHHHHHhcCCC
Confidence              44578899999999999999999888766543221                             12336778899999


Q ss_pred             cceeHHHHHHHHHhC-------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          485 GRISYEEFAVMMKAG-------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       485 G~i~~~Ef~~~~~~~-------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      |.|+.+||..++...       ..+..+|..+|+|+||.||.+||.++|.=
T Consensus       268 G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~ml~  318 (321)
T d1ij5a_         268 GQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVLL  318 (321)
T ss_dssp             SSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            999999999888632       45889999999999999999999998863

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

Probab=99.75  E-value=3.2e-18  Score=152.02  Aligned_cols=153  Identities=17%  Similarity=0.202  Sum_probs=120.4

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHH-----HhCCCCCCHHHHHH-----HHHhcCCCCCCceecchhHhHHHH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGL-----LKGGQNIPEADLQI-----LMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l-----~~~~~~~~~~~~~~-----~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      +++++.+++++|+.+|.|++|+|+.+||..++     +.++..++..+...     .+...+.+.++.+++++|...+..
T Consensus         9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~~~~~~~   88 (189)
T d1qv0a_           9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQ   88 (189)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHhhhccccCCCceehHHHHHHHHH
Confidence            56788899999999999999999999998654     45677666655443     344567888999999999887644


Q ss_pred             hhcc-----------CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHH
Q 009594          427 LKKM-----------ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVM  495 (531)
Q Consensus       427 ~~~~-----------~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~  495 (531)
                      ....           ...+.+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.+|..+|.|+||.|+|+||++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~  168 (189)
T d1qv0a_          89 LATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQ  168 (189)
T ss_dssp             HHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHH
T ss_pred             HHHHhhhccccccHHHHHHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHH
Confidence            2111           12345678999999999999999999999999999999999999999999999999999999988


Q ss_pred             HHhCchHHHHHhhhCccCCC
Q 009594          496 MKAGTDWRKASRQYSRERFN  515 (531)
Q Consensus       496 ~~~~~~~~~~f~~~D~~~~G  515 (531)
                      +..      .|...|++.+|
T Consensus       169 ~~~------~~~~~d~~~~g  182 (189)
T d1qv0a_         169 HLG------FWYTLDPEADG  182 (189)
T ss_dssp             HHH------HHTTCCGGGTT
T ss_pred             HHH------hCCCCCCCCCC
Confidence            753      55566666665

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=1.2e-18  Score=152.87  Aligned_cols=150  Identities=19%  Similarity=0.293  Sum_probs=119.1

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCc--------ccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHH
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGK--------INLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVS  424 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~--------i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~  424 (531)
                      +.|+++|+..+++.|..++.+++|.        ++.+++.... .+..++   -.+++|+.+|.+ ++|.|+|+||+.++
T Consensus         9 T~ft~~EI~~l~~~F~~l~~~~~~~~~~~~~~~i~~~e~~~~~-~l~~~~---~~~rif~~fd~~~~~g~I~f~EFv~~l   84 (180)
T d1xo5a_           9 TFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLP-ELKANP---FKERICRVFSTSPAKDSLSFEDFLDLL   84 (180)
T ss_dssp             CCSCHHHHHHHHHHHHTTSCGGGCSHHHHHHCCEEHHHHHTSH-HHHTCT---THHHHHHHHCCSTTCCEECHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHHHHHCcCccccccccccceEcHHHHhcCc-ccccCh---HHHHHHHhccCCCCCCcCcHHHHHHHH
Confidence            5788999999999999998888765        4555553321 111121   357899999987 69999999999987


Q ss_pred             HHhh-ccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-----CCCCCH----HHHHHHHHhccCCCCcceeHHHHHH
Q 009594          425 VHLK-KMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-----VDTSGE----DVINAIMHDVDTDKDGRISYEEFAV  494 (531)
Q Consensus       425 ~~~~-~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-----~~~~~~----~~~~~~~~~~D~~~dG~i~~~Ef~~  494 (531)
                      .... ....++.++.+|+.||.|++|+|+.+|+..+++.+     +..+++    +.++.+|+.+|.|+||.|||+||.+
T Consensus        85 ~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~EF~~  164 (180)
T d1xo5a_          85 SVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQH  164 (180)
T ss_dssp             HHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred             HHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence            6654 34557789999999999999999999999999875     233333    3366789999999999999999999


Q ss_pred             HHHhCchHHHHHh
Q 009594          495 MMKAGTDWRKASR  507 (531)
Q Consensus       495 ~~~~~~~~~~~f~  507 (531)
                      ++.+.+++.+.|+
T Consensus       165 ~~~~~P~~~~~f~  177 (180)
T d1xo5a_         165 VISRSPDFASSFK  177 (180)
T ss_dssp             HHHHCHHHHHHHH
T ss_pred             HHHhCHHHHhhCe
Confidence            9999999999886

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

Probab=99.73  E-value=7.2e-18  Score=140.71  Aligned_cols=128  Identities=21%  Similarity=0.287  Sum_probs=112.7

Q ss_pred             HHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCC---HHHHHHHH
Q 009594          400 LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSG---EDVINAIM  476 (531)
Q Consensus       400 ~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~---~~~~~~~~  476 (531)
                      .+.+|..+|.|++|.|++.||..++.........+.+..+|+.+|.+++|.|+.+||..++........   ...+..+|
T Consensus         2 ae~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~F   81 (134)
T d1jfja_           2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLY   81 (134)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhcccccccccccccccccccccccccccccccccc
Confidence            467999999999999999999998877766677788999999999999999999999999976543332   34578899


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC--chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG--TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~--~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      +.+|.|++|.|+.+||..++...  +.+.+.|..+|+|+||.||.+||.++|.
T Consensus        82 ~~~D~~~~g~i~~~el~~~~~~~~~~~~~~~~~~~D~d~dG~is~~EF~~~~l  134 (134)
T d1jfja_          82 KLMDVDGDGKLTKEEVTSFFKKHGIEKVAEQVMKADANGDGYITLEEFLEFSL  134 (134)
T ss_dssp             HHHCCSSSSEEEHHHHHHHHTTTTCHHHHHHHHHHHCSSSSEEEHHHHHHHHC
T ss_pred             cccccccCCcccHHHHHHHHHhcCcHHHHHHHHHHCCCCCCCCCHHHHHHHhC
Confidence            99999999999999999999854  5588999999999999999999999874

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.73  E-value=9.7e-18  Score=148.71  Aligned_cols=153  Identities=18%  Similarity=0.254  Sum_probs=128.8

Q ss_pred             CCcccHHHHHHHHHhCCCCCCHHHHHHHHHhc-CCCCCCceecchhHhHHHHhhc-cCcHHHHHHhhcccCCCCCcceeH
Q 009594          376 RGKINLEELRLGLLKGGQNIPEADLQILMEAA-DVDGDGSLNYGEFVAVSVHLKK-MANDEHLHKAFSFFDRNRSGFIEI  453 (531)
Q Consensus       376 ~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~-D~~~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~~~~G~i~~  453 (531)
                      ...++.+++....+.  ...+..+++.+++.+ +.+.+|.|+..||..++..... ....+.+..+|+.+|.|++|.|+.
T Consensus         5 ~S~l~~e~l~~l~~~--t~fs~~Ei~~l~~~F~~~~~~G~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~D~~~~G~I~~   82 (190)
T d1fpwa_           5 TSKLSKDDLTCLKQS--TYFDRREIQQWHKGFLRDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHF   82 (190)
T ss_dssp             SCCSTTHHHHHHTTT--CCSTHHHHHHHHHHHHHHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECH
T ss_pred             cCCCCHHHHHHHHHH--cCCCHHHHHHHHHHHHHHCCCCCccHHHHHHHHHHHCCCCChHHHHHHHHHHhCcCCCCcccH
Confidence            446888888665543  457889999998886 4567999999999998765543 334456789999999999999999


Q ss_pred             HHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCCC
Q 009594          454 EELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERFN  515 (531)
Q Consensus       454 ~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~G  515 (531)
                      +||..++..++....++.++.+|+.+|.|++|.|+++||..++...                  ..+..+|+.+|+|+||
T Consensus        83 ~Ef~~~~~~~~~~~~~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG  162 (190)
T d1fpwa_          83 EEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDG  162 (190)
T ss_dssp             HHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSS
T ss_pred             HHHHHHHHHHccCchHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            9999999998887888999999999999999999999999999631                  2388899999999999


Q ss_pred             cCCHHHHHHHHhhcC
Q 009594          516 SISLKLMREEGLQLA  530 (531)
Q Consensus       516 ~i~~~e~~~~~~~~~  530 (531)
                      .||.+||++.+.+.+
T Consensus       163 ~Is~~EF~~~~~~~p  177 (190)
T d1fpwa_         163 YITLDEFREGSKVDP  177 (190)
T ss_dssp             EEEHHHHHHHHHSST
T ss_pred             cCcHHHHHHHHHHCH
Confidence            999999999987654

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

Probab=99.72  E-value=2.1e-17  Score=146.31  Aligned_cols=153  Identities=14%  Similarity=0.150  Sum_probs=121.0

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHH-----hCCCCCCHHHHHHH-----HHhcCCCCCCceecchhHhHHHH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLL-----KGGQNIPEADLQIL-----MEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~-----~~~~~~~~~~~~~~-----f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      ++.++.+++++|+.+|.|++|+|+.+||..++.     .++..++..+....     +.......++.+++.+|+..+..
T Consensus         7 ~p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (187)
T d1uhka1           7 NPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKK   86 (187)
T ss_dssp             CHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHHhhhhcccccccccccHHHHHHHHHH
Confidence            567788999999999999999999999976554     35666666544333     33445667778999999876544


Q ss_pred             hhcc-----------CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHH
Q 009594          427 LKKM-----------ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVM  495 (531)
Q Consensus       427 ~~~~-----------~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~  495 (531)
                      ....           .....+..+|+.+|.|++|+|+.+||+.+|..+|..+++++++.+|..+|.|+||.|+|+||++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~  166 (187)
T d1uhka1          87 LATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQ  166 (187)
T ss_dssp             HHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHH
T ss_pred             HHHHHHHhhhhhhHHHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHHH
Confidence            3221           12245788999999999999999999999999999999999999999999999999999999976


Q ss_pred             HHhCchHHHHHhhhCccCCC
Q 009594          496 MKAGTDWRKASRQYSRERFN  515 (531)
Q Consensus       496 ~~~~~~~~~~f~~~D~~~~G  515 (531)
                      +..      .|...|++.+|
T Consensus       167 ~~~------~~~~~d~~~~~  180 (187)
T d1uhka1         167 HLG------FWYTMDPACEK  180 (187)
T ss_dssp             HHH------HHTTCCGGGTT
T ss_pred             HHH------hcccCCccccc
Confidence            653      45556666555

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=99.71  E-value=2.4e-18  Score=152.24  Aligned_cols=140  Identities=15%  Similarity=0.222  Sum_probs=113.3

Q ss_pred             hhhHHHhhHHHHhcc-cccCCCCcccHHHHHHHHHhCCC----CCCHH-----------HHHHHHHhcCCCCCCceecch
Q 009594          356 LSVEEVAGLKEAFEM-MDTNKRGKINLEELRLGLLKGGQ----NIPEA-----------DLQILMEAADVDGDGSLNYGE  419 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~-~D~~~~g~i~~~el~~~l~~~~~----~~~~~-----------~~~~~f~~~D~~~~g~i~~~e  419 (531)
                      +|+.+..+++.+|+. +|.|++|.|+.+||..++..++.    .....           ....++...|.+++|.|++++
T Consensus         2 lt~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~   81 (185)
T d2sasa_           2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE   81 (185)
T ss_dssp             CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred             cCHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeH
Confidence            466788899999997 59999999999999998876521    11111           123456778999999999999


Q ss_pred             hHhHHHHhhcc---------CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHH
Q 009594          420 FVAVSVHLKKM---------ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYE  490 (531)
Q Consensus       420 f~~~~~~~~~~---------~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~  490 (531)
                      |...+......         .....+..+|+.+|.|++|+||.+||+.+|..+|  ++.++++.+|..+|.|+||.|+|+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~--l~~~~~~~~f~~~D~d~dG~i~~~  159 (185)
T d2sasa_          82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLN  159 (185)
T ss_dssp             HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTTTTSCCSHH
T ss_pred             hhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHcC--CCHHHHHHHHHHcCCCCCCCCcHH
Confidence            99876543211         1235688999999999999999999999999876  466789999999999999999999


Q ss_pred             HHHHHHH
Q 009594          491 EFAVMMK  497 (531)
Q Consensus       491 Ef~~~~~  497 (531)
                      ||..++.
T Consensus       160 EF~~~~~  166 (185)
T d2sasa_         160 RYKELYY  166 (185)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998875

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=99.71  E-value=1.4e-17  Score=131.82  Aligned_cols=101  Identities=28%  Similarity=0.458  Sum_probs=87.9

Q ss_pred             CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCCCCHH
Q 009594          394 NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDTSGED  470 (531)
Q Consensus       394 ~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~  470 (531)
                      .++.++|.+++..+|.  +|.|+|.||+.++.  .....++.++.+|+.||+|++|+|+.+||+.+|+.+   |..++++
T Consensus         5 ~l~~~di~~~~~~~~~--~G~idf~eF~~~~~--~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~   80 (109)
T d5pala_           5 VLKADDINKAISAFKD--PGTFDYKRFFHLVG--LKGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDT   80 (109)
T ss_dssp             TSCHHHHHHHHHHTCS--TTCCCHHHHHHHHT--CTTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHH
T ss_pred             HccHHHHHHHHHhcCC--CCcCcHHHHHHHHH--hcCCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHH
Confidence            3567889999988864  57899999998654  233456889999999999999999999999999765   6789999


Q ss_pred             HHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          471 VINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       471 ~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +++.+|+.+|.|+||+|+|+||+++|.+
T Consensus        81 e~~~~~~~~D~d~dG~I~~~EF~~~m~~  108 (109)
T d5pala_          81 ETKALLAAGDSDHDGKIGADEFAKMVAQ  108 (109)
T ss_dssp             HHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence            9999999999999999999999999875

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.71  E-value=1.4e-17  Score=149.15  Aligned_cols=153  Identities=19%  Similarity=0.181  Sum_probs=128.7

Q ss_pred             CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhc-CCCCCCceecchhHhHHHHhhcc-CcHHHHHHhhcccCCCCCccee
Q 009594          375 KRGKINLEELRLGLLKGGQNIPEADLQILMEAA-DVDGDGSLNYGEFVAVSVHLKKM-ANDEHLHKAFSFFDRNRSGFIE  452 (531)
Q Consensus       375 ~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~-D~~~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~~~~G~i~  452 (531)
                      ..|.|+.+++......  ...+..++..+++.+ +.+++|.|+++||..++...... .....+..+|+.+|.|++|.|+
T Consensus         4 ~~~~l~~e~l~~l~~~--t~f~~~ei~~l~~~F~~~~~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~   81 (201)
T d1omra_           4 KSGALSKEILEELQLN--TKFTEEELSSWYQSFLKECPSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLD   81 (201)
T ss_dssp             SSCTHHHHHHHHHGGG--CSSCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEE
T ss_pred             ccCCCCHHHHHHHHHh--CCCCHHHHHHHHHHHHHHCcCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEe
Confidence            5688999998666654  557899999998876 67789999999999987765443 3455668899999999999999


Q ss_pred             HHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC--------------------chHHHHHhhhCcc
Q 009594          453 IEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG--------------------TDWRKASRQYSRE  512 (531)
Q Consensus       453 ~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~--------------------~~~~~~f~~~D~~  512 (531)
                      ..||..++..+.....++.++.+|+.+|.|++|.|+++||..++...                    ..+..+|+.+|+|
T Consensus        82 f~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d  161 (201)
T d1omra_          82 FKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKK  161 (201)
T ss_dssp             HHHHHHHHHHHHSSCGGGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCC
T ss_pred             ehhHHHHHHhhcccchHHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCC
Confidence            99999999887766677789999999999999999999999888631                    1267789999999


Q ss_pred             CCCcCCHHHHHHHHhhc
Q 009594          513 RFNSISLKLMREEGLQL  529 (531)
Q Consensus       513 ~~G~i~~~e~~~~~~~~  529 (531)
                      +||.||.+||.+.+...
T Consensus       162 ~dG~Is~~EF~~~~~~~  178 (201)
T d1omra_         162 DDDKLTEKEFIEGTLAN  178 (201)
T ss_dssp             TTCCBCHHHHHHHHHHC
T ss_pred             CCCCCcHHHHHHHHHHC
Confidence            99999999999877653

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=99.71  E-value=1.3e-17  Score=132.01  Aligned_cols=100  Identities=28%  Similarity=0.453  Sum_probs=87.2

Q ss_pred             CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCCCCHHH
Q 009594          395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDTSGEDV  471 (531)
Q Consensus       395 ~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~~~~  471 (531)
                      ++.++|..++..+|  ++|.|+|.||+.++..  .....+.++.+|+.||.|++|+|+.+||+.+|+.+   |..+++++
T Consensus         6 l~~eeI~~~~~~~d--~dG~idf~EF~~~~~~--~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~e   81 (109)
T d1pvaa_           6 LKADDIKKALDAVK--AEGSFNHKKFFALVGL--KAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAE   81 (109)
T ss_dssp             SCHHHHHHHHHHTC--STTCCCHHHHHHHHTC--TTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHH
T ss_pred             CCHHHHHHHHHhcC--CCCCCcHHHHHHHHHH--ccCCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHH
Confidence            46788888888775  4678999999987642  23456789999999999999999999999999877   66789999


Q ss_pred             HHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          472 INAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       472 ~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ++.+|+.+|.|+||+|+|+||+.+|..
T Consensus        82 v~~~~~~~D~d~dG~I~~~EF~~~m~~  108 (109)
T d1pvaa_          82 TKAFLKAADKDGDGKIGIDEFETLVHE  108 (109)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred             HHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence            999999999999999999999999875

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

Probab=99.70  E-value=2.5e-17  Score=144.07  Aligned_cols=138  Identities=20%  Similarity=0.185  Sum_probs=108.8

Q ss_pred             hHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCC----CCCCHH-H----HHHHHHh--cCCCCCCceecchhHhHHHH
Q 009594          358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG----QNIPEA-D----LQILMEA--ADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       358 ~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~----~~~~~~-~----~~~~f~~--~D~~~~g~i~~~ef~~~~~~  426 (531)
                      +.++.+|+.+|..+|.|++|.|+.+||..++..++    ...... .    ....+..  .+.++++.|++++|+..+..
T Consensus         2 ~~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~   81 (174)
T d2scpa_           2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKE   81 (174)
T ss_dssp             HHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcCcHHHHHHHHHh
Confidence            45678999999999999999999999998887652    122211 1    1222332  36788999999999987665


Q ss_pred             hhccC-----cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          427 LKKMA-----NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       427 ~~~~~-----~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .....     ....+..+|+.+|.|++|.||.+||+.+++.++.  +.+++..+|+.+|.|+||.|+++||+.++.
T Consensus        82 ~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~--~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~  155 (174)
T d2scpa_          82 MVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGL--DKTMAPASFDAIDTNNDGLLSLEEFVIAGS  155 (174)
T ss_dssp             HTSCGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CGGGHHHHHHHHCTTCSSEECHHHHHHHHH
T ss_pred             hhcchhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHhh--hhHHHHHHHhhcCCCCCCcEeHHHHHHHHH
Confidence            43322     2345788999999999999999999999998864  567899999999999999999999999875

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.69  E-value=7.2e-17  Score=142.97  Aligned_cols=151  Identities=18%  Similarity=0.100  Sum_probs=123.0

Q ss_pred             cccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCC-CCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHH
Q 009594          378 KINLEELRLGLLKGGQNIPEADLQILMEAADVD-GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEEL  456 (531)
Q Consensus       378 ~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el  456 (531)
                      .++++|+... ++ ....+..+++.+|+.+..+ .+|.|+++||..++...........+..+|+.+|.|++|.|+..||
T Consensus         3 ~~~~e~~~~~-~~-~~~~~~~ei~~~~~~F~~~~~~G~i~~~Ef~~~l~~~~~~~~~~~~~~lf~~~D~d~dG~I~f~Ef   80 (189)
T d1jbaa_           3 QFSWEEAEEN-GA-VGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEY   80 (189)
T ss_dssp             CSSCHHHHHS-SS-CCHHHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHH
T ss_pred             CCCHHHHHHH-hc-cCccCHHHHHHHHHHhcccCCCCeeeHHHHHHHHHHcCCCccHHHHHHHHHHhccCCCCeEeehhH
Confidence            3556665322 21 1234556788899988655 5899999999988765555556778999999999999999999999


Q ss_pred             HHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-----------------------chHHHHHhhhCccC
Q 009594          457 RNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-----------------------TDWRKASRQYSRER  513 (531)
Q Consensus       457 ~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----------------------~~~~~~f~~~D~~~  513 (531)
                      ..++..+.....++.++.+|+.+|.|++|.|+++||..++...                       +.+..+|+.+|+|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~  160 (189)
T d1jbaa_          81 VAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENG  160 (189)
T ss_dssp             HHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSC
T ss_pred             HHHHHhhcccchHHHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCC
Confidence            9999988777778889999999999999999999999887631                       23678999999999


Q ss_pred             CCcCCHHHHHHHHhhcC
Q 009594          514 FNSISLKLMREEGLQLA  530 (531)
Q Consensus       514 ~G~i~~~e~~~~~~~~~  530 (531)
                      ||.||.+||++.+++.+
T Consensus       161 dG~Is~~EF~~~~~~~p  177 (189)
T d1jbaa_         161 DGQLSLNEFVEGARRDK  177 (189)
T ss_dssp             CSCBCHHHHHHHHTTTT
T ss_pred             CCcEeHHHHHHHHHhCH
Confidence            99999999999998754

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

Probab=99.66  E-value=3.2e-16  Score=137.04  Aligned_cols=136  Identities=21%  Similarity=0.310  Sum_probs=111.3

Q ss_pred             HhhHHHHhcccccCCCCcccHHHHHHHHHhC----CCCCCHHHH-----------HHHHHhcCCCCCCceecchhHhHHH
Q 009594          361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG----GQNIPEADL-----------QILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       361 ~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~----~~~~~~~~~-----------~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      ..+|+++|+.+|.|++|.|+.+||..++.++    +......++           ..++...|.+++|.|++.++.....
T Consensus         6 ~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~   85 (176)
T d1nyaa_           6 SDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVTE   85 (176)
T ss_dssp             HHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHHHHh
Confidence            4578999999999999999999999998765    333333332           3345667899999999999988665


Q ss_pred             Hhhcc--------CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          426 HLKKM--------ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       426 ~~~~~--------~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .....        .....++.+|..+|.|++|.|+.+||+.++..++  +++++++.+|..+|.|+||.|+++||+.+++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~  163 (176)
T d1nyaa_          86 NLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELLTAVR  163 (176)
T ss_dssp             HHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHS
T ss_pred             hhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--CcHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence            43222        1235678899999999999999999999999876  5789999999999999999999999999987


Q ss_pred             h
Q 009594          498 A  498 (531)
Q Consensus       498 ~  498 (531)
                      .
T Consensus       164 ~  164 (176)
T d1nyaa_         164 D  164 (176)
T ss_dssp             C
T ss_pred             H
Confidence            4

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

Probab=99.66  E-value=1.5e-16  Score=134.71  Aligned_cols=129  Identities=18%  Similarity=0.236  Sum_probs=113.3

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCC-CCHHHHHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDT-SGEDVINAIMH  477 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~  477 (531)
                      +++.+|..+|.|++|.|+++||..++...........+..+|+.+|.+++|.|+.+||..++...... ...+.+..+|+
T Consensus        10 ~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~   89 (146)
T d1exra_          10 EFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFK   89 (146)
T ss_dssp             HHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChHHHHHHHHH
Confidence            46677999999999999999999988777677788889999999999999999999999988654221 23567889999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      .+|.|++|.|+.+||..++...      +.+..+|+.+|.|+||.|+.+||.++|.
T Consensus        90 ~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l~  145 (146)
T d1exra_          90 VFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMV  145 (146)
T ss_dssp             HHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHH
T ss_pred             HhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhc
Confidence            9999999999999999999843      5699999999999999999999999985

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=3.1e-16  Score=138.52  Aligned_cols=152  Identities=18%  Similarity=0.190  Sum_probs=124.7

Q ss_pred             CCcccHHHHHHHHHhCCCCCCHHHHHHHHHhc-CCCCCCceecchhHhHHHHhhccCc-HHHHHHhhcccCCCCCcceeH
Q 009594          376 RGKINLEELRLGLLKGGQNIPEADLQILMEAA-DVDGDGSLNYGEFVAVSVHLKKMAN-DEHLHKAFSFFDRNRSGFIEI  453 (531)
Q Consensus       376 ~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~-D~~~~g~i~~~ef~~~~~~~~~~~~-~~~~~~~F~~~D~~~~G~i~~  453 (531)
                      +-.++.+++....+.  ..++..++..+++.+ +.+.+|.++..+|...+........ ......+|+.+|.+++|.|+.
T Consensus         2 nskl~~e~i~~l~~~--t~fs~~Ei~~l~~~F~~~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~d~~~dg~I~~   79 (187)
T d1g8ia_           2 NSKLKPEVVEELTRK--TYFTEKEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEF   79 (187)
T ss_dssp             CCSCCHHHHHHHHHT--SSSCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEH
T ss_pred             CccCCHHHHHHHHHh--cCCCHHHHHHHHHHHHHHCCCCCcCHHHHHHHHHHhcCCCCHHHHHHHHHHHhCcCCCCCCcH
Confidence            345677777666654  457889999998877 4567999999999988766544443 345578999999999999999


Q ss_pred             HHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCCC
Q 009594          454 EELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERFN  515 (531)
Q Consensus       454 ~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~G  515 (531)
                      +||..++..+.....++.++.+|+.+|.|+||.|+.+|+..++...                  ..+..+|+.+|+|+||
T Consensus        80 ~EF~~~l~~~~~~~~~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG  159 (187)
T d1g8ia_          80 SEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADG  159 (187)
T ss_dssp             HHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSS
T ss_pred             HHHHHHHHHhccCchhhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCCCCC
Confidence            9999999877655567789999999999999999999999988621                  2378899999999999


Q ss_pred             cCCHHHHHHHHhhc
Q 009594          516 SISLKLMREEGLQL  529 (531)
Q Consensus       516 ~i~~~e~~~~~~~~  529 (531)
                      .||.+||++.+...
T Consensus       160 ~Is~~EF~~~~~~~  173 (187)
T d1g8ia_         160 KLTLQEFQEGSKAD  173 (187)
T ss_dssp             EEEHHHHHHHHHHC
T ss_pred             cEeHHHHHHHHHHC
Confidence            99999999998764

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.64  E-value=8.5e-16  Score=134.99  Aligned_cols=151  Identities=21%  Similarity=0.183  Sum_probs=126.3

Q ss_pred             cccHHHHHHHHHhCCCCCCHHHHHHHHHhc-CCCCCCceecchhHhHHHHhhccC-cHHHHHHhhcccCCCCCcceeHHH
Q 009594          378 KINLEELRLGLLKGGQNIPEADLQILMEAA-DVDGDGSLNYGEFVAVSVHLKKMA-NDEHLHKAFSFFDRNRSGFIEIEE  455 (531)
Q Consensus       378 ~i~~~el~~~l~~~~~~~~~~~~~~~f~~~-D~~~~g~i~~~ef~~~~~~~~~~~-~~~~~~~~F~~~D~~~~G~i~~~e  455 (531)
                      .++.+++....+.  ...+..+++.++..+ +.+++|.|++.||...+....... ....+..+|+.+|.+++|.|+.+|
T Consensus         3 ~l~~~~~~~L~~~--t~fs~~ei~~l~~~F~~~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~lf~~~d~~~~g~i~~~e   80 (181)
T d1bjfa_           3 KLRPEVMQDLLES--TDFTEHEIQEWYKGFLRDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFRE   80 (181)
T ss_dssp             CCCHHHHHHHHHH--SSCCHHHHHHHHHHHHHHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHH
T ss_pred             CCCHHHHHHHHHh--cCCCHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcCCCCCCcEeHHH
Confidence            5777778777666  467888999998875 457899999999999776554333 345568899999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCCCcC
Q 009594          456 LRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERFNSI  517 (531)
Q Consensus       456 l~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~G~i  517 (531)
                      |..++........++.++.+|+.+|.|++|.|+.+||..++...                  ..+..+|+.+|.|+||.|
T Consensus        81 Fl~~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~I  160 (181)
T d1bjfa_          81 FIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKL  160 (181)
T ss_dssp             HHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEE
T ss_pred             HHHHHHHHhhhchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCCCCCcE
Confidence            99999887666667789999999999999999999999999731                  238888999999999999


Q ss_pred             CHHHHHHHHhhcC
Q 009594          518 SLKLMREEGLQLA  530 (531)
Q Consensus       518 ~~~e~~~~~~~~~  530 (531)
                      |.+||++.+...+
T Consensus       161 s~~EF~~~~~~~p  173 (181)
T d1bjfa_         161 SLEEFIRGAKSDP  173 (181)
T ss_dssp             CHHHHHHHHHHCT
T ss_pred             eHHHHHHHHHhCH
Confidence            9999999987654

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=99.64  E-value=4.8e-16  Score=122.52  Aligned_cols=100  Identities=31%  Similarity=0.435  Sum_probs=87.8

Q ss_pred             CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC---CCCCHH
Q 009594          394 NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV---DTSGED  470 (531)
Q Consensus       394 ~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~---~~~~~~  470 (531)
                      .++.+++..++..++.+  |.|+|.||+..+..  .....+.++.+|+.||.|++|+|+.+||+.+++.++   ..++++
T Consensus         4 gls~~di~~~~~~~~~~--gsi~~~eF~~~~~l--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~   79 (107)
T d2pvba_           4 GLKDADVAAALAACSAA--DSFKHKEFFAKVGL--ASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDA   79 (107)
T ss_dssp             TSCHHHHHHHHHHTCST--TCCCHHHHHHHHTG--GGSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHH
T ss_pred             CCCHHHHHHHHHhccCC--CCcCHHHHHHHHhc--ccCCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHH
Confidence            46788999999998764  56999999987642  234667899999999999999999999999999874   568999


Q ss_pred             HHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          471 VINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       471 ~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +++.+|+.+|.|+||+|+|+||+.+|+
T Consensus        80 ~~~~l~~~~D~d~dG~I~~~EF~~~m~  106 (107)
T d2pvba_          80 ETKAFLADGDKDGDGMIGVDEFAAMIK  106 (107)
T ss_dssp             HHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence            999999999999999999999999886

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=7.1e-16  Score=129.54  Aligned_cols=129  Identities=16%  Similarity=0.260  Sum_probs=114.0

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC-CCCCHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV-DTSGEDVINAIM  476 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~  476 (531)
                      ++++++|..+|.|++|.|++.||..++...........+...+..+|.+++|.|+.+||...+.... .....+++..+|
T Consensus         6 ~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~~f   85 (141)
T d2obha1           6 QEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAF   85 (141)
T ss_dssp             HHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhccHHHHHHHH
Confidence            4788899999999999999999999888777777888999999999999999999999999886532 122346689999


Q ss_pred             HhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHH
Q 009594          477 HDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEG  526 (531)
Q Consensus       477 ~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~  526 (531)
                      ..+|.+++|.|+..||..++...      ..+..+|+.+|+|+||.|+.+||.++|
T Consensus        86 ~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~~~m  141 (141)
T d2obha1          86 KLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM  141 (141)
T ss_dssp             HHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred             HHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence            99999999999999999999854      459999999999999999999999986

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.63  E-value=3.1e-16  Score=137.43  Aligned_cols=138  Identities=19%  Similarity=0.222  Sum_probs=116.0

Q ss_pred             CCCCHHHHHHHHHhc-CCCCCCceecchhHhHHHHhhcc-CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHH
Q 009594          393 QNIPEADLQILMEAA-DVDGDGSLNYGEFVAVSVHLKKM-ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGED  470 (531)
Q Consensus       393 ~~~~~~~~~~~f~~~-D~~~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~  470 (531)
                      ...+..+++.+++.+ +.+++|.|+.+||..++...... .....+..+|+.+|.|++|.|+.+||..++..+......+
T Consensus         8 t~ft~~ei~~l~~~F~~~~~~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~~   87 (178)
T d1s6ca_           8 TNFTKRELQVLYRGFKNECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHE   87 (178)
T ss_dssp             SSCCHHHHHHHHHHHHHHCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHCcCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHHhccchHH
Confidence            467889999998886 67789999999999987665443 3455568899999999999999999999997766566678


Q ss_pred             HHHHHHHhccCCCCcceeHHHHHHHHHhC------------------chHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          471 VINAIMHDVDTDKDGRISYEEFAVMMKAG------------------TDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       471 ~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------------------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      .++.+|+.+|.|++|.|+++|+..++...                  ..+..+|+.+|+|+||.||.+||.+.+.+-+
T Consensus        88 ~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~~~i~~~~  165 (178)
T d1s6ca_          88 KLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD  165 (178)
T ss_dssp             HHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCC
T ss_pred             HHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCH
Confidence            89999999999999999999998877521                  2267899999999999999999999887643

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

Probab=99.60  E-value=1.7e-15  Score=120.03  Aligned_cols=100  Identities=25%  Similarity=0.419  Sum_probs=86.6

Q ss_pred             CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC---CCCCHHH
Q 009594          395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV---DTSGEDV  471 (531)
Q Consensus       395 ~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~---~~~~~~~  471 (531)
                      ++.+++..++..++.  +|.|+|.+|+.++..  .....+.++.+|+.||+|++|+|+.+||+.+|+.++   ..+++++
T Consensus         6 ~~~~~i~~~~~~~~~--~~~i~f~eF~~~~~~--~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e   81 (109)
T d1rwya_           6 LSAEDIKKAIGAFTA--ADSFDHKKFFQMVGL--KKKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKE   81 (109)
T ss_dssp             SCHHHHHHHHHTTCS--TTCCCHHHHHHHHTG--GGSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHH
T ss_pred             cCHHHHHHHHHhccc--CCCcCHHHHHHHHcc--ccCCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHH
Confidence            567888888888754  578999999887643  234577899999999999999999999999998764   4688999


Q ss_pred             HHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          472 INAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       472 ~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ++.+|+.+|.|+||+|+|+||+++|..
T Consensus        82 ~~~~~~~~D~d~dG~i~~~EF~~~m~~  108 (109)
T d1rwya_          82 TKTLMAAGDKDGDGKIGVEEFSTLVAE  108 (109)
T ss_dssp             HHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred             HHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            999999999999999999999999875

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.60  E-value=1.9e-15  Score=130.12  Aligned_cols=131  Identities=19%  Similarity=0.271  Sum_probs=112.6

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc----CCCCCHHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE----VDTSGEDVINA  474 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~~~~~~~~~  474 (531)
                      ++++.|..+|.|++|.|++.||..++...........+..+|..+|.+++|.++..|+...+...    ......+.+..
T Consensus        21 el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~  100 (162)
T d1topa_          21 EFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELAN  100 (162)
T ss_dssp             HHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhhcccCcHHHHHH
Confidence            46778999999999999999998888777777778899999999999999999999987766432    11223456788


Q ss_pred             HHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          475 IMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       475 ~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      +|+.+|.|++|.|+.+||..++...      ..+...|..+|+|+||.|+.+||.++|..+
T Consensus       101 aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~~  161 (162)
T d1topa_         101 CFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV  161 (162)
T ss_dssp             HHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHSC
T ss_pred             HHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHHHcC
Confidence            9999999999999999999999843      458999999999999999999999999765

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=3.2e-15  Score=129.06  Aligned_cols=133  Identities=19%  Similarity=0.231  Sum_probs=108.7

Q ss_pred             CCCCHHHH---HHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCC-CC
Q 009594          393 QNIPEADL---QILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDT-SG  468 (531)
Q Consensus       393 ~~~~~~~~---~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~  468 (531)
                      ..++++++   .+.|..+|.|++|.|+++||..+......    ..+..+|+.+|.+++|.|+.+||..++...... ..
T Consensus         8 t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~~----~~~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~~~   83 (165)
T d1auib_           8 SHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQN----PLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDK   83 (165)
T ss_dssp             CSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHTC----TTHHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccCC----HHHHHHHHHHccccchhhhhhhhhhhccccccchhh
Confidence            44566654   45688999999999999999876433221    235678999999999999999999999876533 34


Q ss_pred             HHHHHHHHHhccCCCCcceeHHHHHHHHHhC-----------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          469 EDVINAIMHDVDTDKDGRISYEEFAVMMKAG-----------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       469 ~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      .+.+..+|..+|.|++|.|+.+|+.++++..           ..+..+|..+|.|+||.|+.+||.++|..+
T Consensus        84 ~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~i~~~~  155 (165)
T d1auib_          84 EQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGL  155 (165)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHHHHGGG
T ss_pred             HHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHHhcC
Confidence            5669999999999999999999999998632           237789999999999999999999998743

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.58  E-value=9.3e-15  Score=123.31  Aligned_cols=133  Identities=17%  Similarity=0.233  Sum_probs=115.1

Q ss_pred             CCCHHH---HHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCC-CH
Q 009594          394 NIPEAD---LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTS-GE  469 (531)
Q Consensus       394 ~~~~~~---~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~-~~  469 (531)
                      ++++++   ++.+|..+|.|++|.|+++||..++...........+...+..++.++++.++.+++...+....... +.
T Consensus         3 ~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (146)
T d1lkja_           3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSE   82 (146)
T ss_dssp             CCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCCHH
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccCCcccccHHHHHHHHHHhhccccHH
Confidence            455555   45569999999999999999999887776677788899999999999999999999999987765443 45


Q ss_pred             HHHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          470 DVINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       470 ~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      +.+..+|+.+|.|++|.|+.+||..++...      ..+..+|..+| |+||.|+.+||.++|.
T Consensus        83 ~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~~~m~  145 (146)
T d1lkja_          83 QELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLS  145 (146)
T ss_dssp             HHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC-CSSSEEEHHHHHHHHC
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc-CCCCeEeHHHHHHHhC
Confidence            679999999999999999999999999732      56999999999 9999999999999886

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.58  E-value=7.8e-16  Score=135.08  Aligned_cols=132  Identities=15%  Similarity=0.178  Sum_probs=117.6

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      ++++++|+.+|.|++|.|+++||..++...........+..+|+.+|.+++|.|+.+++..+..........+.+..+|.
T Consensus        10 ~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~e~l~~aF~   89 (182)
T d1s6ia_          10 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLVSAFS   89 (182)
T ss_dssp             CSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTHHHHH
T ss_pred             HHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhccccccchHHHHHHHHHhhcccccHHHHHHHHH
Confidence            35788999999999999999999998887766677889999999999999999999999998876655555567889999


Q ss_pred             hccCCCCcceeHHHHHHHHHh----CchHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          478 DVDTDKDGRISYEEFAVMMKA----GTDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~----~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      .+|.+++|.|+..|+..++..    ...+..+|+.+|.|+||.|+.+||.++|+..
T Consensus        90 ~~D~d~~G~i~~~el~~~l~~~gl~~~ev~~~f~~~D~d~DG~Is~~EF~~~m~~~  145 (182)
T d1s6ia_          90 YFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKR  145 (182)
T ss_dssp             HTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCC
T ss_pred             HHhhcCCCccchhhhhhhhhhcCccHHHHHHHHHHhhcCCCCeEeHHHHHHHHHhC
Confidence            999999999999999999874    3569999999999999999999999999865

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=2.6e-15  Score=118.57  Aligned_cols=102  Identities=21%  Similarity=0.375  Sum_probs=87.3

Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc---CCCCC
Q 009594          392 GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE---VDTSG  468 (531)
Q Consensus       392 ~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~---~~~~~  468 (531)
                      +-.++.++|..+++.++.  +|.++|.+|......  .....+.++.+|+.||.|++|+|+.+||+.+|..+   +..++
T Consensus         3 ~d~ls~~dI~~~l~~~~~--~~s~~~~~F~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~   78 (108)
T d1rroa_           3 TDILSAEDIAAALQECQD--PDTFEPQKFFQTSGL--SKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELT   78 (108)
T ss_dssp             GGTSCHHHHHHHHHHTCS--TTCCCHHHHHHHHSG--GGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCC
T ss_pred             hhhCCHHHHHHHHHhccc--CCCccHHHHHHHHcc--CcCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCC
Confidence            456788899999888754  567999999765432  23466789999999999999999999999999876   45688


Q ss_pred             HHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          469 EDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       469 ~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      +++++.+|+.+|.|+||.|+|+||+.+|+
T Consensus        79 ~~~~~~~~~~~D~d~dG~I~~~EF~~~m~  107 (108)
T d1rroa_          79 ESETKSLMDAADNDGDGKIGADEFQEMVH  107 (108)
T ss_dssp             HHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence            99999999999999999999999999886

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

Probab=99.57  E-value=4.5e-15  Score=130.13  Aligned_cols=126  Identities=20%  Similarity=0.285  Sum_probs=112.1

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMH  477 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~  477 (531)
                      +++..+|..+|.|++|.|+..||..++.......+...+..+|+.+|.|++|.|+.+||...+...      ..+...|.
T Consensus        18 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~~~~~------~~~~~~F~   91 (182)
T d1y1xa_          18 QELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHFI------LSMREGFR   91 (182)
T ss_dssp             SCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHHHHH
T ss_pred             HHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhccccccccccccccccccccccc------cccccchh
Confidence            568999999999999999999999988766666778889999999999999999999999887542      46788899


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      .+|.+++|.|+.+||.+++...      ..+..+|+.+|+|++|.|+.+||.+.|..+
T Consensus        92 ~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l  149 (182)
T d1y1xa_          92 KRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV  149 (182)
T ss_dssp             HHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred             ccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccCCCCCcCHHHHHHHHHHH
Confidence            9999999999999999999853      459999999999999999999999988643

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=99.56  E-value=1.3e-14  Score=127.44  Aligned_cols=137  Identities=20%  Similarity=0.221  Sum_probs=109.0

Q ss_pred             CCCCHHHHHHH---HHhcCCC--CCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCC-
Q 009594          393 QNIPEADLQIL---MEAADVD--GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDT-  466 (531)
Q Consensus       393 ~~~~~~~~~~~---f~~~D~~--~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-  466 (531)
                      ...+.++++.+   |..+|.+  ++|.|+++||..++..... ........+|+.+|.|++|.|+.+||..++..+... 
T Consensus         9 t~Fs~~ei~~L~~~F~~~d~~~~~~G~i~~~ef~~~l~~~~~-~~~~~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~   87 (183)
T d2zfda1           9 TVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNK-KESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNA   87 (183)
T ss_dssp             SSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCSS-CCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTS
T ss_pred             CCCCHHHHHHHHHHHHHHCcCCCCCCcCcHHHHHHHHHhcCC-CCCHHHHHHHHHHccCCCCcCcHHHHHHHHHhhhccC
Confidence            45677776665   4445554  6899999999877643332 233457899999999999999999999998776544 


Q ss_pred             CCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC--------------chHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          467 SGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG--------------TDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       467 ~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~--------------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      ..++.++.+|+.+|.|++|.|+.+|+..++...              +.+..+|..+|+|+||.|+.+||++.+.+.+
T Consensus        88 ~~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p  165 (183)
T d2zfda1          88 PIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVLRHP  165 (183)
T ss_dssp             CHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHHHSG
T ss_pred             cHHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHCH
Confidence            345669999999999999999999999987621              2267889999999999999999999987653

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=99.56  E-value=2.6e-14  Score=119.78  Aligned_cols=128  Identities=15%  Similarity=0.199  Sum_probs=110.4

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhh-cCCCCCHHHHHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALND-EVDTSGEDVINAIMH  477 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~  477 (531)
                      +++++|..+|.|++|.|+..||..++..+......+.+..+++    +++|.|+.+||..++.. +....+.+++..+|+
T Consensus         8 e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~----~~~~~i~~~eF~~~~~~~~~~~~~~~~l~~aF~   83 (142)
T d1wdcb_           8 EMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGTDSEETIRNAFA   83 (142)
T ss_dssp             HHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSCCCHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHH----hccCccccccccccccccccccchhhhHHHhhh
Confidence            4667899999999999999999998887766677777877774    67899999999998865 445556788999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhcCC
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQLAN  531 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~~  531 (531)
                      .+|.|++|.|+.+||..++...      +++.++|+.+|.| +|.|+.+||.++|+..|+
T Consensus        84 ~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-~G~I~y~eF~~~l~~~~~  142 (142)
T d1wdcb_          84 MFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGSGE  142 (142)
T ss_dssp             TTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTSCC
T ss_pred             hhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCC-CCEEcHHHHHHHHhcCCC
Confidence            9999999999999999999853      4589999999998 599999999999987664

>d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.55  E-value=9.4e-15  Score=123.14  Aligned_cols=132  Identities=11%  Similarity=0.134  Sum_probs=108.3

Q ss_pred             CHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCC--CCcceeHHHHHHHHhhcCC---CCCHH
Q 009594          396 PEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRN--RSGFIEIEELRNALNDEVD---TSGED  470 (531)
Q Consensus       396 ~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~--~~G~i~~~el~~~l~~~~~---~~~~~  470 (531)
                      +.++++++|..+|.|++|.|+..||..++..+....+...+..++..++.+  ++|.|+.+||..++.....   ....+
T Consensus         2 ~~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~   81 (145)
T d2mysc_           2 AADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQGTFE   81 (145)
T ss_pred             CHHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccchHH
Confidence            357889999999999999999999999887665556677788888877655  6899999999998875422   23456


Q ss_pred             HHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          471 VINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       471 ~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      ++..+|+.+|.|++|.|+.+||..++...      .++..+++ .|.|+||.|+.+||.+.|..
T Consensus        82 ~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~-~~~d~dG~I~y~eF~~~ll~  144 (145)
T d2mysc_          82 DFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMK-GQEDSNGCINYEAFVKHIMS  144 (145)
T ss_pred             HHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHh-hcCCCCCeEEHHHHHHHHhc
Confidence            78899999999999999999999999853      34777776 58899999999999988764

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.53  E-value=1e-14  Score=127.76  Aligned_cols=131  Identities=15%  Similarity=0.148  Sum_probs=112.3

Q ss_pred             CCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc-CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHH
Q 009594          393 QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM-ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV  471 (531)
Q Consensus       393 ~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~  471 (531)
                      .-+..+++..+|..+|.|++|.|+.+||..++...... ...+.++.+|+.+|.|++|.|+.+||..++...      ..
T Consensus        14 ~~~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~------~~   87 (181)
T d1hqva_          14 ALPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYI------TD   87 (181)
T ss_dssp             CCSCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHHHHH------HH
T ss_pred             CCccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhhhhc------cc
Confidence            34567889999999999999999999999887654333 467889999999999999999999999988653      45


Q ss_pred             HHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          472 INAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       472 ~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      +..+++.+|.+++|.|+.+||..++...      +.+..+++.+|.+++|.|+.+||.+.+..+
T Consensus        88 ~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~~~~~~l  151 (181)
T d1hqva_          88 WQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVL  151 (181)
T ss_dssp             HHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSSCSSCBCHHHHHHHHHHH
T ss_pred             cccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            7789999999999999999999998732      458899999999999999999999887643

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.52  E-value=1.6e-14  Score=105.82  Aligned_cols=70  Identities=39%  Similarity=0.650  Sum_probs=66.1

Q ss_pred             cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       430 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..+++.++.+|+.||.|++|+|+.+||+.+|+.+|..+++++++.+|..+|.|++|+|+|+||+++|+..
T Consensus         5 ~~~eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~~~   74 (75)
T d1jc2a_           5 GKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV   74 (75)
T ss_dssp             CCCHHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHHTC
T ss_pred             CCcHHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence            3567889999999999999999999999999999999999999999999999999999999999998753

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=1.2e-14  Score=124.45  Aligned_cols=85  Identities=14%  Similarity=0.192  Sum_probs=40.0

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASR  507 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~  507 (531)
                      +.++.+++.+|.|++|.|+.+||..++..+      ..+..+|+.+|.|++|.|+.+||..++...      +.+..++.
T Consensus        40 ~~~~~li~~~D~~~~G~i~~~EF~~l~~~~------~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~  113 (165)
T d1k94a_          40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVK  113 (165)
T ss_dssp             HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHhhcc------chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHH
Confidence            344444555555555555555555444332      234445555555555555555555544422      22444444


Q ss_pred             hhCccCCCcCCHHHHHHHH
Q 009594          508 QYSRERFNSISLKLMREEG  526 (531)
Q Consensus       508 ~~D~~~~G~i~~~e~~~~~  526 (531)
                      .+|+  ||.|+.+||.+.|
T Consensus       114 ~~d~--~g~i~~~eFi~~~  130 (165)
T d1k94a_         114 RYSK--NGRIFFDDYVACC  130 (165)
T ss_dssp             HHCB--TTBCBHHHHHHHH
T ss_pred             HcCC--CCcCcHHHHHHHH
Confidence            4443  2445555554444

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

Probab=99.50  E-value=6.4e-14  Score=121.87  Aligned_cols=133  Identities=17%  Similarity=0.210  Sum_probs=103.6

Q ss_pred             HHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc-----CcHH----HHHHhhcc--cCCCCCcceeHHHHHHHHhhcCC
Q 009594          397 EADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM-----ANDE----HLHKAFSF--FDRNRSGFIEIEELRNALNDEVD  465 (531)
Q Consensus       397 ~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~-----~~~~----~~~~~F~~--~D~~~~G~i~~~el~~~l~~~~~  465 (531)
                      .++++.+|+.+|.|++|.|+++||..++......     ....    .....|..  .|.+++|.|+.+||...+.....
T Consensus         5 ~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~   84 (174)
T d2scpa_           5 VQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKEMVK   84 (174)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcCcHHHHHHHHHhhhc
Confidence            3578899999999999999999998876544211     1111    12223333  37788999999999998876532


Q ss_pred             CC-----CHHHHHHHHHhccCCCCcceeHHHHHHHHHhC----chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          466 TS-----GEDVINAIMHDVDTDKDGRISYEEFAVMMKAG----TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       466 ~~-----~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ..     ....+..+|..+|.|+||.||.+||..+++..    +++..+|..+|.|+||.|+.+||.+++.+.
T Consensus        85 ~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~f  157 (174)
T d2scpa_          85 NPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGSDF  157 (174)
T ss_dssp             CGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCCGGGHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHhhhhHHHHHHHhhcCCCCCCcEeHHHHHHHHHHH
Confidence            21     12347789999999999999999999998844    679999999999999999999999988764

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.50  E-value=2.5e-14  Score=122.07  Aligned_cols=130  Identities=18%  Similarity=0.259  Sum_probs=111.2

Q ss_pred             HHHHHHHhcCCCC-CCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc----CCCCCHHHHH
Q 009594          399 DLQILMEAADVDG-DGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE----VDTSGEDVIN  473 (531)
Q Consensus       399 ~~~~~f~~~D~~~-~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~----~~~~~~~~~~  473 (531)
                      +++++|..+|.|+ +|.|+..||..++..+....+...+..++..++.+++|.++.+++.......    ....+.+.+.
T Consensus        15 ~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~   94 (156)
T d1dtla_          15 EFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELS   94 (156)
T ss_dssp             HHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhhccCCCccchhhhhhhhhhcccccccccHHHHHH
Confidence            4566799999995 8999999999988877777788899999999999999999999988765432    2234567789


Q ss_pred             HHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          474 AIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       474 ~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|+.+|.|++|.|+.+||..++...      ..+..+|+.+|+|+||.|+.+||.++|+.
T Consensus        95 ~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l~g  155 (156)
T d1dtla_          95 DLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG  155 (156)
T ss_dssp             HHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC
T ss_pred             HHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHcC
Confidence            99999999999999999999988743      56999999999999999999999999974

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.50  E-value=1.4e-14  Score=103.03  Aligned_cols=64  Identities=31%  Similarity=0.707  Sum_probs=61.4

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHH
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      ++.++.+|+.||+|++|+|+.+||+.+++.+|..+++++++.++..+|.|++|.|+|+||+++|
T Consensus         2 eeel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m   65 (65)
T d1fw4a_           2 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM   65 (65)
T ss_dssp             CHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred             HHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence            4679999999999999999999999999999999999999999999999999999999999874

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=5.8e-15  Score=123.52  Aligned_cols=128  Identities=13%  Similarity=0.125  Sum_probs=104.2

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCC--CCCcceeHHHHHHHHhhcCCC---CCHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDR--NRSGFIEIEELRNALNDEVDT---SGEDVIN  473 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~--~~~G~i~~~el~~~l~~~~~~---~~~~~~~  473 (531)
                      |+++.|..+|.+++|.|+..|+..++..+....+...+..++..++.  +++|.|+..||..++......   ...+++.
T Consensus         1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~l~   80 (139)
T d1w7jb1           1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYL   80 (139)
T ss_dssp             CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCH
T ss_pred             CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhccccHHHHHH
Confidence            46789999999999999999999988877667788889999988874  679999999999988754322   2334578


Q ss_pred             HHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          474 AIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       474 ~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      .+|+.+|.|++|.|+.+||..++...      ..+...+. .|.|+||.|+.+||.+.|.
T Consensus        81 ~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~-~~~d~dg~I~~~eF~~~ll  139 (139)
T d1w7jb1          81 EGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLA-GHEDSNGCINYEAFLKHIL  139 (139)
T ss_dssp             HHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHT-TCCCTTSEEEHHHHHHHTC
T ss_pred             HhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHh-hCCCCCCeEeHHHHHHHhC
Confidence            89999999999999999999999854      34666665 5899999999999998763

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=99.49  E-value=2.8e-14  Score=106.24  Aligned_cols=69  Identities=41%  Similarity=0.693  Sum_probs=65.4

Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .+++.++.+|+.||.|++|+|+.+||+.+|+.+|..+++++++.+|..+|.|+||+|+|+||+.+|+..
T Consensus        12 ~~ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~~~   80 (81)
T d1fi5a_          12 KTEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV   80 (81)
T ss_dssp             CCHHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHSCC
T ss_pred             CCHHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhc
Confidence            456789999999999999999999999999999999999999999999999999999999999998753

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=99.48  E-value=2.9e-14  Score=125.39  Aligned_cols=132  Identities=17%  Similarity=0.222  Sum_probs=105.2

Q ss_pred             HHHHHHHHh-cCCCCCCceecchhHhHHHHhhcc----Cc-----------HHHHHHhhcccCCCCCcceeHHHHHHHHh
Q 009594          398 ADLQILMEA-ADVDGDGSLNYGEFVAVSVHLKKM----AN-----------DEHLHKAFSFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       398 ~~~~~~f~~-~D~~~~g~i~~~ef~~~~~~~~~~----~~-----------~~~~~~~F~~~D~~~~G~i~~~el~~~l~  461 (531)
                      .+++.+|.. +|.|+||.|+++||..++..+...    ..           .......+...|.+++|.|+.+++..++.
T Consensus         8 ~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~~~~~~~   87 (185)
T d2sasa_           8 QKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAMWE   87 (185)
T ss_dssp             HHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred             HHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeHhhHHHH
Confidence            468889997 599999999999998876543211    11           12234567788999999999999999886


Q ss_pred             hcC---------CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC----chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          462 DEV---------DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG----TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       462 ~~~---------~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      ...         .......+..+|+.+|.|++|.||.+||..++...    +++..+|..+|+|+||.|+.+||.+.+.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~l~~~~~~~~f~~~D~d~dG~i~~~EF~~~~~~  167 (185)
T d2sasa_          88 KTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVITDGGKVTFDLNRYKELYYR  167 (185)
T ss_dssp             HHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHHTTTTSCCSHHHHHHHHHH
T ss_pred             HHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHcCCCHHHHHHHHHHcCCCCCCCCcHHHHHHHHHH
Confidence            421         11224458899999999999999999999999843    67999999999999999999999998876


Q ss_pred             c
Q 009594          529 L  529 (531)
Q Consensus       529 ~  529 (531)
                      +
T Consensus       168 f  168 (185)
T d2sasa_         168 L  168 (185)
T ss_dssp             H
T ss_pred             H
Confidence            4

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.48  E-value=9.7e-14  Score=115.89  Aligned_cols=126  Identities=10%  Similarity=0.077  Sum_probs=105.1

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC---CCCCHHHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV---DTSGEDVINA  474 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~---~~~~~~~~~~  474 (531)
                      .+.++.|..+|.|++|.|+++||..++..+....+.+.+..    ++.+++|.|+.+||..++....   .....+++..
T Consensus         5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~----~~~~~~~~i~~~eF~~~~~~~~~~~~~~~~~~l~~   80 (140)
T d1ggwa_           5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITE----IESTLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVK   80 (140)
T ss_dssp             TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHH----HHTTSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhh----hhccccccccchhhhhhhhhhhhcchhhHHHHHHH
Confidence            45788999999999999999999988876655566666554    4678899999999999986432   2345677999


Q ss_pred             HHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          475 IMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       475 ~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +|+.+|.|++|.|+.+||.++|...      +++..+|+.+|.+ ||.|+.+||.+.|..
T Consensus        81 aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m~s  139 (140)
T d1ggwa_          81 GFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVNYHDFVQMILA  139 (140)
T ss_dssp             HHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCS-SCCSTTTHHHHHHHC
T ss_pred             HHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCC-CCEEeHHHHHHHHhc
Confidence            9999999999999999999999742      5689999999988 999999999998864

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.47  E-value=7.5e-14  Score=117.59  Aligned_cols=128  Identities=9%  Similarity=0.127  Sum_probs=105.9

Q ss_pred             HHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhc-ccCCCCCcceeHHHHHHHHhhc------CCCCCHHHH
Q 009594          400 LQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFS-FFDRNRSGFIEIEELRNALNDE------VDTSGEDVI  472 (531)
Q Consensus       400 ~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~-~~D~~~~G~i~~~el~~~l~~~------~~~~~~~~~  472 (531)
                      ++.+|..+|.|++|.|+.+||..++..+....+.+.+..++. ..+.+.+|.|+.+||..++...      ......+.+
T Consensus         4 ~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~l   83 (146)
T d1m45a_           4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTEDF   83 (146)
T ss_dssp             CTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHHH
T ss_pred             HHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccccccccccccccchhhhhhhhhcccccccccchHHHH
Confidence            456899999999999999999998877666677888888885 5666778999999999988532      234456788


Q ss_pred             HHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          473 NAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       473 ~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      ..+|+.+|.+++|.|+.+||..+|...      .++..+|..+|.|+||.|+.+||.+.+.
T Consensus        84 ~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~  144 (146)
T d1m45a_          84 VKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVL  144 (146)
T ss_dssp             HHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred             HHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHHH
Confidence            999999999999999999999999853      4599999999999999999999987664

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=99.47  E-value=2.1e-14  Score=102.85  Aligned_cols=65  Identities=26%  Similarity=0.494  Sum_probs=61.6

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCC-CCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDT-SGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +.++.+|+.||.|++|+|+.+||+.+|..+|.. +++++++.+|..+|.|+||.|+|+||+.+|++
T Consensus         2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~r   67 (68)
T d1c7va_           2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKK   67 (68)
T ss_dssp             HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            568999999999999999999999999999875 79999999999999999999999999999875

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=99.46  E-value=6.4e-14  Score=100.23  Aligned_cols=63  Identities=21%  Similarity=0.428  Sum_probs=61.0

Q ss_pred             HHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       436 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ++.+|+.||.|++|+|+.+||+.+++.+|..+++++++.+|..+|.|+||.|+|+||+.+|.+
T Consensus         3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~   65 (67)
T d1tiza_           3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK   65 (67)
T ss_dssp             HHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred             HHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            688999999999999999999999999999999999999999999999999999999999875

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

Probab=99.45  E-value=3.1e-14  Score=125.16  Aligned_cols=125  Identities=12%  Similarity=0.124  Sum_probs=105.4

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhcc--------CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM--------ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGE  469 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~--------~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~  469 (531)
                      +.++.+|..+| |+||.|+..|+..++......        ...+.+..+++.+|.|++|.|+.+||..++..+      
T Consensus        18 ~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~~------   90 (186)
T d1df0a1          18 DGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTKI------   90 (186)
T ss_dssp             HHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHHH------
T ss_pred             HHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHHHHHHhH------
Confidence            55888999998 899999999998877654222        245678899999999999999999999887653      


Q ss_pred             HHHHHHHHhccCCCCcceeHHHHHHHHHhC-----chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          470 DVINAIMHDVDTDKDGRISYEEFAVMMKAG-----TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       470 ~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ..+..+|+.+|+|++|.|+.+|+..+++..     .++.+++..+|+|++|.|+.+||.++|..+
T Consensus        91 ~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~~~~~~d~d~dg~I~f~eFi~~~~~l  155 (186)
T d1df0a1          91 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRL  155 (186)
T ss_dssp             HHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHHHHHHHHCCSTTEECHHHHHHHHHHH
T ss_pred             HHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHHHHHHHHcCCCCeEeHHHHHHHHHHH
Confidence            568889999999999999999999999843     457788888999999999999999988654

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.45  E-value=5.9e-14  Score=98.19  Aligned_cols=61  Identities=26%  Similarity=0.553  Sum_probs=58.7

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAV  494 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~  494 (531)
                      ++++.+|+.||++++|+|+.+||+.+|+.+|..+++++++.+++.+|.|++|+|+|+||+.
T Consensus         1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~   61 (61)
T d2fcea1           1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE   61 (61)
T ss_dssp             HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred             ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence            4688999999999999999999999999999999999999999999999999999999984

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=99.45  E-value=8.9e-14  Score=103.49  Aligned_cols=69  Identities=29%  Similarity=0.491  Sum_probs=64.8

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      |++++..++++|+.+|+|++|.|+..||+.+|+.+| .++..++..+|..+|.|++|.|+|+||+.++..
T Consensus         1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~   69 (81)
T d2opoa1           1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARA   69 (81)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            468899999999999999999999999999999998 689999999999999999999999999997754

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.45  E-value=7.5e-14  Score=103.04  Aligned_cols=69  Identities=29%  Similarity=0.511  Sum_probs=65.3

Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..++.++.+|+.||.|++|+|+.+||+.+|+.+|..++.++++.+|..+|.|++|.|+|+||+++|++.
T Consensus         6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~   74 (77)
T d1oqpa_           6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKT   74 (77)
T ss_dssp             SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHHT
T ss_pred             cHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHcc
Confidence            346789999999999999999999999999999999999999999999999999999999999999864

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=99.45  E-value=8.7e-14  Score=103.50  Aligned_cols=76  Identities=29%  Similarity=0.463  Sum_probs=71.2

Q ss_pred             hhHhhhhhHHHhhHHHHhcccccCC-CCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          351 VVAEFLSVEEVAGLKEAFEMMDTNK-RGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       351 ~~~~~~~~~~~~~i~~~F~~~D~~~-~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      ..++.++++++..++++|+.||+++ +|.|+..||+.+|+++|..++..+++.++..+|.|++|.|+|+||+.++.+
T Consensus         4 ~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~   80 (82)
T d1wrka1           4 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVR   80 (82)
T ss_dssp             HHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred             HHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            4567889999999999999999995 799999999999999999999999999999999999999999999998753

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=6.6e-14  Score=122.08  Aligned_cols=134  Identities=10%  Similarity=0.121  Sum_probs=101.9

Q ss_pred             CCCCHHHHHHHHH---hcCCCCC--------CceecchhHhHHHHhhccCcHHHHHHhhcccCCC-CCcceeHHHHHHHH
Q 009594          393 QNIPEADLQILME---AADVDGD--------GSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRN-RSGFIEIEELRNAL  460 (531)
Q Consensus       393 ~~~~~~~~~~~f~---~~D~~~~--------g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~-~~G~i~~~el~~~l  460 (531)
                      ..++++++..+++   .++.+++        |.+++++|..+... ...   ....++|+.+|.+ ++|.|+.+||..+|
T Consensus         9 T~ft~~EI~~l~~~F~~l~~~~~~~~~~~~~~~i~~~e~~~~~~l-~~~---~~~~rif~~fd~~~~~g~I~f~EFv~~l   84 (180)
T d1xo5a_           9 TFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPEL-KAN---PFKERICRVFSTSPAKDSLSFEDFLDLL   84 (180)
T ss_dssp             CCSCHHHHHHHHHHHHTTSCGGGCSHHHHHHCCEEHHHHHTSHHH-HTC---TTHHHHHHHHCCSTTCCEECHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHHHHHCcCccccccccccceEcHHHHhcCccc-ccC---hHHHHHHHhccCCCCCCcCcHHHHHHHH
Confidence            3566777766554   4455444        45788888664321 111   1356789999987 69999999999999


Q ss_pred             hhcCCC-CCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC-----------c----hHHHHHhhhCccCCCcCCHHHHHH
Q 009594          461 NDEVDT-SGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG-----------T----DWRKASRQYSRERFNSISLKLMRE  524 (531)
Q Consensus       461 ~~~~~~-~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----------~----~~~~~f~~~D~~~~G~i~~~e~~~  524 (531)
                      ..+... ..++.++.+|+.+|.|++|.|+.+|+..++...           .    .+..+|+.+|.|+||.||.+||.+
T Consensus        85 ~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~EF~~  164 (180)
T d1xo5a_          85 SVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQH  164 (180)
T ss_dssp             HHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred             HHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence            876533 446679999999999999999999999988731           1    166789999999999999999999


Q ss_pred             HHhhcC
Q 009594          525 EGLQLA  530 (531)
Q Consensus       525 ~~~~~~  530 (531)
                      ++...|
T Consensus       165 ~~~~~P  170 (180)
T d1xo5a_         165 VISRSP  170 (180)
T ss_dssp             HHHHCH
T ss_pred             HHHhCH
Confidence            998765

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=99.44  E-value=1.5e-13  Score=102.30  Aligned_cols=72  Identities=32%  Similarity=0.453  Sum_probs=63.9

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc-hHHHHH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT-DWRKAS  506 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~-~~~~~f  506 (531)
                      ..++.+|+.||.|++|+|+.+||+.+|+.+| .++.+++..+|..+|.|++|.|+|+||+.+++... ..++++
T Consensus         6 ~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~e~~   78 (81)
T d2opoa1           6 ADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANRGLVKDVS   78 (81)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCTTTHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHCccchHHHH
Confidence            5689999999999999999999999999999 57899999999999999999999999999998543 334443

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=99.44  E-value=7.2e-13  Score=112.20  Aligned_cols=129  Identities=15%  Similarity=0.096  Sum_probs=106.5

Q ss_pred             HHHHHHHhcC--CCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcC--CCCCHHHHHH
Q 009594          399 DLQILMEAAD--VDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEV--DTSGEDVINA  474 (531)
Q Consensus       399 ~~~~~f~~~D--~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~--~~~~~~~~~~  474 (531)
                      +++++|..+|  .|++|.|+..||..++..+...++.+.+..+ ...|.+++|.|+.+||..++...-  ...+.+++..
T Consensus         8 ~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~-~~~~~~~~~~i~~~eFl~~~~~~~~~~~~~~~~l~~   86 (152)
T d1wdcc_           8 DLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYME   86 (152)
T ss_dssp             HHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHH
T ss_pred             HHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhh-hhhhccccccccccccccccccccccchhHHHhhhh
Confidence            4567799998  4889999999999988776555667777665 456788999999999999887542  3456788999


Q ss_pred             HHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCc--cCCCcCCHHHHHHHHhh
Q 009594          475 IMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSR--ERFNSISLKLMREEGLQ  528 (531)
Q Consensus       475 ~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~--~~~G~i~~~e~~~~~~~  528 (531)
                      +|+.+|.+++|.|+.+||..++...      +++..+++.+|.  |++|.|+.+||.+.|+.
T Consensus        87 aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~~~  148 (152)
T d1wdcc_          87 AFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMA  148 (152)
T ss_dssp             HHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHH
T ss_pred             hhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHHhc
Confidence            9999999999999999999999854      458889998885  55689999999998874

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

Probab=99.43  E-value=3e-13  Score=117.67  Aligned_cols=135  Identities=20%  Similarity=0.251  Sum_probs=107.9

Q ss_pred             CCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhcc----CcH-----------HHHHHhhcccCCCCCcceeHHHHHHH
Q 009594          395 IPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM----AND-----------EHLHKAFSFFDRNRSGFIEIEELRNA  459 (531)
Q Consensus       395 ~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~----~~~-----------~~~~~~F~~~D~~~~G~i~~~el~~~  459 (531)
                      .+.+.++.+|+.+|.|++|.|+++||..++......    ...           ......+...|.+++|.|+..++...
T Consensus         4 ~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~   83 (176)
T d1nyaa_           4 IASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRV   83 (176)
T ss_dssp             HHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHHH
Confidence            346778999999999999999999998876543211    110           12345667789999999999999988


Q ss_pred             HhhcCCCCC--------HHHHHHHHHhccCCCCcceeHHHHHHHHHhC----chHHHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          460 LNDEVDTSG--------EDVINAIMHDVDTDKDGRISYEEFAVMMKAG----TDWRKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       460 l~~~~~~~~--------~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~----~~~~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      +........        .+.+..+|..+|.|+||.|+.+||..++...    ..+..+|..+|.|+||.|+.+||.++++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~  163 (176)
T d1nyaa_          84 TENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELLTAVR  163 (176)
T ss_dssp             HHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHS
T ss_pred             HhhhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhcCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence            865533222        2347789999999999999999999998753    5699999999999999999999999988


Q ss_pred             hc
Q 009594          528 QL  529 (531)
Q Consensus       528 ~~  529 (531)
                      +.
T Consensus       164 ~~  165 (176)
T d1nyaa_         164 DF  165 (176)
T ss_dssp             CC
T ss_pred             HH
Confidence            75

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=99.43  E-value=6.8e-14  Score=101.96  Aligned_cols=70  Identities=36%  Similarity=0.611  Sum_probs=67.4

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      ++++++..++++|+.||.+++|+|+..||+.+++.+|..++++++..++..+|.|++|.|+|+||+.++.
T Consensus         2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~   71 (73)
T d2pq3a1           2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMA   71 (73)
T ss_dssp             CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence            6789999999999999999999999999999999999999999999999999999999999999998775

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

Probab=99.43  E-value=1.1e-14  Score=127.56  Aligned_cols=123  Identities=15%  Similarity=0.153  Sum_probs=89.5

Q ss_pred             HHHHHHhcCCCCCCceecchhHhHHHHhhcc--------CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHH
Q 009594          400 LQILMEAADVDGDGSLNYGEFVAVSVHLKKM--------ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDV  471 (531)
Q Consensus       400 ~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~--------~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~  471 (531)
                      ++++|..+| +.+|.|+..|+..++......        ...+.++.++..+|.|++|.|+.+||..++..+      ..
T Consensus        22 ~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF~~l~~~~------~~   94 (188)
T d1qxpa2          22 FKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRI------RN   94 (188)
T ss_dssp             -----CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHHH------HH
T ss_pred             HHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHHHHHHhhh------HH
Confidence            566888888 558999999987765432111        234678899999999999999999999887654      46


Q ss_pred             HHHHHHhccCCCCcceeHHHHHHHHHhC-----chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          472 INAIMHDVDTDKDGRISYEEFAVMMKAG-----TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       472 ~~~~~~~~D~~~dG~i~~~Ef~~~~~~~-----~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ++.+|+.+|+|++|.|+..||..++...     ..+.......|.+++|.|+.+||.+.|..+
T Consensus        95 ~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~~~~~dg~i~f~eFi~~~~~l  157 (188)
T d1qxpa2          95 YLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRL  157 (188)
T ss_dssp             HHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTSCSSSBCCHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHHhcCCCCcCCHHHHHHHHHHH
Confidence            7889999999999999999999998853     334444444567999999999999887654

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=7.1e-15  Score=126.94  Aligned_cols=133  Identities=12%  Similarity=0.198  Sum_probs=91.3

Q ss_pred             HHHHhcc--cccCCCCcccHHHHHHHHHhCCCCC--CHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHh
Q 009594          364 LKEAFEM--MDTNKRGKINLEELRLGLLKGGQNI--PEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKA  439 (531)
Q Consensus       364 i~~~F~~--~D~~~~g~i~~~el~~~l~~~~~~~--~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~  439 (531)
                      |+++|..  +|.|++|.|+.+|+..++...+...  ..+.+..+|...|.+++|.|+|+||..++..+.   ...++..+
T Consensus         7 l~k~~~k~~~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~---~r~ei~~~   83 (170)
T d2zkmx1           7 LDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLC---PRPEIDEI   83 (170)
T ss_dssp             HHHHHHHHHHSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHS---CCHHHHTT
T ss_pred             HHHHHHHHhcccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhccccccCCCccCHHHHHHHHhccC---CHHHHHHH
Confidence            3444544  7999999999999999986653322  223445567778999999999999999886553   34678999


Q ss_pred             hcccCCCCCcceeHHHHHHHHhhcCC----------CCCHHHHHHHHHhccCCC----CcceeHHHHHHHHHhC
Q 009594          440 FSFFDRNRSGFIEIEELRNALNDEVD----------TSGEDVINAIMHDVDTDK----DGRISYEEFAVMMKAG  499 (531)
Q Consensus       440 F~~~D~~~~G~i~~~el~~~l~~~~~----------~~~~~~~~~~~~~~D~~~----dG~i~~~Ef~~~~~~~  499 (531)
                      |+.||.|++|.||.+||..+|.....          ..+.+.++.++..+..+.    +|.||+++|..+|.+.
T Consensus        84 F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ls~d~F~~fL~S~  157 (170)
T d2zkmx1          84 FTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFLCGP  157 (170)
T ss_dssp             CC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHHHHST
T ss_pred             HHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeECHHHHHHHHcCc
Confidence            99999999999999999999986543          245667889999987764    4889999999988753

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.42  E-value=6.4e-14  Score=103.43  Aligned_cols=72  Identities=33%  Similarity=0.524  Sum_probs=68.6

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      ..++++++.+++++|..+|.|++|+|+.+||+.+|+.+|..++..++..++..+|.+++|.|+|+||+.++.
T Consensus         2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~   73 (77)
T d1f54a_           2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMS   73 (77)
T ss_dssp             CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence            457889999999999999999999999999999999999999999999999999999999999999998764

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.42  E-value=1.5e-13  Score=102.25  Aligned_cols=73  Identities=36%  Similarity=0.600  Sum_probs=69.1

Q ss_pred             hhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       354 ~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      ..++++++.+++++|..||+|++|+|+..||+.+|+.+|..+++.+++.+|..+|.|++|.|+|+||+.++..
T Consensus         6 ~~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~   78 (81)
T d1avsa_           6 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR   78 (81)
T ss_dssp             HHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            4568899999999999999999999999999999999999999999999999999999999999999998753

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=1.5e-13  Score=119.10  Aligned_cols=123  Identities=18%  Similarity=0.191  Sum_probs=91.6

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhhcc-----CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHH
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLKKM-----ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVI  472 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~-----~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~  472 (531)
                      +.+..+|..++ ++||.|+..||..++......     ...+.++.++..+|.|++|.|+.+||..++...      ...
T Consensus         7 ~~~~~~F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~------~~~   79 (172)
T d1juoa_           7 DPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL------NGW   79 (172)
T ss_dssp             CTTHHHHHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH------HHH
T ss_pred             HHHHHHHHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHHHhh------hhh
Confidence            44677888775 678888888888776554221     245777888888888888888888888877543      346


Q ss_pred             HHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          473 NAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       473 ~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                      ...|+.+|.|++|.|+.+|+..++...      +.+..+|+.+|.  +|.|+.+||.++|..+
T Consensus        80 ~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d~--~g~i~~~eF~~~~~~~  140 (172)
T d1juoa_          80 RQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYST--NGKITFDDYIACCVKL  140 (172)
T ss_dssp             HHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTCS--SSSEEHHHHHHHHHHH
T ss_pred             hHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHHh--cCCcCHHHHHHHHHHH
Confidence            678888888888888888888888743      447778888864  5678888888887654

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.41  E-value=2e-13  Score=101.48  Aligned_cols=65  Identities=32%  Similarity=0.541  Sum_probs=62.0

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      +.++.+|+.||.|++|+|+.+||+.+|+.+|..+++.+++.+|..+|.|++|.|+|+||+.+|..
T Consensus        14 ~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~   78 (81)
T d1avsa_          14 AEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR   78 (81)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            46789999999999999999999999999999999999999999999999999999999999863

>d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.41  E-value=2.4e-13  Score=114.26  Aligned_cols=127  Identities=13%  Similarity=0.218  Sum_probs=104.0

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CCCCCHHHHHHHHH
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VDTSGEDVINAIMH  477 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~  477 (531)
                      +++++|..+|.+++|.|+.+||..++..+........   .+..++.+++|.|+.+||..++... ......+++..+|+
T Consensus         8 el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~---~~~~~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~aF~   84 (145)
T d2mysb_           8 DFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNE---ELDAMIKEASGPINFTVFLTMFGEKLKGADPEDVIMGAFK   84 (145)
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHH---HHHHHHHhccCceeechhhhhhhhcccccchHHHHHHHHH
Confidence            4566799999999999999999988765543323322   2345566889999999999988654 44455677999999


Q ss_pred             hccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          478 DVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       478 ~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .+|.+++|.|+.+||.++++..      +++..+++.+|.|++|.|+.+||.++|+.
T Consensus        85 ~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l~~  141 (145)
T d2mysb_          85 VLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITH  141 (145)
T ss_pred             hhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhcc
Confidence            9999999999999999999743      55999999999999999999999999874

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.40  E-value=2.7e-14  Score=107.75  Aligned_cols=85  Identities=26%  Similarity=0.386  Sum_probs=70.0

Q ss_pred             CCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeH
Q 009594          410 DGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISY  489 (531)
Q Consensus       410 ~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~  489 (531)
                      +++|.|+..+.... ..+. ......++.+|+.||.|++|+|+.+||+.+|+.+|..+++++++.+|..+|.|++|.|+|
T Consensus         1 ~~~g~id~~~~~ma-~~l~-~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~   78 (87)
T d1s6ja_           1 HSSGHIDDDDKHMA-ERLS-EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDY   78 (87)
T ss_dssp             CCSSSSSSHHHHSS-SSSC-SSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECH
T ss_pred             CCCCccCchHHHHH-hhCC-HHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeH
Confidence            35788888774321 1111 122245889999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHH
Q 009594          490 EEFAVMM  496 (531)
Q Consensus       490 ~Ef~~~~  496 (531)
                      +||+.+|
T Consensus        79 ~EFl~am   85 (87)
T d1s6ja_          79 GEFIAAT   85 (87)
T ss_dssp             HHHTTCC
T ss_pred             HHHHHHH
Confidence            9998754

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=99.39  E-value=2.2e-13  Score=99.24  Aligned_cols=65  Identities=29%  Similarity=0.558  Sum_probs=62.0

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..++.+|+.||.|++|+|+.+||+.+|+.+|..++++++..++..+|.|++|.|+|+||+.+|..
T Consensus         8 ~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~~   72 (73)
T d2pq3a1           8 AEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR   72 (73)
T ss_dssp             HHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            46889999999999999999999999999999999999999999999999999999999998863

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

Probab=99.39  E-value=3.1e-13  Score=129.78  Aligned_cols=129  Identities=26%  Similarity=0.422  Sum_probs=112.9

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhc
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFS  441 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  441 (531)
                      ..+...|..+|.+++|.++..++...+...+.. .......++..++.+.+|.+.+.+|.......      ..+..+|.
T Consensus       188 ~~~~~~F~~~d~d~~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~------~~~~~~F~  260 (321)
T d1ij5a_         188 AALVADFRKIDTNSNGTLSRKEFREHFVRLGFD-KKSVQDALFRYADEDESDDVGFSEYVHLGLCL------LVLRILYA  260 (321)
T ss_dssp             HTSCCCHHHHCTTCCSEECHHHHHHHHHHTTCC-CHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH------HHHHHHHH
T ss_pred             hhhhHHHHHHhhcccccchhHHHhhhhhccccc-chHHHHHHHHhhhcccccccccccccchhhhh------hHHHHHHH
Confidence            345568899999999999999999999998766 55667888999999999999999998765432      34678999


Q ss_pred             ccCCCCCcceeHHHHHHHHhhcCC-CCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          442 FFDRNRSGFIEIEELRNALNDEVD-TSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       442 ~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .+|.|++|+|+..||+.+|..+|. .++.+++..+|..+|.|+||.|||+||+.+|.
T Consensus       261 ~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~ml  317 (321)
T d1ij5a_         261 FADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVL  317 (321)
T ss_dssp             HTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHH
T ss_pred             HHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence            999999999999999999999986 47778899999999999999999999999875

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.39  E-value=3.3e-13  Score=99.52  Aligned_cols=65  Identities=26%  Similarity=0.527  Sum_probs=62.0

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..++.+|+.||.|++|+|+.+||+.+|+.+|..++++++..++..+|.|++|.|+|+||+.+|..
T Consensus        10 ~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~   74 (77)
T d1f54a_          10 AEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSR   74 (77)
T ss_dssp             HHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTT
T ss_pred             HHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            46889999999999999999999999999999999999999999999999999999999998853

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.38  E-value=4.1e-14  Score=106.76  Aligned_cols=75  Identities=45%  Similarity=0.796  Sum_probs=70.5

Q ss_pred             hhhHhhhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHH
Q 009594          350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVS  424 (531)
Q Consensus       350 ~~~~~~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~  424 (531)
                      ..+++.++++++..++++|+.+|++++|.|+..||+.+++.+|..+++.+++.+|+.+|.|++|.|+|+||+.++
T Consensus        11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am   85 (87)
T d1s6ja_          11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAAT   85 (87)
T ss_dssp             HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred             HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence            456778889999999999999999999999999999999999999999999999999999999999999998754

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=99.37  E-value=5.2e-13  Score=99.21  Aligned_cols=65  Identities=25%  Similarity=0.454  Sum_probs=61.7

Q ss_pred             HHHHHhhcccCCCC-CcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          434 EHLHKAFSFFDRNR-SGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       434 ~~~~~~F~~~D~~~-~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..++.+|+.||.|+ +|.|+..||+.+|+.+|..+++++++.++..+|.|+||.|+|+||+.+|..
T Consensus        15 ~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~   80 (82)
T d1wrka1          15 NEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVR   80 (82)
T ss_dssp             HHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            57889999999995 799999999999999999999999999999999999999999999999874

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=99.37  E-value=2.7e-12  Score=111.15  Aligned_cols=122  Identities=17%  Similarity=0.246  Sum_probs=100.1

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhhcc
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSF  442 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~  442 (531)
                      .+..++..+|.+++|.|+.+|+..+...      ...+...|+.+|.|++|.|+..||..++........++. ...|..
T Consensus        48 ~~~~l~~~~d~d~~g~i~~~ef~~~~~~------~~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~-~~~~~~  120 (173)
T d1alva_          48 TCRSMVAVMDSDTTGKLGFEEFKYLWNN------IKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHL-YSMIIR  120 (173)
T ss_dssp             HHHHHHHHHCTTCSSSBCHHHHHHHHHH------HHHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHH-HHHHHH
T ss_pred             HHHHHHHHhccCCCCcccchhhhhhhhh------hhHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHH-HHHhhc
Confidence            4567788899999999999999887754      245778999999999999999999998776554444444 455666


Q ss_pred             cCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcce--eHHHHHHHHH
Q 009594          443 FDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRI--SYEEFAVMMK  497 (531)
Q Consensus       443 ~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i--~~~Ef~~~~~  497 (531)
                      +|.|++|.|+.+||..++..+      +.+..+|+.+|+|++|.|  +++||+.+..
T Consensus       121 ~d~d~~G~i~~~EF~~~~~~~------~~~~~~f~~~D~d~~G~it~~~~efl~~~~  171 (173)
T d1alva_         121 RYSDEGGNMDFDNFISCLVRL------DAMFRAFKSLDKDGTGQIQVNIQEWLQLTM  171 (173)
T ss_dssp             HHTCSSSCBCHHHHHHHHHHH------HHHHHHHHHHSSSCCSEEEEEHHHHHHHHH
T ss_pred             cccCCCCeEeHHHHHHHHHHH------HHHHHHHHHhCCCCCCcEEecHHHHHHHHH
Confidence            777999999999999998654      467889999999999988  6899998754

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

Probab=99.33  E-value=2.1e-12  Score=113.67  Aligned_cols=131  Identities=15%  Similarity=0.199  Sum_probs=96.3

Q ss_pred             HHHHHHHhcCCCCCCceecchhHhHHHHh-----hccCcHH----HH-HHhhcccCCCCCcceeHHHHHHHHhhc-----
Q 009594          399 DLQILMEAADVDGDGSLNYGEFVAVSVHL-----KKMANDE----HL-HKAFSFFDRNRSGFIEIEELRNALNDE-----  463 (531)
Q Consensus       399 ~~~~~f~~~D~~~~g~i~~~ef~~~~~~~-----~~~~~~~----~~-~~~F~~~D~~~~G~i~~~el~~~l~~~-----  463 (531)
                      .++.+|..+|.|++|.|+++||...+...     .......    .+ ...+...+.+.+|.|+.+|+..++...     
T Consensus        15 r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~~~~~~~~~~~~~   94 (189)
T d1qv0a_          15 RHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSEL   94 (189)
T ss_dssp             HHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHhhhccccCCCceehHHHHHHHHHHHHHhh
Confidence            47789999999999999999998754321     1111111    12 233566788899999999998887532     


Q ss_pred             ----CC--CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC------chHHHHHhhhCccCCCcCCHHHHHHHHhhc
Q 009594          464 ----VD--TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG------TDWRKASRQYSRERFNSISLKLMREEGLQL  529 (531)
Q Consensus       464 ----~~--~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~  529 (531)
                          ..  ....+.+..+|..+|.|++|.|+.+||..++...      +.+..+|+.+|.|+||.|+.+||.+.+.++
T Consensus        95 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~~~  172 (189)
T d1qv0a_          95 KKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLGF  172 (189)
T ss_dssp             HHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHHHHHH
T ss_pred             hccccccHHHHHHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh
Confidence                11  1123457779999999999999999999999842      459999999999999999999999988764

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.32  E-value=1e-12  Score=93.08  Aligned_cols=62  Identities=34%  Similarity=0.671  Sum_probs=59.5

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhH
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAV  423 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~  423 (531)
                      ..|+++|+.||++++|+|+.+||+.+++.+|..+++.+++.++..+|.|++|.|+|+||+.+
T Consensus         3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~   64 (65)
T d1fw4a_           3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQM   64 (65)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHH
Confidence            36899999999999999999999999999999999999999999999999999999999875

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.31  E-value=1.1e-12  Score=95.72  Aligned_cols=65  Identities=31%  Similarity=0.535  Sum_probs=61.7

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      .+|+++|+.||++++|+|+..||+.+|+.+|..++..+++.++..+|.|++|.|+|+||+.++..
T Consensus         9 eel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~~   73 (75)
T d1jc2a_           9 EELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG   73 (75)
T ss_dssp             HHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            36899999999999999999999999999999999999999999999999999999999998753

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=99.29  E-value=1.5e-12  Score=92.86  Aligned_cols=64  Identities=36%  Similarity=0.529  Sum_probs=60.6

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      .++++|+.+|+|++|+|+..||+.+++.+|..+++++++.+|..+|.|++|.|+|+||+.++..
T Consensus         2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~   65 (67)
T d1tiza_           2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK   65 (67)
T ss_dssp             THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred             hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            4689999999999999999999999999999999999999999999999999999999988753

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.27  E-value=2.5e-12  Score=89.75  Aligned_cols=60  Identities=27%  Similarity=0.628  Sum_probs=57.9

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHh
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVA  422 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~  422 (531)
                      +|+++|..||++++|+|+..||+.+|+.+|..++..++..+|+.+|.|++|.|+|+||+.
T Consensus         2 el~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~   61 (61)
T d2fcea1           2 DFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE   61 (61)
T ss_dssp             HHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred             hHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence            688999999999999999999999999999999999999999999999999999999973

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=99.26  E-value=3.8e-12  Score=94.44  Aligned_cols=64  Identities=38%  Similarity=0.658  Sum_probs=61.1

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      .+|+++|..||++++|+|+..||+.+++.+|..++..+++.+|..+|.|++|.|+|+||+.++.
T Consensus        15 e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~   78 (81)
T d1fi5a_          15 EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMK   78 (81)
T ss_dssp             HHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHS
T ss_pred             HHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence            4689999999999999999999999999999999999999999999999999999999998764

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.26  E-value=3.1e-12  Score=94.17  Aligned_cols=66  Identities=26%  Similarity=0.480  Sum_probs=62.3

Q ss_pred             HhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHH
Q 009594          361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVH  426 (531)
Q Consensus       361 ~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~  426 (531)
                      ..+|+++|+.+|.|++|+|+.+||..+|+.+|..++..++..+|+.+|.|++|.|+|+||+.++..
T Consensus         8 ~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k   73 (77)
T d1oqpa_           8 REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKK   73 (77)
T ss_dssp             HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence            457899999999999999999999999999999999999999999999999999999999998754

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=99.25  E-value=1.6e-12  Score=92.85  Aligned_cols=64  Identities=28%  Similarity=0.556  Sum_probs=59.9

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      ++|+++|+.||.+++|+|+..||+.+++.+|.. .+.++++.+|..+|.|++|.|+|+||+.++.
T Consensus         2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~   66 (68)
T d1c7va_           2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIK   66 (68)
T ss_dssp             HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence            358899999999999999999999999999875 7999999999999999999999999998875

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

Probab=99.23  E-value=8e-12  Score=109.63  Aligned_cols=131  Identities=15%  Similarity=0.165  Sum_probs=96.8

Q ss_pred             HHHHHHHHhcCCCCCCceecchhHhHHHHhh--c---cCcHHH-----HHHhhcccCCCCCcceeHHHHHHHHhhc----
Q 009594          398 ADLQILMEAADVDGDGSLNYGEFVAVSVHLK--K---MANDEH-----LHKAFSFFDRNRSGFIEIEELRNALNDE----  463 (531)
Q Consensus       398 ~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~--~---~~~~~~-----~~~~F~~~D~~~~G~i~~~el~~~l~~~----  463 (531)
                      +.++.+|..+|.|++|.|+++||..++....  .   ......     ....+.......++.++..++..++..+    
T Consensus        12 ~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (187)
T d1uhka1          12 GRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKKLATDE   91 (187)
T ss_dssp             HHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHHhhhhcccccccccccHHHHHHHHHHHHHHH
Confidence            4577899999999999999999987654321  1   111111     2233344556667778888887766432    


Q ss_pred             -----CCC--CCHHHHHHHHHhccCCCCcceeHHHHHHHHHh------CchHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          464 -----VDT--SGEDVINAIMHDVDTDKDGRISYEEFAVMMKA------GTDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       464 -----~~~--~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~------~~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                           ...  .....+..+|..+|.|++|.|+.+||..++..      .+.+..+|..+|.|+||.|+.+||.+.+.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~~  169 (187)
T d1uhka1          92 LEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHLG  169 (187)
T ss_dssp             HHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred             HHhhhhhhHHHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHHHHHH
Confidence                 111  12234778999999999999999999999974      246999999999999999999999998765

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.22  E-value=3.9e-12  Score=93.20  Aligned_cols=67  Identities=30%  Similarity=0.482  Sum_probs=58.6

Q ss_pred             cHHHHHHhhcccCCC--CCcceeHHHHHHHHhhcCCCCC--HHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          432 NDEHLHKAFSFFDRN--RSGFIEIEELRNALNDEVDTSG--EDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~--~~G~i~~~el~~~l~~~~~~~~--~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ..++++.+|+.||.+  ++|+|+.+||+.+|+.+|..++  +.+++.++..+|.|+||.|+|+||+.+|.+
T Consensus         3 s~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~   73 (76)
T d1qx2a_           3 SPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKK   73 (76)
T ss_dssp             CHHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHH
Confidence            467899999999654  4799999999999999986654  457999999999999999999999999875

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=99.22  E-value=1.7e-11  Score=96.31  Aligned_cols=94  Identities=12%  Similarity=0.185  Sum_probs=78.4

Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC---------ch
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG---------TD  501 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~---------~~  501 (531)
                      ...+++..++..+|  ++|.|+.+||..++...  ..+.+.++.+|+.+|.|++|.|+.+|+..+++..         ..
T Consensus         6 l~~eeI~~~~~~~d--~dG~idf~EF~~~~~~~--~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~e   81 (109)
T d1pvaa_           6 LKADDIKKALDAVK--AEGSFNHKKFFALVGLK--AMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAE   81 (109)
T ss_dssp             SCHHHHHHHHHHTC--STTCCCHHHHHHHHTCT--TSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHH
T ss_pred             CCHHHHHHHHHhcC--CCCCCcHHHHHHHHHHc--cCCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHH
Confidence            34567777777665  56889999999887543  3467889999999999999999999999888642         34


Q ss_pred             HHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          502 WRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       502 ~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +..+|+.+|+|+||.|+.+||.++|.+
T Consensus        82 v~~~~~~~D~d~dG~I~~~EF~~~m~~  108 (109)
T d1pvaa_          82 TKAFLKAADKDGDGKIGIDEFETLVHE  108 (109)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred             HHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence            889999999999999999999999864

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=9.9e-12  Score=92.92  Aligned_cols=65  Identities=20%  Similarity=0.409  Sum_probs=61.6

Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHH
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMM  496 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~  496 (531)
                      ....+..+|+.+|.+++|+|+.+||+.+|..++..+++++++.++..+|.|++|.|+|.||+..+
T Consensus        18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f   82 (83)
T d1wlza1          18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF   82 (83)
T ss_dssp             THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence            34678999999999999999999999999999999999999999999999999999999999875

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=99.21  E-value=2.6e-11  Score=95.19  Aligned_cols=94  Identities=16%  Similarity=0.190  Sum_probs=78.9

Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC---------ch
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG---------TD  501 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~---------~~  501 (531)
                      ...+++.+++..+|  .+|.|+.+||..++...  ..++++++.+|+.+|.|++|.|+.+|+..+++..         .+
T Consensus         6 l~~~di~~~~~~~~--~~G~idf~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e   81 (109)
T d5pala_           6 LKADDINKAISAFK--DPGTFDYKRFFHLVGLK--GKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTE   81 (109)
T ss_dssp             SCHHHHHHHHHHTC--STTCCCHHHHHHHHTCT--TCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHH
T ss_pred             ccHHHHHHHHHhcC--CCCcCcHHHHHHHHHhc--CCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHH
Confidence            34567888888876  46889999999877532  3367889999999999999999999999888631         44


Q ss_pred             HHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          502 WRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       502 ~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +..+|+.+|.|+||.|+.+||.++|++
T Consensus        82 ~~~~~~~~D~d~dG~I~~~EF~~~m~~  108 (109)
T d5pala_          82 TKALLAAGDSDHDGKIGADEFAKMVAQ  108 (109)
T ss_dssp             HHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence            999999999999999999999999875

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

Probab=99.12  E-value=1e-10  Score=91.93  Aligned_cols=94  Identities=15%  Similarity=0.203  Sum_probs=79.4

Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC---------ch
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG---------TD  501 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~---------~~  501 (531)
                      ...+++..++..++.  +|.|+.+||..++....  .+.++++.+|+.+|.|++|.|+.+||..+++..         ..
T Consensus         6 ~~~~~i~~~~~~~~~--~~~i~f~eF~~~~~~~~--~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e   81 (109)
T d1rwya_           6 LSAEDIKKAIGAFTA--ADSFDHKKFFQMVGLKK--KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKE   81 (109)
T ss_dssp             SCHHHHHHHHHTTCS--TTCCCHHHHHHHHTGGG--SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHH
T ss_pred             cCHHHHHHHHHhccc--CCCcCHHHHHHHHcccc--CCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHH
Confidence            355678888888754  57899999988875432  367889999999999999999999999999741         34


Q ss_pred             HHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          502 WRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       502 ~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +..+|+.+|.|+||.|+.+||.++|++
T Consensus        82 ~~~~~~~~D~d~dG~i~~~EF~~~m~~  108 (109)
T d1rwya_          82 TKTLMAAGDKDGDGKIGVEEFSTLVAE  108 (109)
T ss_dssp             HHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred             HHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            899999999999999999999999875

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=99.09  E-value=2.1e-11  Score=89.32  Aligned_cols=68  Identities=24%  Similarity=0.487  Sum_probs=58.3

Q ss_pred             CcHHHHHHhhcccCC-C-CCcceeHHHHHHHHhhc--CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          431 ANDEHLHKAFSFFDR-N-RSGFIEIEELRNALNDE--VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~-~-~~G~i~~~el~~~l~~~--~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ...+.++.+|+.||. + ++|+|+.+||+.+|+.+  +...++++++.++..+|.|+||.|+|+||+.+|.+
T Consensus         4 ~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~   75 (78)
T d1cb1a_           4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKK   75 (78)
T ss_dssp             CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence            346789999999975 3 45899999999999987  44556677999999999999999999999999875

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

Probab=99.08  E-value=9.8e-11  Score=89.10  Aligned_cols=70  Identities=26%  Similarity=0.420  Sum_probs=59.9

Q ss_pred             HHHHHhhccc-CCCCC-cceeHHHHHHHHhhcC-----CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCchHH
Q 009594          434 EHLHKAFSFF-DRNRS-GFIEIEELRNALNDEV-----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTDWR  503 (531)
Q Consensus       434 ~~~~~~F~~~-D~~~~-G~i~~~el~~~l~~~~-----~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~~~  503 (531)
                      +.+..+|+.| |.||+ |+|+.+||+.+|..++     ...++++++.+|..+|.|+||.|+|+||+.+|.....+.
T Consensus         9 ~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~~~~   85 (93)
T d1zfsa1           9 ETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALTVAC   85 (93)
T ss_dssp             HHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHHHH
Confidence            5678899888 88875 9999999999998764     345788999999999999999999999999998655443

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.05  E-value=5.6e-11  Score=93.20  Aligned_cols=64  Identities=31%  Similarity=0.542  Sum_probs=38.2

Q ss_pred             HhhHHHHhcccccCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHhcCCCCCCceecchhHhHH
Q 009594          361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAADVDGDGSLNYGEFVAVS  424 (531)
Q Consensus       361 ~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~---~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~  424 (531)
                      ...++++|+.||+|++|+|+.+||+.+++.+   +..+++++++.+|+.+|.|+||.|+|+||+.++
T Consensus        40 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d~dG~I~~~EF~~~m  106 (108)
T d1rroa_          40 ASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMV  106 (108)
T ss_dssp             HHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHHHHH
T ss_pred             HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence            3455566666666666666666666666554   234555666666666666666666666665544

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.05  E-value=9.2e-11  Score=87.48  Aligned_cols=65  Identities=25%  Similarity=0.351  Sum_probs=61.3

Q ss_pred             HHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHH
Q 009594          360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVS  424 (531)
Q Consensus       360 ~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~  424 (531)
                      ....+.++|..+|.+++|+|+.+||+.+|..++..++++++..+|..+|.|++|.|+|.||+..+
T Consensus        18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f   82 (83)
T d1wlza1          18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF   82 (83)
T ss_dssp             THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence            34679999999999999999999999999999999999999999999999999999999998764

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.05  E-value=1.2e-10  Score=88.94  Aligned_cols=68  Identities=26%  Similarity=0.288  Sum_probs=62.3

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      +++++..+++++|+.+|+|++|+|+.+|+..++.+.+  ++..++..+|+.+|.|++|.|+++||+.++.
T Consensus         4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~am~   71 (95)
T d1c07a_           4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAFH   71 (95)
T ss_dssp             SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence            5678889999999999999999999999999999865  6788999999999999999999999987653

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=99.04  E-value=3.9e-10  Score=88.06  Aligned_cols=92  Identities=12%  Similarity=0.095  Sum_probs=77.6

Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC---------chH
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG---------TDW  502 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~---------~~~  502 (531)
                      +.+++..+++.++.+  |.|+..||..++...+  .+.++++.+|+.+|.|++|.|+.+||..+++..         +.+
T Consensus         6 s~~di~~~~~~~~~~--gsi~~~eF~~~~~l~~--~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~   81 (107)
T d2pvba_           6 KDADVAAALAACSAA--DSFKHKEFFAKVGLAS--KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAET   81 (107)
T ss_dssp             CHHHHHHHHHHTCST--TCCCHHHHHHHHTGGG--SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHH
T ss_pred             CHHHHHHHHHhccCC--CCcCHHHHHHHHhccc--CCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHH
Confidence            456677888877654  5799999998876432  367889999999999999999999999998753         349


Q ss_pred             HHHHhhhCccCCCcCCHHHHHHHHh
Q 009594          503 RKASRQYSRERFNSISLKLMREEGL  527 (531)
Q Consensus       503 ~~~f~~~D~~~~G~i~~~e~~~~~~  527 (531)
                      +++|+.+|+|+||.|+.+||..+|+
T Consensus        82 ~~l~~~~D~d~dG~I~~~EF~~~m~  106 (107)
T d2pvba_          82 KAFLADGDKDGDGMIGVDEFAAMIK  106 (107)
T ss_dssp             HHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCcEeHHHHHHHHc
Confidence            9999999999999999999999886

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

Probab=99.04  E-value=2.2e-10  Score=86.71  Aligned_cols=67  Identities=15%  Similarity=0.388  Sum_probs=58.0

Q ss_pred             HHHHHhhccc-CCCCCc-ceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          434 EHLHKAFSFF-DRNRSG-FIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       434 ~~~~~~F~~~-D~~~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      +.+..+|+.| |.||+| +|+.+||+.+|..     ++...++++++.+|..+|.|+||.|+|+||+.++.+..
T Consensus         9 ~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l~   82 (93)
T d3c1va1           9 DVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA   82 (93)
T ss_dssp             HHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Confidence            5678899998 667654 7999999999986     35678899999999999999999999999999998653

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.03  E-value=5.4e-11  Score=86.97  Aligned_cols=66  Identities=27%  Similarity=0.507  Sum_probs=56.3

Q ss_pred             hhHHHHhcccccC--CCCcccHHHHHHHHHhCCCCCC--HHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          362 AGLKEAFEMMDTN--KRGKINLEELRLGLLKGGQNIP--EADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       362 ~~i~~~F~~~D~~--~~g~i~~~el~~~l~~~~~~~~--~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      .+|+++|+.||.+  ++|+|+.+||+.+|+.+|..++  ..+++.++..+|.|+||.|+|+||+.++...
T Consensus         5 eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~   74 (76)
T d1qx2a_           5 EEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKI   74 (76)
T ss_dssp             HHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence            4678889888654  4799999999999999986654  4579999999999999999999999987654

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.02  E-value=1.5e-10  Score=89.44  Aligned_cols=63  Identities=24%  Similarity=0.400  Sum_probs=49.5

Q ss_pred             HHHhhcccCCCCCcceeHHHHHHHHhhcCCCC----------------CHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          436 LHKAFSFFDRNRSGFIEIEELRNALNDEVDTS----------------GEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       436 ~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~----------------~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      ++.+|+.+|.|+||+|+.+||..++..++..+                ....++.+|..+|.|+||.||++||++++++
T Consensus        18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~~~   96 (99)
T d1snla_          18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQR   96 (99)
T ss_dssp             HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence            57789999999999999999998886532110                1234778999999999999999999988775

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

Probab=99.01  E-value=8.1e-11  Score=88.97  Aligned_cols=66  Identities=24%  Similarity=0.494  Sum_probs=57.2

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhc-----CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDE-----VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      +.+..+|+.||.| +|+|+.+||+.+|...     +...++..++.+|..+|.|+||+|+|+||+.++....
T Consensus         9 e~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~   79 (92)
T d1a4pa_           9 ETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLT   79 (92)
T ss_dssp             HHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHH
Confidence            5688999999987 8999999999999763     3345677899999999999999999999999987643

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.00  E-value=2e-10  Score=87.78  Aligned_cols=63  Identities=21%  Similarity=0.312  Sum_probs=57.5

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ...++.+|+.+|+|++|+|+.+|++.+|...+  ++.+++..+++.+|.|+||.|+++||+.+|.
T Consensus         9 ~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~am~   71 (95)
T d1c07a_           9 KAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAFH   71 (95)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence            35678999999999999999999999998875  5788999999999999999999999988774

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

Probab=99.00  E-value=3e-10  Score=85.64  Aligned_cols=67  Identities=21%  Similarity=0.228  Sum_probs=57.8

Q ss_pred             HHHHHhhccc-CCCCCc-ceeHHHHHHHHhhc-----CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          434 EHLHKAFSFF-DRNRSG-FIEIEELRNALNDE-----VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       434 ~~~~~~F~~~-D~~~~G-~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      +.+..+|+.| |++|+| .|+.+||+.+|+..     +...++++++.+++.+|.|+||.|+|+||+.++....
T Consensus         9 ~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~   82 (93)
T d1ksoa_           9 AAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC   82 (93)
T ss_dssp             HHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence            4567889887 999999 59999999999864     3445788999999999999999999999999998643

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.99  E-value=9.2e-11  Score=100.60  Aligned_cols=124  Identities=11%  Similarity=0.051  Sum_probs=88.2

Q ss_pred             HHHHHHh--cCCCCCCceecchhHhHHHHhhc--cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHH
Q 009594          400 LQILMEA--ADVDGDGSLNYGEFVAVSVHLKK--MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAI  475 (531)
Q Consensus       400 ~~~~f~~--~D~~~~g~i~~~ef~~~~~~~~~--~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~  475 (531)
                      ++.+|..  +|.|++|.|+..|+..++.....  ....+.+..+|...|.+++|.|+.+||..++..+..   ..++..+
T Consensus         7 l~k~~~k~~~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~~---r~ei~~~   83 (170)
T d2zkmx1           7 LDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCP---RPEIDEI   83 (170)
T ss_dssp             HHHHHHHHHHSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHSC---CHHHHTT
T ss_pred             HHHHHHHHhcccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhccccccCCCccCHHHHHHHHhccCC---HHHHHHH
Confidence            4445554  79999999999999887642211  123356677899999999999999999999988753   4678999


Q ss_pred             HHhccCCCCcceeHHHHHHHHHhC----------------chHHHHHhhhCccCC----CcCCHHHHHHHH
Q 009594          476 MHDVDTDKDGRISYEEFAVMMKAG----------------TDWRKASRQYSRERF----NSISLKLMREEG  526 (531)
Q Consensus       476 ~~~~D~~~dG~i~~~Ef~~~~~~~----------------~~~~~~f~~~D~~~~----G~i~~~e~~~~~  526 (531)
                      |..+|.|++|.||.+||..+|...                ..+...+..++.+.+    |.|+.++|...|
T Consensus        84 F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ls~d~F~~fL  154 (170)
T d2zkmx1          84 FTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFL  154 (170)
T ss_dssp             CC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHHH
T ss_pred             HHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeECHHHHHHHH
Confidence            999999999999999999999842                347777888877655    899999999976

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

Probab=98.99  E-value=1.7e-10  Score=88.26  Aligned_cols=66  Identities=12%  Similarity=0.324  Sum_probs=56.1

Q ss_pred             HHHHHhhccc-CCCCC-cceeHHHHHHHHhhcCC--CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSFF-DRNRS-GFIEIEELRNALNDEVD--TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~~-D~~~~-G~i~~~el~~~l~~~~~--~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      +.+..+|+.| |.||+ |+||.+||+.+|+..+.  ..+.+.++.+|..+|.|+||+|+|+||+.++.+.
T Consensus        14 ~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l   83 (98)
T d1yuta1          14 ETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGEL   83 (98)
T ss_dssp             HHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence            4577889887 77875 99999999999987643  3456679999999999999999999999999753

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.98  E-value=5.3e-10  Score=84.82  Aligned_cols=62  Identities=19%  Similarity=0.266  Sum_probs=57.0

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ..++.+|+.+|.|++|+|+.+|++.+|...+  ++.+++..+++.+|.|+||.|+++||+.+|.
T Consensus         9 ~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~~   70 (92)
T d1fi6a_           9 QYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAFH   70 (92)
T ss_dssp             HHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence            4678999999999999999999999999875  5788999999999999999999999987665

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.98  E-value=3.3e-10  Score=85.93  Aligned_cols=68  Identities=24%  Similarity=0.296  Sum_probs=62.0

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      ++++|..+++++|+.+|+|++|+|+.+|+..++.+.+  ++..++..+++.+|.|++|.|+|+||+.++.
T Consensus         3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~~   70 (92)
T d1fi6a_           3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAFH   70 (92)
T ss_dssp             CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence            4778899999999999999999999999999999865  6788999999999999999999999986543

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

Probab=98.96  E-value=2.8e-10  Score=85.03  Aligned_cols=66  Identities=20%  Similarity=0.348  Sum_probs=58.1

Q ss_pred             HHHHHhhccc-CCCCCc-ceeHHHHHHHHhh---cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSFF-DRNRSG-FIEIEELRNALND---EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~~-D~~~~G-~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      ..+..+|..| |++|+| +|+..||+.++..   .+...+++.++.+++.+|.|+||+|+|+||+.++...
T Consensus         9 ~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~l   79 (89)
T d1k8ua_           9 GLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGAL   79 (89)
T ss_dssp             HHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence            4567889888 999999 6999999999986   4666778889999999999999999999999998754

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=98.94  E-value=1e-10  Score=85.61  Aligned_cols=69  Identities=23%  Similarity=0.333  Sum_probs=58.3

Q ss_pred             HHHhhHHHHhccccc--CCCCcccHHHHHHHHHhC--CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          359 EEVAGLKEAFEMMDT--NKRGKINLEELRLGLLKG--GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       359 ~~~~~i~~~F~~~D~--~~~g~i~~~el~~~l~~~--~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      +....|..+|+.||.  ++.|+|+.+||+.+++.+  +...+.++++.++..+|.|+||.|+|+||+.++..+
T Consensus         4 ~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~l   76 (78)
T d1cb1a_           4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKI   76 (78)
T ss_dssp             CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence            446789999999975  345899999999999987  345566779999999999999999999999987654

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

Probab=98.94  E-value=2.1e-10  Score=86.59  Aligned_cols=70  Identities=17%  Similarity=0.285  Sum_probs=59.7

Q ss_pred             HHHhhHHHHhcccccCCCCcccHHHHHHHHHhC-----CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhc
Q 009594          359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-----GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKK  429 (531)
Q Consensus       359 ~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~-----~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~  429 (531)
                      +.+..|..+|+.+|.| +|+|+.+||..++...     +...++..++++|..+|.|+||.|+|+||+.++..+..
T Consensus         6 ~~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~~   80 (92)
T d1a4pa_           6 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTI   80 (92)
T ss_dssp             HHHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHH
Confidence            4567899999999987 8999999999999874     33456778999999999999999999999998765543

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

Probab=98.93  E-value=1.5e-10  Score=88.61  Aligned_cols=70  Identities=17%  Similarity=0.234  Sum_probs=59.0

Q ss_pred             HHHhhHHHHhccc-ccCCC-CcccHHHHHHHHHhCCC--CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh
Q 009594          359 EEVAGLKEAFEMM-DTNKR-GKINLEELRLGLLKGGQ--NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK  428 (531)
Q Consensus       359 ~~~~~i~~~F~~~-D~~~~-g~i~~~el~~~l~~~~~--~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~  428 (531)
                      +.+..+.++|+.| |.+++ |+|+..||+.+++..+.  ..+..+++.+|..+|.|+||.|+|+||+.++..+.
T Consensus        11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l~   84 (98)
T d1yuta1          11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELA   84 (98)
T ss_dssp             HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence            4567899999998 77775 99999999999998643  34666799999999999999999999999876543

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

Probab=98.93  E-value=7.7e-10  Score=84.01  Aligned_cols=70  Identities=21%  Similarity=0.300  Sum_probs=59.6

Q ss_pred             HHHhhHHHHhccc-ccCCC-CcccHHHHHHHHHhCC-----CCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh
Q 009594          359 EEVAGLKEAFEMM-DTNKR-GKINLEELRLGLLKGG-----QNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK  428 (531)
Q Consensus       359 ~~~~~i~~~F~~~-D~~~~-g~i~~~el~~~l~~~~-----~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~  428 (531)
                      .-+..+.++|..| |.|++ |+|+.+||+.+|+..+     ...++.+++.+|+.+|.|+||.|+|+||+.++..+.
T Consensus         6 ~~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~   82 (93)
T d1zfsa1           6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT   82 (93)
T ss_dssp             HHHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence            3456889999988 88875 9999999999998864     355788999999999999999999999999876543

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

Probab=98.89  E-value=1.6e-09  Score=81.92  Aligned_cols=69  Identities=22%  Similarity=0.336  Sum_probs=58.9

Q ss_pred             HHHhhHHHHhccc-ccCCCC-cccHHHHHHHHHhC-----CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          359 EEVAGLKEAFEMM-DTNKRG-KINLEELRLGLLKG-----GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       359 ~~~~~i~~~F~~~-D~~~~g-~i~~~el~~~l~~~-----~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      +.+..|.++|+.| |.+++| +|+.+||+.+++..     +...++++++++|..+|.|+||.|+|+||+.++..+
T Consensus         6 ~~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l   81 (93)
T d3c1va1           6 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI   81 (93)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Confidence            3467899999998 666655 79999999999873     567788999999999999999999999999987654

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

Probab=98.88  E-value=2.8e-10  Score=84.79  Aligned_cols=66  Identities=11%  Similarity=0.237  Sum_probs=56.4

Q ss_pred             HHHHHhhccc-CCCCCcce-eHHHHHHHHhh-cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSFF-DRNRSGFI-EIEELRNALND-EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~~-D~~~~G~i-~~~el~~~l~~-~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      +.+..+|+.| |+||+|.+ +.+||+.++.. ++..++.++++.+++.+|.|+||+|+|+||+.++.+.
T Consensus        10 ~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~l   78 (87)
T d1xk4a1          10 NSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKM   78 (87)
T ss_dssp             HHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            4567788888 89999865 89999999975 5666666779999999999999999999999999863

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

Probab=98.86  E-value=1.5e-09  Score=81.79  Aligned_cols=71  Identities=23%  Similarity=0.248  Sum_probs=60.3

Q ss_pred             hHHHhhHHHHhccc-ccCCCC-cccHHHHHHHHHhC-----CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh
Q 009594          358 VEEVAGLKEAFEMM-DTNKRG-KINLEELRLGLLKG-----GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK  428 (531)
Q Consensus       358 ~~~~~~i~~~F~~~-D~~~~g-~i~~~el~~~l~~~-----~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~  428 (531)
                      ++.+..|..+|+.| |.+++| +|+.+||+.+|++.     +....+.+++++++.+|.|+||.|+|+||+.++..+.
T Consensus         5 E~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~   82 (93)
T d1ksoa_           5 EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC   82 (93)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence            34567888999987 999999 59999999999875     3445688899999999999999999999999876543

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.85  E-value=3.1e-09  Score=80.77  Aligned_cols=62  Identities=23%  Similarity=0.373  Sum_probs=56.0

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ...++.+|+.+| +++|+|+.+|++.+|...|  ++.++++.++..+|.|+||.|+++||+.++.
T Consensus         9 ~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~   70 (95)
T d2jxca1           9 KAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVAMF   70 (95)
T ss_dssp             HHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence            356789999999 8999999999999998876  5788999999999999999999999987665

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.84  E-value=2.3e-09  Score=81.53  Aligned_cols=67  Identities=24%  Similarity=0.364  Sum_probs=60.6

Q ss_pred             hhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       356 ~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      ++.++..++.++|+.+| +++|+|+.+|++.++.+.|  ++..+++.++..+|.|++|.|+++||+.++.
T Consensus         4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~   70 (95)
T d2jxca1           4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVAMF   70 (95)
T ss_dssp             SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence            57788899999999999 8999999999999998865  5788999999999999999999999987543

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

Probab=98.83  E-value=1.2e-09  Score=81.58  Aligned_cols=70  Identities=23%  Similarity=0.316  Sum_probs=60.8

Q ss_pred             hHHHhhHHHHhccc-ccCCCC-cccHHHHHHHHHh---CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          358 VEEVAGLKEAFEMM-DTNKRG-KINLEELRLGLLK---GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       358 ~~~~~~i~~~F~~~-D~~~~g-~i~~~el~~~l~~---~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      +..+..|.++|+.| |++++| +|+..||+..++.   ++...++.+++.+++.+|.|+||.|+|+||+.++..+
T Consensus         5 E~ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~l   79 (89)
T d1k8ua_           5 DQAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGAL   79 (89)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence            34567888999988 999999 6999999999987   5666788899999999999999999999999987644

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

Probab=98.83  E-value=4.5e-09  Score=77.73  Aligned_cols=66  Identities=21%  Similarity=0.412  Sum_probs=54.9

Q ss_pred             HHHHHhhccc-CCCCCc-ceeHHHHHHHHhhc-----CCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          434 EHLHKAFSFF-DRNRSG-FIEIEELRNALNDE-----VDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       434 ~~~~~~F~~~-D~~~~G-~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      +.+..+|..| +.+|++ +|+.+||+.+|+..     +...+++.++.+|+.+|.|+||+|+|+||+.++...
T Consensus         8 ~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l   80 (87)
T d1e8aa_           8 EGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIA   80 (87)
T ss_dssp             HHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence            4577889888 556554 69999999999863     334567889999999999999999999999998753

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.79  E-value=2.1e-09  Score=84.09  Aligned_cols=65  Identities=20%  Similarity=0.243  Sum_probs=58.0

Q ss_pred             CcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          431 ANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       431 ~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ...+.+..+|+.+|+|++|+|+.+|++.+|...|  ++.+++..+++.+|.|++|.|+++||+.+|.
T Consensus        19 ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~   83 (110)
T d1iq3a_          19 EQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFCAAFH   83 (110)
T ss_dssp             SSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhccCCCCeECHHHHHHHHH
Confidence            3456788999999999999999999999998765  5567899999999999999999999997775

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.78  E-value=2.5e-09  Score=81.98  Aligned_cols=62  Identities=19%  Similarity=0.236  Sum_probs=56.7

Q ss_pred             HHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          434 EHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       434 ~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .....+|+.+|.|++|+|+.+|++.++...|  ++.+++..+++.+|.|++|.|+++||+.+|+
T Consensus        11 ~~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~   72 (99)
T d1qjta_          11 PVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVALR   72 (99)
T ss_dssp             THHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence            4567899999999999999999999999866  6889999999999999999999999998876

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

Probab=98.77  E-value=1.3e-09  Score=83.82  Aligned_cols=77  Identities=17%  Similarity=0.341  Sum_probs=58.4

Q ss_pred             HHHHhhcccCCCCCcceeHHHHHHHHhhcCC-------CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc-hHHHHH
Q 009594          435 HLHKAFSFFDRNRSGFIEIEELRNALNDEVD-------TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT-DWRKAS  506 (531)
Q Consensus       435 ~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~-------~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~-~~~~~f  506 (531)
                      .+..+|+.|| +++|.|+.+||+.+|+..+.       ..++..++.+|..+|.|+||.|+|+||+.++.... ...+.|
T Consensus        11 ~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~~~~~~~~   89 (100)
T d1psra_          11 GMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIATDYHKQS   89 (100)
T ss_dssp             HHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHHHHHH
Confidence            4566777776 78999999999999987643       23445689999999999999999999999998643 344444


Q ss_pred             hhhCcc
Q 009594          507 RQYSRE  512 (531)
Q Consensus       507 ~~~D~~  512 (531)
                      ....+-
T Consensus        90 ~~~~~~   95 (100)
T d1psra_          90 HGAAPC   95 (100)
T ss_dssp             TTCCSC
T ss_pred             cCCCCC
Confidence            443333

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=98.76  E-value=2.2e-09  Score=62.21  Aligned_cols=31  Identities=23%  Similarity=0.250  Sum_probs=29.3

Q ss_pred             chHHHHHhhhCccCCCcCCHHHHHHHHhhcC
Q 009594          500 TDWRKASRQYSRERFNSISLKLMREEGLQLA  530 (531)
Q Consensus       500 ~~~~~~f~~~D~~~~G~i~~~e~~~~~~~~~  530 (531)
                      ++++++|+.||+||||+|+.+|++++|+.+|
T Consensus         3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG   33 (33)
T d2hf5a1           3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG   33 (33)
T ss_dssp             HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence            4689999999999999999999999999987

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

Probab=98.75  E-value=1.9e-09  Score=80.19  Aligned_cols=71  Identities=14%  Similarity=0.295  Sum_probs=59.8

Q ss_pred             hHHHhhHHHHhccc-ccCCCCc-ccHHHHHHHHHh-CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh
Q 009594          358 VEEVAGLKEAFEMM-DTNKRGK-INLEELRLGLLK-GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK  428 (531)
Q Consensus       358 ~~~~~~i~~~F~~~-D~~~~g~-i~~~el~~~l~~-~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~  428 (531)
                      +..+..|..+|+.+ |++++|. ++.+||+.++.. ++...+..+++.+++.+|.|+||.|+|+||+.++....
T Consensus         6 E~ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~la   79 (87)
T d1xk4a1           6 EKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMG   79 (87)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence            34556788999988 8999986 599999999875 67666777899999999999999999999999876543

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

Probab=98.74  E-value=1.3e-08  Score=75.19  Aligned_cols=69  Identities=17%  Similarity=0.261  Sum_probs=57.0

Q ss_pred             HHHhhHHHHhccc-ccCCCC-cccHHHHHHHHHhC-----CCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          359 EEVAGLKEAFEMM-DTNKRG-KINLEELRLGLLKG-----GQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       359 ~~~~~i~~~F~~~-D~~~~g-~i~~~el~~~l~~~-----~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      ..+..|.++|+.+ +.++++ +|+++||+.++++.     +...++..++.+|+.+|.|+||.|+|+||+.++..+
T Consensus         5 ~ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l   80 (87)
T d1e8aa_           5 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIA   80 (87)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence            4566788999988 455554 69999999999873     345567889999999999999999999999987654

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.71  E-value=1.9e-09  Score=84.24  Aligned_cols=69  Identities=20%  Similarity=0.217  Sum_probs=61.2

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      .+++++...+.++|+.+|++++|+|+.+|++.+|.+.+  ++..++..+++.+|.|++|.|+++||+.++.
T Consensus        15 ~lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~   83 (110)
T d1iq3a_          15 RITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFCAAFH   83 (110)
T ss_dssp             CCSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhccCCCCeECHHHHHHHHH
Confidence            35778889999999999999999999999999997755  5667899999999999999999999987653

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=98.70  E-value=4.1e-09  Score=61.07  Aligned_cols=32  Identities=31%  Similarity=0.679  Sum_probs=29.8

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhcC
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDEV  464 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~  464 (531)
                      +++++++|+.||+|++|+|+.+||+.+|+.+|
T Consensus         2 eeel~eAF~~FDkDg~G~Is~~EL~~vm~~lG   33 (33)
T d2hf5a1           2 EEEIREAFRVFDKDGNGYISAAELRHVMTNLG   33 (33)
T ss_dssp             HHHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence            57899999999999999999999999998876

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

Probab=98.69  E-value=3e-09  Score=81.70  Aligned_cols=70  Identities=16%  Similarity=0.253  Sum_probs=58.6

Q ss_pred             hhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCC-------CCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-------NIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       357 ~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~-------~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      .++.+..+.++|+.+| +++|.|+..||+.+++..+.       ..++..++.+|+.+|.|+||.|+|+||+.++..+
T Consensus         5 ~E~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l   81 (100)
T d1psra_           5 AERSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDI   81 (100)
T ss_dssp             HHHHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence            3556778889999997 78999999999999998643       2345668999999999999999999999987654

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.65  E-value=1.2e-08  Score=78.37  Aligned_cols=58  Identities=9%  Similarity=0.100  Sum_probs=51.1

Q ss_pred             HHHHHHHhccCCCCcceeHHHHHHHHHhC----------------------chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          471 VINAIMHDVDTDKDGRISYEEFAVMMKAG----------------------TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       471 ~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~----------------------~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      .++.+|+.+|.|+||.|+.+||.++++..                      ..+..+|..+|+|+||.||.+||.+.+..
T Consensus        17 ~~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~~~   96 (99)
T d1snla_          17 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQR   96 (99)
T ss_dssp             CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred             CHHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence            37889999999999999999999998631                      23788999999999999999999998764

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.57  E-value=4e-08  Score=75.05  Aligned_cols=61  Identities=23%  Similarity=0.355  Sum_probs=55.0

Q ss_pred             hHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       363 ~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      ..+++|+.+|.+++|+|+.+|++.++++.|  ++..++..+|+.+|.|++|.|+++||..++.
T Consensus        12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~   72 (99)
T d1qjta_          12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVALR   72 (99)
T ss_dssp             HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence            466899999999999999999999999865  6789999999999999999999999987654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.55  E-value=2.1e-07  Score=85.27  Aligned_cols=140  Identities=17%  Similarity=0.169  Sum_probs=95.2

Q ss_pred             ceeeccccCccCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEEEEE
Q 009594           57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM  136 (531)
Q Consensus        57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  136 (531)
                      .|+..+..+.++.+.||++.  .++..+++|+.........   ..+.+|...++.+..+--+++++.+..+.+..++||
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~   89 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence            46666666556668999876  5677788898765432222   346678999888866656788888888889999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------
Q 009594          137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ----------------------------------------  176 (531)
Q Consensus       137 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------------------------------------  176 (531)
                      ++++|.++.+.....     .....++.+++..+..||+.                                        
T Consensus        90 ~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          90 SEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             Eeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            999998876543211     11223344444445555532                                        


Q ss_pred             -------------------CCeecCCCCCceEeecCCCCCCeEEEeeccccc
Q 009594          177 -------------------GVMHRDLKPENFLFANKKESSPLKAIDFGLSVF  209 (531)
Q Consensus       177 -------------------~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~~  209 (531)
                                         .++|+|+.|.||+++.+   ..+-|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~---~~~~lIDwe~a~~  213 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSGR  213 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC---ceEEEeechhccc
Confidence                               14899999999999642   2245999987754

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

Probab=98.51  E-value=1.4e-07  Score=69.63  Aligned_cols=68  Identities=22%  Similarity=0.429  Sum_probs=55.0

Q ss_pred             HHHHHhhccc-CCCCC-cceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCch
Q 009594          434 EHLHKAFSFF-DRNRS-GFIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGTD  501 (531)
Q Consensus       434 ~~~~~~F~~~-D~~~~-G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~~  501 (531)
                      ..+..+|..| ..+|+ +.++..||+.+|..     ++...++..++.+|+.+|.|+||+|+|+||+.++.....
T Consensus         9 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~la~   83 (90)
T d3cr5x1           9 VALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMITT   83 (90)
T ss_dssp             HHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHHH
Confidence            3567889888 45554 57999999999986     334456778999999999999999999999998876543

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

Probab=98.41  E-value=3.9e-07  Score=67.24  Aligned_cols=69  Identities=23%  Similarity=0.336  Sum_probs=55.8

Q ss_pred             HHHhhHHHHhcccc-cCCC-CcccHHHHHHHHHh-----CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          359 EEVAGLKEAFEMMD-TNKR-GKINLEELRLGLLK-----GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       359 ~~~~~i~~~F~~~D-~~~~-g~i~~~el~~~l~~-----~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      ..+..|-.+|+.+. .+++ ++|++.||+..+++     ++....+..++.+|+.+|.|+||.|+|+||+.++..+
T Consensus         6 ~ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~l   81 (90)
T d3cr5x1           6 KAVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMI   81 (90)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence            34567889999884 4454 57999999999997     3445557789999999999999999999999877544

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

Probab=98.36  E-value=2.4e-07  Score=69.01  Aligned_cols=67  Identities=22%  Similarity=0.369  Sum_probs=54.3

Q ss_pred             HHHHHhhcccC-CCCC-cceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          434 EHLHKAFSFFD-RNRS-GFIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       434 ~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      ..+..+|..|. .+|+ +.++..||+.+|..     ++...+++.++.+|+.+|.|+||+|+|+||+.++....
T Consensus         9 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~la   82 (95)
T d1qlsa_           9 ESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLA   82 (95)
T ss_dssp             HHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence            34667888874 4554 67999999999975     34445677899999999999999999999999988654

>d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.31  E-value=2.2e-07  Score=51.03  Aligned_cols=31  Identities=45%  Similarity=0.813  Sum_probs=26.8

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhhc
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALNDE  463 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~  463 (531)
                      ++++..+|++||+|+||+|+.+||..+++.-
T Consensus         3 EeELae~FRifDkNaDGyiD~eEl~~ilr~t   33 (34)
T d1ctda_           3 EEELANAFRIFDKNADGYIDIEELGEILRAT   33 (34)
T ss_dssp             HHHHHHHHHTTCCSSSSCBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHccCCcccccHHHHHHHHHhc
Confidence            5778889999999999999999999888754

>d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100p [TaxId: 9606]

Probab=98.25  E-value=8.2e-07  Score=65.98  Aligned_cols=67  Identities=21%  Similarity=0.387  Sum_probs=50.5

Q ss_pred             HHHHHhhcccC-CCCC-cceeHHHHHHHHhh-----cCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhCc
Q 009594          434 EHLHKAFSFFD-RNRS-GFIEIEELRNALND-----EVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       434 ~~~~~~F~~~D-~~~~-G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~~  500 (531)
                      ..+..+|..|. .+|+ ++++.+||+.++..     ++...++..++.+|+.+|.|+||+|+|+||+.++....
T Consensus         9 ~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~la   82 (94)
T d1j55a_           9 GMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAIT   82 (94)
T ss_dssp             HHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence            34677888884 3443 58999999999986     23333456799999999999999999999999987643

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

Probab=98.23  E-value=5.9e-07  Score=66.87  Aligned_cols=69  Identities=22%  Similarity=0.298  Sum_probs=55.2

Q ss_pred             HHhhHHHHhcccc-cCCC-CcccHHHHHHHHHh-----CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhh
Q 009594          360 EVAGLKEAFEMMD-TNKR-GKINLEELRLGLLK-----GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLK  428 (531)
Q Consensus       360 ~~~~i~~~F~~~D-~~~~-g~i~~~el~~~l~~-----~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~  428 (531)
                      .+..|-.+|+.+. .+++ ++|++.||+..+.+     ++....+..++.+|+.+|.|+||.|+|+||+.++..+.
T Consensus         7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~la   82 (95)
T d1qlsa_           7 CIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLA   82 (95)
T ss_dssp             HHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence            3556788998875 3454 67999999999986     34445667899999999999999999999998776543

>d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100p [TaxId: 9606]

Probab=98.16  E-value=1.6e-06  Score=64.42  Aligned_cols=68  Identities=15%  Similarity=0.310  Sum_probs=51.3

Q ss_pred             HHhhHHHHhcccc-cCCC-CcccHHHHHHHHHh-----CCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHh
Q 009594          360 EVAGLKEAFEMMD-TNKR-GKINLEELRLGLLK-----GGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHL  427 (531)
Q Consensus       360 ~~~~i~~~F~~~D-~~~~-g~i~~~el~~~l~~-----~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~  427 (531)
                      -+..|-.+|+.+. .+++ +++++.||+..+.+     ++....+..++.+|+.+|.|+||.|+|+||+.++..+
T Consensus         7 ai~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~l   81 (94)
T d1j55a_           7 AMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAI   81 (94)
T ss_dssp             HHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence            4557788999874 3443 58999999999987     3334456679999999999999999999999877544

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.14  E-value=3.2e-06  Score=82.04  Aligned_cols=82  Identities=16%  Similarity=0.168  Sum_probs=51.0

Q ss_pred             ccccCccCceEEEEEEEccCCcEEEEEEeeccc--cC--ChhhHHHHHHHHHHHHhCCCC--CCeeecceEEEcCCeEEE
Q 009594           61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKK--LR--TAVDIEDVRREVQIMKHLPKH--PNIVSLKDTYEDDSAVHI  134 (531)
Q Consensus        61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~--~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~l  134 (531)
                      .+.||.|....||++.+..+++.+++|.-....  ..  -+........|...|+.+..+  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            346899999999999877778899999754311  00  111234556788888877443  245555543  4455678


Q ss_pred             EEeccCCCch
Q 009594          135 VMELCEGGEL  144 (531)
Q Consensus       135 v~e~~~~~~L  144 (531)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987554

>d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]

Probab=97.96  E-value=9e-06  Score=58.62  Aligned_cols=66  Identities=18%  Similarity=0.287  Sum_probs=51.2

Q ss_pred             HHhhHHHHhccccc-C-CCCcccHHHHHHHHHh-CC----CC-CCHHHHHHHHHhcCCCCCCceecchhHhHHH
Q 009594          360 EVAGLKEAFEMMDT-N-KRGKINLEELRLGLLK-GG----QN-IPEADLQILMEAADVDGDGSLNYGEFVAVSV  425 (531)
Q Consensus       360 ~~~~i~~~F~~~D~-~-~~g~i~~~el~~~l~~-~~----~~-~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~  425 (531)
                      -+..|-.+|+.|.. + +.+.+++.||+..+.+ ++    .. ..+..++.+|+.+|.|+||.|+|+||+.++.
T Consensus         8 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~   81 (83)
T d1xk4c1           8 NIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMA   81 (83)
T ss_dssp             HHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHh
Confidence            34567788988853 2 3368999999999987 22    11 2445689999999999999999999998764

>d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]

Probab=97.95  E-value=7.8e-06  Score=58.95  Aligned_cols=64  Identities=27%  Similarity=0.501  Sum_probs=50.2

Q ss_pred             HHHHHhhcccCC-CC-CcceeHHHHHHHHhhc-CC-----CCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          434 EHLHKAFSFFDR-NR-SGFIEIEELRNALNDE-VD-----TSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       434 ~~~~~~F~~~D~-~~-~G~i~~~el~~~l~~~-~~-----~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      ..+..+|..|.. +| .+.++..||+.++... +.     ..++..++.+|+.+|.|+||+|+|+||+.++.
T Consensus        10 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~   81 (83)
T d1xk4c1          10 ETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMA   81 (83)
T ss_dssp             HHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHh
Confidence            346778988843 33 3689999999999853 21     12455689999999999999999999998875

>d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.93  E-value=4.2e-06  Score=45.86  Aligned_cols=29  Identities=14%  Similarity=0.102  Sum_probs=19.5

Q ss_pred             chHHHHHhhhCccCCCcCCHHHHHHHHhh
Q 009594          500 TDWRKASRQYSRERFNSISLKLMREEGLQ  528 (531)
Q Consensus       500 ~~~~~~f~~~D~~~~G~i~~~e~~~~~~~  528 (531)
                      +++.+.|+.||+|+||+|+.+||..+++.
T Consensus         4 eELae~FRifDkNaDGyiD~eEl~~ilr~   32 (34)
T d1ctda_           4 EELANAFRIFDKNADGYIDIEELGEILRA   32 (34)
T ss_dssp             HHHHHHHHTTCCSSSSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccccHHHHHHHHHh
Confidence            44566677777777777777777766653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.85  E-value=1.7e-05  Score=71.63  Aligned_cols=70  Identities=10%  Similarity=0.137  Sum_probs=49.4

Q ss_pred             ceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-CCeeecceEEEcCCeEEEEEeccCCCchH
Q 009594           69 FGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVSLKDTYEDDSAVHIVMELCEGGELF  145 (531)
Q Consensus        69 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~~~L~  145 (531)
                      -+.||+... ..+..+++|.......      ..+..|...++.|..+ -.+++++.+..+.+..++||++++|.++.
T Consensus        24 ~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          24 DAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             SCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             CCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            467898873 5677788897654321      2456678877776333 23677888888888999999999987663

>d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Diacylglycerol kinase alpha, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.85  E-value=3.1e-06  Score=66.24  Aligned_cols=81  Identities=12%  Similarity=0.008  Sum_probs=61.1

Q ss_pred             HhhhhhHHHhhHHHHhcccc---cCCCCcccHHHHHHHHHhCCCC--CCHHHHHHHHHhcCCCCC--------Cceecch
Q 009594          353 AEFLSVEEVAGLKEAFEMMD---TNKRGKINLEELRLGLLKGGQN--IPEADLQILMEAADVDGD--------GSLNYGE  419 (531)
Q Consensus       353 ~~~~~~~~~~~i~~~F~~~D---~~~~g~i~~~el~~~l~~~~~~--~~~~~~~~~f~~~D~~~~--------g~i~~~e  419 (531)
                      .+++++.++.++.+.|....   .+.+|.|+.++|+.++......  .+..-++++|..+|.|++        |.|+|.|
T Consensus        19 ~T~fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~e   98 (118)
T d1tuza_          19 YMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLND   98 (118)
T ss_dssp             HHHHCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHH
T ss_pred             HcCCCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHH
Confidence            35678889999999997543   2578999999999998876432  346678889999999876        7799999


Q ss_pred             hHhHHHHhhccCcH
Q 009594          420 FVAVSVHLKKMAND  433 (531)
Q Consensus       420 f~~~~~~~~~~~~~  433 (531)
                      |+..+..+.....+
T Consensus        99 fv~~LS~l~~G~~e  112 (118)
T d1tuza_          99 VSCYFSLLEGGRPE  112 (118)
T ss_dssp             HHHHHHHHHSCCCS
T ss_pred             HHHHHHHHcCCCHH
Confidence            98877655444333

>d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Diacylglycerol kinase alpha, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.65  E-value=1.7e-05  Score=61.93  Aligned_cols=50  Identities=10%  Similarity=0.154  Sum_probs=24.5

Q ss_pred             CcceeHHHHHHHHhhcCC--CCCHHHHHHHHHhccCCCC--------cceeHHHHHHHHH
Q 009594          448 SGFIEIEELRNALNDEVD--TSGEDVINAIMHDVDTDKD--------GRISYEEFAVMMK  497 (531)
Q Consensus       448 ~G~i~~~el~~~l~~~~~--~~~~~~~~~~~~~~D~~~d--------G~i~~~Ef~~~~~  497 (531)
                      +|.|+.++|+.++..+..  ..+...++.+|..+|.|+|        |.|++.||+..|.
T Consensus        45 ~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~efv~~LS  104 (118)
T d1tuza_          45 GDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFS  104 (118)
T ss_dssp             TTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHHHHHHHH
Confidence            444555555554443321  1223444455555555443        6666666666554

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.04  E-value=0.00078  Score=64.71  Aligned_cols=75  Identities=15%  Similarity=0.104  Sum_probs=52.6

Q ss_pred             ccccCccCceEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCCeeecceEEEcCCeEE
Q 009594           61 GRELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH  133 (531)
Q Consensus        61 ~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  133 (531)
                      ++.|+.|-.-.+|++....       .+..|.+++....  ..   .....+|..+++.+..+.-.+++++++.+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            3578889999999988643       2456777776421  12   23456899999998666556678777643    5


Q ss_pred             EEEeccCCCch
Q 009594          134 IVMELCEGGEL  144 (531)
Q Consensus       134 lv~e~~~~~~L  144 (531)
                      +|+||++|.+|
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            78999998655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.04  E-value=0.0012  Score=61.52  Aligned_cols=73  Identities=12%  Similarity=0.160  Sum_probs=46.7

Q ss_pred             cCceEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-Ceeecc-----eEEEcCCeEEEEEeccC
Q 009594           67 GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-NIVSLK-----DTYEDDSAVHIVMELCE  140 (531)
Q Consensus        67 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~-----~~~~~~~~~~lv~e~~~  140 (531)
                      +.--.||++.. .+|+.+++|+......    ..+.+..|+..+..|..+. -++..+     ..+...+..+.++++++
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            33457999884 6788999999865422    2456778888888773221 112211     12345677889999998


Q ss_pred             CCch
Q 009594          141 GGEL  144 (531)
Q Consensus       141 ~~~L  144 (531)
                      |..+
T Consensus       108 G~~~  111 (325)
T d1zyla1         108 GRQF  111 (325)
T ss_dssp             CEEC
T ss_pred             CcCC
Confidence            7543

>d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Osteonectin
domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.03  E-value=8.2e-05  Score=59.54  Aligned_cols=61  Identities=21%  Similarity=0.295  Sum_probs=45.3

Q ss_pred             HHHHhhcccCCC-CCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          435 HLHKAFSFFDRN-RSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       435 ~~~~~F~~~D~~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      .+...|..+|.| .||.|+..|+..+.+.+  ...+.=++.+++..|.|+||.||+.||..++.
T Consensus        78 ~v~W~F~~LD~n~~D~~L~~~EL~~l~~~L--~~~e~C~~~F~~~CD~n~D~~Is~~EW~~Cf~  139 (151)
T d1sraa_          78 PVHWQFGQLDQHPIDGYLSHTELAPLRAPL--IPMEHCTTRFFETCDLDNDKYIALDEWAGCFG  139 (151)
T ss_dssp             HHHHHHHHHCCTTCSSEECTTTTGGGGSTT--STTGGGHHHHHHHHCTTCSSSEEHHHHHHHTT
T ss_pred             cceeehhhcCCCCCCCccCHHHHHHHHHhh--cCCchHHHHHHHHhcCCCCCcCCHHHHHHHcC
Confidence            356778888888 48888888888765433  12233377788888888888888888888876

>d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Osteonectin
domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.97  E-value=0.021  Score=45.17  Aligned_cols=61  Identities=16%  Similarity=0.269  Sum_probs=47.0

Q ss_pred             HHHHHHHhcCCC-CCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHh
Q 009594          399 DLQILMEAADVD-GDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       399 ~~~~~f~~~D~~-~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~  461 (531)
                      -+...|..+|.| .||.|+..|...+...+  ...+.-++..|+..|.|+||.||..|+...|.
T Consensus        78 ~v~W~F~~LD~n~~D~~L~~~EL~~l~~~L--~~~e~C~~~F~~~CD~n~D~~Is~~EW~~Cf~  139 (151)
T d1sraa_          78 PVHWQFGQLDQHPIDGYLSHTELAPLRAPL--IPMEHCTTRFFETCDLDNDKYIALDEWAGCFG  139 (151)
T ss_dssp             HHHHHHHHHCCTTCSSEECTTTTGGGGSTT--STTGGGHHHHHHHHCTTCSSSEEHHHHHHHTT
T ss_pred             cceeehhhcCCCCCCCccCHHHHHHHHHhh--cCCchHHHHHHHHhcCCCCCcCCHHHHHHHcC
Confidence            466789999999 48999999987754211  23445577788889999999999999998874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.16  E-value=0.056  Score=49.27  Aligned_cols=30  Identities=33%  Similarity=0.528  Sum_probs=24.1

Q ss_pred             cCCeecCCCCCceEeecCCCCCCeEEEeecccc
Q 009594          176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSV  208 (531)
Q Consensus       176 ~~iiH~Dlkp~NIll~~~~~~~~ikl~Dfg~a~  208 (531)
                      .|+||+|+.+.||+++.+.   ..-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~---v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE---LSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE---EEEECCCTTCE
T ss_pred             cccccCCcchhhhhccccc---ceeEecccccc
Confidence            3799999999999997432   35789999875

>d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!)
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=94.93  E-value=0.02  Score=41.89  Aligned_cols=67  Identities=10%  Similarity=0.275  Sum_probs=52.9

Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhc-CC-CCCHHHHHHHHHhccCCC----CcceeHHHHHHHHHhC
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDE-VD-TSGEDVINAIMHDVDTDK----DGRISYEEFAVMMKAG  499 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~-~~-~~~~~~~~~~~~~~D~~~----dG~i~~~Ef~~~~~~~  499 (531)
                      ...++..+|..+-.+ .+.+|.++|..+|... +. ..+.+.+..+|..+..+.    .|.+|++.|..+|.+.
T Consensus         6 ~R~ei~~if~~ys~~-~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S~   78 (94)
T d1qasa1           6 QRAEIDRAFEEAAGS-AETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSA   78 (94)
T ss_dssp             CCHHHHHHHHHHHTT-SSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHSS
T ss_pred             ccHHHHHHHHHHhCC-CCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcCc
Confidence            345688899888544 4679999999999875 43 468888999999987653    3679999999999854

>d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=94.15  E-value=0.11  Score=33.49  Aligned_cols=72  Identities=21%  Similarity=0.278  Sum_probs=59.1

Q ss_pred             hhhhHHHhhHHHHhcccccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhc-CCCCC-CceecchhHhHHHH
Q 009594          355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAA-DVDGD-GSLNYGEFVAVSVH  426 (531)
Q Consensus       355 ~~~~~~~~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~-D~~~~-g~i~~~ef~~~~~~  426 (531)
                      .+.+++.++-.++|+.||.+....-...+-..+|.++|...+..+.+.++++. .+.+| ..|.-+|++.+.+.
T Consensus         7 algpeekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkeargpkgdkknigpeewltlcsk   80 (86)
T d1j7qa_           7 ALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPEEWLTLCSK   80 (86)
T ss_dssp             CCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTTHHHHHHHH
T ss_pred             ccCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHhcCCCCccccCCHHHHHHHHHH
Confidence            34567788889999999999999999999999999999999999999998865 33333 35888898887643

>d1h8ba_ a.39.1.7 (A:) alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: alpha-Actinin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.92  E-value=0.072  Score=35.99  Aligned_cols=63  Identities=19%  Similarity=0.339  Sum_probs=49.1

Q ss_pred             cCcHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccC-----CCCcceeHHHHHHHHHhCc
Q 009594          430 MANDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDT-----DKDGRISYEEFAVMMKAGT  500 (531)
Q Consensus       430 ~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~-----~~dG~i~~~Ef~~~~~~~~  500 (531)
                      ..+.+.+..+|+.+ .++..+||.+||++.|       +.++++-++..+-.     -..|..+|..|.+.+-+..
T Consensus         4 ~~TaEqv~~aFr~l-A~~KpyVT~~dL~~~L-------~peqaeyc~~~M~~y~~~~~~~~ayDY~sF~~~l~ges   71 (73)
T d1h8ba_           4 TDTAEQVIASFRIL-ASDKPYILAEELRREL-------PPDQAQYCIKRMPAYSGPGSVPGALDYAAFSSALYGES   71 (73)
T ss_dssp             CSTHHHHHHHHHHH-TTSCSSBCHHHHHHHS-------CHHHHHHHHHHSCSCCCSSCCTTCBCHHHHHHHHTCCS
T ss_pred             cccHHHHHHHHHHH-hCCCCeeCHHHHHhhc-------CHHHHHHHHHHCcccCCCCCCCCcccHHHHHHHHhccc
Confidence            45678899999999 5678999999999865       56678888887732     2367899999998876543

>d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=92.01  E-value=0.32  Score=31.23  Aligned_cols=67  Identities=21%  Similarity=0.300  Sum_probs=54.9

Q ss_pred             cHHHHHHhhcccCCCCCcceeHHHHHHHHhhcCCCCCHHHHHHHHHhccC-CC-CcceeHHHHHHHHHh
Q 009594          432 NDEHLHKAFSFFDRNRSGFIEIEELRNALNDEVDTSGEDVINAIMHDVDT-DK-DGRISYEEFAVMMKA  498 (531)
Q Consensus       432 ~~~~~~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~-~~-dG~i~~~Ef~~~~~~  498 (531)
                      ..++...+|.+||.|....-...+-..+|..+|...+..+.+.++++.-- .+ ...|..+||+.++.+
T Consensus        12 ekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkeargpkgdkknigpeewltlcsk   80 (86)
T d1j7qa_          12 EKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPEEWLTLCSK   80 (86)
T ss_dssp             HHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTTHHHHHHHH
T ss_pred             hHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHhcCCCCccccCCHHHHHHHHHH
Confidence            34667889999999999999999999999999999999999999988733 22 234888999887764

>d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]}

class: All alpha proteins
fold: Type I dockerin domain
superfamily: Type I dockerin domain
family: Type I dockerin domain
domain: Endo-1,4-beta-xylanase Y
species: Clostridium thermocellum [TaxId: 1515]

Probab=91.25  E-value=0.18  Score=32.83  Aligned_cols=50  Identities=24%  Similarity=0.308  Sum_probs=27.0

Q ss_pred             CCCCCcceeHHHHHHHHhhc-CC-CCCHHHHHHHHHhccCCCCcceeHHHHHHHHH
Q 009594          444 DRNRSGFIEIEELRNALNDE-VD-TSGEDVINAIMHDVDTDKDGRISYEEFAVMMK  497 (531)
Q Consensus       444 D~~~~G~i~~~el~~~l~~~-~~-~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~  497 (531)
                      |.|+||.|+.-++..+..-+ +. .+++.    -+..+|.|+||.|+..+...+.+
T Consensus         2 DvN~Dg~vni~D~~~l~~~il~~~~~~~~----~~~aaDvn~Dg~i~i~D~~~l~~   53 (59)
T d2cclb1           2 DVNGDGTINSTDLTMLKRSVLRAITLTDD----AKARADVDKNGSINAADVLLLSR   53 (59)
T ss_dssp             CTTCSSSCCHHHHHHHHHHHTTSSCCCHH----HHHHHCTTCSSCCSHHHHHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHHhCCCCCChh----hhhccccCCCCCCCHHHHHHHHH
Confidence            55666666666666665433 22 22222    23446666666666666655443

>d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]}

class: All alpha proteins
fold: Type I dockerin domain
superfamily: Type I dockerin domain
family: Type I dockerin domain
domain: Endo-1,4-beta-xylanase Y
species: Clostridium thermocellum [TaxId: 1515]

Probab=90.38  E-value=0.19  Score=32.67  Aligned_cols=47  Identities=17%  Similarity=0.149  Sum_probs=24.9

Q ss_pred             cCCCCcceeHHHHHHHHHh----CchHHHHHhhhCccCCCcCCHHHHHHHH
Q 009594          480 DTDKDGRISYEEFAVMMKA----GTDWRKASRQYSRERFNSISLKLMREEG  526 (531)
Q Consensus       480 D~~~dG~i~~~Ef~~~~~~----~~~~~~~f~~~D~~~~G~i~~~e~~~~~  526 (531)
                      |.|+||.|+..+.+.+...    ...-...|...|.|+||.|+.-.+..++
T Consensus         2 DvN~Dg~vni~D~~~l~~~il~~~~~~~~~~~aaDvn~Dg~i~i~D~~~l~   52 (59)
T d2cclb1           2 DVNGDGTINSTDLTMLKRSVLRAITLTDDAKARADVDKNGSINAADVLLLS   52 (59)
T ss_dssp             CTTCSSSCCHHHHHHHHHHHTTSSCCCHHHHHHHCTTCSSCCSHHHHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHHhCCCCCChhhhhccccCCCCCCCHHHHHHHH
Confidence            4566666666665555441    1112334455666666666666555544

>d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!)
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=89.79  E-value=0.19  Score=36.32  Aligned_cols=62  Identities=18%  Similarity=0.140  Sum_probs=39.1

Q ss_pred             hhHHHHhcccccCCCCcccHHHHHHHHHhCCC--CCCHHHHHHHHHhcCCCC----CCceecchhHhHH
Q 009594          362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ--NIPEADLQILMEAADVDG----DGSLNYGEFVAVS  424 (531)
Q Consensus       362 ~~i~~~F~~~D~~~~g~i~~~el~~~l~~~~~--~~~~~~~~~~f~~~D~~~----~g~i~~~ef~~~~  424 (531)
                      .+|..+|..+-. +.+.++.++|...|..-..  ..+...+..++..+.++.    .+.++++.|...+
T Consensus         8 ~ei~~if~~ys~-~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL   75 (94)
T d1qasa1           8 AEIDRAFEEAAG-SAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYL   75 (94)
T ss_dssp             HHHHHHHHHHHT-TSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHH
T ss_pred             HHHHHHHHHHhC-CCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHH
Confidence            355666766643 3467888888888887533  345666777777775543    2456666666654

>d1dava_ a.139.1.1 (A:) Cellulosome endoglucanase SS {Clostridium thermocellum [TaxId: 1515]}

class: All alpha proteins
fold: Type I dockerin domain
superfamily: Type I dockerin domain
family: Type I dockerin domain
domain: Cellulosome endoglucanase SS
species: Clostridium thermocellum [TaxId: 1515]

Probab=87.61  E-value=0.055  Score=36.94  Aligned_cols=50  Identities=22%  Similarity=0.206  Sum_probs=24.6

Q ss_pred             CCCCCCceecchhHhHHHHhhccCcHHHHHHhhcccCCCCCcceeHHHHHHHHh
Q 009594          408 DVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAFSFFDRNRSGFIEIEELRNALN  461 (531)
Q Consensus       408 D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~el~~~l~  461 (531)
                      |.|+||.|+..+...+..........    .-+...|.|+||.|+..++..+.+
T Consensus         8 DvN~DG~Vd~~D~~~~~~~i~~~~~~----~~~~~aDvn~DG~Id~~D~~~l~~   57 (71)
T d1dava_           8 DVNDDGKVNSTDAVALKRYVLRSGIS----INTDNADLNEDGRVNSTDLGILKR   57 (71)
T ss_dssp             CSSSSSBSSGGGHHHHHHHHHCSCSC----CCGGGTCSSSSSSCSSHHHHHHHH
T ss_pred             ccCCCCCCcHHHHHHHHHHHcCCCCc----CCCcceecCCCCCcCHHHHHHHHH
Confidence            55666666666655554433222111    112235666666666655555544

>d1eg3a2 a.39.1.7 (A:210-306) Dystrophin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Dystrophin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.50  E-value=1.4  Score=31.26  Aligned_cols=66  Identities=15%  Similarity=0.203  Sum_probs=49.9

Q ss_pred             HHHHHHhhcccCCCCCcceeHHHHHHHHhh-------cCC------CCCHHHHHHHHHhccCCCCcceeHHHHHHHHHhC
Q 009594          433 DEHLHKAFSFFDRNRSGFIEIEELRNALND-------EVD------TSGEDVINAIMHDVDTDKDGRISYEEFAVMMKAG  499 (531)
Q Consensus       433 ~~~~~~~F~~~D~~~~G~i~~~el~~~l~~-------~~~------~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~~  499 (531)
                      .++++-+|+.+ .|.+|.++..-|..+|+.       +|+      ..-+..++.+|...  .+...|+.++|+.++...
T Consensus         3 ~dKyRYlF~qi-sd~~g~~~~~kl~~lL~d~lqlP~~vgE~~sFG~s~ie~sv~sCF~~~--~~~~~i~~~~FL~wl~~e   79 (97)
T d1eg3a2           3 EDKYRYLFKQV-ASSTGFCDQRRLGLLLHDSIQIPRQLGEVASFGGSNIEPSVRSCFQFA--NNKPEIEAALFLDWMRLE   79 (97)
T ss_dssp             HHHHHHHHHHH-SCTTSCBCHHHHHHHHHHHHHHHHHTTCGGGGTCSCCHHHHHHHHHHT--TTCSCBCHHHHHHHHHTC
T ss_pred             HHHHHHHHHHH-hCCCCCCcHHHHHHHHHHHHHHHHHhCcccccCCCcchHHHHHHHhcc--CCCCcccHHHHHHHHHhC
Confidence            46788899988 688999999999998874       233      33367788888764  344569999999999876


Q ss_pred             ch
Q 009594          500 TD  501 (531)
Q Consensus       500 ~~  501 (531)
                      +.
T Consensus        80 Pq   81 (97)
T d1eg3a2          80 PQ   81 (97)
T ss_dssp             CT
T ss_pred             CC
Confidence            43

>d1eg3a1 a.39.1.7 (A:85-209) Dystrophin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Dystrophin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.94  E-value=0.93  Score=34.06  Aligned_cols=80  Identities=11%  Similarity=0.220  Sum_probs=52.6

Q ss_pred             hhHHHHhcccccC-CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHHHHhhccCcHHHHHHhh
Q 009594          362 AGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVSVHLKKMANDEHLHKAF  440 (531)
Q Consensus       362 ~~i~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  440 (531)
                      ..+.++|+....+ ++..++..++..++..            +|..+.+...+.|+.+..+.+.           +.+..
T Consensus        43 ~~~~e~f~~~~l~~~d~~l~v~~l~~~L~~------------iy~~l~~~~~~~v~vp~~~dl~-----------LN~Ll   99 (125)
T d1eg3a1          43 SAACDALDQHNLKQNDQPMDILQIINCLTT------------IYDRLEQEHNNLVNVPLCVDMC-----------LNWLL   99 (125)
T ss_dssp             HHHHHHHHHTTCCCTTSEEEHHHHHHHHHH------------HHHHHHHHSTTTCCHHHHHHHH-----------HHHHH
T ss_pred             HHHHHHHHHcCCCCCccCCCHHHHHHHHHH------------HHHHhhhhCcccCChHHHHHHH-----------HHHHH
Confidence            3455666543332 3457888888777654            4554444444556555544433           56788


Q ss_pred             cccCCCCCcceeHHHHHHHHhhcC
Q 009594          441 SFFDRNRSGFIEIEELRNALNDEV  464 (531)
Q Consensus       441 ~~~D~~~~G~i~~~el~~~l~~~~  464 (531)
                      ..||.+++|+|+.-.++..|..+.
T Consensus       100 nvYD~~rtG~i~vls~KvaL~~LC  123 (125)
T d1eg3a1         100 NVYDTGRTGRIRVLSFKTGIISLC  123 (125)
T ss_dssp             HHHCTTCCSEEEHHHHHHHHHHTS
T ss_pred             HHhCCCCCCeeeehHHHHHHHHHh
Confidence            999999999999999999886653

>d1dava_ a.139.1.1 (A:) Cellulosome endoglucanase SS {Clostridium thermocellum [TaxId: 1515]}

class: All alpha proteins
fold: Type I dockerin domain
superfamily: Type I dockerin domain
family: Type I dockerin domain
domain: Cellulosome endoglucanase SS
species: Clostridium thermocellum [TaxId: 1515]

Probab=84.19  E-value=0.26  Score=33.33  Aligned_cols=49  Identities=20%  Similarity=0.194  Sum_probs=22.0

Q ss_pred             ccCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHhcCCCCCCceecchhHhHH
Q 009594          372 DTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAADVDGDGSLNYGEFVAVS  424 (531)
Q Consensus       372 D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~ef~~~~  424 (531)
                      |.|+||.++..|+..++..+-...+..+    +...|.|+||.|+..++..+.
T Consensus         8 DvN~DG~Vd~~D~~~~~~~i~~~~~~~~----~~~aDvn~DG~Id~~D~~~l~   56 (71)
T d1dava_           8 DVNDDGKVNSTDAVALKRYVLRSGISIN----TDNADLNEDGRVNSTDLGILK   56 (71)
T ss_dssp             CSSSSSBSSGGGHHHHHHHHHCSCSCCC----GGGTCSSSSSSCSSHHHHHHH
T ss_pred             ccCCCCCCcHHHHHHHHHHHcCCCCcCC----CcceecCCCCCcCHHHHHHHH
Confidence            4555555555555444444311111111    123455555555555554443

>d1wlma1 a.39.1.11 (A:8-145) Protein cgi-38 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: p25-alpha
domain: Protein cgi-38
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=82.51  E-value=2  Score=32.91  Aligned_cols=62  Identities=16%  Similarity=0.267  Sum_probs=45.8

Q ss_pred             HHhhcccCC-CCCc-ceeHHHHHHHHhhcC----CCCCHHHHHHHHHhccCCCCcceeHHHHHHHHHh
Q 009594          437 HKAFSFFDR-NRSG-FIEIEELRNALNDEV----DTSGEDVINAIMHDVDTDKDGRISYEEFAVMMKA  498 (531)
Q Consensus       437 ~~~F~~~D~-~~~G-~i~~~el~~~l~~~~----~~~~~~~~~~~~~~~D~~~dG~i~~~Ef~~~~~~  498 (531)
                      -..|..|.. ..+| .++...|..+++..+    ..++..+++.+|..+-.-+...|+|++|...|..
T Consensus        14 F~~F~~fG~~k~~~~~m~~~~f~K~~kd~~lid~K~~T~t~~diiF~k~k~k~~r~i~f~~F~~aL~~   81 (138)
T d1wlma1          14 FRKFAIHGDPKASGQEMNGKNWAKLCKDCKVADGKAVTGTDVDIVFSKVKAKSARVINYEEFKKALEE   81 (138)
T ss_dssp             HHHHHTSSCSSCCSSEEEHHHHHHHHHHTSCCCSSSSCHHHHHHHHHHHSCSSCSEEEHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCcccCCHHHHHHHHHHcCCCcCCccchhhHHHHHHHhhcCCCcccCHHHHHHHHHH
Confidence            344445543 1232 499999999998753    3588899999999986566778999999988864